Citrus Sinensis ID: 008785
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 553 | 2.2.26 [Sep-21-2011] | |||||||
| Q9C823 | 552 | C-type lectin receptor-li | yes | no | 0.813 | 0.815 | 0.649 | 1e-163 | |
| Q9LS95 | 700 | Putative proline-rich rec | no | no | 0.390 | 0.308 | 0.450 | 2e-44 | |
| Q1PEM5 | 513 | Proline-rich receptor-lik | no | no | 0.471 | 0.508 | 0.384 | 5e-44 | |
| Q9XI96 | 699 | Proline-rich receptor-lik | no | no | 0.397 | 0.314 | 0.442 | 1e-43 | |
| C0LGG7 | 953 | Probable LRR receptor-lik | no | no | 0.462 | 0.268 | 0.376 | 3e-43 | |
| Q9FN37 | 1036 | Phytosulfokine receptor 2 | no | no | 0.386 | 0.206 | 0.422 | 6e-43 | |
| Q9FE20 | 456 | Serine/threonine-protein | no | no | 0.379 | 0.460 | 0.448 | 8e-43 | |
| Q9LK03 | 717 | Proline-rich receptor-lik | no | no | 0.399 | 0.308 | 0.417 | 1e-42 | |
| Q9FLV4 | 872 | G-type lectin S-receptor- | no | no | 0.468 | 0.297 | 0.365 | 2e-42 | |
| C0LGD7 | 953 | Probable LRR receptor-lik | no | no | 0.455 | 0.264 | 0.392 | 3e-42 |
| >sp|Q9C823|Y1523_ARATH C-type lectin receptor-like tyrosine-protein kinase At1g52310 OS=Arabidopsis thaliana GN=At1g52310 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 575 bits (1483), Expect = e-163, Method: Compositional matrix adjust.
Identities = 298/459 (64%), Positives = 356/459 (77%), Gaps = 9/459 (1%)
Query: 13 QCFLLLVAYYVLQLVASDTISNQSSNGQLAASMNK-DWKAPCPPDWIINEEKSKCFGYIG 71
Q L+ +L L + DTIS +S+ Q A K CPPDWII ++KC+ Y
Sbjct: 11 QSLFLISCLALLCLASLDTISCEST--QNATDFKKRSQTVSCPPDWIIGPNQTKCYAYFK 68
Query: 72 NFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINT-TVGLSWKW 130
N SW++SE +C+ GGHLA+L S +E QKLC NV+ CW+GGRS+N+ T G W W
Sbjct: 69 NSTSWEKSEMFCRTYGGHLASLASSKELSFVQKLCNGNVSSCWIGGRSMNSSTSGFRWSW 128
Query: 131 SD-NMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICM 189
SD +WN+S+ + C + ++C V+NGS S+ ERCN SH F+C
Sbjct: 129 SDPKTPQWNQSMFPKVPIRTRCGNGNGSSSCRANICIAVTNGSSSIFGERCNASHAFVCA 188
Query: 190 VEHENKCYYLHCHREYLITLGVVSGLILLTTFAIVIWLLAYRRSKRRRKSRKLSNPAASA 249
V+ + KC +CH+ YL+ L VVSGLIL TTFAI++WLL Y+RSK+RRKSRK+SNPA+S+
Sbjct: 189 VDSDIKCR--NCHK-YLVILAVVSGLILFTTFAIILWLLVYKRSKKRRKSRKVSNPASSS 245
Query: 250 LVPPS-WKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQR 308
V P WK+FT+EELRS+TKNFSE NRL GD+KTGGTYSG L DG++VAVKRLKRSSFQR
Sbjct: 246 SVVPPSWKIFTSEELRSMTKNFSEANRLAGDAKTGGTYSGGLSDGTKVAVKRLKRSSFQR 305
Query: 309 KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDW 368
KKEFYSEI R A+L+HPN+VA+KGCCYDHG+R+IVYEF+ +GPLDRWLHH+PRGGRSLDW
Sbjct: 306 KKEFYSEIRRAAKLYHPNVVAIKGCCYDHGERFIVYEFIASGPLDRWLHHVPRGGRSLDW 365
Query: 369 AMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ 428
MR+ +ATTLAQGIAFLHDKVKP VVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ
Sbjct: 366 NMRLNIATTLAQGIAFLHDKVKPQVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ 425
Query: 429 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEI 467
ERTVMAGGTYGYLAPE+VYRNELTTKSDVYSFGVLLLEI
Sbjct: 426 ERTVMAGGTYGYLAPEYVYRNELTTKSDVYSFGVLLLEI 464
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 0EC: .EC: 1 |
| >sp|Q9LS95|PERK6_ARATH Putative proline-rich receptor-like protein kinase PERK6 OS=Arabidopsis thaliana GN=PERK6 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 181 bits (458), Expect = 2e-44, Method: Compositional matrix adjust.
Identities = 100/222 (45%), Positives = 140/222 (63%), Gaps = 6/222 (2%)
Query: 257 VFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEI 316
FT +EL + T+ FS+ +RLLG G + GILP+G +AVK LK S Q ++EF +E+
Sbjct: 324 TFTYDELAAATQGFSQ-SRLLGQGGFGYVHKGILPNGKEIAVKSLKAGSGQGEREFQAEV 382
Query: 317 GRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVAT 376
+R+HH LV++ G C G R +VYEF+ N L+ LH + G+ LDW R+K+A
Sbjct: 383 DIISRVHHRFLVSLVGYCIAGGQRMLVYEFLPNDTLEFHLHG--KSGKVLDWPTRLKIAL 440
Query: 377 TLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGG 436
A+G+A+LH+ P ++HRDI+ASN+LLDE F A + GL+K V T + G
Sbjct: 441 GSAKGLAYLHEDCHPRIIHRDIKASNILLDESFEAKVADFGLAKLSQDNVTHVSTRIM-G 499
Query: 437 TYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVLCRRWWTL 478
T+GYLAPE+ +LT +SDV+SFGV+LLE LV RR L
Sbjct: 500 TFGYLAPEYASSGKLTDRSDVFSFGVMLLE--LVTGRRPVDL 539
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q1PEM5|PERK3_ARATH Proline-rich receptor-like protein kinase PERK3 OS=Arabidopsis thaliana GN=PERK3 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 179 bits (454), Expect = 5e-44, Method: Compositional matrix adjust.
Identities = 103/268 (38%), Positives = 158/268 (58%), Gaps = 7/268 (2%)
Query: 207 ITLGVVSGLILLTTFAIVIWLLAYRRSKRRRKSRKLSNPAASALVPPSWKVFTTEELRSI 266
++ G V G+ + ++ + + KR R + L P L FT EL
Sbjct: 121 LSTGAVVGISIGGGVFVLTLIFFLCKKKRPRDDKALPAPIGLVL-GIHQSTFTYGELARA 179
Query: 267 TKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPN 326
T FSE N LLG+ G Y GIL +G+ VAVK+LK S Q +KEF +E+ +++HH N
Sbjct: 180 TNKFSEAN-LLGEGGFGFVYKGILNNGNEVAVKQLKVGSAQGEKEFQAEVNIISQIHHRN 238
Query: 327 LVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLH 386
LV++ G C R +VYEFV N L+ LH +G +++W++R+K+A + ++G+++LH
Sbjct: 239 LVSLVGYCIAGAQRLLVYEFVPNNTLEFHLHG--KGRPTMEWSLRLKIAVSSSKGLSYLH 296
Query: 387 DKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFV 446
+ P ++HRDI+A+N+L+D +F A + GL+K + + + GT+GYLAPE+
Sbjct: 297 ENCNPKIIHRDIKAANILIDFKFEAKVADFGLAK-IALDTNTHVSTRVMGTFGYLAPEYA 355
Query: 447 YRNELTTKSDVYSFGVLLLEIRLVLCRR 474
+LT KSDVYSFGV+LLE L+ RR
Sbjct: 356 ASGKLTEKSDVYSFGVVLLE--LITGRR 381
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9XI96|PERK7_ARATH Proline-rich receptor-like protein kinase PERK7 OS=Arabidopsis thaliana GN=PERK7 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 178 bits (451), Expect = 1e-43, Method: Compositional matrix adjust.
Identities = 104/235 (44%), Positives = 144/235 (61%), Gaps = 15/235 (6%)
Query: 243 SNPAASALVPPSWKV--------FTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGS 294
S P A +L PP V FT EEL S T+ FS+ +RLLG G + GILP+G
Sbjct: 301 SGPYAPSLPPPHPSVALGFNNSTFTYEELASATQGFSK-DRLLGQGGFGYVHKGILPNGK 359
Query: 295 RVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD-HGDRYIVYEFVVNGPLD 353
+AVK LK S Q ++EF +E+ +R+HH +LV++ G C + G R +VYEF+ N L+
Sbjct: 360 EIAVKSLKAGSGQGEREFQAEVEIISRVHHRHLVSLVGYCSNAGGQRLLVYEFLPNDTLE 419
Query: 354 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHL 413
LH + G +DW R+K+A A+G+A+LH+ P ++HRDI+ASN+LLD F A +
Sbjct: 420 FHLHG--KSGTVMDWPTRLKIALGSAKGLAYLHEDCHPKIIHRDIKASNILLDHNFEAKV 477
Query: 414 MGVGLSKFVPWEVMQERT-VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEI 467
GL+K T VM GT+GYLAPE+ +LT KSDV+SFGV+LLE+
Sbjct: 478 ADFGLAKLSQDNNTHVSTRVM--GTFGYLAPEYASSGKLTEKSDVFSFGVMLLEL 530
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGG7|Y1534_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g53420 OS=Arabidopsis thaliana GN=At1g53420 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 176 bits (447), Expect = 3e-43, Method: Compositional matrix adjust.
Identities = 99/263 (37%), Positives = 152/263 (57%), Gaps = 7/263 (2%)
Query: 207 ITLGVVSGLILLTTFAIVIWLLA--YRRSKRRRKSRKLSNPAASALVPPSWKVFTTEELR 264
++ G + L+++ + IV + +++ R KS+ + + L+ S F+ +++
Sbjct: 562 MSTGTLHTLVVILSIFIVFLVFGTLWKKGYLRSKSQMEKDFKSLELMIAS---FSLRQIK 618
Query: 265 SITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHH 324
T NF NR+ G+ G Y G L DG+ +AVK+L S Q +EF +EIG + LHH
Sbjct: 619 IATNNFDSANRI-GEGGFGPVYKGKLFDGTIIAVKQLSTGSKQGNREFLNEIGMISALHH 677
Query: 325 PNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAF 384
PNLV + GCC + G +VYEFV N L R L LDW R K+ +A+G+A+
Sbjct: 678 PNLVKLYGCCVEGGQLLLVYEFVENNSLARALFGPQETQLRLDWPTRRKICIGVARGLAY 737
Query: 385 LHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPE 444
LH++ + +VHRDI+A+NVLLD++ + GL+K + T +A GT+GY+APE
Sbjct: 738 LHEESRLKIVHRDIKATNVLLDKQLNPKISDFGLAKLDEEDSTHISTRIA-GTFGYMAPE 796
Query: 445 FVYRNELTTKSDVYSFGVLLLEI 467
+ R LT K+DVYSFG++ LEI
Sbjct: 797 YAMRGHLTDKADVYSFGIVALEI 819
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FN37|PSKR2_ARATH Phytosulfokine receptor 2 OS=Arabidopsis thaliana GN=PSKR2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 176 bits (445), Expect = 6e-43, Method: Compositional matrix adjust.
Identities = 93/220 (42%), Positives = 135/220 (61%), Gaps = 6/220 (2%)
Query: 256 KVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSE 315
K + EEL T NFS+ N ++G G Y PDGS+ AVKRL Q ++EF +E
Sbjct: 740 KDLSVEELLKSTNNFSQAN-IIGCGGFGLVYKANFPDGSKAAVKRLSGDCGQMEREFQAE 798
Query: 316 IGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVA 375
+ +R H NLV+++G C DR ++Y F+ NG LD WLH G +L W +R+K+A
Sbjct: 799 VEALSRAEHKNLVSLQGYCKHGNDRLLIYSFMENGSLDYWLHERVDGNMTLIWDVRLKIA 858
Query: 376 TTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV-PWEVMQERTVMA 434
A+G+A+LH +P+V+HRD+++SN+LLDE+F AHL GL++ + P++ ++
Sbjct: 859 QGAARGLAYLHKVCEPNVIHRDVKSSNILLDEKFEAHLADFGLARLLRPYDTHVTTDLV- 917
Query: 435 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVLCRR 474
GT GY+ PE+ T + DVYSFGV+LLE LV RR
Sbjct: 918 -GTLGYIPPEYSQSLIATCRGDVYSFGVVLLE--LVTGRR 954
|
Phytosulfokine receptor with a serine/threonine-protein kinase activity. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FE20|PBS1_ARATH Serine/threonine-protein kinase PBS1 OS=Arabidopsis thaliana GN=PBS1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 175 bits (444), Expect = 8e-43, Method: Compositional matrix adjust.
Identities = 95/212 (44%), Positives = 123/212 (58%), Gaps = 2/212 (0%)
Query: 257 VFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSE 315
F EL + T NF + LG+ G Y G L G VAVK+L R+ Q +EF E
Sbjct: 73 TFAFRELAAATMNFHP-DTFLGEGGFGRVYKGRLDSTGQVVAVKQLDRNGLQGNREFLVE 131
Query: 316 IGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVA 375
+ + LHHPNLV + G C D R +VYEF+ G L+ LH +P +LDW MRMK+A
Sbjct: 132 VLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNMRMKIA 191
Query: 376 TTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG 435
A+G+ FLHDK P V++RD ++SN+LLDE F L GL+K P +
Sbjct: 192 AGAAKGLEFLHDKANPPVIYRDFKSSNILLDEGFHPKLSDFGLAKLGPTGDKSHVSTRVM 251
Query: 436 GTYGYLAPEFVYRNELTTKSDVYSFGVLLLEI 467
GTYGY APE+ +LT KSDVYSFGV+ LE+
Sbjct: 252 GTYGYCAPEYAMTGQLTVKSDVYSFGVVFLEL 283
|
Protein kinase required for plant defense mechanism mediated by the disease resistance (R) protein RPS5. In case of infection by Pseudomonas syringae, RPS5 specifically recognizes the avrPphB type III effector avirulence protein and triggers a defense reaction. AvrPphB may trigger RPS5-mediated defense mechanism via the cleavage of PBS1. Both kinase activity and cleavage by avrPphB are independently required to trigger the RPS5-mediated resistance. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LK03|PERK2_ARATH Proline-rich receptor-like protein kinase PERK2 OS=Arabidopsis thaliana GN=PERK2 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 174 bits (442), Expect = 1e-42, Method: Compositional matrix adjust.
Identities = 99/237 (41%), Positives = 142/237 (59%), Gaps = 16/237 (6%)
Query: 248 SALVPPS----------WKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVA 297
S L PPS F EEL T FSE N LLG G + G+L +G VA
Sbjct: 322 SVLPPPSPGLALGLGIYQGTFNYEELSRATNGFSEAN-LLGQGGFGYVFKGMLRNGKEVA 380
Query: 298 VKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLH 357
VK+LK S Q ++EF +E+G +R+HH +LVA+ G C R +VYEFV N L+ LH
Sbjct: 381 VKQLKEGSSQGEREFQAEVGIISRVHHRHLVALVGYCIADAQRLLVYEFVPNNTLEFHLH 440
Query: 358 HIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVG 417
+G +++W+ R+K+A A+G+++LH+ P ++HRDI+ASN+L+D +F A + G
Sbjct: 441 G--KGRPTMEWSSRLKIAVGSAKGLSYLHENCNPKIIHRDIKASNILIDFKFEAKVADFG 498
Query: 418 LSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVLCRR 474
L+K + + + GT+GYLAPE+ +LT KSDV+SFGV+LLE L+ RR
Sbjct: 499 LAK-IASDTNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVVLLE--LITGRR 552
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FLV4|Y5248_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At5g24080 OS=Arabidopsis thaliana GN=At5g24080 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 174 bits (440), Expect = 2e-42, Method: Compositional matrix adjust.
Identities = 98/268 (36%), Positives = 152/268 (56%), Gaps = 9/268 (3%)
Query: 200 HCHREYLITLGVVSGLILLTTFAIVIWLLAYRRSKRRRKSRKLSNPAASALVPPSWKVFT 259
H R+ ++ + +V G+++L A++ LL Y ++R R N S ++ S FT
Sbjct: 467 HGLRQKVLVIPIVVGMLVLV--ALLGMLLYYNLDRKRTLKRAAKN---SLILCDSPVSFT 521
Query: 260 TEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRF 319
+L++ T NFS+ LLG G Y G + + VAVKRL R+ ++EF +E+
Sbjct: 522 YRDLQNCTNNFSQ---LLGSGGFGTVYKGTVAGETLVAVKRLDRALSHGEREFITEVNTI 578
Query: 320 ARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLA 379
+HH NLV + G C + R +VYE+++NG LD+W+ + LDW R ++A A
Sbjct: 579 GSMHHMNLVRLCGYCSEDSHRLLVYEYMINGSLDKWIFSSEQTANLLDWRTRFEIAVATA 638
Query: 380 QGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYG 439
QGIA+ H++ + ++H DI+ N+LLD+ F + GL+K + E M GT G
Sbjct: 639 QGIAYFHEQCRNRIIHCDIKPENILLDDNFCPKVSDFGLAKMMGRE-HSHVVTMIRGTRG 697
Query: 440 YLAPEFVYRNELTTKSDVYSFGVLLLEI 467
YLAPE+V +T K+DVYS+G+LLLEI
Sbjct: 698 YLAPEWVSNRPITVKADVYSYGMLLLEI 725
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGD7|Y1684_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g06840 OS=Arabidopsis thaliana GN=At1g06840 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 173 bits (439), Expect = 3e-42, Method: Compositional matrix adjust.
Identities = 106/270 (39%), Positives = 151/270 (55%), Gaps = 18/270 (6%)
Query: 207 ITLGVVSGLILLTTF-AIVIW---LLAYRRSKRRRKSRKLSNPAASALVPPSWKVFTTEE 262
I LG V+ + LT A++I + Y RR++S K S L K FT E
Sbjct: 564 IVLGSVAAAVTLTAIIALIIMRKRMRGYSAVARRKRSSKAS------LKIEGVKSFTYAE 617
Query: 263 LRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL 322
L T NF+ ++ G G Y G L G+ VA+KR + S Q +KEF +EI +RL
Sbjct: 618 LALATDNFNSSTQI-GQGGYGKVYKGTLGSGTVVAIKRAQEGSLQGEKEFLTEIELLSRL 676
Query: 323 HHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGI 382
HH NLV++ G C + G++ +VYE++ NG L + + LD+AMR+++A A+GI
Sbjct: 677 HHRNLVSLLGFCDEEGEQMLVYEYMENGTLRDNISV--KLKEPLDFAMRLRIALGSAKGI 734
Query: 383 AFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM-----QERTVMAGGT 437
+LH + P + HRDI+ASN+LLD F A + GLS+ P M Q + + GT
Sbjct: 735 LYLHTEANPPIFHRDIKASNILLDSRFTAKVADFGLSRLAPVPDMEGISPQHVSTVVKGT 794
Query: 438 YGYLAPEFVYRNELTTKSDVYSFGVLLLEI 467
GYL PE+ ++LT KSDVYS GV+LLE+
Sbjct: 795 PGYLDPEYFLTHQLTDKSDVYSLGVVLLEL 824
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 553 | ||||||
| 297745082 | 517 | unnamed protein product [Vitis vinifera] | 0.820 | 0.878 | 0.765 | 0.0 | |
| 225455058 | 542 | PREDICTED: C-type lectin receptor-like t | 0.817 | 0.833 | 0.768 | 0.0 | |
| 255556651 | 552 | kinase, putative [Ricinus communis] gi|2 | 0.835 | 0.836 | 0.758 | 0.0 | |
| 224137796 | 516 | predicted protein [Populus trichocarpa] | 0.746 | 0.800 | 0.792 | 0.0 | |
| 449503381 | 557 | PREDICTED: C-type lectin receptor-like t | 0.830 | 0.824 | 0.677 | 0.0 | |
| 449454927 | 557 | PREDICTED: C-type lectin receptor-like t | 0.830 | 0.824 | 0.675 | 0.0 | |
| 356558437 | 547 | PREDICTED: C-type lectin receptor-like t | 0.788 | 0.797 | 0.690 | 1e-171 | |
| 356532800 | 545 | PREDICTED: C-type lectin receptor-like t | 0.788 | 0.8 | 0.681 | 1e-170 | |
| 294460294 | 550 | unknown [Picea sitchensis] | 0.748 | 0.752 | 0.660 | 1e-166 | |
| 115434006 | 555 | Os01g0104000 [Oryza sativa Japonica Grou | 0.748 | 0.745 | 0.694 | 1e-165 |
| >gi|297745082|emb|CBI38674.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 713 bits (1840), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 356/465 (76%), Positives = 394/465 (84%), Gaps = 11/465 (2%)
Query: 3 LLMEKKLVPLQCFLLLVAYYVLQLVASDTISNQSSNGQLAASMNKDWKAPCPPDWIINEE 62
+ ME KLV LQ LL+++ V QL ASD I ++S S+ +A CPPDWI +
Sbjct: 13 VFMEGKLVRLQFPLLVISCLVFQLRASDAILHESRR-----SLESRKEALCPPDWITGPD 67
Query: 63 KSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINT 122
K+KCF YIGN +SWD SE YCK +GGHLAALTS++E S Q LCG++ NGCWVGGR +N+
Sbjct: 68 KNKCFRYIGNPQSWDVSEAYCKSLGGHLAALTSFQELSSVQNLCGESNNGCWVGGRGVNS 127
Query: 123 TVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNT 182
T G WKWSDN S WNESI +CT+ CH+ +VD CTLV+NGS L+ ERCN
Sbjct: 128 TFGAGWKWSDNTSHWNESIFP------NCTNSSCHIKNSVDSCTLVTNGSTFLIGERCNM 181
Query: 183 SHPFICMVEHENKCYYLHCHREYLITLGVVSGLILLTTFAIVIWLLAYRRSKRRRKSRKL 242
SH ICM++ ENKCY++HCH+EYLI L VVSGLIL TT A+VIWLLAYRRSKRRR+SRKL
Sbjct: 182 SHASICMIDIENKCYHMHCHKEYLIILAVVSGLILSTTLAVVIWLLAYRRSKRRRRSRKL 241
Query: 243 SNPAASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLK 302
SNPAASALVPPSWKVFT EELRSITKNFSEGNRLLGD+KTGGTYSG+LPDGSRVAVKRLK
Sbjct: 242 SNPAASALVPPSWKVFTNEELRSITKNFSEGNRLLGDAKTGGTYSGLLPDGSRVAVKRLK 301
Query: 303 RSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRG 362
RS+FQRKKEFYSEIGR ARLHHPNLVAVKGCCYDHGDRYIVYEF++NGPLDRWLHHIPRG
Sbjct: 302 RSTFQRKKEFYSEIGRVARLHHPNLVAVKGCCYDHGDRYIVYEFIINGPLDRWLHHIPRG 361
Query: 363 GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV 422
GRSLDWAMRMK+ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV
Sbjct: 362 GRSLDWAMRMKIATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV 421
Query: 423 PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEI 467
WEVM + TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEI
Sbjct: 422 SWEVMHQGTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEI 466
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225455058|ref|XP_002263812.1| PREDICTED: C-type lectin receptor-like tyrosine-protein kinase At1g52310-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 712 bits (1839), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 356/463 (76%), Positives = 393/463 (84%), Gaps = 11/463 (2%)
Query: 5 MEKKLVPLQCFLLLVAYYVLQLVASDTISNQSSNGQLAASMNKDWKAPCPPDWIINEEKS 64
ME KLV LQ LL+++ V QL ASD I ++S S+ +A CPPDWI +K+
Sbjct: 1 MEGKLVRLQFPLLVISCLVFQLRASDAILHESRR-----SLESRKEALCPPDWITGPDKN 55
Query: 65 KCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTV 124
KCF YIGN +SWD SE YCK +GGHLAALTS++E S Q LCG++ NGCWVGGR +N+T
Sbjct: 56 KCFRYIGNPQSWDVSEAYCKSLGGHLAALTSFQELSSVQNLCGESNNGCWVGGRGVNSTF 115
Query: 125 GLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSH 184
G WKWSDN S WNESI +CT+ CH+ +VD CTLV+NGS L+ ERCN SH
Sbjct: 116 GAGWKWSDNTSHWNESIFP------NCTNSSCHIKNSVDSCTLVTNGSTFLIGERCNMSH 169
Query: 185 PFICMVEHENKCYYLHCHREYLITLGVVSGLILLTTFAIVIWLLAYRRSKRRRKSRKLSN 244
ICM++ ENKCY++HCH+EYLI L VVSGLIL TT A+VIWLLAYRRSKRRR+SRKLSN
Sbjct: 170 ASICMIDIENKCYHMHCHKEYLIILAVVSGLILSTTLAVVIWLLAYRRSKRRRRSRKLSN 229
Query: 245 PAASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRS 304
PAASALVPPSWKVFT EELRSITKNFSEGNRLLGD+KTGGTYSG+LPDGSRVAVKRLKRS
Sbjct: 230 PAASALVPPSWKVFTNEELRSITKNFSEGNRLLGDAKTGGTYSGLLPDGSRVAVKRLKRS 289
Query: 305 SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGR 364
+FQRKKEFYSEIGR ARLHHPNLVAVKGCCYDHGDRYIVYEF++NGPLDRWLHHIPRGGR
Sbjct: 290 TFQRKKEFYSEIGRVARLHHPNLVAVKGCCYDHGDRYIVYEFIINGPLDRWLHHIPRGGR 349
Query: 365 SLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW 424
SLDWAMRMK+ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV W
Sbjct: 350 SLDWAMRMKIATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVSW 409
Query: 425 EVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEI 467
EVM + TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEI
Sbjct: 410 EVMHQGTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEI 452
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255556651|ref|XP_002519359.1| kinase, putative [Ricinus communis] gi|223541426|gb|EEF42976.1| kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 696 bits (1796), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 351/463 (75%), Positives = 386/463 (83%), Gaps = 1/463 (0%)
Query: 5 MEKKLVPLQCFLLLVAYYVLQLVASDTISNQSSNGQLAASMNKDWKAPCPPDWIINEEKS 64
M+ KL LQ +LL+A VL VA + ISN + + L AS N+ K C W I+ K
Sbjct: 1 MDLKLTHLQFSVLLIAV-VLSFVAPENISNDTIHSPLIASRNESNKGWCHSGWDISPNKK 59
Query: 65 KCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTV 124
KC Y +SWD+SE C GGHLAALTS +E A++LCG+ V+GCWVG R IN+TV
Sbjct: 60 KCLKYFEKSKSWDDSEALCASYGGHLAALTSSQELTFAKQLCGQIVDGCWVGERVINSTV 119
Query: 125 GLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSH 184
G +WKW DN S WNESI + SF+S CT+L CH +AT + CTLV+N + LV ERCN SH
Sbjct: 120 GSNWKWFDNTSYWNESILSGASFDSKCTNLSCHNNATAEFCTLVNNRTTHLVDERCNKSH 179
Query: 185 PFICMVEHENKCYYLHCHREYLITLGVVSGLILLTTFAIVIWLLAYRRSKRRRKSRKLSN 244
FICM++ ENKCY++HCHREYLI L VVSGLIL T A+VIWLLAYRRS++RRKSRKLSN
Sbjct: 180 VFICMLDAENKCYHMHCHREYLIILAVVSGLILCTALAVVIWLLAYRRSRKRRKSRKLSN 239
Query: 245 PAASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRS 304
PAASALVPPSWKVFT EELRSITKNFSEGNRL GD+KTGGTYSG+LPDGSRVAVKRLKRS
Sbjct: 240 PAASALVPPSWKVFTNEELRSITKNFSEGNRLPGDAKTGGTYSGLLPDGSRVAVKRLKRS 299
Query: 305 SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGR 364
SFQRKKEFYSEIGR ARLHHPNLVA+KGCCYDHGDRYIVYEFVVNGPLDRWLHHI RGGR
Sbjct: 300 SFQRKKEFYSEIGRVARLHHPNLVAIKGCCYDHGDRYIVYEFVVNGPLDRWLHHISRGGR 359
Query: 365 SLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW 424
SLDW MRMK+ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW
Sbjct: 360 SLDWTMRMKIATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW 419
Query: 425 EVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEI 467
EVM E TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEI
Sbjct: 420 EVMHEGTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEI 462
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224137796|ref|XP_002326442.1| predicted protein [Populus trichocarpa] gi|222833764|gb|EEE72241.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 666 bits (1719), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 329/415 (79%), Positives = 358/415 (86%), Gaps = 2/415 (0%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNG 112
CP W I+ KSKCF I F+SW+ESE C GGH+A LTS EE AQKLCG+ NG
Sbjct: 18 CPSGWAISPNKSKCFKLIRRFKSWNESENRCMHYGGHVAGLTSSEELSFAQKLCGQTANG 77
Query: 113 CWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS 172
CW GGR +N+T+G WKWSD+ S N+SI F +CTSL C DLCT+V NG+
Sbjct: 78 CWAGGRVMNSTIGFIWKWSDSTSHMNQSI-VPEPFPLNCTSLSCRNSIAADLCTVV-NGT 135
Query: 173 RSLVTERCNTSHPFICMVEHENKCYYLHCHREYLITLGVVSGLILLTTFAIVIWLLAYRR 232
LV ERCN+SH FICM++ E KCY++HCHREYLI L VVSGLIL TT A+VIWLLAYRR
Sbjct: 136 ADLVAERCNSSHAFICMLDVEKKCYHMHCHREYLIILAVVSGLILCTTLAVVIWLLAYRR 195
Query: 233 SKRRRKSRKLSNPAASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPD 292
SK+RRKSRKLSNPAASALVPPSWKVFT EELRSITKNFSEGNRLLGD+KTGGTYSG LPD
Sbjct: 196 SKKRRKSRKLSNPAASALVPPSWKVFTNEELRSITKNFSEGNRLLGDAKTGGTYSGFLPD 255
Query: 293 GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352
GSRVAVKRLKRSSFQRKKEFYSEIGR ARLHHPNLVA+KGCCYDHGDRYIVYEF++NGPL
Sbjct: 256 GSRVAVKRLKRSSFQRKKEFYSEIGRVARLHHPNLVAIKGCCYDHGDRYIVYEFILNGPL 315
Query: 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAH 412
DRWLHH+PRGGRSLDWAMRMK+ATTLAQGIAFLHDKVKPHVVHRDIRAS+VLLDEEFGAH
Sbjct: 316 DRWLHHVPRGGRSLDWAMRMKIATTLAQGIAFLHDKVKPHVVHRDIRASSVLLDEEFGAH 375
Query: 413 LMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEI 467
LMGVGLSKF+PWEVM ERT+MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEI
Sbjct: 376 LMGVGLSKFMPWEVMHERTMMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEI 430
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449503381|ref|XP_004161974.1| PREDICTED: C-type lectin receptor-like tyrosine-protein kinase At1g52310-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 647 bits (1668), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 315/465 (67%), Positives = 376/465 (80%), Gaps = 6/465 (1%)
Query: 9 LVPLQCFLLLVAYYVL----QLVASDTISNQSSNGQLAASMNKDWKAPCPPDWIINEEKS 64
+ P + L ++ +VL ++ SDT+ N+S G S + K CP WII+ K+
Sbjct: 1 MAPTEVKTLFLSLFVLIWLSRMGVSDTMFNESGIGYSVVSRKEISKGRCPHGWIISPSKT 60
Query: 65 KCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTV 124
KCFG++ + +SW++SET C GG+LAAL +Y+E AQ LC + GCWVGGR+ N+
Sbjct: 61 KCFGFMSSPKSWNDSETQCNSFGGNLAALVTYQEFSYAQNLCNGTLGGCWVGGRAFNSLN 120
Query: 125 GLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRS--LVTERCNT 182
WKWSDN+SKWN+SI + S+C + CH + +V+ CTL+ G + L E+CN+
Sbjct: 121 DFVWKWSDNVSKWNDSIFPSATLQSNCKNASCHRNDSVETCTLIFGGPATPFLRDEKCNS 180
Query: 183 SHPFICMVEHENKCYYLHCHREYLITLGVVSGLILLTTFAIVIWLLAYRRSKRRRKSRKL 242
SHPFICM+ +++C+ +HCH+EYL+ L VVSGLI TT A+VIWLLA++RSK+RR+SRK
Sbjct: 181 SHPFICMINLDDRCHRMHCHKEYLVILAVVSGLIFCTTLAVVIWLLAHKRSKKRRRSRKP 240
Query: 243 SNPAASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLK 302
SNPAASALVPP W+VFT EELRS+TKNFSEGNRLLGD+KTGGTYSG+LPDGSRVA+KRLK
Sbjct: 241 SNPAASALVPPLWRVFTKEELRSMTKNFSEGNRLLGDAKTGGTYSGLLPDGSRVAIKRLK 300
Query: 303 RSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRG 362
+SSFQRKKEF+SEI R ARL HPNLVA+KGCCYDHGDRYIVYEF+VNGPLDRWLHH+PRG
Sbjct: 301 KSSFQRKKEFHSEIARVARLRHPNLVALKGCCYDHGDRYIVYEFIVNGPLDRWLHHVPRG 360
Query: 363 GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV 422
GRSLDW MRMK+ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSK V
Sbjct: 361 GRSLDWTMRMKIATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKLV 420
Query: 423 PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEI 467
+EVM ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEI
Sbjct: 421 AYEVMHERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEI 465
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449454927|ref|XP_004145205.1| PREDICTED: C-type lectin receptor-like tyrosine-protein kinase At1g52310-like [Cucumis sativus] gi|449473071|ref|XP_004153775.1| PREDICTED: C-type lectin receptor-like tyrosine-protein kinase At1g52310-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 643 bits (1658), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 314/465 (67%), Positives = 375/465 (80%), Gaps = 6/465 (1%)
Query: 9 LVPLQCFLLLVAYYVL----QLVASDTISNQSSNGQLAASMNKDWKAPCPPDWIINEEKS 64
+ P + L ++ +VL ++ SDT+ N+S G S + K CP WII+ K+
Sbjct: 1 MAPTEVKTLFLSLFVLIWLSRMGVSDTMFNESGIGYSVVSRKEISKGRCPHGWIISPSKT 60
Query: 65 KCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTV 124
KCFG++ + +SW++SET C GG+LAAL +Y+E AQ LC + GCWVGGR+ N+
Sbjct: 61 KCFGFMSSPKSWNDSETQCNSFGGNLAALVTYQEFSYAQNLCNGTLGGCWVGGRAFNSLN 120
Query: 125 GLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRS--LVTERCNT 182
WKWSDN+SKWN+SI + S+C + C + +V+ CTL+ G + L E+CN+
Sbjct: 121 DFVWKWSDNVSKWNDSIFPSATLQSNCKNASCLRNDSVETCTLIFGGPATPFLRDEKCNS 180
Query: 183 SHPFICMVEHENKCYYLHCHREYLITLGVVSGLILLTTFAIVIWLLAYRRSKRRRKSRKL 242
SHPFICM+ +++C+ +HCH+EYL+ L VVSGLI TT A+VIWLLA++RSK+RR+SRK
Sbjct: 181 SHPFICMINLDDRCHRMHCHKEYLVILAVVSGLIFCTTLAVVIWLLAHKRSKKRRRSRKP 240
Query: 243 SNPAASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLK 302
SNPAASALVPP W+VFT EELRS+TKNFSEGNRLLGD+KTGGTYSG+LPDGSRVA+KRLK
Sbjct: 241 SNPAASALVPPLWRVFTKEELRSMTKNFSEGNRLLGDAKTGGTYSGLLPDGSRVAIKRLK 300
Query: 303 RSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRG 362
+SSFQRKKEF+SEI R ARL HPNLVA+KGCCYDHGDRYIVYEF+VNGPLDRWLHH+PRG
Sbjct: 301 KSSFQRKKEFHSEIARVARLRHPNLVALKGCCYDHGDRYIVYEFIVNGPLDRWLHHVPRG 360
Query: 363 GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV 422
GRSLDW MRMK+ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSK V
Sbjct: 361 GRSLDWTMRMKIATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKLV 420
Query: 423 PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEI 467
+EVM ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEI
Sbjct: 421 AYEVMHERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEI 465
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356558437|ref|XP_003547513.1| PREDICTED: C-type lectin receptor-like tyrosine-protein kinase At1g52310-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 609 bits (1570), Expect = e-171, Method: Compositional matrix adjust.
Identities = 306/443 (69%), Positives = 354/443 (79%), Gaps = 7/443 (1%)
Query: 27 VASDTISNQSSNGQLAASMNKDWKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI 86
+AS+ N++ G S+N+D K PCP WI++ K+KCF ++G +SW++SET C +
Sbjct: 20 LASNATLNETC-GYFDGSLNRDPKVPCPIGWIMDPNKTKCFLHVGRPQSWNDSETCCSKY 78
Query: 87 GGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGS 146
GGHL +LTS E AQ LCG+++N CWVGG+ +N T G W WSDN S WN SI ++
Sbjct: 79 GGHLVSLTSLPELQFAQGLCGESINSCWVGGQRVNATAGNQWMWSDN-SPWNNSIFSMVE 137
Query: 147 FNSSC--TSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVEHENKCYYLHCHRE 204
C T CH ++T +LCT+V+N S SL TERCN H +C+++ + KC +H RE
Sbjct: 138 VPPHCNGTGPSCHRNSTDNLCTVVTNNSNSLTTERCNNPHASLCILDIDTKCNQMHRRRE 197
Query: 205 YLITLGVVSGLILLTTFAIVIWLLAYRRSKRRRKSRKLSNPAASALVPPSWKVFTTEELR 264
Y I L VVS LIL TT A+V+WLL Y+R K+RR+SRKLS P AS PSWKVFT EELR
Sbjct: 198 YFIILTVVSALILSTTLAVVVWLLVYKRGKKRRRSRKLSIPGASL---PSWKVFTKEELR 254
Query: 265 SITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHH 324
SITKNFSEGNRL+GD+KTGGTYSG++ DGS+VAVKRLKRS+FQRKKEFYSEIGR ARL H
Sbjct: 255 SITKNFSEGNRLVGDTKTGGTYSGVVSDGSKVAVKRLKRSNFQRKKEFYSEIGRVARLRH 314
Query: 325 PNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAF 384
PNLVAV GCCYDHGDRYIVYEFV NGPLD+WLHHIPRGGRSLDWAMRMK+ATTLAQGIAF
Sbjct: 315 PNLVAVMGCCYDHGDRYIVYEFVANGPLDKWLHHIPRGGRSLDWAMRMKIATTLAQGIAF 374
Query: 385 LHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPE 444
LHDKVKP VVHRDIR SNVLLDEEFGA LMGVGLSKFVP+EVM ERTVMAGGTYGYLAPE
Sbjct: 375 LHDKVKPQVVHRDIRTSNVLLDEEFGARLMGVGLSKFVPYEVMHERTVMAGGTYGYLAPE 434
Query: 445 FVYRNELTTKSDVYSFGVLLLEI 467
FVYRNELTTKSDVYSFGVLLLEI
Sbjct: 435 FVYRNELTTKSDVYSFGVLLLEI 457
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356532800|ref|XP_003534958.1| PREDICTED: C-type lectin receptor-like tyrosine-protein kinase At1g52310-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 605 bits (1560), Expect = e-170, Method: Compositional matrix adjust.
Identities = 302/443 (68%), Positives = 358/443 (80%), Gaps = 7/443 (1%)
Query: 27 VASDTISNQSSNGQLAASMNKDWKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI 86
+AS+ N++ G S+N+D K PCP W+++ K+KCF ++G +SW++SET C +
Sbjct: 20 LASNATLNETC-GYFDGSLNRDPKVPCPIGWVMDPNKTKCFLHVGRPQSWNDSETCCSKY 78
Query: 87 GGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGS 146
GGHL +LTS +E AQ LCG+++N CW+GG+ +N+T G W WS+N S WN SI ++ +
Sbjct: 79 GGHLVSLTSLQELQFAQSLCGESINSCWIGGQRLNSTAGYQWMWSNN-SPWNNSIFSMVN 137
Query: 147 FNSSC--TSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVEHENKCYYLHCHRE 204
C T CH ++T +LCT+V+N S SL+TERC+ H +C+++ + K +H RE
Sbjct: 138 VPPHCNGTGPSCHRNSTDNLCTVVTNNSNSLITERCDNPHASLCILDIDTKRNQMHRRRE 197
Query: 205 YLITLGVVSGLILLTTFAIVIWLLAYRRSKRRRKSRKLSNPAASALVPPSWKVFTTEELR 264
YLI L VVS LIL TT ++V+WLL Y+R K+RR+SRKLS P AS PSWKVFT EELR
Sbjct: 198 YLIILTVVSTLILSTTLSVVVWLLVYKRGKKRRRSRKLSIPGASL---PSWKVFTKEELR 254
Query: 265 SITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHH 324
SITKNFSEGNRL+GD+KTGGTYSG+L DGS+VAVKRLKRSSFQRKKEFYSEI R ARL H
Sbjct: 255 SITKNFSEGNRLVGDAKTGGTYSGVLSDGSKVAVKRLKRSSFQRKKEFYSEISRVARLRH 314
Query: 325 PNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAF 384
PNLVAV GCCYDHGDRYIVYEFV NGPLD+WLHHIPRGGR+LDWAMRMK+ATTLAQGIAF
Sbjct: 315 PNLVAVMGCCYDHGDRYIVYEFVANGPLDKWLHHIPRGGRNLDWAMRMKIATTLAQGIAF 374
Query: 385 LHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPE 444
LHDKVKP VVHRDIRASNVLLDEEFGA LMGVGLSKFVP+EVM ERTVMAGGTYGYLAPE
Sbjct: 375 LHDKVKPQVVHRDIRASNVLLDEEFGAQLMGVGLSKFVPYEVMHERTVMAGGTYGYLAPE 434
Query: 445 FVYRNELTTKSDVYSFGVLLLEI 467
FVYRNELTTKSDVYSFGVLLLEI
Sbjct: 435 FVYRNELTTKSDVYSFGVLLLEI 457
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|294460294|gb|ADE75729.1| unknown [Picea sitchensis] | Back alignment and taxonomy information |
|---|
Score = 592 bits (1525), Expect = e-166, Method: Compositional matrix adjust.
Identities = 274/415 (66%), Positives = 331/415 (79%), Gaps = 1/415 (0%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNG 112
CP W + CF + N SW+ SE C+ GHLAALTS +E Q C NG
Sbjct: 31 CPTGWNSAPNRKNCFLLVSNASSWNHSEAVCQNHSGHLAALTSVQELKYVQAFCRNISNG 90
Query: 113 CWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS 172
CWVGGR +N+ G SW+WSD+ + WN S+ +C++ C D CTLV+NG
Sbjct: 91 CWVGGRGVNSQKGFSWEWSDHRTLWNNSVFPGAPSPLNCSNSSCLNTNLTDFCTLVTNGQ 150
Query: 173 RSLVTERCNTSHPFICMVEHENKCYYLHCHREYLITLGVVSGLILLTTFAIVIWLLAYRR 232
+LV +RCNTSH F+CM+ ENKC + CH+EY++ L VVSG+IL +T A+VIWLLAYR+
Sbjct: 151 VALVGDRCNTSHDFVCMLSKENKCEHGPCHKEYIVILAVVSGMILSSTLAVVIWLLAYRQ 210
Query: 233 SKRRRKSRKLSNPAASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPD 292
SKRR+KSRK+S+P+++ALVPPSW+V++ +ELR TKNFSEGNRLLGD+KTGGTY G+LPD
Sbjct: 211 SKRRKKSRKISSPSSAALVPPSWRVYSNDELRMTTKNFSEGNRLLGDAKTGGTYRGVLPD 270
Query: 293 GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352
GS VAVK+L++SSFQ KKEF+SEI R ARL HPNLVA+KGCCY+HG+RYIVYEFV NGPL
Sbjct: 271 GSLVAVKKLQKSSFQSKKEFFSEIRRIARLSHPNLVAIKGCCYEHGERYIVYEFVANGPL 330
Query: 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAH 412
DRWLH++P+GGRSLDW MRM++ATTLAQGIAFLHDKVKPHVVHRDIRA+NVLLDEEFGAH
Sbjct: 331 DRWLHYLPKGGRSLDWRMRMRIATTLAQGIAFLHDKVKPHVVHRDIRANNVLLDEEFGAH 390
Query: 413 LMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEI 467
++GVGLSKFVPWE + ERT MAG +GYLAPEFVYRNELTTKSDVYSFGVLLLE+
Sbjct: 391 ILGVGLSKFVPWEGLHERTAMAGA-HGYLAPEFVYRNELTTKSDVYSFGVLLLEL 444
|
Source: Picea sitchensis Species: Picea sitchensis Genus: Picea Family: Pinaceae Order: Coniferales Class: Coniferopsida Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|115434006|ref|NP_001041761.1| Os01g0104000 [Oryza sativa Japonica Group] gi|52075662|dbj|BAD44832.1| putative protein kinase [Oryza sativa Japonica Group] gi|113531292|dbj|BAF03675.1| Os01g0104000 [Oryza sativa Japonica Group] gi|125568686|gb|EAZ10201.1| hypothetical protein OsJ_00032 [Oryza sativa Japonica Group] | Back alignment and taxonomy information |
|---|
Score = 588 bits (1517), Expect = e-165, Method: Compositional matrix adjust.
Identities = 289/416 (69%), Positives = 334/416 (80%), Gaps = 2/416 (0%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKE-IGGHLAALTSYEEEHSAQKLCGKNVN 111
CP W I KCF YI SWD SE C+ HLAAL+S ++ + A+ LCG + +
Sbjct: 32 CPDGWQITPALDKCFIYIPTPLSWDRSEALCRNNFTAHLAALSSLQDLNLAKSLCGPSPS 91
Query: 112 GCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNG 171
GCWVGG NT +WKWSD+ S WN++ ++C++ C + T D CTLV+N
Sbjct: 92 GCWVGGHRNNTASAFAWKWSDDSSSWNDTAFPADPLRANCSTTGCALATTNDACTLVTNT 151
Query: 172 SRSLVTERCNTSHPFICMVEHENKCYYLHCHREYLITLGVVSGLILLTTFAIVIWLLAYR 231
+L +RC+ SH ICM+ HE++CY+ HCH+EY I L VVSG ILLTT A+V+WLL YR
Sbjct: 152 HAALTAKRCSDSHGLICMINHEDRCYHDHCHKEYFIVLVVVSGFILLTTLAVVVWLLVYR 211
Query: 232 RSKRRRKSRKLSNPAASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILP 291
RSKRRR+SR+ S+ +A+ALVPP WKVFT+EELRSITKNFSEGNRL G++KTGGTYSGILP
Sbjct: 212 RSKRRRRSREGSSTSATALVPPLWKVFTSEELRSITKNFSEGNRLPGNAKTGGTYSGILP 271
Query: 292 DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP 351
DGSRVA+KRLKRSS QRKK+FYSEIGR A+L+HPNLVAVKGCCYDHGDR+IVYEFV NGP
Sbjct: 272 DGSRVAIKRLKRSSLQRKKDFYSEIGRVAKLYHPNLVAVKGCCYDHGDRFIVYEFVANGP 331
Query: 352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGA 411
LD WLHH+PRGGR LDW MRM+VATTLAQGIAFLHDKVKP VVHRDIRASNVLLDEEFG+
Sbjct: 332 LDVWLHHVPRGGRCLDWPMRMRVATTLAQGIAFLHDKVKPQVVHRDIRASNVLLDEEFGS 391
Query: 412 HLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEI 467
HLMGVGLSKFVPWEVM ERTV A TYGYLAPEF+YRNELTTKSDVYSFGVLLLEI
Sbjct: 392 HLMGVGLSKFVPWEVMHERTVKA-ATYGYLAPEFIYRNELTTKSDVYSFGVLLLEI 446
|
Source: Oryza sativa Japonica Group Species: Oryza sativa Genus: Oryza Family: Poaceae Order: Poales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 553 | ||||||
| TAIR|locus:2018189 | 552 | AT1G52310 [Arabidopsis thalian | 0.783 | 0.784 | 0.649 | 4.9e-156 | |
| TAIR|locus:2009630 | 953 | AT1G53420 [Arabidopsis thalian | 0.376 | 0.218 | 0.428 | 3.7e-45 | |
| TAIR|locus:2095334 | 393 | AT3G09010 [Arabidopsis thalian | 0.372 | 0.524 | 0.453 | 2.8e-43 | |
| TAIR|locus:2157042 | 953 | AT5G49760 [Arabidopsis thalian | 0.466 | 0.270 | 0.385 | 3.8e-43 | |
| TAIR|locus:2093999 | 700 | PERK6 "proline-rich extensin-l | 0.381 | 0.301 | 0.456 | 3.9e-43 | |
| TAIR|locus:2017923 | 390 | AT1G16670 [Arabidopsis thalian | 0.379 | 0.538 | 0.420 | 9.3e-43 | |
| TAIR|locus:2045620 | 494 | AT2G42960 [Arabidopsis thalian | 0.394 | 0.441 | 0.427 | 1.4e-42 | |
| TAIR|locus:2139474 | 670 | PERK5 "proline-rich extensin-l | 0.397 | 0.328 | 0.418 | 2.3e-42 | |
| TAIR|locus:2026925 | 708 | PERK9 "proline-rich extensin-l | 0.370 | 0.289 | 0.429 | 3.5e-42 | |
| TAIR|locus:2010282 | 699 | PERK7 "proline-rich extensin-l | 0.397 | 0.314 | 0.442 | 4.1e-42 |
| TAIR|locus:2018189 AT1G52310 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1521 (540.5 bits), Expect = 4.9e-156, P = 4.9e-156
Identities = 287/442 (64%), Positives = 342/442 (77%)
Query: 30 DTISNQSSNGQLAASMNK-DWKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGG 88
DTIS +S+ Q A K CPPDWII ++KC+ Y N SW++SE +C+ GG
Sbjct: 28 DTISCEST--QNATDFKKRSQTVSCPPDWIIGPNQTKCYAYFKNSTSWEKSEMFCRTYGG 85
Query: 89 HLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINT-TVGLSWKWSDNMS-KWNESIHAVGS 146
HLA+L S +E QKLC NV+ CW+GGRS+N+ T G W WSD + +WN+S+
Sbjct: 86 HLASLASSKELSFVQKLCNGNVSSCWIGGRSMNSSTSGFRWSWSDPKTPQWNQSMFPKVP 145
Query: 147 FNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVEHENKCYYLHCHREYL 206
+ C + ++C V+NGS S+ ERCN SH F+C V+ + KC +CH+ YL
Sbjct: 146 IRTRCGNGNGSSSCRANICIAVTNGSSSIFGERCNASHAFVCAVDSDIKCR--NCHK-YL 202
Query: 207 ITLGVVSGLILLTTFAIVIWLLAYXXXXXXXXXXXLSNPAASA-LVPPSWKVFTTEELRS 265
+ L VVSGLIL TTFAI++WLL Y +SNPA+S+ +VPPSWK+FT+EELRS
Sbjct: 203 VILAVVSGLILFTTFAIILWLLVYKRSKKRRKSRKVSNPASSSSVVPPSWKIFTSEELRS 262
Query: 266 ITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHP 325
+TKNFSE NRL GD+KTGGTYSG L DG++VAVKRLKRSSFQRKKEFYSEI R A+L+HP
Sbjct: 263 MTKNFSEANRLAGDAKTGGTYSGGLSDGTKVAVKRLKRSSFQRKKEFYSEIRRAAKLYHP 322
Query: 326 NLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFL 385
N+VA+KGCCYDHG+R+IVYEF+ +GPLDRWLHH+PRGGRSLDW MR+ +ATTLAQGIAFL
Sbjct: 323 NVVAIKGCCYDHGERFIVYEFIASGPLDRWLHHVPRGGRSLDWNMRLNIATTLAQGIAFL 382
Query: 386 HDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEF 445
HDKVKP VVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPE+
Sbjct: 383 HDKVKPQVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEY 442
Query: 446 VYRNELTTKSDVYSFGVLLLEI 467
VYRNELTTKSDVYSFGVLLLEI
Sbjct: 443 VYRNELTTKSDVYSFGVLLLEI 464
|
|
| TAIR|locus:2009630 AT1G53420 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 437 (158.9 bits), Expect = 3.7e-45, Sum P(2) = 3.7e-45
Identities = 90/210 (42%), Positives = 128/210 (60%)
Query: 258 FTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIG 317
F+ +++ T NF NR+ G+ G Y G L DG+ +AVK+L S Q +EF +EIG
Sbjct: 612 FSLRQIKIATNNFDSANRI-GEGGFGPVYKGKLFDGTIIAVKQLSTGSKQGNREFLNEIG 670
Query: 318 RFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATT 377
+ LHHPNLV + GCC + G +VYEFV N L R L LDW R K+
Sbjct: 671 MISALHHPNLVKLYGCCVEGGQLLLVYEFVENNSLARALFGPQETQLRLDWPTRRKICIG 730
Query: 378 LAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT 437
+A+G+A+LH++ + +VHRDI+A+NVLLD++ + GL+K + T +AG T
Sbjct: 731 VARGLAYLHEESRLKIVHRDIKATNVLLDKQLNPKISDFGLAKLDEEDSTHISTRIAG-T 789
Query: 438 YGYLAPEFVYRNELTTKSDVYSFGVLLLEI 467
+GY+APE+ R LT K+DVYSFG++ LEI
Sbjct: 790 FGYMAPEYAMRGHLTDKADVYSFGIVALEI 819
|
|
| TAIR|locus:2095334 AT3G09010 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 457 (165.9 bits), Expect = 2.8e-43, P = 2.8e-43
Identities = 98/216 (45%), Positives = 133/216 (61%)
Query: 256 KVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSE 315
+VF+ LRS T +F NR+ G G + G+L DG++VAVK L S Q +EF +E
Sbjct: 32 RVFSYNSLRSATDSFHPTNRI-GGGGYGVVFKGVLRDGTQVAVKSLSAESKQGTREFLTE 90
Query: 316 IGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRS----LDWAMR 371
I + +HHPNLV + GCC + +R +VYE++ N L L G RS LDW+ R
Sbjct: 91 INLISNIHHPNLVKLIGCCIEGNNRILVYEYLENNSLASVL----LGSRSRYVPLDWSKR 146
Query: 372 MKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT 431
+ A G+AFLH++V+PHVVHRDI+ASN+LLD F + GL+K P V T
Sbjct: 147 AAICVGTASGLAFLHEEVEPHVVHRDIKASNILLDSNFSPKIGDFGLAKLFPDNVTHVST 206
Query: 432 VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEI 467
+AG T GYLAPE+ +LT K+DVYSFG+L+LE+
Sbjct: 207 RVAG-TVGYLAPEYALLGQLTKKADVYSFGILVLEV 241
|
|
| TAIR|locus:2157042 AT5G49760 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 465 (168.7 bits), Expect = 3.8e-43, P = 3.8e-43
Identities = 104/270 (38%), Positives = 149/270 (55%)
Query: 207 ITLGVVSGLILLTTFAIVIWLLAYXXXXXXXXXXXLSNPAA------SALVPPSW---KV 257
I +G V G+++L + + A +NP A S++ P K
Sbjct: 559 ILIGAVVGVVVLLLLLTIAGIYALRQKKRAERATGQNNPFAKWDTSKSSIDAPQLMGAKA 618
Query: 258 FTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIG 317
FT EEL+ T NFSE N + G G Y GILP+G +A+KR ++ S Q EF +EI
Sbjct: 619 FTFEELKKCTDNFSEANDV-GGGGYGKVYRGILPNGQLIAIKRAQQGSLQGGLEFKTEIE 677
Query: 318 RFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATT 377
+R+HH N+V + G C+D ++ +VYE++ NG L L + G LDW R+K+A
Sbjct: 678 LLSRVHHKNVVRLLGFCFDRNEQMLVYEYISNGSLKDSLSG--KSGIRLDWTRRLKIALG 735
Query: 378 LAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT 437
+G+A+LH+ P ++HRDI+++N+LLDE A + GLSK V T GT
Sbjct: 736 SGKGLAYLHELADPPIIHRDIKSNNILLDENLTAKVADFGLSKLVGDPEKTHVTTQVKGT 795
Query: 438 YGYLAPEFVYRNELTTKSDVYSFGVLLLEI 467
GYL PE+ N+LT KSDVY FGV+LLE+
Sbjct: 796 MGYLDPEYYMTNQLTEKSDVYGFGVVLLEL 825
|
|
| TAIR|locus:2093999 PERK6 "proline-rich extensin-like receptor kinase 6" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 459 (166.6 bits), Expect = 3.9e-43, P = 3.9e-43
Identities = 99/217 (45%), Positives = 139/217 (64%)
Query: 258 FTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIG 317
FT +EL + T+ FS+ +RLLG G + GILP+G +AVK LK S Q ++EF +E+
Sbjct: 325 FTYDELAAATQGFSQ-SRLLGQGGFGYVHKGILPNGKEIAVKSLKAGSGQGEREFQAEVD 383
Query: 318 RFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATT 377
+R+HH LV++ G C G R +VYEF+ N L+ LH + G+ LDW R+K+A
Sbjct: 384 IISRVHHRFLVSLVGYCIAGGQRMLVYEFLPNDTLEFHLHG--KSGKVLDWPTRLKIALG 441
Query: 378 LAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT 437
A+G+A+LH+ P ++HRDI+ASN+LLDE F A + GL+K V T + G T
Sbjct: 442 SAKGLAYLHEDCHPRIIHRDIKASNILLDESFEAKVADFGLAKLSQDNVTHVSTRIMG-T 500
Query: 438 YGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVLCRR 474
+GYLAPE+ +LT +SDV+SFGV+LLE LV RR
Sbjct: 501 FGYLAPEYASSGKLTDRSDVFSFGVMLLE--LVTGRR 535
|
|
| TAIR|locus:2017923 AT1G16670 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 452 (164.2 bits), Expect = 9.3e-43, P = 9.3e-43
Identities = 90/214 (42%), Positives = 130/214 (60%)
Query: 256 KVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSE 315
K++ E+R T +FS N++ G+ G Y G L DG A+K L S Q KEF +E
Sbjct: 27 KIYKYREIRQATDDFSAENKI-GEGGFGSVYKGCLKDGKLAAIKVLSAESRQGVKEFLTE 85
Query: 316 IGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWL--HHIPRGGRSLDWAMRMK 373
I + + H NLV + GCC + R +VY F+ N LD+ L R G DW+ R
Sbjct: 86 INVISEIQHENLVKLYGCCVEGNHRILVYNFLENNSLDKTLLAGGYTRSGIQFDWSSRAN 145
Query: 374 VATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVM 433
+ +A+G+AFLH++V+PH++HRDI+ASN+LLD+ + GL++ +P + T +
Sbjct: 146 ICVGVAKGLAFLHEEVRPHIIHRDIKASNILLDKYLSPKISDFGLARLMPPNMTHVSTRV 205
Query: 434 AGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEI 467
AG T GYLAPE+ R +LT K+D+YSFGVLL+EI
Sbjct: 206 AG-TIGYLAPEYAVRGQLTRKADIYSFGVLLMEI 238
|
|
| TAIR|locus:2045620 AT2G42960 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 430 (156.4 bits), Expect = 1.4e-42, Sum P(2) = 1.4e-42
Identities = 95/222 (42%), Positives = 130/222 (58%)
Query: 245 PAASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRS 304
P S L W FT +L T F+ N +LG+ G Y G L +G+ VAVK+L +
Sbjct: 160 PEISHLGWGHW--FTLRDLELATNRFAPVN-VLGEGGYGVVYRGKLVNGTEVAVKKLLNN 216
Query: 305 SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGR 364
Q +KEF E+ + H NLV + G C + R +VYE+V +G L++WLH R
Sbjct: 217 LGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYVNSGNLEQWLHGAMRQHG 276
Query: 365 SLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW 424
+L W RMK+ T AQ +A+LH+ ++P VVHRDI+ASN+L+D+EF A L GL+K +
Sbjct: 277 NLTWEARMKIITGTAQALAYLHEAIEPKVVHRDIKASNILIDDEFNAKLSDFGLAKLLD- 335
Query: 425 EVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLE 466
T GT+GY+APE+ L KSD+YSFGVLLLE
Sbjct: 336 SGESHITTRVMGTFGYVAPEYANTGLLNEKSDIYSFGVLLLE 377
|
|
| TAIR|locus:2139474 PERK5 "proline-rich extensin-like receptor kinase 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 435 (158.2 bits), Expect = 2.3e-42, Sum P(2) = 2.3e-42
Identities = 95/227 (41%), Positives = 138/227 (60%)
Query: 242 LSNPAASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRL 301
+ +P A+ L + FT +EL T+ F++ N LLG G + G+LP G VAVK L
Sbjct: 285 IPSPQAATL-GHNQSTFTYDELSIATEGFAQSN-LLGQGGFGYVHKGVLPSGKEVAVKSL 342
Query: 302 KRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPR 361
K S Q ++EF +E+ +R+HH +LV++ G C G R +VYEF+ N L+ LH +
Sbjct: 343 KLGSGQGEREFQAEVDIISRVHHRHLVSLVGYCISGGQRLLVYEFIPNNTLEFHLHG--K 400
Query: 362 GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF 421
G LDW R+K+A A+G+A+LH+ P ++HRDI+A+N+LLD F + GL+K
Sbjct: 401 GRPVLDWPTRVKIALGSARGLAYLHEDCHPRIIHRDIKAANILLDFSFETKVADFGLAKL 460
Query: 422 VPWEVMQERT-VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEI 467
T VM GT+GYLAPE+ +L+ KSDV+SFGV+LLE+
Sbjct: 461 SQDNYTHVSTRVM--GTFGYLAPEYASSGKLSDKSDVFSFGVMLLEL 505
|
|
| TAIR|locus:2026925 PERK9 "proline-rich extensin-like receptor kinase 9" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 430 (156.4 bits), Expect = 3.5e-42, Sum P(2) = 3.5e-42
Identities = 91/212 (42%), Positives = 133/212 (62%)
Query: 257 VFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEI 316
+F+ EEL T FS+ N LLG+ G Y GILPDG VAVK+LK Q +EF +E+
Sbjct: 364 LFSYEELVKATNGFSQEN-LLGEGGFGCVYKGILPDGRVVAVKQLKIGGGQGDREFKAEV 422
Query: 317 GRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRS-LDWAMRMKVA 375
+R+HH +LV++ G C R ++Y++V N L LH G +S LDWA R+K+A
Sbjct: 423 ETLSRIHHRHLVSIVGHCISGDRRLLIYDYVSNNDLYFHLH----GEKSVLDWATRVKIA 478
Query: 376 TTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG 435
A+G+A+LH+ P ++HRDI++SN+LL++ F A + GL++ + T
Sbjct: 479 AGAARGLAYLHEDCHPRIIHRDIKSSNILLEDNFDARVSDFGLARLA-LDCNTHITTRVI 537
Query: 436 GTYGYLAPEFVYRNELTTKSDVYSFGVLLLEI 467
GT+GY+APE+ +LT KSDV+SFGV+LLE+
Sbjct: 538 GTFGYMAPEYASSGKLTEKSDVFSFGVVLLEL 569
|
|
| TAIR|locus:2010282 PERK7 "proline-rich extensin-like receptor kinase 7" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 450 (163.5 bits), Expect = 4.1e-42, P = 4.1e-42
Identities = 104/235 (44%), Positives = 144/235 (61%)
Query: 243 SNPAASALVPPSWKV--------FTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGS 294
S P A +L PP V FT EEL S T+ FS+ +RLLG G + GILP+G
Sbjct: 301 SGPYAPSLPPPHPSVALGFNNSTFTYEELASATQGFSK-DRLLGQGGFGYVHKGILPNGK 359
Query: 295 RVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHG-DRYIVYEFVVNGPLD 353
+AVK LK S Q ++EF +E+ +R+HH +LV++ G C + G R +VYEF+ N L+
Sbjct: 360 EIAVKSLKAGSGQGEREFQAEVEIISRVHHRHLVSLVGYCSNAGGQRLLVYEFLPNDTLE 419
Query: 354 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHL 413
LH + G +DW R+K+A A+G+A+LH+ P ++HRDI+ASN+LLD F A +
Sbjct: 420 FHLHG--KSGTVMDWPTRLKIALGSAKGLAYLHEDCHPKIIHRDIKASNILLDHNFEAKV 477
Query: 414 MGVGLSKFVPWEVMQERT-VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEI 467
GL+K T VM GT+GYLAPE+ +LT KSDV+SFGV+LLE+
Sbjct: 478 ADFGLAKLSQDNNTHVSTRVM--GTFGYLAPEYASSGKLTEKSDVFSFGVMLLEL 530
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9C823 | Y1523_ARATH | 2, ., 7, ., 1, 0, ., 1 | 0.6492 | 0.8137 | 0.8152 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 553 | |||
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 4e-34 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-33 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-32 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-32 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-32 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 6e-31 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 8e-31 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 6e-25 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-24 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-24 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 9e-24 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-22 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-22 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-21 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-20 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 5e-20 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 5e-20 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-19 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 7e-18 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-17 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-17 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-17 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-17 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-16 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-16 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-16 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-16 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-16 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 4e-16 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 6e-16 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-15 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-15 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-15 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 4e-15 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 4e-15 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 5e-15 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 5e-15 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 6e-15 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 6e-15 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 6e-15 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 7e-15 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 7e-15 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 8e-15 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 9e-15 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-14 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-14 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-14 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-14 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-14 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-14 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-14 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 4e-14 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 5e-14 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 6e-14 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 8e-14 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-13 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-13 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-13 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-13 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 3e-13 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 4e-13 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 5e-13 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 5e-13 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 6e-13 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 6e-13 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 7e-13 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 8e-13 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 9e-13 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-12 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-12 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-12 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-12 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-12 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-12 | |
| smart00034 | 124 | smart00034, CLECT, C-type lectin (CTL) or carbohyd | 3e-12 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-12 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 4e-12 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 4e-12 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 9e-12 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-11 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-11 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-11 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-11 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-11 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-11 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-11 | |
| cd00037 | 116 | cd00037, CLECT, C-type lectin (CTL)/C-type lectin- | 2e-11 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-11 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-11 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-11 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-11 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-11 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 3e-11 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 4e-11 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 4e-11 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 4e-11 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 4e-11 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 4e-11 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 5e-11 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 5e-11 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 9e-11 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-10 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-10 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-10 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-10 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-10 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 2e-10 | |
| cd03594 | 129 | cd03594, CLECT_REG-1_like, C-type lectin-like doma | 2e-10 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-10 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 4e-10 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 4e-10 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 4e-10 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 5e-10 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 5e-10 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 5e-10 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 5e-10 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 6e-10 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 6e-10 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 7e-10 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 8e-10 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-09 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-09 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-09 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-09 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-09 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-09 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 3e-09 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-09 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 4e-09 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 4e-09 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 4e-09 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 4e-09 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 5e-09 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 5e-09 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 5e-09 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 5e-09 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 6e-09 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 6e-09 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 7e-09 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 8e-09 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 8e-09 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 9e-09 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 9e-09 | |
| cd03590 | 126 | cd03590, CLECT_DC-SIGN_like, C-type lectin-like do | 1e-08 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-08 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 1e-08 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-08 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-08 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-08 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-08 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-08 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-08 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-08 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 3e-08 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 4e-08 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 4e-08 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 5e-08 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 6e-08 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 6e-08 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 6e-08 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 6e-08 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 7e-08 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 7e-08 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 8e-08 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 8e-08 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 9e-08 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-07 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-07 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-07 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-07 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-07 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-07 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 3e-07 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-07 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 4e-07 | |
| cd03593 | 116 | cd03593, CLECT_NK_receptors_like, C-type lectin-li | 4e-07 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 4e-07 | |
| pfam00059 | 108 | pfam00059, Lectin_C, Lectin C-type domain | 4e-07 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 5e-07 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 5e-07 | |
| cd03603 | 118 | cd03603, CLECT_VCBS, A bacterial subgroup of the C | 5e-07 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 6e-07 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 6e-07 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 6e-07 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 6e-07 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 6e-07 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 7e-07 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 7e-07 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 9e-07 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-06 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-06 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-06 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-06 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-06 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-06 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-06 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-06 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-06 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-06 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 4e-06 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 4e-06 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 5e-06 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 6e-06 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 6e-06 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 7e-06 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 7e-06 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 7e-06 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 7e-06 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 9e-06 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-05 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-05 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-05 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-05 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-05 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-05 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-05 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-05 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-05 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-05 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-05 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 3e-05 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 4e-05 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 4e-05 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 4e-05 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 5e-05 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 5e-05 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 6e-05 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 6e-05 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 7e-05 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 9e-05 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-04 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-04 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-04 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-04 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-04 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-04 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-04 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-04 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-04 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-04 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 3e-04 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-04 | |
| cd03589 | 137 | cd03589, CLECT_CEL-1_like, C-type lectin-like doma | 3e-04 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 4e-04 | |
| cd03588 | 124 | cd03588, CLECT_CSPGs, C-type lectin-like domain (C | 5e-04 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 6e-04 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 7e-04 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 8e-04 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 8e-04 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 0.001 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 0.001 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 0.001 | |
| PHA02642 | 216 | PHA02642, PHA02642, C-type lectin-like protein; Pr | 0.001 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 0.001 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 0.001 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 0.001 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 0.002 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 0.002 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 0.003 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 0.003 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 4e-34
Identities = 63/196 (32%), Positives = 95/196 (48%), Gaps = 28/196 (14%)
Query: 284 GTYSGILPDGS-RVAVKRLKRSSFQR-KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRY 341
GT G +VAVK LK + + ++EF E +L HPN+V + G C Y
Sbjct: 18 GTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRLLGVCTQGEPLY 77
Query: 342 IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRAS 401
IV E++ G L +L + G L +++A +A+G+ +L K + VHRD+ A
Sbjct: 78 IVTEYMPGGDLLDFLR---KHGEKLTLKDLLQMALQIAKGMEYLESK---NFVHRDLAAR 131
Query: 402 NVLLDEE-------FGAHLMGVGLSKFVPWEVMQERTVMAGGTYG---YLAPEFVYRNEL 451
N L+ E F GLS+ + + + GG ++APE + +
Sbjct: 132 NCLVTENLVVKISDF-------GLSRDIYED---DYYRKRGGGKLPIKWMAPESLKDGKF 181
Query: 452 TTKSDVYSFGVLLLEI 467
T+KSDV+SFGVLL EI
Sbjct: 182 TSKSDVWSFGVLLWEI 197
|
Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 125 bits (317), Expect = 3e-33
Identities = 53/179 (29%), Positives = 89/179 (49%), Gaps = 11/179 (6%)
Query: 292 DGSRVAVKRLKRSSFQRKKE-FYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 350
G +VA+K +K+ E EI +L+HPN+V + G D Y+V E+ G
Sbjct: 17 TGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGG 76
Query: 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG 410
L L L +++ + +G+ +LH ++HRD++ N+LLD + G
Sbjct: 77 SLKDLLKENEGK---LSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNG 130
Query: 411 -AHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPE-FVYRNELTTKSDVYSFGVLLLEI 467
L GLSK + + +T++ GT Y+APE + + + KSD++S GV+L E+
Sbjct: 131 KVKLADFGLSKLLTSDKSLLKTIV--GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 2e-32
Identities = 60/193 (31%), Positives = 90/193 (46%), Gaps = 15/193 (7%)
Query: 284 GTYSGILPDGSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYI 342
G G + VAVK LK S + +K+F E +L HPN+V + G C + Y+
Sbjct: 14 GKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYL 73
Query: 343 VYEFVVNGPLDRWL-----HHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRD 397
V E++ G L +L +L + A +A+G+ +L K VHRD
Sbjct: 74 VLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRD 130
Query: 398 IRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY---GYLAPEFVYRNELTTK 454
+ A N L+ E+ + GLS+ V + + G ++APE + T+K
Sbjct: 131 LAARNCLVGEDLVVKISDFGLSRDVYDD---DYYRKKTGGKLPIRWMAPESLKDGIFTSK 187
Query: 455 SDVYSFGVLLLEI 467
SDV+SFGVLL EI
Sbjct: 188 SDVWSFGVLLWEI 200
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 124 bits (315), Expect = 2e-32
Identities = 60/189 (31%), Positives = 90/189 (47%), Gaps = 14/189 (7%)
Query: 284 GTYSGILPDGS-RVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRY 341
GT G VAVK LK S Q+ +EF E +L HPN+V + G C +
Sbjct: 18 GTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLM 77
Query: 342 IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRAS 401
IV E++ G L +L + L + + A +A+G+ +L K + +HRD+ A
Sbjct: 78 IVMEYMPGGDLLDYLR--KNRPKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAAR 132
Query: 402 NVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT---YGYLAPEFVYRNELTTKSDVY 458
N L+ E + GLS+ + + G ++APE + + T+KSDV+
Sbjct: 133 NCLVGENLVVKISDFGLSRDLY----DDDYYKVKGGKLPIRWMAPESLKEGKFTSKSDVW 188
Query: 459 SFGVLLLEI 467
SFGVLL EI
Sbjct: 189 SFGVLLWEI 197
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 2e-32
Identities = 60/189 (31%), Positives = 91/189 (48%), Gaps = 15/189 (7%)
Query: 284 GTYSGILPDGSR-VAVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRY 341
G G VAVK LK +S Q+ +EF E +L HPN+V + G C + Y
Sbjct: 18 GKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKLLGVCTEEEPLY 77
Query: 342 IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRAS 401
IV E++ G L +L + L + + A +A+G+ +L K + +HRD+ A
Sbjct: 78 IVMEYMEGGDLLSYLR---KNRPKLSLSDLLSFALQIARGMEYLESK---NFIHRDLAAR 131
Query: 402 NVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT---YGYLAPEFVYRNELTTKSDVY 458
N L+ E + GLS+ + + G ++APE + + T+KSDV+
Sbjct: 132 NCLVGENLVVKISDFGLSRDLY----DDDYYRKRGGKLPIRWMAPESLKEGKFTSKSDVW 187
Query: 459 SFGVLLLEI 467
SFGVLL EI
Sbjct: 188 SFGVLLWEI 196
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 6e-31
Identities = 63/196 (32%), Positives = 87/196 (44%), Gaps = 13/196 (6%)
Query: 275 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKE--FYSEIGRFARLHHPNLVAVK 331
R LG G Y G VAVK LK+ S + KK+ EI RL HPN+V +
Sbjct: 5 RKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLI 64
Query: 332 GCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKP 391
D Y+V E+ G L +L G L K+A + +G+ +LH
Sbjct: 65 DAFEDKDHLYLVMEYCEGGDLFDYL----SRGGPLSEDEAKKIALQILRGLEYLHSN--- 117
Query: 392 HVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFV-YRNE 450
++HRD++ N+LLDE + GL+K GT Y+APE + N
Sbjct: 118 GIIHRDLKPENILLDENGVVKIADFGLAKK--LLKSSSSLTTFVGTPWYMAPEVLLGGNG 175
Query: 451 LTTKSDVYSFGVLLLE 466
K DV+S GV+L E
Sbjct: 176 YGPKVDVWSLGVILYE 191
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 8e-31
Identities = 53/177 (29%), Positives = 81/177 (45%), Gaps = 11/177 (6%)
Query: 292 DGSRVAVKRLKRSSFQRKKE-FYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 350
G VA+K +K+ ++ +E EI +L HPN+V + D Y+V E+ G
Sbjct: 23 TGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDVFEDEDKLYLVMEYCEGG 82
Query: 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG 410
L L RG S D A + + +LH K +VHRD++ N+LLDE+
Sbjct: 83 DLFDLLKK--RGRLSEDEA--RFYLRQILSALEYLHSK---GIVHRDLKPENILLDEDGH 135
Query: 411 AHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEI 467
L GL++ + V GT Y+APE + D++S GV+L E+
Sbjct: 136 VKLADFGLARQLDPGEKLTTFV---GTPEYMAPEVLLGKGYGKAVDIWSLGVILYEL 189
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 6e-25
Identities = 54/191 (28%), Positives = 89/191 (46%), Gaps = 10/191 (5%)
Query: 277 LGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY 335
+G G Y G VA+K +K S ++K++ +EI + HPN+V G
Sbjct: 8 IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL 67
Query: 336 DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 395
+ +IV EF G L L ++L + V L +G+ +LH ++H
Sbjct: 68 KKDELWIVMEFCSGGSLKDLLKST---NQTLTESQIAYVCKELLKGLEYLHSN---GIIH 121
Query: 396 RDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKS 455
RDI+A+N+LL + L+ GLS + + R M GT ++APE + K+
Sbjct: 122 RDIKAANILLTSDGEVKLIDFGLSAQL--SDTKARNTMV-GTPYWMAPEVINGKPYDYKA 178
Query: 456 DVYSFGVLLLE 466
D++S G+ +E
Sbjct: 179 DIWSLGITAIE 189
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 2e-24
Identities = 63/194 (32%), Positives = 93/194 (47%), Gaps = 16/194 (8%)
Query: 276 LLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY 335
+G + G G G +VAVK LK S + F +E L HPNLV + G
Sbjct: 13 TIGKGEFGDVMLGDY-RGQKVAVKCLKDDS-TAAQAFLAEASVMTTLRHPNLVQLLGVVL 70
Query: 336 DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 395
YIV E++ G L +L RG + A ++ A + +G+ +L +K + VH
Sbjct: 71 QGNPLYIVTEYMAKGSLVDYLR--SRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVH 125
Query: 396 RDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTT 453
RD+ A NVL+ E+ A + GL+K + G + APE + + +T
Sbjct: 126 RDLAARNVLVSEDLVAKVSDFGLAK-------EASQGQDSGKLPVKWTAPEALREKKFST 178
Query: 454 KSDVYSFGVLLLEI 467
KSDV+SFG+LL EI
Sbjct: 179 KSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 63/244 (25%), Positives = 99/244 (40%), Gaps = 27/244 (11%)
Query: 275 RLLGDSKTGGTYSGILPD-GSRVAVK--RLKRSSFQRKKEFYSEIGRFARLHHPNLVAVK 331
LLG G Y + D G +AVK L S + + EI + L HPN+V
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 332 GCCYD--HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV 389
G D I E+V G L + + G+ L + K + +G+A+LH
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLS---SLLKKFGK-LPEPVIRKYTRQILEGLAYLHSN- 120
Query: 390 KPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRN 449
+VHRDI+ +N+L+D + L G +K + E T GT ++APE +
Sbjct: 121 --GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGE 178
Query: 450 ELTTKSDVYSFGVLLLEIRLVLCRRWWTLYTLVHSMSLLCAQECLMLFISCNNW----PS 505
E +D++S G ++E+ W L + + I + P
Sbjct: 179 EYGRAADIWSLGCTVIEM-ATGKPPWSELGNPMA----------ALYKIGSSGEPPEIPE 227
Query: 506 HLSQ 509
HLS+
Sbjct: 228 HLSE 231
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 9e-24
Identities = 58/196 (29%), Positives = 102/196 (52%), Gaps = 13/196 (6%)
Query: 275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCC 334
R LG G + G+ + RVA+K LK ++++F E+ RL H +L+++ C
Sbjct: 12 RKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVC 71
Query: 335 YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVV 394
YI+ E + G L +L P G+ L A + +A +A+G+A+L ++ + +
Sbjct: 72 SVGEPVYIITELMEKGSLLAFLRS-PE-GQVLPVASLIDMACQVAEGMAYLEEQ---NSI 126
Query: 395 HRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT---YGYLAPEFVYRNEL 451
HRD+ A N+L+ E+ + GL++ +++E ++ Y + APE
Sbjct: 127 HRDLAARNILVGEDLVCKVADFGLAR-----LIKEDVYLSSDKKIPYKWTAPEAASHGTF 181
Query: 452 TTKSDVYSFGVLLLEI 467
+TKSDV+SFG+LL E+
Sbjct: 182 STKSDVWSFGILLYEM 197
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 97.5 bits (243), Expect = 1e-22
Identities = 50/189 (26%), Positives = 90/189 (47%), Gaps = 19/189 (10%)
Query: 293 GSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR--YIVYEFVVN 349
G +VAVK L S Q + +F EI L H N+V KG C G R ++ E++ +
Sbjct: 33 GEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPS 92
Query: 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF 409
G L ++ R ++ + ++ + +G+ +L + +HRD+ A N+L++ E
Sbjct: 93 GSLR---DYLQRHRDQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESED 146
Query: 410 GAHLMGVGLSKFVPWEVMQERTVMAGGTYG-----YLAPEFVYRNELTTKSDVYSFGVLL 464
+ GL+K +P +++ G + APE + ++ ++ SDV+SFGV L
Sbjct: 147 LVKISDFGLAKVLP----EDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTL 202
Query: 465 LEIRLVLCR 473
E+
Sbjct: 203 YEL-FTYGD 210
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.7 bits (241), Expect = 2e-22
Identities = 61/195 (31%), Positives = 97/195 (49%), Gaps = 11/195 (5%)
Query: 275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCC 334
R LG + G + G+ + + VAVK LK + K+F +E +L HP L+ + C
Sbjct: 12 RKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD-PKDFLAEAQIMKKLRHPKLIQLYAVC 70
Query: 335 YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVV 394
YIV E + G L +L GR+L + +A +A G+A+L + + +
Sbjct: 71 TLEEPIYIVTELMKYGSLLEYLQG--GAGRALKLPQLIDMAAQVASGMAYLEAQ---NYI 125
Query: 395 HRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELT 452
HRD+ A NVL+ E + GL++ + ++ + R G + + APE N +
Sbjct: 126 HRDLAARNVLVGENNICKVADFGLARVIKEDIYEARE---GAKFPIKWTAPEAALYNRFS 182
Query: 453 TKSDVYSFGVLLLEI 467
KSDV+SFG+LL EI
Sbjct: 183 IKSDVWSFGILLTEI 197
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 93.8 bits (233), Expect = 2e-21
Identities = 61/194 (31%), Positives = 95/194 (48%), Gaps = 12/194 (6%)
Query: 277 LGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY 335
LG + G Y G+ VAVK LK + +EF E + HPNLV + G C
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCT 72
Query: 336 DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 395
YI+ EF+ G L +L R + ++ + + +AT ++ + +L K + +H
Sbjct: 73 REPPFYIITEFMTYGNLLDYLRECNR--QEVNAVVLLYMATQISSAMEYLEKK---NFIH 127
Query: 396 RDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTT 453
RD+ A N L+ E + GLS+ + + T AG + + APE + N+ +
Sbjct: 128 RDLAARNCLVGENHLVKVADFGLSRLMTGDTY---TAHAGAKFPIKWTAPESLAYNKFSI 184
Query: 454 KSDVYSFGVLLLEI 467
KSDV++FGVLL EI
Sbjct: 185 KSDVWAFGVLLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 91.5 bits (227), Expect = 1e-20
Identities = 61/179 (34%), Positives = 91/179 (50%), Gaps = 12/179 (6%)
Query: 293 GSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR--YIVYEFVVN 349
G VAVK LKR Q + EI L+H N+V KGCC + G + ++ E+V
Sbjct: 33 GEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYV-- 90
Query: 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF 409
PL ++P+ L+ A + A + +G+A+LH + H +HRD+ A NVLLD +
Sbjct: 91 -PLGSLRDYLPK--HKLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDR 144
Query: 410 GAHLMGVGLSKFVPWEVMQERTVMAGGT-YGYLAPEFVYRNELTTKSDVYSFGVLLLEI 467
+ GL+K VP R G + + A E + N+ + SDV+SFGV L E+
Sbjct: 145 LVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYEL 203
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 92.1 bits (227), Expect = 5e-20
Identities = 63/207 (30%), Positives = 95/207 (45%), Gaps = 18/207 (8%)
Query: 275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKE---FYSEIGRFARL-HHPNLVAV 330
R LG+ G Y D VA+K L + + KE F EI A L H PN+V +
Sbjct: 6 RKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKL 63
Query: 331 KGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVK 390
D G Y+V E+V G L+ L I R G + + + + +LH K
Sbjct: 64 YDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEAL-FILAQILSALEYLHSK-- 120
Query: 391 PHVVHRDIRASNVLLDEE-FGAHLMGVGLSKFVPWEV----MQERTVMAGGTYGYLAPEF 445
++HRDI+ N+LLD + L+ GL+K +P + + GT GY+APE
Sbjct: 121 -GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEV 179
Query: 446 VYRNEL---TTKSDVYSFGVLLLEIRL 469
+ L ++ SD++S G+ L E+
Sbjct: 180 LLGLSLAYASSSSDIWSLGITLYELLT 206
|
Length = 384 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.2 bits (222), Expect = 5e-20
Identities = 58/204 (28%), Positives = 98/204 (48%), Gaps = 19/204 (9%)
Query: 269 NFSEGNRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRK--KEFYSEIGRFARLHHP 325
N+ G+ L+G G Y G+ L G VA+K++ + + K EI L HP
Sbjct: 1 NYQLGD-LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHP 59
Query: 326 NLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQ---GI 382
N+V G YI+ E+ NG L + + SL VA + Q G+
Sbjct: 60 NIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESL-------VAVYVYQVLQGL 112
Query: 383 AFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLA 442
A+LH++ V+HRDI+A+N+L ++ L G++ + + +V+ GT ++A
Sbjct: 113 AYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVV--GTPYWMA 167
Query: 443 PEFVYRNELTTKSDVYSFGVLLLE 466
PE + + +T SD++S G ++E
Sbjct: 168 PEVIEMSGASTASDIWSLGCTVIE 191
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.1 bits (219), Expect = 2e-19
Identities = 61/200 (30%), Positives = 94/200 (47%), Gaps = 19/200 (9%)
Query: 274 NRLLGDSKTG----GTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVA 329
R LG + G GT++G VAVK LK + + F E +L H LV
Sbjct: 11 ERKLGAGQFGEVWMGTWNGTTK----VAVKTLKPGTMS-PEAFLQEAQIMKKLRHDKLVQ 65
Query: 330 VKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV 389
+ C + YIV E++ G L +L G+ L + +A +A+G+A+L +
Sbjct: 66 LYAVCSEEEPIYIVTEYMSKGSLLDFLKS--GEGKKLRLPQLVDMAAQIAEGMAYLESR- 122
Query: 390 KPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVY 447
+ +HRD+ A N+L+ E + GL++ + + E T G + + APE
Sbjct: 123 --NYIHRDLAARNILVGENLVCKIADFGLARLIEDD---EYTAREGAKFPIKWTAPEAAN 177
Query: 448 RNELTTKSDVYSFGVLLLEI 467
T KSDV+SFG+LL EI
Sbjct: 178 YGRFTIKSDVWSFGILLTEI 197
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 7e-18
Identities = 45/175 (25%), Positives = 84/175 (48%), Gaps = 14/175 (8%)
Query: 296 VAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRW 355
VA+K ++ + + +F E +L HPNLV + G C +IV E++ NG L +
Sbjct: 31 VAIKMIREGAMS-EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNY 89
Query: 356 LHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMG 415
L + + + + + + + +L +HRD+ A N L+ E+ +
Sbjct: 90 LRERKGKLGT---EWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSD 143
Query: 416 VGLSKFVPWEVMQERTVMAGGT---YGYLAPEFVYRNELTTKSDVYSFGVLLLEI 467
GL+++ V+ ++ + GT + PE + ++KSDV+SFGVL+ E+
Sbjct: 144 FGLARY----VLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 82.5 bits (205), Expect = 1e-17
Identities = 46/181 (25%), Positives = 81/181 (44%), Gaps = 15/181 (8%)
Query: 292 DGSRVAVKR--LKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 349
DG +K L S + +++ +E+ +L+HPN++ + G IV E+
Sbjct: 24 DGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADG 83
Query: 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF 409
G L + + + G+ + L + +LH + ++HRDI+ N+ L
Sbjct: 84 GDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNG 140
Query: 410 GAHLMGVGLSKFVPWEVMQERTVMAG---GTYGYLAPEFVYRNE-LTTKSDVYSFGVLLL 465
L G+SK V+ +A GT YL+PE + +N+ KSD++S G +L
Sbjct: 141 LVKLGDFGISK-----VLSSTVDLAKTVVGTPYYLSPE-LCQNKPYNYKSDIWSLGCVLY 194
Query: 466 E 466
E
Sbjct: 195 E 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 2e-17
Identities = 60/193 (31%), Positives = 95/193 (49%), Gaps = 12/193 (6%)
Query: 277 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD 336
LG + G + G ++VA+K LK+ S + F +E +L HP LV +
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS-PEAFLAEANLMKQLQHPRLVRLYAVVTQ 72
Query: 337 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 396
YI+ E++ NG L +L G L + +A +A+G+AF+ K + +HR
Sbjct: 73 E-PIYIITEYMENGSLVDFLK--TPEGIKLTINKLIDMAAQIAEGMAFIERK---NYIHR 126
Query: 397 DIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTTK 454
D+RA+N+L+ E + GL++ + E T G + + APE + T K
Sbjct: 127 DLRAANILVSETLCCKIADFGLARLI---EDNEYTAREGAKFPIKWTAPEAINYGTFTIK 183
Query: 455 SDVYSFGVLLLEI 467
SDV+SFG+LL EI
Sbjct: 184 SDVWSFGILLTEI 196
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 82.4 bits (204), Expect = 2e-17
Identities = 62/233 (26%), Positives = 98/233 (42%), Gaps = 28/233 (12%)
Query: 275 RLLGDSKTGGTYSGI-LPDGSRVAVK--RLKRSSFQRKKEFYSEIGRFARLHHPNLVAVK 331
+G G Y+ + L G +AVK R++ + + KE E+ L HPNLV
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 332 GCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKP 391
G YI E+ G L+ L H GR LD + L +G+A+LH
Sbjct: 66 GVEVHREKVYIFMEYCSGGTLEELLEH----GRILDEHVIRVYTLQLLEGLAYLHSH--- 118
Query: 392 HVVHRDIRASNVLLDE-------EFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPE 444
+VHRDI+ +N+ LD +FG + + + E +Q GT Y+APE
Sbjct: 119 GIVHRDIKPANIFLDHNGVIKLGDFGCAVK-LKNNTTTMGEEVQSLA----GTPAYMAPE 173
Query: 445 FVYRNELTTK---SDVYSFGVLLLEIRLVLCRRWWTLYTLVHS-MSLLCAQEC 493
+ + +D++S G ++LE + +R W+ M + A
Sbjct: 174 VITGGKGKGHGRAADIWSLGCVVLE--MATGKRPWSELDNEFQIMFHVGAGHK 224
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 2e-17
Identities = 52/174 (29%), Positives = 91/174 (52%), Gaps = 12/174 (6%)
Query: 296 VAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRW 355
VA+K +K S + EF E +L H LV + G C YIV E++ NG L
Sbjct: 31 VAIKMIKEGSMS-EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCL--- 86
Query: 356 LHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMG 415
L+++ G+ + +++ + +G+A+L K +HRD+ A N L+D++ +
Sbjct: 87 LNYLREHGKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSD 143
Query: 416 VGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTTKSDVYSFGVLLLEI 467
GLS++V + E T G + + PE + ++ ++KSDV++FGVL+ E+
Sbjct: 144 FGLSRYV---LDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 1e-16
Identities = 54/175 (30%), Positives = 87/175 (49%), Gaps = 13/175 (7%)
Query: 293 GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352
G +VAVK +K + F E +LHH NLV + G H YIV E + G L
Sbjct: 29 GQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVIL-HNGLYIVMELMSKGNL 85
Query: 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAH 412
+L RG + ++ + +A+G+ +L K +VHRD+ A N+L+ E+ A
Sbjct: 86 VNFLR--TRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAK 140
Query: 413 LMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEI 467
+ GL++ V + + + APE + + ++KSDV+S+GVLL E+
Sbjct: 141 VSDFGLARVGSMGVDNSKLPVK-----WTAPEALKHKKFSSKSDVWSYGVLLWEV 190
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 1e-16
Identities = 60/213 (28%), Positives = 104/213 (48%), Gaps = 28/213 (13%)
Query: 277 LGDSKTGGTYSGIL--PDG----SRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVA 329
LG+ G Y G L P+ + VA+K LK + + ++EF E + L HPN+V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 330 VKGCCYDHGDRYIVYEFVVNGPLDRWL-HHIP-----------RGGRSLDWAMRMKVATT 377
+ G C +++E++ +G L +L + P SLD + + +A
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 378 LAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV---PWEVMQERTVMA 434
+A G+ +L H VHRD+ A N L+ E + GLS+ + + +Q ++++
Sbjct: 133 IAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189
Query: 435 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEI 467
++ PE + + TT+SD++SFGV+L EI
Sbjct: 190 ---VRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 2e-16
Identities = 51/200 (25%), Positives = 96/200 (48%), Gaps = 13/200 (6%)
Query: 274 NRLLGDSKTGGTYSGILPDGSR----VAVKRLK-RSSFQRKKEFYSEIGRFARLHHPNLV 328
+++G + G G L + VA+K LK SS +++ +F +E + HPN++
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68
Query: 329 AVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDK 388
++G I+ E++ NG LD++L G+ + + +A G+ +L +
Sbjct: 69 RLEGVVTKSRPVMIITEYMENGSLDKFLRE--NDGK-FTVGQLVGMLRGIASGMKYLSEM 125
Query: 389 VKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT-YGYLAPEFVY 447
VHRD+ A N+L++ + GLS+ + + T G + APE +
Sbjct: 126 N---YVHRDLAARNILVNSNLVCKVSDFGLSRRLE-DSEATYTTKGGKIPIRWTAPEAIA 181
Query: 448 RNELTTKSDVYSFGVLLLEI 467
+ T+ SDV+SFG+++ E+
Sbjct: 182 YRKFTSASDVWSFGIVMWEV 201
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 2e-16
Identities = 66/217 (30%), Positives = 101/217 (46%), Gaps = 35/217 (16%)
Query: 275 RLLGDSKTGGTYSG----ILPDGS---RVAVKRLKR-SSFQRKKEFYSEIGRFARLHHPN 326
LG G Y G IL GS RVAVK L++ ++ Q KKEF E + +HPN
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 327 LVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRS-------LDWAMRMKVATTLA 379
+V + G C + +YI+ E + G L L ++ R R L + + +A
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDL---LSYL-RDARVERFGPPLLTLKELLDICLDVA 116
Query: 380 QGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGV-----GLSKFV----PWEVMQER 430
+G +L H +HRD+ A N L+ E+ V GL++ + + E
Sbjct: 117 KGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEG 173
Query: 431 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEI 467
+ ++APE + + TT+SDV+SFGVL+ EI
Sbjct: 174 LL----PVRWMAPESLLDGKFTTQSDVWSFGVLMWEI 206
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 4e-16
Identities = 65/265 (24%), Positives = 119/265 (44%), Gaps = 33/265 (12%)
Query: 211 VVSGLILLTTFAIVIWLLAYRRSKRRRKSRKLSNPAASALVPPSWKV--FTTEELRSITK 268
+ L A+V + + R + + +++ N + W++ F ++ +SIT
Sbjct: 632 ITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGT------WELQFFDSKVSKSITI 685
Query: 269 N-----FSEGNRLLGDSKTGGTYSG-ILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL 322
N E N ++ K G +Y G + +G + VK + + SEI +L
Sbjct: 686 NDILSSLKEEN-VISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPS----SEIADMGKL 740
Query: 323 HHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGI 382
HPN+V + G C Y+++E++ L L R+L W R K+A +A+ +
Sbjct: 741 QHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL-------RNLSWERRRKIAIGIAKAL 793
Query: 383 AFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLA 442
FLH + P VV ++ +++D + HL + L P + + Y+A
Sbjct: 794 RFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSL----PGLLCTDTKCFISS--AYVA 846
Query: 443 PEFVYRNELTTKSDVYSFGVLLLEI 467
PE ++T KSD+Y FG++L+E+
Sbjct: 847 PETRETKDITEKSDIYGFGLILIEL 871
|
Length = 968 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 4e-16
Identities = 54/194 (27%), Positives = 99/194 (51%), Gaps = 14/194 (7%)
Query: 277 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD 336
+G + G + G + +VA+K + R +++F E +L HP LV + G C +
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTI-REGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTE 70
Query: 337 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 396
+V+EF+ +G L +L RG S + + M + +G+A+L +V+HR
Sbjct: 71 RSPICLVFEFMEHGCLSDYLRA-QRGKFSQETLLGM--CLDVCEGMAYLESS---NVIHR 124
Query: 397 DIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT---YGYLAPEFVYRNELTT 453
D+ A N L+ E + G+++F V+ ++ + GT + +PE ++ ++
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMTRF----VLDDQYTSSTGTKFPVKWSSPEVFSFSKYSS 180
Query: 454 KSDVYSFGVLLLEI 467
KSDV+SFGVL+ E+
Sbjct: 181 KSDVWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 6e-16
Identities = 55/180 (30%), Positives = 92/180 (51%), Gaps = 17/180 (9%)
Query: 295 RVAVKRLKRSSFQRKKE-FYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352
+VAVK LK ++ ++E SE+ + L +H N+V + G C G ++ E+ G L
Sbjct: 67 KVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDL 126
Query: 353 DRWLHHIPRGGRS-LDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGA 411
+L R S L + + +A+G+AFL K + +HRD+ A NVLL
Sbjct: 127 LNFLR---RKRESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIV 180
Query: 412 HLMGVGLSKFVPWEVMQERT-VMAGGTY---GYLAPEFVYRNELTTKSDVYSFGVLLLEI 467
+ GL++ ++M + V+ G ++APE ++ T +SDV+S+G+LL EI
Sbjct: 181 KICDFGLAR----DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEI 236
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 1e-15
Identities = 56/207 (27%), Positives = 97/207 (46%), Gaps = 17/207 (8%)
Query: 275 RLLGDSKTGGTYSGIL--PDGS--RVAVKRLKRSSFQRK--KEFYSEIGRFARLHHPNLV 328
++LG+ + G G L DGS +VAVK +K +EF SE HPN++
Sbjct: 5 KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVM 64
Query: 329 AVKGCCYDHGDR------YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRM--KVATTLAQ 380
+ G C++ ++ F+ +G L +L + GG ++ K +A
Sbjct: 65 KLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIAL 124
Query: 381 GIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGY 440
G+ +L ++ + +HRD+ A N +L E+ + GLSK + + +A +
Sbjct: 125 GMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKW 181
Query: 441 LAPEFVYRNELTTKSDVYSFGVLLLEI 467
+A E + T+KSDV++FGV + EI
Sbjct: 182 IAIESLADRVYTSKSDVWAFGVTMWEI 208
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 1e-15
Identities = 56/195 (28%), Positives = 91/195 (46%), Gaps = 11/195 (5%)
Query: 275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCC 334
+ LG + G + G + ++VAVK LK + + F E L H LV +
Sbjct: 12 KKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS-VQAFLEEANLMKTLQHDKLVRLYAVV 70
Query: 335 YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVV 394
YI+ E++ G L +L G + + + +A+G+A++ K + +
Sbjct: 71 TKEEPIYIITEYMAKGSLLDFLK--SDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYI 125
Query: 395 HRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELT 452
HRD+RA+NVL+ E + GL++ + E T G + + APE + T
Sbjct: 126 HRDLRAANVLVSESLMCKIADFGLARVIE---DNEYTAREGAKFPIKWTAPEAINFGSFT 182
Query: 453 TKSDVYSFGVLLLEI 467
KSDV+SFG+LL EI
Sbjct: 183 IKSDVWSFGILLYEI 197
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 2e-15
Identities = 56/179 (31%), Positives = 92/179 (51%), Gaps = 11/179 (6%)
Query: 293 GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR--YIVYEFVVNG 350
G VAVK+L+ S+ + ++F EI L H N+V KG CY G R +V E++ G
Sbjct: 33 GEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYG 92
Query: 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG 410
L +L + LD + A+ + +G+ +L K VHRD+ N+L++ E
Sbjct: 93 SLRDYLQ---KHRERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENR 146
Query: 411 AHLMGVGLSKFVPWEVMQERTVMAGGT--YGYLAPEFVYRNELTTKSDVYSFGVLLLEI 467
+ GL+K +P + + G + + Y APE + ++ + SDV+SFGV+L E+
Sbjct: 147 VKIGDFGLTKVLPQDKEYYKVREPGESPIFWY-APESLTESKFSVASDVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 75.7 bits (187), Expect = 4e-15
Identities = 50/205 (24%), Positives = 91/205 (44%), Gaps = 36/205 (17%)
Query: 277 LGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY 335
+G+ +G Y G VA+K+++ Q K+ +EI HPN+V
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKMRLRK-QNKELIINEILIMKDCKHPNIVDYYDSYL 85
Query: 336 DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMK------VATTLAQGIAFLHDKV 389
+ ++V E++ G L + +RM V + QG+ +LH +
Sbjct: 86 VGDELWVVMEYMDGGSLTDIITQNF---------VRMNEPQIAYVCREVLQGLEYLHSQ- 135
Query: 390 KPHVVHRDIRASNVLLDEE-------FGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLA 442
+V+HRDI++ N+LL ++ FG L+K +R + G Y ++A
Sbjct: 136 --NVIHRDIKSDNILLSKDGSVKLADFG---FAAQLTKEK-----SKRNSVVGTPY-WMA 184
Query: 443 PEFVYRNELTTKSDVYSFGVLLLEI 467
PE + R + K D++S G++ +E+
Sbjct: 185 PEVIKRKDYGPKVDIWSLGIMCIEM 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 4e-15
Identities = 62/202 (30%), Positives = 89/202 (44%), Gaps = 28/202 (13%)
Query: 276 LLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKK-EFYSEIGRFARLHHPNLVAVKGCC 334
LLG G + G L D + VAVK K Q K +F SE + HPN+V + G C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 335 YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVV 394
YIV E V G +L + + L +K A A G+A+L K + +
Sbjct: 62 TQRQPIYIVMELVPGGD---FLSFLRKKKDELKTKQLVKFALDAAAGMAYLESK---NCI 115
Query: 395 HRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYG----------YLAPE 444
HRD+ A N L+ E + G+S+ QE G Y + APE
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSR-------QED----DGIYSSSGLKQIPIKWTAPE 164
Query: 445 FVYRNELTTKSDVYSFGVLLLE 466
+ +++SDV+S+G+LL E
Sbjct: 165 ALNYGRYSSESDVWSYGILLWE 186
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 5e-15
Identities = 56/197 (28%), Positives = 94/197 (47%), Gaps = 32/197 (16%)
Query: 296 VAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR 354
VAVK L+ S +++F E+ +RL PN+ + G C ++ E++ NG L++
Sbjct: 49 VAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQ 108
Query: 355 WLH-HIPR------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE 407
+L H+ +SL ++ + +AT +A G+ +L + VHRD+ N L+ +
Sbjct: 109 FLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRNCLVGK 165
Query: 408 EFGAHLMGVGLSKFVPWEVMQERTVMAGGTYG----------YLAPEFVYRNELTTKSDV 457
+ + G+S R + + Y ++A E V + TTKSDV
Sbjct: 166 NYTIKIADFGMS----------RNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDV 215
Query: 458 YSFGVLLLEIRLVLCRR 474
++FGV L EI L LCR
Sbjct: 216 WAFGVTLWEI-LTLCRE 231
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 5e-15
Identities = 54/205 (26%), Positives = 88/205 (42%), Gaps = 29/205 (14%)
Query: 275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLH-HPNLVAVKGC 333
+G G Y G+L + VAVK + + K + + + + HPN+V + G
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGV 60
Query: 334 CYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHV 393
C YIV E V G L L + + L ++++ A G+ +L K +
Sbjct: 61 CVQKQPIYIVMELVPGGSL---LTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESK---NC 114
Query: 394 VHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYG-----------YLA 442
+HRD+ A N L+ E + G+S+ +E GG Y + A
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSR-------EE----EGGIYTVSDGLKQIPIKWTA 163
Query: 443 PEFVYRNELTTKSDVYSFGVLLLEI 467
PE + T++SDV+S+G+LL E
Sbjct: 164 PEALNYGRYTSESDVWSYGILLWET 188
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 6e-15
Identities = 62/211 (29%), Positives = 96/211 (45%), Gaps = 26/211 (12%)
Query: 275 RLLGDSKTG----GTYSGILPDGSR--VAVKRLKRSSFQRKKE-FYSEIGRFARLHHPNL 327
R LG G G Y G D VAVK L S ++ + F E ++ +H N+
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71
Query: 328 VAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHI-PRGGRSLDWAMR--MKVATTLAQGIAF 384
V + G ++ R+I+ E + G L +L PR R M+ + A +A+G +
Sbjct: 72 VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131
Query: 385 LHDKVKPHVVHRDIRASNVLLDEEFG----AHLMGVGLSKFVPWEVMQERTVMAGGT--- 437
L + H +HRDI A N LL + G A + G+++ ++ + GG
Sbjct: 132 LEEN---HFIHRDIAARNCLLTCK-GPGRVAKIADFGMAR----DIYRASYYRKGGRAML 183
Query: 438 -YGYLAPEFVYRNELTTKSDVYSFGVLLLEI 467
++ PE T+K+DV+SFGVLL EI
Sbjct: 184 PIKWMPPEAFLDGIFTSKTDVWSFGVLLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 6e-15
Identities = 54/179 (30%), Positives = 84/179 (46%), Gaps = 12/179 (6%)
Query: 296 VAVKRL-KRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR 354
V VK L K + EF E+ F +L H N+V + G C + Y++ E+ G L +
Sbjct: 38 VLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQ 97
Query: 355 WL-----HHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF 409
+L L ++ + T +A G+ L VHRD+ A N L+ +
Sbjct: 98 FLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQR 154
Query: 410 GAHLMGVGLSKFV-PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEI 467
+ + LSK V E + R + +LAPE V ++ +TKSDV+SFGVL+ E+
Sbjct: 155 EVKVSLLSLSKDVYNSEYYKLRNALI--PLRWLAPEAVQEDDFSTKSDVWSFGVLMWEV 211
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 6e-15
Identities = 59/223 (26%), Positives = 102/223 (45%), Gaps = 28/223 (12%)
Query: 277 LGDSKTGGTY----SGILPDGSR--VAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAV 330
LG+ G + +LP+ + VAVK LK +S +++F E L H ++V
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 331 KGCCYDHGDRYIVYEFVVNGPLDRWLH------HIPRGGR-----SLDWAMRMKVATTLA 379
G C + +V+E++ +G L+R+L I GG L + +A+ +A
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 380 QGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGG--- 436
G+ +L H VHRD+ N L+ + + G+S+ ++ GG
Sbjct: 133 SGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSR----DIYSTDYYRVGGRTM 185
Query: 437 -TYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVLCRRWWTL 478
++ PE + + TT+SD++SFGV+L EI + W+ L
Sbjct: 186 LPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQL 228
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 7e-15
Identities = 68/247 (27%), Positives = 106/247 (42%), Gaps = 30/247 (12%)
Query: 294 SRVAVKRLKRSSFQRK-KEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNGP 351
S VAVK LK + ++ + SE+ + H N++ + G C G Y+V E+ +G
Sbjct: 43 STVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGN 102
Query: 352 LDRWLH-HIPRG-----------GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIR 399
L +L P G +L + A +A+G+ FL K +HRD+
Sbjct: 103 LRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLA 159
Query: 400 ASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYS 459
A NVL+ E+ + GL++ + +T ++APE ++ T +SDV+S
Sbjct: 160 ARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWS 219
Query: 460 FGVLLLEIRLVLCRRW-----WTLYTLV---HSMS--LLCAQECLMLFISCNNWPSHLSQ 509
FGVLL EI + + L+ L+ + M C QE L C W SQ
Sbjct: 220 FGVLLWEIFTLGGSPYPGIPVEELFKLLKEGYRMEKPQNCTQELYHLMRDC--WHEVPSQ 277
Query: 510 S-KFCNL 515
F L
Sbjct: 278 RPTFKQL 284
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 7e-15
Identities = 56/176 (31%), Positives = 88/176 (50%), Gaps = 13/176 (7%)
Query: 293 GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY-DHGDRYIVYEFVVNGP 351
G++VAVK +K + + F +E +L H NLV + G + G YIV E++ G
Sbjct: 29 GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGS 86
Query: 352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGA 411
L +L RG L +K + + + + +L + VHRD+ A NVL+ E+ A
Sbjct: 87 LVDYLR--SRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVA 141
Query: 412 HLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEI 467
+ GL+K Q+ + + APE + + +TKSDV+SFG+LL EI
Sbjct: 142 KVSDFGLTKEA--SSTQDTGKLP---VKWTAPEALREKKFSTKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 8e-15
Identities = 59/209 (28%), Positives = 99/209 (47%), Gaps = 23/209 (11%)
Query: 276 LLGDSKTGGTYSGILP-DGSRV--AVKRLKR-SSFQRKKEFYSEIGRFARL-HHPNLVAV 330
++G+ G + DG R+ A+KR+K +S ++F E+ +L HHPN++ +
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61
Query: 331 KGCCYDHGDRYIVYEFVVNGPL------DRWLHHIPRGGR------SLDWAMRMKVATTL 378
G C G Y+ E+ +G L R L P +L + A +
Sbjct: 62 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121
Query: 379 AQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY 438
A+G+ +L K +HRD+ A N+L+ E + A + GLS+ + + + M
Sbjct: 122 ARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLPV 175
Query: 439 GYLAPEFVYRNELTTKSDVYSFGVLLLEI 467
++A E + + TT SDV+S+GVLL EI
Sbjct: 176 RWMAIESLNYSVYTTNSDVWSYGVLLWEI 204
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 9e-15
Identities = 64/209 (30%), Positives = 104/209 (49%), Gaps = 23/209 (11%)
Query: 276 LLGDSKTGGTYSGILP-DGSRV--AVKRLKR-SSFQRKKEFYSEIGRFARL-HHPNLVAV 330
++G+ G ++ DG ++ A+K LK +S ++F E+ +L HHPN++ +
Sbjct: 9 VIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINL 68
Query: 331 KGCCYDHGDRYIVYEFVVNGPL------DRWLHHIPRGGR------SLDWAMRMKVATTL 378
G C + G YI E+ G L R L P + +L ++ A+ +
Sbjct: 69 LGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDV 128
Query: 379 AQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY 438
A G+ +L +K +HRD+ A NVL+ E + + GLS+ EV ++T M
Sbjct: 129 ATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSR--GEEVYVKKT-MGRLPV 182
Query: 439 GYLAPEFVYRNELTTKSDVYSFGVLLLEI 467
++A E + + TTKSDV+SFGVLL EI
Sbjct: 183 RWMAIESLNYSVYTTKSDVWSFGVLLWEI 211
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 1e-14
Identities = 66/207 (31%), Positives = 95/207 (45%), Gaps = 36/207 (17%)
Query: 277 LGDSKTGGTYSGI--LPDGSR--VAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVK 331
LG G G+ + G VAVK LK+ KKEF E A+L HP +V +
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 332 GCCYDHGDRYI-VYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVK 390
G C G+ + V E GPL ++L + R + + ++A +A G+A+L K
Sbjct: 63 GVC--KGEPLMLVMELAPLGPLLKYL----KKRREIPVSDLKELAHQVAMGMAYLESK-- 114
Query: 391 PHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY-----------G 439
H VHRD+ A NVLL A + G+S R + AG Y
Sbjct: 115 -HFVHRDLAARNVLLVNRHQAKISDFGMS----------RALGAGSDYYRATTAGRWPLK 163
Query: 440 YLAPEFVYRNELTTKSDVYSFGVLLLE 466
+ APE + + ++KSDV+S+GV L E
Sbjct: 164 WYAPECINYGKFSSKSDVWSYGVTLWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 1e-14
Identities = 64/199 (32%), Positives = 101/199 (50%), Gaps = 30/199 (15%)
Query: 289 ILPDGSRV--AVKRLKR-SSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVY 344
I DG R+ A+KR+K +S ++F E+ +L HHPN++ + G C G Y+
Sbjct: 28 IKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAI 87
Query: 345 EFVVNGPLDRWLHHIPRGGRSLD----WAMRMKVATTL------------AQGIAFLHDK 388
E+ +G L +L R R L+ +A+ A+TL A+G+ +L K
Sbjct: 88 EYAPHGNLLDFL----RKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK 143
Query: 389 VKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYR 448
+HRD+ A N+L+ E + A + GLS+ EV ++T M ++A E +
Sbjct: 144 ---QFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKT-MGRLPVRWMAIESLNY 197
Query: 449 NELTTKSDVYSFGVLLLEI 467
+ TT SDV+S+GVLL EI
Sbjct: 198 SVYTTNSDVWSYGVLLWEI 216
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-14
Identities = 56/203 (27%), Positives = 93/203 (45%), Gaps = 23/203 (11%)
Query: 292 DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP 351
D VAVK LK + +K+F E L H ++V G C D +V+E++ +G
Sbjct: 34 DKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGD 93
Query: 352 LDRWLH-HIP-----------RGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIR 399
L+++L H P + L + + +A+ +A G+ +L + H VHRD+
Sbjct: 94 LNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLA 150
Query: 400 ASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGG----TYGYLAPEFVYRNELTTKS 455
N L+ + G+S+ +V GG ++ PE + + TT+S
Sbjct: 151 TRNCLVGANLLVKIGDFGMSR----DVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTES 206
Query: 456 DVYSFGVLLLEIRLVLCRRWWTL 478
DV+SFGV+L EI + W+ L
Sbjct: 207 DVWSFGVILWEIFTYGKQPWFQL 229
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 73.1 bits (180), Expect = 2e-14
Identities = 53/192 (27%), Positives = 94/192 (48%), Gaps = 18/192 (9%)
Query: 282 TGGTYSGIL--PDGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHG 338
G S +L P G +AVK ++ +K+ E+ + + P +V G Y++G
Sbjct: 13 NSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNG 72
Query: 339 DRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDI 398
D I E++ G LD+ L + + K+A + +G+ +LH+K ++HRD+
Sbjct: 73 DISICMEYMDGGSLDKIL---KEVQGRIPERILGKIAVAVLKGLTYLHEKH--KIIHRDV 127
Query: 399 RASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG---GTYGYLAPEFVYRNELTTKS 455
+ SN+L++ L G+S Q +A GT Y+APE + N+ + KS
Sbjct: 128 KPSNILVNSRGQIKLCDFGVSG-------QLVNSLAKTFVGTSSYMAPERIQGNDYSVKS 180
Query: 456 DVYSFGVLLLEI 467
D++S G+ L+E+
Sbjct: 181 DIWSLGLSLIEL 192
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 2e-14
Identities = 58/185 (31%), Positives = 91/185 (49%), Gaps = 13/185 (7%)
Query: 293 GSRVAVKRLK-RSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYI--VYEFVVN 349
G +VAVK LK S + EI L+H N+V KG C + G I + EF+ +
Sbjct: 33 GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPS 92
Query: 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF 409
G L +L PR ++ ++K A + +G+ +L + VHRD+ A NVL++ E
Sbjct: 93 GSLKEYL---PRNKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEH 146
Query: 410 GAHLMGVGLSKFVPW--EVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEI 467
+ GL+K + E + + + Y APE + +++ SDV+SFGV L E+
Sbjct: 147 QVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWY-APECLIQSKFYIASDVWSFGVTLYEL 205
Query: 468 RLVLC 472
L C
Sbjct: 206 -LTYC 209
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 73.6 bits (180), Expect = 2e-14
Identities = 61/238 (25%), Positives = 102/238 (42%), Gaps = 30/238 (12%)
Query: 296 VAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRW 355
VAVK LK +S +K+F+ E L H ++V G C + +V+E++ +G L+++
Sbjct: 38 VAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKF 97
Query: 356 LH-HIPRG--------GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD 406
L H P L + + +A +A G+ +L + H VHRD+ N L+
Sbjct: 98 LRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVG 154
Query: 407 EEFGAHLMGVGLSKFVPWEVMQERTVMAGG----TYGYLAPEFVYRNELTTKSDVYSFGV 462
E + G+S+ +V GG ++ PE + + TT+SDV+S GV
Sbjct: 155 ENLLVKIGDFGMSR----DVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGV 210
Query: 463 LLLEIRLVLCRRWWTLYT----------LVHSMSLLCAQECLMLFISCNNWPSHLSQS 510
+L EI + W+ L V C +E L + C H+ +
Sbjct: 211 VLWEIFTYGKQPWYQLSNNEVIECITQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLN 268
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 2e-14
Identities = 46/152 (30%), Positives = 73/152 (48%), Gaps = 19/152 (12%)
Query: 323 HHPNLVAVKGCCYDHGDR--YIVYEFVVNGPLDRWLHHI-PRGGRSLDWAMRMKVATTLA 379
P +V G D I E+ G LD + RGGR + + K+A ++
Sbjct: 57 KSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVL-GKIAESVL 115
Query: 380 QGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLS-KFVPWEVMQERTVMAG--- 435
+G+++LH + ++HRDI+ SN+LL + L G+S + V +AG
Sbjct: 116 KGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELV--------NSLAGTFT 164
Query: 436 GTYGYLAPEFVYRNELTTKSDVYSFGVLLLEI 467
GT Y+APE + + SDV+S G+ LLE+
Sbjct: 165 GTSFYMAPERIQGKPYSITSDVWSLGLTLLEV 196
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 4e-14
Identities = 56/212 (26%), Positives = 101/212 (47%), Gaps = 16/212 (7%)
Query: 275 RLLGDSKTGGTYSGILPDGSR----VAVKRLKRSSFQRKK-EFYSEIGRFARLHHPNLVA 329
+++G + G + GIL R VA+K LK ++++ +F SE + H N++
Sbjct: 11 KVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIR 70
Query: 330 VKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV 389
++G I+ E++ NG LD++L S ++ +A G+ +L D
Sbjct: 71 LEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLR---GIAAGMKYLSDM- 126
Query: 390 KPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGG---TYGYLAPEFV 446
+ VHRD+ A N+L++ + GLS+ + E E T G + APE +
Sbjct: 127 --NYVHRDLAARNILVNSNLECKVSDFGLSRVL--EDDPEGTYTTSGGKIPIRWTAPEAI 182
Query: 447 YRNELTTKSDVYSFGVLLLEIRLVLCRRWWTL 478
+ T+ SDV+SFG+++ E+ R +W +
Sbjct: 183 AYRKFTSASDVWSFGIVMWEVMSFGERPYWDM 214
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 5e-14
Identities = 55/211 (26%), Positives = 91/211 (43%), Gaps = 44/211 (20%)
Query: 288 GILP--DGSRVAVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVY 344
G+LP + VAVK LK +S + +F E A HPN+V + G C +++
Sbjct: 28 GLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLF 87
Query: 345 EFVVNGPLD--------RWLHHIPRGGRS----------LDWAMRMKVATTLAQGIAFLH 386
E++ G L+ R + S L ++ +A +A G+A+L
Sbjct: 88 EYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS 147
Query: 387 DKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYG------- 439
++ VHRD+ N L+ E + GLS R + + Y
Sbjct: 148 ER---KFVHRDLATRNCLVGENMVVKIADFGLS----------RNIYSADYYKASENDAI 194
Query: 440 ---YLAPEFVYRNELTTKSDVYSFGVLLLEI 467
++ PE ++ N TT+SDV+++GV+L EI
Sbjct: 195 PIRWMPPESIFYNRYTTESDVWAYGVVLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 6e-14
Identities = 56/195 (28%), Positives = 88/195 (45%), Gaps = 14/195 (7%)
Query: 277 LGDSKTGGTYSGILPDGSRV-AVKRLKRSSFQR--KKEFYSEIGRFARLHHPNLVAVKGC 333
+G G + + RV A+K++ S R ++E E A+L ++
Sbjct: 8 IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYES 67
Query: 334 CYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSL--DWAMRMKVATTLAQGIAFLHDKVKP 391
D G IV E+ NG L + L + GR L D R + L G+A LH K
Sbjct: 68 FLDKGKLNIVMEYAENGDLHKLLKM--QRGRPLPEDQVWRFFIQILL--GLAHLHSK--- 120
Query: 392 HVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNEL 451
++HRDI++ N+ LD + +G++K + T++ GT YL+PE
Sbjct: 121 KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIV--GTPYYLSPELCEDKPY 178
Query: 452 TTKSDVYSFGVLLLE 466
KSDV++ GV+L E
Sbjct: 179 NEKSDVWALGVVLYE 193
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 8e-14
Identities = 56/194 (28%), Positives = 94/194 (48%), Gaps = 14/194 (7%)
Query: 277 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD 336
LG+ + G + G ++VAVK LK + + F E +L H LV + +
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS-PESFLEEAQIMKKLRHDKLVQLYAVVSE 72
Query: 337 HGDRYIVYEFVVNGPLDRWLHHIPRG-GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 395
YIV E++ G L L + G GR+L + +A +A G+A++ + + +H
Sbjct: 73 E-PIYIVTEYMSKGSL---LDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIH 125
Query: 396 RDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTT 453
RD+R++N+L+ + + GL++ + E T G + + APE T
Sbjct: 126 RDLRSANILVGDGLVCKIADFGLARLIE---DNEYTARQGAKFPIKWTAPEAALYGRFTI 182
Query: 454 KSDVYSFGVLLLEI 467
KSDV+SFG+LL E+
Sbjct: 183 KSDVWSFGILLTEL 196
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 1e-13
Identities = 59/213 (27%), Positives = 101/213 (47%), Gaps = 28/213 (13%)
Query: 277 LGDSKTGGTYSG--ILP---DGSRVAVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLVAV 330
LG+ G Y G LP VA+K LK ++ Q+ EF E A LHHPN+V +
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 331 KGCCYDHGDRYIVYEFVVNGPLDRWL----HHIPRG---------GRSLDWAMRMKVATT 377
G +++E++ G L +L H G SLD + +A
Sbjct: 73 LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132
Query: 378 LAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV---PWEVMQERTVMA 434
+A G+ +L VH+D+ A N+L+ E+ + +GLS+ + + +Q ++++
Sbjct: 133 IAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLP 189
Query: 435 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEI 467
++ PE + + ++ SD++SFGV+L EI
Sbjct: 190 ---IRWMPPEAIMYGKFSSDSDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 1e-13
Identities = 58/214 (27%), Positives = 99/214 (46%), Gaps = 28/214 (13%)
Query: 275 RLLGDSKTGGTYSG----ILPDGSR--VAVKRLKRSSFQR-KKEFYSEIGRFARLHHPNL 327
R LG+ G + G + P+ + VAVK LK ++ +K+F E H N+
Sbjct: 11 RELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENI 70
Query: 328 VAVKGCCYDHGDRYIVYEFVVNGPLDRWLH-HIPRGGRS---------LDWAMRMKVATT 377
V G C + +V+E++ +G L+++L H P L + +++A
Sbjct: 71 VKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQ 130
Query: 378 LAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT 437
+A G+ +L + H VHRD+ N L+ + + G+S+ +V GG
Sbjct: 131 IASGMVYLASQ---HFVHRDLATRNCLVGYDLVVKIGDFGMSR----DVYTTDYYRVGGH 183
Query: 438 ----YGYLAPEFVYRNELTTKSDVYSFGVLLLEI 467
++ PE + + TT+SDV+SFGV+L EI
Sbjct: 184 TMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEI 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 70.9 bits (173), Expect = 1e-13
Identities = 56/194 (28%), Positives = 91/194 (46%), Gaps = 14/194 (7%)
Query: 277 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD 336
LG G + G ++VA+K LK + + F E +L H LV + +
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMM-PEAFLQEAQIMKKLRHDKLVPLYAVVSE 72
Query: 337 HGDRYIVYEFVVNGPLDRWLHHIPRG-GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 395
YIV EF+ G L L + G G+ L + +A +A G+A++ + + +H
Sbjct: 73 E-PIYIVTEFMGKGSL---LDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIH 125
Query: 396 RDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTT 453
RD+RA+N+L+ + + GL++ + E T G + + APE T
Sbjct: 126 RDLRAANILVGDNLVCKIADFGLARLIE---DNEYTARQGAKFPIKWTAPEAALYGRFTI 182
Query: 454 KSDVYSFGVLLLEI 467
KSDV+SFG+LL E+
Sbjct: 183 KSDVWSFGILLTEL 196
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 3e-13
Identities = 57/202 (28%), Positives = 95/202 (47%), Gaps = 21/202 (10%)
Query: 275 RLLGDSKTGGTYSGI-LPDGSRVAVKRLK-----RSSFQRKKEFYSEIGRFARLHHPNLV 328
LLG G Y G+ L DG AVK + ++ + K+ EI ++L HPN+V
Sbjct: 6 ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65
Query: 329 AVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDK 388
G + + YI E V G L + L + G + +R+ L G+ +LHD+
Sbjct: 66 QYLGTEREEDNLYIFLELVPGGSLAKLLK---KYGSFPEPVIRLYTRQILL-GLEYLHDR 121
Query: 389 VKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV--MAGGTYGYLAPEFV 446
+ VHRDI+ +N+L+D L G++K +V++ G Y ++APE +
Sbjct: 122 ---NTVHRDIKGANILVDTNGVVKLADFGMAK----QVVEFSFAKSFKGSPY-WMAPEVI 173
Query: 447 YR-NELTTKSDVYSFGVLLLEI 467
+ +D++S G +LE+
Sbjct: 174 AQQGGYGLAADIWSLGCTVLEM 195
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 3e-13
Identities = 49/181 (27%), Positives = 83/181 (45%), Gaps = 8/181 (4%)
Query: 290 LPDGSRVAVKRLKRSSFQRKK---EFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF 346
L DG VA+K+++ K + EI +L HPN++ ++ + IV E
Sbjct: 24 LLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLEL 83
Query: 347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD 406
G L R + H + R + K L + +H K ++HRDI+ +NV +
Sbjct: 84 ADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFIT 140
Query: 407 EEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLE 466
L +GL +F + +++ GT Y++PE ++ N KSD++S G LL E
Sbjct: 141 ATGVVKLGDLGLGRFFSSKTTAAHSLV--GTPYYMSPERIHENGYNFKSDIWSLGCLLYE 198
Query: 467 I 467
+
Sbjct: 199 M 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 4e-13
Identities = 52/199 (26%), Positives = 92/199 (46%), Gaps = 24/199 (12%)
Query: 290 LPDGSRVAVKRLKRSSFQRK-KEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV 348
+ VAVK LK ++ + ++ SE +++HP+++ + G C G ++ E+
Sbjct: 27 RAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAK 86
Query: 349 NGPLDRWLH--------HIPRGG------------RSLDWAMRMKVATTLAQGIAFLHDK 388
G L +L ++ G R+L + A +++G+ +L +
Sbjct: 87 YGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM 146
Query: 389 VKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYR 448
+VHRD+ A NVL+ E + GLS+ V E + ++A E ++
Sbjct: 147 ---KLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFD 203
Query: 449 NELTTKSDVYSFGVLLLEI 467
+ TT+SDV+SFGVLL EI
Sbjct: 204 HIYTTQSDVWSFGVLLWEI 222
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 5e-13
Identities = 55/206 (26%), Positives = 98/206 (47%), Gaps = 27/206 (13%)
Query: 275 RLLGDSKTGGTYSGI-LPDGSR----VAVKRLKRSSFQR-KKEFYSEIGRFARLHHPNLV 328
++LG G Y G+ +P+G + VA+K L+ + + KE E A + HP++V
Sbjct: 13 KVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVV 72
Query: 329 AVKGCCYDHGDRY-IVYEFVVNGPLDRWLH-HIPRGGRS--LDWAMRMKVATTLAQGIAF 384
+ G C + ++ + + G L ++ H G L+W +A+G+++
Sbjct: 73 RLLGICL--SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWC------VQIAKGMSY 124
Query: 385 LHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGG---TYGYL 441
L +K +VHRD+ A NVL+ + GL+K + + E+ A G ++
Sbjct: 125 LEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLD---VDEKEYHAEGGKVPIKWM 178
Query: 442 APEFVYRNELTTKSDVYSFGVLLLEI 467
A E + T KSDV+S+GV + E+
Sbjct: 179 ALESILHRIYTHKSDVWSYGVTVWEL 204
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 5e-13
Identities = 57/193 (29%), Positives = 90/193 (46%), Gaps = 12/193 (6%)
Query: 277 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD 336
LG G + G +RVA+K LK + + F E +L H LV + +
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVSE 72
Query: 337 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 396
YIV E++ G L +L G+ L + +A +A G+A++ + + VHR
Sbjct: 73 E-PIYIVTEYMSKGSLLDFLKG--EMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 126
Query: 397 DIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTTK 454
D+RA+N+L+ E + GL++ + E T G + + APE T K
Sbjct: 127 DLRAANILVGENLVCKVADFGLARLIE---DNEYTARQGAKFPIKWTAPEAALYGRFTIK 183
Query: 455 SDVYSFGVLLLEI 467
SDV+SFG+LL E+
Sbjct: 184 SDVWSFGILLTEL 196
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 6e-13
Identities = 58/215 (26%), Positives = 97/215 (45%), Gaps = 20/215 (9%)
Query: 261 EELRSIT------KNFSEGNRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFY 313
E+LR+I K ++ ++ G +G Y+ I + G VA+K++ +K+
Sbjct: 6 EKLRTIVSVGDPKKKYTRFEKI-GQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELII 64
Query: 314 SEIGRFARLHHPNLVAVKGCCYDHGDR-YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRM 372
+EI HPN+V Y GD ++V E++ G L + +D
Sbjct: 65 NEILVMRENKHPNIVNYLDS-YLVGDELWVVMEYLAGGSLTDVVTET-----CMDEGQIA 118
Query: 373 KVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV 432
V Q + FLH V+HRDI++ N+LL + L G + E +R+
Sbjct: 119 AVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-QSKRST 174
Query: 433 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEI 467
M G Y ++APE V R K D++S G++ +E+
Sbjct: 175 MVGTPY-WMAPEVVTRKAYGPKVDIWSLGIMAIEM 208
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.3 bits (168), Expect = 6e-13
Identities = 49/173 (28%), Positives = 80/173 (46%), Gaps = 12/173 (6%)
Query: 297 AVKRL-KRSSFQRKKEFYSEIGRF--ARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 353
A+K L K+ +RK+ ++ R +R++HP +V + Y+V E+ G L
Sbjct: 22 AMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL- 80
Query: 354 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHL 413
H+ + GR + R A + + +LH +++RD++ N+LLD + L
Sbjct: 81 --FSHLSKEGRFSEERARFYAAE-IVLALEYLHSL---GIIYRDLKPENILLDADGHIKL 134
Query: 414 MGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLE 466
GL+K + E + T GT YLAPE + D +S GVLL E
Sbjct: 135 TDFGLAKELSSEGSRTNTFC--GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYE 185
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 7e-13
Identities = 50/175 (28%), Positives = 88/175 (50%), Gaps = 12/175 (6%)
Query: 295 RVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR 354
+VA+K + + +++F E +L HP LV + G C YIV EF+ NG L
Sbjct: 30 KVAIKAINEGAMS-EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLN 88
Query: 355 WLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLM 414
+L +G S D M + + + +G+ +L + +HRD+ A N L+ +
Sbjct: 89 YLRQ-RQGKLSKD--MLLSMCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVS 142
Query: 415 GVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTTKSDVYSFGVLLLEI 467
G++++V + E T +G + + PE ++ ++KSDV+SFGVL+ E+
Sbjct: 143 DFGMTRYV---LDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 8e-13
Identities = 54/197 (27%), Positives = 98/197 (49%), Gaps = 26/197 (13%)
Query: 296 VAVKRLK-RSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR 354
VAVK L+ ++ + +F E+ +RL PN++ + G C D ++ E++ NG L++
Sbjct: 49 VAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQ 108
Query: 355 WL--HHIPRG-------------GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIR 399
+L HH+ ++ ++ + VA +A G+ +L + VHRD+
Sbjct: 109 FLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVHRDLA 165
Query: 400 ASNVLLDEEFGAHLMGVGLSKFV---PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSD 456
N L+ E + G+S+ + + +Q R V+ ++A E + + TT SD
Sbjct: 166 TRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLP---IRWMAWECILMGKFTTASD 222
Query: 457 VYSFGVLLLEIRLVLCR 473
V++FGV L EI L+LC+
Sbjct: 223 VWAFGVTLWEI-LMLCK 238
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 9e-13
Identities = 56/207 (27%), Positives = 97/207 (46%), Gaps = 23/207 (11%)
Query: 276 LLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSF-----QRKKEFYS----EIGRFARLHHP 325
L+G G Y G+ G +AVK+++ S RK+ EI L H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 326 NLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFL 385
N+V G D I E+V G + L++ +L +R V L +G+ +L
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETL---VRNFVRQIL-KGLNYL 122
Query: 386 HDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM-----QERTVMAGGTYGY 440
H++ ++HRDI+ +N+L+D + G + G+SK + + R + G + +
Sbjct: 123 HNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVF-W 178
Query: 441 LAPEFVYRNELTTKSDVYSFGVLLLEI 467
+APE V + T K+D++S G L++E+
Sbjct: 179 MAPEVVKQTSYTRKADIWSLGCLVVEM 205
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 1e-12
Identities = 58/215 (26%), Positives = 99/215 (46%), Gaps = 20/215 (9%)
Query: 261 EELRSIT------KNFSEGNRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFY 313
E+LR+I K ++ ++ G +G ++ I + G VA+K++ +K+
Sbjct: 6 EKLRTIVSIGDPKKKYTRYEKI-GQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELII 64
Query: 314 SEIGRFARLHHPNLVAVKGCCYDHGDR-YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRM 372
+EI L +PN+V + GD ++V E++ G L + +D A
Sbjct: 65 NEILVMKELKNPNIVNFLDS-FLVGDELFVVMEYLAGGSLTDVVTET-----CMDEAQIA 118
Query: 373 KVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV 432
V Q + FLH V+HRDI++ NVLL + L G + E +R+
Sbjct: 119 AVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE-QSKRST 174
Query: 433 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEI 467
M G Y ++APE V R K D++S G++ +E+
Sbjct: 175 MVGTPY-WMAPEVVTRKAYGPKVDIWSLGIMAIEM 208
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 2e-12
Identities = 53/200 (26%), Positives = 91/200 (45%), Gaps = 26/200 (13%)
Query: 284 GTYSGILPD--GSRVAVKRL-KRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR 340
G G++ +RVA+K + + +S + + EF +E + ++V + G
Sbjct: 25 GLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84
Query: 341 YIVYEFVVNGPLDRWL--------HHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPH 392
+V E + G L +L ++ G +L ++M A +A G+A+L K
Sbjct: 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQM--AAEIADGMAYLAAK---K 139
Query: 393 VVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL-----APEFVY 447
VHRD+ A N ++ E+ + G+++ + E G G L APE +
Sbjct: 140 FVHRDLAARNCMVAEDLTVKIGDFGMTRDI-----YETDYYRKGGKGLLPVRWMAPESLK 194
Query: 448 RNELTTKSDVYSFGVLLLEI 467
TTKSDV+SFGV+L E+
Sbjct: 195 DGVFTTKSDVWSFGVVLWEM 214
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 2e-12
Identities = 47/179 (26%), Positives = 83/179 (46%), Gaps = 8/179 (4%)
Query: 292 DGSRVAVKRLKRSSF---QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV 348
DG VA+K+++ + + + EI +L+HPN++ + + IV E
Sbjct: 26 DGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELAD 85
Query: 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE 408
G L R + H + R + K L + +H + V+HRDI+ +NV +
Sbjct: 86 AGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITAT 142
Query: 409 FGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEI 467
L +GL +F + +++ GT Y++PE ++ N KSD++S G LL E+
Sbjct: 143 GVVKLGDLGLGRFFSSKTTAAHSLV--GTPYYMSPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 2e-12
Identities = 55/212 (25%), Positives = 95/212 (44%), Gaps = 26/212 (12%)
Query: 270 FSEGNRLLGDSKTGGTYSGILPDGSRVAVKRL------KRSSFQRKKEFYSEIGRFARLH 323
+++G +LG G Y G+ G +AVK++ ++ + ++ E+ L
Sbjct: 2 WTKGE-VLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLK 60
Query: 324 HPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIA 383
H N+V G C D I EFV G + L+ R G + K + G+A
Sbjct: 61 HVNIVQYLGTCLDDNTISIFMEFVPGGSISSILN---RFGPLPEPVFC-KYTKQILDGVA 116
Query: 384 FLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW--------EVMQERTVMAG 435
+LH+ VVHRDI+ +NV+L L+ G ++ + W +++ M G
Sbjct: 117 YLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKS---MHG 170
Query: 436 GTYGYLAPEFVYRNELTTKSDVYSFGVLLLEI 467
Y ++APE + + KSD++S G + E+
Sbjct: 171 TPY-WMAPEVINESGYGRKSDIWSIGCTVFEM 201
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 2e-12
Identities = 40/146 (27%), Positives = 72/146 (49%), Gaps = 10/146 (6%)
Query: 321 RLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQ 380
L+HP LV + D + Y+V + ++ G L R+ H+ + + + ++ + +
Sbjct: 56 ELNHPFLVNLWYSFQDEENMYLVVDLLLGGDL-RY--HLSQKVKFSEEQVKFWICE-IVL 111
Query: 381 GIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGY 440
+ +LH K ++HRDI+ N+LLDE+ H+ ++ V + + T GT GY
Sbjct: 112 ALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTS---GTPGY 165
Query: 441 LAPEFVYRNELTTKSDVYSFGVLLLE 466
+APE + R + D +S GV E
Sbjct: 166 MAPEVLCRQGYSVAVDWWSLGVTAYE 191
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 2e-12
Identities = 51/182 (28%), Positives = 94/182 (51%), Gaps = 24/182 (13%)
Query: 293 GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR-YIVYEFVVNGP 351
G +VAVK++ QR++ ++E+ HPN+V + Y GD ++V EF+ G
Sbjct: 44 GRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSS-YLVGDELWVVMEFLEGGA 102
Query: 352 LDRWLHHIPRGGRSLDWAMRM---KVATT---LAQGIAFLHDKVKPHVVHRDIRASNVLL 405
L + H RM ++AT + + ++FLH + V+HRDI++ ++LL
Sbjct: 103 LTDIVTH-----------TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILL 148
Query: 406 DEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLL 465
+ L G V EV + ++++ GT ++APE + R T+ D++S G++++
Sbjct: 149 TSDGRVKLSDFGFCAQVSKEVPRRKSLV--GTPYWMAPEVISRLPYGTEVDIWSLGIMVI 206
Query: 466 EI 467
E+
Sbjct: 207 EM 208
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|214480 smart00034, CLECT, C-type lectin (CTL) or carbohydrate-recognition domain (CRD) | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 3e-12
Identities = 32/138 (23%), Positives = 60/138 (43%), Gaps = 17/138 (12%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNG 112
CP WI K C+ + ++W++++ +C+ +GGHLA++ S E L + +
Sbjct: 1 CPSGWISYGGK--CYKFSTEKKTWEDAQAFCQSLGGHLASIHSEAENDFVASLLKNSGSS 58
Query: 113 --CWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSN 170
W+G ++ SW+WSD S S+++ P + + C ++S
Sbjct: 59 DYYWIGLSDPDSNG--SWQWSDG-SGPV-------SYSNWAPGEP---NNSSGDCVVLST 105
Query: 171 GSRSLVTERCNTSHPFIC 188
C + PF+C
Sbjct: 106 SGGKWNDVSCTSKLPFVC 123
|
Many of these domains function as calcium-dependent carbohydrate binding modules. Length = 124 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 67.2 bits (165), Expect = 3e-12
Identities = 49/177 (27%), Positives = 81/177 (45%), Gaps = 19/177 (10%)
Query: 296 VAVKRLKRSSFQRKKE---FYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352
A+K L ++ + K+ +E + HP LV + G D + Y+V E+V G L
Sbjct: 29 YALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGEL 88
Query: 353 DRWLHHIPRGGR-SLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGA 411
H+ + GR A LA + +LH +V+RD++ N+LLD +
Sbjct: 89 ---FSHLRKSGRFPEPVARFYAAQVVLA--LEYLHSL---DIVYRDLKPENLLLDSDGYI 140
Query: 412 HLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKS-DVYSFGVLLLEI 467
+ G +K V RT GT YLAPE + ++ K+ D ++ G+L+ E+
Sbjct: 141 KITDFGFAKRVK-----GRTYTLCGTPEYLAPE-IILSKGYGKAVDWWALGILIYEM 191
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 4e-12
Identities = 47/176 (26%), Positives = 93/176 (52%), Gaps = 12/176 (6%)
Query: 293 GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR-YIVYEFVVNGP 351
G +VAVK++ QR++ ++E+ HH N+V + Y GD ++V EF+ G
Sbjct: 47 GKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNS-YLVGDELWVVMEFLEGGA 105
Query: 352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGA 411
L + H ++ V ++ + +++LH++ V+HRDI++ ++LL +
Sbjct: 106 LTDIVTHT-----RMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRI 157
Query: 412 HLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEI 467
L G V EV + ++++ GT ++APE + R T+ D++S G++++E+
Sbjct: 158 KLSDFGFCAQVSKEVPKRKSLV--GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEM 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 4e-12
Identities = 56/192 (29%), Positives = 85/192 (44%), Gaps = 8/192 (4%)
Query: 277 LGDSKTGGTYSGIL-PDGSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCC 334
+G G +SG L D + VAVK + + K +F E + HPN+V + G C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 335 YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVV 394
YIV E V G +L G L +++ A G+ +L K H +
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFLRT---EGPRLKVKELIQMVENAAAGMEYLESK---HCI 116
Query: 395 HRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTK 454
HRD+ A N L+ E+ + G+S+ V M + APE + +++
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSE 176
Query: 455 SDVYSFGVLLLE 466
SDV+SFG+LL E
Sbjct: 177 SDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 9e-12
Identities = 55/214 (25%), Positives = 95/214 (44%), Gaps = 18/214 (8%)
Query: 261 EELRSIT------KNFSEGNRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFY 313
E+LRSI K ++ ++ G +G Y+ I + G VA+K++ +K+
Sbjct: 6 EKLRSIVSVGDPKKKYTRFEKI-GQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELII 64
Query: 314 SEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMK 373
+EI +PN+V + ++V E++ G L + +D
Sbjct: 65 NEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET-----CMDEGQIAA 119
Query: 374 VATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVM 433
V Q + FLH V+HRDI++ N+LL + L G + E +R+ M
Sbjct: 120 VCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-QSKRSTM 175
Query: 434 AGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEI 467
G Y ++APE V R K D++S G++ +E+
Sbjct: 176 VGTPY-WMAPEVVTRKAYGPKVDIWSLGIMAIEM 208
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 1e-11
Identities = 50/180 (27%), Positives = 84/180 (46%), Gaps = 13/180 (7%)
Query: 293 GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352
G A K ++ S + ++F EI + HPN+V + + +I+ EF G L
Sbjct: 30 GLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGAL 89
Query: 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAH 412
D + + RG L V + + + FLH V+HRD++A N+LL +
Sbjct: 90 DSIMLELERG---LTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVK 143
Query: 413 LMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFV----YR-NELTTKSDVYSFGVLLLEI 467
L G+S +Q+R G Y ++APE V ++ N K+D++S G+ L+E+
Sbjct: 144 LADFGVSAKNKST-LQKRDTFIGTPY-WMAPEVVACETFKDNPYDYKADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 55/198 (27%), Positives = 93/198 (46%), Gaps = 16/198 (8%)
Query: 277 LGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY 335
LGD G Y + G+ A K ++ S + +++ EI A +HP +V + G Y
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 336 DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 395
G +I+ EF G +D + + RG L + + + + +LH ++H
Sbjct: 80 WDGKLWIMIEFCPGGAVDAIMLELDRG---LTEPQIQVICRQMLEALQYLHSM---KIIH 133
Query: 396 RDIRASNVLLDEEFGAHLMGVGLS-KFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTT- 453
RD++A NVLL + L G+S K V + +Q R G Y ++APE V +
Sbjct: 134 RDLKAGNVLLTLDGDIKLADFGVSAKNV--KTLQRRDSFIGTPY-WMAPEVVMCETMKDT 190
Query: 454 ----KSDVYSFGVLLLEI 467
K+D++S G+ L+E+
Sbjct: 191 PYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 1e-11
Identities = 58/206 (28%), Positives = 93/206 (45%), Gaps = 16/206 (7%)
Query: 275 RLLGDSKTGGTYSGILPDGS---RVAVKRLKRSSFQRKK--EFYSEIGRFARLHHPNLVA 329
+ LG+ + G G L +VAVK +K + R + +F SE HPN++
Sbjct: 5 KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMR 64
Query: 330 VKGCCYDHGDR------YIVYEFVVNGPLDRWLHHIPRGGRS--LDWAMRMKVATTLAQG 381
+ G C + ++ F+ +G L +L + G L M +K T +A G
Sbjct: 65 LIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASG 124
Query: 382 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 441
+ +L K +HRD+ A N +L+E + GLSK + + +A ++
Sbjct: 125 MEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWI 181
Query: 442 APEFVYRNELTTKSDVYSFGVLLLEI 467
A E + TTKSDV+SFGV + EI
Sbjct: 182 AIESLADRVYTTKSDVWSFGVTMWEI 207
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 2e-11
Identities = 54/196 (27%), Positives = 89/196 (45%), Gaps = 12/196 (6%)
Query: 274 NRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGC 333
+ LG + G + ++VAVK +K S + F +E L H LV +
Sbjct: 11 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKLHAV 69
Query: 334 CYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHV 393
YI+ EF+ G L +L G + + +A+G+AF+ + +
Sbjct: 70 VTKE-PIYIITEFMAKGSLLDFLK--SDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NY 123
Query: 394 VHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNEL 451
+HRD+RA+N+L+ + GL++ + E T G + + APE +
Sbjct: 124 IHRDLRAANILVSASLVCKIADFGLARVIE---DNEYTAREGAKFPIKWTAPEAINFGSF 180
Query: 452 TTKSDVYSFGVLLLEI 467
T KSDV+SFG+LL+EI
Sbjct: 181 TIKSDVWSFGILLMEI 196
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 2e-11
Identities = 45/181 (24%), Positives = 84/181 (46%), Gaps = 8/181 (4%)
Query: 290 LPDGSRVAVKRLK---RSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF 346
L D VA+K+++ + +++ EI +L+HPN++ + + IV E
Sbjct: 24 LLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLEL 83
Query: 347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD 406
G L + + + + R + K L + +H + V+HRDI+ +NV +
Sbjct: 84 ADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFIT 140
Query: 407 EEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLE 466
L +GL +F + +++ GT Y++PE ++ N KSD++S G LL E
Sbjct: 141 ATGVVKLGDLGLGRFFSSKTTAAHSLV--GTPYYMSPERIHENGYNFKSDIWSLGCLLYE 198
Query: 467 I 467
+
Sbjct: 199 M 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 51/190 (26%), Positives = 89/190 (46%), Gaps = 21/190 (11%)
Query: 294 SRVAVKRLKRSSFQRK-KEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNGP 351
++VAVK LK + ++ + SE+ + H N++ + G C G Y++ E+ G
Sbjct: 51 TKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 110
Query: 352 LDRWLH--------------HIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRD 397
L +L +P L + + A +A+G+ +L K +HRD
Sbjct: 111 LREYLRARRPPGMEYCYNPTQVPE--EQLSFKDLVSCAYQVARGMEYLASK---KCIHRD 165
Query: 398 IRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDV 457
+ A NVL+ E+ + GL++ + ++T ++APE ++ T +SDV
Sbjct: 166 LAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDV 225
Query: 458 YSFGVLLLEI 467
+SFGVLL EI
Sbjct: 226 WSFGVLLWEI 235
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 52/194 (26%), Positives = 95/194 (48%), Gaps = 27/194 (13%)
Query: 296 VAVKRLKRSSFQR-KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR 354
VAVK L+ + + +F EI +RL +PN++ + G C ++ E++ NG L++
Sbjct: 47 VAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQ 106
Query: 355 WL------------HHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASN 402
+L ++IP S+ A + +A +A G+ +L + VHRD+ N
Sbjct: 107 FLSQREIESTFTHANNIP----SVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRN 159
Query: 403 VLLDEEFGAHLMGVGLSKFV---PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYS 459
L+ + + G+S+ + + +Q R V+ ++A E + + TT SDV++
Sbjct: 160 CLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLP---IRWMAWESILLGKFTTASDVWA 216
Query: 460 FGVLLLEIRLVLCR 473
FGV L E+ LC+
Sbjct: 217 FGVTLWEM-FTLCK 229
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|153057 cd00037, CLECT, C-type lectin (CTL)/C-type lectin-like (CTLD) domain | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 2e-11
Identities = 32/130 (24%), Positives = 56/130 (43%), Gaps = 22/130 (16%)
Query: 65 KCFGYIGNFRSWDESETYCKEIGGHLAALTSYEE-EHSAQKLCGKNVNGCWVGGRSINTT 123
C+ + +W+E++ YC+ +GGHLA++ S EE + A L + + W+G +++
Sbjct: 1 SCYKFSTEKLTWEEAQEYCRSLGGHLASIHSEEENDFLASLLKKSSSSDVWIGLNDLSS- 59
Query: 124 VGLSWKWSD-----NMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTE 178
+WKWSD + + W G + C L S+
Sbjct: 60 -EGTWKWSDGSPLVDYTNWAPGEPNPGG-SEDCV-------------VLSSSSDGKWNDV 104
Query: 179 RCNTSHPFIC 188
C++ PFIC
Sbjct: 105 SCSSKLPFIC 114
|
CLECT: C-type lectin (CTL)/C-type lectin-like (CTLD) domain; protein domains homologous to the carbohydrate-recognition domains (CRDs) of the C-type lectins. This group is chiefly comprised of eukaryotic CTLDs, but contains some, as yet functionally uncharacterized, bacterial CTLDs. Many CTLDs are calcium-dependent carbohydrate binding modules; other CTLDs bind protein ligands, lipids, and inorganic surfaces, including CaCO3 and ice. Animal C-type lectins are involved in such functions as extracellular matrix organization, endocytosis, complement activation, pathogen recognition, and cell-cell interactions. For example: mannose-binding lectin and lung surfactant proteins A and D bind carbohydrates on surfaces (e.g. pathogens, allergens, necrotic, and apoptotic cells) and mediate functions associated with killing and phagocytosis; P (platlet)-, E (endothelial)-, and L (leukocyte)- selectins (sels) mediate the initial attachment, tethering, and rolling of lymphocytes on inflamed vascular walls enabling subsequent lymphocyte adhesion and transmigration. CTLDs may bind a variety of carbohydrate ligands including mannose, N-acetylglucosamine, galactose, N-acetylgalactosamine, and fucose. Several CTLDs bind to protein ligands, and only some of these binding interactions are Ca2+-dependent; including the CTLDs of Coagulation Factors IX/X (IX/X) and Von Willebrand Factor (VWF) binding proteins, and natural killer cell receptors. C-type lectins, such as lithostathine, and some type II antifreeze glycoproteins function in a Ca2+-independent manner to bind inorganic surfaces. Many proteins in this group contain a single CTLD; these CTLDs associate with each other through several different surfaces to form dimers, trimers, or tetramers, from which ligand-binding sites project in different orientations. Various vertebrate type 1 transmembrane proteins including macrophage mannose receptor, endo180, phospholipase A2 receptor, and dendritic and epithelial cell receptor (DEC205) have extracellular domains containing 8 or more CTLDs; these CTLDs remain in the parent model. In some members (IX/X and VWF binding proteins), a loop extends to the adjoining domain to form a loop-swapped dimer. A similar conformation is seen in the macrophage mannose receptor CRD4's putative non-sugar bound form of the domain in the acid environment of the endosome. Lineage specific expansions of CTLDs have occurred in several animal lineages including Drosophila melanogaster and Caenorhabditis elegans; these CTLDs also remain in the parent model. Length = 116 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 2e-11
Identities = 48/189 (25%), Positives = 86/189 (45%), Gaps = 22/189 (11%)
Query: 293 GSRVAVKRLKRSSFQRKKEFYSEIGRFAR---------LHH---PNLVAVKGCCYDHGDR 340
GS VK + + KK + R +H P +V+ G + +
Sbjct: 19 GSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNI 78
Query: 341 YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRA 400
+ EF+ G LDR I + G + + K+A + +G+ +L++ ++HRDI+
Sbjct: 79 CMCMEFMDCGSLDR----IYKKGGPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKP 132
Query: 401 SNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSF 460
SN+L++ L G+S E++ GT Y++PE + + T KSDV+S
Sbjct: 133 SNILVNSRGQIKLCDFGVSG----ELINSIADTFVGTSTYMSPERIQGGKYTVKSDVWSL 188
Query: 461 GVLLLEIRL 469
G+ ++E+ L
Sbjct: 189 GISIIELAL 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 64.1 bits (157), Expect = 2e-11
Identities = 48/191 (25%), Positives = 80/191 (41%), Gaps = 29/191 (15%)
Query: 296 VAVKRLKRSSFQR-KKEFYSEIGR--FARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNGP 351
A+K L + + KK Y +I + RL HP ++ + D + Y V E+ NG
Sbjct: 29 YAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGE 88
Query: 352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE--- 408
L L +I + G SLD A + + +LH K ++HRD++ N+LLD++
Sbjct: 89 L---LQYIRKYG-SLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHI 141
Query: 409 ----FGA-----------HLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTT 453
FG G + E + R GT Y++PE +
Sbjct: 142 KITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGK 201
Query: 454 KSDVYSFGVLL 464
SD+++ G ++
Sbjct: 202 SSDLWALGCII 212
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 3e-11
Identities = 58/215 (26%), Positives = 102/215 (47%), Gaps = 22/215 (10%)
Query: 276 LLGDSKTGGTYSGIL-PDGSR---VAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAV 330
++G + G G L G R VA+K LK + +++++F SE + HPN++ +
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 331 KGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIA----FLH 386
+G I+ EF+ NG LD +L R D + + +GIA +L
Sbjct: 71 EGVVTKSRPVMIITEFMENGALDSFL-------RQNDGQFTVIQLVGMLRGIAAGMKYLS 123
Query: 387 DKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER-TVMAGGTYG--YLAP 443
+ + VHRD+ A N+L++ + GLS+F+ + T GG + AP
Sbjct: 124 EM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAP 180
Query: 444 EFVYRNELTTKSDVYSFGVLLLEIRLVLCRRWWTL 478
E + + T+ SDV+S+G+++ E+ R +W +
Sbjct: 181 EAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM 215
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 3e-11
Identities = 48/193 (24%), Positives = 94/193 (48%), Gaps = 13/193 (6%)
Query: 277 LGDSKTGGT-YSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY 335
+G+ TG + + G VAVK++ QR++ ++E+ H N+V + Y
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNS-Y 86
Query: 336 DHGDR-YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVV 394
GD ++V EF+ G L + H ++ V + + ++ LH + V+
Sbjct: 87 LVGDELWVVMEFLEGGALTDIVTHT-----RMNEEQIAAVCLAVLKALSVLHAQ---GVI 138
Query: 395 HRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTK 454
HRDI++ ++LL + L G V EV + ++++ GT ++APE + R +
Sbjct: 139 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV--GTPYWMAPELISRLPYGPE 196
Query: 455 SDVYSFGVLLLEI 467
D++S G++++E+
Sbjct: 197 VDIWSLGIMVIEM 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 3e-11
Identities = 55/197 (27%), Positives = 95/197 (48%), Gaps = 11/197 (5%)
Query: 277 LGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRK-KEFYSEIGRFARLHHPNLVAVKGCC 334
+G T Y+ I LP+ +VA+KR+ Q E E+ ++ +HPN+V
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF 68
Query: 335 YDHGDRYIVYEFVVNGP-LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHV 393
+ ++V ++ G LD PRGG LD A+ V + +G+ +LH +
Sbjct: 69 VVGDELWLVMPYLSGGSLLDIMKSSYPRGG--LDEAIIATVLKEVLKGLEYLHSNGQ--- 123
Query: 394 VHRDIRASNVLLDEEFGAHL--MGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY-RNE 450
+HRDI+A N+LL E+ + GV S + ++ GT ++APE + +
Sbjct: 124 IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHG 183
Query: 451 LTTKSDVYSFGVLLLEI 467
K+D++SFG+ +E+
Sbjct: 184 YDFKADIWSFGITAIEL 200
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 3e-11
Identities = 57/215 (26%), Positives = 102/215 (47%), Gaps = 22/215 (10%)
Query: 275 RLLGDSKTGGTYSGILP-DGSR---VAVKRLKRSSFQR-KKEFYSEIGRFARLHHPNLVA 329
+++G + G SG L G R VA+K LK ++ +++F SE + HPN++
Sbjct: 10 KVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIH 69
Query: 330 VKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV 389
++G IV E++ NG LD +L + + + +A G+ +L D
Sbjct: 70 LEGVVTKSKPVMIVTEYMENGSLDAFLR---KHDGQFTVIQLVGMLRGIASGMKYLSDM- 125
Query: 390 KPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYG------YLAP 443
VHRD+ A N+L++ + GLS+ V+++ A T G + AP
Sbjct: 126 --GYVHRDLAARNILVNSNLVCKVSDFGLSR-----VLEDDPEAAYTTRGGKIPIRWTAP 178
Query: 444 EFVYRNELTTKSDVYSFGVLLLEIRLVLCRRWWTL 478
E + + T+ SDV+S+G+++ E+ R +W +
Sbjct: 179 EAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEM 213
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 63.6 bits (154), Expect = 4e-11
Identities = 56/215 (26%), Positives = 97/215 (45%), Gaps = 20/215 (9%)
Query: 261 EELRSIT------KNFSEGNRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFY 313
E+LRSI K ++ ++ G +G Y+ + + G VA++++ +K+
Sbjct: 7 EKLRSIVSVGDPKKKYTRFEKI-GQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELII 65
Query: 314 SEIGRFARLHHPNLVAVKGCCYDHGDR-YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRM 372
+EI +PN+V Y GD ++V E++ G L + +D
Sbjct: 66 NEILVMRENKNPNIVNYLDS-YLVGDELWVVMEYLAGGSLTDVVTET-----CMDEGQIA 119
Query: 373 KVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV 432
V Q + FLH V+HRDI++ N+LL + L G + E +R+
Sbjct: 120 AVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-QSKRST 175
Query: 433 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEI 467
M G Y ++APE V R K D++S G++ +E+
Sbjct: 176 MVGTPY-WMAPEVVTRKAYGPKVDIWSLGIMAIEM 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 4e-11
Identities = 53/198 (26%), Positives = 90/198 (45%), Gaps = 21/198 (10%)
Query: 276 LLGDSKTGGTYSGI-LPDGSRVAVK--RLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKG 332
LG+ G Y I G VA+K ++ + KE I + P +V G
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKE----ISILKQCDSPYIVKYYG 65
Query: 333 CCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQ---GIAFLHDKV 389
+ + D +IV E+ G + + ++L ++A L Q G+ +LH
Sbjct: 66 SYFKNTDLWIVMEYCGAGSV---SDIMKITNKTLTEE---EIAAILYQTLKGLEYLHSN- 118
Query: 390 KPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRN 449
+HRDI+A N+LL+EE A L G+S + + + TV+ GT ++APE +
Sbjct: 119 --KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVI--GTPFWMAPEVIQEI 174
Query: 450 ELTTKSDVYSFGVLLLEI 467
K+D++S G+ +E+
Sbjct: 175 GYNNKADIWSLGITAIEM 192
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 4e-11
Identities = 58/199 (29%), Positives = 91/199 (45%), Gaps = 13/199 (6%)
Query: 274 NRLLGDSKTGGTYSGI--LPDGSR--VAVKRLKRSSFQRKKE-FYSEIGRFARLHHPNLV 328
R +G+ + G Y G+ P+ + VAVK K + +E F E + HP++V
Sbjct: 11 GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70
Query: 329 AVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDK 388
+ G ++ +IV E G L +L SLD A + + L+ +A+L K
Sbjct: 71 KLIGVITEN-PVWIVMELAPLGELRSYLQ---VNKYSLDLASLILYSYQLSTALAYLESK 126
Query: 389 VKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYR 448
VHRDI A NVL+ L GLS+++ E + + ++APE +
Sbjct: 127 ---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKL-PIKWMAPESINF 182
Query: 449 NELTTKSDVYSFGVLLLEI 467
T+ SDV+ FGV + EI
Sbjct: 183 RRFTSASDVWMFGVCMWEI 201
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 63.0 bits (154), Expect = 4e-11
Identities = 49/183 (26%), Positives = 86/183 (46%), Gaps = 21/183 (11%)
Query: 291 PDGSRVAVKRLKRSSFQRKKEFYSEIGRFAR-LH---HPNLVAVKGCCYDHGDRYIVYEF 346
P G A+K++ +EF ++ R + L P +V G Y G+ IV E+
Sbjct: 24 PTGKIYALKKIH---VDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80
Query: 347 VVNGPLDRWL---HHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNV 403
+ G L L IP + +A + +G+ +LH K H++HRDI+ SN+
Sbjct: 81 MDGGSLADLLKKVGKIPE-------PVLAYIARQILKGLDYLHTKR--HIIHRDIKPSNL 131
Query: 404 LLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVL 463
L++ + + G+SK + E ++ GT Y++PE + + +D++S G+
Sbjct: 132 LINSKGEVKIADFGISKVL--ENTLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLT 189
Query: 464 LLE 466
LLE
Sbjct: 190 LLE 192
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 4e-11
Identities = 58/202 (28%), Positives = 95/202 (47%), Gaps = 16/202 (7%)
Query: 275 RLLGDSKTGGTYSGIL--PDGSRV--AVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLVA 329
R++G G Y G L DG ++ AVK L R + + ++F E HPN+++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 330 VKGCCY-DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDK 388
+ G C G +V ++ +G L + I + + +A+G+ +L K
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHGDL---RNFIRSETHNPTVKDLIGFGLQVAKGMEYLASK 117
Query: 389 VKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV---PWEVMQERTVMAGGTYGYLAPEF 445
VHRD+ A N +LDE F + GL++ + + + T A ++A E
Sbjct: 118 ---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHT-GAKLPVKWMALES 173
Query: 446 VYRNELTTKSDVYSFGVLLLEI 467
+ + TTKSDV+SFGVLL E+
Sbjct: 174 LQTQKFTTKSDVWSFGVLLWEL 195
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 5e-11
Identities = 47/178 (26%), Positives = 82/178 (46%), Gaps = 9/178 (5%)
Query: 292 DGSRVAVKR--LKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 349
D S V K L R S + +++ +EI + L HPN++A D I E+
Sbjct: 24 DDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANG 83
Query: 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF 409
G L + + G+ + M + + ++++H K ++HRDI+ N+ L +
Sbjct: 84 GTLYDKIVR--QKGQLFEEEMVLWYLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAG 138
Query: 410 GAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEI 467
L G+SK + E TV+ GT Y++PE + KSD+++ G +L E+
Sbjct: 139 LIKLGDFGISKILGSEYSMAETVV--GTPYYMSPELCQGVKYNFKSDIWALGCVLYEL 194
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 5e-11
Identities = 48/183 (26%), Positives = 91/183 (49%), Gaps = 19/183 (10%)
Query: 292 DGSRVAVKRLKRSSFQRKK--EFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 349
DG + +K + S K+ E E+ + + HPN+V + ++G+ YIV ++
Sbjct: 24 DGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEG 83
Query: 350 GPLDRWLHHIPRG-----GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 404
G L + ++ RG + LDW +++ +A + +HD+ ++HRDI++ N+
Sbjct: 84 GDLYKKINA-QRGVLFPEDQILDWFVQICLA------LKHVHDR---KILHRDIKSQNIF 133
Query: 405 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLL 464
L ++ L G+++ + V RT + GT YL+PE KSD+++ G +L
Sbjct: 134 LTKDGTIKLGDFGIARVLNSTVELARTCI--GTPYYLSPEICENRPYNNKSDIWALGCVL 191
Query: 465 LEI 467
E+
Sbjct: 192 YEM 194
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 9e-11
Identities = 49/190 (25%), Positives = 84/190 (44%), Gaps = 22/190 (11%)
Query: 291 PDGSRVAVKRLKRSSFQRKKEFY--SEIGRFARLHHPNLVAVKGCCYDHG-DR-----YI 342
DG + K + + K++ SE+ L HPN+V YD DR YI
Sbjct: 23 SDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRY----YDRIIDRSNQTLYI 78
Query: 343 VYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPH--VVHRDIRA 400
V E+ G L + + + + ++ ++ T L + H++ P V+HRD++
Sbjct: 79 VMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKP 138
Query: 401 SNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG---GTYGYLAPEFVYRNELTTKSDV 457
+N+ LD L GL+K ++ + A GT Y++PE + KSD+
Sbjct: 139 ANIFLDANNNVKLGDFGLAK-----ILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDI 193
Query: 458 YSFGVLLLEI 467
+S G L+ E+
Sbjct: 194 WSLGCLIYEL 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 45/145 (31%), Positives = 67/145 (46%), Gaps = 11/145 (7%)
Query: 324 HPNLVAVKGCCYDHGDR-YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGI 382
HP L + C+ DR + V E+V G L + HI R GR D A + G+
Sbjct: 55 HPFLTQLH-SCFQTKDRLFFVMEYVNGGDL---MFHIQRSGR-FDEPRARFYAAEIVLGL 109
Query: 383 AFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLA 442
FLH++ +++RD++ NVLLD E + G+ K + T GT Y+A
Sbjct: 110 QFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFC--GTPDYIA 164
Query: 443 PEFVYRNELTTKSDVYSFGVLLLEI 467
PE + D ++ GVLL E+
Sbjct: 165 PEILSYQPYGPAVDWWALGVLLYEM 189
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 1e-10
Identities = 48/191 (25%), Positives = 93/191 (48%), Gaps = 14/191 (7%)
Query: 284 GTYSGI-----LPDGSRVAVKRLKRSSF--QRKKEFYSEIGRFARLHHPNLVAVKGCCYD 336
G+Y + L D A+K + S + +++ +EI A ++HPN+++ K D
Sbjct: 11 GSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLD 70
Query: 337 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 396
IV E+ G L + + + + + ++ L +G+ LH++ ++HR
Sbjct: 71 GNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHR 127
Query: 397 DIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSD 456
D++++N+LL + +G+SK + + +T + GT Y+APE + KSD
Sbjct: 128 DLKSANILLVANDLVKIGDLGISKVL--KKNMAKTQI--GTPHYMAPEVWKGRPYSYKSD 183
Query: 457 VYSFGVLLLEI 467
++S G LL E+
Sbjct: 184 IWSLGCLLYEM 194
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 1e-10
Identities = 49/182 (26%), Positives = 82/182 (45%), Gaps = 18/182 (9%)
Query: 292 DGSRVAVKRLKRSSFQR--KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 349
G VA+K++K K EI L+HPN++ + GD Y+V+EF
Sbjct: 23 TGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF--- 79
Query: 350 GPLDRWLHHIPRG-GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE 408
+D L+ + + R L ++ L QG+AF H ++HRD++ N+L++ E
Sbjct: 80 --MDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SHGILHRDLKPENLLINTE 134
Query: 409 FGAHLMGVGLSKFV--PWEVMQERTVMAGGTYGYLAPEFVYRNEL-TTKSDVYSFGVLLL 465
L GL++ P V T Y APE + ++ +T D++S G +
Sbjct: 135 GVLKLADFGLARSFGSPVRPYTHYVV----TRWYRAPELLLGDKGYSTPVDIWSVGCIFA 190
Query: 466 EI 467
E+
Sbjct: 191 EL 192
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.9 bits (151), Expect = 1e-10
Identities = 46/204 (22%), Positives = 87/204 (42%), Gaps = 19/204 (9%)
Query: 276 LLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGC 333
++G+ G Y G VA+K + ++E E + +HPN+ G
Sbjct: 13 VIGEGTYGKVYKARHKKTGQLVAIKIMD-IIEDEEEEIKEEYNILRKYSNHPNIATFYGA 71
Query: 334 CY------DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD 387
+ ++V E G + + + + G+ L + +G+A+LH+
Sbjct: 72 FIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHE 131
Query: 388 KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY 447
V+HRDI+ N+LL + L+ G+S + + + T + GT ++APE +
Sbjct: 132 N---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI--GTPYWMAPEVIA 186
Query: 448 RNE-----LTTKSDVYSFGVLLLE 466
+E +SDV+S G+ +E
Sbjct: 187 CDEQPDASYDARSDVWSLGITAIE 210
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 55/180 (30%), Positives = 80/180 (44%), Gaps = 19/180 (10%)
Query: 293 GSRVAVKRLKRSSFQRKKE---FYSEIGRFARLHHPNLVAVKGCCYDHGDR-YIVYEFVV 348
G A+K LK+ + K+ E L HP +V + C + +R Y + EFVV
Sbjct: 43 GEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMM-CSFQDENRVYFLLEFVV 101
Query: 349 NGPLDRWLHHIPRGGR-SLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE 407
G L H+ + GR D A LA +LH K +++RD++ N+LLD
Sbjct: 102 GGEL---FTHLRKAGRFPNDVAKFYHAELVLA--FEYLHSK---DIIYRDLKPENLLLDN 153
Query: 408 EFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEI 467
+ + G +K VP +RT GT YLAPE + D ++ GVLL E
Sbjct: 154 KGHVKVTDFGFAKKVP-----DRTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEF 208
|
Length = 329 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 2e-10
Identities = 55/191 (28%), Positives = 84/191 (43%), Gaps = 40/191 (20%)
Query: 295 RVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR 354
RV +K L S F+ +++ H +L V G C + +V EFV +GPLD
Sbjct: 46 RVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDV 105
Query: 355 WLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD----EEFG 410
L +G + W ++ VA LA +++L DK ++VH ++ A N+LL E
Sbjct: 106 CLRK-EKGRVPVAW--KITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGLAEGT 159
Query: 411 AHLM-----GVGLSKF--------VPWEVMQERTVMAGGTYGYLAPEFVYR-NELTTKSD 456
+ + GV + +PW +APE V N L+T +D
Sbjct: 160 SPFIKLSDPGVSFTALSREERVERIPW----------------IAPECVPGGNSLSTAAD 203
Query: 457 VYSFGVLLLEI 467
+SFG LLEI
Sbjct: 204 KWSFGTTLLEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|153064 cd03594, CLECT_REG-1_like, C-type lectin-like domain (CTLD) of the type found in Human REG-1 (lithostathine), REG-4, and avian eggshell-specific proteins: ansocalcin, structhiocalcin-1(SCA-1), and -2(SCA-2) | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 2e-10
Identities = 35/146 (23%), Positives = 51/146 (34%), Gaps = 29/146 (19%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI--GGHLAALTSYEE-----EH-SAQK 104
CP W+ K C+GY SW ++E +C++ G HLA++ S E S+ +
Sbjct: 1 CPKGWL--PYKGNCYGYFRQPLSWSDAELFCQKYGPGAHLASIHSPAEAAAIASLISSYQ 58
Query: 105 LCGKNVNGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNS--SCTSLPCHVHATV 162
+ V W+G W+WSD S + C L
Sbjct: 59 KAYQPV---WIGLHDPQQ--SRGWEWSDGSKLDYRSWDRNPPYARGGYCAELSR------ 107
Query: 163 DLCTLVSNGSRSLVTERCNTSHPFIC 188
S G C +PFIC
Sbjct: 108 ------STGFLKWNDANCEERNPFIC 127
|
CLECT_REG-1_like: C-type lectin-like domain (CTLD) of the type found in Human REG-1 (lithostathine), REG-4, and avian eggshell-specific proteins: ansocalcin, structhiocalcin-1(SCA-1), and -2(SCA-2). CTLD refers to a domain homologous to the carbohydrate-recognition domains (CRDs) of the C-type lectins. REG-1 is a proliferating factor which participates in various kinds of tissue regeneration including pancreatic beta-cell regeneration, regeneration of intestinal mucosa, regeneration of motor neurons, and perhaps in tissue regeneration of damaged heart. REG-1 may play a role on the pathophysiology of Alzheimer's disease and in the development of gastric cancers. Its expression is correlated with reduced survival from early-stage colorectal cancer. REG-1 also binds and aggregates several bacterial strains from the intestinal flora and it has been suggested that it is involved in the control of the intestinal bacterial ecosystem. Rat lithostathine has calcium carbonate crystal inhibitor activity in vitro. REG-IV is unregulated in pancreatic, gastric, hepatocellular, and prostrate adenocarcinomas. REG-IV activates the EGF receptor/Akt/AP-1 signaling pathway in colorectal carcinoma. Ansocalcin, SCA-1 and -2 are found at high concentration in the calcified egg shell layer of goose and ostrich, respectively and tend to form aggregates. Ansocalcin nucleates calcite crystal aggregates in vitro. Length = 129 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 3e-10
Identities = 56/191 (29%), Positives = 89/191 (46%), Gaps = 27/191 (14%)
Query: 296 VAVKRLKRSSFQR-------KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV 348
VAVK LK + ++ + E IG+ H N++ + G C G Y++ E+
Sbjct: 50 VAVKMLKDDATEKDLSDLVSEMEMMKMIGK-----HKNIINLLGACTQDGPLYVIVEYAS 104
Query: 349 NGPLDRWLH-HIPRG-------GRSLDWAMRMK--VATT--LAQGIAFLHDKVKPHVVHR 396
G L +L P G R D M K V+ T +A+G+ +L + +HR
Sbjct: 105 KGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHR 161
Query: 397 DIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSD 456
D+ A NVL+ E + GL++ V ++T ++APE ++ T +SD
Sbjct: 162 DLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSD 221
Query: 457 VYSFGVLLLEI 467
V+SFGVL+ EI
Sbjct: 222 VWSFGVLMWEI 232
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 60.9 bits (147), Expect = 4e-10
Identities = 53/202 (26%), Positives = 99/202 (49%), Gaps = 19/202 (9%)
Query: 275 RLLGDSKTGGTYSGI-LPDGSRV----AVKRLKRSSFQRKK-EFYSEIGRFARLHHPNLV 328
++LG G Y GI +P+G V A+K L ++ + EF E A + HP+LV
Sbjct: 13 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 72
Query: 329 AVKGCCYDHGDRYIVYEFVVNGPLDRWLH-HIPRGGRSL--DWAMRMKVATTLAQGIAFL 385
+ G C + +V + + +G L ++H H G L +W ++ +A+G+ +L
Sbjct: 73 RLLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQ------IAKGMMYL 125
Query: 386 HDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEF 445
++ +VHRD+ A NVL+ + GL++ + + + ++A E
Sbjct: 126 EER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALEC 182
Query: 446 VYRNELTTKSDVYSFGVLLLEI 467
++ + T +SDV+S+GV + E+
Sbjct: 183 IHYRKFTHQSDVWSYGVTIWEL 204
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 4e-10
Identities = 58/213 (27%), Positives = 86/213 (40%), Gaps = 38/213 (17%)
Query: 277 LGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRK---------KEFYSEIGRFARLHHPN 326
LG Y G+L V + S K F+ ++L H +
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 327 LVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLH 386
LV + G C + +V E+V GPLD +LH SL W ++ VA LA + +L
Sbjct: 63 LVKLYGVCVRDENI-MVEEYVKFGPLDVFLHREK-NNVSLHW--KLDVAKQLASALHYLE 118
Query: 387 DKVKPHVVHRDIRASNVLL---DEEFGAHLM------GVGLSKFVPWEVMQERTVMAGGT 437
DK +VH ++ N+L+ G G+ ++ + E ER
Sbjct: 119 DK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPIT-VLSREERVERI------ 168
Query: 438 YGYLAPEFVYRN---ELTTKSDVYSFGVLLLEI 467
++APE RN LT +D +SFG LLEI
Sbjct: 169 -PWIAPEC-IRNGQASLTIAADKWSFGTTLLEI 199
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 4e-10
Identities = 56/208 (26%), Positives = 90/208 (43%), Gaps = 19/208 (9%)
Query: 269 NFSEGNRLLGDSKTGGTYSGILPD-GSRVAVKRLK--RSSFQRKKEFYS---EIGRFARL 322
N+ G +LLG G Y D G +AVK++ S + KKE + EI L
Sbjct: 3 NWRRG-KLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL 61
Query: 323 HHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGI 382
H +V GC D I E++ G + + G +L + K + +G+
Sbjct: 62 QHERIVQYYGCLRDDETLSIFMEYMPGGSVK---DQLKAYG-ALTETVTRKYTRQILEGV 117
Query: 383 AFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE---RTVMAGGTYG 439
+LH +VHRDI+ +N+L D L G SK + ++V GT
Sbjct: 118 EYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVT--GTPY 172
Query: 440 YLAPEFVYRNELTTKSDVYSFGVLLLEI 467
+++PE + K+DV+S G ++E+
Sbjct: 173 WMSPEVISGEGYGRKADVWSVGCTVVEM 200
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 60.0 bits (146), Expect = 5e-10
Identities = 43/188 (22%), Positives = 76/188 (40%), Gaps = 26/188 (13%)
Query: 293 GSRVAVKRLKRSSFQRK---KEFYSEIGRFARLHHPNLVAVKGCCYDHGDR-YIVYEFVV 348
G A+K +K++ RK + +E ++ P +V + + Y+V E++
Sbjct: 18 GDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY-YSFQGKKNLYLVMEYLP 76
Query: 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE 408
G L L ++ SLD + + + +LH ++HRD++ N+L+D
Sbjct: 77 GGDLASLLENV----GSLDEDVARIYIAEIVLALEYLH---SNGIIHRDLKPDNILIDSN 129
Query: 409 FGAHLMGVGLSKFVPWEVMQERTVMAG----------GTYGYLAPEFVYRNELTTKSDVY 458
L GLSK + R + GT Y+APE + + D +
Sbjct: 130 GHLKLTDFGLSKVG----LVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWW 185
Query: 459 SFGVLLLE 466
S G +L E
Sbjct: 186 SLGCILYE 193
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 5e-10
Identities = 56/200 (28%), Positives = 90/200 (45%), Gaps = 22/200 (11%)
Query: 284 GTYSGIL-----PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCY-- 335
GTY + DGS AVK L S +E +E L +HPN+V G Y
Sbjct: 33 GTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKA 91
Query: 336 DH---GDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPH 392
D G ++V E G + + + G+ LD AM + G+ LH+
Sbjct: 92 DKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---R 148
Query: 393 VVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFV-----Y 447
++HRD++ +N+LL E G L+ G+S + ++ T + GT ++APE + Y
Sbjct: 149 IIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV--GTPFWMAPEVIACEQQY 206
Query: 448 RNELTTKSDVYSFGVLLLEI 467
+ DV+S G+ +E+
Sbjct: 207 DYSYDARCDVWSLGITAIEL 226
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 5e-10
Identities = 43/135 (31%), Positives = 67/135 (49%), Gaps = 10/135 (7%)
Query: 334 CYDHGDR-YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPH 392
C+ DR Y V E+V G L ++ I + GR + A +A G+ FLH K
Sbjct: 69 CFQTMDRLYFVMEYVNGGDL---MYQIQQVGR-FKEPHAVFYAAEIAIGLFFLHSK---G 121
Query: 393 VVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELT 452
+++RD++ NV+LD E + G+ K W+ + +T GT Y+APE +
Sbjct: 122 IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFC--GTPDYIAPEIIAYQPYG 179
Query: 453 TKSDVYSFGVLLLEI 467
D ++FGVLL E+
Sbjct: 180 KSVDWWAFGVLLYEM 194
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 5e-10
Identities = 51/183 (27%), Positives = 96/183 (52%), Gaps = 12/183 (6%)
Query: 291 PDGSRVAVKRLKRS-SFQRKKEFYSEIGRFAR-LHHPNLVAVKGCCYDHGDRYIVYEFVV 348
P G+ +AVKR++ + + Q +K ++ R + P V G + GD +I E V+
Sbjct: 24 PTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME-VM 82
Query: 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE 408
+ LD++ + G ++ + K+A ++ + + +LH K+ V+HRD++ SNVL++
Sbjct: 83 DTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRN 140
Query: 409 FGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFV----YRNELTTKSDVYSFGVLL 464
L G+S ++ V +T+ A G Y+APE + + KSDV+S G+ +
Sbjct: 141 GQVKLCDFGISGYLVDSVA--KTIDA-GCKPYMAPERINPELNQKGYDVKSDVWSLGITM 197
Query: 465 LEI 467
+E+
Sbjct: 198 IEL 200
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 6e-10
Identities = 41/175 (23%), Positives = 86/175 (49%), Gaps = 10/175 (5%)
Query: 293 GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352
G +VAVK + QR++ ++E+ H N+V + + +++ EF+ G L
Sbjct: 46 GRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105
Query: 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAH 412
+ L+ V ++ Q + +LH + V+HRDI++ ++LL +
Sbjct: 106 TDIVSQT-----RLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVK 157
Query: 413 LMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEI 467
L G + +V + ++++ GT ++APE + R T+ D++S G++++E+
Sbjct: 158 LSDFGFCAQISKDVPKRKSLV--GTPYWMAPEVISRTPYGTEVDIWSLGIMVIEM 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 6e-10
Identities = 49/182 (26%), Positives = 87/182 (47%), Gaps = 16/182 (8%)
Query: 292 DGSRVAVKRL--KRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY-DHGDRYIVYEFVV 348
DG + +K+L + +S + +K E ++L HPN+VA + + G YIV F
Sbjct: 24 DGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCE 83
Query: 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE 408
G L L + G+ L ++ +A + +LH+K H++HRD++ NV L
Sbjct: 84 GGDLYHKLKE--QKGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRT 138
Query: 409 FGAHLMGVGLSKFVPWEVMQERTVMAG---GTYGYLAPEFVYRNELTTKSDVYSFGVLLL 465
+ +G+++ V++ + MA GT Y++PE KSDV++ G +
Sbjct: 139 NIIKVGDLGIAR-----VLENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVY 193
Query: 466 EI 467
E+
Sbjct: 194 EM 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 7e-10
Identities = 55/210 (26%), Positives = 93/210 (44%), Gaps = 24/210 (11%)
Query: 275 RLLGDSKTGGTYSGILPD------GSRVAVKRLKRSSFQRKK-EFYSEIGRFARLHHPNL 327
R LG G Y G D +RVAVK + S+ R++ EF +E ++
Sbjct: 12 RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 71
Query: 328 VAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHI------PRGGRSLDWAMRMKVATTLAQG 381
V + G +V E + +G L +L + G +++A +A G
Sbjct: 72 VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 131
Query: 382 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT---- 437
+A+L+ K VHRD+ A N ++ +F + G+++ ++ + GG
Sbjct: 132 MAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR----DIYETDYYRKGGKGLLP 184
Query: 438 YGYLAPEFVYRNELTTKSDVYSFGVLLLEI 467
++APE + TT SD++SFGV+L EI
Sbjct: 185 VRWMAPESLKDGVFTTSSDMWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 8e-10
Identities = 54/215 (25%), Positives = 92/215 (42%), Gaps = 22/215 (10%)
Query: 276 LLGDSKTGGTYSGI-LPDGSRVAVKR--LKRSSFQRKKE--------FYSEIGRFARLHH 324
L+G G Y + + G +AVK+ L + R SEI L H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 325 PNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAF 384
N+V G I E+V G + L GR + + + +G+A+
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLR---TYGR-FEEQLVRFFTEQVLEGLAY 123
Query: 385 LHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPE 444
LH K ++HRD++A N+L+D + + G+SK ++ + G+ ++APE
Sbjct: 124 LHSK---GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPE 180
Query: 445 FV--YRNELTTKSDVYSFGVLLLEIRLVLCRRWWT 477
+ Y + K D++S G ++LE + RR W+
Sbjct: 181 VIHSYSQGYSAKVDIWSLGCVVLE--MFAGRRPWS 213
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 1e-09
Identities = 50/189 (26%), Positives = 95/189 (50%), Gaps = 18/189 (9%)
Query: 296 VAVKRLKRSSFQR-KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR 354
VAVK L+ + + + +F EI +RL PN++ + C ++ E++ NG L++
Sbjct: 49 VAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQ 108
Query: 355 WL--HHIPRGG-----RSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE 407
+L H ++ ++ + +AT +A G+ +L + VHRD+ N L+ +
Sbjct: 109 FLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNCLVGK 165
Query: 408 EFGAHLMGVGLSKFV---PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLL 464
+ + G+S+ + + +Q R V+ +++ E + + TT SDV++FGV L
Sbjct: 166 NYTIKIADFGMSRNLYSGDYYRIQGRAVLP---IRWMSWESILLGKFTTASDVWAFGVTL 222
Query: 465 LEIRLVLCR 473
EI L LC+
Sbjct: 223 WEI-LTLCK 230
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 1e-09
Identities = 53/197 (26%), Positives = 91/197 (46%), Gaps = 46/197 (23%)
Query: 291 PD-GSRVAVKRLKRSSFQRKKEFYSEIGR--FARLHHPNLVAVKGCCYDHGDRYIVYEFV 347
PD G A+K LK+++ + + +++ R A ++HP +V + G Y++ +F+
Sbjct: 21 PDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL 80
Query: 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPH--------------- 392
RGG + T L++ + F + VK +
Sbjct: 81 -------------RGG---------DLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG 118
Query: 393 VVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM--QERTVMAGGTYGYLAPEFVYRNE 450
+++RD++ N+LLDEE L GLSK E + +++ GT Y+APE V R
Sbjct: 119 IIYRDLKPENILLDEEGHIKLTDFGLSK----ESIDHEKKAYSFCGTVEYMAPEVVNRRG 174
Query: 451 LTTKSDVYSFGVLLLEI 467
T +D +SFGVL+ E+
Sbjct: 175 HTQSADWWSFGVLMFEM 191
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 53/193 (27%), Positives = 86/193 (44%), Gaps = 31/193 (16%)
Query: 296 VAVKRLKR-------SSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV 348
VAVK LK S + E IG+ H N++ + G C G Y++ E+
Sbjct: 47 VAVKMLKDDATDKDLSDLVSEMEMMKMIGK-----HKNIINLLGACTQDGPLYVLVEYAS 101
Query: 349 NGPLDRWLHHIPRGGRSLDWAMR--------------MKVATTLAQGIAFLHDKVKPHVV 394
G L +L R +D++ + A +A+G+ +L + +
Sbjct: 102 KGNLREYLR--ARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCI 156
Query: 395 HRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTK 454
HRD+ A NVL+ E+ + GL++ V ++T ++APE ++ T +
Sbjct: 157 HRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ 216
Query: 455 SDVYSFGVLLLEI 467
SDV+SFGVLL EI
Sbjct: 217 SDVWSFGVLLWEI 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 1e-09
Identities = 53/211 (25%), Positives = 97/211 (45%), Gaps = 26/211 (12%)
Query: 275 RLLGDSKTGGTYSGIL-------PDGSRVAVKRLKRSSFQRKK-EFYSEIGRFARLHHPN 326
R LG G Y GI P+ +RVA+K + ++ R++ EF +E + +
Sbjct: 12 RELGQGSFGMVYEGIAKGVVKDEPE-TRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 70
Query: 327 LVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHI-----PRGGRSLDWAMRM-KVATTLAQ 380
+V + G ++ E + G L +L + ++ +M ++A +A
Sbjct: 71 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIAD 130
Query: 381 GIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT--- 437
G+A+L+ VHRD+ A N ++ E+F + G+++ ++ + GG
Sbjct: 131 GMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYRKGGKGLL 183
Query: 438 -YGYLAPEFVYRNELTTKSDVYSFGVLLLEI 467
+++PE + TT SDV+SFGV+L EI
Sbjct: 184 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 49/193 (25%), Positives = 87/193 (45%), Gaps = 27/193 (13%)
Query: 294 SRVAVKRLKRSSFQR-------KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF 346
VAVK LK ++ + + E IG+ H N++ + G C G Y++ E+
Sbjct: 45 VTVAVKMLKDNATDKDLADLISEMELMKLIGK-----HKNIINLLGVCTQEGPLYVIVEY 99
Query: 347 VVNGPLDRWLH--------HIPRGGRSLDWAMRMK----VATTLAQGIAFLHDKVKPHVV 394
G L +L + + + + K A +A+G+ +L + +
Sbjct: 100 AAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCI 156
Query: 395 HRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTK 454
HRD+ A NVL+ E+ + GL++ V ++T ++APE ++ T +
Sbjct: 157 HRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQ 216
Query: 455 SDVYSFGVLLLEI 467
SDV+SFG+L+ EI
Sbjct: 217 SDVWSFGILMWEI 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 2e-09
Identities = 43/136 (31%), Positives = 66/136 (48%), Gaps = 10/136 (7%)
Query: 333 CCYDHGDR-YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKP 391
C+ DR Y V E+V G L ++HI + G+ + A +A G+ FLH K
Sbjct: 68 SCFQTMDRLYFVMEYVNGGDL---MYHIQQVGK-FKEPHAVFYAAEIAIGLFFLHSK--- 120
Query: 392 HVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNEL 451
+++RD++ NV+LD E + G+ K + RT GT Y+APE +
Sbjct: 121 GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFC--GTPDYIAPEIIAYQPY 178
Query: 452 TTKSDVYSFGVLLLEI 467
D ++FGVLL E+
Sbjct: 179 GKSVDWWAFGVLLYEM 194
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 3e-09
Identities = 54/220 (24%), Positives = 94/220 (42%), Gaps = 42/220 (19%)
Query: 277 LGDSKTGGTYSGIL------PDGSRVAVKRLK-RSSFQRKKEFYSEIGRFARLHHPNLVA 329
LG+ + G Y G L VA+K LK ++ ++EF E +RL HPN+V
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVC 72
Query: 330 VKGCCYDHGDRYIVYEFVVNGPLDRWL----HHIPRGGRSLDWAMR--------MKVATT 377
+ G +++ + + L +L H G D ++ + + T
Sbjct: 73 LLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQ 132
Query: 378 LAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT 437
+A G+ FL HVVH+D+ NVL+ ++ + +GL R V A
Sbjct: 133 IAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLF----------REVYAADY 179
Query: 438 YG----------YLAPEFVYRNELTTKSDVYSFGVLLLEI 467
Y +++PE + + + SD++S+GV+L E+
Sbjct: 180 YKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEV 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 42/150 (28%), Positives = 70/150 (46%), Gaps = 10/150 (6%)
Query: 319 FARLHHPNLVAVKGCCYDHGDR-YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATT 377
A P + C+ DR Y V E+V G L ++HI + G+ + A
Sbjct: 54 LALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDL---MYHIQQVGK-FKEPQAVFYAAE 109
Query: 378 LAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT 437
++ G+ FLH + +++RD++ NV+LD E + G+ K + + RT GT
Sbjct: 110 ISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFC--GT 164
Query: 438 YGYLAPEFVYRNELTTKSDVYSFGVLLLEI 467
Y+APE + D +++GVLL E+
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAYGVLLYEM 194
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 4e-09
Identities = 67/241 (27%), Positives = 109/241 (45%), Gaps = 36/241 (14%)
Query: 245 PAASALVPPSWKVFTTEELRSITKNFSEGNRL--LGDSKTGGTYSGIL--PDGSRVAVKR 300
P S+ S + S K+ SE R+ +G S GGT ++ P G A+K
Sbjct: 48 PPPSSSSSSSSSSSASGSAPSAAKSLSELERVNRIG-SGAGGTVYKVIHRPTGRLYALKV 106
Query: 301 L---KRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH-GDRYIVYEFVVNGPLDRWL 356
+ + +R + EI ++HPN+V +DH G+ ++ EF+ G L+
Sbjct: 107 IYGNHEDTVRR--QICREIEILRDVNHPNVVKCHDM-FDHNGEIQVLLEFMDGGSLEG-- 161
Query: 357 HHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGV 416
HI D VA + GIA+LH + H+VHRDI+ SN+L++ +
Sbjct: 162 THIADEQFLAD------VARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADF 212
Query: 417 GLSKFVPWEVMQ--ERTVMAGGTYGYLAPEFVYRNELTT------KSDVYSFGVLLLEIR 468
G+S+ + + M +V GT Y++PE + +L D++S GV +LE
Sbjct: 213 GVSRILA-QTMDPCNSSV---GTIAYMSPERI-NTDLNHGAYDGYAGDIWSLGVSILEFY 267
Query: 469 L 469
L
Sbjct: 268 L 268
|
Length = 353 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 4e-09
Identities = 48/188 (25%), Positives = 86/188 (45%), Gaps = 23/188 (12%)
Query: 293 GSRVAVKRLKRSSFQRKKE---FYSEIGRFARLHHPNLVAV--KGCCYDHGDRYIVYEFV 347
G VA+K L+ + + + + F E ARL+HPN+VA+ G G + V+E+V
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPP-GLLFAVFEYV 61
Query: 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL-- 405
R L + +L ++ + +A H++ +VHRD++ N+++
Sbjct: 62 PG----RTLREVLAADGALPAGETGRLMLQVLDALACAHNQ---GIVHRDLKPQNIMVSQ 114
Query: 406 -DEEFGAHLMGVGLSKFVP--WEVMQERTVMAG---GTYGYLAPEFVYRNE-LTTKSDVY 458
A ++ G+ +P + GT Y APE + R E +T SD+Y
Sbjct: 115 TGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQL-RGEPVTPNSDLY 173
Query: 459 SFGVLLLE 466
++G++ LE
Sbjct: 174 AWGLIFLE 181
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 4e-09
Identities = 53/204 (25%), Positives = 94/204 (46%), Gaps = 23/204 (11%)
Query: 275 RLLGDSKTGGTYSGI-LPDGSR----VAVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLV 328
++LG G Y G+ +P+G + VA+K L+ +S + KE E A + +P++
Sbjct: 13 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 72
Query: 329 AVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRS--LDWAMRMKVATTLAQGIAFLH 386
+ G C + I LD H G L+W ++ +A+G+ +L
Sbjct: 73 RLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGMNYLE 126
Query: 387 DKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGG---TYGYLAP 443
++ +VHRD+ A NVL+ + GL+K + + E+ A G ++A
Sbjct: 127 ER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD---EKEYHAEGGKVPIKWMAL 180
Query: 444 EFVYRNELTTKSDVYSFGVLLLEI 467
E + T +SDV+S+GV + E+
Sbjct: 181 ESILHRIYTHQSDVWSYGVTVWEL 204
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 4e-09
Identities = 47/189 (24%), Positives = 92/189 (48%), Gaps = 26/189 (13%)
Query: 293 GSRVAVKRLK--RSSFQRKKEFYS----EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF 346
G+ +AVK++ R++ ++E EI ARL+HP+++ + G + + E+
Sbjct: 25 GTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEW 84
Query: 347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD 406
+ G + L + A+ + L +G+++LH+ ++HRD++ +N+L+D
Sbjct: 85 MAGGSVSHLLSKYG----AFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLID 137
Query: 407 EEFGAHLMGVGLSKFVPWEVMQERTVMAG-------GTYGYLAPEFVYRNELTTKS-DVY 458
G L ++ F + + AG GT ++APE V R E +S DV+
Sbjct: 138 ST-GQRLR---IADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPE-VLRGEQYGRSCDVW 192
Query: 459 SFGVLLLEI 467
S G +++E+
Sbjct: 193 SVGCVIIEM 201
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 5e-09
Identities = 49/181 (27%), Positives = 84/181 (46%), Gaps = 18/181 (9%)
Query: 296 VAVKRLKRSSFQRKKEF---YSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352
VA+KR ++S ++K+ +SE ++HP V + G D Y+V EFV+ G
Sbjct: 59 VAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEF 118
Query: 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKP-HVVHRDIRASNVLLDEEFGA 411
+L R V A I + + ++ ++V+RD++ N+LLD++
Sbjct: 119 FTFLRRNKR--------FPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFI 170
Query: 412 HLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVL 471
+ G +K V+ RT GT Y+APE + +D ++ G+ + EI LV
Sbjct: 171 KMTDFGFAK-----VVDTRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEI-LVG 224
Query: 472 C 472
C
Sbjct: 225 C 225
|
Length = 340 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 5e-09
Identities = 47/185 (25%), Positives = 82/185 (44%), Gaps = 33/185 (17%)
Query: 296 VAVKRLKRS---SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352
VA+K++ S S ++ ++ E+ R+ HPN + KGC ++V E+ +
Sbjct: 53 VAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLGSAS 112
Query: 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE----- 407
D H + L + QG+A+LH +++HRDI+A N+LL E
Sbjct: 113 DLLEVH----KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVK 165
Query: 408 --EFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY---RNELTTKSDVYSFGV 462
+FG+ + + FV GT ++APE + + K DV+S G+
Sbjct: 166 LADFGSASIASPANSFV-------------GTPYWMAPEVILAMDEGQYDGKVDVWSLGI 212
Query: 463 LLLEI 467
+E+
Sbjct: 213 TCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 5e-09
Identities = 48/147 (32%), Positives = 68/147 (46%), Gaps = 15/147 (10%)
Query: 324 HPNLVAVKGCCYDHGDR-YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGI 382
HP L + CC+ DR + V EFV G L + HI + R D A A + +
Sbjct: 55 HPFLTQLY-CCFQTPDRLFFVMEFVNGGDL---MFHIQKS-RRFDEARARFYAAEITSAL 109
Query: 383 AFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGY 440
FLHDK +++RD++ NVLLD E L G+ K E + + GT Y
Sbjct: 110 MFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCK----EGIFNGKTTSTFCGTPDY 162
Query: 441 LAPEFVYRNELTTKSDVYSFGVLLLEI 467
+APE + D ++ GVLL E+
Sbjct: 163 IAPEILQEMLYGPSVDWWAMGVLLYEM 189
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 5e-09
Identities = 48/179 (26%), Positives = 77/179 (43%), Gaps = 19/179 (10%)
Query: 293 GSRVAVKRLKRSSFQRKKEFYSEIGRFARLH----HPNLVAVKGCCYDHGDR-YIVYEFV 347
G A+K LK+S K + + A + P VA + D Y+V E++
Sbjct: 21 GDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPY-VAKLYYSFQSKDYLYLVMEYL 79
Query: 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE 407
G + + GG DWA + + G+ LH + ++HRDI+ N+L+D+
Sbjct: 80 NGGDCASLIKTL--GGLPEDWAK--QYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQ 132
Query: 408 EFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLE 466
L GLS+ + ++ V GT YLAPE + SD +S G ++ E
Sbjct: 133 TGHLKLTDFGLSRNG---LENKKFV---GTPDYLAPETILGVGDDKMSDWWSLGCVIFE 185
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 6e-09
Identities = 46/189 (24%), Positives = 90/189 (47%), Gaps = 15/189 (7%)
Query: 283 GGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHH----PNLVAVKGCCYDHG 338
GG + + S + + R K + K ++I R ++ H P +V G Y G
Sbjct: 18 GGVVTKVQHKPSGLIMAR-KLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG 76
Query: 339 DRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDI 398
+ I E + G LD+ L + + + + KV+ + +G+A+L +K ++HRD+
Sbjct: 77 EISICMEHMDGGSLDQVL----KEAKRIPEEILGKVSIAVLRGLAYLREK--HQIMHRDV 130
Query: 399 RASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVY 458
+ SN+L++ L G+S +++ GT Y++PE + + +SD++
Sbjct: 131 KPSNILVNSRGEIKLCDFGVSG----QLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIW 186
Query: 459 SFGVLLLEI 467
S G+ L+E+
Sbjct: 187 SMGLSLVEL 195
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 6e-09
Identities = 59/196 (30%), Positives = 85/196 (43%), Gaps = 21/196 (10%)
Query: 292 DGSRV-AVKRLKRSSFQRKKEFYSEIG------RFARLHHPNLVAVKGCCYDHGDRYIVY 344
D R+ A+K L + KKE IG R P +V +K D Y+V
Sbjct: 16 DTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVT 75
Query: 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 404
+++ G L W H+ + GR + + +A L + LH K +V+RD++ N+L
Sbjct: 76 DYMSGGEL-FW--HLQKEGRFSEDRAKFYIAE-LVLALEHLH---KYDIVYRDLKPENIL 128
Query: 405 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKS-DVYSFGVL 463
LD L GLSK + T GT YLAPE + + TK D +S GVL
Sbjct: 129 LDATGHIALCDFGLSK--ANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVL 186
Query: 464 LLEIRLVLCRRWWTLY 479
+ E +C W Y
Sbjct: 187 VFE----MCCGWSPFY 198
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 7e-09
Identities = 46/182 (25%), Positives = 81/182 (44%), Gaps = 27/182 (14%)
Query: 296 VAVKRLKRSSFQ---RKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352
VA+K++ S Q + ++ E+ +L HPN + +GC ++V E+ +
Sbjct: 43 VAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSAS 102
Query: 353 DRW-LHHIPRGGRSLDWAMRMKVATTL---AQGIAFLHDKVKPHVVHRDIRASNVLLDEE 408
D +H P +++A QG+A+LH +++HRD++A N+LL E
Sbjct: 103 DLLEVHKKP--------LQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEP 151
Query: 409 FGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY---RNELTTKSDVYSFGVLLL 465
V L F +M G Y ++APE + + K DV+S G+ +
Sbjct: 152 -----GLVKLGDFGSASIMAPANXFVGTPY-WMAPEVILAMDEGQYDGKVDVWSLGITCI 205
Query: 466 EI 467
E+
Sbjct: 206 EL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 8e-09
Identities = 44/156 (28%), Positives = 72/156 (46%), Gaps = 13/156 (8%)
Query: 315 EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKV 374
EI L+HPN+V + + Y+V+EF+ + L +++ P G L +
Sbjct: 49 EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPL--PLIKSY 105
Query: 375 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF--VPWEVMQERTV 432
L QG+AF H V+HRD++ N+L++ E L GL++ VP V
Sbjct: 106 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV 162
Query: 433 MAGGTYGYLAPEFVYRNEL-TTKSDVYSFGVLLLEI 467
T Y APE + + +T D++S G + E+
Sbjct: 163 ----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEM 194
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 8e-09
Identities = 51/180 (28%), Positives = 82/180 (45%), Gaps = 16/180 (8%)
Query: 293 GSRVAVKRLKRSSFQR--KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 350
G VA+K+ S + KK EI +L H NLV + Y+V+EFV +
Sbjct: 26 GQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHT 85
Query: 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG 410
LD L P G LD + K + +GI F H +++HRDI+ N+L+ +
Sbjct: 86 VLDD-LEKYPNG---LDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGV 138
Query: 411 AHLMGVGLSKFV--PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKS-DVYSFGVLLLEI 467
L G ++ + P EV + T Y APE + + ++ D+++ G L+ E+
Sbjct: 139 VKLCDFGFARTLAAPGEVYTDYV----ATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEM 194
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 9e-09
Identities = 51/197 (25%), Positives = 84/197 (42%), Gaps = 14/197 (7%)
Query: 277 LGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY 335
LGD G Y + G A K + S + +++ EI A HPN+V + Y
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 336 DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 395
+ +I+ EF G +D + + R L V + + +LH+ ++H
Sbjct: 73 YENNLWILIEFCAGGAVDAVMLELE---RPLTEPQIRVVCKQTLEALNYLHEN---KIIH 126
Query: 396 RDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY-----RNE 450
RD++A N+L + L G+S +Q R G Y ++APE V
Sbjct: 127 RDLKAGNILFTLDGDIKLADFGVSA-KNTRTIQRRDSFIGTPY-WMAPEVVMCETSKDRP 184
Query: 451 LTTKSDVYSFGVLLLEI 467
K+DV+S G+ L+E+
Sbjct: 185 YDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 9e-09
Identities = 50/197 (25%), Positives = 86/197 (43%), Gaps = 22/197 (11%)
Query: 284 GTYSGILPDGSR-VAVKRLK-RSSFQRKKEFYSEIGRFARLHHPNLVAVKGCC-YDHGDR 340
G P V VK +K +S + E L H N++ + C D
Sbjct: 25 GILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84
Query: 341 YIVYEFVVNGPLDRWLH---HIPR-GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 396
+++Y ++ G L +L ++L + +A +A G+++LH + V+H+
Sbjct: 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHK 141
Query: 397 DIRASNVLLDEEFGAHLMGVGLSK-FVPWEVM-----QERTVMAGGTYGYLAPEFVYRNE 450
DI A N ++DEE + LS+ P + + R V ++A E + E
Sbjct: 142 DIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVK------WMALESLVNKE 195
Query: 451 LTTKSDVYSFGVLLLEI 467
++ SDV+SFGVLL E+
Sbjct: 196 YSSASDVWSFGVLLWEL 212
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|153060 cd03590, CLECT_DC-SIGN_like, C-type lectin-like domain (CTLD) of the type found in human dendritic cell (DC)-specific intercellular adhesion molecule 3-grabbing non-integrin (DC-SIGN) and the related receptor, DC-SIGN receptor (DC-SIGNR) | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 1e-08
Identities = 26/82 (31%), Positives = 41/82 (50%), Gaps = 7/82 (8%)
Query: 53 CPPDWIINEEKSKCFGYIGNFR-SWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVN 111
CP +W +S C+ + + SW+ES +C+++G HL + S EE+ K+ N +
Sbjct: 1 CPTNWK--SFQSSCY-FFSTEKKSWEESRQFCEDMGAHLVIINSQEEQEFISKILSGNRS 57
Query: 112 GCWVGGRSINTTVGLSWKWSDN 133
W+G T G WKW D
Sbjct: 58 -YWIGLSDEETE-G-EWKWVDG 76
|
CLECT_DC-SIGN_like: C-type lectin-like domain (CTLD) of the type found in human dendritic cell (DC)-specific intercellular adhesion molecule 3-grabbing non-integrin (DC-SIGN) and the related receptor, DC-SIGN receptor (DC-SIGNR). This group also contains proteins similar to hepatic asialoglycoprotein receptor (ASGP-R) and langerin in human. These proteins are type II membrane proteins with a CTLD ectodomain. CTLD refers to a domain homologous to the carbohydrate-recognition domains (CRDs) of the C-type lectins. DC-SIGN is thought to mediate the initial contact between dendritic cells and resting T cells, and may also mediate the rolling of DCs on epithelium. DC-SIGN and DC-SIGNR bind to oligosaccharides present on human tissues, as well as, on pathogens including parasites, bacteria, and viruses. DC-SIGN and DC-SIGNR bind to HIV enhancing viral infection of T cells. DC-SIGN and DC-SIGNR are homotetrameric, and contain four CTLDs stabilized by a coiled coil of alpha helices. The hepatic ASGP-R is an endocytic recycling receptor which binds and internalizes desialylated glycoproteins having a terminal galactose or N-acetylgalactosamine residues on their N-linked carbohydrate chains, via the clathrin-coated pit mediated endocytic pathway, and delivers them to lysosomes for degradation. It has been proposed that glycoproteins bearing terminal Sia (sialic acid) alpha2, 6GalNAc and Sia alpha2, 6Gal are endogenous ligands for ASGP-R and that ASGP-R participates in regulating the relative concentration of serum glycoproteins bearing alpha 2,6-linked Sia. The human ASGP-R is a hetero-oligomer composed of two subunits, both of which are found within this group. Langerin is expressed in a subset of dendritic leukocytes, the Langerhans cells (LC). Langerin induces the formation of Birbeck Granules (BGs) and associates with these BGs following internalization. Langerin binds, in a calcium-dependent manner, to glyco-conjugates containing mannose and related sugars mediating their uptake and degradation. Langerin molecules oligomerize as trimers with three CTLDs held together by a coiled-coil of alpha helices. Length = 126 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 1e-08
Identities = 51/183 (27%), Positives = 75/183 (40%), Gaps = 26/183 (14%)
Query: 296 VAVKRLKRSSFQR-KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL-- 352
VAVK LK +F E L H NL+ + G H +V E G L
Sbjct: 26 VAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLTHPLM-MVTELAPLGSLLD 84
Query: 353 ---DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF 409
L H D+A++ +A G+ +L K +HRD+ A N+LL +
Sbjct: 85 RLRKDALGHFLIS-TLCDYAVQ------IANGMRYLESK---RFIHRDLAARNILLASDD 134
Query: 410 GAHLMGVGLSKFVPWE----VMQE-RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLL 464
+ GL + +P VM+E V + + APE + + SDV+ FGV L
Sbjct: 135 KVKIGDFGLMRALPQNEDHYVMEEHLKV----PFAWCAPESLRTRTFSHASDVWMFGVTL 190
Query: 465 LEI 467
E+
Sbjct: 191 WEM 193
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 1e-08
Identities = 60/213 (28%), Positives = 91/213 (42%), Gaps = 35/213 (16%)
Query: 277 LGDSKTGGTYSGILPDGS-------------RVAVKRLKRSSFQRKKEFYSEIGRFARLH 323
LG Y+GIL +V +K L S F+ ++
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 324 HPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIA 383
H ++V + G C + +V EFV GPLD ++H R L + KVA LA ++
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMH---RKSDVLTTPWKFKVAKQLASALS 119
Query: 384 FLHDKVKPHVVHRDIRASNVLL-----DEEFGAHLMGVGLSK-FVPWEVM--QERTVMAG 435
+L DK +VH ++ N+LL D E G + LS +P V+ QE
Sbjct: 120 YLEDK---DLVHGNVCTKNILLAREGIDGECGPF---IKLSDPGIPITVLSRQECV---- 169
Query: 436 GTYGYLAPEFVYRNE-LTTKSDVYSFGVLLLEI 467
++APE V ++ L+ +D +SFG L EI
Sbjct: 170 ERIPWIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 1e-08
Identities = 52/180 (28%), Positives = 84/180 (46%), Gaps = 13/180 (7%)
Query: 292 DGSRV-AVKRLKRSSFQRKKEF---YSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV 347
D R+ A+K ++++ + E +E A+++ P +V +K Y+V F+
Sbjct: 16 DTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFI 75
Query: 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE 407
G L HH+ R GR R A L + LH K +V++RD++ N+LLD
Sbjct: 76 NGGEL---FHHLQREGRFDLSRARFYTAELLC-ALENLH---KFNVIYRDLKPENILLDY 128
Query: 408 EFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEI 467
+ L GL K + ++T GT YLAPE + + T D ++ GVLL E+
Sbjct: 129 QGHIALCDFGLCKLNMKD--DDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEM 186
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 1e-08
Identities = 50/214 (23%), Positives = 90/214 (42%), Gaps = 34/214 (15%)
Query: 273 GNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVK 331
GN G G + G+ +RV VK L+ S+ + F E+ + L+HPN++
Sbjct: 4 GNGWFGKVLLGEAHRGM--SKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCL 61
Query: 332 GCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRM--------KVATTLAQGIA 383
G C + +V EF G L +L RS + ++A +A G+
Sbjct: 62 GQCIESIPYLLVLEFCPLGDLKNYL-------RSNRGMVAQMAQKDVLQRMACEVASGLL 114
Query: 384 FLHDKVKPHVVHRDIRASNVLLDEEFGAHL--MGVGLSKFVP-WEVMQERTVMAGGTYGY 440
+LH + +H D+ N L + + G+ L ++ + + ++ + +
Sbjct: 115 WLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVP---LRW 168
Query: 441 LAPEFV-------YRNELTTKSDVYSFGVLLLEI 467
LAPE V + T KS+++S GV + E+
Sbjct: 169 LAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 2e-08
Identities = 34/114 (29%), Positives = 51/114 (44%), Gaps = 9/114 (7%)
Query: 296 VAVKRLK--RSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 353
VA+K+ K KK E+ +L H N+V +K G Y+V+E+V L+
Sbjct: 29 VAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLE 88
Query: 354 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE 407
L P G L L Q IA+ H +++HRDI+ N+L+ E
Sbjct: 89 L-LEASPGG---LPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSE 135
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 47/178 (26%), Positives = 75/178 (42%), Gaps = 19/178 (10%)
Query: 296 VAVKRLKRSSFQ---RKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352
VAVK++ S Q + ++ E+ +L HPN + KGC ++V E+ +
Sbjct: 49 VAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCLGSAS 108
Query: 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAH 412
D H + L + QG+A+LH +HRDI+A N+LL E
Sbjct: 109 DLLEVH----KKPLQEVEIAAITHGALQGLAYLHSHNM---IHRDIKAGNILLTEP---- 157
Query: 413 LMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY---RNELTTKSDVYSFGVLLLEI 467
V L+ F G Y ++APE + + K DV+S G+ +E+
Sbjct: 158 -GQVKLADFGSASKSSPANSFVGTPY-WMAPEVILAMDEGQYDGKVDVWSLGITCIEL 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 2e-08
Identities = 52/202 (25%), Positives = 91/202 (45%), Gaps = 16/202 (7%)
Query: 275 RLLGDSKTGGTYSGILPD-GSRVAVKRLK--RSSFQRKKEFYS---EIGRFARLHHPNLV 328
+LLG G Y D G +A K+++ S + KE + EI L H +V
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIV 67
Query: 329 AVKGCCYDHGDRY--IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLH 386
GC D ++ I E++ G + L + +L ++ K + +G+++LH
Sbjct: 68 QYYGCLRDRAEKTLTIFMEYMPGGSVKDQL----KAYGALTESVTRKYTRQILEGMSYLH 123
Query: 387 DKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA-GGTYGYLAPEF 445
+ +VHRDI+ +N+L D L G SK + M + + GT +++PE
Sbjct: 124 SNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEV 180
Query: 446 VYRNELTTKSDVYSFGVLLLEI 467
+ K+DV+S G ++E+
Sbjct: 181 ISGEGYGRKADVWSLGCTVVEM 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 2e-08
Identities = 51/182 (28%), Positives = 82/182 (45%), Gaps = 23/182 (12%)
Query: 296 VAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRW 355
V +K L +S + F+ ++L H +LV G C + +V E+V G LD +
Sbjct: 30 VLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTY 89
Query: 356 LHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAH--- 412
L + ++ + +++VA LA + FL DK + H ++ A NVLL E
Sbjct: 90 LK---KNKNLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGN 143
Query: 413 -----LMGVGLSKFV-PWEVMQERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLL 465
L G+S V P E++ ER ++ PE + L+ +D +SFG L
Sbjct: 144 PPFIKLSDPGISITVLPKEILLERI-------PWVPPECIENPQNLSLAADKWSFGTTLW 196
Query: 466 EI 467
EI
Sbjct: 197 EI 198
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 2e-08
Identities = 45/186 (24%), Positives = 84/186 (45%), Gaps = 24/186 (12%)
Query: 292 DGSRVAVKR--LKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 349
D +K L + + K+ E+ A++ HPN+V ++G +IV E+
Sbjct: 24 DSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDG 83
Query: 350 GPLDRWLHHIPRG-----GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 404
G L + ++ RG + L W ++ ++ G+ +HD+ ++HRDI++ N+
Sbjct: 84 GDLMKRINR-QRGVLFSEDQILSWFVQ------ISLGLKHIHDR---KILHRDIKSQNIF 133
Query: 405 LDEEFGAHLMGVGLSKFVPWEVMQERTVMA---GGTYGYLAPEFVYRNELTTKSDVYSFG 461
L + + M L F + + +A GT YL+PE K+D++S G
Sbjct: 134 LSK----NGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLG 189
Query: 462 VLLLEI 467
+L E+
Sbjct: 190 CVLYEL 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 3e-08
Identities = 53/211 (25%), Positives = 88/211 (41%), Gaps = 24/211 (11%)
Query: 269 NFSEGNR--LLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHP 325
+ E +LG G Y+ L R+A+K + + + + EI + L H
Sbjct: 6 EYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHR 65
Query: 326 NLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVAT------TLA 379
N+V G ++G I E V G L L RS ++ T +
Sbjct: 66 NIVQYLGSDSENGFFKIFMEQVPGGSLSALL-------RSKWGPLKDNEQTIIFYTKQIL 118
Query: 380 QGIAFLHDKVKPHVVHRDIRASNVLLDEEFGA-HLMGVGLSKFVPWEVMQERTVMAGGTY 438
+G+ +LHD +VHRDI+ NVL++ G + G SK + + T GT
Sbjct: 119 EGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG--INPCTETFTGTL 173
Query: 439 GYLAPEFVYRNE--LTTKSDVYSFGVLLLEI 467
Y+APE + + +D++S G ++E+
Sbjct: 174 QYMAPEVIDKGPRGYGAPADIWSLGCTIVEM 204
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 4e-08
Identities = 40/130 (30%), Positives = 67/130 (51%), Gaps = 20/130 (15%)
Query: 351 PLDRWLHHIPRGGR---------SLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRAS 401
P D++L P R +L + + + +A G+ FL K + VHRD+ A
Sbjct: 212 PYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAAR 268
Query: 402 NVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT----YGYLAPEFVYRNELTTKSDV 457
NVL+ E + GL++ ++M++ ++ G+ ++APE ++ N TT SDV
Sbjct: 269 NVLICEGKLVKICDFGLAR----DIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDV 324
Query: 458 YSFGVLLLEI 467
+SFG+LL EI
Sbjct: 325 WSFGILLWEI 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 4e-08
Identities = 38/147 (25%), Positives = 69/147 (46%), Gaps = 12/147 (8%)
Query: 321 RLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQ 380
+ HP ++ + +D Y++ E+V G L +L R + + A+ +
Sbjct: 57 EVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYL----RNSGRFSNSTGLFYASEIVC 112
Query: 381 GIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGY 440
+ +LH K +V+RD++ N+LLD+E L G +K + ++RT GT Y
Sbjct: 113 ALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKL-----RDRTWTLCGTPEY 164
Query: 441 LAPEFVYRNELTTKSDVYSFGVLLLEI 467
LAPE + D ++ G+L+ E+
Sbjct: 165 LAPEVIQSKGHNKAVDWWALGILIYEM 191
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 5e-08
Identities = 45/157 (28%), Positives = 77/157 (49%), Gaps = 14/157 (8%)
Query: 315 EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKV 374
EI L HPN+V ++ Y+++EF ++ L ++L +P G+ +D A +K
Sbjct: 49 EISLLKELQHPNIVCLQDVLMQESRLYLIFEF-LSMDLKKYLDSLP-KGQYMD-AELVKS 105
Query: 375 AT-TLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF--VPWEVMQERT 431
+ QGI F H + V+HRD++ N+L+D + L GL++ +P V
Sbjct: 106 YLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEV 162
Query: 432 VMAGGTYGYLAPEFVYRNEL-TTKSDVYSFGVLLLEI 467
V T Y APE + + +T D++S G + E+
Sbjct: 163 V----TLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEM 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 6e-08
Identities = 35/94 (37%), Positives = 55/94 (58%), Gaps = 11/94 (11%)
Query: 378 LAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT-VMAGG 436
+A+G+ FL K + VHRD+ A NVLL + + GL++ ++M + V G
Sbjct: 246 VARGMEFLASK---NCVHRDLAARNVLLAQGKIVKICDFGLAR----DIMHDSNYVSKGS 298
Query: 437 TY---GYLAPEFVYRNELTTKSDVYSFGVLLLEI 467
T+ ++APE ++ N TT SDV+S+G+LL EI
Sbjct: 299 TFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEI 332
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 6e-08
Identities = 53/210 (25%), Positives = 97/210 (46%), Gaps = 14/210 (6%)
Query: 275 RLLGDSKTGGTYSGILPDGSR----VAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVA 329
R+LG + G G L S+ VA+ L+ S ++++ F +E + H N+V
Sbjct: 11 RILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVR 70
Query: 330 VKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV 389
++G IV E++ NG LD +L + L M + LA G+ +L +
Sbjct: 71 LEGVITRGNTMMIVTEYMSNGALDSFLR---KHEGQLVAGQLMGMLPGLASGMKYLSEM- 126
Query: 390 KPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYG-YLAPEFVYR 448
VH+ + A VL++ + + G + E + T M+G + + APE +
Sbjct: 127 --GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIY--TTMSGKSPVLWAAPEAIQY 182
Query: 449 NELTTKSDVYSFGVLLLEIRLVLCRRWWTL 478
+ ++ SDV+SFG+++ E+ R +W +
Sbjct: 183 HHFSSASDVWSFGIVMWEVMSYGERPYWDM 212
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 6e-08
Identities = 51/178 (28%), Positives = 84/178 (47%), Gaps = 19/178 (10%)
Query: 296 VAVKRLKRSSFQR--KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 353
VAVK LK + K E E +L +P +V + G C + +V E GPL+
Sbjct: 25 VAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGIC-EAESWMLVMELAELGPLN 83
Query: 354 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHL 413
++L + + ++ ++ G+ +L + + VHRD+ A NVLL + A +
Sbjct: 84 KFLQK----NKHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKI 136
Query: 414 MGVGLSKFVPWEVMQERTVMAGGTYG-----YLAPEFVYRNELTTKSDVYSFGVLLLE 466
GLSK + + T+G + APE + + ++KSDV+SFGVL+ E
Sbjct: 137 SDFGLSK----ALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 6e-08
Identities = 39/143 (27%), Positives = 73/143 (51%), Gaps = 10/143 (6%)
Query: 325 PNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAF 384
P +V G Y G+ I E + G LD+ L + GR + + KV+ + +G+ +
Sbjct: 63 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGR-IPEQILGKVSIAVIKGLTY 118
Query: 385 LHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPE 444
L +K K ++HRD++ SN+L++ L G+S +++ GT Y++PE
Sbjct: 119 LREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSG----QLIDSMANSFVGTRSYMSPE 172
Query: 445 FVYRNELTTKSDVYSFGVLLLEI 467
+ + +SD++S G+ L+E+
Sbjct: 173 RLQGTHYSVQSDIWSMGLSLVEM 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 7e-08
Identities = 55/221 (24%), Positives = 87/221 (39%), Gaps = 32/221 (14%)
Query: 275 RLLGDSKTGGTYSGILPDGSR-VAVKRLKR--SSFQR-KKEFYSEIGRFARLHHPNLVAV 330
RL+G G Y P SR VA+K+++ S KK F E A L HP +V V
Sbjct: 8 RLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPV 67
Query: 331 KGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSL--DWAMRMKVAT------TLAQGI 382
C D Y ++ L L + SL + A + V + I
Sbjct: 68 YSICSDGDPVYYTMPYIEGYTLKSLLKSV-WQKESLSKELAEKTSVGAFLSIFHKICATI 126
Query: 383 AFLHDKVKPHVVHRDIRASNVLLDE-------EFGAHLMGVG-------LSKFVPWEVMQ 428
++H K V+HRD++ N+LL ++GA + +
Sbjct: 127 EYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYS 183
Query: 429 ERTVMAG--GTYGYLAPEFVYRNELTTKSDVYSFGVLLLEI 467
T+ GT Y+APE + + +D+Y+ GV+L ++
Sbjct: 184 SMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQM 224
|
Length = 932 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 7e-08
Identities = 41/150 (27%), Positives = 68/150 (45%), Gaps = 9/150 (6%)
Query: 319 FARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIP-RGGRSLDWAMRMKVATT 377
A++ HPN+VA K G YIV E+ G L + I + G+ ++
Sbjct: 52 LAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDL---MQKIKLQRGKLFPEDTILQWFVQ 108
Query: 378 LAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT 437
+ G+ +H+K V+HRDI++ N+ L + L G ++ + T + GT
Sbjct: 109 MCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV--GT 163
Query: 438 YGYLAPEFVYRNELTTKSDVYSFGVLLLEI 467
Y+ PE KSD++S G +L E+
Sbjct: 164 PYYVPPEIWENMPYNNKSDIWSLGCILYEL 193
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 8e-08
Identities = 57/207 (27%), Positives = 90/207 (43%), Gaps = 17/207 (8%)
Query: 275 RLLGDSKTGGTYSGILP--DGS--RVAVKRLKRSSFQRK--KEFYSEIGRFARLHHPNLV 328
R+LG + G L DGS +VAVK LK F +EF E HPN++
Sbjct: 5 RMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVI 64
Query: 329 AVKGCCYDHGDR------YIVYEFVVNGPLDRWL--HHIPRGGRSLDWAMRMKVATTLAQ 380
+ G + ++ F+ +G L +L I +L ++ +A
Sbjct: 65 KLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIAS 124
Query: 381 GIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGY 440
G+ +L K + +HRD+ A N +L+E + GLSK + + + +
Sbjct: 125 GMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKW 181
Query: 441 LAPEFVYRNELTTKSDVYSFGVLLLEI 467
LA E + N TT SDV++FGV + EI
Sbjct: 182 LALESLADNVYTTHSDVWAFGVTMWEI 208
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 8e-08
Identities = 50/205 (24%), Positives = 87/205 (42%), Gaps = 17/205 (8%)
Query: 273 GNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFAR-LHHPNLVAVK 331
GN G Y+ +RV VK LK ++ +++ + + G R L HPN++
Sbjct: 4 GNGWFGKVLLSEIYTD--TGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCL 61
Query: 332 GCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKP 391
G C + +V+E+ G L +L R+ + ++A +A G+ +H K
Sbjct: 62 GQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH---KH 118
Query: 392 HVVHRDIRASNVLLDEEFGAHL--MGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFV--- 446
+ +H D+ N L + + G+G S++ + E +LAPE V
Sbjct: 119 NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCV--PLRWLAPELVGEF 176
Query: 447 ----YRNELTTKSDVYSFGVLLLEI 467
E T S+V++ GV L E+
Sbjct: 177 HGGLITAEQTKPSNVWALGVTLWEL 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 9e-08
Identities = 55/195 (28%), Positives = 85/195 (43%), Gaps = 22/195 (11%)
Query: 284 GTYSGIL-----PDGSRVAVKRLKRSSFQRKKEFYSEIGR----FARLHHPNLVAVKGCC 334
G++ +L DGS AVK L++ + +KKE + L HP LV +
Sbjct: 6 GSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSF 65
Query: 335 YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVV 394
Y V ++V G L H+ R L+ R A +A I +LH +++
Sbjct: 66 QTAEKLYFVLDYVNGGEL---FFHLQRERCFLEPRARF-YAAEVASAIGYLHSL---NII 118
Query: 395 HRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM--QERTVMAGGTYGYLAPEFVYRNELT 452
+RD++ N+LLD + L GL K E + +E T GT YLAPE + +
Sbjct: 119 YRDLKPENILLDSQGHVVLTDFGLCK----EGVEPEETTSTFCGTPEYLAPEVLRKEPYD 174
Query: 453 TKSDVYSFGVLLLEI 467
D + G +L E+
Sbjct: 175 RTVDWWCLGAVLYEM 189
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 34/115 (29%), Positives = 63/115 (54%), Gaps = 15/115 (13%)
Query: 362 GGRSLDWAM-----RMKVATTLAQ---GIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHL 413
GG +LD ++AT L + G+ +LH + K +HRDI+A+NVLL E+ L
Sbjct: 86 GGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKK---IHRDIKAANVLLSEQGDVKL 142
Query: 414 MGVGLS-KFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEI 467
G++ + ++ + V GT ++APE + ++ +K+D++S G+ +E+
Sbjct: 143 ADFGVAGQLTDTQIKRNTFV---GTPFWMAPEVIQQSAYDSKADIWSLGITAIEL 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 1e-07
Identities = 52/218 (23%), Positives = 95/218 (43%), Gaps = 21/218 (9%)
Query: 256 KVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGI-LPDGSR----VAVKRLK-RSSFQRK 309
++ ELR + +LLG G + GI +P+G VA+K ++ RS Q
Sbjct: 2 RILKETELRKL--------KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTF 53
Query: 310 KEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWA 369
+E + L H +V + G C +V + PL L H+ + SLD
Sbjct: 54 QEITDHMLAMGSLDHAYIVRLLGIC-PGASLQLVTQLS---PLGSLLDHVRQHRDSLDPQ 109
Query: 370 MRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE 429
+ +A+G+ +L + +VHR++ A N+LL + + G++ + + +
Sbjct: 110 RLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKY 166
Query: 430 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEI 467
++A E + T +SDV+S+GV + E+
Sbjct: 167 FYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEM 204
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.9 bits (128), Expect = 1e-07
Identities = 48/197 (24%), Positives = 83/197 (42%), Gaps = 41/197 (20%)
Query: 292 DGSRVAVKRLKRSSFQRKKEFYS-----EIGRFARLHHPNLVAVKGCCYDH--GDRYIVY 344
G VA+K+++ + +KE + EI +L HPN+V +K G Y+V+
Sbjct: 23 TGELVALKKIR---MENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF 79
Query: 345 EFV---VNGPLDRWLHHIPRGG-RSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRA 400
E++ + G LD + M+ L +G+ +LH ++HRDI+
Sbjct: 80 EYMDHDLTGLLDSPEVKFTESQIKCY---MKQ-----LLEGLQYLHSN---GILHRDIKG 128
Query: 401 SNVLLDEEFGAHLMGVGLSKF---VPWEVMQERTVMAGGTYGYLAPE-----FVYRNELT 452
SN+L++ + L GL++ R + T Y PE Y
Sbjct: 129 SNILINNDGVLKLADFGLARPYTKRNSADYTNRVI----TLWYRPPELLLGATRY----G 180
Query: 453 TKSDVYSFGVLLLEIRL 469
+ D++S G +L E+ L
Sbjct: 181 PEVDMWSVGCILAELFL 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 41/146 (28%), Positives = 71/146 (48%), Gaps = 16/146 (10%)
Query: 325 PNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAF 384
P +V G Y G+ I E + G LD+ L R + + K++ + +G+ +
Sbjct: 59 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR----IPENILGKISIAVLRGLTY 114
Query: 385 LHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG---GTYGYL 441
L +K K ++HRD++ SN+L++ L G+S Q MA GT Y+
Sbjct: 115 LREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSG-------QLIDSMANSFVGTRSYM 165
Query: 442 APEFVYRNELTTKSDVYSFGVLLLEI 467
+PE + T +SD++S G+ L+E+
Sbjct: 166 SPERLQGTHYTVQSDIWSLGLSLVEM 191
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 2e-07
Identities = 46/201 (22%), Positives = 87/201 (43%), Gaps = 22/201 (10%)
Query: 276 LLGDSKTGGTYSGI-LPDGSRVAVKRLKR-------SSFQRKKEFYSEIGRFARLHHPNL 327
L+G G Y G +P G VA+K + S QR+ S++ + PN+
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQP---PNI 64
Query: 328 VAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD 387
G +I+ E+ G + + P + + +R + + ++H
Sbjct: 65 TKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIR-----EVLVALKYIH- 118
Query: 388 KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY 447
K V+HRDI+A+N+L+ L G++ + + +R+ G Y ++APE +
Sbjct: 119 --KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLN-QNSSKRSTFVGTPY-WMAPEVIT 174
Query: 448 R-NELTTKSDVYSFGVLLLEI 467
TK+D++S G+ + E+
Sbjct: 175 EGKYYDTKADIWSLGITIYEM 195
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 2e-07
Identities = 53/204 (25%), Positives = 91/204 (44%), Gaps = 23/204 (11%)
Query: 275 RLLGDSKTGGTYSGI-LPDGSR----VAVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLV 328
++LG G Y GI +PDG VA+K L+ +S + KE E A + P +
Sbjct: 13 KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVC 72
Query: 329 AVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRS--LDWAMRMKVATTLAQGIAFLH 386
+ G C + + LD + R G L+W ++ +A+G+++L
Sbjct: 73 RLLGICLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQ------IAKGMSYLE 126
Query: 387 DKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGG---TYGYLAP 443
+ +VHRD+ A NVL+ + GL++ + + E A G ++A
Sbjct: 127 EV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLD---IDETEYHADGGKVPIKWMAL 180
Query: 444 EFVYRNELTTKSDVYSFGVLLLEI 467
E + T +SDV+S+GV + E+
Sbjct: 181 ESILHRRFTHQSDVWSYGVTVWEL 204
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 3e-07
Identities = 53/211 (25%), Positives = 84/211 (39%), Gaps = 26/211 (12%)
Query: 263 LRSITKNFSEG-NRLLGDSKTGGTYSGILPDGSRVAVKR--LKRSSFQRKKEFYSEIGRF 319
L I K F + L K T VAVK+ L S + K EI
Sbjct: 3 LTLIGKCFEDLMIVHLAKHKPTNTL---------VAVKKINLDSCSKEDLKLLQQEIITS 53
Query: 320 ARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWL-HHIPRGGRSLDWAMRMKVATTL 378
+L HPN++ + Y+V + G + L H P G L A +K +
Sbjct: 54 RQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILK---DV 110
Query: 379 AQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY 438
+ ++H K +HR ++AS++LL + L G+ S + ++R V
Sbjct: 111 LNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKS 167
Query: 439 G-----YLAPEFVYRNEL--TTKSDVYSFGV 462
+L+PE + +N KSD+YS G+
Sbjct: 168 SVKNLPWLSPEVLQQNLQGYNEKSDIYSVGI 198
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 3e-07
Identities = 34/108 (31%), Positives = 59/108 (54%), Gaps = 11/108 (10%)
Query: 364 RSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVP 423
LD ++ ++ +AQG+ FL K + +HRD+ A NVLL + A + GL++
Sbjct: 207 WPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLAR--- 260
Query: 424 WEVMQERTVMAGGT----YGYLAPEFVYRNELTTKSDVYSFGVLLLEI 467
++M + + G ++APE ++ T +SDV+S+G+LL EI
Sbjct: 261 -DIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 307
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 4e-07
Identities = 52/179 (29%), Positives = 85/179 (47%), Gaps = 21/179 (11%)
Query: 296 VAVKRLKRSSFQRKKEFYSEIGRFARLHH----PNLVAVKGCCYDHGDRYIVYEFVVNGP 351
VA+K LK + +K E+ R A + H P +V + G C + +V E GP
Sbjct: 25 VAIKVLKN---ENEKSVRDEMMREAEIMHQLDNPYIVRMIGVC-EAEALMLVMEMASGGP 80
Query: 352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQ---GIAFLHDKVKPHVVHRDIRASNVLLDEE 408
L+++L G+ D V + Q G+ +L K + VHRD+ A NVLL +
Sbjct: 81 LNKFL-----SGKK-DEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQ 131
Query: 409 FGAHLMGVGLSKFVPWEVMQERTVMAGG-TYGYLAPEFVYRNELTTKSDVYSFGVLLLE 466
A + GLSK + + + AG + APE + + +++SDV+S+G+ + E
Sbjct: 132 HYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWE 190
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|153063 cd03593, CLECT_NK_receptors_like, C-type lectin-like domain (CTLD) of the type found in natural killer cell receptors (NKRs) | Back alignment and domain information |
|---|
Score = 48.5 bits (116), Expect = 4e-07
Identities = 34/137 (24%), Positives = 51/137 (37%), Gaps = 22/137 (16%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNG 112
CP DWI K C+ + ++W+ES+ C L + EE Q G +
Sbjct: 1 CPKDWICYGNK--CYYFSMEKKTWNESKEACSSKNSSLLKIDDEEELEFLQSQIGS--SS 56
Query: 113 CWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS 172
W+G + WKW D S N + GS S C +S+
Sbjct: 57 YWIGLSREKS--EKPWKWIDG-SPLNNLFNIRGSTKS-------------GNCAYLSST- 99
Query: 173 RSLVTERCNTSHPFICM 189
+ +E C+T +IC
Sbjct: 100 -GIYSEDCSTKKRWICE 115
|
CLECT_NK_receptors_like: C-type lectin-like domain (CTLD) of the type found in natural killer cell receptors (NKRs), including proteins similar to oxidized low density lipoprotein (OxLDL) receptor (LOX-1), CD94, CD69, NKG2-A and -D, osteoclast inhibitory lectin (OCIL), dendritic cell-associated C-type lectin-1 (dectin-1), human myeloid inhibitory C-type lectin-like receptor (MICL), mast cell-associated functional antigen (MAFA), killer cell lectin-like receptors: subfamily F, member 1 (KLRF1) and subfamily B, member 1 (KLRB1), and lys49 receptors. CTLD refers to a domain homologous to the carbohydrate-recognition domains (CRDs) of the C-type lectins. NKRs are variously associated with activation or inhibition of natural killer (NK) cells. Activating NKRs stimulate cytolysis by NK cells of virally infected or transformed cells; inhibitory NKRs block cytolysis upon recognition of markers of healthy self cells. Most Lys49 receptors are inhibitory; some are stimulatory. OCIL inhibits NK cell function via binding to the receptor NKRP1D. Murine OCIL in addition to inhibiting NK cell function inhibits osteoclast differentiation. MAFA clusters with the type I Fc epsilon receptor (FcepsilonRI) and inhibits the mast cells secretory response to FcepsilonRI stimulus. CD72 is a negative regulator of B cell receptor signaling. NKG2D is an activating receptor for stress-induced antigens; human NKG2D ligands include the stress induced MHC-I homologs, MICA, MICB, and ULBP family of glycoproteins Several NKRs have a carbohydrate-binding capacity which is not mediated through calcium ions (e.g. OCIL binds a range of high molecular weight sulfated glycosaminoglycans including dextran sulfate, fucoidan, and gamma-carrageenan sugars). Dectin-1 binds fungal beta-glucans and in involved in the innate immune responses to fungal pathogens. MAFA binds saccharides having terminal alpha-D mannose residues in a calcium-dependent manner. LOX-1 is the major receptor for OxLDL in endothelial cells and thought to play a role in the pathology of atherosclerosis. Some NKRs exist as homodimers (e.g.Lys49, NKG2D, CD69, LOX-1) and some as heterodimers (e.g. CD94/NKG2A). Dectin-1 can function as a monomer in vitro. Length = 116 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 4e-07
Identities = 46/147 (31%), Positives = 67/147 (45%), Gaps = 15/147 (10%)
Query: 324 HPNLVAVKGCCYDHGDR-YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGI 382
HP L A+ CC+ DR + V E+V G L + I R R D A + +
Sbjct: 55 HPFLTALH-CCFQTKDRLFFVMEYVNGGDL---MFQIQRS-RKFDEPRSRFYAAEVTLAL 109
Query: 383 AFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE--RTVMAGGTYGY 440
FLH + V++RD++ N+LLD E L G+ K E + T GT Y
Sbjct: 110 MFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCK----EGILNGVTTTTFCGTPDY 162
Query: 441 LAPEFVYRNELTTKSDVYSFGVLLLEI 467
+APE + E D ++ GVL+ E+
Sbjct: 163 IAPEILQELEYGPSVDWWALGVLMYEM 189
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|215684 pfam00059, Lectin_C, Lectin C-type domain | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 4e-07
Identities = 30/116 (25%), Positives = 53/116 (45%), Gaps = 11/116 (9%)
Query: 74 RSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSDN 133
++W E+E C+++GGHL ++ S EE+ L + W+G INT +W W+D
Sbjct: 3 KTWAEAEAACQKLGGHLVSIQSAEEQDFLTSLVKASNTYAWIGLTDINT--EGTWVWTDG 60
Query: 134 MSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICM 189
S N + A G N+ + C V + ++ + E C + ++C
Sbjct: 61 -SPVNYTNWAPGEPNNKGGNEDC-VE-------IYTDTNGKWNDEPCGSKRLYVCE 107
|
This family includes both long and short form C-type. Length = 108 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 5e-07
Identities = 40/129 (31%), Positives = 61/129 (47%), Gaps = 13/129 (10%)
Query: 341 YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRA 400
+ V E++ G L + HI + D A + G+ FLH K +V+RD++
Sbjct: 72 FFVMEYLNGGDL---MFHIQSCHK-FDLPRATFYAAEIICGLQFLHSK---GIVYRDLKL 124
Query: 401 SNVLLDEEFGAHLMGVGLSKFVPWEVM--QERTVMAGGTYGYLAPEFVYRNELTTKSDVY 458
N+LLD + + G+ K E M +T GT Y+APE + + T D +
Sbjct: 125 DNILLDTDGHIKIADFGMCK----ENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSVDWW 180
Query: 459 SFGVLLLEI 467
SFGVLL E+
Sbjct: 181 SFGVLLYEM 189
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 5e-07
Identities = 50/205 (24%), Positives = 90/205 (43%), Gaps = 19/205 (9%)
Query: 275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVA---- 329
++G+ G Y G ++A ++ + ++E EI + HH N+
Sbjct: 22 EVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGA 81
Query: 330 -VKGCCYDHGDR-YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD 387
+K H D+ ++V EF G + + + DW + + +G+A LH
Sbjct: 82 FIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY--ICREILRGLAHLHA 139
Query: 388 KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY 447
V+HRDI+ NVLL E L+ G+S + V + T + GT ++APE +
Sbjct: 140 H---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI--GTPYWMAPEVIA 194
Query: 448 RNE-----LTTKSDVYSFGVLLLEI 467
+E +SD++S G+ +E+
Sbjct: 195 CDENPDATYDYRSDIWSLGITAIEM 219
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|153073 cd03603, CLECT_VCBS, A bacterial subgroup of the C-type lectin-like (CTLD) domain; a subgroup of bacterial protein domains homologous to the carbohydrate-recognition domains (CRDs) of the C-type lectins | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 5e-07
Identities = 21/70 (30%), Positives = 31/70 (44%), Gaps = 7/70 (10%)
Query: 75 SWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSDN- 133
+W+ ++T + +GGHL + S EE G W+G S T G +WKWSD
Sbjct: 11 TWEAAQTLAESLGGHLVTINSAEENDWLLSNFGGYGAS-WIGA-SDAATEG-TWKWSDGE 67
Query: 134 ---MSKWNES 140
+ W
Sbjct: 68 ESTYTNWGSG 77
|
CLECT_VCBS: A bacterial subgroup of the C-type lectin-like (CTLD) domain; a subgroup of bacterial protein domains homologous to the carbohydrate-recognition domains (CRDs) of the C-type lectins. Many CTLDs are calcium-dependent carbohydrate binding modules; other CTLDs bind protein ligands, lipids, and inorganic surfaces including CaCO3 and ice. Bacterial CTLDs within this group are functionally uncharacterized. Animal C-type lectins are involved in such functions as extracellular matrix organization, endocytosis, complement activation, pathogen recognition, and cell-cell interactions. CTLDs may bind a variety of carbohydrate ligands including mannose, N-acetylglucosamine, galactose, N-acetylgalactosamine, and fucose. CTLDs associate with each other through several different surfaces to form dimers, trimers, or tetramers from which ligand-binding sites project in different orientations. In some CTLDs a loop extends to the adjoining domain to form a loop-swapped dimer. Length = 118 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 6e-07
Identities = 54/204 (26%), Positives = 90/204 (44%), Gaps = 23/204 (11%)
Query: 277 LGDSKTGGTYSGI-LPDGSR-VAVKRLKRSSFQRKKEFYSEIGRFARL------HHPNLV 328
+G+ G + L +G R VA+KR++ + + S I A L HPN+V
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPL-STIREVAVLRHLETFEHPNVV 67
Query: 329 AV-KGCCYDHGDR----YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIA 383
+ C DR +V+E V + L +L +P G + M L +G+
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMF--QLLRGLD 124
Query: 384 FLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAP 443
FLH VVHRD++ N+L+ L GL++ +++ V+ T Y AP
Sbjct: 125 FLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV---TLWYRAP 178
Query: 444 EFVYRNELTTKSDVYSFGVLLLEI 467
E + ++ T D++S G + E+
Sbjct: 179 EVLLQSSYATPVDLWSVGCIFAEM 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 6e-07
Identities = 32/90 (35%), Positives = 50/90 (55%), Gaps = 3/90 (3%)
Query: 378 LAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT 437
+A+G+ FL + +HRD+ A N+LL E + GL++ + + R A
Sbjct: 183 VARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239
Query: 438 YGYLAPEFVYRNELTTKSDVYSFGVLLLEI 467
++APE ++ TT+SDV+SFGVLL EI
Sbjct: 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEI 269
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 6e-07
Identities = 39/128 (30%), Positives = 61/128 (47%), Gaps = 11/128 (8%)
Query: 341 YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRA 400
+ V E++ G L + HI GR + R A + G+ FLH K +++RD++
Sbjct: 72 FFVMEYLNGGDL---MFHIQSSGRFDEARARFYAAEIIC-GLQFLHKK---GIIYRDLKL 124
Query: 401 SNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA-GGTYGYLAPEFVYRNELTTKSDVYS 459
NVLLD++ + G+ K + E GT Y+APE + + D +S
Sbjct: 125 DNVLLDKDGHIKIADFGMCKE---NMNGEGKASTFCGTPDYIAPEILKGQKYNESVDWWS 181
Query: 460 FGVLLLEI 467
FGVLL E+
Sbjct: 182 FGVLLYEM 189
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 51.2 bits (123), Expect = 6e-07
Identities = 51/179 (28%), Positives = 73/179 (40%), Gaps = 20/179 (11%)
Query: 297 AVKRLKRSSFQRKKE---FYSEIGRF---ARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 350
A+K LK+ + E E F HP LV + C V E+ G
Sbjct: 28 AIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEYAAGG 87
Query: 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG 410
L + HI S A+ L G+ +LH+ +V+RD++ N+LLD E
Sbjct: 88 DL---MMHIHTDVFSEPRAVFYAACVVL--GLQYLHEN---KIVYRDLKLDNLLLDTEGF 139
Query: 411 AHLMGVGLSKFVPWEVM--QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEI 467
+ GL K E M +RT GT +LAPE + T D + GVL+ E+
Sbjct: 140 VKIADFGLCK----EGMGFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEM 194
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 6e-07
Identities = 54/208 (25%), Positives = 92/208 (44%), Gaps = 17/208 (8%)
Query: 269 NFSEGNRLLGDSKTGGTYSGILPD-GSRVAVKRL--KRSSFQRKKEFYS---EIGRFARL 322
N+ G +LLG G Y D G +AVK++ S + KE + EI L
Sbjct: 3 NWRLG-KLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNL 61
Query: 323 HHPNLVAVKGCCYDHGDR--YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQ 380
H +V GC D ++ I E++ G + L + +L + + + Q
Sbjct: 62 RHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQL----KAYGALTENVTRRYTRQILQ 117
Query: 381 GIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA-GGTYG 439
G+++LH + +VHRDI+ +N+L D L G SK + M + + GT
Sbjct: 118 GVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPY 174
Query: 440 YLAPEFVYRNELTTKSDVYSFGVLLLEI 467
+++PE + K+DV+S ++E+
Sbjct: 175 WMSPEVISGEGYGRKADVWSVACTVVEM 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 7e-07
Identities = 40/147 (27%), Positives = 70/147 (47%), Gaps = 13/147 (8%)
Query: 323 HHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGI 382
+HP LV + C + V E+V G L + H+ R + + R A ++ +
Sbjct: 54 NHPFLVGLHSCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAE-ISLAL 109
Query: 383 AFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ--ERTVMAGGTYGY 440
+LH++ +++RD++ NVLLD E L G+ K E ++ + T GT Y
Sbjct: 110 NYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCK----EGLRPGDTTSTFCGTPNY 162
Query: 441 LAPEFVYRNELTTKSDVYSFGVLLLEI 467
+APE + + D ++ GVL+ E+
Sbjct: 163 IAPEILRGEDYGFSVDWWALGVLMFEM 189
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 7e-07
Identities = 67/278 (24%), Positives = 119/278 (42%), Gaps = 59/278 (21%)
Query: 296 VAVKRLK---RSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352
VA+K++ + S ++ ++ E+ +L HPN + KGC ++V E+ +
Sbjct: 43 VAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCLGSAS 102
Query: 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE----- 407
D H + + ++ A + QG+A+LH + +HRDI+A N+LL E
Sbjct: 103 DILEVH-KKPLQEVEIA---AICHGALQGLAYLHSHER---IHRDIKAGNILLTEPGTVK 155
Query: 408 --EFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY---RNELTTKSDVYSFGV 462
+FG+ + + FV GT ++APE + + K DV+S G+
Sbjct: 156 LADFGSASLVSPANSFV-------------GTPYWMAPEVILAMDEGQYDGKVDVWSLGI 202
Query: 463 LLLEIRLVLCRRWWTLYTLVHSMSLLCAQECLMLFISCNNWPS----HLSQSKFCNLKLW 518
+E L R L+ + ++MS L I+ N+ P+ S F N
Sbjct: 203 TCIE----LAERKPPLFNM-NAMSAL-------YHIAQNDSPTLSSNDWSDY-FRN---- 245
Query: 519 VFAILTIRKVQFEFP----LLRLAVSFAESNRTIVIEL 552
F ++K+ + P LL+ E T++I+L
Sbjct: 246 -FVDSCLQKIPQDRPSSEELLKHRFVLRERPPTVIIDL 282
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 9e-07
Identities = 25/93 (26%), Positives = 44/93 (47%), Gaps = 6/93 (6%)
Query: 375 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA 434
A + G+ LH + +V+RD++ NVLLD+ + +GL+ + ++
Sbjct: 101 AAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELK---GGKKIKGR 154
Query: 435 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEI 467
GT GY+APE + D ++ G L E+
Sbjct: 155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEM 187
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 1e-06
Identities = 27/88 (30%), Positives = 46/88 (52%), Gaps = 5/88 (5%)
Query: 380 QGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYG 439
G+ LH + +++RD++ NVLLD + + +GL+ V + Q +T GT G
Sbjct: 108 SGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLA--VELKDGQSKTKGYAGTPG 162
Query: 440 YLAPEFVYRNELTTKSDVYSFGVLLLEI 467
++APE + E D ++ GV L E+
Sbjct: 163 FMAPELLQGEEYDFSVDYFALGVTLYEM 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 1e-06
Identities = 40/127 (31%), Positives = 59/127 (46%), Gaps = 9/127 (7%)
Query: 341 YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRA 400
+ V EF+ G L + HI GR D A + G+ FLH K +++RD++
Sbjct: 72 FFVMEFLNGGDL---MFHIQDKGR-FDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKL 124
Query: 401 SNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSF 460
NV+LD + + G+ K R GT Y+APE + + T D +SF
Sbjct: 125 DNVMLDRDGHIKIADFGMCK--ENVFGDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSF 182
Query: 461 GVLLLEI 467
GVLL E+
Sbjct: 183 GVLLYEM 189
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 1e-06
Identities = 32/90 (35%), Positives = 50/90 (55%), Gaps = 3/90 (3%)
Query: 378 LAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT 437
+A+G+ FL + +HRD+ A N+LL E + GL++ + + R A
Sbjct: 182 VARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238
Query: 438 YGYLAPEFVYRNELTTKSDVYSFGVLLLEI 467
++APE ++ TT+SDV+SFGVLL EI
Sbjct: 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEI 268
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 1e-06
Identities = 30/97 (30%), Positives = 56/97 (57%), Gaps = 8/97 (8%)
Query: 374 VATTLAQ---GIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER 430
+AT L + G+ +LH + K +HRDI+A+NVLL E+ L G++ + ++
Sbjct: 103 IATILREILKGLDYLHSERK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRN 159
Query: 431 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEI 467
T + GT ++APE + ++ K+D++S G+ +E+
Sbjct: 160 TFV--GTPFWMAPEVIKQSAYDFKADIWSLGITAIEL 194
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 1e-06
Identities = 31/90 (34%), Positives = 49/90 (54%), Gaps = 3/90 (3%)
Query: 378 LAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT 437
+A+G+ FL + +HRD+ A N+LL E + GL++ + + R A
Sbjct: 188 VAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244
Query: 438 YGYLAPEFVYRNELTTKSDVYSFGVLLLEI 467
++APE ++ T +SDV+SFGVLL EI
Sbjct: 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEI 274
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 1e-06
Identities = 38/159 (23%), Positives = 74/159 (46%), Gaps = 12/159 (7%)
Query: 310 KEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWA 369
++ EI ++ P + G +I+ E++ G L P LD
Sbjct: 47 EDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP-----LDET 101
Query: 370 MRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLS-KFVPWEVMQ 428
+ + +G+ +LH + K +HRDI+A+NVLL E L G++ + ++ +
Sbjct: 102 QIATILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR 158
Query: 429 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEI 467
V GT ++APE + ++ +K+D++S G+ +E+
Sbjct: 159 NTFV---GTPFWMAPEVIKQSAYDSKADIWSLGITAIEL 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.2 bits (118), Expect = 2e-06
Identities = 56/198 (28%), Positives = 90/198 (45%), Gaps = 28/198 (14%)
Query: 283 GGTYSGI-----LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH 337
GTY + + G VA+K +K + EI HPN+VA G Y
Sbjct: 13 SGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGS-YLR 71
Query: 338 GDR-YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVA----TTLAQGIAFLHDKVKPH 392
D+ +IV E+ G L ++ + RG S ++A TL +G+A+LH+
Sbjct: 72 RDKLWIVMEYCGGGSLQD-IYQVTRGPLSEL-----QIAYVCRETL-KGLAYLHET---G 121
Query: 393 VVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELT 452
+HRDI+ +N+LL E+ L G+S + + +R G Y ++APE V E
Sbjct: 122 KIHRDIKGANILLTEDGDVKLADFGVSAQLT-ATIAKRKSFIGTPY-WMAPE-VAAVERK 178
Query: 453 ----TKSDVYSFGVLLLE 466
K D+++ G+ +E
Sbjct: 179 GGYDGKCDIWALGITAIE 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 2e-06
Identities = 31/82 (37%), Positives = 44/82 (53%), Gaps = 1/82 (1%)
Query: 392 HVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNEL 451
H++HRDI+++N+LL L G SK V + GT Y+APE R
Sbjct: 163 HMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPY 222
Query: 452 TTKSDVYSFGVLLLEIRLVLCR 473
+ K+D++S GVLL E+ L L R
Sbjct: 223 SKKADMFSLGVLLYEL-LTLKR 243
|
Length = 496 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 2e-06
Identities = 41/146 (28%), Positives = 69/146 (47%), Gaps = 13/146 (8%)
Query: 324 HPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIA 383
HP LV + C + V EFV G L + H+ R + + R + ++ +
Sbjct: 55 HPFLVGLHSCFQTESRLFFVIEFVSGGDL---MFHMQRQRKLPEEHARF-YSAEISLALN 110
Query: 384 FLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ--ERTVMAGGTYGYL 441
FLH++ +++RD++ NVLLD E L G+ K E ++ + T GT Y+
Sbjct: 111 FLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCK----EGIRPGDTTSTFCGTPNYI 163
Query: 442 APEFVYRNELTTKSDVYSFGVLLLEI 467
APE + + D ++ GVL+ E+
Sbjct: 164 APEILRGEDYGFSVDWWALGVLMFEM 189
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 2e-06
Identities = 41/146 (28%), Positives = 67/146 (45%), Gaps = 13/146 (8%)
Query: 324 HPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIA 383
+P LV + C ++V E+V G L + H+ R R L A + +
Sbjct: 55 NPFLVGLHSCFQTTSRLFLVIEYVNGGDL---MFHMQRQ-RKLPEEHARFYAAEICIALN 110
Query: 384 FLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ--ERTVMAGGTYGYL 441
FLH++ +++RD++ NVLLD + L G+ K E + + T GT Y+
Sbjct: 111 FLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCK----EGLGPGDTTSTFCGTPNYI 163
Query: 442 APEFVYRNELTTKSDVYSFGVLLLEI 467
APE + E D ++ GVL+ E+
Sbjct: 164 APEILRGEEYGFSVDWWALGVLMFEM 189
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 48.6 bits (115), Expect = 3e-06
Identities = 49/204 (24%), Positives = 88/204 (43%), Gaps = 19/204 (9%)
Query: 276 LLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCC 334
L+G+ G Y G ++A ++ + ++E EI + HH N+ G
Sbjct: 13 LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 72
Query: 335 YDHG------DRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDK 388
++V EF G + + + G +L + + +G++ LH
Sbjct: 73 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLH-- 128
Query: 389 VKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYR 448
+ V+HRDI+ NVLL E L+ G+S + V + T + GT ++APE +
Sbjct: 129 -QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI--GTPYWMAPEVIAC 185
Query: 449 NE-----LTTKSDVYSFGVLLLEI 467
+E KSD++S G+ +E+
Sbjct: 186 DENPDATYDFKSDLWSLGITAIEM 209
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 4e-06
Identities = 36/128 (28%), Positives = 60/128 (46%), Gaps = 12/128 (9%)
Query: 342 IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRAS 401
+V + G L ++H+ G + + A + G+ LH + +V+RD++
Sbjct: 77 LVLTLMNGGDLKFHIYHMGEAG--FEEGRAVFYAAEICCGLEDLH---QERIVYRDLKPE 131
Query: 402 NVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYRNELTTKSDVYS 459
N+LLD+ + +GL+ VP E + G GT GY+APE V T D ++
Sbjct: 132 NILLDDHGHIRISDLGLAVHVP-----EGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWA 186
Query: 460 FGVLLLEI 467
G LL E+
Sbjct: 187 LGCLLYEM 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 4e-06
Identities = 37/130 (28%), Positives = 62/130 (47%), Gaps = 12/130 (9%)
Query: 341 YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRA 400
+++ ++V G L H+ + + +R+ +A + + LH + +++RDI+
Sbjct: 81 HLILDYVNGGEL---FTHLYQREHFTESEVRVYIAE-IVLALDHLH---QLGIIYRDIKL 133
Query: 401 SNVLLDEEFGAHLMGVGLSK-FVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKS--DV 457
N+LLD E L GLSK F+ E +ER GT Y+APE + D
Sbjct: 134 ENILLDSEGHVVLTDFGLSKEFLAEE--EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDW 191
Query: 458 YSFGVLLLEI 467
+S GVL E+
Sbjct: 192 WSLGVLTFEL 201
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 5e-06
Identities = 48/177 (27%), Positives = 80/177 (45%), Gaps = 17/177 (9%)
Query: 297 AVKRLKRSSFQRKKE---FYSEIGRFAR-LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352
AVK L++ + +KKE SE + + HP LV + Y V +++ G L
Sbjct: 24 AVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGEL 83
Query: 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAH 412
+H+ R L+ R A +A + +LH ++V+RD++ N+LLD +
Sbjct: 84 ---FYHLQRERCFLEPRARF-YAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIV 136
Query: 413 LMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYRNELTTKSDVYSFGVLLLEI 467
L GL K E ++ + GT YLAPE +++ D + G +L E+
Sbjct: 137 LTDFGLCK----ENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEM 189
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 6e-06
Identities = 31/77 (40%), Positives = 44/77 (57%), Gaps = 4/77 (5%)
Query: 393 VVHRDIRASNVLLDEEFGAHLMGVGLSK-FVPWEVMQERTVMAGGTYGYLAPEFVYRNEL 451
+V+RDI+ N+LLD E L GLSK F+ E +ERT GT Y+APE +
Sbjct: 126 IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE--KERTYSFCGTIEYMAPEIIRGKGG 183
Query: 452 TTKS-DVYSFGVLLLEI 467
K+ D +S G+L+ E+
Sbjct: 184 HGKAVDWWSLGILIFEL 200
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 6e-06
Identities = 45/195 (23%), Positives = 84/195 (43%), Gaps = 17/195 (8%)
Query: 277 LGDSKTGGTYSGILPDGSRV-AVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCC 334
LG G Y R+ AVK + + + +K+ SE+ + P ++ G
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 335 YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVV 394
+ I EF+ G LD + R + + ++A + +G+ +L ++
Sbjct: 69 FVENRISICTEFMDGGSLDVY--------RKIPEHVLGRIAVAVVKGLTYLWSL---KIL 117
Query: 395 HRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTK 454
HRD++ SN+L++ L G+S +++ GT Y+APE + +
Sbjct: 118 HRDVKPSNMLVNTRGQVKLCDFGVST----QLVNSIAKTYVGTNAYMAPERISGEQYGIH 173
Query: 455 SDVYSFGVLLLEIRL 469
SDV+S G+ +E+ L
Sbjct: 174 SDVWSLGISFMELAL 188
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.7 bits (114), Expect = 7e-06
Identities = 47/155 (30%), Positives = 73/155 (47%), Gaps = 13/155 (8%)
Query: 315 EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKV 374
EI L+HPN+V + + Y+V+EF ++ L +++ P G LD +
Sbjct: 48 EISLLKELNHPNIVRLLDVVHSENKLYLVFEF-LDLDLKKYMDSSPLTG--LDPPLIKSY 104
Query: 375 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSK-F-VPWEVMQERTV 432
L QGIA+ H V+HRD++ N+L+D E L GL++ F VP V
Sbjct: 105 LYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV 161
Query: 433 MAGGTYGYLAPEFVYRNEL-TTKSDVYSFGVLLLE 466
T Y APE + + +T D++S G + E
Sbjct: 162 ----TLWYRAPEILLGSRQYSTPVDIWSIGCIFAE 192
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 7e-06
Identities = 30/112 (26%), Positives = 62/112 (55%), Gaps = 9/112 (8%)
Query: 357 HHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGV 416
+H+ + G + MR AT + G+ +H++ VV+RD++ +N+LLDE + +
Sbjct: 86 YHLSQHGVFSEKEMRF-YATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDL 141
Query: 417 GLSKFVPWEVMQERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEI 467
GL+ + +++ + GT+GY+APE + + + +D +S G +L ++
Sbjct: 142 GLA----CDFSKKKPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKL 189
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 7e-06
Identities = 39/158 (24%), Positives = 70/158 (44%), Gaps = 15/158 (9%)
Query: 314 SEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMK 373
+E L HPN++ + IV E+ G L ++ R LD +
Sbjct: 48 NECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQK--RCNSLLDEDTILH 105
Query: 374 VATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER--- 430
+ + +H K+ ++HRD++ N+LLD+ H M V + F +++ +
Sbjct: 106 FFVQILLALHHVHTKL---ILHRDLKTQNILLDK----HKMVVKIGDFGISKILSSKSKA 158
Query: 431 -TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEI 467
TV+ GT Y++PE KSD+++ G +L E+
Sbjct: 159 YTVV--GTPCYISPELCEGKPYNQKSDIWALGCVLYEL 194
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 7e-06
Identities = 53/186 (28%), Positives = 85/186 (45%), Gaps = 24/186 (12%)
Query: 293 GSRVAVKRLKRSSFQRK---KEFYSEIGRFARLHHPNLVAVKGCCYDHG-----DRYIVY 344
+VA+K++ ++F + K EI L H N++A+K D YIVY
Sbjct: 30 NEKVAIKKIA-NAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVY 88
Query: 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 404
E +D LH I R ++L L +G+ ++H +V+HRD++ SN+L
Sbjct: 89 EL-----MDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLL 140
Query: 405 LDEEFGAHLMGVGLSKF--VPWEVMQERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFG 461
L+ + GL++ + M E V T Y APE + +E TT DV+S G
Sbjct: 141 LNANCDLKICDFGLARTTSEKGDFMTEYVV----TRWYRAPELLLNCSEYTTAIDVWSVG 196
Query: 462 VLLLEI 467
+ E+
Sbjct: 197 CIFAEL 202
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 9e-06
Identities = 43/190 (22%), Positives = 79/190 (41%), Gaps = 19/190 (10%)
Query: 286 YSGILPDGSRVAVKRLKRSSFQRKK---EFYSEIGRFARLHHPNLVAVKGCCYDHGDRY- 341
Y GI + V ++ K+ K +EI R+ N++ + G D D
Sbjct: 37 YKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLP 95
Query: 342 ---IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV-KPHVVHRD 397
++ E+ G L L + L + ++ +A +G+ L+ KP+ ++
Sbjct: 96 RLSLILEYCTRGYLREVL----DKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPY---KN 148
Query: 398 IRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDV 457
+ + + L+ E + ++ GL K + + M +Y L F +E T K D+
Sbjct: 149 LTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMVYFSYKMLNDIF---SEYTIKDDI 205
Query: 458 YSFGVLLLEI 467
YS GV+L EI
Sbjct: 206 YSLGVVLWEI 215
|
Length = 283 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 1e-05
Identities = 24/104 (23%), Positives = 55/104 (52%), Gaps = 6/104 (5%)
Query: 364 RSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVP 423
R L + + + +G+ +LH + ++HRD++ N+ +++ + +G ++F
Sbjct: 152 RPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQF-- 206
Query: 424 WEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEI 467
V+ + GT APE + R++ +K+D++S G++L E+
Sbjct: 207 -PVVAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEM 249
|
Length = 357 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 1e-05
Identities = 50/195 (25%), Positives = 84/195 (43%), Gaps = 23/195 (11%)
Query: 284 GTYSGI-----LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHG 338
GTY + + G A+K +K + EI H N+VA G
Sbjct: 20 GTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRD 79
Query: 339 DRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDI 398
+I EF G L ++H+ A V+ QG+ +LH K K +HRDI
Sbjct: 80 KLWICMEFCGGGSLQD-IYHVTGPLSESQIAY---VSRETLQGLYYLHSKGK---MHRDI 132
Query: 399 RASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEF--VYR----NELT 452
+ +N+LL + L G+S + + + ++ + GT ++APE V R N+L
Sbjct: 133 KGANILLTDNGHVKLADFGVSAQITATIAKRKSFI--GTPYWMAPEVAAVERKGGYNQLC 190
Query: 453 TKSDVYSFGVLLLEI 467
D+++ G+ +E+
Sbjct: 191 ---DIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 1e-05
Identities = 49/182 (26%), Positives = 80/182 (43%), Gaps = 17/182 (9%)
Query: 292 DGSRVAVKRLKRSSFQRKKE---FYSEIGRFAR-LHHPNLVAVKGCCYDHGDRYIVYEFV 347
DG AVK L++ + +KKE +E + + HP LV + Y V ++V
Sbjct: 19 DGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYV 78
Query: 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE 407
G L H+ R + R A +A + +LH ++++RD++ N+LLD
Sbjct: 79 NGGEL---FFHLQRERSFPEPRARF-YAAEIASALGYLHSL---NIIYRDLKPENILLDS 131
Query: 408 EFGAHLMGVGLSKFVPWEVMQ--ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLL 465
+ L GL K E ++ + T GT YLAPE + + D + G +L
Sbjct: 132 QGHVVLTDFGLCK----EGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLY 187
Query: 466 EI 467
E+
Sbjct: 188 EM 189
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 39/157 (24%), Positives = 65/157 (41%), Gaps = 18/157 (11%)
Query: 318 RFARLHHPNLVAVKGCCYD-HGDRYIVYEFV---VNGPLDRWLHHIPRGGRSLDWAMRMK 373
R HPN+V + C DR V V+ L +L +P G +
Sbjct: 55 RLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAE-----T 109
Query: 374 VATTLAQ---GIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER 430
+ + Q G+ FLH +VHRD++ N+L+ L GL++ ++
Sbjct: 110 IKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTP 166
Query: 431 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEI 467
V+ T Y APE + ++ T D++S G + E+
Sbjct: 167 VVV---TLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 1e-05
Identities = 52/202 (25%), Positives = 90/202 (44%), Gaps = 16/202 (7%)
Query: 275 RLLGDSKTGGTYSGILPD-GSRVAVKRLK--RSSFQRKKEFYS---EIGRFARLHHPNLV 328
+LLG G Y D G +AVK+++ S + KE + EI L H +V
Sbjct: 8 KLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIV 67
Query: 329 AVKGCCYDHGDRY--IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLH 386
GC D +R I E + G + L + +L + K + +G+++LH
Sbjct: 68 QYYGCLRDPMERTLSIFMEHMPGGSIKDQL----KSYGALTENVTRKYTRQILEGVSYLH 123
Query: 387 DKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA-GGTYGYLAPEF 445
+ +VHRDI+ +N+L D L G SK + + + + GT +++PE
Sbjct: 124 SNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEV 180
Query: 446 VYRNELTTKSDVYSFGVLLLEI 467
+ K+D++S G ++E+
Sbjct: 181 ISGEGYGRKADIWSVGCTVVEM 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 2e-05
Identities = 38/152 (25%), Positives = 70/152 (46%), Gaps = 15/152 (9%)
Query: 321 RLHHPNLVAVKGCCYDHGDR-YIVYEFVVNGPLDRWLHHIPRGGRSLD----WAMRMKVA 375
+L HPN+V + DR YIV + + PL + + + W + +++
Sbjct: 65 QLRHPNIVRYYKT-FLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMV 123
Query: 376 TTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG 435
L +LH + + +VHRD+ +N++L E+ + GL+K + + +
Sbjct: 124 LALR----YLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAK---QKQPESKLTSVV 174
Query: 436 GTYGYLAPEFVYRNELTTKSDVYSFGVLLLEI 467
GT Y PE V K+DV++FG +L ++
Sbjct: 175 GTILYSCPEIVKNEPYGEKADVWAFGCILYQM 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 2e-05
Identities = 52/217 (23%), Positives = 99/217 (45%), Gaps = 23/217 (10%)
Query: 264 RSITKNFSEGNRLLGDSKTGGTYSGILPDGS-RVAVKRLKRSSFQRKKEFYSEIGRFARL 322
RS K++ GN ++G+ G Y I D S +VA+K++ + + +E L
Sbjct: 62 RSPNKSYKLGN-IIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLI----MKNL 116
Query: 323 HHPNLVAVKGCCYDHGDRY--------IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKV 374
+H N++ +K Y + +V EF+ + +++ H R +L +
Sbjct: 117 NHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLY 175
Query: 375 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD-EEFGAHLMGVGLSKFVPWEVMQERTVM 433
+ L + +A++H K + HRD++ N+L+D L G +K + + +R+V
Sbjct: 176 SYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNL---LAGQRSVS 229
Query: 434 AGGTYGYLAPEFVY-RNELTTKSDVYSFGVLLLEIRL 469
+ Y APE + TT D++S G ++ E+ L
Sbjct: 230 YICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMIL 266
|
Length = 440 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.5 bits (111), Expect = 2e-05
Identities = 23/96 (23%), Positives = 46/96 (47%), Gaps = 11/96 (11%)
Query: 315 EIGRFARLHHPNLVAVKGCCYDHGDR--YIVYEFVVNGPLDRWL---HHIPRGGRSLDWA 369
EI L H N+V++ +H D+ Y+++++ + D W H S+ +
Sbjct: 52 EIALLRELKHENVVSLVEVFLEHADKSVYLLFDYAEH---DLWQIIKFHRQAKRVSIPPS 108
Query: 370 MRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL 405
M + + G+ +LH V+HRD++ +N+L+
Sbjct: 109 MVKSLLWQILNGVHYLHSN---WVLHRDLKPANILV 141
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 2e-05
Identities = 40/169 (23%), Positives = 75/169 (44%), Gaps = 10/169 (5%)
Query: 299 KRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHH 358
KRLK+ S ++ EI +++ P +V + +V + G L +++
Sbjct: 29 KRLKKKSGEKMALLEKEI--LEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYN 86
Query: 359 IPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGL 418
+ G R L+ + + + GI LH +V+RD++ NVLLD++ L +GL
Sbjct: 87 V--GERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGL 141
Query: 419 SKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEI 467
+ + + GT GY+APE + + D ++ G + E+
Sbjct: 142 AVELK---DGKTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEM 187
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 2e-05
Identities = 58/208 (27%), Positives = 90/208 (43%), Gaps = 22/208 (10%)
Query: 273 GNRLLGDSKTGGTYSGILPDGSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVK 331
GN G G SG P ++V VK L+ S S Q + +F E + L H NL+
Sbjct: 4 GNGWFGKVILGEVNSGYTP--AQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 332 GCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSL--DWAMRMKVATTLAQGIAFLHDKV 389
G C + +V EF G L +L R + D ++A +A G+ LH
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLRSC-RKAELMTPDPTTLQRMACEIALGLLHLH--- 117
Query: 390 KPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY---GYLAPEF- 445
K + +H D+ N LL + + GLS + ++ V + ++APE
Sbjct: 118 KNNFIHSDLALRNCLLTADLTVKIGDYGLSHN---KYKEDYYVTPDQLWVPLRWIAPELV 174
Query: 446 --VYRNEL----TTKSDVYSFGVLLLEI 467
V+ N L T +S+V+S GV + E+
Sbjct: 175 DEVHGNLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 45.7 bits (109), Expect = 2e-05
Identities = 43/183 (23%), Positives = 80/183 (43%), Gaps = 19/183 (10%)
Query: 291 PDGSRVAVKRLKRSS-FQRKKE--FYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV 347
A+K +K+ + ++ +SE +HP +V + D Y++ E+
Sbjct: 16 SKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYC 75
Query: 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVAT-TLAQGIAFLHDKVKPHVVHRDIRASNVLLD 406
+ G L L G ++ R +A LA +LH++ +++RD++ N+LLD
Sbjct: 76 LGGELWTILRDR---GLFDEYTARFYIACVVLA--FEYLHNR---GIIYRDLKPENLLLD 127
Query: 407 EEFGAHLMGVGLSKFVPWEVMQ--ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLL 464
L+ G +K ++ ++T GT Y+APE + D +S G+LL
Sbjct: 128 SNGYVKLVDFGFAK-----KLKSGQKTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILL 182
Query: 465 LEI 467
E+
Sbjct: 183 YEL 185
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 3e-05
Identities = 26/84 (30%), Positives = 45/84 (53%), Gaps = 5/84 (5%)
Query: 385 LHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVP-WEVMQERTVMAGGTYGYLAP 443
L D + +V+RD++ N+LLD+ + +GL+ +P E ++ R GT GY+AP
Sbjct: 115 LEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRV----GTVGYMAP 170
Query: 444 EFVYRNELTTKSDVYSFGVLLLEI 467
E + + T D + G L+ E+
Sbjct: 171 EVINNEKYTFSPDWWGLGCLIYEM 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.7 bits (109), Expect = 4e-05
Identities = 40/154 (25%), Positives = 63/154 (40%), Gaps = 36/154 (23%)
Query: 341 YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVA-TTLAQGIAFLHDKVKPHVVHRDIR 399
Y+V E++ G L L I + + A R +A LA + +H K +HRDI+
Sbjct: 77 YLVMEYMPGGDLMNLL--IRKDVFPEETA-RFYIAELVLA--LDSVH---KLGFIHRDIK 128
Query: 400 ASNVLLDEE-------FG-----------------AHLMGVGLSKFVPWEVMQERTVMAG 435
N+L+D + FG +H + + V ++R V A
Sbjct: 129 PDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRAN 188
Query: 436 ---GTYGYLAPEFVYRNELTTKSDVYSFGVLLLE 466
GT Y+APE + + D +S GV+L E
Sbjct: 189 STVGTPDYIAPEVLRGTPYGLECDWWSLGVILYE 222
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 4e-05
Identities = 46/188 (24%), Positives = 86/188 (45%), Gaps = 27/188 (14%)
Query: 291 PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIV------- 343
P R+ KR+K S + + +EI RL+H N++ ++ + Y++
Sbjct: 190 PKCERLIAKRVKAGS-RAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFD 248
Query: 344 -YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASN 402
Y F+ + D W R L R + L + ++HDK ++HRDI+ N
Sbjct: 249 LYSFMYDEAFD-W------KDRPLLKQTR-AIMKQLLCAVEYIHDKK---LIHRDIKLEN 297
Query: 403 VLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLA---PEFVYRNELTTKSDVYS 459
+ L+ + G ++G +P+E +ER G G +A PE + + +D++S
Sbjct: 298 IFLNCD-GKIVLG-DFGTAMPFE--KEREAFDYGWVGTVATNSPEILAGDGYCEITDIWS 353
Query: 460 FGVLLLEI 467
G++LL++
Sbjct: 354 CGLILLDM 361
|
Length = 501 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 4e-05
Identities = 27/88 (30%), Positives = 45/88 (51%), Gaps = 6/88 (6%)
Query: 383 AFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLA 442
A + K + ++HRD++ SN+LLD L G+S + + + R G Y+A
Sbjct: 119 ALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDA---GCRPYMA 175
Query: 443 PEFV---YRNELTTKSDVYSFGVLLLEI 467
PE + R+ +SDV+S G+ L E+
Sbjct: 176 PERIDPSARDGYDVRSDVWSLGITLYEV 203
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 44.9 bits (107), Expect = 5e-05
Identities = 53/193 (27%), Positives = 85/193 (44%), Gaps = 46/193 (23%)
Query: 296 VAVKRLKRSSFQRKKEFYS-----EIGRFARLHHPNLVAVK----GCCYDHGDRYIVYEF 346
VA+K+LK +++KE + EI +L HPN+V VK G + Y+V E+
Sbjct: 33 VALKKLK---MEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGS--NLDKIYMVMEY 87
Query: 347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQ---GIAFLHDKVKPHVVHRDIRASNV 403
V + L + + + +V + Q G+A LHD ++HRD++ SN+
Sbjct: 88 VEH-DLKSLMETMKQPFLQ------SEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNL 137
Query: 404 LLDE-------EFG-AHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY-RNELTTK 454
LL+ +FG A G L + V T Y APE + E +T
Sbjct: 138 LLNNRGILKICDFGLAREYGSPLKPYTQLVV----------TLWYRAPELLLGAKEYSTA 187
Query: 455 SDVYSFGVLLLEI 467
D++S G + E+
Sbjct: 188 IDMWSVGCIFAEL 200
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.8 bits (107), Expect = 5e-05
Identities = 37/164 (22%), Positives = 69/164 (42%), Gaps = 42/164 (25%)
Query: 321 RLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLA- 379
L HPN+V + + Y+V+E+ + L ++L P + + ++
Sbjct: 54 ELKHPNIVKLLDVIHTERKLYLVFEYC-DMDLKKYLDKRPGP-------LSPNLIKSIMY 105
Query: 380 ---QGIAFLHDKVKPHVVHRDIRASNVLLDEE-------FG-AHLMGVGLSKFVPWEVMQ 428
+G+A+ H ++HRD++ N+L++ + FG A G+ L + EV+
Sbjct: 106 QLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTH-EVV- 160
Query: 429 ERTVMAGGTYGYLAPE-----FVYRNELTTKSDVYSFGVLLLEI 467
T Y APE Y +T D++S G + E+
Sbjct: 161 --------TLWYRAPEILLGSKHY----STAVDIWSVGCIFAEM 192
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 6e-05
Identities = 44/178 (24%), Positives = 76/178 (42%), Gaps = 11/178 (6%)
Query: 293 GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPN--LVAVKGCCYDHGDRYIVYEFVVNG 350
G A KRL++ +++K + L N V Y+ D + ++NG
Sbjct: 25 GKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNG 84
Query: 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG 410
D H G + + A + G+ LH + + V+RD++ N+LLD+
Sbjct: 85 G-DLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH---RENTVYRDLKPENILLDDYGH 140
Query: 411 AHLMGVGLSKFVP-WEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEI 467
+ +GL+ +P E ++ R GT GY+APE + T D + G L+ E+
Sbjct: 141 IRISDLGLAVKIPEGESIRGRV----GTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEM 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 6e-05
Identities = 55/196 (28%), Positives = 86/196 (43%), Gaps = 30/196 (15%)
Query: 293 GSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYI-VYEFVVN 349
G +VA+K++ + K E+ H N++A++ G + VY VV
Sbjct: 30 GKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY--VVM 87
Query: 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE-- 407
++ LHHI + L L +G+ ++H +V+HRD++ SN+L++E
Sbjct: 88 DLMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIH---SANVIHRDLKPSNLLVNEDC 144
Query: 408 -----EFGAHLMGVGLSKFVPWEV---MQERTVMAGGTYGYLAPEFVYR-NELTTKSDVY 458
+FG M GLS P E M E T Y APE + E TT D++
Sbjct: 145 ELRIGDFG---MARGLSSS-PTEHKYFMTEYV----ATRWYRAPELLLSLPEYTTAIDMW 196
Query: 459 SFGVLLLEIRLVLCRR 474
S G + E+ L RR
Sbjct: 197 SVGCIFAEM---LGRR 209
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 7e-05
Identities = 51/180 (28%), Positives = 75/180 (41%), Gaps = 13/180 (7%)
Query: 292 DGSRVAVKRL-KRSSFQRKKEFYSEIGR---FARLHHPNLVAVKGCCYDHGDRYIVYEFV 347
DG AVK L K+ RK++ + R + HP LV + Y V +FV
Sbjct: 19 DGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFV 78
Query: 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE 407
G L H+ R RS A +A + +LH ++V+RD++ N+LLD
Sbjct: 79 NGGEL---FFHLQRE-RSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDS 131
Query: 408 EFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEI 467
+ L GL K + T GT YLAPE + + D + G +L E+
Sbjct: 132 QGHVVLTDFGLCK--EGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEM 189
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 9e-05
Identities = 50/200 (25%), Positives = 89/200 (44%), Gaps = 22/200 (11%)
Query: 284 GTYSGILP-----DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLH-HPNLVAVKGCCYD- 336
GTY + +GS+ AVK L +E +E L HPN+V G Y
Sbjct: 29 GTYGKVFKVLNKKNGSKAAVKILD-PIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKK 87
Query: 337 ---HGDR-YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPH 392
+GD+ ++V E G + + + G ++ + + G+ LH
Sbjct: 88 DVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---K 144
Query: 393 VVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY-RNEL 451
+HRD++ +N+LL E G L+ G+S + ++ T + GT ++APE + +L
Sbjct: 145 TIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV--GTPFWMAPEVIACEQQL 202
Query: 452 TT----KSDVYSFGVLLLEI 467
+ + DV+S G+ +E+
Sbjct: 203 DSTYDARCDVWSLGITAIEL 222
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 1e-04
Identities = 42/163 (25%), Positives = 76/163 (46%), Gaps = 26/163 (15%)
Query: 315 EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLH-HIPRGGRSLDWAMRMK 373
EI L H N+V + + +V+E++ + L +++ H RG LD
Sbjct: 48 EISLMKELKHENIVRLHDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGA--LDPNTVKS 104
Query: 374 VATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE-------EFG-AHLMGVGLSKFVPWE 425
L +GIAF H+ V+HRD++ N+L+++ +FG A G+ ++ F E
Sbjct: 105 FTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSN-E 160
Query: 426 VMQERTVMAGGTYGYLAPEFVYRNEL-TTKSDVYSFGVLLLEI 467
V+ T Y AP+ + + +T D++S G ++ E+
Sbjct: 161 VV---------TLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEM 194
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 1e-04
Identities = 51/191 (26%), Positives = 84/191 (43%), Gaps = 40/191 (20%)
Query: 301 LKRSSFQRKKEFY-----SEIGRFARLHHPNLVAVKGCCYDHGDR----------YIVYE 345
LK+ +KE + EI +L+H N+V +K D D Y+V+E
Sbjct: 37 LKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFE 96
Query: 346 FV---VNGPLDRWLHHIPRGG-RSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRAS 401
++ + G L+ L H +S MK L +G+ + H K + +HRDI+ S
Sbjct: 97 YMDHDLMGLLESGLVHFSEDHIKSF-----MK---QLLEGLNYCHKK---NFLHRDIKCS 145
Query: 402 NVLLDEEFGAHLMGVGLSKFVPWEVMQER----TVMAGGTYGYLAPEFVYRNELTTKS-D 456
N+LL+ + L GL++ + + R V+ T Y PE + E + D
Sbjct: 146 NILLNNKGQIKLADFGLARL--YNSEESRPYTNKVI---TLWYRPPELLLGEERYGPAID 200
Query: 457 VYSFGVLLLEI 467
V+S G +L E+
Sbjct: 201 VWSCGCILGEL 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.8 bits (104), Expect = 1e-04
Identities = 28/88 (31%), Positives = 51/88 (57%), Gaps = 5/88 (5%)
Query: 380 QGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYG 439
G+ +LH++ K +HRDI+A+N+LL EE L G+S + M +R G +
Sbjct: 109 LGLEYLHEEGK---IHRDIKAANILLSEEGDVKLADFGVSGQLT-STMSKRNTFVGTPF- 163
Query: 440 YLAPEFVYRNELTTKSDVYSFGVLLLEI 467
++APE + ++ K+D++S G+ +E+
Sbjct: 164 WMAPEVIKQSGYDEKADIWSLGITAIEL 191
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 1e-04
Identities = 29/112 (25%), Positives = 61/112 (54%), Gaps = 9/112 (8%)
Query: 357 HHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGV 416
+H+ + G + MR A + G+ +H++ VV+RD++ +N+LLDE + +
Sbjct: 86 YHLSQHGVFSEAEMRF-YAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDL 141
Query: 417 GLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEI 467
GL+ + +++ + GT+GY+APE + + + +D +S G +L ++
Sbjct: 142 GLA----CDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKL 189
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 2e-04
Identities = 30/107 (28%), Positives = 56/107 (52%), Gaps = 11/107 (10%)
Query: 365 SLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW 424
+LD + + +A+G++FL K + +HRD+ A N+LL + GL++
Sbjct: 210 ALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLAR---- 262
Query: 425 EVMQERTVMAGGT----YGYLAPEFVYRNELTTKSDVYSFGVLLLEI 467
++ + + G ++APE ++ T +SDV+S+G+LL EI
Sbjct: 263 DIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEI 309
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 50/192 (26%), Positives = 82/192 (42%), Gaps = 17/192 (8%)
Query: 284 GTYSGI-----LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHG 338
GTY + L G AVK +K EI H N+VA G
Sbjct: 20 GTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSRE 79
Query: 339 DRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDI 398
+I E+ G L ++H+ L A V QG+A+LH K K +HRDI
Sbjct: 80 KLWICMEYCGGGSLQD-IYHVTGPLSELQIAY---VCRETLQGLAYLHSKGK---MHRDI 132
Query: 399 RASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEF--VYRN-ELTTKS 455
+ +N+LL + L G++ + + + ++ + GT ++APE V +N
Sbjct: 133 KGANILLTDNGDVKLADFGVAAKITATIAKRKSFI--GTPYWMAPEVAAVEKNGGYNQLC 190
Query: 456 DVYSFGVLLLEI 467
D+++ G+ +E+
Sbjct: 191 DIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 2e-04
Identities = 35/149 (23%), Positives = 66/149 (44%), Gaps = 6/149 (4%)
Query: 319 FARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTL 378
++L HP +V + I+ E+ LD L + G++L + L
Sbjct: 56 LSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQL 115
Query: 379 AQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY 438
G+ ++H + ++HRD++A N+ L + G+S+ + T GT
Sbjct: 116 LLGVHYMHQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATTFT--GTP 169
Query: 439 GYLAPEFVYRNELTTKSDVYSFGVLLLEI 467
Y++PE + +KSD++S G +L E+
Sbjct: 170 YYMSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 43.3 bits (103), Expect = 2e-04
Identities = 46/197 (23%), Positives = 81/197 (41%), Gaps = 41/197 (20%)
Query: 292 DGSRVAVKRLKRSSFQRKKE-----FYSEIGRFARLHHPN---LVAVKGCCYDHGDR-YI 342
G VA+K++K + K+ EI L HPN L+ V + H +
Sbjct: 24 TGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDV----FGHKSNINL 79
Query: 343 VYEFVVNGPLDRWLHHIPRGGRSLDWA-------MRMKVATTLAQGIAFLHDKVKPHVVH 395
V+EF ++ L + + +S+ M M +G+ +LH ++H
Sbjct: 80 VFEF-----METDLEKVIKD-KSIVLTPADIKSYMLM-----TLRGLEYLHSN---WILH 125
Query: 396 RDIRASNVLLDEEFGAHLMGVGLSKFV--PWEVMQERTVMAGGTYGYLAPEFVY-RNELT 452
RD++ +N+L+ + L GL++ P M + V T Y APE ++
Sbjct: 126 RDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV----TRWYRAPELLFGARHYG 181
Query: 453 TKSDVYSFGVLLLEIRL 469
D++S G + E+ L
Sbjct: 182 VGVDMWSVGCIFAELLL 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 27/84 (32%), Positives = 43/84 (51%), Gaps = 7/84 (8%)
Query: 388 KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY 447
K K V+HRD++ SN+LLD L G+S + + R+ G Y+APE +
Sbjct: 131 KEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRS---AGCAAYMAPERID 187
Query: 448 RNELTTK----SDVYSFGVLLLEI 467
+ K +DV+S G+ L+E+
Sbjct: 188 PPDPNPKYDIRADVWSLGISLVEL 211
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 49/187 (26%), Positives = 78/187 (41%), Gaps = 18/187 (9%)
Query: 293 GSRVAVKRLKRSSFQRKKEFYSEIGRFARLH---HPNLVAVKGCCYDHGDRYIVYEFVVN 349
G A+K LK+ K E + L HP L A+K H V E+
Sbjct: 20 GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANG 79
Query: 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF 409
G L H+ R R + + +LH + +VV+RD++ N++LD++
Sbjct: 80 GEL---FFHLSRE-RVFSEDRARFYGAEIVSALDYLH--SEKNVVYRDLKLENLMLDKDG 133
Query: 410 GAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYRNELTTKSDVYSFGVLLLEI 467
+ GL K E +++ M GT YLAPE + N+ D + GV++ E+
Sbjct: 134 HIKITDFGLCK----EGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEM 189
Query: 468 RLVLCRR 474
+C R
Sbjct: 190 ---MCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 2e-04
Identities = 45/174 (25%), Positives = 74/174 (42%), Gaps = 10/174 (5%)
Query: 296 VAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 353
VA+K+ K S + + K+ E+ L N+V +K G Y+V+E+V L+
Sbjct: 29 VAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLE 88
Query: 354 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHL 413
L +P G KV + + Q I +H K +VHRDI+ N+L+ L
Sbjct: 89 -LLEEMPNG------VPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKL 141
Query: 414 MGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEI 467
G ++ + E T Y +PE + D++S G +L E+
Sbjct: 142 CDFGFARNLS-EGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGEL 194
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 3e-04
Identities = 43/153 (28%), Positives = 67/153 (43%), Gaps = 16/153 (10%)
Query: 324 HPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIA 383
HP L A+K H V E+ G L H+ R + R A + +
Sbjct: 54 HPFLTALKYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAE-IVSALE 109
Query: 384 FLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYL 441
+LH + VV+RDI+ N++LD++ + GL K E + + M GT YL
Sbjct: 110 YLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK----EGISDGATMKTFCGTPEYL 162
Query: 442 APEFVYRNELTTKSDVYSFGVLLLEIRLVLCRR 474
APE + N+ D + GV++ E+ +C R
Sbjct: 163 APEVLEDNDYGRAVDWWGLGVVMYEM---MCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 3e-04
Identities = 29/78 (37%), Positives = 40/78 (51%), Gaps = 5/78 (6%)
Query: 393 VVHRDIRASNVLLDEEFGAHLMGVGLSK-FVPWEVMQERTVMAGGTYGYLAPEFVYRNEL 451
+++RDI+ N+LLD L GLSK F EV ER GT Y+AP+ V +
Sbjct: 126 IIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEV--ERAYSFCGTIEYMAPDIVRGGDG 183
Query: 452 --TTKSDVYSFGVLLLEI 467
D +S GVL+ E+
Sbjct: 184 GHDKAVDWWSMGVLMYEL 201
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|153059 cd03589, CLECT_CEL-1_like, C-type lectin-like domain (CTLD) of the type found in CEL-1 from Cucumaria echinata and Echinoidin from Anthocidaris crassispina | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 3e-04
Identities = 28/152 (18%), Positives = 48/152 (31%), Gaps = 33/152 (21%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIG-----GHLAALTSYEEEHSAQKLCG 107
CP W C+ + G+ +W+E+E C+ HL ++ S EE L
Sbjct: 1 CPTFW--TAFGGYCYRFFGDRLTWEEAELRCRSFSIPGLIAHLVSIHSQEENDFVYDL-- 56
Query: 108 KNVNGCWVGGRSINTTVGL-------SWKWSD----NMSKWNESIHAVGSFNSSCTSLPC 156
+GL ++W+D + +KW N C +
Sbjct: 57 --FESSRGPDTPYGLWIGLHDRTSEGPFEWTDGSPVDFTKWAGGQPDNYGGNEDCVQMWR 114
Query: 157 HVHATVDLCTLVSNGSRSLVTERCNTSHPFIC 188
+ +S C+ P+IC
Sbjct: 115 R-----------GDAGQSWNDMPCDAVFPYIC 135
|
CLECT_CEL-1_like: C-type lectin-like domain (CTLD) of the type found in CEL-1 from Cucumaria echinata and Echinoidin from Anthocidaris crassispina. CTLD refers to a domain homologous to the carbohydrate-recognition domains (CRDs) of the C-type lectins. The CEL-1 CTLD binds three calcium ions and has a high specificity for N-acteylgalactosamine (GalNAc). CEL-1 exhibits strong cytotoxicity which is inhibited by GalNAc. This protein may play a role as a toxin defending against predation. Echinoidin is found in the coelomic fluid of the sea urchin and is specific for GalBeta1-3GalNAc. Echinoidin has a cell adhesive activity towards human cancer cells which is not mediated through the CTLD. Both CEL-1 and Echinoidin are multimeric proteins comprised of multiple dimers linked by disulfide bonds. Length = 137 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 4e-04
Identities = 32/112 (28%), Positives = 53/112 (47%), Gaps = 26/112 (23%)
Query: 375 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVP-WEVMQERTVM 433
A + G+ LH + +V+RD++ N+LLD+ + +GL+ +P E ++ R
Sbjct: 108 AAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRV-- 162
Query: 434 AGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVLCRRWWTLYTLVHSM 485
GT GY+APE V K++ Y+F WW L L++ M
Sbjct: 163 --GTVGYMAPEVV-------KNERYTFSP-----------DWWGLGCLIYEM 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|153058 cd03588, CLECT_CSPGs, C-type lectin-like domain (CTLD) of the type found in chondroitin sulfate proteoglycan core proteins | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 5e-04
Identities = 20/81 (24%), Positives = 41/81 (50%), Gaps = 9/81 (11%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNG 112
C W ++ + C+ + + +W+++E C+E GHL+++ + EE Q+ N
Sbjct: 1 CEEGW--DKFQGHCYRHFPDRETWEDAERRCREQQGHLSSIVTPEE----QEFVNNNAQD 54
Query: 113 C-WVGGRSINTTVGLSWKWSD 132
W+G + T+ ++WSD
Sbjct: 55 YQWIGLN--DRTIEGDFRWSD 73
|
CLECT_CSPGs: C-type lectin-like domain (CTLD) of the type found in chondroitin sulfate proteoglycan core proteins (CSPGs) in human and chicken aggrecan, frog brevican, and zebra fish dermacan. CTLD refers to a domain homologous to the carbohydrate-recognition domains (CRDs) of the C-type lectins. In cartilage, aggrecan forms cartilage link protein stabilized aggregates with hyaluronan (HA). These aggregates contribute to the tissue's load bearing properties. Aggregates having other CSPGs substituting for aggrecan may contribute to the structural integrity of many different tissues. Xenopus brevican is expressed in the notochord and the brain during early embryogenesis. Zebra fish dermacan is expressed in dermal bones and may play a role in dermal bone development. CSPGs do contain LINK domain(s) which bind HA. These LINK domains are considered by one classification system to be a variety of CTLD, but are omitted from this hierarchical classification based on insignificant sequence similarity. Length = 124 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.5 bits (98), Expect = 6e-04
Identities = 43/156 (27%), Positives = 73/156 (46%), Gaps = 22/156 (14%)
Query: 321 RLHHPNLVAVKGCCYD-HGDR----YIVYEFVVNGPLDRWLHHIPRGGRSLD---WAMRM 372
HPN+V + C+ DR +V+E V + L +L P+ G + MR
Sbjct: 57 SFEHPNIVRLLDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLPPETIKDLMRQ 115
Query: 373 KVATTLAQGIAFLHDKVKPH-VVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT 431
L +G+ FLH H +VHRD++ N+L+ + + GL++ +E M +
Sbjct: 116 -----LLRGVDFLHS----HRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFE-MALTS 165
Query: 432 VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEI 467
V+ T Y APE + ++ T D++S G + E+
Sbjct: 166 VVV--TLWYRAPEVLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 7e-04
Identities = 41/160 (25%), Positives = 72/160 (45%), Gaps = 20/160 (12%)
Query: 315 EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKV 374
EI + H N+V ++ + Y+V+E++ + L + + P ++ R+ +
Sbjct: 51 EISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYL-DLDLKKHMDSSPDFAKNP----RL-I 104
Query: 375 ATTLAQ---GIAFLHDKVKPHVVHRDIRASNVLLDEEFGA-HLMGVGLSKF--VPWEVMQ 428
T L Q GIA+ H V+HRD++ N+L+D A L GL++ +P
Sbjct: 105 KTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFT 161
Query: 429 ERTVMAGGTYGYLAPEFVY-RNELTTKSDVYSFGVLLLEI 467
V T Y APE + +T D++S G + E+
Sbjct: 162 HEVV----TLWYRAPEILLGSRHYSTPVDIWSVGCIFAEM 197
|
Length = 294 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 41.1 bits (97), Expect = 8e-04
Identities = 42/171 (24%), Positives = 69/171 (40%), Gaps = 38/171 (22%)
Query: 293 GSRVAVKR--LKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR-YIVYEFVVN 349
G VA+K+ L+R + EI HP +V + + HG +V E++ +
Sbjct: 25 GETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV-FPHGSGFVLVMEYMPS 83
Query: 350 GPLDRWLHHIPRG-----GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 404
L L R +S MRM L +G+A++H ++HRD++ +N+L
Sbjct: 84 D-LSEVLRDEERPLPEAQVKSY---MRM-----LLKGVAYMHAN---GIMHRDLKPANLL 131
Query: 405 LDE-------EFG-AHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY 447
+ +FG A L + +V T Y APE +Y
Sbjct: 132 ISADGVLKIADFGLARLFSEEEPRLYSHQV---------ATRWYRAPELLY 173
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 8e-04
Identities = 54/211 (25%), Positives = 87/211 (41%), Gaps = 30/211 (14%)
Query: 275 RLLGDSKTGGTYSGIL-----PDGSRVAVKRLKRSSFQRKKEF---YSEIGRFARLHHPN 326
+LLG GT+ ++ G A+K LK+ K E +E HP
Sbjct: 1 KLLGK----GTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPF 56
Query: 327 LVAVKGCCYDHGDRY-IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFL 385
L ++K + DR V E+V G L H+ R R + + +L
Sbjct: 57 LTSLK-YSFQTKDRLCFVMEYVNGGEL---FFHLSRE-RVFSEDRTRFYGAEIVSALDYL 111
Query: 386 HDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAP 443
H +V+RD++ N++LD++ + GL K E + + M GT YLAP
Sbjct: 112 HSG---KIVYRDLKLENLMLDKDGHIKITDFGLCK----EGITDAATMKTFCGTPEYLAP 164
Query: 444 EFVYRNELTTKSDVYSFGVLLLEIRLVLCRR 474
E + N+ D + GV++ E+ +C R
Sbjct: 165 EVLEDNDYGRAVDWWGLGVVMYEM---MCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.001
Identities = 36/151 (23%), Positives = 70/151 (46%), Gaps = 13/151 (8%)
Query: 325 PNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAF 384
P +V G + G Y+ E++ G LD+ + +R ++ + +G+ F
Sbjct: 59 PYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLR-RITYAVVKGLKF 117
Query: 385 LHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPE 444
L ++ +++HRD++ +NVL++ L G+S + + + G Y+APE
Sbjct: 118 LKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI----GCQSYMAPE 171
Query: 445 FVY------RNELTTKSDVYSFGVLLLEIRL 469
+ T +SDV+S G+ +LE+ L
Sbjct: 172 RIKSGGPNQNPTYTVQSDVWSLGLSILEMAL 202
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.001
Identities = 24/96 (25%), Positives = 48/96 (50%), Gaps = 4/96 (4%)
Query: 372 MKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT 431
+ + ++ + I +LH+ ++HRDI+A N+ ++ L G + F P ++ +
Sbjct: 185 LAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACF-PVDINANKY 240
Query: 432 VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEI 467
GT APE + R+ D++S G++L E+
Sbjct: 241 YGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEM 276
|
Length = 391 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.0 bits (97), Expect = 0.001
Identities = 32/128 (25%), Positives = 60/128 (46%), Gaps = 26/128 (20%)
Query: 293 GSRVAVKRLKRSSFQRKKEFYS--------EIGRFARL-HHPNLVAVKGCCYDHGDRYIV 343
G VA+K++K K+FYS E+ +L HPN+V +K ++ + Y V
Sbjct: 24 GELVAIKKMK-------KKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFV 76
Query: 344 YEFVVNGPLDRWLHHI--PRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRAS 401
+E+ ++ L+ + R G+ ++ + + QG+A +H K HRD++
Sbjct: 77 FEY-----MEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH---KHGFFHRDLKPE 128
Query: 402 NVLLDEEF 409
N+L+
Sbjct: 129 NLLVSGPE 136
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|165024 PHA02642, PHA02642, C-type lectin-like protein; Provisional | Back alignment and domain information |
|---|
Score = 40.1 bits (93), Expect = 0.001
Identities = 26/94 (27%), Positives = 44/94 (46%), Gaps = 7/94 (7%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNG 112
CP WI KCF + + ++W T+C +G L + + EE + ++ K+ +
Sbjct: 88 CPKGWI--GFGYKCFYFSEDSKNWTFGNTFCTSLGATLVKVETEEELNFLKRY--KDSSD 143
Query: 113 CWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGS 146
W+G + WKW+DN S +N S G+
Sbjct: 144 HWIGLN--RESSNHPWKWADN-SNYNASFVITGT 174
|
Length = 216 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 0.001
Identities = 57/222 (25%), Positives = 101/222 (45%), Gaps = 37/222 (16%)
Query: 262 ELRSITKNFSEGNRLLGDSKTGGTYSGI------LPDGSRVAVKRLKRSSFQRKKEFYS- 314
RS+T F + NR+ G+ GTY GI G VA+K+++ +++
Sbjct: 2 RCRSVT-EFEKLNRI-GE----GTY-GIVYRARDTTSGEIVALKKVR---MDNERDGIPI 51
Query: 315 ----EIGRFARLHHPNLVAVKGCCY-DHGDR-YIVYEFVVNGPLDRWLHHIPRGGRSLDW 368
EI L HPN+V +K H D ++V E+ L L ++P
Sbjct: 52 SSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYC-EQDLASLLDNMPT---PFSE 107
Query: 369 AMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF--VPWEV 426
+ + L +G+ +LH+ ++HRD++ SN+LL ++ + GL++ +P +
Sbjct: 108 SQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKP 164
Query: 427 MQERTVMAGGTYGYLAPEFVYRNELTTKS-DVYSFGVLLLEI 467
M + V T Y APE + T + D+++ G +L E+
Sbjct: 165 MTPKVV----TLWYRAPELLLGCTTYTTAIDMWAVGCILAEL 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.001
Identities = 25/75 (33%), Positives = 39/75 (52%)
Query: 393 VVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELT 452
++HRD++++N+ L L G SK V + GT YLAPE R +
Sbjct: 190 MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYS 249
Query: 453 TKSDVYSFGVLLLEI 467
K+D++S GV+L E+
Sbjct: 250 KKADMWSLGVILYEL 264
|
Length = 478 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 40.6 bits (96), Expect = 0.001
Identities = 32/127 (25%), Positives = 54/127 (42%), Gaps = 23/127 (18%)
Query: 293 GSRVAVKRLKRSSFQRK---KEFYSEIGRFARLHHPNLVAVK-----GCCYDHGDRYIVY 344
G +VA+K++ F K EI L H N++ + D D YIV
Sbjct: 25 GRKVAIKKISNV-FDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVT 83
Query: 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQ---GIAFLHDKVKPHVVHRDIRAS 401
E ++ LH + + + L + L Q G+ +LH +V+HRD++ S
Sbjct: 84 EL-----METDLHKVIKSPQPLTDD---HIQYFLYQILRGLKYLH---SANVIHRDLKPS 132
Query: 402 NVLLDEE 408
N+L++
Sbjct: 133 NILVNSN 139
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.002
Identities = 40/169 (23%), Positives = 77/169 (45%), Gaps = 23/169 (13%)
Query: 315 EIGRFARLHHPNLVAVKGCCYDHGDR--YIVYEFVVNGPLDRW----LHHIPRGGRSLDW 368
EI L HPN++A++ H DR ++++++ + D W H + +
Sbjct: 48 EIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH---DLWHIIKFHRASKANKKPMQ 104
Query: 369 AMRMKVATTLAQ---GIAFLHDKVKPHVVHRDIRASNVLL----DEEFGAHLMGVGLSKF 421
R V + L Q GI +LH V+HRD++ +N+L+ E + +G ++
Sbjct: 105 LPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161
Query: 422 V--PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKS-DVYSFGVLLLEI 467
P + + + + T+ Y APE + TK+ D+++ G + E+
Sbjct: 162 FNSPLKPLADLDPVV-VTFWYRAPELLLGARHYTKAIDIWAIGCIFAEL 209
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.002
Identities = 56/202 (27%), Positives = 91/202 (45%), Gaps = 40/202 (19%)
Query: 295 RVAVKRLKRSSF----QRKKEFYS-EIGRFARLHHPNLVAVKGCCYDHGDRYI--VYEFV 347
R A+K++ + + Q ++ F +I FA +P +V++ C ++ R++ V E+V
Sbjct: 28 RFAMKKINKQNLILRNQIQQVFVERDILTFA--ENPFVVSMF-CSFE-TKRHLCMVMEYV 83
Query: 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVA-TTLAQGIAFLHDKVKPHVVHRDIRASNVLLD 406
G L +I G +D A RM A T LA + +LH+ +VHRD++ N+L+
Sbjct: 84 EGGDCATLLKNI--GALPVDMA-RMYFAETVLA--LEYLHNY---GIVHRDLKPDNLLIT 135
Query: 407 EEFGAHLMGVGLSKFVPWEVMQERTVMAG----------------GTYGYLAPEFVYRNE 450
L GLSK +M T + GT Y+APE + R
Sbjct: 136 SMGHIKLTDFGLSKI---GLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQG 192
Query: 451 LTTKSDVYSFGVLLLEIRLVLC 472
D ++ G++L E LV C
Sbjct: 193 YGKPVDWWAMGIILYEF-LVGC 213
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 0.003
Identities = 49/208 (23%), Positives = 89/208 (42%), Gaps = 49/208 (23%)
Query: 284 GTYSGILP-----DGSRVAVKRLK--------RSSFQRKKEFYSEIGRFARLHHPNLVAV 330
GTY + VA+KR++ SS R EI L H N+V +
Sbjct: 11 GTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR------EICLLKELKHKNIVRL 64
Query: 331 KGCCYD--HGDR--YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATT----LAQGI 382
YD H D+ +V+E+ + L ++ S + + ++ + L +G+
Sbjct: 65 ----YDVLHSDKKLTLVFEYC-DQDLKKYFD-------SCNGDIDPEIVKSFMFQLLKGL 112
Query: 383 AFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF--VPWEVMQERTVMAGGTYGY 440
AF H +V+HRD++ N+L+++ L GL++ +P V T Y
Sbjct: 113 AFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV----TLWY 165
Query: 441 LAPEFVYRNEL-TTKSDVYSFGVLLLEI 467
P+ ++ +L +T D++S G + E+
Sbjct: 166 RPPDVLFGAKLYSTSIDMWSAGCIFAEL 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.003
Identities = 43/181 (23%), Positives = 78/181 (43%), Gaps = 23/181 (12%)
Query: 296 VAVKRLKRSSFQRK---KEFYSEIGRFARLHHPNLVAV------KGCCYDHGDRYIVYEF 346
VA+K+L R FQ + K Y E+ ++H N++ + + + D YIV E
Sbjct: 52 VAIKKLSRP-FQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL 110
Query: 347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD 406
+D L + + LD + + GI LH ++HRD++ SN+++
Sbjct: 111 -----MDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVK 160
Query: 407 EEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLE 466
+ ++ GL++ M V+ T Y APE + D++S G ++ E
Sbjct: 161 SDCTLKILDFGLARTAGTSFMMTPYVV---TRYYRAPEVILGMGYKENVDIWSVGCIMGE 217
Query: 467 I 467
+
Sbjct: 218 M 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 553 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.98 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.95 | |
| PHA02642 | 216 | C-type lectin-like protein; Provisional | 99.95 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.95 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.94 | |
| cd03599 | 153 | CLECT_DGCR2_like C-type lectin-like domain (CTLD) | 99.94 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.94 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.93 | |
| cd03588 | 124 | CLECT_CSPGs C-type lectin-like domain (CTLD) of th | 99.93 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.93 | |
| cd03596 | 129 | CLECT_tetranectin_like C-type lectin-like domain ( | 99.92 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.92 | |
| cd03597 | 129 | CLECT_attractin_like C-type lectin-like domain (CT | 99.92 | |
| PHA03097 | 157 | C-type lectin-like protein; Provisional | 99.92 | |
| cd03589 | 137 | CLECT_CEL-1_like C-type lectin-like domain (CTLD) | 99.92 | |
| cd03590 | 126 | CLECT_DC-SIGN_like C-type lectin-like domain (CTLD | 99.91 | |
| cd03593 | 116 | CLECT_NK_receptors_like C-type lectin-like domain | 99.91 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.91 | |
| PHA02953 | 170 | IEV and EEV membrane glycoprotein; Provisional | 99.91 | |
| cd03594 | 129 | CLECT_REG-1_like C-type lectin-like domain (CTLD) | 99.9 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.9 | |
| PHA02867 | 167 | C-type lectin protein; Provisional | 99.89 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.88 | |
| cd03591 | 114 | CLECT_collectin_like C-type lectin-like domain (CT | 99.87 | |
| cd03598 | 117 | CLECT_EMBP_like C-type lectin-like domain (CTLD) o | 99.87 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.86 | |
| cd03603 | 118 | CLECT_VCBS A bacterial subgroup of the C-type lect | 99.86 | |
| cd03601 | 119 | CLECT_TC14_like C-type lectin-like domain (CTLD) o | 99.86 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.85 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.85 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.85 | |
| smart00034 | 126 | CLECT C-type lectin (CTL) or carbohydrate-recognit | 99.84 | |
| TIGR00864 | 2740 | PCC polycystin cation channel protein. Note: this | 99.84 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.84 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.84 | |
| cd03592 | 115 | CLECT_selectins_like C-type lectin-like domain (CT | 99.83 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.82 | |
| cd03602 | 108 | CLECT_1 C-type lectin (CTL)/C-type lectin-like (CT | 99.82 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.82 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.82 | |
| cd03595 | 149 | CLECT_chondrolectin_like C-type lectin-like domain | 99.81 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.81 | |
| cd03600 | 141 | CLECT_thrombomodulin_like C-type lectin-like domai | 99.8 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.77 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.77 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.76 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.75 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.75 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.74 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.74 | |
| PHA02911 | 213 | C-type lectin-like protein; Provisional | 99.74 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.73 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.73 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.73 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.72 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.7 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.65 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.64 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.64 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.62 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.55 | |
| cd00037 | 116 | CLECT C-type lectin (CTL)/C-type lectin-like (CTLD | 99.54 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.52 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.51 | |
| PF00059 | 105 | Lectin_C: Lectin C-type domain; InterPro: IPR00130 | 99.47 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.37 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.37 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.31 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.29 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.25 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.17 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.16 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.16 | |
| PF05473 | 200 | Herpes_UL45: UL45 protein; InterPro: IPR008646 Thi | 99.11 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.11 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.99 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.96 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.94 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.77 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.72 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.64 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.63 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.6 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.54 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.42 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.26 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.24 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.23 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.23 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.23 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.21 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.15 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.15 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.05 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.01 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.9 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.81 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.69 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.67 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.63 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.61 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.6 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.59 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.54 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-50 Score=412.23 Aligned_cols=260 Identities=41% Similarity=0.654 Sum_probs=220.6
Q ss_pred CCcccCHHHHHHhhcccCCCCeeecccCceeEEEEEeCCCCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeE
Q 008785 254 SWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGC 333 (553)
Q Consensus 254 ~~~~~~~~el~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~ 333 (553)
....|+++++..+|++|+..+.+ |+|+||.||+|.+++|+.||||++.........+|.+|+.++.+++|||+|+|+||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~i-g~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGy 139 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLI-GEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGY 139 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcce-ecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEE
Confidence 56789999999999999998876 99999999999999999999998877643314569999999999999999999999
Q ss_pred EeeCCc-eEEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeE
Q 008785 334 CYDHGD-RYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAH 412 (553)
Q Consensus 334 ~~~~~~-~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~k 412 (553)
|.+.+. .+||+|||++|+|.++|+..... .++|.++++|+.++|+||+|||+.+.+.|+||||||+|||+|+++++|
T Consensus 140 C~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aK 217 (361)
T KOG1187|consen 140 CLEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAK 217 (361)
T ss_pred EecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEE
Confidence 999995 99999999999999999863222 789999999999999999999999989999999999999999999999
Q ss_pred EeeccccccCCc-ccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcCcc-------cccchHHH----
Q 008785 413 LMGVGLSKFVPW-EVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVLC-------RRWWTLYT---- 480 (553)
Q Consensus 413 l~Dfgla~~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~~-------~~~~~l~~---- 480 (553)
|+|||+|+..+. ....... . .||.+|+|||++..+..+.|+|||||||+|+||++..+ .....+.+
T Consensus 218 lsDFGLa~~~~~~~~~~~~~-~-~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~ 295 (361)
T KOG1187|consen 218 LSDFGLAKLGPEGDTSVSTT-V-MGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKP 295 (361)
T ss_pred ccCccCcccCCccccceeee-c-CCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHH
Confidence 999999976654 2211111 1 49999999999999999999999999999999997332 12222333
Q ss_pred HHhcCCH----------------HHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008785 481 LVHSMSL----------------LCAQECLMLFISCNNWPSHLSQSKFCNLKLW 518 (553)
Q Consensus 481 ~~~~~~~----------------~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l 518 (553)
.+..+.+ .....+..++.+|++.+|.+||+|.||++.+
T Consensus 296 ~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L 349 (361)
T KOG1187|consen 296 LLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKEL 349 (361)
T ss_pred HHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHH
Confidence 3333222 3566789999999999999999999998877
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-46 Score=383.57 Aligned_cols=243 Identities=28% Similarity=0.411 Sum_probs=204.5
Q ss_pred ecccCceeEEEEEeCCCCEEEEEEeccCChhh--HHHHHHHHHHhhccCCCceeeEeeEEeeCC-ceEEEEEccCCCCHH
Q 008785 277 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQR--KKEFYSEIGRFARLHHPNLVAVKGCCYDHG-DRYIVYEFVVNGPLD 353 (553)
Q Consensus 277 iG~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~--~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~-~~~lV~E~~~~gsL~ 353 (553)
+|+|+||+||+|.+.....||||++....... .++|.+|+.+|.+++|||||+++|++.+.. ...|||||+++|+|.
T Consensus 49 iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~GsL~ 128 (362)
T KOG0192|consen 49 LGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGGSLS 128 (362)
T ss_pred cccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCCcHH
Confidence 59999999999999544459999998754322 569999999999999999999999999987 799999999999999
Q ss_pred HHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC-ceecCCCCCcEEecCCC-CeEEeeccccccCCccccccee
Q 008785 354 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPH-VVHRDIRASNVLLDEEF-GAHLMGVGLSKFVPWEVMQERT 431 (553)
Q Consensus 354 ~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~-ivHrDlkp~NILl~~~~-~~kl~Dfgla~~~~~~~~~~~~ 431 (553)
++|+.. ....+++..++.++.|||+||.|||++ + ||||||||+|||++.++ .+||+|||+++........ .
T Consensus 129 ~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~~~--~ 201 (362)
T KOG0192|consen 129 VLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISKTS--M 201 (362)
T ss_pred HHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeecccccc--c
Confidence 999763 456799999999999999999999999 8 99999999999999997 9999999999876543211 1
Q ss_pred eecCcccccccccccc--CCCCCcccchHhHHHHHHHHhcC-cccccchHHH----HHhcCCH-----HHHHHHHHHHhh
Q 008785 432 VMAGGTYGYLAPEFVY--RNELTTKSDVYSFGVLLLEIRLV-LCRRWWTLYT----LVHSMSL-----LCAQECLMLFIS 499 (553)
Q Consensus 432 ~~~~gt~~y~aPE~~~--~~~~t~ksDVwSlGvil~ell~~-~~~~~~~l~~----~~~~~~~-----~~~~~l~~l~~~ 499 (553)
....||+.|||||++. ...|+.|+|||||||++|||++. .|.......+ ....+.. .++..+..++.+
T Consensus 202 ~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~~~~l~~l~~~ 281 (362)
T KOG0192|consen 202 TSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKECPPHLSSLMER 281 (362)
T ss_pred cCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHH
Confidence 1133999999999999 56899999999999999999984 4555444333 3223222 578899999999
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHhhcc
Q 008785 500 CNNWPSHLSQSKFCNLKLWVFAILTIR 526 (553)
Q Consensus 500 Cl~~dP~~RPs~~evl~~l~~~~~~~~ 526 (553)
||+.||+.||++.+++..+...+....
T Consensus 282 CW~~dp~~RP~f~ei~~~l~~~~~~~~ 308 (362)
T KOG0192|consen 282 CWLVDPSRRPSFLEIVSRLESIMSHIS 308 (362)
T ss_pred hCCCCCCcCCCHHHHHHHHHHHHHhhc
Confidence 999999999999999999887666444
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-47 Score=386.29 Aligned_cols=238 Identities=26% Similarity=0.375 Sum_probs=206.5
Q ss_pred ecccCceeEEEEEeCCCCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCCHHHHh
Q 008785 277 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWL 356 (553)
Q Consensus 277 iG~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l 356 (553)
||+|.||.||.|.++....||+|.++.. ....++|.+|+++|++|+|+|||+++|+|..++.+|||||||+.|+|.+||
T Consensus 214 LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~yL 292 (468)
T KOG0197|consen 214 LGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLDYL 292 (468)
T ss_pred hcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcHHHHh
Confidence 5999999999999977779999999876 344578999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccceeeecCc
Q 008785 357 HHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGG 436 (553)
Q Consensus 357 ~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g 436 (553)
+. ..+..+...+.+.++.|||+||+||+++ ++|||||.++|||++++..+||+|||+|+...++......... -
T Consensus 293 r~--~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~~k-f 366 (468)
T KOG0197|consen 293 RT--REGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASEGGK-F 366 (468)
T ss_pred hh--cCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCCCceeecCCCC-C
Confidence 86 4567799999999999999999999999 9999999999999999999999999999965544433322221 4
Q ss_pred cccccccccccCCCCCcccchHhHHHHHHHHhcC--cc---cccchHHHHHhcCCH-----HHHHHHHHHHhhccCCCCC
Q 008785 437 TYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLV--LC---RRWWTLYTLVHSMSL-----LCAQECLMLFISCNNWPSH 506 (553)
Q Consensus 437 t~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~--~~---~~~~~l~~~~~~~~~-----~~~~~l~~l~~~Cl~~dP~ 506 (553)
+..|.|||++..+.++.|||||||||+||||+|. .| ....++++.+++|-. .++..+.+++..||+.+|+
T Consensus 367 PIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P~~CP~~vY~lM~~CW~~~P~ 446 (468)
T KOG0197|consen 367 PIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRPEGCPDEVYELMKSCWHEDPE 446 (468)
T ss_pred CceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCCCCCCHHHHHHHHHHhhCCcc
Confidence 6789999999999999999999999999999982 22 233455557777655 8899999999999999999
Q ss_pred CCCCHHHHHHHHHHH
Q 008785 507 LSQSKFCNLKLWVFA 521 (553)
Q Consensus 507 ~RPs~~evl~~l~~~ 521 (553)
+|||+..+...+...
T Consensus 447 ~RPtF~~L~~~l~~~ 461 (468)
T KOG0197|consen 447 DRPTFETLREVLEDF 461 (468)
T ss_pred cCCCHHHHHHHHHHh
Confidence 999999877766543
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-47 Score=354.92 Aligned_cols=243 Identities=22% Similarity=0.293 Sum_probs=207.8
Q ss_pred ecccCceeEEEEE-eCCCCEEEEEEeccC--ChhhHHHHHHHHHHhhccCCCceeeEee-EEeeCCc-eEEEEEccCCCC
Q 008785 277 LGDSKTGGTYSGI-LPDGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKG-CCYDHGD-RYIVYEFVVNGP 351 (553)
Q Consensus 277 iG~G~~g~Vy~~~-~~~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~-~~~~~~~-~~lV~E~~~~gs 351 (553)
||+|.||+||++. ..+|..||.|.+.-. +....++...|+.+|++|+|||||++++ .+.++.. ++||||||.+|+
T Consensus 27 IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE~c~~GD 106 (375)
T KOG0591|consen 27 IGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVMELCDAGD 106 (375)
T ss_pred HcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHHhhcccC
Confidence 4999999999998 568999999998744 4556788999999999999999999999 4444555 899999999999
Q ss_pred HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC-CceecCCCCCcEEecCCCCeEEeeccccccCCcccccce
Q 008785 352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKP-HVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER 430 (553)
Q Consensus 352 L~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~-~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 430 (553)
|.+.++..++..+.+++..+++++.|++.||.++|+.+.. -|+||||||.||+|+.+|.+||+|||+++++........
T Consensus 107 LsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s~~tfA~ 186 (375)
T KOG0591|consen 107 LSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLSSKTTFAH 186 (375)
T ss_pred HHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhcchhHHHH
Confidence 9999998888888999999999999999999999994321 289999999999999999999999999999876654333
Q ss_pred eeecCccccccccccccCCCCCcccchHhHHHHHHHHhc-CcccccchHHH---HHhcCCH------HHHHHHHHHHhhc
Q 008785 431 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-VLCRRWWTLYT---LVHSMSL------LCAQECLMLFISC 500 (553)
Q Consensus 431 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-~~~~~~~~l~~---~~~~~~~------~~~~~l~~l~~~C 500 (553)
.. .|||.||+||.+.+.+|+.||||||+||++|||.. ..|+...++.+ .+.+|.. ..+..+..|+..|
T Consensus 187 S~--VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~~~YS~~l~~li~~c 264 (375)
T KOG0591|consen 187 SL--VGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPDEHYSTDLRELINMC 264 (375)
T ss_pred hh--cCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcHHHhhhHHHHHHHHH
Confidence 32 39999999999999999999999999999999996 44554445544 7777776 5678899999999
Q ss_pred cCCCCCCCCCHHHHHHHHHHH
Q 008785 501 NNWPSHLSQSKFCNLKLWVFA 521 (553)
Q Consensus 501 l~~dP~~RPs~~evl~~l~~~ 521 (553)
+..||+.||+...++..+...
T Consensus 265 i~vd~~~RP~t~~~v~di~~~ 285 (375)
T KOG0591|consen 265 IAVDPEQRPDTVPYVQDIQSE 285 (375)
T ss_pred ccCCcccCCCcchHHHHHHHH
Confidence 999999999977777665543
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-46 Score=393.73 Aligned_cols=246 Identities=26% Similarity=0.334 Sum_probs=212.8
Q ss_pred ecccCceeEEEEEeC------CCCEEEEEEeccCChh-hHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCC
Q 008785 277 LGDSKTGGTYSGILP------DGSRVAVKRLKRSSFQ-RKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 349 (553)
Q Consensus 277 iG~G~~g~Vy~~~~~------~g~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 349 (553)
||+|+||+||+|... +...||||.++..... ...+|.+|++++..++|||||+|+|+|.+++..++|+|||..
T Consensus 494 LGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~MvFEYm~~ 573 (774)
T KOG1026|consen 494 LGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMVFEYMDH 573 (774)
T ss_pred hcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEEEEeccc
Confidence 499999999999853 3457999999987555 788999999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCC------C----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeecccc
Q 008785 350 GPLDRWLHHIPR------G----GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLS 419 (553)
Q Consensus 350 gsL~~~l~~~~~------~----~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla 419 (553)
|||.+||..... . ..+++..+.+.||.|||.||.||-++ .+|||||..+|+||.++..+||+|||++
T Consensus 574 GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~l~VKIsDfGLs 650 (774)
T KOG1026|consen 574 GDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGENLVVKISDFGLS 650 (774)
T ss_pred ccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccceEEEecccccc
Confidence 999999975321 1 23388999999999999999999999 9999999999999999999999999999
Q ss_pred ccCCcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhc-----CcccccchHHHHHhcCCH-----HH
Q 008785 420 KFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-----VLCRRWWTLYTLVHSMSL-----LC 489 (553)
Q Consensus 420 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-----~~~~~~~~l~~~~~~~~~-----~~ 489 (553)
+..-............-+++|||||.+..++||.+||||||||+|||+++ +....+++.++.+.+|++ .+
T Consensus 651 RdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g~lL~~Pe~C 730 (774)
T KOG1026|consen 651 RDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAGQLLSCPENC 730 (774)
T ss_pred hhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcCCcccCCCCC
Confidence 87665444332211114679999999999999999999999999999997 334455677779999988 88
Q ss_pred HHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHhhc
Q 008785 490 AQECLMLFISCNNWPSHLSQSKFCNLKLWVFAILTI 525 (553)
Q Consensus 490 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~~~~~~ 525 (553)
+.++.+|+..||+.+|++||+++||-.+|.......
T Consensus 731 P~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s 766 (774)
T KOG1026|consen 731 PTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQAS 766 (774)
T ss_pred CHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcC
Confidence 999999999999999999999999999887766544
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=378.50 Aligned_cols=242 Identities=21% Similarity=0.271 Sum_probs=211.3
Q ss_pred cCCCCeeecccCceeEEEEEe-CCCCEEEEEEeccC---ChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEE
Q 008785 270 FSEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRS---SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYE 345 (553)
Q Consensus 270 ~~~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 345 (553)
.+...++||+|||+.+|.++. ..|+.||+|++.+. .....+.+.+|+++.++|+|||||+++++|++.+..|||+|
T Consensus 19 ~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLE 98 (592)
T KOG0575|consen 19 RYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLE 98 (592)
T ss_pred eeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEE
Confidence 344566779999999999997 77999999999874 34456789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcc
Q 008785 346 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE 425 (553)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~ 425 (553)
+|++|+|..+++ ....+++.+++.+++||+.||.|||++ +|+|||||..|+|++++.++||+|||+|..+..+
T Consensus 99 LC~~~sL~el~K----rrk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 99 LCHRGSLMELLK----RRKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred ecCCccHHHHHH----hcCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecCc
Confidence 999999999986 346799999999999999999999999 9999999999999999999999999999987755
Q ss_pred cccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcCccc-ccchHHH---HHhcCCH----HHHHHHHHHH
Q 008785 426 VMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVLCR-RWWTLYT---LVHSMSL----LCAQECLMLF 497 (553)
Q Consensus 426 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~~~-~~~~l~~---~~~~~~~----~~~~~l~~l~ 497 (553)
... ..+.+|||.|.|||++....++..+||||+||+||.|+.+.|+ +...+.+ .++.... ..+.+..+||
T Consensus 172 ~Er--k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~~ls~~A~dLI 249 (592)
T KOG0575|consen 172 GER--KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPSHLSAEAKDLI 249 (592)
T ss_pred ccc--cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcccccccCHHHHHHH
Confidence 333 3344699999999999999999999999999999999985444 4444544 5555554 6677889999
Q ss_pred hhccCCCCCCCCCHHHHHHHHHH
Q 008785 498 ISCNNWPSHLSQSKFCNLKLWVF 520 (553)
Q Consensus 498 ~~Cl~~dP~~RPs~~evl~~l~~ 520 (553)
.++|+.||.+|||+++||.+-.+
T Consensus 250 ~~lL~~~P~~Rpsl~~vL~h~Ff 272 (592)
T KOG0575|consen 250 RKLLRPNPSERPSLDEVLDHPFF 272 (592)
T ss_pred HHHhcCCcccCCCHHHHhcCHhh
Confidence 99999999999999999998655
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=359.10 Aligned_cols=239 Identities=22% Similarity=0.319 Sum_probs=202.3
Q ss_pred eecccCceeEEEEEeC-CCCEEEEEEeccC-ChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCc-eEEEEEccCCCCH
Q 008785 276 LLGDSKTGGTYSGILP-DGSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGD-RYIVYEFVVNGPL 352 (553)
Q Consensus 276 ~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~-~~lV~E~~~~gsL 352 (553)
.||+|..|+||++.++ +++.+|+|++... +....+++.+|++++++.+||+||++||.|...+. ..|+||||.+|||
T Consensus 86 ~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDgGSL 165 (364)
T KOG0581|consen 86 VLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDGGSL 165 (364)
T ss_pred hcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCCCCH
Confidence 4599999999999975 5889999999544 45567899999999999999999999999999995 9999999999999
Q ss_pred HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCceecCCCCCcEEecCCCCeEEeeccccccCCccccccee
Q 008785 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD-KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT 431 (553)
Q Consensus 353 ~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~ 431 (553)
++++... +.+++...-+|+.+|++||.|||+ + +||||||||+|||++..|.+||+|||.++.+... ..
T Consensus 166 d~~~k~~----g~i~E~~L~~ia~~VL~GL~YLh~~~---~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS----~a 234 (364)
T KOG0581|consen 166 DDILKRV----GRIPEPVLGKIARAVLRGLSYLHEER---KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS----IA 234 (364)
T ss_pred HHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhhcc---CeeeccCCHHHeeeccCCCEEeccccccHHhhhh----hc
Confidence 9999652 559999999999999999999996 6 9999999999999999999999999999877655 12
Q ss_pred eecCccccccccccccCCCCCcccchHhHHHHHHHHhc----Cccc-----ccchHHHHHhcCCH------HHHHHHHHH
Q 008785 432 VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL----VLCR-----RWWTLYTLVHSMSL------LCAQECLML 496 (553)
Q Consensus 432 ~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~----~~~~-----~~~~l~~~~~~~~~------~~~~~l~~l 496 (553)
....||..|||||.+.+..|+.++||||||++++|+.. ..+. ...++...+-.+.. .+++++.++
T Consensus 235 ~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS~ef~~F 314 (364)
T KOG0581|consen 235 NTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFSPEFRSF 314 (364)
T ss_pred ccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCCHHHHHH
Confidence 22339999999999999999999999999999999996 2221 22233444444332 478889999
Q ss_pred HhhccCCCCCCCCCHHHHHHHHHHHHhhc
Q 008785 497 FISCNNWPSHLSQSKFCNLKLWVFAILTI 525 (553)
Q Consensus 497 ~~~Cl~~dP~~RPs~~evl~~l~~~~~~~ 525 (553)
+..||+.||.+|||+.|++++-...-.+.
T Consensus 315 V~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~ 343 (364)
T KOG0581|consen 315 VSCCLRKDPSERPSAKQLLQHPFIKKFED 343 (364)
T ss_pred HHHHhcCCcccCCCHHHHhcCHHHhhccc
Confidence 99999999999999999999855543333
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-46 Score=363.11 Aligned_cols=246 Identities=22% Similarity=0.244 Sum_probs=206.0
Q ss_pred hhcccCCCCeeecccCceeEEEEEe-CCCCEEEEEEeccCChh-------hHHHHHHHHHHhhccCCCceeeEeeEEeeC
Q 008785 266 ITKNFSEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQ-------RKKEFYSEIGRFARLHHPNLVAVKGCCYDH 337 (553)
Q Consensus 266 ~~~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~~~~~~~~-------~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 337 (553)
..++++...+.+|+|+||.|-+|.- ++|+.||||++.+.... ....+.+|+++|++|+|||||++++++...
T Consensus 169 s~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ 248 (475)
T KOG0615|consen 169 SFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVP 248 (475)
T ss_pred hhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecC
Confidence 3566677777789999999999985 46999999999764211 223467999999999999999999999999
Q ss_pred CceEEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCC---CCeEEe
Q 008785 338 GDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE---FGAHLM 414 (553)
Q Consensus 338 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~---~~~kl~ 414 (553)
+..|+||||++||+|.+++-. ...+.+..-..++.|++.|+.|||++ ||+||||||+|||+..+ ..+||+
T Consensus 249 ds~YmVlE~v~GGeLfd~vv~----nk~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKIt 321 (475)
T KOG0615|consen 249 DSSYMVLEYVEGGELFDKVVA----NKYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKIT 321 (475)
T ss_pred CceEEEEEEecCccHHHHHHh----ccccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEec
Confidence 999999999999999999854 34577777789999999999999999 99999999999999766 789999
Q ss_pred eccccccCCcccccceeeecCccccccccccccCCCC---CcccchHhHHHHHHHHhcCcccc-----cchHHHHHhcCC
Q 008785 415 GVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNEL---TTKSDVYSFGVLLLEIRLVLCRR-----WWTLYTLVHSMS 486 (553)
Q Consensus 415 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---t~ksDVwSlGvil~ell~~~~~~-----~~~l~~~~~~~~ 486 (553)
|||+|+....... ..+.+|||.|.|||++.+..+ ..+.|+||+||+||-+++..++. +.++.+++..|+
T Consensus 322 DFGlAK~~g~~sf---m~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~ 398 (475)
T KOG0615|consen 322 DFGLAKVSGEGSF---MKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGR 398 (475)
T ss_pred ccchhhcccccee---hhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCc
Confidence 9999998764332 334569999999999987653 34789999999999999744332 334666777777
Q ss_pred H--------HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 008785 487 L--------LCAQECLMLFISCNNWPSHLSQSKFCNLKLWVFA 521 (553)
Q Consensus 487 ~--------~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~~ 521 (553)
+ ....+..+++.++|..||++|||+.|+|++-...
T Consensus 399 y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~ 441 (475)
T KOG0615|consen 399 YAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFK 441 (475)
T ss_pred ccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhh
Confidence 6 7788999999999999999999999999985444
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-45 Score=356.51 Aligned_cols=240 Identities=23% Similarity=0.304 Sum_probs=200.8
Q ss_pred cccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccC--ChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEE
Q 008785 268 KNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVY 344 (553)
Q Consensus 268 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 344 (553)
.+|....++ |+|+||+||+|+++ ++..||||.+.+. ..+..+.+..|+.+|+.++|||||++++++.+++..||||
T Consensus 10 ~~y~~~~~i-G~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 10 GDYELSREI-GSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred ccceehhhc-cCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 455555664 99999999999975 4889999999876 4556677899999999999999999999999999999999
Q ss_pred EccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCC------CCeEEeeccc
Q 008785 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE------FGAHLMGVGL 418 (553)
Q Consensus 345 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~------~~~kl~Dfgl 418 (553)
|||.||||.+||+. ...+++..+..++.|||.||++||++ +||||||||+||||+.. -.+||+|||+
T Consensus 89 EyC~gGDLs~yi~~----~~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGf 161 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRR----RGRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGF 161 (429)
T ss_pred EeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccch
Confidence 99999999999975 23699999999999999999999999 99999999999999765 4589999999
Q ss_pred cccCCcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcCccc-ccchHHH---HHhcCCH-------
Q 008785 419 SKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVLCR-RWWTLYT---LVHSMSL------- 487 (553)
Q Consensus 419 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~~~-~~~~l~~---~~~~~~~------- 487 (553)
|+.+....... +.+|++.|||||++...+|+.|+|+||.|+|+|+++++.++ ......+ .+++++-
T Consensus 162 AR~L~~~~~a~---tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~ 238 (429)
T KOG0595|consen 162 ARFLQPGSMAE---TLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPA 238 (429)
T ss_pred hhhCCchhHHH---HhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhh
Confidence 99987554333 34599999999999999999999999999999999984433 3333333 4554443
Q ss_pred HHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008785 488 LCAQECLMLFISCNNWPSHLSQSKFCNLKLW 518 (553)
Q Consensus 488 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l 518 (553)
.....+.+++..-+..+|.+|-+..+-+.+-
T Consensus 239 ~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~ 269 (429)
T KOG0595|consen 239 ELSNPLRELLISLLQRNPKDRISFEDFFDHP 269 (429)
T ss_pred hccCchhhhhhHHHhcCccccCchHHhhhhh
Confidence 4445566888888899999998888866553
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-45 Score=381.94 Aligned_cols=253 Identities=22% Similarity=0.350 Sum_probs=215.3
Q ss_pred CCCeeecccCceeEEEEEeCC----CCEEEEEEeccCC-hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEc
Q 008785 272 EGNRLLGDSKTGGTYSGILPD----GSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF 346 (553)
Q Consensus 272 ~~~~~iG~G~~g~Vy~~~~~~----g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 346 (553)
..+++||.|.||.||+|+++. ...||||.++... .+.+.+|+.|+.||.+++||||++|.|+.......+||.||
T Consensus 632 ~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEy 711 (996)
T KOG0196|consen 632 KIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEY 711 (996)
T ss_pred EEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhhh
Confidence 346789999999999999753 4579999999874 45578999999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCccc
Q 008785 347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV 426 (553)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 426 (553)
|++|+|+.||+. ++..+++.++..++++||.||+||.+. ++|||||.++|||++.+..+|++|||+++.+.++.
T Consensus 712 MENGsLDsFLR~---~DGqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~ 785 (996)
T KOG0196|consen 712 MENGSLDSFLRQ---NDGQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 785 (996)
T ss_pred hhCCcHHHHHhh---cCCceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccceeecccCC
Confidence 999999999986 445699999999999999999999999 99999999999999999999999999999876554
Q ss_pred ccceeee-cCccccccccccccCCCCCcccchHhHHHHHHHHhcCcccccchH-----HHHHhcCCH-----HHHHHHHH
Q 008785 427 MQERTVM-AGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVLCRRWWTL-----YTLVHSMSL-----LCAQECLM 495 (553)
Q Consensus 427 ~~~~~~~-~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~~~~~~~l-----~~~~~~~~~-----~~~~~l~~ 495 (553)
....+.. ..-+.+|.|||.+...++|.+||||||||+|||.+++...+..++ .+.+++|-. .++..|.+
T Consensus 786 ~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpPmDCP~aL~q 865 (996)
T KOG0196|consen 786 EAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPPMDCPAALYQ 865 (996)
T ss_pred CccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCCCCCcHHHHH
Confidence 2222111 113579999999999999999999999999999998655554443 335555432 89999999
Q ss_pred HHhhccCCCCCCCCCHHHHHHHHHHHHhhcccccc
Q 008785 496 LFISCNNWPSHLSQSKFCNLKLWVFAILTIRKVQF 530 (553)
Q Consensus 496 l~~~Cl~~dP~~RPs~~evl~~l~~~~~~~~~~~~ 530 (553)
|++.||+.|-++||++.||+..|-..+.+-..+..
T Consensus 866 LMldCWqkdR~~RP~F~qiV~~lDklIrnP~SLk~ 900 (996)
T KOG0196|consen 866 LMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNSLKT 900 (996)
T ss_pred HHHHHHHHHhhcCCCHHHHHHHHHHHhcCchhhcc
Confidence 99999999999999999999998877766554443
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=385.55 Aligned_cols=252 Identities=29% Similarity=0.378 Sum_probs=211.8
Q ss_pred CCCeeecccCceeEEEEEeCC--CC----EEEEEEeccC-ChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEE
Q 008785 272 EGNRLLGDSKTGGTYSGILPD--GS----RVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVY 344 (553)
Q Consensus 272 ~~~~~iG~G~~g~Vy~~~~~~--g~----~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 344 (553)
....+||+|+||.||+|...+ |. .||||.+++. +.+...+|++|..+|++++|||||+++|++.+.+..+|++
T Consensus 695 ~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~l 774 (1025)
T KOG1095|consen 695 TLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLILL 774 (1025)
T ss_pred EeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEEe
Confidence 345678999999999999654 43 4999999876 4566789999999999999999999999999999999999
Q ss_pred EccCCCCHHHHhccCCC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeecccccc
Q 008785 345 EFVVNGPLDRWLHHIPR---GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF 421 (553)
Q Consensus 345 E~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~ 421 (553)
|||++|+|..||++.+. ....++..+.+.++.|||+|+.||+++ ++|||||.++|+||++...+||+|||+|+.
T Consensus 775 eyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDFGlArD 851 (1025)
T KOG1095|consen 775 EYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADFGLARD 851 (1025)
T ss_pred hhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcccchhHh
Confidence 99999999999987422 145689999999999999999999999 999999999999999999999999999995
Q ss_pred CCcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhc--Ccccc---cchHHH-HHhcCCH----HHHH
Q 008785 422 VPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL--VLCRR---WWTLYT-LVHSMSL----LCAQ 491 (553)
Q Consensus 422 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~--~~~~~---~~~l~~-~~~~~~~----~~~~ 491 (553)
+.............-+.+|||||.+..+.+|.|+|||||||+|||+++ ..|.. ..++.. ..+.|++ .++.
T Consensus 852 iy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~~P~~CP~ 931 (1025)
T KOG1095|consen 852 IYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLDPPSYCPE 931 (1025)
T ss_pred hhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccCCCCCCCh
Confidence 544433322222224579999999999999999999999999999997 22333 333333 5667776 7889
Q ss_pred HHHHHHhhccCCCCCCCCCHHHHHHHHHHHHhhcc
Q 008785 492 ECLMLFISCNNWPSHLSQSKFCNLKLWVFAILTIR 526 (553)
Q Consensus 492 ~l~~l~~~Cl~~dP~~RPs~~evl~~l~~~~~~~~ 526 (553)
.+.+++..||+.+|++||++..|++++...+....
T Consensus 932 ~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~ 966 (1025)
T KOG1095|consen 932 KLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAAL 966 (1025)
T ss_pred HHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhc
Confidence 99999999999999999999999998877665543
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=347.66 Aligned_cols=240 Identities=25% Similarity=0.318 Sum_probs=201.0
Q ss_pred eecccCceeEEEEEeCCCCEEEEEEeccCCh-hhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCCHHH
Q 008785 276 LLGDSKTGGTYSGILPDGSRVAVKRLKRSSF-QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR 354 (553)
Q Consensus 276 ~iG~G~~g~Vy~~~~~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~ 354 (553)
.||+|.||.|..+....+..||||+++.... ..+.+|.+|+++|.+|+|||||+++|+|..++.+++++|||++|+|.+
T Consensus 545 kiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEnGDLnq 624 (807)
T KOG1094|consen 545 KIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMENGDLNQ 624 (807)
T ss_pred hhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhcCcHHH
Confidence 3599999999999997789999999997644 445899999999999999999999999999999999999999999999
Q ss_pred HhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccceeeec
Q 008785 355 WLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA 434 (553)
Q Consensus 355 ~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 434 (553)
||..... ..+.-....+|+.||+.||+||.+. ++|||||.++|+|++.++++||+|||+++.+-..........+
T Consensus 625 Fl~ahea--pt~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vqgr~ 699 (807)
T KOG1094|consen 625 FLSAHEL--PTAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQGRA 699 (807)
T ss_pred HHHhccC--cccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccccCCceeeecce
Confidence 9976321 2245566678999999999999999 9999999999999999999999999999977665554433333
Q ss_pred CccccccccccccCCCCCcccchHhHHHHHHHHhc---Cccc---ccchHHH----HHhc-CCH-------HHHHHHHHH
Q 008785 435 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL---VLCR---RWWTLYT----LVHS-MSL-------LCAQECLML 496 (553)
Q Consensus 435 ~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~---~~~~---~~~~l~~----~~~~-~~~-------~~~~~l~~l 496 (553)
.-+.+|||||.+..+++|.+||||+||+++||+++ ..|. .+...++ +... +.. .++..+.++
T Consensus 700 vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~cp~~lyel 779 (807)
T KOG1094|consen 700 VLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPACPQGLYEL 779 (807)
T ss_pred eeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCcCcHHHHHH
Confidence 35789999999999999999999999999999995 2222 2333333 2221 111 778889999
Q ss_pred HhhccCCCCCCCCCHHHHHHHHHH
Q 008785 497 FISCNNWPSHLSQSKFCNLKLWVF 520 (553)
Q Consensus 497 ~~~Cl~~dP~~RPs~~evl~~l~~ 520 (553)
+.+||+.|-++|||++++...+..
T Consensus 780 ml~Cw~~es~~RPsFe~lh~~lq~ 803 (807)
T KOG1094|consen 780 MLRCWRRESEQRPSFEQLHLFLQE 803 (807)
T ss_pred HHHHhchhhhcCCCHHHHHHHHHH
Confidence 999999999999999999887754
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=334.27 Aligned_cols=239 Identities=21% Similarity=0.228 Sum_probs=199.7
Q ss_pred ccCCCCeeecccCceeEEEEEeCC-CCEEEEEEeccCC---hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEE
Q 008785 269 NFSEGNRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVY 344 (553)
Q Consensus 269 ~~~~~~~~iG~G~~g~Vy~~~~~~-g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 344 (553)
+|... ++||+|+||+||.++.++ ++.+|+|++++.. ....+...+|..+|.+++||.||+++-.|++.+.+|+|+
T Consensus 26 dF~~l-kviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVl 104 (357)
T KOG0598|consen 26 DFEIL-KVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVL 104 (357)
T ss_pred heeee-eeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEE
Confidence 45443 456999999999999655 8899999998753 234567889999999999999999999999999999999
Q ss_pred EccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCc
Q 008785 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW 424 (553)
Q Consensus 345 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~ 424 (553)
||+.||.|..+|++ ...+++..+.-++.+|+.||.|||++ |||||||||+|||+|++|.++|+|||+++..-.
T Consensus 105 d~~~GGeLf~hL~~----eg~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~ 177 (357)
T KOG0598|consen 105 DYLNGGELFYHLQR----EGRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDLK 177 (357)
T ss_pred eccCCccHHHHHHh----cCCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence 99999999999964 35689999999999999999999999 999999999999999999999999999986544
Q ss_pred ccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcCc-ccccc---hHHHHHhcCCH-----HHHHHHHH
Q 008785 425 EVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVL-CRRWW---TLYTLVHSMSL-----LCAQECLM 495 (553)
Q Consensus 425 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~-~~~~~---~l~~~~~~~~~-----~~~~~l~~ 495 (553)
.... +...+||+.|||||++.+.+|+..+|.||+|+++|||+++. |.... .+.+.+..++. ....+..+
T Consensus 178 ~~~~--t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~~ls~~ard 255 (357)
T KOG0598|consen 178 DGDA--TRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPGYLSEEARD 255 (357)
T ss_pred CCCc--cccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCccCCHHHHH
Confidence 4322 33356999999999999999999999999999999999843 33333 34445555553 36778899
Q ss_pred HHhhccCCCCCCCC----CHHHHHHH
Q 008785 496 LFISCNNWPSHLSQ----SKFCNLKL 517 (553)
Q Consensus 496 l~~~Cl~~dP~~RP----s~~evl~~ 517 (553)
++...|..||++|- .+.+|-++
T Consensus 256 ll~~LL~rdp~~RLg~~~d~~~ik~H 281 (357)
T KOG0598|consen 256 LLKKLLKRDPRQRLGGPGDAEEIKRH 281 (357)
T ss_pred HHHHHhccCHHHhcCCCCChHHhhcC
Confidence 99999999999995 45554443
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-42 Score=338.38 Aligned_cols=245 Identities=24% Similarity=0.340 Sum_probs=196.8
Q ss_pred CeeecccCceeEEEEEeCC-CCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCC--ceEEEEEccCCC
Q 008785 274 NRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHG--DRYIVYEFVVNG 350 (553)
Q Consensus 274 ~~~iG~G~~g~Vy~~~~~~-g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~--~~~lV~E~~~~g 350 (553)
.+.||+|+||.||.+...+ |+..|||.+...+....+.+.+|+.+|++++|||||+++|...... ..+++|||+++|
T Consensus 22 ~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~G 101 (313)
T KOG0198|consen 22 GKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPGG 101 (313)
T ss_pred hccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccCCC
Confidence 4567999999999999765 8999999998764334677899999999999999999999855544 589999999999
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecC-CCCeEEeeccccccCCcccc-c
Q 008785 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE-EFGAHLMGVGLSKFVPWEVM-Q 428 (553)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~-~~~~kl~Dfgla~~~~~~~~-~ 428 (553)
+|.+++... ++ .+++..+..+.+||++||+|||++ ||+||||||+|||++. ++.+||+|||++........ .
T Consensus 102 sL~~~~~~~--g~-~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~ 175 (313)
T KOG0198|consen 102 SLSDLIKRY--GG-KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKS 175 (313)
T ss_pred cHHHHHHHc--CC-CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCccccccccccccc
Confidence 999999752 22 699999999999999999999999 9999999999999999 79999999999987663111 1
Q ss_pred ceeeecCccccccccccccCCC-CCcccchHhHHHHHHHHhcC-ccccc-chHHH----HHhcCCH-----HHHHHHHHH
Q 008785 429 ERTVMAGGTYGYLAPEFVYRNE-LTTKSDVYSFGVLLLEIRLV-LCRRW-WTLYT----LVHSMSL-----LCAQECLML 496 (553)
Q Consensus 429 ~~~~~~~gt~~y~aPE~~~~~~-~t~ksDVwSlGvil~ell~~-~~~~~-~~l~~----~~~~~~~-----~~~~~l~~l 496 (553)
.......||+.|||||++.++. ...++|||||||++.||+|. .|... ....+ ....... ..+.+..++
T Consensus 176 ~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~a~~F 255 (313)
T KOG0198|consen 176 DSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSDEAKDF 255 (313)
T ss_pred cccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCHHHHHH
Confidence 1122234999999999998643 34599999999999999994 33333 11122 1112211 567788999
Q ss_pred HhhccCCCCCCCCCHHHHHHHHHHHHhh
Q 008785 497 FISCNNWPSHLSQSKFCNLKLWVFAILT 524 (553)
Q Consensus 497 ~~~Cl~~dP~~RPs~~evl~~l~~~~~~ 524 (553)
+.+|+..||++|||+.++|++.......
T Consensus 256 l~~C~~~~p~~Rpta~eLL~hpf~~~~~ 283 (313)
T KOG0198|consen 256 LRKCFKRDPEKRPTAEELLEHPFLKQNS 283 (313)
T ss_pred HHHHhhcCcccCcCHHHHhhChhhhccc
Confidence 9999999999999999999987554433
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=350.03 Aligned_cols=254 Identities=22% Similarity=0.332 Sum_probs=206.1
Q ss_pred hhcccCCCCeeecccCceeEEEEEeCCCCEEEEEEeccC--ChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEE
Q 008785 266 ITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIV 343 (553)
Q Consensus 266 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 343 (553)
++.++......||+|.||+||+|.+. ..||||+++.. .....+.|.+|+..+++-+|.||+-+.|+|...+. .||
T Consensus 389 Ip~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIi 465 (678)
T KOG0193|consen 389 IPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AII 465 (678)
T ss_pred cCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eee
Confidence 33333334445699999999999984 46999999865 34457889999999999999999999999998877 999
Q ss_pred EEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCC
Q 008785 344 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVP 423 (553)
Q Consensus 344 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~ 423 (553)
+.+|+|-+|+.+|+. ....++..+.+.|+.|||+||.|||.+ +|||||||..||++.+++++||+|||++....
T Consensus 466 TqwCeGsSLY~hlHv---~etkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~ 539 (678)
T KOG0193|consen 466 TQWCEGSSLYTHLHV---QETKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGLATVKT 539 (678)
T ss_pred ehhccCchhhhhccc---hhhhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccceeeee
Confidence 999999999999986 335688999999999999999999999 99999999999999999999999999997544
Q ss_pred cccccceeeecCccccccccccccC---CCCCcccchHhHHHHHHHHhcC-cccccchHHH----HHhcCCH--------
Q 008785 424 WEVMQERTVMAGGTYGYLAPEFVYR---NELTTKSDVYSFGVLLLEIRLV-LCRRWWTLYT----LVHSMSL-------- 487 (553)
Q Consensus 424 ~~~~~~~~~~~~gt~~y~aPE~~~~---~~~t~ksDVwSlGvil~ell~~-~~~~~~~l~~----~~~~~~~-------- 487 (553)
.-..........|..-|||||+++. .+|++.+||||||+++|||++. .|.. .+..+ ++..|-+
T Consensus 540 ~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys-i~~~dqIifmVGrG~l~pd~s~~~ 618 (678)
T KOG0193|consen 540 RWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS-IQNRDQIIFMVGRGYLMPDLSKIR 618 (678)
T ss_pred eeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC-CCChhheEEEecccccCccchhhh
Confidence 3322222222338889999999974 5799999999999999999972 2332 22222 3444422
Q ss_pred -HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHhhccccc
Q 008785 488 -LCAQECLMLFISCNNWPSHLSQSKFCNLKLWVFAILTIRKVQ 529 (553)
Q Consensus 488 -~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~~~~~~~~~~ 529 (553)
.++.++.+|+..||..++++||.+.+|+..++..+....++.
T Consensus 619 s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~pki~ 661 (678)
T KOG0193|consen 619 SNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSLPKIN 661 (678)
T ss_pred ccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcccccc
Confidence 778899999999999999999999999998887776554443
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-43 Score=346.79 Aligned_cols=242 Identities=21% Similarity=0.338 Sum_probs=195.4
Q ss_pred ccCCCCeeecccCceeEEEEEe-CCCCEEEEEEeccCChhhHHH--HHHHHHHhhccC-CCceeeEeeEEeeCC-ceEEE
Q 008785 269 NFSEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKE--FYSEIGRFARLH-HPNLVAVKGCCYDHG-DRYIV 343 (553)
Q Consensus 269 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~--~~~E~~~l~~l~-HpnIv~l~~~~~~~~-~~~lV 343 (553)
+|....++ |.|+||.||+|+. .+|+.||||++++.-.. .++ =++|+..|++|+ |||||++.+++.+.+ .+|+|
T Consensus 11 RY~~i~kl-GDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV 88 (538)
T KOG0661|consen 11 RYTVIRKL-GDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV 88 (538)
T ss_pred HHHHHHHh-cCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence 34444556 9999999999995 45899999999876322 333 368999999998 999999999999988 89999
Q ss_pred EEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCC
Q 008785 344 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVP 423 (553)
Q Consensus 344 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~ 423 (553)
||||+ .+|.+++++ .++.+++..+..|+.||++||+|+|.+ |+.|||+||+|||+..+..+||+|||+|+.+.
T Consensus 89 fE~Md-~NLYqLmK~---R~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 89 FEFMD-CNLYQLMKD---RNRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREVR 161 (538)
T ss_pred HHhhh-hhHHHHHhh---cCCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEecccccccccc
Confidence 99995 599999986 367899999999999999999999999 99999999999999988899999999999876
Q ss_pred cccccceeeecCccccccccccccC-CCCCcccchHhHHHHHHHHhcCcccc-----cchHHH---HHh-----------
Q 008785 424 WEVMQERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIRLVLCRR-----WWTLYT---LVH----------- 483 (553)
Q Consensus 424 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwSlGvil~ell~~~~~~-----~~~l~~---~~~----------- 483 (553)
....... .. .|..|+|||++.. +-|+.+.|+||+|||++|+.+..|-. -+++.. .+.
T Consensus 162 SkpPYTe--YV-STRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~ 238 (538)
T KOG0661|consen 162 SKPPYTE--YV-STRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGY 238 (538)
T ss_pred cCCCcch--hh-hcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHH
Confidence 5433221 22 7899999999864 56899999999999999999622211 111221 110
Q ss_pred ----cCCH---------------HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 008785 484 ----SMSL---------------LCAQECLMLFISCNNWPSHLSQSKFCNLKLWVFAI 522 (553)
Q Consensus 484 ----~~~~---------------~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~~~ 522 (553)
.-.+ ..+.++.+++.+|+.+||++|||+.|.+++-.+..
T Consensus 239 ~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~ 296 (538)
T KOG0661|consen 239 NLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQV 296 (538)
T ss_pred HHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccc
Confidence 0000 66778999999999999999999999999865544
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=323.34 Aligned_cols=240 Identities=21% Similarity=0.199 Sum_probs=193.4
Q ss_pred CCCCeeecccCceeEEEEEeCC-CCEEEEEEeccCC--hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEcc
Q 008785 271 SEGNRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV 347 (553)
Q Consensus 271 ~~~~~~iG~G~~g~Vy~~~~~~-g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 347 (553)
....++ |+|+||.||+++.++ |+.||||++..+. ..-.+-.++|+++|++++|||+|.++.+|.....++||+|||
T Consensus 5 E~Lgkv-GEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~ 83 (396)
T KOG0593|consen 5 EKLGKV-GEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYC 83 (396)
T ss_pred hhhhcc-ccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeec
Confidence 334455 999999999999765 9999999997653 333466789999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccc
Q 008785 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM 427 (553)
Q Consensus 348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 427 (553)
+..-|. -|.. ....++...+.+++.|++.|+.|+|++ ++|||||||+||||+.++.+||+|||+|+.+.....
T Consensus 84 dhTvL~-eLe~---~p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd 156 (396)
T KOG0593|consen 84 DHTVLH-ELER---YPNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGD 156 (396)
T ss_pred chHHHH-HHHh---ccCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcCCcc
Confidence 764443 3443 445689999999999999999999999 999999999999999999999999999998874333
Q ss_pred cceeeecCccccccccccccC-CCCCcccchHhHHHHHHHHhcCccc----cc-chHHH-HHhcCCH-------------
Q 008785 428 QERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIRLVLCR----RW-WTLYT-LVHSMSL------------- 487 (553)
Q Consensus 428 ~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwSlGvil~ell~~~~~----~~-~~l~~-~~~~~~~------------- 487 (553)
..+..+ .|..|+|||.+.+ .+|+...||||.||++.||+++.|- .+ +.+.- ...-|.+
T Consensus 157 ~YTDYV--ATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~ 234 (396)
T KOG0593|consen 157 NYTDYV--ATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPF 234 (396)
T ss_pred hhhhhh--hhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCc
Confidence 222222 7899999999987 6899999999999999999973322 11 11111 1111111
Q ss_pred --------------------HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 008785 488 --------------------LCAQECLMLFISCNNWPSHLSQSKFCNLKLWVF 520 (553)
Q Consensus 488 --------------------~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~ 520 (553)
....-++++++.|++.||++|++.+|++.+-.+
T Consensus 235 F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yF 287 (396)
T KOG0593|consen 235 FHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYF 287 (396)
T ss_pred eeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHH
Confidence 455578999999999999999999999977444
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-42 Score=347.35 Aligned_cols=235 Identities=23% Similarity=0.322 Sum_probs=205.1
Q ss_pred eecccCceeEEEEE-eCCCCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCCHHH
Q 008785 276 LLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR 354 (553)
Q Consensus 276 ~iG~G~~g~Vy~~~-~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~ 354 (553)
-||+|+.|.||.+. ..+++.||||++.......++-+++|+.+|+..+|+|||.+++.|...+.+|+|||||+||+|.+
T Consensus 280 kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsLTD 359 (550)
T KOG0578|consen 280 KIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSLTD 359 (550)
T ss_pred hhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCchhh
Confidence 35999999999998 45688999999998877778889999999999999999999999999999999999999999999
Q ss_pred HhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccceeeec
Q 008785 355 WLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA 434 (553)
Q Consensus 355 ~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 434 (553)
.+.. ..+++.++..|+++++.||+|||.+ +|+|||||.+|||++.++.+||+|||++..+........+.
T Consensus 360 vVt~-----~~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR~Tm-- 429 (550)
T KOG0578|consen 360 VVTK-----TRMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKRSTM-- 429 (550)
T ss_pred hhhc-----ccccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccccCccccc--
Confidence 8865 3489999999999999999999999 99999999999999999999999999999887766543332
Q ss_pred CccccccccccccCCCCCcccchHhHHHHHHHHhcCcccc--cchHHH---HHhcCCH------HHHHHHHHHHhhccCC
Q 008785 435 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVLCRR--WWTLYT---LVHSMSL------LCAQECLMLFISCNNW 503 (553)
Q Consensus 435 ~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~~~~--~~~l~~---~~~~~~~------~~~~~l~~l~~~Cl~~ 503 (553)
.|||.|||||++....|++|.||||||++++||+-+.|.. +..+.. .-.+|.. ..+..+.+++.+||..
T Consensus 430 VGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~~cL~~ 509 (550)
T KOG0578|consen 430 VGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDFLDRCLVV 509 (550)
T ss_pred cCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHHHHHHhhc
Confidence 2999999999999999999999999999999999643332 222322 2234444 7788999999999999
Q ss_pred CCCCCCCHHHHHHHHHH
Q 008785 504 PSHLSQSKFCNLKLWVF 520 (553)
Q Consensus 504 dP~~RPs~~evl~~l~~ 520 (553)
||.+||++.|+|++-..
T Consensus 510 dv~~RasA~eLL~HpFl 526 (550)
T KOG0578|consen 510 DVEQRASAKELLEHPFL 526 (550)
T ss_pred chhcCCCHHHHhcChhh
Confidence 99999999999998655
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=343.00 Aligned_cols=247 Identities=23% Similarity=0.283 Sum_probs=195.2
Q ss_pred CeeecccCceeEEEEEe------CCCCEEEEEEeccCC-hhhHHHHHHHHHHhhcc-CCCceeeEeeEEeeCC-ceEEEE
Q 008785 274 NRLLGDSKTGGTYSGIL------PDGSRVAVKRLKRSS-FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHG-DRYIVY 344 (553)
Q Consensus 274 ~~~iG~G~~g~Vy~~~~------~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~-~~~lV~ 344 (553)
.+.||+|+||.||+|.. .+++.||||+++... ......+.+|+.++.++ +||||+++++++...+ ..++||
T Consensus 12 ~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ 91 (338)
T cd05102 12 GKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGPLMVIV 91 (338)
T ss_pred eeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCceEEEE
Confidence 34569999999999974 235689999997543 23456789999999999 8999999999887654 579999
Q ss_pred EccCCCCHHHHhccCCCC----------------------------------------------------------CCCC
Q 008785 345 EFVVNGPLDRWLHHIPRG----------------------------------------------------------GRSL 366 (553)
Q Consensus 345 E~~~~gsL~~~l~~~~~~----------------------------------------------------------~~~l 366 (553)
||+++|+|.+++...... ...+
T Consensus 92 ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 171 (338)
T cd05102 92 EFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPL 171 (338)
T ss_pred ecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccccccCCC
Confidence 999999999998642110 1347
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccceeeecCccccccccccc
Q 008785 367 DWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFV 446 (553)
Q Consensus 367 ~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~ 446 (553)
++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++...............+++.|+|||++
T Consensus 172 ~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~ 248 (338)
T cd05102 172 TMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESI 248 (338)
T ss_pred CHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCcHHh
Confidence 8888999999999999999999 9999999999999999999999999999865433222222222366789999999
Q ss_pred cCCCCCcccchHhHHHHHHHHhc-C-ccccc----chHHHHHhcCCH-----HHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 008785 447 YRNELTTKSDVYSFGVLLLEIRL-V-LCRRW----WTLYTLVHSMSL-----LCAQECLMLFISCNNWPSHLSQSKFCNL 515 (553)
Q Consensus 447 ~~~~~t~ksDVwSlGvil~ell~-~-~~~~~----~~l~~~~~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl 515 (553)
.+..++.++||||||+++|||++ . .|... ..+...+..+.. ..+..+.+++.+||+.||++|||+.|++
T Consensus 249 ~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~ 328 (338)
T cd05102 249 FDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKERPTFSALV 328 (338)
T ss_pred hcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 99999999999999999999986 2 23222 122233333322 4567799999999999999999999999
Q ss_pred HHHHHHHh
Q 008785 516 KLWVFAIL 523 (553)
Q Consensus 516 ~~l~~~~~ 523 (553)
+.+...+.
T Consensus 329 ~~l~~~~~ 336 (338)
T cd05102 329 EILGDLLQ 336 (338)
T ss_pred HHHHHHHh
Confidence 99876654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=345.58 Aligned_cols=244 Identities=27% Similarity=0.307 Sum_probs=201.9
Q ss_pred eeecccCceeEEEEEeCC--C---CEEEEEEeccC---ChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEc
Q 008785 275 RLLGDSKTGGTYSGILPD--G---SRVAVKRLKRS---SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF 346 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~~--g---~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 346 (553)
+.||+|+||.||+|.+.. + ..||||..+.. ......+|.+|+++|++++|||||++||++....+++||||+
T Consensus 163 kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivmEl 242 (474)
T KOG0194|consen 163 KKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVMEL 242 (474)
T ss_pred ceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEEEe
Confidence 456999999999999653 2 23899999852 356678999999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCccc
Q 008785 347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV 426 (553)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 426 (553)
|.||+|.++|+. ....++..++..++.++|.||+|||++ +++||||.++|+|++.++.+||+|||+++......
T Consensus 243 ~~gGsL~~~L~k---~~~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~~ 316 (474)
T KOG0194|consen 243 CNGGSLDDYLKK---NKKSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQYV 316 (474)
T ss_pred cCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCccccccCCccee
Confidence 999999999986 333699999999999999999999999 99999999999999999999999999998664222
Q ss_pred ccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhc--CcccccchHHH---HH-hcCCH-----HHHHHHHH
Q 008785 427 MQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL--VLCRRWWTLYT---LV-HSMSL-----LCAQECLM 495 (553)
Q Consensus 427 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~--~~~~~~~~l~~---~~-~~~~~-----~~~~~l~~ 495 (553)
..... ..-+..|+|||.+..+.|+.++|||||||++||+++ ..|.......+ .+ .++-. ..+..+..
T Consensus 317 ~~~~~--~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~~~p~~~~~ 394 (474)
T KOG0194|consen 317 MKKFL--KKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPSKTPKELAK 394 (474)
T ss_pred ecccc--ccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCCCCHHHHHH
Confidence 11111 125679999999999999999999999999999997 23333333333 34 32222 66778888
Q ss_pred HHhhccCCCCCCCCCHHHHHHHHHHHHhhcc
Q 008785 496 LFISCNNWPSHLSQSKFCNLKLWVFAILTIR 526 (553)
Q Consensus 496 l~~~Cl~~dP~~RPs~~evl~~l~~~~~~~~ 526 (553)
++.+||..+|++||||.++.+.+........
T Consensus 395 ~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 395 VMKQCWKKDPEDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred HHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence 9999999999999999999998877665544
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=326.03 Aligned_cols=247 Identities=19% Similarity=0.252 Sum_probs=201.2
Q ss_pred CeeecccCceeEEEEE-eCCCCEEEEEEeccCChh-hHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCC
Q 008785 274 NRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQ-RKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP 351 (553)
Q Consensus 274 ~~~iG~G~~g~Vy~~~-~~~g~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gs 351 (553)
...||.|..++||+|+ .+.++.||||++.-.... ..+.+.+|+..|+.++||||++++..|..+..+|+||.||.+||
T Consensus 31 ~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfMa~GS 110 (516)
T KOG0582|consen 31 QEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFMAGGS 110 (516)
T ss_pred EEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhhcCCc
Confidence 4456999999999999 566899999999865333 35889999999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCccccccee
Q 008785 352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT 431 (553)
Q Consensus 352 L~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~ 431 (553)
+.+.++..-. ..+++..+..|++++++||.|||++ |.||||||+.||||+++|.+||+|||.+..+.........
T Consensus 111 ~ldIik~~~~--~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~~~ 185 (516)
T KOG0582|consen 111 LLDIIKTYYP--DGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQVT 185 (516)
T ss_pred HHHHHHHHcc--ccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeecccCceeeE
Confidence 9999987433 4499999999999999999999999 9999999999999999999999999998766554432222
Q ss_pred --eecCccccccccccccC--CCCCcccchHhHHHHHHHHhcCccc-ccchHHH----HHhcCC-------H------HH
Q 008785 432 --VMAGGTYGYLAPEFVYR--NELTTKSDVYSFGVLLLEIRLVLCR-RWWTLYT----LVHSMS-------L------LC 489 (553)
Q Consensus 432 --~~~~gt~~y~aPE~~~~--~~~t~ksDVwSlGvil~ell~~~~~-~~~~l~~----~~~~~~-------~------~~ 489 (553)
....||+.|||||++.. ..|+.|+||||||++..||..+..+ ..-...+ .+++.. + ..
T Consensus 186 rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~d~~k~~ 265 (516)
T KOG0582|consen 186 RFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLDKDEDKKF 265 (516)
T ss_pred eeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCChHHhhhh
Confidence 23349999999999654 4699999999999999999963222 1111111 111111 0 56
Q ss_pred HHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHhhc
Q 008785 490 AQECLMLFISCNNWPSHLSQSKFCNLKLWVFAILTI 525 (553)
Q Consensus 490 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~~~~~~ 525 (553)
...+.+++..||..||.+|||+++++++-.+.....
T Consensus 266 ~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~ 301 (516)
T KOG0582|consen 266 SKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKS 301 (516)
T ss_pred cHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccc
Confidence 668999999999999999999999999866655443
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=339.79 Aligned_cols=237 Identities=23% Similarity=0.256 Sum_probs=199.8
Q ss_pred CCeeecccCceeEEEEEeC-CCCEEEEEEeccC----Ch-hhHHHHHHHHHHhhccC-CCceeeEeeEEeeCCceEEEEE
Q 008785 273 GNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS----SF-QRKKEFYSEIGRFARLH-HPNLVAVKGCCYDHGDRYIVYE 345 (553)
Q Consensus 273 ~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~----~~-~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lV~E 345 (553)
..+.||+|+||+|+.|... +|+.||+|++.+. .. ...+.+.+|+.++++++ ||||++++.++......|+|||
T Consensus 21 ~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~ivmE 100 (370)
T KOG0583|consen 21 LGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIYIVME 100 (370)
T ss_pred eeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEEEEE
Confidence 3445699999999999854 5899999987664 12 23456678999999998 9999999999999999999999
Q ss_pred ccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCC-CCeEEeeccccccCCc
Q 008785 346 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE-FGAHLMGVGLSKFVPW 424 (553)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~-~~~kl~Dfgla~~~~~ 424 (553)
|+.+|+|.+++.. ...+.+..+..++.|++.|++|+|++ ||+||||||+|||++.+ +++||+|||++.....
T Consensus 101 y~~gGdL~~~i~~----~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~ 173 (370)
T KOG0583|consen 101 YCSGGDLFDYIVN----KGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGLSAISPG 173 (370)
T ss_pred ecCCccHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEeccccccccCC
Confidence 9999999999974 35688899999999999999999999 99999999999999999 9999999999987741
Q ss_pred ccccceeeecCccccccccccccCCC-CC-cccchHhHHHHHHHHhc-CcccccchHHH---HHhcCCH----HH-HHHH
Q 008785 425 EVMQERTVMAGGTYGYLAPEFVYRNE-LT-TKSDVYSFGVLLLEIRL-VLCRRWWTLYT---LVHSMSL----LC-AQEC 493 (553)
Q Consensus 425 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~t-~ksDVwSlGvil~ell~-~~~~~~~~l~~---~~~~~~~----~~-~~~l 493 (553)
........+||+.|+|||++.+.. |+ .++||||+||+||.|++ ..|+.+.+... .+..+.+ .. +.++
T Consensus 174 --~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~~~~S~~~ 251 (370)
T KOG0583|consen 174 --EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPSYLLSPEA 251 (370)
T ss_pred --CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCCCcCCHHH
Confidence 112233445999999999999877 85 78999999999999997 55555555444 5556665 33 7888
Q ss_pred HHHHhhccCCCCCCCCCHHHHHHHH
Q 008785 494 LMLFISCNNWPSHLSQSKFCNLKLW 518 (553)
Q Consensus 494 ~~l~~~Cl~~dP~~RPs~~evl~~l 518 (553)
..++.+|+..||..|+|+.+|+++-
T Consensus 252 ~~Li~~mL~~~P~~R~t~~~i~~h~ 276 (370)
T KOG0583|consen 252 RSLIEKMLVPDPSTRITLLEILEHP 276 (370)
T ss_pred HHHHHHHcCCCcccCCCHHHHhhCh
Confidence 9999999999999999999999763
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=309.49 Aligned_cols=253 Identities=21% Similarity=0.287 Sum_probs=203.4
Q ss_pred eecccCceeEEEEEe-CCCCEEEEEEeccCChhh--HHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCCH
Q 008785 276 LLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQR--KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352 (553)
Q Consensus 276 ~iG~G~~g~Vy~~~~-~~g~~vAvK~~~~~~~~~--~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL 352 (553)
.+|+|.||.||+|+. .+|+.||||+++.....+ .....+|++.|+.++||||+.++++|...+.+.||+|||+. +|
T Consensus 9 ~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm~t-dL 87 (318)
T KOG0659|consen 9 KLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFMPT-DL 87 (318)
T ss_pred hhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEeccc-cH
Confidence 459999999999995 469999999998764332 35678999999999999999999999999999999999964 89
Q ss_pred HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccceee
Q 008785 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV 432 (553)
Q Consensus 353 ~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~ 432 (553)
...+++ ....++..++..++.++++||+|+|++ .|+||||||.|+|++++|.+||+|||+|+.+..........
T Consensus 88 e~vIkd---~~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~~~ 161 (318)
T KOG0659|consen 88 EVVIKD---KNIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQTHQ 161 (318)
T ss_pred HHHhcc---cccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCCCcccccc
Confidence 999975 556799999999999999999999999 99999999999999999999999999999887654433332
Q ss_pred ecCccccccccccccCC-CCCcccchHhHHHHHHHHhcCcccc--cchHHH---HHh-cCC-------------------
Q 008785 433 MAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIRLVLCRR--WWTLYT---LVH-SMS------------------- 486 (553)
Q Consensus 433 ~~~gt~~y~aPE~~~~~-~~t~ksDVwSlGvil~ell~~~~~~--~~~l~~---~~~-~~~------------------- 486 (553)
+ -|..|+|||.+.+. .|+...|+||.|||+.||+-..|.. +.++.+ .+. -|.
T Consensus 162 V--~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~ 239 (318)
T KOG0659|consen 162 V--VTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQ 239 (318)
T ss_pred e--eeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHh
Confidence 2 68899999999875 5899999999999999999422110 111111 000 000
Q ss_pred ---------H--HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHhhccccccccccccc
Q 008785 487 ---------L--LCAQECLMLFISCNNWPSHLSQSKFCNLKLWVFAILTIRKVQFEFPLLRL 537 (553)
Q Consensus 487 ---------~--~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~~~~~~~~~~~~~p~~~~ 537 (553)
+ .......+++..++..||.+|+|++|++++--+..........+.|.+..
T Consensus 240 ~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~pt~~~~lp~p~~ 301 (318)
T KOG0659|consen 240 QFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPLPTPPSKLPIPST 301 (318)
T ss_pred cCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCCCCChhhCcCCcc
Confidence 0 45667799999999999999999999999866655555555555554443
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=347.10 Aligned_cols=244 Identities=23% Similarity=0.317 Sum_probs=206.9
Q ss_pred CeeecccCceeEEEEEe-CCCC----EEEEEEeccC-ChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEcc
Q 008785 274 NRLLGDSKTGGTYSGIL-PDGS----RVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV 347 (553)
Q Consensus 274 ~~~iG~G~~g~Vy~~~~-~~g~----~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 347 (553)
.++||+|+||+||+|.+ ++|+ +||||++... ..+...+++.|+-+|.+++|||+++++|+|..+. +.||++||
T Consensus 701 ~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~m 779 (1177)
T KOG1025|consen 701 DKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLM 779 (1177)
T ss_pred hceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhc
Confidence 45679999999999995 4443 7999998754 4556789999999999999999999999998876 88999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccc
Q 008785 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM 427 (553)
Q Consensus 348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 427 (553)
+.|+|.+|++. .+..+-....+.|..|||+||.|||.+ +++||||.++|||+.....+||.|||+++....+..
T Consensus 780 P~G~LlDyvr~---hr~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ 853 (1177)
T KOG1025|consen 780 PLGCLLDYVRE---HRDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK 853 (1177)
T ss_pred ccchHHHHHHH---hhccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence 99999999986 345688889999999999999999999 999999999999999999999999999998877665
Q ss_pred cceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcC--ccccc---chHHHHHhcCCH-----HHHHHHHHHH
Q 008785 428 QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLV--LCRRW---WTLYTLVHSMSL-----LCAQECLMLF 497 (553)
Q Consensus 428 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~--~~~~~---~~l~~~~~~~~~-----~~~~~l~~l~ 497 (553)
+.......-.+.|||-|.++...|+.++|||||||++||++|+ .|.+. .++.++++.|.. .+..++..++
T Consensus 854 ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLsqPpiCtiDVy~~m 933 (1177)
T KOG1025|consen 854 EYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLSQPPICTIDVYMVM 933 (1177)
T ss_pred cccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCCCCCCccHHHHHHH
Confidence 5544433356789999999999999999999999999999983 33333 344557776655 6778899999
Q ss_pred hhccCCCCCCCCCHHHHHHHHHHHHhh
Q 008785 498 ISCNNWPSHLSQSKFCNLKLWVFAILT 524 (553)
Q Consensus 498 ~~Cl~~dP~~RPs~~evl~~l~~~~~~ 524 (553)
.+||..|++.||+++++...+-.+...
T Consensus 934 vkCwmid~~~rp~fkel~~~fs~~ard 960 (1177)
T KOG1025|consen 934 VKCWMIDADSRPTFKELAEEFSRMARD 960 (1177)
T ss_pred HHHhccCcccCccHHHHHHHHHHHhcC
Confidence 999999999999999988876555443
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=340.98 Aligned_cols=244 Identities=27% Similarity=0.398 Sum_probs=209.6
Q ss_pred CeeecccCceeEEEEEeCC-CCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCCH
Q 008785 274 NRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352 (553)
Q Consensus 274 ~~~iG~G~~g~Vy~~~~~~-g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL 352 (553)
+++ |-|.||.||.|.|+. .-.||||.++.. .-..++|++|+.+|+.++|||+|+|+|+|..+...|||+|||..|+|
T Consensus 273 hKL-GGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGNL 350 (1157)
T KOG4278|consen 273 HKL-GGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGNL 350 (1157)
T ss_pred ecc-CCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCccH
Confidence 445 999999999999976 568999999876 44578999999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccceee
Q 008785 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV 432 (553)
Q Consensus 353 ~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~ 432 (553)
.+||++. +...++.-..+.++.||+.||+||..+ ++|||||.++|+|+.++..+|++|||+++++..+.......
T Consensus 351 LdYLRec--nr~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTAHAG 425 (1157)
T KOG4278|consen 351 LDYLREC--NRSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTAHAG 425 (1157)
T ss_pred HHHHHHh--chhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhhhcCCceecccC
Confidence 9999874 445578888899999999999999999 99999999999999999999999999999987654433221
Q ss_pred ecCccccccccccccCCCCCcccchHhHHHHHHHHhcC--cccccch---HHHHHhcCCH-----HHHHHHHHHHhhccC
Q 008785 433 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLV--LCRRWWT---LYTLVHSMSL-----LCAQECLMLFISCNN 502 (553)
Q Consensus 433 ~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~--~~~~~~~---l~~~~~~~~~-----~~~~~l~~l~~~Cl~ 502 (553)
+.-++.|.|||.+....++.|+|||+|||+||||.++ .|....+ .++++++|-. .+++.+++|+.+||+
T Consensus 426 -AKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~PeGCPpkVYeLMraCW~ 504 (1157)
T KOG4278|consen 426 -AKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDGPEGCPPKVYELMRACWN 504 (1157)
T ss_pred -ccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccCCCCCCHHHHHHHHHHhc
Confidence 1136789999999999999999999999999999983 3333333 4446665533 789999999999999
Q ss_pred CCCCCCCCHHHHHHHHHHHHhhc
Q 008785 503 WPSHLSQSKFCNLKLWVFAILTI 525 (553)
Q Consensus 503 ~dP~~RPs~~evl~~l~~~~~~~ 525 (553)
++|.+||++.|+-+.++.++.+.
T Consensus 505 WsPsDRPsFaeiHqafEtmf~~s 527 (1157)
T KOG4278|consen 505 WSPSDRPSFAEIHQAFETMFSSS 527 (1157)
T ss_pred CCcccCccHHHHHHHHHHHhccc
Confidence 99999999999999888877543
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=334.16 Aligned_cols=236 Identities=22% Similarity=0.270 Sum_probs=193.2
Q ss_pred ecccCceeEEEEEe-CCCCEEEEEEeccCC--hhhHHHHHHHHHHhhccCCCceeeEeeEEeeC--CceEEEEEccCCCC
Q 008785 277 LGDSKTGGTYSGIL-PDGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH--GDRYIVYEFVVNGP 351 (553)
Q Consensus 277 iG~G~~g~Vy~~~~-~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~~lV~E~~~~gs 351 (553)
||+|.||.||+++. .+|+.||+|+++... ........+||.+|++|+||||++|.+...+. +.+|||+|||+. |
T Consensus 125 IGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMdh-D 203 (560)
T KOG0600|consen 125 IGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMDH-D 203 (560)
T ss_pred hcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEecccc-h
Confidence 49999999999994 569999999998654 33345678999999999999999999998876 689999999965 8
Q ss_pred HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCccccccee
Q 008785 352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT 431 (553)
Q Consensus 352 L~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~ 431 (553)
|..++.. .+-.+++.++..++.|++.||+|+|++ ||+|||||.+|||||.+|.+||+|||+|+++........+
T Consensus 204 L~GLl~~---p~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~~~T 277 (560)
T KOG0600|consen 204 LSGLLSS---PGVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSAPYT 277 (560)
T ss_pred hhhhhcC---CCcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeeccCCCCcccc
Confidence 8888864 456799999999999999999999999 9999999999999999999999999999988766544333
Q ss_pred eecCccccccccccccCC-CCCcccchHhHHHHHHHHhcCccccc--chHHH--------------HHhcCCH-------
Q 008785 432 VMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIRLVLCRRW--WTLYT--------------LVHSMSL------- 487 (553)
Q Consensus 432 ~~~~gt~~y~aPE~~~~~-~~t~ksDVwSlGvil~ell~~~~~~~--~~l~~--------------~~~~~~~------- 487 (553)
... -|..|.|||.+.+. .|+.+.|+||.||||.||+...|... .++.+ .|....+
T Consensus 278 ~rV-vTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~k 356 (560)
T KOG0600|consen 278 SRV-VTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIFK 356 (560)
T ss_pred cce-EEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcccccC
Confidence 222 69999999999875 69999999999999999996333211 11111 1110000
Q ss_pred --------------HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 008785 488 --------------LCAQECLMLFISCNNWPSHLSQSKFCNLKLWVF 520 (553)
Q Consensus 488 --------------~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~ 520 (553)
..+...++|+..+|..||++|.|+.++|+.-.+
T Consensus 357 p~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF 403 (560)
T KOG0600|consen 357 PQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYF 403 (560)
T ss_pred CCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCccc
Confidence 556678999999999999999999999976433
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=336.39 Aligned_cols=248 Identities=19% Similarity=0.251 Sum_probs=203.5
Q ss_pred hcccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCCh---hhHHHHHHHHHHhhcc-CCCceeeEeeEEeeCCceE
Q 008785 267 TKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF---QRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRY 341 (553)
Q Consensus 267 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~ 341 (553)
.++|.-+. +||+|+|++|++++.. .++.||||++.+.-. ...+-+..|-.+|.+| .||.|++|+-.|.+...+|
T Consensus 72 ~~DF~Fg~-~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY 150 (604)
T KOG0592|consen 72 PNDFKFGK-ILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY 150 (604)
T ss_pred hhhcchhh-eeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence 34555544 4599999999999954 589999999976522 2234466788889999 8999999999999999999
Q ss_pred EEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeecccccc
Q 008785 342 IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF 421 (553)
Q Consensus 342 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~ 421 (553)
+|+||+++|+|.++|++. +.+++.....++.+|+.||+|||++ |||||||||+|||+|+|+++||+|||.|+.
T Consensus 151 FvLe~A~nGdll~~i~K~----Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK~ 223 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLIKKY----GSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAKI 223 (604)
T ss_pred EEEEecCCCcHHHHHHHh----CcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeecccccc
Confidence 999999999999999763 5699999999999999999999999 999999999999999999999999999998
Q ss_pred CCccccc---------cee--eecCccccccccccccCCCCCcccchHhHHHHHHHHhcCcccc----cchHHHHHhcCC
Q 008785 422 VPWEVMQ---------ERT--VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVLCRR----WWTLYTLVHSMS 486 (553)
Q Consensus 422 ~~~~~~~---------~~~--~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~~~~----~~~l~~~~~~~~ 486 (553)
+...... ... ....||..|.+||++.++..++.+|+|+||||||+|+.+.|.. .-.+.+.+..-.
T Consensus 224 l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~ 303 (604)
T KOG0592|consen 224 LSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALD 303 (604)
T ss_pred CChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhc
Confidence 7654222 111 2345999999999999999999999999999999999744332 222333332222
Q ss_pred H----HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 008785 487 L----LCAQECLMLFISCNNWPSHLSQSKFCNLKLWVFAI 522 (553)
Q Consensus 487 ~----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~~~ 522 (553)
. ..++.+.+|+.+.|..||++|+|..||-++..+.-
T Consensus 304 y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~ 343 (604)
T KOG0592|consen 304 YEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEG 343 (604)
T ss_pred ccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCccccc
Confidence 2 56788899999999999999999999998866544
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=324.43 Aligned_cols=240 Identities=24% Similarity=0.370 Sum_probs=192.0
Q ss_pred eeecccCceeEEEEEeCCCCEEEEEEeccCChhhHHHHHHHHHHhhc--cCCCceeeEeeEEeeCC----ceEEEEEccC
Q 008785 275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFAR--LHHPNLVAVKGCCYDHG----DRYIVYEFVV 348 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~--l~HpnIv~l~~~~~~~~----~~~lV~E~~~ 348 (553)
+++|+|.||.||+|.+ +++.||||++.. ...+.|.+|-++.+. ++|+||+++++.-.... +.+||+||.+
T Consensus 216 eli~~Grfg~V~KaqL-~~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~ 291 (534)
T KOG3653|consen 216 ELIGRGRFGCVWKAQL-DNRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHP 291 (534)
T ss_pred HHhhcCccceeehhhc-cCceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeecc
Confidence 3579999999999999 569999999975 356678888777765 58999999999866554 7899999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC------CCCCceecCCCCCcEEecCCCCeEEeeccccccC
Q 008785 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDK------VKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV 422 (553)
Q Consensus 349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~------~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~ 422 (553)
.|+|.+||.. ..++|....+|+..+++||+|||+. ++|+|+|||||++|||+.+|+++.|+|||+|..+
T Consensus 292 kGsL~dyL~~-----ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~ 366 (534)
T KOG3653|consen 292 KGSLCDYLKA-----NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRL 366 (534)
T ss_pred CCcHHHHHHh-----ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEe
Confidence 9999999975 5699999999999999999999954 5789999999999999999999999999999988
Q ss_pred CcccccceeeecCccccccccccccCCC-C-----CcccchHhHHHHHHHHhc----C--c-ccccc-------------
Q 008785 423 PWEVMQERTVMAGGTYGYLAPEFVYRNE-L-----TTKSDVYSFGVLLLEIRL----V--L-CRRWW------------- 476 (553)
Q Consensus 423 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~-----t~ksDVwSlGvil~ell~----~--~-~~~~~------------- 476 (553)
.............||.+|||||++.+.- + -.+.||||+|.+||||++ . . +.+.+
T Consensus 367 ~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~ 446 (534)
T KOG3653|consen 367 EPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTL 446 (534)
T ss_pred cCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCH
Confidence 7665554444455999999999996532 1 246899999999999995 1 1 11111
Q ss_pred -hHHH-HH-hcCCH---------HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHh
Q 008785 477 -TLYT-LV-HSMSL---------LCAQECLMLFISCNNWPSHLSQSKFCNLKLWVFAIL 523 (553)
Q Consensus 477 -~l~~-~~-~~~~~---------~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~~~~ 523 (553)
++.+ .+ ++.+. ....-+.+.+..||+.||+.|.|+.=+.+++...+.
T Consensus 447 e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~ 505 (534)
T KOG3653|consen 447 EEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMM 505 (534)
T ss_pred HHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhc
Confidence 1111 11 12221 556678899999999999999999999888655443
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=339.26 Aligned_cols=230 Identities=26% Similarity=0.389 Sum_probs=193.8
Q ss_pred eecccCceeEEEEEeCCCCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCCHHHH
Q 008785 276 LLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRW 355 (553)
Q Consensus 276 ~iG~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~ 355 (553)
-+|.|+.|.||+|++ .++.||||+++.-. ..+|+-|++|+||||+.+.|+|....-.+||||||..|-|..+
T Consensus 131 WlGSGaQGAVF~Grl-~netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~V 202 (904)
T KOG4721|consen 131 WLGSGAQGAVFLGRL-HNETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEV 202 (904)
T ss_pred hhccCcccceeeeec-cCceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHHH
Confidence 359999999999999 67899999986432 2478889999999999999999999999999999999999999
Q ss_pred hccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccceeeecC
Q 008785 356 LHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG 435 (553)
Q Consensus 356 l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~ 435 (553)
|+. ++.++......+..+||.||.|||.+ .|||||||.-||||..+..+||+|||.++...... +...++
T Consensus 203 Lka----~~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~S---TkMSFa 272 (904)
T KOG4721|consen 203 LKA----GRPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDKS---TKMSFA 272 (904)
T ss_pred Hhc----cCccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhhh---hhhhhh
Confidence 964 56788899999999999999999999 99999999999999999999999999998765432 223345
Q ss_pred ccccccccccccCCCCCcccchHhHHHHHHHHhc-CcccccchHHH-HHhcC--CH------HHHHHHHHHHhhccCCCC
Q 008785 436 GTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-VLCRRWWTLYT-LVHSM--SL------LCAQECLMLFISCNNWPS 505 (553)
Q Consensus 436 gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-~~~~~~~~l~~-~~~~~--~~------~~~~~l~~l~~~Cl~~dP 505 (553)
||..|||||++.+.+.+.|+|||||||+||||+| -.|..+.+-.. .+.-| .+ .++.-+.-|+++||+..|
T Consensus 273 GTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~GfklL~Kqcw~sKp 352 (904)
T KOG4721|consen 273 GTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKLLLKQCWNSKP 352 (904)
T ss_pred hhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHHHHHHHHHHhcCC
Confidence 9999999999999999999999999999999998 33333222111 11111 11 778889999999999999
Q ss_pred CCCCCHHHHHHHHHHHHh
Q 008785 506 HLSQSKFCNLKLWVFAIL 523 (553)
Q Consensus 506 ~~RPs~~evl~~l~~~~~ 523 (553)
.+|||+.+|+.+|..+--
T Consensus 353 RNRPSFrqil~HldIa~p 370 (904)
T KOG4721|consen 353 RNRPSFRQILLHLDIASP 370 (904)
T ss_pred CCCccHHHHHHHHhhcCH
Confidence 999999999999865443
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=328.55 Aligned_cols=241 Identities=23% Similarity=0.306 Sum_probs=190.7
Q ss_pred eeecccCceeEEEEEeCC-----------------CCEEEEEEeccCC-hhhHHHHHHHHHHhhccCCCceeeEeeEEee
Q 008785 275 RLLGDSKTGGTYSGILPD-----------------GSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYD 336 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~~-----------------g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 336 (553)
+.||+|+||.||++...+ +..||+|.+.... .....++.+|+.++.+++||||+++++++.+
T Consensus 11 ~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 90 (304)
T cd05096 11 EKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVD 90 (304)
T ss_pred eEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEec
Confidence 346999999999998532 3369999997653 3345679999999999999999999999999
Q ss_pred CCceEEEEEccCCCCHHHHhccCCC---------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCC
Q 008785 337 HGDRYIVYEFVVNGPLDRWLHHIPR---------------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRAS 401 (553)
Q Consensus 337 ~~~~~lV~E~~~~gsL~~~l~~~~~---------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~ 401 (553)
.+..++||||+++|+|.+++..... ....+++..+..++.||+.||.|||+. +|+||||||+
T Consensus 91 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~ivH~dlkp~ 167 (304)
T cd05096 91 EDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVHRDLATR 167 (304)
T ss_pred CCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---CccccCcchh
Confidence 9999999999999999999864211 113478889999999999999999999 9999999999
Q ss_pred cEEecCCCCeEEeeccccccCCcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhc---Ccccc---c
Q 008785 402 NVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL---VLCRR---W 475 (553)
Q Consensus 402 NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~---~~~~~---~ 475 (553)
|||+++++.+||+|||+++...............++..|+|||++..+.++.++||||||+++|||++ ..|.. .
T Consensus 168 Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~ 247 (304)
T cd05096 168 NCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTD 247 (304)
T ss_pred heEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCCcCCH
Confidence 99999999999999999976543322211122225788999999988899999999999999999985 22222 1
Q ss_pred chHHH----HHhcCC--------HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008785 476 WTLYT----LVHSMS--------LLCAQECLMLFISCNNWPSHLSQSKFCNLKLW 518 (553)
Q Consensus 476 ~~l~~----~~~~~~--------~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l 518 (553)
....+ ...... ...+..+.+++.+||+.||++|||+.||.+.+
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l 302 (304)
T cd05096 248 EQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFL 302 (304)
T ss_pred HHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHH
Confidence 22221 111110 13457899999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=324.50 Aligned_cols=233 Identities=20% Similarity=0.290 Sum_probs=191.5
Q ss_pred eeecccCceeEEEEEeCCCCEEEEEEeccCChhh---HHHHHHHHHHhhccCCCceeeEeeEEee----CCceEEEEEcc
Q 008785 275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQR---KKEFYSEIGRFARLHHPNLVAVKGCCYD----HGDRYIVYEFV 347 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~---~~~~~~E~~~l~~l~HpnIv~l~~~~~~----~~~~~lV~E~~ 347 (553)
..+|+|++|.||+|.+ +|+.||||.++...... .+.+.+|+.+|++++||||++++|++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 4569999999999998 78999999997653322 4678899999999999999999999877 34679999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccc
Q 008785 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM 427 (553)
Q Consensus 348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 427 (553)
++|+|.+++.. ...+++.....++.|++.||.|||+. .+++||||||+|||+++++.+||+|||+++.......
T Consensus 105 ~~g~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~~ 178 (283)
T PHA02988 105 TRGYLREVLDK----EKDLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPPF 178 (283)
T ss_pred CCCcHHHHHhh----CCCCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEECCCCcEEEcccchHhhhccccc
Confidence 99999999964 24588999999999999999999973 1788999999999999999999999999976543221
Q ss_pred cceeeecCccccccccccccC--CCCCcccchHhHHHHHHHHhcC-cccccc---hHHHHH-hcC-CH----HHHHHHHH
Q 008785 428 QERTVMAGGTYGYLAPEFVYR--NELTTKSDVYSFGVLLLEIRLV-LCRRWW---TLYTLV-HSM-SL----LCAQECLM 495 (553)
Q Consensus 428 ~~~~~~~~gt~~y~aPE~~~~--~~~t~ksDVwSlGvil~ell~~-~~~~~~---~l~~~~-~~~-~~----~~~~~l~~ 495 (553)
...|+..|+|||++.+ ..++.++|||||||++|||++. .|.... .+...+ ..+ .. ..+..+.+
T Consensus 179 -----~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~ 253 (283)
T PHA02988 179 -----KNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKC 253 (283)
T ss_pred -----cccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHHHH
Confidence 1237889999999976 6789999999999999999973 333322 333332 221 11 56778999
Q ss_pred HHhhccCCCCCCCCCHHHHHHHHH
Q 008785 496 LFISCNNWPSHLSQSKFCNLKLWV 519 (553)
Q Consensus 496 l~~~Cl~~dP~~RPs~~evl~~l~ 519 (553)
++.+||+.||++|||+.|+++.+.
T Consensus 254 li~~cl~~dp~~Rps~~ell~~l~ 277 (283)
T PHA02988 254 IVEACTSHDSIKRPNIKEILYNLS 277 (283)
T ss_pred HHHHHhcCCcccCcCHHHHHHHHH
Confidence 999999999999999999998763
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=324.87 Aligned_cols=239 Identities=28% Similarity=0.417 Sum_probs=190.3
Q ss_pred eeecccCceeEEEEEeC-----CCCEEEEEEeccC-ChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccC
Q 008785 275 RLLGDSKTGGTYSGILP-----DGSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV 348 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~-----~g~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 348 (553)
+.||.|.||.||+|.+. .+..|+||.++.. .....+.+.+|++.+++++||||++++|++...+..++|+||++
T Consensus 5 ~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~~ 84 (259)
T PF07714_consen 5 KQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYCP 84 (259)
T ss_dssp EEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--T
T ss_pred eEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccccc
Confidence 45699999999999986 2568999999654 33457889999999999999999999999998888999999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCccccc
Q 008785 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ 428 (553)
Q Consensus 349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 428 (553)
+|+|.++|... ....+++..+..|+.||+.||.|||++ +++|+||+++||++++++.+||+|||++.........
T Consensus 85 ~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 85 GGSLDDYLKSK--NKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp TEBHHHHHHHT--CTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred ccccccccccc--ccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccc
Confidence 99999999873 345689999999999999999999999 9999999999999999999999999999876322222
Q ss_pred ceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhc-C-ccccc---chHHHHHhcCCH-----HHHHHHHHHHh
Q 008785 429 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-V-LCRRW---WTLYTLVHSMSL-----LCAQECLMLFI 498 (553)
Q Consensus 429 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-~-~~~~~---~~l~~~~~~~~~-----~~~~~l~~l~~ 498 (553)
...........|+|||.+....++.++||||||+++|||++ . .+..+ ..+.+.+.++.. ..+..+.+++.
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 239 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPIPDNCPKDIYSLIQ 239 (259)
T ss_dssp EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTSBTTSBHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccceeccchhHHHHHHHH
Confidence 11112226778999999998889999999999999999998 2 33322 223333333322 46778999999
Q ss_pred hccCCCCCCCCCHHHHHHHH
Q 008785 499 SCNNWPSHLSQSKFCNLKLW 518 (553)
Q Consensus 499 ~Cl~~dP~~RPs~~evl~~l 518 (553)
+||+.||++|||+.++++.|
T Consensus 240 ~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 240 QCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp HHT-SSGGGS--HHHHHHHH
T ss_pred HHcCCChhhCcCHHHHHhcC
Confidence 99999999999999999875
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=337.52 Aligned_cols=248 Identities=24% Similarity=0.297 Sum_probs=196.3
Q ss_pred cCCCCeeecccCceeEEEEEe------CCCCEEEEEEeccCC-hhhHHHHHHHHHHhhcc-CCCceeeEeeEEeeCCceE
Q 008785 270 FSEGNRLLGDSKTGGTYSGIL------PDGSRVAVKRLKRSS-FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRY 341 (553)
Q Consensus 270 ~~~~~~~iG~G~~g~Vy~~~~------~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~ 341 (553)
|... +.||+|+||.||+|.. .++..||||+++... ....+.+.+|+.++..+ +||||+++++++.+.+..+
T Consensus 37 ~~~~-~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~ 115 (375)
T cd05104 37 LSFG-KTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTL 115 (375)
T ss_pred eehh-heecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcce
Confidence 4443 4559999999999973 235689999997542 33456788999999999 8999999999999999999
Q ss_pred EEEEccCCCCHHHHhccCCC------------------------------------------------------------
Q 008785 342 IVYEFVVNGPLDRWLHHIPR------------------------------------------------------------ 361 (553)
Q Consensus 342 lV~E~~~~gsL~~~l~~~~~------------------------------------------------------------ 361 (553)
+||||+++|+|.++++....
T Consensus 116 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (375)
T cd05104 116 VITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYI 195 (375)
T ss_pred eeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceec
Confidence 99999999999999864211
Q ss_pred -----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccce
Q 008785 362 -----------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER 430 (553)
Q Consensus 362 -----------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 430 (553)
....+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++..........
T Consensus 196 ~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 272 (375)
T cd05104 196 DQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVV 272 (375)
T ss_pred ccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCcccccc
Confidence 112478889999999999999999999 999999999999999999999999999986543322111
Q ss_pred eeecCccccccccccccCCCCCcccchHhHHHHHHHHhc-C-ccccc----chHHHHHhcCCH-----HHHHHHHHHHhh
Q 008785 431 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-V-LCRRW----WTLYTLVHSMSL-----LCAQECLMLFIS 499 (553)
Q Consensus 431 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-~-~~~~~----~~l~~~~~~~~~-----~~~~~l~~l~~~ 499 (553)
.....++..|+|||++.+..++.++||||||+++|||++ . .|... ..+.+.+..+.. ..+.++.+++.+
T Consensus 273 ~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 352 (375)
T cd05104 273 KGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYDIMKS 352 (375)
T ss_pred cCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCHHHHHHHHH
Confidence 111225668999999999999999999999999999996 2 22221 223333333321 345689999999
Q ss_pred ccCCCCCCCCCHHHHHHHHHHH
Q 008785 500 CNNWPSHLSQSKFCNLKLWVFA 521 (553)
Q Consensus 500 Cl~~dP~~RPs~~evl~~l~~~ 521 (553)
||+.||++|||+.||++.+...
T Consensus 353 cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 353 CWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred HccCChhHCcCHHHHHHHHHhh
Confidence 9999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=331.66 Aligned_cols=233 Identities=21% Similarity=0.197 Sum_probs=193.3
Q ss_pred eecccCceeEEEEEeC-CCCEEEEEEeccCC---hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCC
Q 008785 276 LLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP 351 (553)
Q Consensus 276 ~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gs 351 (553)
+||+|+||.||++... +|+.||||+++... ......+.+|+.++++++||||+++++++...+..++||||+++|+
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~ 81 (323)
T cd05571 2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGE 81 (323)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCc
Confidence 4699999999999864 58999999997542 2334567889999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCccccccee
Q 008785 352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT 431 (553)
Q Consensus 352 L~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~ 431 (553)
|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.........
T Consensus 82 L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~-- 152 (323)
T cd05571 82 LFFHLSR----ERVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATM-- 152 (323)
T ss_pred HHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcc--
Confidence 9998864 34689999999999999999999999 99999999999999999999999999987543222111
Q ss_pred eecCccccccccccccCCCCCcccchHhHHHHHHHHhcCc-ccccc---hHHHHHhcCCH----HHHHHHHHHHhhccCC
Q 008785 432 VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVL-CRRWW---TLYTLVHSMSL----LCAQECLMLFISCNNW 503 (553)
Q Consensus 432 ~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~-~~~~~---~l~~~~~~~~~----~~~~~l~~l~~~Cl~~ 503 (553)
....||+.|+|||++.+..++.++|||||||++|||++.. |.... .+...+..+.. ..+..+.+++.+||+.
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~ 232 (323)
T cd05571 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLLKK 232 (323)
T ss_pred cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccC
Confidence 1223899999999999999999999999999999999733 33222 23333333332 4567889999999999
Q ss_pred CCCCCC-----CHHHHHHH
Q 008785 504 PSHLSQ-----SKFCNLKL 517 (553)
Q Consensus 504 dP~~RP-----s~~evl~~ 517 (553)
||++|| ++.+++++
T Consensus 233 dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 233 DPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred CHHHcCCCCCCCHHHHHcC
Confidence 999999 89999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=323.88 Aligned_cols=239 Identities=18% Similarity=0.203 Sum_probs=194.2
Q ss_pred eeecccCceeEEEEEe-CCCCEEEEEEeccCCh---hhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCC
Q 008785 275 RLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSF---QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 350 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~-~~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 350 (553)
+.||+|+||.||++.. .+|+.||+|.+..... .....+.+|+.++++++||||+++++++.+.+..++||||+++|
T Consensus 6 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~g 85 (285)
T cd05631 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGG 85 (285)
T ss_pred EEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEecCCC
Confidence 4569999999999986 4689999999875432 23346789999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccce
Q 008785 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER 430 (553)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 430 (553)
+|.+++.. .....+++..+..++.|++.||+|||+. +|+||||||+|||+++++.++|+|||++.........
T Consensus 86 ~L~~~~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-- 158 (285)
T cd05631 86 DLKFHIYN--MGNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETV-- 158 (285)
T ss_pred cHHHHHHh--hCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCee--
Confidence 99988864 2234589999999999999999999999 9999999999999999999999999999765432211
Q ss_pred eeecCccccccccccccCCCCCcccchHhHHHHHHHHhcCc-ccccc-------hHHHHHhcCCH----HHHHHHHHHHh
Q 008785 431 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVL-CRRWW-------TLYTLVHSMSL----LCAQECLMLFI 498 (553)
Q Consensus 431 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~-~~~~~-------~l~~~~~~~~~----~~~~~l~~l~~ 498 (553)
....||+.|+|||++.+..++.++|||||||++|||++.. |.... .+...+..... ..+..+.+|+.
T Consensus 159 -~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~ 237 (285)
T cd05631 159 -RGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICR 237 (285)
T ss_pred -cCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHHH
Confidence 1223899999999999999999999999999999999733 32211 11112222221 45678899999
Q ss_pred hccCCCCCCCCC-----HHHHHHHHHHH
Q 008785 499 SCNNWPSHLSQS-----KFCNLKLWVFA 521 (553)
Q Consensus 499 ~Cl~~dP~~RPs-----~~evl~~l~~~ 521 (553)
+||+.||++||+ +++++++-...
T Consensus 238 ~~l~~~P~~R~~~~~~~~~~~~~h~~~~ 265 (285)
T cd05631 238 MLLTKNPKERLGCRGNGAAGVKQHPIFK 265 (285)
T ss_pred HHhhcCHHHhcCCCCCCHHHHhcCHhhc
Confidence 999999999997 89999874443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=318.30 Aligned_cols=240 Identities=21% Similarity=0.278 Sum_probs=194.7
Q ss_pred CeeecccCceeEEEEEeC----CCCEEEEEEeccCC-hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccC
Q 008785 274 NRLLGDSKTGGTYSGILP----DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV 348 (553)
Q Consensus 274 ~~~iG~G~~g~Vy~~~~~----~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 348 (553)
.++||+|+||.||+|.+. .+..||+|.++... ......+.+|+..+++++||||+++++++...+..++||||++
T Consensus 10 ~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 89 (266)
T cd05064 10 ERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMS 89 (266)
T ss_pred eeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEEEEeCC
Confidence 345699999999999853 35689999998653 3345678999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCccccc
Q 008785 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ 428 (553)
Q Consensus 349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 428 (553)
+|+|.+++.. ....+++..++.++.|++.||+|||+. +++||||||+||+++.++.++++|||.+.........
T Consensus 90 ~~~L~~~l~~---~~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~~~ 163 (266)
T cd05064 90 NGALDSFLRK---HEGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIY 163 (266)
T ss_pred CCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCcccccccccchh
Confidence 9999999964 234689999999999999999999999 9999999999999999999999999987654322211
Q ss_pred ceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhc--Cccccc---chHHHHHhcCCH-----HHHHHHHHHHh
Q 008785 429 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL--VLCRRW---WTLYTLVHSMSL-----LCAQECLMLFI 498 (553)
Q Consensus 429 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~--~~~~~~---~~l~~~~~~~~~-----~~~~~l~~l~~ 498 (553)
. .....++..|+|||.+.+..++.++||||||+++||+++ ..|... ..+.+.+..+.. ..+..+.+++.
T Consensus 164 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 242 (266)
T cd05064 164 T-TMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPRNCPNLLHQLML 242 (266)
T ss_pred c-ccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHH
Confidence 1 111225678999999999999999999999999999875 233322 223333333321 55678999999
Q ss_pred hccCCCCCCCCCHHHHHHHHHH
Q 008785 499 SCNNWPSHLSQSKFCNLKLWVF 520 (553)
Q Consensus 499 ~Cl~~dP~~RPs~~evl~~l~~ 520 (553)
+||+.+|++|||+.||++.+..
T Consensus 243 ~c~~~~p~~RP~~~~i~~~l~~ 264 (266)
T cd05064 243 DCWQKERGERPRFSQIHSILSK 264 (266)
T ss_pred HHcCCCchhCCCHHHHHHHHHh
Confidence 9999999999999999987644
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=335.80 Aligned_cols=237 Identities=22% Similarity=0.242 Sum_probs=207.9
Q ss_pred CeeecccCceeEEEEEe-CCCCEEEEEEeccCC---hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCC
Q 008785 274 NRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 349 (553)
Q Consensus 274 ~~~iG~G~~g~Vy~~~~-~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 349 (553)
.+-||.|+.|.|-.|+. .+|+.+|||++.+.. ......+.+|+.+|+-++||||+++|+++++..++|+|.||+++
T Consensus 17 gkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv~g 96 (786)
T KOG0588|consen 17 GKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYVPG 96 (786)
T ss_pred cccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEecCC
Confidence 44569999999999985 469999999997652 22345688999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccc
Q 008785 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE 429 (553)
Q Consensus 350 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 429 (553)
|-|+++|.. .+.+++.++.+++.||+.|+.|+|.. +|+||||||+|+|||..+++||+|||+|..-..+..-.
T Consensus 97 GELFdylv~----kG~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gklLe 169 (786)
T KOG0588|consen 97 GELFDYLVR----KGPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKLLE 169 (786)
T ss_pred chhHHHHHh----hCCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecccCCcccc
Confidence 999999964 35689999999999999999999999 99999999999999999999999999998765544333
Q ss_pred eeeecCccccccccccccCCCC-CcccchHhHHHHHHHHhc-CcccccchHHH---HHhcCCH----HHHHHHHHHHhhc
Q 008785 430 RTVMAGGTYGYLAPEFVYRNEL-TTKSDVYSFGVLLLEIRL-VLCRRWWTLYT---LVHSMSL----LCAQECLMLFISC 500 (553)
Q Consensus 430 ~~~~~~gt~~y~aPE~~~~~~~-t~ksDVwSlGvil~ell~-~~~~~~~~l~~---~~~~~~~----~~~~~l~~l~~~C 500 (553)
+.+|+|.|.|||++.+.+| +.++||||.|||||.|++ ..|++++++.. .++.|.+ ..+.++.+|+.+|
T Consensus 170 ---TSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs~Is~eaQdLLr~m 246 (786)
T KOG0588|consen 170 ---TSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPSNISSEAQDLLRRM 246 (786)
T ss_pred ---ccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCCcCCHHHHHHHHHH
Confidence 3359999999999999998 579999999999999998 66777777666 6677887 7788899999999
Q ss_pred cCCCCCCCCCHHHHHHHHHH
Q 008785 501 NNWPSHLSQSKFCNLKLWVF 520 (553)
Q Consensus 501 l~~dP~~RPs~~evl~~l~~ 520 (553)
+..||+.|.|+.||+++-..
T Consensus 247 l~VDp~~RiT~~eI~kHP~l 266 (786)
T KOG0588|consen 247 LDVDPSTRITTEEILKHPFL 266 (786)
T ss_pred hccCccccccHHHHhhCchh
Confidence 99999999999999998544
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=329.45 Aligned_cols=234 Identities=22% Similarity=0.290 Sum_probs=198.4
Q ss_pred eeecccCceeEEEEEeC-CCCEEEEEEeccCCh-hhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCCH
Q 008785 275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF-QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL 352 (553)
..||+|+||.||+|... .++.||+|++.-... ...+++.+|+.+|.+++++||.++||.+..+..++++||||.||++
T Consensus 19 ~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGsv 98 (467)
T KOG0201|consen 19 ELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGSV 98 (467)
T ss_pred hhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcch
Confidence 34599999999999964 488999999986543 3467899999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccceee
Q 008785 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV 432 (553)
Q Consensus 353 ~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~ 432 (553)
.+.|+. +..+++..+.-++++++.||.|||++ +.+|||||+.|||+..+|.+||+|||.+..+....... .
T Consensus 99 ~~lL~~----~~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr--~ 169 (467)
T KOG0201|consen 99 LDLLKS----GNILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR--K 169 (467)
T ss_pred hhhhcc----CCCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechhhcc--c
Confidence 999863 34457888888999999999999999 99999999999999999999999999998776655443 2
Q ss_pred ecCccccccccccccCCCCCcccchHhHHHHHHHHhcCccccc-chHHH---HHhcCCH-----HHHHHHHHHHhhccCC
Q 008785 433 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVLCRRW-WTLYT---LVHSMSL-----LCAQECLMLFISCNNW 503 (553)
Q Consensus 433 ~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~~~~~-~~l~~---~~~~~~~-----~~~~~l~~l~~~Cl~~ 503 (553)
...||+.|||||++....|+.|+||||||++.+||++..|+.. ..... ++.+... .....+.+++..||+.
T Consensus 170 tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~~~S~~~kEFV~~CL~k 249 (467)
T KOG0201|consen 170 TFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDGDFSPPFKEFVEACLDK 249 (467)
T ss_pred cccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccccccCHHHHHHHHHHhhc
Confidence 3349999999999998899999999999999999997443322 11111 2222221 6778899999999999
Q ss_pred CCCCCCCHHHHHHH
Q 008785 504 PSHLSQSKFCNLKL 517 (553)
Q Consensus 504 dP~~RPs~~evl~~ 517 (553)
||++|||+.++|++
T Consensus 250 ~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 250 NPEFRPSAKELLKH 263 (467)
T ss_pred CcccCcCHHHHhhh
Confidence 99999999999986
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=317.34 Aligned_cols=237 Identities=20% Similarity=0.253 Sum_probs=208.5
Q ss_pred ecccCceeEEEEEe-CCCCEEEEEEeccCChh---hHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCCH
Q 008785 277 LGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQ---RKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352 (553)
Q Consensus 277 iG~G~~g~Vy~~~~-~~g~~vAvK~~~~~~~~---~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL 352 (553)
||+|.||.|-++.- ..|+.||||.+++.... +.-.+.+|+++|+.|+||||++++.+|++.+.+.|||||..+|.|
T Consensus 61 LGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivMEYaS~GeL 140 (668)
T KOG0611|consen 61 LGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVMEYASGGEL 140 (668)
T ss_pred hcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEEecCCccH
Confidence 59999999999985 57999999999876443 445578999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccceee
Q 008785 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV 432 (553)
Q Consensus 353 ~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~ 432 (553)
++|+.+ .+.+++.+...+++||.+|+.|+|.+ +++|||||.+|||+|.++++||+|||++..+.....-.
T Consensus 141 YDYiSe----r~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~~~kfLq--- 210 (668)
T KOG0611|consen 141 YDYISE----RGSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYADKKFLQ--- 210 (668)
T ss_pred HHHHHH----hccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhccccHHH---
Confidence 999975 35699999999999999999999999 99999999999999999999999999998776554332
Q ss_pred ecCccccccccccccCCCC-CcccchHhHHHHHHHHhc----CcccccchHHHHHhcCCH---HHHHHHHHHHhhccCCC
Q 008785 433 MAGGTYGYLAPEFVYRNEL-TTKSDVYSFGVLLLEIRL----VLCRRWWTLYTLVHSMSL---LCAQECLMLFISCNNWP 504 (553)
Q Consensus 433 ~~~gt~~y~aPE~~~~~~~-t~ksDVwSlGvil~ell~----~~~~~~~~l~~~~~~~~~---~~~~~l~~l~~~Cl~~d 504 (553)
+++|++-|.+||.+.+.+| ++..|-|||||+||.|+- +...+...++..+..|.. ..+....-||..||..|
T Consensus 211 TFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~~PSdA~gLIRwmLmVN 290 (668)
T KOG0611|consen 211 TFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPETPSDASGLIRWMLMVN 290 (668)
T ss_pred HhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCCCCchHHHHHHHHHhcC
Confidence 4569999999999999988 588999999999999983 555666677778888887 55667788999999999
Q ss_pred CCCCCCHHHHHHHHHHHHh
Q 008785 505 SHLSQSKFCNLKLWVFAIL 523 (553)
Q Consensus 505 P~~RPs~~evl~~l~~~~~ 523 (553)
|++|.|+.+|..+|..-..
T Consensus 291 P~RRATieDiAsHWWvNwg 309 (668)
T KOG0611|consen 291 PERRATIEDIASHWWVNWG 309 (668)
T ss_pred cccchhHHHHhhhheeecc
Confidence 9999999999999876543
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-40 Score=329.88 Aligned_cols=233 Identities=21% Similarity=0.261 Sum_probs=201.0
Q ss_pred eecccCceeEEEEEeC-CCCEEEEEEeccCC--hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCCH
Q 008785 276 LLGDSKTGGTYSGILP-DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352 (553)
Q Consensus 276 ~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL 352 (553)
.||+|+||.||+|+.+ +.+.||+|.+.+.. .+..+.+.+|++++++++|||||.++++|++..+.++|.||+.| +|
T Consensus 9 ~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a~g-~L 87 (808)
T KOG0597|consen 9 MIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYAVG-DL 87 (808)
T ss_pred HhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhhhh-hH
Confidence 4599999999999965 47899999997653 34456789999999999999999999999999999999999976 99
Q ss_pred HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccceee
Q 008785 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV 432 (553)
Q Consensus 353 ~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~ 432 (553)
..+|.. +..++++.+..++.|+..||.|||+. +|+|||+||.|||++.++.+|++|||+|+....... ..+.
T Consensus 88 ~~il~~----d~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~-vlts 159 (808)
T KOG0597|consen 88 FTILEQ----DGKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTS-VLTS 159 (808)
T ss_pred HHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhcccCce-eeee
Confidence 999964 45699999999999999999999999 999999999999999999999999999998765432 2222
Q ss_pred ecCccccccccccccCCCCCcccchHhHHHHHHHHhcCccc-ccchHHH---HHhcCCH----HHHHHHHHHHhhccCCC
Q 008785 433 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVLCR-RWWTLYT---LVHSMSL----LCAQECLMLFISCNNWP 504 (553)
Q Consensus 433 ~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~~~-~~~~l~~---~~~~~~~----~~~~~l~~l~~~Cl~~d 504 (553)
+ .|||.|||||...+++|+..+|.||+|||+||+..+.|. ...++.+ .+..... .....+..++...|..|
T Consensus 160 i-kGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~~~S~~f~nfl~gLL~kd 238 (808)
T KOG0597|consen 160 I-KGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPSTASSSFVNFLQGLLIKD 238 (808)
T ss_pred c-cCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcccccHHHHHHHHHHhhcC
Confidence 2 399999999999999999999999999999999985544 4444444 3333333 67778999999999999
Q ss_pred CCCCCCHHHHHHHH
Q 008785 505 SHLSQSKFCNLKLW 518 (553)
Q Consensus 505 P~~RPs~~evl~~l 518 (553)
|..|.|-.+++.+-
T Consensus 239 P~~RltW~~Ll~Hp 252 (808)
T KOG0597|consen 239 PAQRLTWTDLLGHP 252 (808)
T ss_pred hhhcccHHHHhcCh
Confidence 99999999999874
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=313.27 Aligned_cols=240 Identities=23% Similarity=0.303 Sum_probs=195.6
Q ss_pred cCCCCeeecccCceeEEEEEeCCCCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCC
Q 008785 270 FSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 349 (553)
Q Consensus 270 ~~~~~~~iG~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 349 (553)
|.... .||+|+||.||++.+.++..+|+|.++... ...+++.+|+.++++++||||+++++++.+.+..++||||+++
T Consensus 6 ~~~~~-~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~ 83 (256)
T cd05114 6 LTFMK-ELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMEN 83 (256)
T ss_pred cEEee-EecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCC
Confidence 33433 459999999999999888899999987543 3356789999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccc
Q 008785 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE 429 (553)
Q Consensus 350 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 429 (553)
|+|.+++... ...+++..+..++.|++.||+|||++ +++||||||+||++++++.+||+|||.++.........
T Consensus 84 ~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05114 84 GCLLNYLRQR---QGKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS 157 (256)
T ss_pred CcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence 9999998642 23588999999999999999999999 99999999999999999999999999998654332221
Q ss_pred eeeecCccccccccccccCCCCCcccchHhHHHHHHHHhc-Cc-ccccc---hHHHHHhcCCH-----HHHHHHHHHHhh
Q 008785 430 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-VL-CRRWW---TLYTLVHSMSL-----LCAQECLMLFIS 499 (553)
Q Consensus 430 ~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-~~-~~~~~---~l~~~~~~~~~-----~~~~~l~~l~~~ 499 (553)
.. ...++..|+|||.+.+..++.++||||||+++|||++ .. |.... .....+..+.. ..+..+.+++.+
T Consensus 158 ~~-~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~ 236 (256)
T cd05114 158 SS-GAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMTVYEVMYS 236 (256)
T ss_pred cC-CCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHH
Confidence 11 1125668999999988889999999999999999997 33 33222 23333333221 345678999999
Q ss_pred ccCCCCCCCCCHHHHHHHH
Q 008785 500 CNNWPSHLSQSKFCNLKLW 518 (553)
Q Consensus 500 Cl~~dP~~RPs~~evl~~l 518 (553)
||+.+|++|||+.++++.+
T Consensus 237 c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 237 CWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred HccCCcccCcCHHHHHHhh
Confidence 9999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=302.81 Aligned_cols=221 Identities=22% Similarity=0.278 Sum_probs=192.6
Q ss_pred eecccCceeEEEEEeC-CCCEEEEEEeccCCh---hhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCC
Q 008785 276 LLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF---QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP 351 (553)
Q Consensus 276 ~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gs 351 (553)
.+|.|+||+|...+.+ +|..+|+|++++... ...+...+|..+|+.+.||.++++++.+.+.+.+|+||||++||.
T Consensus 51 tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvmeyv~GGE 130 (355)
T KOG0616|consen 51 TLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEYVPGGE 130 (355)
T ss_pred eeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEeccCCcc
Confidence 4599999999999965 488999999987643 334567889999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCccccccee
Q 008785 352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT 431 (553)
Q Consensus 352 L~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~ 431 (553)
|..+|+. .+.+++..++.++.||+.||+|||+. +|++|||||+|||+|.+|.+||+|||.|+..... +
T Consensus 131 lFS~Lrk----~~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r-----T 198 (355)
T KOG0616|consen 131 LFSYLRK----SGRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR-----T 198 (355)
T ss_pred HHHHHHh----cCCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEecCc-----E
Confidence 9999975 34699999999999999999999999 9999999999999999999999999999876532 4
Q ss_pred eecCccccccccccccCCCCCcccchHhHHHHHHHHhcCc-c---cccchHHHHHhcCCH----HHHHHHHHHHhhccCC
Q 008785 432 VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVL-C---RRWWTLYTLVHSMSL----LCAQECLMLFISCNNW 503 (553)
Q Consensus 432 ~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~-~---~~~~~l~~~~~~~~~----~~~~~l~~l~~~Cl~~ 503 (553)
.+.+|||.|+|||.+...+|+.++|.|||||++|||+... | .+...+++.+-++++ .....+.+|+...++.
T Consensus 199 ~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~~fs~~~kdLl~~LL~v 278 (355)
T KOG0616|consen 199 WTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPSYFSSDAKDLLKKLLQV 278 (355)
T ss_pred EEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCcccCHHHHHHHHHHHhh
Confidence 4566999999999999999999999999999999999633 2 233445556667776 5677888999999999
Q ss_pred CCCCC
Q 008785 504 PSHLS 508 (553)
Q Consensus 504 dP~~R 508 (553)
|-..|
T Consensus 279 D~t~R 283 (355)
T KOG0616|consen 279 DLTKR 283 (355)
T ss_pred hhHhh
Confidence 98888
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=325.28 Aligned_cols=232 Identities=22% Similarity=0.209 Sum_probs=191.2
Q ss_pred ecccCceeEEEEEeC-CCCEEEEEEeccC---ChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCCH
Q 008785 277 LGDSKTGGTYSGILP-DGSRVAVKRLKRS---SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352 (553)
Q Consensus 277 iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL 352 (553)
||+|+||.||++... +++.||+|.++.. .......+.+|+.++.+++||||+++++++.+.+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 599999999999975 4889999999753 233456778999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccceee
Q 008785 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV 432 (553)
Q Consensus 353 ~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~ 432 (553)
.+++.. ...+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++........ ..
T Consensus 81 ~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~--~~ 151 (312)
T cd05585 81 FHHLQR----EGRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDK--TN 151 (312)
T ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCc--cc
Confidence 999864 24589999999999999999999999 9999999999999999999999999999754322211 12
Q ss_pred ecCccccccccccccCCCCCcccchHhHHHHHHHHhcCc-ccccch---HHHHHhcCCH----HHHHHHHHHHhhccCCC
Q 008785 433 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVL-CRRWWT---LYTLVHSMSL----LCAQECLMLFISCNNWP 504 (553)
Q Consensus 433 ~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~-~~~~~~---l~~~~~~~~~----~~~~~l~~l~~~Cl~~d 504 (553)
...||+.|+|||++.+..++.++|||||||++|||++.. |....+ +...+..+.. ..+..+.+++.+||+.|
T Consensus 152 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 231 (312)
T cd05585 152 TFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRD 231 (312)
T ss_pred cccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHcCCC
Confidence 223899999999999999999999999999999999833 332222 2222222222 45678899999999999
Q ss_pred CCCCC---CHHHHHHH
Q 008785 505 SHLSQ---SKFCNLKL 517 (553)
Q Consensus 505 P~~RP---s~~evl~~ 517 (553)
|++|| ++.|++++
T Consensus 232 p~~R~~~~~~~e~l~h 247 (312)
T cd05585 232 PTRRLGYNGAQEIKNH 247 (312)
T ss_pred HHHcCCCCCHHHHHcC
Confidence 99997 46787776
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=364.54 Aligned_cols=242 Identities=24% Similarity=0.369 Sum_probs=190.7
Q ss_pred hhcccCCCCeeecccCceeEEEEEe-CCCCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEE
Q 008785 266 ITKNFSEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVY 344 (553)
Q Consensus 266 ~~~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 344 (553)
+...+.+.+ +||+|+||.||+|.. .+|..||||+++..... ...|++.+++++|||||+++|++.+.+..++||
T Consensus 688 ~~~~~~~~~-~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~ 762 (968)
T PLN00113 688 ILSSLKEEN-VISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIH 762 (968)
T ss_pred HHhhCCccc-EEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEE
Confidence 334555544 559999999999996 47899999998754322 234688899999999999999999999999999
Q ss_pred EccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCc
Q 008785 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW 424 (553)
Q Consensus 345 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~ 424 (553)
||+++|+|.++++. ++|..+..++.||+.||+|||+.+.++|+||||||+||+++.++.+++. ||.......
T Consensus 763 Ey~~~g~L~~~l~~-------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~ 834 (968)
T PLN00113 763 EYIEGKNLSEVLRN-------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT 834 (968)
T ss_pred eCCCCCcHHHHHhc-------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc
Confidence 99999999999953 7899999999999999999996666699999999999999999888875 665543321
Q ss_pred ccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcCccccc------chHHHH----Hhc--------C-
Q 008785 425 EVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVLCRRW------WTLYTL----VHS--------M- 485 (553)
Q Consensus 425 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~~~~~------~~l~~~----~~~--------~- 485 (553)
.. ...+|+.|+|||++.+..++.++|||||||++|||++.....+ ..+.+. ... .
T Consensus 835 ~~------~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 908 (968)
T PLN00113 835 DT------KCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPS 908 (968)
T ss_pred CC------CccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCcc
Confidence 11 1127899999999999999999999999999999998332211 112210 000 0
Q ss_pred -------CHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHhhcc
Q 008785 486 -------SLLCAQECLMLFISCNNWPSHLSQSKFCNLKLWVFAILTIR 526 (553)
Q Consensus 486 -------~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~~~~~~~ 526 (553)
......++.+++.+||+.||++||||.|+++.+........
T Consensus 909 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~~ 956 (968)
T PLN00113 909 IRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSSS 956 (968)
T ss_pred ccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcccc
Confidence 01455678899999999999999999999999877655443
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=317.55 Aligned_cols=246 Identities=26% Similarity=0.363 Sum_probs=198.3
Q ss_pred cCCCCeeecccCceeEEEEEeCC------CCEEEEEEeccCC-hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEE
Q 008785 270 FSEGNRLLGDSKTGGTYSGILPD------GSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYI 342 (553)
Q Consensus 270 ~~~~~~~iG~G~~g~Vy~~~~~~------g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 342 (553)
|..... ||+|+||.||+|.... ...||+|.++... .....++.+|+.++++++||||+++++++.+.+..++
T Consensus 7 ~~~~~~-lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 85 (283)
T cd05048 7 VRFLEE-LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCM 85 (283)
T ss_pred cchhhc-ccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEE
Confidence 333344 4999999999998643 2579999987543 3345678999999999999999999999999999999
Q ss_pred EEEccCCCCHHHHhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCC
Q 008785 343 VYEFVVNGPLDRWLHHIPR------------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG 410 (553)
Q Consensus 343 V~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~ 410 (553)
+|||+++|+|.+++..... ....+++..+..++.|++.||.|||++ +++||||||+||++++++.
T Consensus 86 ~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05048 86 LFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLT 162 (283)
T ss_pred EEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCCc
Confidence 9999999999999965311 114588899999999999999999999 9999999999999999999
Q ss_pred eEEeeccccccCCcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhc-C-ccc---ccchHHHHHhcC
Q 008785 411 AHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-V-LCR---RWWTLYTLVHSM 485 (553)
Q Consensus 411 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-~-~~~---~~~~l~~~~~~~ 485 (553)
++|+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ . .|. ...++...+..+
T Consensus 163 ~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~~~ 242 (283)
T cd05048 163 VKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSR 242 (283)
T ss_pred EEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence 99999999976543322111122226788999999988899999999999999999996 2 232 223444444444
Q ss_pred CH-----HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 008785 486 SL-----LCAQECLMLFISCNNWPSHLSQSKFCNLKLWV 519 (553)
Q Consensus 486 ~~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~ 519 (553)
.. ..+.++.+++.+||+.||++||++.||+++|.
T Consensus 243 ~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~ 281 (283)
T cd05048 243 QLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLR 281 (283)
T ss_pred CcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHh
Confidence 33 56788999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=332.17 Aligned_cols=250 Identities=26% Similarity=0.332 Sum_probs=196.2
Q ss_pred ccCCCCeeecccCceeEEEEEeC------CCCEEEEEEeccCC-hhhHHHHHHHHHHhhcc-CCCceeeEeeEEeeCCce
Q 008785 269 NFSEGNRLLGDSKTGGTYSGILP------DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDR 340 (553)
Q Consensus 269 ~~~~~~~~iG~G~~g~Vy~~~~~------~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~ 340 (553)
+|...+ .||+|+||.||++... ++..||||.++... ......+.+|+.+++.+ +||||+++++++...+..
T Consensus 39 ~~~~~~-~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~ 117 (374)
T cd05106 39 NLQFGK-TLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPV 117 (374)
T ss_pred Hceehh-eecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCe
Confidence 444444 4599999999998742 24589999997643 33456788999999999 899999999999999999
Q ss_pred EEEEEccCCCCHHHHhccCCC-----------------------------------------------------------
Q 008785 341 YIVYEFVVNGPLDRWLHHIPR----------------------------------------------------------- 361 (553)
Q Consensus 341 ~lV~E~~~~gsL~~~l~~~~~----------------------------------------------------------- 361 (553)
++||||+++|+|.+++.....
T Consensus 118 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (374)
T cd05106 118 LVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDS 197 (374)
T ss_pred EEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccc
Confidence 999999999999999854210
Q ss_pred -------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccceeeec
Q 008785 362 -------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA 434 (553)
Q Consensus 362 -------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 434 (553)
....+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++..............
T Consensus 198 ~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~ 274 (374)
T cd05106 198 KDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNA 274 (374)
T ss_pred cchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCC
Confidence 113478889999999999999999999 9999999999999999999999999999765433221111122
Q ss_pred CccccccccccccCCCCCcccchHhHHHHHHHHhc-Cc-ccccc----hHHHHHhcCCH-----HHHHHHHHHHhhccCC
Q 008785 435 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-VL-CRRWW----TLYTLVHSMSL-----LCAQECLMLFISCNNW 503 (553)
Q Consensus 435 ~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-~~-~~~~~----~l~~~~~~~~~-----~~~~~l~~l~~~Cl~~ 503 (553)
.+++.|+|||++.+..++.++||||||+++|||++ .. |.... .+...+..+.. ..+..+.+++.+||+.
T Consensus 275 ~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 354 (374)
T cd05106 275 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKMCWNL 354 (374)
T ss_pred CCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHHHHHHcCC
Confidence 25678999999998899999999999999999986 32 22221 12223322211 3467899999999999
Q ss_pred CCCCCCCHHHHHHHHHHHH
Q 008785 504 PSHLSQSKFCNLKLWVFAI 522 (553)
Q Consensus 504 dP~~RPs~~evl~~l~~~~ 522 (553)
||++|||+.++++.+...+
T Consensus 355 dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 355 EPTERPTFSQISQLIQRQL 373 (374)
T ss_pred ChhhCcCHHHHHHHHHHHh
Confidence 9999999999999886643
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=340.85 Aligned_cols=241 Identities=18% Similarity=0.155 Sum_probs=198.2
Q ss_pred CeeecccCceeEEEEEeC-C-CCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCC
Q 008785 274 NRLLGDSKTGGTYSGILP-D-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP 351 (553)
Q Consensus 274 ~~~iG~G~~g~Vy~~~~~-~-g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gs 351 (553)
.++||+|++|.||++... + ++.||+|.+..........+.+|+.+++.++||||+++++++...+..+|||||+++|+
T Consensus 72 ~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~gg~ 151 (478)
T PTZ00267 72 TTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGD 151 (478)
T ss_pred EEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCCCCC
Confidence 456699999999999854 3 67899998876655556678889999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCccccccee
Q 008785 352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT 431 (553)
Q Consensus 352 L~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~ 431 (553)
|.+++.........+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++...........
T Consensus 152 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~~ 228 (478)
T PTZ00267 152 LNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVA 228 (478)
T ss_pred HHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCccccccc
Confidence 9998865333445688999999999999999999999 9999999999999999999999999999876543222222
Q ss_pred eecCccccccccccccCCCCCcccchHhHHHHHHHHhcC-cccccch---HHHHHhcCCH-----HHHHHHHHHHhhccC
Q 008785 432 VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLV-LCRRWWT---LYTLVHSMSL-----LCAQECLMLFISCNN 502 (553)
Q Consensus 432 ~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~-~~~~~~~---l~~~~~~~~~-----~~~~~l~~l~~~Cl~ 502 (553)
....||+.|+|||++.+..++.++|||||||++|||++. .|..... +...+..+.. ..+..+.+++.+||+
T Consensus 229 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~ 308 (478)
T PTZ00267 229 SSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMKALLDPLLS 308 (478)
T ss_pred cccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCccCCHHHHHHHHHHhc
Confidence 233489999999999999999999999999999999983 3333222 2222222222 456789999999999
Q ss_pred CCCCCCCCHHHHHHH
Q 008785 503 WPSHLSQSKFCNLKL 517 (553)
Q Consensus 503 ~dP~~RPs~~evl~~ 517 (553)
.||++|||+.+++++
T Consensus 309 ~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 309 KNPALRPTTQQLLHT 323 (478)
T ss_pred cChhhCcCHHHHHhC
Confidence 999999999999865
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=323.72 Aligned_cols=234 Identities=19% Similarity=0.180 Sum_probs=194.7
Q ss_pred eeecccCceeEEEEEeC-CCCEEEEEEeccCC---hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCC
Q 008785 275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 350 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 350 (553)
+.||+|+||.||++... +|+.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||||+++|
T Consensus 7 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 86 (291)
T cd05612 7 KTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGG 86 (291)
T ss_pred eeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeCCCCC
Confidence 34599999999999975 58999999997542 234566889999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccce
Q 008785 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER 430 (553)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 430 (553)
+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++......
T Consensus 87 ~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~---- 155 (291)
T cd05612 87 ELFSYLRN----SGRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT---- 155 (291)
T ss_pred CHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccCCc----
Confidence 99999964 24588999999999999999999999 99999999999999999999999999997654321
Q ss_pred eeecCccccccccccccCCCCCcccchHhHHHHHHHHhcC-cccccc---hHHHHHhcCCH----HHHHHHHHHHhhccC
Q 008785 431 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLV-LCRRWW---TLYTLVHSMSL----LCAQECLMLFISCNN 502 (553)
Q Consensus 431 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~-~~~~~~---~l~~~~~~~~~----~~~~~l~~l~~~Cl~ 502 (553)
....||+.|+|||++.+..++.++||||||+++|||++. .|.... .+.+.+..+.. ..+..+.+++.+||+
T Consensus 156 -~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~ 234 (291)
T cd05612 156 -WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKDLIKKLLV 234 (291)
T ss_pred -ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCccCCHHHHHHHHHHcC
Confidence 112389999999999988899999999999999999973 333222 23333333333 346678999999999
Q ss_pred CCCCCCCC-----HHHHHHHHHH
Q 008785 503 WPSHLSQS-----KFCNLKLWVF 520 (553)
Q Consensus 503 ~dP~~RPs-----~~evl~~l~~ 520 (553)
.||.+||+ +.|++++-..
T Consensus 235 ~dp~~R~~~~~~~~~~~l~h~~~ 257 (291)
T cd05612 235 VDRTRRLGNMKNGADDVKNHRWF 257 (291)
T ss_pred CCHHHccCCccCCHHHHhcCccc
Confidence 99999995 9999988433
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=326.77 Aligned_cols=233 Identities=22% Similarity=0.215 Sum_probs=192.1
Q ss_pred eecccCceeEEEEEeC-CCCEEEEEEeccCC---hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCC
Q 008785 276 LLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP 351 (553)
Q Consensus 276 ~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gs 351 (553)
+||+|+||.||++... +|+.||+|+++... ......+.+|+.++++++||||+++++++...+..++||||+++|+
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~ 81 (323)
T cd05595 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGE 81 (323)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCCc
Confidence 4699999999999964 58999999997542 2334567889999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCccccccee
Q 008785 352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT 431 (553)
Q Consensus 352 L~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~ 431 (553)
|..++.. ...+++..+..++.||+.||.|||++ +|+||||||+|||+++++.+||+|||+++........ .
T Consensus 82 L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~--~ 152 (323)
T cd05595 82 LFFHLSR----ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--M 152 (323)
T ss_pred HHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCc--c
Confidence 9988864 24589999999999999999999999 9999999999999999999999999998753222111 1
Q ss_pred eecCccccccccccccCCCCCcccchHhHHHHHHHHhcC-cccccc---hHHHHHhcCCH----HHHHHHHHHHhhccCC
Q 008785 432 VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLV-LCRRWW---TLYTLVHSMSL----LCAQECLMLFISCNNW 503 (553)
Q Consensus 432 ~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~-~~~~~~---~l~~~~~~~~~----~~~~~l~~l~~~Cl~~ 503 (553)
....||+.|+|||++.+..++.++|||||||++|||++. .|.... .+...+..+.. ..+..+.+++.+||+.
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~ 232 (323)
T cd05595 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKK 232 (323)
T ss_pred ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccC
Confidence 122389999999999999999999999999999999973 333222 22222222222 4567889999999999
Q ss_pred CCCCCC-----CHHHHHHH
Q 008785 504 PSHLSQ-----SKFCNLKL 517 (553)
Q Consensus 504 dP~~RP-----s~~evl~~ 517 (553)
||++|| ++.+++++
T Consensus 233 dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 233 DPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred CHHHhCCCCCCCHHHHHcC
Confidence 999998 89999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=327.86 Aligned_cols=235 Identities=21% Similarity=0.275 Sum_probs=201.8
Q ss_pred eecccCceeEEEEEeC-CCCEEEEEEeccCC--hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCc-eEEEEEccCCCC
Q 008785 276 LLGDSKTGGTYSGILP-DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGD-RYIVYEFVVNGP 351 (553)
Q Consensus 276 ~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~-~~lV~E~~~~gs 351 (553)
.+|+|+||.++..+.+ ++..|++|.+.... ...++...+|+.++++++|||||.+++.+..++. .+|||+|++||+
T Consensus 11 ~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~eGg~ 90 (426)
T KOG0589|consen 11 QVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEYCEGGD 90 (426)
T ss_pred hcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEeecCCCC
Confidence 4599999999988754 57899999987543 3344578899999999999999999999999988 899999999999
Q ss_pred HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCccccccee
Q 008785 352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT 431 (553)
Q Consensus 352 L~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~ 431 (553)
|.+.+... .+..++++.+..++.|++.|+.|||++ +|+|||||+.||+++.+..+||+|||+|+..........
T Consensus 91 l~~~i~~~--k~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~~a~- 164 (426)
T KOG0589|consen 91 LAQLIKEQ--KGVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDSLAS- 164 (426)
T ss_pred HHHHHHHH--hhccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCCchhhhh-
Confidence 99999873 356789999999999999999999999 999999999999999999999999999998876652222
Q ss_pred eecCccccccccccccCCCCCcccchHhHHHHHHHHhc----CcccccchHHHHHhcCCH-----HHHHHHHHHHhhccC
Q 008785 432 VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL----VLCRRWWTLYTLVHSMSL-----LCAQECLMLFISCNN 502 (553)
Q Consensus 432 ~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~----~~~~~~~~l~~~~~~~~~-----~~~~~l~~l~~~Cl~ 502 (553)
...||+.||.||.+.+.+|+.|+|||||||++|||++ +...+...++..+..+.. ....++..++..|+.
T Consensus 165 -tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~~ys~el~~lv~~~l~ 243 (426)
T KOG0589|consen 165 -TVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPSMYSSELRSLVKSMLR 243 (426)
T ss_pred -eecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCccccHHHHHHHHHHhh
Confidence 2339999999999999999999999999999999997 333333444444444443 778889999999999
Q ss_pred CCCCCCCCHHHHHHH
Q 008785 503 WPSHLSQSKFCNLKL 517 (553)
Q Consensus 503 ~dP~~RPs~~evl~~ 517 (553)
.+|..||++.++|.+
T Consensus 244 ~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 244 KNPEHRPSALELLRR 258 (426)
T ss_pred cCCccCCCHHHHhhC
Confidence 999999999999987
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=325.98 Aligned_cols=233 Identities=21% Similarity=0.204 Sum_probs=192.7
Q ss_pred eecccCceeEEEEEeC-CCCEEEEEEeccCC---hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCC
Q 008785 276 LLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP 351 (553)
Q Consensus 276 ~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gs 351 (553)
+||+|+||.||++... +|+.||+|+++... ......+.+|+.+++.++||||+++++++...+..++||||+++|+
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~ 81 (328)
T cd05593 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGE 81 (328)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCC
Confidence 4699999999999864 58999999997542 2334678899999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCccccccee
Q 008785 352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT 431 (553)
Q Consensus 352 L~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~ 431 (553)
|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++........ .
T Consensus 82 L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~--~ 152 (328)
T cd05593 82 LFFHLSR----ERVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAAT--M 152 (328)
T ss_pred HHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCcccc--c
Confidence 9988854 24589999999999999999999999 9999999999999999999999999998754322111 1
Q ss_pred eecCccccccccccccCCCCCcccchHhHHHHHHHHhcC-cccccch---HHHHHhcCCH----HHHHHHHHHHhhccCC
Q 008785 432 VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLV-LCRRWWT---LYTLVHSMSL----LCAQECLMLFISCNNW 503 (553)
Q Consensus 432 ~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~-~~~~~~~---l~~~~~~~~~----~~~~~l~~l~~~Cl~~ 503 (553)
....||+.|+|||++.+..++.++|||||||++|||++. .|..... +...+..+.. ..+..+.+++.+||+.
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~ 232 (328)
T cd05593 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLLIK 232 (328)
T ss_pred ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCCCCCCHHHHHHHHHHcCC
Confidence 123389999999999988999999999999999999983 3332222 2223322222 4567789999999999
Q ss_pred CCCCCC-----CHHHHHHH
Q 008785 504 PSHLSQ-----SKFCNLKL 517 (553)
Q Consensus 504 dP~~RP-----s~~evl~~ 517 (553)
||++|| ++.|++++
T Consensus 233 dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 233 DPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CHHHcCCCCCCCHHHHhcC
Confidence 999997 89999976
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=323.76 Aligned_cols=247 Identities=19% Similarity=0.245 Sum_probs=197.4
Q ss_pred ccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccC-ChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEc
Q 008785 269 NFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF 346 (553)
Q Consensus 269 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 346 (553)
+|..... ||+|+||.||++... +|..||+|.+... .....+.+.+|++++++++||||+++++++...+..++||||
T Consensus 6 ~y~~~~~-lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 84 (331)
T cd06649 6 DFERISE-LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 84 (331)
T ss_pred cceEEEe-ecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeec
Confidence 4444444 599999999999975 5889999998764 233456799999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCccc
Q 008785 347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV 426 (553)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 426 (553)
+++|+|.+++.. ...+++..+..++.|++.||.|||+. .+|+||||||+|||+++++.+||+|||++.......
T Consensus 85 ~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 158 (331)
T cd06649 85 MDGGSLDQVLKE----AKRIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 158 (331)
T ss_pred CCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhc--CCEEcCCCChhhEEEcCCCcEEEccCcccccccccc
Confidence 999999999964 23588999999999999999999985 159999999999999999999999999987654322
Q ss_pred ccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcC-cccccc---hHHHHHh-------------------
Q 008785 427 MQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLV-LCRRWW---TLYTLVH------------------- 483 (553)
Q Consensus 427 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~-~~~~~~---~l~~~~~------------------- 483 (553)
. ....|++.|+|||++.+..++.++||||||+++|||++. .|.... .+...+.
T Consensus 159 ~----~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (331)
T cd06649 159 A----NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPR 234 (331)
T ss_pred c----ccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccc
Confidence 1 112389999999999988999999999999999999973 222111 1111000
Q ss_pred ---------------------------cCC------HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHhhcc
Q 008785 484 ---------------------------SMS------LLCAQECLMLFISCNNWPSHLSQSKFCNLKLWVFAILTIR 526 (553)
Q Consensus 484 ---------------------------~~~------~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~~~~~~~ 526 (553)
... ...+.++.+++.+||+.||++|||+.|++++....-.+..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~~~ 310 (331)
T cd06649 235 PPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSEVE 310 (331)
T ss_pred cccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhcccc
Confidence 000 0245678999999999999999999999999655444333
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-39 Score=327.26 Aligned_cols=232 Identities=22% Similarity=0.229 Sum_probs=194.3
Q ss_pred eeecccCceeEEEEEeC-CCCEEEEEEeccCC---hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCC
Q 008785 275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 350 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 350 (553)
+.||+|+||.||++... +|+.||+|.++... ....+.+.+|+.++++++||||+++++++.+.+..++||||+++|
T Consensus 24 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 103 (329)
T PTZ00263 24 ETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGG 103 (329)
T ss_pred EEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcCCCCC
Confidence 45699999999999975 48899999997542 233467889999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccce
Q 008785 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER 430 (553)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 430 (553)
+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 104 ~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~--- 173 (329)
T PTZ00263 104 ELFTHLRK----AGRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTF--- 173 (329)
T ss_pred hHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCCCcc---
Confidence 99999864 24578899999999999999999999 999999999999999999999999999986543221
Q ss_pred eeecCccccccccccccCCCCCcccchHhHHHHHHHHhcC-cccccc---hHHHHHhcCCH----HHHHHHHHHHhhccC
Q 008785 431 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLV-LCRRWW---TLYTLVHSMSL----LCAQECLMLFISCNN 502 (553)
Q Consensus 431 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~-~~~~~~---~l~~~~~~~~~----~~~~~l~~l~~~Cl~ 502 (553)
...||+.|+|||++.+..++.++|||||||++|||++. .|.... ...+.+..+.. ..+..+.+++.+||+
T Consensus 174 --~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~ 251 (329)
T PTZ00263 174 --TLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRARDLVKGLLQ 251 (329)
T ss_pred --eecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCCCCCCHHHHHHHHHHhh
Confidence 22389999999999999999999999999999999983 333222 23334444443 355678999999999
Q ss_pred CCCCCCCC-----HHHHHHHH
Q 008785 503 WPSHLSQS-----KFCNLKLW 518 (553)
Q Consensus 503 ~dP~~RPs-----~~evl~~l 518 (553)
.||.+||+ +.+++++-
T Consensus 252 ~dP~~R~~~~~~~~~~ll~hp 272 (329)
T PTZ00263 252 TDHTKRLGTLKGGVADVKNHP 272 (329)
T ss_pred cCHHHcCCCCCCCHHHHhcCC
Confidence 99999997 78888773
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=315.24 Aligned_cols=249 Identities=24% Similarity=0.311 Sum_probs=200.0
Q ss_pred cCCCCeeecccCceeEEEEEeC------CCCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEE
Q 008785 270 FSEGNRLLGDSKTGGTYSGILP------DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIV 343 (553)
Q Consensus 270 ~~~~~~~iG~G~~g~Vy~~~~~------~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 343 (553)
|...+ .||+|+||.||++... ++..+|+|.+........+.+.+|+.++++++||||+++++++...+..++|
T Consensus 7 ~~~~~-~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (288)
T cd05093 7 IVLKR-ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMV 85 (288)
T ss_pred eeecc-ccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 33334 4599999999999842 3457999999876666677899999999999999999999999999999999
Q ss_pred EEccCCCCHHHHhccCC---------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEe
Q 008785 344 YEFVVNGPLDRWLHHIP---------RGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLM 414 (553)
Q Consensus 344 ~E~~~~gsL~~~l~~~~---------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~ 414 (553)
|||+++++|.+++.... .....+++..+..++.|++.||+|||++ +++||||||+||++++++.+||+
T Consensus 86 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~kl~ 162 (288)
T cd05093 86 FEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIG 162 (288)
T ss_pred EEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEEec
Confidence 99999999999986432 1223589999999999999999999999 99999999999999999999999
Q ss_pred eccccccCCcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhc-Ccc-ccc---chHHHHHhcCCH--
Q 008785 415 GVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-VLC-RRW---WTLYTLVHSMSL-- 487 (553)
Q Consensus 415 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-~~~-~~~---~~l~~~~~~~~~-- 487 (553)
|||+++...............++..|+|||++.+..++.++||||||+++|||++ ..+ ... ..+...+..+..
T Consensus 163 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~~~~ 242 (288)
T cd05093 163 DFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQ 242 (288)
T ss_pred cCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCcCC
Confidence 9999976543322111111225778999999988889999999999999999997 332 222 223333444432
Q ss_pred ---HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 008785 488 ---LCAQECLMLFISCNNWPSHLSQSKFCNLKLWVFAI 522 (553)
Q Consensus 488 ---~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~~~ 522 (553)
..+..+.+++.+||+.||.+|||+.++++.+....
T Consensus 243 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~ 280 (288)
T cd05093 243 RPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLA 280 (288)
T ss_pred CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 45678999999999999999999999988765544
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=320.84 Aligned_cols=249 Identities=19% Similarity=0.302 Sum_probs=197.1
Q ss_pred ccCCCCeeecccCceeEEEEEeC-CCC----EEEEEEeccCC-hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEE
Q 008785 269 NFSEGNRLLGDSKTGGTYSGILP-DGS----RVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYI 342 (553)
Q Consensus 269 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~----~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 342 (553)
+|...+ .||+|+||.||+|.+. +|+ .||+|.++... ....+++.+|+.+++.++||||++++|++... ..++
T Consensus 8 ~f~~~~-~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 8 EFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hceeee-eeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 344444 4599999999999864 333 48999997543 34567889999999999999999999998764 5789
Q ss_pred EEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccC
Q 008785 343 VYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV 422 (553)
Q Consensus 343 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~ 422 (553)
++||+++|+|.+++.. ....+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++..
T Consensus 86 v~e~~~~g~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~ 159 (316)
T cd05108 86 ITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (316)
T ss_pred eeecCCCCCHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEccccccccc
Confidence 9999999999999975 234588899999999999999999999 9999999999999999999999999999876
Q ss_pred CcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhc--Ccccccc---hHHHHHhcCCH-----HHHHH
Q 008785 423 PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL--VLCRRWW---TLYTLVHSMSL-----LCAQE 492 (553)
Q Consensus 423 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~--~~~~~~~---~l~~~~~~~~~-----~~~~~ 492 (553)
.............++..|+|||++.+..++.++||||||+++|||++ ..|.... .+.+.+..+.. ..+..
T Consensus 160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (316)
T cd05108 160 GADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTID 239 (316)
T ss_pred cCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHH
Confidence 54332222221224678999999999999999999999999999986 2333222 22223333221 34567
Q ss_pred HHHHHhhccCCCCCCCCCHHHHHHHHHHHHhhc
Q 008785 493 CLMLFISCNNWPSHLSQSKFCNLKLWVFAILTI 525 (553)
Q Consensus 493 l~~l~~~Cl~~dP~~RPs~~evl~~l~~~~~~~ 525 (553)
+.+++.+||..+|++|||+.+++..+.....+.
T Consensus 240 ~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 240 VYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 899999999999999999999999877665443
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=315.10 Aligned_cols=240 Identities=23% Similarity=0.325 Sum_probs=196.3
Q ss_pred eecccCceeEEEEEeCC------CCEEEEEEeccCChh-hHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccC
Q 008785 276 LLGDSKTGGTYSGILPD------GSRVAVKRLKRSSFQ-RKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV 348 (553)
Q Consensus 276 ~iG~G~~g~Vy~~~~~~------g~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 348 (553)
.||+|+||.||+|...+ ++.||||.++..... ..+.+.+|++++++++||||+++++++......++||||++
T Consensus 12 ~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 91 (280)
T cd05049 12 ELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYME 91 (280)
T ss_pred hccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeEEEEecCC
Confidence 45999999999998643 478999999865443 45789999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCC----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccc
Q 008785 349 NGPLDRWLHHIP----------RGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGL 418 (553)
Q Consensus 349 ~gsL~~~l~~~~----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgl 418 (553)
+|+|.+++.... .....+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||+
T Consensus 92 ~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~kl~d~g~ 168 (280)
T cd05049 92 HGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLVVKIGDFGM 168 (280)
T ss_pred CCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCeEEECCccc
Confidence 999999997531 1234578899999999999999999999 999999999999999999999999999
Q ss_pred cccCCcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhc-Cc-cc---ccchHHHHHhcCCH-----H
Q 008785 419 SKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-VL-CR---RWWTLYTLVHSMSL-----L 488 (553)
Q Consensus 419 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-~~-~~---~~~~l~~~~~~~~~-----~ 488 (553)
+................+++.|+|||++.+..++.++||||||+++|||++ .. |. ....+.+.+..+.. .
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 248 (280)
T cd05049 169 SRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGRLLQRPRT 248 (280)
T ss_pred ceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCcCCCCCC
Confidence 975433221111111225778999999999999999999999999999996 32 22 22233334444443 4
Q ss_pred HHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008785 489 CAQECLMLFISCNNWPSHLSQSKFCNLKLW 518 (553)
Q Consensus 489 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l 518 (553)
.+..+.+++.+||+.||++||++.|+++.+
T Consensus 249 ~~~~~~~li~~~l~~~p~~Rp~~~eil~~l 278 (280)
T cd05049 249 CPSEVYDIMLGCWKRDPQQRINIKDIHERL 278 (280)
T ss_pred CCHHHHHHHHHHcCCCcccCCCHHHHHHHh
Confidence 567899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=313.75 Aligned_cols=248 Identities=21% Similarity=0.337 Sum_probs=196.1
Q ss_pred hcccCCCCeeecccCceeEEEEEeC------CCCEEEEEEeccCC-hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCc
Q 008785 267 TKNFSEGNRLLGDSKTGGTYSGILP------DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGD 339 (553)
Q Consensus 267 ~~~~~~~~~~iG~G~~g~Vy~~~~~------~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 339 (553)
.++|...++ ||+|+||.||+|... .+..||||++.... .....++.+|+.+++.++||||+++++++.+...
T Consensus 5 ~~~~~~~~~-ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 5 REKITMSRE-LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred HHHceeeee-eccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 345555555 499999999998753 25679999986542 3345678999999999999999999999999999
Q ss_pred eEEEEEccCCCCHHHHhccCCCC------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEE
Q 008785 340 RYIVYEFVVNGPLDRWLHHIPRG------GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHL 413 (553)
Q Consensus 340 ~~lV~E~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl 413 (553)
.++||||+++|+|.+++...... ...+++..+..++.|++.||.|||+. +++||||||+||++++++.++|
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEEE
Confidence 99999999999999998653211 23467888999999999999999999 9999999999999999999999
Q ss_pred eeccccccCCcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhc--Ccccccc---hHHHHHhcCCH-
Q 008785 414 MGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL--VLCRRWW---TLYTLVHSMSL- 487 (553)
Q Consensus 414 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~--~~~~~~~---~l~~~~~~~~~- 487 (553)
+|||+++...............+++.|+|||++.+..++.++||||||+++|||++ ..|.... ...+.+..+..
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~ 240 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLL 240 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC
Confidence 99999876543322211112225778999999998889999999999999999997 2232222 22222222222
Q ss_pred ----HHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008785 488 ----LCAQECLMLFISCNNWPSHLSQSKFCNLKLW 518 (553)
Q Consensus 488 ----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l 518 (553)
..+..+.+++.+||+.||++|||+.|+++.+
T Consensus 241 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l 275 (277)
T cd05062 241 DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 275 (277)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHh
Confidence 4566789999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=310.04 Aligned_cols=239 Identities=21% Similarity=0.315 Sum_probs=188.0
Q ss_pred eeecccCceeEEEEEeCCCCEEEEEEeccCChhhHHHHHHHHHHhhc--cCCCceeeEeeEEeeCC----ceEEEEEccC
Q 008785 275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFAR--LHHPNLVAVKGCCYDHG----DRYIVYEFVV 348 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~--l~HpnIv~l~~~~~~~~----~~~lV~E~~~ 348 (553)
+.||+|.||.||+|.+ .|+.||||++... +++.+.+|.++... |+|+||+.+++.-..+. .+|||++|.+
T Consensus 217 e~IGkGRyGEVwrG~w-rGe~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYHe 292 (513)
T KOG2052|consen 217 EIIGKGRFGEVWRGRW-RGEDVAVKIFSSR---DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYHE 292 (513)
T ss_pred EEecCccccceeeccc-cCCceEEEEeccc---chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeeccc
Confidence 5579999999999999 7899999999754 45567788888876 49999999999866543 4699999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-----CCCCceecCCCCCcEEecCCCCeEEeeccccccCC
Q 008785 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDK-----VKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVP 423 (553)
Q Consensus 349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~-----~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~ 423 (553)
.|||+|||.. ..++....++++..+|.||+|||.. .+|.|.|||||+.|||+..++.+.|+|+|+|-...
T Consensus 293 ~GSL~DyL~r-----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~ 367 (513)
T KOG2052|consen 293 HGSLYDYLNR-----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD 367 (513)
T ss_pred CCcHHHHHhh-----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEec
Confidence 9999999964 5689999999999999999999944 48899999999999999999999999999997665
Q ss_pred ccccc--ceeeecCccccccccccccCCC----C--CcccchHhHHHHHHHHhc-----------Ccc-----cccchHH
Q 008785 424 WEVMQ--ERTVMAGGTYGYLAPEFVYRNE----L--TTKSDVYSFGVLLLEIRL-----------VLC-----RRWWTLY 479 (553)
Q Consensus 424 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~----~--t~ksDVwSlGvil~ell~-----------~~~-----~~~~~l~ 479 (553)
..... .......||.+|||||++...- + -..+||||||.++||++- ..| +.+.++.
T Consensus 368 ~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~e 447 (513)
T KOG2052|consen 368 SDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFE 447 (513)
T ss_pred ccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHH
Confidence 44221 1222334999999999986421 1 235899999999999982 111 1122222
Q ss_pred H---HHhcCCH-----------HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 008785 480 T---LVHSMSL-----------LCAQECLMLFISCNNWPSHLSQSKFCNLKLWVFAI 522 (553)
Q Consensus 480 ~---~~~~~~~-----------~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~~~ 522 (553)
+ .+.-.++ .....+.++++.||..||+-|-|+--|-+.+-...
T Consensus 448 eMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~ 504 (513)
T KOG2052|consen 448 EMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLS 504 (513)
T ss_pred HHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHh
Confidence 2 1111111 77788999999999999999999999888775544
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-38 Score=309.65 Aligned_cols=246 Identities=21% Similarity=0.291 Sum_probs=198.0
Q ss_pred ccCCCCeeecccCceeEEEEEeCC----CCEEEEEEeccCC-hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEE
Q 008785 269 NFSEGNRLLGDSKTGGTYSGILPD----GSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIV 343 (553)
Q Consensus 269 ~~~~~~~~iG~G~~g~Vy~~~~~~----g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 343 (553)
+|.... .||+|+||.||+|.+.. ...||||.++... .....++.+|+.++++++||||+++++++.+.+..+++
T Consensus 5 ~~~~~~-~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 5 YVTIEK-VIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred Hceeee-EecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 454444 45999999999999743 4589999987543 33456789999999999999999999999999999999
Q ss_pred EEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCC
Q 008785 344 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVP 423 (553)
Q Consensus 344 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~ 423 (553)
|||+++++|.+++.. ....+++..+..++.|++.||+|||++ +|+||||||+||++++++.++|+|||++....
T Consensus 84 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 157 (266)
T cd05033 84 TEYMENGSLDKFLRE---NDGKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRLE 157 (266)
T ss_pred EEcCCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhccc
Confidence 999999999999864 223689999999999999999999999 99999999999999999999999999998765
Q ss_pred cccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhc-Cc-cccc---chHHHHHhcCCH-----HHHHHH
Q 008785 424 WEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-VL-CRRW---WTLYTLVHSMSL-----LCAQEC 493 (553)
Q Consensus 424 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-~~-~~~~---~~l~~~~~~~~~-----~~~~~l 493 (553)
............+++.|+|||.+.+..++.++||||||+++|||++ .. |... ..+.+.+..+.. ..+..+
T Consensus 158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 237 (266)
T cd05033 158 DSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPMDCPSAL 237 (266)
T ss_pred ccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHH
Confidence 2222111112225678999999998899999999999999999986 22 2211 222333332211 456789
Q ss_pred HHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 008785 494 LMLFISCNNWPSHLSQSKFCNLKLWVFA 521 (553)
Q Consensus 494 ~~l~~~Cl~~dP~~RPs~~evl~~l~~~ 521 (553)
.+++.+|++.+|++||++.|+++.+...
T Consensus 238 ~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 238 YQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred HHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 9999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=327.99 Aligned_cols=245 Identities=24% Similarity=0.350 Sum_probs=209.0
Q ss_pred CCeeecccCceeEEEEEeCC---CC--EEEEEEeccC-ChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEc
Q 008785 273 GNRLLGDSKTGGTYSGILPD---GS--RVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF 346 (553)
Q Consensus 273 ~~~~iG~G~~g~Vy~~~~~~---g~--~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 346 (553)
.+++||.|-||.||+|++.+ |+ .||||..+.+ ...+.+.|++|+.+|++++|||||+++|+|.+. ..|||||+
T Consensus 393 l~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~WivmEL 471 (974)
T KOG4257|consen 393 LKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIVMEL 471 (974)
T ss_pred HHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEEEec
Confidence 35678999999999999644 33 5999999874 456678899999999999999999999998764 68999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCccc
Q 008785 347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV 426 (553)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 426 (553)
++-|.|..||+. +...++......++.||+.||+|||+. ++|||||..+|||+....-+||+|||+++.+..+.
T Consensus 472 ~~~GELr~yLq~---nk~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~ 545 (974)
T KOG4257|consen 472 APLGELREYLQQ---NKDSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDA 545 (974)
T ss_pred ccchhHHHHHHh---ccccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhhhccccc
Confidence 999999999985 456789999999999999999999999 99999999999999999999999999999988776
Q ss_pred ccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhc--Cccccc---chHHHHHhcCCH-----HHHHHHHHH
Q 008785 427 MQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL--VLCRRW---WTLYTLVHSMSL-----LCAQECLML 496 (553)
Q Consensus 427 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~--~~~~~~---~~l~~~~~~~~~-----~~~~~l~~l 496 (553)
........ -+..|||||.+.-.++|.+||||-|||++||++. ..|+.+ .+....+++|.. .+++.+..|
T Consensus 546 yYkaS~~k-LPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P~nCPp~LYsl 624 (974)
T KOG4257|consen 546 YYKASRGK-LPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCPPNCPPALYSL 624 (974)
T ss_pred hhhccccc-cceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCCCCCChHHHHH
Confidence 55544322 5678999999999999999999999999999996 334333 233335666654 889999999
Q ss_pred HhhccCCCCCCCCCHHHHHHHHHHHHhhc
Q 008785 497 FISCNNWPSHLSQSKFCNLKLWVFAILTI 525 (553)
Q Consensus 497 ~~~Cl~~dP~~RPs~~evl~~l~~~~~~~ 525 (553)
+.+||.++|.+||.+.|+...+.....++
T Consensus 625 mskcWayeP~kRPrftei~~~lsdv~qee 653 (974)
T KOG4257|consen 625 MSKCWAYEPSKRPRFTEIKAILSDVLQEE 653 (974)
T ss_pred HHHHhccCcccCCcHHHHHHHHHHHHHHh
Confidence 99999999999999999988877766533
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=310.41 Aligned_cols=242 Identities=24% Similarity=0.332 Sum_probs=197.2
Q ss_pred cCCCCeeecccCceeEEEEEeCCCCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCC
Q 008785 270 FSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 349 (553)
Q Consensus 270 ~~~~~~~iG~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 349 (553)
|....+ ||+|++|.||+|...++..||+|.+.... ...+.+.+|+.++++++||||+++++.+.+.+..+++|||+++
T Consensus 8 ~~~~~~-lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 85 (261)
T cd05072 8 IKLVKK-LGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAK 85 (261)
T ss_pred eEEeee-cCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCC
Confidence 434444 49999999999998888899999987643 3457889999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccc
Q 008785 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE 429 (553)
Q Consensus 350 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 429 (553)
|+|.+++... ....+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||++..........
T Consensus 86 ~~L~~~l~~~--~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (261)
T cd05072 86 GSLLDFLKSD--EGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTA 160 (261)
T ss_pred CcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCCceec
Confidence 9999999752 334588899999999999999999999 99999999999999999999999999998765432211
Q ss_pred eeeecCccccccccccccCCCCCcccchHhHHHHHHHHhc-Cc-cccc---chHHHHHhcCCH-----HHHHHHHHHHhh
Q 008785 430 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-VL-CRRW---WTLYTLVHSMSL-----LCAQECLMLFIS 499 (553)
Q Consensus 430 ~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-~~-~~~~---~~l~~~~~~~~~-----~~~~~l~~l~~~ 499 (553)
.. ...++..|+|||++....++.++||||||+++|||++ .. |... ......+..+.. ..+..+.+++.+
T Consensus 161 ~~-~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 239 (261)
T cd05072 161 RE-GAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDELYDIMKT 239 (261)
T ss_pred cC-CCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHH
Confidence 11 1125678999999988889999999999999999997 32 2222 222223322211 456789999999
Q ss_pred ccCCCCCCCCCHHHHHHHHH
Q 008785 500 CNNWPSHLSQSKFCNLKLWV 519 (553)
Q Consensus 500 Cl~~dP~~RPs~~evl~~l~ 519 (553)
|++.+|++|||+.++.+.+.
T Consensus 240 ~l~~~p~~Rp~~~~i~~~l~ 259 (261)
T cd05072 240 CWKEKAEERPTFDYLQSVLD 259 (261)
T ss_pred HccCCcccCcCHHHHHHHHh
Confidence 99999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=307.85 Aligned_cols=237 Identities=26% Similarity=0.355 Sum_probs=191.5
Q ss_pred eecccCceeEEEEEeC-CCCEEEEEEeccC-ChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCCHH
Q 008785 276 LLGDSKTGGTYSGILP-DGSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 353 (553)
Q Consensus 276 ~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~ 353 (553)
.||+|+||.||+|... +++.||+|.+... .......+.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 81 (252)
T cd05084 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFL 81 (252)
T ss_pred ccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHH
Confidence 3699999999999975 6899999988654 2344577999999999999999999999999999999999999999999
Q ss_pred HHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccceeee
Q 008785 354 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVM 433 (553)
Q Consensus 354 ~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 433 (553)
+++.. ....+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||++..............
T Consensus 82 ~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 155 (252)
T cd05084 82 TFLRT---EGPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM 155 (252)
T ss_pred HHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence 99864 234588999999999999999999999 999999999999999999999999999875443211111111
Q ss_pred cCccccccccccccCCCCCcccchHhHHHHHHHHhc-Ccc-cc---cchHHHHHhcC-CH----HHHHHHHHHHhhccCC
Q 008785 434 AGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-VLC-RR---WWTLYTLVHSM-SL----LCAQECLMLFISCNNW 503 (553)
Q Consensus 434 ~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-~~~-~~---~~~l~~~~~~~-~~----~~~~~l~~l~~~Cl~~ 503 (553)
...+..|+|||.+.++.++.++||||||+++|||++ ..+ .. .......+..+ .. ..+..+.+++.+|++.
T Consensus 156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 235 (252)
T cd05084 156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWEY 235 (252)
T ss_pred CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCcccCCHHHHHHHHHHcCC
Confidence 113457999999988889999999999999999996 222 21 11222222221 11 4567899999999999
Q ss_pred CCCCCCCHHHHHHHH
Q 008785 504 PSHLSQSKFCNLKLW 518 (553)
Q Consensus 504 dP~~RPs~~evl~~l 518 (553)
+|++|||+.++++.|
T Consensus 236 ~p~~Rps~~~~~~~l 250 (252)
T cd05084 236 DPGQRPSFSTVHQEL 250 (252)
T ss_pred ChhhCcCHHHHHHHH
Confidence 999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=310.69 Aligned_cols=243 Identities=27% Similarity=0.400 Sum_probs=197.2
Q ss_pred cCCCCeeecccCceeEEEEEeCC-CCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccC
Q 008785 270 FSEGNRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV 348 (553)
Q Consensus 270 ~~~~~~~iG~G~~g~Vy~~~~~~-g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 348 (553)
|...+ .||+|++|.||+|...+ ++.||+|.++.. .....++.+|++++++++||||+++++++...+..+++|||++
T Consensus 8 ~~~~~-~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (263)
T cd05052 8 ITMKH-KLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT 85 (263)
T ss_pred eEEee-ecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCC
Confidence 33434 45999999999999754 889999998764 3345678999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCccccc
Q 008785 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ 428 (553)
Q Consensus 349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 428 (553)
+++|.+++.. .....+++..++.++.|++.||+|||++ +++||||||+||++++++.+||+|||++.........
T Consensus 86 ~~~L~~~~~~--~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~ 160 (263)
T cd05052 86 YGNLLDYLRE--CNRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 160 (263)
T ss_pred CCcHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence 9999999865 2334689999999999999999999999 9999999999999999999999999999876543221
Q ss_pred ceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhc-C-cccccch---HHHHHhcCC-H----HHHHHHHHHHh
Q 008785 429 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-V-LCRRWWT---LYTLVHSMS-L----LCAQECLMLFI 498 (553)
Q Consensus 429 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-~-~~~~~~~---l~~~~~~~~-~----~~~~~l~~l~~ 498 (553)
... ...++..|+|||.+.+..++.++||||||+++|||++ . .+..... +...+..+. . ..+..+.+++.
T Consensus 161 ~~~-~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 239 (263)
T cd05052 161 AHA-GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPPKVYELMR 239 (263)
T ss_pred ccC-CCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHH
Confidence 111 1114568999999988899999999999999999997 2 2322222 222333221 1 45678999999
Q ss_pred hccCCCCCCCCCHHHHHHHHHH
Q 008785 499 SCNNWPSHLSQSKFCNLKLWVF 520 (553)
Q Consensus 499 ~Cl~~dP~~RPs~~evl~~l~~ 520 (553)
+||+.||++|||+.++++.+..
T Consensus 240 ~cl~~~p~~Rp~~~~l~~~l~~ 261 (263)
T cd05052 240 ACWQWNPSDRPSFAEIHQAFET 261 (263)
T ss_pred HHccCCcccCCCHHHHHHHHHh
Confidence 9999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=309.20 Aligned_cols=235 Identities=25% Similarity=0.343 Sum_probs=193.1
Q ss_pred eecccCceeEEEEEeCCCCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCCHHHH
Q 008785 276 LLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRW 355 (553)
Q Consensus 276 ~iG~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~ 355 (553)
.||+|++|.||.|...++..||+|.++... ...+++.+|+.++++++||||+++++++.+.+..++||||+++|+|.++
T Consensus 11 ~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~ 89 (256)
T cd05113 11 ELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNY 89 (256)
T ss_pred EecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCcHHHH
Confidence 459999999999998777789999987543 3356789999999999999999999999998899999999999999999
Q ss_pred hccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccceeeecC
Q 008785 356 LHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG 435 (553)
Q Consensus 356 l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~ 435 (553)
+.. ....+++..+..++.||+.||+|||+. +++|+||||+||++++++.+||+|||.++.......... ....
T Consensus 90 i~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~-~~~~ 162 (256)
T cd05113 90 LRE---HGKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS-VGSK 162 (256)
T ss_pred HHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCceeec-CCCc
Confidence 864 223689999999999999999999999 999999999999999999999999999876543322111 1112
Q ss_pred ccccccccccccCCCCCcccchHhHHHHHHHHhc-Cc-ccc---cchHHHHHhcCCH-----HHHHHHHHHHhhccCCCC
Q 008785 436 GTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-VL-CRR---WWTLYTLVHSMSL-----LCAQECLMLFISCNNWPS 505 (553)
Q Consensus 436 gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-~~-~~~---~~~l~~~~~~~~~-----~~~~~l~~l~~~Cl~~dP 505 (553)
++..|+|||.+.+..++.++||||||+++|||++ .. |.. ...+...+..+.. ..+..+.+++.+||+.||
T Consensus 163 ~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p 242 (256)
T cd05113 163 FPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKVYAIMYSCWHEKA 242 (256)
T ss_pred cChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCc
Confidence 5678999999988889999999999999999996 32 322 2223333333221 456788999999999999
Q ss_pred CCCCCHHHHHHHH
Q 008785 506 HLSQSKFCNLKLW 518 (553)
Q Consensus 506 ~~RPs~~evl~~l 518 (553)
++||++.++++.+
T Consensus 243 ~~Rp~~~~ll~~~ 255 (256)
T cd05113 243 EERPTFQQLLSSI 255 (256)
T ss_pred ccCCCHHHHHHhh
Confidence 9999999999765
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=324.73 Aligned_cols=233 Identities=22% Similarity=0.210 Sum_probs=191.9
Q ss_pred eecccCceeEEEEEeC-CCCEEEEEEeccCC---hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCC
Q 008785 276 LLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP 351 (553)
Q Consensus 276 ~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gs 351 (553)
+||+|+||.||++... +|+.||+|+++... ......+.+|++++..++||||+++++++...+..++||||+++|+
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~ 81 (325)
T cd05594 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGE 81 (325)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCc
Confidence 4699999999999864 58999999997642 2334567889999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccce
Q 008785 352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD-KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER 430 (553)
Q Consensus 352 L~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 430 (553)
|.+++.. ...+++..+..++.||+.||+|||+ . +|+||||||+|||+++++.+||+|||+++.........
T Consensus 82 L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~- 153 (325)
T cd05594 82 LFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM- 153 (325)
T ss_pred HHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCccc-
Confidence 9998854 2458999999999999999999997 7 99999999999999999999999999987543222111
Q ss_pred eeecCccccccccccccCCCCCcccchHhHHHHHHHHhcC-cccccc---hHHHHHhcCCH----HHHHHHHHHHhhccC
Q 008785 431 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLV-LCRRWW---TLYTLVHSMSL----LCAQECLMLFISCNN 502 (553)
Q Consensus 431 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~-~~~~~~---~l~~~~~~~~~----~~~~~l~~l~~~Cl~ 502 (553)
....||+.|+|||++.+..++.++||||||+++|||++. .|.... .+...+..+.. ..+..+.+++.+||+
T Consensus 154 -~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~ 232 (325)
T cd05594 154 -KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLK 232 (325)
T ss_pred -ccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhh
Confidence 122389999999999988999999999999999999983 333222 23333332222 456778999999999
Q ss_pred CCCCCCC-----CHHHHHHH
Q 008785 503 WPSHLSQ-----SKFCNLKL 517 (553)
Q Consensus 503 ~dP~~RP-----s~~evl~~ 517 (553)
.||++|| ++.+++++
T Consensus 233 ~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 233 KDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred cCHHHhCCCCCCCHHHHhcC
Confidence 9999996 89999976
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=293.72 Aligned_cols=241 Identities=24% Similarity=0.265 Sum_probs=203.0
Q ss_pred ccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCCh---hhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEE
Q 008785 269 NFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF---QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVY 344 (553)
Q Consensus 269 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 344 (553)
+|.. .+.||+|.||.||.|+.+ ++-.||+|++.+... ....++.+|+++-+.|+||||+++|++|.+....||++
T Consensus 23 dfei-gr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLil 101 (281)
T KOG0580|consen 23 DFEI-GRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLIL 101 (281)
T ss_pred hccc-cccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEE
Confidence 4544 445699999999999964 477999999976532 23577899999999999999999999999999999999
Q ss_pred EccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCc
Q 008785 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW 424 (553)
Q Consensus 345 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~ 424 (553)
||.++|+|...|+. .....+++.....++.|+|.||.|+|.+ +++||||||+|+|++.++..|++|||.+-..+.
T Consensus 102 Eya~~gel~k~L~~--~~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~ 176 (281)
T KOG0580|consen 102 EYAPRGELYKDLQE--GRMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 176 (281)
T ss_pred EecCCchHHHHHHh--cccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeecCC
Confidence 99999999999985 3445688889999999999999999999 999999999999999999999999999976542
Q ss_pred ccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcCcc-cccc---hHHHHHhcCCH----HHHHHHHHH
Q 008785 425 EVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVLC-RRWW---TLYTLVHSMSL----LCAQECLML 496 (553)
Q Consensus 425 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~~-~~~~---~l~~~~~~~~~----~~~~~l~~l 496 (553)
. ...+.+||..|.|||...+..++...|+|++|++.||++...| +..+ +.+..+.+-++ ..+....++
T Consensus 177 ~----kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p~~is~~a~dl 252 (281)
T KOG0580|consen 177 N----KRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFPSTISGGAADL 252 (281)
T ss_pred C----CceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCCcccChhHHHH
Confidence 2 2234459999999999999999999999999999999996333 3332 33334444333 677789999
Q ss_pred HhhccCCCCCCCCCHHHHHHHHH
Q 008785 497 FISCNNWPSHLSQSKFCNLKLWV 519 (553)
Q Consensus 497 ~~~Cl~~dP~~RPs~~evl~~l~ 519 (553)
|.+|+..+|.+|.+..|+++++.
T Consensus 253 I~~ll~~~p~~r~~l~~v~~hpw 275 (281)
T KOG0580|consen 253 ISRLLVKNPIERLALTEVMDHPW 275 (281)
T ss_pred HHHHhccCccccccHHHHhhhHH
Confidence 99999999999999999999853
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=314.00 Aligned_cols=239 Identities=18% Similarity=0.191 Sum_probs=193.6
Q ss_pred ecccCceeEEEEEeC-CCCEEEEEEeccCCh---hhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCCH
Q 008785 277 LGDSKTGGTYSGILP-DGSRVAVKRLKRSSF---QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352 (553)
Q Consensus 277 iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL 352 (553)
||+|+||+||++... +|+.||+|.+..... ...+.+..|+.++++++||||+++.+++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 599999999999865 588999999975422 2235678899999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccceee
Q 008785 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV 432 (553)
Q Consensus 353 ~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~ 432 (553)
.+++.........+++..+..++.||+.||+|||+. +|+||||||+||++++++.++|+|||++.......... .
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~--~ 155 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKT--K 155 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccc--c
Confidence 988865334455689999999999999999999999 99999999999999999999999999997654332211 1
Q ss_pred ecCccccccccccccCCCCCcccchHhHHHHHHHHhcC-cccccc-------hHHHHHhcCCH----HHHHHHHHHHhhc
Q 008785 433 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLV-LCRRWW-------TLYTLVHSMSL----LCAQECLMLFISC 500 (553)
Q Consensus 433 ~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~-~~~~~~-------~l~~~~~~~~~----~~~~~l~~l~~~C 500 (553)
...||+.|+|||++.+..++.++||||||+++|||++. .|.... .+...+..+.. ..+..+.+++.+|
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 235 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEAL 235 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHH
Confidence 22389999999999999999999999999999999973 232211 11111111111 4567899999999
Q ss_pred cCCCCCCCC-----CHHHHHHHHHH
Q 008785 501 NNWPSHLSQ-----SKFCNLKLWVF 520 (553)
Q Consensus 501 l~~dP~~RP-----s~~evl~~l~~ 520 (553)
|+.||++|| ++.+++++-..
T Consensus 236 l~~~P~~R~~~~~~~~~~~l~h~~~ 260 (280)
T cd05608 236 LAKDPEKRLGFRDGNCDGLRTHPLF 260 (280)
T ss_pred hcCCHHHhcCCCCCCHHHHhcChhh
Confidence 999999999 78888887433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=337.65 Aligned_cols=249 Identities=20% Similarity=0.184 Sum_probs=199.9
Q ss_pred hhcccCCCCeeecccCceeEEEEEe-CCCCEEEEEEeccC--ChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCC----
Q 008785 266 ITKNFSEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHG---- 338 (553)
Q Consensus 266 ~~~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~---- 338 (553)
..++|.... .||+|+||.||++.. .+|+.||||.+... .......+.+|+..+..++|+||+++++.+...+
T Consensus 30 ~~~rY~i~~-~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 30 QAKKYWISR-VLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred cCCCEEEEE-EEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 344555544 559999999999985 46899999998754 3344567889999999999999999988765432
Q ss_pred ----ceEEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEe
Q 008785 339 ----DRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLM 414 (553)
Q Consensus 339 ----~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~ 414 (553)
..++||||+++|+|.+++.........+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL~ 185 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLG 185 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEEE
Confidence 25899999999999999976444456789999999999999999999999 99999999999999999999999
Q ss_pred eccccccCCcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhc-CcccccchHH---HHHhcCCH---
Q 008785 415 GVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-VLCRRWWTLY---TLVHSMSL--- 487 (553)
Q Consensus 415 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-~~~~~~~~l~---~~~~~~~~--- 487 (553)
|||+++...............||+.|+|||++.+..++.++||||||+++|||++ ..|....... .....+..
T Consensus 186 DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~~~ 265 (496)
T PTZ00283 186 DFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPL 265 (496)
T ss_pred ecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCC
Confidence 9999986554322222223348999999999999999999999999999999998 3343333332 22222222
Q ss_pred --HHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008785 488 --LCAQECLMLFISCNNWPSHLSQSKFCNLKLW 518 (553)
Q Consensus 488 --~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l 518 (553)
..+..+.+++.+||+.||++||++.+++++-
T Consensus 266 ~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p 298 (496)
T PTZ00283 266 PPSISPEMQEIVTALLSSDPKRRPSSSKLLNMP 298 (496)
T ss_pred CCCCCHHHHHHHHHHcccChhhCcCHHHHHhCH
Confidence 5567899999999999999999999999763
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=337.81 Aligned_cols=247 Identities=17% Similarity=0.172 Sum_probs=201.0
Q ss_pred CeeecccCceeEEEEEeCCC-CEEEEEEeccCChhhHHHHHHHHHHhhccC-CCceeeEee-EEeeC------CceEEEE
Q 008785 274 NRLLGDSKTGGTYSGILPDG-SRVAVKRLKRSSFQRKKEFYSEIGRFARLH-HPNLVAVKG-CCYDH------GDRYIVY 344 (553)
Q Consensus 274 ~~~iG~G~~g~Vy~~~~~~g-~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~-~~~~~------~~~~lV~ 344 (553)
.++|.+|||+.||.+....+ ..||+|++-..+....+.+.+|+++|++|. |||||.+++ ..... -+.+|.|
T Consensus 42 ~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~EvllLm 121 (738)
T KOG1989|consen 42 EKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLLM 121 (738)
T ss_pred EEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEeeh
Confidence 56789999999999998776 999999998888888999999999999996 999999999 33221 2468999
Q ss_pred EccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCc
Q 008785 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW 424 (553)
Q Consensus 345 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~ 424 (553)
|||+||.|-+++... ....|++.++++|+.|+++|+++||.. +|+|||||||-+||||..++..||+|||.+.....
T Consensus 122 EyC~gg~Lvd~mn~R--lq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~~ 198 (738)
T KOG1989|consen 122 EYCKGGSLVDFMNTR--LQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSATTKIL 198 (738)
T ss_pred hhccCCcHHHHHHHH--HhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccccccccC
Confidence 999999999999863 334499999999999999999999985 78899999999999999999999999999864332
Q ss_pred ccccc-------eeeecCcccccccccccc---CCCCCcccchHhHHHHHHHHhc-CcccccchHHHHHhcCCH------
Q 008785 425 EVMQE-------RTVMAGGTYGYLAPEFVY---RNELTTKSDVYSFGVLLLEIRL-VLCRRWWTLYTLVHSMSL------ 487 (553)
Q Consensus 425 ~~~~~-------~~~~~~gt~~y~aPE~~~---~~~~t~ksDVwSlGvil~ell~-~~~~~~~~l~~~~~~~~~------ 487 (553)
..... .......|+.|+|||++. +.+.++|+|||||||+||-|+- ..|++...-. .|-.+.+
T Consensus 199 ~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l-aIlng~Y~~P~~p 277 (738)
T KOG1989|consen 199 SPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL-AILNGNYSFPPFP 277 (738)
T ss_pred CCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce-eEEeccccCCCCc
Confidence 22110 011122789999999874 6788999999999999999995 3344333111 2333333
Q ss_pred HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHhh
Q 008785 488 LCAQECLMLFISCNNWPSHLSQSKFCNLKLWVFAILT 524 (553)
Q Consensus 488 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~~~~~ 524 (553)
.....+.+||..||+.||.+||++.||+..+.++...
T Consensus 278 ~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~ 314 (738)
T KOG1989|consen 278 NYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANK 314 (738)
T ss_pred cHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcC
Confidence 7888999999999999999999999999987766543
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=321.42 Aligned_cols=233 Identities=20% Similarity=0.198 Sum_probs=191.0
Q ss_pred eecccCceeEEEEEe----CCCCEEEEEEeccCC----hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEcc
Q 008785 276 LLGDSKTGGTYSGIL----PDGSRVAVKRLKRSS----FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV 347 (553)
Q Consensus 276 ~iG~G~~g~Vy~~~~----~~g~~vAvK~~~~~~----~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 347 (553)
.||+|+||.||++.. .+++.||||+++... ......+.+|+.+++.++||||+++++++..++..|+||||+
T Consensus 3 ~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 82 (323)
T cd05584 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEYL 82 (323)
T ss_pred eeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeCC
Confidence 469999999999985 357899999997532 223456788999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccc
Q 008785 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM 427 (553)
Q Consensus 348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 427 (553)
++|+|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 83 ~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (323)
T cd05584 83 SGGELFMHLER----EGIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT 155 (323)
T ss_pred CCchHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC
Confidence 99999999864 24578888999999999999999999 999999999999999999999999999875432221
Q ss_pred cceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcC-cccccch---HHHHHhcCCH----HHHHHHHHHHhh
Q 008785 428 QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLV-LCRRWWT---LYTLVHSMSL----LCAQECLMLFIS 499 (553)
Q Consensus 428 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~-~~~~~~~---l~~~~~~~~~----~~~~~l~~l~~~ 499 (553)
. .....||+.|+|||++.+..++.++||||||+++|||++. .|....+ ..+.+..+.. ..+..+.+++.+
T Consensus 156 ~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 233 (323)
T cd05584 156 V--THTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLKK 233 (323)
T ss_pred c--ccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 1 1122389999999999988899999999999999999973 3332222 2223333333 456778999999
Q ss_pred ccCCCCCCCC-----CHHHHHHH
Q 008785 500 CNNWPSHLSQ-----SKFCNLKL 517 (553)
Q Consensus 500 Cl~~dP~~RP-----s~~evl~~ 517 (553)
||+.||++|| ++.+++++
T Consensus 234 ~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 234 LLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred HcccCHhHcCCCCCCCHHHHhcC
Confidence 9999999999 89998876
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=307.45 Aligned_cols=235 Identities=23% Similarity=0.320 Sum_probs=192.4
Q ss_pred eecccCceeEEEEEeCCCCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCCHHHH
Q 008785 276 LLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRW 355 (553)
Q Consensus 276 ~iG~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~ 355 (553)
.||+|+||.||++..+++..+|+|.+.... ...+.+.+|+.++++++||||+++++++...+..++||||+++++|.++
T Consensus 11 ~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 89 (256)
T cd05059 11 ELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNY 89 (256)
T ss_pred hhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCCCHHHH
Confidence 459999999999998778899999987543 2345788999999999999999999999999999999999999999999
Q ss_pred hccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccceeeecC
Q 008785 356 LHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG 435 (553)
Q Consensus 356 l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~ 435 (553)
+.. ....+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||+++........... ...
T Consensus 90 l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~-~~~ 162 (256)
T cd05059 90 LRE---RKGKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ-GTK 162 (256)
T ss_pred HHh---cccCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceecccccccccC-CCC
Confidence 864 223689999999999999999999999 9999999999999999999999999999765432211111 111
Q ss_pred ccccccccccccCCCCCcccchHhHHHHHHHHhc-C-ccccc---chHHHHHhcCC-----HHHHHHHHHHHhhccCCCC
Q 008785 436 GTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-V-LCRRW---WTLYTLVHSMS-----LLCAQECLMLFISCNNWPS 505 (553)
Q Consensus 436 gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-~-~~~~~---~~l~~~~~~~~-----~~~~~~l~~l~~~Cl~~dP 505 (553)
++..|+|||.+.+..++.++||||||+++|||++ . .|... ......+..+. ...+..+.+++.+||+.+|
T Consensus 163 ~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p 242 (256)
T cd05059 163 FPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEVYTIMYSCWHEKP 242 (256)
T ss_pred CCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhcCCh
Confidence 4457999999998899999999999999999997 2 22221 22222332221 1457789999999999999
Q ss_pred CCCCCHHHHHHHH
Q 008785 506 HLSQSKFCNLKLW 518 (553)
Q Consensus 506 ~~RPs~~evl~~l 518 (553)
++|||+.|+++.+
T Consensus 243 ~~Rpt~~~~l~~l 255 (256)
T cd05059 243 EDRPAFKKLLSQL 255 (256)
T ss_pred hhCcCHHHHHHHh
Confidence 9999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=312.33 Aligned_cols=244 Identities=24% Similarity=0.337 Sum_probs=199.0
Q ss_pred eeecccCceeEEEEEeC------CCCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccC
Q 008785 275 RLLGDSKTGGTYSGILP------DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV 348 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~------~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 348 (553)
..||+|+||.||++... ++..+++|.++.......+.+.+|+.++++++||||+++++++...+..++||||++
T Consensus 11 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 90 (291)
T cd05094 11 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMK 90 (291)
T ss_pred eeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEEecCC
Confidence 35699999999999742 355799999987766667789999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeec
Q 008785 349 NGPLDRWLHHIPR------------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGV 416 (553)
Q Consensus 349 ~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Df 416 (553)
+++|.+++..... ....+++..+..++.||+.||+|||++ +|+||||||+||++++++.++|+||
T Consensus 91 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df 167 (291)
T cd05094 91 HGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDF 167 (291)
T ss_pred CCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEEECCC
Confidence 9999999965221 123488999999999999999999999 9999999999999999999999999
Q ss_pred cccccCCcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhc-Cc-cccc---chHHHHHhcCCH----
Q 008785 417 GLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-VL-CRRW---WTLYTLVHSMSL---- 487 (553)
Q Consensus 417 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-~~-~~~~---~~l~~~~~~~~~---- 487 (553)
|++................++..|+|||++.+..++.++||||||+++|||++ .. |... ....+.+..+..
T Consensus 168 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~ 247 (291)
T cd05094 168 GMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRVLERP 247 (291)
T ss_pred CcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhCCCCCCCC
Confidence 99976543322211122226788999999998899999999999999999997 33 3222 223333333332
Q ss_pred -HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 008785 488 -LCAQECLMLFISCNNWPSHLSQSKFCNLKLWVFA 521 (553)
Q Consensus 488 -~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~~ 521 (553)
..+..+.+++.+||+.||++|||+.++++.+...
T Consensus 248 ~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~ 282 (291)
T cd05094 248 RVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHAL 282 (291)
T ss_pred ccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence 4567899999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=323.16 Aligned_cols=232 Identities=22% Similarity=0.185 Sum_probs=192.8
Q ss_pred eeecccCceeEEEEEeC-CCCEEEEEEeccCC---hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCC
Q 008785 275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 350 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 350 (553)
+.||+|+||.||+|... +++.||||+++... ......+.+|+.++..++||||+++++++.+.+..++||||+++|
T Consensus 7 ~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~g~ 86 (333)
T cd05600 7 TQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGG 86 (333)
T ss_pred EEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeCCCCC
Confidence 34599999999999976 48899999997642 233467889999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccce
Q 008785 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER 430 (553)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 430 (553)
+|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 87 ~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~~----- 154 (333)
T cd05600 87 DFRTLLNN----LGVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTY----- 154 (333)
T ss_pred CHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCcccccc-----
Confidence 99999964 24588999999999999999999999 9999999999999999999999999999765431
Q ss_pred eeecCccccccccccccCCCCCcccchHhHHHHHHHHhcC-cccccchH---HHHHhcCC--H----------HHHHHHH
Q 008785 431 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLV-LCRRWWTL---YTLVHSMS--L----------LCAQECL 494 (553)
Q Consensus 431 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~-~~~~~~~l---~~~~~~~~--~----------~~~~~l~ 494 (553)
.....||+.|+|||++.+..++.++|||||||++|||++. .|....+. ...+.... . ..+..+.
T Consensus 155 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~ 234 (333)
T cd05600 155 ANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAW 234 (333)
T ss_pred cCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHH
Confidence 1122389999999999988999999999999999999973 33322222 22111110 0 3367899
Q ss_pred HHHhhccCCCCCCCCCHHHHHHHH
Q 008785 495 MLFISCNNWPSHLSQSKFCNLKLW 518 (553)
Q Consensus 495 ~l~~~Cl~~dP~~RPs~~evl~~l 518 (553)
+++.+||..+|.+||++.+++++-
T Consensus 235 ~li~~~l~~~~~rr~s~~~ll~h~ 258 (333)
T cd05600 235 DLITKLINDPSRRFGSLEDIKNHP 258 (333)
T ss_pred HHHHHHhhChhhhcCCHHHHHhCc
Confidence 999999999999999999999874
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=303.14 Aligned_cols=255 Identities=22% Similarity=0.266 Sum_probs=197.5
Q ss_pred ccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCChhh--HHHHHHHHHHhhccCCCceeeEeeEEeeC--CceEEE
Q 008785 269 NFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQR--KKEFYSEIGRFARLHHPNLVAVKGCCYDH--GDRYIV 343 (553)
Q Consensus 269 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~~~--~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~~lV 343 (553)
+|...++| ++|+||.||+|+.+ +++.||+|+++...... .-.-++|+.+|.+++|||||.+..+.... +.+|+|
T Consensus 77 efe~lnrI-~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 77 EFEKLNRI-EEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHhhc-ccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 45555666 99999999999965 58899999998653211 13357999999999999999999887743 568999
Q ss_pred EEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCC
Q 008785 344 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVP 423 (553)
Q Consensus 344 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~ 423 (553)
||||+. +|..++... ...+...++.-++.|+++|++|||++ .|+||||||+|+|+.+.|.+||+|||+|+.+.
T Consensus 156 Me~~Eh-DLksl~d~m---~q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg 228 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMETM---KQPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYG 228 (419)
T ss_pred HHHHHh-hHHHHHHhc---cCCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhc
Confidence 999965 899999763 35789999999999999999999999 99999999999999999999999999999887
Q ss_pred cccccceeeecCccccccccccccCC-CCCcccchHhHHHHHHHHhcCccccc-----ch---HHHHHh-----------
Q 008785 424 WEVMQERTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIRLVLCRRW-----WT---LYTLVH----------- 483 (553)
Q Consensus 424 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwSlGvil~ell~~~~~~~-----~~---l~~~~~----------- 483 (553)
......+..+ -|..|+|||.+.+. .|+.+.|+||+|||+.|++...|-.. ++ +..++.
T Consensus 229 sp~k~~T~lV--VTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~ 306 (419)
T KOG0663|consen 229 SPLKPYTPLV--VTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYS 306 (419)
T ss_pred CCcccCcceE--EEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCcc
Confidence 6543333222 68999999999875 58999999999999999995222111 11 111110
Q ss_pred ------cCCH---------------HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHhhccccccccc
Q 008785 484 ------SMSL---------------LCAQECLMLFISCNNWPSHLSQSKFCNLKLWVFAILTIRKVQFEFP 533 (553)
Q Consensus 484 ------~~~~---------------~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~~~~~~~~~~~~~p 533 (553)
.-++ .....-.+|+...+..||.+|.|+.|.|++-.+.-......+-.+|
T Consensus 307 ~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p~~P~~~P 377 (419)
T KOG0663|consen 307 ELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLPIDPSMFP 377 (419)
T ss_pred ccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCCCCChhhcC
Confidence 0000 2346778999999999999999999999986555433333333333
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=307.99 Aligned_cols=243 Identities=26% Similarity=0.316 Sum_probs=192.7
Q ss_pred eeecccCceeEEEEEeCCC-C--EEEEEEeccC--ChhhHHHHHHHHHHhhccCCCceeeEeeEEeeC------CceEEE
Q 008785 275 RLLGDSKTGGTYSGILPDG-S--RVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH------GDRYIV 343 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~~g-~--~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~------~~~~lV 343 (553)
+.||+|+||.||+|...++ . .||+|.++.. .....+.+.+|+.++++++||||+++++++... ...+++
T Consensus 5 ~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v 84 (272)
T cd05075 5 KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVI 84 (272)
T ss_pred cccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcEEE
Confidence 4569999999999997553 3 6999998754 334457789999999999999999999987532 246899
Q ss_pred EEccCCCCHHHHhccCC--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeecccccc
Q 008785 344 YEFVVNGPLDRWLHHIP--RGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF 421 (553)
Q Consensus 344 ~E~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~ 421 (553)
|||+++|+|.+++.... .....+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++.
T Consensus 85 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 161 (272)
T cd05075 85 LPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKK 161 (272)
T ss_pred EEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCCcccc
Confidence 99999999999874321 2234588999999999999999999999 999999999999999999999999999987
Q ss_pred CCcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhc-C-cccc---cchHHHHHhcCCH-----HHHH
Q 008785 422 VPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-V-LCRR---WWTLYTLVHSMSL-----LCAQ 491 (553)
Q Consensus 422 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-~-~~~~---~~~l~~~~~~~~~-----~~~~ 491 (553)
..............+++.|+|||.+.+..++.++||||||+++|||++ . .|.. ...+.+.+..+.. ..+.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (272)
T cd05075 162 IYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPPDCLD 241 (272)
T ss_pred cCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCH
Confidence 654322111122236778999999998899999999999999999987 2 2222 2233333333322 4567
Q ss_pred HHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 008785 492 ECLMLFISCNNWPSHLSQSKFCNLKLWVF 520 (553)
Q Consensus 492 ~l~~l~~~Cl~~dP~~RPs~~evl~~l~~ 520 (553)
.+.+++.+||+.||++|||+.++++.+..
T Consensus 242 ~~~~li~~~l~~~p~~Rps~~~l~~~l~~ 270 (272)
T cd05075 242 GLYSLMSSCWLLNPKDRPSFETLRCELEK 270 (272)
T ss_pred HHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 78999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=314.37 Aligned_cols=235 Identities=20% Similarity=0.193 Sum_probs=187.9
Q ss_pred eeecccCceeEEEEEeC-CCCEEEEEEeccCC--hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCC
Q 008785 275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP 351 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gs 351 (553)
+.||+|+||.||+++.. +++.||+|+++... ....+.+.+|+.++++++||||+++++++...+..++||||+++++
T Consensus 7 ~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 86 (287)
T cd07848 7 GVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNM 86 (287)
T ss_pred EEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecCCCCH
Confidence 34599999999999975 47899999997542 2334678899999999999999999999999999999999999887
Q ss_pred HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCccccccee
Q 008785 352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT 431 (553)
Q Consensus 352 L~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~ 431 (553)
+..+.. ....+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++............
T Consensus 87 l~~~~~----~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 159 (287)
T cd07848 87 LELLEE----MPNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYT 159 (287)
T ss_pred HHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCccccccccccccc
Confidence 765543 234589999999999999999999999 9999999999999999999999999999876433221111
Q ss_pred eecCccccccccccccCCCCCcccchHhHHHHHHHHhcCcc-cccch----HHHHHh---------------cCCH----
Q 008785 432 VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVLC-RRWWT----LYTLVH---------------SMSL---- 487 (553)
Q Consensus 432 ~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~~-~~~~~----l~~~~~---------------~~~~---- 487 (553)
...|++.|+|||++.+..++.++|||||||++|||++..+ ....+ +..... ....
T Consensus 160 -~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (287)
T cd07848 160 -EYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLR 238 (287)
T ss_pred -ccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccc
Confidence 1238899999999998889999999999999999997332 22111 110000 0000
Q ss_pred ----------------HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008785 488 ----------------LCAQECLMLFISCNNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 488 ----------------~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 517 (553)
..+..+.+++.+||+.||++|||+.|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 239 FPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred cCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 145568999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=326.04 Aligned_cols=243 Identities=28% Similarity=0.348 Sum_probs=193.4
Q ss_pred eeecccCceeEEEEEeCC------CCEEEEEEeccCC-hhhHHHHHHHHHHhhccC-CCceeeEeeEEeeCCceEEEEEc
Q 008785 275 RLLGDSKTGGTYSGILPD------GSRVAVKRLKRSS-FQRKKEFYSEIGRFARLH-HPNLVAVKGCCYDHGDRYIVYEF 346 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~~------g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lV~E~ 346 (553)
++||+|+||.||+|.... +..||||+++... ....+.+.+|+++++++. ||||+++++++.+.+..++||||
T Consensus 43 ~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey 122 (400)
T cd05105 43 RILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIITEY 122 (400)
T ss_pred heecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceEEEEEe
Confidence 456999999999998521 3479999997543 334567999999999996 99999999999999999999999
Q ss_pred cCCCCHHHHhccCCC-----------------------------------------------------------------
Q 008785 347 VVNGPLDRWLHHIPR----------------------------------------------------------------- 361 (553)
Q Consensus 347 ~~~gsL~~~l~~~~~----------------------------------------------------------------- 361 (553)
+++|+|.++|.....
T Consensus 123 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 202 (400)
T cd05105 123 CFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEASKYSD 202 (400)
T ss_pred cCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhhhhhhh
Confidence 999999998864210
Q ss_pred ---------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEe
Q 008785 362 ---------------------------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLM 414 (553)
Q Consensus 362 ---------------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~ 414 (553)
....+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+
T Consensus 203 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill~~~~~~kL~ 279 (400)
T cd05105 203 IQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLLAQGKIVKIC 279 (400)
T ss_pred cccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEEeCCCEEEEE
Confidence 113478888999999999999999999 99999999999999999999999
Q ss_pred eccccccCCcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhc--Cccccc----chHHHHHhcCCH-
Q 008785 415 GVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL--VLCRRW----WTLYTLVHSMSL- 487 (553)
Q Consensus 415 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~--~~~~~~----~~l~~~~~~~~~- 487 (553)
|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ ..|... ..+...+..+..
T Consensus 280 DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~~~~~~~~ 359 (400)
T cd05105 280 DFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRM 359 (400)
T ss_pred eCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHHHhcCCCC
Confidence 9999986543322211222236778999999988899999999999999999985 233222 122222232211
Q ss_pred ----HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 008785 488 ----LCAQECLMLFISCNNWPSHLSQSKFCNLKLWVF 520 (553)
Q Consensus 488 ----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~ 520 (553)
..+..+.+++.+||+.||++|||+.++.+.+..
T Consensus 360 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~ 396 (400)
T cd05105 360 AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVES 396 (400)
T ss_pred CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHH
Confidence 456789999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=307.19 Aligned_cols=238 Identities=27% Similarity=0.379 Sum_probs=195.7
Q ss_pred eeecccCceeEEEEEeCCCCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCCHHH
Q 008785 275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR 354 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~ 354 (553)
+.||+|++|.||+|...+++.||+|.++... ...+++.+|+.++++++||||+++++++...+..+++|||+++++|.+
T Consensus 12 ~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 90 (261)
T cd05068 12 RKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLE 90 (261)
T ss_pred EEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecccCCcHHH
Confidence 4559999999999998788899999997653 345678999999999999999999999999999999999999999999
Q ss_pred HhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccceeeec
Q 008785 355 WLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA 434 (553)
Q Consensus 355 ~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 434 (553)
++... ....+++..+..++.|++.||.|||+. +++||||||+||++++++.++|+|||+++........... ..
T Consensus 91 ~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~-~~ 164 (261)
T cd05068 91 YLQGG--AGRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEARE-GA 164 (261)
T ss_pred HHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCCcccccC-CC
Confidence 99752 235689999999999999999999999 9999999999999999999999999999876533221111 11
Q ss_pred CccccccccccccCCCCCcccchHhHHHHHHHHhc-Cc-cccc---chHHHHHhcCC-H----HHHHHHHHHHhhccCCC
Q 008785 435 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-VL-CRRW---WTLYTLVHSMS-L----LCAQECLMLFISCNNWP 504 (553)
Q Consensus 435 ~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-~~-~~~~---~~l~~~~~~~~-~----~~~~~l~~l~~~Cl~~d 504 (553)
..+..|+|||++.+..++.++||||||+++|||++ .. |... ..+...+..+. . ..+..+.+++.+|++.+
T Consensus 165 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 244 (261)
T cd05068 165 KFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGCPKELYDIMLDCWKED 244 (261)
T ss_pred cCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHhhcC
Confidence 13457999999988899999999999999999997 33 2212 22222332221 1 45678999999999999
Q ss_pred CCCCCCHHHHHHHHH
Q 008785 505 SHLSQSKFCNLKLWV 519 (553)
Q Consensus 505 P~~RPs~~evl~~l~ 519 (553)
|++||++.++++.+.
T Consensus 245 P~~Rp~~~~l~~~l~ 259 (261)
T cd05068 245 PDDRPTFETLQWKLE 259 (261)
T ss_pred cccCCCHHHHHHHHh
Confidence 999999999998764
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=320.92 Aligned_cols=234 Identities=22% Similarity=0.231 Sum_probs=191.4
Q ss_pred eecccCceeEEEEEeCC-CCEEEEEEeccCC---hhhHHHHHHHHHHhhcc-CCCceeeEeeEEeeCCceEEEEEccCCC
Q 008785 276 LLGDSKTGGTYSGILPD-GSRVAVKRLKRSS---FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNG 350 (553)
Q Consensus 276 ~iG~G~~g~Vy~~~~~~-g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~~g 350 (553)
+||+|+||.||+|...+ ++.||||+++... ....+.+..|.+++..+ +||||+++++++.+.+..++||||+++|
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 81 (321)
T cd05591 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGG 81 (321)
T ss_pred ccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCC
Confidence 46999999999999754 7899999997642 23345677888888876 7999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccce
Q 008785 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER 430 (553)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 430 (553)
+|.+++.. ...+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++..........
T Consensus 82 ~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~- 153 (321)
T cd05591 82 DLMFQIQR----SRKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTT- 153 (321)
T ss_pred cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCCccc-
Confidence 99988864 24588999999999999999999999 99999999999999999999999999987543222111
Q ss_pred eeecCccccccccccccCCCCCcccchHhHHHHHHHHhcC-ccccc---chHHHHHhcCCH----HHHHHHHHHHhhccC
Q 008785 431 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLV-LCRRW---WTLYTLVHSMSL----LCAQECLMLFISCNN 502 (553)
Q Consensus 431 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~-~~~~~---~~l~~~~~~~~~----~~~~~l~~l~~~Cl~ 502 (553)
....||+.|+|||++.+..++.++||||||+++|||++. .|... ..+.+.+..+.. ..+..+.+++.+||+
T Consensus 154 -~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~L~ 232 (321)
T cd05591 154 -TTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMT 232 (321)
T ss_pred -cccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhc
Confidence 122389999999999988999999999999999999973 33322 223333333332 346788999999999
Q ss_pred CCCCCCC-------CHHHHHHHH
Q 008785 503 WPSHLSQ-------SKFCNLKLW 518 (553)
Q Consensus 503 ~dP~~RP-------s~~evl~~l 518 (553)
.||++|| ++.+++++-
T Consensus 233 ~dp~~R~~~~~~~~~~~~~~~hp 255 (321)
T cd05591 233 KNPNKRLGCVASQGGEDAIKQHP 255 (321)
T ss_pred cCHHHcCCCCCCCCCHHHHhcCC
Confidence 9999999 889998774
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=310.81 Aligned_cols=241 Identities=25% Similarity=0.340 Sum_probs=194.2
Q ss_pred eeecccCceeEEEEEe-----CCCCEEEEEEeccCC-hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccC
Q 008785 275 RLLGDSKTGGTYSGIL-----PDGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV 348 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~-----~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 348 (553)
+.||+|+||.||+|.. .++..||+|.++... ......+.+|+.++++++||||+++++++......++||||++
T Consensus 11 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 90 (283)
T cd05090 11 EELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLN 90 (283)
T ss_pred eeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEEEcCC
Confidence 3459999999999984 246789999997543 3344678899999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEee
Q 008785 349 NGPLDRWLHHIPR-------------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMG 415 (553)
Q Consensus 349 ~gsL~~~l~~~~~-------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~D 415 (553)
+|+|.+++..... ....+++.++..++.|++.||+|||++ +++||||||+|||+++++.+||+|
T Consensus 91 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~~~kl~d 167 (283)
T cd05090 91 QGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQLHVKISD 167 (283)
T ss_pred CCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCCcEEecc
Confidence 9999999853211 123478899999999999999999999 999999999999999999999999
Q ss_pred ccccccCCcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhc-Cc-ccc---cchHHHHHhcCCH---
Q 008785 416 VGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-VL-CRR---WWTLYTLVHSMSL--- 487 (553)
Q Consensus 416 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-~~-~~~---~~~l~~~~~~~~~--- 487 (553)
||+++...............++..|+|||++.+..++.++||||||+++|||++ .. |.. ...+.+.+..+..
T Consensus 168 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 247 (283)
T cd05090 168 LGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQLLPC 247 (283)
T ss_pred ccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCC
Confidence 999976543322221222225678999999988889999999999999999996 32 221 2233343433332
Q ss_pred --HHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008785 488 --LCAQECLMLFISCNNWPSHLSQSKFCNLKLW 518 (553)
Q Consensus 488 --~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l 518 (553)
..+..+.+++.+||+.||++||++.+|++++
T Consensus 248 ~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l 280 (283)
T cd05090 248 SEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRL 280 (283)
T ss_pred CCCCCHHHHHHHHHHcccCcccCcCHHHHHHHh
Confidence 4567899999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=303.89 Aligned_cols=236 Identities=26% Similarity=0.335 Sum_probs=193.8
Q ss_pred eecccCceeEEEEEeCCCCEEEEEEeccCC-hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCCHHH
Q 008785 276 LLGDSKTGGTYSGILPDGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR 354 (553)
Q Consensus 276 ~iG~G~~g~Vy~~~~~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~ 354 (553)
+||+|+||.||+|...++..||+|.++... ......+.+|+.++++++||||+++++++...+..++||||+++++|.+
T Consensus 2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 81 (250)
T cd05085 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLS 81 (250)
T ss_pred ccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHH
Confidence 469999999999998889999999987653 2334578899999999999999999999999999999999999999999
Q ss_pred HhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccceeeec
Q 008785 355 WLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA 434 (553)
Q Consensus 355 ~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 434 (553)
++.. ....+++..+..++.|++.||.|||++ +++||||||+||++++++.+||+|||++........... ...
T Consensus 82 ~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~-~~~ 154 (250)
T cd05085 82 FLRK---KKDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSS-GLK 154 (250)
T ss_pred HHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccC-CCC
Confidence 9864 234578999999999999999999999 999999999999999999999999999875443222111 111
Q ss_pred CccccccccccccCCCCCcccchHhHHHHHHHHhc-Cc-ccccchH---HHHHhcCCH-----HHHHHHHHHHhhccCCC
Q 008785 435 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-VL-CRRWWTL---YTLVHSMSL-----LCAQECLMLFISCNNWP 504 (553)
Q Consensus 435 ~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-~~-~~~~~~l---~~~~~~~~~-----~~~~~l~~l~~~Cl~~d 504 (553)
.++..|+|||++....++.++||||||+++||+++ .. |...... ...+..+.. ..+..+.+++.+|++.+
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 234 (250)
T cd05085 155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDYK 234 (250)
T ss_pred CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccC
Confidence 24678999999988889999999999999999997 22 3322222 222222211 45678999999999999
Q ss_pred CCCCCCHHHHHHHH
Q 008785 505 SHLSQSKFCNLKLW 518 (553)
Q Consensus 505 P~~RPs~~evl~~l 518 (553)
|++|||+.|+++.+
T Consensus 235 p~~Rp~~~~l~~~l 248 (250)
T cd05085 235 PENRPKFSELQKEL 248 (250)
T ss_pred cccCCCHHHHHHHh
Confidence 99999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=320.63 Aligned_cols=233 Identities=24% Similarity=0.275 Sum_probs=191.1
Q ss_pred eecccCceeEEEEEeC-CCCEEEEEEeccCC---hhhHHHHHHHHHHhhcc-CCCceeeEeeEEeeCCceEEEEEccCCC
Q 008785 276 LLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNG 350 (553)
Q Consensus 276 ~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~~g 350 (553)
+||+|+||.||++... +++.||||+++... ....+.+..|..++..+ +||||+++++++.+.+..++||||+++|
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g 81 (320)
T cd05590 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGG 81 (320)
T ss_pred eeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCCc
Confidence 4699999999999975 48899999997542 23345677888888876 7999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccce
Q 008785 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER 430 (553)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 430 (553)
+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++........
T Consensus 82 ~L~~~i~~----~~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~-- 152 (320)
T cd05590 82 DLMFHIQK----SRRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKT-- 152 (320)
T ss_pred hHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCc--
Confidence 99998864 24589999999999999999999999 9999999999999999999999999998754322111
Q ss_pred eeecCccccccccccccCCCCCcccchHhHHHHHHHHhcC-ccccc---chHHHHHhcCCH----HHHHHHHHHHhhccC
Q 008785 431 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLV-LCRRW---WTLYTLVHSMSL----LCAQECLMLFISCNN 502 (553)
Q Consensus 431 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~-~~~~~---~~l~~~~~~~~~----~~~~~l~~l~~~Cl~ 502 (553)
.....||+.|+|||++.+..++.++||||||+++|||++. .|... ..+.+.+..+.. ..+..+.+++.+||+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~ 232 (320)
T cd05590 153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMT 232 (320)
T ss_pred ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHcc
Confidence 1122389999999999988999999999999999999973 33322 233334433333 456778999999999
Q ss_pred CCCCCCCCH------HHHHHH
Q 008785 503 WPSHLSQSK------FCNLKL 517 (553)
Q Consensus 503 ~dP~~RPs~------~evl~~ 517 (553)
.||++||++ .+++++
T Consensus 233 ~dP~~R~~~~~~~~~~~~~~h 253 (320)
T cd05590 233 KNPTMRLGSLTLGGEEAILRH 253 (320)
T ss_pred cCHHHCCCCCCCCCHHHHHcC
Confidence 999999998 777776
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=310.79 Aligned_cols=239 Identities=23% Similarity=0.310 Sum_probs=193.8
Q ss_pred ecccCceeEEEEEeCC------CCEEEEEEeccCCh-hhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCC
Q 008785 277 LGDSKTGGTYSGILPD------GSRVAVKRLKRSSF-QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 349 (553)
Q Consensus 277 iG~G~~g~Vy~~~~~~------g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 349 (553)
||+|+||.||+|...+ +..||+|+++.... ...+.+.+|+.++++++||||+++++++.+.+..++++||+++
T Consensus 13 lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~e~~~~ 92 (283)
T cd05091 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSH 92 (283)
T ss_pred hCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEEEEcCCC
Confidence 4999999999998632 47899999975532 2346788999999999999999999999999999999999999
Q ss_pred CCHHHHhccCC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeecc
Q 008785 350 GPLDRWLHHIP------------RGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVG 417 (553)
Q Consensus 350 gsL~~~l~~~~------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg 417 (553)
++|.+++.... .....+++..+..++.|++.||+|||++ +|+||||||+||++++++.+||+|||
T Consensus 93 ~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~kl~Dfg 169 (283)
T cd05091 93 SDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLG 169 (283)
T ss_pred CcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCCceEecccc
Confidence 99999985311 1123478889999999999999999999 99999999999999999999999999
Q ss_pred ccccCCcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhc-Cc-cc---ccchHHHHHhcCCH-----
Q 008785 418 LSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-VL-CR---RWWTLYTLVHSMSL----- 487 (553)
Q Consensus 418 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-~~-~~---~~~~l~~~~~~~~~----- 487 (553)
+++...............+++.|+|||++.++.++.++||||||+++|||++ .. +. ....+.+.+..+..
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~ 249 (283)
T cd05091 170 LFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQVLPCPD 249 (283)
T ss_pred cccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCCCC
Confidence 9886543322221222225778999999988889999999999999999996 22 22 22334444444332
Q ss_pred HHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008785 488 LCAQECLMLFISCNNWPSHLSQSKFCNLKLW 518 (553)
Q Consensus 488 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l 518 (553)
..+..+.+++.+||+.+|++||++.+|++.+
T Consensus 250 ~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l 280 (283)
T cd05091 250 DCPAWVYTLMLECWNEFPSRRPRFKDIHSRL 280 (283)
T ss_pred CCCHHHHHHHHHHhCCCcccCCCHHHHHHHh
Confidence 5677899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=312.73 Aligned_cols=249 Identities=26% Similarity=0.331 Sum_probs=198.8
Q ss_pred ccCCCCeeecccCceeEEEEEeCC------CCEEEEEEeccC-ChhhHHHHHHHHHHhhcc-CCCceeeEeeEEeeCCce
Q 008785 269 NFSEGNRLLGDSKTGGTYSGILPD------GSRVAVKRLKRS-SFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDR 340 (553)
Q Consensus 269 ~~~~~~~~iG~G~~g~Vy~~~~~~------g~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~ 340 (553)
+|... +.||+|+||.||++...+ ...+|+|.+... ......++.+|+.++.++ +||||+++++++...+..
T Consensus 13 ~~~~~-~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 91 (293)
T cd05053 13 RLTLG-KPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPL 91 (293)
T ss_pred HeEEe-eEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCe
Confidence 34443 456999999999998642 368999998754 233456788999999999 899999999999999999
Q ss_pred EEEEEccCCCCHHHHhccCC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCC
Q 008785 341 YIVYEFVVNGPLDRWLHHIP------------RGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE 408 (553)
Q Consensus 341 ~lV~E~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~ 408 (553)
+++|||+++|+|.+++.... .....+++..++.++.|++.||+|||+. +|+||||||+||+++++
T Consensus 92 ~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil~~~~ 168 (293)
T cd05053 92 YVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTED 168 (293)
T ss_pred EEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEEEcCC
Confidence 99999999999999996421 2345689999999999999999999999 99999999999999999
Q ss_pred CCeEEeeccccccCCcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhc--Ccccccc---hHHHHHh
Q 008785 409 FGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL--VLCRRWW---TLYTLVH 483 (553)
Q Consensus 409 ~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~--~~~~~~~---~l~~~~~ 483 (553)
+.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ ..|.... .+.+.+.
T Consensus 169 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 248 (293)
T cd05053 169 HVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLK 248 (293)
T ss_pred CeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHHHH
Confidence 9999999999987654322221211225678999999988889999999999999999986 2232222 2333333
Q ss_pred cCCH-----HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 008785 484 SMSL-----LCAQECLMLFISCNNWPSHLSQSKFCNLKLWVFA 521 (553)
Q Consensus 484 ~~~~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~~ 521 (553)
.+.. ..+..+.+++.+||+.||++|||+.|+++.+...
T Consensus 249 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~ 291 (293)
T cd05053 249 EGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291 (293)
T ss_pred cCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence 3322 4567899999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=309.15 Aligned_cols=240 Identities=20% Similarity=0.260 Sum_probs=191.0
Q ss_pred eecccCceeEEEEEeC-CCC----EEEEEEeccCCh-hhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCC
Q 008785 276 LLGDSKTGGTYSGILP-DGS----RVAVKRLKRSSF-QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 349 (553)
Q Consensus 276 ~iG~G~~g~Vy~~~~~-~g~----~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 349 (553)
.||+|+||.||+|.+. +|+ .|++|.+..... ....++..|+..+++++||||+++++++. ....++++||+++
T Consensus 14 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~i~e~~~~ 92 (279)
T cd05111 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQLVTQLSPL 92 (279)
T ss_pred ccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEEEEEeCCC
Confidence 4599999999999964 344 478888764422 23467888898999999999999999875 4567899999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccc
Q 008785 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE 429 (553)
Q Consensus 350 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 429 (553)
|+|.+++.. ....+++..+..++.||+.||+|||++ +++||||||+||++++++.+||+|||+++.........
T Consensus 93 gsL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~~~ 166 (279)
T cd05111 93 GSLLDHVRQ---HRDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKY 166 (279)
T ss_pred CcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceeccCCCccc
Confidence 999999964 234689999999999999999999999 99999999999999999999999999998654332222
Q ss_pred eeeecCccccccccccccCCCCCcccchHhHHHHHHHHhc-Cc-cccc---chHHHHHhcCCH-----HHHHHHHHHHhh
Q 008785 430 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-VL-CRRW---WTLYTLVHSMSL-----LCAQECLMLFIS 499 (553)
Q Consensus 430 ~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-~~-~~~~---~~l~~~~~~~~~-----~~~~~l~~l~~~ 499 (553)
......++..|+|||.+.++.++.++||||||+++||+++ .. |... ..+.+.+..+.. ..+..+.+++.+
T Consensus 167 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 246 (279)
T cd05111 167 FYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQICTIDVYMVMVK 246 (279)
T ss_pred ccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCCCCCHHHHHHHHH
Confidence 2222236778999999998899999999999999999996 32 2222 223334444433 345578889999
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHH
Q 008785 500 CNNWPSHLSQSKFCNLKLWVFAI 522 (553)
Q Consensus 500 Cl~~dP~~RPs~~evl~~l~~~~ 522 (553)
||..||++|||+.|+++.+...+
T Consensus 247 c~~~~p~~Rps~~el~~~l~~~~ 269 (279)
T cd05111 247 CWMIDENVRPTFKELANEFTRMA 269 (279)
T ss_pred HcCCCcccCcCHHHHHHHHHHHH
Confidence 99999999999999999776644
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=306.87 Aligned_cols=230 Identities=26% Similarity=0.330 Sum_probs=185.1
Q ss_pred ecccCceeEEEEEeCC-------------CCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEE
Q 008785 277 LGDSKTGGTYSGILPD-------------GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIV 343 (553)
Q Consensus 277 iG~G~~g~Vy~~~~~~-------------g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 343 (553)
||+|+||.||+|...+ ...||+|.+..........+.+|+.+++.++||||+++++++......++|
T Consensus 3 lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~lv 82 (262)
T cd05077 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMV 82 (262)
T ss_pred cccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEEE
Confidence 5999999999998532 235899998766555566788999999999999999999999999999999
Q ss_pred EEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCC-------eEEeec
Q 008785 344 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG-------AHLMGV 416 (553)
Q Consensus 344 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~-------~kl~Df 416 (553)
|||+++|+|..++.. ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++. ++++||
T Consensus 83 ~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 83 EEFVEFGPLDLFMHR---KSDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred EecccCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 999999999998864 234589999999999999999999999 9999999999999987654 899999
Q ss_pred cccccCCcccccceeeecCcccccccccccc-CCCCCcccchHhHHHHHHHHhc--CcccccchHHH--HHhcCCH----
Q 008785 417 GLSKFVPWEVMQERTVMAGGTYGYLAPEFVY-RNELTTKSDVYSFGVLLLEIRL--VLCRRWWTLYT--LVHSMSL---- 487 (553)
Q Consensus 417 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~t~ksDVwSlGvil~ell~--~~~~~~~~l~~--~~~~~~~---- 487 (553)
|++....... ...++..|+|||.+. +..++.++||||||+++|||+. ..|.......+ ....+..
T Consensus 157 g~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 230 (262)
T cd05077 157 GIPITVLSRQ------ECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYEGQCMLVT 230 (262)
T ss_pred CCCccccCcc------cccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHHHhcCccCCC
Confidence 9986543221 112778899999886 4668999999999999999984 23332222222 1111111
Q ss_pred HHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008785 488 LCAQECLMLFISCNNWPSHLSQSKFCNLKLW 518 (553)
Q Consensus 488 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l 518 (553)
.....+.+++.+||+.||.+||++.+|++.+
T Consensus 231 ~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 231 PSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred CChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 3456789999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=312.08 Aligned_cols=246 Identities=20% Similarity=0.214 Sum_probs=193.7
Q ss_pred HhhcccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCChh--------------hHHHHHHHHHHhhccCCCceee
Q 008785 265 SITKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQ--------------RKKEFYSEIGRFARLHHPNLVA 329 (553)
Q Consensus 265 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~~--------------~~~~~~~E~~~l~~l~HpnIv~ 329 (553)
...+.|....++ |+|.||.|-+|... +++.||||++.+.... ..+.+.+|+.+|++++|||||+
T Consensus 94 k~lNqy~l~~ei-G~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 94 KQLNQYELIKEI-GSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred eehhheehhhhh-cCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 345566666666 99999999999954 6899999999753211 1357899999999999999999
Q ss_pred EeeEEeeC--CceEEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecC
Q 008785 330 VKGCCYDH--GDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE 407 (553)
Q Consensus 330 l~~~~~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~ 407 (553)
|+.+..+. +.+|||+|||..|.+... +.....+++.+++++++++..||+|||.+ |||||||||+|+||++
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~w~----p~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~ 245 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVKWC----PPDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSS 245 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCccccC----CCCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcC
Confidence 99998764 578999999999887432 12223389999999999999999999999 9999999999999999
Q ss_pred CCCeEEeeccccccCCccccc---ceeeecCccccccccccccCCC----CCcccchHhHHHHHHHHhc-CcccccchHH
Q 008785 408 EFGAHLMGVGLSKFVPWEVMQ---ERTVMAGGTYGYLAPEFVYRNE----LTTKSDVYSFGVLLLEIRL-VLCRRWWTLY 479 (553)
Q Consensus 408 ~~~~kl~Dfgla~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~----~t~ksDVwSlGvil~ell~-~~~~~~~~l~ 479 (553)
+|.+||+|||.+......... .......|||.|+|||...++. .+.+.||||+||+||.|+- ..|+.+....
T Consensus 246 ~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~ 325 (576)
T KOG0585|consen 246 DGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFEL 325 (576)
T ss_pred CCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHH
Confidence 999999999999866332111 1111133999999999998732 3578899999999999995 4455444444
Q ss_pred H---HHhcCCH------HHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008785 480 T---LVHSMSL------LCAQECLMLFISCNNWPSHLSQSKFCNLKLW 518 (553)
Q Consensus 480 ~---~~~~~~~------~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l 518 (553)
+ .+.+..+ .....+.+|++++|..||..|.+..+|..+.
T Consensus 326 ~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp 373 (576)
T KOG0585|consen 326 ELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP 373 (576)
T ss_pred HHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence 3 4444444 4577899999999999999999999988763
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=307.75 Aligned_cols=243 Identities=26% Similarity=0.415 Sum_probs=201.5
Q ss_pred ccCCCCeeecccCceeEEEEEeCCCCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccC
Q 008785 269 NFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV 348 (553)
Q Consensus 269 ~~~~~~~~iG~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 348 (553)
+|...+. ||+|+||.||+|...+++.+|+|.++.........+.+|+.+++.++||||+++++++.+.+..++||||++
T Consensus 7 ~y~~~~~-ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 85 (261)
T cd05148 7 EFTLERK-LGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELME 85 (261)
T ss_pred HHHHhhh-hccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecc
Confidence 3444344 499999999999998899999999987766567789999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCccccc
Q 008785 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ 428 (553)
Q Consensus 349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 428 (553)
+|+|.+++... ....+++..+..++.|++.||.|||++ +++||||||+||++++++.+||+|||.+.........
T Consensus 86 ~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~ 160 (261)
T cd05148 86 KGSLLAFLRSP--EGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL 160 (261)
T ss_pred cCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCcccc
Confidence 99999999752 345689999999999999999999999 9999999999999999999999999999766433221
Q ss_pred ceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhc-C-ccccc---chHHHHHhcCC-----HHHHHHHHHHHh
Q 008785 429 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-V-LCRRW---WTLYTLVHSMS-----LLCAQECLMLFI 498 (553)
Q Consensus 429 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-~-~~~~~---~~l~~~~~~~~-----~~~~~~l~~l~~ 498 (553)
.. ...++..|+|||.+.+..++.++||||||+++|+|++ . .|... ......+..+. ...+..+.+++.
T Consensus 161 ~~--~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 238 (261)
T cd05148 161 SS--DKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEIYKIML 238 (261)
T ss_pred cc--CCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCCCCCCCHHHHHHHH
Confidence 11 1225678999999988899999999999999999996 2 23222 22333333221 156678999999
Q ss_pred hccCCCCCCCCCHHHHHHHHH
Q 008785 499 SCNNWPSHLSQSKFCNLKLWV 519 (553)
Q Consensus 499 ~Cl~~dP~~RPs~~evl~~l~ 519 (553)
+||+.||.+|||+.++++.|.
T Consensus 239 ~~l~~~p~~Rpt~~~l~~~L~ 259 (261)
T cd05148 239 ECWAAEPEDRPSFKALREELD 259 (261)
T ss_pred HHcCCCchhCcCHHHHHHHHh
Confidence 999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=305.65 Aligned_cols=245 Identities=21% Similarity=0.282 Sum_probs=198.5
Q ss_pred ccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccC---ChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEE
Q 008785 269 NFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS---SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVY 344 (553)
Q Consensus 269 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 344 (553)
+|.... .||+|+||.||+|... +++.||||.++.. .......+.+|+.++++++||||+++++++.+.+..++|+
T Consensus 3 ~~~i~~-~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 3 NFQIEK-KIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred ceeeee-eeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 344434 4599999999999964 6899999988642 2344567899999999999999999999999999999999
Q ss_pred EccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCc
Q 008785 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW 424 (553)
Q Consensus 345 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~ 424 (553)
||+++|+|.+++.........+++..+..++.|++.||.|||++ +++||||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 99999999998865444445688999999999999999999999 999999999999999999999999999887654
Q ss_pred ccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcCc-cccc-----chHHHHHhcCCH------HHHHH
Q 008785 425 EVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVL-CRRW-----WTLYTLVHSMSL------LCAQE 492 (553)
Q Consensus 425 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~-~~~~-----~~l~~~~~~~~~------~~~~~ 492 (553)
...... ...+++.|+|||.+.+..++.++|+||||+++|||++.. |... ..+...+..... ..+..
T Consensus 159 ~~~~~~--~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (267)
T cd08228 159 KTTAAH--SLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEK 236 (267)
T ss_pred hhHHHh--cCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHH
Confidence 322111 123788999999998888999999999999999999732 3211 122223322221 45577
Q ss_pred HHHHHhhccCCCCCCCCCHHHHHHHHH
Q 008785 493 CLMLFISCNNWPSHLSQSKFCNLKLWV 519 (553)
Q Consensus 493 l~~l~~~Cl~~dP~~RPs~~evl~~l~ 519 (553)
+.+++.+||+.+|++||++.++++.+.
T Consensus 237 ~~~li~~cl~~~p~~Rp~~~~vl~~~~ 263 (267)
T cd08228 237 LRELVSMCIYPDPDQRPDIGYVHQIAK 263 (267)
T ss_pred HHHHHHHHCCCCcccCcCHHHHHHHHH
Confidence 999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=306.26 Aligned_cols=243 Identities=24% Similarity=0.347 Sum_probs=194.0
Q ss_pred eeecccCceeEEEEEeCC----CCEEEEEEeccCC--hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCc------eEE
Q 008785 275 RLLGDSKTGGTYSGILPD----GSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGD------RYI 342 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~~----g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~------~~l 342 (553)
++||+|+||.||+|.... +..||+|.++... ....+.+.+|+..++.++||||+++++++..... .++
T Consensus 5 ~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~ 84 (273)
T cd05035 5 KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMV 84 (273)
T ss_pred cccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcccEE
Confidence 456999999999998643 3679999987542 3345678999999999999999999998876554 799
Q ss_pred EEEccCCCCHHHHhccCC--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccc
Q 008785 343 VYEFVVNGPLDRWLHHIP--RGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSK 420 (553)
Q Consensus 343 V~E~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~ 420 (553)
+|||+++|+|..++.... .....+++..+..++.|++.||.|||+. +++||||||+||++++++.+||+|||+++
T Consensus 85 v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~ 161 (273)
T cd05035 85 ILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSK 161 (273)
T ss_pred EEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCcccee
Confidence 999999999999985432 2234689999999999999999999999 99999999999999999999999999998
Q ss_pred cCCcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhc-C-cccc---cchHHHHHhcCCH-----HHH
Q 008785 421 FVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-V-LCRR---WWTLYTLVHSMSL-----LCA 490 (553)
Q Consensus 421 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-~-~~~~---~~~l~~~~~~~~~-----~~~ 490 (553)
...............++..|+|||.+.+..++.++||||||+++|||++ . .|.. ...+.+.+..+.. ..+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (273)
T cd05035 162 KIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQPEDCL 241 (273)
T ss_pred eccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcCCC
Confidence 6644332222222225678999999988889999999999999999986 2 2222 2223333333222 566
Q ss_pred HHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 008785 491 QECLMLFISCNNWPSHLSQSKFCNLKLWVF 520 (553)
Q Consensus 491 ~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~ 520 (553)
..+.+++.+||+.||++|||+.|+++.+..
T Consensus 242 ~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~ 271 (273)
T cd05035 242 DELYDLMYSCWRADPKDRPTFTKLREVLEN 271 (273)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 789999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=317.00 Aligned_cols=242 Identities=19% Similarity=0.176 Sum_probs=194.6
Q ss_pred cccCCCCeeecccCceeEEEEEeCC-CCEEEEEEeccCChhh---HHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEE
Q 008785 268 KNFSEGNRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQR---KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIV 343 (553)
Q Consensus 268 ~~~~~~~~~iG~G~~g~Vy~~~~~~-g~~vAvK~~~~~~~~~---~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 343 (553)
++|.... +||+|+||.||.++-++ |..+|+|++++..... ...+..|-.+|...++|+||+|+-.|.+...+|||
T Consensus 141 ~DFe~Lk-~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLi 219 (550)
T KOG0605|consen 141 DDFELLK-VIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLI 219 (550)
T ss_pred ccchhhe-eeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEE
Confidence 4555444 45999999999999654 9999999999875433 45678899999999999999999999999999999
Q ss_pred EEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCC
Q 008785 344 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVP 423 (553)
Q Consensus 344 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~ 423 (553)
|||++||++..+|.. ...|++..+..++.+++.|+.-||+. |+|||||||+|+|||..|.+||+|||++.-+.
T Consensus 220 MEylPGGD~mTLL~~----~~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~ 292 (550)
T KOG0605|consen 220 MEYLPGGDMMTLLMR----KDTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD 292 (550)
T ss_pred EEecCCccHHHHHHh----cCcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchhh
Confidence 999999999999964 45699999999999999999999999 99999999999999999999999999984321
Q ss_pred cc----------------------ccc-----ce------------------eeecCccccccccccccCCCCCcccchH
Q 008785 424 WE----------------------VMQ-----ER------------------TVMAGGTYGYLAPEFVYRNELTTKSDVY 458 (553)
Q Consensus 424 ~~----------------------~~~-----~~------------------~~~~~gt~~y~aPE~~~~~~~t~ksDVw 458 (553)
.. ... .. .....|||.|||||++.+..|+..+|.|
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwW 372 (550)
T KOG0605|consen 293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWW 372 (550)
T ss_pred hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHH
Confidence 10 000 00 0012399999999999999999999999
Q ss_pred hHHHHHHHHhcCccc-ccchHHH---HHhcCC--------HHHHHHHHHHHhhccCCCCCCCCC---HHHHHHHH
Q 008785 459 SFGVLLLEIRLVLCR-RWWTLYT---LVHSMS--------LLCAQECLMLFISCNNWPSHLSQS---KFCNLKLW 518 (553)
Q Consensus 459 SlGvil~ell~~~~~-~~~~l~~---~~~~~~--------~~~~~~l~~l~~~Cl~~dP~~RPs---~~evl~~l 518 (553)
|||||+||||.+.|+ ......+ .+...+ .....+..+||.+|+. ||++|.- +.||-++-
T Consensus 373 SLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HP 446 (550)
T KOG0605|consen 373 SLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHP 446 (550)
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCC
Confidence 999999999974333 3332222 222111 1666889999999999 9999975 77766653
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=322.55 Aligned_cols=236 Identities=20% Similarity=0.265 Sum_probs=193.8
Q ss_pred ccCCCCeeecccCceeEEEEEeCC--CCEEEEEEeccCC---hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEE
Q 008785 269 NFSEGNRLLGDSKTGGTYSGILPD--GSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIV 343 (553)
Q Consensus 269 ~~~~~~~~iG~G~~g~Vy~~~~~~--g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 343 (553)
+|.... .||+|+||.||+|...+ +..||+|.+.... ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 31 ~y~~~~-~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 31 DFNFIR-TLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hcEEEE-EEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 344434 45999999999998643 3689999986532 23346788999999999999999999999999999999
Q ss_pred EEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCC
Q 008785 344 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVP 423 (553)
Q Consensus 344 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~ 423 (553)
|||+++|+|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++....
T Consensus 110 ~Ey~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~ 182 (340)
T PTZ00426 110 LEFVIGGEFFTFLRR----NKRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD 182 (340)
T ss_pred EeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence 999999999999964 24588999999999999999999999 99999999999999999999999999998654
Q ss_pred cccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcCc-ccccc---hHHHHHhcCCH----HHHHHHHH
Q 008785 424 WEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVL-CRRWW---TLYTLVHSMSL----LCAQECLM 495 (553)
Q Consensus 424 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~-~~~~~---~l~~~~~~~~~----~~~~~l~~ 495 (553)
... ....||+.|+|||++.+..++.++|||||||++|||++.. |.... .+.+.+..+.. ..+..+.+
T Consensus 183 ~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ 257 (340)
T PTZ00426 183 TRT-----YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNNCKH 257 (340)
T ss_pred CCc-----ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHH
Confidence 321 1223899999999999888999999999999999999733 33222 22333333332 44567889
Q ss_pred HHhhccCCCCCCCC-----CHHHHHHH
Q 008785 496 LFISCNNWPSHLSQ-----SKFCNLKL 517 (553)
Q Consensus 496 l~~~Cl~~dP~~RP-----s~~evl~~ 517 (553)
++.+|++.||++|+ ++.+++++
T Consensus 258 li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 258 LMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred HHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 99999999999995 89999987
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=309.06 Aligned_cols=247 Identities=25% Similarity=0.327 Sum_probs=197.9
Q ss_pred eeecccCceeEEEEEeC------CCCEEEEEEeccCC-hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEcc
Q 008785 275 RLLGDSKTGGTYSGILP------DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV 347 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~------~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 347 (553)
.+||+|+||.||+|... ....+|+|.+.... .....++.+|+.+++.++||||+++++.+...+..++++||+
T Consensus 6 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 85 (290)
T cd05045 6 KTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYA 85 (290)
T ss_pred ccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEEEec
Confidence 34599999999999853 23579999887553 334567899999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecC
Q 008785 348 VNGPLDRWLHHIPR--------------------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE 407 (553)
Q Consensus 348 ~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~ 407 (553)
.+|+|.+++..... ....+++..+..++.|++.||.|||+. +++||||||+|||+++
T Consensus 86 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~nill~~ 162 (290)
T cd05045 86 KYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARNVLVAE 162 (290)
T ss_pred CCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---CeehhhhhhheEEEcC
Confidence 99999999864221 123578999999999999999999999 9999999999999999
Q ss_pred CCCeEEeeccccccCCcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhc-Cc-ccc---cchHHHHH
Q 008785 408 EFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-VL-CRR---WWTLYTLV 482 (553)
Q Consensus 408 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-~~-~~~---~~~l~~~~ 482 (553)
++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ .. |.. ...+.+.+
T Consensus 163 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~ 242 (290)
T cd05045 163 GRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLL 242 (290)
T ss_pred CCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence 99999999999976543322222222235678999999988889999999999999999997 32 222 22333333
Q ss_pred hcCCH-----HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHhh
Q 008785 483 HSMSL-----LCAQECLMLFISCNNWPSHLSQSKFCNLKLWVFAILT 524 (553)
Q Consensus 483 ~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~~~~~ 524 (553)
..+.. ..+..+.+++.+||+.+|++||++.++++.+...+.+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~ 289 (290)
T cd05045 243 KTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK 289 (290)
T ss_pred hCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhc
Confidence 32211 4567899999999999999999999999998776643
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=316.75 Aligned_cols=233 Identities=21% Similarity=0.192 Sum_probs=186.3
Q ss_pred eecccCceeEEEEEeC-CCCEEEEEEeccCC---hhhHHHHHHHHHHhhcc-CCCceeeEeeEEeeCCceEEEEEccCCC
Q 008785 276 LLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNG 350 (553)
Q Consensus 276 ~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~~g 350 (553)
.||+|+||.||+|... +++.||||.++... ....+.+..|..++..+ +||||+++++++...+..++||||+++|
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg 81 (316)
T cd05592 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGG 81 (316)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence 4699999999999975 47899999997542 22334556677777654 8999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccce
Q 008785 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER 430 (553)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 430 (553)
+|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 82 ~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~-- 152 (316)
T cd05592 82 DLMFHIQS----SGRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGK-- 152 (316)
T ss_pred cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCc--
Confidence 99998864 23589999999999999999999999 9999999999999999999999999999754322211
Q ss_pred eeecCccccccccccccCCCCCcccchHhHHHHHHHHhcC-ccccc---chHHHHHhcCCH----HHHHHHHHHHhhccC
Q 008785 431 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLV-LCRRW---WTLYTLVHSMSL----LCAQECLMLFISCNN 502 (553)
Q Consensus 431 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~-~~~~~---~~l~~~~~~~~~----~~~~~l~~l~~~Cl~ 502 (553)
.....||+.|+|||++.+..++.++|||||||++|||++. .|... ..+...+..... ..+..+.+++.+||+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ll~~~l~ 232 (316)
T cd05592 153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLFE 232 (316)
T ss_pred cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHcc
Confidence 1122389999999999988999999999999999999973 33222 223332222221 456678899999999
Q ss_pred CCCCCCCCHH-HHHHH
Q 008785 503 WPSHLSQSKF-CNLKL 517 (553)
Q Consensus 503 ~dP~~RPs~~-evl~~ 517 (553)
.||++||++. +++++
T Consensus 233 ~~P~~R~~~~~~l~~h 248 (316)
T cd05592 233 RDPTKRLGVDGDIRQH 248 (316)
T ss_pred CCHHHcCCChHHHHcC
Confidence 9999999975 55554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=312.12 Aligned_cols=238 Identities=18% Similarity=0.236 Sum_probs=187.2
Q ss_pred cCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCC-hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEcc
Q 008785 270 FSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV 347 (553)
Q Consensus 270 ~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 347 (553)
|.... .||+|+||.||+|... +++.||+|.++... ......+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 7 y~~~~-~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 85 (288)
T cd07871 7 YVKLD-KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYL 85 (288)
T ss_pred ceEee-EEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCC
Confidence 44444 4599999999999865 58899999997543 223456789999999999999999999999998999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccc
Q 008785 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM 427 (553)
Q Consensus 348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 427 (553)
+ |+|.+++.. ....+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++.......
T Consensus 86 ~-~~l~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~ 158 (288)
T cd07871 86 D-SDLKQYLDN---CGNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK 158 (288)
T ss_pred C-cCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence 7 599998864 234578899999999999999999999 999999999999999999999999999975433221
Q ss_pred cceeeecCccccccccccccC-CCCCcccchHhHHHHHHHHhcCcc-cccchHHH----HH---hc------------C-
Q 008785 428 QERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIRLVLC-RRWWTLYT----LV---HS------------M- 485 (553)
Q Consensus 428 ~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwSlGvil~ell~~~~-~~~~~l~~----~~---~~------------~- 485 (553)
.. ....+++.|+|||.+.+ ..++.++||||+|+++|||++..+ .......+ .. .. .
T Consensus 159 ~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07871 159 TY--SNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEE 236 (288)
T ss_pred cc--cCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchh
Confidence 11 11227899999998865 568999999999999999997332 22211111 00 00 0
Q ss_pred ------------CH-----HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008785 486 ------------SL-----LCAQECLMLFISCNNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 486 ------------~~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 517 (553)
.. ....+..+++.+||+.||.+|||+.|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 237 FRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred hhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00 124567899999999999999999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=319.18 Aligned_cols=233 Identities=21% Similarity=0.202 Sum_probs=189.9
Q ss_pred eecccCceeEEEEEeC-CCCEEEEEEeccCC---hhhHHHHHHHHHHhhcc-CCCceeeEeeEEeeCCceEEEEEccCCC
Q 008785 276 LLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNG 350 (553)
Q Consensus 276 ~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~~g 350 (553)
+||+|+||.||++... +++.||+|+++... ....+.+.+|..++.++ +||||+++++++.+.+..++||||+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g 81 (329)
T cd05588 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGG 81 (329)
T ss_pred eEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999965 58899999998642 23345678899999998 7999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccce
Q 008785 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER 430 (553)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 430 (553)
+|.+++.. ...+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++........
T Consensus 82 ~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~-- 152 (329)
T cd05588 82 DLMFHMQR----QRKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDT-- 152 (329)
T ss_pred CHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCCCc--
Confidence 99988854 24689999999999999999999999 9999999999999999999999999998753222111
Q ss_pred eeecCccccccccccccCCCCCcccchHhHHHHHHHHhcCc-ccc--------c----chHHHHHhcCCH----HHHHHH
Q 008785 431 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVL-CRR--------W----WTLYTLVHSMSL----LCAQEC 493 (553)
Q Consensus 431 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~-~~~--------~----~~l~~~~~~~~~----~~~~~l 493 (553)
.....||+.|+|||++.+..++.++|||||||++|||++.. |.. . ..+.+.+..+.. ..+..+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~ 232 (329)
T cd05588 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKA 232 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCCCHHH
Confidence 11223899999999999999999999999999999999732 221 1 112222333322 455678
Q ss_pred HHHHhhccCCCCCCCCC------HHHHHHH
Q 008785 494 LMLFISCNNWPSHLSQS------KFCNLKL 517 (553)
Q Consensus 494 ~~l~~~Cl~~dP~~RPs------~~evl~~ 517 (553)
.+++.+||+.||.+||+ +.+++++
T Consensus 233 ~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 233 SSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred HHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 99999999999999997 6888876
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=317.77 Aligned_cols=246 Identities=23% Similarity=0.284 Sum_probs=194.7
Q ss_pred eeecccCceeEEEEEeC------CCCEEEEEEeccCC-hhhHHHHHHHHHHhhcc-CCCceeeEeeEEeeC-CceEEEEE
Q 008785 275 RLLGDSKTGGTYSGILP------DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDH-GDRYIVYE 345 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~------~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~-~~~~lV~E 345 (553)
+.||+|+||.||+|... +++.||+|+++... ....+.+.+|+.++.++ +||||+++++++... ...+++||
T Consensus 13 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~~~v~e 92 (337)
T cd05054 13 KPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPLMVIVE 92 (337)
T ss_pred cccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCEEEEEe
Confidence 45699999999999742 25789999997542 23346788999999999 899999999988754 56789999
Q ss_pred ccCCCCHHHHhccCCCC---------------------------------------------------------CCCCCH
Q 008785 346 FVVNGPLDRWLHHIPRG---------------------------------------------------------GRSLDW 368 (553)
Q Consensus 346 ~~~~gsL~~~l~~~~~~---------------------------------------------------------~~~l~~ 368 (553)
|+++|+|.+++...... ...+++
T Consensus 93 y~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 172 (337)
T cd05054 93 YCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTL 172 (337)
T ss_pred cCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhhcCCCH
Confidence 99999999998642110 125789
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccceeeecCccccccccccccC
Q 008785 369 AMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYR 448 (553)
Q Consensus 369 ~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 448 (553)
..+..++.||+.||+|||++ +|+||||||+|||+++++.++|+|||+++...............++..|+|||++.+
T Consensus 173 ~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 249 (337)
T cd05054 173 EDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFD 249 (337)
T ss_pred HHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcHHhcC
Confidence 99999999999999999999 999999999999999999999999999987644332222222236778999999999
Q ss_pred CCCCcccchHhHHHHHHHHhc-Cc-cccc----chHHHHHhcCCH-----HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008785 449 NELTTKSDVYSFGVLLLEIRL-VL-CRRW----WTLYTLVHSMSL-----LCAQECLMLFISCNNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 449 ~~~t~ksDVwSlGvil~ell~-~~-~~~~----~~l~~~~~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 517 (553)
..++.++|||||||++|||++ .. |... ..+...+..+.. .....+.+++.+||+.+|++||++.|++++
T Consensus 250 ~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~ 329 (337)
T cd05054 250 KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEI 329 (337)
T ss_pred CCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 999999999999999999986 32 2211 222223333222 345678999999999999999999999999
Q ss_pred HHHHHh
Q 008785 518 WVFAIL 523 (553)
Q Consensus 518 l~~~~~ 523 (553)
+...+.
T Consensus 330 l~~~~~ 335 (337)
T cd05054 330 LGDLLQ 335 (337)
T ss_pred HHHHHh
Confidence 877664
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=317.42 Aligned_cols=233 Identities=22% Similarity=0.223 Sum_probs=191.2
Q ss_pred eecccCceeEEEEEeCC-CCEEEEEEeccCC---hhhHHHHHHHHHHhhcc-CCCceeeEeeEEeeCCceEEEEEccCCC
Q 008785 276 LLGDSKTGGTYSGILPD-GSRVAVKRLKRSS---FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNG 350 (553)
Q Consensus 276 ~iG~G~~g~Vy~~~~~~-g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~~g 350 (553)
+||+|+||.||++.... ++.||||+++... ......+.+|..++..+ +||||+++++++.+.+..++||||+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 81 (318)
T cd05570 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGG 81 (318)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence 46999999999999754 7899999998642 23345677888898888 7999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccce
Q 008785 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER 430 (553)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 430 (553)
+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.........
T Consensus 82 ~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~- 153 (318)
T cd05570 82 DLMFHIQR----SGRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTT- 153 (318)
T ss_pred CHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcc-
Confidence 99998864 23589999999999999999999999 99999999999999999999999999987532222111
Q ss_pred eeecCccccccccccccCCCCCcccchHhHHHHHHHHhcC-ccccc---chHHHHHhcCCH----HHHHHHHHHHhhccC
Q 008785 431 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLV-LCRRW---WTLYTLVHSMSL----LCAQECLMLFISCNN 502 (553)
Q Consensus 431 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~-~~~~~---~~l~~~~~~~~~----~~~~~l~~l~~~Cl~ 502 (553)
....|++.|+|||++.+..++.++|||||||++|||++. .|... ..+...+..+.. ..+..+.+++.+||+
T Consensus 154 -~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~ 232 (318)
T cd05570 154 -STFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFLT 232 (318)
T ss_pred -cceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHcc
Confidence 122389999999999999999999999999999999973 33322 222233333222 456788999999999
Q ss_pred CCCCCCCCH-----HHHHHH
Q 008785 503 WPSHLSQSK-----FCNLKL 517 (553)
Q Consensus 503 ~dP~~RPs~-----~evl~~ 517 (553)
.||++|||+ .+++++
T Consensus 233 ~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 233 KNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred CCHHHcCCCCCCCHHHHhcC
Confidence 999999999 888876
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=318.89 Aligned_cols=233 Identities=20% Similarity=0.205 Sum_probs=189.0
Q ss_pred eecccCceeEEEEEeC-CCCEEEEEEeccC---ChhhHHHHHHHHHHhhcc-CCCceeeEeeEEeeCCceEEEEEccCCC
Q 008785 276 LLGDSKTGGTYSGILP-DGSRVAVKRLKRS---SFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNG 350 (553)
Q Consensus 276 ~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~~g 350 (553)
+||+|+||.||++... +++.||+|++++. .......+.+|+.++.++ +||||+++++++.+.+..++||||+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~~ 81 (329)
T cd05618 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGG 81 (329)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCCC
Confidence 5799999999999965 4789999999864 223345677899888877 8999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccce
Q 008785 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER 430 (553)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 430 (553)
+|..++.. ...+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++........
T Consensus 82 ~L~~~~~~----~~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~-- 152 (329)
T cd05618 82 DLMFHMQR----QRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT-- 152 (329)
T ss_pred CHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCc--
Confidence 99988854 24589999999999999999999999 9999999999999999999999999998753322211
Q ss_pred eeecCccccccccccccCCCCCcccchHhHHHHHHHHhcCc-ccc--------c----chHHHHHhcCCH----HHHHHH
Q 008785 431 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVL-CRR--------W----WTLYTLVHSMSL----LCAQEC 493 (553)
Q Consensus 431 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~-~~~--------~----~~l~~~~~~~~~----~~~~~l 493 (553)
.....||+.|+|||++.+..++.++||||||+++|||++.. |.. . ..+.+.+..+.. ..+..+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~ 232 (329)
T cd05618 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKA 232 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCCCHHH
Confidence 11223899999999999999999999999999999999732 221 0 012222222222 456678
Q ss_pred HHHHhhccCCCCCCCCC------HHHHHHH
Q 008785 494 LMLFISCNNWPSHLSQS------KFCNLKL 517 (553)
Q Consensus 494 ~~l~~~Cl~~dP~~RPs------~~evl~~ 517 (553)
.+++.+||+.||++||+ +.+++++
T Consensus 233 ~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 233 ASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred HHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 89999999999999998 5788776
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=306.18 Aligned_cols=244 Identities=23% Similarity=0.286 Sum_probs=194.6
Q ss_pred CeeecccCceeEEEEEeCC-CCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCc-----eEEEEEcc
Q 008785 274 NRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGD-----RYIVYEFV 347 (553)
Q Consensus 274 ~~~iG~G~~g~Vy~~~~~~-g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~-----~~lV~E~~ 347 (553)
.+++|.|+||.||+|.... ++.||||++-.... ---+|+.+|+++.|||||++.-+|..... ..+|||||
T Consensus 29 ~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleym 104 (364)
T KOG0658|consen 29 VRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYM 104 (364)
T ss_pred eEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhc
Confidence 4567999999999999654 78999999865422 12369999999999999999988875432 35899999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCC-CCeEEeeccccccCCccc
Q 008785 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE-FGAHLMGVGLSKFVPWEV 426 (553)
Q Consensus 348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~-~~~kl~Dfgla~~~~~~~ 426 (553)
+. +|.+++++..+.+..++...+.-+..||.+||+|||+. +|+||||||.|+|+|.+ |.+||+|||.|+.+..+.
T Consensus 105 P~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~e 180 (364)
T KOG0658|consen 105 PE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGE 180 (364)
T ss_pred hH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcceeeccCC
Confidence 76 89999987655667788899999999999999999998 99999999999999987 899999999999887665
Q ss_pred ccceeeecCccccccccccccCC-CCCcccchHhHHHHHHHHhcCccc-----ccchHHHHHh-----------cCC---
Q 008785 427 MQERTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIRLVLCR-----RWWTLYTLVH-----------SMS--- 486 (553)
Q Consensus 427 ~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwSlGvil~ell~~~~~-----~~~~l~~~~~-----------~~~--- 486 (553)
...... .|..|+|||.+.+. .|+.+.||||.||++.||+-..|- ....++..++ ...
T Consensus 181 pniSYi---cSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y 257 (364)
T KOG0658|consen 181 PNISYI---CSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNY 257 (364)
T ss_pred CceeEE---EeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCccc
Confidence 443222 67899999999875 699999999999999999942221 1112222110 000
Q ss_pred -------H-----------HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHhhcccc
Q 008785 487 -------L-----------LCAQECLMLFISCNNWPSHLSQSKFCNLKLWVFAILTIRKV 528 (553)
Q Consensus 487 -------~-----------~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~~~~~~~~~ 528 (553)
+ ..+++..+++.+++.++|.+|.++.|++.+-.+..+.....
T Consensus 258 ~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~~~ 317 (364)
T KOG0658|consen 258 TEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDPNT 317 (364)
T ss_pred ccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCcCc
Confidence 0 56778999999999999999999999999977777666533
|
|
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=311.32 Aligned_cols=249 Identities=23% Similarity=0.320 Sum_probs=198.5
Q ss_pred cCCCCeeecccCceeEEEEEeC--------CCCEEEEEEeccCC-hhhHHHHHHHHHHhhcc-CCCceeeEeeEEeeCCc
Q 008785 270 FSEGNRLLGDSKTGGTYSGILP--------DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGD 339 (553)
Q Consensus 270 ~~~~~~~iG~G~~g~Vy~~~~~--------~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~ 339 (553)
|... +.||+|+||.||++... ++..||+|.++... .....++.+|+.+++.+ +||||+++++++...+.
T Consensus 17 ~~~~-~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 95 (304)
T cd05101 17 LTLG-KPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGP 95 (304)
T ss_pred eeec-ceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecCCc
Confidence 4343 44599999999999741 24579999987542 34457789999999999 89999999999999999
Q ss_pred eEEEEEccCCCCHHHHhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecC
Q 008785 340 RYIVYEFVVNGPLDRWLHHIPR------------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE 407 (553)
Q Consensus 340 ~~lV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~ 407 (553)
.+++|||+++|+|.+++..... ....+++..+..++.||+.||.|||++ +++||||||+||++++
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nili~~ 172 (304)
T cd05101 96 LYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVLVTE 172 (304)
T ss_pred eEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceEEEcC
Confidence 9999999999999999975321 123578889999999999999999999 9999999999999999
Q ss_pred CCCeEEeeccccccCCcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhc--Cccccc---chHHHHH
Q 008785 408 EFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL--VLCRRW---WTLYTLV 482 (553)
Q Consensus 408 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~--~~~~~~---~~l~~~~ 482 (553)
++.+||+|||+++...............+++.|+|||++.+..++.++||||||+++|||++ ..+... ..+.+.+
T Consensus 173 ~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~ 252 (304)
T cd05101 173 NNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL 252 (304)
T ss_pred CCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHH
Confidence 99999999999986654332222222225678999999988889999999999999999997 223222 2333333
Q ss_pred hcCCH-----HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 008785 483 HSMSL-----LCAQECLMLFISCNNWPSHLSQSKFCNLKLWVFAI 522 (553)
Q Consensus 483 ~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~~~ 522 (553)
..+.. ..+..+.+++.+||+.+|++|||+.|+++.+...+
T Consensus 253 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~ 297 (304)
T cd05101 253 KEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRIL 297 (304)
T ss_pred HcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHH
Confidence 33322 45678999999999999999999999999886544
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=324.36 Aligned_cols=242 Identities=22% Similarity=0.316 Sum_probs=204.6
Q ss_pred eeecccCceeEEEEEeCC--CC--EEEEEEeccCChh-hHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCC
Q 008785 275 RLLGDSKTGGTYSGILPD--GS--RVAVKRLKRSSFQ-RKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 349 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~~--g~--~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 349 (553)
++||+|.||.|++|.|.. |+ .||||.++..... ..++|++|+.+|.+|+|||+++|||+..+ ....+|+|+++.
T Consensus 116 e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELapl 194 (1039)
T KOG0199|consen 116 ELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAPL 194 (1039)
T ss_pred HHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhccc
Confidence 457999999999999864 44 6999999877554 57899999999999999999999999888 678899999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccc
Q 008785 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE 429 (553)
Q Consensus 350 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 429 (553)
|+|.+.|+. .....+.......++.|||.||.||.++ ++|||||..+|+|+...-.+||+|||+.+.+.......
T Consensus 195 GSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Y 269 (1039)
T KOG0199|consen 195 GSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMY 269 (1039)
T ss_pred chHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCCCCcce
Confidence 999999986 3445678888899999999999999999 99999999999999999999999999999887654332
Q ss_pred ee-eecCccccccccccccCCCCCcccchHhHHHHHHHHhcCccccc-----chHHHHHhcCCH-----HHHHHHHHHHh
Q 008785 430 RT-VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVLCRRW-----WTLYTLVHSMSL-----LCAQECLMLFI 498 (553)
Q Consensus 430 ~~-~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~~~~~-----~~l~~~~~~~~~-----~~~~~l~~l~~ 498 (553)
.. ....-...|.|||.+....++.+||||+|||++|||+++....+ ..+.+.+++|.. .+++.++++++
T Consensus 270 vm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLpRPk~csedIY~imk 349 (1039)
T KOG0199|consen 270 VMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLPRPKYCSEDIYQIMK 349 (1039)
T ss_pred EecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCCCCCCChHHHHHHHH
Confidence 11 11113568999999999999999999999999999998554433 345556666655 88999999999
Q ss_pred hccCCCCCCCCCHHHHHHHHHHHH
Q 008785 499 SCNNWPSHLSQSKFCNLKLWVFAI 522 (553)
Q Consensus 499 ~Cl~~dP~~RPs~~evl~~l~~~~ 522 (553)
.||..+|.+|||+..|.+.++..+
T Consensus 350 ~cWah~paDRptFsair~~~~l~e 373 (1039)
T KOG0199|consen 350 NCWAHNPADRPTFSAIREDLVLAE 373 (1039)
T ss_pred HhccCCccccccHHHHHHhHHHHh
Confidence 999999999999999986654433
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=315.64 Aligned_cols=245 Identities=19% Similarity=0.239 Sum_probs=194.7
Q ss_pred cccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccC-ChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEE
Q 008785 268 KNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYE 345 (553)
Q Consensus 268 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 345 (553)
++|....+ ||+|+||.||++... ++..+|+|.++.. .......+.+|++++++++||||+++++++.+.+..++|||
T Consensus 5 ~~y~~~~~-lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 5 DDFEKISE-LGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhheecc-ccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 34545444 599999999999975 5889999998764 23345678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcc
Q 008785 346 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE 425 (553)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~ 425 (553)
|+++|+|.+++.. ...+++..+..++.|++.||.|||+. .+|+||||||+|||+++++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~ 157 (333)
T cd06650 84 HMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (333)
T ss_pred cCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence 9999999999964 23588899999999999999999974 16999999999999999999999999998755322
Q ss_pred cccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcC-cccccch---HHHHH-------------------
Q 008785 426 VMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLV-LCRRWWT---LYTLV------------------- 482 (553)
Q Consensus 426 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~-~~~~~~~---l~~~~------------------- 482 (553)
.. ....|+..|+|||++.+..++.++|||||||++|||++. .|..... +...+
T Consensus 158 ~~----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (333)
T cd06650 158 MA----NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRP 233 (333)
T ss_pred cc----ccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCC
Confidence 11 112388999999999988899999999999999999962 2222111 11000
Q ss_pred -------------------------hcCC-H-----HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHh
Q 008785 483 -------------------------HSMS-L-----LCAQECLMLFISCNNWPSHLSQSKFCNLKLWVFAIL 523 (553)
Q Consensus 483 -------------------------~~~~-~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~~~~ 523 (553)
.... . ..+.++.+++.+||+.||++|||+.|++++-.....
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 305 (333)
T cd06650 234 PGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 305 (333)
T ss_pred ccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence 0000 0 134578899999999999999999999988655433
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=308.68 Aligned_cols=233 Identities=19% Similarity=0.202 Sum_probs=187.6
Q ss_pred ecccCceeEEEEEeC-CCCEEEEEEeccCCh---hhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCCH
Q 008785 277 LGDSKTGGTYSGILP-DGSRVAVKRLKRSSF---QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352 (553)
Q Consensus 277 iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL 352 (553)
||+|+||.||++... +|+.||+|.+..... .....+..|++++++++||||+++++++.+....++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 599999999999865 589999999975322 2234566799999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccceee
Q 008785 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV 432 (553)
Q Consensus 353 ~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~ 432 (553)
.+++.. .....+++..+..++.|++.||+|||+. +|+||||||+||++++++.++|+|||++......... .
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~---~ 152 (277)
T cd05607 81 KYHIYN--VGERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTI---T 152 (277)
T ss_pred HHHHHh--ccccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCcee---e
Confidence 988864 2334588999999999999999999999 9999999999999999999999999998765433211 1
Q ss_pred ecCccccccccccccCCCCCcccchHhHHHHHHHHhcCc-ccccc-------hHHHHHhcCCH-----HHHHHHHHHHhh
Q 008785 433 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVL-CRRWW-------TLYTLVHSMSL-----LCAQECLMLFIS 499 (553)
Q Consensus 433 ~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~-~~~~~-------~l~~~~~~~~~-----~~~~~l~~l~~~ 499 (553)
...|++.|+|||++.+..++.++|||||||++|||++.. |.... .+......+.. ..+.++.+++.+
T Consensus 153 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 232 (277)
T cd05607 153 QRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRL 232 (277)
T ss_pred ccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHH
Confidence 223889999999999888999999999999999999732 32211 11111111111 356778999999
Q ss_pred ccCCCCCCCCCHHHHHHH
Q 008785 500 CNNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 500 Cl~~dP~~RPs~~evl~~ 517 (553)
||+.||++||++.|+++.
T Consensus 233 ~L~~~P~~R~~~~~~~~~ 250 (277)
T cd05607 233 FLAKKPEDRLGSREKNDD 250 (277)
T ss_pred HhccCHhhCCCCccchhh
Confidence 999999999999665543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=302.89 Aligned_cols=237 Identities=22% Similarity=0.307 Sum_probs=190.7
Q ss_pred ecccCceeEEEEEeC---CCCEEEEEEeccCC-hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCCH
Q 008785 277 LGDSKTGGTYSGILP---DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352 (553)
Q Consensus 277 iG~G~~g~Vy~~~~~---~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL 352 (553)
||+|+||.||+|.+. ++..||+|+++... ....+.+.+|+.++++++||||+++++++. .+..++||||+++|+|
T Consensus 3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~L 81 (257)
T cd05115 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGPL 81 (257)
T ss_pred cCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCCH
Confidence 599999999999864 35579999997653 233567899999999999999999999875 4578999999999999
Q ss_pred HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCccccccee-
Q 008785 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT- 431 (553)
Q Consensus 353 ~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~- 431 (553)
.+++.. ....+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||++............
T Consensus 82 ~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05115 82 NKFLSG---KKDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR 155 (257)
T ss_pred HHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence 999864 234689999999999999999999999 9999999999999999999999999999765433221111
Q ss_pred eecCccccccccccccCCCCCcccchHhHHHHHHHHhc--Ccccccc---hHHHHHhcCCH-----HHHHHHHHHHhhcc
Q 008785 432 VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL--VLCRRWW---TLYTLVHSMSL-----LCAQECLMLFISCN 501 (553)
Q Consensus 432 ~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~--~~~~~~~---~l~~~~~~~~~-----~~~~~l~~l~~~Cl 501 (553)
....++..|+|||++....++.++||||||+++||+++ ..|.... .....+..+.. ..+.++.+++.+||
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~ 235 (257)
T cd05115 156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYALMKDCW 235 (257)
T ss_pred CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHc
Confidence 11113578999999988889999999999999999985 2333222 22233333322 45678999999999
Q ss_pred CCCCCCCCCHHHHHHHHHH
Q 008785 502 NWPSHLSQSKFCNLKLWVF 520 (553)
Q Consensus 502 ~~dP~~RPs~~evl~~l~~ 520 (553)
..||++||++.+|.+.+..
T Consensus 236 ~~~~~~Rp~~~~i~~~l~~ 254 (257)
T cd05115 236 IYKWEDRPNFAKVEERMRT 254 (257)
T ss_pred CCChhhCcCHHHHHHHHhh
Confidence 9999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=317.22 Aligned_cols=233 Identities=22% Similarity=0.218 Sum_probs=187.6
Q ss_pred eecccCceeEEEEEeC-CCCEEEEEEeccCC---hhhHHHHHHHHHHhhcc-CCCceeeEeeEEeeCCceEEEEEccCCC
Q 008785 276 LLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNG 350 (553)
Q Consensus 276 ~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~~g 350 (553)
+||+|+||.||++... +|+.||+|.++... ......+..|..++... +||||+++++++.+.+..|+||||+++|
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g 81 (316)
T cd05620 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGG 81 (316)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCCC
Confidence 4699999999999975 48899999997642 12345567788888764 8999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccce
Q 008785 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER 430 (553)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 430 (553)
+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++........
T Consensus 82 ~L~~~i~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-- 152 (316)
T cd05620 82 DLMFHIQD----KGRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNR-- 152 (316)
T ss_pred cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCc--
Confidence 99998864 24588999999999999999999999 9999999999999999999999999998743222111
Q ss_pred eeecCccccccccccccCCCCCcccchHhHHHHHHHHhcC-cccccc---hHHHHHhcCCH----HHHHHHHHHHhhccC
Q 008785 431 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLV-LCRRWW---TLYTLVHSMSL----LCAQECLMLFISCNN 502 (553)
Q Consensus 431 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~-~~~~~~---~l~~~~~~~~~----~~~~~l~~l~~~Cl~ 502 (553)
.....||+.|+|||++.+..++.++||||||+++|||++. .|.... .+.+.+..+.. .....+.+++.+||+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 232 (316)
T cd05620 153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFE 232 (316)
T ss_pred eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHcc
Confidence 1223389999999999999999999999999999999973 333222 23333322222 346678999999999
Q ss_pred CCCCCCCCHH-HHHHH
Q 008785 503 WPSHLSQSKF-CNLKL 517 (553)
Q Consensus 503 ~dP~~RPs~~-evl~~ 517 (553)
.||++||++. +++++
T Consensus 233 ~dP~~R~~~~~~~~~h 248 (316)
T cd05620 233 RDPTRRLGVVGNIRGH 248 (316)
T ss_pred CCHHHcCCChHHHHcC
Confidence 9999999985 66644
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=315.79 Aligned_cols=233 Identities=21% Similarity=0.238 Sum_probs=187.7
Q ss_pred eecccCceeEEEEEeCC-CCEEEEEEeccCC---hhhHHHHHHHHHHhhcc-CCCceeeEeeEEeeCCceEEEEEccCCC
Q 008785 276 LLGDSKTGGTYSGILPD-GSRVAVKRLKRSS---FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNG 350 (553)
Q Consensus 276 ~iG~G~~g~Vy~~~~~~-g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~~g 350 (553)
.||+|+||.||+|...+ ++.||||.++... ......+..|..++..+ +||||+++++++.+.+..++||||+++|
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g 81 (316)
T cd05619 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGG 81 (316)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCCC
Confidence 46999999999999754 7899999997642 12345566788888764 8999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccce
Q 008785 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER 430 (553)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 430 (553)
+|.+++.. ...+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++.........
T Consensus 82 ~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~- 153 (316)
T cd05619 82 DLMFHIQS----CHKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKT- 153 (316)
T ss_pred cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCce-
Confidence 99999864 24588999999999999999999999 99999999999999999999999999987532221111
Q ss_pred eeecCccccccccccccCCCCCcccchHhHHHHHHHHhcC-cccccc---hHHHHHhcCCH----HHHHHHHHHHhhccC
Q 008785 431 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLV-LCRRWW---TLYTLVHSMSL----LCAQECLMLFISCNN 502 (553)
Q Consensus 431 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~-~~~~~~---~l~~~~~~~~~----~~~~~l~~l~~~Cl~ 502 (553)
....||+.|+|||++.+..++.++|||||||++|||++. .|.... .+.+.+..+.. .....+.+++.+||+
T Consensus 154 -~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~ 232 (316)
T cd05619 154 -CTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLFV 232 (316)
T ss_pred -eeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHhc
Confidence 122389999999999988999999999999999999973 333222 23332222222 355678899999999
Q ss_pred CCCCCCCCHH-HHHHH
Q 008785 503 WPSHLSQSKF-CNLKL 517 (553)
Q Consensus 503 ~dP~~RPs~~-evl~~ 517 (553)
.||++||++. +++++
T Consensus 233 ~~P~~R~~~~~~l~~h 248 (316)
T cd05619 233 REPERRLGVKGDIRQH 248 (316)
T ss_pred cCHhhcCCChHHHHcC
Confidence 9999999997 66654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=306.97 Aligned_cols=246 Identities=22% Similarity=0.308 Sum_probs=196.9
Q ss_pred ccCCCCeeecccCceeEEEEEeCC------CCEEEEEEeccCC-hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceE
Q 008785 269 NFSEGNRLLGDSKTGGTYSGILPD------GSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRY 341 (553)
Q Consensus 269 ~~~~~~~~iG~G~~g~Vy~~~~~~------g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 341 (553)
+|.... .||+|+||.||+|...+ +..||+|.+.... ......+.+|+.+++.++||||+++++++......+
T Consensus 7 ~~~~~~-~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~ 85 (277)
T cd05032 7 KITLIR-ELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTL 85 (277)
T ss_pred HeeEEe-EecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcE
Confidence 344434 45999999999998643 3689999987553 344567889999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHhccCCCC------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEee
Q 008785 342 IVYEFVVNGPLDRWLHHIPRG------GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMG 415 (553)
Q Consensus 342 lV~E~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~D 415 (553)
+||||+++|+|.+++...... ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|
T Consensus 86 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl~d 162 (277)
T cd05032 86 VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIGD 162 (277)
T ss_pred EEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEECC
Confidence 999999999999999653221 23478889999999999999999999 999999999999999999999999
Q ss_pred ccccccCCcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhc-Cc-cccc---chHHHHHhcCCH---
Q 008785 416 VGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-VL-CRRW---WTLYTLVHSMSL--- 487 (553)
Q Consensus 416 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-~~-~~~~---~~l~~~~~~~~~--- 487 (553)
||+++...............++..|+|||.+.+..++.++||||||+++||+++ .. +... ..+.+.+..+..
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~ 242 (277)
T cd05032 163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHLDL 242 (277)
T ss_pred cccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCCCCCC
Confidence 999876543322111122226788999999988889999999999999999996 22 2222 223333333322
Q ss_pred --HHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008785 488 --LCAQECLMLFISCNNWPSHLSQSKFCNLKLW 518 (553)
Q Consensus 488 --~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l 518 (553)
..+..+.+++.+||+.+|++|||+.++++.+
T Consensus 243 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l 275 (277)
T cd05032 243 PENCPDKLLELMRMCWQYNPKMRPTFLEIVSSL 275 (277)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHh
Confidence 4577899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=301.80 Aligned_cols=246 Identities=24% Similarity=0.316 Sum_probs=199.9
Q ss_pred ccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccC---ChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEE
Q 008785 269 NFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS---SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVY 344 (553)
Q Consensus 269 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 344 (553)
+|.... .||+|++|.||+|... +|+.||+|.++.. .....+.+.+|++++++++|+||+++++.+.+.+..++||
T Consensus 3 ~y~~~~-~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 3 NFKIEK-KIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred ceeeee-eeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 444434 4599999999999976 6899999988642 2334567899999999999999999999999999999999
Q ss_pred EccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCc
Q 008785 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW 424 (553)
Q Consensus 345 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~ 424 (553)
||+++|+|.+++.........+++.++..++.|++.||.|||+. +++||||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 99999999999875444456689999999999999999999999 999999999999999999999999999876543
Q ss_pred ccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcC-ccccc--ch---HHHHHhcCCH------HHHHH
Q 008785 425 EVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLV-LCRRW--WT---LYTLVHSMSL------LCAQE 492 (553)
Q Consensus 425 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~-~~~~~--~~---l~~~~~~~~~------~~~~~ 492 (553)
...... ...+++.|+|||.+.+..++.++||||||+++|+|++. .|... .+ +.+.+..+.. ..+..
T Consensus 159 ~~~~~~--~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (267)
T cd08224 159 KTTAAH--SLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEE 236 (267)
T ss_pred CCcccc--eecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCHH
Confidence 322111 12378899999999888899999999999999999973 23211 12 2222222222 45568
Q ss_pred HHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 008785 493 CLMLFISCNNWPSHLSQSKFCNLKLWVF 520 (553)
Q Consensus 493 l~~l~~~Cl~~dP~~RPs~~evl~~l~~ 520 (553)
+.+++.+||+.+|++|||+.+|++.+..
T Consensus 237 ~~~~i~~cl~~~p~~Rp~~~~il~~~~~ 264 (267)
T cd08224 237 LRDLVSRCINPDPEKRPDISYVLQVAKE 264 (267)
T ss_pred HHHHHHHHcCCCcccCCCHHHHHHHHHH
Confidence 8999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=306.17 Aligned_cols=241 Identities=21% Similarity=0.313 Sum_probs=192.8
Q ss_pred eeecccCceeEEEEEeC-CCC----EEEEEEeccC-ChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccC
Q 008785 275 RLLGDSKTGGTYSGILP-DGS----RVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV 348 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~-~g~----~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 348 (553)
+.||+|+||.||+|.+. +|+ .||+|+++.. ......++.+|+.++..++||||+++++++.. ...++++||++
T Consensus 13 ~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l~~~~~~ 91 (279)
T cd05109 13 KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQLVTQLMP 91 (279)
T ss_pred eecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEEEEEcCC
Confidence 34599999999999853 444 4899998754 33445778999999999999999999999875 45789999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCccccc
Q 008785 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ 428 (553)
Q Consensus 349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 428 (553)
+|+|.+++.. ....+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++........
T Consensus 92 ~g~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~~ 165 (279)
T cd05109 92 YGCLLDYVRE---NKDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETE 165 (279)
T ss_pred CCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceeecccccce
Confidence 9999999864 234589999999999999999999999 9999999999999999999999999999876533222
Q ss_pred ceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhc-C-ccccc---chHHHHHhcCCH-----HHHHHHHHHHh
Q 008785 429 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-V-LCRRW---WTLYTLVHSMSL-----LCAQECLMLFI 498 (553)
Q Consensus 429 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-~-~~~~~---~~l~~~~~~~~~-----~~~~~l~~l~~ 498 (553)
.......+++.|+|||...+..++.++||||||+++|||++ . .|... ..+...+..+.. ..+..+.+++.
T Consensus 166 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 245 (279)
T cd05109 166 YHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTIDVYMIMV 245 (279)
T ss_pred eecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCccCCHHHHHHHH
Confidence 11111124678999999988899999999999999999986 2 22222 223334444322 45678899999
Q ss_pred hccCCCCCCCCCHHHHHHHHHHHH
Q 008785 499 SCNNWPSHLSQSKFCNLKLWVFAI 522 (553)
Q Consensus 499 ~Cl~~dP~~RPs~~evl~~l~~~~ 522 (553)
+||+.||++||++.++++.+....
T Consensus 246 ~~l~~dp~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05109 246 KCWMIDSECRPRFRELVDEFSRMA 269 (279)
T ss_pred HHcCCChhhCcCHHHHHHHHHHhh
Confidence 999999999999999998775543
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=307.92 Aligned_cols=250 Identities=22% Similarity=0.324 Sum_probs=196.0
Q ss_pred ccCCCCeeecccCceeEEEEEeCC------CCEEEEEEeccCC-hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceE
Q 008785 269 NFSEGNRLLGDSKTGGTYSGILPD------GSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRY 341 (553)
Q Consensus 269 ~~~~~~~~iG~G~~g~Vy~~~~~~------g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 341 (553)
+|.... .||+|+||.||+|..++ +..||+|.++... ......+.+|+.++++++||||+++++++.+.+..+
T Consensus 7 ~~~i~~-~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 85 (288)
T cd05061 7 KITLLR-ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTL 85 (288)
T ss_pred Hceeee-eecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcE
Confidence 444444 45999999999997532 4589999987543 234456889999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHhccCCC------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEee
Q 008785 342 IVYEFVVNGPLDRWLHHIPR------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMG 415 (553)
Q Consensus 342 lV~E~~~~gsL~~~l~~~~~------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~D 415 (553)
+||||+++|+|.+++..... ....+++..+..++.|++.||.|||++ +|+||||||+||++++++.++|+|
T Consensus 86 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~L~D 162 (288)
T cd05061 86 VVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGD 162 (288)
T ss_pred EEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEEECc
Confidence 99999999999999975321 123456778899999999999999999 999999999999999999999999
Q ss_pred ccccccCCcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhc--Cccccc---chHHHHHhcCCH---
Q 008785 416 VGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL--VLCRRW---WTLYTLVHSMSL--- 487 (553)
Q Consensus 416 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~--~~~~~~---~~l~~~~~~~~~--- 487 (553)
||+++...............++..|+|||.+.++.++.++||||||+++|||++ ..|... ..+.+.+..+..
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 242 (288)
T cd05061 163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQ 242 (288)
T ss_pred CCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 999986543322111111225678999999988899999999999999999996 222222 223232222211
Q ss_pred --HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 008785 488 --LCAQECLMLFISCNNWPSHLSQSKFCNLKLWVFAI 522 (553)
Q Consensus 488 --~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~~~ 522 (553)
..+..+.+++.+|++.||++|||+.++++.+...+
T Consensus 243 ~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 243 PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 44678999999999999999999999998876543
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=316.21 Aligned_cols=233 Identities=21% Similarity=0.239 Sum_probs=187.4
Q ss_pred eeecccCceeEEEEEeC-CCCEEEEEEeccCC---hhhHHHHHHHHHHh---hccCCCceeeEeeEEeeCCceEEEEEcc
Q 008785 275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRF---ARLHHPNLVAVKGCCYDHGDRYIVYEFV 347 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l---~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 347 (553)
+.||+|+||.||++... +|+.||||+++... ....+.+.+|+.++ ++++||||+++++++.+.+..|+||||+
T Consensus 5 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~E~~ 84 (324)
T cd05589 5 AVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEYA 84 (324)
T ss_pred EEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEEcCC
Confidence 45699999999999865 58999999997542 22234566666554 5678999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccc
Q 008785 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM 427 (553)
Q Consensus 348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 427 (553)
++|+|..++.. ..+++..+..++.||+.||+|||+. +|+||||||+||++++++.+||+|||+++.......
T Consensus 85 ~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~ 156 (324)
T cd05589 85 AGGDLMMHIHT-----DVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGD 156 (324)
T ss_pred CCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCC
Confidence 99999988753 3589999999999999999999999 999999999999999999999999999875332221
Q ss_pred cceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcC-cccccc---hHHHHHhcCCH----HHHHHHHHHHhh
Q 008785 428 QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLV-LCRRWW---TLYTLVHSMSL----LCAQECLMLFIS 499 (553)
Q Consensus 428 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~-~~~~~~---~l~~~~~~~~~----~~~~~l~~l~~~ 499 (553)
. .....|++.|+|||.+.+..++.++||||||+++|||++. .|.... .+.+.+..+.. ..+..+.+++.+
T Consensus 157 ~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~ 234 (324)
T cd05589 157 R--TSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAISIMRR 234 (324)
T ss_pred c--ccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 1 1223389999999999998999999999999999999973 333222 22232322222 456778999999
Q ss_pred ccCCCCCCCC-----CHHHHHHH
Q 008785 500 CNNWPSHLSQ-----SKFCNLKL 517 (553)
Q Consensus 500 Cl~~dP~~RP-----s~~evl~~ 517 (553)
||+.||++|| ++.+++++
T Consensus 235 ~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 235 LLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred HhhcCHhHcCCCCCCCHHHHhhC
Confidence 9999999999 67787775
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=307.12 Aligned_cols=231 Identities=27% Similarity=0.318 Sum_probs=182.6
Q ss_pred eecccCceeEEEEEeCC-------------------------CCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeE
Q 008785 276 LLGDSKTGGTYSGILPD-------------------------GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAV 330 (553)
Q Consensus 276 ~iG~G~~g~Vy~~~~~~-------------------------g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l 330 (553)
.||+|+||.||+|.+.. ...||+|.+..........+.+|+.++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 36999999999997421 23589999976554455678899999999999999999
Q ss_pred eeEEeeCCceEEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCC-
Q 008785 331 KGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF- 409 (553)
Q Consensus 331 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~- 409 (553)
++++.+....++||||+++|+|..++.. ....+++..+..++.||+.||+|||++ +|+||||||+|||+++.+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~~ 155 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRK---EKGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGL 155 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccCc
Confidence 9999999999999999999999999864 234688999999999999999999999 999999999999997643
Q ss_pred ------CeEEeeccccccCCcccccceeeecCccccccccccccC-CCCCcccchHhHHHHHHHHh-c-Ccccccc---h
Q 008785 410 ------GAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIR-L-VLCRRWW---T 477 (553)
Q Consensus 410 ------~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwSlGvil~ell-~-~~~~~~~---~ 477 (553)
.+|++|||++........ ..++..|+|||.+.+ ..++.++||||||+++|||+ + ..|.... .
T Consensus 156 ~~~~~~~~kl~d~g~~~~~~~~~~------~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~ 229 (274)
T cd05076 156 AEGTSPFIKLSDPGVSFTALSREE------RVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE 229 (274)
T ss_pred ccCccceeeecCCccccccccccc------cccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH
Confidence 379999998764322111 126788999998865 56899999999999999996 3 2222211 1
Q ss_pred HHHHHhcC-CH--HHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008785 478 LYTLVHSM-SL--LCAQECLMLFISCNNWPSHLSQSKFCNLKLW 518 (553)
Q Consensus 478 l~~~~~~~-~~--~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l 518 (553)
........ .. .....+.+++.+||+.+|++|||+.++++.|
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 230 KERFYEKKHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred HHHHHHhccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 11111111 11 2345789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=319.42 Aligned_cols=233 Identities=24% Similarity=0.259 Sum_probs=190.0
Q ss_pred eecccCceeEEEEEe----CCCCEEEEEEeccCCh--hhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCC
Q 008785 276 LLGDSKTGGTYSGIL----PDGSRVAVKRLKRSSF--QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 349 (553)
Q Consensus 276 ~iG~G~~g~Vy~~~~----~~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 349 (553)
.||+|+||.||++.. .+|+.||+|+++.... .....+.+|++++++++||||+++++++.+.+..|+||||+++
T Consensus 3 ~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 82 (318)
T cd05582 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRG 82 (318)
T ss_pred eeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCCC
Confidence 469999999999874 3588999999976432 2345677899999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccc
Q 008785 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE 429 (553)
Q Consensus 350 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 429 (553)
|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++........
T Consensus 83 ~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~- 154 (318)
T cd05582 83 GDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK- 154 (318)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCc-
Confidence 999999854 24589999999999999999999999 9999999999999999999999999998765433211
Q ss_pred eeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcC-cccccc---hHHHHHhcCCH----HHHHHHHHHHhhcc
Q 008785 430 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLV-LCRRWW---TLYTLVHSMSL----LCAQECLMLFISCN 501 (553)
Q Consensus 430 ~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~-~~~~~~---~l~~~~~~~~~----~~~~~l~~l~~~Cl 501 (553)
.....||+.|+|||.+.+..++.++||||||+++|||++. .|.... .....+..+.. ..+..+.+++.+||
T Consensus 155 -~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l 233 (318)
T cd05582 155 -AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRALF 233 (318)
T ss_pred -eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHh
Confidence 1223389999999999888899999999999999999973 333222 22223333322 45677899999999
Q ss_pred CCCCCCCCC-----HHHHHHH
Q 008785 502 NWPSHLSQS-----KFCNLKL 517 (553)
Q Consensus 502 ~~dP~~RPs-----~~evl~~ 517 (553)
+.||++||+ +.+++++
T Consensus 234 ~~~P~~R~~a~~~~~~~~~~~ 254 (318)
T cd05582 234 KRNPANRLGAGPDGVEEIKRH 254 (318)
T ss_pred hcCHhHcCCCCCCCHHHHhCC
Confidence 999999999 5556654
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=322.88 Aligned_cols=227 Identities=23% Similarity=0.301 Sum_probs=193.6
Q ss_pred eeecccCceeEEEEEeC-CCCEEEEEEeccCCh---hhHHHHHHHHHHhhcc-CCCceeeEeeEEeeCCceEEEEEccCC
Q 008785 275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF---QRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVN 349 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~~ 349 (553)
++||+|.||+|+.+..+ +++.+|||++++... .+.+....|.+++... +||.+++++..|.+.+++|.||||+.|
T Consensus 374 ~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey~~G 453 (694)
T KOG0694|consen 374 AVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEYVAG 453 (694)
T ss_pred EEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEecCC
Confidence 46799999999999975 488999999998743 3456677888888777 599999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccc
Q 008785 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE 429 (553)
Q Consensus 350 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 429 (553)
|++..+.+ ...+++..+..++..|+.||+|||++ +||+||||.+|||+|.+|.+||+|||+++..-....
T Consensus 454 gdm~~~~~-----~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g~-- 523 (694)
T KOG0694|consen 454 GDLMHHIH-----TDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQGD-- 523 (694)
T ss_pred CcEEEEEe-----cccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccccccCCCCC--
Confidence 99654433 35699999999999999999999999 999999999999999999999999999986543332
Q ss_pred eeeecCccccccccccccCCCCCcccchHhHHHHHHHHhc----CcccccchHHHHHhcCCH----HHHHHHHHHHhhcc
Q 008785 430 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL----VLCRRWWTLYTLVHSMSL----LCAQECLMLFISCN 501 (553)
Q Consensus 430 ~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~----~~~~~~~~l~~~~~~~~~----~~~~~l~~l~~~Cl 501 (553)
.+.+.+|||.|||||++.+..|+.+.|.|||||+||||+. +..++..++.+.+..... ..+.+...++.+.+
T Consensus 524 ~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~~ls~ea~~il~~ll 603 (694)
T KOG0694|consen 524 RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSKEAIAIMRRLL 603 (694)
T ss_pred ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCcccHHHHHHHHHHh
Confidence 4456679999999999999999999999999999999995 344455667774444333 67888999999999
Q ss_pred CCCCCCCCCH
Q 008785 502 NWPSHLSQSK 511 (553)
Q Consensus 502 ~~dP~~RPs~ 511 (553)
..||++|.-+
T Consensus 604 ~k~p~kRLG~ 613 (694)
T KOG0694|consen 604 RKNPEKRLGS 613 (694)
T ss_pred ccCcccccCC
Confidence 9999999877
|
|
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=306.03 Aligned_cols=247 Identities=25% Similarity=0.320 Sum_probs=194.4
Q ss_pred ccCCCCeeecccCceeEEEEEeCC------CCEEEEEEeccCC-hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceE
Q 008785 269 NFSEGNRLLGDSKTGGTYSGILPD------GSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRY 341 (553)
Q Consensus 269 ~~~~~~~~iG~G~~g~Vy~~~~~~------g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 341 (553)
+|...+ .||+|++|.||+|...+ +..||+|.++... ......+.+|+.++++++||||+++++++.+.+..+
T Consensus 7 ~~~~~~-~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 85 (277)
T cd05036 7 SITLLR-ALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRF 85 (277)
T ss_pred HcEeee-ECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcE
Confidence 344433 55999999999999753 5689999887543 334567899999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHhccCCC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCC---CeEEee
Q 008785 342 IVYEFVVNGPLDRWLHHIPR---GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF---GAHLMG 415 (553)
Q Consensus 342 lV~E~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~---~~kl~D 415 (553)
+||||+++++|.+++..... ....+++..+..++.||+.||+|||++ +++||||||+||+++.++ .+||+|
T Consensus 86 lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl~d 162 (277)
T cd05036 86 ILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIAD 162 (277)
T ss_pred EEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEecc
Confidence 99999999999999975321 123589999999999999999999999 999999999999998754 589999
Q ss_pred ccccccCCcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhc-C-ccccc---chHHHHHhcC-CH--
Q 008785 416 VGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-V-LCRRW---WTLYTLVHSM-SL-- 487 (553)
Q Consensus 416 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-~-~~~~~---~~l~~~~~~~-~~-- 487 (553)
||+++................+..|+|||++.+..++.++|||||||++|||++ . .|... ..+.+.+..+ ..
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~ 242 (277)
T cd05036 163 FGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRLDP 242 (277)
T ss_pred CccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCC
Confidence 999986633222111111113568999999998899999999999999999986 2 22222 2333333222 11
Q ss_pred --HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 008785 488 --LCAQECLMLFISCNNWPSHLSQSKFCNLKLWV 519 (553)
Q Consensus 488 --~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~ 519 (553)
..+..+.+++.+|++.+|++|||+.++++++.
T Consensus 243 ~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 243 PKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 45678899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=301.37 Aligned_cols=240 Identities=28% Similarity=0.393 Sum_probs=198.7
Q ss_pred eecccCceeEEEEEeCC----CCEEEEEEeccCChh-hHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCC
Q 008785 276 LLGDSKTGGTYSGILPD----GSRVAVKRLKRSSFQ-RKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 350 (553)
Q Consensus 276 ~iG~G~~g~Vy~~~~~~----g~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 350 (553)
.||+|+||.||++...+ +..||+|.++..... ..+.+.+|++.+..++||||+++++++.+....++||||++++
T Consensus 2 ~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 81 (262)
T cd00192 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGG 81 (262)
T ss_pred ccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccCC
Confidence 46999999999999754 789999999876433 3678899999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcc
Q 008785 351 PLDRWLHHIPRG-----GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE 425 (553)
Q Consensus 351 sL~~~l~~~~~~-----~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~ 425 (553)
+|.+++...... ...+++..+..++.|++.||+|||++ +++||||||+||++++++.++|+|||.+......
T Consensus 82 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 158 (262)
T cd00192 82 DLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD 158 (262)
T ss_pred cHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEcccccccccccc
Confidence 999999763211 36689999999999999999999999 9999999999999999999999999999876654
Q ss_pred cccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcC--cccccc---hHHHHHhcCCH-----HHHHHHHH
Q 008785 426 VMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLV--LCRRWW---TLYTLVHSMSL-----LCAQECLM 495 (553)
Q Consensus 426 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~--~~~~~~---~l~~~~~~~~~-----~~~~~l~~ 495 (553)
..........++..|+|||.+....++.++||||||+++|||++. .|.... .+.+.+..+.. ..+..+.+
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (262)
T cd00192 159 DYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPDELYE 238 (262)
T ss_pred cccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCccCChHHHH
Confidence 321222223378899999999888899999999999999999972 333222 23333332221 45688999
Q ss_pred HHhhccCCCCCCCCCHHHHHHHH
Q 008785 496 LFISCNNWPSHLSQSKFCNLKLW 518 (553)
Q Consensus 496 l~~~Cl~~dP~~RPs~~evl~~l 518 (553)
++.+||+.||++|||+.|+++.+
T Consensus 239 li~~~l~~~p~~Rps~~~l~~~l 261 (262)
T cd00192 239 LMLSCWQLDPEDRPTFSELVERL 261 (262)
T ss_pred HHHHHccCCcccCcCHHHHHHhh
Confidence 99999999999999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=310.07 Aligned_cols=247 Identities=25% Similarity=0.284 Sum_probs=196.9
Q ss_pred ccCCCCeeecccCceeEEEEEeC------CCCEEEEEEeccCC-hhhHHHHHHHHHHhhcc-CCCceeeEeeEEeeCCce
Q 008785 269 NFSEGNRLLGDSKTGGTYSGILP------DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDR 340 (553)
Q Consensus 269 ~~~~~~~~iG~G~~g~Vy~~~~~------~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~ 340 (553)
+|...+ .||+|+||.||++... ++..||||.++... ....+.+.+|+.+++++ +||||+++++++...+..
T Consensus 36 ~~~~~~-~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 114 (302)
T cd05055 36 NLSFGK-TLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI 114 (302)
T ss_pred HeEEcc-eeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence 454444 4599999999999741 24579999987653 33456789999999999 799999999999999999
Q ss_pred EEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccc
Q 008785 341 YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSK 420 (553)
Q Consensus 341 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~ 420 (553)
++||||+++|+|.++++.. ....+++.++..++.|++.||+|||++ +|+|+||||+|||+++++.++++|||+++
T Consensus 115 ~lv~e~~~~~~L~~~i~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~~~ 189 (302)
T cd05055 115 LVITEYCCYGDLLNFLRRK--RESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLAR 189 (302)
T ss_pred EEEEEcCCCCcHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCcccc
Confidence 9999999999999999652 223489999999999999999999999 99999999999999999999999999998
Q ss_pred cCCcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhc-Cc-ccccc----hHHHHHhcCCH-----HH
Q 008785 421 FVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-VL-CRRWW----TLYTLVHSMSL-----LC 489 (553)
Q Consensus 421 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-~~-~~~~~----~l~~~~~~~~~-----~~ 489 (553)
...............++..|+|||.+.+..++.++||||||+++|||++ .. |.... .+...+..+.. ..
T Consensus 190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (302)
T cd05055 190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPEHA 269 (302)
T ss_pred cccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCCCCCC
Confidence 6543322111111225678999999998899999999999999999986 32 32221 12223332211 34
Q ss_pred HHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 008785 490 AQECLMLFISCNNWPSHLSQSKFCNLKLWVFA 521 (553)
Q Consensus 490 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~~ 521 (553)
+..+.+++.+|++.+|++|||+.|+++.+...
T Consensus 270 ~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 270 PAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred CHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 67899999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=307.21 Aligned_cols=241 Identities=22% Similarity=0.293 Sum_probs=195.1
Q ss_pred eecccCceeEEEEEeC------CCCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCC
Q 008785 276 LLGDSKTGGTYSGILP------DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 349 (553)
Q Consensus 276 ~iG~G~~g~Vy~~~~~------~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 349 (553)
.||+|+||.||++... ++..+|+|.++.........+.+|++++++++||||+++++++.+.+..+++|||+++
T Consensus 12 ~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 91 (280)
T cd05092 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRH 91 (280)
T ss_pred ccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEEecCCC
Confidence 4599999999999742 3568999999877666678899999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccc
Q 008785 350 GPLDRWLHHIPR-----------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGL 418 (553)
Q Consensus 350 gsL~~~l~~~~~-----------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgl 418 (553)
|+|.+++..... ....+++..+..++.|++.||+|||+. +++||||||+|||+++++.+||+|||+
T Consensus 92 ~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~ 168 (280)
T cd05092 92 GDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLVVKIGDFGM 168 (280)
T ss_pred CCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCCEEECCCCc
Confidence 999999865321 113578999999999999999999999 999999999999999999999999999
Q ss_pred cccCCcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhc-Cc-cccc---chHHHHHhcCCH-----H
Q 008785 419 SKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-VL-CRRW---WTLYTLVHSMSL-----L 488 (553)
Q Consensus 419 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-~~-~~~~---~~l~~~~~~~~~-----~ 488 (553)
+................+++.|+|||++.+..++.++||||||+++|||++ .. |... ....+.+..+.. .
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 248 (280)
T cd05092 169 SRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGRELERPRT 248 (280)
T ss_pred eeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHcCccCCCCCC
Confidence 875543222111111225678999999998899999999999999999997 33 2222 222222322221 4
Q ss_pred HHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 008785 489 CAQECLMLFISCNNWPSHLSQSKFCNLKLWV 519 (553)
Q Consensus 489 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~ 519 (553)
.+..+.+++.+||+.||.+||++.||++.+.
T Consensus 249 ~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 249 CPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred CCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 5678999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=300.97 Aligned_cols=236 Identities=24% Similarity=0.292 Sum_probs=195.5
Q ss_pred eeecccCceeEEEEEeC-CCCEEEEEEeccC--ChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCC
Q 008785 275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP 351 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gs 351 (553)
+.||+|++|.||++... +++.|++|.+... .......+.+|+.++++++||||+++++++.+.+..++||||+++++
T Consensus 6 ~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 85 (256)
T cd08529 6 NKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGD 85 (256)
T ss_pred EEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCCCCc
Confidence 34699999999999975 5889999998643 34456788999999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCccccccee
Q 008785 352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT 431 (553)
Q Consensus 352 L~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~ 431 (553)
|.+++... ....+++..+..++.|++.||.|||+. +++||||||+||++++++.++|+|||++...........
T Consensus 86 L~~~l~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~~- 159 (256)
T cd08529 86 LHKLLKMQ--RGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFAN- 159 (256)
T ss_pred HHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCccchhh-
Confidence 99999752 235689999999999999999999999 999999999999999999999999999886654322211
Q ss_pred eecCccccccccccccCCCCCcccchHhHHHHHHHHhcCc-ccccc---hHHHHHhcCCH-----HHHHHHHHHHhhccC
Q 008785 432 VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVL-CRRWW---TLYTLVHSMSL-----LCAQECLMLFISCNN 502 (553)
Q Consensus 432 ~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~-~~~~~---~l~~~~~~~~~-----~~~~~l~~l~~~Cl~ 502 (553)
...|++.|+|||++.+..++.++|+||||+++|||++.. |.... .....+..+.. ..+..+.+++.+||+
T Consensus 160 -~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 238 (256)
T cd08529 160 -TIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQCLT 238 (256)
T ss_pred -ccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHHcc
Confidence 123788999999999989999999999999999999732 32222 22222222222 456789999999999
Q ss_pred CCCCCCCCHHHHHHH
Q 008785 503 WPSHLSQSKFCNLKL 517 (553)
Q Consensus 503 ~dP~~RPs~~evl~~ 517 (553)
.+|++||++.+++++
T Consensus 239 ~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 239 KDYRQRPDTFQLLRN 253 (256)
T ss_pred CCcccCcCHHHHhhC
Confidence 999999999999874
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=316.93 Aligned_cols=233 Identities=22% Similarity=0.234 Sum_probs=186.9
Q ss_pred eecccCceeEEEEEeC-CCCEEEEEEeccCCh---hhHHHHHHHHH-HhhccCCCceeeEeeEEeeCCceEEEEEccCCC
Q 008785 276 LLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF---QRKKEFYSEIG-RFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 350 (553)
Q Consensus 276 ~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~---~~~~~~~~E~~-~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 350 (553)
+||+|+||+||++... +|+.||||++..... .....+..|.. +++.++||||+++++.+.+.+..++||||+++|
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g 81 (323)
T cd05575 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGG 81 (323)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCC
Confidence 4699999999999975 589999999975422 22344555554 567899999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccce
Q 008785 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER 430 (553)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 430 (553)
+|.+++.. ...+++..+..++.||+.||.|||++ +|+||||||+|||+++++.+||+|||+++........
T Consensus 82 ~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~-- 152 (323)
T cd05575 82 ELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKT-- 152 (323)
T ss_pred CHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCc--
Confidence 99998864 34588999999999999999999999 9999999999999999999999999998753322111
Q ss_pred eeecCccccccccccccCCCCCcccchHhHHHHHHHHhcC-cccccc---hHHHHHhcCCH----HHHHHHHHHHhhccC
Q 008785 431 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLV-LCRRWW---TLYTLVHSMSL----LCAQECLMLFISCNN 502 (553)
Q Consensus 431 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~-~~~~~~---~l~~~~~~~~~----~~~~~l~~l~~~Cl~ 502 (553)
.....||+.|+|||++.+..++.++|||||||++|||++. .|.... .+.+.+..+.. ..+..+.+++.+||+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~ 232 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLLQ 232 (323)
T ss_pred cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhh
Confidence 1122389999999999999999999999999999999973 333322 23332322222 457789999999999
Q ss_pred CCCCCCCCHH----HHHHH
Q 008785 503 WPSHLSQSKF----CNLKL 517 (553)
Q Consensus 503 ~dP~~RPs~~----evl~~ 517 (553)
.||++||++. +++++
T Consensus 233 ~~p~~R~~~~~~~~~il~~ 251 (323)
T cd05575 233 KDRTKRLGAKDDFLEIKNH 251 (323)
T ss_pred cCHHhCCCCCCCHHHHHcC
Confidence 9999999984 66554
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=319.61 Aligned_cols=230 Identities=23% Similarity=0.312 Sum_probs=183.6
Q ss_pred eecccCceeEEEEEeC-CCCEEEEEEeccCC-hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCCHH
Q 008785 276 LLGDSKTGGTYSGILP-DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 353 (553)
Q Consensus 276 ~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~ 353 (553)
.||+|+||.||++... +|+.||||++.... ......+.+|++++++++|+||+++++++.+.+..++||||+++|+|.
T Consensus 81 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 160 (353)
T PLN00034 81 RIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLE 160 (353)
T ss_pred hccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCCCccc
Confidence 4599999999999965 58999999996543 334567899999999999999999999999999999999999999985
Q ss_pred HHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccceeee
Q 008785 354 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVM 433 (553)
Q Consensus 354 ~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 433 (553)
+. ...++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++......... ..
T Consensus 161 ~~--------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~--~~ 227 (353)
T PLN00034 161 GT--------HIADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPC--NS 227 (353)
T ss_pred cc--------ccCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceecccccccc--cc
Confidence 43 2356778889999999999999999 99999999999999999999999999998654322111 12
Q ss_pred cCccccccccccccC-----CCCCcccchHhHHHHHHHHhcC-cccc---cchHHH---HHhcC-----CHHHHHHHHHH
Q 008785 434 AGGTYGYLAPEFVYR-----NELTTKSDVYSFGVLLLEIRLV-LCRR---WWTLYT---LVHSM-----SLLCAQECLML 496 (553)
Q Consensus 434 ~~gt~~y~aPE~~~~-----~~~t~ksDVwSlGvil~ell~~-~~~~---~~~l~~---~~~~~-----~~~~~~~l~~l 496 (553)
..||..|+|||++.. ...+.++|||||||++|||++. .+.. ...... .+... ....+..+.++
T Consensus 228 ~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 307 (353)
T PLN00034 228 SVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASREFRHF 307 (353)
T ss_pred cccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCHHHHHH
Confidence 238999999998743 2345689999999999999973 2221 111111 11111 11556789999
Q ss_pred HhhccCCCCCCCCCHHHHHHHH
Q 008785 497 FISCNNWPSHLSQSKFCNLKLW 518 (553)
Q Consensus 497 ~~~Cl~~dP~~RPs~~evl~~l 518 (553)
+.+||+.||++|||+.|++++-
T Consensus 308 i~~~l~~~P~~Rpt~~ell~hp 329 (353)
T PLN00034 308 ISCCLQREPAKRWSAMQLLQHP 329 (353)
T ss_pred HHHHccCChhhCcCHHHHhcCc
Confidence 9999999999999999999874
|
|
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=308.10 Aligned_cols=248 Identities=24% Similarity=0.333 Sum_probs=197.4
Q ss_pred cccCCCCeeecccCceeEEEEEeC------CCCEEEEEEeccCC-hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCce
Q 008785 268 KNFSEGNRLLGDSKTGGTYSGILP------DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR 340 (553)
Q Consensus 268 ~~~~~~~~~iG~G~~g~Vy~~~~~------~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 340 (553)
++|....++ |+|+||.||++... ++..||+|.+.... .....++.+|+.++++++||||+++++++.+....
T Consensus 5 ~~~~~~~~l-g~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 5 NNIEYVRDI-GQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred Hhceecccc-cccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 345555555 99999999999863 46789999987653 33456799999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHhccCC------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCc
Q 008785 341 YIVYEFVVNGPLDRWLHHIP------------------RGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASN 402 (553)
Q Consensus 341 ~lV~E~~~~gsL~~~l~~~~------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~N 402 (553)
+++|||+++|+|.+++.... .....+++..++.++.|++.||.|||++ +++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHhh
Confidence 99999999999999996421 1123578889999999999999999999 99999999999
Q ss_pred EEecCCCCeEEeeccccccCCcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhc-C-ccccc---ch
Q 008785 403 VLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-V-LCRRW---WT 477 (553)
Q Consensus 403 ILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-~-~~~~~---~~ 477 (553)
|++++++.++|+|||++.................+..|+|||.+.+..++.++||||||+++|||++ . .|... ..
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~ 240 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE 240 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999999875433221111111124667999999988899999999999999999986 2 23322 23
Q ss_pred HHHHHhcCCH-----HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 008785 478 LYTLVHSMSL-----LCAQECLMLFISCNNWPSHLSQSKFCNLKLWV 519 (553)
Q Consensus 478 l~~~~~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~ 519 (553)
....+..+.. ..+..+.+++.+||+.+|++|||+.|+++.|.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 241 VIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred HHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 3333333332 45678999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=310.01 Aligned_cols=252 Identities=24% Similarity=0.323 Sum_probs=198.9
Q ss_pred ccCCCCeeecccCceeEEEEEeC--------CCCEEEEEEeccCC-hhhHHHHHHHHHHhhcc-CCCceeeEeeEEeeCC
Q 008785 269 NFSEGNRLLGDSKTGGTYSGILP--------DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHG 338 (553)
Q Consensus 269 ~~~~~~~~iG~G~~g~Vy~~~~~--------~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~ 338 (553)
+|..... ||+|+||.||++... ++..||+|.++... .....++.+|+.+++++ +||||+++++++...+
T Consensus 19 ~~~i~~~-lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (307)
T cd05098 19 RLVLGKP-LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 97 (307)
T ss_pred HeEEeee-eccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 3444444 599999999999752 23579999998642 33456788999999999 7999999999999999
Q ss_pred ceEEEEEccCCCCHHHHhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEec
Q 008785 339 DRYIVYEFVVNGPLDRWLHHIPR------------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD 406 (553)
Q Consensus 339 ~~~lV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~ 406 (553)
..++||||+++|+|.+++..... ....+++.+++.++.|++.||+|||+. +++||||||+||+++
T Consensus 98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~ 174 (307)
T cd05098 98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVT 174 (307)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheEEc
Confidence 99999999999999999975321 123588999999999999999999999 999999999999999
Q ss_pred CCCCeEEeeccccccCCcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhc-C-cccccc---hHHHH
Q 008785 407 EEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-V-LCRRWW---TLYTL 481 (553)
Q Consensus 407 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-~-~~~~~~---~l~~~ 481 (553)
+++.+||+|||.++...............+++.|+|||++.+..++.++||||||+++|||++ . .|.... .+...
T Consensus 175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~~ 254 (307)
T cd05098 175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 254 (307)
T ss_pred CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHH
Confidence 999999999999876543221111111124568999999988889999999999999999996 2 232222 22333
Q ss_pred HhcCCH-----HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHhh
Q 008785 482 VHSMSL-----LCAQECLMLFISCNNWPSHLSQSKFCNLKLWVFAILT 524 (553)
Q Consensus 482 ~~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~~~~~ 524 (553)
+..+.. ..+..+.+++.+||+.+|++|||+.++++.+...+..
T Consensus 255 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~ 302 (307)
T cd05098 255 LKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302 (307)
T ss_pred HHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence 333322 4567889999999999999999999999998776544
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=308.05 Aligned_cols=246 Identities=22% Similarity=0.297 Sum_probs=194.3
Q ss_pred ccCCCCeeecccCceeEEEEEeCC-----------------CCEEEEEEeccCC-hhhHHHHHHHHHHhhccCCCceeeE
Q 008785 269 NFSEGNRLLGDSKTGGTYSGILPD-----------------GSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAV 330 (553)
Q Consensus 269 ~~~~~~~~iG~G~~g~Vy~~~~~~-----------------g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l 330 (553)
+|....+ ||+|+||.||++...+ +..||+|.+.... ....+.+.+|++++++++||||+++
T Consensus 6 ~~~~~~~-lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~ 84 (296)
T cd05051 6 PLNFVEK-LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL 84 (296)
T ss_pred hCccccc-ccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 3444444 4999999999988543 2468999987653 3456788999999999999999999
Q ss_pred eeEEeeCCceEEEEEccCCCCHHHHhccCCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcE
Q 008785 331 KGCCYDHGDRYIVYEFVVNGPLDRWLHHIPR-------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNV 403 (553)
Q Consensus 331 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NI 403 (553)
++++..++..+++|||+++++|.+++..... ....+++..+..++.|++.||+|||+. +++||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~Ni 161 (296)
T cd05051 85 LGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhce
Confidence 9999999999999999999999999965321 123589999999999999999999999 999999999999
Q ss_pred EecCCCCeEEeeccccccCCcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhc---Cccccc---ch
Q 008785 404 LLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL---VLCRRW---WT 477 (553)
Q Consensus 404 Ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~---~~~~~~---~~ 477 (553)
++++++.++|+|||+++...............+++.|+|||++.+..++.++||||||+++|||++ ..|... ..
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05051 162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQ 241 (296)
T ss_pred eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHH
Confidence 999999999999999976543322222222236778999999988889999999999999999986 222222 12
Q ss_pred HHHHHhc----CCH--------HHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008785 478 LYTLVHS----MSL--------LCAQECLMLFISCNNWPSHLSQSKFCNLKLW 518 (553)
Q Consensus 478 l~~~~~~----~~~--------~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l 518 (553)
....... ... ..+.++.+++.+||+.||.+|||+.|+++.|
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L 294 (296)
T cd05051 242 VIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFL 294 (296)
T ss_pred HHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHh
Confidence 2221111 000 3357899999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=289.77 Aligned_cols=245 Identities=21% Similarity=0.245 Sum_probs=198.9
Q ss_pred CeeecccCceeEEEEE-eCCCCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCC-----ceEEEEEcc
Q 008785 274 NRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHG-----DRYIVYEFV 347 (553)
Q Consensus 274 ~~~iG~G~~g~Vy~~~-~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~-----~~~lV~E~~ 347 (553)
.+.+|+|||+.||.+. ..+++.+|+|++.....++.+..++|++..++++||||++++++...+. ..||+++|.
T Consensus 26 ~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll~Pyy 105 (302)
T KOG2345|consen 26 QRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLLLPYY 105 (302)
T ss_pred eeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEEeehh
Confidence 4556999999999998 5678999999999887788899999999999999999999998876443 489999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccc
Q 008785 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM 427 (553)
Q Consensus 348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 427 (553)
..|+|.+.+......+..+++.+++.|+.+|++||++||+. .+++.||||||.|||+.+++.+++.|||.+....-...
T Consensus 106 ~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i~i~ 184 (302)
T KOG2345|consen 106 KRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSATQAPIQIE 184 (302)
T ss_pred ccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCccccceEee
Confidence 99999999988777777899999999999999999999998 34599999999999999999999999999876543211
Q ss_pred cce-------eeecCcccccccccccc---CCCCCcccchHhHHHHHHHHhcCcccccc------hHHHHHhcCCH----
Q 008785 428 QER-------TVMAGGTYGYLAPEFVY---RNELTTKSDVYSFGVLLLEIRLVLCRRWW------TLYTLVHSMSL---- 487 (553)
Q Consensus 428 ~~~-------~~~~~gt~~y~aPE~~~---~~~~t~ksDVwSlGvil~ell~~~~~~~~------~l~~~~~~~~~---- 487 (553)
... ......|..|+|||.+. +...++++|||||||+||+|+-...+.+. ++.=.+..+++
T Consensus 185 ~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv~n~q~s~P~ 264 (302)
T KOG2345|consen 185 GSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAVQNAQISIPN 264 (302)
T ss_pred chHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEeeeccccccCC
Confidence 110 01112688999999885 44568999999999999999842221111 11112333333
Q ss_pred --HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 008785 488 --LCAQECLMLFISCNNWPSHLSQSKFCNLKLWV 519 (553)
Q Consensus 488 --~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~ 519 (553)
..+..+.++++.|++.||..||++.+++.++.
T Consensus 265 ~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d 298 (302)
T KOG2345|consen 265 SSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLD 298 (302)
T ss_pred CCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHH
Confidence 57888999999999999999999999998764
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=292.06 Aligned_cols=243 Identities=18% Similarity=0.278 Sum_probs=202.8
Q ss_pred hcccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCC-----h---hhHHHHHHHHHHhhcc-CCCceeeEeeEEee
Q 008785 267 TKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS-----F---QRKKEFYSEIGRFARL-HHPNLVAVKGCCYD 336 (553)
Q Consensus 267 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~-----~---~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~ 336 (553)
-++|..+ +++|+|..++|-++..+ .|..+|+|++.... . .-.+.-.+|+.+|+++ .||+|+++.+++++
T Consensus 16 y~~y~pk-eilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes 94 (411)
T KOG0599|consen 16 YAKYEPK-EILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES 94 (411)
T ss_pred HhhcChH-HHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence 3445444 45599999999988864 58899999986321 1 1134567899999998 69999999999999
Q ss_pred CCceEEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeec
Q 008785 337 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGV 416 (553)
Q Consensus 337 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Df 416 (553)
+...++|+|.|+.|.|.|+|.+ .-.++++...+|++|+..|+.|||.+ +||||||||+|||++++.++||+||
T Consensus 95 ~sF~FlVFdl~prGELFDyLts----~VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDF 167 (411)
T KOG0599|consen 95 DAFVFLVFDLMPRGELFDYLTS----KVTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDF 167 (411)
T ss_pred cchhhhhhhhcccchHHHHhhh----heeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEecc
Confidence 9999999999999999999964 45689999999999999999999999 9999999999999999999999999
Q ss_pred cccccCCcccccceeeecCcccccccccccc------CCCCCcccchHhHHHHHHHHhcCcccccch----HHHHHhcCC
Q 008785 417 GLSKFVPWEVMQERTVMAGGTYGYLAPEFVY------RNELTTKSDVYSFGVLLLEIRLVLCRRWWT----LYTLVHSMS 486 (553)
Q Consensus 417 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~t~ksDVwSlGvil~ell~~~~~~~~~----l~~~~~~~~ 486 (553)
|.|..+..+..-. -.+|||+|.|||.+. ...|+...|.||.|||+|.|+.+.|+.+.. +..++.+|+
T Consensus 168 GFa~~l~~GekLr---elCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGk 244 (411)
T KOG0599|consen 168 GFACQLEPGEKLR---ELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGK 244 (411)
T ss_pred ceeeccCCchhHH---HhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcc
Confidence 9998877654322 234999999999885 346889999999999999999866655432 233677777
Q ss_pred H--------HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 008785 487 L--------LCAQECLMLFISCNNWPSHLSQSKFCNLKLWVF 520 (553)
Q Consensus 487 ~--------~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~ 520 (553)
. +.+....+|+.+||+.||.+|.|+.|+|++-..
T Consensus 245 yqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff 286 (411)
T KOG0599|consen 245 YQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFF 286 (411)
T ss_pred cccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHH
Confidence 6 677889999999999999999999999998554
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=302.21 Aligned_cols=237 Identities=25% Similarity=0.326 Sum_probs=192.0
Q ss_pred eecccCceeEEEEEeCCCCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCCHHHH
Q 008785 276 LLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRW 355 (553)
Q Consensus 276 ~iG~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~ 355 (553)
.||+|+||.||+|...++..||+|.++... ...+.+.+|+.++++++||||+++++++. ....++||||+++|+|.++
T Consensus 13 ~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~ 90 (262)
T cd05071 13 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGSLLDF 90 (262)
T ss_pred ecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCCCCcHHHH
Confidence 459999999999998777789999998643 23467899999999999999999999874 4568999999999999999
Q ss_pred hccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccceeeecC
Q 008785 356 LHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG 435 (553)
Q Consensus 356 l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~ 435 (553)
+... ....+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||.++.......... ....
T Consensus 91 ~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~-~~~~ 164 (262)
T cd05071 91 LKGE--MGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR-QGAK 164 (262)
T ss_pred Hhhc--cccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeeccccccccc-cCCc
Confidence 9752 234578999999999999999999999 999999999999999999999999999976543322111 1122
Q ss_pred ccccccccccccCCCCCcccchHhHHHHHHHHhc-Ccc-cc---cchHHHHHhcCC-----HHHHHHHHHHHhhccCCCC
Q 008785 436 GTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-VLC-RR---WWTLYTLVHSMS-----LLCAQECLMLFISCNNWPS 505 (553)
Q Consensus 436 gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-~~~-~~---~~~l~~~~~~~~-----~~~~~~l~~l~~~Cl~~dP 505 (553)
++..|+|||+..+..++.++||||||+++|||++ ..+ .. ...+...+..+. ...+..+.+++.+|++.||
T Consensus 165 ~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p 244 (262)
T cd05071 165 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEP 244 (262)
T ss_pred ccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCCccccCHHHHHHHHHHccCCc
Confidence 5678999999988899999999999999999997 332 21 222222222221 1567789999999999999
Q ss_pred CCCCCHHHHHHHHHH
Q 008785 506 HLSQSKFCNLKLWVF 520 (553)
Q Consensus 506 ~~RPs~~evl~~l~~ 520 (553)
++||++.++++.+..
T Consensus 245 ~~Rp~~~~~~~~l~~ 259 (262)
T cd05071 245 EERPTFEYLQAFLED 259 (262)
T ss_pred ccCCCHHHHHHHHHH
Confidence 999999999988754
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=301.50 Aligned_cols=241 Identities=24% Similarity=0.333 Sum_probs=190.7
Q ss_pred eecccCceeEEEEEeCC----CCEEEEEEeccC-ChhhHHHHHHHHHHhhccCCCceeeEeeEEee-CCceEEEEEccCC
Q 008785 276 LLGDSKTGGTYSGILPD----GSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD-HGDRYIVYEFVVN 349 (553)
Q Consensus 276 ~iG~G~~g~Vy~~~~~~----g~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~~lV~E~~~~ 349 (553)
+||+|+||.||+|...+ +..||+|.+... .....+.+.+|+.+++.++||||+++++++.. ++..+++|||+.+
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~ 81 (262)
T cd05058 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKH 81 (262)
T ss_pred cccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCCC
Confidence 46999999999998532 357999998643 33456788899999999999999999998764 5568999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccc
Q 008785 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE 429 (553)
Q Consensus 350 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 429 (553)
|+|.+++.. ....+++..+..++.|++.||.|||+. +++||||||+|||+++++.+||+|||+++.........
T Consensus 82 ~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~ 155 (262)
T cd05058 82 GDLRNFIRS---ETHNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS 155 (262)
T ss_pred CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence 999999964 223467788899999999999999999 99999999999999999999999999997554321111
Q ss_pred --eeeecCccccccccccccCCCCCcccchHhHHHHHHHHhc-Ccc-cccc---hHHHHHhcCCH-----HHHHHHHHHH
Q 008785 430 --RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-VLC-RRWW---TLYTLVHSMSL-----LCAQECLMLF 497 (553)
Q Consensus 430 --~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-~~~-~~~~---~l~~~~~~~~~-----~~~~~l~~l~ 497 (553)
......++..|+|||.+.+..++.++||||||+++|||++ ..+ .... .+...+..+.. ..+..+.+++
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 235 (262)
T cd05058 156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLYEVM 235 (262)
T ss_pred ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHH
Confidence 1111225678999999988889999999999999999997 332 2222 22222222221 3467899999
Q ss_pred hhccCCCCCCCCCHHHHHHHHHHHH
Q 008785 498 ISCNNWPSHLSQSKFCNLKLWVFAI 522 (553)
Q Consensus 498 ~~Cl~~dP~~RPs~~evl~~l~~~~ 522 (553)
.+||+.+|++||++.|+++.+...+
T Consensus 236 ~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 236 LSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred HHHcCCChhhCCCHHHHHHHHHHHh
Confidence 9999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=304.76 Aligned_cols=246 Identities=23% Similarity=0.289 Sum_probs=197.7
Q ss_pred CeeecccCceeEEEEEeCC-----CCEEEEEEeccC-ChhhHHHHHHHHHHhhccCCCceeeEeeEEee-CCceEEEEEc
Q 008785 274 NRLLGDSKTGGTYSGILPD-----GSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD-HGDRYIVYEF 346 (553)
Q Consensus 274 ~~~iG~G~~g~Vy~~~~~~-----g~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~~lV~E~ 346 (553)
.++||+|+||.||+|...+ +..||+|+++.. .......+.+|+.++++++||||+++++++.. ....++++||
T Consensus 11 ~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~~ 90 (280)
T cd05043 11 SDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPY 90 (280)
T ss_pred eeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCEEEEEc
Confidence 3466999999999999765 688999998754 33446778999999999999999999998776 4678999999
Q ss_pred cCCCCHHHHhccCCCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccC
Q 008785 347 VVNGPLDRWLHHIPRG----GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV 422 (553)
Q Consensus 347 ~~~gsL~~~l~~~~~~----~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~ 422 (553)
+++|+|.+++...... ...+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||+++..
T Consensus 91 ~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d~g~~~~~ 167 (280)
T cd05043 91 MNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDL 167 (280)
T ss_pred CCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECCCCCcccc
Confidence 9999999998653222 15689999999999999999999999 9999999999999999999999999999865
Q ss_pred CcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhc-C-ccccc---chHHHHHhcCCH-----HHHHH
Q 008785 423 PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-V-LCRRW---WTLYTLVHSMSL-----LCAQE 492 (553)
Q Consensus 423 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-~-~~~~~---~~l~~~~~~~~~-----~~~~~ 492 (553)
.............++..|+|||++.+..++.++||||||+++||+++ . .|... .++...+..+.. ..+..
T Consensus 168 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (280)
T cd05043 168 FPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRLAQPINCPDE 247 (280)
T ss_pred cCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCCCCCCCcCCHH
Confidence 43322211111225678999999988889999999999999999996 3 22222 223333332211 45678
Q ss_pred HHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 008785 493 CLMLFISCNNWPSHLSQSKFCNLKLWVFAI 522 (553)
Q Consensus 493 l~~l~~~Cl~~dP~~RPs~~evl~~l~~~~ 522 (553)
+.+++.+||+.||++|||+.++++.+....
T Consensus 248 ~~~li~~~l~~~p~~Rps~~~~~~~l~~~~ 277 (280)
T cd05043 248 LFAVMACCWALDPEERPSFSQLVQCLTDFH 277 (280)
T ss_pred HHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 999999999999999999999999876654
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=301.34 Aligned_cols=235 Identities=25% Similarity=0.318 Sum_probs=191.1
Q ss_pred ecccCceeEEEEEeC---CCCEEEEEEeccCC--hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCC
Q 008785 277 LGDSKTGGTYSGILP---DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP 351 (553)
Q Consensus 277 iG~G~~g~Vy~~~~~---~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gs 351 (553)
||+|+||.||+|.++ ++..||+|+++... ....+++.+|+.++++++||||+++++++. .+..++||||+++|+
T Consensus 3 lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~~ 81 (257)
T cd05116 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELGP 81 (257)
T ss_pred CCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCCc
Confidence 599999999999753 47889999987543 334578899999999999999999999875 456789999999999
Q ss_pred HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCccccccee
Q 008785 352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT 431 (553)
Q Consensus 352 L~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~ 431 (553)
|.+++.. ...+++..+..++.|++.||+|||++ +++||||||+||++++++.+||+|||++............
T Consensus 82 L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 154 (257)
T cd05116 82 LNKFLQK----NKHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA 154 (257)
T ss_pred HHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence 9999964 23588999999999999999999999 9999999999999999999999999999876543221111
Q ss_pred -eecCccccccccccccCCCCCcccchHhHHHHHHHHhc-C-ccccc---chHHHHHhcCCH-----HHHHHHHHHHhhc
Q 008785 432 -VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-V-LCRRW---WTLYTLVHSMSL-----LCAQECLMLFISC 500 (553)
Q Consensus 432 -~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-~-~~~~~---~~l~~~~~~~~~-----~~~~~l~~l~~~C 500 (553)
....++..|+|||.+....++.++||||||+++|||++ . .|... ..+.+.+..+.. ..+..+.+++.+|
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~ 234 (257)
T cd05116 155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMKLC 234 (257)
T ss_pred cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHH
Confidence 11124578999999988889999999999999999996 3 33322 233334444332 4677899999999
Q ss_pred cCCCCCCCCCHHHHHHHHH
Q 008785 501 NNWPSHLSQSKFCNLKLWV 519 (553)
Q Consensus 501 l~~dP~~RPs~~evl~~l~ 519 (553)
|+.||++||++.+|.+.|.
T Consensus 235 ~~~~p~~Rp~~~~i~~~l~ 253 (257)
T cd05116 235 WTYGVDERPGFAVVELRLR 253 (257)
T ss_pred hccCchhCcCHHHHHHHHh
Confidence 9999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=300.93 Aligned_cols=235 Identities=25% Similarity=0.366 Sum_probs=191.3
Q ss_pred eecccCceeEEEEEeCCCCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCCHHHH
Q 008785 276 LLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRW 355 (553)
Q Consensus 276 ~iG~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~ 355 (553)
.||+|++|.||++..+++..||+|.++.... ..+.+.+|+.++++++||||+++++++. ....+++|||+++++|.++
T Consensus 13 ~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~ 90 (260)
T cd05070 13 KLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMSKGSLLDF 90 (260)
T ss_pred eeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecCCCcHHHH
Confidence 4599999999999988888999999976533 3567899999999999999999999875 4568999999999999999
Q ss_pred hccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccceeeecC
Q 008785 356 LHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG 435 (553)
Q Consensus 356 l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~ 435 (553)
+.. .....+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||++............. ..
T Consensus 91 ~~~--~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~-~~ 164 (260)
T cd05070 91 LKD--GEGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQG-AK 164 (260)
T ss_pred HHh--cCCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCcccccccC-CC
Confidence 875 2334589999999999999999999999 99999999999999999999999999997654332211111 11
Q ss_pred ccccccccccccCCCCCcccchHhHHHHHHHHhc-Cc-ccccc---hHHHHHhcC-CH----HHHHHHHHHHhhccCCCC
Q 008785 436 GTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-VL-CRRWW---TLYTLVHSM-SL----LCAQECLMLFISCNNWPS 505 (553)
Q Consensus 436 gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-~~-~~~~~---~l~~~~~~~-~~----~~~~~l~~l~~~Cl~~dP 505 (553)
++..|+|||.+.+..++.++||||||+++|||++ .. |.... +..+.+..+ .. ..+..+.+++.+|+..+|
T Consensus 165 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 244 (260)
T cd05070 165 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHELMLQCWKKDP 244 (260)
T ss_pred CCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccCc
Confidence 5568999999988889999999999999999997 33 22222 223333222 11 456789999999999999
Q ss_pred CCCCCHHHHHHHH
Q 008785 506 HLSQSKFCNLKLW 518 (553)
Q Consensus 506 ~~RPs~~evl~~l 518 (553)
++|||+.++.+.+
T Consensus 245 ~~Rpt~~~l~~~l 257 (260)
T cd05070 245 EERPTFEYLQSFL 257 (260)
T ss_pred ccCcCHHHHHHHH
Confidence 9999999988765
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=309.27 Aligned_cols=248 Identities=23% Similarity=0.321 Sum_probs=196.7
Q ss_pred eeecccCceeEEEEEeC--------CCCEEEEEEeccCC-hhhHHHHHHHHHHhhcc-CCCceeeEeeEEeeCCceEEEE
Q 008785 275 RLLGDSKTGGTYSGILP--------DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVY 344 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~--------~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~ 344 (553)
+.||+|+||.||++... .+..||+|.++... .....++.+|+.+++++ +||||+++++++.+.+..+++|
T Consensus 18 ~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 97 (314)
T cd05099 18 KPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIV 97 (314)
T ss_pred eeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCCceEEEE
Confidence 34599999999999742 24579999987542 33456788999999999 6999999999999999999999
Q ss_pred EccCCCCHHHHhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeE
Q 008785 345 EFVVNGPLDRWLHHIPR------------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAH 412 (553)
Q Consensus 345 E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~k 412 (553)
||+++|+|.+++..... ....+++..+..++.|++.||.|||++ |++||||||+|||+++++.+|
T Consensus 98 e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~~~~~~k 174 (314)
T cd05099 98 EYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLVTEDNVMK 174 (314)
T ss_pred ecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEEEcCCCcEE
Confidence 99999999999975321 124588999999999999999999999 999999999999999999999
Q ss_pred EeeccccccCCcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhc-C-ccccc---chHHHHHhcCCH
Q 008785 413 LMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-V-LCRRW---WTLYTLVHSMSL 487 (553)
Q Consensus 413 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-~-~~~~~---~~l~~~~~~~~~ 487 (553)
|+|||+++...............++..|+|||++.+..++.++||||||+++|||++ . .|... ..+.+.+..+..
T Consensus 175 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~ 254 (314)
T cd05099 175 IADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLREGHR 254 (314)
T ss_pred EccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC
Confidence 999999986543222111111124567999999988889999999999999999997 2 22222 223333333321
Q ss_pred -----HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHhhc
Q 008785 488 -----LCAQECLMLFISCNNWPSHLSQSKFCNLKLWVFAILTI 525 (553)
Q Consensus 488 -----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~~~~~~ 525 (553)
..+..+.+++.+||+.+|++|||+.|+++.+.......
T Consensus 255 ~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~ 297 (314)
T cd05099 255 MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAV 297 (314)
T ss_pred CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHh
Confidence 44668889999999999999999999999887665433
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=308.88 Aligned_cols=238 Identities=20% Similarity=0.279 Sum_probs=182.5
Q ss_pred cCCCCeeecccCceeEEEEEeC--CCCEEEEEEeccCC--hhhHHHHHHHHHHhhcc---CCCceeeEeeEEee-----C
Q 008785 270 FSEGNRLLGDSKTGGTYSGILP--DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARL---HHPNLVAVKGCCYD-----H 337 (553)
Q Consensus 270 ~~~~~~~iG~G~~g~Vy~~~~~--~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l---~HpnIv~l~~~~~~-----~ 337 (553)
|.... .||+|+||.||++... +|+.||+|.++... ......+.+|+.+++.+ +||||+++++++.. .
T Consensus 3 Y~~~~-~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~ 81 (290)
T cd07862 3 YECVA-EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 81 (290)
T ss_pred cceee-EeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence 33434 4599999999999863 46789999987542 22234566777776665 69999999999852 3
Q ss_pred CceEEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeecc
Q 008785 338 GDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVG 417 (553)
Q Consensus 338 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg 417 (553)
...++||||+. ++|.+++... ....+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||
T Consensus 82 ~~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T cd07862 82 TKLTLVFEHVD-QDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFG 155 (290)
T ss_pred CcEEEEEccCC-CCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEcccc
Confidence 45899999996 6999998652 334589999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcCcccc-cc---hHHH-HHhc--------
Q 008785 418 LSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVLCRR-WW---TLYT-LVHS-------- 484 (553)
Q Consensus 418 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~~~~-~~---~l~~-~~~~-------- 484 (553)
+++....... .....||+.|+|||++.+..++.++||||||+++|||++..+.. .. +... .+..
T Consensus 156 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~ 232 (290)
T cd07862 156 LARIYSFQMA---LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 232 (290)
T ss_pred ceEeccCCcc---cccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhh
Confidence 9976543311 11223899999999998889999999999999999999733321 11 1111 1100
Q ss_pred ---------CC--------H-----HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008785 485 ---------MS--------L-----LCAQECLMLFISCNNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 485 ---------~~--------~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 517 (553)
.. + ..+..+.+++.+||+.||++|||+.|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 233 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred chhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 00 0 234567899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=302.05 Aligned_cols=246 Identities=22% Similarity=0.346 Sum_probs=197.0
Q ss_pred ccCCCCeeecccCceeEEEEEeCC-C---CEEEEEEeccC-ChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEE
Q 008785 269 NFSEGNRLLGDSKTGGTYSGILPD-G---SRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIV 343 (553)
Q Consensus 269 ~~~~~~~~iG~G~~g~Vy~~~~~~-g---~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 343 (553)
+|... +.||+|+||.||+|.... + ..+|+|.++.. .....+.+.+|++++++++||||+++.+++.+.+..++|
T Consensus 6 ~~~~~-~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (268)
T cd05063 6 HITKQ-KVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII 84 (268)
T ss_pred HceEe-eEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence 44443 456999999999999753 3 37999998765 334467789999999999999999999999999999999
Q ss_pred EEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCC
Q 008785 344 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVP 423 (553)
Q Consensus 344 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~ 423 (553)
|||+++++|.+++.. ....+++.++..++.|++.||+|||+. +++||||||+||++++++.+||+|||++....
T Consensus 85 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 85 TEYMENGALDKYLRD---HDGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLE 158 (268)
T ss_pred EEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceecc
Confidence 999999999999864 234689999999999999999999999 99999999999999999999999999997654
Q ss_pred ccccccee-eecCccccccccccccCCCCCcccchHhHHHHHHHHhc--Cccccc---chHHHHHhcCCH-----HHHHH
Q 008785 424 WEVMQERT-VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL--VLCRRW---WTLYTLVHSMSL-----LCAQE 492 (553)
Q Consensus 424 ~~~~~~~~-~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~--~~~~~~---~~l~~~~~~~~~-----~~~~~ 492 (553)
........ .....+..|+|||++.+..++.++||||||+++|||++ ..|... ..+...+..+.. ..+..
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 238 (268)
T cd05063 159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDCPSA 238 (268)
T ss_pred cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCCCCCCCHH
Confidence 33221111 11113457999999988889999999999999999886 333322 223333332211 45678
Q ss_pred HHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 008785 493 CLMLFISCNNWPSHLSQSKFCNLKLWVFA 521 (553)
Q Consensus 493 l~~l~~~Cl~~dP~~RPs~~evl~~l~~~ 521 (553)
+.+++.+|++.+|++||++.+|++.+...
T Consensus 239 ~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 239 VYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred HHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 99999999999999999999999987553
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=309.26 Aligned_cols=236 Identities=19% Similarity=0.183 Sum_probs=192.3
Q ss_pred eeecccCceeEEEEEeC-CCCEEEEEEeccCCh---hhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCC
Q 008785 275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF---QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 350 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 350 (553)
++||+|+||.||++... +++.||+|.+..... .....+.+|+.++++++||||+++++.+.+.+..++||||+++|
T Consensus 6 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 85 (285)
T cd05605 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGG 85 (285)
T ss_pred EEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEeccCCC
Confidence 45699999999999964 589999999975422 22345788999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccce
Q 008785 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER 430 (553)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 430 (553)
+|.+++.. .....+++..+..++.|++.||.|||+. +++||||||+||++++++.++|+|||++.........
T Consensus 86 ~L~~~~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~-- 158 (285)
T cd05605 86 DLKFHIYN--MGNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETI-- 158 (285)
T ss_pred cHHHHHHh--cCcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCcc--
Confidence 99988864 2334589999999999999999999999 9999999999999999999999999999765432221
Q ss_pred eeecCccccccccccccCCCCCcccchHhHHHHHHHHhcCc-ccccc---h----HHHHHhcCCH----HHHHHHHHHHh
Q 008785 431 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVL-CRRWW---T----LYTLVHSMSL----LCAQECLMLFI 498 (553)
Q Consensus 431 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~-~~~~~---~----l~~~~~~~~~----~~~~~l~~l~~ 498 (553)
....|++.|+|||++.+..++.++||||||+++|||++.. |.... . +...+..+.. ..+..+.+++.
T Consensus 159 -~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 237 (285)
T cd05605 159 -RGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICR 237 (285)
T ss_pred -ccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHHH
Confidence 1223889999999999888999999999999999999732 22221 1 1112222221 45677899999
Q ss_pred hccCCCCCCCC-----CHHHHHHHH
Q 008785 499 SCNNWPSHLSQ-----SKFCNLKLW 518 (553)
Q Consensus 499 ~Cl~~dP~~RP-----s~~evl~~l 518 (553)
+||+.||++|| ++.+++++-
T Consensus 238 ~~l~~~P~~R~~~~~~~~~~l~~~~ 262 (285)
T cd05605 238 QLLTKDPGFRLGCRGEGAEEVKAHP 262 (285)
T ss_pred HHccCCHHHhcCCCCCCHHHHhcCc
Confidence 99999999999 888998763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=302.45 Aligned_cols=241 Identities=27% Similarity=0.378 Sum_probs=191.8
Q ss_pred eecccCceeEEEEEeCC-CC--EEEEEEeccC-ChhhHHHHHHHHHHhhcc-CCCceeeEeeEEeeCCceEEEEEccCCC
Q 008785 276 LLGDSKTGGTYSGILPD-GS--RVAVKRLKRS-SFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNG 350 (553)
Q Consensus 276 ~iG~G~~g~Vy~~~~~~-g~--~vAvK~~~~~-~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~~g 350 (553)
+||+|+||.||+|...+ +. .+|+|.++.. .....+.+.+|+.++.++ +||||+++++++...+..++||||+++|
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHG 81 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCC
Confidence 46999999999999754 43 5789988753 334456789999999999 8999999999999999999999999999
Q ss_pred CHHHHhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccc
Q 008785 351 PLDRWLHHIPR------------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGL 418 (553)
Q Consensus 351 sL~~~l~~~~~------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgl 418 (553)
+|.+++..... ....+++.++..++.|++.||+|||+. +++||||||+||++++++.+||+|||+
T Consensus 82 ~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfgl 158 (270)
T cd05047 82 NLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGL 158 (270)
T ss_pred cHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCCC
Confidence 99999865321 123478999999999999999999999 999999999999999999999999999
Q ss_pred cccCCcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhc--Ccccccc---hHHHHHhcCC-----HH
Q 008785 419 SKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL--VLCRRWW---TLYTLVHSMS-----LL 488 (553)
Q Consensus 419 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~--~~~~~~~---~l~~~~~~~~-----~~ 488 (553)
+....... .......+..|+|||++....++.++||||||+++|||++ ..|.... .+.+.+..+. ..
T Consensus 159 ~~~~~~~~---~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 235 (270)
T cd05047 159 SRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLN 235 (270)
T ss_pred ccccchhh---hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCCCCCCCc
Confidence 86322111 1111124567999999988889999999999999999996 2333222 2222222221 14
Q ss_pred HHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 008785 489 CAQECLMLFISCNNWPSHLSQSKFCNLKLWVFAI 522 (553)
Q Consensus 489 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~~~ 522 (553)
.+..+.+++.+|++.||.+|||+.++++.+...+
T Consensus 236 ~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 236 CDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred CCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 5567899999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=308.83 Aligned_cols=241 Identities=22% Similarity=0.284 Sum_probs=189.8
Q ss_pred eecccCceeEEEEEeCC---------------CCEEEEEEeccC-ChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCc
Q 008785 276 LLGDSKTGGTYSGILPD---------------GSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGD 339 (553)
Q Consensus 276 ~iG~G~~g~Vy~~~~~~---------------g~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 339 (553)
.||+|+||.||++...+ ...||+|.++.. .....+.+.+|++++++++||||+++++++...+.
T Consensus 12 ~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~ 91 (295)
T cd05097 12 KLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDP 91 (295)
T ss_pred ccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEcCCCc
Confidence 45999999999987532 235899999764 33445679999999999999999999999999999
Q ss_pred eEEEEEccCCCCHHHHhccCC--------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCe
Q 008785 340 RYIVYEFVVNGPLDRWLHHIP--------RGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGA 411 (553)
Q Consensus 340 ~~lV~E~~~~gsL~~~l~~~~--------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~ 411 (553)
.++||||+++++|.+++.... .....+++..+..++.|++.||+|||+. +++||||||+||++++++.+
T Consensus 92 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nill~~~~~~ 168 (295)
T cd05097 92 LCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNCLVGNHYTI 168 (295)
T ss_pred cEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhEEEcCCCcE
Confidence 999999999999999986421 1112468889999999999999999999 99999999999999999999
Q ss_pred EEeeccccccCCcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhc--C-ccccc---chHHHH----
Q 008785 412 HLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL--V-LCRRW---WTLYTL---- 481 (553)
Q Consensus 412 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~--~-~~~~~---~~l~~~---- 481 (553)
||+|||++................++..|+|||++.++.++.++||||||+++|||++ . .|... ......
T Consensus 169 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~ 248 (295)
T cd05097 169 KIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEF 248 (295)
T ss_pred EecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHHHHHHHHh
Confidence 9999999976543322111112225678999999988889999999999999999986 1 12211 122111
Q ss_pred Hhc-CC-------HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 008785 482 VHS-MS-------LLCAQECLMLFISCNNWPSHLSQSKFCNLKLWV 519 (553)
Q Consensus 482 ~~~-~~-------~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~ 519 (553)
... +. ...+..+.+++.+||+.||++|||+.+|++.|.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 249 FRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred hhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 111 11 034578999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=304.44 Aligned_cols=240 Identities=25% Similarity=0.354 Sum_probs=191.1
Q ss_pred eeecccCceeEEEEEeC-----CCCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeEEeeC--CceEEEEEcc
Q 008785 275 RLLGDSKTGGTYSGILP-----DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH--GDRYIVYEFV 347 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~-----~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~~lV~E~~ 347 (553)
+.||+|+||.||++... +++.||+|.++.......+.+.+|++++++++||||+++++++... ...++||||+
T Consensus 10 ~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~ 89 (284)
T cd05081 10 QQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYL 89 (284)
T ss_pred eeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEEEec
Confidence 35699999999999743 4789999999877666677899999999999999999999987543 4579999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccc
Q 008785 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM 427 (553)
Q Consensus 348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 427 (553)
++|+|.+++.. ....+++..+..++.|++.||+|||++ +++||||||+||++++++.+||+|||++........
T Consensus 90 ~~~~L~~~l~~---~~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~ 163 (284)
T cd05081 90 PYGSLRDYLQK---HRERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKE 163 (284)
T ss_pred CCCCHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCcccccccCCCc
Confidence 99999999964 224589999999999999999999999 999999999999999999999999999987654322
Q ss_pred ccee-eecCccccccccccccCCCCCcccchHhHHHHHHHHhcCcccc---cchH-----------------HHHHhcCC
Q 008785 428 QERT-VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVLCRR---WWTL-----------------YTLVHSMS 486 (553)
Q Consensus 428 ~~~~-~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~~~~---~~~l-----------------~~~~~~~~ 486 (553)
.... ....++..|+|||++.+..++.++||||||+++|||++..... .... .+.+..+.
T Consensus 164 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (284)
T cd05081 164 YYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNG 243 (284)
T ss_pred ceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHhcCC
Confidence 1111 1111345699999998888999999999999999999722111 0011 11111111
Q ss_pred H-----HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 008785 487 L-----LCAQECLMLFISCNNWPSHLSQSKFCNLKLWVF 520 (553)
Q Consensus 487 ~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~ 520 (553)
. ..+..+.+++.+||+.+|++|||+.|+++.+..
T Consensus 244 ~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~ 282 (284)
T cd05081 244 RLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEA 282 (284)
T ss_pred cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHh
Confidence 1 345679999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=310.68 Aligned_cols=241 Identities=17% Similarity=0.196 Sum_probs=187.6
Q ss_pred ccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCCh-hhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEc
Q 008785 269 NFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF-QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF 346 (553)
Q Consensus 269 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 346 (553)
+|.... .||+|+||.||+|... +++.||||+++.... .....+.+|+.++++++||||+++++++.+....++||||
T Consensus 6 ~y~~~~-~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (303)
T cd07869 6 SYEKLE-KLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEY 84 (303)
T ss_pred cceEee-eEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEEC
Confidence 454444 4599999999999975 588999999975432 2234678899999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCccc
Q 008785 347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV 426 (553)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 426 (553)
++ ++|.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||++.......
T Consensus 85 ~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 157 (303)
T cd07869 85 VH-TDLCQYMDK---HPGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVPS 157 (303)
T ss_pred CC-cCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence 95 688887764 234588899999999999999999999 99999999999999999999999999987543222
Q ss_pred ccceeeecCccccccccccccC-CCCCcccchHhHHHHHHHHhcCc-ccccc-hHHH----HH---hc------------
Q 008785 427 MQERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIRLVL-CRRWW-TLYT----LV---HS------------ 484 (553)
Q Consensus 427 ~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwSlGvil~ell~~~-~~~~~-~l~~----~~---~~------------ 484 (553)
... ....+|+.|+|||++.+ ..++.++|||||||++|||++.. |.... +..+ .. ..
T Consensus 158 ~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T cd07869 158 HTY--SNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSL 235 (303)
T ss_pred ccC--CCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhc
Confidence 111 12237899999999865 45789999999999999999733 22211 1111 00 00
Q ss_pred -------------CCH-------HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 008785 485 -------------MSL-------LCAQECLMLFISCNNWPSHLSQSKFCNLKLWV 519 (553)
Q Consensus 485 -------------~~~-------~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~ 519 (553)
..+ ..+..+.+++.+||+.||++|||+.|++++-.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~ 290 (303)
T cd07869 236 PHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEY 290 (303)
T ss_pred cccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcc
Confidence 000 12246789999999999999999999998643
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=304.40 Aligned_cols=240 Identities=20% Similarity=0.200 Sum_probs=192.4
Q ss_pred ccCCCCeeecccCceeEEEEEe-CCCCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEcc
Q 008785 269 NFSEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV 347 (553)
Q Consensus 269 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 347 (553)
+|.....+ |+|+||.||+|.. .+++.||+|++..........+.+|+.++++++||||+++++.+...+..++||||+
T Consensus 10 ~y~~~~~l-g~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~ 88 (267)
T cd06646 10 DYELIQRV-GSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC 88 (267)
T ss_pred hcchhhee-ecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence 34444444 9999999999996 468899999997654455567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccc
Q 008785 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM 427 (553)
Q Consensus 348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 427 (553)
++++|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+||++++++.++|+|||++........
T Consensus 89 ~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06646 89 GGGSLQDIYHV----TGPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA 161 (267)
T ss_pred CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeeccccc
Confidence 99999998864 24588999999999999999999999 999999999999999999999999999986543221
Q ss_pred cceeeecCcccccccccccc---CCCCCcccchHhHHHHHHHHhcCcc-cccchHHH---HHhcCC---------HHHHH
Q 008785 428 QERTVMAGGTYGYLAPEFVY---RNELTTKSDVYSFGVLLLEIRLVLC-RRWWTLYT---LVHSMS---------LLCAQ 491 (553)
Q Consensus 428 ~~~~~~~~gt~~y~aPE~~~---~~~~t~ksDVwSlGvil~ell~~~~-~~~~~l~~---~~~~~~---------~~~~~ 491 (553)
.. ....|++.|+|||.+. ...++.++||||||+++|||++..+ .......+ .+.... ...+.
T Consensus 162 ~~--~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd06646 162 KR--KSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSS 239 (267)
T ss_pred cc--CccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCH
Confidence 11 1123788999999874 3457889999999999999997332 21111111 111111 13457
Q ss_pred HHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008785 492 ECLMLFISCNNWPSHLSQSKFCNLKLW 518 (553)
Q Consensus 492 ~l~~l~~~Cl~~dP~~RPs~~evl~~l 518 (553)
.+.+++.+||+.+|++|||+.++++++
T Consensus 240 ~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 240 TFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred HHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 889999999999999999999999754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=307.27 Aligned_cols=245 Identities=27% Similarity=0.347 Sum_probs=194.1
Q ss_pred eeecccCceeEEEEEeCC-CC--EEEEEEeccC-ChhhHHHHHHHHHHhhcc-CCCceeeEeeEEeeCCceEEEEEccCC
Q 008785 275 RLLGDSKTGGTYSGILPD-GS--RVAVKRLKRS-SFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVN 349 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~~-g~--~vAvK~~~~~-~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~~ 349 (553)
.+||+|+||.||+|...+ +. .+|+|.++.. .....+.+.+|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus 8 ~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 87 (297)
T cd05089 8 DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPY 87 (297)
T ss_pred eeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEEecCC
Confidence 356999999999998754 33 5799988753 334456789999999999 799999999999999999999999999
Q ss_pred CCHHHHhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeecc
Q 008785 350 GPLDRWLHHIPR------------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVG 417 (553)
Q Consensus 350 gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg 417 (553)
|+|.+++..... ....+++..+..++.|++.||+|||++ +++||||||+|||+++++.+||+|||
T Consensus 88 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg 164 (297)
T cd05089 88 GNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFG 164 (297)
T ss_pred CcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeEEECCcC
Confidence 999999965221 113588999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhc-C-cccccc---hHHHHHhcCCH-----
Q 008785 418 LSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-V-LCRRWW---TLYTLVHSMSL----- 487 (553)
Q Consensus 418 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-~-~~~~~~---~l~~~~~~~~~----- 487 (553)
++........ ......+..|+|||++.+..++.++||||||+++|||++ . .|.... ++.+.+..+..
T Consensus 165 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 241 (297)
T cd05089 165 LSRGEEVYVK---KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRMEKPR 241 (297)
T ss_pred CCccccceec---cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCC
Confidence 9864322111 111113557999999988889999999999999999996 3 233222 22333322211
Q ss_pred HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHhhc
Q 008785 488 LCAQECLMLFISCNNWPSHLSQSKFCNLKLWVFAILTI 525 (553)
Q Consensus 488 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~~~~~~ 525 (553)
..+..+.+++.+||+.+|.+|||+.++++.+...+...
T Consensus 242 ~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 242 NCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 45678899999999999999999999999987655444
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=314.31 Aligned_cols=234 Identities=21% Similarity=0.203 Sum_probs=188.6
Q ss_pred eeecccCceeEEEEEeCC-CCEEEEEEeccCC---hhhHHHHHHHHHHhhccCC-CceeeEeeEEeeCCceEEEEEccCC
Q 008785 275 RLLGDSKTGGTYSGILPD-GSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHH-PNLVAVKGCCYDHGDRYIVYEFVVN 349 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~~-g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H-pnIv~l~~~~~~~~~~~lV~E~~~~ 349 (553)
+.||+|+||.||+|...+ ++.||||+++... ....+.+..|..++..++| ++|+++++++.+.+..|+||||+++
T Consensus 6 ~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 85 (324)
T cd05587 6 MVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNG 85 (324)
T ss_pred EEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcCCCC
Confidence 356999999999999754 7899999997542 2345667889999999976 5688899999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccc
Q 008785 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE 429 (553)
Q Consensus 350 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 429 (553)
|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++........
T Consensus 86 g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~- 157 (324)
T cd05587 86 GDLMYHIQQ----VGKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT- 157 (324)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCc-
Confidence 999998864 24588999999999999999999999 9999999999999999999999999998743222111
Q ss_pred eeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcCc-cccc---chHHHHHhcCCH----HHHHHHHHHHhhcc
Q 008785 430 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVL-CRRW---WTLYTLVHSMSL----LCAQECLMLFISCN 501 (553)
Q Consensus 430 ~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~-~~~~---~~l~~~~~~~~~----~~~~~l~~l~~~Cl 501 (553)
.....||+.|+|||++.+..++.++|||||||++|||++.. |... ..+...+..... ..+..+.+++.+||
T Consensus 158 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l 236 (324)
T cd05587 158 -TRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLL 236 (324)
T ss_pred -eeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHh
Confidence 12233899999999999999999999999999999999733 3222 223333333322 45677889999999
Q ss_pred CCCCCCCCCH-----HHHHHH
Q 008785 502 NWPSHLSQSK-----FCNLKL 517 (553)
Q Consensus 502 ~~dP~~RPs~-----~evl~~ 517 (553)
+.||.+||+. .+++++
T Consensus 237 ~~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 237 TKHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred hcCHHHcCCCCCCCHHHHhcC
Confidence 9999999986 676665
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=298.41 Aligned_cols=237 Identities=25% Similarity=0.352 Sum_probs=194.4
Q ss_pred eecccCceeEEEEEeCCCCEEEEEEeccCChh-hHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCCHHH
Q 008785 276 LLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQ-RKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR 354 (553)
Q Consensus 276 ~iG~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~ 354 (553)
+||+|++|.||++...+++.||+|.++..... ....+.+|++++++++||||+++++++.+....++||||+++++|.+
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~ 81 (251)
T cd05041 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLT 81 (251)
T ss_pred ccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHHH
Confidence 46999999999999877999999998765433 56789999999999999999999999999999999999999999999
Q ss_pred HhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccceeeec
Q 008785 355 WLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA 434 (553)
Q Consensus 355 ~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 434 (553)
++.. ....+++..+..++.+++.||.|||++ +++||||||+||+++.++.++|+|||++...............
T Consensus 82 ~l~~---~~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (251)
T cd05041 82 FLRK---KKNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK 155 (251)
T ss_pred HHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence 9864 233578999999999999999999999 9999999999999999999999999999765432211111112
Q ss_pred CccccccccccccCCCCCcccchHhHHHHHHHHhc-C-cccccc---hHHHHHhcCC-H----HHHHHHHHHHhhccCCC
Q 008785 435 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-V-LCRRWW---TLYTLVHSMS-L----LCAQECLMLFISCNNWP 504 (553)
Q Consensus 435 ~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-~-~~~~~~---~l~~~~~~~~-~----~~~~~l~~l~~~Cl~~d 504 (553)
.++..|+|||.+.++.++.++|+||||+++|||++ . .|.... .....+..+. . ..+..+.+++.+|++.+
T Consensus 156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 235 (251)
T cd05041 156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLMLQCWAYD 235 (251)
T ss_pred cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHhccC
Confidence 24567999999988899999999999999999997 2 222221 2222332221 1 45678999999999999
Q ss_pred CCCCCCHHHHHHHH
Q 008785 505 SHLSQSKFCNLKLW 518 (553)
Q Consensus 505 P~~RPs~~evl~~l 518 (553)
|.+|||+.|+++.+
T Consensus 236 p~~Rp~~~ell~~l 249 (251)
T cd05041 236 PENRPSFSEIYNEL 249 (251)
T ss_pred hhhCcCHHHHHHHh
Confidence 99999999999876
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=298.99 Aligned_cols=238 Identities=21% Similarity=0.287 Sum_probs=189.4
Q ss_pred ecccCceeEEEEEe-CCCCEEEEEEeccCChh--hHHHHHHHHHHhhccCCCc-eeeEeeEEeeCC------ceEEEEEc
Q 008785 277 LGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQ--RKKEFYSEIGRFARLHHPN-LVAVKGCCYDHG------DRYIVYEF 346 (553)
Q Consensus 277 iG~G~~g~Vy~~~~-~~g~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~Hpn-Iv~l~~~~~~~~------~~~lV~E~ 346 (553)
+|+|+||+||+|+. .+|+.||+|+++..... ......+|+.+|++|+|+| ||++++++.+.+ ..++|+||
T Consensus 19 lGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvfe~ 98 (323)
T KOG0594|consen 19 LGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVFEF 98 (323)
T ss_pred hCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEEEEe
Confidence 49999999999995 46899999999865332 2355689999999999999 999999999877 78999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCccc
Q 008785 347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV 426 (553)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 426 (553)
+. -+|.+++.........++...+..++.||+.||+|||++ +|+||||||+||||+++|.+||+|||+|+...-..
T Consensus 99 ~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~ip~ 174 (323)
T KOG0594|consen 99 LD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGLARAFSIPM 174 (323)
T ss_pred ec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccchHHHhcCCc
Confidence 95 599999987543324577789999999999999999999 99999999999999999999999999999665332
Q ss_pred ccceeeecCccccccccccccCC-CCCcccchHhHHHHHHHHhcCccccc--chHHH------HHhcC------------
Q 008785 427 MQERTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIRLVLCRRW--WTLYT------LVHSM------------ 485 (553)
Q Consensus 427 ~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwSlGvil~ell~~~~~~~--~~l~~------~~~~~------------ 485 (553)
...... .+|..|.|||++.+. .|+...||||+|||+.||++..+... .++.+ .+...
T Consensus 175 ~~yt~e--vvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~ 252 (323)
T KOG0594|consen 175 RTYTPE--VVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLP 252 (323)
T ss_pred cccccc--EEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCccccc
Confidence 222222 278899999999887 68999999999999999996322211 11111 11100
Q ss_pred --C--H--------------HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 008785 486 --S--L--------------LCAQECLMLFISCNNWPSHLSQSKFCNLKLWVF 520 (553)
Q Consensus 486 --~--~--------------~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~ 520 (553)
+ + .......+++..|++.+|++|.|+..++++-.+
T Consensus 253 ~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf 305 (323)
T KOG0594|consen 253 DYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYF 305 (323)
T ss_pred cccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhh
Confidence 0 0 222478999999999999999999999987433
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=319.34 Aligned_cols=245 Identities=26% Similarity=0.322 Sum_probs=194.1
Q ss_pred eeecccCceeEEEEEeC------CCCEEEEEEeccCC-hhhHHHHHHHHHHhhccC-CCceeeEeeEEeeCCceEEEEEc
Q 008785 275 RLLGDSKTGGTYSGILP------DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLH-HPNLVAVKGCCYDHGDRYIVYEF 346 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~------~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lV~E~ 346 (553)
+.||+|+||.||+|.+. .++.||||+++... ....+.+.+|+.+|.++. ||||+++++++...+..++||||
T Consensus 43 ~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~iv~E~ 122 (401)
T cd05107 43 RTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIITEY 122 (401)
T ss_pred hhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcEEEEec
Confidence 45599999999999863 24689999998643 223457889999999997 99999999999999999999999
Q ss_pred cCCCCHHHHhccCCC-----------------------------------------------------------------
Q 008785 347 VVNGPLDRWLHHIPR----------------------------------------------------------------- 361 (553)
Q Consensus 347 ~~~gsL~~~l~~~~~----------------------------------------------------------------- 361 (553)
+++|+|.++++....
T Consensus 123 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 202 (401)
T cd05107 123 CRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTVKYA 202 (401)
T ss_pred cCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcchhhhhhh
Confidence 999999999964211
Q ss_pred -----------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeE
Q 008785 362 -----------------------------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAH 412 (553)
Q Consensus 362 -----------------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~k 412 (553)
....+++..+..++.||+.||+|||+. +++||||||+|||+++++.+|
T Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~NiLl~~~~~~k 279 (401)
T cd05107 203 DIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNVLICEGKLVK 279 (401)
T ss_pred hhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcceEEEeCCCEEE
Confidence 112467788899999999999999999 999999999999999999999
Q ss_pred EeeccccccCCcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhc-C-cccccch----HHHHHhcCC
Q 008785 413 LMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-V-LCRRWWT----LYTLVHSMS 486 (553)
Q Consensus 413 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-~-~~~~~~~----l~~~~~~~~ 486 (553)
|+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ . .|..... +...+..+.
T Consensus 280 L~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~~~~~~~ 359 (401)
T cd05107 280 ICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGY 359 (401)
T ss_pred EEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHHcCC
Confidence 999999976533221111111226788999999988889999999999999999996 2 2322211 222222221
Q ss_pred -H----HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 008785 487 -L----LCAQECLMLFISCNNWPSHLSQSKFCNLKLWVFAI 522 (553)
Q Consensus 487 -~----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~~~ 522 (553)
. ..+..+.+++.+||+.+|.+||++.||++.|...+
T Consensus 360 ~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 360 RMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 1 35678999999999999999999999999886654
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=320.10 Aligned_cols=236 Identities=18% Similarity=0.206 Sum_probs=186.9
Q ss_pred ccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEcc
Q 008785 269 NFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV 347 (553)
Q Consensus 269 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 347 (553)
.|... +.||+|+||.||++... +++.||+|... ...+.+|+.++++++||||+++++++......++|+|++
T Consensus 93 ~y~~~-~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~ 165 (391)
T PHA03212 93 GFSIL-ETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY 165 (391)
T ss_pred CcEEE-EEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC
Confidence 34443 45699999999999964 58899999753 234678999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccc
Q 008785 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM 427 (553)
Q Consensus 348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 427 (553)
. ++|.+++.. ...+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++........
T Consensus 166 ~-~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~ 237 (391)
T PHA03212 166 K-TDLYCYLAA----KRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA 237 (391)
T ss_pred C-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCcccccccccc
Confidence 4 789888854 24588999999999999999999999 999999999999999999999999999975432211
Q ss_pred cceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcCc-cccc-----------chHHH---------------
Q 008785 428 QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVL-CRRW-----------WTLYT--------------- 480 (553)
Q Consensus 428 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~-~~~~-----------~~l~~--------------- 480 (553)
.. .....||+.|+|||++.+..++.++|||||||++|||++.. +... ..+..
T Consensus 238 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~ 316 (391)
T PHA03212 238 NK-YYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPID 316 (391)
T ss_pred cc-cccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcc
Confidence 11 11223899999999999999999999999999999999732 1110 00000
Q ss_pred -------HH----hc-----C-C------HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 008785 481 -------LV----HS-----M-S------LLCAQECLMLFISCNNWPSHLSQSKFCNLKLWVF 520 (553)
Q Consensus 481 -------~~----~~-----~-~------~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~ 520 (553)
.+ .. + . ...+..+.+++.+||+.||.+|||+.|++++-..
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f 379 (391)
T PHA03212 317 AQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAF 379 (391)
T ss_pred hhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhh
Confidence 00 00 0 0 0345678999999999999999999999987543
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=302.73 Aligned_cols=241 Identities=22% Similarity=0.296 Sum_probs=196.3
Q ss_pred eeecccCceeEEEEEe-CCCCEEEEEEeccC---ChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCC
Q 008785 275 RLLGDSKTGGTYSGIL-PDGSRVAVKRLKRS---SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 350 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~-~~g~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 350 (553)
+.||+|++|.||++.. .+++.||||.+... ......++.+|+.+++.++||||+++++++.+.+..+++|||++++
T Consensus 8 ~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~ 87 (267)
T cd08229 8 KKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAG 87 (267)
T ss_pred hhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEecCCC
Confidence 3459999999999995 47899999988653 2334567889999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccce
Q 008785 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER 430 (553)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 430 (553)
+|.+++.........+++..+..++.||+.||.|||++ +++|+||||+||+++.++.++|+|||++..........
T Consensus 88 ~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~- 163 (267)
T cd08229 88 DLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA- 163 (267)
T ss_pred CHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhccccCCccc-
Confidence 99999875333445689999999999999999999999 99999999999999999999999999987654332211
Q ss_pred eeecCccccccccccccCCCCCcccchHhHHHHHHHHhcCc-ccccc-----hHHHHHhcCCH------HHHHHHHHHHh
Q 008785 431 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVL-CRRWW-----TLYTLVHSMSL------LCAQECLMLFI 498 (553)
Q Consensus 431 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~-~~~~~-----~l~~~~~~~~~------~~~~~l~~l~~ 498 (553)
....++..|+|||.+.+..++.++||||||+++|||++.. |.... .+...+..... ..+..+.+++.
T Consensus 164 -~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 242 (267)
T cd08229 164 -HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVN 242 (267)
T ss_pred -ccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHHHHHHH
Confidence 1123788999999998888999999999999999999732 32111 11122222111 46678999999
Q ss_pred hccCCCCCCCCCHHHHHHHHHH
Q 008785 499 SCNNWPSHLSQSKFCNLKLWVF 520 (553)
Q Consensus 499 ~Cl~~dP~~RPs~~evl~~l~~ 520 (553)
+||+.||.+|||+.+|++.+..
T Consensus 243 ~~l~~~p~~Rpt~~~i~~~~~~ 264 (267)
T cd08229 243 MCINPDPEKRPDITYVYDVAKR 264 (267)
T ss_pred HhcCCCcccCCCHHHHHHHHhh
Confidence 9999999999999999987643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=315.02 Aligned_cols=238 Identities=19% Similarity=0.240 Sum_probs=185.4
Q ss_pred eeecccCceeEEEEEeC-CCCEEEEEEeccC--ChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCC-----ceEEEEEc
Q 008785 275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHG-----DRYIVYEF 346 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~-----~~~lV~E~ 346 (553)
+.||+|+||.||+|... +|+.||||+++.. .......+.+|+.++++++||||+++++++.... ..|+||||
T Consensus 6 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e~ 85 (338)
T cd07859 6 EVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFEL 85 (338)
T ss_pred EEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEEEec
Confidence 45699999999999964 5899999998743 2233457889999999999999999999886432 47999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCccc
Q 008785 347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV 426 (553)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 426 (553)
+. ++|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 86 ~~-~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~ 157 (338)
T cd07859 86 ME-SDLHQVIKA----NDDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 157 (338)
T ss_pred CC-CCHHHHHHh----cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCcccccccccc
Confidence 95 689988854 24589999999999999999999999 99999999999999999999999999997543222
Q ss_pred ccc-eeeecCccccccccccccC--CCCCcccchHhHHHHHHHHhcCcc-cccchHHH------------------HHhc
Q 008785 427 MQE-RTVMAGGTYGYLAPEFVYR--NELTTKSDVYSFGVLLLEIRLVLC-RRWWTLYT------------------LVHS 484 (553)
Q Consensus 427 ~~~-~~~~~~gt~~y~aPE~~~~--~~~t~ksDVwSlGvil~ell~~~~-~~~~~l~~------------------~~~~ 484 (553)
... ......||+.|+|||++.+ ..++.++|||||||++|||++..+ ....+... .+..
T Consensus 158 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 237 (338)
T cd07859 158 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRN 237 (338)
T ss_pred CccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhh
Confidence 111 1112238999999999865 678999999999999999998432 21111110 0000
Q ss_pred CC-------------H-------HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 008785 485 MS-------------L-------LCAQECLMLFISCNNWPSHLSQSKFCNLKLWVF 520 (553)
Q Consensus 485 ~~-------------~-------~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~ 520 (553)
.. . ..+..+.+++.+||+.||++|||+.|++++-..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f 293 (338)
T cd07859 238 EKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYF 293 (338)
T ss_pred hhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchh
Confidence 00 0 123567899999999999999999999988443
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=308.71 Aligned_cols=245 Identities=27% Similarity=0.362 Sum_probs=193.4
Q ss_pred eeecccCceeEEEEEeC-CCC--EEEEEEeccC-ChhhHHHHHHHHHHhhcc-CCCceeeEeeEEeeCCceEEEEEccCC
Q 008785 275 RLLGDSKTGGTYSGILP-DGS--RVAVKRLKRS-SFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVN 349 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~-~g~--~vAvK~~~~~-~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~~ 349 (553)
..||+|+||.||+|... ++. .+|+|.++.. .......+.+|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus 13 ~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 92 (303)
T cd05088 13 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 92 (303)
T ss_pred eeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEEeCCC
Confidence 45699999999999964 354 4688877653 233456788999999999 899999999999999999999999999
Q ss_pred CCHHHHhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeecc
Q 008785 350 GPLDRWLHHIPR------------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVG 417 (553)
Q Consensus 350 gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg 417 (553)
|+|.+++..... ....+++..++.++.|++.||+|||++ +++||||||+|||+++++.+||+|||
T Consensus 93 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~~kl~dfg 169 (303)
T cd05088 93 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG 169 (303)
T ss_pred CcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCcEEeCccc
Confidence 999999965321 123578999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhc-Cc-cccc---chHHHHHhcCC-----H
Q 008785 418 LSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-VL-CRRW---WTLYTLVHSMS-----L 487 (553)
Q Consensus 418 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-~~-~~~~---~~l~~~~~~~~-----~ 487 (553)
++....... ......++..|+|||++.+..++.++||||||+++|||++ .. |... ....+.+..+. .
T Consensus 170 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 246 (303)
T cd05088 170 LSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPL 246 (303)
T ss_pred cCcccchhh---hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCcCCCCC
Confidence 986432111 1111124667999999988889999999999999999996 22 2222 22222232221 1
Q ss_pred HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHhhc
Q 008785 488 LCAQECLMLFISCNNWPSHLSQSKFCNLKLWVFAILTI 525 (553)
Q Consensus 488 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~~~~~~ 525 (553)
..+..+.+++.+||+.+|++||++.++++.+...+...
T Consensus 247 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~ 284 (303)
T cd05088 247 NCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 284 (303)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 35678899999999999999999999999986655444
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=318.43 Aligned_cols=241 Identities=22% Similarity=0.200 Sum_probs=193.6
Q ss_pred ccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCCh---hhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEE
Q 008785 269 NFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF---QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVY 344 (553)
Q Consensus 269 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 344 (553)
+|.... .||+|+||.||++... +|+.||+|+++.... .....+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 2 ~y~~~~-~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 2 DFDVKS-LVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CceEEE-EEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 344434 4599999999999965 588999999986422 23466888999999999999999999999999999999
Q ss_pred EccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCc
Q 008785 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW 424 (553)
Q Consensus 345 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~ 424 (553)
||+++|+|.+++.. ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~ 154 (330)
T cd05601 81 EYQPGGDLLSLLNR---YEDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTA 154 (330)
T ss_pred CCCCCCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCC
Confidence 99999999999975 234689999999999999999999999 999999999999999999999999999986654
Q ss_pred ccccceeeecCcccccccccccc------CCCCCcccchHhHHHHHHHHhcC-cccccchH---HH-HHhcCCH------
Q 008785 425 EVMQERTVMAGGTYGYLAPEFVY------RNELTTKSDVYSFGVLLLEIRLV-LCRRWWTL---YT-LVHSMSL------ 487 (553)
Q Consensus 425 ~~~~~~~~~~~gt~~y~aPE~~~------~~~~t~ksDVwSlGvil~ell~~-~~~~~~~l---~~-~~~~~~~------ 487 (553)
..... .....||+.|+|||++. ...++.++||||||+++|||++. .|...... .. .......
T Consensus 155 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 233 (330)
T cd05601 155 NKMVN-SKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPED 233 (330)
T ss_pred CCcee-eecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCC
Confidence 33221 12234899999999986 45678999999999999999973 33322221 12 2211111
Q ss_pred -HHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008785 488 -LCAQECLMLFISCNNWPSHLSQSKFCNLKLW 518 (553)
Q Consensus 488 -~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l 518 (553)
..+..+.+++..|+. +|++|||+.+++++-
T Consensus 234 ~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~ 264 (330)
T cd05601 234 PKVSSDFLDLIQSLLC-GQKERLGYEGLCCHP 264 (330)
T ss_pred CCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCC
Confidence 356778999999998 999999999999763
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=304.47 Aligned_cols=242 Identities=24% Similarity=0.334 Sum_probs=192.8
Q ss_pred CeeecccCceeEEEEEe-----CCCCEEEEEEeccCC-hhhHHHHHHHHHHhhccCCCceeeEeeEEeeC--CceEEEEE
Q 008785 274 NRLLGDSKTGGTYSGIL-----PDGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH--GDRYIVYE 345 (553)
Q Consensus 274 ~~~iG~G~~g~Vy~~~~-----~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~~lV~E 345 (553)
.+.||+|+||.||.+.. .++..||+|.++... ......+.+|+.++++++||||+++++++.+. ...++|||
T Consensus 9 ~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e 88 (284)
T cd05079 9 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIME 88 (284)
T ss_pred ceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceEEEEE
Confidence 44569999999999974 347889999987553 33456789999999999999999999998875 56799999
Q ss_pred ccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcc
Q 008785 346 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE 425 (553)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~ 425 (553)
|+++++|.+++.. ....+++..+..++.|++.||+|||++ +++||||||+||++++++.++|+|||+++.....
T Consensus 89 ~~~g~~L~~~l~~---~~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~ 162 (284)
T cd05079 89 FLPSGSLKEYLPR---NKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD 162 (284)
T ss_pred ccCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCccccccccC
Confidence 9999999999864 223589999999999999999999999 9999999999999999999999999999866433
Q ss_pred cccc-eeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcCcccccch-------------------HHHHHhcC
Q 008785 426 VMQE-RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVLCRRWWT-------------------LYTLVHSM 485 (553)
Q Consensus 426 ~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~~~~~~~-------------------l~~~~~~~ 485 (553)
.... ......++..|+|||++.+..++.++||||||+++|||++........ ....+..+
T Consensus 163 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (284)
T cd05079 163 KEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEG 242 (284)
T ss_pred ccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHcC
Confidence 2211 111223677899999998888999999999999999999732211100 11111221
Q ss_pred CH-----HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 008785 486 SL-----LCAQECLMLFISCNNWPSHLSQSKFCNLKLWVFA 521 (553)
Q Consensus 486 ~~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~~ 521 (553)
.. ..+..+.+++.+||+.||++|||+.++++.+...
T Consensus 243 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 243 KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred ccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 11 3567899999999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=300.22 Aligned_cols=237 Identities=27% Similarity=0.371 Sum_probs=193.1
Q ss_pred eeecccCceeEEEEEeCCCCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCCHHH
Q 008785 275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR 354 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~ 354 (553)
+.||+|+||.||+|..++++.||+|.+.... ....++.+|+.++++++||||+++++++ ..+..+++|||+++|+|.+
T Consensus 12 ~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~v~e~~~~~~L~~ 89 (260)
T cd05067 12 KKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVV-TQEPIYIITEYMENGSLVD 89 (260)
T ss_pred eeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEE-ccCCcEEEEEcCCCCCHHH
Confidence 4569999999999999889999999997653 3456789999999999999999999986 4567899999999999999
Q ss_pred HhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccceeeec
Q 008785 355 WLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA 434 (553)
Q Consensus 355 ~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 434 (553)
++.. ..+..+++.++..++.|++.||+|||+. +++||||||+||++++++.++|+|||++............ ..
T Consensus 90 ~~~~--~~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~-~~ 163 (260)
T cd05067 90 FLKT--PEGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTARE-GA 163 (260)
T ss_pred HHHh--cCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCCCccccc-CC
Confidence 9865 2345689999999999999999999999 9999999999999999999999999999765532221111 11
Q ss_pred CccccccccccccCCCCCcccchHhHHHHHHHHhc-Cc-ccc---cchHHHHHhcCCH-----HHHHHHHHHHhhccCCC
Q 008785 435 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-VL-CRR---WWTLYTLVHSMSL-----LCAQECLMLFISCNNWP 504 (553)
Q Consensus 435 ~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-~~-~~~---~~~l~~~~~~~~~-----~~~~~l~~l~~~Cl~~d 504 (553)
.++..|+|||++....++.++||||||+++||+++ .. |.. ...+...+..+.. ..+..+.+++.+|++.+
T Consensus 164 ~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 243 (260)
T cd05067 164 KFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEELYELMRLCWKEK 243 (260)
T ss_pred cccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCC
Confidence 25678999999988889999999999999999997 33 222 2223333332211 45568999999999999
Q ss_pred CCCCCCHHHHHHHHH
Q 008785 505 SHLSQSKFCNLKLWV 519 (553)
Q Consensus 505 P~~RPs~~evl~~l~ 519 (553)
|++|||++++++.+.
T Consensus 244 p~~Rp~~~~l~~~l~ 258 (260)
T cd05067 244 PEERPTFEYLRSVLE 258 (260)
T ss_pred hhhCCCHHHHHHHhh
Confidence 999999999998763
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=298.68 Aligned_cols=232 Identities=28% Similarity=0.396 Sum_probs=193.5
Q ss_pred eeecccCceeEEEEEeCCCCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCCHHH
Q 008785 275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR 354 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~ 354 (553)
+.||+|++|.||++.. .|+.||+|.++.... ..+++.+|+.++++++||||+++++++.+.+..++||||+++++|.+
T Consensus 12 ~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~ 89 (256)
T cd05039 12 ATIGKGEFGDVMLGDY-RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVD 89 (256)
T ss_pred eeeecCCCceEEEEEe-cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCCcHHH
Confidence 4459999999999987 589999999987644 56789999999999999999999999999899999999999999999
Q ss_pred HhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccceeeec
Q 008785 355 WLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA 434 (553)
Q Consensus 355 ~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 434 (553)
++.. .....+++..+..++.|++.||.|||++ +++||||||+||++++++.++|+|||.++....... ..
T Consensus 90 ~~~~--~~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-----~~ 159 (256)
T cd05039 90 YLRS--RGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-----SG 159 (256)
T ss_pred HHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccccccccc-----cC
Confidence 9975 2223689999999999999999999999 999999999999999999999999999986633221 11
Q ss_pred CccccccccccccCCCCCcccchHhHHHHHHHHhc-C-ccccc---chHHHHHhcC-CH----HHHHHHHHHHhhccCCC
Q 008785 435 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-V-LCRRW---WTLYTLVHSM-SL----LCAQECLMLFISCNNWP 504 (553)
Q Consensus 435 ~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-~-~~~~~---~~l~~~~~~~-~~----~~~~~l~~l~~~Cl~~d 504 (553)
..+..|+|||++....++.++||||||+++||+++ . .|... ..+.+.+..+ .. ..+..+.+++.+||+.+
T Consensus 160 ~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 239 (256)
T cd05039 160 KLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPEVYKVMKDCWELD 239 (256)
T ss_pred CCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCccCCCHHHHHHHHHHhccC
Confidence 24667999999988889999999999999999986 2 22222 2222222222 11 45678999999999999
Q ss_pred CCCCCCHHHHHHHH
Q 008785 505 SHLSQSKFCNLKLW 518 (553)
Q Consensus 505 P~~RPs~~evl~~l 518 (553)
|++|||+.++++.+
T Consensus 240 p~~Rp~~~~l~~~l 253 (256)
T cd05039 240 PAKRPTFKQLREQL 253 (256)
T ss_pred hhhCcCHHHHHHHH
Confidence 99999999999876
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=307.06 Aligned_cols=246 Identities=22% Similarity=0.294 Sum_probs=192.2
Q ss_pred ccCCCCeeecccCceeEEEEEeC-----------------CCCEEEEEEeccC-ChhhHHHHHHHHHHhhccCCCceeeE
Q 008785 269 NFSEGNRLLGDSKTGGTYSGILP-----------------DGSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAV 330 (553)
Q Consensus 269 ~~~~~~~~iG~G~~g~Vy~~~~~-----------------~g~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l 330 (553)
+|...+ .||+|+||.||++... ++..||+|.++.. .....+++.+|+.++++++||||+++
T Consensus 6 ~~~~~~-~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 6 RLTFKE-KLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hceeee-eccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 344444 4599999999998532 2346999999764 33445789999999999999999999
Q ss_pred eeEEeeCCceEEEEEccCCCCHHHHhccCCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcE
Q 008785 331 KGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRG-------GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNV 403 (553)
Q Consensus 331 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~-------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NI 403 (553)
++++...+..++||||+++|+|.+++...... ...+++..+..++.|++.||+|||+. +++||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChheE
Confidence 99999999999999999999999998753211 13477889999999999999999999 999999999999
Q ss_pred EecCCCCeEEeeccccccCCcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhc---Ccccccc---h
Q 008785 404 LLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL---VLCRRWW---T 477 (553)
Q Consensus 404 Ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~---~~~~~~~---~ 477 (553)
|+++++.++|+|||+++...............+++.|+|||....+.++.++||||||+++|||++ ..|.... .
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ 241 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence 999999999999999976543322111111224678999999888889999999999999999986 1222211 1
Q ss_pred HHH----HHhc-C-------CHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008785 478 LYT----LVHS-M-------SLLCAQECLMLFISCNNWPSHLSQSKFCNLKLW 518 (553)
Q Consensus 478 l~~----~~~~-~-------~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l 518 (553)
... .... + ....+..+.+++.+||+.||++|||+.+|++.|
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l 294 (296)
T cd05095 242 VIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATL 294 (296)
T ss_pred HHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHH
Confidence 111 1100 0 014567899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=320.22 Aligned_cols=238 Identities=20% Similarity=0.187 Sum_probs=188.8
Q ss_pred eeecccCceeEEEEEeC-CCCEEEEEEeccCC---hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCC
Q 008785 275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 350 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 350 (553)
+.||+|+||+||+|... +++.||||+++... ......+.+|+.++++++||||+++++++.+.+..++||||+++|
T Consensus 7 ~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~~gg 86 (381)
T cd05626 7 KTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGG 86 (381)
T ss_pred EEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecCCCC
Confidence 34599999999999864 58899999997642 233467889999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCccccc--
Q 008785 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ-- 428 (553)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~-- 428 (553)
+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 87 ~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~ 159 (381)
T cd05626 87 DMMSLLIR----MEVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKY 159 (381)
T ss_pred cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCccccccccccc
Confidence 99999864 23588899999999999999999999 9999999999999999999999999997543210000
Q ss_pred -------------------------------------------ceeeecCccccccccccccCCCCCcccchHhHHHHHH
Q 008785 429 -------------------------------------------ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLL 465 (553)
Q Consensus 429 -------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ 465 (553)
.......||+.|+|||++.+..++.++|||||||++|
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~ 239 (381)
T cd05626 160 YQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILF 239 (381)
T ss_pred ccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHH
Confidence 0001124899999999999889999999999999999
Q ss_pred HHhcCc-ccccch---HHH-HHh-cCCH------HHHHHHHHHHhh--ccCCCCCCCCCHHHHHHHHH
Q 008785 466 EIRLVL-CRRWWT---LYT-LVH-SMSL------LCAQECLMLFIS--CNNWPSHLSQSKFCNLKLWV 519 (553)
Q Consensus 466 ell~~~-~~~~~~---l~~-~~~-~~~~------~~~~~l~~l~~~--Cl~~dP~~RPs~~evl~~l~ 519 (553)
||++.. |..... ... .+. .... ..+.++.+++.+ |+..+|..||++.|++++-.
T Consensus 240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~ 307 (381)
T cd05626 240 EMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPF 307 (381)
T ss_pred HHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcc
Confidence 999733 322211 111 211 1111 356778888877 66777778999999998743
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=313.72 Aligned_cols=234 Identities=22% Similarity=0.229 Sum_probs=188.8
Q ss_pred eeecccCceeEEEEEeC-CCCEEEEEEeccCC---hhhHHHHHHHHHHhhcc-CCCceeeEeeEEeeCCceEEEEEccCC
Q 008785 275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVN 349 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~~ 349 (553)
+.||+|+||.||+|... +++.||||++++.. ......+..|..++..+ +||+|+++++++.+.+..++||||+++
T Consensus 6 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 85 (323)
T cd05616 6 MVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYVNG 85 (323)
T ss_pred EEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcCCCC
Confidence 34699999999999865 47899999997642 22334567788888777 689999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccc
Q 008785 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE 429 (553)
Q Consensus 350 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 429 (553)
|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++........
T Consensus 86 g~L~~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~- 157 (323)
T cd05616 86 GDLMYQIQQ----VGRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVT- 157 (323)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCc-
Confidence 999998864 23588999999999999999999999 9999999999999999999999999998754322211
Q ss_pred eeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcC-ccccc---chHHHHHhcCCH----HHHHHHHHHHhhcc
Q 008785 430 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLV-LCRRW---WTLYTLVHSMSL----LCAQECLMLFISCN 501 (553)
Q Consensus 430 ~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~-~~~~~---~~l~~~~~~~~~----~~~~~l~~l~~~Cl 501 (553)
.....||+.|+|||++.+..++.++|||||||++|||++. .|... ..+...+..+.. ..+..+.+++.+|+
T Consensus 158 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~l 236 (323)
T cd05616 158 -TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLM 236 (323)
T ss_pred -cccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcCCHHHHHHHHHHc
Confidence 1123389999999999999999999999999999999983 33322 233333333332 45678899999999
Q ss_pred CCCCCCCCCH-----HHHHHH
Q 008785 502 NWPSHLSQSK-----FCNLKL 517 (553)
Q Consensus 502 ~~dP~~RPs~-----~evl~~ 517 (553)
+.||.+|++. .+++++
T Consensus 237 ~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05616 237 TKHPGKRLGCGPEGERDIKEH 257 (323)
T ss_pred ccCHHhcCCCCCCCHHHHhcC
Confidence 9999999985 666654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=319.31 Aligned_cols=231 Identities=23% Similarity=0.293 Sum_probs=193.9
Q ss_pred CeeecccCceeEEEEEe-CCCCEEEEEEeccC---ChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCC
Q 008785 274 NRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRS---SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 349 (553)
Q Consensus 274 ~~~iG~G~~g~Vy~~~~-~~g~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 349 (553)
.+| |.|+||.||.+.. .+.+.||||++.-. +....+++++|+..|.+++|||++.+.|+|..+...||||||| -
T Consensus 32 rEI-GHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYC-l 109 (948)
T KOG0577|consen 32 REI-GHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYC-L 109 (948)
T ss_pred HHh-cCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHH-h
Confidence 444 9999999999995 45789999999744 3455788999999999999999999999999999999999999 5
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccc
Q 008785 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE 429 (553)
Q Consensus 350 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 429 (553)
||-.|++.. ...++.+..+..|..+.+.||+|||+. +.||||||+.|||+++.|.+||+|||.|....+..+
T Consensus 110 GSAsDlleV---hkKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PAns-- 181 (948)
T KOG0577|consen 110 GSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAPANS-- 181 (948)
T ss_pred ccHHHHHHH---HhccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCchhc--
Confidence 688888765 335688999999999999999999999 999999999999999999999999999977654432
Q ss_pred eeeecCcccccccccccc---CCCCCcccchHhHHHHHHHHhcC-cccccchHHH---HHhcCC---H---HHHHHHHHH
Q 008785 430 RTVMAGGTYGYLAPEFVY---RNELTTKSDVYSFGVLLLEIRLV-LCRRWWTLYT---LVHSMS---L---LCAQECLML 496 (553)
Q Consensus 430 ~~~~~~gt~~y~aPE~~~---~~~~t~ksDVwSlGvil~ell~~-~~~~~~~l~~---~~~~~~---~---~~~~~l~~l 496 (553)
+.|||.|||||++. .+.|+-|+|||||||+..||.-. .|....+-.. .+.++. + ..+..+..+
T Consensus 182 ----FvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~F 257 (948)
T KOG0577|consen 182 ----FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNF 257 (948)
T ss_pred ----ccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHHH
Confidence 23999999999985 57899999999999999999963 3333333222 222221 1 778889999
Q ss_pred HhhccCCCCCCCCCHHHHHHHH
Q 008785 497 FISCNNWPSHLSQSKFCNLKLW 518 (553)
Q Consensus 497 ~~~Cl~~dP~~RPs~~evl~~l 518 (553)
+..||..-|.+|||..++|++-
T Consensus 258 vd~CLqKipqeRptse~ll~H~ 279 (948)
T KOG0577|consen 258 VDSCLQKIPQERPTSEELLKHR 279 (948)
T ss_pred HHHHHhhCcccCCcHHHHhhcc
Confidence 9999999999999999998763
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=320.65 Aligned_cols=236 Identities=19% Similarity=0.157 Sum_probs=190.5
Q ss_pred eeecccCceeEEEEEeC-CCCEEEEEEeccCC---hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCC
Q 008785 275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 350 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 350 (553)
+.||+|+||.||++... +|+.||||+++... ......+.+|+.++..++||||+++++++.+.+..++||||+++|
T Consensus 7 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g 86 (364)
T cd05599 7 KVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPGG 86 (364)
T ss_pred EEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCCCCc
Confidence 45699999999999975 58999999997542 233456788999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccc-
Q 008785 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE- 429 (553)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~- 429 (553)
+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++..........
T Consensus 87 ~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~ 159 (364)
T cd05599 87 DMMTLLMK----KDTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEF 159 (364)
T ss_pred HHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceeccccccccc
Confidence 99999864 23589999999999999999999999 99999999999999999999999999987543211000
Q ss_pred -----------------------------------eeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcC-ccc
Q 008785 430 -----------------------------------RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLV-LCR 473 (553)
Q Consensus 430 -----------------------------------~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~-~~~ 473 (553)
......||+.|+|||++.+..++.++|||||||++|||++. .|.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf 239 (364)
T cd05599 160 YRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPF 239 (364)
T ss_pred cccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCC
Confidence 00112389999999999999999999999999999999973 333
Q ss_pred ccchHHH---HHhcC--CH------HHHHHHHHHHhhccCCCCCCCCC---HHHHHHHH
Q 008785 474 RWWTLYT---LVHSM--SL------LCAQECLMLFISCNNWPSHLSQS---KFCNLKLW 518 (553)
Q Consensus 474 ~~~~l~~---~~~~~--~~------~~~~~l~~l~~~Cl~~dP~~RPs---~~evl~~l 518 (553)
...+..+ .+... .+ ..+..+.+++.+|+. +|.+||+ +.|++++-
T Consensus 240 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~ 297 (364)
T cd05599 240 CSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHP 297 (364)
T ss_pred CCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCC
Confidence 3322222 11111 11 346778899999996 9999998 99998863
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=319.90 Aligned_cols=240 Identities=18% Similarity=0.131 Sum_probs=192.7
Q ss_pred ccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCC---hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEE
Q 008785 269 NFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVY 344 (553)
Q Consensus 269 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 344 (553)
+|.... .||+|+||.||++... +++.||+|.++... ......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 44 ~y~~~~-~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~ 122 (370)
T cd05596 44 DFDVIK-VIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVM 122 (370)
T ss_pred HcEEEE-EEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEE
Confidence 444443 4599999999999965 58899999997532 223455788999999999999999999999999999999
Q ss_pred EccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCc
Q 008785 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW 424 (553)
Q Consensus 345 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~ 424 (553)
||+++|+|.+++.. ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 123 Ey~~gg~L~~~l~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~ 194 (370)
T cd05596 123 EYMPGGDLVNLMSN-----YDIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA 194 (370)
T ss_pred cCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence 99999999999864 2478888999999999999999999 999999999999999999999999999976543
Q ss_pred ccccceeeecCccccccccccccCC----CCCcccchHhHHHHHHHHhcC-cccccchHH---HHHhcCC--H------H
Q 008785 425 EVMQERTVMAGGTYGYLAPEFVYRN----ELTTKSDVYSFGVLLLEIRLV-LCRRWWTLY---TLVHSMS--L------L 488 (553)
Q Consensus 425 ~~~~~~~~~~~gt~~y~aPE~~~~~----~~t~ksDVwSlGvil~ell~~-~~~~~~~l~---~~~~~~~--~------~ 488 (553)
..... .....||+.|+|||++.+. .++.++|||||||++|||++. .|....+.. ..+..+. . .
T Consensus 195 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 273 (370)
T cd05596 195 NGMVR-CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIE 273 (370)
T ss_pred CCccc-CCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCC
Confidence 32211 1123489999999998653 478999999999999999973 333333322 2222211 1 3
Q ss_pred HHHHHHHHHhhccCCCCCC--CCCHHHHHHHH
Q 008785 489 CAQECLMLFISCNNWPSHL--SQSKFCNLKLW 518 (553)
Q Consensus 489 ~~~~l~~l~~~Cl~~dP~~--RPs~~evl~~l 518 (553)
.+..+.+++.+||+.+|.+ |||+.|++++-
T Consensus 274 ~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~ 305 (370)
T cd05596 274 ISKQAKDLICAFLTDREVRLGRNGVDEIKSHP 305 (370)
T ss_pred CCHHHHHHHHHHccChhhccCCCCHHHHhcCc
Confidence 5678899999999999987 99999999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=315.76 Aligned_cols=229 Identities=23% Similarity=0.249 Sum_probs=184.0
Q ss_pred eecccCceeEEEEEeC-CCCEEEEEEeccCC---hhhHHHHHHHHH-HhhccCCCceeeEeeEEeeCCceEEEEEccCCC
Q 008785 276 LLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIG-RFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 350 (553)
Q Consensus 276 ~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~-~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 350 (553)
+||+|+||.||++... +|+.||+|++.... ......+..|.. +++.++||||+++++.+...+..++||||+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (325)
T cd05604 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGG 81 (325)
T ss_pred ceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCCC
Confidence 4699999999999864 58999999997542 223345556655 467789999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccce
Q 008785 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER 430 (553)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 430 (553)
+|..++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++........
T Consensus 82 ~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~-- 152 (325)
T cd05604 82 ELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDT-- 152 (325)
T ss_pred CHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCC--
Confidence 99988854 34689999999999999999999999 9999999999999999999999999998753222111
Q ss_pred eeecCccccccccccccCCCCCcccchHhHHHHHHHHhcC-cccccc---hHHHHHhcCCH----HHHHHHHHHHhhccC
Q 008785 431 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLV-LCRRWW---TLYTLVHSMSL----LCAQECLMLFISCNN 502 (553)
Q Consensus 431 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~-~~~~~~---~l~~~~~~~~~----~~~~~l~~l~~~Cl~ 502 (553)
.....||+.|+|||++.+..++.++|||||||++|||++. .|.... .+.+.+..+.. ..+..+.+++.+|++
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ll~ 232 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELLE 232 (325)
T ss_pred cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCCCCCCHHHHHHHHHHhc
Confidence 1122389999999999999999999999999999999973 333222 22332222222 456678899999999
Q ss_pred CCCCCCCCHHH
Q 008785 503 WPSHLSQSKFC 513 (553)
Q Consensus 503 ~dP~~RPs~~e 513 (553)
.+|.+||++.+
T Consensus 233 ~~p~~R~~~~~ 243 (325)
T cd05604 233 KDRQRRLGAKE 243 (325)
T ss_pred cCHHhcCCCCC
Confidence 99999998853
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=314.71 Aligned_cols=235 Identities=19% Similarity=0.172 Sum_probs=188.2
Q ss_pred eeecccCceeEEEEEe----CCCCEEEEEEeccCC----hhhHHHHHHHHHHhhcc-CCCceeeEeeEEeeCCceEEEEE
Q 008785 275 RLLGDSKTGGTYSGIL----PDGSRVAVKRLKRSS----FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYE 345 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~----~~g~~vAvK~~~~~~----~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E 345 (553)
+.||+|+||.||++.. .+++.||+|++++.. ....+.+.+|+.++..+ +||||+++++++...+..++|||
T Consensus 6 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (332)
T cd05614 6 KVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLILD 85 (332)
T ss_pred EEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEEEEe
Confidence 4469999999999875 358899999997532 22345678899999999 59999999999999999999999
Q ss_pred ccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcc
Q 008785 346 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE 425 (553)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~ 425 (553)
|+++|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 86 ~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~ 158 (332)
T cd05614 86 YVSGGEMFTHLYQ----RDNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSE 158 (332)
T ss_pred CCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCcccccc
Confidence 9999999999864 24589999999999999999999999 9999999999999999999999999999765333
Q ss_pred cccceeeecCccccccccccccCC-CCCcccchHhHHHHHHHHhcCc-ccc---c----chHHHHHhcCCH----HHHHH
Q 008785 426 VMQERTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIRLVL-CRR---W----WTLYTLVHSMSL----LCAQE 492 (553)
Q Consensus 426 ~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwSlGvil~ell~~~-~~~---~----~~l~~~~~~~~~----~~~~~ 492 (553)
..... ....||+.|+|||++.+. .++.++||||||+++|||++.. |.. . ..+...+..... ..+..
T Consensus 159 ~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (332)
T cd05614 159 EKERT-YSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPE 237 (332)
T ss_pred CCCcc-ccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHH
Confidence 22211 123389999999998765 4789999999999999999733 221 1 111112222111 45677
Q ss_pred HHHHHhhccCCCCCCCC-----CHHHHHHH
Q 008785 493 CLMLFISCNNWPSHLSQ-----SKFCNLKL 517 (553)
Q Consensus 493 l~~l~~~Cl~~dP~~RP-----s~~evl~~ 517 (553)
+.+++.+||+.||++|| ++.+++++
T Consensus 238 ~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 238 AQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred HHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 89999999999999999 78898876
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=304.31 Aligned_cols=236 Identities=22% Similarity=0.289 Sum_probs=192.5
Q ss_pred eecccCceeEEEEEeCC-CCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCCHHH
Q 008785 276 LLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR 354 (553)
Q Consensus 276 ~iG~G~~g~Vy~~~~~~-g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~ 354 (553)
.||+|+||.||+|.... +..+|+|.+........+.+.+|+.+++.++||||+++++.+...+..++||||+++++|..
T Consensus 12 ~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~~l~~ 91 (282)
T cd06643 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDA 91 (282)
T ss_pred hcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCCCcHHH
Confidence 46999999999999764 77899999987666667789999999999999999999999999999999999999999998
Q ss_pred HhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccceeeec
Q 008785 355 WLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA 434 (553)
Q Consensus 355 ~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 434 (553)
++.. ....+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++......... ....
T Consensus 92 ~~~~---~~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~--~~~~ 163 (282)
T cd06643 92 VMLE---LERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR--RDSF 163 (282)
T ss_pred HHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccccccccccccccc--cccc
Confidence 8754 234689999999999999999999999 9999999999999999999999999998765432211 1122
Q ss_pred Ccccccccccccc-----CCCCCcccchHhHHHHHHHHhcCc-ccccchHHH---HHhcCC-------HHHHHHHHHHHh
Q 008785 435 GGTYGYLAPEFVY-----RNELTTKSDVYSFGVLLLEIRLVL-CRRWWTLYT---LVHSMS-------LLCAQECLMLFI 498 (553)
Q Consensus 435 ~gt~~y~aPE~~~-----~~~~t~ksDVwSlGvil~ell~~~-~~~~~~l~~---~~~~~~-------~~~~~~l~~l~~ 498 (553)
.+++.|+|||++. +..++.++|||||||++|||++.. |.......+ .+..+. ...+..+.+++.
T Consensus 164 ~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 243 (282)
T cd06643 164 IGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDFLK 243 (282)
T ss_pred cccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHHHHHH
Confidence 3889999999884 345788999999999999999743 322222111 111111 145678999999
Q ss_pred hccCCCCCCCCCHHHHHHHHH
Q 008785 499 SCNNWPSHLSQSKFCNLKLWV 519 (553)
Q Consensus 499 ~Cl~~dP~~RPs~~evl~~l~ 519 (553)
+||+.||.+||++.+++++-.
T Consensus 244 ~~l~~~p~~Rp~~~~il~~~~ 264 (282)
T cd06643 244 KCLEKNVDARWTTTQLLQHPF 264 (282)
T ss_pred HHccCChhhCcCHHHHhcCCC
Confidence 999999999999999988653
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=319.56 Aligned_cols=236 Identities=22% Similarity=0.192 Sum_probs=193.8
Q ss_pred eeecccCceeEEEEEeC-CCCEEEEEEeccCC---hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCC
Q 008785 275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 350 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 350 (553)
+.||+|+||.||++... +|+.||||+++... ......+.+|+.++..++||||+++++++.+.+..++||||+++|
T Consensus 7 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 86 (350)
T cd05573 7 KVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPGG 86 (350)
T ss_pred EEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcCCCCC
Confidence 35699999999999975 58999999997542 233567889999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCccc----
Q 008785 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV---- 426 (553)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~---- 426 (553)
+|.+++... ..+++..+..++.||+.||+|||+. ||+||||||+|||++.++.+||+|||++.......
T Consensus 87 ~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~ 159 (350)
T cd05573 87 DLMNLLIRK----DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREY 159 (350)
T ss_pred CHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcccc
Confidence 999999652 4689999999999999999999999 99999999999999999999999999997654432
Q ss_pred -----------------------ccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcC-cccccchH---H
Q 008785 427 -----------------------MQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLV-LCRRWWTL---Y 479 (553)
Q Consensus 427 -----------------------~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~-~~~~~~~l---~ 479 (553)
.........||+.|+|||++.+..++.++|||||||++|||++. .|...... .
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~ 239 (350)
T cd05573 160 YLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETY 239 (350)
T ss_pred cccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHHH
Confidence 00011122389999999999999999999999999999999973 33322222 2
Q ss_pred HHHhc--CCH------HHHHHHHHHHhhccCCCCCCCCC-HHHHHHHH
Q 008785 480 TLVHS--MSL------LCAQECLMLFISCNNWPSHLSQS-KFCNLKLW 518 (553)
Q Consensus 480 ~~~~~--~~~------~~~~~l~~l~~~Cl~~dP~~RPs-~~evl~~l 518 (553)
..+.. ... ..+..+.+++.+|+. ||.+||+ +.+++++.
T Consensus 240 ~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp 286 (350)
T cd05573 240 NKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHP 286 (350)
T ss_pred HHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCC
Confidence 22222 111 347889999999997 9999999 99999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=302.92 Aligned_cols=245 Identities=28% Similarity=0.385 Sum_probs=191.7
Q ss_pred ccCCCCeeecccCceeEEEEEe-----CCCCEEEEEEeccCC-hhhHHHHHHHHHHhhccCCCceeeEeeEEeeC--Cce
Q 008785 269 NFSEGNRLLGDSKTGGTYSGIL-----PDGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH--GDR 340 (553)
Q Consensus 269 ~~~~~~~~iG~G~~g~Vy~~~~-----~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~ 340 (553)
.+....+.||+|+||+||.+.. .++..||+|.++... ......+.+|++++++++||||+++++++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (283)
T cd05080 4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGL 83 (283)
T ss_pred hhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceE
Confidence 3434445679999999988653 357899999997653 23456788999999999999999999988764 357
Q ss_pred EEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccc
Q 008785 341 YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSK 420 (553)
Q Consensus 341 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~ 420 (553)
+++|||+++|+|.+++.. ..+++.++..++.|++.||.|||++ +++||||||+||++++++.++|+|||+++
T Consensus 84 ~lv~e~~~~~~l~~~~~~-----~~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~ 155 (283)
T cd05080 84 QLIMEYVPLGSLRDYLPK-----HKLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAK 155 (283)
T ss_pred EEEecCCCCCCHHHHHHH-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeeccccc
Confidence 899999999999999864 3489999999999999999999999 99999999999999999999999999998
Q ss_pred cCCcccccce-eeecCccccccccccccCCCCCcccchHhHHHHHHHHhcC-ccccc--chHHH----------------
Q 008785 421 FVPWEVMQER-TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLV-LCRRW--WTLYT---------------- 480 (553)
Q Consensus 421 ~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~-~~~~~--~~l~~---------------- 480 (553)
.......... .....++..|+|||.+.+..++.++||||||+++|||++. .|... ..+.+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd05080 156 AVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIE 235 (283)
T ss_pred ccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhh
Confidence 6654322111 1112256679999999888899999999999999999973 22111 11111
Q ss_pred HHhcCC-----HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 008785 481 LVHSMS-----LLCAQECLMLFISCNNWPSHLSQSKFCNLKLWVFA 521 (553)
Q Consensus 481 ~~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~~ 521 (553)
....+. ...+..+.+++.+||+.+|++|||+.++++.+...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 236 LLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred hhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 111110 02357899999999999999999999999877543
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=317.16 Aligned_cols=241 Identities=19% Similarity=0.159 Sum_probs=188.4
Q ss_pred ccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCC---hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEE
Q 008785 269 NFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVY 344 (553)
Q Consensus 269 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 344 (553)
+|... +.||+|+||+||++... +++.||||+++... ......+.+|+.++.+++||||+++++.+.+....++||
T Consensus 2 ~y~~~-~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 2 DFESL-KVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CceEe-EEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 34443 45599999999999865 48899999997542 223456788999999999999999999999999999999
Q ss_pred EccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCc
Q 008785 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW 424 (553)
Q Consensus 345 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~ 424 (553)
||+++|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~ 153 (363)
T cd05628 81 EFLPGGDMMTLLMK----KDTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKK 153 (363)
T ss_pred cCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCcccccc
Confidence 99999999999964 24589999999999999999999999 999999999999999999999999999875432
Q ss_pred cccc---------------------------------ceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcC-
Q 008785 425 EVMQ---------------------------------ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLV- 470 (553)
Q Consensus 425 ~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~- 470 (553)
.... .......||+.|+|||++.+..++.++|||||||++|||++.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~ 233 (363)
T cd05628 154 AHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (363)
T ss_pred cccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCC
Confidence 1100 001123489999999999999999999999999999999973
Q ss_pred cccccch---HHHHHhc--CCH------HHHHHHHHHHhhccC--CCCCCCCCHHHHHHH
Q 008785 471 LCRRWWT---LYTLVHS--MSL------LCAQECLMLFISCNN--WPSHLSQSKFCNLKL 517 (553)
Q Consensus 471 ~~~~~~~---l~~~~~~--~~~------~~~~~l~~l~~~Cl~--~dP~~RPs~~evl~~ 517 (553)
.|..... ....+.. ... .....+.+++.+++. .++..||++.|++++
T Consensus 234 ~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 234 PPFCSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCCCCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 3333222 2222222 111 345667777776433 344567999999987
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=312.40 Aligned_cols=234 Identities=20% Similarity=0.200 Sum_probs=189.0
Q ss_pred eecccCceeEEEEEeC-CCCEEEEEEeccCC---hhhHHHHHHHHHHhhcc-CCCceeeEeeEEeeCCceEEEEEccCCC
Q 008785 276 LLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNG 350 (553)
Q Consensus 276 ~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~~g 350 (553)
+||+|+||.||++... +++.||+|+++... ....+.+.+|+.++.++ +||||+++++++.+.+..++||||+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 81 (327)
T cd05617 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGG 81 (327)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCC
Confidence 4699999999999965 47899999998642 23345678899999888 6999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccce
Q 008785 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER 430 (553)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 430 (553)
+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++........
T Consensus 82 ~L~~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~-- 152 (327)
T cd05617 82 DLMFHMQR----QRKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDT-- 152 (327)
T ss_pred cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCc--
Confidence 99988854 24589999999999999999999999 9999999999999999999999999998753222111
Q ss_pred eeecCccccccccccccCCCCCcccchHhHHHHHHHHhcCccccc-----------chHHHHHhcCCH----HHHHHHHH
Q 008785 431 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVLCRRW-----------WTLYTLVHSMSL----LCAQECLM 495 (553)
Q Consensus 431 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~~~~~-----------~~l~~~~~~~~~----~~~~~l~~ 495 (553)
.....||+.|+|||++.+..++.++||||||+++|||++...... ..+.+.+..... ..+..+.+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 232 (327)
T cd05617 153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASH 232 (327)
T ss_pred eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 122338999999999999999999999999999999997322211 112222222222 34567899
Q ss_pred HHhhccCCCCCCCCCH------HHHHHHH
Q 008785 496 LFISCNNWPSHLSQSK------FCNLKLW 518 (553)
Q Consensus 496 l~~~Cl~~dP~~RPs~------~evl~~l 518 (553)
++.+||+.||++||++ .+++++-
T Consensus 233 li~~~L~~dP~~R~~~~~~~~~~~i~~h~ 261 (327)
T cd05617 233 VLKGFLNKDPKERLGCQPQTGFSDIKSHT 261 (327)
T ss_pred HHHHHhccCHHHcCCCCCCCCHHHHHcCC
Confidence 9999999999999984 6777663
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=312.66 Aligned_cols=247 Identities=23% Similarity=0.279 Sum_probs=192.7
Q ss_pred eeecccCceeEEEEEe------CCCCEEEEEEeccCC-hhhHHHHHHHHHHhhcc-CCCceeeEeeEEeeC-CceEEEEE
Q 008785 275 RLLGDSKTGGTYSGIL------PDGSRVAVKRLKRSS-FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDH-GDRYIVYE 345 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~------~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~-~~~~lV~E 345 (553)
+.||+|+||.||+|.. .+++.||||+++... ......+.+|+.++.++ +||||+++++++... ...+++||
T Consensus 13 ~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~e 92 (343)
T cd05103 13 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVE 92 (343)
T ss_pred ccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCceEEEEe
Confidence 3459999999999973 347899999997643 23356788999999999 789999999988754 45789999
Q ss_pred ccCCCCHHHHhccCCC---------------------------------------------------------------C
Q 008785 346 FVVNGPLDRWLHHIPR---------------------------------------------------------------G 362 (553)
Q Consensus 346 ~~~~gsL~~~l~~~~~---------------------------------------------------------------~ 362 (553)
|+++|+|.+++..... .
T Consensus 93 y~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (343)
T cd05103 93 FCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLY 172 (343)
T ss_pred ccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhhhhhhhh
Confidence 9999999999864210 0
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccceeeecCccccccc
Q 008785 363 GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLA 442 (553)
Q Consensus 363 ~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~a 442 (553)
...+++..+..++.||+.||+|||++ +|+||||||+||++++++.+||+|||++................++..|+|
T Consensus 173 ~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~a 249 (343)
T cd05103 173 KKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 249 (343)
T ss_pred hccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCcceEC
Confidence 12367888899999999999999999 999999999999999999999999999976543322111112225678999
Q ss_pred cccccCCCCCcccchHhHHHHHHHHhc--Cccccc----chHHHHHhcCCH-----HHHHHHHHHHhhccCCCCCCCCCH
Q 008785 443 PEFVYRNELTTKSDVYSFGVLLLEIRL--VLCRRW----WTLYTLVHSMSL-----LCAQECLMLFISCNNWPSHLSQSK 511 (553)
Q Consensus 443 PE~~~~~~~t~ksDVwSlGvil~ell~--~~~~~~----~~l~~~~~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPs~ 511 (553)
||.+.+..++.++||||||+++|||++ ..|... ..+...+..+.. ..+..+.+++.+||+.||++|||+
T Consensus 250 PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rps~ 329 (343)
T cd05103 250 PETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTF 329 (343)
T ss_pred cHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHHccCChhhCcCH
Confidence 999988889999999999999999985 222221 122222322221 245678999999999999999999
Q ss_pred HHHHHHHHHHHhh
Q 008785 512 FCNLKLWVFAILT 524 (553)
Q Consensus 512 ~evl~~l~~~~~~ 524 (553)
.|+++++...+.+
T Consensus 330 ~eil~~l~~~~~~ 342 (343)
T cd05103 330 SELVEHLGNLLQA 342 (343)
T ss_pred HHHHHHHHHHHhc
Confidence 9999998776653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=313.43 Aligned_cols=228 Identities=23% Similarity=0.247 Sum_probs=182.6
Q ss_pred eecccCceeEEEEEeC-CCCEEEEEEeccCCh---hhHHHHHHHHH-HhhccCCCceeeEeeEEeeCCceEEEEEccCCC
Q 008785 276 LLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF---QRKKEFYSEIG-RFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 350 (553)
Q Consensus 276 ~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~---~~~~~~~~E~~-~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 350 (553)
+||+|+||.||++... +|+.||+|++..... .....+.+|.. +++.++||||+++++++.+.+..++||||+++|
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (321)
T cd05603 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGG 81 (321)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence 4699999999999975 588999999975422 22344555654 578899999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccce
Q 008785 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER 430 (553)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 430 (553)
+|..++.. ...+++..+..++.||+.||.|||+. +|+||||||+||+++.++.+||+|||+++........
T Consensus 82 ~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~-- 152 (321)
T cd05603 82 ELFFHLQR----ERCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEET-- 152 (321)
T ss_pred CHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCc--
Confidence 99988853 24578889999999999999999999 9999999999999999999999999998753222111
Q ss_pred eeecCccccccccccccCCCCCcccchHhHHHHHHHHhcC-cccccch---HHHHHhcCCH----HHHHHHHHHHhhccC
Q 008785 431 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLV-LCRRWWT---LYTLVHSMSL----LCAQECLMLFISCNN 502 (553)
Q Consensus 431 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~-~~~~~~~---l~~~~~~~~~----~~~~~l~~l~~~Cl~ 502 (553)
.....||+.|+|||++.+..++.++|||||||++|||++. .|....+ +.+.+..+.. .....+.+++.+||+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~ 232 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVGLLH 232 (321)
T ss_pred cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHcc
Confidence 1122389999999999988999999999999999999973 3332222 2233322222 455678899999999
Q ss_pred CCCCCCCCHH
Q 008785 503 WPSHLSQSKF 512 (553)
Q Consensus 503 ~dP~~RPs~~ 512 (553)
.||.+||++.
T Consensus 233 ~~p~~R~~~~ 242 (321)
T cd05603 233 KDQRRRLGAK 242 (321)
T ss_pred CCHhhcCCCC
Confidence 9999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=313.71 Aligned_cols=231 Identities=21% Similarity=0.228 Sum_probs=183.7
Q ss_pred eecccCceeEEEEEeC-CCCEEEEEEeccCCh---hhHHHHHHHHH-HhhccCCCceeeEeeEEeeCCceEEEEEccCCC
Q 008785 276 LLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF---QRKKEFYSEIG-RFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 350 (553)
Q Consensus 276 ~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~---~~~~~~~~E~~-~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 350 (553)
.||+|+||.||++... +++.||+|++..... .....+..|.. +++.++||||+++++++.+.+..++||||+++|
T Consensus 2 ~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~ 81 (325)
T cd05602 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGG 81 (325)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCC
Confidence 4699999999999975 478899999975421 22234444544 567889999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccce
Q 008785 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER 430 (553)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 430 (553)
+|.+++.. ...+++..+..++.||+.||.|||+. ||+||||||+|||++.++.+||+|||+++........
T Consensus 82 ~L~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~-- 152 (325)
T cd05602 82 ELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGT-- 152 (325)
T ss_pred cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCC--
Confidence 99999864 24578888899999999999999999 9999999999999999999999999998754322111
Q ss_pred eeecCccccccccccccCCCCCcccchHhHHHHHHHHhcC-cccccc---hHHHHHhcCCH----HHHHHHHHHHhhccC
Q 008785 431 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLV-LCRRWW---TLYTLVHSMSL----LCAQECLMLFISCNN 502 (553)
Q Consensus 431 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~-~~~~~~---~l~~~~~~~~~----~~~~~l~~l~~~Cl~ 502 (553)
.....||+.|+|||++.+..++.++|||||||++|||++. .|.... .+.+.+..... ..+..+.+++.+|++
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~ 232 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQ 232 (325)
T ss_pred cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCCCCCCCHHHHHHHHHHcc
Confidence 1223389999999999999999999999999999999973 333222 22222222222 456788999999999
Q ss_pred CCCCCCCCHHHHH
Q 008785 503 WPSHLSQSKFCNL 515 (553)
Q Consensus 503 ~dP~~RPs~~evl 515 (553)
.||.+||++.+.+
T Consensus 233 ~~p~~R~~~~~~~ 245 (325)
T cd05602 233 KDRTKRLGAKDDF 245 (325)
T ss_pred cCHHHCCCCCCCH
Confidence 9999999987433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=298.13 Aligned_cols=236 Identities=25% Similarity=0.337 Sum_probs=190.7
Q ss_pred eecccCceeEEEEEeCCCCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCCHHHH
Q 008785 276 LLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRW 355 (553)
Q Consensus 276 ~iG~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~ 355 (553)
.||+|++|.||++...++..||+|.+.... ...+.+.+|+.++++++|||++++++++. .+..+++|||+++|+|.++
T Consensus 13 ~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~ 90 (260)
T cd05069 13 KLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGKGSLLDF 90 (260)
T ss_pred eecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCCCCHHHH
Confidence 459999999999998777789999987543 34567889999999999999999999875 4568999999999999999
Q ss_pred hccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccceeeecC
Q 008785 356 LHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG 435 (553)
Q Consensus 356 l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~ 435 (553)
+... ....+++..+..++.|++.||.|||+. +++||||||+||++++++.++|+|||++............ ...
T Consensus 91 ~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~-~~~ 164 (260)
T cd05069 91 LKEG--DGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQ-GAK 164 (260)
T ss_pred HhhC--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCcccccC-CCc
Confidence 9752 334588999999999999999999999 9999999999999999999999999999765433221111 112
Q ss_pred ccccccccccccCCCCCcccchHhHHHHHHHHhc-Cc-cccc---chHHHHHhcC-CH----HHHHHHHHHHhhccCCCC
Q 008785 436 GTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-VL-CRRW---WTLYTLVHSM-SL----LCAQECLMLFISCNNWPS 505 (553)
Q Consensus 436 gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-~~-~~~~---~~l~~~~~~~-~~----~~~~~l~~l~~~Cl~~dP 505 (553)
++..|+|||...+..++.++||||||+++|||++ .. |... ......+..+ .. ..+..+.+++.+||+.||
T Consensus 165 ~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 244 (260)
T cd05069 165 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHELMKLCWKKDP 244 (260)
T ss_pred cchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHHccCCc
Confidence 5678999999988889999999999999999997 33 2222 1222222222 11 456789999999999999
Q ss_pred CCCCCHHHHHHHHH
Q 008785 506 HLSQSKFCNLKLWV 519 (553)
Q Consensus 506 ~~RPs~~evl~~l~ 519 (553)
++||++.++++.+.
T Consensus 245 ~~Rp~~~~i~~~l~ 258 (260)
T cd05069 245 DERPTFEYIQSFLE 258 (260)
T ss_pred ccCcCHHHHHHHHh
Confidence 99999999998763
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=298.28 Aligned_cols=236 Identities=22% Similarity=0.248 Sum_probs=194.6
Q ss_pred eeecccCceeEEEEEeC-CCCEEEEEEeccC-ChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCCH
Q 008785 275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL 352 (553)
+.||+|+||.||++... +++.||+|.++.. .....+.+.+|+.++++++||||+++++.+.+.+..+++|||+++|+|
T Consensus 6 ~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l 85 (255)
T cd08219 6 RVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDL 85 (255)
T ss_pred EEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCCCcH
Confidence 45699999999999965 5889999998643 334457788999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccceee
Q 008785 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV 432 (553)
Q Consensus 353 ~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~ 432 (553)
.+++.. .....+++..+..++.|++.||.|||++ +|+|+||||+||++++++.++++|||.+...........
T Consensus 86 ~~~~~~--~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~-- 158 (255)
T cd08219 86 MQKIKL--QRGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYAC-- 158 (255)
T ss_pred HHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeecccccccc--
Confidence 998864 2334578999999999999999999999 999999999999999999999999999976543322111
Q ss_pred ecCccccccccccccCCCCCcccchHhHHHHHHHHhc-CcccccchH---HHHHhcCCH-----HHHHHHHHHHhhccCC
Q 008785 433 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-VLCRRWWTL---YTLVHSMSL-----LCAQECLMLFISCNNW 503 (553)
Q Consensus 433 ~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-~~~~~~~~l---~~~~~~~~~-----~~~~~l~~l~~~Cl~~ 503 (553)
...|++.|+|||++.+..++.++|+||||+++|+|++ ..|....+. ...+..+.. ..+..+.+++.+||+.
T Consensus 159 ~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 238 (255)
T cd08219 159 TYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQMFKR 238 (255)
T ss_pred cccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCCcccCHHHHHHHHHHHhC
Confidence 1237889999999988889999999999999999997 333333322 223333322 4566789999999999
Q ss_pred CCCCCCCHHHHHHH
Q 008785 504 PSHLSQSKFCNLKL 517 (553)
Q Consensus 504 dP~~RPs~~evl~~ 517 (553)
||++|||+.+++.+
T Consensus 239 ~P~~Rp~~~~il~~ 252 (255)
T cd08219 239 NPRSRPSATTILSR 252 (255)
T ss_pred CcccCCCHHHHhhc
Confidence 99999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=299.67 Aligned_cols=241 Identities=22% Similarity=0.349 Sum_probs=193.2
Q ss_pred CeeecccCceeEEEEEeCC-C---CEEEEEEeccC-ChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccC
Q 008785 274 NRLLGDSKTGGTYSGILPD-G---SRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV 348 (553)
Q Consensus 274 ~~~iG~G~~g~Vy~~~~~~-g---~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 348 (553)
.+.||+|+||.||+|.... + ..||||.++.. ......+|.+|+.++++++||||+++++++.+++..++||||++
T Consensus 9 ~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T cd05065 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFME 88 (269)
T ss_pred EeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEecCC
Confidence 3456999999999999653 3 36999998764 34456789999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCccccc
Q 008785 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ 428 (553)
Q Consensus 349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 428 (553)
+|+|.+++.. ....+++.++..++.|++.||.|||++ +++||||||+||+++.++.+||+|||++.........
T Consensus 89 ~~~L~~~l~~---~~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~ 162 (269)
T cd05065 89 NGALDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSD 162 (269)
T ss_pred CCcHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccccccCccc
Confidence 9999999865 234589999999999999999999999 9999999999999999999999999998765433221
Q ss_pred cee-eecC--ccccccccccccCCCCCcccchHhHHHHHHHHhc--Ccccccc---hHHHHHhcC-C----HHHHHHHHH
Q 008785 429 ERT-VMAG--GTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL--VLCRRWW---TLYTLVHSM-S----LLCAQECLM 495 (553)
Q Consensus 429 ~~~-~~~~--gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~--~~~~~~~---~l~~~~~~~-~----~~~~~~l~~ 495 (553)
... .... .+..|+|||++.+..++.++||||||+++||+++ ..|.... +..+.+... . ...+..+.+
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 242 (269)
T cd05065 163 PTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMDCPTALHQ 242 (269)
T ss_pred cccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCcccCCHHHHH
Confidence 111 1111 2457999999998899999999999999999886 2333222 222222221 1 145667899
Q ss_pred HHhhccCCCCCCCCCHHHHHHHHHH
Q 008785 496 LFISCNNWPSHLSQSKFCNLKLWVF 520 (553)
Q Consensus 496 l~~~Cl~~dP~~RPs~~evl~~l~~ 520 (553)
++.+||+.+|++||++.++++.+..
T Consensus 243 li~~~l~~~p~~Rp~~~~i~~~l~~ 267 (269)
T cd05065 243 LMLDCWQKDRNARPKFGQIVSTLDK 267 (269)
T ss_pred HHHHHcCCChhhCcCHHHHHHHHHh
Confidence 9999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=300.81 Aligned_cols=238 Identities=20% Similarity=0.289 Sum_probs=183.6
Q ss_pred ecccCceeEEEEEeCCC---CEEEEEEeccCC-hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCCH
Q 008785 277 LGDSKTGGTYSGILPDG---SRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352 (553)
Q Consensus 277 iG~G~~g~Vy~~~~~~g---~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL 352 (553)
||+|+||.||+|...++ ..+++|.++... ....+.+.+|+.+++.++||||+++++.+.+....++||||+++|+|
T Consensus 3 lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 82 (268)
T cd05086 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGDL 82 (268)
T ss_pred CCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCcH
Confidence 59999999999985443 356777776543 34467899999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccceee
Q 008785 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV 432 (553)
Q Consensus 353 ~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~ 432 (553)
.+++..........+...+..++.||+.||+|||+. +++||||||+|||++.++.++|+|||++.............
T Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~ 159 (268)
T cd05086 83 KSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETED 159 (268)
T ss_pred HHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhccc
Confidence 999975332334567778889999999999999999 99999999999999999999999999986432221111111
Q ss_pred ecCccccccccccccC-------CCCCcccchHhHHHHHHHHhc--Ccccccc---hHHH-HHhcCCH---------HHH
Q 008785 433 MAGGTYGYLAPEFVYR-------NELTTKSDVYSFGVLLLEIRL--VLCRRWW---TLYT-LVHSMSL---------LCA 490 (553)
Q Consensus 433 ~~~gt~~y~aPE~~~~-------~~~t~ksDVwSlGvil~ell~--~~~~~~~---~l~~-~~~~~~~---------~~~ 490 (553)
...++..|+|||++.. ..++.++||||||+++|||++ ..|.... .... .+..+.. ...
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (268)
T cd05086 160 DKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPYS 239 (268)
T ss_pred CCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCCc
Confidence 2237889999998743 245789999999999999986 2232221 2222 2222211 346
Q ss_pred HHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008785 491 QECLMLFISCNNWPSHLSQSKFCNLKLW 518 (553)
Q Consensus 491 ~~l~~l~~~Cl~~dP~~RPs~~evl~~l 518 (553)
..+.+++..|| .+|++||++.||++.+
T Consensus 240 ~~~~~l~~~c~-~~P~~Rp~~~~i~~~l 266 (268)
T cd05086 240 ERWYEVLQFCW-LSPEKRATAEEVHRLL 266 (268)
T ss_pred HHHHHHHHHHh-hCcccCCCHHHHHHHh
Confidence 67888999999 6799999999998876
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=298.65 Aligned_cols=238 Identities=22% Similarity=0.262 Sum_probs=193.7
Q ss_pred eecccCceeEEEEEeCC--C--CEEEEEEeccCCh-hhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCC
Q 008785 276 LLGDSKTGGTYSGILPD--G--SRVAVKRLKRSSF-QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 350 (553)
Q Consensus 276 ~iG~G~~g~Vy~~~~~~--g--~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 350 (553)
.||+|++|.||+|.+.+ + ..||||.++.... ...+.+.+|+.++++++||||+++++.+.+ ...++||||+++|
T Consensus 2 ~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~ 80 (257)
T cd05040 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPLG 80 (257)
T ss_pred cCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCCC
Confidence 46999999999999643 3 3699999987755 566789999999999999999999999988 8899999999999
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccc-
Q 008785 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE- 429 (553)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~- 429 (553)
+|.+++..... ..+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||++..........
T Consensus 81 ~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 155 (257)
T cd05040 81 SLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV 155 (257)
T ss_pred cHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEecccccccccccccccee
Confidence 99999976321 4689999999999999999999999 99999999999999999999999999998765432111
Q ss_pred eeeecCccccccccccccCCCCCcccchHhHHHHHHHHhc-Cc-cccc---chHHHHHh-cCCH-----HHHHHHHHHHh
Q 008785 430 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-VL-CRRW---WTLYTLVH-SMSL-----LCAQECLMLFI 498 (553)
Q Consensus 430 ~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-~~-~~~~---~~l~~~~~-~~~~-----~~~~~l~~l~~ 498 (553)
......++..|+|||++.+..++.++||||||+++|||++ .. |... ..+...+. .+.. ..+..+.+++.
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 235 (257)
T cd05040 156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVML 235 (257)
T ss_pred cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHHH
Confidence 1112236788999999988899999999999999999997 33 2222 22222111 1111 45678999999
Q ss_pred hccCCCCCCCCCHHHHHHHHH
Q 008785 499 SCNNWPSHLSQSKFCNLKLWV 519 (553)
Q Consensus 499 ~Cl~~dP~~RPs~~evl~~l~ 519 (553)
+|++.+|++|||+.++++.+.
T Consensus 236 ~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 236 QCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred HHCCCCcccCCCHHHHHHHhc
Confidence 999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=320.10 Aligned_cols=234 Identities=23% Similarity=0.284 Sum_probs=197.2
Q ss_pred ecccCceeEEEEEeCC-CCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCCHHHH
Q 008785 277 LGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRW 355 (553)
Q Consensus 277 iG~G~~g~Vy~~~~~~-g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~ 355 (553)
||.|+||.||++..++ +-.-|-|++...+....++++-|+++|+.+.||+||+|++.|...+.+||+.|||.||-.+..
T Consensus 40 LGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGAVDai 119 (1187)
T KOG0579|consen 40 LGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGGAVDAI 119 (1187)
T ss_pred hcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCchHhHH
Confidence 3999999999999765 445678888877778889999999999999999999999999999999999999999999998
Q ss_pred hccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccceeeecC
Q 008785 356 LHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG 435 (553)
Q Consensus 356 l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~ 435 (553)
+-+ -++.+++.++..+++|++.||.|||++ +|||||||+.|||++-+|.++|+|||.+......... ...+.
T Consensus 120 mlE---L~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qk--RDsFI 191 (1187)
T KOG0579|consen 120 MLE---LGRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQK--RDSFI 191 (1187)
T ss_pred HHH---hccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchhHHhh--hcccc
Confidence 875 346799999999999999999999999 9999999999999999999999999998765433222 22344
Q ss_pred cccccccccccc-----CCCCCcccchHhHHHHHHHHhcCcc-cccchHHH-HH--hcCC---H----HHHHHHHHHHhh
Q 008785 436 GTYGYLAPEFVY-----RNELTTKSDVYSFGVLLLEIRLVLC-RRWWTLYT-LV--HSMS---L----LCAQECLMLFIS 499 (553)
Q Consensus 436 gt~~y~aPE~~~-----~~~~t~ksDVwSlGvil~ell~~~~-~~~~~l~~-~~--~~~~---~----~~~~~l~~l~~~ 499 (553)
|||.|||||+.. ..+|+.++||||||++|.||....| ..+.+... ++ .+.. + .....+.+++.+
T Consensus 192 GTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~F~DfLk~ 271 (1187)
T KOG0579|consen 192 GTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRSFSDFLKR 271 (1187)
T ss_pred CCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhHHHHHHHH
Confidence 999999999874 5789999999999999999996333 33333333 22 1111 1 677789999999
Q ss_pred ccCCCCCCCCCHHHHHHHH
Q 008785 500 CNNWPSHLSQSKFCNLKLW 518 (553)
Q Consensus 500 Cl~~dP~~RPs~~evl~~l 518 (553)
||..||..||++++++++-
T Consensus 272 cL~Knp~~Rp~aaqll~Hp 290 (1187)
T KOG0579|consen 272 CLVKNPRNRPPAAQLLKHP 290 (1187)
T ss_pred HHhcCCccCCCHHHHhhCc
Confidence 9999999999999999864
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=317.50 Aligned_cols=242 Identities=18% Similarity=0.146 Sum_probs=191.0
Q ss_pred cccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCC---hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEE
Q 008785 268 KNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIV 343 (553)
Q Consensus 268 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 343 (553)
++|.... .||+|+||.||++... +++.||+|++.+.. ......+.+|+.+++.++||||+++++++.+++..++|
T Consensus 43 ~~y~~~~-~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv 121 (370)
T cd05621 43 EDYDVVK-VIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMV 121 (370)
T ss_pred HHCeEEE-EEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence 3444433 4599999999999975 48899999986531 22345678899999999999999999999999999999
Q ss_pred EEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCC
Q 008785 344 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVP 423 (553)
Q Consensus 344 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~ 423 (553)
|||+++|+|.+++.. ..+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||++....
T Consensus 122 ~Ey~~gg~L~~~l~~-----~~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~ 193 (370)
T cd05621 122 MEYMPGGDLVNLMSN-----YDVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMD 193 (370)
T ss_pred EcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccceecc
Confidence 999999999999864 2478899999999999999999999 99999999999999999999999999998654
Q ss_pred cccccceeeecCccccccccccccCC----CCCcccchHhHHHHHHHHhcC-cccccchHH---HHHhcC--CH------
Q 008785 424 WEVMQERTVMAGGTYGYLAPEFVYRN----ELTTKSDVYSFGVLLLEIRLV-LCRRWWTLY---TLVHSM--SL------ 487 (553)
Q Consensus 424 ~~~~~~~~~~~~gt~~y~aPE~~~~~----~~t~ksDVwSlGvil~ell~~-~~~~~~~l~---~~~~~~--~~------ 487 (553)
..... ......||+.|+|||++.+. .++.++|||||||++|||++. .|....+.. ..+... ..
T Consensus 194 ~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~ 272 (370)
T cd05621 194 ETGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDV 272 (370)
T ss_pred cCCce-ecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcc
Confidence 33221 11223489999999998754 378899999999999999973 333333222 222211 11
Q ss_pred HHHHHHHHHHhhccCCCCCC--CCCHHHHHHHHH
Q 008785 488 LCAQECLMLFISCNNWPSHL--SQSKFCNLKLWV 519 (553)
Q Consensus 488 ~~~~~l~~l~~~Cl~~dP~~--RPs~~evl~~l~ 519 (553)
..+..+.+++..|+..+|.+ |||+.|++++-.
T Consensus 273 ~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~ 306 (370)
T cd05621 273 EISKHAKNLICAFLTDREVRLGRNGVEEIKQHPF 306 (370)
T ss_pred cCCHHHHHHHHHHccCchhccCCCCHHHHhcCcc
Confidence 34667889999999755543 899999999843
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=303.12 Aligned_cols=231 Identities=24% Similarity=0.298 Sum_probs=186.0
Q ss_pred eecccCceeEEEEEeCC--------CCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEcc
Q 008785 276 LLGDSKTGGTYSGILPD--------GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV 347 (553)
Q Consensus 276 ~iG~G~~g~Vy~~~~~~--------g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 347 (553)
.||+|+||.||+|.... ...||+|.+........+.+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYV 81 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEecC
Confidence 36999999999998642 2358999987665555678899999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCC--------eEEeecccc
Q 008785 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG--------AHLMGVGLS 419 (553)
Q Consensus 348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~--------~kl~Dfgla 419 (553)
++|+|.+++.. ....+++..+..++.||+.||+|||+. +|+||||||+||+++.++. ++++|||++
T Consensus 82 ~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 82 KFGSLDTYLKK---NKNLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred CCCcHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEecccccc
Confidence 99999999974 233689999999999999999999999 9999999999999987765 599999988
Q ss_pred ccCCcccccceeeecCccccccccccccCC-CCCcccchHhHHHHHHHHhcCc-c-cccchHHH---HHhc-CCH--HHH
Q 008785 420 KFVPWEVMQERTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIRLVL-C-RRWWTLYT---LVHS-MSL--LCA 490 (553)
Q Consensus 420 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwSlGvil~ell~~~-~-~~~~~l~~---~~~~-~~~--~~~ 490 (553)
....... ...+++.|+|||++.+. .++.++||||||+++|||++.. + ....+... .... ..+ ...
T Consensus 156 ~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (258)
T cd05078 156 ITVLPKE------ILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYEDRHQLPAPKW 229 (258)
T ss_pred cccCCch------hccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHHHccccCCCCCc
Confidence 6543221 12278899999999764 5799999999999999999842 2 22111111 1111 111 344
Q ss_pred HHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008785 491 QECLMLFISCNNWPSHLSQSKFCNLKLW 518 (553)
Q Consensus 491 ~~l~~l~~~Cl~~dP~~RPs~~evl~~l 518 (553)
.++.+++.+||+.||++|||+.++++.|
T Consensus 230 ~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 230 TELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred HHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 6789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=299.53 Aligned_cols=239 Identities=23% Similarity=0.269 Sum_probs=184.9
Q ss_pred eecccCceeEEEEEeCC---CCEEEEEEeccCC-hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCC
Q 008785 276 LLGDSKTGGTYSGILPD---GSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP 351 (553)
Q Consensus 276 ~iG~G~~g~Vy~~~~~~---g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gs 351 (553)
.||+|+||.||+|...+ +..+|+|.++... ......+.+|+.++++++||||+++++++.+....++||||+++|+
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD 81 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence 36999999999998643 4579999987653 2334578899999999999999999999999999999999999999
Q ss_pred HHHHhccCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccce
Q 008785 352 LDRWLHHIPR-GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER 430 (553)
Q Consensus 352 L~~~l~~~~~-~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 430 (553)
|.+++..... .....++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++...........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~ 158 (269)
T cd05087 82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT 158 (269)
T ss_pred HHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence 9999975322 223467778889999999999999999 999999999999999999999999999875443322111
Q ss_pred eeecCccccccccccccCC-------CCCcccchHhHHHHHHHHhc-Cc-ccccch---HHH-HHhcCCH---------H
Q 008785 431 TVMAGGTYGYLAPEFVYRN-------ELTTKSDVYSFGVLLLEIRL-VL-CRRWWT---LYT-LVHSMSL---------L 488 (553)
Q Consensus 431 ~~~~~gt~~y~aPE~~~~~-------~~t~ksDVwSlGvil~ell~-~~-~~~~~~---l~~-~~~~~~~---------~ 488 (553)
.....++..|+|||++.+. .++.++||||||+++|||++ .. |..... ... .+..... .
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (269)
T cd05087 159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLP 238 (269)
T ss_pred CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCC
Confidence 1122367889999988542 35789999999999999985 32 332211 111 1111111 3
Q ss_pred HHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008785 489 CAQECLMLFISCNNWPSHLSQSKFCNLKLW 518 (553)
Q Consensus 489 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l 518 (553)
.+..+.+++..|+ .+|++|||+.||++.|
T Consensus 239 ~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l 267 (269)
T cd05087 239 LSDRWYEVMQFCW-LQPEQRPSAEEVHLLL 267 (269)
T ss_pred CChHHHHHHHHHh-cCcccCCCHHHHHHHh
Confidence 4566888999999 5899999999999765
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=300.91 Aligned_cols=241 Identities=27% Similarity=0.370 Sum_probs=192.8
Q ss_pred eecccCceeEEEEEeCC-------CCEEEEEEeccCC-hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEcc
Q 008785 276 LLGDSKTGGTYSGILPD-------GSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV 347 (553)
Q Consensus 276 ~iG~G~~g~Vy~~~~~~-------g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 347 (553)
+||+|+||.||+|...+ +..||||.+.... ......+.+|+.++++++||||+++++++...+..++||||+
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM 81 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence 46999999999998643 2579999886543 244677899999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCC-----CeEEeecccc
Q 008785 348 VNGPLDRWLHHIPR---GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF-----GAHLMGVGLS 419 (553)
Q Consensus 348 ~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~-----~~kl~Dfgla 419 (553)
++|+|.+++..... ....+++.++..++.|++.||+|||+. +++|+||||+||+++.++ .++++|||++
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred CCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 99999999975221 224478899999999999999999999 999999999999999877 8999999999
Q ss_pred ccCCcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhc-Cc-cccc---chHHHHHhcCC-H----HH
Q 008785 420 KFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-VL-CRRW---WTLYTLVHSMS-L----LC 489 (553)
Q Consensus 420 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-~~-~~~~---~~l~~~~~~~~-~----~~ 489 (553)
+...............++..|+|||++.++.++.++||||||+++|||++ .. |... .+....+..+. . ..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (269)
T cd05044 159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKPENC 238 (269)
T ss_pred cccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCccCCcccc
Confidence 76543322211112225678999999999999999999999999999986 32 2222 22222222221 1 56
Q ss_pred HHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 008785 490 AQECLMLFISCNNWPSHLSQSKFCNLKLWV 519 (553)
Q Consensus 490 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~ 519 (553)
+..+.+++.+||..+|.+||++.++++.+.
T Consensus 239 ~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 239 PDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred hHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 678999999999999999999999998763
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=321.52 Aligned_cols=230 Identities=22% Similarity=0.232 Sum_probs=184.1
Q ss_pred eeecccCceeEEEEEeCC-CCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCCHH
Q 008785 275 RLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 353 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~~-g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~ 353 (553)
..||+|+||.||++.... ++.||||.... ..+.+|+++|++++|||||++++++...+..++|||++ .++|.
T Consensus 175 ~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~-~~~L~ 247 (461)
T PHA03211 175 RALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY-RSDLY 247 (461)
T ss_pred EEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc-CCCHH
Confidence 446999999999999764 78999996432 23568999999999999999999999999999999999 57898
Q ss_pred HHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccceeee
Q 008785 354 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVM 433 (553)
Q Consensus 354 ~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 433 (553)
+++.. ....+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++.............
T Consensus 248 ~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 321 (461)
T PHA03211 248 TYLGA---RLRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYG 321 (461)
T ss_pred HHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceecccccccccccc
Confidence 88864 234689999999999999999999999 999999999999999999999999999986543322211122
Q ss_pred cCccccccccccccCCCCCcccchHhHHHHHHHHhcCc-c-----------cccchHHHHHhcCCH--------------
Q 008785 434 AGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVL-C-----------RRWWTLYTLVHSMSL-------------- 487 (553)
Q Consensus 434 ~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~-~-----------~~~~~l~~~~~~~~~-------------- 487 (553)
..||+.|+|||++.+..++.++|||||||++|||+... + .....+.+.+.....
T Consensus 322 ~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~ 401 (461)
T PHA03211 322 IAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLV 401 (461)
T ss_pred cCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHH
Confidence 34899999999999999999999999999999997411 0 011122222221110
Q ss_pred ------------------------HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008785 488 ------------------------LCAQECLMLFISCNNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 488 ------------------------~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 517 (553)
.....+.+|+.+||+.||.+|||+.|+|++
T Consensus 402 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 402 SQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred HHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 122367889999999999999999999986
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=297.54 Aligned_cols=236 Identities=23% Similarity=0.360 Sum_probs=193.0
Q ss_pred eeecccCceeEEEEEeCCCCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCCHHH
Q 008785 275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR 354 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~ 354 (553)
+.||+|+||.||++...+++.+|+|.++... ....++.+|++++++++||||+++++++......++||||+++++|.+
T Consensus 10 ~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~ 88 (256)
T cd05112 10 QEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSD 88 (256)
T ss_pred eeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCCcHHH
Confidence 3469999999999998778899999987543 234678999999999999999999999999999999999999999999
Q ss_pred HhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccceeeec
Q 008785 355 WLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA 434 (553)
Q Consensus 355 ~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 434 (553)
++.. ....+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++............ ..
T Consensus 89 ~~~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~-~~ 161 (256)
T cd05112 89 YLRA---QRGKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST-GT 161 (256)
T ss_pred HHHh---CccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCcccccC-CC
Confidence 9864 223578999999999999999999999 9999999999999999999999999998765433221111 11
Q ss_pred CccccccccccccCCCCCcccchHhHHHHHHHHhc-C-cccccc---hHHHHHhcC-CH----HHHHHHHHHHhhccCCC
Q 008785 435 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-V-LCRRWW---TLYTLVHSM-SL----LCAQECLMLFISCNNWP 504 (553)
Q Consensus 435 ~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-~-~~~~~~---~l~~~~~~~-~~----~~~~~l~~l~~~Cl~~d 504 (553)
.++..|+|||.+.++.++.++||||||+++|||++ . .|.... .+.+.+..+ .. ..+..+.+++.+||+.+
T Consensus 162 ~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~ 241 (256)
T cd05112 162 KFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVYELMQHCWKER 241 (256)
T ss_pred ccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHcccC
Confidence 14678999999988889999999999999999996 2 333222 233333222 11 34677999999999999
Q ss_pred CCCCCCHHHHHHHH
Q 008785 505 SHLSQSKFCNLKLW 518 (553)
Q Consensus 505 P~~RPs~~evl~~l 518 (553)
|++|||+.++++.+
T Consensus 242 p~~Rp~~~~~l~~l 255 (256)
T cd05112 242 PEDRPSFSLLLHQL 255 (256)
T ss_pred hhhCCCHHHHHHhh
Confidence 99999999999875
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=298.45 Aligned_cols=241 Identities=22% Similarity=0.275 Sum_probs=193.5
Q ss_pred ccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCC-----hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEE
Q 008785 269 NFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS-----FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYI 342 (553)
Q Consensus 269 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~-----~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 342 (553)
+|...+ .||+|++|.||.+... +++.||+|.+.... ......+.+|+.++++++||||+++++++.+.+..++
T Consensus 3 ~~~~~~-~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 3 NWRRGK-LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred cccccc-eecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 455544 4599999999999864 58999999986542 1223568899999999999999999999999999999
Q ss_pred EEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccC
Q 008785 343 VYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV 422 (553)
Q Consensus 343 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~ 422 (553)
|+||+++++|.+++.. ...+++..+..++.|++.||.|||+. +++||||+|+||++++++.++|+|||+++..
T Consensus 82 v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~ 154 (263)
T cd06625 82 FMEYMPGGSVKDQLKA----YGALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRL 154 (263)
T ss_pred EEEECCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceec
Confidence 9999999999999864 23578899999999999999999999 9999999999999999999999999998765
Q ss_pred Cccccccee-eecCccccccccccccCCCCCcccchHhHHHHHHHHhcC-cccccchHHH----HHhc-CC--H--HHHH
Q 008785 423 PWEVMQERT-VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLV-LCRRWWTLYT----LVHS-MS--L--LCAQ 491 (553)
Q Consensus 423 ~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~-~~~~~~~l~~----~~~~-~~--~--~~~~ 491 (553)
......... ....++..|+|||++.+..++.++||||||+++|||++. .|....+... .... .. . ..+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (263)
T cd06625 155 QTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSP 234 (263)
T ss_pred cccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCH
Confidence 432211110 112377899999999998899999999999999999983 3332222211 1111 11 1 4567
Q ss_pred HHHHHHhhccCCCCCCCCCHHHHHHH
Q 008785 492 ECLMLFISCNNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 492 ~l~~l~~~Cl~~dP~~RPs~~evl~~ 517 (553)
.+.+++.+||+.+|.+|||+.|++++
T Consensus 235 ~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 235 DARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred HHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 88999999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=299.59 Aligned_cols=243 Identities=21% Similarity=0.236 Sum_probs=192.3
Q ss_pred hhcccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEE
Q 008785 266 ITKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVY 344 (553)
Q Consensus 266 ~~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 344 (553)
.++++.... +||+|+||.||+|... ++..||+|.+........+.+.+|+.++++++||||+++++++...+..++|+
T Consensus 6 ~~~~~~~~~-~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 84 (268)
T cd06624 6 EYDENGERV-VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFM 84 (268)
T ss_pred ccccCCceE-EEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEE
Confidence 344444443 5699999999999965 57889999998776666778999999999999999999999999999999999
Q ss_pred EccCCCCHHHHhccCCCCCCCC--CHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecC-CCCeEEeecccccc
Q 008785 345 EFVVNGPLDRWLHHIPRGGRSL--DWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE-EFGAHLMGVGLSKF 421 (553)
Q Consensus 345 E~~~~gsL~~~l~~~~~~~~~l--~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~-~~~~kl~Dfgla~~ 421 (553)
||+++++|.+++... ...+ ++..+..++.||+.||+|||+. +|+||||||+||+++. ++.++|+|||++..
T Consensus 85 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~ 158 (268)
T cd06624 85 EQVPGGSLSALLRSK---WGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKR 158 (268)
T ss_pred ecCCCCCHHHHHHHh---cccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhhee
Confidence 999999999999742 1234 7888899999999999999999 9999999999999976 67899999999876
Q ss_pred CCcccccceeeecCccccccccccccCCC--CCcccchHhHHHHHHHHhcCccc-ccch--HHHHHhc------CCH--H
Q 008785 422 VPWEVMQERTVMAGGTYGYLAPEFVYRNE--LTTKSDVYSFGVLLLEIRLVLCR-RWWT--LYTLVHS------MSL--L 488 (553)
Q Consensus 422 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~t~ksDVwSlGvil~ell~~~~~-~~~~--l~~~~~~------~~~--~ 488 (553)
........ ....+++.|+|||++.+.. ++.++||||||+++|+|++..+. .... ....... ..+ .
T Consensus 159 ~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (268)
T cd06624 159 LAGINPCT--ETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPES 236 (268)
T ss_pred cccCCCcc--ccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcc
Confidence 54322111 1122788999999986644 78999999999999999973322 1111 0111111 111 4
Q ss_pred HHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008785 489 CAQECLMLFISCNNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 489 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 517 (553)
....+.+++.+||+.+|.+|||+.|++++
T Consensus 237 ~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 237 LSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred cCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 56678999999999999999999999874
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=310.54 Aligned_cols=232 Identities=23% Similarity=0.321 Sum_probs=198.6
Q ss_pred eeecccCceeEEEEEeCC-CCEEEEEEeccCChh---hHHHHHHHHHHhhccC-CCceeeEeeEEeeCCceEEEEEccCC
Q 008785 275 RLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQ---RKKEFYSEIGRFARLH-HPNLVAVKGCCYDHGDRYIVYEFVVN 349 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~~-g~~vAvK~~~~~~~~---~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lV~E~~~~ 349 (553)
+.||+|.||.||+++.+. |+.+|+|.+++.... ....+.+|+.+|+++. |||||.+++++++....++|||++.|
T Consensus 41 ~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvmEL~~G 120 (382)
T KOG0032|consen 41 RELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLVMELCEG 120 (382)
T ss_pred hhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEEEecCC
Confidence 456999999999999765 999999999876433 3468999999999998 99999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCC----CCeEEeeccccccCCcc
Q 008785 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE----FGAHLMGVGLSKFVPWE 425 (553)
Q Consensus 350 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~----~~~kl~Dfgla~~~~~~ 425 (553)
|.|.+.+... .+++..+..++.|++.++.|||+. ||+||||||+|+|+... +.+|++|||++......
T Consensus 121 GeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~~ 192 (382)
T KOG0032|consen 121 GELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKPG 192 (382)
T ss_pred chHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCCCceEccCC
Confidence 9999999763 399999999999999999999999 99999999999999643 47999999999987762
Q ss_pred cccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcCccccc-c---hHHHHHhcCCH--------HHHHHH
Q 008785 426 VMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVLCRRW-W---TLYTLVHSMSL--------LCAQEC 493 (553)
Q Consensus 426 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~~~~~-~---~l~~~~~~~~~--------~~~~~l 493 (553)
......+||+.|+|||++...+|+..+||||+||++|.|+...++.. . .....+..+.+ .....+
T Consensus 193 ---~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~~a 269 (382)
T KOG0032|consen 193 ---ERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISESA 269 (382)
T ss_pred ---ceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCHHH
Confidence 22333449999999999998999999999999999999997333322 2 22224444444 668889
Q ss_pred HHHHhhccCCCCCCCCCHHHHHHH
Q 008785 494 LMLFISCNNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 494 ~~l~~~Cl~~dP~~RPs~~evl~~ 517 (553)
.+++..++..||..|+|+.++|++
T Consensus 270 kd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 270 KDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred HHHHHHhcccCcccCCCHHHHhcC
Confidence 999999999999999999999996
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=299.32 Aligned_cols=241 Identities=20% Similarity=0.239 Sum_probs=192.0
Q ss_pred eeecccCceeEEEEEeC-CCCEEEEEEecc--CChhhHHHHHHHHHHhhccCCCceeeEeeEEee-----CCceEEEEEc
Q 008785 275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD-----HGDRYIVYEF 346 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-----~~~~~lV~E~ 346 (553)
+.||+|+||.|..+... +|+.||||++.. ......++..+|+++|+.++|+||+.+++++.. -+..|+|+|+
T Consensus 28 ~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~el 107 (359)
T KOG0660|consen 28 EPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFEL 107 (359)
T ss_pred ccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehhH
Confidence 34599999999999964 589999999973 345556788999999999999999999999875 3568999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCccc
Q 008785 347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV 426 (553)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 426 (553)
| +-+|.+.++. +..++......++.||+.||+|+|+. +|+||||||+|+|++.+...||+|||+|+......
T Consensus 108 M-etDL~~iik~----~~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~ 179 (359)
T KOG0660|consen 108 M-ETDLHQIIKS----QQDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFF 179 (359)
T ss_pred H-hhHHHHHHHc----CccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccceeeccccC
Confidence 9 6699999964 34599999999999999999999999 99999999999999999999999999999876431
Q ss_pred ccce-eeecCccccccccccccC-CCCCcccchHhHHHHHHHHhcCcccc-cchHH------------------HHHhcC
Q 008785 427 MQER-TVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIRLVLCRR-WWTLY------------------TLVHSM 485 (553)
Q Consensus 427 ~~~~-~~~~~gt~~y~aPE~~~~-~~~t~ksDVwSlGvil~ell~~~~~~-~~~l~------------------~~~~~~ 485 (553)
.... +.. ..|..|.|||.+.. ..||.+.||||.|||+.||++..|-. ..+-+ ..+...
T Consensus 180 ~~~~mTeY-VaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~ 258 (359)
T KOG0660|consen 180 EDGFMTEY-VATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSE 258 (359)
T ss_pred cccchhcc-eeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccH
Confidence 1111 111 26889999998864 57999999999999999999633211 11111 111100
Q ss_pred CH--------------------HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHhh
Q 008785 486 SL--------------------LCAQECLMLFISCNNWPSHLSQSKFCNLKLWVFAILT 524 (553)
Q Consensus 486 ~~--------------------~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~~~~~ 524 (553)
.. ...+..++|+.++|..||.+|+|+.|.|++-..+..-
T Consensus 259 ~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~h 317 (359)
T KOG0660|consen 259 KARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYH 317 (359)
T ss_pred HHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhc
Confidence 00 5566789999999999999999999999986555443
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=299.89 Aligned_cols=238 Identities=21% Similarity=0.272 Sum_probs=183.4
Q ss_pred ecccCceeEEEEEeCC---CCEEEEEEeccCC-hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCCH
Q 008785 277 LGDSKTGGTYSGILPD---GSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352 (553)
Q Consensus 277 iG~G~~g~Vy~~~~~~---g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL 352 (553)
||+|+||.||+|...+ ...+|+|.+.... ......+.+|+..++.++||||+++++.+.+....++||||+++|+|
T Consensus 3 lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~L 82 (269)
T cd05042 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDL 82 (269)
T ss_pred CCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCcH
Confidence 5999999999997544 3478888876543 33356788999999999999999999999999999999999999999
Q ss_pred HHHhccCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCccccccee
Q 008785 353 DRWLHHIPR-GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT 431 (553)
Q Consensus 353 ~~~l~~~~~-~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~ 431 (553)
.+++..... .....++.....++.||+.||+|||+. +|+||||||+|||+++++.+||+|||++............
T Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~ 159 (269)
T cd05042 83 KNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITK 159 (269)
T ss_pred HHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchheecc
Confidence 999975322 123356778899999999999999999 9999999999999999999999999998754332211111
Q ss_pred eecCccccccccccccC-------CCCCcccchHhHHHHHHHHhc-C-cccccch----HHHHHhcCCH---------HH
Q 008785 432 VMAGGTYGYLAPEFVYR-------NELTTKSDVYSFGVLLLEIRL-V-LCRRWWT----LYTLVHSMSL---------LC 489 (553)
Q Consensus 432 ~~~~gt~~y~aPE~~~~-------~~~t~ksDVwSlGvil~ell~-~-~~~~~~~----l~~~~~~~~~---------~~ 489 (553)
....+++.|+|||++.. ..++.++||||||+++|||++ . .|..... +...+..+.. ..
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (269)
T cd05042 160 DCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLKY 239 (269)
T ss_pred CCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCcccccC
Confidence 12225678999998743 356889999999999999997 2 2222211 1122222221 44
Q ss_pred HHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008785 490 AQECLMLFISCNNWPSHLSQSKFCNLKLW 518 (553)
Q Consensus 490 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~l 518 (553)
+..+.+++..|+ .||++|||+.||++.+
T Consensus 240 ~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 240 SDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred CHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 566778888998 5999999999999865
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=296.18 Aligned_cols=237 Identities=28% Similarity=0.367 Sum_probs=190.8
Q ss_pred eecccCceeEEEEEeCC----CCEEEEEEeccCCh-hhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCC
Q 008785 276 LLGDSKTGGTYSGILPD----GSRVAVKRLKRSSF-QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 350 (553)
Q Consensus 276 ~iG~G~~g~Vy~~~~~~----g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 350 (553)
.||+|+||.||+|.+.. +..||+|.+..... ...+++.+|+.++++++||||+++++++. .+..++||||+++|
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~ 80 (257)
T cd05060 2 ELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPLG 80 (257)
T ss_pred ccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCCC
Confidence 36999999999998533 26899999986543 34567899999999999999999999876 45689999999999
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccce
Q 008785 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER 430 (553)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 430 (553)
+|.+++... ..+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||+++..........
T Consensus 81 ~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 81 PLLKYLKKR----REIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred cHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence 999999642 3689999999999999999999999 999999999999999999999999999986543322111
Q ss_pred e-eecCccccccccccccCCCCCcccchHhHHHHHHHHhc--Cccccc---chHHHHHhcCCH-----HHHHHHHHHHhh
Q 008785 431 T-VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL--VLCRRW---WTLYTLVHSMSL-----LCAQECLMLFIS 499 (553)
Q Consensus 431 ~-~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~--~~~~~~---~~l~~~~~~~~~-----~~~~~l~~l~~~ 499 (553)
. ....++..|+|||.+.+..++.++||||||+++|||++ ..|... ..+...+..+.. ..+..+.+++.+
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 233 (257)
T cd05060 154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIYSIMLS 233 (257)
T ss_pred cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHH
Confidence 1 11113567999999988899999999999999999996 333222 223333333322 456788999999
Q ss_pred ccCCCCCCCCCHHHHHHHHHH
Q 008785 500 CNNWPSHLSQSKFCNLKLWVF 520 (553)
Q Consensus 500 Cl~~dP~~RPs~~evl~~l~~ 520 (553)
||+.+|++|||+.++++.+..
T Consensus 234 cl~~~p~~Rp~~~~l~~~l~~ 254 (257)
T cd05060 234 CWKYRPEDRPTFSELESTFRR 254 (257)
T ss_pred HhcCChhhCcCHHHHHHHHHh
Confidence 999999999999999987743
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=298.10 Aligned_cols=240 Identities=22% Similarity=0.316 Sum_probs=193.2
Q ss_pred eeecccCceeEEEEEeC-C---CCEEEEEEeccCC-hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCC
Q 008785 275 RLLGDSKTGGTYSGILP-D---GSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 349 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~-~---g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 349 (553)
+.||+|+||.||+|... + +..+|+|.++... ......+.+|+.++++++||||+++++++.+.+..++||||+++
T Consensus 10 ~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 89 (267)
T cd05066 10 KVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMEN 89 (267)
T ss_pred eeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCCC
Confidence 45599999999999863 2 3379999987543 33456889999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccc
Q 008785 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE 429 (553)
Q Consensus 350 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 429 (553)
++|.+++.. ....+++.++..++.|++.||.|||+. +++||||||+||+++.++.++|+|||++..........
T Consensus 90 ~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~ 163 (267)
T cd05066 90 GSLDAFLRK---HDGQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAA 163 (267)
T ss_pred CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCccccccccccee
Confidence 999999964 234589999999999999999999999 99999999999999999999999999998765432211
Q ss_pred eee-ecCccccccccccccCCCCCcccchHhHHHHHHHHhc-C-cccccc---hHHHHHhcCCH-----HHHHHHHHHHh
Q 008785 430 RTV-MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-V-LCRRWW---TLYTLVHSMSL-----LCAQECLMLFI 498 (553)
Q Consensus 430 ~~~-~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-~-~~~~~~---~l~~~~~~~~~-----~~~~~l~~l~~ 498 (553)
... ...++..|+|||++.+..++.++||||||+++||+++ . .|.... .....+.++.. ..+..+.+++.
T Consensus 164 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 243 (267)
T cd05066 164 YTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMDCPAALHQLML 243 (267)
T ss_pred eecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCCCCCCCCHHHHHHHH
Confidence 111 1113567999999988889999999999999999885 2 232222 22233332211 44678899999
Q ss_pred hccCCCCCCCCCHHHHHHHHHH
Q 008785 499 SCNNWPSHLSQSKFCNLKLWVF 520 (553)
Q Consensus 499 ~Cl~~dP~~RPs~~evl~~l~~ 520 (553)
+|++.+|.+||++.++++.+..
T Consensus 244 ~~l~~~p~~Rp~~~~i~~~l~~ 265 (267)
T cd05066 244 DCWQKDRNERPKFEQIVSILDK 265 (267)
T ss_pred HHcccCchhCCCHHHHHHHHHh
Confidence 9999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=303.19 Aligned_cols=235 Identities=23% Similarity=0.284 Sum_probs=191.5
Q ss_pred eecccCceeEEEEEeCC-CCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCCHHH
Q 008785 276 LLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR 354 (553)
Q Consensus 276 ~iG~G~~g~Vy~~~~~~-g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~ 354 (553)
.||+|+||.||+|.... ++.||+|.+........+.+.+|+.++++++||||+++++.+..++..++||||+++++|..
T Consensus 19 ~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 98 (292)
T cd06644 19 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDA 98 (292)
T ss_pred eecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCCCCcHHH
Confidence 35999999999999754 88999999987766667889999999999999999999999999999999999999999988
Q ss_pred HhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccceeeec
Q 008785 355 WLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA 434 (553)
Q Consensus 355 ~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 434 (553)
++.. ....+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||++.......... ...
T Consensus 99 ~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~--~~~ 170 (292)
T cd06644 99 IMLE---LDRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRR--DSF 170 (292)
T ss_pred HHHh---hcCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceecccccccc--cee
Confidence 8754 234589999999999999999999999 99999999999999999999999999987543222111 112
Q ss_pred Ccccccccccccc-----CCCCCcccchHhHHHHHHHHhcCccc-ccchHHH---HHhcCCH-------HHHHHHHHHHh
Q 008785 435 GGTYGYLAPEFVY-----RNELTTKSDVYSFGVLLLEIRLVLCR-RWWTLYT---LVHSMSL-------LCAQECLMLFI 498 (553)
Q Consensus 435 ~gt~~y~aPE~~~-----~~~~t~ksDVwSlGvil~ell~~~~~-~~~~l~~---~~~~~~~-------~~~~~l~~l~~ 498 (553)
.+++.|+|||++. ...++.++||||||+++|||++..+. ...+..+ .+..... ..+..+.+++.
T Consensus 171 ~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 250 (292)
T cd06644 171 IGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFRDFLK 250 (292)
T ss_pred cCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcccCHHHHHHHH
Confidence 2788999999985 34568899999999999999984332 2222111 1111111 34567899999
Q ss_pred hccCCCCCCCCCHHHHHHHH
Q 008785 499 SCNNWPSHLSQSKFCNLKLW 518 (553)
Q Consensus 499 ~Cl~~dP~~RPs~~evl~~l 518 (553)
+||+.||++||++.+++++-
T Consensus 251 ~~l~~~p~~Rp~~~~il~~~ 270 (292)
T cd06644 251 TALDKHPETRPSAAQLLEHP 270 (292)
T ss_pred HHhcCCcccCcCHHHHhcCc
Confidence 99999999999999998863
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=301.18 Aligned_cols=241 Identities=22% Similarity=0.295 Sum_probs=189.6
Q ss_pred cccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCChhhHHHHHHHHHHhhcc-CCCceeeEeeEEeeC------Cc
Q 008785 268 KNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDH------GD 339 (553)
Q Consensus 268 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~------~~ 339 (553)
+.|..... ||+|+||.||+|... +++.||+|.+.... .....+.+|+.++.++ +||||+++++++... ..
T Consensus 6 ~~y~~~~~-lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~ 83 (272)
T cd06637 6 GIFELVEL-VGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ 83 (272)
T ss_pred hhhhHHHh-eeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcE
Confidence 34444444 599999999999965 48899999987553 3456788999999998 799999999998753 35
Q ss_pred eEEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeecccc
Q 008785 340 RYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLS 419 (553)
Q Consensus 340 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla 419 (553)
.++||||+++|+|.+++... ....+++..+..++.|++.||+|||++ +|+||||||+||++++++.++|+|||++
T Consensus 84 ~~iv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg~~ 158 (272)
T cd06637 84 LWLVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVS 158 (272)
T ss_pred EEEEEEcCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCCCc
Confidence 79999999999999998752 334688999999999999999999999 9999999999999999999999999999
Q ss_pred ccCCcccccceeeecCcccccccccccc-----CCCCCcccchHhHHHHHHHHhcCc-ccccchHHH---HHhcCCH---
Q 008785 420 KFVPWEVMQERTVMAGGTYGYLAPEFVY-----RNELTTKSDVYSFGVLLLEIRLVL-CRRWWTLYT---LVHSMSL--- 487 (553)
Q Consensus 420 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDVwSlGvil~ell~~~-~~~~~~l~~---~~~~~~~--- 487 (553)
......... .....|++.|+|||++. +..++.++|||||||++|||++.. |........ .......
T Consensus 159 ~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 236 (272)
T cd06637 159 AQLDRTVGR--RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRL 236 (272)
T ss_pred eeccccccc--CCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCC
Confidence 765432211 11223889999999986 345788999999999999999733 322211111 1111111
Q ss_pred ---HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008785 488 ---LCAQECLMLFISCNNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 488 ---~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 517 (553)
..+..+.+++.+||..||.+|||+.+++++
T Consensus 237 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 237 KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 456789999999999999999999999874
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=303.76 Aligned_cols=240 Identities=20% Similarity=0.278 Sum_probs=195.7
Q ss_pred ccCCCCeeecccCceeEEEEEe-CCCCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEcc
Q 008785 269 NFSEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV 347 (553)
Q Consensus 269 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 347 (553)
+|.... .||+|++|.||+|.. .+++.||+|.+........+.+.+|+.+++.++||||+++++.+......++||||+
T Consensus 21 ~y~~~~-~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 21 KYTRFE-KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred ceeeEE-EecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 343433 459999999999985 458899999998765556678899999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccc
Q 008785 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM 427 (553)
Q Consensus 348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 427 (553)
++++|.+++.. ..+++.++..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||++........
T Consensus 100 ~~~~L~~~~~~-----~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 171 (296)
T cd06654 100 AGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (296)
T ss_pred CCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhcccccc
Confidence 99999999854 3478899999999999999999999 999999999999999999999999999876543221
Q ss_pred cceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcCc-ccccchH----HHHHhcCC------HHHHHHHHHH
Q 008785 428 QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVL-CRRWWTL----YTLVHSMS------LLCAQECLML 496 (553)
Q Consensus 428 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~-~~~~~~l----~~~~~~~~------~~~~~~l~~l 496 (553)
.. ....+++.|+|||.+.+..++.++||||||+++|||++.. |...... ......+. ...+..+.++
T Consensus 172 ~~--~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 249 (296)
T cd06654 172 KR--STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDF 249 (296)
T ss_pred cc--CcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHH
Confidence 11 1123888999999998888999999999999999999733 3222211 11111111 1455678999
Q ss_pred HhhccCCCCCCCCCHHHHHHHHH
Q 008785 497 FISCNNWPSHLSQSKFCNLKLWV 519 (553)
Q Consensus 497 ~~~Cl~~dP~~RPs~~evl~~l~ 519 (553)
+.+||..+|++|||+.+++++-.
T Consensus 250 i~~~l~~~p~~Rpt~~eil~~~~ 272 (296)
T cd06654 250 LNRCLDMDVEKRGSAKELLQHQF 272 (296)
T ss_pred HHHHCcCCcccCcCHHHHhhChh
Confidence 99999999999999999998643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=303.65 Aligned_cols=252 Identities=20% Similarity=0.282 Sum_probs=195.3
Q ss_pred HHHHHHhhcccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCChhhHHHHHHHHHHhhcc-CCCceeeEeeEEe--
Q 008785 260 TEELRSITKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCY-- 335 (553)
Q Consensus 260 ~~el~~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~-- 335 (553)
++.+..+.++|.....+ |+|+||.||++... +++.+|+|.++... .....+.+|+.+++++ +||||+++++++.
T Consensus 10 ~~~~~~~~~~~~~~~~l-g~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 87 (286)
T cd06638 10 FDSFPDPSDTWEIIETI-GKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKK 87 (286)
T ss_pred eecCCCcccceeeeeee-ccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence 34455667777666554 99999999999864 48899999886532 2346688899999999 6999999999875
Q ss_pred ---eCCceEEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeE
Q 008785 336 ---DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAH 412 (553)
Q Consensus 336 ---~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~k 412 (553)
.++..++||||+++++|.+++.........+++..+..++.|++.||.|||+. +++||||||+||++++++.++
T Consensus 88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~k 164 (286)
T cd06638 88 DVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVK 164 (286)
T ss_pred ccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCEE
Confidence 33568999999999999998864323345688999999999999999999999 999999999999999999999
Q ss_pred EeeccccccCCcccccceeeecCccccccccccccC-----CCCCcccchHhHHHHHHHHhcCc-ccccchHHH-H--Hh
Q 008785 413 LMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYR-----NELTTKSDVYSFGVLLLEIRLVL-CRRWWTLYT-L--VH 483 (553)
Q Consensus 413 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~t~ksDVwSlGvil~ell~~~-~~~~~~l~~-~--~~ 483 (553)
|+|||++.......... ....|++.|+|||++.. ..++.++||||||+++|||++.. |........ . ..
T Consensus 165 l~dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~ 242 (286)
T cd06638 165 LVDFGVSAQLTSTRLRR--NTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIP 242 (286)
T ss_pred EccCCceeecccCCCcc--ccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhcc
Confidence 99999987654322111 12238899999998753 45788999999999999999733 322222111 1 11
Q ss_pred cCC---H----HHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008785 484 SMS---L----LCAQECLMLFISCNNWPSHLSQSKFCNLKLW 518 (553)
Q Consensus 484 ~~~---~----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l 518 (553)
.+. . ..+..+.+++.+||+.||++|||+.|++++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 243 RNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred ccCCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 111 0 2356789999999999999999999999864
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=296.16 Aligned_cols=242 Identities=26% Similarity=0.378 Sum_probs=196.4
Q ss_pred ccCCCCeeecccCceeEEEEEeCCCCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccC
Q 008785 269 NFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV 348 (553)
Q Consensus 269 ~~~~~~~~iG~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 348 (553)
+|.... .||+|++|.||++..+++..||||.+.... ...+++.+|+.++++++||||+++++++.+....++||||++
T Consensus 7 ~~~i~~-~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 84 (261)
T cd05034 7 SLKLER-KLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMS 84 (261)
T ss_pred heeeee-eeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccC
Confidence 344433 459999999999998888899999998653 345678999999999999999999999998889999999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCccccc
Q 008785 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ 428 (553)
Q Consensus 349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 428 (553)
+++|.+++.. .....+++..+..++.|++.||.|||++ +++||||||+||++++++.++|+|||.+.........
T Consensus 85 ~~~L~~~i~~--~~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 159 (261)
T cd05034 85 KGSLLDFLKS--GEGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYT 159 (261)
T ss_pred CCCHHHHHhc--cccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccchhhh
Confidence 9999999975 2334689999999999999999999999 9999999999999999999999999998766532211
Q ss_pred ceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhc-Cc-cccc---chHHHHHhcC-C----HHHHHHHHHHHh
Q 008785 429 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-VL-CRRW---WTLYTLVHSM-S----LLCAQECLMLFI 498 (553)
Q Consensus 429 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-~~-~~~~---~~l~~~~~~~-~----~~~~~~l~~l~~ 498 (553)
.... ..++..|+|||.+.+..++.++||||||+++||+++ .. |... ....+.+..+ . ...+..+.+++.
T Consensus 160 ~~~~-~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 238 (261)
T cd05034 160 AREG-AKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCPEELYDLML 238 (261)
T ss_pred hhhc-cCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Confidence 1111 114568999999998889999999999999999997 33 2222 2222222221 1 144678999999
Q ss_pred hccCCCCCCCCCHHHHHHHH
Q 008785 499 SCNNWPSHLSQSKFCNLKLW 518 (553)
Q Consensus 499 ~Cl~~dP~~RPs~~evl~~l 518 (553)
+|++.+|.+||++.++++.+
T Consensus 239 ~~l~~~p~~Rp~~~~l~~~l 258 (261)
T cd05034 239 QCWDKDPEERPTFEYLQSFL 258 (261)
T ss_pred HHcccCcccCCCHHHHHHHH
Confidence 99999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=307.66 Aligned_cols=248 Identities=24% Similarity=0.309 Sum_probs=197.1
Q ss_pred eeecccCceeEEEEEeCC--------CCEEEEEEeccCC-hhhHHHHHHHHHHhhcc-CCCceeeEeeEEeeCCceEEEE
Q 008785 275 RLLGDSKTGGTYSGILPD--------GSRVAVKRLKRSS-FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVY 344 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~~--------g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~ 344 (553)
+.||+|+||.||++.... +..||+|.++... ....+++.+|+.+++++ +||||+++++++...+..+++|
T Consensus 18 ~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 97 (334)
T cd05100 18 KPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLV 97 (334)
T ss_pred ceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCCceEEEE
Confidence 455999999999997421 2369999887542 33457889999999999 8999999999999999999999
Q ss_pred EccCCCCHHHHhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeE
Q 008785 345 EFVVNGPLDRWLHHIPR------------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAH 412 (553)
Q Consensus 345 E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~k 412 (553)
||+++|+|.+++..... ....+++..+..++.|++.||.|||++ +++||||||+||++++++.+|
T Consensus 98 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nill~~~~~~k 174 (334)
T cd05100 98 EYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVLVTEDNVMK 174 (334)
T ss_pred ecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEE
Confidence 99999999999975321 223578899999999999999999999 999999999999999999999
Q ss_pred EeeccccccCCcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhc-C-ccccc---chHHHHHhcCCH
Q 008785 413 LMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-V-LCRRW---WTLYTLVHSMSL 487 (553)
Q Consensus 413 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-~-~~~~~---~~l~~~~~~~~~ 487 (553)
|+|||+++...............++..|+|||++.+..++.++||||||+++|||++ . .+... ..+...+..+..
T Consensus 175 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~ 254 (334)
T cd05100 175 IADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGHR 254 (334)
T ss_pred ECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC
Confidence 999999976543322111111224567999999998899999999999999999997 2 33322 223333333221
Q ss_pred -----HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHhhc
Q 008785 488 -----LCAQECLMLFISCNNWPSHLSQSKFCNLKLWVFAILTI 525 (553)
Q Consensus 488 -----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~~~~~~ 525 (553)
..+..+.+++.+||+.+|++|||+.|+++.+...+...
T Consensus 255 ~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~ 297 (334)
T cd05100 255 MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT 297 (334)
T ss_pred CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence 45668899999999999999999999999987766444
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=317.79 Aligned_cols=240 Identities=19% Similarity=0.159 Sum_probs=188.8
Q ss_pred cCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCC---hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEE
Q 008785 270 FSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYE 345 (553)
Q Consensus 270 ~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 345 (553)
|... +.||+|+||.||++... +|+.||||++.... ....+.+.+|++++++++||||+++++++.+.+..|+|||
T Consensus 3 y~~~-~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E 81 (377)
T cd05629 3 FHTV-KVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIME 81 (377)
T ss_pred ceEe-EEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEe
Confidence 4443 34599999999999864 58999999986532 2234668889999999999999999999999999999999
Q ss_pred ccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcc
Q 008785 346 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE 425 (553)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~ 425 (553)
|+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~gg~L~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~ 154 (377)
T cd05629 82 FLPGGDLMTMLIK----YDTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ 154 (377)
T ss_pred CCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence 9999999999864 24588999999999999999999999 9999999999999999999999999998632210
Q ss_pred ccc------------c---------------------------------eeeecCccccccccccccCCCCCcccchHhH
Q 008785 426 VMQ------------E---------------------------------RTVMAGGTYGYLAPEFVYRNELTTKSDVYSF 460 (553)
Q Consensus 426 ~~~------------~---------------------------------~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSl 460 (553)
... . ......||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 234 (377)
T cd05629 155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL 234 (377)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence 000 0 0001248999999999998899999999999
Q ss_pred HHHHHHHhcCc-ccccc---hHHHHHhc--CCH------HHHHHHHHHHhhccCCCCCCC---CCHHHHHHHH
Q 008785 461 GVLLLEIRLVL-CRRWW---TLYTLVHS--MSL------LCAQECLMLFISCNNWPSHLS---QSKFCNLKLW 518 (553)
Q Consensus 461 Gvil~ell~~~-~~~~~---~l~~~~~~--~~~------~~~~~l~~l~~~Cl~~dP~~R---Ps~~evl~~l 518 (553)
||++|||++.. |.... .....+.. ..+ ..+..+.+++.+|+. +|.+| ||+.|++++-
T Consensus 235 Gvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp 306 (377)
T cd05629 235 GAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHP 306 (377)
T ss_pred chhhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCC
Confidence 99999999833 33222 22222211 111 345678899999997 66664 6999999874
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=297.59 Aligned_cols=229 Identities=25% Similarity=0.320 Sum_probs=185.0
Q ss_pred eecccCceeEEEEEeCCCC-----------EEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEE
Q 008785 276 LLGDSKTGGTYSGILPDGS-----------RVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVY 344 (553)
Q Consensus 276 ~iG~G~~g~Vy~~~~~~g~-----------~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 344 (553)
.||+|+||.||+|...+.. .|++|.+...... ...+.+|+.++++++||||+++++++.. ...++||
T Consensus 2 ~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~ 79 (259)
T cd05037 2 HLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE 79 (259)
T ss_pred cccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence 4699999999999976533 5888887655333 6788999999999999999999999888 7789999
Q ss_pred EccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCC-------CeEEeecc
Q 008785 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF-------GAHLMGVG 417 (553)
Q Consensus 345 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~-------~~kl~Dfg 417 (553)
||+++|+|.+++... ...+++..+..++.||+.||+|||++ +|+||||||+||+++.++ .+||+|||
T Consensus 80 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 80 EYVKFGPLDVFLHRE---KNNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EcCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCCCC
Confidence 999999999999752 22689999999999999999999999 999999999999999887 79999999
Q ss_pred ccccCCcccccceeeecCccccccccccccCC--CCCcccchHhHHHHHHHHhcC--cccccch---HHHHHhcCC-H--
Q 008785 418 LSKFVPWEVMQERTVMAGGTYGYLAPEFVYRN--ELTTKSDVYSFGVLLLEIRLV--LCRRWWT---LYTLVHSMS-L-- 487 (553)
Q Consensus 418 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~t~ksDVwSlGvil~ell~~--~~~~~~~---l~~~~~~~~-~-- 487 (553)
++....... ...++..|+|||++... .++.++||||||+++|||++. .+..... ....+.... .
T Consensus 154 ~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 227 (259)
T cd05037 154 IPITVLSRE------ERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHRLPM 227 (259)
T ss_pred ccccccccc------ccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhcCCCCCC
Confidence 997654311 11267789999999876 789999999999999999873 2222211 111111111 1
Q ss_pred HHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008785 488 LCAQECLMLFISCNNWPSHLSQSKFCNLKLW 518 (553)
Q Consensus 488 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l 518 (553)
.....+.+++.+||..+|.+|||+.++++.+
T Consensus 228 ~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 228 PDCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred CCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 2336889999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=295.62 Aligned_cols=232 Identities=27% Similarity=0.369 Sum_probs=189.5
Q ss_pred eeecccCceeEEEEEeCCCCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeEEe-eCCceEEEEEccCCCCHH
Q 008785 275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY-DHGDRYIVYEFVVNGPLD 353 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~~lV~E~~~~gsL~ 353 (553)
+.||+|+||.||++.. .|..||+|.++... ..+.+.+|+.++++++|||++++++++. +.+..+++|||+++++|.
T Consensus 12 ~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~ 88 (256)
T cd05082 12 QTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLV 88 (256)
T ss_pred eeecccCCCeEEEEEE-cCCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCCcHH
Confidence 4569999999999987 58889999987542 3467899999999999999999999765 445689999999999999
Q ss_pred HHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccceeee
Q 008785 354 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVM 433 (553)
Q Consensus 354 ~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 433 (553)
+++.. .....+++..+..++.|++.||+|||++ +++||||||+||++++++.+||+|||++........ .
T Consensus 89 ~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~-----~ 158 (256)
T cd05082 89 DYLRS--RGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD-----T 158 (256)
T ss_pred HHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccccCC-----C
Confidence 99875 2334588999999999999999999999 999999999999999999999999999875433221 1
Q ss_pred cCccccccccccccCCCCCcccchHhHHHHHHHHhc-C-cccccchHH---HHHhcCCH-----HHHHHHHHHHhhccCC
Q 008785 434 AGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-V-LCRRWWTLY---TLVHSMSL-----LCAQECLMLFISCNNW 503 (553)
Q Consensus 434 ~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-~-~~~~~~~l~---~~~~~~~~-----~~~~~l~~l~~~Cl~~ 503 (553)
..++..|+|||++.+..++.++||||||+++|||++ . .|.....+. ..+..+.. ..+..+.+++.+|++.
T Consensus 159 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 238 (256)
T cd05082 159 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVYDVMKQCWHL 238 (256)
T ss_pred CccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhcC
Confidence 125668999999988889999999999999999996 2 233222222 23322211 4567889999999999
Q ss_pred CCCCCCCHHHHHHHHH
Q 008785 504 PSHLSQSKFCNLKLWV 519 (553)
Q Consensus 504 dP~~RPs~~evl~~l~ 519 (553)
+|++|||+.++++.+.
T Consensus 239 ~p~~Rpt~~~l~~~l~ 254 (256)
T cd05082 239 DAATRPSFLQLREQLE 254 (256)
T ss_pred ChhhCcCHHHHHHHHh
Confidence 9999999999998763
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=297.75 Aligned_cols=242 Identities=25% Similarity=0.319 Sum_probs=194.1
Q ss_pred eeecccCceeEEEEEeCC----CCEEEEEEeccCC-hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCC
Q 008785 275 RLLGDSKTGGTYSGILPD----GSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 349 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~~----g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 349 (553)
+.||+|+||.||+|...+ ...||||...... ....+.+.+|+.++++++||||+++++++.+ +..++||||+++
T Consensus 12 ~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv~e~~~~ 90 (270)
T cd05056 12 RCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIVMELAPL 90 (270)
T ss_pred eeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEEEEcCCC
Confidence 456999999999998644 2479999987654 4456789999999999999999999998875 567899999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccc
Q 008785 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE 429 (553)
Q Consensus 350 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 429 (553)
|+|.+++.. ....+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||+++.........
T Consensus 91 ~~L~~~l~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~ 164 (270)
T cd05056 91 GELRSYLQV---NKYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYK 164 (270)
T ss_pred CcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeeccccccee
Confidence 999999964 233589999999999999999999999 99999999999999999999999999997665432221
Q ss_pred eeeecCccccccccccccCCCCCcccchHhHHHHHHHHhc--Ccccccc---hHHHHHhcCCH-----HHHHHHHHHHhh
Q 008785 430 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL--VLCRRWW---TLYTLVHSMSL-----LCAQECLMLFIS 499 (553)
Q Consensus 430 ~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~--~~~~~~~---~l~~~~~~~~~-----~~~~~l~~l~~~ 499 (553)
.. ...++..|+|||.+....++.++||||||+++||+++ ..|.... .....+..+.. ..+..+.+++.+
T Consensus 165 ~~-~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 243 (270)
T cd05056 165 AS-KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTK 243 (270)
T ss_pred cC-CCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHH
Confidence 11 1124568999999988889999999999999999885 2233222 22223333221 556789999999
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHhh
Q 008785 500 CNNWPSHLSQSKFCNLKLWVFAILT 524 (553)
Q Consensus 500 Cl~~dP~~RPs~~evl~~l~~~~~~ 524 (553)
|+..+|++|||+.++++.+.....+
T Consensus 244 ~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 244 CWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred HcCCChhhCcCHHHHHHHHHHHHhc
Confidence 9999999999999999987664433
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=298.94 Aligned_cols=245 Identities=26% Similarity=0.315 Sum_probs=195.2
Q ss_pred ccCCCCeeecccCceeEEEEEeC------CCCEEEEEEeccCChh-hHHHHHHHHHHhhccCCCceeeEeeEEeeCCceE
Q 008785 269 NFSEGNRLLGDSKTGGTYSGILP------DGSRVAVKRLKRSSFQ-RKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRY 341 (553)
Q Consensus 269 ~~~~~~~~iG~G~~g~Vy~~~~~------~g~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 341 (553)
+|..... ||+|+||.||+|..+ +.+.||+|.+...... ..+++.+|+.++++++||||+++++++.+.+..+
T Consensus 6 ~~~~~~~-lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 6 NLQEITT-LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred hceeeee-ecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 3444344 599999999999964 2467999998765433 4578999999999999999999999999988999
Q ss_pred EEEEccCCCCHHHHhccCCCC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeec
Q 008785 342 IVYEFVVNGPLDRWLHHIPRG-----GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGV 416 (553)
Q Consensus 342 lV~E~~~~gsL~~~l~~~~~~-----~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Df 416 (553)
+||||+++|+|.+++...... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEccc
Confidence 999999999999999753211 12589999999999999999999999 9999999999999999999999999
Q ss_pred cccccCCcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcC--cccc---cchHHHHHhcCCH----
Q 008785 417 GLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLV--LCRR---WWTLYTLVHSMSL---- 487 (553)
Q Consensus 417 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~--~~~~---~~~l~~~~~~~~~---- 487 (553)
|++........... ....++..|+|||.+.+..++.++||||||+++|+|++. .+.. ...+......+..
T Consensus 162 ~~~~~~~~~~~~~~-~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 240 (275)
T cd05046 162 SLSKDVYNSEYYKL-RNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPV 240 (275)
T ss_pred ccccccCccccccc-CCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCCC
Confidence 99875432221111 111257789999999888889999999999999999962 2222 2223333332222
Q ss_pred --HHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008785 488 --LCAQECLMLFISCNNWPSHLSQSKFCNLKLW 518 (553)
Q Consensus 488 --~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l 518 (553)
..+..+.+++.+||+.+|++|||+.|+++.+
T Consensus 241 ~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l 273 (275)
T cd05046 241 PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSAL 273 (275)
T ss_pred CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHh
Confidence 4567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-39 Score=292.66 Aligned_cols=232 Identities=21% Similarity=0.249 Sum_probs=195.6
Q ss_pred eecccCceeEEEEEe-CCCCEEEEEEeccC--ChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCCH
Q 008785 276 LLGDSKTGGTYSGIL-PDGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352 (553)
Q Consensus 276 ~iG~G~~g~Vy~~~~-~~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL 352 (553)
.||+|.|+.||+... ++|+.+|+|++... +..+.+++.+|+++...|+||||+++.+...+.+..|||+|+|.||+|
T Consensus 18 ~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~m~G~dl 97 (355)
T KOG0033|consen 18 ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL 97 (355)
T ss_pred HHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEecccchHH
Confidence 459999999999885 46899999988643 334568899999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCC---CCeEEeeccccccCCcccccc
Q 008785 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE---FGAHLMGVGLSKFVPWEVMQE 429 (553)
Q Consensus 353 ~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~---~~~kl~Dfgla~~~~~~~~~~ 429 (553)
..-+-. ....++..+-..++||+++|.|+|.+ +|||||+||+|+++... -.+||+|||+|........
T Consensus 98 ~~eIV~----R~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~~-- 168 (355)
T KOG0033|consen 98 FEDIVA----REFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGEA-- 168 (355)
T ss_pred HHHHHH----HHHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEEeCCccc--
Confidence 665532 14467888889999999999999999 99999999999999543 4589999999987762221
Q ss_pred eeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcCccc----ccchHHHHHhcCCH--------HHHHHHHHHH
Q 008785 430 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVLCR----RWWTLYTLVHSMSL--------LCAQECLMLF 497 (553)
Q Consensus 430 ~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~~~----~~~~l~~~~~~~~~--------~~~~~l~~l~ 497 (553)
.....|||+|||||++...+|+..+||||-|||||-|+...++ +...+++.+.+|.. ...++..+|+
T Consensus 169 -~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~Lv 247 (355)
T KOG0033|consen 169 -WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAKSLI 247 (355)
T ss_pred -cccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHHHHHH
Confidence 2223399999999999999999999999999999999974333 33467777777766 6677899999
Q ss_pred hhccCCCCCCCCCHHHHHHH
Q 008785 498 ISCNNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 498 ~~Cl~~dP~~RPs~~evl~~ 517 (553)
.+||..||++|.|+.|.|++
T Consensus 248 rrML~~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 248 RRMLTVNPKKRITADEALKH 267 (355)
T ss_pred HHHhccChhhhccHHHHhCC
Confidence 99999999999999999976
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=295.83 Aligned_cols=237 Identities=23% Similarity=0.345 Sum_probs=193.0
Q ss_pred CeeecccCceeEEEEEeCCCCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCCHH
Q 008785 274 NRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 353 (553)
Q Consensus 274 ~~~iG~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~ 353 (553)
.+.||+|+||.||++...++..+|+|.++.. ....+.+.+|+.++++++|+||+++++.+.+ ...+++|||+++|+|.
T Consensus 11 ~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~~~L~ 88 (260)
T cd05073 11 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLL 88 (260)
T ss_pred EeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCCCCcHH
Confidence 3446999999999999878888999998764 3345678999999999999999999999887 7789999999999999
Q ss_pred HHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccceeee
Q 008785 354 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVM 433 (553)
Q Consensus 354 ~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 433 (553)
+++... ....+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||.+............ .
T Consensus 89 ~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~-~ 162 (260)
T cd05073 89 DFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTARE-G 162 (260)
T ss_pred HHHHhC--CccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCCCccccc-C
Confidence 999752 334578899999999999999999999 9999999999999999999999999998765432221111 1
Q ss_pred cCccccccccccccCCCCCcccchHhHHHHHHHHhc-Ccc-cccc---hHHHHHhcCCH-----HHHHHHHHHHhhccCC
Q 008785 434 AGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-VLC-RRWW---TLYTLVHSMSL-----LCAQECLMLFISCNNW 503 (553)
Q Consensus 434 ~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-~~~-~~~~---~l~~~~~~~~~-----~~~~~l~~l~~~Cl~~ 503 (553)
..++..|+|||++....++.++|+||||+++|++++ ... .... .+...+..+.. ..+..+.+++.+|++.
T Consensus 163 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 242 (260)
T cd05073 163 AKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMRCWKN 242 (260)
T ss_pred CcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCcccCCHHHHHHHHHHccc
Confidence 125678999999988889999999999999999997 332 2222 22333333211 4567899999999999
Q ss_pred CCCCCCCHHHHHHHH
Q 008785 504 PSHLSQSKFCNLKLW 518 (553)
Q Consensus 504 dP~~RPs~~evl~~l 518 (553)
+|++||++.++++.|
T Consensus 243 ~p~~Rp~~~~l~~~L 257 (260)
T cd05073 243 RPEERPTFEYIQSVL 257 (260)
T ss_pred CcccCcCHHHHHHHH
Confidence 999999999998865
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=301.20 Aligned_cols=238 Identities=20% Similarity=0.218 Sum_probs=192.3
Q ss_pred eeecccCceeEEEEEeC-CCCEEEEEEeccCC---hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCC
Q 008785 275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 350 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 350 (553)
++||+|+||.||++... +++.||+|.+.... ......+.+|+.++++++|+||+.+++.+.+.+..++||||+++|
T Consensus 6 ~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~ 85 (285)
T cd05630 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGG 85 (285)
T ss_pred EEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEecCCC
Confidence 45699999999999965 58899999987542 222356788999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccce
Q 008785 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER 430 (553)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 430 (553)
+|.+++.. .....+++..+..++.|++.||.|||+. +|+||||||+||++++++.++|+|||++.........
T Consensus 86 ~L~~~l~~--~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~-- 158 (285)
T cd05630 86 DLKFHIYH--MGEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTI-- 158 (285)
T ss_pred cHHHHHHH--hcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCccc--
Confidence 99998864 2334589999999999999999999999 9999999999999999999999999998765432211
Q ss_pred eeecCccccccccccccCCCCCcccchHhHHHHHHHHhcCc-ccccc-------hHHHHHhcCC----HHHHHHHHHHHh
Q 008785 431 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVL-CRRWW-------TLYTLVHSMS----LLCAQECLMLFI 498 (553)
Q Consensus 431 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~-~~~~~-------~l~~~~~~~~----~~~~~~l~~l~~ 498 (553)
....|+..|+|||++.+..++.++||||||+++|||++.. |.... .......... ...+..+.+++.
T Consensus 159 -~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 237 (285)
T cd05630 159 -KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCK 237 (285)
T ss_pred -cCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHHHHHHH
Confidence 1123899999999999889999999999999999999733 22211 1111111111 145667899999
Q ss_pred hccCCCCCCCCC-----HHHHHHHHHH
Q 008785 499 SCNNWPSHLSQS-----KFCNLKLWVF 520 (553)
Q Consensus 499 ~Cl~~dP~~RPs-----~~evl~~l~~ 520 (553)
+||+.||++||| +.|++++-..
T Consensus 238 ~~l~~~p~~R~s~~~~~~~~~~~h~~~ 264 (285)
T cd05630 238 MLLCKDPKERLGCQGGGAREVKEHPLF 264 (285)
T ss_pred HHhhcCHHHccCCCCCchHHHHcChhh
Confidence 999999999999 8999987443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=302.56 Aligned_cols=241 Identities=22% Similarity=0.280 Sum_probs=197.2
Q ss_pred cCCCCeeecccCceeEEEEEe-CCCCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccC
Q 008785 270 FSEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV 348 (553)
Q Consensus 270 ~~~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 348 (553)
|.... .||.|++|.||+|.. .+|+.||+|.+........+.+.+|+.+++.++||||+++++++...+..++|+||++
T Consensus 21 y~~~~-~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 99 (296)
T cd06655 21 YTRYE-KIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLA 99 (296)
T ss_pred EEEEE-EEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecC
Confidence 44434 459999999999985 4689999999976655566788999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCccccc
Q 008785 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ 428 (553)
Q Consensus 349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 428 (553)
+++|.+++.. ..+++.++..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++.........
T Consensus 100 ~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 171 (296)
T cd06655 100 GGSLTDVVTE-----TCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK 171 (296)
T ss_pred CCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhccccccc
Confidence 9999998854 3489999999999999999999999 9999999999999999999999999998765433221
Q ss_pred ceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcCc-ccccchHHH----HHhcCC------HHHHHHHHHHH
Q 008785 429 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVL-CRRWWTLYT----LVHSMS------LLCAQECLMLF 497 (553)
Q Consensus 429 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~-~~~~~~l~~----~~~~~~------~~~~~~l~~l~ 497 (553)
. ....++..|+|||.+.+..++.++||||||+++|+|++.. |....+..+ ....+. ...+..+.+++
T Consensus 172 ~--~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 249 (296)
T cd06655 172 R--STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFL 249 (296)
T ss_pred C--CCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHHH
Confidence 1 1123788999999998888999999999999999999833 322221111 111111 14566789999
Q ss_pred hhccCCCCCCCCCHHHHHHHHHHH
Q 008785 498 ISCNNWPSHLSQSKFCNLKLWVFA 521 (553)
Q Consensus 498 ~~Cl~~dP~~RPs~~evl~~l~~~ 521 (553)
.+||..||.+|||+.+++++-...
T Consensus 250 ~~~l~~dp~~Rpt~~~il~~~~~~ 273 (296)
T cd06655 250 NRCLEMDVEKRGSAKELLQHPFLK 273 (296)
T ss_pred HHHhhcChhhCCCHHHHhhChHhh
Confidence 999999999999999999875443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=318.20 Aligned_cols=237 Identities=22% Similarity=0.243 Sum_probs=197.9
Q ss_pred CeeecccCceeEEEEEeCC-CCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCCH
Q 008785 274 NRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352 (553)
Q Consensus 274 ~~~iG~G~~g~Vy~~~~~~-g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL 352 (553)
..++|+|.||+||.|+..+ ...+|||-+...+....+-+..|+.+.++|+|.|||+++|.+.+++..-|.||-++||+|
T Consensus 580 rvVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSL 659 (1226)
T KOG4279|consen 580 RVVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSL 659 (1226)
T ss_pred eEEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcH
Confidence 3568999999999999655 557999999988777778899999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCC--CHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecC-CCCeEEeeccccccCCcccccc
Q 008785 353 DRWLHHIPRGGRSL--DWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE-EFGAHLMGVGLSKFVPWEVMQE 429 (553)
Q Consensus 353 ~~~l~~~~~~~~~l--~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~-~~~~kl~Dfgla~~~~~~~~~~ 429 (553)
.++|+. .-.++ ++..+-.+.+||++||.|||++ .|||||||-+|+|++. .|.+||+|||.++.+..-..
T Consensus 660 SsLLrs---kWGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP-- 731 (1226)
T KOG4279|consen 660 SSLLRS---KWGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINP-- 731 (1226)
T ss_pred HHHHHh---ccCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccCCc--
Confidence 999975 22334 7788889999999999999999 9999999999999975 68899999999987653322
Q ss_pred eeeecCccccccccccccCC--CCCcccchHhHHHHHHHHhcCcccccc--hH-HHHHhcCCH--------HHHHHHHHH
Q 008785 430 RTVMAGGTYGYLAPEFVYRN--ELTTKSDVYSFGVLLLEIRLVLCRRWW--TL-YTLVHSMSL--------LCAQECLML 496 (553)
Q Consensus 430 ~~~~~~gt~~y~aPE~~~~~--~~t~ksDVwSlGvil~ell~~~~~~~~--~l-~~~~~~~~~--------~~~~~l~~l 496 (553)
-+.+.-||..|||||++..+ .|+.++|||||||++.||.|+.|+... +. ..+.+-|-+ ....+...+
T Consensus 732 ~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~F 811 (1226)
T KOG4279|consen 732 CTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNF 811 (1226)
T ss_pred cccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHH
Confidence 22223399999999999866 489999999999999999996655432 11 113333333 677889999
Q ss_pred HhhccCCCCCCCCCHHHHHHHH
Q 008785 497 FISCNNWPSHLSQSKFCNLKLW 518 (553)
Q Consensus 497 ~~~Cl~~dP~~RPs~~evl~~l 518 (553)
+++|+.+||.+||++.++|+.-
T Consensus 812 ilrcFepd~~~R~sA~~LL~Dp 833 (1226)
T KOG4279|consen 812 ILRCFEPDPCDRPSAKDLLQDP 833 (1226)
T ss_pred HHHHcCCCcccCccHHHhccCc
Confidence 9999999999999999998753
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=332.04 Aligned_cols=249 Identities=21% Similarity=0.231 Sum_probs=191.2
Q ss_pred cCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCC---hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEE
Q 008785 270 FSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYE 345 (553)
Q Consensus 270 ~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 345 (553)
|...+ .||+|+||.||+|... +|+.||||+++... ....+++.+|++++++++||||+++++++.+.+..++|||
T Consensus 4 YeIi~-~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVME 82 (932)
T PRK13184 4 YDIIR-LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMP 82 (932)
T ss_pred eEEEE-EEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEE
Confidence 43434 4599999999999965 48999999997542 2335678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhccCCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccc
Q 008785 346 FVVNGPLDRWLHHIPR-------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGL 418 (553)
Q Consensus 346 ~~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgl 418 (553)
|+++|+|.+++..... .....++..+..++.||+.||+|||+. +|+||||||+|||++.++.++|+|||+
T Consensus 83 Y~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFGL 159 (932)
T PRK13184 83 YIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGA 159 (932)
T ss_pred cCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecCc
Confidence 9999999999864211 123456778899999999999999999 999999999999999999999999999
Q ss_pred cccCCccccc----------------ceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcCc-ccccchHHH-
Q 008785 419 SKFVPWEVMQ----------------ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVL-CRRWWTLYT- 480 (553)
Q Consensus 419 a~~~~~~~~~----------------~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~-~~~~~~l~~- 480 (553)
++........ .......||+.|+|||++.+..++.++|||||||++|||++.. |........
T Consensus 160 Ak~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki 239 (932)
T PRK13184 160 AIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKI 239 (932)
T ss_pred ceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhh
Confidence 9865211100 0001123899999999999999999999999999999999833 332221111
Q ss_pred ----HHhcCC-----HHHHHHHHHHHhhccCCCCCCCCCHHHHH-HHHHHHH
Q 008785 481 ----LVHSMS-----LLCAQECLMLFISCNNWPSHLSQSKFCNL-KLWVFAI 522 (553)
Q Consensus 481 ----~~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl-~~l~~~~ 522 (553)
.+.... ...+..+.+++.+|++.||++||+..+.+ +.+...+
T Consensus 240 ~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~l 291 (932)
T PRK13184 240 SYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHL 291 (932)
T ss_pred hhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 110000 14456789999999999999997655544 4444433
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=309.21 Aligned_cols=234 Identities=20% Similarity=0.201 Sum_probs=187.8
Q ss_pred eeecccCceeEEEEEeC-CCCEEEEEEeccCC---hhhHHHHHHHHHHhhccC-CCceeeEeeEEeeCCceEEEEEccCC
Q 008785 275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLH-HPNLVAVKGCCYDHGDRYIVYEFVVN 349 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lV~E~~~~ 349 (553)
++||+|+||.||++... +|+.||+|+++... ....+.+..|..++..+. ||+|+++++++.+.+..|+||||+++
T Consensus 6 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey~~~ 85 (323)
T cd05615 6 MVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNG 85 (323)
T ss_pred EEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcCCCC
Confidence 45699999999999865 58899999997542 223456778888888885 67888899999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccc
Q 008785 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE 429 (553)
Q Consensus 350 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 429 (553)
|+|.+++.. ...+++.++..++.||+.||.|||++ +|+||||||+|||+++++.+||+|||+++........
T Consensus 86 g~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~- 157 (323)
T cd05615 86 GDLMYHIQQ----VGKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVT- 157 (323)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCCCCcc-
Confidence 999999864 24589999999999999999999999 9999999999999999999999999998754322211
Q ss_pred eeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcCc-cccc---chHHHHHhcCCH----HHHHHHHHHHhhcc
Q 008785 430 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVL-CRRW---WTLYTLVHSMSL----LCAQECLMLFISCN 501 (553)
Q Consensus 430 ~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~-~~~~---~~l~~~~~~~~~----~~~~~l~~l~~~Cl 501 (553)
.....||+.|+|||++.+..++.++||||||+++|||++.. |... ..+.+.+..+.. ..+..+.+++.+||
T Consensus 158 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l 236 (323)
T cd05615 158 -TRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLM 236 (323)
T ss_pred -ccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHc
Confidence 12233899999999999889999999999999999999733 3222 223333322222 45677899999999
Q ss_pred CCCCCCCCCH-----HHHHHH
Q 008785 502 NWPSHLSQSK-----FCNLKL 517 (553)
Q Consensus 502 ~~dP~~RPs~-----~evl~~ 517 (553)
+.+|++|++. .+++++
T Consensus 237 ~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05615 237 TKHPSKRLGCGPEGERDIREH 257 (323)
T ss_pred ccCHhhCCCCCCCCHHHHhcC
Confidence 9999999985 455554
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=313.10 Aligned_cols=232 Identities=22% Similarity=0.207 Sum_probs=185.0
Q ss_pred ecccCceeEEEEEeC-CCCEEEEEEeccCCh---hhHHHHHHHHHHhhcc---CCCceeeEeeEEeeCCceEEEEEccCC
Q 008785 277 LGDSKTGGTYSGILP-DGSRVAVKRLKRSSF---QRKKEFYSEIGRFARL---HHPNLVAVKGCCYDHGDRYIVYEFVVN 349 (553)
Q Consensus 277 iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l---~HpnIv~l~~~~~~~~~~~lV~E~~~~ 349 (553)
||+|+||+||+|... +|+.||||++..... .....+..|..++.+. +||||+++++.+.+....|+||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 599999999999965 489999999975422 2233455677776665 699999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccc
Q 008785 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE 429 (553)
Q Consensus 350 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 429 (553)
|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++........
T Consensus 81 g~L~~~l~~----~~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~- 152 (330)
T cd05586 81 GELFWHLQK----EGRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT- 152 (330)
T ss_pred ChHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCC-
Confidence 999998864 34589999999999999999999999 9999999999999999999999999998754322211
Q ss_pred eeeecCccccccccccccCC-CCCcccchHhHHHHHHHHhcC-cccccc---hHHHHHhcCCH-----HHHHHHHHHHhh
Q 008785 430 RTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIRLV-LCRRWW---TLYTLVHSMSL-----LCAQECLMLFIS 499 (553)
Q Consensus 430 ~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwSlGvil~ell~~-~~~~~~---~l~~~~~~~~~-----~~~~~l~~l~~~ 499 (553)
.....||+.|+|||++.+. .++.++|||||||++|||++. .|.... .+...+..+.. ..+..+.+++.+
T Consensus 153 -~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~ 231 (330)
T cd05586 153 -TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKG 231 (330)
T ss_pred -ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHH
Confidence 1122389999999998754 479999999999999999973 333322 23333333322 356778999999
Q ss_pred ccCCCCCCCC----CHHHHHHH
Q 008785 500 CNNWPSHLSQ----SKFCNLKL 517 (553)
Q Consensus 500 Cl~~dP~~RP----s~~evl~~ 517 (553)
||+.||.+|| ++.+++++
T Consensus 232 ~L~~~P~~R~~~~~~~~~ll~h 253 (330)
T cd05586 232 LLNRNPQHRLGAHRDAVELKEH 253 (330)
T ss_pred HcCCCHHHCCCCCCCHHHHhcC
Confidence 9999999998 67787775
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=307.27 Aligned_cols=237 Identities=16% Similarity=0.227 Sum_probs=179.3
Q ss_pred eeecccCceeEEEEEeC---CCCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeEEee--CCceEEEEEccCC
Q 008785 275 RLLGDSKTGGTYSGILP---DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD--HGDRYIVYEFVVN 349 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~---~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--~~~~~lV~E~~~~ 349 (553)
..||+|+||.||+|... +++.||+|.++... ....+.+|+.++++++||||+++++++.. ....+++|||+.
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~- 83 (317)
T cd07868 7 CKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE- 83 (317)
T ss_pred cccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC-
Confidence 34699999999999864 46789999997542 23457789999999999999999998865 345789999985
Q ss_pred CCHHHHhccCC-----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEe----cCCCCeEEeeccccc
Q 008785 350 GPLDRWLHHIP-----RGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL----DEEFGAHLMGVGLSK 420 (553)
Q Consensus 350 gsL~~~l~~~~-----~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl----~~~~~~kl~Dfgla~ 420 (553)
++|.+++.... .....+++..+..++.||+.||+|||+. +|+||||||+|||+ +.++.+||+|||+++
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07868 84 HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCcee
Confidence 58888875321 1223588999999999999999999999 99999999999999 456789999999998
Q ss_pred cCCcccccc-eeeecCccccccccccccCC-CCCcccchHhHHHHHHHHhcCccccc--------------chHHHHHhc
Q 008785 421 FVPWEVMQE-RTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIRLVLCRRW--------------WTLYTLVHS 484 (553)
Q Consensus 421 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwSlGvil~ell~~~~~~~--------------~~l~~~~~~ 484 (553)
......... ......||+.|+|||++.+. .++.++||||+||++|||++..+... ..+...+..
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 240 (317)
T cd07868 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNV 240 (317)
T ss_pred ccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHh
Confidence 664332111 11122389999999998764 58999999999999999997332211 000000000
Q ss_pred ---------------------------CC--------------HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008785 485 ---------------------------MS--------------LLCAQECLMLFISCNNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 485 ---------------------------~~--------------~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 517 (553)
.. ......+.+++.+||+.||.+|||+.|++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~h 314 (317)
T cd07868 241 MGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD 314 (317)
T ss_pred cCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00 0112357899999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=300.20 Aligned_cols=234 Identities=24% Similarity=0.283 Sum_probs=193.1
Q ss_pred ecccCceeEEEEEeC-CCCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCCHHHH
Q 008785 277 LGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRW 355 (553)
Q Consensus 277 iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~ 355 (553)
||+|++|.||++... ++..||+|.++.......+.+.+|+.++++++||||+++++.+.+.+..++||||+++++|.++
T Consensus 13 l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 92 (280)
T cd06611 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSI 92 (280)
T ss_pred hcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccCCCcHHHH
Confidence 499999999999974 5889999999877666677899999999999999999999999999999999999999999999
Q ss_pred hccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccceeeecC
Q 008785 356 LHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG 435 (553)
Q Consensus 356 l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~ 435 (553)
+.. ....+++..+..++.|++.||.|||+. +|+||||||+||+++.++.++|+|||++.......... ....
T Consensus 93 ~~~---~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~--~~~~ 164 (280)
T cd06611 93 MLE---LERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKR--DTFI 164 (280)
T ss_pred HHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhccccccc--ceee
Confidence 864 234689999999999999999999999 99999999999999999999999999987654332211 1223
Q ss_pred cccccccccccc-----CCCCCcccchHhHHHHHHHHhcCc-ccccchHHH---HHhcCCH-------HHHHHHHHHHhh
Q 008785 436 GTYGYLAPEFVY-----RNELTTKSDVYSFGVLLLEIRLVL-CRRWWTLYT---LVHSMSL-------LCAQECLMLFIS 499 (553)
Q Consensus 436 gt~~y~aPE~~~-----~~~~t~ksDVwSlGvil~ell~~~-~~~~~~l~~---~~~~~~~-------~~~~~l~~l~~~ 499 (553)
+++.|+|||.+. ...++.++||||||+++|||++.. |....+..+ .+..+.. ..+..+.+++.+
T Consensus 165 ~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 244 (280)
T cd06611 165 GTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFNDFLKS 244 (280)
T ss_pred cchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCHHHHHHHHH
Confidence 888999999875 345778999999999999999843 332222111 2222211 345688999999
Q ss_pred ccCCCCCCCCCHHHHHHHH
Q 008785 500 CNNWPSHLSQSKFCNLKLW 518 (553)
Q Consensus 500 Cl~~dP~~RPs~~evl~~l 518 (553)
||+.+|.+||++.+++++-
T Consensus 245 ~l~~~p~~Rps~~~il~~~ 263 (280)
T cd06611 245 CLVKDPDDRPTAAELLKHP 263 (280)
T ss_pred HhccChhhCcCHHHHhcCh
Confidence 9999999999999999873
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=294.64 Aligned_cols=238 Identities=23% Similarity=0.301 Sum_probs=194.8
Q ss_pred ccCCCCeeecccCceeEEEEEeCC-CCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEcc
Q 008785 269 NFSEGNRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV 347 (553)
Q Consensus 269 ~~~~~~~~iG~G~~g~Vy~~~~~~-g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 347 (553)
+|..... ||+|++|.||+|...+ ++.||+|.++.... .+++.+|++++++++||||+++++.+.+....++++||+
T Consensus 4 ~y~~~~~-i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 4 VFDILEK-LGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred cchhhhh-hcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 3444444 4999999999999765 78999999976532 678999999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccc
Q 008785 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM 427 (553)
Q Consensus 348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 427 (553)
++++|.+++.. ....+++..+..++.|++.||.|||+. +++||||+|+||++++++.++|+|||++........
T Consensus 81 ~~~~L~~~l~~---~~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (256)
T cd06612 81 GAGSVSDIMKI---TNKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA 154 (256)
T ss_pred CCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCcc
Confidence 99999999864 235689999999999999999999999 999999999999999999999999999987654322
Q ss_pred cceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcCc-ccccchHHH---HHhcC---CH----HHHHHHHHH
Q 008785 428 QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVL-CRRWWTLYT---LVHSM---SL----LCAQECLML 496 (553)
Q Consensus 428 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~-~~~~~~l~~---~~~~~---~~----~~~~~l~~l 496 (553)
.. ....++..|+|||++.+..++.++||||||+++|||++.. |.......+ .+... .. .....+.++
T Consensus 155 ~~--~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (256)
T cd06612 155 KR--NTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDF 232 (256)
T ss_pred cc--ccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHH
Confidence 11 1222788999999998889999999999999999999733 322221111 11111 11 345678999
Q ss_pred HhhccCCCCCCCCCHHHHHHH
Q 008785 497 FISCNNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 497 ~~~Cl~~dP~~RPs~~evl~~ 517 (553)
+.+||+.||++|||+.|++++
T Consensus 233 i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 233 VKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred HHHHHhcChhhCcCHHHHhcC
Confidence 999999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=297.41 Aligned_cols=242 Identities=21% Similarity=0.324 Sum_probs=195.2
Q ss_pred eeecccCceeEEEEEeCC-CC----EEEEEEeccCC-hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccC
Q 008785 275 RLLGDSKTGGTYSGILPD-GS----RVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV 348 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~~-g~----~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 348 (553)
+.||+|+||.||+|..++ |+ .||+|.++... .....++.+|+.++++++||||+++++++.. ...++||||++
T Consensus 13 ~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~ 91 (279)
T cd05057 13 KVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLITQLMP 91 (279)
T ss_pred ceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEEEecCC
Confidence 356999999999999643 33 69999987654 3345788999999999999999999999887 78899999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCccccc
Q 008785 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ 428 (553)
Q Consensus 349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 428 (553)
+|+|.+++.. ....+++..+..++.||+.||+|||+. +++||||||+||++++++.+||+|||+++........
T Consensus 92 ~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~~ 165 (279)
T cd05057 92 LGCLLDYVRN---HKDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKE 165 (279)
T ss_pred CCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCcccccccCcccc
Confidence 9999999864 234589999999999999999999999 9999999999999999999999999999876533222
Q ss_pred ceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhc-C-ccccc---chHHHHHhcCCH-----HHHHHHHHHHh
Q 008785 429 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-V-LCRRW---WTLYTLVHSMSL-----LCAQECLMLFI 498 (553)
Q Consensus 429 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-~-~~~~~---~~l~~~~~~~~~-----~~~~~l~~l~~ 498 (553)
.......++..|+|||.+....++.++|+||||+++||+++ . .|... .++.+.+..+.. ..+..+.+++.
T Consensus 166 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (279)
T cd05057 166 YHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPPICTIDVYMVLV 245 (279)
T ss_pred eecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHH
Confidence 11111114568999999988889999999999999999997 3 23222 233334433322 34567889999
Q ss_pred hccCCCCCCCCCHHHHHHHHHHHHh
Q 008785 499 SCNNWPSHLSQSKFCNLKLWVFAIL 523 (553)
Q Consensus 499 ~Cl~~dP~~RPs~~evl~~l~~~~~ 523 (553)
+||..||++|||+.++++.+.....
T Consensus 246 ~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 246 KCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred HHcCCChhhCCCHHHHHHHHHHHHh
Confidence 9999999999999999998866544
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=297.27 Aligned_cols=233 Identities=20% Similarity=0.223 Sum_probs=189.0
Q ss_pred eecccCceeEEEEEeC-CCCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCCHHH
Q 008785 276 LLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR 354 (553)
Q Consensus 276 ~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~ 354 (553)
.||+|+||.||++... +++.||+|.++.........+.+|+.+++.++||||+++++.+...+..++||||+++++|.+
T Consensus 16 ~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~ 95 (267)
T cd06645 16 RIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQD 95 (267)
T ss_pred HhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCcHHH
Confidence 3599999999999864 588999999987655555678899999999999999999999999999999999999999999
Q ss_pred HhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccceeeec
Q 008785 355 WLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA 434 (553)
Q Consensus 355 ~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 434 (553)
++.. ...+++.++..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++......... ....
T Consensus 96 ~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~--~~~~ 166 (267)
T cd06645 96 IYHV----TGPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAK--RKSF 166 (267)
T ss_pred HHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCcccc--cccc
Confidence 9864 24589999999999999999999999 9999999999999999999999999998755432211 1122
Q ss_pred Ccccccccccccc---CCCCCcccchHhHHHHHHHHhcCc-ccccch-HHH--HHhcCCH---------HHHHHHHHHHh
Q 008785 435 GGTYGYLAPEFVY---RNELTTKSDVYSFGVLLLEIRLVL-CRRWWT-LYT--LVHSMSL---------LCAQECLMLFI 498 (553)
Q Consensus 435 ~gt~~y~aPE~~~---~~~~t~ksDVwSlGvil~ell~~~-~~~~~~-l~~--~~~~~~~---------~~~~~l~~l~~ 498 (553)
.|+..|+|||++. ...++.++|||||||++|||++.. |..... ... ....... ..+..+.+++.
T Consensus 167 ~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 246 (267)
T cd06645 167 IGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHFVK 246 (267)
T ss_pred cCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHHHHHHH
Confidence 3889999999874 456889999999999999999733 221111 111 1111111 34467889999
Q ss_pred hccCCCCCCCCCHHHHHHH
Q 008785 499 SCNNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 499 ~Cl~~dP~~RPs~~evl~~ 517 (553)
+|++.+|++|||+.+++++
T Consensus 247 ~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 247 MALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred HHccCCchhCcCHHHHhcC
Confidence 9999999999999998864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=316.96 Aligned_cols=235 Identities=20% Similarity=0.178 Sum_probs=186.0
Q ss_pred eeecccCceeEEEEEeC-CCCEEEEEEeccCC---hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCC
Q 008785 275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 350 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 350 (553)
+.||+|+||.||+|... +++.||+|++.... ......+.+|+.++++++||||+++++.+.+.+..++||||+++|
T Consensus 7 ~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~~gg 86 (382)
T cd05625 7 KTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGG 86 (382)
T ss_pred EEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCCCCC
Confidence 34699999999999964 58899999997542 233467889999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccc---
Q 008785 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM--- 427 (553)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~--- 427 (553)
+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++........
T Consensus 87 ~L~~~l~~----~~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~ 159 (382)
T cd05625 87 DMMSLLIR----MGIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 159 (382)
T ss_pred cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCccccccccccc
Confidence 99999864 23578899999999999999999999 999999999999999999999999999753211000
Q ss_pred ------------------------------------------cceeeecCccccccccccccCCCCCcccchHhHHHHHH
Q 008785 428 ------------------------------------------QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLL 465 (553)
Q Consensus 428 ------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ 465 (553)
........||+.|+|||++.+..++.++|||||||++|
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~ 239 (382)
T cd05625 160 YQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 239 (382)
T ss_pred cccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHH
Confidence 00001124899999999999999999999999999999
Q ss_pred HHhcCc-ccccchHHH----HHhc-CCH------HHHHHHHHHHhhccCCCCCCCCC---HHHHHHH
Q 008785 466 EIRLVL-CRRWWTLYT----LVHS-MSL------LCAQECLMLFISCNNWPSHLSQS---KFCNLKL 517 (553)
Q Consensus 466 ell~~~-~~~~~~l~~----~~~~-~~~------~~~~~l~~l~~~Cl~~dP~~RPs---~~evl~~ 517 (553)
||++.. |....+..+ .... ... ..+..+.+++.+++ .+|.+|++ +.|++++
T Consensus 240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h 305 (382)
T cd05625 240 EMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAH 305 (382)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcC
Confidence 999833 332222111 1111 111 34667788887765 49999997 9998876
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=294.27 Aligned_cols=235 Identities=21% Similarity=0.251 Sum_probs=193.5
Q ss_pred eeecccCceeEEEEEeC-CCCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCCHH
Q 008785 275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 353 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~ 353 (553)
+.+|+|++|.||++... +++.+|+|.+........+.+.+|+.++++++||||+++++++.+.+..+++|||+++++|.
T Consensus 9 ~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~~l~ 88 (262)
T cd06613 9 QRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQ 88 (262)
T ss_pred EEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCCCcHH
Confidence 34599999999999975 47899999998766556788999999999999999999999999999999999999999999
Q ss_pred HHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccceeee
Q 008785 354 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVM 433 (553)
Q Consensus 354 ~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 433 (553)
+++.. ....+++..+..++.|++.||+|||+. +++||||+|+||++++++.++|+|||.+.......... ..
T Consensus 89 ~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~--~~ 160 (262)
T cd06613 89 DIYQV---TRGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKR--KS 160 (262)
T ss_pred HHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhhhcc--cc
Confidence 98864 224689999999999999999999999 99999999999999999999999999987654322111 11
Q ss_pred cCccccccccccccCC---CCCcccchHhHHHHHHHHhcCc-ccccchHHH---HHhcC---------CHHHHHHHHHHH
Q 008785 434 AGGTYGYLAPEFVYRN---ELTTKSDVYSFGVLLLEIRLVL-CRRWWTLYT---LVHSM---------SLLCAQECLMLF 497 (553)
Q Consensus 434 ~~gt~~y~aPE~~~~~---~~t~ksDVwSlGvil~ell~~~-~~~~~~l~~---~~~~~---------~~~~~~~l~~l~ 497 (553)
..++..|+|||.+... .++.++||||||+++|||++.. |.......+ .+... ....+..+.+++
T Consensus 161 ~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 240 (262)
T cd06613 161 FIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHDFI 240 (262)
T ss_pred ccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHHHHHH
Confidence 2378899999998776 7899999999999999999833 222211111 11111 114567799999
Q ss_pred hhccCCCCCCCCCHHHHHHH
Q 008785 498 ISCNNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 498 ~~Cl~~dP~~RPs~~evl~~ 517 (553)
.+||..+|.+|||+.+++++
T Consensus 241 ~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 241 KKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred HHHcCCChhhCCCHHHHhcC
Confidence 99999999999999998863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=297.46 Aligned_cols=231 Identities=19% Similarity=0.289 Sum_probs=188.4
Q ss_pred eeecccCceeEEEEEe-CCCCEEEEEEeccC-ChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCCH
Q 008785 275 RLLGDSKTGGTYSGIL-PDGSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~-~~g~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL 352 (553)
++||+|+||.||+|.. .+++.||+|.+... ......++.+|+.++++++||||+++++.+...+..++||||+++++|
T Consensus 7 ~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l 86 (279)
T cd06619 7 EILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSL 86 (279)
T ss_pred eeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCCCCh
Confidence 4569999999999985 46889999998754 334456789999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccceee
Q 008785 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV 432 (553)
Q Consensus 353 ~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~ 432 (553)
..+. .+++..+..++.|++.||.|||+. +|+|+||||+||+++.++.++|+|||++........ .
T Consensus 87 ~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~~----~ 151 (279)
T cd06619 87 DVYR--------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIA----K 151 (279)
T ss_pred HHhh--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceecccccc----c
Confidence 6542 367888999999999999999999 999999999999999999999999999976543221 1
Q ss_pred ecCccccccccccccCCCCCcccchHhHHHHHHHHhcCc-ccccc----------hHHHHHhcCC------HHHHHHHHH
Q 008785 433 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVL-CRRWW----------TLYTLVHSMS------LLCAQECLM 495 (553)
Q Consensus 433 ~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~-~~~~~----------~l~~~~~~~~------~~~~~~l~~ 495 (553)
...|+..|+|||++.+..++.++||||||+++|+|++.. |.... .....+.... ...+..+.+
T Consensus 152 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (279)
T cd06619 152 TYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVH 231 (279)
T ss_pred CCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHHH
Confidence 123889999999999889999999999999999999732 22110 1111111111 135567899
Q ss_pred HHhhccCCCCCCCCCHHHHHHHHHH
Q 008785 496 LFISCNNWPSHLSQSKFCNLKLWVF 520 (553)
Q Consensus 496 l~~~Cl~~dP~~RPs~~evl~~l~~ 520 (553)
++.+|++.+|++||++.|++++-..
T Consensus 232 li~~~l~~~P~~Rp~~~eil~~~~~ 256 (279)
T cd06619 232 FITQCMRKQPKERPAPENLMDHPFI 256 (279)
T ss_pred HHHHHhhCChhhCCCHHHHhcCccc
Confidence 9999999999999999999987433
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=317.35 Aligned_cols=235 Identities=20% Similarity=0.164 Sum_probs=186.8
Q ss_pred eecccCceeEEEEEeC-CCCEEEEEEeccCCh---hhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCC
Q 008785 276 LLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF---QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP 351 (553)
Q Consensus 276 ~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gs 351 (553)
.||+|+||.||++... +++.||||++..... .....+.+|+.++++++||||+++++.+.+.+..++||||+++|+
T Consensus 8 ~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~ 87 (376)
T cd05598 8 TIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGD 87 (376)
T ss_pred EEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeCCCCCc
Confidence 4599999999999964 488999999975422 234567899999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccc----
Q 008785 352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM---- 427 (553)
Q Consensus 352 L~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~---- 427 (553)
|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++........
T Consensus 88 L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~ 160 (376)
T cd05598 88 MMSLLIR----LGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (376)
T ss_pred HHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccccc
Confidence 9999964 24588889999999999999999999 999999999999999999999999999753210000
Q ss_pred -------------------------------------cceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcC
Q 008785 428 -------------------------------------QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLV 470 (553)
Q Consensus 428 -------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~ 470 (553)
........||+.|+|||++.+..++.++|||||||++|||++.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~G 240 (376)
T cd05598 161 QKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVG 240 (376)
T ss_pred ccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhhC
Confidence 0000112489999999999999999999999999999999973
Q ss_pred -cccccchHHH---HHhcC--CH------HHHHHHHHHHhhccCCCCCCCC---CHHHHHHHH
Q 008785 471 -LCRRWWTLYT---LVHSM--SL------LCAQECLMLFISCNNWPSHLSQ---SKFCNLKLW 518 (553)
Q Consensus 471 -~~~~~~~l~~---~~~~~--~~------~~~~~l~~l~~~Cl~~dP~~RP---s~~evl~~l 518 (553)
.|.......+ .+... .. ..+..+.+++.+|+ .+|.+|| |+.|++++-
T Consensus 241 ~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~ 302 (376)
T cd05598 241 QPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHP 302 (376)
T ss_pred CCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCC
Confidence 3332222211 11111 11 34567788888876 5999999 999999873
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=313.55 Aligned_cols=236 Identities=20% Similarity=0.256 Sum_probs=185.9
Q ss_pred eeecccCceeEEEEEeC-CCCEEEEEEeccC--ChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCC-----ceEEEEEc
Q 008785 275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHG-----DRYIVYEF 346 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~-----~~~lV~E~ 346 (553)
+.||+|+||.||++... +|+.||||++... .......+.+|+.+++.++||||+++++++...+ ..|+||||
T Consensus 6 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~ 85 (372)
T cd07853 6 RPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTEL 85 (372)
T ss_pred ceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEeec
Confidence 34599999999999964 6899999998653 2334567889999999999999999999998776 78999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCccc
Q 008785 347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV 426 (553)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 426 (553)
+. ++|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||+++++.+||+|||+++......
T Consensus 86 ~~-~~l~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~ 157 (372)
T cd07853 86 MQ-SDLHKIIVS----PQPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDE 157 (372)
T ss_pred cc-cCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceeecccCc
Confidence 96 678887743 34689999999999999999999999 99999999999999999999999999997654332
Q ss_pred ccceeeecCccccccccccccCC-CCCcccchHhHHHHHHHHhcCc-ccccchH---HHHH----h--------------
Q 008785 427 MQERTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIRLVL-CRRWWTL---YTLV----H-------------- 483 (553)
Q Consensus 427 ~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwSlGvil~ell~~~-~~~~~~l---~~~~----~-------------- 483 (553)
..... ...+++.|+|||++.+. .++.++|||||||++|||++.. +...... .+.+ .
T Consensus 158 ~~~~~-~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 236 (372)
T cd07853 158 SKHMT-QEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGA 236 (372)
T ss_pred cccCC-CCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHH
Confidence 21111 12278899999998764 4799999999999999999733 2211111 1100 0
Q ss_pred -----cCC-----H--------HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 008785 484 -----SMS-----L--------LCAQECLMLFISCNNWPSHLSQSKFCNLKLWV 519 (553)
Q Consensus 484 -----~~~-----~--------~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~ 519 (553)
... . ..+..+.+++.+||+.||++|||+.|++++-.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~ 290 (372)
T cd07853 237 RAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPY 290 (372)
T ss_pred HHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHh
Confidence 000 0 12456889999999999999999999998754
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=314.09 Aligned_cols=245 Identities=19% Similarity=0.154 Sum_probs=192.7
Q ss_pred HhhcccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCC---hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCce
Q 008785 265 SITKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR 340 (553)
Q Consensus 265 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 340 (553)
...++|.... .||+|+||.||++... +++.||+|++.... ......+.+|+.+++.++||||+++++.+.+.+..
T Consensus 40 ~~~~~y~i~~-~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (371)
T cd05622 40 MKAEDYEVVK-VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL 118 (371)
T ss_pred cchhhcEEEE-EEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEE
Confidence 3345666654 4599999999999975 48899999986532 22345678899999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccc
Q 008785 341 YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSK 420 (553)
Q Consensus 341 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~ 420 (553)
++||||+++|+|.+++.. ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++.
T Consensus 119 ~lv~Ey~~gg~L~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~a~ 190 (371)
T cd05622 119 YMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCM 190 (371)
T ss_pred EEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCcee
Confidence 999999999999999864 3478888999999999999999999 99999999999999999999999999998
Q ss_pred cCCcccccceeeecCccccccccccccCC----CCCcccchHhHHHHHHHHhcC-cccccchH---HHHHhcC--CH---
Q 008785 421 FVPWEVMQERTVMAGGTYGYLAPEFVYRN----ELTTKSDVYSFGVLLLEIRLV-LCRRWWTL---YTLVHSM--SL--- 487 (553)
Q Consensus 421 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~t~ksDVwSlGvil~ell~~-~~~~~~~l---~~~~~~~--~~--- 487 (553)
......... .....||+.|+|||++.+. .++.++|||||||++|||++. .|....+. ...+... ..
T Consensus 191 ~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~ 269 (371)
T cd05622 191 KMNKEGMVR-CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFP 269 (371)
T ss_pred EcCcCCccc-ccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCC
Confidence 664332211 1223489999999998653 378999999999999999973 33333332 2222211 11
Q ss_pred ---HHHHHHHHHHhhccCCCCCC--CCCHHHHHHHHH
Q 008785 488 ---LCAQECLMLFISCNNWPSHL--SQSKFCNLKLWV 519 (553)
Q Consensus 488 ---~~~~~l~~l~~~Cl~~dP~~--RPs~~evl~~l~ 519 (553)
..+..+.+++..|+..+|.+ ||++.|++++..
T Consensus 270 ~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~ 306 (371)
T cd05622 270 DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLF 306 (371)
T ss_pred CcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcc
Confidence 45677899999999844433 789999998753
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=298.36 Aligned_cols=235 Identities=21% Similarity=0.278 Sum_probs=200.4
Q ss_pred CeeecccCceeEEEEEeC-CCCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCCH
Q 008785 274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352 (553)
Q Consensus 274 ~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL 352 (553)
.++ |+|+||.||++.++ .|..||||.+... .+.+++.+|+.+|.++..|++|++||.+....++|+|||||..|+.
T Consensus 39 ~KL-GEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGSi 115 (502)
T KOG0574|consen 39 GKL-GEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGSI 115 (502)
T ss_pred HHh-cCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCcH
Confidence 455 99999999999965 5999999999865 4678899999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccceee
Q 008785 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV 432 (553)
Q Consensus 353 ~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~ 432 (553)
.+.++- .+..+++.++..++++.++||+|||.. .-+|||||+.|||++.+|.+||+|||.|..+........+
T Consensus 116 SDI~R~---R~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKRNT- 188 (502)
T KOG0574|consen 116 SDIMRA---RRKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKRNT- 188 (502)
T ss_pred HHHHHH---hcCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhHHhhCc-
Confidence 999975 456799999999999999999999998 9999999999999999999999999999876654333322
Q ss_pred ecCccccccccccccCCCCCcccchHhHHHHHHHHhcCccc-ccchHHH---HHhcCCH-------HHHHHHHHHHhhcc
Q 008785 433 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVLCR-RWWTLYT---LVHSMSL-------LCAQECLMLFISCN 501 (553)
Q Consensus 433 ~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~~~-~~~~l~~---~~~~~~~-------~~~~~l~~l~~~Cl 501 (553)
..|||.|||||++..-.|+.++||||||++..||.-..|. .+..... ++..... ..+.++.++++.||
T Consensus 189 -VIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi~~CL 267 (502)
T KOG0574|consen 189 -VIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFIRSCL 267 (502)
T ss_pred -cccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHHHHHHHh
Confidence 3399999999999999999999999999999999964333 2222222 2222111 56778999999999
Q ss_pred CCCCCCCCCHHHHHHHHH
Q 008785 502 NWPSHLSQSKFCNLKLWV 519 (553)
Q Consensus 502 ~~dP~~RPs~~evl~~l~ 519 (553)
-.+|++|-|+.+++++-.
T Consensus 268 iK~PE~R~TA~~L~~H~F 285 (502)
T KOG0574|consen 268 IKKPEERKTALRLCEHTF 285 (502)
T ss_pred cCCHHHHHHHHHHhhhhh
Confidence 999999999999988743
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=299.25 Aligned_cols=236 Identities=19% Similarity=0.177 Sum_probs=191.4
Q ss_pred eeecccCceeEEEEEeC-CCCEEEEEEeccCCh---hhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCC
Q 008785 275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF---QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 350 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 350 (553)
++||+|+||+||++... +++.||+|.+..... .....+.+|++++++++|+||+++.+.+..++..++||||++++
T Consensus 6 ~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 85 (285)
T cd05632 6 RVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGG 85 (285)
T ss_pred EEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEeccCc
Confidence 45699999999999864 588999999875432 22345788999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccce
Q 008785 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER 430 (553)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 430 (553)
+|.+++.. .....+++..+..++.|++.||.|||+. +|+||||||+||++++++.++|+|||++.........
T Consensus 86 ~L~~~~~~--~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~-- 158 (285)
T cd05632 86 DLKFHIYN--MGNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESI-- 158 (285)
T ss_pred cHHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCCcc--
Confidence 99988864 2334689999999999999999999999 9999999999999999999999999998765432211
Q ss_pred eeecCccccccccccccCCCCCcccchHhHHHHHHHHhcCc-ccccch---HHH----HHhcCCH----HHHHHHHHHHh
Q 008785 431 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVL-CRRWWT---LYT----LVHSMSL----LCAQECLMLFI 498 (553)
Q Consensus 431 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~-~~~~~~---l~~----~~~~~~~----~~~~~l~~l~~ 498 (553)
....|+..|+|||++.+..++.++|+||||+++|||++.. |..... ..+ .+..+.. ..+..+.+++.
T Consensus 159 -~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 237 (285)
T cd05632 159 -RGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICK 237 (285)
T ss_pred -cCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHHH
Confidence 1123899999999999889999999999999999999732 322211 111 1222111 45667899999
Q ss_pred hccCCCCCCCCC-----HHHHHHHH
Q 008785 499 SCNNWPSHLSQS-----KFCNLKLW 518 (553)
Q Consensus 499 ~Cl~~dP~~RPs-----~~evl~~l 518 (553)
.|++.||++||+ +.+++++-
T Consensus 238 ~~l~~~P~~R~~~~~~~~~~l~~~~ 262 (285)
T cd05632 238 MLLTKDPKQRLGCQEEGAGEVKRHP 262 (285)
T ss_pred HHccCCHhHcCCCcccChHHHHcCh
Confidence 999999999999 77888773
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=302.63 Aligned_cols=240 Identities=20% Similarity=0.245 Sum_probs=192.8
Q ss_pred ccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccC-ChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEc
Q 008785 269 NFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF 346 (553)
Q Consensus 269 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 346 (553)
+|..... ||+|+||.||++... ++..||+|.++.. ......++.+|++++.+++||||+++++.+.+++..++||||
T Consensus 2 ~~~~~~~-lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 2 DFEKLGE-LGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CceEEee-ccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 3444444 599999999999865 5788999998754 233456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcc
Q 008785 347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD-KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE 425 (553)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~ 425 (553)
+++++|.+++.. ...+++..+..++.|++.||.|||+ . +++||||||+|||+++++.+||+|||++......
T Consensus 81 ~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (308)
T cd06615 81 MDGGSLDQVLKK----AGRIPENILGKISIAVLRGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 153 (308)
T ss_pred cCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhhC---CEEECCCChHHEEEecCCcEEEccCCCccccccc
Confidence 999999999964 2458899999999999999999997 5 8999999999999999999999999998755332
Q ss_pred cccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcCc-ccccch---HHHHHhc-----------------
Q 008785 426 VMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVL-CRRWWT---LYTLVHS----------------- 484 (553)
Q Consensus 426 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~-~~~~~~---l~~~~~~----------------- 484 (553)
.. ....++..|+|||.+.+..++.++||||||+++|||++.. |....+ ....+..
T Consensus 154 ~~----~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (308)
T cd06615 154 MA----NSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGH 229 (308)
T ss_pred cc----ccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCC
Confidence 21 1123788999999998888999999999999999999732 221111 1111100
Q ss_pred --------------------CCH-----HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 008785 485 --------------------MSL-----LCAQECLMLFISCNNWPSHLSQSKFCNLKLWVF 520 (553)
Q Consensus 485 --------------------~~~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~ 520 (553)
... ..+..+.+++.+||+.||++|||+.|++++...
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~ 290 (308)
T cd06615 230 PPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFI 290 (308)
T ss_pred CCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhh
Confidence 000 134568999999999999999999999998554
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=292.55 Aligned_cols=237 Identities=22% Similarity=0.238 Sum_probs=195.4
Q ss_pred eeecccCceeEEEEEe-CCCCEEEEEEeccC--ChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCC
Q 008785 275 RLLGDSKTGGTYSGIL-PDGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP 351 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~-~~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gs 351 (553)
++||+|+||.||.+.. .+++.+++|.+... +.....++.+|+.++++++||||+++++++.+.+..+++|||+++|+
T Consensus 6 ~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~~~~ 85 (256)
T cd08221 6 RVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGT 85 (256)
T ss_pred eEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEecCCCc
Confidence 3569999999998885 35889999998654 34456778999999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCccccccee
Q 008785 352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT 431 (553)
Q Consensus 352 L~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~ 431 (553)
|.+++... ....+++.++..++.|++.||.|||+. +++||||+|+||++++++.+||+|||++..........
T Consensus 86 L~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~-- 158 (256)
T cd08221 86 LYDKIVRQ--KGQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMA-- 158 (256)
T ss_pred HHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEcccccccc--
Confidence 99999752 235689999999999999999999999 99999999999999999999999999997664433211
Q ss_pred eecCccccccccccccCCCCCcccchHhHHHHHHHHhcCc-ccccc---hHHHHHhcCCH-----HHHHHHHHHHhhccC
Q 008785 432 VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVL-CRRWW---TLYTLVHSMSL-----LCAQECLMLFISCNN 502 (553)
Q Consensus 432 ~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~-~~~~~---~l~~~~~~~~~-----~~~~~l~~l~~~Cl~ 502 (553)
....+++.|+|||.+.+..++.++||||||+++|||++.. +.... .....+..+.. ..+..+.+++.+||+
T Consensus 159 ~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 238 (256)
T cd08221 159 ETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSLLQ 238 (256)
T ss_pred cccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHHcc
Confidence 1223789999999998888899999999999999999732 22222 22223333333 456789999999999
Q ss_pred CCCCCCCCHHHHHHHH
Q 008785 503 WPSHLSQSKFCNLKLW 518 (553)
Q Consensus 503 ~dP~~RPs~~evl~~l 518 (553)
.+|++||++.++++++
T Consensus 239 ~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 239 QDPEKRPTADEVLDQP 254 (256)
T ss_pred cCcccCCCHHHHhhCc
Confidence 9999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=320.39 Aligned_cols=242 Identities=20% Similarity=0.279 Sum_probs=185.1
Q ss_pred ccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeEEeeC--------Cc
Q 008785 269 NFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH--------GD 339 (553)
Q Consensus 269 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--------~~ 339 (553)
+|... +.||+|+||.||+|... +++.||||++.... ....+|+.+|++++||||+++++++... ..
T Consensus 67 ~y~~~-~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 141 (440)
T PTZ00036 67 SYKLG-NIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIF 141 (440)
T ss_pred eEEEe-EEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceE
Confidence 34443 45699999999999974 58899999986532 2335799999999999999999887542 13
Q ss_pred eEEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCC-CeEEeeccc
Q 008785 340 RYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF-GAHLMGVGL 418 (553)
Q Consensus 340 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~-~~kl~Dfgl 418 (553)
.++||||++ ++|.+++.........+++..+..++.||+.||+|||+. +|+||||||+|||++.++ .+||+|||+
T Consensus 142 l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DFGl 217 (440)
T PTZ00036 142 LNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDFGS 217 (440)
T ss_pred EEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeecccc
Confidence 578999997 578777765434556789999999999999999999999 999999999999998664 699999999
Q ss_pred cccCCcccccceeeecCccccccccccccCC-CCCcccchHhHHHHHHHHhcCccc-ccch----HHHHHh-cC------
Q 008785 419 SKFVPWEVMQERTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIRLVLCR-RWWT----LYTLVH-SM------ 485 (553)
Q Consensus 419 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwSlGvil~ell~~~~~-~~~~----l~~~~~-~~------ 485 (553)
++......... ...||+.|+|||++.+. .++.++|||||||++|||++..+. .... +...+. .+
T Consensus 218 a~~~~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~ 294 (440)
T PTZ00036 218 AKNLLAGQRSV---SYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQ 294 (440)
T ss_pred chhccCCCCcc---cCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 98654332211 12388999999998764 689999999999999999974332 2211 111110 00
Q ss_pred -------------------CH------HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 008785 486 -------------------SL------LCAQECLMLFISCNNWPSHLSQSKFCNLKLWVFAI 522 (553)
Q Consensus 486 -------------------~~------~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~~~ 522 (553)
.+ ..+.++.+|+.+||..||.+|||+.|++++-...-
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~ 356 (440)
T PTZ00036 295 LKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDD 356 (440)
T ss_pred HHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHh
Confidence 00 12467899999999999999999999999855443
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=302.47 Aligned_cols=244 Identities=21% Similarity=0.327 Sum_probs=193.9
Q ss_pred eeecccCceeEEEEEeC-CCC----EEEEEEeccCCh-hhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccC
Q 008785 275 RLLGDSKTGGTYSGILP-DGS----RVAVKRLKRSSF-QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV 348 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~-~g~----~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 348 (553)
+.||+|+||.||+|... +|. .||+|.+..... ....++.+|+.++++++||||+++++++... ..++++||++
T Consensus 13 ~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e~~~ 91 (303)
T cd05110 13 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQLMP 91 (303)
T ss_pred cccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-CceeeehhcC
Confidence 35699999999999864 344 579998876432 3345788999999999999999999998754 5679999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCccccc
Q 008785 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ 428 (553)
Q Consensus 349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 428 (553)
+|+|.+++.. ....+++..+..++.|++.||.|||++ +|+||||||+||++++++.+||+|||+++........
T Consensus 92 ~g~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~ 165 (303)
T cd05110 92 HGCLLDYVHE---HKDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKE 165 (303)
T ss_pred CCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccccccccccCcccc
Confidence 9999999864 234588999999999999999999999 9999999999999999999999999999866533222
Q ss_pred ceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhc--Cccccc---chHHHHHhcCCH-----HHHHHHHHHHh
Q 008785 429 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL--VLCRRW---WTLYTLVHSMSL-----LCAQECLMLFI 498 (553)
Q Consensus 429 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~--~~~~~~---~~l~~~~~~~~~-----~~~~~l~~l~~ 498 (553)
.......++..|+|||++.+..++.++||||||+++|||++ ..|... ..+.+.+..+.. ..+..+.+++.
T Consensus 166 ~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 245 (303)
T cd05110 166 YNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTIDVYMVMV 245 (303)
T ss_pred cccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHH
Confidence 11112225678999999988899999999999999999986 333322 223334433322 34567899999
Q ss_pred hccCCCCCCCCCHHHHHHHHHHHHhhc
Q 008785 499 SCNNWPSHLSQSKFCNLKLWVFAILTI 525 (553)
Q Consensus 499 ~Cl~~dP~~RPs~~evl~~l~~~~~~~ 525 (553)
+||..+|++||++.++++.+.....+.
T Consensus 246 ~c~~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (303)
T cd05110 246 KCWMIDADSRPKFKELAAEFSRMARDP 272 (303)
T ss_pred HHcCCChhhCcCHHHHHHHHHHHHhch
Confidence 999999999999999999877665444
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=303.19 Aligned_cols=242 Identities=18% Similarity=0.236 Sum_probs=188.9
Q ss_pred cCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCCh-hhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEcc
Q 008785 270 FSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF-QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV 347 (553)
Q Consensus 270 ~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 347 (553)
|.... .||+|+||.||+|... +++.||+|.++.... .....+.+|+.++++++||||+++++++..++..++||||+
T Consensus 8 y~~~~-~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 86 (309)
T cd07872 8 YIKLE-KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYL 86 (309)
T ss_pred eEEEE-EecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCC
Confidence 43333 4599999999999965 578999999875432 23346788999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccc
Q 008785 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM 427 (553)
Q Consensus 348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 427 (553)
++ +|.+++.. ....+++..+..++.|++.||+|||++ +|+||||||+||++++++.+||+|||+++.......
T Consensus 87 ~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 159 (309)
T cd07872 87 DK-DLKQYMDD---CGNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK 159 (309)
T ss_pred CC-CHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence 74 88888764 234578899999999999999999999 999999999999999999999999999875433221
Q ss_pred cceeeecCccccccccccccC-CCCCcccchHhHHHHHHHHhcCcc-cccchH---HH----HHhc--------------
Q 008785 428 QERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIRLVLC-RRWWTL---YT----LVHS-------------- 484 (553)
Q Consensus 428 ~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwSlGvil~ell~~~~-~~~~~l---~~----~~~~-------------- 484 (553)
.. ....+++.|+|||.+.+ ..++.++||||||+++|||++..+ ....+. .. .+..
T Consensus 160 ~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07872 160 TY--SNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDE 237 (309)
T ss_pred cc--ccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhh
Confidence 11 11237889999998865 458999999999999999997332 221111 11 0000
Q ss_pred ------CC----------HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 008785 485 ------MS----------LLCAQECLMLFISCNNWPSHLSQSKFCNLKLWVFA 521 (553)
Q Consensus 485 ------~~----------~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~~ 521 (553)
.. ...+..+.+++.+||+.||.+|||+.|++++-...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~ 290 (309)
T cd07872 238 FKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFR 290 (309)
T ss_pred hhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhh
Confidence 00 02345788999999999999999999999875443
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=309.04 Aligned_cols=241 Identities=20% Similarity=0.235 Sum_probs=187.0
Q ss_pred hhcccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccC--ChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCC----
Q 008785 266 ITKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHG---- 338 (553)
Q Consensus 266 ~~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~---- 338 (553)
+.++|... +.||+|+||.||++... +|+.||||++... .......+.+|+.+++.++||||+++++++...+
T Consensus 19 ~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 19 VLKRYQQL-KPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hhhceEEE-EEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence 44566554 45599999999999864 5899999999753 2334567889999999999999999999986543
Q ss_pred --ceEEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeec
Q 008785 339 --DRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGV 416 (553)
Q Consensus 339 --~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Df 416 (553)
..++||||+++ +|.+.+.. .+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+||
T Consensus 98 ~~~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Df 167 (359)
T cd07876 98 FQDVYLVMELMDA-NLCQVIHM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF 167 (359)
T ss_pred cceeEEEEeCCCc-CHHHHHhc------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecC
Confidence 46999999965 66666532 378889999999999999999999 9999999999999999999999999
Q ss_pred cccccCCcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcCc-ccccchHHH----HH---------
Q 008785 417 GLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVL-CRRWWTLYT----LV--------- 482 (553)
Q Consensus 417 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~-~~~~~~l~~----~~--------- 482 (553)
|+++........ ....||+.|+|||++.+..++.++||||||+++|||++.. +....+..+ .+
T Consensus 168 g~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 244 (359)
T cd07876 168 GLARTACTNFMM---TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAE 244 (359)
T ss_pred CCccccccCccC---CCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHH
Confidence 999754332211 1123889999999999999999999999999999999732 221111000 00
Q ss_pred -------------hc-CC-----H-----------------HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 008785 483 -------------HS-MS-----L-----------------LCAQECLMLFISCNNWPSHLSQSKFCNLKLWVF 520 (553)
Q Consensus 483 -------------~~-~~-----~-----------------~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~ 520 (553)
.. .. + .....+.+++.+||..||++|||+.|++++-..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~ 318 (359)
T cd07876 245 FMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYI 318 (359)
T ss_pred HHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchh
Confidence 00 00 0 123567899999999999999999999998543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=297.10 Aligned_cols=235 Identities=20% Similarity=0.271 Sum_probs=193.3
Q ss_pred eecccCceeEEEEEeC-CCCEEEEEEeccCC-hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCCHH
Q 008785 276 LLGDSKTGGTYSGILP-DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 353 (553)
Q Consensus 276 ~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~ 353 (553)
.||+|+||.||+|... +++.||+|.++... ....+.+.+|+.++++++||||+++++++...+..++||||+++++|.
T Consensus 11 ~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 90 (277)
T cd06642 11 RIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSAL 90 (277)
T ss_pred HhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccCCCcHH
Confidence 3599999999999864 47899999987543 334567899999999999999999999999999999999999999999
Q ss_pred HHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccceeee
Q 008785 354 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVM 433 (553)
Q Consensus 354 ~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 433 (553)
+++.. ..+++..+..++.|++.||.|||++ +++|+||+|+||++++++.++|+|||++.......... ..
T Consensus 91 ~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~--~~ 160 (277)
T cd06642 91 DLLKP-----GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR--NT 160 (277)
T ss_pred HHhhc-----CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcchhh--hc
Confidence 98853 3588999999999999999999999 99999999999999999999999999997655432211 11
Q ss_pred cCccccccccccccCCCCCcccchHhHHHHHHHHhcCccc-ccc---hHHHHHhcCCH-----HHHHHHHHHHhhccCCC
Q 008785 434 AGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVLCR-RWW---TLYTLVHSMSL-----LCAQECLMLFISCNNWP 504 (553)
Q Consensus 434 ~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~~~-~~~---~l~~~~~~~~~-----~~~~~l~~l~~~Cl~~d 504 (553)
..++..|+|||++.+..++.++||||||+++|||++..+. ... .....+..+.. ..+..+.+++.+||+.+
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 240 (277)
T cd06642 161 FVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACLNKD 240 (277)
T ss_pred ccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCCCCcccCHHHHHHHHHHccCC
Confidence 2378899999999988899999999999999999984332 211 11112222111 45677899999999999
Q ss_pred CCCCCCHHHHHHHHHH
Q 008785 505 SHLSQSKFCNLKLWVF 520 (553)
Q Consensus 505 P~~RPs~~evl~~l~~ 520 (553)
|++||++.+++++...
T Consensus 241 p~~Rp~~~~il~~~~~ 256 (277)
T cd06642 241 PRFRPTAKELLKHKFI 256 (277)
T ss_pred cccCcCHHHHHHhHHH
Confidence 9999999999997543
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=299.80 Aligned_cols=253 Identities=23% Similarity=0.282 Sum_probs=198.2
Q ss_pred cCHHHHHHhhcccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCChhhHHHHHHHHHHhhcc-CCCceeeEeeEEe
Q 008785 258 FTTEELRSITKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCY 335 (553)
Q Consensus 258 ~~~~el~~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~ 335 (553)
++.+++..++++|.....+ |+|+||.||++... +++.+|+|.+.... .....+.+|+.++.++ +||||+++++++.
T Consensus 12 ~~~~~~~~~~~~y~~~~~l-~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~ 89 (291)
T cd06639 12 LGLESLGDPTDTWEIIETI-GKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFY 89 (291)
T ss_pred hhcccCCCCCCCeEEEEEe-ecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEE
Confidence 4455666677778776655 99999999999974 58899999987542 2345678899999999 8999999999987
Q ss_pred eC-----CceEEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCC
Q 008785 336 DH-----GDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG 410 (553)
Q Consensus 336 ~~-----~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~ 410 (553)
.. +..++||||+++|+|.++++........+++..+..++.|++.||.|||+. +++||||||+||++++++.
T Consensus 90 ~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~ 166 (291)
T cd06639 90 KADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGG 166 (291)
T ss_pred eccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCC
Confidence 54 357999999999999998864333445689999999999999999999999 9999999999999999999
Q ss_pred eEEeeccccccCCcccccceeeecCccccccccccccCC-----CCCcccchHhHHHHHHHHhcCc-ccccchHHH---H
Q 008785 411 AHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRN-----ELTTKSDVYSFGVLLLEIRLVL-CRRWWTLYT---L 481 (553)
Q Consensus 411 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~t~ksDVwSlGvil~ell~~~-~~~~~~l~~---~ 481 (553)
+||+|||++.......... ....|+..|+|||++... .++.++||||||+++|||++.. |........ .
T Consensus 167 ~kl~dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~ 244 (291)
T cd06639 167 VKLVDFGVSAQLTSTRLRR--NTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFK 244 (291)
T ss_pred EEEeecccchhcccccccc--cCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHH
Confidence 9999999987654332211 112378899999987643 3689999999999999999743 322221111 1
Q ss_pred HhcCCH-------HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008785 482 VHSMSL-------LCAQECLMLFISCNNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 482 ~~~~~~-------~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 517 (553)
+..+.. .....+.+++.+||+.+|++||++.|++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 245 IPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred HhcCCCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 211111 344578999999999999999999999875
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=301.73 Aligned_cols=239 Identities=21% Similarity=0.287 Sum_probs=195.7
Q ss_pred cccCCCCeeecccCceeEEEEEe-CCCCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEc
Q 008785 268 KNFSEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF 346 (553)
Q Consensus 268 ~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 346 (553)
++|..... ||+|++|.||++.. .+++.||+|.+........+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus 19 ~~y~~~~~-lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 19 KKYTRFEK-IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhceeeee-eccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 34555444 59999999999996 46999999999876555667789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCccc
Q 008785 347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV 426 (553)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 426 (553)
+++++|.+++.. ..+++.++..++.|++.||.|||+. +++||||||+|||++.++.++|+|||++.......
T Consensus 98 ~~~~~L~~~~~~-----~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~ 169 (297)
T cd06656 98 LAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (297)
T ss_pred cCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCc
Confidence 999999999854 3478899999999999999999999 99999999999999999999999999987654332
Q ss_pred ccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcCcc-cccchHHH----HHhcCC------HHHHHHHHH
Q 008785 427 MQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVLC-RRWWTLYT----LVHSMS------LLCAQECLM 495 (553)
Q Consensus 427 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~~-~~~~~l~~----~~~~~~------~~~~~~l~~ 495 (553)
... ....+++.|+|||.+.+..++.++||||||+++|++++..+ ....+... ....+. ...+..+.+
T Consensus 170 ~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (297)
T cd06656 170 SKR--STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRD 247 (297)
T ss_pred cCc--CcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHH
Confidence 211 11237889999999998889999999999999999997332 22211111 111111 144567889
Q ss_pred HHhhccCCCCCCCCCHHHHHHH
Q 008785 496 LFISCNNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 496 l~~~Cl~~dP~~RPs~~evl~~ 517 (553)
++.+||+.+|++||++.+++++
T Consensus 248 li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 248 FLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred HHHHHccCChhhCcCHHHHhcC
Confidence 9999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=303.13 Aligned_cols=237 Identities=17% Similarity=0.245 Sum_probs=179.0
Q ss_pred eeecccCceeEEEEEeCC---CCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeEEee--CCceEEEEEccCC
Q 008785 275 RLLGDSKTGGTYSGILPD---GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD--HGDRYIVYEFVVN 349 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~~---g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--~~~~~lV~E~~~~ 349 (553)
..||+|+||.||+|...+ +..||+|.++... ....+.+|+.++++++||||+++++++.. +...++||||++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~- 83 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE- 83 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC-
Confidence 346999999999999653 5789999987543 23457889999999999999999998864 456799999986
Q ss_pred CCHHHHhccCC-----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEe----cCCCCeEEeeccccc
Q 008785 350 GPLDRWLHHIP-----RGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL----DEEFGAHLMGVGLSK 420 (553)
Q Consensus 350 gsL~~~l~~~~-----~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl----~~~~~~kl~Dfgla~ 420 (553)
++|.+++.... .....+++..+..++.||+.||.|||+. +|+||||||+|||+ ++++.+||+|||+++
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 84 HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 57877774311 1223588999999999999999999999 99999999999999 556789999999998
Q ss_pred cCCcccccc-eeeecCccccccccccccCC-CCCcccchHhHHHHHHHHhcCcccccc--------------hHHHHHh-
Q 008785 421 FVPWEVMQE-RTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIRLVLCRRWW--------------TLYTLVH- 483 (553)
Q Consensus 421 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwSlGvil~ell~~~~~~~~--------------~l~~~~~- 483 (553)
......... ......||+.|+|||++.+. .++.++||||||+++|||++..+.... .+.....
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 240 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSV 240 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHh
Confidence 665432211 11122378999999998764 579999999999999999973322110 0000000
Q ss_pred --------------------------cC--------------CHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008785 484 --------------------------SM--------------SLLCAQECLMLFISCNNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 484 --------------------------~~--------------~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 517 (553)
.. .......+.+++.+||+.||.+|||+.|++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~h 314 (317)
T cd07867 241 MGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQD 314 (317)
T ss_pred cCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcC
Confidence 00 00123457789999999999999999999874
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=291.80 Aligned_cols=236 Identities=22% Similarity=0.279 Sum_probs=191.5
Q ss_pred eeecccCceeEEEEEeC-CCCEEEEEEeccCC--hhhHHHHHHHHHHhhccCCCceeeEeeEEeeC-CceEEEEEccCCC
Q 008785 275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH-GDRYIVYEFVVNG 350 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~-~~~~lV~E~~~~g 350 (553)
+.||+|++|.||.+... +++.||+|.+.... ....+.+.+|+.++++++|||++++++.+... ...+++|||++++
T Consensus 6 ~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~ 85 (257)
T cd08223 6 RVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGG 85 (257)
T ss_pred EEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecccCCC
Confidence 45699999999999965 47899999987542 33456788999999999999999999987643 4578999999999
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccce
Q 008785 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER 430 (553)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 430 (553)
+|.+++.. .....+++.++..++.|++.||+|||+. +++||||||+||++++++.++|+|||++..........
T Consensus 86 ~l~~~l~~--~~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~- 159 (257)
T cd08223 86 DLYHKLKE--QKGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMA- 159 (257)
T ss_pred cHHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEecccCCcc-
Confidence 99999975 2234589999999999999999999999 99999999999999999999999999997654322211
Q ss_pred eeecCccccccccccccCCCCCcccchHhHHHHHHHHhcC-cccccchH---HHHHhcCCH-----HHHHHHHHHHhhcc
Q 008785 431 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLV-LCRRWWTL---YTLVHSMSL-----LCAQECLMLFISCN 501 (553)
Q Consensus 431 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~-~~~~~~~l---~~~~~~~~~-----~~~~~l~~l~~~Cl 501 (553)
....+++.|+|||++.+..++.++||||||++++||++. .+....+. ...+..+.. ..+..+.+++.+|+
T Consensus 160 -~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 238 (257)
T cd08223 160 -STLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIATML 238 (257)
T ss_pred -ccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHHHh
Confidence 122378899999999998999999999999999999983 23222222 222222222 46678999999999
Q ss_pred CCCCCCCCCHHHHHHH
Q 008785 502 NWPSHLSQSKFCNLKL 517 (553)
Q Consensus 502 ~~dP~~RPs~~evl~~ 517 (553)
+.||++|||+.+++++
T Consensus 239 ~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 239 SKRPEKRPSVKSILRQ 254 (257)
T ss_pred ccCcccCCCHHHHhcC
Confidence 9999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=292.20 Aligned_cols=236 Identities=21% Similarity=0.290 Sum_probs=193.4
Q ss_pred eeecccCceeEEEEEeC-CCCEEEEEEeccC--ChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCC
Q 008785 275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP 351 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gs 351 (553)
+.||+|+||.+|.+... +|+.||+|.+... ......++.+|+.++++++||||+++++++.+.+..++|+||+++++
T Consensus 6 ~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 85 (256)
T cd08218 6 KKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGD 85 (256)
T ss_pred EEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecCCCCc
Confidence 34599999999999864 5889999998743 23345678999999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCccccccee
Q 008785 352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT 431 (553)
Q Consensus 352 L~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~ 431 (553)
|.+++.. .....+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++...........
T Consensus 86 l~~~~~~--~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~- 159 (256)
T cd08218 86 LYKKINA--QRGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELAR- 159 (256)
T ss_pred HHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhhh-
Confidence 9998864 2234578999999999999999999999 999999999999999999999999999976544322111
Q ss_pred eecCccccccccccccCCCCCcccchHhHHHHHHHHhcCc-ccccch---HHHHHhcCCH-----HHHHHHHHHHhhccC
Q 008785 432 VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVL-CRRWWT---LYTLVHSMSL-----LCAQECLMLFISCNN 502 (553)
Q Consensus 432 ~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~-~~~~~~---l~~~~~~~~~-----~~~~~l~~l~~~Cl~ 502 (553)
...|++.|+|||++.+..++.++|+||||+++++|++.. +..... ....+..+.. ..+..+.+++.+||+
T Consensus 160 -~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 238 (256)
T cd08218 160 -TCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQLFK 238 (256)
T ss_pred -hccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCCcccCCHHHHHHHHHHhh
Confidence 122788999999998888999999999999999999733 222222 2222222222 456789999999999
Q ss_pred CCCCCCCCHHHHHHH
Q 008785 503 WPSHLSQSKFCNLKL 517 (553)
Q Consensus 503 ~dP~~RPs~~evl~~ 517 (553)
.+|++||++.+++++
T Consensus 239 ~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 239 RNPRDRPSVNSILEK 253 (256)
T ss_pred CChhhCcCHHHHhhC
Confidence 999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=294.02 Aligned_cols=235 Identities=20% Similarity=0.260 Sum_probs=194.4
Q ss_pred eecccCceeEEEEEeC-CCCEEEEEEeccCC-hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCCHH
Q 008785 276 LLGDSKTGGTYSGILP-DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 353 (553)
Q Consensus 276 ~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~ 353 (553)
.||.|+||.||+|... +++.||+|.++... ......+.+|+.++++++||||+++++++.+.+..++||||+++|+|.
T Consensus 11 ~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 90 (277)
T cd06640 11 RIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSAL 90 (277)
T ss_pred hcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCCCCcHH
Confidence 3599999999999975 48899999987543 344577899999999999999999999999999999999999999999
Q ss_pred HHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccceeee
Q 008785 354 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVM 433 (553)
Q Consensus 354 ~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 433 (553)
+++.. ..+++.++..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++.......... ..
T Consensus 91 ~~i~~-----~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~--~~ 160 (277)
T cd06640 91 DLLRA-----GPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR--NT 160 (277)
T ss_pred HHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCcccc--cc
Confidence 99853 3478899999999999999999999 99999999999999999999999999997654332211 11
Q ss_pred cCccccccccccccCCCCCcccchHhHHHHHHHHhcCccc-ccch---HHHHHhcCCH-----HHHHHHHHHHhhccCCC
Q 008785 434 AGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVLCR-RWWT---LYTLVHSMSL-----LCAQECLMLFISCNNWP 504 (553)
Q Consensus 434 ~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~~~-~~~~---l~~~~~~~~~-----~~~~~l~~l~~~Cl~~d 504 (553)
..++..|+|||++.+..++.++|+||||+++|||++..+. .... ....+..+.. ..+..+.+++.+||+.+
T Consensus 161 ~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 240 (277)
T cd06640 161 FVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDACLNKD 240 (277)
T ss_pred ccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCCCCchhhhHHHHHHHHHHcccC
Confidence 2378889999999888899999999999999999984332 2221 1112222111 56778999999999999
Q ss_pred CCCCCCHHHHHHHHHH
Q 008785 505 SHLSQSKFCNLKLWVF 520 (553)
Q Consensus 505 P~~RPs~~evl~~l~~ 520 (553)
|++||++.+++++...
T Consensus 241 p~~Rp~~~~il~~~~~ 256 (277)
T cd06640 241 PSFRPTAKELLKHKFI 256 (277)
T ss_pred cccCcCHHHHHhChHh
Confidence 9999999999987544
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=305.66 Aligned_cols=237 Identities=19% Similarity=0.137 Sum_probs=187.4
Q ss_pred eeecccCceeEEEEEeC-CCCEEEEEEeccCC---hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCC
Q 008785 275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 350 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 350 (553)
+.||+|+||.||++... +++.||+|++.+.. ....+.+.+|+.++..++||||+++++++.+.+..++||||+++|
T Consensus 7 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~ 86 (331)
T cd05597 7 KVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYVGG 86 (331)
T ss_pred EEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEecCCCC
Confidence 34699999999999965 48999999997532 223456888999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccce
Q 008785 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER 430 (553)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 430 (553)
+|.+++.. ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++...........
T Consensus 87 ~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 160 (331)
T cd05597 87 DLLTLLSK---FEDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQS 160 (331)
T ss_pred cHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCccc
Confidence 99999964 234588999999999999999999999 999999999999999999999999999876543322211
Q ss_pred eeecCccccccccccccC-----CCCCcccchHhHHHHHHHHhc-CcccccchHHH---HHhc--CCH-------HHHHH
Q 008785 431 TVMAGGTYGYLAPEFVYR-----NELTTKSDVYSFGVLLLEIRL-VLCRRWWTLYT---LVHS--MSL-------LCAQE 492 (553)
Q Consensus 431 ~~~~~gt~~y~aPE~~~~-----~~~t~ksDVwSlGvil~ell~-~~~~~~~~l~~---~~~~--~~~-------~~~~~ 492 (553)
....||+.|+|||++.. ..++.++|||||||++|||++ ..|....+..+ .+.. ... ..+..
T Consensus 161 -~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 239 (331)
T cd05597 161 -NVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEE 239 (331)
T ss_pred -cceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCHH
Confidence 12238999999999863 457889999999999999998 33433333322 1211 111 34667
Q ss_pred HHHHHhhccCC--CCCCCCCHHHHHHHH
Q 008785 493 CLMLFISCNNW--PSHLSQSKFCNLKLW 518 (553)
Q Consensus 493 l~~l~~~Cl~~--dP~~RPs~~evl~~l 518 (553)
+.+++.+|+.. ++..||++.+++++-
T Consensus 240 ~~~li~~ll~~~~~r~~r~~~~~~l~hp 267 (331)
T cd05597 240 AKDLIRRLICSPETRLGRNGLQDFKDHP 267 (331)
T ss_pred HHHHHHHHccCcccccCCCCHHHHhcCC
Confidence 88888887754 444489999999883
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=291.11 Aligned_cols=236 Identities=27% Similarity=0.379 Sum_probs=194.2
Q ss_pred eecccCceeEEEEEeCC-----CCEEEEEEeccCChh-hHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCC
Q 008785 276 LLGDSKTGGTYSGILPD-----GSRVAVKRLKRSSFQ-RKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 349 (553)
Q Consensus 276 ~iG~G~~g~Vy~~~~~~-----g~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 349 (553)
.||+|+||.||++...+ +..||+|.++..... ..+.+.+|+..+..++||||+++++++.+.+..+++|||+++
T Consensus 6 ~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~~~~ 85 (258)
T smart00219 6 KLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYMEG 85 (258)
T ss_pred eeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEeccCC
Confidence 45999999999999754 388999999766433 567899999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccc
Q 008785 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE 429 (553)
Q Consensus 350 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 429 (553)
++|.+++... ....+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||++..........
T Consensus 86 ~~l~~~~~~~--~~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 160 (258)
T smart00219 86 GDLLDYLRKN--RPKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYK 160 (258)
T ss_pred CCHHHHHHhh--hhccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceecccccccc
Confidence 9999999752 112289999999999999999999999 99999999999999999999999999998765442222
Q ss_pred eeeecCccccccccccccCCCCCcccchHhHHHHHHHHhc-C-cccccc---hHHHHHhcCCH-----HHHHHHHHHHhh
Q 008785 430 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-V-LCRRWW---TLYTLVHSMSL-----LCAQECLMLFIS 499 (553)
Q Consensus 430 ~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-~-~~~~~~---~l~~~~~~~~~-----~~~~~l~~l~~~ 499 (553)
.. ...+++.|+|||.+.+..++.++||||||++++||++ . .|.... .+.+.+..+.. ..+..+.+++.+
T Consensus 161 ~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 239 (258)
T smart00219 161 KK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKPENCPPEIYKLMLQ 239 (258)
T ss_pred cc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHHHH
Confidence 21 1226789999999988889999999999999999997 2 232222 22223332222 457789999999
Q ss_pred ccCCCCCCCCCHHHHHHH
Q 008785 500 CNNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 500 Cl~~dP~~RPs~~evl~~ 517 (553)
|++.||++|||+.|+++.
T Consensus 240 ~l~~~p~~Rpt~~~ll~~ 257 (258)
T smart00219 240 CWAEDPEDRPTFSELVEI 257 (258)
T ss_pred HCcCChhhCcCHHHHHhh
Confidence 999999999999999875
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=308.47 Aligned_cols=232 Identities=17% Similarity=0.262 Sum_probs=182.2
Q ss_pred ccCCCCeeecccCceeEEEEEeCC-CCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEcc
Q 008785 269 NFSEGNRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV 347 (553)
Q Consensus 269 ~~~~~~~~iG~G~~g~Vy~~~~~~-g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 347 (553)
+|.... .||+|+||.||+|.... ++.||+|+.... ....|+.++++++||||+++++++...+..++||||+
T Consensus 67 ~y~~~~-~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 139 (357)
T PHA03209 67 GYTVIK-TLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY 139 (357)
T ss_pred CcEEEE-EecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEcc
Confidence 344444 45999999999999754 678999986443 2356899999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccc
Q 008785 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM 427 (553)
Q Consensus 348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 427 (553)
.++|.+++.. ....+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 140 -~~~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 212 (357)
T PHA03209 140 -SSDLYTYLTK---RSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPA 212 (357)
T ss_pred -CCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccccCcc
Confidence 5688888864 335689999999999999999999999 999999999999999999999999999975432211
Q ss_pred cceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcCc-cc-----cc---------chHHHHHhc-C------
Q 008785 428 QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVL-CR-----RW---------WTLYTLVHS-M------ 485 (553)
Q Consensus 428 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~-~~-----~~---------~~l~~~~~~-~------ 485 (553)
. ....||+.|+|||++.+..++.++|||||||++|||++.. +. .. ..+.+.+.. +
T Consensus 213 ~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 289 (357)
T PHA03209 213 F---LGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEF 289 (357)
T ss_pred c---ccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhc
Confidence 1 1123899999999999999999999999999999999511 11 00 011111100 0
Q ss_pred ---C---------------------------HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008785 486 ---S---------------------------LLCAQECLMLFISCNNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 486 ---~---------------------------~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 517 (553)
. ...+..+.+++.+||+.||++|||+.|++++
T Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h 351 (357)
T PHA03209 290 PRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY 351 (357)
T ss_pred CCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence 0 0123345569999999999999999999986
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=300.93 Aligned_cols=237 Identities=20% Similarity=0.261 Sum_probs=194.3
Q ss_pred eecccCceeEEEEEeC-CCCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCCHHH
Q 008785 276 LLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR 354 (553)
Q Consensus 276 ~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~ 354 (553)
.||+|+||.||++... ++..||||.+........+.+.+|+.++++++||||+++++.+...+..++||||+++++|.+
T Consensus 29 ~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~ 108 (292)
T cd06658 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTD 108 (292)
T ss_pred cccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHHH
Confidence 3599999999999864 588999999977655666778999999999999999999999999999999999999999999
Q ss_pred HhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccceeeec
Q 008785 355 WLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA 434 (553)
Q Consensus 355 ~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 434 (553)
++.. ..+++..+..++.||+.||+|||++ +|+||||||+||++++++.++|+|||++........... ..
T Consensus 109 ~~~~-----~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~--~~ 178 (292)
T cd06658 109 IVTH-----TRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRK--SL 178 (292)
T ss_pred HHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCc--ee
Confidence 8853 3478999999999999999999999 999999999999999999999999999875543322111 12
Q ss_pred CccccccccccccCCCCCcccchHhHHHHHHHHhcC-cccccchHH---HHHhc---CC----HHHHHHHHHHHhhccCC
Q 008785 435 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLV-LCRRWWTLY---TLVHS---MS----LLCAQECLMLFISCNNW 503 (553)
Q Consensus 435 ~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~-~~~~~~~l~---~~~~~---~~----~~~~~~l~~l~~~Cl~~ 503 (553)
.|+..|+|||.+.+..++.++||||||+++|||++. .|....... ..+.. .. ...+..+.+++.+|+..
T Consensus 179 ~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 258 (292)
T cd06658 179 VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLMLVR 258 (292)
T ss_pred ecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHHHHHHccC
Confidence 378899999999888899999999999999999973 232222211 11111 11 13456788999999999
Q ss_pred CCCCCCCHHHHHHHHHHHH
Q 008785 504 PSHLSQSKFCNLKLWVFAI 522 (553)
Q Consensus 504 dP~~RPs~~evl~~l~~~~ 522 (553)
||.+|||+.|++++-....
T Consensus 259 ~P~~Rpt~~~il~~~~~~~ 277 (292)
T cd06658 259 EPSQRATAQELLQHPFLKL 277 (292)
T ss_pred ChhHCcCHHHHhhChhhhc
Confidence 9999999999998754443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=291.92 Aligned_cols=237 Identities=22% Similarity=0.287 Sum_probs=194.0
Q ss_pred eecccCceeEEEEEeC-CCCEEEEEEeccC--ChhhHHHHHHHHHHhhccCCCceeeEeeEEee--CCceEEEEEccCCC
Q 008785 276 LLGDSKTGGTYSGILP-DGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD--HGDRYIVYEFVVNG 350 (553)
Q Consensus 276 ~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--~~~~~lV~E~~~~g 350 (553)
.+|.|+||.||++... +|+.||+|.+... .....+.+.+|+.++++++||||+++++++.. ....+++|||++++
T Consensus 7 ~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~~~~ 86 (265)
T cd08217 7 TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGG 86 (265)
T ss_pred eeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehhccCC
Confidence 4599999999999854 5889999998754 23445678899999999999999999998764 34579999999999
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHH-----hCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcc
Q 008785 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLH-----DKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE 425 (553)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH-----~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~ 425 (553)
+|.+++.........+++..+..++.||+.||.||| +. +++||||+|+||++++++.+||+|||++......
T Consensus 87 ~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~~ 163 (265)
T cd08217 87 DLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLGDFGLAKILGHD 163 (265)
T ss_pred CHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEecccccccccCC
Confidence 999999764444567899999999999999999999 76 9999999999999999999999999999876544
Q ss_pred cccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcC-ccccc---chHHHHHhcCCH-----HHHHHHHHH
Q 008785 426 VMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLV-LCRRW---WTLYTLVHSMSL-----LCAQECLML 496 (553)
Q Consensus 426 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~-~~~~~---~~l~~~~~~~~~-----~~~~~l~~l 496 (553)
..... ...+++.|+|||.+.+..++.++||||||+++|+|++. .|... ..+.+.+..+.. ..+..+.++
T Consensus 164 ~~~~~--~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 241 (265)
T cd08217 164 SSFAK--TYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYSSELNEV 241 (265)
T ss_pred ccccc--ccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCCCccccCHHHHHH
Confidence 32111 12378899999999888899999999999999999973 23222 223333333332 556789999
Q ss_pred HhhccCCCCCCCCCHHHHHHH
Q 008785 497 FISCNNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 497 ~~~Cl~~dP~~RPs~~evl~~ 517 (553)
+.+|++.+|++||++.+|+++
T Consensus 242 ~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 242 IKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred HHHHccCCcccCCCHHHHhhC
Confidence 999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=298.56 Aligned_cols=234 Identities=22% Similarity=0.296 Sum_probs=181.2
Q ss_pred eeecccCceeEEEEEeC-CCCEEEEEEeccCCh--hhHHHHHHHHHHhhcc---CCCceeeEeeEEeeC-----CceEEE
Q 008785 275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF--QRKKEFYSEIGRFARL---HHPNLVAVKGCCYDH-----GDRYIV 343 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l---~HpnIv~l~~~~~~~-----~~~~lV 343 (553)
+.||+|+||.||++... +|+.||+|.++.... .....+.+|+.+++.+ +||||+++++++... ...+++
T Consensus 6 ~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~~lv 85 (288)
T cd07863 6 AEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLV 85 (288)
T ss_pred eEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceEEEE
Confidence 34599999999999965 588999999875421 1223456677777665 799999999988653 347999
Q ss_pred EEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCC
Q 008785 344 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVP 423 (553)
Q Consensus 344 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~ 423 (553)
|||++ ++|.+++... ....+++..+..++.|++.||.|||+. +|+||||||+|||+++++.+||+|||++....
T Consensus 86 ~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~ 159 (288)
T cd07863 86 FEHVD-QDLRTYLDKV--PPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLARIYS 159 (288)
T ss_pred Ecccc-cCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCcccccc
Confidence 99997 5898888652 234589999999999999999999999 99999999999999999999999999998654
Q ss_pred cccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcCccccc-c----hHHHHHh---------------
Q 008785 424 WEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVLCRRW-W----TLYTLVH--------------- 483 (553)
Q Consensus 424 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~~~~~-~----~l~~~~~--------------- 483 (553)
...... ...||..|+|||++.+..++.++|||||||++|||++..+... . .+.....
T Consensus 160 ~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07863 160 CQMALT---PVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVT 236 (288)
T ss_pred CcccCC---CccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccccc
Confidence 332111 1237889999999998899999999999999999997433221 1 1111100
Q ss_pred --cCCH-------------HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008785 484 --SMSL-------------LCAQECLMLFISCNNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 484 --~~~~-------------~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 517 (553)
.... ..+..+.+++.+||+.||++|||+.|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 237 LPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred ccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0000 235567899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=295.02 Aligned_cols=234 Identities=29% Similarity=0.376 Sum_probs=190.2
Q ss_pred eeecccCceeEEEEEeCC-CCEEEEEEeccCChhhHH--HHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCC
Q 008785 275 RLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRKK--EFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP 351 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~~-g~~vAvK~~~~~~~~~~~--~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gs 351 (553)
+.||+|+||+||++.... ++.||+|.+......... ...+|+.++++++||||+++++++.+....++||||+++++
T Consensus 5 ~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~~~ 84 (260)
T PF00069_consen 5 KKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCPGGS 84 (260)
T ss_dssp EEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEETTEB
T ss_pred EEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccccccc
Confidence 457999999999999765 568999999877544432 34569999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCccccccee
Q 008785 352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT 431 (553)
Q Consensus 352 L~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~ 431 (553)
|.+++.. ...+++..+..++.|++.||.|||+. +++||||||+||++++++.++|+|||.+....... ...
T Consensus 85 L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~--~~~ 155 (260)
T PF00069_consen 85 LQDYLQK----NKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLSENN--ENF 155 (260)
T ss_dssp HHHHHHH----HSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEESTSTT--SEB
T ss_pred ccccccc----cccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc--ccc
Confidence 9999972 34589999999999999999999999 99999999999999999999999999997542111 111
Q ss_pred eecCcccccccccccc-CCCCCcccchHhHHHHHHHHhcC-cccccc---hHHHHH---hcCCH--------HHHHHHHH
Q 008785 432 VMAGGTYGYLAPEFVY-RNELTTKSDVYSFGVLLLEIRLV-LCRRWW---TLYTLV---HSMSL--------LCAQECLM 495 (553)
Q Consensus 432 ~~~~gt~~y~aPE~~~-~~~~t~ksDVwSlGvil~ell~~-~~~~~~---~l~~~~---~~~~~--------~~~~~l~~ 495 (553)
....++..|+|||++. +..++.++||||+|+++|+|++. .+.... +....+ ..... .....+.+
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 235 (260)
T PF00069_consen 156 NPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRD 235 (260)
T ss_dssp SSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHH
Confidence 2223889999999998 78899999999999999999973 332222 111111 11111 12478999
Q ss_pred HHhhccCCCCCCCCCHHHHHHH
Q 008785 496 LFISCNNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 496 l~~~Cl~~dP~~RPs~~evl~~ 517 (553)
++..||+.||++|||+.+++++
T Consensus 236 li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 236 LIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp HHHHHSSSSGGGSTTHHHHHTS
T ss_pred HHHHHccCChhHCcCHHHHhcC
Confidence 9999999999999999999874
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=308.51 Aligned_cols=240 Identities=19% Similarity=0.218 Sum_probs=187.1
Q ss_pred hhcccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccC--ChhhHHHHHHHHHHhhccCCCceeeEeeEEeeC-----
Q 008785 266 ITKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH----- 337 (553)
Q Consensus 266 ~~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~----- 337 (553)
..++|.... .||+|+||.||++... .++.||||.+... .......+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~-~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 15 VLKRYQNLK-PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhceeEEE-EeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 445665544 4599999999999864 5889999999754 233456788999999999999999999988644
Q ss_pred -CceEEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeec
Q 008785 338 -GDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGV 416 (553)
Q Consensus 338 -~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Df 416 (553)
...++||||+++ +|.+.+.. .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+||
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Df 163 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF 163 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeC
Confidence 346999999965 67776642 478889999999999999999999 9999999999999999999999999
Q ss_pred cccccCCcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcCc-ccccchHHH----HHh--------
Q 008785 417 GLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVL-CRRWWTLYT----LVH-------- 483 (553)
Q Consensus 417 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~-~~~~~~l~~----~~~-------- 483 (553)
|+++........ ....||+.|+|||++.+..++.++||||||+++|||++.. +....+..+ .+.
T Consensus 164 g~~~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (355)
T cd07874 164 GLARTAGTSFMM---TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE 240 (355)
T ss_pred cccccCCCcccc---CCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 999865433211 1123899999999999889999999999999999999732 222111111 000
Q ss_pred --------------cC-C--------------H--------HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 008785 484 --------------SM-S--------------L--------LCAQECLMLFISCNNWPSHLSQSKFCNLKLWV 519 (553)
Q Consensus 484 --------------~~-~--------------~--------~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~ 519 (553)
.. . . .....+.+++.+||+.||++|||+.|++++-.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~ 313 (355)
T cd07874 241 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPY 313 (355)
T ss_pred HHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcc
Confidence 00 0 0 12346789999999999999999999999843
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=313.16 Aligned_cols=244 Identities=21% Similarity=0.321 Sum_probs=198.1
Q ss_pred ccCCCCeeecccCceeEEEEEeCC-CCEEEEEEecc----CChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCc--eE
Q 008785 269 NFSEGNRLLGDSKTGGTYSGILPD-GSRVAVKRLKR----SSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGD--RY 341 (553)
Q Consensus 269 ~~~~~~~~iG~G~~g~Vy~~~~~~-g~~vAvK~~~~----~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~--~~ 341 (553)
.|..-..+||+|+|-+||+|.... |..||=-.++. .+....++|..|+.+|+.|+||||+++|..+.+... ..
T Consensus 40 Ry~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in 119 (632)
T KOG0584|consen 40 RYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTIN 119 (632)
T ss_pred ceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceee
Confidence 344445678999999999999743 77777433332 234456889999999999999999999999998765 78
Q ss_pred EEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCC-CCeEEeeccccc
Q 008785 342 IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE-FGAHLMGVGLSK 420 (553)
Q Consensus 342 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~-~~~kl~Dfgla~ 420 (553)
+|+|.+..|+|..|+++. +.++...+..|++||++||.|||++ .|+|+|||||.+||+|+.+ |.+||+|+|+|.
T Consensus 120 ~iTEL~TSGtLr~Y~kk~----~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAt 194 (632)
T KOG0584|consen 120 FITELFTSGTLREYRKKH----RRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLAT 194 (632)
T ss_pred eeeecccCCcHHHHHHHh----ccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHH
Confidence 999999999999999764 3478889999999999999999997 8899999999999999865 889999999998
Q ss_pred cCCcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhc-Cc----ccccchHHHHHhcCCH------HH
Q 008785 421 FVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-VL----CRRWWTLYTLVHSMSL------LC 489 (553)
Q Consensus 421 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-~~----~~~~~~l~~~~~~~~~------~~ 489 (553)
......... ..|||.|||||+.. ..|+...||||||++++||+| -. ..+...++..+-.|.- -.
T Consensus 195 l~r~s~aks----vIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~ 269 (632)
T KOG0584|consen 195 LLRKSHAKS----VIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVK 269 (632)
T ss_pred Hhhccccce----eccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccC
Confidence 765443222 23999999999875 789999999999999999998 22 2334455555555544 33
Q ss_pred HHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHh
Q 008785 490 AQECLMLFISCNNWPSHLSQSKFCNLKLWVFAIL 523 (553)
Q Consensus 490 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~~~~ 523 (553)
.+++.++|.+|+.. .++|||+.|+|++-.+...
T Consensus 270 dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 270 DPEVREFIEKCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred CHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence 56799999999999 9999999999988665543
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=300.34 Aligned_cols=234 Identities=19% Similarity=0.235 Sum_probs=193.0
Q ss_pred eecccCceeEEEEEeC-CCCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCCHHH
Q 008785 276 LLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR 354 (553)
Q Consensus 276 ~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~ 354 (553)
.||+|+||.||++... +++.||+|.+........+.+.+|+.++..++||||+++++++...+..++||||+++++|.+
T Consensus 28 ~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~~ 107 (297)
T cd06659 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTD 107 (297)
T ss_pred hcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHHH
Confidence 3599999999999864 689999999976555556778899999999999999999999999999999999999999999
Q ss_pred HhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccceeeec
Q 008785 355 WLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA 434 (553)
Q Consensus 355 ~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 434 (553)
++.. ..+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++.......... ...
T Consensus 108 ~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~--~~~ 177 (297)
T cd06659 108 IVSQ-----TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR--KSL 177 (297)
T ss_pred HHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhcccccccc--cce
Confidence 8753 3588999999999999999999999 99999999999999999999999999987554332211 122
Q ss_pred CccccccccccccCCCCCcccchHhHHHHHHHHhcCc-ccccchH---HHHHhcCCH-------HHHHHHHHHHhhccCC
Q 008785 435 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVL-CRRWWTL---YTLVHSMSL-------LCAQECLMLFISCNNW 503 (553)
Q Consensus 435 ~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~-~~~~~~l---~~~~~~~~~-------~~~~~l~~l~~~Cl~~ 503 (553)
.|+..|+|||++.+..++.++||||||+++|||++.. |...... ...+..... ..+..+.+++.+||+.
T Consensus 178 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~ 257 (297)
T cd06659 178 VGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLTR 257 (297)
T ss_pred ecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHHHhcC
Confidence 3889999999998888999999999999999999733 3222211 112221111 3456789999999999
Q ss_pred CCCCCCCHHHHHHHHH
Q 008785 504 PSHLSQSKFCNLKLWV 519 (553)
Q Consensus 504 dP~~RPs~~evl~~l~ 519 (553)
+|.+||++.+++++-.
T Consensus 258 ~P~~Rps~~~ll~~~~ 273 (297)
T cd06659 258 EPQERATAQELLDHPF 273 (297)
T ss_pred CcccCcCHHHHhhChh
Confidence 9999999999999643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=291.93 Aligned_cols=236 Identities=25% Similarity=0.370 Sum_probs=190.7
Q ss_pred eeecccCceeEEEEEeCCCCEEEEEEeccCC------hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccC
Q 008785 275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSS------FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV 348 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~~g~~vAvK~~~~~~------~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 348 (553)
+.||+|+||.||+|...+|+.+|+|.++... ......+.+|+.++++++|+||+++++++.+.+..++++||++
T Consensus 6 ~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 85 (265)
T cd06631 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFVP 85 (265)
T ss_pred ceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEecCC
Confidence 3469999999999998889999999987432 1223568899999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccc-
Q 008785 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM- 427 (553)
Q Consensus 349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~- 427 (553)
+++|.+++.. ...+++..+..++.|++.||+|||+. +|+|+||+|+||++++++.++|+|||++........
T Consensus 86 ~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 158 (265)
T cd06631 86 GGSISSILNR----FGPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLH 158 (265)
T ss_pred CCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhhhcccc
Confidence 9999999964 23578899999999999999999999 999999999999999999999999999875432111
Q ss_pred ---cceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcCc-ccccch-HHH--HHhcC--CH-----HHHHHH
Q 008785 428 ---QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVL-CRRWWT-LYT--LVHSM--SL-----LCAQEC 493 (553)
Q Consensus 428 ---~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~-~~~~~~-l~~--~~~~~--~~-----~~~~~l 493 (553)
........|+..|+|||++.+..++.++||||||+++|||++.. |....+ ... .+... .. ..+..+
T Consensus 159 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (265)
T cd06631 159 GTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAA 238 (265)
T ss_pred ccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCHHH
Confidence 11111223788999999999888999999999999999999833 332211 111 11111 11 456778
Q ss_pred HHHHhhccCCCCCCCCCHHHHHHH
Q 008785 494 LMLFISCNNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 494 ~~l~~~Cl~~dP~~RPs~~evl~~ 517 (553)
.+++.+||+.+|++||++.|++++
T Consensus 239 ~~~i~~~l~~~p~~Rp~~~~~l~~ 262 (265)
T cd06631 239 IDFVTSCLTRDQHERPSALQLLRH 262 (265)
T ss_pred HHHHHHHhcCCcccCCCHHHHhcC
Confidence 999999999999999999998864
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=292.43 Aligned_cols=237 Identities=20% Similarity=0.287 Sum_probs=191.3
Q ss_pred eecccCceeEEEEEeCC--CCEEEEEEeccC----------ChhhHHHHHHHHHHhhc-cCCCceeeEeeEEeeCCceEE
Q 008785 276 LLGDSKTGGTYSGILPD--GSRVAVKRLKRS----------SFQRKKEFYSEIGRFAR-LHHPNLVAVKGCCYDHGDRYI 342 (553)
Q Consensus 276 ~iG~G~~g~Vy~~~~~~--g~~vAvK~~~~~----------~~~~~~~~~~E~~~l~~-l~HpnIv~l~~~~~~~~~~~l 342 (553)
.||+|+||.||+|.... ++.+|+|.+... ......++.+|+.++.+ ++||||+++++++.+.+..++
T Consensus 7 ~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~l 86 (269)
T cd08528 7 HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRLYI 86 (269)
T ss_pred hhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccCCeEEE
Confidence 45999999999999765 688999988632 12234567789988875 799999999999999999999
Q ss_pred EEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCceecCCCCCcEEecCCCCeEEeecccccc
Q 008785 343 VYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD-KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF 421 (553)
Q Consensus 343 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~ 421 (553)
+|||+++++|.+++.........+++..+..++.|++.||.|||+ . +++||||+|+||++++++.++|+|||.+..
T Consensus 87 v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~ 163 (269)
T cd08528 87 VMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK---RIVHRDLTPNNIMLGEDDKVTITDFGLAKQ 163 (269)
T ss_pred EEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC---ceeecCCCHHHEEECCCCcEEEecccceee
Confidence 999999999999886543444568999999999999999999996 5 899999999999999999999999999976
Q ss_pred CCcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcCc-ccccchH---HHHHhcCCH------HHHH
Q 008785 422 VPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVL-CRRWWTL---YTLVHSMSL------LCAQ 491 (553)
Q Consensus 422 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~-~~~~~~l---~~~~~~~~~------~~~~ 491 (553)
..... ......|+..|+|||.+.+..++.++||||||+++|||++.. |...... ...+..+.. ..+.
T Consensus 164 ~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (269)
T cd08528 164 KQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMYSE 240 (269)
T ss_pred ccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCcccCCH
Confidence 54432 111223888999999999888999999999999999999733 3222222 222222211 3467
Q ss_pred HHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008785 492 ECLMLFISCNNWPSHLSQSKFCNLKLW 518 (553)
Q Consensus 492 ~l~~l~~~Cl~~dP~~RPs~~evl~~l 518 (553)
.+.+++.+||+.||++||++.|+..++
T Consensus 241 ~l~~li~~cl~~~p~~Rp~~~e~~~~~ 267 (269)
T cd08528 241 DVTDVITSCLTPDAEARPDIIQVSAMI 267 (269)
T ss_pred HHHHHHHHHCCCCCccCCCHHHHHHHh
Confidence 899999999999999999999988765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=292.15 Aligned_cols=236 Identities=22% Similarity=0.331 Sum_probs=190.5
Q ss_pred eeecccCceeEEEEEeC-CCCEEEEEEeccCChh---------hHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEE
Q 008785 275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQ---------RKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVY 344 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~~---------~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 344 (553)
.+||+|++|.||+|... +++.||+|.+...... ..+.+.+|+.++++++||||+++++++.+.+..+++|
T Consensus 6 ~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (267)
T cd06628 6 ALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLNIFL 85 (267)
T ss_pred ceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccEEEE
Confidence 35699999999999864 5889999988654221 1256888999999999999999999999999999999
Q ss_pred EccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCc
Q 008785 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW 424 (553)
Q Consensus 345 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~ 424 (553)
||+++++|.+++.. ...+++..+..++.|++.||+|||+. +++||||+|+||++++++.++|+|||.++....
T Consensus 86 e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06628 86 EYVPGGSVAALLNN----YGAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEA 158 (267)
T ss_pred EecCCCCHHHHHHh----ccCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCCccccc
Confidence 99999999999964 24578899999999999999999999 999999999999999999999999999886653
Q ss_pred ccccc----eeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcC-cccccchHHH---HHhcCC-----HHHHH
Q 008785 425 EVMQE----RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLV-LCRRWWTLYT---LVHSMS-----LLCAQ 491 (553)
Q Consensus 425 ~~~~~----~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~-~~~~~~~l~~---~~~~~~-----~~~~~ 491 (553)
..... ......|+..|+|||.+.+..++.++||||||+++|+|++. .|.....-.. .+.... ...+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (267)
T cd06628 159 NSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNISS 238 (267)
T ss_pred ccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCCcCCcccCH
Confidence 21111 01112378899999999888899999999999999999973 3332221111 111111 15677
Q ss_pred HHHHHHhhccCCCCCCCCCHHHHHHH
Q 008785 492 ECLMLFISCNNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 492 ~l~~l~~~Cl~~dP~~RPs~~evl~~ 517 (553)
.+.+++.+||+.||.+||++.|++++
T Consensus 239 ~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 239 EAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred HHHHHHHHHccCCchhCcCHHHHhhC
Confidence 88999999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=294.18 Aligned_cols=232 Identities=21% Similarity=0.257 Sum_probs=192.9
Q ss_pred eecccCceeEEEEEeC-CCCEEEEEEeccCC-hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCCHH
Q 008785 276 LLGDSKTGGTYSGILP-DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 353 (553)
Q Consensus 276 ~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~ 353 (553)
.||.|++|.||+|... +++.||+|.+.... ......+.+|+.++++++||||+++++++.+....++|+||+++++|.
T Consensus 8 ~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~ 87 (274)
T cd06609 8 CIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCL 87 (274)
T ss_pred hhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeCCCcHH
Confidence 3599999999999965 58899999987653 344567889999999999999999999999999999999999999999
Q ss_pred HHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccceeee
Q 008785 354 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVM 433 (553)
Q Consensus 354 ~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 433 (553)
+++.. ..+++..+..++.|++.||.|||+. +++||||+|+||++++++.++|+|||+++.......... .
T Consensus 88 ~~~~~-----~~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~--~ 157 (274)
T cd06609 88 DLLKP-----GKLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRN--T 157 (274)
T ss_pred HHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeecccccccc--c
Confidence 99864 2689999999999999999999999 999999999999999999999999999987654422111 1
Q ss_pred cCccccccccccccCCCCCcccchHhHHHHHHHHhcCc-ccccch---HHHHHhcCCH-----H-HHHHHHHHHhhccCC
Q 008785 434 AGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVL-CRRWWT---LYTLVHSMSL-----L-CAQECLMLFISCNNW 503 (553)
Q Consensus 434 ~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~-~~~~~~---l~~~~~~~~~-----~-~~~~l~~l~~~Cl~~ 503 (553)
..+++.|+|||++.+..++.++||||||+++|||++.. |....+ ....+..+.. . .+..+.+++.+||..
T Consensus 158 ~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~ 237 (274)
T cd06609 158 FVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSLCLNK 237 (274)
T ss_pred ccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcccccCHHHHHHHHHHhhC
Confidence 23788999999999888999999999999999999833 322211 1112222211 2 567899999999999
Q ss_pred CCCCCCCHHHHHHH
Q 008785 504 PSHLSQSKFCNLKL 517 (553)
Q Consensus 504 dP~~RPs~~evl~~ 517 (553)
+|++|||+.+++++
T Consensus 238 ~p~~Rpt~~~il~~ 251 (274)
T cd06609 238 DPKERPSAKELLKH 251 (274)
T ss_pred ChhhCcCHHHHhhC
Confidence 99999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=302.42 Aligned_cols=240 Identities=16% Similarity=0.179 Sum_probs=186.0
Q ss_pred eeccc--CceeEEEEEe-CCCCEEEEEEeccCC--hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCC
Q 008785 276 LLGDS--KTGGTYSGIL-PDGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 350 (553)
Q Consensus 276 ~iG~G--~~g~Vy~~~~-~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 350 (553)
+||+| +|++||++.. .+|+.||+|.++... ....+.+.+|+.+++.++||||+++++++..++..++||||+++|
T Consensus 5 ~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~ 84 (327)
T cd08227 5 VIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYG 84 (327)
T ss_pred hccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccCCC
Confidence 56999 7889999986 468999999997542 233456778999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccc-
Q 008785 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE- 429 (553)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~- 429 (553)
+|.+++... ....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.++++||+.+..........
T Consensus 85 ~l~~~~~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~ 159 (327)
T cd08227 85 SAKDLICTH--FMDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLR 159 (327)
T ss_pred cHHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhcccccccccc
Confidence 999998642 234589999999999999999999999 99999999999999999999999998654332111100
Q ss_pred ----eeeecCccccccccccccC--CCCCcccchHhHHHHHHHHhcCc-ccccch----HHHHHhc--------C-----
Q 008785 430 ----RTVMAGGTYGYLAPEFVYR--NELTTKSDVYSFGVLLLEIRLVL-CRRWWT----LYTLVHS--------M----- 485 (553)
Q Consensus 430 ----~~~~~~gt~~y~aPE~~~~--~~~t~ksDVwSlGvil~ell~~~-~~~~~~----l~~~~~~--------~----- 485 (553)
......++..|+|||++.+ ..++.++|||||||++|||++.. |..... ....... .
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (327)
T cd08227 160 VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAE 239 (327)
T ss_pred ccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhh
Confidence 0111226778999999876 45899999999999999999732 222111 0000000 0
Q ss_pred ------------------------------------CHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 008785 486 ------------------------------------SLLCAQECLMLFISCNNWPSHLSQSKFCNLKLWVF 520 (553)
Q Consensus 486 ------------------------------------~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~ 520 (553)
.......+.+++.+||+.||++|||+.|++++-..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f 310 (327)
T cd08227 240 ELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFF 310 (327)
T ss_pred hcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhh
Confidence 00234578899999999999999999999987544
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=304.39 Aligned_cols=236 Identities=18% Similarity=0.156 Sum_probs=187.0
Q ss_pred eeecccCceeEEEEEeCC-CCEEEEEEeccCC---hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCC
Q 008785 275 RLLGDSKTGGTYSGILPD-GSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 350 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~~-g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 350 (553)
+.||+|+||.||++..+. ++.||+|++.+.. ......+.+|+.++..++||||+++++++.+.+..++||||+++|
T Consensus 7 ~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey~~~g 86 (332)
T cd05623 7 KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVGG 86 (332)
T ss_pred EEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEeccCCC
Confidence 345999999999999754 7889999996532 222345788999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccce
Q 008785 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER 430 (553)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 430 (553)
+|.+++.. ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++..........
T Consensus 87 ~L~~~l~~---~~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~- 159 (332)
T cd05623 87 DLLTLLSK---FEDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ- 159 (332)
T ss_pred cHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheecccCCcce-
Confidence 99999964 234589999999999999999999999 99999999999999999999999999987554322211
Q ss_pred eeecCcccccccccccc-----CCCCCcccchHhHHHHHHHHhc-CcccccchHHH---HHhcCC--H-------HHHHH
Q 008785 431 TVMAGGTYGYLAPEFVY-----RNELTTKSDVYSFGVLLLEIRL-VLCRRWWTLYT---LVHSMS--L-------LCAQE 492 (553)
Q Consensus 431 ~~~~~gt~~y~aPE~~~-----~~~~t~ksDVwSlGvil~ell~-~~~~~~~~l~~---~~~~~~--~-------~~~~~ 492 (553)
.....||+.|+|||++. ...++.++|||||||++|||++ ..|....+..+ .+.... . ..+..
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~ 239 (332)
T cd05623 160 SSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSED 239 (332)
T ss_pred ecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCHH
Confidence 11234899999999986 3468899999999999999998 33433333322 221111 1 34677
Q ss_pred HHHHHhhccCCCC--CCCCCHHHHHHH
Q 008785 493 CLMLFISCNNWPS--HLSQSKFCNLKL 517 (553)
Q Consensus 493 l~~l~~~Cl~~dP--~~RPs~~evl~~ 517 (553)
+.+++.+|+..+| ..||++.|++++
T Consensus 240 ~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 240 AKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred HHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 8899998875544 447899999988
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=290.38 Aligned_cols=231 Identities=27% Similarity=0.386 Sum_probs=188.5
Q ss_pred eeecccCceeEEEEEeCCCCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCCHHH
Q 008785 275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR 354 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~ 354 (553)
+.||+|+||.||++.. +++.||+|.++... ..+.+.+|+.++++++||||+++++++... ..+++|||+++++|.+
T Consensus 12 ~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~~~L~~ 87 (254)
T cd05083 12 EIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSKGNLVN 87 (254)
T ss_pred eeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCCCCHHH
Confidence 4559999999999975 78889999987542 346788999999999999999999998654 5799999999999999
Q ss_pred HhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccceeeec
Q 008785 355 WLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA 434 (553)
Q Consensus 355 ~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 434 (553)
++.. .....+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++........ ..
T Consensus 88 ~l~~--~~~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~~-----~~ 157 (254)
T cd05083 88 FLRT--RGRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVD-----NS 157 (254)
T ss_pred HHHh--cCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceeccccCC-----CC
Confidence 9975 2334588999999999999999999999 999999999999999999999999999875432211 11
Q ss_pred CccccccccccccCCCCCcccchHhHHHHHHHHhc-C-cccccch---HHHHHhcCCH-----HHHHHHHHHHhhccCCC
Q 008785 435 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-V-LCRRWWT---LYTLVHSMSL-----LCAQECLMLFISCNNWP 504 (553)
Q Consensus 435 ~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-~-~~~~~~~---l~~~~~~~~~-----~~~~~l~~l~~~Cl~~d 504 (553)
..+..|+|||.+.+..++.++|+||||+++|||++ . .|..... +...+..+.. ..+..+.+++.+||+.+
T Consensus 158 ~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 237 (254)
T cd05083 158 KLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVYVLMTSCWETE 237 (254)
T ss_pred CCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHHcCCC
Confidence 14567999999988899999999999999999986 2 2332222 2223333221 45678899999999999
Q ss_pred CCCCCCHHHHHHHHH
Q 008785 505 SHLSQSKFCNLKLWV 519 (553)
Q Consensus 505 P~~RPs~~evl~~l~ 519 (553)
|++||++.++++.+.
T Consensus 238 p~~Rp~~~~l~~~l~ 252 (254)
T cd05083 238 PKKRPSFHKLREKLE 252 (254)
T ss_pred hhhCcCHHHHHHHHc
Confidence 999999999998763
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=296.77 Aligned_cols=235 Identities=24% Similarity=0.324 Sum_probs=185.7
Q ss_pred eecccCceeEEEEEeC-CCCEEEEEEeccCC--hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCCH
Q 008785 276 LLGDSKTGGTYSGILP-DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352 (553)
Q Consensus 276 ~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL 352 (553)
.||+|++|.||+|... ++..||+|.++... ......+.+|+.++++++||||+++++++.+++..++||||++ ++|
T Consensus 7 ~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l 85 (285)
T cd07861 7 KIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS-MDL 85 (285)
T ss_pred EecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCC-CCH
Confidence 4599999999999975 58999999987542 2234678899999999999999999999999999999999997 689
Q ss_pred HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccceee
Q 008785 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV 432 (553)
Q Consensus 353 ~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~ 432 (553)
.+++.... .+..+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||++.......... .
T Consensus 86 ~~~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~--~ 159 (285)
T cd07861 86 KKYLDSLP-KGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVY--T 159 (285)
T ss_pred HHHHhcCC-CCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCcccc--c
Confidence 88886532 235689999999999999999999999 99999999999999999999999999987553321111 1
Q ss_pred ecCccccccccccccCC-CCCcccchHhHHHHHHHHhcCcccc-cchH----HHHHh-----------------------
Q 008785 433 MAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIRLVLCRR-WWTL----YTLVH----------------------- 483 (553)
Q Consensus 433 ~~~gt~~y~aPE~~~~~-~~t~ksDVwSlGvil~ell~~~~~~-~~~l----~~~~~----------------------- 483 (553)
...+++.|+|||++.+. .++.++||||||+++|||++..+.. .... .....
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (285)
T cd07861 160 HEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTF 239 (285)
T ss_pred CCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhc
Confidence 11268899999988654 4789999999999999999843222 1110 00000
Q ss_pred ----cCCH-----HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008785 484 ----SMSL-----LCAQECLMLFISCNNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 484 ----~~~~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 517 (553)
.+.. ..+.++.+++.+||+.||++|||+.+++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 240 PKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred cccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 0000 235677899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=295.56 Aligned_cols=249 Identities=22% Similarity=0.287 Sum_probs=192.9
Q ss_pred HHHHHHhhcccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCChhhHHHHHHHHHHhhcc-CCCceeeEeeEEee-
Q 008785 260 TEELRSITKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYD- 336 (553)
Q Consensus 260 ~~el~~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~- 336 (553)
..++......|.... .+|+|+||.||+|... +++.||+|.+.... ....++..|+.+++++ +||||+++++++..
T Consensus 8 ~~~~~~~~~~~~~~~-~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 8 LSALRDPAGIFELVE-VVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhcChhhhhhhhe-eeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 334444455565544 4599999999999974 58899999986653 3346688899999998 79999999999863
Q ss_pred -----CCceEEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCe
Q 008785 337 -----HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGA 411 (553)
Q Consensus 337 -----~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~ 411 (553)
....+++|||+++|+|.+++... ....+++..+..++.||+.||.|||+. +|+||||||+||++++++.+
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~ 160 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNT--KGNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEV 160 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCE
Confidence 35679999999999999998752 234578888999999999999999999 99999999999999999999
Q ss_pred EEeeccccccCCcccccceeeecCcccccccccccc-----CCCCCcccchHhHHHHHHHHhcCc-ccccchHHH----H
Q 008785 412 HLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY-----RNELTTKSDVYSFGVLLLEIRLVL-CRRWWTLYT----L 481 (553)
Q Consensus 412 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDVwSlGvil~ell~~~-~~~~~~l~~----~ 481 (553)
+|+|||++......... .....|++.|+|||.+. +..++.++||||||+++|||++.. |........ .
T Consensus 161 ~l~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~ 238 (282)
T cd06636 161 KLVDFGVSAQLDRTVGR--RNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLI 238 (282)
T ss_pred EEeeCcchhhhhccccC--CCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhH
Confidence 99999998755322111 11223888999999876 346788999999999999999833 322221111 1
Q ss_pred HhcCCH-----HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008785 482 VHSMSL-----LCAQECLMLFISCNNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 482 ~~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 517 (553)
...... ..+..+.+++.+||+.||.+|||+.|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 239 PRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred hhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 111111 456789999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=294.07 Aligned_cols=240 Identities=23% Similarity=0.320 Sum_probs=192.2
Q ss_pred eeecccCceeEEEEEeC-----CCCEEEEEEeccCChh-hHHHHHHHHHHhhccCCCceeeEeeEEee--CCceEEEEEc
Q 008785 275 RLLGDSKTGGTYSGILP-----DGSRVAVKRLKRSSFQ-RKKEFYSEIGRFARLHHPNLVAVKGCCYD--HGDRYIVYEF 346 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~-----~g~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--~~~~~lV~E~ 346 (553)
+.||+|+||.||++.+. ++..||||.++..... ....+.+|++++++++||||+++++++.. ....+++|||
T Consensus 10 ~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~ 89 (284)
T cd05038 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEY 89 (284)
T ss_pred eeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEEEEec
Confidence 34599999999999864 3678999999866443 46789999999999999999999999887 5578999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCccc
Q 008785 347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV 426 (553)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 426 (553)
+++++|.+++.. ....+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++.......
T Consensus 90 ~~~~~l~~~l~~---~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 163 (284)
T cd05038 90 LPSGSLRDYLQR---HRDQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDK 163 (284)
T ss_pred CCCCCHHHHHHh---CccccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccccccccccCC
Confidence 999999999965 223589999999999999999999999 99999999999999999999999999998765332
Q ss_pred ccce-eeecCccccccccccccCCCCCcccchHhHHHHHHHHhcCcccccc-------------------hHHHHHhcCC
Q 008785 427 MQER-TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVLCRRWW-------------------TLYTLVHSMS 486 (553)
Q Consensus 427 ~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~~~~~~-------------------~l~~~~~~~~ 486 (553)
.... .....++..|+|||.+.+..++.++||||||+++|||++....... .+.+.+..+.
T Consensus 164 ~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (284)
T cd05038 164 DYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGE 243 (284)
T ss_pred cceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHcCC
Confidence 2111 1111245679999999888999999999999999999972211111 0111222211
Q ss_pred H-----HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 008785 487 L-----LCAQECLMLFISCNNWPSHLSQSKFCNLKLWVF 520 (553)
Q Consensus 487 ~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~ 520 (553)
. ..+..+.+++.+||+.+|++|||+.|+++.+..
T Consensus 244 ~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~ 282 (284)
T cd05038 244 RLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDR 282 (284)
T ss_pred cCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhh
Confidence 1 345689999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=310.07 Aligned_cols=236 Identities=19% Similarity=0.173 Sum_probs=188.1
Q ss_pred eeecccCceeEEEEEeC-CCCEEEEEEeccCC---hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCC
Q 008785 275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 350 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 350 (553)
+.||+|+||.||++... +++.||+|+++... ......+.+|+.++.+++||||+++++.+.+.+..++||||+++|
T Consensus 7 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~gg 86 (360)
T cd05627 7 KVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGG 86 (360)
T ss_pred EEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCc
Confidence 45699999999999965 58999999997532 223466788999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCccccc--
Q 008785 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ-- 428 (553)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~-- 428 (553)
+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++.........
T Consensus 87 ~L~~~l~~----~~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~ 159 (360)
T cd05627 87 DMMTLLMK----KDTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEF 159 (360)
T ss_pred cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCccccccccccc
Confidence 99999864 24589999999999999999999999 9999999999999999999999999998754321100
Q ss_pred -------------------------------ceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcC-cccccc
Q 008785 429 -------------------------------ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLV-LCRRWW 476 (553)
Q Consensus 429 -------------------------------~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~-~~~~~~ 476 (553)
.......||+.|+|||++.+..++.++|||||||++|||++. .|....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~ 239 (360)
T cd05627 160 YRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSE 239 (360)
T ss_pred ccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCCC
Confidence 001122489999999999999999999999999999999983 333222
Q ss_pred h---HHHHHhc--CCH------HHHHHHHHHHhhccCCCCCCCCC---HHHHHHHH
Q 008785 477 T---LYTLVHS--MSL------LCAQECLMLFISCNNWPSHLSQS---KFCNLKLW 518 (553)
Q Consensus 477 ~---l~~~~~~--~~~------~~~~~l~~l~~~Cl~~dP~~RPs---~~evl~~l 518 (553)
. ....+.. ... ..+..+.+++.+++. ||.+|++ +.|++++-
T Consensus 240 ~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp 294 (360)
T cd05627 240 TPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHP 294 (360)
T ss_pred CHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCC
Confidence 2 2222221 111 345678888888764 9999984 78888773
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=289.82 Aligned_cols=235 Identities=20% Similarity=0.254 Sum_probs=191.5
Q ss_pred eeecccCceeEEEEEeC-CCCEEEEEEeccCC--hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCC
Q 008785 275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP 351 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gs 351 (553)
+.||+|++|.||++... +++.+|+|.+.... ......+.+|+.++++++||||+++++.+...+..++||||+++++
T Consensus 6 ~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 85 (256)
T cd08220 6 RVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGT 85 (256)
T ss_pred EEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecCCCCC
Confidence 35699999999999864 58899999987542 3345778999999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCC-CCeEEeeccccccCCcccccce
Q 008785 352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE-FGAHLMGVGLSKFVPWEVMQER 430 (553)
Q Consensus 352 L~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~-~~~kl~Dfgla~~~~~~~~~~~ 430 (553)
|.+++.. .....+++..+..++.|++.||+|||++ +++||||+|+||+++++ +.+||+|||.+..........
T Consensus 86 L~~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~- 159 (256)
T cd08220 86 LAEYIQK--RCNSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAY- 159 (256)
T ss_pred HHHHHHH--hcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcccc-
Confidence 9999975 2344589999999999999999999999 99999999999999865 457999999998665432211
Q ss_pred eeecCccccccccccccCCCCCcccchHhHHHHHHHHhc-Ccccccch---HHHHHhcCCH-----HHHHHHHHHHhhcc
Q 008785 431 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-VLCRRWWT---LYTLVHSMSL-----LCAQECLMLFISCN 501 (553)
Q Consensus 431 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-~~~~~~~~---l~~~~~~~~~-----~~~~~l~~l~~~Cl 501 (553)
...++..|+|||.+.+..++.++||||||+++|+|++ ..+....+ ....+..+.. ..+..+.+++.+||
T Consensus 160 --~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 237 (256)
T cd08220 160 --TVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLILSML 237 (256)
T ss_pred --ccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCCCCCcCHHHHHHHHHHc
Confidence 1227889999999988889999999999999999997 22322222 2222222211 45678999999999
Q ss_pred CCCCCCCCCHHHHHHH
Q 008785 502 NWPSHLSQSKFCNLKL 517 (553)
Q Consensus 502 ~~dP~~RPs~~evl~~ 517 (553)
+.+|++|||+.|++++
T Consensus 238 ~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 238 NLDPSKRPQLSQIMAQ 253 (256)
T ss_pred cCChhhCCCHHHHhhC
Confidence 9999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=291.75 Aligned_cols=243 Identities=24% Similarity=0.295 Sum_probs=190.9
Q ss_pred eeecccCceeEEEEEeC----CCCEEEEEEeccC--ChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCC------ceEE
Q 008785 275 RLLGDSKTGGTYSGILP----DGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHG------DRYI 342 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~----~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~------~~~l 342 (553)
++||+|+||.||+|.+. +++.||||.++.. .....+++.+|+.++++++||||+++++++.... ..++
T Consensus 5 ~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 84 (273)
T cd05074 5 RMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMV 84 (273)
T ss_pred hcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccceEE
Confidence 35699999999999853 3678999998754 2344677899999999999999999999886542 2478
Q ss_pred EEEccCCCCHHHHhccCC--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccc
Q 008785 343 VYEFVVNGPLDRWLHHIP--RGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSK 420 (553)
Q Consensus 343 V~E~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~ 420 (553)
++||+++|+|.+++.... .....+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++
T Consensus 85 ~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg~~~ 161 (273)
T cd05074 85 ILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSK 161 (273)
T ss_pred EEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcccccc
Confidence 999999999998875321 1223578899999999999999999999 99999999999999999999999999998
Q ss_pred cCCcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhc-Cc-cccc---chHHHHHhcCCH-----HHH
Q 008785 421 FVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-VL-CRRW---WTLYTLVHSMSL-----LCA 490 (553)
Q Consensus 421 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-~~-~~~~---~~l~~~~~~~~~-----~~~ 490 (553)
...............+++.|++||.+....++.++||||||+++|||++ .. +... ..+...+..+.. ..+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (273)
T cd05074 162 KIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQPPDCL 241 (273)
T ss_pred cccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCCCCCCCC
Confidence 6543322111112225678999999988889999999999999999987 22 2222 223333322221 456
Q ss_pred HHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 008785 491 QECLMLFISCNNWPSHLSQSKFCNLKLWVF 520 (553)
Q Consensus 491 ~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~ 520 (553)
..+.+++.+||+.+|++|||+.++++.+..
T Consensus 242 ~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~ 271 (273)
T cd05074 242 EDVYELMCQCWSPEPKCRPSFQHLRDQLEL 271 (273)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 789999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=306.10 Aligned_cols=240 Identities=20% Similarity=0.210 Sum_probs=187.3
Q ss_pred hhcccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccC--ChhhHHHHHHHHHHhhccCCCceeeEeeEEeeC-----
Q 008785 266 ITKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH----- 337 (553)
Q Consensus 266 ~~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~----- 337 (553)
+.++|..... ||+|+||.||++... .++.||||++... .......+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~-lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~ 100 (364)
T cd07875 22 VLKRYQNLKP-IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 100 (364)
T ss_pred hhcceeEEEE-eecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence 3456665544 599999999999964 5889999999753 233456788999999999999999999987643
Q ss_pred -CceEEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeec
Q 008785 338 -GDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGV 416 (553)
Q Consensus 338 -~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Df 416 (553)
...|+||||+++ +|.+++.. .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+||
T Consensus 101 ~~~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Df 170 (364)
T cd07875 101 FQDVYIVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF 170 (364)
T ss_pred cCeEEEEEeCCCC-CHHHHHHh------cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeC
Confidence 346999999964 77777642 378889999999999999999999 9999999999999999999999999
Q ss_pred cccccCCcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcCc-ccccchHHH----HHh--------
Q 008785 417 GLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVL-CRRWWTLYT----LVH-------- 483 (553)
Q Consensus 417 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~-~~~~~~l~~----~~~-------- 483 (553)
|+++........ ....+|+.|+|||++.+..++.++|||||||++|||++.. +....+..+ .+.
T Consensus 171 G~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 247 (364)
T cd07875 171 GLARTAGTSFMM---TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPE 247 (364)
T ss_pred CCccccCCCCcc---cCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence 999865433211 1123899999999999999999999999999999999732 222111111 000
Q ss_pred --------------c-CC-----H-----------------HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 008785 484 --------------S-MS-----L-----------------LCAQECLMLFISCNNWPSHLSQSKFCNLKLWV 519 (553)
Q Consensus 484 --------------~-~~-----~-----------------~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~ 519 (553)
. .. . .....+.+++.+||+.||++|||+.|++++-.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~ 320 (364)
T cd07875 248 FMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY 320 (364)
T ss_pred HHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcc
Confidence 0 00 0 11346789999999999999999999999843
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=331.65 Aligned_cols=248 Identities=19% Similarity=0.226 Sum_probs=192.0
Q ss_pred hcccCCCCeeecccCceeEEEEEeCC-CCEEEEEEeccC--ChhhHHHHHHHHHHhhccCCCceeeEeeEEeeC--CceE
Q 008785 267 TKNFSEGNRLLGDSKTGGTYSGILPD-GSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH--GDRY 341 (553)
Q Consensus 267 ~~~~~~~~~~iG~G~~g~Vy~~~~~~-g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~~ 341 (553)
..+|..... ||+|+||.||++.... +..||+|.+... .......+..|+.++++|+|||||++++++.+. ...|
T Consensus 12 l~~YeIl~k-LG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ly 90 (1021)
T PTZ00266 12 LNEYEVIKK-IGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLY 90 (1021)
T ss_pred cCCEEEEEE-EecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEE
Confidence 345555444 5999999999999654 778999998754 233456789999999999999999999988654 4589
Q ss_pred EEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC----CCceecCCCCCcEEecCC---------
Q 008785 342 IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVK----PHVVHRDIRASNVLLDEE--------- 408 (553)
Q Consensus 342 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~----~~ivHrDlkp~NILl~~~--------- 408 (553)
|||||+++|+|.++|.........+++..++.|+.||+.||.|||+... .+|+||||||+||||+.+
T Consensus 91 IVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~ 170 (1021)
T PTZ00266 91 ILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITA 170 (1021)
T ss_pred EEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccc
Confidence 9999999999999997533334569999999999999999999998511 259999999999999642
Q ss_pred --------CCeEEeeccccccCCcccccceeeecCccccccccccccC--CCCCcccchHhHHHHHHHHhcC-cccccc-
Q 008785 409 --------FGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYR--NELTTKSDVYSFGVLLLEIRLV-LCRRWW- 476 (553)
Q Consensus 409 --------~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~t~ksDVwSlGvil~ell~~-~~~~~~- 476 (553)
..+||+|||++......... ....||+.|+|||++.+ ..++.++|||||||+||||++. .|+...
T Consensus 171 ~~~n~ng~~iVKLsDFGlAr~l~~~s~~---~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~ 247 (1021)
T PTZ00266 171 QANNLNGRPIAKIGDFGLSKNIGIESMA---HSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN 247 (1021)
T ss_pred cccccCCCCceEEccCCccccccccccc---cccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence 34899999999865433221 12238999999999864 4588999999999999999983 333221
Q ss_pred ---hHHHHHhcCCH----HHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008785 477 ---TLYTLVHSMSL----LCAQECLMLFISCNNWPSHLSQSKFCNLKLW 518 (553)
Q Consensus 477 ---~l~~~~~~~~~----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l 518 (553)
.+...+..+.. ..+..+.+|+..||+.+|.+||++.|+|++-
T Consensus 248 ~~~qli~~lk~~p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~ 296 (1021)
T PTZ00266 248 NFSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQ 296 (1021)
T ss_pred cHHHHHHHHhcCCCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccH
Confidence 22222322221 3467899999999999999999999999763
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=293.41 Aligned_cols=242 Identities=23% Similarity=0.302 Sum_probs=193.1
Q ss_pred cCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCCh-hhHHHHHHHHHHhhccCCCceeeEeeEEeeC--CceEEEEE
Q 008785 270 FSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF-QRKKEFYSEIGRFARLHHPNLVAVKGCCYDH--GDRYIVYE 345 (553)
Q Consensus 270 ~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~~lV~E 345 (553)
|....+ ||.|++|.||++... +++.||+|.+..... ....++.+|++++++++||||+++++++.+. +..++|||
T Consensus 3 ~~~~~~-lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 81 (287)
T cd06621 3 IVELSR-LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAME 81 (287)
T ss_pred eEEEEE-eccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEE
Confidence 333344 499999999999975 488999999875432 3457789999999999999999999988654 46899999
Q ss_pred ccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcc
Q 008785 346 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE 425 (553)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~ 425 (553)
|+++++|.+++.........+++..+..++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++......
T Consensus 82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 158 (287)
T cd06621 82 YCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS 158 (287)
T ss_pred ecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeecccccccccc
Confidence 9999999998765333445688999999999999999999999 9999999999999999999999999998755432
Q ss_pred cccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcCc-ccccc--------hHHHHHhcCC----------
Q 008785 426 VMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVL-CRRWW--------TLYTLVHSMS---------- 486 (553)
Q Consensus 426 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~-~~~~~--------~l~~~~~~~~---------- 486 (553)
... ...++..|+|||.+.+..++.++||||||+++|||++.. |.... ++...+....
T Consensus 159 ~~~----~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd06621 159 LAG----TFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGN 234 (287)
T ss_pred ccc----cccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCC
Confidence 211 122778899999998889999999999999999999732 22211 1222222111
Q ss_pred -HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 008785 487 -LLCAQECLMLFISCNNWPSHLSQSKFCNLKLWV 519 (553)
Q Consensus 487 -~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~ 519 (553)
...+..+.+++.+||+.+|++|||+.|++++-.
T Consensus 235 ~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~ 268 (287)
T cd06621 235 GIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPW 268 (287)
T ss_pred CCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcc
Confidence 134567899999999999999999999998743
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=289.95 Aligned_cols=240 Identities=23% Similarity=0.302 Sum_probs=186.7
Q ss_pred ccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCC-----hhhHHHHHHHHHHhhccCCCceeeEeeEEeeC--Cce
Q 008785 269 NFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS-----FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH--GDR 340 (553)
Q Consensus 269 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~-----~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~ 340 (553)
+|.... +||+|+||.||++... ++..||+|.++... ......+.+|+.++++++||||+++++++.+. ...
T Consensus 3 ~~~~~~-~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 3 NWRRGK-LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred Cccccc-eecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 455544 4599999999999864 58999999986432 22345688999999999999999999988763 567
Q ss_pred EEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccc
Q 008785 341 YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSK 420 (553)
Q Consensus 341 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~ 420 (553)
++++||+++++|.+++.. ...+++.....++.|++.||+|||+. +++||||||+||++++++.++|+|||+++
T Consensus 82 ~l~~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~ 154 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKA----YGALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK 154 (266)
T ss_pred EEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCcc
Confidence 899999999999999864 23478899999999999999999999 99999999999999999999999999987
Q ss_pred cCCcccccc-eeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcCc-ccccchHHH----HHhcC---CH--HH
Q 008785 421 FVPWEVMQE-RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVL-CRRWWTLYT----LVHSM---SL--LC 489 (553)
Q Consensus 421 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~-~~~~~~l~~----~~~~~---~~--~~ 489 (553)
......... ......++..|+|||++.+..++.++||||||+++|||++.. |........ ..... .+ ..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (266)
T cd06651 155 RLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHI 234 (266)
T ss_pred ccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhc
Confidence 654321111 111123788999999998888999999999999999999733 322221111 11111 11 34
Q ss_pred HHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008785 490 AQECLMLFISCNNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 490 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 517 (553)
...+.+++ +||..+|++||++.|++++
T Consensus 235 ~~~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 235 SEHARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred CHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 45566666 7888999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=297.20 Aligned_cols=237 Identities=23% Similarity=0.286 Sum_probs=189.3
Q ss_pred cCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCC---hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEE
Q 008785 270 FSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYE 345 (553)
Q Consensus 270 ~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 345 (553)
|.... .||+|+||.||+|... +|+.||+|.+.... ....+++.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 17 y~~~~-~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e 95 (307)
T cd06607 17 FTDLR-EIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVME 95 (307)
T ss_pred hhhhe-eecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHH
Confidence 44433 4599999999999965 58999999986432 2334678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcc
Q 008785 346 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE 425 (553)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~ 425 (553)
|+. |+|.+++.. ....+++..+..++.|++.||.|||+. +++||||+|+||++++++.++|+|||++......
T Consensus 96 ~~~-g~l~~~~~~---~~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~ 168 (307)
T cd06607 96 YCL-GSASDILEV---HKKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA 168 (307)
T ss_pred hhC-CCHHHHHHH---cccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCCC
Confidence 996 677777653 224589999999999999999999999 9999999999999999999999999998765432
Q ss_pred cccceeeecCcccccccccccc---CCCCCcccchHhHHHHHHHHhcCc-ccccchHHH---HHhcC-C-----HHHHHH
Q 008785 426 VMQERTVMAGGTYGYLAPEFVY---RNELTTKSDVYSFGVLLLEIRLVL-CRRWWTLYT---LVHSM-S-----LLCAQE 492 (553)
Q Consensus 426 ~~~~~~~~~~gt~~y~aPE~~~---~~~~t~ksDVwSlGvil~ell~~~-~~~~~~l~~---~~~~~-~-----~~~~~~ 492 (553)
. ...+++.|+|||++. ...++.++||||||+++|||++.. |....+... .+..+ . ...+..
T Consensus 169 ~------~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (307)
T cd06607 169 N------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDY 242 (307)
T ss_pred C------CccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHH
Confidence 1 122788999999874 456889999999999999999843 322222111 11111 1 145678
Q ss_pred HHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 008785 493 CLMLFISCNNWPSHLSQSKFCNLKLWVF 520 (553)
Q Consensus 493 l~~l~~~Cl~~dP~~RPs~~evl~~l~~ 520 (553)
+.+++.+||+.||++||++.+++++...
T Consensus 243 ~~~li~~~l~~~p~~Rp~~~~il~~~~~ 270 (307)
T cd06607 243 FRNFVDSCLQKIPQDRPSSEELLKHRFV 270 (307)
T ss_pred HHHHHHHHhcCChhhCcCHHHHhcChhh
Confidence 9999999999999999999999986433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=303.33 Aligned_cols=237 Identities=19% Similarity=0.145 Sum_probs=188.1
Q ss_pred eeecccCceeEEEEEeC-CCCEEEEEEeccCC---hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCC
Q 008785 275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 350 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 350 (553)
+.||+|+||.||++... +++.||+|.+.+.. ......+.+|..++..++||||+++++++.+.+..|+||||+++|
T Consensus 7 ~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~~gg 86 (331)
T cd05624 7 KVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYYVGG 86 (331)
T ss_pred EEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCC
Confidence 34599999999999965 47899999997532 223455788999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccce
Q 008785 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER 430 (553)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 430 (553)
+|.+++.. ....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++..........
T Consensus 87 ~L~~~l~~---~~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~- 159 (331)
T cd05624 87 DLLTLLSK---FEDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQ- 159 (331)
T ss_pred cHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccCCCcee-
Confidence 99999964 234588999999999999999999999 99999999999999999999999999997654332211
Q ss_pred eeecCccccccccccccC-----CCCCcccchHhHHHHHHHHhc-CcccccchHHH---HHhcC--CH-------HHHHH
Q 008785 431 TVMAGGTYGYLAPEFVYR-----NELTTKSDVYSFGVLLLEIRL-VLCRRWWTLYT---LVHSM--SL-------LCAQE 492 (553)
Q Consensus 431 ~~~~~gt~~y~aPE~~~~-----~~~t~ksDVwSlGvil~ell~-~~~~~~~~l~~---~~~~~--~~-------~~~~~ 492 (553)
.....||+.|+|||++.+ +.++.++||||||+++|||++ ..|....+..+ .+... .. ..+..
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~ 239 (331)
T cd05624 160 SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEE 239 (331)
T ss_pred eccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCHH
Confidence 122348999999999865 467899999999999999998 33433332222 22111 11 34678
Q ss_pred HHHHHhhccCCCCCC--CCCHHHHHHHH
Q 008785 493 CLMLFISCNNWPSHL--SQSKFCNLKLW 518 (553)
Q Consensus 493 l~~l~~~Cl~~dP~~--RPs~~evl~~l 518 (553)
+.+++.+|+..++.+ |+++.+++++.
T Consensus 240 ~~~li~~ll~~~~~~~~~~~~~~~~~h~ 267 (331)
T cd05624 240 AKDLIQRLICSRERRLGQNGIEDFKKHA 267 (331)
T ss_pred HHHHHHHHccCchhhcCCCCHHHHhcCC
Confidence 899999998865544 57899998873
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=291.75 Aligned_cols=236 Identities=21% Similarity=0.277 Sum_probs=188.8
Q ss_pred eeecccCceeEEEEEeC-CCCEEEEEEeccCCh----------hhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEE
Q 008785 275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF----------QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIV 343 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~----------~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 343 (553)
+.||+|++|.||+|... +|+.||+|.++.... ...+.+.+|+.++++++||||+++++++...+..++|
T Consensus 7 ~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 86 (272)
T cd06629 7 ELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLSIF 86 (272)
T ss_pred ceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCceEEE
Confidence 45699999999999864 589999998864211 1134678899999999999999999999999999999
Q ss_pred EEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCC
Q 008785 344 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVP 423 (553)
Q Consensus 344 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~ 423 (553)
|||+++|+|.+++... ..+++..+..++.||+.||.|||+. +++||||+|+||++++++.++|+|||+++...
T Consensus 87 ~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~ 159 (272)
T cd06629 87 LEYVPGGSIGSCLRTY----GRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGISKKSD 159 (272)
T ss_pred EecCCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeecccccccc
Confidence 9999999999998642 4688999999999999999999999 99999999999999999999999999997654
Q ss_pred cccccceeeecCccccccccccccCCC--CCcccchHhHHHHHHHHhcC-cccccchHHH-HHh---cC---CH------
Q 008785 424 WEVMQERTVMAGGTYGYLAPEFVYRNE--LTTKSDVYSFGVLLLEIRLV-LCRRWWTLYT-LVH---SM---SL------ 487 (553)
Q Consensus 424 ~~~~~~~~~~~~gt~~y~aPE~~~~~~--~t~ksDVwSlGvil~ell~~-~~~~~~~l~~-~~~---~~---~~------ 487 (553)
............++..|+|||.+.... ++.++|+||||+++||+++. .|........ ..+ .. .+
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (272)
T cd06629 160 DIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSM 239 (272)
T ss_pred ccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccccc
Confidence 322111112223788999999987654 78999999999999999983 3332222211 111 11 01
Q ss_pred HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008785 488 LCAQECLMLFISCNNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 488 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 517 (553)
..+..+.+++.+||+.+|++|||+.+++++
T Consensus 240 ~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 240 NLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred cCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 346789999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=288.70 Aligned_cols=239 Identities=21% Similarity=0.202 Sum_probs=197.3
Q ss_pred eecccCceeEEEEEeCC-CCEEEEEEeccCChh---hHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCC
Q 008785 276 LLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQ---RKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP 351 (553)
Q Consensus 276 ~iG~G~~g~Vy~~~~~~-g~~vAvK~~~~~~~~---~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gs 351 (553)
.||.|.-|+||.+.+.+ +..+|+|++.+.... ...+...|-+||+.++||.++.||+.++.+...+++||||+||+
T Consensus 84 ~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCpGGd 163 (459)
T KOG0610|consen 84 RLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYCPGGD 163 (459)
T ss_pred HcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecCCCcc
Confidence 45999999999999865 589999999876433 34566779999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcc------
Q 008785 352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE------ 425 (553)
Q Consensus 352 L~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~------ 425 (553)
|..+++. +.++.+++..+..++.+++-||+|||-. |||.|||||+||||.++|.+.|+||.++......
T Consensus 164 L~~Lrqk--Qp~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~~s 238 (459)
T KOG0610|consen 164 LHSLRQK--QPGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLVKS 238 (459)
T ss_pred HHHHHhh--CCCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCCCCeeecc
Confidence 9998876 5667799999999999999999999999 9999999999999999999999999987432110
Q ss_pred --------------------------c-cc---------------------ceeeecCccccccccccccCCCCCcccch
Q 008785 426 --------------------------V-MQ---------------------ERTVMAGGTYGYLAPEFVYRNELTTKSDV 457 (553)
Q Consensus 426 --------------------------~-~~---------------------~~~~~~~gt~~y~aPE~~~~~~~t~ksDV 457 (553)
. .. .......||-.|.|||++.+...+.++|.
T Consensus 239 ~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAVDW 318 (459)
T KOG0610|consen 239 SSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAVDW 318 (459)
T ss_pred CCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCchhhH
Confidence 0 00 00112238999999999999999999999
Q ss_pred HhHHHHHHHHhc-----CcccccchHHHHHhc-CCH----HHHHHHHHHHhhccCCCCCCCCC----HHHHHHHHH
Q 008785 458 YSFGVLLLEIRL-----VLCRRWWTLYTLVHS-MSL----LCAQECLMLFISCNNWPSHLSQS----KFCNLKLWV 519 (553)
Q Consensus 458 wSlGvil~ell~-----~~~~~~~~l~~~~~~-~~~----~~~~~l~~l~~~Cl~~dP~~RPs----~~evl~~l~ 519 (553)
|+|||++|||+- ........+.+.+.+ -.+ ..+..+.+||.+.|..||.+|.- +.||-++-.
T Consensus 319 WtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpF 394 (459)
T KOG0610|consen 319 WTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPF 394 (459)
T ss_pred HHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHhhcCcc
Confidence 999999999994 333344455554333 222 56688999999999999999999 888877643
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=309.91 Aligned_cols=238 Identities=18% Similarity=0.208 Sum_probs=187.7
Q ss_pred ccCCCCeeecccCceeEEEEEeC---CCCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEE
Q 008785 269 NFSEGNRLLGDSKTGGTYSGILP---DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYE 345 (553)
Q Consensus 269 ~~~~~~~~iG~G~~g~Vy~~~~~---~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 345 (553)
.|.... .||+|+||.||++... .+..||+|.+... ....+|+.++++++||||+++++++......++|||
T Consensus 93 ~y~i~~-~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e 166 (392)
T PHA03207 93 QYNILS-SLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMP 166 (392)
T ss_pred ceEEEE-eecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEeh
Confidence 344444 4599999999999753 3578999988654 234689999999999999999999999999999999
Q ss_pred ccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcc
Q 008785 346 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE 425 (553)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~ 425 (553)
++. ++|.+++.. ...+++..++.++.||+.||.|||++ +|+||||||+|||++.++.++|+|||++......
T Consensus 167 ~~~-~~l~~~l~~----~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 167 KYK-CDLFTYVDR----SGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238 (392)
T ss_pred hcC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence 995 688888842 34689999999999999999999999 9999999999999999999999999999765543
Q ss_pred cccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcC-cccccc-------hHHHHHh---cC---------
Q 008785 426 VMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLV-LCRRWW-------TLYTLVH---SM--------- 485 (553)
Q Consensus 426 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~-~~~~~~-------~l~~~~~---~~--------- 485 (553)
..........||+.|+|||++.+..++.++|||||||++|||++. .|.... .+...++ ..
T Consensus 239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~ 318 (392)
T PHA03207 239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGS 318 (392)
T ss_pred cccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccc
Confidence 322222223489999999999999999999999999999999962 222111 1111000 00
Q ss_pred ----------C------H---------HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 008785 486 ----------S------L---------LCAQECLMLFISCNNWPSHLSQSKFCNLKLWVF 520 (553)
Q Consensus 486 ----------~------~---------~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~ 520 (553)
. . ..+..+.+++.+||..||.+|||+.|++++-.+
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f 378 (392)
T PHA03207 319 TNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLF 378 (392)
T ss_pred hhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchh
Confidence 0 0 124467789999999999999999999987544
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=303.51 Aligned_cols=241 Identities=19% Similarity=0.242 Sum_probs=187.7
Q ss_pred HhhcccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCC--hhhHHHHHHHHHHhhccCCCceeeEeeEEeeC----
Q 008785 265 SITKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH---- 337 (553)
Q Consensus 265 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~---- 337 (553)
++.++|..... ||+|+||.||++... +++.||||++.... ......+.+|+.++++++||||+++++++...
T Consensus 12 ~~~~~y~~~~~-lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07878 12 EVPERYQNLTP-VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIE 90 (343)
T ss_pred hhhhhhhhhee-cccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccc
Confidence 34556665554 599999999999864 58899999997542 22345678999999999999999999987643
Q ss_pred --CceEEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEee
Q 008785 338 --GDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMG 415 (553)
Q Consensus 338 --~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~D 415 (553)
...++++|++ +++|.+++.. ..+++..+..++.||+.||.|||+. +|+||||||+|||+++++.+||+|
T Consensus 91 ~~~~~~~~~~~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~D 161 (343)
T cd07878 91 NFNEVYLVTNLM-GADLNNIVKC-----QKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILD 161 (343)
T ss_pred ccCcEEEEeecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcC
Confidence 3468999988 7899888753 3589999999999999999999999 999999999999999999999999
Q ss_pred ccccccCCcccccceeeecCccccccccccccC-CCCCcccchHhHHHHHHHHhcCc-ccccchHHH----HHh---cCC
Q 008785 416 VGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIRLVL-CRRWWTLYT----LVH---SMS 486 (553)
Q Consensus 416 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwSlGvil~ell~~~-~~~~~~l~~----~~~---~~~ 486 (553)
||+++...... ....||+.|+|||++.+ ..++.++||||||+++|||++.. +....+..+ ... ...
T Consensus 162 fg~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 236 (343)
T cd07878 162 FGLARQADDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPS 236 (343)
T ss_pred CccceecCCCc-----CCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 99998654321 11238899999999876 56899999999999999999732 222211111 000 000
Q ss_pred H-------------------------------HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 008785 487 L-------------------------------LCAQECLMLFISCNNWPSHLSQSKFCNLKLWVF 520 (553)
Q Consensus 487 ~-------------------------------~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~ 520 (553)
. ...+.+.+++.+|++.||++|||+.|++++-..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~ 301 (343)
T cd07878 237 PEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYF 301 (343)
T ss_pred HHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcch
Confidence 0 112346799999999999999999999998544
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=292.91 Aligned_cols=233 Identities=21% Similarity=0.268 Sum_probs=193.4
Q ss_pred eeecccCceeEEEEEe-CCCCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCCHH
Q 008785 275 RLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 353 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~ 353 (553)
+.||+|++|.||++.. .+++.||+|+++.......+.+.+|+.++++++||||+++++++...+..++++||+++++|.
T Consensus 25 ~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~ 104 (285)
T cd06648 25 VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALT 104 (285)
T ss_pred eEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCHH
Confidence 4569999999999986 468899999987665555677899999999999999999999999999999999999999999
Q ss_pred HHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccceeee
Q 008785 354 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVM 433 (553)
Q Consensus 354 ~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 433 (553)
+++.. ..+++..+..++.|++.||+|||+. +++||||+|+||+++.++.++|+|||.+.......... ..
T Consensus 105 ~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~--~~ 174 (285)
T cd06648 105 DIVTH-----TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRR--KS 174 (285)
T ss_pred HHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCCccc--cc
Confidence 99864 3588999999999999999999999 99999999999999999999999999887554322111 11
Q ss_pred cCccccccccccccCCCCCcccchHhHHHHHHHHhcCc-ccccch---HHHHHhcCCH-------HHHHHHHHHHhhccC
Q 008785 434 AGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVL-CRRWWT---LYTLVHSMSL-------LCAQECLMLFISCNN 502 (553)
Q Consensus 434 ~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~-~~~~~~---l~~~~~~~~~-------~~~~~l~~l~~~Cl~ 502 (553)
..|++.|+|||.+.+..++.++||||||+++|||++.. |....+ ....+..+.. ..+..+.+++.+||+
T Consensus 175 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 254 (285)
T cd06648 175 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRMLV 254 (285)
T ss_pred ccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHHcc
Confidence 23888999999998888999999999999999999833 322222 1222222211 255789999999999
Q ss_pred CCCCCCCCHHHHHHH
Q 008785 503 WPSHLSQSKFCNLKL 517 (553)
Q Consensus 503 ~dP~~RPs~~evl~~ 517 (553)
.+|++|||+.+++++
T Consensus 255 ~~p~~Rpt~~~il~~ 269 (285)
T cd06648 255 RDPAQRATAAELLNH 269 (285)
T ss_pred cChhhCcCHHHHccC
Confidence 999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=305.62 Aligned_cols=240 Identities=21% Similarity=0.260 Sum_probs=192.4
Q ss_pred CeeecccCceeEEEEEeC-CCCEEEEEEeccCChhhHHHHHHHHHHhhccC-C-----CceeeEeeEEeeCCceEEEEEc
Q 008785 274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLH-H-----PNLVAVKGCCYDHGDRYIVYEF 346 (553)
Q Consensus 274 ~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-H-----pnIv~l~~~~~~~~~~~lV~E~ 346 (553)
.++||+|+||.|-++... +++.||||+++.. ..-..+...|+.+|..|+ | -|+|+++++|...++.+||+|.
T Consensus 191 ~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciVfEL 269 (586)
T KOG0667|consen 191 LEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIVFEL 269 (586)
T ss_pred EEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeeeehh
Confidence 356799999999999964 5999999999876 344566678999999996 4 5899999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCC--CCeEEeeccccccCCc
Q 008785 347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE--FGAHLMGVGLSKFVPW 424 (553)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~--~~~kl~Dfgla~~~~~ 424 (553)
+ .-+|.++|+. +....++...+..|+.||+.||.+||.. +|||+||||+||||.+. ..+||+|||.|.+...
T Consensus 270 L-~~NLYellK~--n~f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q 343 (586)
T KOG0667|consen 270 L-STNLYELLKN--NKFRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQ 343 (586)
T ss_pred h-hhhHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEecccccccCC
Confidence 9 5699999987 4556699999999999999999999999 99999999999999764 3689999999987654
Q ss_pred ccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcCccc----ccch-H---HH--------HHhcCC--
Q 008785 425 EVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVLCR----RWWT-L---YT--------LVHSMS-- 486 (553)
Q Consensus 425 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~~~----~~~~-l---~~--------~~~~~~-- 486 (553)
... ...-+..|+|||++.+.+|+.+.||||||||+.||+++.|- +..+ + .+ +++.+.
T Consensus 344 ~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~ 418 (586)
T KOG0667|consen 344 RVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKA 418 (586)
T ss_pred cce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhcccc
Confidence 433 11256789999999999999999999999999999962221 1100 0 00 111000
Q ss_pred ------------------------------------H-----------------HHHHHHHHHHhhccCCCCCCCCCHHH
Q 008785 487 ------------------------------------L-----------------LCAQECLMLFISCNNWPSHLSQSKFC 513 (553)
Q Consensus 487 ------------------------------------~-----------------~~~~~l~~l~~~Cl~~dP~~RPs~~e 513 (553)
. .....+.+++++||.+||++|+|..|
T Consensus 419 ~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~q 498 (586)
T KOG0667|consen 419 HKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQ 498 (586)
T ss_pred ceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHH
Confidence 0 33456899999999999999999999
Q ss_pred HHHHHHHHHhhc
Q 008785 514 NLKLWVFAILTI 525 (553)
Q Consensus 514 vl~~l~~~~~~~ 525 (553)
++++-.......
T Consensus 499 al~Hpfl~~~~~ 510 (586)
T KOG0667|consen 499 ALNHPFLTGTSL 510 (586)
T ss_pred HhcCcccccccc
Confidence 999965544333
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=292.36 Aligned_cols=247 Identities=23% Similarity=0.314 Sum_probs=190.5
Q ss_pred ccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCC-hhhHHHHHHHHHH-hhccCCCceeeEeeEEeeCCceEEEEE
Q 008785 269 NFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS-FQRKKEFYSEIGR-FARLHHPNLVAVKGCCYDHGDRYIVYE 345 (553)
Q Consensus 269 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~~-l~~l~HpnIv~l~~~~~~~~~~~lV~E 345 (553)
+|..... ||+|+||.||++... +|+.||+|.++... ......+..|+.. ++.++||||+++++++..++..+++||
T Consensus 2 ~~~~~~~-ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 2 DLEVIEE-LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CceEEEE-ecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 3444444 599999999999975 58999999997642 2234456667665 556689999999999999999999999
Q ss_pred ccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcc
Q 008785 346 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE 425 (553)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~ 425 (553)
|++ |+|.+++.........+++..+..++.||+.||+|||++ .+++||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSK--LSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 996 789888865433446789999999999999999999974 28999999999999999999999999999765432
Q ss_pred cccceeeecCccccccccccccC----CCCCcccchHhHHHHHHHHhcCc-cccc-----chHHHHHhcCCH-----HHH
Q 008785 426 VMQERTVMAGGTYGYLAPEFVYR----NELTTKSDVYSFGVLLLEIRLVL-CRRW-----WTLYTLVHSMSL-----LCA 490 (553)
Q Consensus 426 ~~~~~~~~~~gt~~y~aPE~~~~----~~~t~ksDVwSlGvil~ell~~~-~~~~-----~~l~~~~~~~~~-----~~~ 490 (553)
... ....++..|+|||.+.+ ..++.++|+||||+++|||++.. |... ..+......... ..+
T Consensus 158 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd06617 158 VAK---TIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFS 234 (283)
T ss_pred ccc---ccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCccccC
Confidence 211 11227889999998864 45688999999999999999733 3221 111122222111 356
Q ss_pred HHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 008785 491 QECLMLFISCNNWPSHLSQSKFCNLKLWVFAI 522 (553)
Q Consensus 491 ~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~~~ 522 (553)
..+.+++.+||..+|++||++.+++++-....
T Consensus 235 ~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 266 (283)
T cd06617 235 PEFQDFVNKCLKKNYKERPNYPELLQHPFFEL 266 (283)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcCchhhh
Confidence 78999999999999999999999998754443
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=287.90 Aligned_cols=233 Identities=25% Similarity=0.348 Sum_probs=191.1
Q ss_pred eeecccCceeEEEEEeC-CCCEEEEEEeccCC-----hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccC
Q 008785 275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS-----FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV 348 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~-----~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 348 (553)
+.||+|++|.||+|... +++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+....++++||++
T Consensus 6 ~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (258)
T cd06632 6 ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELVP 85 (258)
T ss_pred ceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEEecC
Confidence 45699999999999976 68999999986543 2345678999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCccccc
Q 008785 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ 428 (553)
Q Consensus 349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 428 (553)
+++|.+++.. ...+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.+||+|||++........
T Consensus 86 ~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~~- 157 (258)
T cd06632 86 GGSLAKLLKK----YGSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSF- 157 (258)
T ss_pred CCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceecccccc-
Confidence 9999999964 23588999999999999999999999 999999999999999999999999999876543321
Q ss_pred ceeeecCccccccccccccCCC-CCcccchHhHHHHHHHHhcCc-ccccchHHH---HHhc-CCH-----HHHHHHHHHH
Q 008785 429 ERTVMAGGTYGYLAPEFVYRNE-LTTKSDVYSFGVLLLEIRLVL-CRRWWTLYT---LVHS-MSL-----LCAQECLMLF 497 (553)
Q Consensus 429 ~~~~~~~gt~~y~aPE~~~~~~-~t~ksDVwSlGvil~ell~~~-~~~~~~l~~---~~~~-~~~-----~~~~~l~~l~ 497 (553)
.....++..|+|||.+.... ++.++|+||||+++|+|++.. |.....-.+ .+.. +.. .....+.+++
T Consensus 158 --~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 235 (258)
T cd06632 158 --AKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFI 235 (258)
T ss_pred --ccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHH
Confidence 11223788999999987766 899999999999999999733 322221111 1111 111 3467789999
Q ss_pred hhccCCCCCCCCCHHHHHHH
Q 008785 498 ISCNNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 498 ~~Cl~~dP~~RPs~~evl~~ 517 (553)
.+||+.+|++||++.+++++
T Consensus 236 ~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 236 LKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred HHHhhcCcccCcCHHHHhcC
Confidence 99999999999999999864
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=297.83 Aligned_cols=241 Identities=18% Similarity=0.223 Sum_probs=188.3
Q ss_pred eeecccCceeEEEEEeC-CCCEEEEEEeccCC-hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCCH
Q 008785 275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL 352 (553)
+.||+|+||.||+|... +++.||+|.++... ......+.+|+.++++++||||+++++++...+..++||||++ ++|
T Consensus 12 ~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~-~~l 90 (301)
T cd07873 12 DKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDL 90 (301)
T ss_pred eEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEeccc-cCH
Confidence 34599999999999865 58899999987542 2234567889999999999999999999999999999999996 689
Q ss_pred HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccceee
Q 008785 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV 432 (553)
Q Consensus 353 ~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~ 432 (553)
.+++.. ....+++..+..++.||+.||+|||+. +|+||||||+||++++++.++|+|||++.......... .
T Consensus 91 ~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~--~ 162 (301)
T cd07873 91 KQYLDD---CGNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY--S 162 (301)
T ss_pred HHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCcc--c
Confidence 888864 234588999999999999999999999 99999999999999999999999999987543322111 1
Q ss_pred ecCccccccccccccCC-CCCcccchHhHHHHHHHHhcCccc-ccchHHHH-------------------HhcCC-----
Q 008785 433 MAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIRLVLCR-RWWTLYTL-------------------VHSMS----- 486 (553)
Q Consensus 433 ~~~gt~~y~aPE~~~~~-~~t~ksDVwSlGvil~ell~~~~~-~~~~l~~~-------------------~~~~~----- 486 (553)
...+++.|+|||.+.+. .++.++||||||+++|||++..+. ...+..+. .....
T Consensus 163 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (301)
T cd07873 163 NEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYN 242 (301)
T ss_pred ccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccccc
Confidence 12268899999988653 578899999999999999973322 11111110 00000
Q ss_pred -------------HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHhh
Q 008785 487 -------------LLCAQECLMLFISCNNWPSHLSQSKFCNLKLWVFAILT 524 (553)
Q Consensus 487 -------------~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~~~~~ 524 (553)
...+..+.+++.+|++.||.+|||+.|++++-...-+.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~ 293 (301)
T cd07873 243 YPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG 293 (301)
T ss_pred cCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 02355678999999999999999999999875444333
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=291.34 Aligned_cols=244 Identities=20% Similarity=0.249 Sum_probs=192.1
Q ss_pred hcccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCChhhHHHHHHHHHHhhcc-CCCceeeEeeEEeeCCc-----
Q 008785 267 TKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGD----- 339 (553)
Q Consensus 267 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~----- 339 (553)
+++|.... .||+|++|.||+|... +++.|++|.+..... ..+.+.+|+.+++++ +||||+++++++.....
T Consensus 5 ~~~y~~~~-~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 5 TGIFELVE-VIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred hhheehee-eecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 34555544 4599999999999975 578999999876543 346789999999999 79999999999976553
Q ss_pred -eEEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccc
Q 008785 340 -RYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGL 418 (553)
Q Consensus 340 -~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgl 418 (553)
.++||||+++++|.+++......+..+++..+..++.|++.||.|||+. +++||||+|+||++++++.++|+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCcc
Confidence 7999999999999999875333345689999999999999999999999 999999999999999999999999999
Q ss_pred cccCCcccccceeeecCccccccccccccC-----CCCCcccchHhHHHHHHHHhcCc-ccccchHHH---HHhcCCH--
Q 008785 419 SKFVPWEVMQERTVMAGGTYGYLAPEFVYR-----NELTTKSDVYSFGVLLLEIRLVL-CRRWWTLYT---LVHSMSL-- 487 (553)
Q Consensus 419 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~t~ksDVwSlGvil~ell~~~-~~~~~~l~~---~~~~~~~-- 487 (553)
+.......... ....|+..|+|||++.. ..++.++||||||+++|+|++.. |........ .+..+..
T Consensus 160 ~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 237 (275)
T cd06608 160 SAQLDSTLGRR--NTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPT 237 (275)
T ss_pred ceecccchhhh--cCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCC
Confidence 87654332211 12237889999998753 34678999999999999999733 322211111 1111111
Q ss_pred -----HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008785 488 -----LCAQECLMLFISCNNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 488 -----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 517 (553)
..+..+.+++.+||+.||++|||+.|++++
T Consensus 238 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 238 LKSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 345688999999999999999999999874
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=292.74 Aligned_cols=236 Identities=19% Similarity=0.295 Sum_probs=190.5
Q ss_pred eecccCceeEEEEEeC-CCCEEEEEEeccC-ChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCCHH
Q 008785 276 LLGDSKTGGTYSGILP-DGSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 353 (553)
Q Consensus 276 ~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~ 353 (553)
.||+|+||.||++... +|..||+|.++.. .......+.+|+.++++++||||+++++.+...+..++||||+++++|.
T Consensus 8 ~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~ 87 (286)
T cd06622 8 ELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLD 87 (286)
T ss_pred hhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecCCCCHH
Confidence 3599999999999975 6899999998754 3334578899999999999999999999999999999999999999999
Q ss_pred HHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccceee
Q 008785 354 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD-KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV 432 (553)
Q Consensus 354 ~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~ 432 (553)
.++... .....+++..+..++.|++.||.|||+ . +++||||||+||+++.++.++|+|||++.........
T Consensus 88 ~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~---- 159 (286)
T cd06622 88 KLYAGG-VATEGIPEDVLRRITYAVVKGLKFLKEEH---NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAK---- 159 (286)
T ss_pred HHHHhc-cccCCCCHHHHHHHHHHHHHHHHHHHhcC---CEeeCCCCHHHEEECCCCCEEEeecCCcccccCCccc----
Confidence 988642 123468999999999999999999996 5 8999999999999999999999999998765332211
Q ss_pred ecCccccccccccccCC------CCCcccchHhHHHHHHHHhcC-ccccc---chHHH---HHhcCCH-----HHHHHHH
Q 008785 433 MAGGTYGYLAPEFVYRN------ELTTKSDVYSFGVLLLEIRLV-LCRRW---WTLYT---LVHSMSL-----LCAQECL 494 (553)
Q Consensus 433 ~~~gt~~y~aPE~~~~~------~~t~ksDVwSlGvil~ell~~-~~~~~---~~l~~---~~~~~~~-----~~~~~l~ 494 (553)
...+++.|+|||.+.+. .++.++|+||||+++|||++. .|... ..... .+..+.. ..+..+.
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (286)
T cd06622 160 TNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDDAQ 239 (286)
T ss_pred cCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcccCHHHH
Confidence 12378899999998544 358899999999999999973 23221 22222 1112211 4667889
Q ss_pred HHHhhccCCCCCCCCCHHHHHHHHH
Q 008785 495 MLFISCNNWPSHLSQSKFCNLKLWV 519 (553)
Q Consensus 495 ~l~~~Cl~~dP~~RPs~~evl~~l~ 519 (553)
+++.+||+.+|++||++.+++++-.
T Consensus 240 ~li~~~l~~~p~~Rp~~~~l~~~~~ 264 (286)
T cd06622 240 DFVAKCLNKIPNRRPTYAQLLEHPW 264 (286)
T ss_pred HHHHHHcccCcccCCCHHHHhcChh
Confidence 9999999999999999999998743
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=288.82 Aligned_cols=233 Identities=20% Similarity=0.271 Sum_probs=192.1
Q ss_pred eecccCceeEEEEEeC-CCCEEEEEEeccCC-hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCCHH
Q 008785 276 LLGDSKTGGTYSGILP-DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 353 (553)
Q Consensus 276 ~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~ 353 (553)
.||+|+||.||+|... +++.||||.+.... ......+.+|+.++++++||||+++++++.+++..++||||+++++|.
T Consensus 11 ~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~ 90 (277)
T cd06641 11 KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSAL 90 (277)
T ss_pred eEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCCCCcHH
Confidence 4599999999999864 58899999987543 334567889999999999999999999999999999999999999999
Q ss_pred HHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccceeee
Q 008785 354 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVM 433 (553)
Q Consensus 354 ~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 433 (553)
+++.. ..+++..+..++.|++.|+.|||+. +++|+||+|+||+++.++.++|+|||++.......... ..
T Consensus 91 ~~i~~-----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~--~~ 160 (277)
T cd06641 91 DLLEP-----GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR--NT 160 (277)
T ss_pred HHHhc-----CCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccchhhh--cc
Confidence 99853 3588999999999999999999999 99999999999999999999999999987654332211 11
Q ss_pred cCccccccccccccCCCCCcccchHhHHHHHHHHhcCcc-cccch---HHHHHhcCCH-----HHHHHHHHHHhhccCCC
Q 008785 434 AGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVLC-RRWWT---LYTLVHSMSL-----LCAQECLMLFISCNNWP 504 (553)
Q Consensus 434 ~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~~-~~~~~---l~~~~~~~~~-----~~~~~l~~l~~~Cl~~d 504 (553)
..++..|+|||.+.+..++.++|+||||+++|+|++..+ ..... ....+..+.. ..+..+.+++.+||+.+
T Consensus 161 ~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~ 240 (277)
T cd06641 161 FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKE 240 (277)
T ss_pred ccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCCCCcccCHHHHHHHHHHccCC
Confidence 237889999999988888999999999999999998433 22221 1122222211 45678999999999999
Q ss_pred CCCCCCHHHHHHHH
Q 008785 505 SHLSQSKFCNLKLW 518 (553)
Q Consensus 505 P~~RPs~~evl~~l 518 (553)
|.+||++.+++++.
T Consensus 241 p~~Rp~~~~~l~~~ 254 (277)
T cd06641 241 PSFRPTAKELLKHK 254 (277)
T ss_pred hhhCcCHHHHHhCH
Confidence 99999999999974
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=291.90 Aligned_cols=234 Identities=20% Similarity=0.219 Sum_probs=186.5
Q ss_pred eeecccCceeEEEEEeC-CCCEEEEEEeccCC--hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCC
Q 008785 275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP 351 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gs 351 (553)
..||+|++|.||+|... +|+.||+|++.... ....+.+.+|+.++++++||||+++++++......++||||+++++
T Consensus 7 ~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~ 86 (286)
T cd07847 7 SKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTV 86 (286)
T ss_pred eeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEeccCccH
Confidence 34599999999999976 48999999986542 2234567899999999999999999999999999999999999998
Q ss_pred HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCccccccee
Q 008785 352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT 431 (553)
Q Consensus 352 L~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~ 431 (553)
|..++.. ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++...........
T Consensus 87 l~~~~~~----~~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~- 158 (286)
T cd07847 87 LNELEKN----PRGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYT- 158 (286)
T ss_pred HHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCCccccc-
Confidence 8887643 23589999999999999999999999 999999999999999999999999999987654322111
Q ss_pred eecCccccccccccccC-CCCCcccchHhHHHHHHHHhcCcc-cccchHHH---HHhc--C-------------------
Q 008785 432 VMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIRLVLC-RRWWTLYT---LVHS--M------------------- 485 (553)
Q Consensus 432 ~~~~gt~~y~aPE~~~~-~~~t~ksDVwSlGvil~ell~~~~-~~~~~l~~---~~~~--~------------------- 485 (553)
...++..|+|||++.+ ..++.++||||||+++|||++..+ .....-.+ .+.. +
T Consensus 159 -~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07847 159 -DYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGL 237 (286)
T ss_pred -CcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccc
Confidence 1127788999999876 457899999999999999997432 21111111 0000 0
Q ss_pred ---------CH-----HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008785 486 ---------SL-----LCAQECLMLFISCNNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 486 ---------~~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 517 (553)
.. ..+..+.+++.+||+.+|++|||+.|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 238 SIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred cCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 00 234668899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=294.75 Aligned_cols=240 Identities=19% Similarity=0.214 Sum_probs=189.4
Q ss_pred cCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCCh---hhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEE
Q 008785 270 FSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF---QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYE 345 (553)
Q Consensus 270 ~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 345 (553)
|.... .||+|+||.||++... +++.||+|.+..... ...+.+.+|+.+++.++||||+++++.+...+..++|||
T Consensus 3 y~~~~-~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (305)
T cd05609 3 FETIK-LISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVME 81 (305)
T ss_pred ceEee-EeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEe
Confidence 43433 4599999999999965 478999999876532 334678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcc
Q 008785 346 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE 425 (553)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~ 425 (553)
|+++++|.+++.. ...+++..+..++.|++.||.|||+. +++||||||+||++++++.++|+|||+++.....
T Consensus 82 ~~~g~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~ 154 (305)
T cd05609 82 YVEGGDCATLLKN----IGALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS 154 (305)
T ss_pred cCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence 9999999999964 24589999999999999999999999 9999999999999999999999999998642111
Q ss_pred ccc-------------ceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcCc-cccc---chHHHHHhcCCH-
Q 008785 426 VMQ-------------ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVL-CRRW---WTLYTLVHSMSL- 487 (553)
Q Consensus 426 ~~~-------------~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~-~~~~---~~l~~~~~~~~~- 487 (553)
... .......++..|+|||.+.+..++.++|+||||+++|||++.. |... ..+......+..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~ 234 (305)
T cd05609 155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIE 234 (305)
T ss_pred ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC
Confidence 000 0001123778899999998888999999999999999999732 3222 223332222211
Q ss_pred ------HHHHHHHHHHhhccCCCCCCCCCH---HHHHHH
Q 008785 488 ------LCAQECLMLFISCNNWPSHLSQSK---FCNLKL 517 (553)
Q Consensus 488 ------~~~~~l~~l~~~Cl~~dP~~RPs~---~evl~~ 517 (553)
..+..+.+++.+||+.||++||++ .+++++
T Consensus 235 ~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 235 WPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred CCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 356778999999999999999995 555544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=286.95 Aligned_cols=244 Identities=20% Similarity=0.263 Sum_probs=195.4
Q ss_pred ccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCC-hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEc
Q 008785 269 NFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF 346 (553)
Q Consensus 269 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 346 (553)
+|...+. ||.|++|.||+|... ++..+|+|++.... ....+.+.+|+..++.++||||+++++.+...+..++|||+
T Consensus 2 ~y~~~~~-lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 2 DYELIEV-IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred cceeeee-ecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 3444444 599999999999964 57899999987543 23567889999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCccc
Q 008785 347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV 426 (553)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 426 (553)
+++++|.+++.... ....+++..+..++.|++.||+|||+. +++||||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 81 LSGGSLLDIMKSSY-PRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGG 156 (267)
T ss_pred cCCCcHHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence 99999999996521 124589999999999999999999999 99999999999999999999999999987665433
Q ss_pred ccc--eeeecCccccccccccccCC-CCCcccchHhHHHHHHHHhcC-cccccch----HHHHHhcCCH---------HH
Q 008785 427 MQE--RTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIRLV-LCRRWWT----LYTLVHSMSL---------LC 489 (553)
Q Consensus 427 ~~~--~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwSlGvil~ell~~-~~~~~~~----l~~~~~~~~~---------~~ 489 (553)
... ......|+..|+|||++... .++.++|+||||+++|||++. .|..... +.+....... ..
T Consensus 157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (267)
T cd06610 157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKY 236 (267)
T ss_pred cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccccc
Confidence 221 11222378899999998877 789999999999999999983 3322221 1112221111 34
Q ss_pred HHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008785 490 AQECLMLFISCNNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 490 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 517 (553)
+..+.+++.+||..||++|||+.+++++
T Consensus 237 ~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 237 SKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred cHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 5778999999999999999999999874
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=320.95 Aligned_cols=245 Identities=27% Similarity=0.345 Sum_probs=204.0
Q ss_pred eecccCceeEEEEEeCC--------CCEEEEEEeccC-ChhhHHHHHHHHHHhhcc-CCCceeeEeeEEeeCCceEEEEE
Q 008785 276 LLGDSKTGGTYSGILPD--------GSRVAVKRLKRS-SFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYE 345 (553)
Q Consensus 276 ~iG~G~~g~Vy~~~~~~--------g~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E 345 (553)
.+|+|.||.|++|.... ...||||.++.. .....+.+..|+++|+.+ +||||+.++|+|...+..++|+|
T Consensus 303 ~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~~v~E 382 (609)
T KOG0200|consen 303 YLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLYVIVE 382 (609)
T ss_pred eeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceEEEEE
Confidence 67999999999998431 347999999865 334568899999999999 69999999999999999999999
Q ss_pred ccCCCCHHHHhccCC---CC-------C--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEE
Q 008785 346 FVVNGPLDRWLHHIP---RG-------G--RSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHL 413 (553)
Q Consensus 346 ~~~~gsL~~~l~~~~---~~-------~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl 413 (553)
|+..|+|.++|+..+ .. . ..++..+.+.++.|||.||+||++. ++|||||.++|||+.++..+||
T Consensus 383 y~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaRNVLi~~~~~~kI 459 (609)
T KOG0200|consen 383 YAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAARNVLITKNKVIKI 459 (609)
T ss_pred eccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---CccchhhhhhhEEecCCCEEEE
Confidence 999999999998754 00 1 2388999999999999999999999 9999999999999999999999
Q ss_pred eeccccccCCcccccceeeec-CccccccccccccCCCCCcccchHhHHHHHHHHhc--Ccccc----cchHHHHHhcCC
Q 008785 414 MGVGLSKFVPWEVMQERTVMA-GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL--VLCRR----WWTLYTLVHSMS 486 (553)
Q Consensus 414 ~Dfgla~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~--~~~~~----~~~l~~~~~~~~ 486 (553)
+|||+|+.............. .-+..|||||.+....|+.|||||||||+||||++ ..|.. ..++.+.++.|.
T Consensus 460 aDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~~l~~G~ 539 (609)
T KOG0200|consen 460 ADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLEFLKEGN 539 (609)
T ss_pred ccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHHHHhcCC
Confidence 999999976554433322111 02456999999999999999999999999999997 22332 334555666665
Q ss_pred H-----HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHh
Q 008785 487 L-----LCAQECLMLFISCNNWPSHLSQSKFCNLKLWVFAIL 523 (553)
Q Consensus 487 ~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~~~~ 523 (553)
. .+..++.++++.||+.+|++||++.|+.+.+...+.
T Consensus 540 r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~ 581 (609)
T KOG0200|consen 540 RMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ 581 (609)
T ss_pred CCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence 5 678899999999999999999999999999888654
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=292.81 Aligned_cols=239 Identities=21% Similarity=0.274 Sum_probs=195.1
Q ss_pred ccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEcc
Q 008785 269 NFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV 347 (553)
Q Consensus 269 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 347 (553)
+|.... .||+|+||.||++... ++..||+|.+........+.+.+|+.++++++||||+++++.+...+..++|+||+
T Consensus 20 ~~~~~~-~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 20 KYTRFE-KIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hceeee-EecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 454444 4599999999999854 58899999987655555678899999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccc
Q 008785 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM 427 (553)
Q Consensus 348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 427 (553)
++++|.+++.. ..+++..+..++.|++.||.|||++ +++||||||+||+++.++.++|+|||++........
T Consensus 99 ~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~ 170 (293)
T cd06647 99 AGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (293)
T ss_pred CCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence 99999999864 3478899999999999999999999 999999999999999999999999998875543322
Q ss_pred cceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcCc-ccccchHHH----HHhcCCH------HHHHHHHHH
Q 008785 428 QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVL-CRRWWTLYT----LVHSMSL------LCAQECLML 496 (553)
Q Consensus 428 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~-~~~~~~l~~----~~~~~~~------~~~~~l~~l 496 (553)
... ...+++.|+|||.+.+..++.++||||||+++||+++.. |....+... ....+.. ..+..+.++
T Consensus 171 ~~~--~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 248 (293)
T cd06647 171 KRS--TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDF 248 (293)
T ss_pred ccc--cccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHH
Confidence 111 123788999999998888999999999999999999733 322222111 1111111 345678999
Q ss_pred HhhccCCCCCCCCCHHHHHHHH
Q 008785 497 FISCNNWPSHLSQSKFCNLKLW 518 (553)
Q Consensus 497 ~~~Cl~~dP~~RPs~~evl~~l 518 (553)
+.+||..+|.+||++.+++++-
T Consensus 249 i~~~l~~~p~~Rp~~~~il~h~ 270 (293)
T cd06647 249 LNRCLEMDVEKRGSAKELLQHP 270 (293)
T ss_pred HHHHccCChhhCcCHHHHhcCH
Confidence 9999999999999999999884
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=292.31 Aligned_cols=232 Identities=21% Similarity=0.281 Sum_probs=189.7
Q ss_pred eecccCceeEEEEEeC-CCCEEEEEEeccCC-hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCCHH
Q 008785 276 LLGDSKTGGTYSGILP-DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 353 (553)
Q Consensus 276 ~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~ 353 (553)
.||+|+||.||++... +|+.||+|++.... ......+.+|+++++.++||||+++++.+...+..++||||+++++|.
T Consensus 12 ~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 91 (284)
T cd06620 12 DLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLD 91 (284)
T ss_pred HcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEecCCCCCHH
Confidence 4599999999999965 58899999887543 334578899999999999999999999999999999999999999999
Q ss_pred HHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccceee
Q 008785 354 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD-KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV 432 (553)
Q Consensus 354 ~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~ 432 (553)
+++.. ...+++..+..++.+++.||.|||+ . +++||||||+||++++++.++|+|||++........ .
T Consensus 92 ~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~---~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~~----~ 160 (284)
T cd06620 92 RIYKK----GGPIPVEILGKIAVAVVEGLTYLYNVH---RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIA----D 160 (284)
T ss_pred HHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHhc---CeeccCCCHHHEEECCCCcEEEccCCcccchhhhcc----C
Confidence 98864 2458999999999999999999996 5 899999999999999999999999999865432211 1
Q ss_pred ecCccccccccccccCCCCCcccchHhHHHHHHHHhcCc-ccccc-----------hHHH----HHhcC--CH---HHHH
Q 008785 433 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVL-CRRWW-----------TLYT----LVHSM--SL---LCAQ 491 (553)
Q Consensus 433 ~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~-~~~~~-----------~l~~----~~~~~--~~---~~~~ 491 (553)
...|+..|+|||++.+..++.++||||||+++||+++.. |.... .+.+ .+... .+ ..+.
T Consensus 161 ~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd06620 161 TFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPE 240 (284)
T ss_pred ccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCchhcCH
Confidence 223889999999998888999999999999999999722 22111 1111 11111 11 3566
Q ss_pred HHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008785 492 ECLMLFISCNNWPSHLSQSKFCNLKLW 518 (553)
Q Consensus 492 ~l~~l~~~Cl~~dP~~RPs~~evl~~l 518 (553)
.+.+++.+|++.||++|||+.|++++.
T Consensus 241 ~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 241 DLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred HHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 899999999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=282.25 Aligned_cols=246 Identities=19% Similarity=0.279 Sum_probs=203.1
Q ss_pred CHHHHHHhhcccCCCCeeecccCceeEEEEE-eCCCCEEEEEEeccCChhhHHHHHHHHHHhhcc-CCCceeeEeeEEee
Q 008785 259 TTEELRSITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYD 336 (553)
Q Consensus 259 ~~~el~~~~~~~~~~~~~iG~G~~g~Vy~~~-~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~ 336 (553)
+++++..++. ++||+|+++.|-.++ +.+|..||||++.+.....+.++.+|++++.+. .|+||++|+++|++
T Consensus 74 ~F~d~YkLt~------e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEd 147 (463)
T KOG0607|consen 74 KFEDMYKLTS------ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFED 147 (463)
T ss_pred hHHHHHHhHH------HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcc
Confidence 4678877774 467999999999887 668999999999988777888999999999999 59999999999999
Q ss_pred CCceEEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCC---eEE
Q 008785 337 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG---AHL 413 (553)
Q Consensus 337 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~---~kl 413 (553)
+...|||||-|.||+|..++++ ...+++.++..+..+|+.||.|||.+ ||.||||||+|||..+... +||
T Consensus 148 d~~FYLVfEKm~GGplLshI~~----~~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKi 220 (463)
T KOG0607|consen 148 DTRFYLVFEKMRGGPLLSHIQK----RKHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKI 220 (463)
T ss_pred cceEEEEEecccCchHHHHHHH----hhhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceee
Confidence 9999999999999999999875 35689999999999999999999999 9999999999999976543 799
Q ss_pred eeccccccCCcc-----cccceeeecCcccccccccccc-----CCCCCcccchHhHHHHHHHHhcCcccc---------
Q 008785 414 MGVGLSKFVPWE-----VMQERTVMAGGTYGYLAPEFVY-----RNELTTKSDVYSFGVLLLEIRLVLCRR--------- 474 (553)
Q Consensus 414 ~Dfgla~~~~~~-----~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDVwSlGvil~ell~~~~~~--------- 474 (553)
+||.+..-.... .......+..|+..|||||+.. ...|+.++|.||||||+|-|++..++.
T Consensus 221 CDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCG 300 (463)
T KOG0607|consen 221 CDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCG 300 (463)
T ss_pred eccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCC
Confidence 999887533221 1122223455899999999874 235899999999999999999622211
Q ss_pred ----------cchHHHHHhcCCH--------HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008785 475 ----------WWTLYTLVHSMSL--------LCAQECLMLFISCNNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 475 ----------~~~l~~~~~~~~~--------~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 517 (553)
...+.+.+.+|.. ..+.+..+++...+..||.+|.++.+++++
T Consensus 301 WdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnh 361 (463)
T KOG0607|consen 301 WDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNH 361 (463)
T ss_pred ccCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCC
Confidence 1234446677766 677788899999999999999999999985
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=286.71 Aligned_cols=240 Identities=23% Similarity=0.304 Sum_probs=187.1
Q ss_pred ccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCC-----hhhHHHHHHHHHHhhccCCCceeeEeeEEeeC--Cce
Q 008785 269 NFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS-----FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH--GDR 340 (553)
Q Consensus 269 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~-----~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~ 340 (553)
+|... ++||+|+||.||.|... +|+.||||.+.... ....+.+.+|+.++++++||||+++++++.+. ...
T Consensus 3 ~~~~~-~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 3 NWRLG-KLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred cceEe-eEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 44443 45699999999999965 48999999886321 22346788999999999999999999988764 457
Q ss_pred EEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccc
Q 008785 341 YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSK 420 (553)
Q Consensus 341 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~ 420 (553)
+++|||+++++|.+++... ..+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++.
T Consensus 82 ~~v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~ 154 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY----GALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASK 154 (265)
T ss_pred EEEEEecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCcccc
Confidence 8999999999999998642 3478888999999999999999999 99999999999999999999999999987
Q ss_pred cCCcccccc-eeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcCc-ccccch-HHH---HHhcCC---H--HH
Q 008785 421 FVPWEVMQE-RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVL-CRRWWT-LYT---LVHSMS---L--LC 489 (553)
Q Consensus 421 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~-~~~~~~-l~~---~~~~~~---~--~~ 489 (553)
......... ......++..|+|||++.+..++.++||||||+++|||++.. |..... ... ...... . ..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (265)
T cd06652 155 RLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHV 234 (265)
T ss_pred ccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhh
Confidence 654321111 111123788999999998888999999999999999999733 322211 111 111111 1 45
Q ss_pred HHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008785 490 AQECLMLFISCNNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 490 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 517 (553)
...+.+++.+|+. +|++||++.|++++
T Consensus 235 ~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 235 SDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred CHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 5678889999995 99999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=288.70 Aligned_cols=233 Identities=22% Similarity=0.323 Sum_probs=193.2
Q ss_pred eecccCceeEEEEEeC-CCCEEEEEEeccCC-hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCCHH
Q 008785 276 LLGDSKTGGTYSGILP-DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 353 (553)
Q Consensus 276 ~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~ 353 (553)
.||+|++|.||++... +++.||+|.+.... .....++.+|++++++++||||+++++.+...+..++++||+++++|.
T Consensus 8 ~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 87 (265)
T cd06605 8 ELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLD 87 (265)
T ss_pred HhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCCCcHH
Confidence 3599999999999976 58899999987653 344567899999999999999999999999999999999999999999
Q ss_pred HHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccceee
Q 008785 354 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD-KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV 432 (553)
Q Consensus 354 ~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~ 432 (553)
+++... ...+++..+..++.|++.||+|||+ . +++||||||+||++++++.++|+|||.+..........
T Consensus 88 ~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~--- 158 (265)
T cd06605 88 KILKEV---QGRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKT--- 158 (265)
T ss_pred HHHHHc---cCCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhhc---
Confidence 999752 2568899999999999999999999 8 99999999999999999999999999987654322211
Q ss_pred ecCccccccccccccCCCCCcccchHhHHHHHHHHhcC-cccccc-----hHHH---HHhcCC-H-----HHHHHHHHHH
Q 008785 433 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLV-LCRRWW-----TLYT---LVHSMS-L-----LCAQECLMLF 497 (553)
Q Consensus 433 ~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~-~~~~~~-----~l~~---~~~~~~-~-----~~~~~l~~l~ 497 (553)
..++..|+|||.+.+..++.++||||||+++|+|++. .|.... ...+ .+..+. . ..+..+.+++
T Consensus 159 -~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 237 (265)
T cd06605 159 -FVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDFV 237 (265)
T ss_pred -ccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHHHHHHH
Confidence 3388899999999888999999999999999999973 232221 2222 111111 1 2567899999
Q ss_pred hhccCCCCCCCCCHHHHHHHH
Q 008785 498 ISCNNWPSHLSQSKFCNLKLW 518 (553)
Q Consensus 498 ~~Cl~~dP~~RPs~~evl~~l 518 (553)
.+||..||++|||+.+++++-
T Consensus 238 ~~~l~~~p~~Rpt~~~ll~~~ 258 (265)
T cd06605 238 NLCLIKDPRERPSYKELLEHP 258 (265)
T ss_pred HHHcCCCchhCcCHHHHhhCc
Confidence 999999999999999999763
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=294.57 Aligned_cols=238 Identities=21% Similarity=0.226 Sum_probs=192.5
Q ss_pred eeecccCceeEEEEEeCC-CCEEEEEEeccCChh---hHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCC
Q 008785 275 RLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQ---RKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 350 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~~-g~~vAvK~~~~~~~~---~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 350 (553)
+.||+|++|.||++...+ ++.||+|.+...... ..+.+.+|+++++.++||||+++++.+.+....++||||+.++
T Consensus 7 ~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 86 (316)
T cd05574 7 KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGG 86 (316)
T ss_pred eeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEecCCC
Confidence 345999999999999764 899999999765322 4567889999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccc-
Q 008785 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE- 429 (553)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~- 429 (553)
+|.+++.. .....+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++..........
T Consensus 87 ~L~~~~~~--~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~ 161 (316)
T cd05574 87 ELFRLLQR--QPGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVS 161 (316)
T ss_pred CHHHHHHh--CCCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhcccccccccc
Confidence 99999864 2335689999999999999999999999 99999999999999999999999999987543221100
Q ss_pred --------------------------eeeecCccccccccccccCCCCCcccchHhHHHHHHHHhc-Ccccccch----H
Q 008785 430 --------------------------RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-VLCRRWWT----L 478 (553)
Q Consensus 430 --------------------------~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-~~~~~~~~----l 478 (553)
......|+..|+|||++.+..++.++||||||+++|+|++ ..|....+ +
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~ 241 (316)
T cd05574 162 KALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDETF 241 (316)
T ss_pred cccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHHHH
Confidence 0001137888999999998889999999999999999997 22322221 1
Q ss_pred HHHHhcCC-H----HHHHHHHHHHhhccCCCCCCCCC----HHHHHHH
Q 008785 479 YTLVHSMS-L----LCAQECLMLFISCNNWPSHLSQS----KFCNLKL 517 (553)
Q Consensus 479 ~~~~~~~~-~----~~~~~l~~l~~~Cl~~dP~~RPs----~~evl~~ 517 (553)
.+...... . ..+..+.+++.+||..||++||| +.|++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 242 SNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred HHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 11221111 1 35788999999999999999999 8888886
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=289.71 Aligned_cols=242 Identities=21% Similarity=0.271 Sum_probs=197.0
Q ss_pred hcccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEE
Q 008785 267 TKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYE 345 (553)
Q Consensus 267 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 345 (553)
.++|.... .+|+|++|.||+|... ++..||+|+++.... ....+.+|++.+++++||||+++++.+...+..++++|
T Consensus 18 ~~~~~~~~-~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 18 RELYKNLE-KIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred cccchHhH-hccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 34444444 4599999999999976 588999999986644 56778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcc
Q 008785 346 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE 425 (553)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~ 425 (553)
|+++++|.+++.... ..+++..+..++.|++.||.|||+. |++|+||+|+||+++.++.++|+|||++......
T Consensus 96 ~~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 169 (286)
T cd06614 96 YMDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE 169 (286)
T ss_pred ccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhccc
Confidence 999999999997521 3689999999999999999999999 9999999999999999999999999988755433
Q ss_pred cccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcCc-ccccchHHH---HH-hcCCH------HHHHHHH
Q 008785 426 VMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVL-CRRWWTLYT---LV-HSMSL------LCAQECL 494 (553)
Q Consensus 426 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~-~~~~~~l~~---~~-~~~~~------~~~~~l~ 494 (553)
.... ....++..|+|||.+.+..++.++||||||+++|+|++.. |........ .+ ..+.. ..+..+.
T Consensus 170 ~~~~--~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 247 (286)
T cd06614 170 KSKR--NSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFK 247 (286)
T ss_pred hhhh--ccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHH
Confidence 2111 1122778999999998888999999999999999999733 322222111 11 11111 2567899
Q ss_pred HHHhhccCCCCCCCCCHHHHHHHH
Q 008785 495 MLFISCNNWPSHLSQSKFCNLKLW 518 (553)
Q Consensus 495 ~l~~~Cl~~dP~~RPs~~evl~~l 518 (553)
+++.+|++.+|.+|||+.+++++-
T Consensus 248 ~li~~~l~~~p~~Rpt~~~il~~~ 271 (286)
T cd06614 248 DFLNKCLVKDPEKRPSAEELLQHP 271 (286)
T ss_pred HHHHHHhccChhhCcCHHHHhhCh
Confidence 999999999999999999999854
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=291.70 Aligned_cols=232 Identities=21% Similarity=0.236 Sum_probs=193.0
Q ss_pred eeecccCceeEEEEEeC-CCCEEEEEEeccCC---hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCC
Q 008785 275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 350 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 350 (553)
+.||+|++|.||++... +++.||+|.++... ....+.+.+|++++++++||||+++++++.+.+..++||||++++
T Consensus 7 ~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~ 86 (290)
T cd05580 7 KTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGG 86 (290)
T ss_pred EEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEecCCCC
Confidence 45699999999999965 58999999987542 234567889999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccce
Q 008785 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER 430 (553)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 430 (553)
+|.+++.. ...+++..+..++.|++.||.|||+. +++||||+|+||++++++.+||+|||++......
T Consensus 87 ~L~~~~~~----~~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~----- 154 (290)
T cd05580 87 ELFSHLRK----SGRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR----- 154 (290)
T ss_pred CHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-----
Confidence 99999864 24689999999999999999999999 9999999999999999999999999999876543
Q ss_pred eeecCccccccccccccCCCCCcccchHhHHHHHHHHhcCc-ccccch---HHHHHhcCCH----HHHHHHHHHHhhccC
Q 008785 431 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVL-CRRWWT---LYTLVHSMSL----LCAQECLMLFISCNN 502 (553)
Q Consensus 431 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~-~~~~~~---l~~~~~~~~~----~~~~~l~~l~~~Cl~ 502 (553)
.....+++.|+|||.+.+...+.++||||||+++|+|++.. |....+ ..+.+..+.. ..+..+.+++.+||.
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 234 (290)
T cd05580 155 TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKDLIRNLLQ 234 (290)
T ss_pred CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCCccCCHHHHHHHHHHcc
Confidence 11223889999999998888899999999999999999732 322222 2222223332 446788999999999
Q ss_pred CCCCCCC-----CHHHHHHHH
Q 008785 503 WPSHLSQ-----SKFCNLKLW 518 (553)
Q Consensus 503 ~dP~~RP-----s~~evl~~l 518 (553)
.||.+|| ++.|++++-
T Consensus 235 ~~p~~R~~~~~~~~~~l~~~~ 255 (290)
T cd05580 235 VDLTKRLGNLKNGVNDIKNHP 255 (290)
T ss_pred CCHHHccCcccCCHHHHHcCc
Confidence 9999999 888888653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=286.94 Aligned_cols=236 Identities=20% Similarity=0.291 Sum_probs=191.4
Q ss_pred eeecccCceeEEEEEeC-CCCEEEEEEeccCC--hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCC
Q 008785 275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP 351 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gs 351 (553)
+.||+|+||.||++... +|..||+|.+.... ....+.+.+|+.++++++||||+++++.+.+.+..++|+||+++++
T Consensus 6 ~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 85 (257)
T cd08225 6 KKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGD 85 (257)
T ss_pred EEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCCCCc
Confidence 34699999999999975 48899999986542 2345678899999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCC-CeEEeeccccccCCcccccce
Q 008785 352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF-GAHLMGVGLSKFVPWEVMQER 430 (553)
Q Consensus 352 L~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~-~~kl~Dfgla~~~~~~~~~~~ 430 (553)
|.+++.. .....+++..+..++.|++.||.|||+. +++|+||||+||++++++ .+||+|||.+..........
T Consensus 86 L~~~~~~--~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~- 159 (257)
T cd08225 86 LMKRINR--QRGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELA- 159 (257)
T ss_pred HHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCCcccc-
Confidence 9999865 2234579999999999999999999999 999999999999999885 46999999987664332211
Q ss_pred eeecCccccccccccccCCCCCcccchHhHHHHHHHHhcC-cccccchHHH---HHhcCCH-----HHHHHHHHHHhhcc
Q 008785 431 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLV-LCRRWWTLYT---LVHSMSL-----LCAQECLMLFISCN 501 (553)
Q Consensus 431 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~-~~~~~~~l~~---~~~~~~~-----~~~~~l~~l~~~Cl 501 (553)
....|++.|+|||++.+..++.++|+||||+++|||++. .|.......+ ....+.. ..+..+.+++.+|+
T Consensus 160 -~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 238 (257)
T cd08225 160 -YTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLISQLF 238 (257)
T ss_pred -cccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCCCCCCCCHHHHHHHHHHh
Confidence 122388899999999888899999999999999999973 3332222222 1112211 34667999999999
Q ss_pred CCCCCCCCCHHHHHHH
Q 008785 502 NWPSHLSQSKFCNLKL 517 (553)
Q Consensus 502 ~~dP~~RPs~~evl~~ 517 (553)
..+|++|||+.|++++
T Consensus 239 ~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 239 KVSPRDRPSITSILKR 254 (257)
T ss_pred ccChhhCcCHHHHhhC
Confidence 9999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=283.88 Aligned_cols=234 Identities=23% Similarity=0.334 Sum_probs=196.2
Q ss_pred eeecccCceeEEEEEeCC-CCEEEEEEeccCCh-hhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCCH
Q 008785 275 RLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSF-QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~~-g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL 352 (553)
+.||+|++|.||++...+ ++.||||++..... .....+.+|+..+.+++||||+++++++...+..++||||+++++|
T Consensus 7 ~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 86 (264)
T cd06623 7 KVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGSL 86 (264)
T ss_pred eeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCCCcH
Confidence 456999999999999764 89999999987644 4567899999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCceecCCCCCcEEecCCCCeEEeeccccccCCccccccee
Q 008785 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD-KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT 431 (553)
Q Consensus 353 ~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~ 431 (553)
.+++... ..+++..+..++.|++.||+|||+ . +++||||+|+||+++.++.++|+|||.+...........
T Consensus 87 ~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~- 158 (264)
T cd06623 87 ADLLKKV----GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCN- 158 (264)
T ss_pred HHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccCCCccc-
Confidence 9999642 568999999999999999999999 8 999999999999999999999999999986654332221
Q ss_pred eecCccccccccccccCCCCCcccchHhHHHHHHHHhcC-cccccc------hHHHHHhcCCH-----H-HHHHHHHHHh
Q 008785 432 VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLV-LCRRWW------TLYTLVHSMSL-----L-CAQECLMLFI 498 (553)
Q Consensus 432 ~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~-~~~~~~------~l~~~~~~~~~-----~-~~~~l~~l~~ 498 (553)
...++..|+|||.+.+..++.++|+||||+++|||++. .|.... .+...+..... . .+..+.+++.
T Consensus 159 -~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 237 (264)
T cd06623 159 -TFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFIS 237 (264)
T ss_pred -ceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHHHHHHH
Confidence 12278899999999888899999999999999999973 332222 22222222221 3 5778999999
Q ss_pred hccCCCCCCCCCHHHHHHH
Q 008785 499 SCNNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 499 ~Cl~~dP~~RPs~~evl~~ 517 (553)
+||+.+|++|||+.|++++
T Consensus 238 ~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 238 ACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred HHccCChhhCCCHHHHHhC
Confidence 9999999999999999987
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=290.79 Aligned_cols=239 Identities=21% Similarity=0.303 Sum_probs=187.1
Q ss_pred cCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCC--hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEc
Q 008785 270 FSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF 346 (553)
Q Consensus 270 ~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 346 (553)
|..... ||+|++|.||+|+.. +|+.||||.++... ......+.+|++++++++||||+++++++.+.+..++||||
T Consensus 2 y~~~~~-l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 2 FQKVEK-IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred ceeeee-ecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 334344 499999999999875 58999999987542 22345788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCccc
Q 008785 347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV 426 (553)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 426 (553)
+. ++|.+++... ....+++..+..++.|++.||+|||+. +++||||+|+||++++++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~--~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~ 154 (284)
T cd07860 81 LH-QDLKKFMDAS--PLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 154 (284)
T ss_pred cc-cCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCc
Confidence 95 6899888652 335689999999999999999999999 99999999999999999999999999987654322
Q ss_pred ccceeeecCccccccccccccCCC-CCcccchHhHHHHHHHHhcCc-ccccch----HHHHHhc----------------
Q 008785 427 MQERTVMAGGTYGYLAPEFVYRNE-LTTKSDVYSFGVLLLEIRLVL-CRRWWT----LYTLVHS---------------- 484 (553)
Q Consensus 427 ~~~~~~~~~gt~~y~aPE~~~~~~-~t~ksDVwSlGvil~ell~~~-~~~~~~----l~~~~~~---------------- 484 (553)
... ....+++.|+|||++.+.. ++.++||||||+++|||++.. +....+ +...+..
T Consensus 155 ~~~--~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07860 155 RTY--THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLP 232 (284)
T ss_pred ccc--ccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHH
Confidence 111 1112678899999887644 588999999999999999733 221111 1111100
Q ss_pred -----------CCH-----HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008785 485 -----------MSL-----LCAQECLMLFISCNNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 485 -----------~~~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 517 (553)
..+ ..+..+.+++.+|++.||++|||+.+++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 233 DYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred HHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 000 234567889999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=292.68 Aligned_cols=234 Identities=18% Similarity=0.187 Sum_probs=184.4
Q ss_pred eeecccCceeEEEEEeC-CCCEEEEEEeccCCh--hhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCC
Q 008785 275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF--QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP 351 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gs 351 (553)
+.||+|++|.||++... +|+.||+|.++.... .....+.+|+.++++++||||+++++++.+.+..++|+||++ ++
T Consensus 6 ~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~ 84 (284)
T cd07839 6 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCD-QD 84 (284)
T ss_pred EEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecCC-CC
Confidence 34699999999999975 589999999875422 223567889999999999999999999999999999999996 58
Q ss_pred HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCccccccee
Q 008785 352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT 431 (553)
Q Consensus 352 L~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~ 431 (553)
|.+++.. ....+++..+..++.||+.||.|||+. +++||||||+||+++.++.+||+|||+++.........
T Consensus 85 l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~-- 156 (284)
T cd07839 85 LKKYFDS---CNGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCY-- 156 (284)
T ss_pred HHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCc--
Confidence 8887754 234589999999999999999999999 99999999999999999999999999997654322111
Q ss_pred eecCccccccccccccCC-CCCcccchHhHHHHHHHHhc-Cccc-ccchHHH----HHh---c---------------C-
Q 008785 432 VMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIRL-VLCR-RWWTLYT----LVH---S---------------M- 485 (553)
Q Consensus 432 ~~~~gt~~y~aPE~~~~~-~~t~ksDVwSlGvil~ell~-~~~~-~~~~l~~----~~~---~---------------~- 485 (553)
....+++.|+|||++.+. .++.++||||||+++|||++ ..|. ...+..+ ... . .
T Consensus 157 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07839 157 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKP 236 (284)
T ss_pred CCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccc
Confidence 112268899999998764 46899999999999999997 2221 1111110 000 0 0
Q ss_pred -------------CHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008785 486 -------------SLLCAQECLMLFISCNNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 486 -------------~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 517 (553)
....+..+.+++.+||+.||.+|||+.|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 237 YPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred cCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 00235678899999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=297.90 Aligned_cols=237 Identities=17% Similarity=0.172 Sum_probs=191.1
Q ss_pred CeeecccCceeEEEEEeCCCCEEEEEEecc--CChhhHHHHHHHHHHhhcc-CCCceeeEeeEEeeCCceEEEEEccCCC
Q 008785 274 NRLLGDSKTGGTYSGILPDGSRVAVKRLKR--SSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNG 350 (553)
Q Consensus 274 ~~~iG~G~~g~Vy~~~~~~g~~vAvK~~~~--~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~~g 350 (553)
-+.||+||.+.||++...+.+.||+|++.. .+....+-|.+|+..|.+| .|.+||++++|-..++.+|+||||= ..
T Consensus 366 lk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~G-d~ 444 (677)
T KOG0596|consen 366 LKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMECG-DI 444 (677)
T ss_pred HHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeecc-cc
Confidence 345699999999999998889999998754 3556678899999999999 5999999999999999999999976 67
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccce
Q 008785 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER 430 (553)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 430 (553)
+|.++|+.. . ..++.-.++.+..|++.++.++|.. ||||.||||.|+|+-. |.+||+|||+|..+..+.....
T Consensus 445 DL~kiL~k~--~-~~~~~~~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DTTsI~ 517 (677)
T KOG0596|consen 445 DLNKILKKK--K-SIDPDWFLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDTTSIV 517 (677)
T ss_pred cHHHHHHhc--c-CCCchHHHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEe-eeEEeeeechhcccCcccccee
Confidence 999999862 2 2233237888999999999999999 9999999999999976 6899999999998887766655
Q ss_pred eeecCccccccccccccCC-----------CCCcccchHhHHHHHHHHhcCcccccc--hHHH---HHhcC-------CH
Q 008785 431 TVMAGGTYGYLAPEFVYRN-----------ELTTKSDVYSFGVLLLEIRLVLCRRWW--TLYT---LVHSM-------SL 487 (553)
Q Consensus 431 ~~~~~gt~~y~aPE~~~~~-----------~~t~ksDVwSlGvil~ell~~~~~~~~--~l~~---~~~~~-------~~ 487 (553)
.....||+.||+||.+... ..+.+|||||+|||||+|+-..++... +... .+... ..
T Consensus 518 kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~Iefp~~ 597 (677)
T KOG0596|consen 518 KDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEIEFPDI 597 (677)
T ss_pred eccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCccccccCC
Confidence 5556699999999998532 256789999999999999963333221 1222 22221 11
Q ss_pred HHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008785 488 LCAQECLMLFISCNNWPSHLSQSKFCNLKLW 518 (553)
Q Consensus 488 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l 518 (553)
....++.++++.||.+||++|||+.++|++-
T Consensus 598 ~~~~~li~~mK~CL~rdPkkR~si~eLLqhp 628 (677)
T KOG0596|consen 598 PENDELIDVMKCCLARDPKKRWSIPELLQHP 628 (677)
T ss_pred CCchHHHHHHHHHHhcCcccCCCcHHHhcCc
Confidence 3333499999999999999999999999864
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=287.06 Aligned_cols=233 Identities=19% Similarity=0.273 Sum_probs=190.0
Q ss_pred eecccCceeEEEEEe-CCCCEEEEEEeccC-ChhhHHHHHHHHHHhhccC---CCceeeEeeEEeeCCceEEEEEccCCC
Q 008785 276 LLGDSKTGGTYSGIL-PDGSRVAVKRLKRS-SFQRKKEFYSEIGRFARLH---HPNLVAVKGCCYDHGDRYIVYEFVVNG 350 (553)
Q Consensus 276 ~iG~G~~g~Vy~~~~-~~g~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~---HpnIv~l~~~~~~~~~~~lV~E~~~~g 350 (553)
.||+|+||.||+|.. .+++.||+|.++.. ......++.+|+.++++++ |||++++++++.+....++||||++++
T Consensus 8 ~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~~~~~ 87 (277)
T cd06917 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGG 87 (277)
T ss_pred heeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEecCCCC
Confidence 459999999999996 46899999998754 2344567889999999996 999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccce
Q 008785 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER 430 (553)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 430 (553)
+|.+++.. ..+++..+..++.|++.||.|||+. +++||||+|+||++++++.++|+|||++..........
T Consensus 88 ~L~~~~~~-----~~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~- 158 (277)
T cd06917 88 SVRTLMKA-----GPIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKR- 158 (277)
T ss_pred cHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcccc-
Confidence 99999854 2689999999999999999999999 99999999999999999999999999998765433221
Q ss_pred eeecCccccccccccccCC-CCCcccchHhHHHHHHHHhcCc-ccccchHHH---HHhcCCH------HHHHHHHHHHhh
Q 008785 431 TVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIRLVL-CRRWWTLYT---LVHSMSL------LCAQECLMLFIS 499 (553)
Q Consensus 431 ~~~~~gt~~y~aPE~~~~~-~~t~ksDVwSlGvil~ell~~~-~~~~~~l~~---~~~~~~~------~~~~~l~~l~~~ 499 (553)
....|+..|+|||.+.++ .++.++||||||+++|+|++.. |........ .+..... ..+..+.+++.+
T Consensus 159 -~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 237 (277)
T cd06917 159 -STFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREFVAA 237 (277)
T ss_pred -ccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCCcccCCHHHHHHHHH
Confidence 122388899999988654 4689999999999999999733 322222222 1111111 256789999999
Q ss_pred ccCCCCCCCCCHHHHHHHH
Q 008785 500 CNNWPSHLSQSKFCNLKLW 518 (553)
Q Consensus 500 Cl~~dP~~RPs~~evl~~l 518 (553)
||+.||++||++.+++++-
T Consensus 238 ~l~~~p~~R~~~~~il~~~ 256 (277)
T cd06917 238 CLDEEPKERLSAEELLKSK 256 (277)
T ss_pred HcCCCcccCcCHHHHhhCh
Confidence 9999999999999999863
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=315.46 Aligned_cols=250 Identities=18% Similarity=0.177 Sum_probs=182.9
Q ss_pred hhcccCCCCeeecccCceeEEEEEeCC--CCEEEEE------------------EeccCChhhHHHHHHHHHHhhccCCC
Q 008785 266 ITKNFSEGNRLLGDSKTGGTYSGILPD--GSRVAVK------------------RLKRSSFQRKKEFYSEIGRFARLHHP 325 (553)
Q Consensus 266 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~--g~~vAvK------------------~~~~~~~~~~~~~~~E~~~l~~l~Hp 325 (553)
...+|....+| |+|+||+||++..+. +..+++| .++. .......+.+|+.+|++++||
T Consensus 146 ~~~~Y~ii~~L-G~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~-~~~~~~~~~~Ei~il~~l~Hp 223 (501)
T PHA03210 146 FLAHFRVIDDL-PAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKA-GSRAAIQLENEILALGRLNHE 223 (501)
T ss_pred hhhccEEEeEe-cCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhc-chHHHHHHHHHHHHHHhCCCC
Confidence 44566665555 999999999987532 2222222 1111 122345688999999999999
Q ss_pred ceeeEeeEEeeCCceEEEEEccCCCCHHHHhccCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEE
Q 008785 326 NLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIP-RGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 404 (553)
Q Consensus 326 nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~-~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NIL 404 (553)
||+++++++.+.+..|+|+|++ +++|.+++.... ..........+..++.||+.||.|||++ +|+||||||+|||
T Consensus 224 nIv~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NIL 299 (501)
T PHA03210 224 NILKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIF 299 (501)
T ss_pred CcCcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEE
Confidence 9999999999999999999998 457777765321 1122234567788999999999999999 9999999999999
Q ss_pred ecCCCCeEEeeccccccCCcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcCc--ccc------cc
Q 008785 405 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVL--CRR------WW 476 (553)
Q Consensus 405 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~--~~~------~~ 476 (553)
++.++.+||+|||+++........... ...||+.|+|||++.+..++.++|||||||++|||++.. +.. ..
T Consensus 300 l~~~~~vkL~DFGla~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~ 378 (501)
T PHA03210 300 LNCDGKIVLGDFGTAMPFEKEREAFDY-GWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGK 378 (501)
T ss_pred ECCCCCEEEEeCCCceecCcccccccc-cccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHH
Confidence 999999999999999866543222111 123899999999999999999999999999999999622 111 11
Q ss_pred hHHHHHh---------------------cCCH--------------HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 008785 477 TLYTLVH---------------------SMSL--------------LCAQECLMLFISCNNWPSHLSQSKFCNLKLWVFA 521 (553)
Q Consensus 477 ~l~~~~~---------------------~~~~--------------~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~~ 521 (553)
.+.+.+. .... ..+..+.+++.+||+.||++|||+.|+|++-.+.
T Consensus 379 ~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~ 458 (501)
T PHA03210 379 QLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFS 458 (501)
T ss_pred HHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhh
Confidence 1111111 0000 1234567778999999999999999999875554
Q ss_pred H
Q 008785 522 I 522 (553)
Q Consensus 522 ~ 522 (553)
.
T Consensus 459 ~ 459 (501)
T PHA03210 459 A 459 (501)
T ss_pred c
Confidence 3
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=289.08 Aligned_cols=239 Identities=19% Similarity=0.226 Sum_probs=185.2
Q ss_pred ccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCCh-hhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEc
Q 008785 269 NFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF-QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF 346 (553)
Q Consensus 269 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 346 (553)
+|... +.||+|++|.||+|..+ +++.||||.+..... .....+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 6 ~y~~~-~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 6 TYKKL-DKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred ceeEE-EEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 34443 34599999999999975 589999999875432 2234577899999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCccc
Q 008785 347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV 426 (553)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 426 (553)
+. ++|.+++.. ....+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||+++......
T Consensus 85 ~~-~~L~~~~~~---~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 157 (291)
T cd07844 85 LD-TDLKQYMDD---CGGGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPS 157 (291)
T ss_pred CC-CCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCC
Confidence 97 599998864 223688999999999999999999999 99999999999999999999999999987543221
Q ss_pred ccceeeecCccccccccccccC-CCCCcccchHhHHHHHHHHhcCc-ccccch-HHH----HHh---c------------
Q 008785 427 MQERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIRLVL-CRRWWT-LYT----LVH---S------------ 484 (553)
Q Consensus 427 ~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwSlGvil~ell~~~-~~~~~~-l~~----~~~---~------------ 484 (553)
... ....++..|+|||++.+ ..++.++||||||+++|||++.. +..... ..+ ..+ .
T Consensus 158 ~~~--~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (291)
T cd07844 158 KTY--SNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSN 235 (291)
T ss_pred ccc--cccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhc
Confidence 111 11126788999998865 45789999999999999999732 221111 000 000 0
Q ss_pred -------------C-------CHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008785 485 -------------M-------SLLCAQECLMLFISCNNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 485 -------------~-------~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 517 (553)
. .......+.+++.+|++.+|++|||+.|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 236 PEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred cccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 0 00112667899999999999999999998864
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=292.35 Aligned_cols=234 Identities=23% Similarity=0.211 Sum_probs=186.2
Q ss_pred eeecccCceeEEEEEeC-CCCEEEEEEeccCCh--hhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCC
Q 008785 275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF--QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP 351 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gs 351 (553)
+.||+|+||.||+|... +++.||+|.+..... ...+.+.+|+++++.++||||+++++++.+.+..++||||+++++
T Consensus 7 ~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 86 (286)
T cd07846 7 GLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTV 86 (286)
T ss_pred eeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecCCccH
Confidence 34599999999999976 489999999865422 234678899999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCccccccee
Q 008785 352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT 431 (553)
Q Consensus 352 L~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~ 431 (553)
|..+... ...+++..+..++.||+.||+|||+. +++||||+|+||++++++.++|+|||++...........
T Consensus 87 l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~- 158 (286)
T cd07846 87 LDDLEKY----PNGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYT- 158 (286)
T ss_pred HHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccccC-
Confidence 9887643 23489999999999999999999999 999999999999999999999999999876544322111
Q ss_pred eecCccccccccccccC-CCCCcccchHhHHHHHHHHhcCcccc-cchHHH----HH--------------hcCC-----
Q 008785 432 VMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIRLVLCRR-WWTLYT----LV--------------HSMS----- 486 (553)
Q Consensus 432 ~~~~gt~~y~aPE~~~~-~~~t~ksDVwSlGvil~ell~~~~~~-~~~l~~----~~--------------~~~~----- 486 (553)
...++..|+|||++.+ ..++.++||||||+++|||++..+.. .....+ .. ....
T Consensus 159 -~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07846 159 -DYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGM 237 (286)
T ss_pred -cccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhcc
Confidence 1227889999999875 34788999999999999999743221 111110 00 0000
Q ss_pred ---------------HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008785 487 ---------------LLCAQECLMLFISCNNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 487 ---------------~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 517 (553)
...+..+.+++.+||+.+|++||++.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 238 RLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred ccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 0235678999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=285.99 Aligned_cols=236 Identities=19% Similarity=0.293 Sum_probs=189.9
Q ss_pred eeecccCceeEEEEEe-CCCCEEEEEEeccCC------hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEcc
Q 008785 275 RLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSS------FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV 347 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~-~~g~~vAvK~~~~~~------~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 347 (553)
++||+|++|.||++.. .+++.||+|.++... ....+.+.+|+.++++++||||+++++++.+.+..++|+||+
T Consensus 6 ~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~ 85 (268)
T cd06630 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWM 85 (268)
T ss_pred ceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEEecc
Confidence 3559999999999985 468999999987532 123467899999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCC-CeEEeeccccccCCccc
Q 008785 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF-GAHLMGVGLSKFVPWEV 426 (553)
Q Consensus 348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~-~~kl~Dfgla~~~~~~~ 426 (553)
++++|.+++.. ...+++..+..++.|++.||.|||++ +++||||+|+||+++.++ .++|+|||.+.......
T Consensus 86 ~~~~L~~~l~~----~~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~ 158 (268)
T cd06630 86 AGGSVSHLLSK----YGAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKG 158 (268)
T ss_pred CCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccccccccccccc
Confidence 99999999864 23588999999999999999999999 999999999999998775 58999999987665432
Q ss_pred ccce--eeecCccccccccccccCCCCCcccchHhHHHHHHHHhcCc-ccccch---HHHHH-h----c--CCH--HHHH
Q 008785 427 MQER--TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVL-CRRWWT---LYTLV-H----S--MSL--LCAQ 491 (553)
Q Consensus 427 ~~~~--~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~-~~~~~~---l~~~~-~----~--~~~--~~~~ 491 (553)
.... .....++..|+|||.+.+..++.++||||+|+++++|++.. |..... ....+ . . ... ..+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (268)
T cd06630 159 TGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSP 238 (268)
T ss_pred ccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhCH
Confidence 1111 11123788999999998888999999999999999999733 222111 11111 1 1 111 4567
Q ss_pred HHHHHHhhccCCCCCCCCCHHHHHHH
Q 008785 492 ECLMLFISCNNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 492 ~l~~l~~~Cl~~dP~~RPs~~evl~~ 517 (553)
.+.+++.+|+..+|++|||+.+++++
T Consensus 239 ~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 239 GLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred HHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 89999999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=290.97 Aligned_cols=234 Identities=19% Similarity=0.220 Sum_probs=187.3
Q ss_pred eecccCceeEEEEEeC-CCCEEEEEEeccCChh-----hHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCC
Q 008785 276 LLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQ-----RKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 349 (553)
Q Consensus 276 ~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~~-----~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 349 (553)
.||+|++|.||+|... +|+.||||.++..... ....+.+|+.++++++||||+++++++.+.+..++||||+ +
T Consensus 7 ~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~ 85 (298)
T cd07841 7 KLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFEFM-E 85 (298)
T ss_pred eeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEEccc-C
Confidence 4699999999999965 5899999999765332 2355778999999999999999999999999999999999 9
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccc
Q 008785 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE 429 (553)
Q Consensus 350 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 429 (553)
|+|.+++... ...+++..+..++.||++||.|||++ +++||||||+||+++.++.++|+|||++..........
T Consensus 86 ~~L~~~i~~~---~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~ 159 (298)
T cd07841 86 TDLEKVIKDK---SIVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKM 159 (298)
T ss_pred CCHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeeccCCCccc
Confidence 9999999642 23689999999999999999999999 99999999999999999999999999997665432211
Q ss_pred eeeecCccccccccccccC-CCCCcccchHhHHHHHHHHhcCcccc----cchHHH-HHhc-C-----------------
Q 008785 430 RTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIRLVLCRR----WWTLYT-LVHS-M----------------- 485 (553)
Q Consensus 430 ~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwSlGvil~ell~~~~~~----~~~l~~-~~~~-~----------------- 485 (553)
. ...+++.|+|||.+.+ ..++.++||||||+++|||++..+.. ...... .... +
T Consensus 160 ~--~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (298)
T cd07841 160 T--HQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYV 237 (298)
T ss_pred c--ccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccc
Confidence 1 1126778999998854 45789999999999999999743321 111111 1000 0
Q ss_pred ------C-------HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008785 486 ------S-------LLCAQECLMLFISCNNWPSHLSQSKFCNLKLW 518 (553)
Q Consensus 486 ------~-------~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l 518 (553)
. ...+..+.+++.+||+.||++|||+.|++++-
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~ 283 (298)
T cd07841 238 EFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHP 283 (298)
T ss_pred cccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCc
Confidence 0 02356788999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=279.12 Aligned_cols=233 Identities=24% Similarity=0.329 Sum_probs=194.5
Q ss_pred eecccCceeEEEEEeC-CCCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCCHHH
Q 008785 276 LLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR 354 (553)
Q Consensus 276 ~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~ 354 (553)
.||+|++|.||++... +++.|++|++..........+.+|+..+++++||||+++++++......++++||+++++|.+
T Consensus 7 ~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~ 86 (253)
T cd05122 7 KIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKD 86 (253)
T ss_pred eeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCCcHHH
Confidence 4599999999999975 688999999987655566789999999999999999999999999999999999999999999
Q ss_pred HhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccceeeec
Q 008785 355 WLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA 434 (553)
Q Consensus 355 ~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 434 (553)
++... ...+++..+..++.|++.||.|||+. +++||||+|+||++++++.++|+|||.+........ ....
T Consensus 87 ~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~~~~ 157 (253)
T cd05122 87 LLKST---NQTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---RNTM 157 (253)
T ss_pred HHhhc---CCCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc---ccce
Confidence 98652 24689999999999999999999998 999999999999999999999999999987654432 1122
Q ss_pred CccccccccccccCCCCCcccchHhHHHHHHHHhcCc-ccccchHHH---HHhcCCH-------HHHHHHHHHHhhccCC
Q 008785 435 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVL-CRRWWTLYT---LVHSMSL-------LCAQECLMLFISCNNW 503 (553)
Q Consensus 435 ~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~-~~~~~~l~~---~~~~~~~-------~~~~~l~~l~~~Cl~~ 503 (553)
.++..|+|||.+....++.++||||||+++++|++.. |....+..+ ....... ..+..+.+++.+||+.
T Consensus 158 ~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 237 (253)
T cd05122 158 VGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKCLQK 237 (253)
T ss_pred ecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHHHHHHHHccC
Confidence 3788999999998888999999999999999999733 322221111 1111111 2267899999999999
Q ss_pred CCCCCCCHHHHHHH
Q 008785 504 PSHLSQSKFCNLKL 517 (553)
Q Consensus 504 dP~~RPs~~evl~~ 517 (553)
||++|||+.|++++
T Consensus 238 ~p~~R~t~~~~l~~ 251 (253)
T cd05122 238 NPEKRPTAEQLLKH 251 (253)
T ss_pred ChhhCCCHHHHhcC
Confidence 99999999999864
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=289.91 Aligned_cols=240 Identities=22% Similarity=0.286 Sum_probs=191.2
Q ss_pred cCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCC---hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEE
Q 008785 270 FSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYE 345 (553)
Q Consensus 270 ~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 345 (553)
|...+. ||+|+||.||++... ++..||+|.+.... ......+.+|++++++++|||++++++++.+....++|||
T Consensus 27 f~~~~~-lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 27 FTDLRE-IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhe-eccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 333344 599999999999964 58899999987432 2334678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcc
Q 008785 346 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE 425 (553)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~ 425 (553)
|+. |+|.+.+.. ....+++.++..++.|++.||.|||+. +++||||+|+||+++.++.++|+|||++......
T Consensus 106 ~~~-g~l~~~~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (317)
T cd06635 106 YCL-GSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA 178 (317)
T ss_pred CCC-CCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCCc
Confidence 996 578777753 234589999999999999999999999 9999999999999999999999999998754432
Q ss_pred cccceeeecCcccccccccccc---CCCCCcccchHhHHHHHHHHhcCcc-cccch---HHH-HHhcCCH-----HHHHH
Q 008785 426 VMQERTVMAGGTYGYLAPEFVY---RNELTTKSDVYSFGVLLLEIRLVLC-RRWWT---LYT-LVHSMSL-----LCAQE 492 (553)
Q Consensus 426 ~~~~~~~~~~gt~~y~aPE~~~---~~~~t~ksDVwSlGvil~ell~~~~-~~~~~---l~~-~~~~~~~-----~~~~~ 492 (553)
. ...+++.|+|||++. .+.++.++||||||+++|||++..+ ..... ... ....+.. ..+..
T Consensus 179 ~------~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (317)
T cd06635 179 N------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDY 252 (317)
T ss_pred c------cccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHH
Confidence 1 122788999999974 4568899999999999999997432 22211 111 2222111 45667
Q ss_pred HHHHHhhccCCCCCCCCCHHHHHHHHHHHHh
Q 008785 493 CLMLFISCNNWPSHLSQSKFCNLKLWVFAIL 523 (553)
Q Consensus 493 l~~l~~~Cl~~dP~~RPs~~evl~~l~~~~~ 523 (553)
+.+++.+||+.+|.+||++.+++++......
T Consensus 253 l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~ 283 (317)
T cd06635 253 FRNFVDSCLQKIPQDRPTSEELLKHMFVLRE 283 (317)
T ss_pred HHHHHHHHccCCcccCcCHHHHHhChhhhcc
Confidence 8999999999999999999999998655443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=291.09 Aligned_cols=235 Identities=20% Similarity=0.252 Sum_probs=197.6
Q ss_pred CeeecccCceeEEEEEe-CCCCEEEEEEeccCCh--hhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCC
Q 008785 274 NRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSF--QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 350 (553)
Q Consensus 274 ~~~iG~G~~g~Vy~~~~-~~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 350 (553)
.+-||+|.|..|-.+++ -.|+.||||++.+... .....+.+|++.|+-++|||||+||.+......+|||+|+-.+|
T Consensus 23 ekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELGD~G 102 (864)
T KOG4717|consen 23 EKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELGDGG 102 (864)
T ss_pred hhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEecCCc
Confidence 44569999999998874 3799999999987633 33567899999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecC-CCCeEEeeccccccCCcccccc
Q 008785 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE-EFGAHLMGVGLSKFVPWEVMQE 429 (553)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~-~~~~kl~Dfgla~~~~~~~~~~ 429 (553)
+|++|+-. ....+++....+++.||+.|+.|+|+. .+|||||||+|+.+-+ -|-+||.|||++..+..+..-.
T Consensus 103 Dl~DyImK---He~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~kL~ 176 (864)
T KOG4717|consen 103 DLFDYIMK---HEEGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKKLT 176 (864)
T ss_pred hHHHHHHh---hhccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCCcchhh
Confidence 99999964 445699999999999999999999999 9999999999998755 5789999999998776554332
Q ss_pred eeeecCccccccccccccCCCCC-cccchHhHHHHHHHHhcCc-c---cccchHHHHHhcCCH----HHHHHHHHHHhhc
Q 008785 430 RTVMAGGTYGYLAPEFVYRNELT-TKSDVYSFGVLLLEIRLVL-C---RRWWTLYTLVHSMSL----LCAQECLMLFISC 500 (553)
Q Consensus 430 ~~~~~~gt~~y~aPE~~~~~~~t-~ksDVwSlGvil~ell~~~-~---~~~~~l~~~~~~~~~----~~~~~l~~l~~~C 500 (553)
..+|+..|-|||++.+..|+ ++.||||||||||.|+... | .++.+-..++..-+. ....++.+||..|
T Consensus 177 ---TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPshvS~eCrdLI~sM 253 (864)
T KOG4717|consen 177 ---TSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPSHVSKECRDLIQSM 253 (864)
T ss_pred ---cccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCchhhhHHHHHHHHHH
Confidence 34599999999999999996 6789999999999999633 2 233333334444333 7788999999999
Q ss_pred cCCCCCCCCCHHHHHHH
Q 008785 501 NNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 501 l~~dP~~RPs~~evl~~ 517 (553)
|..||.+|.|.+||...
T Consensus 254 LvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 254 LVRDPKKRASLEEIVST 270 (864)
T ss_pred HhcCchhhccHHHHhcc
Confidence 99999999999998875
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=310.59 Aligned_cols=239 Identities=15% Similarity=0.148 Sum_probs=179.6
Q ss_pred hhcccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCChhhHHHHHHHHHHhhccC------CCceeeEeeEEeeC-
Q 008785 266 ITKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLH------HPNLVAVKGCCYDH- 337 (553)
Q Consensus 266 ~~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~------HpnIv~l~~~~~~~- 337 (553)
..++|.... .||+|+||+||++... .++.||||+++... ....++..|+.+++.++ |++++++++++...
T Consensus 127 ~~~~y~i~~-~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~ 204 (467)
T PTZ00284 127 STQRFKILS-LLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNET 204 (467)
T ss_pred CCCcEEEEE-EEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCC
Confidence 345565544 4599999999999864 47899999997532 22344566777776664 45689999988765
Q ss_pred CceEEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCceecCCCCCcEEecCCC-------
Q 008785 338 GDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD-KVKPHVVHRDIRASNVLLDEEF------- 409 (553)
Q Consensus 338 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~ivHrDlkp~NILl~~~~------- 409 (553)
+..++|||++ +++|.+++.. ...+++..+..|+.||+.||.|||+ . +|+||||||+|||++.++
T Consensus 205 ~~~~iv~~~~-g~~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~~~~~~~~~~~ 276 (467)
T PTZ00284 205 GHMCIVMPKY-GPCLLDWIMK----HGPFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILMETSDTVVDPVT 276 (467)
T ss_pred ceEEEEEecc-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEecCCccccccc
Confidence 4678999988 7789888864 2458999999999999999999997 6 999999999999998765
Q ss_pred ---------CeEEeeccccccCCcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcCcc-cccch--
Q 008785 410 ---------GAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVLC-RRWWT-- 477 (553)
Q Consensus 410 ---------~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~~-~~~~~-- 477 (553)
.+||+|||.+...... .....||+.|+|||++.+..++.++|||||||++|||++..+ .....
T Consensus 277 ~~~~~~~~~~vkl~DfG~~~~~~~~-----~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~ 351 (467)
T PTZ00284 277 NRALPPDPCRVRICDLGGCCDERHS-----RTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNL 351 (467)
T ss_pred ccccCCCCceEEECCCCccccCccc-----cccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH
Confidence 4999999987643221 112238999999999999999999999999999999997332 21111
Q ss_pred -HHHHHhc--C-----------------------C------------------H---HHHHHHHHHHhhccCCCCCCCCC
Q 008785 478 -LYTLVHS--M-----------------------S------------------L---LCAQECLMLFISCNNWPSHLSQS 510 (553)
Q Consensus 478 -l~~~~~~--~-----------------------~------------------~---~~~~~l~~l~~~Cl~~dP~~RPs 510 (553)
....+.. | . . .....+.+|+.+||..||++|||
T Consensus 352 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t 431 (467)
T PTZ00284 352 EHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLN 431 (467)
T ss_pred HHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCC
Confidence 1110000 0 0 0 11345779999999999999999
Q ss_pred HHHHHHHHH
Q 008785 511 KFCNLKLWV 519 (553)
Q Consensus 511 ~~evl~~l~ 519 (553)
+.|+|++-.
T Consensus 432 a~e~L~Hp~ 440 (467)
T PTZ00284 432 ARQMTTHPY 440 (467)
T ss_pred HHHHhcCcc
Confidence 999998743
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=283.44 Aligned_cols=231 Identities=20% Similarity=0.196 Sum_probs=190.5
Q ss_pred ecccCceeEEEEEeCC-CCEEEEEEeccCC---hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCCH
Q 008785 277 LGDSKTGGTYSGILPD-GSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352 (553)
Q Consensus 277 iG~G~~g~Vy~~~~~~-g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL 352 (553)
||.|++|.||++.... ++.||+|.+.... ....+.+.+|+.++++++||||+++++.+.+....++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 5999999999999754 8999999997542 23456789999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccceee
Q 008785 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV 432 (553)
Q Consensus 353 ~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~ 432 (553)
.+++.. ...+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++........ ..
T Consensus 81 ~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~---~~ 150 (262)
T cd05572 81 WTILRD----RGLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQK---TW 150 (262)
T ss_pred HHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccc---cc
Confidence 999964 23488999999999999999999999 999999999999999999999999999987654321 11
Q ss_pred ecCccccccccccccCCCCCcccchHhHHHHHHHHhcC-cccccch-----HHHHHhc--CCH----HHHHHHHHHHhhc
Q 008785 433 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLV-LCRRWWT-----LYTLVHS--MSL----LCAQECLMLFISC 500 (553)
Q Consensus 433 ~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~-~~~~~~~-----l~~~~~~--~~~----~~~~~l~~l~~~C 500 (553)
...+++.|+|||.+.+..++.++|+||||+++|||++. .|..... +...+.. ... ..+..+.+++.+|
T Consensus 151 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 230 (262)
T cd05572 151 TFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQL 230 (262)
T ss_pred cccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHH
Confidence 22378899999999888899999999999999999972 2222111 2222221 111 3467899999999
Q ss_pred cCCCCCCCCC-----HHHHHHH
Q 008785 501 NNWPSHLSQS-----KFCNLKL 517 (553)
Q Consensus 501 l~~dP~~RPs-----~~evl~~ 517 (553)
|+.+|++||+ +.|++++
T Consensus 231 l~~~p~~R~~~~~~~~~~l~~~ 252 (262)
T cd05572 231 LRRNPEERLGNLKGGIKDIKKH 252 (262)
T ss_pred ccCChhhCcCCcccCHHHHhcC
Confidence 9999999999 8888775
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=289.46 Aligned_cols=233 Identities=21% Similarity=0.261 Sum_probs=192.2
Q ss_pred eecccCceeEEEEEeC-CCCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCCHHH
Q 008785 276 LLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR 354 (553)
Q Consensus 276 ~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~ 354 (553)
.||+|+||.||++... +|+.||||.+..........+.+|+.++++++||||+++++.+...+..++||||+++++|.+
T Consensus 27 ~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 106 (292)
T cd06657 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTD 106 (292)
T ss_pred HcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHHH
Confidence 4699999999999874 689999999876555566779999999999999999999999999999999999999999999
Q ss_pred HhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccceeeec
Q 008785 355 WLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA 434 (553)
Q Consensus 355 ~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 434 (553)
++.. ..+++..+..++.|++.||+|||+. +++||||+|+||++++++.++|+|||++.......... ...
T Consensus 107 ~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~--~~~ 176 (292)
T cd06657 107 IVTH-----TRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR--KSL 176 (292)
T ss_pred HHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceecccccccc--ccc
Confidence 8753 3478999999999999999999999 99999999999999999999999999987654322111 122
Q ss_pred CccccccccccccCCCCCcccchHhHHHHHHHHhcCc-ccccch---HHHHHhcC---CH----HHHHHHHHHHhhccCC
Q 008785 435 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVL-CRRWWT---LYTLVHSM---SL----LCAQECLMLFISCNNW 503 (553)
Q Consensus 435 ~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~-~~~~~~---l~~~~~~~---~~----~~~~~l~~l~~~Cl~~ 503 (553)
.|++.|+|||.+.+..++.++|+||||+++|||++.. |..... ....+..+ .. ..+..+.+++.+||+.
T Consensus 177 ~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 256 (292)
T cd06657 177 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVR 256 (292)
T ss_pred ccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHHhC
Confidence 3788999999998888899999999999999999733 322221 11122111 11 3466789999999999
Q ss_pred CCCCCCCHHHHHHHH
Q 008785 504 PSHLSQSKFCNLKLW 518 (553)
Q Consensus 504 dP~~RPs~~evl~~l 518 (553)
+|.+||++.+++++-
T Consensus 257 ~P~~R~~~~~ll~~~ 271 (292)
T cd06657 257 DPAQRATAAELLKHP 271 (292)
T ss_pred CcccCcCHHHHhcCh
Confidence 999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=287.33 Aligned_cols=235 Identities=19% Similarity=0.218 Sum_probs=189.3
Q ss_pred eeecccCceeEEEEEeC-CCCEEEEEEeccCC--hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCC
Q 008785 275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP 351 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gs 351 (553)
+.||+|++|.||+|... +|+.||+|++.... ......+.+|+.++++++||||+++++++......++||||+ +++
T Consensus 6 ~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~-~~~ 84 (286)
T cd07832 6 GRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM-PSD 84 (286)
T ss_pred eecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc-CCC
Confidence 34599999999999964 58999999997653 233567899999999999999999999999999999999999 999
Q ss_pred HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCccccccee
Q 008785 352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT 431 (553)
Q Consensus 352 L~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~ 431 (553)
|.+++... ...+++.++..++.||+.||+|||+. +++|+||||+||++++++.++|+|||++...........
T Consensus 85 L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~- 157 (286)
T cd07832 85 LSEVLRDE---ERPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLY- 157 (286)
T ss_pred HHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCcc-
Confidence 99998652 25689999999999999999999999 999999999999999999999999999986654322111
Q ss_pred eecCccccccccccccCC-CCCcccchHhHHHHHHHHhcCcccccc----hHHH-HHh---c---------------CC-
Q 008785 432 VMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIRLVLCRRWW----TLYT-LVH---S---------------MS- 486 (553)
Q Consensus 432 ~~~~gt~~y~aPE~~~~~-~~t~ksDVwSlGvil~ell~~~~~~~~----~l~~-~~~---~---------------~~- 486 (553)
....++..|+|||.+.+. .++.++||||+|++++||++..+.... .... .+. . +.
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07832 158 SHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKI 237 (286)
T ss_pred ccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcc
Confidence 112378899999998654 468999999999999999974332111 0000 000 0 00
Q ss_pred ---------H-----HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008785 487 ---------L-----LCAQECLMLFISCNNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 487 ---------~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 517 (553)
. .....+.+++.+|++.+|.+|||+.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 238 TFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred cCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0 235788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=289.09 Aligned_cols=235 Identities=22% Similarity=0.228 Sum_probs=187.9
Q ss_pred eeecccCceeEEEEEeC-CCCEEEEEEeccCC--hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCC
Q 008785 275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP 351 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gs 351 (553)
+.||+|++|.||+|... +++.||+|.++... ....+.+.+|++++++++||||+++++++.+.+..++||||++++.
T Consensus 7 ~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~ 86 (288)
T cd07833 7 GVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTL 86 (288)
T ss_pred EEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecCCCCH
Confidence 34599999999999976 48899999987542 2335778999999999999999999999999999999999999877
Q ss_pred HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCccccccee
Q 008785 352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT 431 (553)
Q Consensus 352 L~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~ 431 (553)
+..+... ...+++..+..++.||+.||.|||+. +++||||+|+||++++++.+||+|||++............
T Consensus 87 l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~ 159 (288)
T cd07833 87 LELLEAS----PGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLT 159 (288)
T ss_pred HHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCCcccccc
Confidence 7665532 24489999999999999999999999 9999999999999999999999999998876544321111
Q ss_pred eecCccccccccccccCC-CCCcccchHhHHHHHHHHhcCccc-ccchHHH-HH---h---------------c----C-
Q 008785 432 VMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIRLVLCR-RWWTLYT-LV---H---------------S----M- 485 (553)
Q Consensus 432 ~~~~gt~~y~aPE~~~~~-~~t~ksDVwSlGvil~ell~~~~~-~~~~l~~-~~---~---------------~----~- 485 (553)
...++..|+|||++.+. .++.++||||||+++|+|++..+. ......+ .. . . +
T Consensus 160 -~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07833 160 -DYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGV 238 (288)
T ss_pred -CcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccccc
Confidence 12378889999999888 789999999999999999973322 1111111 00 0 0 0
Q ss_pred CH---------------HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008785 486 SL---------------LCAQECLMLFISCNNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 486 ~~---------------~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 517 (553)
.. ..+..+.+++.+||+.+|++|||+.+++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 239 AFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred ccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 00 126779999999999999999999998864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=286.62 Aligned_cols=234 Identities=20% Similarity=0.198 Sum_probs=188.4
Q ss_pred ecccCceeEEEEEeC-CCCEEEEEEeccCCh---hhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCCH
Q 008785 277 LGDSKTGGTYSGILP-DGSRVAVKRLKRSSF---QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352 (553)
Q Consensus 277 iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL 352 (553)
||+|+||+||++... +|+.||+|.+..... .....+.+|+.++++++||||+++++.+...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 599999999999854 589999999875422 2345567899999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccceee
Q 008785 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV 432 (553)
Q Consensus 353 ~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~ 432 (553)
.+++... ....+++..+..++.|++.||.|||+. +++||||+|+||++++++.++|+|||.+......... .
T Consensus 81 ~~~l~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~---~ 152 (277)
T cd05577 81 KYHIYNV--GEPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKI---K 152 (277)
T ss_pred HHHHHHc--CcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccCCcc---c
Confidence 9998752 224689999999999999999999999 9999999999999999999999999998765432111 1
Q ss_pred ecCccccccccccccCCCCCcccchHhHHHHHHHHhcCc-ccccc-------hHHHHHhcCCH----HHHHHHHHHHhhc
Q 008785 433 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVL-CRRWW-------TLYTLVHSMSL----LCAQECLMLFISC 500 (553)
Q Consensus 433 ~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~-~~~~~-------~l~~~~~~~~~----~~~~~l~~l~~~C 500 (553)
...++..|+|||++.+..++.++||||||+++|+|++.. |.... .+......... ..+..+.+++.+|
T Consensus 153 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 232 (277)
T cd05577 153 GRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEAL 232 (277)
T ss_pred cccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHH
Confidence 122778999999998888999999999999999999732 22111 11111111111 4567889999999
Q ss_pred cCCCCCCCC-----CHHHHHHHH
Q 008785 501 NNWPSHLSQ-----SKFCNLKLW 518 (553)
Q Consensus 501 l~~dP~~RP-----s~~evl~~l 518 (553)
|+.||.+|| ++.+++++-
T Consensus 233 l~~~p~~R~~~~~~~~~~ll~h~ 255 (277)
T cd05577 233 LQKDPEKRLGCRGGSADEVREHP 255 (277)
T ss_pred ccCChhHccCCCcccHHHHHhCh
Confidence 999999999 777787753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=289.87 Aligned_cols=242 Identities=21% Similarity=0.232 Sum_probs=185.6
Q ss_pred ccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCCh--hhHHHHHHHHHHhhccC-CCceeeEeeEEeeCCc-----
Q 008785 269 NFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF--QRKKEFYSEIGRFARLH-HPNLVAVKGCCYDHGD----- 339 (553)
Q Consensus 269 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~----- 339 (553)
+|.... .||+|+||.||+|... +|+.||||.++.... .....+.+|+.++++++ ||||+++++++...+.
T Consensus 2 ~y~~~~-~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 2 AYEKLE-KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CceEee-EecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 344444 4599999999999965 589999999865422 23457888999999994 6999999999887665
Q ss_pred eEEEEEccCCCCHHHHhccCCCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecC-CCCeEEeecc
Q 008785 340 RYIVYEFVVNGPLDRWLHHIPRG-GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE-EFGAHLMGVG 417 (553)
Q Consensus 340 ~~lV~E~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~-~~~~kl~Dfg 417 (553)
.|+||||+++ +|.+++...... ...+++..+..++.||+.||.|||+. +|+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999975 898888653222 34689999999999999999999999 9999999999999998 8899999999
Q ss_pred ccccCCcccccceeeecCccccccccccccC-CCCCcccchHhHHHHHHHHhcCcc-cccch-HHH---HHh--------
Q 008785 418 LSKFVPWEVMQERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIRLVLC-RRWWT-LYT---LVH-------- 483 (553)
Q Consensus 418 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwSlGvil~ell~~~~-~~~~~-l~~---~~~-------- 483 (553)
+++.......... ...+++.|+|||++.+ ..++.++||||||+++|||++..+ ....+ ... ...
T Consensus 157 ~~~~~~~~~~~~~--~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (295)
T cd07837 157 LGRAFSIPVKSYT--HEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQ 234 (295)
T ss_pred cceecCCCccccC--CcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 9875533211111 1126788999998865 457999999999999999997332 21111 110 000
Q ss_pred ---------------cCC--------HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008785 484 ---------------SMS--------LLCAQECLMLFISCNNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 484 ---------------~~~--------~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 517 (553)
... ...+..+.+++.+||+.||.+|||+.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 235 VWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred hCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 000 0245678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=282.34 Aligned_cols=236 Identities=25% Similarity=0.319 Sum_probs=191.8
Q ss_pred eeecccCceeEEEEEeC-CCCEEEEEEeccCCh--hhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCC
Q 008785 275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF--QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP 351 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gs 351 (553)
+.||+|++|.||+|... +++.||+|.++.... ...+.+.+|+.++++++||||+++++.+.+.+..++|+||+++++
T Consensus 6 ~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 85 (264)
T cd06626 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGT 85 (264)
T ss_pred eEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecCCCCc
Confidence 45699999999999965 688999999986544 356789999999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCccccccee
Q 008785 352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT 431 (553)
Q Consensus 352 L~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~ 431 (553)
|.+++.. ...+++..+..++.|++.||.|||+. +++||||+|+||++++++.+||+|||++............
T Consensus 86 L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~ 158 (264)
T cd06626 86 LEELLEH----GRILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGE 158 (264)
T ss_pred HHHHHhh----cCCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccc
Confidence 9999864 23478889999999999999999999 9999999999999999999999999999876543222111
Q ss_pred --eecCccccccccccccCCC---CCcccchHhHHHHHHHHhcCc-ccccc----hHHHHHhcCCH-------HHHHHHH
Q 008785 432 --VMAGGTYGYLAPEFVYRNE---LTTKSDVYSFGVLLLEIRLVL-CRRWW----TLYTLVHSMSL-------LCAQECL 494 (553)
Q Consensus 432 --~~~~gt~~y~aPE~~~~~~---~t~ksDVwSlGvil~ell~~~-~~~~~----~l~~~~~~~~~-------~~~~~l~ 494 (553)
....++..|+|||++.... ++.++||||||+++||+++.. |.... .....+..+.. ..+..+.
T Consensus 159 ~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (264)
T cd06626 159 EVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGK 238 (264)
T ss_pred cccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCHHHH
Confidence 1123788999999998766 889999999999999999733 32211 11111111111 3367788
Q ss_pred HHHhhccCCCCCCCCCHHHHHHH
Q 008785 495 MLFISCNNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 495 ~l~~~Cl~~dP~~RPs~~evl~~ 517 (553)
+++.+||+.+|.+|||+.|++++
T Consensus 239 ~li~~~l~~~p~~R~~~~~i~~~ 261 (264)
T cd06626 239 DFLDRCLESDPKKRPTASELLQH 261 (264)
T ss_pred HHHHHHccCCcccCCCHHHHhcC
Confidence 99999999999999999998864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=287.75 Aligned_cols=233 Identities=19% Similarity=0.204 Sum_probs=181.5
Q ss_pred ecccCceeEEEEEeC-CCCEEEEEEeccCCh---hhHHHHHHHHHHh---hccCCCceeeEeeEEeeCCceEEEEEccCC
Q 008785 277 LGDSKTGGTYSGILP-DGSRVAVKRLKRSSF---QRKKEFYSEIGRF---ARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 349 (553)
Q Consensus 277 iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~---~~~~~~~~E~~~l---~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 349 (553)
||+|+||.||++... +++.||+|.+..... .....+.+|..++ ...+||||+.+++.+...+..++||||+++
T Consensus 2 lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (279)
T cd05633 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMNG 81 (279)
T ss_pred cccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCCC
Confidence 699999999999975 588999999865421 1223344454333 334799999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccc
Q 008785 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE 429 (553)
Q Consensus 350 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 429 (553)
|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||+++++.++|+|||++........
T Consensus 82 ~~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~-- 152 (279)
T cd05633 82 GDLHYHLSQ----HGVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-- 152 (279)
T ss_pred CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccCc--
Confidence 999998864 24589999999999999999999999 999999999999999999999999999875433221
Q ss_pred eeeecCccccccccccccC-CCCCcccchHhHHHHHHHHhcCc-cccc---chH--HH-HHhcCC--H--HHHHHHHHHH
Q 008785 430 RTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIRLVL-CRRW---WTL--YT-LVHSMS--L--LCAQECLMLF 497 (553)
Q Consensus 430 ~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwSlGvil~ell~~~-~~~~---~~l--~~-~~~~~~--~--~~~~~l~~l~ 497 (553)
....|+..|+|||.+.+ ..++.++||||||+++|||++.. |... ... .. ...... + ..+..+.+++
T Consensus 153 --~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 230 (279)
T cd05633 153 --HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLL 230 (279)
T ss_pred --cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHHHHH
Confidence 11238999999998864 55899999999999999999732 2211 111 11 111111 1 4567889999
Q ss_pred hhccCCCCCCCC-----CHHHHHHHHHH
Q 008785 498 ISCNNWPSHLSQ-----SKFCNLKLWVF 520 (553)
Q Consensus 498 ~~Cl~~dP~~RP-----s~~evl~~l~~ 520 (553)
.+||+.||++|| |+.|++++..+
T Consensus 231 ~~~l~~~p~~R~~~~~~~~~~~~~h~~~ 258 (279)
T cd05633 231 EGLLQRDVSKRLGCLGRGAQEVKEHVFF 258 (279)
T ss_pred HHHhcCCHHHhcCCCCCCHHHHHhCccc
Confidence 999999999999 69999987433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=281.62 Aligned_cols=241 Identities=22% Similarity=0.277 Sum_probs=201.5
Q ss_pred eeecccCceeEEEEEeCC------CCEEEEEEeccC-ChhhHHHHHHHHHHhhccCCCceeeEeeEEeeC-CceEEEEEc
Q 008785 275 RLLGDSKTGGTYSGILPD------GSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH-GDRYIVYEF 346 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~~------g~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~-~~~~lV~E~ 346 (553)
-++.+|.||.||+|.+.+ .+.|-+|.++.. +.-....++.|.-.+..+.|||+.++.+++.+. ..+++++.+
T Consensus 290 ~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y~~ 369 (563)
T KOG1024|consen 290 CLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLYPA 369 (563)
T ss_pred hhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEEec
Confidence 456999999999997653 456788888765 444567899999999999999999999998765 557899999
Q ss_pred cCCCCHHHHhccC----CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccC
Q 008785 347 VVNGPLDRWLHHI----PRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV 422 (553)
Q Consensus 347 ~~~gsL~~~l~~~----~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~ 422 (553)
+.-|+|..||... ....+.++..+...++.|++.|++|||.+ ++||.||.++|++||+..++||+|=.+++.+
T Consensus 370 ~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~LqVkltDsaLSRDL 446 (563)
T KOG1024|consen 370 TGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQLQVKLTDSALSRDL 446 (563)
T ss_pred cCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---CcccchhhhhcceehhheeEEeccchhcccc
Confidence 9999999999832 23456688889999999999999999999 9999999999999999999999999999987
Q ss_pred CcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhc--CcccccchHHH---HHhcCCH-----HHHHH
Q 008785 423 PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL--VLCRRWWTLYT---LVHSMSL-----LCAQE 492 (553)
Q Consensus 423 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~--~~~~~~~~l~~---~~~~~~~-----~~~~~ 492 (553)
.....+........+..||+||.+.+..|+.++|||||||+||||++ +.|.-+.+..+ .++.|.. +++.+
T Consensus 447 FP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyRlaQP~NCPDe 526 (563)
T KOG1024|consen 447 FPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYRLAQPFNCPDE 526 (563)
T ss_pred CcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccceecCCCCCcHH
Confidence 76655544333336789999999999999999999999999999997 44444433333 5665543 89999
Q ss_pred HHHHHhhccCCCCCCCCCHHHHHHHH
Q 008785 493 CLMLFISCNNWPSHLSQSKFCNLKLW 518 (553)
Q Consensus 493 l~~l~~~Cl~~dP~~RPs~~evl~~l 518 (553)
+..++.-||...|++||+++|+..-|
T Consensus 527 Lf~vMacCWallpeeRPsf~Qlv~cL 552 (563)
T KOG1024|consen 527 LFTVMACCWALLPEERPSFSQLVICL 552 (563)
T ss_pred HHHHHHHHHhcCcccCCCHHHHHHHH
Confidence 99999999999999999999988765
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=280.11 Aligned_cols=238 Identities=22% Similarity=0.280 Sum_probs=197.0
Q ss_pred eeecccCceeEEEEEeC-CCCEEEEEEeccCCh--hhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCC
Q 008785 275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF--QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP 351 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gs 351 (553)
+.||+|++|.||++... ++..||+|.+..... .....+.+|++++++++|||++++++.+...+..++|+||+++++
T Consensus 6 ~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~~~ 85 (258)
T cd08215 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGD 85 (258)
T ss_pred eeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecCCCc
Confidence 34699999999999975 588999999976533 456778999999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCccccccee
Q 008785 352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT 431 (553)
Q Consensus 352 L~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~ 431 (553)
|.+++.........+++..+..++.+++.||.|||+. +++|+||+|+||++++++.++|+|||.+......... .
T Consensus 86 L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~ 160 (258)
T cd08215 86 LSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDL--A 160 (258)
T ss_pred HHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCcce--e
Confidence 9999976433346799999999999999999999999 9999999999999999999999999999766544311 1
Q ss_pred eecCccccccccccccCCCCCcccchHhHHHHHHHHhcC-cccccchH---HHHHhcCCH-----HHHHHHHHHHhhccC
Q 008785 432 VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLV-LCRRWWTL---YTLVHSMSL-----LCAQECLMLFISCNN 502 (553)
Q Consensus 432 ~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~-~~~~~~~l---~~~~~~~~~-----~~~~~l~~l~~~Cl~ 502 (553)
....|++.|+|||.+.+..++.++|+||+|+++++|++. .+....+. ......+.. ..+..+.+++.+||+
T Consensus 161 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 240 (258)
T cd08215 161 KTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNLVSSLLQ 240 (258)
T ss_pred cceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcC
Confidence 122378899999999888899999999999999999973 33323222 222222212 456788999999999
Q ss_pred CCCCCCCCHHHHHHH
Q 008785 503 WPSHLSQSKFCNLKL 517 (553)
Q Consensus 503 ~dP~~RPs~~evl~~ 517 (553)
.+|++|||+.+++++
T Consensus 241 ~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 241 KDPEERPSIAQILQS 255 (258)
T ss_pred CChhhCcCHHHHhcC
Confidence 999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=284.80 Aligned_cols=234 Identities=18% Similarity=0.243 Sum_probs=190.8
Q ss_pred ecccCceeEEEEEeCC-CCEEEEEEeccCCh---hhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCCH
Q 008785 277 LGDSKTGGTYSGILPD-GSRVAVKRLKRSSF---QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352 (553)
Q Consensus 277 iG~G~~g~Vy~~~~~~-g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL 352 (553)
||.|+||.||++...+ |+.||+|.+..... ...+.+.+|+.++++++||||+++++.+......+++|||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 4899999999999865 89999999976543 3456788999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCccccc----
Q 008785 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ---- 428 (553)
Q Consensus 353 ~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~---- 428 (553)
.+++... ..+++..+..++.|++.||+|||+. +++||||+|+||++++++.++|+|||++.........
T Consensus 81 ~~~l~~~----~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 153 (265)
T cd05579 81 ASLLENV----GSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND 153 (265)
T ss_pred HHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence 9999642 2689999999999999999999999 9999999999999999999999999998754433210
Q ss_pred --ceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcCc-ccc---cchHHHHHhcCCH----H--HHHHHHHH
Q 008785 429 --ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVL-CRR---WWTLYTLVHSMSL----L--CAQECLML 496 (553)
Q Consensus 429 --~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~-~~~---~~~l~~~~~~~~~----~--~~~~l~~l 496 (553)
.......++..|+|||.......+.++||||||+++||+++.. +.. .......+..+.. . .+..+.++
T Consensus 154 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (265)
T cd05579 154 DEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDL 233 (265)
T ss_pred ccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCccccCCHHHHHH
Confidence 0111223778999999998888999999999999999999732 222 2222333333232 2 26789999
Q ss_pred HhhccCCCCCCCCCH---HHHHHH
Q 008785 497 FISCNNWPSHLSQSK---FCNLKL 517 (553)
Q Consensus 497 ~~~Cl~~dP~~RPs~---~evl~~ 517 (553)
+.+||+.+|++|||+ .+++++
T Consensus 234 i~~~l~~~p~~Rpt~~~~~~~l~~ 257 (265)
T cd05579 234 ISKLLVPDPEKRLGAKSIEEIKNH 257 (265)
T ss_pred HHHHhcCCHhhcCCCccHHHHhcC
Confidence 999999999999999 665553
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=282.02 Aligned_cols=235 Identities=23% Similarity=0.282 Sum_probs=195.3
Q ss_pred eecccCceeEEEEEeC-CCCEEEEEEeccCC--hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCCH
Q 008785 276 LLGDSKTGGTYSGILP-DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352 (553)
Q Consensus 276 ~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL 352 (553)
.||+|++|.||++... +++.+|+|.+.... ......+.+|+.++++++||||+++++++.+....++||||+++++|
T Consensus 7 ~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L 86 (256)
T cd08530 7 KLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDL 86 (256)
T ss_pred eecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcCCCCH
Confidence 4599999999999854 58899999987542 33456788999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccceee
Q 008785 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV 432 (553)
Q Consensus 353 ~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~ 432 (553)
.+++.........+++..+..++.|++.||+|||+. +++||||+|+||++++++.+||+|||++.........
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~---- 159 (256)
T cd08530 87 SKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAK---- 159 (256)
T ss_pred HHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccCCcc----
Confidence 999875333345689999999999999999999999 9999999999999999999999999999876544111
Q ss_pred ecCccccccccccccCCCCCcccchHhHHHHHHHHhcC-cccccch---HHHHHhcCCH-----HHHHHHHHHHhhccCC
Q 008785 433 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLV-LCRRWWT---LYTLVHSMSL-----LCAQECLMLFISCNNW 503 (553)
Q Consensus 433 ~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~-~~~~~~~---l~~~~~~~~~-----~~~~~l~~l~~~Cl~~ 503 (553)
...+++.|+|||.+.+..++.++|+||||+++|||++. .|....+ +...+..+.. ..+..+.+++.+|++.
T Consensus 160 ~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 239 (256)
T cd08530 160 TQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIRSMLQV 239 (256)
T ss_pred cccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCchhhCHHHHHHHHHHcCC
Confidence 12378899999999988899999999999999999973 3332222 2223333332 5667899999999999
Q ss_pred CCCCCCCHHHHHHH
Q 008785 504 PSHLSQSKFCNLKL 517 (553)
Q Consensus 504 dP~~RPs~~evl~~ 517 (553)
+|++|||+.+++++
T Consensus 240 ~p~~Rp~~~~~l~~ 253 (256)
T cd08530 240 KPKLRPNCDKILAS 253 (256)
T ss_pred CcccCCCHHHHhcC
Confidence 99999999999874
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=287.30 Aligned_cols=240 Identities=18% Similarity=0.173 Sum_probs=185.0
Q ss_pred cccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCCh-hhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEE
Q 008785 268 KNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF-QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYE 345 (553)
Q Consensus 268 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 345 (553)
++|.... .||+|+||.||+|... +|+.||+|.++.... .....+.+|+.+++.++|+||+++++++.+.+..++|||
T Consensus 5 ~~y~~~~-~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 83 (291)
T cd07870 5 TSYLNLE-KLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE 83 (291)
T ss_pred ceeEEEE-EEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence 4454444 4599999999999864 588999999975432 223467889999999999999999999999999999999
Q ss_pred ccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcc
Q 008785 346 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE 425 (553)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~ 425 (553)
|+. ++|.+++.. ....+++..+..++.|++.||.|||+. +|+||||||+||+++.++.++|+|||+++.....
T Consensus 84 ~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 156 (291)
T cd07870 84 YMH-TDLAQYMIQ---HPGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIP 156 (291)
T ss_pred ccc-CCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence 995 677777653 224578888999999999999999999 9999999999999999999999999998754332
Q ss_pred cccceeeecCccccccccccccCC-CCCcccchHhHHHHHHHHhcCcccc-cch-----HHHHHh---------------
Q 008785 426 VMQERTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIRLVLCRR-WWT-----LYTLVH--------------- 483 (553)
Q Consensus 426 ~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwSlGvil~ell~~~~~~-~~~-----l~~~~~--------------- 483 (553)
.... ....+++.|+|||.+.+. .++.++||||||+++|||++..+.. ... +.+.+.
T Consensus 157 ~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (291)
T cd07870 157 SQTY--SSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSK 234 (291)
T ss_pred CCCC--CCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhh
Confidence 2111 112268899999998754 5788999999999999999733221 110 000000
Q ss_pred -------------cCC-------HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008785 484 -------------SMS-------LLCAQECLMLFISCNNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 484 -------------~~~-------~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 517 (553)
... ......+.+++.+|+..||++|||+.|++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 235 LPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred cccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 000 0124578899999999999999999998864
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=318.96 Aligned_cols=247 Identities=21% Similarity=0.257 Sum_probs=187.0
Q ss_pred HHhhcccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCC-hhhHHHHHHHHHHhhccCCCceeeEeeEEee-----
Q 008785 264 RSITKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYD----- 336 (553)
Q Consensus 264 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~----- 336 (553)
.+..++|.+.. +||+||||.||+++.+ ||+.||||++.... ......+.+|+..|++|+|||||+++..+.+
T Consensus 475 SRY~~DFEEL~-lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~ 553 (1351)
T KOG1035|consen 475 SRYLNDFEELE-LLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAEL 553 (1351)
T ss_pred hhHhhhhHHHH-HhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcc
Confidence 34556666654 5599999999999954 79999999998653 3334678899999999999999999832200
Q ss_pred -------------------------------------------------------------------------C------
Q 008785 337 -------------------------------------------------------------------------H------ 337 (553)
Q Consensus 337 -------------------------------------------------------------------------~------ 337 (553)
.
T Consensus 554 ~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~t 633 (1351)
T KOG1035|consen 554 TVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNT 633 (1351)
T ss_pred ccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccc
Confidence 0
Q ss_pred -----------------------------------CceEEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHH
Q 008785 338 -----------------------------------GDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGI 382 (553)
Q Consensus 338 -----------------------------------~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL 382 (553)
..+||-||||+..+|.++++... ..-.....++++++|++||
T Consensus 634 S~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~---~~~~~d~~wrLFreIlEGL 710 (1351)
T KOG1035|consen 634 SDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNH---FNSQRDEAWRLFREILEGL 710 (1351)
T ss_pred cccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcc---cchhhHHHHHHHHHHHHHH
Confidence 02389999999988888886421 1114567889999999999
Q ss_pred HHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCC---c-------------ccccceeeecCccccccccccc
Q 008785 383 AFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVP---W-------------EVMQERTVMAGGTYGYLAPEFV 446 (553)
Q Consensus 383 ~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~---~-------------~~~~~~~~~~~gt~~y~aPE~~ 446 (553)
+|+|+. |||||||||.||+++++..+||+|||+|.... . ...........||.-|+|||++
T Consensus 711 aYIH~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll 787 (1351)
T KOG1035|consen 711 AYIHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELL 787 (1351)
T ss_pred HHHHhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHh
Confidence 999999 99999999999999999999999999998721 0 0001011223399999999999
Q ss_pred cCC---CCCcccchHhHHHHHHHHhc-Cccc-ccchHHHHHhcCCH--------HHHHHHHHHHhhccCCCCCCCCCHHH
Q 008785 447 YRN---ELTTKSDVYSFGVLLLEIRL-VLCR-RWWTLYTLVHSMSL--------LCAQECLMLFISCNNWPSHLSQSKFC 513 (553)
Q Consensus 447 ~~~---~~t~ksDVwSlGvil~ell~-~~~~-~~~~l~~~~~~~~~--------~~~~~l~~l~~~Cl~~dP~~RPs~~e 513 (553)
.+. .|+.|+|+||||||++||+- +... +-....+.++.|.+ ...+.-..+|..++++||++|||+.|
T Consensus 788 ~~~~~~~Yn~KiDmYSLGIVlFEM~yPF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~e 867 (1351)
T KOG1035|consen 788 SDTSSNKYNSKIDMYSLGIVLFEMLYPFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATE 867 (1351)
T ss_pred cccccccccchhhhHHHHHHHHHHhccCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHH
Confidence 764 49999999999999999984 2221 22233444555555 33345578899999999999999999
Q ss_pred HHHH
Q 008785 514 NLKL 517 (553)
Q Consensus 514 vl~~ 517 (553)
+|+.
T Consensus 868 LL~s 871 (1351)
T KOG1035|consen 868 LLNS 871 (1351)
T ss_pred Hhhc
Confidence 9874
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=290.91 Aligned_cols=238 Identities=18% Similarity=0.241 Sum_probs=183.5
Q ss_pred eecccCceeEEEEEeCC---CCEEEEEEeccCC---hhhHHHHHHHHHHhhccCCCceeeEeeEEeeC--CceEEEEEcc
Q 008785 276 LLGDSKTGGTYSGILPD---GSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH--GDRYIVYEFV 347 (553)
Q Consensus 276 ~iG~G~~g~Vy~~~~~~---g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~~lV~E~~ 347 (553)
.||+|++|.||+|.... ++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+. ...++||||+
T Consensus 7 ~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~ 86 (316)
T cd07842 7 CIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLLFDYA 86 (316)
T ss_pred EeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEEEeCC
Confidence 35999999999999754 7899999998732 33346678899999999999999999999988 7799999999
Q ss_pred CCCCHHHHhccCCCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecC----CCCeEEeeccccccC
Q 008785 348 VNGPLDRWLHHIPRG-GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE----EFGAHLMGVGLSKFV 422 (553)
Q Consensus 348 ~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~----~~~~kl~Dfgla~~~ 422 (553)
++ +|.+++...... ...+++..+..++.||+.||.|||+. +|+||||||+||+++. ++.+||+|||++...
T Consensus 87 ~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~ 162 (316)
T cd07842 87 EH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLF 162 (316)
T ss_pred Cc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCCcccccc
Confidence 64 777776543222 23689999999999999999999999 9999999999999999 899999999999865
Q ss_pred Cccccc-ceeeecCccccccccccccCC-CCCcccchHhHHHHHHHHhcCccccc----c----------hHHH---HHh
Q 008785 423 PWEVMQ-ERTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIRLVLCRRW----W----------TLYT---LVH 483 (553)
Q Consensus 423 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwSlGvil~ell~~~~~~~----~----------~l~~---~~~ 483 (553)
...... .......+++.|+|||++.+. .++.++||||||++++||++..+... . .+.. .+.
T Consensus 163 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 242 (316)
T cd07842 163 NAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLG 242 (316)
T ss_pred CCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHHhC
Confidence 433221 111112378899999988764 57899999999999999996322110 0 0000 000
Q ss_pred -----------------------------cCCH--------HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008785 484 -----------------------------SMSL--------LCAQECLMLFISCNNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 484 -----------------------------~~~~--------~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 517 (553)
.... .....+.+++.+||+.||++|||+.|++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 243 TPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred CCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0000 123468899999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=286.46 Aligned_cols=239 Identities=23% Similarity=0.259 Sum_probs=186.9
Q ss_pred ccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCChh--hHHHHHHHHHHhhccCCCceeeEeeEEeeC--CceEEE
Q 008785 269 NFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQ--RKKEFYSEIGRFARLHHPNLVAVKGCCYDH--GDRYIV 343 (553)
Q Consensus 269 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~~lV 343 (553)
+|..... ||+|++|.||+|..+ +++.||+|.++..... ....+.+|+.++.+++||||+++++++... +..++|
T Consensus 6 ~y~~~~~-lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 6 EYEKLNR-IEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhh-hcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 4444444 499999999999976 4889999999754322 234567899999999999999999998877 889999
Q ss_pred EEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCC
Q 008785 344 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVP 423 (553)
Q Consensus 344 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~ 423 (553)
|||++ ++|.+++... ...+++..+..++.||+.||+|||+. +++||||||+||++++++.++|+|||++....
T Consensus 85 ~e~~~-~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 157 (293)
T cd07843 85 MEYVE-HDLKSLMETM---KQPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYG 157 (293)
T ss_pred ehhcC-cCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence 99996 5999888642 23689999999999999999999999 99999999999999999999999999998665
Q ss_pred cccccceeeecCccccccccccccCC-CCCcccchHhHHHHHHHHhcCccc-ccchHHH----HH---------------
Q 008785 424 WEVMQERTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIRLVLCR-RWWTLYT----LV--------------- 482 (553)
Q Consensus 424 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwSlGvil~ell~~~~~-~~~~l~~----~~--------------- 482 (553)
...... ....+++.|+|||.+.+. .++.++|+||||+++|||++..+. ......+ ..
T Consensus 158 ~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (293)
T cd07843 158 SPLKPY--TQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFS 235 (293)
T ss_pred CCcccc--ccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhh
Confidence 432111 112268889999998754 468999999999999999974322 1111000 00
Q ss_pred -----hcCC------------H-H--HHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008785 483 -----HSMS------------L-L--CAQECLMLFISCNNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 483 -----~~~~------------~-~--~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 517 (553)
.... + . ....+.+++.+||+.||++|||+.|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 236 ELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred ccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0000 0 1 36678899999999999999999999874
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=297.01 Aligned_cols=234 Identities=21% Similarity=0.289 Sum_probs=198.5
Q ss_pred CeeecccCceeEEEEEeC-CCCEEEEEEeccCC--hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCC
Q 008785 274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 350 (553)
Q Consensus 274 ~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 350 (553)
.+.||+|.|+.|..++.. .|..||||.+.+.. ....+.+.+|+++|+.|+|||||+++.+......+|+||||+.+|
T Consensus 61 ~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya~~g 140 (596)
T KOG0586|consen 61 IKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYASGG 140 (596)
T ss_pred eeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEeccCc
Confidence 445699999999999964 59999999998763 333456899999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccce
Q 008785 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER 430 (553)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 430 (553)
.++++|... ....+..+..++.|+.+|++|+|++ +|+|||||++||||+.+.++||+|||++.++......
T Consensus 141 e~~~yl~~~----gr~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~~l-- 211 (596)
T KOG0586|consen 141 ELFDYLVKH----GRMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFDYGLML-- 211 (596)
T ss_pred hhHHHHHhc----ccchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeecccccc--
Confidence 999999752 3355588889999999999999999 9999999999999999999999999999988754332
Q ss_pred eeecCccccccccccccCCCC-CcccchHhHHHHHHHHhc-CcccccchHHH---HHhcCCH----HHHHHHHHHHhhcc
Q 008785 431 TVMAGGTYGYLAPEFVYRNEL-TTKSDVYSFGVLLLEIRL-VLCRRWWTLYT---LVHSMSL----LCAQECLMLFISCN 501 (553)
Q Consensus 431 ~~~~~gt~~y~aPE~~~~~~~-t~ksDVwSlGvil~ell~-~~~~~~~~l~~---~~~~~~~----~~~~~l~~l~~~Cl 501 (553)
...+|++.|.|||++.+..| ++++|+||+|+++|-|+. ..|++.+.+.+ ..-.|++ ....++.+++.+.+
T Consensus 212 -qt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~~ms~dce~lLrk~l 290 (596)
T KOG0586|consen 212 -QTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPFYMSCDCEDLLRKFL 290 (596)
T ss_pred -cccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccceeechhHHHHHHhh
Confidence 33459999999999998877 689999999999999996 45555555544 3333333 55667888999999
Q ss_pred CCCCCCCCCHHHHHHH
Q 008785 502 NWPSHLSQSKFCNLKL 517 (553)
Q Consensus 502 ~~dP~~RPs~~evl~~ 517 (553)
-.+|.+|++++++.+.
T Consensus 291 vl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 291 VLNPSKRGPCDQIMKD 306 (596)
T ss_pred ccCccccCCHHHhhhh
Confidence 9999999999999987
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=288.83 Aligned_cols=254 Identities=20% Similarity=0.213 Sum_probs=205.2
Q ss_pred HHHhhcccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCCh---hhHHHHHHHHHHhhccCCCceeeEeeEEeeCC
Q 008785 263 LRSITKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF---QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHG 338 (553)
Q Consensus 263 l~~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 338 (553)
..-.+.+.-...++||+|+||.||.+... +|+.+|.|.+.+... ......++|-.+|.+++.|.||.+--.|++.+
T Consensus 179 ~qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd 258 (591)
T KOG0986|consen 179 LQPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKD 258 (591)
T ss_pred hhhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCC
Confidence 34455555556778899999999999865 499999999865432 33456789999999999999999999999999
Q ss_pred ceEEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccc
Q 008785 339 DRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGL 418 (553)
Q Consensus 339 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgl 418 (553)
.+++|+..|.||+|.-+|.+ .++..+++..+..++.+|+.||++||.. +||.|||||+|||+|+.|.++|+|+|+
T Consensus 259 ~LClVLtlMNGGDLkfHiyn--~g~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGL 333 (591)
T KOG0986|consen 259 ALCLVLTLMNGGDLKFHIYN--HGNPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGL 333 (591)
T ss_pred ceEEEEEeecCCceeEEeec--cCCCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccce
Confidence 99999999999999988876 4556799999999999999999999999 999999999999999999999999999
Q ss_pred cccCCcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcCc-ccc-------cchHHHHHhcCCH---
Q 008785 419 SKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVL-CRR-------WWTLYTLVHSMSL--- 487 (553)
Q Consensus 419 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~-~~~-------~~~l~~~~~~~~~--- 487 (553)
|..+......... .||.+|||||++.+..|+...|.||+||++|||+... |.. ..++..++.+...
T Consensus 334 Avei~~g~~~~~r---vGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~ 410 (591)
T KOG0986|consen 334 AVEIPEGKPIRGR---VGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYS 410 (591)
T ss_pred EEecCCCCccccc---cCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcc
Confidence 9887766543322 3999999999999999999999999999999999522 211 1122223333222
Q ss_pred -HHHHHHHHHHhhccCCCCCCCCC-----HHHHHHHHHHHHhh
Q 008785 488 -LCAQECLMLFISCNNWPSHLSQS-----KFCNLKLWVFAILT 524 (553)
Q Consensus 488 -~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~~l~~~~~~ 524 (553)
..+++..++....|..||++|.- +.+|-++-.+.-.+
T Consensus 411 ~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~ln 453 (591)
T KOG0986|consen 411 DKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLN 453 (591)
T ss_pred cccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCC
Confidence 66778888888999999999864 45666665544433
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=286.53 Aligned_cols=239 Identities=20% Similarity=0.296 Sum_probs=186.4
Q ss_pred eecccCceeEEEEEeC-CCCEEEEEEeccCC-hhhHHHHHHHHHHhhccC-CCceeeEeeEEeeCCceEEEEEccCCCCH
Q 008785 276 LLGDSKTGGTYSGILP-DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLH-HPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352 (553)
Q Consensus 276 ~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lV~E~~~~gsL 352 (553)
.||+|+||.||++... +++.||+|.+.... ......+.+|+.++.++. ||||+++++++...+..+++|||+. +++
T Consensus 11 ~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~-~~l 89 (288)
T cd06616 11 EIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMD-ISL 89 (288)
T ss_pred HhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEeccc-CCH
Confidence 4599999999999965 48999999987543 234567889999999996 9999999999999999999999985 466
Q ss_pred HHHhccC-CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCccccccee
Q 008785 353 DRWLHHI-PRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT 431 (553)
Q Consensus 353 ~~~l~~~-~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~ 431 (553)
.++.... ......+++..+..++.|++.||+|||+. .+++||||||+||+++.++.++|+|||++..........
T Consensus 90 ~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~-- 165 (288)
T cd06616 90 DKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKT-- 165 (288)
T ss_pred HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEEeecchhHHhccCCccc--
Confidence 5543211 12235689999999999999999999963 289999999999999999999999999987654322111
Q ss_pred eecCccccccccccccCC---CCCcccchHhHHHHHHHHhcCc-ccccc-hHHHHHh---cCC---H------HHHHHHH
Q 008785 432 VMAGGTYGYLAPEFVYRN---ELTTKSDVYSFGVLLLEIRLVL-CRRWW-TLYTLVH---SMS---L------LCAQECL 494 (553)
Q Consensus 432 ~~~~gt~~y~aPE~~~~~---~~t~ksDVwSlGvil~ell~~~-~~~~~-~l~~~~~---~~~---~------~~~~~l~ 494 (553)
...|++.|+|||++.+. .++.++||||||+++|||++.. |.... ...+.+. .+. + ..+..+.
T Consensus 166 -~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 244 (288)
T cd06616 166 -RDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREFSPSFV 244 (288)
T ss_pred -cccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCCccCHHHH
Confidence 11278899999998766 6899999999999999999733 32221 2222111 111 1 3567899
Q ss_pred HHHhhccCCCCCCCCCHHHHHHHHHH
Q 008785 495 MLFISCNNWPSHLSQSKFCNLKLWVF 520 (553)
Q Consensus 495 ~l~~~Cl~~dP~~RPs~~evl~~l~~ 520 (553)
+++.+||+.||++|||+.+|+++-..
T Consensus 245 ~li~~~l~~~p~~Rpt~~~i~~~~~~ 270 (288)
T cd06616 245 NFINLCLIKDESKRPKYKELLEHPFI 270 (288)
T ss_pred HHHHHHccCChhhCcCHHHHhcChhh
Confidence 99999999999999999999987544
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=279.80 Aligned_cols=229 Identities=20% Similarity=0.205 Sum_probs=182.0
Q ss_pred eecccCceeEEEEEeC-CCCEEEEEEeccCChh---hHHHHHHHHHHh-hccCCCceeeEeeEEeeCCceEEEEEccCCC
Q 008785 276 LLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQ---RKKEFYSEIGRF-ARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 350 (553)
Q Consensus 276 ~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~~---~~~~~~~E~~~l-~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 350 (553)
.||+|++|.||+|... +|+.||+|.++..... ....+..|..++ ...+||||+++++++.+.+..++|+||++++
T Consensus 3 ~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 82 (260)
T cd05611 3 PISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGG 82 (260)
T ss_pred cCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCCC
Confidence 3599999999999864 5889999999764322 223345555444 4458999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccce
Q 008785 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER 430 (553)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 430 (553)
+|.+++.. ...+++..+..++.|++.||.|||+. +++||||+|+||++++++.++|+|||+++......
T Consensus 83 ~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~---- 151 (260)
T cd05611 83 DCASLIKT----LGGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENK---- 151 (260)
T ss_pred CHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccccc----
Confidence 99999964 23588999999999999999999999 99999999999999999999999999987543311
Q ss_pred eeecCccccccccccccCCCCCcccchHhHHHHHHHHhcCc-ccc---cchHHHHHhcCCH--------HHHHHHHHHHh
Q 008785 431 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVL-CRR---WWTLYTLVHSMSL--------LCAQECLMLFI 498 (553)
Q Consensus 431 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~-~~~---~~~l~~~~~~~~~--------~~~~~l~~l~~ 498 (553)
...+++.|+|||.+.+..++.++||||||+++|||++.. |.. ...+...+..+.. ..+..+.+++.
T Consensus 152 --~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 229 (260)
T cd05611 152 --KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLIN 229 (260)
T ss_pred --cCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHH
Confidence 122788999999998888899999999999999999732 222 2222222222221 35678999999
Q ss_pred hccCCCCCCCCCH---HHHHHH
Q 008785 499 SCNNWPSHLSQSK---FCNLKL 517 (553)
Q Consensus 499 ~Cl~~dP~~RPs~---~evl~~ 517 (553)
+||+.||++||++ .|++++
T Consensus 230 ~~l~~~p~~R~~~~~~~~~l~~ 251 (260)
T cd05611 230 RLLCMDPAKRLGANGYQEIKSH 251 (260)
T ss_pred HHccCCHHHccCCCcHHHHHcC
Confidence 9999999999966 465544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=276.70 Aligned_cols=236 Identities=25% Similarity=0.300 Sum_probs=194.8
Q ss_pred eeecccCceeEEEEEeC-CCCEEEEEEeccCCh--hhHHHHHHHHHHhhccCCCceeeEeeEEeeC--CceEEEEEccCC
Q 008785 275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF--QRKKEFYSEIGRFARLHHPNLVAVKGCCYDH--GDRYIVYEFVVN 349 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~~lV~E~~~~ 349 (553)
+.||+|++|.||+|... +++.|++|.+..... ...+.+.+|+.++++++||||+++++.+.+. ...++++||+++
T Consensus 6 ~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~ 85 (260)
T cd06606 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSG 85 (260)
T ss_pred eEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEecCC
Confidence 45699999999999976 589999999876542 4567889999999999999999999999988 789999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccc
Q 008785 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE 429 (553)
Q Consensus 350 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 429 (553)
++|.+++... ..+++..+..++.|++.||+|||+. +++|+||+|+||++++++.++|+|||.+..........
T Consensus 86 ~~L~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~ 158 (260)
T cd06606 86 GSLSSLLKKF----GKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGE 158 (260)
T ss_pred CcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEecccccccc
Confidence 9999999752 2689999999999999999999999 99999999999999999999999999998766543211
Q ss_pred eeeecCccccccccccccCCCCCcccchHhHHHHHHHHhc-Ccccccch-HHH-HHhc---CCH-----HHHHHHHHHHh
Q 008785 430 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-VLCRRWWT-LYT-LVHS---MSL-----LCAQECLMLFI 498 (553)
Q Consensus 430 ~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-~~~~~~~~-l~~-~~~~---~~~-----~~~~~l~~l~~ 498 (553)
......++..|+|||.+.....+.++||||||+++++|++ ..|..... ... .... ... ..+..+.+++.
T Consensus 159 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~ 238 (260)
T cd06606 159 GTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLR 238 (260)
T ss_pred cccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHHH
Confidence 1112237889999999988889999999999999999997 33332221 111 1111 111 45678999999
Q ss_pred hccCCCCCCCCCHHHHHHH
Q 008785 499 SCNNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 499 ~Cl~~dP~~RPs~~evl~~ 517 (553)
+|++.||++||++.|++++
T Consensus 239 ~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 239 KCLRRDPKKRPTADELLQH 257 (260)
T ss_pred HhCcCChhhCCCHHHHhhC
Confidence 9999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=281.63 Aligned_cols=238 Identities=21% Similarity=0.205 Sum_probs=184.8
Q ss_pred HHHHhhcccCCCCee-ecccCceeEEEEEeC-CCCEEEEEEeccCChhhHHHHHHHHHHhhcc-CCCceeeEeeEEeeCC
Q 008785 262 ELRSITKNFSEGNRL-LGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHG 338 (553)
Q Consensus 262 el~~~~~~~~~~~~~-iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~ 338 (553)
++....+++...+.+ +|+|+||.||++..+ ++..+|+|.+........ |+.....+ +||||+++++.+...+
T Consensus 8 ~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~ 82 (267)
T PHA03390 8 ELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLK 82 (267)
T ss_pred HHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCC
Confidence 334444555544443 699999999999964 588999999875432211 22222222 7999999999999999
Q ss_pred ceEEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCC-CeEEeecc
Q 008785 339 DRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF-GAHLMGVG 417 (553)
Q Consensus 339 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~-~~kl~Dfg 417 (553)
..++||||+++|+|.+++.. ...+++..+..++.|++.||.|||+. +++||||||+||+++.++ .++|+|||
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg 155 (267)
T PHA03390 83 GHVLIMDYIKDGDLFDLLKK----EGKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYG 155 (267)
T ss_pred eeEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCc
Confidence 99999999999999999964 23689999999999999999999999 999999999999999998 99999999
Q ss_pred ccccCCcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcCc-cccc---ch--HHHHHh--cCCH--
Q 008785 418 LSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVL-CRRW---WT--LYTLVH--SMSL-- 487 (553)
Q Consensus 418 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~-~~~~---~~--l~~~~~--~~~~-- 487 (553)
++........ ..++..|+|||++.+..++.++||||||+++|||++.. |... .. ...... ....
T Consensus 156 ~~~~~~~~~~------~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 229 (267)
T PHA03390 156 LCKIIGTPSC------YDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPF 229 (267)
T ss_pred cceecCCCcc------CCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCc
Confidence 9876543221 22788999999999889999999999999999999732 2211 11 111111 1111
Q ss_pred --HHHHHHHHHHhhccCCCCCCCCC-HHHHHHH
Q 008785 488 --LCAQECLMLFISCNNWPSHLSQS-KFCNLKL 517 (553)
Q Consensus 488 --~~~~~l~~l~~~Cl~~dP~~RPs-~~evl~~ 517 (553)
..+..+.+++.+||+.+|.+||+ +.|++++
T Consensus 230 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h 262 (267)
T PHA03390 230 IKNVSKNANDFVQSMLKYNINYRLTNYNEIIKH 262 (267)
T ss_pred ccccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence 46788999999999999999996 6998864
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=283.49 Aligned_cols=232 Identities=20% Similarity=0.243 Sum_probs=191.0
Q ss_pred eeecccCceeEEEEEeC-CCCEEEEEEeccCC---hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCC
Q 008785 275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 350 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 350 (553)
+.||.|+||.||++... +++.||+|.+.... ....+.+.+|++++++++||||+++++.+.+....++|+||++++
T Consensus 6 ~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 85 (258)
T cd05578 6 RVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGG 85 (258)
T ss_pred EEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeCCCCC
Confidence 45699999999999975 48999999997542 234578899999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccce
Q 008785 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER 430 (553)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 430 (553)
+|.+++.. ...+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++.........
T Consensus 86 ~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-- 156 (258)
T cd05578 86 DLRYHLSQ----KVKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT-- 156 (258)
T ss_pred CHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCCccc--
Confidence 99999964 24688999999999999999999999 9999999999999999999999999998765543211
Q ss_pred eeecCccccccccccccCCCCCcccchHhHHHHHHHHhcC-cccccc------hHHHHHhcCCH----HHHHHHHHHHhh
Q 008785 431 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLV-LCRRWW------TLYTLVHSMSL----LCAQECLMLFIS 499 (553)
Q Consensus 431 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~-~~~~~~------~l~~~~~~~~~----~~~~~l~~l~~~ 499 (553)
....|+..|+|||.+.+..++.++|+||||+++|+|++. .|.... .+......... ..+..+.+++.+
T Consensus 157 -~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 235 (258)
T cd05578 157 -TSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINK 235 (258)
T ss_pred -cccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccCcccCcHHHHHHHHH
Confidence 122378899999999888899999999999999999962 222221 11122111111 556789999999
Q ss_pred ccCCCCCCCCCH--HHHHH
Q 008785 500 CNNWPSHLSQSK--FCNLK 516 (553)
Q Consensus 500 Cl~~dP~~RPs~--~evl~ 516 (553)
||+.||.+||++ .|+++
T Consensus 236 ~l~~~p~~R~~~~~~~l~~ 254 (258)
T cd05578 236 LLERDPQKRLGDNLKDLKN 254 (258)
T ss_pred HccCChhHcCCccHHHHhc
Confidence 999999999999 77654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=283.68 Aligned_cols=235 Identities=23% Similarity=0.298 Sum_probs=185.7
Q ss_pred eeecccCceeEEEEEeC-CCCEEEEEEeccCC--hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCC
Q 008785 275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP 351 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gs 351 (553)
+.||+|++|.||+|... +|..||+|++.... ......+.+|+.++++++||||+++++++.+.+..+++|||++ ++
T Consensus 5 ~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~-~~ 83 (283)
T cd07835 5 EKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD-LD 83 (283)
T ss_pred eEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC-cC
Confidence 34599999999999964 69999999987543 2234568899999999999999999999999999999999994 69
Q ss_pred HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCccccccee
Q 008785 352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT 431 (553)
Q Consensus 352 L~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~ 431 (553)
|.+++... ....+++..+..++.|++.||+|||+. +++||||+|+||++++++.++|+|||++...........
T Consensus 84 l~~~~~~~--~~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~- 157 (283)
T cd07835 84 LKKYMDSS--PLTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYT- 157 (283)
T ss_pred HHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccccC-
Confidence 99998652 224689999999999999999999999 999999999999999999999999999975543221111
Q ss_pred eecCccccccccccccCC-CCCcccchHhHHHHHHHHhcCccc-ccch----HHHHHh----------------------
Q 008785 432 VMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIRLVLCR-RWWT----LYTLVH---------------------- 483 (553)
Q Consensus 432 ~~~~gt~~y~aPE~~~~~-~~t~ksDVwSlGvil~ell~~~~~-~~~~----l~~~~~---------------------- 483 (553)
...++..|+|||++.+. .++.++||||||+++|||++..+. ...+ +.+..+
T Consensus 158 -~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd07835 158 -HEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPT 236 (283)
T ss_pred -ccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhh
Confidence 11267889999988664 578999999999999999974322 1111 111000
Q ss_pred --cC---CH-----HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008785 484 --SM---SL-----LCAQECLMLFISCNNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 484 --~~---~~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 517 (553)
.. .. ..+..+.+++.+|++.||.+|||+.|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 237 FPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred cccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00 00 233678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=282.79 Aligned_cols=240 Identities=21% Similarity=0.250 Sum_probs=187.1
Q ss_pred cCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCCh-hhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEcc
Q 008785 270 FSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF-QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV 347 (553)
Q Consensus 270 ~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 347 (553)
|...++ ||+|++|.||+|+.. +|+.||||.++.... .....+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 2 y~~~~~-l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 2 FKQLEK-LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred ceEeee-eccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 333344 499999999999975 588999999976532 23466788999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccc
Q 008785 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM 427 (553)
Q Consensus 348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 427 (553)
+ ++|.+++.... ....+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||++........
T Consensus 81 ~-~~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~ 155 (284)
T cd07836 81 D-KDLKKYMDTHG-VRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN 155 (284)
T ss_pred C-ccHHHHHHhcC-CCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc
Confidence 7 48888886522 234589999999999999999999999 999999999999999999999999999975543221
Q ss_pred cceeeecCccccccccccccCC-CCCcccchHhHHHHHHHHhcCc-ccccchHHH----HHh--------------c-C-
Q 008785 428 QERTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIRLVL-CRRWWTLYT----LVH--------------S-M- 485 (553)
Q Consensus 428 ~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwSlGvil~ell~~~-~~~~~~l~~----~~~--------------~-~- 485 (553)
.. ....++..|+|||++.+. .++.++||||||+++|||++.. +....+..+ ... . .
T Consensus 156 ~~--~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07836 156 TF--SNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPE 233 (284)
T ss_pred cc--ccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCch
Confidence 11 112267889999988654 4688999999999999999732 221111111 000 0 0
Q ss_pred ---C-----------H--HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008785 486 ---S-----------L--LCAQECLMLFISCNNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 486 ---~-----------~--~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 517 (553)
. . ..+..+.+++.+|++.||.+||++.|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred hcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0 0 234667899999999999999999999864
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=275.72 Aligned_cols=234 Identities=24% Similarity=0.326 Sum_probs=193.0
Q ss_pred eeecccCceeEEEEEeC-CCCEEEEEEeccCCh--hhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCC
Q 008785 275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF--QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP 351 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gs 351 (553)
+.||+|++|.||++... +++.||+|.+..... ...+.+.+|++++++++|||++++++++.+.+..+++|||+++++
T Consensus 6 ~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~ 85 (254)
T cd06627 6 DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENGS 85 (254)
T ss_pred eEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecCCCCc
Confidence 45699999999999865 578999999987643 456789999999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCccccccee
Q 008785 352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT 431 (553)
Q Consensus 352 L~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~ 431 (553)
|.+++.. ...+++..+..++.|++.||.|||+. +++||||+|+||+++.++.++|+|||.+..........
T Consensus 86 L~~~~~~----~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~-- 156 (254)
T cd06627 86 LRQIIKK----FGPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDD-- 156 (254)
T ss_pred HHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCcccc--
Confidence 9999864 24689999999999999999999999 99999999999999999999999999998765433221
Q ss_pred eecCccccccccccccCCCCCcccchHhHHHHHHHHhcCc-ccccch-HHH---HHhcCCH----HHHHHHHHHHhhccC
Q 008785 432 VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVL-CRRWWT-LYT---LVHSMSL----LCAQECLMLFISCNN 502 (553)
Q Consensus 432 ~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~-~~~~~~-l~~---~~~~~~~----~~~~~l~~l~~~Cl~ 502 (553)
....++..|+|||...+..++.++||||||+++|+|++.. |..... ... ....... ..+..+.+++.+||+
T Consensus 157 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 236 (254)
T cd06627 157 ASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQCFQ 236 (254)
T ss_pred cccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHHh
Confidence 1123788999999998878899999999999999999733 222211 111 1111111 456788999999999
Q ss_pred CCCCCCCCHHHHHHH
Q 008785 503 WPSHLSQSKFCNLKL 517 (553)
Q Consensus 503 ~dP~~RPs~~evl~~ 517 (553)
.+|++|||+.+++++
T Consensus 237 ~~p~~R~~~~~~l~~ 251 (254)
T cd06627 237 KDPNLRPTAKQLLKH 251 (254)
T ss_pred CChhhCcCHHHHhcC
Confidence 999999999998863
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=284.29 Aligned_cols=240 Identities=18% Similarity=0.247 Sum_probs=185.1
Q ss_pred ccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCCh--hhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEE
Q 008785 269 NFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF--QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYE 345 (553)
Q Consensus 269 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 345 (553)
+|..... ||+|++|.||+|... +|+.||+|.+..... ...+.+.+|++++++++||||+++++++.+....++|||
T Consensus 3 ~y~~~~~-l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 3 QYEKVEK-IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred ceEEEEE-ecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 3444444 499999999999975 588999999865422 234678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecC-CCCeEEeeccccccCCc
Q 008785 346 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE-EFGAHLMGVGLSKFVPW 424 (553)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~-~~~~kl~Dfgla~~~~~ 424 (553)
|++ ++|.+++.. .....+++..+..++.||+.||+|||++ +++||||+|+||+++. ++.+||+|||++.....
T Consensus 82 ~~~-~~l~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~ 155 (294)
T PLN00009 82 YLD-LDLKKHMDS--SPDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (294)
T ss_pred ccc-ccHHHHHHh--CCCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence 995 588887754 2333467888889999999999999999 9999999999999985 45789999999976543
Q ss_pred ccccceeeecCccccccccccccCC-CCCcccchHhHHHHHHHHhcCcccc-cch----HHHHHh---c-----------
Q 008785 425 EVMQERTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIRLVLCRR-WWT----LYTLVH---S----------- 484 (553)
Q Consensus 425 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwSlGvil~ell~~~~~~-~~~----l~~~~~---~----------- 484 (553)
..... ....+++.|+|||++.+. .++.++||||||+++|+|++..+.. ... +..... .
T Consensus 156 ~~~~~--~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (294)
T PLN00009 156 PVRTF--THEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTS 233 (294)
T ss_pred Ccccc--ccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccc
Confidence 21111 111267899999988664 5789999999999999999843321 111 111100 0
Q ss_pred -------------CCH-----HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008785 485 -------------MSL-----LCAQECLMLFISCNNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 485 -------------~~~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 517 (553)
... ..+..+.+++.+|++.+|++||++.+++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 234 LPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred chhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 234668899999999999999999999986
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=286.30 Aligned_cols=241 Identities=17% Similarity=0.195 Sum_probs=185.7
Q ss_pred eccc--CceeEEEEEeC-CCCEEEEEEeccCC--hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCC
Q 008785 277 LGDS--KTGGTYSGILP-DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP 351 (553)
Q Consensus 277 iG~G--~~g~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gs 351 (553)
||+| +||+||++... +|+.||+|++.... ....+.+.+|+.+++.++||||+++++++...+..++|+||+.+++
T Consensus 6 ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~~ 85 (328)
T cd08226 6 IGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGS 85 (328)
T ss_pred hCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCCC
Confidence 3555 99999999964 69999999987542 3345678899999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccce-
Q 008785 352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER- 430 (553)
Q Consensus 352 L~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~- 430 (553)
|.+++... ....+++..+..++.|++.||+|||+. +++||||||+||+++.++.++++||+.+...........
T Consensus 86 l~~~l~~~--~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (328)
T cd08226 86 ANSLLKTY--FPEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV 160 (328)
T ss_pred HHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence 99998753 234588999999999999999999999 999999999999999999999999986543221111100
Q ss_pred ----eeecCccccccccccccCC--CCCcccchHhHHHHHHHHhcCc-ccccc----hHHHHHhc---------------
Q 008785 431 ----TVMAGGTYGYLAPEFVYRN--ELTTKSDVYSFGVLLLEIRLVL-CRRWW----TLYTLVHS--------------- 484 (553)
Q Consensus 431 ----~~~~~gt~~y~aPE~~~~~--~~t~ksDVwSlGvil~ell~~~-~~~~~----~l~~~~~~--------------- 484 (553)
.....++..|+|||++.+. .++.++||||||+++|||++.. |.... .+...+..
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (328)
T cd08226 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEE 240 (328)
T ss_pred cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhh
Confidence 0111245679999999764 4789999999999999999732 22111 11110000
Q ss_pred -----------------------------C------CHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 008785 485 -----------------------------M------SLLCAQECLMLFISCNNWPSHLSQSKFCNLKLWVFAI 522 (553)
Q Consensus 485 -----------------------------~------~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~~~ 522 (553)
. .......+.+++.+||+.||++|||+.|++++-...-
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~ 313 (328)
T cd08226 241 SRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQ 313 (328)
T ss_pred hhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHH
Confidence 0 0034567899999999999999999999998855433
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=285.20 Aligned_cols=238 Identities=19% Similarity=0.177 Sum_probs=185.3
Q ss_pred cccCceeEEEEEeCCCCEEEEEEeccC--ChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCCHHHH
Q 008785 278 GDSKTGGTYSGILPDGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRW 355 (553)
Q Consensus 278 G~G~~g~Vy~~~~~~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~ 355 (553)
|.|+++.||++.. +++.||||+++.. .....+.+.+|+.++++++||||+++++++.+.+..+++|||+++|+|.++
T Consensus 11 ~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~ 89 (314)
T cd08216 11 EDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDL 89 (314)
T ss_pred cCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHH
Confidence 5556666666655 7999999998754 344567899999999999999999999999999999999999999999999
Q ss_pred hccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCccccc-----ce
Q 008785 356 LHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ-----ER 430 (553)
Q Consensus 356 l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~-----~~ 430 (553)
+... ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||.+......... ..
T Consensus 90 l~~~--~~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~ 164 (314)
T cd08216 90 LKTH--FPEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDF 164 (314)
T ss_pred HHHh--cccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeeccccccccccccc
Confidence 9752 234588999999999999999999999 9999999999999999999999999988654322110 01
Q ss_pred eeecCccccccccccccC--CCCCcccchHhHHHHHHHHhcC-cccccch----HHHHHhc--------C----------
Q 008785 431 TVMAGGTYGYLAPEFVYR--NELTTKSDVYSFGVLLLEIRLV-LCRRWWT----LYTLVHS--------M---------- 485 (553)
Q Consensus 431 ~~~~~gt~~y~aPE~~~~--~~~t~ksDVwSlGvil~ell~~-~~~~~~~----l~~~~~~--------~---------- 485 (553)
.....++..|+|||++.. ..++.++||||||+++|||++. .|..... +.+.+.. .
T Consensus 165 ~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (314)
T cd08216 165 PKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMS 244 (314)
T ss_pred cccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcC
Confidence 111226778999999865 3588999999999999999972 2222111 1111100 0
Q ss_pred -------------------CHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 008785 486 -------------------SLLCAQECLMLFISCNNWPSHLSQSKFCNLKLWVFA 521 (553)
Q Consensus 486 -------------------~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~~ 521 (553)
.......+.+++.+||+.||++|||+.|++++-...
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~ 299 (314)
T cd08216 245 QSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFK 299 (314)
T ss_pred cccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHh
Confidence 003456788999999999999999999999985543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=281.12 Aligned_cols=231 Identities=19% Similarity=0.218 Sum_probs=180.9
Q ss_pred eecccCceeEEEEEeC-CCCEEEEEEeccCC-hhhHHHHHHHHHHhhccC-CCceeeEeeEEeeC--CceEEEEEccCCC
Q 008785 276 LLGDSKTGGTYSGILP-DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLH-HPNLVAVKGCCYDH--GDRYIVYEFVVNG 350 (553)
Q Consensus 276 ~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~--~~~~lV~E~~~~g 350 (553)
.||+|+||.||+|... +++.||+|.++... ........+|+..+.++. ||||+++++++.+. +..++||||++ |
T Consensus 6 ~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~ 84 (282)
T cd07831 6 KIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMD-M 84 (282)
T ss_pred eccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecCC-c
Confidence 4599999999999964 58899999987542 222234567899999985 99999999999987 88999999996 5
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccce
Q 008785 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER 430 (553)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 430 (553)
+|.+++.. ....+++..+..++.|++.||.|||+. +++||||+|+||+++. +.+||+|||+++..........
T Consensus 85 ~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~~~ 157 (282)
T cd07831 85 NLYELIKG---RKRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPYTE 157 (282)
T ss_pred cHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccCCCcCC
Confidence 88888764 224689999999999999999999999 9999999999999999 9999999999986543322111
Q ss_pred eeecCccccccccccccC-CCCCcccchHhHHHHHHHHhcCc-ccccch---HHHHHh---------------c---CC-
Q 008785 431 TVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIRLVL-CRRWWT---LYTLVH---------------S---MS- 486 (553)
Q Consensus 431 ~~~~~gt~~y~aPE~~~~-~~~t~ksDVwSlGvil~ell~~~-~~~~~~---l~~~~~---------------~---~~- 486 (553)
..++..|+|||++.. ..++.++|||||||++|||++.. +....+ ....+. . ..
T Consensus 158 ---~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
T cd07831 158 ---YISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNY 234 (282)
T ss_pred ---CCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccc
Confidence 227889999997654 55789999999999999999732 222111 111000 0 00
Q ss_pred --------------HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008785 487 --------------LLCAQECLMLFISCNNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 487 --------------~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 517 (553)
...+..+.+++.+||+.+|++|||+.+++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 235 NFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred cCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 0245789999999999999999999999875
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=291.69 Aligned_cols=239 Identities=20% Similarity=0.236 Sum_probs=187.5
Q ss_pred hhcccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccC--ChhhHHHHHHHHHHhhccCCCceeeEeeEEeeC-----
Q 008785 266 ITKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH----- 337 (553)
Q Consensus 266 ~~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~----- 337 (553)
+.+.|.... .||+|+||.||++... +|+.||||.+... .......+.+|+.++++++||||+++++++...
T Consensus 14 ~~~~y~~~~-~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 14 VLKRYQNLK-PIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred hhcceEEEE-EeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence 445666554 4599999999999964 6899999998643 233456778899999999999999999988644
Q ss_pred -CceEEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeec
Q 008785 338 -GDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGV 416 (553)
Q Consensus 338 -~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Df 416 (553)
...++||||+. ++|.+.+.. .++...+..++.|++.||+|||+. +++||||||+||+++.++.+||+||
T Consensus 93 ~~~~~lv~e~~~-~~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Df 162 (353)
T cd07850 93 FQDVYLVMELMD-ANLCQVIQM------DLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF 162 (353)
T ss_pred cCcEEEEEeccC-CCHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccC
Confidence 34699999995 588887753 288899999999999999999999 9999999999999999999999999
Q ss_pred cccccCCcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcCc-ccccchH-----------------
Q 008785 417 GLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVL-CRRWWTL----------------- 478 (553)
Q Consensus 417 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~-~~~~~~l----------------- 478 (553)
|+++........ ....++..|+|||.+.+..++.++||||||+++|+|++.. +....+.
T Consensus 163 g~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 239 (353)
T cd07850 163 GLARTAGTSFMM---TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDE 239 (353)
T ss_pred ccceeCCCCCCC---CCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence 999865433221 1122788999999999999999999999999999999732 2211110
Q ss_pred -HH--------HHhcCC------H------------------HHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008785 479 -YT--------LVHSMS------L------------------LCAQECLMLFISCNNWPSHLSQSKFCNLKLW 518 (553)
Q Consensus 479 -~~--------~~~~~~------~------------------~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l 518 (553)
.+ ...... + ..+..+.+++.+||+.||++|||+.|+|++-
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~ 312 (353)
T cd07850 240 FMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHP 312 (353)
T ss_pred HHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcCh
Confidence 00 000000 0 1245678999999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=280.44 Aligned_cols=231 Identities=19% Similarity=0.191 Sum_probs=181.7
Q ss_pred ecccCceeEEEEEeC-CCCEEEEEEeccCChh---hHHHHHHHHH---HhhccCCCceeeEeeEEeeCCceEEEEEccCC
Q 008785 277 LGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQ---RKKEFYSEIG---RFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 349 (553)
Q Consensus 277 iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~~---~~~~~~~E~~---~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 349 (553)
||+|+||.||++... +++.||+|.+...... ....+..|.. .++..+||||+++++++.+.+..++||||+++
T Consensus 2 ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~g 81 (278)
T cd05606 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNG 81 (278)
T ss_pred cccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCCC
Confidence 699999999999864 5889999998754221 1222344433 44445899999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccc
Q 008785 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE 429 (553)
Q Consensus 350 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 429 (553)
|+|.+++.. ...+++..+..++.|++.||.|||+. +++||||||+||++++++.++|+|||++........
T Consensus 82 ~~L~~~l~~----~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~-- 152 (278)
T cd05606 82 GDLHYHLSQ----HGVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-- 152 (278)
T ss_pred CcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccCC--
Confidence 999998853 24589999999999999999999999 999999999999999999999999999875533221
Q ss_pred eeeecCccccccccccccCC-CCCcccchHhHHHHHHHHhcCc-ccccc---hHHH---HHhcCCH----HHHHHHHHHH
Q 008785 430 RTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIRLVL-CRRWW---TLYT---LVHSMSL----LCAQECLMLF 497 (553)
Q Consensus 430 ~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwSlGvil~ell~~~-~~~~~---~l~~---~~~~~~~----~~~~~l~~l~ 497 (553)
....|+..|+|||.+.++ .++.++||||+|+++|||++.. |.... .... ....... ..+..+.+++
T Consensus 153 --~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li 230 (278)
T cd05606 153 --HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLL 230 (278)
T ss_pred --cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCCcCCHHHHHHH
Confidence 112389999999998754 6899999999999999999733 32221 1111 1111111 3467899999
Q ss_pred hhccCCCCCCCC-----CHHHHHHHH
Q 008785 498 ISCNNWPSHLSQ-----SKFCNLKLW 518 (553)
Q Consensus 498 ~~Cl~~dP~~RP-----s~~evl~~l 518 (553)
.+|+..+|.+|| ++.+++++-
T Consensus 231 ~~~l~~~p~~R~~~~~~~~~~ll~~~ 256 (278)
T cd05606 231 EGLLQRDVNRRLGCLGRGAQEVKEHP 256 (278)
T ss_pred HHHhhcCHHhccCCCCCCHHHHHhCc
Confidence 999999999999 999999753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=284.62 Aligned_cols=241 Identities=20% Similarity=0.298 Sum_probs=187.7
Q ss_pred cCCCCeeecccCceeEEEEEeCC-CCEEEEEEeccCC-hhhHHHHHHHHHHhhccC-CCceeeEeeEEeeCCceEEEEEc
Q 008785 270 FSEGNRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSS-FQRKKEFYSEIGRFARLH-HPNLVAVKGCCYDHGDRYIVYEF 346 (553)
Q Consensus 270 ~~~~~~~iG~G~~g~Vy~~~~~~-g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lV~E~ 346 (553)
|.... .||+|++|.||+|...+ ++.||||.++... ......+..|+.++.+.. ||||+++++++.+....+++|||
T Consensus 17 ~~~~~-~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~ 95 (296)
T cd06618 17 LENLG-EIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMEL 95 (296)
T ss_pred heeee-EeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeec
Confidence 33334 45999999999999865 8999999997643 233456777887777774 99999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcc
Q 008785 347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD-KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE 425 (553)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~ 425 (553)
++ ++|.+++.. ....+++..+..++.|++.||+|||+ . +|+||||+|+||++++++.+||+|||++......
T Consensus 96 ~~-~~l~~l~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~~---~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~ 168 (296)
T cd06618 96 MS-TCLDKLLKR---IQGPIPEDILGKMTVAIVKALHYLKEKH---GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDS 168 (296)
T ss_pred cC-cCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhhC---CEecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence 84 577777654 22368999999999999999999996 5 8999999999999999999999999998765433
Q ss_pred cccceeeecCccccccccccccCCC----CCcccchHhHHHHHHHHhcCc-cccc----chHHH-HHhcCCH------HH
Q 008785 426 VMQERTVMAGGTYGYLAPEFVYRNE----LTTKSDVYSFGVLLLEIRLVL-CRRW----WTLYT-LVHSMSL------LC 489 (553)
Q Consensus 426 ~~~~~~~~~~gt~~y~aPE~~~~~~----~t~ksDVwSlGvil~ell~~~-~~~~----~~l~~-~~~~~~~------~~ 489 (553)
..... ..++..|+|||.+.+.. ++.++||||||+++|||++.. |... ..... .+..... ..
T Consensus 169 ~~~~~---~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (296)
T cd06618 169 KAKTR---SAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGF 245 (296)
T ss_pred CcccC---CCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCCCCC
Confidence 22211 12778999999987543 789999999999999999733 3222 11111 2222111 35
Q ss_pred HHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 008785 490 AQECLMLFISCNNWPSHLSQSKFCNLKLWVFA 521 (553)
Q Consensus 490 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~~ 521 (553)
+.++.+++.+||+.||.+||++.+++++....
T Consensus 246 ~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~ 277 (296)
T cd06618 246 SPDFCSFVDLCLTKDHRKRPKYRELLQHPFIR 277 (296)
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHhcChhhh
Confidence 67899999999999999999999999875443
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=280.75 Aligned_cols=235 Identities=22% Similarity=0.252 Sum_probs=186.2
Q ss_pred eeecccCceeEEEEEeCC-CCEEEEEEeccCC--hhhHHHHHHHHHHhhccCCCceeeEeeEEeeC--CceEEEEEccCC
Q 008785 275 RLLGDSKTGGTYSGILPD-GSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH--GDRYIVYEFVVN 349 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~~-g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~~lV~E~~~~ 349 (553)
+.||+|++|.||+|...+ |+.||+|.++... ......+.+|+.++++++|||++++++++.+. +..++||||++
T Consensus 5 ~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~- 83 (287)
T cd07840 5 AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMD- 83 (287)
T ss_pred EEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEecccc-
Confidence 345999999999999764 8899999998653 33346788999999999999999999999988 78999999997
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccc
Q 008785 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE 429 (553)
Q Consensus 350 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 429 (553)
++|.+++.. ....+++..+..++.||+.||+|||+. +++|+||+|+||++++++.++|+|||++..........
T Consensus 84 ~~l~~~~~~---~~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~ 157 (287)
T cd07840 84 HDLTGLLDS---PEVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSAD 157 (287)
T ss_pred ccHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCCCccc
Confidence 489888864 224689999999999999999999999 99999999999999999999999999998665443211
Q ss_pred eeeecCccccccccccccC-CCCCcccchHhHHHHHHHHhcCc-ccccchHH---H-HHhc-------------------
Q 008785 430 RTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIRLVL-CRRWWTLY---T-LVHS------------------- 484 (553)
Q Consensus 430 ~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwSlGvil~ell~~~-~~~~~~l~---~-~~~~------------------- 484 (553)
.. ...++..|+|||.+.+ ..++.++||||||+++|||++.. +....... . ....
T Consensus 158 ~~-~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (287)
T cd07840 158 YT-NRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFE 236 (287)
T ss_pred cc-ccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhh
Confidence 11 1226788999998764 45789999999999999999732 22111110 0 0000
Q ss_pred -----C--------CH-H-HHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008785 485 -----M--------SL-L-CAQECLMLFISCNNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 485 -----~--------~~-~-~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 517 (553)
. .+ . .+..+.+++.+||+.+|.+||++.+++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 237 NLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred hccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 0 00 1 26778999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=282.76 Aligned_cols=231 Identities=22% Similarity=0.285 Sum_probs=186.2
Q ss_pred eecccCceeEEEEEeC-CCCEEEEEEeccC---ChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCC
Q 008785 276 LLGDSKTGGTYSGILP-DGSRVAVKRLKRS---SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP 351 (553)
Q Consensus 276 ~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gs 351 (553)
.||+|++|.||+|... +++.||+|.+... ......++.+|+++++.++|||++++++++......++||||+. |+
T Consensus 22 ~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~ 100 (308)
T cd06634 22 EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GS 100 (308)
T ss_pred heeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEccC-CC
Confidence 3599999999999965 5789999998642 22344678899999999999999999999999999999999996 68
Q ss_pred HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCccccccee
Q 008785 352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT 431 (553)
Q Consensus 352 L~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~ 431 (553)
|.+++.. ....+++..+..++.|++.||.|||+. +++||||+|+||+++.++.++|+|||++.......
T Consensus 101 l~~~~~~---~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~----- 169 (308)
T cd06634 101 ASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN----- 169 (308)
T ss_pred HHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecCcc-----
Confidence 8877753 234588999999999999999999999 99999999999999999999999999987654321
Q ss_pred eecCcccccccccccc---CCCCCcccchHhHHHHHHHHhcCc-ccccch---HHHHHhcCCH------HHHHHHHHHHh
Q 008785 432 VMAGGTYGYLAPEFVY---RNELTTKSDVYSFGVLLLEIRLVL-CRRWWT---LYTLVHSMSL------LCAQECLMLFI 498 (553)
Q Consensus 432 ~~~~gt~~y~aPE~~~---~~~~t~ksDVwSlGvil~ell~~~-~~~~~~---l~~~~~~~~~------~~~~~l~~l~~ 498 (553)
...+++.|+|||.+. ...++.++||||||+++|||++.. |..... ....+..+.. ..+..+.+++.
T Consensus 170 -~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 248 (308)
T cd06634 170 -XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVD 248 (308)
T ss_pred -cccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHHHHHH
Confidence 122788999999874 356788999999999999999743 322211 1111211111 46677899999
Q ss_pred hccCCCCCCCCCHHHHHHHHH
Q 008785 499 SCNNWPSHLSQSKFCNLKLWV 519 (553)
Q Consensus 499 ~Cl~~dP~~RPs~~evl~~l~ 519 (553)
+||+.+|++||++.+++++..
T Consensus 249 ~cl~~~P~~Rp~~~~ll~~~~ 269 (308)
T cd06634 249 SCLQKIPQDRPTSEVLLKHRF 269 (308)
T ss_pred HHhhCCcccCCCHHHHhhCcc
Confidence 999999999999999998743
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=285.65 Aligned_cols=243 Identities=21% Similarity=0.269 Sum_probs=187.2
Q ss_pred cccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCChh--hHHHHHHHHHHhhccCCCceeeEeeEEeeC--CceEE
Q 008785 268 KNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQ--RKKEFYSEIGRFARLHHPNLVAVKGCCYDH--GDRYI 342 (553)
Q Consensus 268 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~~l 342 (553)
.+|...+. ||+|+||.||+|... +|+.||+|.++..... ....+.+|+.++++++||||+++++++.+. +..++
T Consensus 7 ~~y~~~~~-ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 7 TEFEKLNR-IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred cceeEeee-eeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 34555444 599999999999975 5899999998754322 233567899999999999999999998765 45899
Q ss_pred EEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccC
Q 008785 343 VYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV 422 (553)
Q Consensus 343 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~ 422 (553)
||||+. ++|.+++... ...+++..+..++.||+.||+|||+. +++||||||+||++++++.+||+|||++...
T Consensus 86 v~e~~~-~~l~~~l~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~ 158 (309)
T cd07845 86 VMEYCE-QDLASLLDNM---PTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTY 158 (309)
T ss_pred EEecCC-CCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeec
Confidence 999996 5888888642 25689999999999999999999999 9999999999999999999999999999866
Q ss_pred CcccccceeeecCccccccccccccC-CCCCcccchHhHHHHHHHHhcCccc-ccch---HHHHHhc-------------
Q 008785 423 PWEVMQERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIRLVLCR-RWWT---LYTLVHS------------- 484 (553)
Q Consensus 423 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwSlGvil~ell~~~~~-~~~~---l~~~~~~------------- 484 (553)
........ ...+++.|+|||.+.+ ..++.++||||||+++|||++..+. ...+ ....+..
T Consensus 159 ~~~~~~~~--~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
T cd07845 159 GLPAKPMT--PKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGF 236 (309)
T ss_pred CCccCCCC--cccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhh
Confidence 53321111 1125778999999865 4578999999999999999973322 1111 1110000
Q ss_pred ------CCH---------------HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 008785 485 ------MSL---------------LCAQECLMLFISCNNWPSHLSQSKFCNLKLWVF 520 (553)
Q Consensus 485 ------~~~---------------~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~ 520 (553)
+.. ..+..+.+++.+|++.||++|||+.|++++-..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f 293 (309)
T cd07845 237 SDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYF 293 (309)
T ss_pred hcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhh
Confidence 000 135677899999999999999999999987544
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=283.11 Aligned_cols=229 Identities=22% Similarity=0.293 Sum_probs=184.5
Q ss_pred ecccCceeEEEEEeC-CCCEEEEEEeccCC---hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCCH
Q 008785 277 LGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352 (553)
Q Consensus 277 iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL 352 (553)
||+|+||.||+|+.. +|+.||+|.+.... ......+.+|+.++++++|||++++++++.+....|+||||+. |+|
T Consensus 29 lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l 107 (313)
T cd06633 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL-GSA 107 (313)
T ss_pred eccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCC-CCH
Confidence 599999999999964 58899999987532 2334678899999999999999999999999999999999995 678
Q ss_pred HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccceee
Q 008785 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV 432 (553)
Q Consensus 353 ~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~ 432 (553)
.+++.. ....+++.++..++.||+.||.|||+. +++||||+|+||++++++.+||+|||++.......
T Consensus 108 ~~~l~~---~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~~------ 175 (313)
T cd06633 108 SDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSPAN------ 175 (313)
T ss_pred HHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCCCC------
Confidence 777753 234589999999999999999999999 99999999999999999999999999986432211
Q ss_pred ecCcccccccccccc---CCCCCcccchHhHHHHHHHHhcCc-ccccchHHH----HHhcCCH-----HHHHHHHHHHhh
Q 008785 433 MAGGTYGYLAPEFVY---RNELTTKSDVYSFGVLLLEIRLVL-CRRWWTLYT----LVHSMSL-----LCAQECLMLFIS 499 (553)
Q Consensus 433 ~~~gt~~y~aPE~~~---~~~~t~ksDVwSlGvil~ell~~~-~~~~~~l~~----~~~~~~~-----~~~~~l~~l~~~ 499 (553)
...|+..|+|||++. ...++.++||||||+++|||++.. |....+... ....... ..+..+.+++.+
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 255 (313)
T cd06633 176 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVDY 255 (313)
T ss_pred CccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHHHHH
Confidence 123788999999984 456889999999999999999733 332222111 1111111 345678999999
Q ss_pred ccCCCCCCCCCHHHHHHHH
Q 008785 500 CNNWPSHLSQSKFCNLKLW 518 (553)
Q Consensus 500 Cl~~dP~~RPs~~evl~~l 518 (553)
||+.+|.+||++.+++++-
T Consensus 256 ~l~~~P~~Rp~~~~~l~~~ 274 (313)
T cd06633 256 CLQKIPQERPASAELLRHD 274 (313)
T ss_pred HccCChhhCcCHHHHhcCc
Confidence 9999999999999999763
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=288.05 Aligned_cols=247 Identities=17% Similarity=0.190 Sum_probs=190.6
Q ss_pred hhcccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCChhh--------------HHHHHHHHHHhhccCCCceeeE
Q 008785 266 ITKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQR--------------KKEFYSEIGRFARLHHPNLVAV 330 (553)
Q Consensus 266 ~~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~~~--------------~~~~~~E~~~l~~l~HpnIv~l 330 (553)
+.+.|.....+||+|+||.||+|... +++.||||.++...... ...+.+|++++++++||||+++
T Consensus 6 ~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~ 85 (335)
T PTZ00024 6 ISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGL 85 (335)
T ss_pred cccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeee
Confidence 34455555667799999999999965 58999999987542221 1257799999999999999999
Q ss_pred eeEEeeCCceEEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCC
Q 008785 331 KGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG 410 (553)
Q Consensus 331 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~ 410 (553)
++++...+..++||||+. |+|.+++.. ...+++.....++.|++.||+|||+. +++||||+|+||+++.++.
T Consensus 86 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~ 157 (335)
T PTZ00024 86 VDVYVEGDFINLVMDIMA-SDLKKVVDR----KIRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGI 157 (335)
T ss_pred eEEEecCCcEEEEEeccc-cCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCC
Confidence 999999999999999996 689998853 34588999999999999999999999 9999999999999999999
Q ss_pred eEEeeccccccCCcccc------------cceeeecCccccccccccccCC-CCCcccchHhHHHHHHHHhcCccc-ccc
Q 008785 411 AHLMGVGLSKFVPWEVM------------QERTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIRLVLCR-RWW 476 (553)
Q Consensus 411 ~kl~Dfgla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwSlGvil~ell~~~~~-~~~ 476 (553)
++|+|||++........ ........+++.|+|||.+.+. .++.++||||||+++|||++..+. ...
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~ 237 (335)
T PTZ00024 158 CKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGE 237 (335)
T ss_pred EEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999976541110 0011112267889999998764 468999999999999999973322 111
Q ss_pred ---hHHH----HHhcC-----------------------CH-----HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 008785 477 ---TLYT----LVHSM-----------------------SL-----LCAQECLMLFISCNNWPSHLSQSKFCNLKLWVF 520 (553)
Q Consensus 477 ---~l~~----~~~~~-----------------------~~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~ 520 (553)
.... .+... .. ..+..+.+++.+||+.+|++|||+.|++.+-..
T Consensus 238 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~ 316 (335)
T PTZ00024 238 NEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYF 316 (335)
T ss_pred CHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCccc
Confidence 1111 00000 00 225678899999999999999999999986544
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=275.32 Aligned_cols=250 Identities=17% Similarity=0.241 Sum_probs=190.0
Q ss_pred ccCCCCeeecccCceeEEEEEeCC-----CCEEEEEEeccCCh--hhHHHHHHHHHHhhccCCCceeeEeeEEee-CCce
Q 008785 269 NFSEGNRLLGDSKTGGTYSGILPD-----GSRVAVKRLKRSSF--QRKKEFYSEIGRFARLHHPNLVAVKGCCYD-HGDR 340 (553)
Q Consensus 269 ~~~~~~~~iG~G~~g~Vy~~~~~~-----g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~ 340 (553)
.|....++ |+|.||.||++.-.+ ...+|||+++.... .-.....+|+.+++.++||||+.+..++.+ +..+
T Consensus 25 ~ye~ig~I-g~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 25 EYEGIGKI-GRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred Hhhcccee-cccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 34444444 999999999997432 23799999986522 123557899999999999999999999988 6778
Q ss_pred EEEEEccCCCCHHHHhccCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCC----CCeEEee
Q 008785 341 YIVYEFVVNGPLDRWLHHIP-RGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE----FGAHLMG 415 (553)
Q Consensus 341 ~lV~E~~~~gsL~~~l~~~~-~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~----~~~kl~D 415 (553)
++++||.+. +|.+.++..+ ...+.++...+..|+.||+.|+.|||++ =|+||||||.|||+..+ |.+||+|
T Consensus 104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEeec
Confidence 999999965 8988886532 2346789999999999999999999999 89999999999999877 8999999
Q ss_pred ccccccCCcccccc-eeeecCccccccccccccCC-CCCcccchHhHHHHHHHHhcCc--------------ccccchHH
Q 008785 416 VGLSKFVPWEVMQE-RTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIRLVL--------------CRRWWTLY 479 (553)
Q Consensus 416 fgla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwSlGvil~ell~~~--------------~~~~~~l~ 479 (553)
||+++.+...-... ......-|..|.|||.+.+. .||++.||||.|||+.||++.. |.....+.
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~ 259 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD 259 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence 99999876542221 11112268999999999875 5899999999999999999511 22221111
Q ss_pred H---HHhcCC-----------------------------H--------HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 008785 480 T---LVHSMS-----------------------------L--------LCAQECLMLFISCNNWPSHLSQSKFCNLKLWV 519 (553)
Q Consensus 480 ~---~~~~~~-----------------------------~--------~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~ 519 (553)
. ++.... + .-++...+|+..+|+.||.+|.|+.|.+++..
T Consensus 260 rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~y 339 (438)
T KOG0666|consen 260 RIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPY 339 (438)
T ss_pred HHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccc
Confidence 1 100000 0 12334789999999999999999999999866
Q ss_pred HHHh
Q 008785 520 FAIL 523 (553)
Q Consensus 520 ~~~~ 523 (553)
+..-
T Consensus 340 F~~d 343 (438)
T KOG0666|consen 340 FTED 343 (438)
T ss_pred cccC
Confidence 5443
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=278.67 Aligned_cols=234 Identities=23% Similarity=0.303 Sum_probs=183.8
Q ss_pred eeecccCceeEEEEEeCC-CCEEEEEEeccCCh--hhHHHHHHHHHHhhcc---CCCceeeEeeEEeeCCc-----eEEE
Q 008785 275 RLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSF--QRKKEFYSEIGRFARL---HHPNLVAVKGCCYDHGD-----RYIV 343 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~~-g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l---~HpnIv~l~~~~~~~~~-----~~lV 343 (553)
..||+|+||.||+|...+ ++.||+|.++.... .....+.+|+.+++++ +||||+++++++.+.+. .+++
T Consensus 5 ~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l~ 84 (287)
T cd07838 5 AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLV 84 (287)
T ss_pred EEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeEEE
Confidence 346999999999999865 89999999974322 2234566787777665 69999999999998776 8999
Q ss_pred EEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCC
Q 008785 344 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVP 423 (553)
Q Consensus 344 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~ 423 (553)
|||+. ++|.+++... ....+++..+..++.|++.||.|||+. +++|+||+|+||++++++.+||+|||++....
T Consensus 85 ~e~~~-~~l~~~l~~~--~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~ 158 (287)
T cd07838 85 FEHVD-QDLATYLSKC--PKPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYS 158 (287)
T ss_pred ehhcc-cCHHHHHHHc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcceecc
Confidence 99996 5899888652 223589999999999999999999999 99999999999999999999999999997764
Q ss_pred cccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcCcccc-cchHHH----HHh---------------
Q 008785 424 WEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVLCRR-WWTLYT----LVH--------------- 483 (553)
Q Consensus 424 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~~~~-~~~l~~----~~~--------------- 483 (553)
....... ..++..|+|||++.+..++.++|+||||+++|||++..+.. .....+ ...
T Consensus 159 ~~~~~~~---~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07838 159 FEMALTS---VVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVS 235 (287)
T ss_pred CCccccc---ccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcc
Confidence 3322111 12678899999999889999999999999999999743321 111111 100
Q ss_pred -------cCC---H-----HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008785 484 -------SMS---L-----LCAQECLMLFISCNNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 484 -------~~~---~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 517 (553)
.+. . .....+.+++.+||+.||++||++.|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 236 LPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred cchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 000 0 345677899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=278.45 Aligned_cols=237 Identities=20% Similarity=0.248 Sum_probs=187.6
Q ss_pred eeecccCceeEEEEEeCC-CCEEEEEEeccC-----ChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccC
Q 008785 275 RLLGDSKTGGTYSGILPD-GSRVAVKRLKRS-----SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV 348 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~~-g~~vAvK~~~~~-----~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 348 (553)
+.||+|+||.||++.... +..+++|.++.. .......+.+|+.++++++||||+++++++.+....++||||++
T Consensus 6 ~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (260)
T cd08222 6 QRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIITEYCE 85 (260)
T ss_pred eeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEEEeCC
Confidence 346999999999998643 455666666532 12234457789999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCccccc
Q 008785 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ 428 (553)
Q Consensus 349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 428 (553)
+++|.+++.........+++..+..++.|++.||.|||+. +++|+||+|+||++++ +.++|+|||.+.........
T Consensus 86 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~~~ 161 (260)
T cd08222 86 GRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSCDL 161 (260)
T ss_pred CCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecCCCccc
Confidence 9999998875434456789999999999999999999999 9999999999999976 56999999998765433221
Q ss_pred ceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcC-cccccchHHH---HHhcCCH-----HHHHHHHHHHhh
Q 008785 429 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLV-LCRRWWTLYT---LVHSMSL-----LCAQECLMLFIS 499 (553)
Q Consensus 429 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~-~~~~~~~l~~---~~~~~~~-----~~~~~l~~l~~~ 499 (553)
. ....|++.|+|||.+.+..++.++|+||||+++|+|++. .+........ .+..+.. ..+..+.+++.+
T Consensus 162 ~--~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 239 (260)
T cd08222 162 A--TTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSIMQS 239 (260)
T ss_pred c--cCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCCcchhcHHHHHHHHH
Confidence 1 122378899999999888889999999999999999973 2332222222 2222221 566789999999
Q ss_pred ccCCCCCCCCCHHHHHHH
Q 008785 500 CNNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 500 Cl~~dP~~RPs~~evl~~ 517 (553)
||+.+|++||++.|++++
T Consensus 240 ~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 240 MLNKDPSLRPSAAEILRN 257 (260)
T ss_pred HhcCChhhCcCHHHHhhC
Confidence 999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=281.89 Aligned_cols=242 Identities=22% Similarity=0.240 Sum_probs=186.9
Q ss_pred hcccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCC--hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCC-----
Q 008785 267 TKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHG----- 338 (553)
Q Consensus 267 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~----- 338 (553)
.++|.....+ |+|+||.||+|... +|+.||+|.++... ......+.+|+.++++++||||+++++++.+..
T Consensus 6 ~~~~~~~~~l-g~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~ 84 (302)
T cd07864 6 VDKFDIIGQI-GEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF 84 (302)
T ss_pred hhhhheeeee-cccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence 4456555544 99999999999975 48899999997542 223456788999999999999999999987654
Q ss_pred -----ceEEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEE
Q 008785 339 -----DRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHL 413 (553)
Q Consensus 339 -----~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl 413 (553)
..++|+||+++ ++.+++.. ....+++..+..++.||+.||+|||+. +|+||||||+||++++++.+||
T Consensus 85 ~~~~~~~~lv~e~~~~-~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~kl 157 (302)
T cd07864 85 KKDKGAFYLVFEYMDH-DLMGLLES---GLVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKL 157 (302)
T ss_pred cccCCcEEEEEcccCc-cHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEEe
Confidence 68999999975 77777754 234689999999999999999999999 9999999999999999999999
Q ss_pred eeccccccCCcccccceeeecCccccccccccccC-CCCCcccchHhHHHHHHHHhcCcc-cccchHHH---HHhc---C
Q 008785 414 MGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIRLVLC-RRWWTLYT---LVHS---M 485 (553)
Q Consensus 414 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwSlGvil~ell~~~~-~~~~~l~~---~~~~---~ 485 (553)
+|||++............ ...++..|+|||.+.+ ..++.++||||||+++|||++..+ ....+..+ .+.. +
T Consensus 158 ~dfg~~~~~~~~~~~~~~-~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~ 236 (302)
T cd07864 158 ADFGLARLYNSEESRPYT-NKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGS 236 (302)
T ss_pred CcccccccccCCcccccc-cceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence 999999866543321111 1125778999998865 357899999999999999997332 21111111 0000 0
Q ss_pred C-------------------------------HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008785 486 S-------------------------------LLCAQECLMLFISCNNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 486 ~-------------------------------~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 517 (553)
. ...+..+.+++.+||+.||++|||+.+++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 237 PCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred CChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0 0235788999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=281.22 Aligned_cols=237 Identities=14% Similarity=0.178 Sum_probs=173.6
Q ss_pred CeeecccCceeEEEEEeCC----CCEEEEEEeccCChhh-----------HHHHHHHHHHhhccCCCceeeEeeEEeeCC
Q 008785 274 NRLLGDSKTGGTYSGILPD----GSRVAVKRLKRSSFQR-----------KKEFYSEIGRFARLHHPNLVAVKGCCYDHG 338 (553)
Q Consensus 274 ~~~iG~G~~g~Vy~~~~~~----g~~vAvK~~~~~~~~~-----------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 338 (553)
.++||+|+||.||+|...+ +..+|+|+........ ......+...+..++|+||+++++++....
T Consensus 17 ~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~ 96 (294)
T PHA02882 17 DKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGCGSFKR 96 (294)
T ss_pred eeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEeeeEec
Confidence 4456999999999999754 3456777543222111 011233445566779999999999766543
Q ss_pred ----ceEEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEe
Q 008785 339 ----DRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLM 414 (553)
Q Consensus 339 ----~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~ 414 (553)
..++++|++. .++.+.+.. ....++..+..++.|++.||+|||+. +|+||||||+|||++.++.++|+
T Consensus 97 ~~~~~~~~~~~~~~-~~~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~~~~~l~ 168 (294)
T PHA02882 97 CRMYYRFILLEKLV-ENTKEIFKR----IKCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNNRGYII 168 (294)
T ss_pred CCceEEEEEEehhc-cCHHHHHHh----hccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCcEEEE
Confidence 3478888874 467666643 12357788899999999999999999 99999999999999999999999
Q ss_pred eccccccCCccccc-----ceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcC-cccccc----hH------
Q 008785 415 GVGLSKFVPWEVMQ-----ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLV-LCRRWW----TL------ 478 (553)
Q Consensus 415 Dfgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~-~~~~~~----~l------ 478 (553)
|||+|+........ .......||+.|+|||+..+..++.++|||||||++|||++. .|.... .+
T Consensus 169 DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~ 248 (294)
T PHA02882 169 DYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKC 248 (294)
T ss_pred EcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHH
Confidence 99999765432111 111122489999999999999999999999999999999973 332211 11
Q ss_pred --HHHHhcCCH---HHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008785 479 --YTLVHSMSL---LCAQECLMLFISCNNWPSHLSQSKFCNLKLW 518 (553)
Q Consensus 479 --~~~~~~~~~---~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l 518 (553)
...+..+.. ..+..+.+++..|++.+|++||++.++++.+
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 249 DFIKRLHEGKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHHHHhhhhhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 122233332 4567799999999999999999999998754
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=282.52 Aligned_cols=242 Identities=19% Similarity=0.222 Sum_probs=183.0
Q ss_pred cccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCCh--hhHHHHHHHHHHhhccCCCceeeEeeEEeeCCc-----
Q 008785 268 KNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF--QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGD----- 339 (553)
Q Consensus 268 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~----- 339 (553)
++|..... ||+|+||.||++... +++.||||.+..... .....+.+|+.++++++||||+++++++...+.
T Consensus 12 ~~y~~~~~-lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 12 SKYEKLAK-IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hheEEEEE-eecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 34555444 599999999999965 589999999865422 223456789999999999999999999876543
Q ss_pred ---eEEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeec
Q 008785 340 ---RYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGV 416 (553)
Q Consensus 340 ---~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Df 416 (553)
.++||||+. ++|.+++.. ....+++.++..++.||+.||+|||++ +++|+||||+||+++.++.+||+||
T Consensus 91 ~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~df 163 (310)
T cd07865 91 KGSFYLVFEFCE-HDLAGLLSN---KNVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADF 163 (310)
T ss_pred CceEEEEEcCCC-cCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcC
Confidence 499999995 588888764 234589999999999999999999999 9999999999999999999999999
Q ss_pred cccccCCcccccc--eeeecCccccccccccccCCC-CCcccchHhHHHHHHHHhcCccc-ccch---HHHHHhc-----
Q 008785 417 GLSKFVPWEVMQE--RTVMAGGTYGYLAPEFVYRNE-LTTKSDVYSFGVLLLEIRLVLCR-RWWT---LYTLVHS----- 484 (553)
Q Consensus 417 gla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~-~t~ksDVwSlGvil~ell~~~~~-~~~~---l~~~~~~----- 484 (553)
|++.......... ......++..|+|||.+.+.. ++.++||||||+++|||++..+. ...+ ....+..
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~ 243 (310)
T cd07865 164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSI 243 (310)
T ss_pred CCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 9997654332211 111122678899999886643 68899999999999999973321 1111 0000000
Q ss_pred ---------------------CCH----------HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008785 485 ---------------------MSL----------LCAQECLMLFISCNNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 485 ---------------------~~~----------~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 517 (553)
... .....+.+++.+||+.||++|||+.|++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 244 TPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred ChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 000 113456789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=279.88 Aligned_cols=235 Identities=18% Similarity=0.163 Sum_probs=186.6
Q ss_pred eeecccCceeEEEEEe----CCCCEEEEEEeccCCh----hhHHHHHHHHHHhhcc-CCCceeeEeeEEeeCCceEEEEE
Q 008785 275 RLLGDSKTGGTYSGIL----PDGSRVAVKRLKRSSF----QRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYE 345 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~----~~g~~vAvK~~~~~~~----~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E 345 (553)
+.||+|+||.||.+.. .+|+.||+|+++.... ...+.+.+|+.++.++ +||||+++++.+..+...++|||
T Consensus 6 ~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (290)
T cd05613 6 KVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILD 85 (290)
T ss_pred eeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEEEEe
Confidence 3459999999999985 3689999999975422 2346678899999999 69999999999999889999999
Q ss_pred ccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcc
Q 008785 346 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE 425 (553)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~ 425 (553)
|+++++|.+++.. ...+++..+..++.|++.||.|||+. +++||||+|+|||+++++.+||+|||++......
T Consensus 86 ~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 158 (290)
T cd05613 86 YINGGELFTHLSQ----RERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHED 158 (290)
T ss_pred cCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccceecccc
Confidence 9999999999864 24578899999999999999999999 9999999999999999999999999999765433
Q ss_pred cccceeeecCccccccccccccCC--CCCcccchHhHHHHHHHHhcCc-cccc-------chHHHHHhcCCH----HHHH
Q 008785 426 VMQERTVMAGGTYGYLAPEFVYRN--ELTTKSDVYSFGVLLLEIRLVL-CRRW-------WTLYTLVHSMSL----LCAQ 491 (553)
Q Consensus 426 ~~~~~~~~~~gt~~y~aPE~~~~~--~~t~ksDVwSlGvil~ell~~~-~~~~-------~~l~~~~~~~~~----~~~~ 491 (553)
..... ....|+..|+|||.+... .++.++||||||+++|+|++.. |... ..+...+..... ....
T Consensus 159 ~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (290)
T cd05613 159 EVERA-YSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSA 237 (290)
T ss_pred ccccc-ccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCCccCCH
Confidence 22211 122378899999998753 4688999999999999999733 3211 111111111111 3456
Q ss_pred HHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 008785 492 ECLMLFISCNNWPSHLSQ-----SKFCNLKL 517 (553)
Q Consensus 492 ~l~~l~~~Cl~~dP~~RP-----s~~evl~~ 517 (553)
.+.+++.+||+.||++|| ++.+++++
T Consensus 238 ~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 238 LAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred HHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 788999999999999997 77888775
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=289.31 Aligned_cols=242 Identities=19% Similarity=0.231 Sum_probs=186.0
Q ss_pred hcccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCC-hhhHHHHHHHHHHhhccCCCceeeEeeEEeeC-----Cc
Q 008785 267 TKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH-----GD 339 (553)
Q Consensus 267 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~-----~~ 339 (553)
.++|.... .||+|++|.||+|... +|+.||||.++... ......+.+|+.++++++||||+++++++... ..
T Consensus 4 ~~~y~i~~-~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 4 GPRYQNLS-YIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred ccceEEEE-EEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 34555544 4599999999999854 58999999987432 23446688999999999999999999987654 34
Q ss_pred eEEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeecccc
Q 008785 340 RYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLS 419 (553)
Q Consensus 340 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla 419 (553)
.++|+||+. ++|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 83 ~~lv~e~~~-~~l~~~~~~-----~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~ 153 (336)
T cd07849 83 VYIVQELME-TDLYKLIKT-----QHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLA 153 (336)
T ss_pred EEEEehhcc-cCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccce
Confidence 799999996 588887753 3589999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCcccccce-eeecCccccccccccccC-CCCCcccchHhHHHHHHHHhcCccc-ccchHHH-------HHhc-----
Q 008785 420 KFVPWEVMQER-TVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIRLVLCR-RWWTLYT-------LVHS----- 484 (553)
Q Consensus 420 ~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~-~~~t~ksDVwSlGvil~ell~~~~~-~~~~l~~-------~~~~----- 484 (553)
........... .....|++.|+|||.+.+ ..++.++||||||+++|||++..+. ...+... .+..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~ 233 (336)
T cd07849 154 RIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQED 233 (336)
T ss_pred eeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHH
Confidence 76543222111 111237889999998754 4689999999999999999973322 1111100 0000
Q ss_pred ------------------CC---H-----HHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008785 485 ------------------MS---L-----LCAQECLMLFISCNNWPSHLSQSKFCNLKLW 518 (553)
Q Consensus 485 ------------------~~---~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l 518 (553)
.. . ..+..+.+++.+||+.||++|||+.|++++-
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp 293 (336)
T cd07849 234 LNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHP 293 (336)
T ss_pred HHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCc
Confidence 00 0 1245688999999999999999999999983
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=265.93 Aligned_cols=233 Identities=21% Similarity=0.306 Sum_probs=190.0
Q ss_pred ecccCceeEEEEEeCC-CCEEEEEEeccC-ChhhHHHHHHHHHHhhccC-CCceeeEeeEEeeCCceEEEEEccCCCCHH
Q 008785 277 LGDSKTGGTYSGILPD-GSRVAVKRLKRS-SFQRKKEFYSEIGRFARLH-HPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 353 (553)
Q Consensus 277 iG~G~~g~Vy~~~~~~-g~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~ 353 (553)
||.|+.|.|++.+... |...|||.+.+. +....++++..+.++.+-+ .|.||+.+|+|..+...++.||.|. .-++
T Consensus 100 lGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs-~C~e 178 (391)
T KOG0983|consen 100 LGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS-TCAE 178 (391)
T ss_pred hcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH-HHHH
Confidence 5999999999999754 899999999876 3445677888888887775 8999999999999999999999984 3456
Q ss_pred HHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccceeee
Q 008785 354 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVM 433 (553)
Q Consensus 354 ~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 433 (553)
.+|+. ...++++..+-++...+.+||.||.+++ +|+|||+||+|||+|+.|++|++|||++..+.....+....
T Consensus 179 kLlkr---ik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAhtrsA- 252 (391)
T KOG0983|consen 179 KLLKR---IKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAHTRSA- 252 (391)
T ss_pred HHHHH---hcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeeccccccccc-
Confidence 66653 3456888888899999999999998774 99999999999999999999999999998876655444332
Q ss_pred cCccccccccccccC---CCCCcccchHhHHHHHHHHhc-Ccccc----cchHHH-HHhcCCH------HHHHHHHHHHh
Q 008785 434 AGGTYGYLAPEFVYR---NELTTKSDVYSFGVLLLEIRL-VLCRR----WWTLYT-LVHSMSL------LCAQECLMLFI 498 (553)
Q Consensus 434 ~~gt~~y~aPE~~~~---~~~t~ksDVwSlGvil~ell~-~~~~~----~~~l~~-~~~~~~~------~~~~~l~~l~~ 498 (553)
|.+.|||||.+.- ..|+.++||||||++++||.| ..|.. +.+... .+++... ..++.+.+++.
T Consensus 253 --GC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~gFSp~F~~fv~ 330 (391)
T KOG0983|consen 253 --GCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMGFSPDFQSFVK 330 (391)
T ss_pred --CCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccCcCHHHHHHHH
Confidence 8999999999863 468999999999999999998 33332 222333 2222211 47889999999
Q ss_pred hccCCCCCCCCCHHHHHHHH
Q 008785 499 SCNNWPSHLSQSKFCNLKLW 518 (553)
Q Consensus 499 ~Cl~~dP~~RPs~~evl~~l 518 (553)
.||..|+.+||...++|++-
T Consensus 331 ~CL~kd~r~RP~Y~~Ll~h~ 350 (391)
T KOG0983|consen 331 DCLTKDHRKRPKYNKLLEHP 350 (391)
T ss_pred HHhhcCcccCcchHHHhcCc
Confidence 99999999999999999763
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-33 Score=274.20 Aligned_cols=240 Identities=22% Similarity=0.293 Sum_probs=188.3
Q ss_pred ccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccC-----ChhhHHHHHHHHHHhhccCCCceeeEeeEEeeC--Cce
Q 008785 269 NFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS-----SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH--GDR 340 (553)
Q Consensus 269 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~-----~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~ 340 (553)
+|... ++||+|++|.||+|... +++.||+|.+... .......+.+|+.++++++||||+++++++.+. +..
T Consensus 3 ~~~~~-~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 3 NWRLG-KLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred ceeee-eeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 34443 45699999999999964 5899999987532 123346788999999999999999999998764 457
Q ss_pred EEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccc
Q 008785 341 YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSK 420 (553)
Q Consensus 341 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~ 420 (553)
++++||+++++|.+++.. ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||+++
T Consensus 82 ~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~ 154 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKA----YGALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK 154 (264)
T ss_pred EEEEEeCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcccccc
Confidence 899999999999999864 23478899999999999999999999 99999999999999999999999999997
Q ss_pred cCCccccc-ceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcC-cccccchHHH----HHhcCC---H--HH
Q 008785 421 FVPWEVMQ-ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLV-LCRRWWTLYT----LVHSMS---L--LC 489 (553)
Q Consensus 421 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~-~~~~~~~l~~----~~~~~~---~--~~ 489 (553)
........ .......++..|+|||.+.+..++.++|+||||+++|||++. .|........ ...... + ..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~ 234 (264)
T cd06653 155 RIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGV 234 (264)
T ss_pred ccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCccc
Confidence 65432111 111112378899999999888899999999999999999973 3332222111 211111 1 55
Q ss_pred HHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008785 490 AQECLMLFISCNNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 490 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 517 (553)
...+.+++.+|+. +|..||++.+++++
T Consensus 235 ~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 235 SDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred CHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 6789999999999 57999999998865
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=270.94 Aligned_cols=240 Identities=18% Similarity=0.194 Sum_probs=198.2
Q ss_pred HhhcccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCChhhHHHHHHHHHHhhcc-CCCceeeEeeEEeeC----C
Q 008785 265 SITKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDH----G 338 (553)
Q Consensus 265 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~----~ 338 (553)
.++.+|....++||-|-.|.|-.+..+ +|+.+|+|++... ....+|+++.-.. .|||||++++++.+. .
T Consensus 58 ~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rk 132 (400)
T KOG0604|consen 58 SITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRK 132 (400)
T ss_pred cchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCce
Confidence 577888888899999999999998865 5899999998654 3345677765555 699999999998753 3
Q ss_pred ceEEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecC---CCCeEEee
Q 008785 339 DRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE---EFGAHLMG 415 (553)
Q Consensus 339 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~---~~~~kl~D 415 (553)
-+.+|||.|+||.|.+-+++ ++...+++.++..|++||+.|+.|||+. +|.||||||+|+|... |..+||+|
T Consensus 133 cLLiVmE~meGGeLfsriq~--~g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtD 207 (400)
T KOG0604|consen 133 CLLIVMECMEGGELFSRIQD--RGDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTD 207 (400)
T ss_pred eeEeeeecccchHHHHHHHH--cccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEecc
Confidence 46899999999999999987 5667899999999999999999999999 9999999999999964 45689999
Q ss_pred ccccccCCcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcCccccc--------chHHHHHhcCCH
Q 008785 416 VGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVLCRRW--------WTLYTLVHSMSL 487 (553)
Q Consensus 416 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~~~~~--------~~l~~~~~~~~~ 487 (553)
||+|+..... ....+.+-||.|.|||++....|+..+|+||+||++|-|+...|... ..+...+..|..
T Consensus 208 fGFAK~t~~~---~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy 284 (400)
T KOG0604|consen 208 FGFAKETQEP---GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQY 284 (400)
T ss_pred cccccccCCC---ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCc
Confidence 9999865432 22334457999999999998999999999999999999996333322 123336666665
Q ss_pred --------HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008785 488 --------LCAQECLMLFISCNNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 488 --------~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 517 (553)
..++...++|...|..+|.+|.|+.|++++
T Consensus 285 ~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 285 EFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred cCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 677788999999999999999999999876
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=286.54 Aligned_cols=242 Identities=21% Similarity=0.258 Sum_probs=186.4
Q ss_pred hcccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccC--ChhhHHHHHHHHHHhhcc-CCCceeeEeeEEeeC--Cce
Q 008785 267 TKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS--SFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDH--GDR 340 (553)
Q Consensus 267 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~--~~~ 340 (553)
.++|..... ||+|+||.||+|... +|+.||+|++... .......+.+|+.+++++ +||||+++++++... ...
T Consensus 6 ~~~y~~~~~-lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 6 LRKYEILQK-LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhHHHHhHh-hcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 344555444 499999999999975 5889999988542 233445678899999999 999999999988654 357
Q ss_pred EEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccc
Q 008785 341 YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSK 420 (553)
Q Consensus 341 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~ 420 (553)
++||||++ ++|..++.. ..+++..+..++.||+.||+|||+. +|+||||||+||++++++.+||+|||++.
T Consensus 85 ~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~ 155 (337)
T cd07852 85 YLVFEYME-TDLHAVIRA-----NILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLAR 155 (337)
T ss_pred EEEecccc-cCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchh
Confidence 99999996 599988854 2678899999999999999999999 99999999999999999999999999998
Q ss_pred cCCccccc---ceeeecCccccccccccccC-CCCCcccchHhHHHHHHHHhcCcccc-cch---HHH-H----------
Q 008785 421 FVPWEVMQ---ERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIRLVLCRR-WWT---LYT-L---------- 481 (553)
Q Consensus 421 ~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwSlGvil~ell~~~~~~-~~~---l~~-~---------- 481 (553)
........ .......|+..|+|||.+.+ ..++.++||||||+++|||++..+.. ... ... .
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 235 (337)
T cd07852 156 SLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAE 235 (337)
T ss_pred ccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 65443221 11111237889999998765 45789999999999999999733221 110 000 0
Q ss_pred -------------Hh---cCC---H-----HHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008785 482 -------------VH---SMS---L-----LCAQECLMLFISCNNWPSHLSQSKFCNLKLW 518 (553)
Q Consensus 482 -------------~~---~~~---~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l 518 (553)
+. ... . ..+..+.+++.+||+.||++|||+.+++++-
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~ 296 (337)
T cd07852 236 DIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHP 296 (337)
T ss_pred HHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhCh
Confidence 00 000 0 2356789999999999999999999999883
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=286.46 Aligned_cols=242 Identities=22% Similarity=0.233 Sum_probs=187.3
Q ss_pred cccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccC--ChhhHHHHHHHHHHhhccCCCceeeEeeEEeeC-----Cc
Q 008785 268 KNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH-----GD 339 (553)
Q Consensus 268 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~-----~~ 339 (553)
+.|.... .||+|+||.||++... +++.||||.++.. .......+.+|+.+++.++||||+++++++... ..
T Consensus 5 ~~y~~~~-~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 5 TKYVPIK-PIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred cceeEEE-EeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 3454444 5699999999999964 5899999998753 223345677899999999999999999987654 34
Q ss_pred eEEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeecccc
Q 008785 340 RYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLS 419 (553)
Q Consensus 340 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla 419 (553)
.++|+||+. ++|.+++.. ...+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||++
T Consensus 84 ~~lv~e~~~-~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~ 155 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRS----SQTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLA 155 (337)
T ss_pred EEEEEeCCC-CCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccc
Confidence 799999995 789888853 24589999999999999999999999 9999999999999999999999999999
Q ss_pred ccCCcccccceeeecCccccccccccccC-CCCCcccchHhHHHHHHHHhcCcc-cccchHHH-------H---------
Q 008785 420 KFVPWEVMQERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIRLVLC-RRWWTLYT-------L--------- 481 (553)
Q Consensus 420 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwSlGvil~ell~~~~-~~~~~l~~-------~--------- 481 (553)
.......... ....++..|+|||.+.+ ..++.++||||||+++|+|++..+ ....+..+ .
T Consensus 156 ~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 233 (337)
T cd07858 156 RTTSEKGDFM--TEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDL 233 (337)
T ss_pred cccCCCcccc--cccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHh
Confidence 8654332111 11227889999998865 468999999999999999997332 21111000 0
Q ss_pred -----------Hhc------CCH-----HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 008785 482 -----------VHS------MSL-----LCAQECLMLFISCNNWPSHLSQSKFCNLKLWVF 520 (553)
Q Consensus 482 -----------~~~------~~~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~ 520 (553)
++. ... ..+..+.+++.+||+.+|++|||+.|++++-..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~ 294 (337)
T cd07858 234 GFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYL 294 (337)
T ss_pred hhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcch
Confidence 000 000 345678899999999999999999999998443
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=277.84 Aligned_cols=233 Identities=23% Similarity=0.290 Sum_probs=187.8
Q ss_pred eecccCceeEEEEEeC-CCCEEEEEEeccCCh--hhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCCH
Q 008785 276 LLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF--QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352 (553)
Q Consensus 276 ~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL 352 (553)
.||+|++|.||++... +|+.+|+|.++.... .....+.+|+.++++++||||+++++++...+..++|+||+++ +|
T Consensus 6 ~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~-~l 84 (283)
T cd05118 6 KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT-DL 84 (283)
T ss_pred eeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccCC-CH
Confidence 4599999999999975 588999999876532 2456788999999999999999999999999999999999965 88
Q ss_pred HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccceee
Q 008785 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV 432 (553)
Q Consensus 353 ~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~ 432 (553)
.+++.. ....+++..+..++.|++.||.|||+. +++|+||||+||++++++.++|+|||.+.......... .
T Consensus 85 ~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~--~ 156 (283)
T cd05118 85 YKLIKD---RQRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPY--T 156 (283)
T ss_pred HHHHHh---hcccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccc--c
Confidence 888864 225689999999999999999999999 99999999999999999999999999987665443111 1
Q ss_pred ecCccccccccccccCC-CCCcccchHhHHHHHHHHhcCc-ccccchHHH----HHh---c---------------C---
Q 008785 433 MAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIRLVL-CRRWWTLYT----LVH---S---------------M--- 485 (553)
Q Consensus 433 ~~~gt~~y~aPE~~~~~-~~t~ksDVwSlGvil~ell~~~-~~~~~~l~~----~~~---~---------------~--- 485 (553)
...++..|+|||.+.+. .++.++|+||||+++|+|++.. +....+..+ ... . .
T Consensus 157 ~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd05118 157 HYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFS 236 (283)
T ss_pred CccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhh
Confidence 12277889999998776 7899999999999999999833 221111111 000 0 0
Q ss_pred ----C--------HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008785 486 ----S--------LLCAQECLMLFISCNNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 486 ----~--------~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 517 (553)
. ...+..+.+++.+||+.||.+||++.+++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 237 FPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 0 0245679999999999999999999999874
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=279.41 Aligned_cols=235 Identities=19% Similarity=0.238 Sum_probs=191.3
Q ss_pred eecccCceeEEEEEeC-CCCEEEEEEeccC---ChhhHHHHHHHHHHhhccC-CCceeeEeeEEeeCCceEEEEEccCCC
Q 008785 276 LLGDSKTGGTYSGILP-DGSRVAVKRLKRS---SFQRKKEFYSEIGRFARLH-HPNLVAVKGCCYDHGDRYIVYEFVVNG 350 (553)
Q Consensus 276 ~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lV~E~~~~g 350 (553)
.||+|++|.||++... +|+.||+|++... .......+.+|+.++.+++ ||||+++++++.+.+..++||||++++
T Consensus 8 ~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 87 (280)
T cd05581 8 IIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNG 87 (280)
T ss_pred eecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEcCCCCC
Confidence 4599999999999975 6899999998753 2233467889999999998 999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCccccc--
Q 008785 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ-- 428 (553)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~-- 428 (553)
+|.+++.. ...+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++++|||++.........
T Consensus 88 ~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~ 160 (280)
T cd05581 88 ELLQYIRK----YGSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPES 160 (280)
T ss_pred cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccCCcccccc
Confidence 99999965 23699999999999999999999999 9999999999999999999999999998765543221
Q ss_pred ----------------ceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcCc-ccccc---hHHHHHhcCCH-
Q 008785 429 ----------------ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVL-CRRWW---TLYTLVHSMSL- 487 (553)
Q Consensus 429 ----------------~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~-~~~~~---~l~~~~~~~~~- 487 (553)
.......++..|+|||......++.++||||||++++++++.. |.... ...+.+.....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 240 (280)
T cd05581 161 NKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEYS 240 (280)
T ss_pred CCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhcCCC
Confidence 1111223688999999998888999999999999999999732 22221 11122212111
Q ss_pred ---HHHHHHHHHHhhccCCCCCCCCCH----HHHHHH
Q 008785 488 ---LCAQECLMLFISCNNWPSHLSQSK----FCNLKL 517 (553)
Q Consensus 488 ---~~~~~l~~l~~~Cl~~dP~~RPs~----~evl~~ 517 (553)
..+..+.+++.+||+.+|++|||+ .+++++
T Consensus 241 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 241 FPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred CCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 456789999999999999999999 887764
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=275.82 Aligned_cols=233 Identities=21% Similarity=0.344 Sum_probs=184.1
Q ss_pred eecccCceeEEEEEeCC-CCEEEEEEeccCCh-hhHHHHHHHHHHhhccC-CCceeeEeeEEeeCCceEEEEEccCCCCH
Q 008785 276 LLGDSKTGGTYSGILPD-GSRVAVKRLKRSSF-QRKKEFYSEIGRFARLH-HPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352 (553)
Q Consensus 276 ~iG~G~~g~Vy~~~~~~-g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lV~E~~~~gsL 352 (553)
.||+|++|.||+|...+ ++.||||.+..... .......+|+..+++++ ||||+++++++.+.+..++||||+ +|+|
T Consensus 6 ~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~l 84 (283)
T cd07830 6 QLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-EGNL 84 (283)
T ss_pred eeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-CCCH
Confidence 45999999999999764 78999999875422 22334567999999998 999999999999999999999999 8899
Q ss_pred HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccceee
Q 008785 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV 432 (553)
Q Consensus 353 ~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~ 432 (553)
.+++... ....+++..+..++.|++.+|.|||++ +++|+||+|+||++++++.++|+|||++...........
T Consensus 85 ~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~-- 157 (283)
T cd07830 85 YQLMKDR--KGKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTD-- 157 (283)
T ss_pred HHHHHhc--ccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCCCcCC--
Confidence 9988652 234689999999999999999999999 999999999999999999999999999976543322111
Q ss_pred ecCccccccccccccC-CCCCcccchHhHHHHHHHHhcCcccc-cchHHH----HH------------------hc----
Q 008785 433 MAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIRLVLCRR-WWTLYT----LV------------------HS---- 484 (553)
Q Consensus 433 ~~~gt~~y~aPE~~~~-~~~t~ksDVwSlGvil~ell~~~~~~-~~~l~~----~~------------------~~---- 484 (553)
..++..|+|||++.+ ..++.++|+||||++++||++..+.. .....+ .. ..
T Consensus 158 -~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd07830 158 -YVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFR 236 (283)
T ss_pred -CCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccccc
Confidence 127888999998854 45789999999999999999733211 111100 00 00
Q ss_pred ------CCH-----HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008785 485 ------MSL-----LCAQECLMLFISCNNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 485 ------~~~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 517 (553)
... .....+.+++.+||+.||++|||+.|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 237 FPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred ccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 000 123678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=286.26 Aligned_cols=235 Identities=20% Similarity=0.289 Sum_probs=199.2
Q ss_pred CeeecccCceeEEEEEeC-CCCEEEEEEeccCC--hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCC
Q 008785 274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 350 (553)
Q Consensus 274 ~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 350 (553)
.++||+|.||+||-|+.+ +|+.||||++.+.. .+....+.+|+.+|.+++||.||.+...|++.+..++|||-+ +|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HG 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cc
Confidence 356799999999999964 69999999997653 344578899999999999999999999999999999999999 56
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCC---CCeEEeeccccccCCcccc
Q 008785 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE---FGAHLMGVGLSKFVPWEVM 427 (553)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~---~~~kl~Dfgla~~~~~~~~ 427 (553)
++.+.+-. .....+++.....++.||+.||.|||.+ +|+|+||||+|||+.+. -++||+|||.|+++.....
T Consensus 648 DMLEMILS--sEkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF 722 (888)
T KOG4236|consen 648 DMLEMILS--SEKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF 722 (888)
T ss_pred hHHHHHHH--hhcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchhhh
Confidence 77666654 2345688888889999999999999999 99999999999999654 4689999999999886654
Q ss_pred cceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhc-Ccc-cccchHHHHHhcCCH--------HHHHHHHHHH
Q 008785 428 QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-VLC-RRWWTLYTLVHSMSL--------LCAQECLMLF 497 (553)
Q Consensus 428 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-~~~-~~~~~l~~~~~~~~~--------~~~~~l~~l~ 497 (553)
... ..|||.|.|||++++..|+..-|+||.|||+|--++ ..| .++.++-+.+.+..+ +.....+++|
T Consensus 723 Rrs---VVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaFMyPp~PW~eis~~AidlI 799 (888)
T KOG4236|consen 723 RRS---VVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAFMYPPNPWSEISPEAIDLI 799 (888)
T ss_pred hhh---hcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhccccccCCCchhhcCHHHHHHH
Confidence 432 239999999999999999999999999999998886 334 345567677777666 6777889999
Q ss_pred hhccCCCCCCCCCHHHHHHH
Q 008785 498 ISCNNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 498 ~~Cl~~dP~~RPs~~evl~~ 517 (553)
...|+..-.+|-|....+.+
T Consensus 800 n~LLqVkm~kRysvdk~lsh 819 (888)
T KOG4236|consen 800 NNLLQVKMRKRYSVDKSLSH 819 (888)
T ss_pred HHHHHHHHHHhcchHhhccc
Confidence 99999999999999887754
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=272.10 Aligned_cols=231 Identities=23% Similarity=0.231 Sum_probs=190.0
Q ss_pred ecccCceeEEEEEeC-CCCEEEEEEeccCCh---hhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCCH
Q 008785 277 LGDSKTGGTYSGILP-DGSRVAVKRLKRSSF---QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352 (553)
Q Consensus 277 iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL 352 (553)
||+|++|.||++... +++.||+|.++.... .....+..|+.++++++||||+++++.+...+..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 599999999999975 489999999876532 2456788999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccceee
Q 008785 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV 432 (553)
Q Consensus 353 ~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~ 432 (553)
.+++.. ...+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++......... ..
T Consensus 81 ~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~--~~ 151 (250)
T cd05123 81 FSHLSK----EGRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSR--TN 151 (250)
T ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCCCc--cc
Confidence 999964 23589999999999999999999999 9999999999999999999999999998765443211 11
Q ss_pred ecCccccccccccccCCCCCcccchHhHHHHHHHHhcC-cccccc---hHHHHHhcCCH----HHHHHHHHHHhhccCCC
Q 008785 433 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLV-LCRRWW---TLYTLVHSMSL----LCAQECLMLFISCNNWP 504 (553)
Q Consensus 433 ~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~-~~~~~~---~l~~~~~~~~~----~~~~~l~~l~~~Cl~~d 504 (553)
...++..|+|||...+...+.++|+||||+++||+++. .|.... .+.+.+..+.. ..+..+.+++.+||..|
T Consensus 152 ~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~ 231 (250)
T cd05123 152 TFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQKD 231 (250)
T ss_pred CCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhcCC
Confidence 22378899999999888889999999999999999973 232222 22222222322 44678899999999999
Q ss_pred CCCCCCH---HHHHH
Q 008785 505 SHLSQSK---FCNLK 516 (553)
Q Consensus 505 P~~RPs~---~evl~ 516 (553)
|++||++ .++++
T Consensus 232 p~~R~~~~~~~~l~~ 246 (250)
T cd05123 232 PTKRLGSGGAEEIKA 246 (250)
T ss_pred HhhCCCcccHHHHHh
Confidence 9999999 56554
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=293.25 Aligned_cols=245 Identities=22% Similarity=0.273 Sum_probs=189.6
Q ss_pred CeeecccCceeEEEEEe-CCCCEEEEEEeccCC-hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCC------ceEEEEE
Q 008785 274 NRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHG------DRYIVYE 345 (553)
Q Consensus 274 ~~~iG~G~~g~Vy~~~~-~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~------~~~lV~E 345 (553)
.+.||+|+||.||+|+. ..|+.||||.++... ....+...+|+++|++++|||||+++++-.+.. ...+|||
T Consensus 18 ~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmE 97 (732)
T KOG4250|consen 18 DERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVME 97 (732)
T ss_pred hhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEe
Confidence 34569999999999994 469999999998753 344677889999999999999999999865443 4689999
Q ss_pred ccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEec--CCCC--eEEeecccccc
Q 008785 346 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD--EEFG--AHLMGVGLSKF 421 (553)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~--~~~~--~kl~Dfgla~~ 421 (553)
||.+|||...|.. +.+...+++.+.+.++.+++.||.|||++ ||+||||||.||++- ++|+ -||+|||.|+.
T Consensus 98 yC~gGsL~~~L~~-PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Are 173 (732)
T KOG4250|consen 98 YCSGGSLRKVLNS-PENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARE 173 (732)
T ss_pred ecCCCcHHHHhcC-cccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeeccccccc
Confidence 9999999999986 34567799999999999999999999999 999999999999984 3343 69999999998
Q ss_pred CCcccccceeeecCccccccccccccC-CCCCcccchHhHHHHHHHHhc----Ccccccc-hH----HHH----------
Q 008785 422 VPWEVMQERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIRL----VLCRRWW-TL----YTL---------- 481 (553)
Q Consensus 422 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwSlGvil~ell~----~~~~~~~-~l----~~~---------- 481 (553)
.+.+.. .....||..|.+||.+.+ ..|+..+|.|||||++||.+| +.|.... +. ...
T Consensus 174 l~d~s~---~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i 250 (732)
T KOG4250|consen 174 LDDNSL---FTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAI 250 (732)
T ss_pred CCCCCe---eeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeE
Confidence 876542 223349999999999985 789999999999999999997 3332222 11 111
Q ss_pred ----HhcCCH--------------HHHHHHHHHHhhccCCCCCCCC--CHHHHHHHHHHHHhhc
Q 008785 482 ----VHSMSL--------------LCAQECLMLFISCNNWPSHLSQ--SKFCNLKLWVFAILTI 525 (553)
Q Consensus 482 ----~~~~~~--------------~~~~~l~~l~~~Cl~~dP~~RP--s~~evl~~l~~~~~~~ 525 (553)
-.+|.+ .....+-..+..+|..+|.+|- ...+....+-..+...
T Consensus 251 ~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~~ 314 (732)
T KOG4250|consen 251 GAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNLK 314 (732)
T ss_pred eeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhhh
Confidence 111222 3444566677777888888888 6666555554444433
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=285.63 Aligned_cols=244 Identities=19% Similarity=0.254 Sum_probs=188.0
Q ss_pred cccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCC--hhhHHHHHHHHHHhhccCCCceeeEeeEEee----CCce
Q 008785 268 KNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYD----HGDR 340 (553)
Q Consensus 268 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~----~~~~ 340 (553)
.+|.... .||+|++|.||+|... +|+.||+|++.... ......+.+|+.++++++||||+++++++.. ....
T Consensus 5 ~~y~~~~-~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 5 SRYKPIE-NIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hceeeee-eeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 4455444 4599999999999965 58999999987542 2335677889999999999999999998763 3457
Q ss_pred EEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccc
Q 008785 341 YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSK 420 (553)
Q Consensus 341 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~ 420 (553)
++||||+. |+|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+||++++++.+||+|||++.
T Consensus 84 ~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~ 155 (334)
T cd07855 84 YVVMDLME-SDLHHIIHS----DQPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMAR 155 (334)
T ss_pred EEEEehhh-hhHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccce
Confidence 99999995 689988853 24489999999999999999999999 99999999999999999999999999997
Q ss_pred cCCccccccee--eecCccccccccccccC-CCCCcccchHhHHHHHHHHhcCcc-cccchHHH----------------
Q 008785 421 FVPWEVMQERT--VMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIRLVLC-RRWWTLYT---------------- 480 (553)
Q Consensus 421 ~~~~~~~~~~~--~~~~gt~~y~aPE~~~~-~~~t~ksDVwSlGvil~ell~~~~-~~~~~l~~---------------- 480 (553)
........... ....++..|+|||.+.+ ..++.++||||||+++|||++..+ ....+...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~ 235 (334)
T cd07855 156 GLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEV 235 (334)
T ss_pred eecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHh
Confidence 65433221111 11237889999998865 458999999999999999997322 21111100
Q ss_pred -----------HHhc-C---C-------HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 008785 481 -----------LVHS-M---S-------LLCAQECLMLFISCNNWPSHLSQSKFCNLKLWVF 520 (553)
Q Consensus 481 -----------~~~~-~---~-------~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~ 520 (553)
.+.. . . ...+..+.+++.+||+.+|.+|||+.+++++-..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~ 297 (334)
T cd07855 236 LNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFL 297 (334)
T ss_pred hhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhh
Confidence 0000 0 0 0245778999999999999999999999987444
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-33 Score=277.88 Aligned_cols=234 Identities=20% Similarity=0.169 Sum_probs=185.1
Q ss_pred eeecccCceeEEEEEe----CCCCEEEEEEeccCC----hhhHHHHHHHHHHhhcc-CCCceeeEeeEEeeCCceEEEEE
Q 008785 275 RLLGDSKTGGTYSGIL----PDGSRVAVKRLKRSS----FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYE 345 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~----~~g~~vAvK~~~~~~----~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E 345 (553)
+.||+|++|.||++.. .+++.||||.++... ....+.+.+|+.++.++ +||||+++++.+......++|||
T Consensus 6 ~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~e 85 (288)
T cd05583 6 RVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLILD 85 (288)
T ss_pred EEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEEEEe
Confidence 4569999999999884 357899999987542 22345688999999999 69999999999999999999999
Q ss_pred ccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcc
Q 008785 346 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE 425 (553)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~ 425 (553)
|+++|+|.+++.. ...+++..+..++.|++.||.|||+. +++||||+|+||+++.++.++|+|||+++.....
T Consensus 86 ~~~~~~L~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 158 (288)
T cd05583 86 YVNGGELFTHLYQ----REHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAE 158 (288)
T ss_pred cCCCCcHHHHHhh----cCCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECccccccccc
Confidence 9999999999863 24588999999999999999999999 9999999999999999999999999998765443
Q ss_pred cccceeeecCccccccccccccCCC--CCcccchHhHHHHHHHHhcCc-cccc-------chHHHHHhcCCH----HHHH
Q 008785 426 VMQERTVMAGGTYGYLAPEFVYRNE--LTTKSDVYSFGVLLLEIRLVL-CRRW-------WTLYTLVHSMSL----LCAQ 491 (553)
Q Consensus 426 ~~~~~~~~~~gt~~y~aPE~~~~~~--~t~ksDVwSlGvil~ell~~~-~~~~-------~~l~~~~~~~~~----~~~~ 491 (553)
..... ....|+..|+|||.+.+.. .+.++||||||+++|||++.. |... ..+...+..... ..+.
T Consensus 159 ~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd05583 159 EEERA-YSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSA 237 (288)
T ss_pred ccccc-ccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCCCcccCH
Confidence 22111 1223788999999987654 788999999999999999733 3211 111111111111 4566
Q ss_pred HHHHHHhhccCCCCCCCCCHHHHHH
Q 008785 492 ECLMLFISCNNWPSHLSQSKFCNLK 516 (553)
Q Consensus 492 ~l~~l~~~Cl~~dP~~RPs~~evl~ 516 (553)
.+.+++.+||+.||++|||+.++.+
T Consensus 238 ~l~~li~~~l~~~p~~R~t~~~~~~ 262 (288)
T cd05583 238 EARDFIQKLLEKDPKKRLGANGADE 262 (288)
T ss_pred HHHHHHHHHhcCCHhhccCcchHHH
Confidence 7899999999999999999876644
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-33 Score=284.55 Aligned_cols=237 Identities=17% Similarity=0.258 Sum_probs=183.3
Q ss_pred hcccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCC--hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCC-----
Q 008785 267 TKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHG----- 338 (553)
Q Consensus 267 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~----- 338 (553)
.++|... ..||+|+||.||+|... +|+.||||+++... ......+.+|+.++++++||||+++++++....
T Consensus 14 ~~~y~~~-~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 92 (342)
T cd07879 14 PERYTSL-KQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEF 92 (342)
T ss_pred ccceEEE-EEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCC
Confidence 3566554 45599999999999964 68999999987532 223456889999999999999999999987543
Q ss_pred -ceEEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeecc
Q 008785 339 -DRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVG 417 (553)
Q Consensus 339 -~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg 417 (553)
..++|+||+. .+|.+++. ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||
T Consensus 93 ~~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg 162 (342)
T cd07879 93 QDFYLVMPYMQ-TDLQKIMG------HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFG 162 (342)
T ss_pred ceEEEEecccc-cCHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCC
Confidence 4589999996 47776652 2488999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCcccccceeeecCccccccccccccC-CCCCcccchHhHHHHHHHHhcCc-ccccchHHH----HHh--------
Q 008785 418 LSKFVPWEVMQERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIRLVL-CRRWWTLYT----LVH-------- 483 (553)
Q Consensus 418 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwSlGvil~ell~~~-~~~~~~l~~----~~~-------- 483 (553)
+++....... ...++..|+|||.+.+ ..++.++||||||+++|||++.. +....+..+ .+.
T Consensus 163 ~~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 237 (342)
T cd07879 163 LARHADAEMT-----GYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPE 237 (342)
T ss_pred CCcCCCCCCC-----CceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence 9876432211 1126788999999876 46899999999999999999732 222211111 100
Q ss_pred ------c---------------CCH-----HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 008785 484 ------S---------------MSL-----LCAQECLMLFISCNNWPSHLSQSKFCNLKLWV 519 (553)
Q Consensus 484 ------~---------------~~~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~ 519 (553)
. ... ..+..+.+++.+||+.||++||++.+++++-.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~ 299 (342)
T cd07879 238 FVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPY 299 (342)
T ss_pred HHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcc
Confidence 0 000 12356789999999999999999999998733
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=282.65 Aligned_cols=244 Identities=18% Similarity=0.263 Sum_probs=188.9
Q ss_pred HHhhcccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccC--ChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCC--
Q 008785 264 RSITKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHG-- 338 (553)
Q Consensus 264 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~-- 338 (553)
..+.++|..... ||+|+||.||++... +|..||||.+... .......+.+|+.++++++||||+++++++....
T Consensus 11 ~~~~~~y~~~~~-lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07880 11 WEVPDRYRDLKQ-VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL 89 (343)
T ss_pred hccccceEEEEE-eeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence 345556665544 599999999999854 6899999998653 2223456889999999999999999999987654
Q ss_pred ----ceEEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEe
Q 008785 339 ----DRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLM 414 (553)
Q Consensus 339 ----~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~ 414 (553)
..++||||+ +++|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.++|+
T Consensus 90 ~~~~~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~ 160 (343)
T cd07880 90 DRFHDFYLVMPFM-GTDLGKLMKH-----EKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKIL 160 (343)
T ss_pred cccceEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEe
Confidence 358999999 7799888753 3589999999999999999999999 99999999999999999999999
Q ss_pred eccccccCCcccccceeeecCccccccccccccC-CCCCcccchHhHHHHHHHHhcCc-ccccchH----HHHHh-----
Q 008785 415 GVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIRLVL-CRRWWTL----YTLVH----- 483 (553)
Q Consensus 415 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwSlGvil~ell~~~-~~~~~~l----~~~~~----- 483 (553)
|||++........ ...+++.|+|||.+.+ ..++.++|+||||+++|++++.. +...... .+...
T Consensus 161 dfg~~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 235 (343)
T cd07880 161 DFGLARQTDSEMT-----GYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTP 235 (343)
T ss_pred ecccccccccCcc-----ccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 9999976543211 1227889999999876 45889999999999999999733 2221111 00000
Q ss_pred ---------cC---------------CH-----HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 008785 484 ---------SM---------------SL-----LCAQECLMLFISCNNWPSHLSQSKFCNLKLWVFAI 522 (553)
Q Consensus 484 ---------~~---------------~~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~~~ 522 (553)
.. .+ ..+..+.+++.+|++.||++|||+.+++++-...-
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~ 303 (343)
T cd07880 236 SKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEE 303 (343)
T ss_pred CHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhh
Confidence 00 00 23445789999999999999999999998744433
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=282.31 Aligned_cols=238 Identities=19% Similarity=0.232 Sum_probs=189.1
Q ss_pred eeecccCceeEEEEEeCC-CCEEEEEEeccCC--hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCC-----ceEEEEEc
Q 008785 275 RLLGDSKTGGTYSGILPD-GSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHG-----DRYIVYEF 346 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~~-g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~-----~~~lV~E~ 346 (553)
+.||+|++|.||++...+ |+.||||.+.... ....+.+.+|+.+++.++||||+++++++.... ..|++|||
T Consensus 6 ~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~ 85 (330)
T cd07834 6 KPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTEL 85 (330)
T ss_pred eeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEEecc
Confidence 456999999999999754 8999999987643 344567899999999999999999999988775 78999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCccc
Q 008785 347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV 426 (553)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 426 (553)
++ ++|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||++.......
T Consensus 86 ~~-~~l~~~l~~----~~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~ 157 (330)
T cd07834 86 ME-TDLHKVIKS----PQPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDE 157 (330)
T ss_pred hh-hhHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEeecccc
Confidence 97 589888854 23689999999999999999999999 99999999999999999999999999998765442
Q ss_pred cc-ceeeecCccccccccccccCC-CCCcccchHhHHHHHHHHhcCccc-ccchHH---H-H------------------
Q 008785 427 MQ-ERTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIRLVLCR-RWWTLY---T-L------------------ 481 (553)
Q Consensus 427 ~~-~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwSlGvil~ell~~~~~-~~~~l~---~-~------------------ 481 (553)
.. .......++..|+|||.+.+. .++.++|+||||+++|+|++..+. ...... . .
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 237 (330)
T cd07834 158 DEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSE 237 (330)
T ss_pred cccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhcccc
Confidence 10 001112278889999999887 789999999999999999973322 111110 0 0
Q ss_pred -----Hh---cC-CH-------HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 008785 482 -----VH---SM-SL-------LCAQECLMLFISCNNWPSHLSQSKFCNLKLWVF 520 (553)
Q Consensus 482 -----~~---~~-~~-------~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~ 520 (553)
+. .. .. ..+..+.+++.+||+.+|++|||+.+++++-..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~ 292 (330)
T cd07834 238 KARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYL 292 (330)
T ss_pred chhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccH
Confidence 00 00 00 235678899999999999999999999998433
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=274.85 Aligned_cols=233 Identities=21% Similarity=0.266 Sum_probs=187.5
Q ss_pred eecccCceeEEEEEeCC-CCEEEEEEeccCC--hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCCH
Q 008785 276 LLGDSKTGGTYSGILPD-GSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352 (553)
Q Consensus 276 ~iG~G~~g~Vy~~~~~~-g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL 352 (553)
.||+|++|.||+|+..+ ++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+.+..++||||++ ++|
T Consensus 6 ~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~~l 84 (282)
T cd07829 6 KLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD-MDL 84 (282)
T ss_pred cccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC-cCH
Confidence 45999999999999764 8999999998653 2334677889999999999999999999999999999999997 599
Q ss_pred HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccceee
Q 008785 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV 432 (553)
Q Consensus 353 ~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~ 432 (553)
.+++... ...+++..+..++.|++.||+|||+. +|+||||+|+||++++++.++|+|||.++...........
T Consensus 85 ~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~- 157 (282)
T cd07829 85 KKYLDKR---PGPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTH- 157 (282)
T ss_pred HHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCccccCc-
Confidence 9999752 24689999999999999999999999 9999999999999999999999999999866543221111
Q ss_pred ecCccccccccccccCC-CCCcccchHhHHHHHHHHhcCcc-cccchHHH----HHh-------------------c---
Q 008785 433 MAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIRLVLC-RRWWTLYT----LVH-------------------S--- 484 (553)
Q Consensus 433 ~~~gt~~y~aPE~~~~~-~~t~ksDVwSlGvil~ell~~~~-~~~~~l~~----~~~-------------------~--- 484 (553)
..++..|+|||.+.+. .++.++||||||+++|||++..+ .......+ ... .
T Consensus 158 -~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
T cd07829 158 -EVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTF 236 (282)
T ss_pred -cccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccc
Confidence 1256789999998776 78999999999999999997332 22211111 000 0
Q ss_pred -----CCH-----HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008785 485 -----MSL-----LCAQECLMLFISCNNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 485 -----~~~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 517 (553)
... ..+..+.+++.+||..||++||++.+++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 237 PKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred cccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 000 235679999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=282.55 Aligned_cols=249 Identities=18% Similarity=0.248 Sum_probs=193.0
Q ss_pred ccCHHHHHHhhcccCCCCeeecccCceeEEEEEe-CCCCEEEEEEeccCC--hhhHHHHHHHHHHhhccCCCceeeEeeE
Q 008785 257 VFTTEELRSITKNFSEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGC 333 (553)
Q Consensus 257 ~~~~~el~~~~~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~ 333 (553)
....+++..++++|..... ||+|+||.||++.. .+|+.||+|+++... ....+.+.+|+.++++++||||++++++
T Consensus 6 ~~~~~~~~~~~~~y~~~~~-lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~ 84 (345)
T cd07877 6 QELNKTIWEVPERYQNLSP-VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84 (345)
T ss_pred hhHHHHHhhccCceEEEEE-eeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeee
Confidence 3445677778888876654 59999999999985 468899999997542 2334668899999999999999999998
Q ss_pred EeeC------CceEEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecC
Q 008785 334 CYDH------GDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE 407 (553)
Q Consensus 334 ~~~~------~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~ 407 (553)
+... ...+++++++ +++|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+||++++
T Consensus 85 ~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~ 155 (345)
T cd07877 85 FTPARSLEEFNDVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE 155 (345)
T ss_pred eeecccccccccEEEEehhc-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcC
Confidence 8643 3467888887 7899888753 3489999999999999999999999 9999999999999999
Q ss_pred CCCeEEeeccccccCCcccccceeeecCccccccccccccC-CCCCcccchHhHHHHHHHHhcCcc-cccchH---HH-H
Q 008785 408 EFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIRLVLC-RRWWTL---YT-L 481 (553)
Q Consensus 408 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwSlGvil~ell~~~~-~~~~~l---~~-~ 481 (553)
++.+||+|||++....... ....++..|+|||.+.+ ..++.++||||||+++|||++..+ ...... .. .
T Consensus 156 ~~~~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~ 230 (345)
T cd07877 156 DCELKILDFGLARHTDDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 230 (345)
T ss_pred CCCEEEecccccccccccc-----cccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 9999999999987543221 11227889999998866 468899999999999999997332 211111 00 0
Q ss_pred Hh-cC----------------------------CH-----HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 008785 482 VH-SM----------------------------SL-----LCAQECLMLFISCNNWPSHLSQSKFCNLKLWVF 520 (553)
Q Consensus 482 ~~-~~----------------------------~~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~ 520 (553)
.. .+ .+ ..+..+.+++.+|++.||.+|||+.+++++-..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f 303 (345)
T cd07877 231 LRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 303 (345)
T ss_pred HHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhh
Confidence 00 00 00 124567899999999999999999999988543
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=280.49 Aligned_cols=241 Identities=22% Similarity=0.261 Sum_probs=188.2
Q ss_pred HHHhhcccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccC--ChhhHHHHHHHHHHhhccCCCceeeEeeEEee-CC
Q 008785 263 LRSITKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD-HG 338 (553)
Q Consensus 263 l~~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~ 338 (553)
+..++++|.... .||+|+||.||++... +|+.||||.+... .....+.+.+|+.++++++||||+++++++.. ..
T Consensus 5 ~~~~~~~y~~~~-~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 83 (328)
T cd07856 5 VFEITNRYVDLQ-PVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLE 83 (328)
T ss_pred eeccccceEEEE-eecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC
Confidence 345666776654 4599999999999855 6899999988643 22335678899999999999999999999876 45
Q ss_pred ceEEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccc
Q 008785 339 DRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGL 418 (553)
Q Consensus 339 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgl 418 (553)
..++++||+ +++|.+++.. ..+++..+..++.|++.||+|||+. +++||||+|+||++++++.++|+|||.
T Consensus 84 ~~~lv~e~~-~~~L~~~~~~-----~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~ 154 (328)
T cd07856 84 DIYFVTELL-GTDLHRLLTS-----RPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGL 154 (328)
T ss_pred cEEEEeehh-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCcccc
Confidence 789999998 6789888853 3478888889999999999999999 999999999999999999999999999
Q ss_pred cccCCcccccceeeecCccccccccccccC-CCCCcccchHhHHHHHHHHhcCcccc-cchHH-------HH--------
Q 008785 419 SKFVPWEVMQERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIRLVLCRR-WWTLY-------TL-------- 481 (553)
Q Consensus 419 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwSlGvil~ell~~~~~~-~~~l~-------~~-------- 481 (553)
+........ ...++..|+|||.+.+ ..++.++||||||+++|||++..+.. ..... +.
T Consensus 155 ~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~ 229 (328)
T cd07856 155 ARIQDPQMT-----GYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDV 229 (328)
T ss_pred ccccCCCcC-----CCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 875432211 1126788999998765 56899999999999999999743221 11100 00
Q ss_pred ------------Hhc----CCH-------HHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008785 482 ------------VHS----MSL-------LCAQECLMLFISCNNWPSHLSQSKFCNLKLW 518 (553)
Q Consensus 482 ------------~~~----~~~-------~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l 518 (553)
+.. ... ..+..+.+++.+||+.+|++|||+.+++.+-
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~ 289 (328)
T cd07856 230 INTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHP 289 (328)
T ss_pred HHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCC
Confidence 000 000 1346789999999999999999999998763
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=315.25 Aligned_cols=248 Identities=25% Similarity=0.304 Sum_probs=195.9
Q ss_pred HHHhhcccCCCCeeecccCceeEEEEEe-CCCCEEEEEEeccCC--hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCc
Q 008785 263 LRSITKNFSEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGD 339 (553)
Q Consensus 263 l~~~~~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 339 (553)
+..++-+...++.+ |.|.||.||.+.. .+|+..|+|-++... ......+.+|..++..++|||+|+++|+-...+.
T Consensus 1230 lsnV~~rWqrg~~I-g~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRek 1308 (1509)
T KOG4645|consen 1230 LSNVTFRWQRGNFI-GGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREK 1308 (1509)
T ss_pred hccceeeecccccc-CCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHH
Confidence 33455555566666 9999999999995 458899999887543 2334667889999999999999999999999999
Q ss_pred eEEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeecccc
Q 008785 340 RYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLS 419 (553)
Q Consensus 340 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla 419 (553)
.+|.||||++|+|.+.+.. ++..++.....+..|++.|++|||++ |||||||||+||+++.+|.+|++|||.|
T Consensus 1309 v~IFMEyC~~GsLa~ll~~----gri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa 1381 (1509)
T KOG4645|consen 1309 VYIFMEYCEGGSLASLLEH----GRIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSA 1381 (1509)
T ss_pred HHHHHHHhccCcHHHHHHh----cchhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccce
Confidence 9999999999999999864 34466677777889999999999999 9999999999999999999999999999
Q ss_pred ccCCcccccce--eeecCccccccccccccCC---CCCcccchHhHHHHHHHHhc-Ccccccc-hHHH---HHhcCCH--
Q 008785 420 KFVPWEVMQER--TVMAGGTYGYLAPEFVYRN---ELTTKSDVYSFGVLLLEIRL-VLCRRWW-TLYT---LVHSMSL-- 487 (553)
Q Consensus 420 ~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~---~~t~ksDVwSlGvil~ell~-~~~~~~~-~l~~---~~~~~~~-- 487 (553)
..+........ .....||+.|||||++.+. ....+.||||+||++.||+| ..|...- +-.+ .+..|..
T Consensus 1382 ~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq 1461 (1509)
T KOG4645|consen 1382 VKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQ 1461 (1509)
T ss_pred eEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCC
Confidence 87765421111 0112399999999999753 45678999999999999998 3443211 1111 2222222
Q ss_pred ---HHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008785 488 ---LCAQECLMLFISCNNWPSHLSQSKFCNLKLW 518 (553)
Q Consensus 488 ---~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l 518 (553)
..+.+-.+++.+||..||++|-++.|++++-
T Consensus 1462 ~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~ 1495 (1509)
T KOG4645|consen 1462 IPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHA 1495 (1509)
T ss_pred CchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhh
Confidence 5667788999999999999999999988764
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=267.95 Aligned_cols=243 Identities=19% Similarity=0.330 Sum_probs=193.1
Q ss_pred ecccCceeEEEEEeC-CCCEEEEEEeccCCh-hhHHHHHHHHHHhhcc-CCCceeeEeeEEeeCCceEEEEEccCCCCHH
Q 008785 277 LGDSKTGGTYSGILP-DGSRVAVKRLKRSSF-QRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 353 (553)
Q Consensus 277 iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~ 353 (553)
||.|+||+|++-.++ .|+..|||+++.... ....+++.|.+...+- +.||||++||.+..++..|+-||+| ..||+
T Consensus 72 iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM-d~SlD 150 (361)
T KOG1006|consen 72 IGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM-DISLD 150 (361)
T ss_pred hcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH-hhhHH
Confidence 599999999998864 599999999987644 5567788888765554 7999999999999999999999999 55776
Q ss_pred HHhccC-CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccceee
Q 008785 354 RWLHHI-PRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV 432 (553)
Q Consensus 354 ~~l~~~-~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~ 432 (553)
.+.+.. ......+++.-+-.|..-...||.||-.. ..|||||+||+|||++..|.+||+|||.+..+..+.....
T Consensus 151 klYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiAkT~-- 226 (361)
T KOG1006|consen 151 KLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIAKTV-- 226 (361)
T ss_pred HHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEeeecccchHhHHHHHHhhh--
Confidence 654321 12234588888889999999999999866 4899999999999999999999999999976654433222
Q ss_pred ecCccccccccccccC--CCCCcccchHhHHHHHHHHhc--CcccccchHHH---HHhcCCH----------HHHHHHHH
Q 008785 433 MAGGTYGYLAPEFVYR--NELTTKSDVYSFGVLLLEIRL--VLCRRWWTLYT---LVHSMSL----------LCAQECLM 495 (553)
Q Consensus 433 ~~~gt~~y~aPE~~~~--~~~t~ksDVwSlGvil~ell~--~~~~~~~~l~~---~~~~~~~----------~~~~~l~~ 495 (553)
..|...|||||.+.. ..|+.+|||||||++|+|+.+ +....+.++.+ .+..|.. .....+.+
T Consensus 227 -daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~s~~~~~ 305 (361)
T KOG1006|consen 227 -DAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVHYSFSMVR 305 (361)
T ss_pred -ccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcccccccCHHHHH
Confidence 228889999999863 358999999999999999998 33345555655 3333333 57788999
Q ss_pred HHhhccCCCCCCCCCHHHHHHHHHHHHhhc
Q 008785 496 LFISCNNWPSHLSQSKFCNLKLWVFAILTI 525 (553)
Q Consensus 496 l~~~Cl~~dP~~RPs~~evl~~l~~~~~~~ 525 (553)
++..|+..|-++||+..++++.-.-.+-+.
T Consensus 306 fintCl~Kd~~~Rpky~~Lk~~~fyr~y~~ 335 (361)
T KOG1006|consen 306 FINTCLIKDRSDRPKYDDLKKFPFYRMYAV 335 (361)
T ss_pred HHHHHhhcccccCcchhhhhcCchhhhhhh
Confidence 999999999999999999988755555443
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=268.25 Aligned_cols=215 Identities=17% Similarity=0.122 Sum_probs=171.7
Q ss_pred cCceeEEEEEeC-CCCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCCHHHHhcc
Q 008785 280 SKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHH 358 (553)
Q Consensus 280 G~~g~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~ 358 (553)
|.+|.||++... +++.||+|.++... .+.+|...+....||||+++++++.+.+..++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 889999999964 58899999997653 233455555566799999999999999999999999999999999864
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccceeeecCccc
Q 008785 359 IPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY 438 (553)
Q Consensus 359 ~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~ 438 (553)
. ..+++..+..++.|++.||.|||+. +++||||||+||+++.++.++++|||.+........ ...++.
T Consensus 79 ~----~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~~-----~~~~~~ 146 (237)
T cd05576 79 F----LNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCD-----GEAVEN 146 (237)
T ss_pred h----cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccccc-----cCCcCc
Confidence 2 3489999999999999999999999 999999999999999999999999998765543211 112567
Q ss_pred cccccccccCCCCCcccchHhHHHHHHHHhcCcccccchHHHHHhcCC----HHHHHHHHHHHhhccCCCCCCCCCH
Q 008785 439 GYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVLCRRWWTLYTLVHSMS----LLCAQECLMLFISCNNWPSHLSQSK 511 (553)
Q Consensus 439 ~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~~~~~~~l~~~~~~~~----~~~~~~l~~l~~~Cl~~dP~~RPs~ 511 (553)
.|+|||.+.+..++.++||||+|+++|||++..+.............. ...+..+.+++.+|++.||++||++
T Consensus 147 ~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~ 223 (237)
T cd05576 147 MYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGINTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGA 223 (237)
T ss_pred cccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcccccccCCcccCCHHHHHHHHHHccCCHHHhcCC
Confidence 899999998888999999999999999999743221111111000000 1345678999999999999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=281.23 Aligned_cols=243 Identities=21% Similarity=0.216 Sum_probs=184.8
Q ss_pred cccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeEEeeC---------
Q 008785 268 KNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH--------- 337 (553)
Q Consensus 268 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--------- 337 (553)
.+|.... .||.|+||.||+|... +|+.||+|.+........+.+.+|++++++++||||+++++++...
T Consensus 5 ~~y~~~~-~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 5 SRYMDLR-PLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred cceEEEE-EecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 3444434 4599999999999964 5889999999776656667889999999999999999999876654
Q ss_pred -----CceEEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecC-CCCe
Q 008785 338 -----GDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE-EFGA 411 (553)
Q Consensus 338 -----~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~-~~~~ 411 (553)
...++||||++ ++|.+++.. ..+++..+..++.||+.||.|||+. +++||||||+||+++. ++.+
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~ 154 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQ-----GPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVL 154 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceE
Confidence 34689999996 589888753 3588999999999999999999999 9999999999999974 5678
Q ss_pred EEeeccccccCCcccccce-eeecCccccccccccccC-CCCCcccchHhHHHHHHHHhcCc-ccccchHHH----HHh-
Q 008785 412 HLMGVGLSKFVPWEVMQER-TVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIRLVL-CRRWWTLYT----LVH- 483 (553)
Q Consensus 412 kl~Dfgla~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~-~~~t~ksDVwSlGvil~ell~~~-~~~~~~l~~----~~~- 483 (553)
|++|||++........... .....++..|+|||.+.. ..++.++|||||||++|||++.. +.....-.+ .+.
T Consensus 155 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~ 234 (342)
T cd07854 155 KIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILES 234 (342)
T ss_pred EECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 9999999976533211111 111126888999998754 45788999999999999999733 221111000 000
Q ss_pred ----------------------cCC-----H-----HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 008785 484 ----------------------SMS-----L-----LCAQECLMLFISCNNWPSHLSQSKFCNLKLWVF 520 (553)
Q Consensus 484 ----------------------~~~-----~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~ 520 (553)
... . ..+..+.+++.+||+.||.+|||+.|++++-..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~ 303 (342)
T cd07854 235 VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYM 303 (342)
T ss_pred cCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcc
Confidence 000 0 234567899999999999999999999987433
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=276.25 Aligned_cols=242 Identities=21% Similarity=0.234 Sum_probs=182.6
Q ss_pred cccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCChh--hHHHHHHHHHHhhccCCCceeeEeeEEeeCC------
Q 008785 268 KNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQ--RKKEFYSEIGRFARLHHPNLVAVKGCCYDHG------ 338 (553)
Q Consensus 268 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~------ 338 (553)
++|..... ||+|++|.||+|... +++.||||.+...... ....+.+|++++++++||||+++++++.+..
T Consensus 8 ~~y~~~~~-lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 8 RDYEILGK-LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred ccEEEEEE-eccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 45555444 599999999999965 5889999998654222 2345778999999999999999999876543
Q ss_pred --ceEEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeec
Q 008785 339 --DRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGV 416 (553)
Q Consensus 339 --~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Df 416 (553)
..++|+||+.+ +|...+.. ....+++..+..++.|+++||+|||+. +|+||||||+||++++++.++|+||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~---~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~df 159 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLEN---PSVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADF 159 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcC
Confidence 36999999964 67776653 234689999999999999999999999 9999999999999999999999999
Q ss_pred cccccCCcccccce---------eeecCccccccccccccCC-CCCcccchHhHHHHHHHHhcCcccc-cchHH---H-H
Q 008785 417 GLSKFVPWEVMQER---------TVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIRLVLCRR-WWTLY---T-L 481 (553)
Q Consensus 417 gla~~~~~~~~~~~---------~~~~~gt~~y~aPE~~~~~-~~t~ksDVwSlGvil~ell~~~~~~-~~~l~---~-~ 481 (553)
|+++.......... .....+++.|+|||.+.+. .++.++||||||+++|||++..+.. ..+.. . .
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~ 239 (311)
T cd07866 160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLI 239 (311)
T ss_pred ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 99976543221111 0111267889999987654 5789999999999999999743321 11111 1 0
Q ss_pred Hhc-C---------------------------CH-----HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008785 482 VHS-M---------------------------SL-----LCAQECLMLFISCNNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 482 ~~~-~---------------------------~~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 517 (553)
... + .. .....+.+++.+|++.||.+|||+.|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 240 FKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred HHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 000 0 00 223568899999999999999999998864
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-32 Score=282.94 Aligned_cols=239 Identities=17% Similarity=0.248 Sum_probs=187.9
Q ss_pred HhhcccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccC--ChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCc--
Q 008785 265 SITKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGD-- 339 (553)
Q Consensus 265 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~-- 339 (553)
.+.++|.... .||+|++|.||+|... +++.||||++... +......+.+|+.++++++||||+++++++...+.
T Consensus 12 ~~~~~y~~~~-~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07851 12 EVPDRYQNLS-PVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLE 90 (343)
T ss_pred cccCceEEEE-EeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccc
Confidence 3455665544 4599999999999975 4789999998753 22334667889999999999999999998776554
Q ss_pred ----eEEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEee
Q 008785 340 ----RYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMG 415 (553)
Q Consensus 340 ----~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~D 415 (553)
.++|+||+ +++|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.++|+|
T Consensus 91 ~~~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~d 161 (343)
T cd07851 91 DFQDVYLVTHLM-GADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILD 161 (343)
T ss_pred ccccEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcc
Confidence 89999998 6799998853 3589999999999999999999999 999999999999999999999999
Q ss_pred ccccccCCcccccceeeecCccccccccccccC-CCCCcccchHhHHHHHHHHhcCc-ccccchHHH----HHh------
Q 008785 416 VGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIRLVL-CRRWWTLYT----LVH------ 483 (553)
Q Consensus 416 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwSlGvil~ell~~~-~~~~~~l~~----~~~------ 483 (553)
||++....... ....++..|+|||.+.+ ..++.++||||||+++||+++.. +.......+ ...
T Consensus 162 fg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~ 236 (343)
T cd07851 162 FGLARHTDDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPD 236 (343)
T ss_pred ccccccccccc-----cCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCC
Confidence 99997654321 11227888999998865 36789999999999999999733 221111111 000
Q ss_pred -----------------------cCCH-----HHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008785 484 -----------------------SMSL-----LCAQECLMLFISCNNWPSHLSQSKFCNLKLW 518 (553)
Q Consensus 484 -----------------------~~~~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l 518 (553)
...+ ..+..+.+++.+||+.||++|||+.|++++-
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~ 299 (343)
T cd07851 237 EELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHP 299 (343)
T ss_pred HHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCC
Confidence 0000 1356789999999999999999999999874
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.5e-32 Score=276.43 Aligned_cols=238 Identities=18% Similarity=0.186 Sum_probs=182.0
Q ss_pred eeecccCceeEEEEEeC-C--CCEEEEEEeccC--ChhhHHHHHHHHHHhhcc-CCCceeeEeeEEeeC----CceEEEE
Q 008785 275 RLLGDSKTGGTYSGILP-D--GSRVAVKRLKRS--SFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDH----GDRYIVY 344 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~-~--g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~----~~~~lV~ 344 (553)
+.||+|+||.||++... . +..||+|.+... .....+.+.+|+.+++++ +||||+++++.+... ...++++
T Consensus 6 ~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~ 85 (332)
T cd07857 6 KELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLYE 85 (332)
T ss_pred EEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEEEEE
Confidence 45699999999999964 3 678999998753 222346788999999999 599999999875432 4568999
Q ss_pred EccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCc
Q 008785 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW 424 (553)
Q Consensus 345 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~ 424 (553)
||+. ++|.+++.. ...+++..+..++.||+.||.|||+. +++||||||+|||+++++.+||+|||++.....
T Consensus 86 e~~~-~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~ 157 (332)
T cd07857 86 ELME-ADLHQIIRS----GQPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARGFSE 157 (332)
T ss_pred eccc-CCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCceeccc
Confidence 9985 689988853 34689999999999999999999999 999999999999999999999999999976543
Q ss_pred ccccce--eeecCccccccccccccC-CCCCcccchHhHHHHHHHHhcCccc-ccch---HHH---------------HH
Q 008785 425 EVMQER--TVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIRLVLCR-RWWT---LYT---------------LV 482 (553)
Q Consensus 425 ~~~~~~--~~~~~gt~~y~aPE~~~~-~~~t~ksDVwSlGvil~ell~~~~~-~~~~---l~~---------------~~ 482 (553)
...... .....|+..|+|||++.+ ..++.++||||||+++|+|++..+. ...+ ... .+
T Consensus 158 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (332)
T cd07857 158 NPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRI 237 (332)
T ss_pred ccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 221111 111237889999998765 4689999999999999999963322 1111 000 00
Q ss_pred hc---------------CCH-----HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 008785 483 HS---------------MSL-----LCAQECLMLFISCNNWPSHLSQSKFCNLKLWVF 520 (553)
Q Consensus 483 ~~---------------~~~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~ 520 (553)
.. ..+ .....+.+++.+|++.||.+|||+.|++++-..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~ 295 (332)
T cd07857 238 GSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYL 295 (332)
T ss_pred hhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhh
Confidence 00 000 124678999999999999999999999987443
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.3e-33 Score=262.57 Aligned_cols=256 Identities=21% Similarity=0.234 Sum_probs=203.8
Q ss_pred eeecccCceeEEEEEeC-CCCEEEEEEeccCChhhH---HHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCC
Q 008785 275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRK---KEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 350 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~~~~---~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 350 (553)
++||+|.||+|..++-+ .|+.+|+|++++.-.-.+ ..-+.|-++|+..+||.+..+.-.|...+.++.||||+.||
T Consensus 174 KvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMeyanGG 253 (516)
T KOG0690|consen 174 KVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEYANGG 253 (516)
T ss_pred HHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEEccCc
Confidence 46799999999999854 589999999987643333 33467889999999999999998899999999999999999
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccce
Q 008785 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER 430 (553)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 430 (553)
.|.-+|.. .+.+++.....+..+|..||.|||++ +||.||||.+|.|+|.+|.+||+|||+++..-... ..
T Consensus 254 eLf~HLsr----er~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g--~t 324 (516)
T KOG0690|consen 254 ELFFHLSR----ERVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYG--DT 324 (516)
T ss_pred eEeeehhh----hhcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhccccc--ce
Confidence 99888853 45688899999999999999999999 99999999999999999999999999997543222 23
Q ss_pred eeecCccccccccccccCCCCCcccchHhHHHHHHHHhc----CcccccchHHHHHhcCCH----HHHHHHHHHHhhccC
Q 008785 431 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL----VLCRRWWTLYTLVHSMSL----LCAQECLMLFISCNN 502 (553)
Q Consensus 431 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~----~~~~~~~~l~~~~~~~~~----~~~~~l~~l~~~Cl~ 502 (553)
....+|||.|.|||++....|+.+.|.|.+||++|||+. +...+...+.+++--+.+ ...++...|+...|.
T Consensus 325 ~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr~ls~eAktLLsGLL~ 404 (516)
T KOG0690|consen 325 TKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPRTLSPEAKTLLSGLLK 404 (516)
T ss_pred eccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCccCCHHHHHHHHHHhh
Confidence 445679999999999999999999999999999999996 334445566775544444 566777888889999
Q ss_pred CCCCCCC-----CHHHHHHHHHHHHhh---ccccccccccccccc
Q 008785 503 WPSHLSQ-----SKFCNLKLWVFAILT---IRKVQFEFPLLRLAV 539 (553)
Q Consensus 503 ~dP~~RP-----s~~evl~~l~~~~~~---~~~~~~~~p~~~~~~ 539 (553)
.||++|. .+.||.++-.++-.. .-....++|-.+|..
T Consensus 405 kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~~Kki~PPfKPqVt 449 (516)
T KOG0690|consen 405 KDPKKRLGGGPDDAKEIMRHRFFASVDWEATYRKKIEPPFKPQVT 449 (516)
T ss_pred cChHhhcCCCchhHHHHHhhhhhccCCHHHHHHhccCCCCCCCcc
Confidence 9999995 366666654443321 123344445555544
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-32 Score=237.55 Aligned_cols=238 Identities=18% Similarity=0.204 Sum_probs=186.2
Q ss_pred CCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCCh--hhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEcc
Q 008785 271 SEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF--QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV 347 (553)
Q Consensus 271 ~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 347 (553)
...+++ |+|.||+||+|+.. .++.||+|.++..+. ......++|+.+++.+.|.|||+++++...+..+-+|+|||
T Consensus 5 dkmeki-gegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~c 83 (292)
T KOG0662|consen 5 DKMEKI-GEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC 83 (292)
T ss_pred HHHHhh-cCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHh
Confidence 334455 99999999999955 488999999875432 23467889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccc
Q 008785 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM 427 (553)
Q Consensus 348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 427 (553)
. .+|..|... -+..++.+....++.|+++||.|.|++ ++.|||+||.|.||+.+|..|++|||+++.+.-...
T Consensus 84 d-qdlkkyfds---lng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipvr 156 (292)
T KOG0662|consen 84 D-QDLKKYFDS---LNGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR 156 (292)
T ss_pred h-HHHHHHHHh---cCCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCceE
Confidence 5 588888765 345689999999999999999999999 999999999999999999999999999997764432
Q ss_pred cceeeecCccccccccccccCCC-CCcccchHhHHHHHHHHhc-Ccc---ccc--chHHHHHh-cCCH------------
Q 008785 428 QERTVMAGGTYGYLAPEFVYRNE-LTTKSDVYSFGVLLLEIRL-VLC---RRW--WTLYTLVH-SMSL------------ 487 (553)
Q Consensus 428 ~~~~~~~~gt~~y~aPE~~~~~~-~t~ksDVwSlGvil~ell~-~~~---~~~--~~l~~~~~-~~~~------------ 487 (553)
-....+ -|..|.+|.++.+.. |+...|+||-|||+.|+.. ..| ..+ +.+..... -|..
T Consensus 157 cysaev--vtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lp 234 (292)
T KOG0662|consen 157 CYSAEV--VTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLP 234 (292)
T ss_pred eeecee--eeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCC
Confidence 221111 588999999998765 7999999999999999984 222 111 11211110 1110
Q ss_pred -------------------HHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008785 488 -------------------LCAQECLMLFISCNNWPSHLSQSKFCNLKLW 518 (553)
Q Consensus 488 -------------------~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l 518 (553)
.....=.++++..+.-+|..|.++.+.+++-
T Consensus 235 dyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhp 284 (292)
T KOG0662|consen 235 DYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHP 284 (292)
T ss_pred CCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCc
Confidence 2222346788888888999999999988753
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=294.67 Aligned_cols=144 Identities=24% Similarity=0.354 Sum_probs=126.5
Q ss_pred ccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCC---hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEE
Q 008785 269 NFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVY 344 (553)
Q Consensus 269 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 344 (553)
+|.... .||+|+||.||+|... +++.||||+++... ......+.+|+.+++.++||||+++++++...+..|+||
T Consensus 5 ~y~i~~-~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 5 EFVIVK-PISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CEEEEE-EEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 344443 4599999999999976 58999999997542 233467889999999999999999999999999999999
Q ss_pred EccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccc
Q 008785 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSK 420 (553)
Q Consensus 345 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~ 420 (553)
||+.+++|.+++.. ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~----~~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHI----YGYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999999864 23578899999999999999999999 99999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=256.86 Aligned_cols=227 Identities=23% Similarity=0.292 Sum_probs=190.0
Q ss_pred CceeEEEEEeCC-CCEEEEEEeccCChhh-HHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCCHHHHhcc
Q 008785 281 KTGGTYSGILPD-GSRVAVKRLKRSSFQR-KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHH 358 (553)
Q Consensus 281 ~~g~Vy~~~~~~-g~~vAvK~~~~~~~~~-~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~ 358 (553)
+||.||+|...+ |+.+|+|++....... .+.+.+|++.+++++|+||+++++.+......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 589999999864 8999999998765444 68899999999999999999999999999999999999999999999865
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccceeeecCccc
Q 008785 359 IPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY 438 (553)
Q Consensus 359 ~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~ 438 (553)
. ..+++..+..++.+++.++.|||+. +++|+||+|+||++++++.++|+|||.+........ .....++.
T Consensus 81 ~----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~ 150 (244)
T smart00220 81 R----GRLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGL---LTTFVGTP 150 (244)
T ss_pred c----cCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeeccccc---cccccCCc
Confidence 2 2288999999999999999999999 999999999999999999999999999987654321 11222788
Q ss_pred cccccccccCCCCCcccchHhHHHHHHHHhcCc-cccc----chHHHHHhcCCH----H---HHHHHHHHHhhccCCCCC
Q 008785 439 GYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVL-CRRW----WTLYTLVHSMSL----L---CAQECLMLFISCNNWPSH 506 (553)
Q Consensus 439 ~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~-~~~~----~~l~~~~~~~~~----~---~~~~l~~l~~~Cl~~dP~ 506 (553)
.|++||.+....++.++||||||+++++|++.. +... ..+.+.+..+.. . .+..+.+++.+|+..+|+
T Consensus 151 ~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~ 230 (244)
T smart00220 151 EYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPE 230 (244)
T ss_pred CCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCch
Confidence 999999998888999999999999999999732 2222 223333333333 1 667899999999999999
Q ss_pred CCCCHHHHHHH
Q 008785 507 LSQSKFCNLKL 517 (553)
Q Consensus 507 ~RPs~~evl~~ 517 (553)
+||++.+++++
T Consensus 231 ~Rp~~~~~~~~ 241 (244)
T smart00220 231 KRLTAEEALQH 241 (244)
T ss_pred hccCHHHHhhC
Confidence 99999999873
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.5e-32 Score=278.19 Aligned_cols=234 Identities=22% Similarity=0.208 Sum_probs=188.7
Q ss_pred ccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCChhhHHHHHHHHHHhhcc-CCCceeeEeeEEeeCCceEEEEEc
Q 008785 269 NFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEF 346 (553)
Q Consensus 269 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E~ 346 (553)
.|..... +|.|+|+.|-++... +++..++|++.+.. .+-.+|+.++... +||||+++.+++.+..+.|+|||+
T Consensus 323 ~y~~~~~-~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~ 397 (612)
T KOG0603|consen 323 SYEFREE-LGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMEL 397 (612)
T ss_pred hhccccc-cCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeeehh
Confidence 3333344 499999999988854 58899999997652 2234566666555 799999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEe-cCCCCeEEeeccccccCCcc
Q 008785 347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL-DEEFGAHLMGVGLSKFVPWE 425 (553)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl-~~~~~~kl~Dfgla~~~~~~ 425 (553)
+.+|-|.+-+... . .....+..|+.+|+.|+.|||++ |+|||||||+|||+ ++.+.++|+|||.++.....
T Consensus 398 l~g~ell~ri~~~----~-~~~~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~ 469 (612)
T KOG0603|consen 398 LDGGELLRRIRSK----P-EFCSEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS 469 (612)
T ss_pred ccccHHHHHHHhc----c-hhHHHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence 9999887766531 2 22267778999999999999999 99999999999999 68899999999999876544
Q ss_pred cccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcC----cccc-cchHHHHHhcCCH--HHHHHHHHHHh
Q 008785 426 VMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLV----LCRR-WWTLYTLVHSMSL--LCAQECLMLFI 498 (553)
Q Consensus 426 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~----~~~~-~~~l~~~~~~~~~--~~~~~l~~l~~ 498 (553)
....+-|..|.|||++...+|++++|+||||++||+|+++ ...+ +.++...+..+++ ..+....+|+.
T Consensus 470 -----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~s~~vS~~AKdLl~ 544 (612)
T KOG0603|consen 470 -----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKFSECVSDEAKDLLQ 544 (612)
T ss_pred -----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCccccccCHHHHHHHH
Confidence 1222357889999999999999999999999999999972 1222 2356667777766 67788999999
Q ss_pred hccCCCCCCCCCHHHHHHHHHH
Q 008785 499 SCNNWPSHLSQSKFCNLKLWVF 520 (553)
Q Consensus 499 ~Cl~~dP~~RPs~~evl~~l~~ 520 (553)
.||+.||.+||++.++..+-..
T Consensus 545 ~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 545 QLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred HhccCChhhCcChhhhccCcch
Confidence 9999999999999999987433
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=282.45 Aligned_cols=236 Identities=23% Similarity=0.296 Sum_probs=193.2
Q ss_pred CeeecccCceeEEEEEe-CCCCEEEEEEeccCChhhHHHHHHHHHHhhcc-CCCceeeEeeEEee-----CCceEEEEEc
Q 008785 274 NRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYD-----HGDRYIVYEF 346 (553)
Q Consensus 274 ~~~iG~G~~g~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~-----~~~~~lV~E~ 346 (553)
.+.||.|.+|.||+++. ++|+.+|+|++... ....+++..|.++++.. +|||++.++|++.. ++.+||||||
T Consensus 24 ~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~-~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEf 102 (953)
T KOG0587|consen 24 IEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT-EDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVMEF 102 (953)
T ss_pred EEEEeeccceeEEEEeeeecCceeeeEeecCC-ccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEeec
Confidence 34569999999999994 56899999998765 34456778888999888 79999999999874 4678999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCccc
Q 008785 347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV 426 (553)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 426 (553)
|.+||.-|+++... +..+.|..+..|++.++.||.|||.+ .++|||||-.|||++.++.+||.|||++..++...
T Consensus 103 C~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLvDFGvSaQldsT~ 177 (953)
T KOG0587|consen 103 CGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDSTV 177 (953)
T ss_pred cCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEeeeeeeeeeeccc
Confidence 99999999998754 67799999999999999999999999 99999999999999999999999999998776543
Q ss_pred ccceeeecCccccccccccccC-----CCCCcccchHhHHHHHHHHhcCcc-cccchHHH-HHh---cCCH------HHH
Q 008785 427 MQERTVMAGGTYGYLAPEFVYR-----NELTTKSDVYSFGVLLLEIRLVLC-RRWWTLYT-LVH---SMSL------LCA 490 (553)
Q Consensus 427 ~~~~~~~~~gt~~y~aPE~~~~-----~~~t~ksDVwSlGvil~ell~~~~-~~~~~l~~-~~~---~~~~------~~~ 490 (553)
....+ ..||+.|||||++.- ..|+..+|+||||++..||.-..| ..+..... ++. +... ...
T Consensus 178 grRnT--~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPkLkrp~kWs 255 (953)
T KOG0587|consen 178 GRRNT--FIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKRPKKWS 255 (953)
T ss_pred ccccC--cCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCccccchhhHH
Confidence 33322 339999999999963 347789999999999999985332 22222222 221 1111 678
Q ss_pred HHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008785 491 QECLMLFISCNNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 491 ~~l~~l~~~Cl~~dP~~RPs~~evl~~ 517 (553)
.++.++|..||..|-..||++.+++++
T Consensus 256 ~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 256 KKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred HHHHHHHHHHHhhccccCcchhhhccC
Confidence 889999999999999999999999865
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-31 Score=286.48 Aligned_cols=244 Identities=16% Similarity=0.183 Sum_probs=160.6
Q ss_pred hcccCCCCeeecccCceeEEEEEeCC-----CCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeE------Ee
Q 008785 267 TKNFSEGNRLLGDSKTGGTYSGILPD-----GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGC------CY 335 (553)
Q Consensus 267 ~~~~~~~~~~iG~G~~g~Vy~~~~~~-----g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~------~~ 335 (553)
.++|...+ .||+|+||.||+|...+ +..||||++...... +...+| .+....+.+++.+... ..
T Consensus 131 ~~~y~l~~-~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 131 KDDFVLGK-KLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred cCCeEEeE-EEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 34555444 45999999999999754 689999998653221 111111 1112222222222211 23
Q ss_pred eCCceEEEEEccCCCCHHHHhccCCCC----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCC
Q 008785 336 DHGDRYIVYEFVVNGPLDRWLHHIPRG----------------GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIR 399 (553)
Q Consensus 336 ~~~~~~lV~E~~~~gsL~~~l~~~~~~----------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlk 399 (553)
.....++||||+++++|.+++...... ........+..++.||+.||.|||++ +|+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCC
Confidence 456789999999999999998642100 00112334567999999999999999 99999999
Q ss_pred CCcEEecC-CCCeEEeeccccccCCcccccceeeecCccccccccccccCC----------------------CCCcccc
Q 008785 400 ASNVLLDE-EFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRN----------------------ELTTKSD 456 (553)
Q Consensus 400 p~NILl~~-~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~t~ksD 456 (553)
|+|||+++ ++.+||+|||+|+........... ...+++.|+|||.+... .++.++|
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~-~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPK-EFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccccCCc-ccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 99999986 578999999999865433222211 22388999999966422 2345679
Q ss_pred hHhHHHHHHHHhcCcccccchHHH---HHhcCCH-------------------------HHHHHHHHHHhhccCCCCCCC
Q 008785 457 VYSFGVLLLEIRLVLCRRWWTLYT---LVHSMSL-------------------------LCAQECLMLFISCNNWPSHLS 508 (553)
Q Consensus 457 VwSlGvil~ell~~~~~~~~~l~~---~~~~~~~-------------------------~~~~~l~~l~~~Cl~~dP~~R 508 (553)
||||||++|||+......+..+.. .+..... .......+|+.+||+.||++|
T Consensus 362 VwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR 441 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQR 441 (566)
T ss_pred cHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccC
Confidence 999999999999622222222111 1111000 011234589999999999999
Q ss_pred CCHHHHHHHHH
Q 008785 509 QSKFCNLKLWV 519 (553)
Q Consensus 509 Ps~~evl~~l~ 519 (553)
||+.|++++-.
T Consensus 442 ~ta~e~L~Hpf 452 (566)
T PLN03225 442 ISAKAALAHPY 452 (566)
T ss_pred CCHHHHhCCcC
Confidence 99999998743
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-32 Score=287.46 Aligned_cols=242 Identities=23% Similarity=0.225 Sum_probs=186.7
Q ss_pred cccCCCCeeecccCcee-EEEEEeCCCCEEEEEEeccCChhhHHHHHHHHHHhhcc-CCCceeeEeeEEeeCCceEEEEE
Q 008785 268 KNFSEGNRLLGDSKTGG-TYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYE 345 (553)
Q Consensus 268 ~~~~~~~~~iG~G~~g~-Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E 345 (553)
+.+...++++|.|+.|+ ||+|.+ +|+.||||++-.. ..+...+|+..|..- +|||||++++.-.+....||..|
T Consensus 508 k~~~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalE 583 (903)
T KOG1027|consen 508 KLFFSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALE 583 (903)
T ss_pred eeeeccHHHcccCCCCcEEEEEee-CCceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEeh
Confidence 33444566789998874 699999 8899999998643 234567899999888 69999999999888899999999
Q ss_pred ccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecC---C--CCeEEeeccccc
Q 008785 346 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE---E--FGAHLMGVGLSK 420 (553)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~---~--~~~kl~Dfgla~ 420 (553)
.| ..+|.+++.................+..|+++||+|||+. +||||||||.||||+. + .+++|+|||+++
T Consensus 584 LC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsK 659 (903)
T KOG1027|consen 584 LC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSK 659 (903)
T ss_pred Hh-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEeccccccc
Confidence 99 5699999976311111111134567889999999999998 9999999999999976 2 568999999999
Q ss_pred cCCccccccee-eecCccccccccccccCCCCCcccchHhHHHHHHHHhcC--cccccchHHH-HHhcCCH-----HHHH
Q 008785 421 FVPWEVMQERT-VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLV--LCRRWWTLYT-LVHSMSL-----LCAQ 491 (553)
Q Consensus 421 ~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~--~~~~~~~l~~-~~~~~~~-----~~~~ 491 (553)
....+...... ....||-+|+|||++....-+.++||+|+||++|..++. .|..+..-.+ -+-.|.. ....
T Consensus 660 kl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~~~~L~~L~~~~ 739 (903)
T KOG1027|consen 660 KLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTGNYTLVHLEPLP 739 (903)
T ss_pred ccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhcCccceeeeccCc
Confidence 88766443322 233499999999999988888999999999999999983 3333322222 2222322 1122
Q ss_pred --HHHHHHhhccCCCCCCCCCHHHHHHH
Q 008785 492 --ECLMLFISCNNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 492 --~l~~l~~~Cl~~dP~~RPs~~evl~~ 517 (553)
...+||.+|++++|..||++.+||.+
T Consensus 740 d~eA~dLI~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 740 DCEAKDLISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred hHHHHHHHHHhcCCCcccCCCHHHHhCC
Confidence 78999999999999999999999965
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-32 Score=294.33 Aligned_cols=249 Identities=20% Similarity=0.150 Sum_probs=201.7
Q ss_pred HHHHhhcccCCCCeeecccCceeEEEEEeCC-CCEEEEEEeccCC---hhhHHHHHHHHHHhhccCCCceeeEeeEEeeC
Q 008785 262 ELRSITKNFSEGNRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH 337 (553)
Q Consensus 262 el~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~-g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 337 (553)
+++-...+|... ++||+|+||.|...+.+. ++.||.|++.+.. .....-|..|-.+|..-+.+-|++++-.|.+.
T Consensus 69 ~lrl~~~Dfeil-KvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~ 147 (1317)
T KOG0612|consen 69 ELRLKAEDFEIL-KVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE 147 (1317)
T ss_pred HHhCCHHhhHHH-HHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence 334344455543 456999999999999754 8899999998742 23346688899999999999999999999999
Q ss_pred CceEEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeecc
Q 008785 338 GDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVG 417 (553)
Q Consensus 338 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg 417 (553)
.++|+|||||+||+|-.+|.. .+ .+++..+..++..|..||.-||+. |+|||||||+|||||..|.+||+|||
T Consensus 148 ~~LYlVMdY~pGGDlltLlSk---~~-~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFG 220 (1317)
T KOG0612|consen 148 RYLYLVMDYMPGGDLLTLLSK---FD-RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFG 220 (1317)
T ss_pred cceEEEEecccCchHHHHHhh---cC-CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccch
Confidence 999999999999999999975 22 699999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCcccccceeeecCcccccccccccc----C-CCCCcccchHhHHHHHHHHhc-CcccccchHHH---HHh--cCC
Q 008785 418 LSKFVPWEVMQERTVMAGGTYGYLAPEFVY----R-NELTTKSDVYSFGVLLLEIRL-VLCRRWWTLYT---LVH--SMS 486 (553)
Q Consensus 418 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~t~ksDVwSlGvil~ell~-~~~~~~~~l~~---~~~--~~~ 486 (553)
.+-.+..++.-. ..++.|||.|.+||++. + +.|++.+|.||+||++|||+. ..|+..+++++ .+. +..
T Consensus 221 sClkm~~dG~V~-s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~ 299 (1317)
T KOG0612|consen 221 SCLKMDADGTVR-SSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKES 299 (1317)
T ss_pred hHHhcCCCCcEE-eccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhh
Confidence 998777554433 33445999999999985 2 678999999999999999996 55666666666 221 112
Q ss_pred H------HHHHHHHHHHhhccCCCCCCCCC---HHHHHHHHHH
Q 008785 487 L------LCAQECLMLFISCNNWPSHLSQS---KFCNLKLWVF 520 (553)
Q Consensus 487 ~------~~~~~l~~l~~~Cl~~dP~~RPs---~~evl~~l~~ 520 (553)
+ ..+....+||.+.+. +|+.|.. +.++-.+..+
T Consensus 300 l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF 341 (1317)
T KOG0612|consen 300 LSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFF 341 (1317)
T ss_pred cCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccc
Confidence 2 566778888887665 7888887 9998877544
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=277.14 Aligned_cols=246 Identities=18% Similarity=0.199 Sum_probs=175.1
Q ss_pred hcccCCCCeeecccCceeEEEEEe-----------------CCCCEEEEEEeccCChhhHHHH--------------HHH
Q 008785 267 TKNFSEGNRLLGDSKTGGTYSGIL-----------------PDGSRVAVKRLKRSSFQRKKEF--------------YSE 315 (553)
Q Consensus 267 ~~~~~~~~~~iG~G~~g~Vy~~~~-----------------~~g~~vAvK~~~~~~~~~~~~~--------------~~E 315 (553)
.++|...++| |+|+||.||+|.. .+++.||||+++.......++| ..|
T Consensus 144 ~d~F~i~~~L-G~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 144 SDDFQLRDKL-GGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred ccCceEeeEe-ecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 4567666555 9999999999964 2356899999975433333333 346
Q ss_pred HHHhhccCCCce-----eeEeeEEee--------CCceEEEEEccCCCCHHHHhccCCC--------------------C
Q 008785 316 IGRFARLHHPNL-----VAVKGCCYD--------HGDRYIVYEFVVNGPLDRWLHHIPR--------------------G 362 (553)
Q Consensus 316 ~~~l~~l~HpnI-----v~l~~~~~~--------~~~~~lV~E~~~~gsL~~~l~~~~~--------------------~ 362 (553)
+.++.+++|.++ ++++++|.. .+..+|||||+++|+|.++|+.... .
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 677777766554 677777653 3567999999999999999864211 0
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccceeeecCccccccc
Q 008785 363 GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLA 442 (553)
Q Consensus 363 ~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~a 442 (553)
...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++........... ....+++.|+|
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~-~~g~~tp~Y~a 378 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNP-LYGMLDPRYSP 378 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCc-cccCCCcceeC
Confidence 12346778899999999999999999 999999999999999999999999999976543321111 11125789999
Q ss_pred cccccCCCC----------------------CcccchHhHHHHHHHHhcCc--ccccchHHH--------------HHhc
Q 008785 443 PEFVYRNEL----------------------TTKSDVYSFGVLLLEIRLVL--CRRWWTLYT--------------LVHS 484 (553)
Q Consensus 443 PE~~~~~~~----------------------t~ksDVwSlGvil~ell~~~--~~~~~~l~~--------------~~~~ 484 (553)
||.+..... ..+.||||+||+++||+... +.......+ .+..
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~ 458 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKG 458 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcc
Confidence 998754321 13479999999999999622 222111111 1111
Q ss_pred CCH------HHHHHHHHHHhhccCCCC---CCCCCHHHHHHH
Q 008785 485 MSL------LCAQECLMLFISCNNWPS---HLSQSKFCNLKL 517 (553)
Q Consensus 485 ~~~------~~~~~l~~l~~~Cl~~dP---~~RPs~~evl~~ 517 (553)
... .......+++.+++..+| .+|+|+.|+|++
T Consensus 459 ~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 459 QKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred cCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 111 345678999999998766 689999999986
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=261.40 Aligned_cols=227 Identities=22% Similarity=0.271 Sum_probs=186.2
Q ss_pred eeecccCceeEEEEEeCC-CCEEEEEEeccCCh---hhHHHHHHHHHHhhcc-CCCceeeEeeEEeeCCceEEEEEccCC
Q 008785 275 RLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSF---QRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVN 349 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~~-g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~~ 349 (553)
.+||+|+||.|..+..+. .+.+|||++++.-. .+.+--..|-++|+-. +-|.++++..++.+-+.+|.||||+.|
T Consensus 355 ~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVMEyvnG 434 (683)
T KOG0696|consen 355 MVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVMEYVNG 434 (683)
T ss_pred EEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEEEEecC
Confidence 467999999999998654 67899999987622 2223335566666665 678999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccc
Q 008785 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE 429 (553)
Q Consensus 350 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 429 (553)
|+|--.+++. ..+.++.+..++.+||-||-|||++ ||+.||||.+|||+|.+|.+||+|||+++..-.+. .
T Consensus 435 GDLMyhiQQ~----GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~--~ 505 (683)
T KOG0696|consen 435 GDLMYHIQQV----GKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDG--V 505 (683)
T ss_pred chhhhHHHHh----cccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeecccccccccCC--c
Confidence 9998888753 3477788899999999999999999 99999999999999999999999999998544333 2
Q ss_pred eeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcCc----ccccchHHHHHhcCCH----HHHHHHHHHHhhcc
Q 008785 430 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVL----CRRWWTLYTLVHSMSL----LCAQECLMLFISCN 501 (553)
Q Consensus 430 ~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~----~~~~~~l~~~~~~~~~----~~~~~l~~l~~~Cl 501 (553)
.+.+.+|||.|+|||++...+|+..+|.|||||+||||+... ..+..++.+.+.+... ..+.+...+....+
T Consensus 506 TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPKslSkEAv~ickg~l 585 (683)
T KOG0696|consen 506 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPKSLSKEAVAICKGLL 585 (683)
T ss_pred ceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCcccccHHHHHHHHHHh
Confidence 345567999999999999999999999999999999999633 3334456665555444 67778888899999
Q ss_pred CCCCCCCCC
Q 008785 502 NWPSHLSQS 510 (553)
Q Consensus 502 ~~dP~~RPs 510 (553)
...|.+|.-
T Consensus 586 tK~P~kRLG 594 (683)
T KOG0696|consen 586 TKHPGKRLG 594 (683)
T ss_pred hcCCccccC
Confidence 999999854
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=257.50 Aligned_cols=243 Identities=19% Similarity=0.232 Sum_probs=191.2
Q ss_pred hcccCCCCeeecccCceeEEEEEeCC-CCEEEEEEeccCChhhHHHHHHHHHHhhccC-C-Cc----eeeEeeEEeeCCc
Q 008785 267 TKNFSEGNRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLH-H-PN----LVAVKGCCYDHGD 339 (553)
Q Consensus 267 ~~~~~~~~~~iG~G~~g~Vy~~~~~~-g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-H-pn----Iv~l~~~~~~~~~ 339 (553)
++.|..... +|+|.||.|-.+.... +..||||+++.- ....+..+-|+++|.++. + |+ +|++.++|.-.++
T Consensus 88 ~~Ry~i~~~-lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrgh 165 (415)
T KOG0671|consen 88 TNRYEIVDL-LGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGH 165 (415)
T ss_pred ccceehhhh-hcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCc
Confidence 455555444 5999999999988544 789999999865 234566678999999993 2 22 7888899999999
Q ss_pred eEEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecC------------
Q 008785 340 RYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE------------ 407 (553)
Q Consensus 340 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~------------ 407 (553)
.+||+|.+ |-|+.++|.. ++-.+++...+..|+.|++++++|||+. +++|-||||+|||+.+
T Consensus 166 iCivfell-G~S~~dFlk~--N~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~k~~ 239 (415)
T KOG0671|consen 166 ICIVFELL-GLSTFDFLKE--NNYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNPKKK 239 (415)
T ss_pred eEEEEecc-ChhHHHHhcc--CCccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEeccCCc
Confidence 99999998 6799999976 5567789999999999999999999999 9999999999999842
Q ss_pred --------CCCeEEeeccccccCCcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcC----ccccc
Q 008785 408 --------EFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLV----LCRRW 475 (553)
Q Consensus 408 --------~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~----~~~~~ 475 (553)
+..++|+|||.|.+..... ... ..|..|.|||++.+-+++.++||||+||||.|+.++ ...++
T Consensus 240 ~~~~r~~ks~~I~vIDFGsAtf~~e~h----s~i-VsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen 314 (415)
T KOG0671|consen 240 VCFIRPLKSTAIKVIDFGSATFDHEHH----STI-VSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHEN 314 (415)
T ss_pred cceeccCCCcceEEEecCCcceeccCc----cee-eeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCc
Confidence 2347999999998754332 111 278999999999999999999999999999999961 11221
Q ss_pred -ch--HHH---------HHhcC---------CH-----------------------------HHHHHHHHHHhhccCCCC
Q 008785 476 -WT--LYT---------LVHSM---------SL-----------------------------LCAQECLMLFISCNNWPS 505 (553)
Q Consensus 476 -~~--l~~---------~~~~~---------~~-----------------------------~~~~~l~~l~~~Cl~~dP 505 (553)
.. +.+ ++... ++ ....++.+|+.++|..||
T Consensus 315 ~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP 394 (415)
T KOG0671|consen 315 LEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDP 394 (415)
T ss_pred HHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCc
Confidence 11 111 11111 10 566789999999999999
Q ss_pred CCCCCHHHHHHHHHHHH
Q 008785 506 HLSQSKFCNLKLWVFAI 522 (553)
Q Consensus 506 ~~RPs~~evl~~l~~~~ 522 (553)
.+|+|+.|+|.+-.+..
T Consensus 395 ~~RiTl~EAL~HpFF~~ 411 (415)
T KOG0671|consen 395 ARRITLREALSHPFFAR 411 (415)
T ss_pred cccccHHHHhcCHHhhc
Confidence 99999999998866543
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=260.45 Aligned_cols=237 Identities=20% Similarity=0.268 Sum_probs=187.0
Q ss_pred eecccCceeEEEEEe-CCCCEEEEEEeccCCh-------hhHHHHHHHHHHhhccCCCceeeEeeEEe-eCCceEEEEEc
Q 008785 276 LLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSF-------QRKKEFYSEIGRFARLHHPNLVAVKGCCY-DHGDRYIVYEF 346 (553)
Q Consensus 276 ~iG~G~~g~Vy~~~~-~~g~~vAvK~~~~~~~-------~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~~lV~E~ 346 (553)
+||+|+|+.||++.. ...+.||||+-..... ...+...+|.++.+.|+||.||++|+++. +.+..+-|+||
T Consensus 470 LLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTVLEY 549 (775)
T KOG1151|consen 470 LLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVLEY 549 (775)
T ss_pred HhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccceeeeee
Confidence 579999999999984 4578899998643311 11244678999999999999999999987 45668999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecC---CCCeEEeeccccccCC
Q 008785 347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE---EFGAHLMGVGLSKFVP 423 (553)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~---~~~~kl~Dfgla~~~~ 423 (553)
|+|.+|+-||+. .+.+++.++..|+.||+.||.||... +++|||-||||.|||+.+ .|.+||+|||+++.+.
T Consensus 550 ceGNDLDFYLKQ----hklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMd 624 (775)
T KOG1151|consen 550 CEGNDLDFYLKQ----HKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMD 624 (775)
T ss_pred cCCCchhHHHHh----hhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecchhhhcc
Confidence 999999999965 35689999999999999999999985 889999999999999954 4779999999999887
Q ss_pred cccccc-----eeeecCccccccccccccCC----CCCcccchHhHHHHHHHHhc-Ccccccc----hHHH---HHhcCC
Q 008785 424 WEVMQE-----RTVMAGGTYGYLAPEFVYRN----ELTTKSDVYSFGVLLLEIRL-VLCRRWW----TLYT---LVHSMS 486 (553)
Q Consensus 424 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~----~~t~ksDVwSlGvil~ell~-~~~~~~~----~l~~---~~~~~~ 486 (553)
.+.... .+....||..|++||.+.-+ ..+.|.||||.|||+|..+- ..|+... ++.+ .++...
T Consensus 625 ddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIlkAtE 704 (775)
T KOG1151|consen 625 DDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTILKATE 704 (775)
T ss_pred CCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchhccee
Confidence 654332 12233499999999998643 46899999999999999996 3333322 2222 222222
Q ss_pred H------HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008785 487 L------LCAQECLMLFISCNNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 487 ~------~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 517 (553)
. ....+..++|.+||.+.-++|....++...
T Consensus 705 VqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~d 741 (775)
T KOG1151|consen 705 VQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACD 741 (775)
T ss_pred ccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccC
Confidence 2 556678899999999999999999887765
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-31 Score=236.39 Aligned_cols=187 Identities=26% Similarity=0.478 Sum_probs=157.8
Q ss_pred ecccCceeEEEEEe-CCCCEEEEEEeccC-ChhhHHHHHHHHHHhhcc-CCCceeeEeeEEeeCCceEEEEEccCCCCHH
Q 008785 277 LGDSKTGGTYSGIL-PDGSRVAVKRLKRS-SFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 353 (553)
Q Consensus 277 iG~G~~g~Vy~~~~-~~g~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~ 353 (553)
||+|++|.|=+-++ .+|...|+|.++.. ..+...+.++|+.+..+. ..|.+|.+||...+.++.++.||.| .-||+
T Consensus 54 lGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M-~tSld 132 (282)
T KOG0984|consen 54 LGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELM-DTSLD 132 (282)
T ss_pred hcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHh-hhhHH
Confidence 49999999876664 46999999999865 334456788888876655 7999999999999999999999999 55898
Q ss_pred HHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccceeee
Q 008785 354 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVM 433 (553)
Q Consensus 354 ~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 433 (553)
.+-.+--..+..+++..+-+|+..+..||.|||++ ..++|||+||+||||+.+|++|++|||.+..+.++.... .
T Consensus 133 kfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiAkt---~ 207 (282)
T KOG0984|consen 133 KFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIAKT---M 207 (282)
T ss_pred HHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccccceeehhhhHHH---H
Confidence 88766555677899999999999999999999987 599999999999999999999999999998776543322 1
Q ss_pred cCccccccccccccC----CCCCcccchHhHHHHHHHHhc
Q 008785 434 AGGTYGYLAPEFVYR----NELTTKSDVYSFGVLLLEIRL 469 (553)
Q Consensus 434 ~~gt~~y~aPE~~~~----~~~t~ksDVwSlGvil~ell~ 469 (553)
..|...|||||.+.. ..|+.||||||||+++.||.+
T Consensus 208 daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~ 247 (282)
T KOG0984|consen 208 DAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAI 247 (282)
T ss_pred hcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhh
Confidence 228889999998853 378999999999999999997
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8e-32 Score=248.23 Aligned_cols=238 Identities=20% Similarity=0.241 Sum_probs=181.7
Q ss_pred eecccCceeEEEEEeCC-CCEEEEEEeccCC--hhhHHHHHHHHHHhhccCCCceeeEeeEEeeC--------CceEEEE
Q 008785 276 LLGDSKTGGTYSGILPD-GSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH--------GDRYIVY 344 (553)
Q Consensus 276 ~iG~G~~g~Vy~~~~~~-g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--------~~~~lV~ 344 (553)
.||+|.||.||+++.++ |+.||+|++-... ..-....++|+++|..|.|+|++.++..|... ...|+|+
T Consensus 24 kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylVf 103 (376)
T KOG0669|consen 24 KIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYLVF 103 (376)
T ss_pred hcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeeeeH
Confidence 35999999999999654 7789998764321 11234568999999999999999999887643 3479999
Q ss_pred EccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCc
Q 008785 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW 424 (553)
Q Consensus 345 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~ 424 (553)
.+|+. +|..+|.. ....++..++.+++.++..||.|+|.. .|+|||+||+|+||+.++.+||+|||+++.+..
T Consensus 104 ~~ceh-DLaGlLsn---~~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGlar~fs~ 176 (376)
T KOG0669|consen 104 DFCEH-DLAGLLSN---RKVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGLARAFST 176 (376)
T ss_pred HHhhh-hHHHHhcC---ccccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeeccccccceec
Confidence 99965 89888864 335689999999999999999999999 999999999999999999999999999976654
Q ss_pred cccccee--eecCccccccccccccCC-CCCcccchHhHHHHHHHHhcCcccccch------------------------
Q 008785 425 EVMQERT--VMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIRLVLCRRWWT------------------------ 477 (553)
Q Consensus 425 ~~~~~~~--~~~~gt~~y~aPE~~~~~-~~t~ksDVwSlGvil~ell~~~~~~~~~------------------------ 477 (553)
....... ....-|..|.+||.+.+. .|+++.|||+-|||+.||.+..|....+
T Consensus 177 ~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~ 256 (376)
T KOG0669|consen 177 SKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNV 256 (376)
T ss_pred ccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCc
Confidence 3221111 111148899999999865 6899999999999999999743322111
Q ss_pred ----HHHHH-----hcCCH----H------HHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 008785 478 ----LYTLV-----HSMSL----L------CAQECLMLFISCNNWPSHLSQSKFCNLKLWVF 520 (553)
Q Consensus 478 ----l~~~~-----~~~~~----~------~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~ 520 (553)
+.+.+ .+++. + -.....+|+..++..||.+||.+++++++-.+
T Consensus 257 d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F 318 (376)
T KOG0669|consen 257 DNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFF 318 (376)
T ss_pred ccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhh
Confidence 11111 01111 1 12367889999999999999999999987543
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=233.30 Aligned_cols=210 Identities=28% Similarity=0.420 Sum_probs=182.7
Q ss_pred ecccCceeEEEEEeCC-CCEEEEEEeccCChh-hHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCCHHH
Q 008785 277 LGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQ-RKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR 354 (553)
Q Consensus 277 iG~G~~g~Vy~~~~~~-g~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~ 354 (553)
||+|.+|.||++...+ ++.+++|++...... ..+.+.+|+..++.++|++|+++++++......++++|++++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 5899999999999855 899999999876432 35778999999999999999999999999899999999999999999
Q ss_pred HhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecC-CCCeEEeeccccccCCcccccceeee
Q 008785 355 WLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE-EFGAHLMGVGLSKFVPWEVMQERTVM 433 (553)
Q Consensus 355 ~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~-~~~~kl~Dfgla~~~~~~~~~~~~~~ 433 (553)
++... ...+++..+..++.+++.+|.+||+. +++|+||+|.||+++. ++.++|+|||.+......... ...
T Consensus 81 ~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~--~~~ 152 (215)
T cd00180 81 LLKEN---EGKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSL--LKT 152 (215)
T ss_pred HHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcch--hhc
Confidence 98642 14588999999999999999999999 9999999999999999 899999999999766543210 111
Q ss_pred cCccccccccccccCC-CCCcccchHhHHHHHHHHhcCcccccchHHHHHhcCCHHHHHHHHHHHhhccCCCCCCCCCHH
Q 008785 434 AGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIRLVLCRRWWTLYTLVHSMSLLCAQECLMLFISCNNWPSHLSQSKF 512 (553)
Q Consensus 434 ~~gt~~y~aPE~~~~~-~~t~ksDVwSlGvil~ell~~~~~~~~~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ 512 (553)
..+...|++||..... ..+.++|+|++|+++++| ..+.+++..|++.||++||++.
T Consensus 153 ~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-----------------------~~~~~~l~~~l~~~p~~R~~~~ 209 (215)
T cd00180 153 IVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-----------------------PELKDLIRKMLQKDPEKRPSAK 209 (215)
T ss_pred ccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------HHHHHHHHHHhhCCcccCcCHH
Confidence 2267889999998877 788999999999999998 5788999999999999999999
Q ss_pred HHHHH
Q 008785 513 CNLKL 517 (553)
Q Consensus 513 evl~~ 517 (553)
++++.
T Consensus 210 ~l~~~ 214 (215)
T cd00180 210 EILEH 214 (215)
T ss_pred HHhhC
Confidence 98864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-30 Score=260.51 Aligned_cols=234 Identities=20% Similarity=0.171 Sum_probs=197.3
Q ss_pred ecccCceeEEEEEeCCCC-EEEEEEeccC---ChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCCH
Q 008785 277 LGDSKTGGTYSGILPDGS-RVAVKRLKRS---SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352 (553)
Q Consensus 277 iG~G~~g~Vy~~~~~~g~-~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL 352 (553)
||-|+||.|=....+... .+|+|.+++. +....+.+..|-.+|...+.|.||++|..|.++...|+.||-|-||.|
T Consensus 428 LGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGGEl 507 (732)
T KOG0614|consen 428 LGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLGGEL 507 (732)
T ss_pred cccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcCchh
Confidence 599999999988875533 4899998764 344566788999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccceee
Q 008785 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV 432 (553)
Q Consensus 353 ~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~ 432 (553)
...|+. ...++......++..+.+|++|||++ +||.|||||+|.+++.+|-+||.|||.|+.+..+. .+.
T Consensus 508 WTiLrd----Rg~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~---KTw 577 (732)
T KOG0614|consen 508 WTILRD----RGSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR---KTW 577 (732)
T ss_pred hhhhhh----cCCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhccCC---cee
Confidence 999964 45688888999999999999999999 99999999999999999999999999999877553 455
Q ss_pred ecCccccccccccccCCCCCcccchHhHHHHHHHHhcCccc-ccc---hHHHHHhcCCH------HHHHHHHHHHhhccC
Q 008785 433 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVLCR-RWW---TLYTLVHSMSL------LCAQECLMLFISCNN 502 (553)
Q Consensus 433 ~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~~~-~~~---~l~~~~~~~~~------~~~~~l~~l~~~Cl~ 502 (553)
+.+|||.|.|||++.+...+.++|.||||+++|||++..|+ ... ..++++-+|-- .......+++++.+.
T Consensus 578 TFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~Lik~LCr 657 (732)
T KOG0614|consen 578 TFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTATDLIKKLCR 657 (732)
T ss_pred eecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHHHHHHHHHh
Confidence 66799999999999999999999999999999999984433 222 23334444432 566678889999999
Q ss_pred CCCCCCCC-----HHHHHHHHHH
Q 008785 503 WPSHLSQS-----KFCNLKLWVF 520 (553)
Q Consensus 503 ~dP~~RPs-----~~evl~~l~~ 520 (553)
.+|.+|.- +.+|-++-.+
T Consensus 658 ~~P~ERLG~~~~gI~DIkkH~Wf 680 (732)
T KOG0614|consen 658 DNPTERLGYQKGGINDIKKHRWF 680 (732)
T ss_pred cCcHhhhccccCChHHHHhhhhh
Confidence 99999976 7788777433
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-30 Score=240.79 Aligned_cols=239 Identities=19% Similarity=0.241 Sum_probs=184.3
Q ss_pred eeecccCceeEEEEEeC-CCCEEEEEEeccC--ChhhHHHHHHHHHHhhccCCCceeeEeeEEeeC-----CceEEEEEc
Q 008785 275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH-----GDRYIVYEF 346 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~-----~~~~lV~E~ 346 (553)
+-||-|+||.||..+.+ +|+.||+|++..- +....+.+.+|+++|..++|.|++..++...-. .++|+++|.
T Consensus 59 RPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TEL 138 (449)
T KOG0664|consen 59 RPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTEL 138 (449)
T ss_pred CcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHH
Confidence 34699999999999964 6999999998753 334457889999999999999999998876543 246889999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCccc
Q 008785 347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV 426 (553)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 426 (553)
|. .+|...+- ....++...+.-+..||++||+|||+. +|+||||||.|.|++.|..+||+|||+++....+.
T Consensus 139 mQ-SDLHKIIV----SPQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~ 210 (449)
T KOG0664|consen 139 MQ-SDLHKIIV----SPQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWDQRD 210 (449)
T ss_pred HH-hhhhheec----cCCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccchhh
Confidence 84 47777663 456788889999999999999999999 99999999999999999999999999999766554
Q ss_pred ccceeeecCccccccccccccCC-CCCcccchHhHHHHHHHHhc-------CcccccchHHH-HHhc-----------CC
Q 008785 427 MQERTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIRL-------VLCRRWWTLYT-LVHS-----------MS 486 (553)
Q Consensus 427 ~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwSlGvil~ell~-------~~~~~~~~l~~-~~~~-----------~~ 486 (553)
....+.-. -|..|.|||.+.+. .|+.+.||||.|||+.|++. ..|...-++.. ++.. |.
T Consensus 211 ~~hMTqEV-VTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGA 289 (449)
T KOG0664|consen 211 RLNMTHEV-VTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGA 289 (449)
T ss_pred hhhhHHHH-HHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhh
Confidence 43332222 57889999999875 58999999999999999994 22222222211 1111 10
Q ss_pred H-----------------------HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 008785 487 L-----------------------LCAQECLMLFISCNNWPSHLSQSKFCNLKLWVFAI 522 (553)
Q Consensus 487 ~-----------------------~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~~~ 522 (553)
- .-..+...+...++..||+.|.+..+.+.+.-..-
T Consensus 290 k~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e 348 (449)
T KOG0664|consen 290 KNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEE 348 (449)
T ss_pred HHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccc
Confidence 0 22334567778889999999999999988764433
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.2e-30 Score=264.08 Aligned_cols=238 Identities=21% Similarity=0.250 Sum_probs=196.7
Q ss_pred cCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccC
Q 008785 270 FSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV 348 (553)
Q Consensus 270 ~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 348 (553)
|....++ |.|++|.||+++.. .++..|+|+++-....+..-+.+|+-+++..+|||||.++|.+......++.||||.
T Consensus 17 yellqrv-gsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycg 95 (829)
T KOG0576|consen 17 YELLQRV-GSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCG 95 (829)
T ss_pred hhheeee-cCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecC
Confidence 4343445 99999999999954 589999999997766666778899999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCccccc
Q 008785 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ 428 (553)
Q Consensus 349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 428 (553)
+|+|.+.-+ ....+++.++....+..++||+|||+. +-+|||||-.|||+++.+.+|++|||.+..+......
T Consensus 96 ggslQdiy~----~TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqitati~K 168 (829)
T KOG0576|consen 96 GGSLQDIYH----VTGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAK 168 (829)
T ss_pred CCcccceee----ecccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhhhhhh
Confidence 999988664 346799999999999999999999999 9999999999999999999999999999776654433
Q ss_pred ceeeecCcccccccccccc---CCCCCcccchHhHHHHHHHHhc-CcccccchHHH---HHhcCCH---------HHHHH
Q 008785 429 ERTVMAGGTYGYLAPEFVY---RNELTTKSDVYSFGVLLLEIRL-VLCRRWWTLYT---LVHSMSL---------LCAQE 492 (553)
Q Consensus 429 ~~~~~~~gt~~y~aPE~~~---~~~~t~ksDVwSlGvil~ell~-~~~~~~~~l~~---~~~~~~~---------~~~~~ 492 (553)
... ..||+.|||||+.. .+.|..++|||+.|++..|+-- ..|..+....+ +..+..+ ...+.
T Consensus 169 rks--fiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~ 246 (829)
T KOG0576|consen 169 RKS--FIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEF 246 (829)
T ss_pred hhc--ccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHH
Confidence 333 33999999999874 5789999999999999999875 33333332222 2221111 66777
Q ss_pred HHHHHhhccCCCCCCCCCHHHHHHH
Q 008785 493 CLMLFISCNNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 493 l~~l~~~Cl~~dP~~RPs~~evl~~ 517 (553)
+-++++.|+..+|++|||+..+|.+
T Consensus 247 fh~fvK~altknpKkRptaeklL~h 271 (829)
T KOG0576|consen 247 FHNFVKGALTKNPKKRPTAEKLLQH 271 (829)
T ss_pred HHHHHHHHhcCCCccCCChhhheec
Confidence 8899999999999999999998865
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-29 Score=228.42 Aligned_cols=231 Identities=19% Similarity=0.290 Sum_probs=184.7
Q ss_pred CeeecccCceeEEEEE-eCCCCEEEEEEeccCChhhHHHHHHHHHHhhccC-CCceeeEeeEEeeCC--ceEEEEEccCC
Q 008785 274 NRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLH-HPNLVAVKGCCYDHG--DRYIVYEFVVN 349 (553)
Q Consensus 274 ~~~iG~G~~g~Vy~~~-~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~--~~~lV~E~~~~ 349 (553)
+++ |+|.++.||.|. ..+.+.++||++++. ..+.+.+|+.+|..|. ||||++++++..+.. .+.|++||+.+
T Consensus 44 rk~-GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n 119 (338)
T KOG0668|consen 44 RKV-GRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNN 119 (338)
T ss_pred HHH-cCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhhcc
Confidence 455 999999999998 457889999999864 4567889999999997 999999999987653 46899999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCC-CCeEEeeccccccCCccccc
Q 008785 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE-FGAHLMGVGLSKFVPWEVMQ 428 (553)
Q Consensus 350 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~-~~~kl~Dfgla~~~~~~~~~ 428 (553)
.+...+.. .++...+..++.+++.||.|+|+. ||.|||+||.|++||.. -.++|+|+|+|.+.......
T Consensus 120 ~Dfk~ly~-------tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eY 189 (338)
T KOG0668|consen 120 TDFKQLYP-------TLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY 189 (338)
T ss_pred ccHHHHhh-------hhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhhcCCCcee
Confidence 88876653 478888999999999999999999 99999999999999865 56899999999987766544
Q ss_pred ceeeecCccccccccccccC-CCCCcccchHhHHHHHHHHhc------CcccccchHHH------------HHhcCCH--
Q 008785 429 ERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIRL------VLCRRWWTLYT------------LVHSMSL-- 487 (553)
Q Consensus 429 ~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwSlGvil~ell~------~~~~~~~~l~~------------~~~~~~~-- 487 (553)
.... .+..|.-||.+.. ..|+..-|+|||||++..|+- ....+.++++. .+.+-.+
T Consensus 190 nVRV---ASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~L 266 (338)
T KOG0668|consen 190 NVRV---ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDL 266 (338)
T ss_pred eeee---ehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCC
Confidence 3222 5677899999875 457899999999999999993 22223334433 1110000
Q ss_pred --------------------------HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 008785 488 --------------------------LCAQECLMLFISCNNWPSHLSQSKFCNLKLWVFA 521 (553)
Q Consensus 488 --------------------------~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~~ 521 (553)
...++..+++...|..|..+|||+.|.+.+-.+.
T Consensus 267 dp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~ 326 (338)
T KOG0668|consen 267 DPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFA 326 (338)
T ss_pred ChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHH
Confidence 3347889999999999999999999999875443
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7e-29 Score=236.95 Aligned_cols=227 Identities=21% Similarity=0.230 Sum_probs=183.5
Q ss_pred eeecccCceeEEEEEeCC-CCEEEEEEeccCC---hhhHHHHHHHHHHhhcc-CCCceeeEeeEEeeCCceEEEEEccCC
Q 008785 275 RLLGDSKTGGTYSGILPD-GSRVAVKRLKRSS---FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVN 349 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~~-g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~~ 349 (553)
.+||+|+|.+|..+.++. .+.+|+|++++.- .++.+-...|-.+..+- +||.+|.+..+|.++..++.|.||++|
T Consensus 256 ~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvieyv~g 335 (593)
T KOG0695|consen 256 RVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYVNG 335 (593)
T ss_pred eeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEecC
Confidence 457999999999998654 7889999998752 33344456677676665 799999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccc
Q 008785 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE 429 (553)
Q Consensus 350 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 429 (553)
|+|--+++. .+.++++.+..+..+|.-||.|||++ ||+.||||.+|+|+|..|.+||+|+|+++..-....
T Consensus 336 gdlmfhmqr----qrklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~l~~gd-- 406 (593)
T KOG0695|consen 336 GDLMFHMQR----QRKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPGD-- 406 (593)
T ss_pred cceeeehhh----hhcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcCCCCCc--
Confidence 999766643 45699999999999999999999999 999999999999999999999999999986543332
Q ss_pred eeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcCc-cc-----------ccchHHHHHhcCCH----HHHHHH
Q 008785 430 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVL-CR-----------RWWTLYTLVHSMSL----LCAQEC 493 (553)
Q Consensus 430 ~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~-~~-----------~~~~l~~~~~~~~~----~~~~~l 493 (553)
.+.+.+|||.|.|||.+++..|....|.|++||+++||+... |. ..+.+.+.+-+.++ ..+...
T Consensus 407 ~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiriprslsvka 486 (593)
T KOG0695|consen 407 TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPRSLSVKA 486 (593)
T ss_pred ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccceeehhh
Confidence 334556999999999999999999999999999999999511 11 11234444444343 445566
Q ss_pred HHHHhhccCCCCCCCCC
Q 008785 494 LMLFISCNNWPSHLSQS 510 (553)
Q Consensus 494 ~~l~~~Cl~~dP~~RPs 510 (553)
..+++.-|+.||.+|.-
T Consensus 487 s~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 487 SHVLKGFLNKDPKERLG 503 (593)
T ss_pred HHHHHHhhcCCcHHhcC
Confidence 77888899999999854
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-28 Score=249.03 Aligned_cols=188 Identities=23% Similarity=0.324 Sum_probs=157.4
Q ss_pred cCCCCeeecccCceeEEEEEeCC-CCEEEEEEeccCChhh--------HHHHHHHHHHhhccC---CCceeeEeeEEeeC
Q 008785 270 FSEGNRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQR--------KKEFYSEIGRFARLH---HPNLVAVKGCCYDH 337 (553)
Q Consensus 270 ~~~~~~~iG~G~~g~Vy~~~~~~-g~~vAvK~~~~~~~~~--------~~~~~~E~~~l~~l~---HpnIv~l~~~~~~~ 337 (553)
|..... +|+|+||.|+.+.++. ...|+||.+.+...-. .-.+-.|+++|..++ |+||++++++|+++
T Consensus 563 yttlq~-lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEdd 641 (772)
T KOG1152|consen 563 YTTLQP-LGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDD 641 (772)
T ss_pred ceeeee-ccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecC
Confidence 334444 4999999999999765 5679999987652111 122456999999997 99999999999999
Q ss_pred CceEEEEEcc-CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeec
Q 008785 338 GDRYIVYEFV-VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGV 416 (553)
Q Consensus 338 ~~~~lV~E~~-~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Df 416 (553)
+..||+||-. ++.+|.+++.- ...+++.++..|+.||+.|+++||+. +|||||||-+|+.++.+|-+||+||
T Consensus 642 d~yyl~te~hg~gIDLFd~IE~----kp~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klidf 714 (772)
T KOG1152|consen 642 DYYYLETEVHGEGIDLFDFIEF----KPRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLIDF 714 (772)
T ss_pred CeeEEEecCCCCCcchhhhhhc----cCccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEeec
Confidence 9999999975 46689999964 35689999999999999999999999 9999999999999999999999999
Q ss_pred cccccCCcccccceeeecCccccccccccccCCCC-CcccchHhHHHHHHHHhc
Q 008785 417 GLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNEL-TTKSDVYSFGVLLLEIRL 469 (553)
Q Consensus 417 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDVwSlGvil~ell~ 469 (553)
|.|.....+... +..||..|.|||++.+.+| +..-|||++|++||.++-
T Consensus 715 gsaa~~ksgpfd----~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivy 764 (772)
T KOG1152|consen 715 GSAAYTKSGPFD----VFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVY 764 (772)
T ss_pred cchhhhcCCCcc----eeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEe
Confidence 999876655432 2339999999999998887 567899999999998874
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.2e-28 Score=244.18 Aligned_cols=234 Identities=18% Similarity=0.128 Sum_probs=189.7
Q ss_pred eeecccCceeEEEEEeCC-CCEEEEEEeccCChhhHHHHHHHHHHhhccC------CCceeeEeeEEeeCCceEEEEEcc
Q 008785 275 RLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLH------HPNLVAVKGCCYDHGDRYIVYEFV 347 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~~-g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~------HpnIv~l~~~~~~~~~~~lV~E~~ 347 (553)
...|+|-|++|.+|.... |..||||++..+. ...+.=+.|+++|++|+ --|+++|+..|...++++||+|-+
T Consensus 438 ~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLClVFE~L 516 (752)
T KOG0670|consen 438 GYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLCLVFEPL 516 (752)
T ss_pred eccccceeeeeeeccccCCCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeEEEehhh
Confidence 345999999999999654 8899999998763 33445578999999994 357999999999999999999988
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCC-CCeEEeeccccccCCccc
Q 008785 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE-FGAHLMGVGLSKFVPWEV 426 (553)
Q Consensus 348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~-~~~kl~Dfgla~~~~~~~ 426 (553)
.-+|.++|+...+ +-.|....+..++.|+..||..|-.. +|+|.||||.|||+++. ..+||+|||.|.+.....
T Consensus 517 -slNLRevLKKyG~-nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~ene 591 (752)
T KOG0670|consen 517 -SLNLREVLKKYGR-NVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNILKLCDFGSASFASENE 591 (752)
T ss_pred -hchHHHHHHHhCc-ccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcceeeeccCcccccccccc
Confidence 5589999987643 34588889999999999999999998 99999999999999876 457999999998766544
Q ss_pred ccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhc----CcccccchHHH------------HHhcCCH---
Q 008785 427 MQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL----VLCRRWWTLYT------------LVHSMSL--- 487 (553)
Q Consensus 427 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~----~~~~~~~~l~~------------~~~~~~~--- 487 (553)
..... -+..|.|||++.+.+|+...|+||.||+||||.+ +.......+.. ++..|.+
T Consensus 592 itPYL----VSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dq 667 (752)
T KOG0670|consen 592 ITPYL----VSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQ 667 (752)
T ss_pred ccHHH----HHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhh
Confidence 33222 3557999999999999999999999999999997 22222223322 3333333
Q ss_pred -------------------------------------------------HHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008785 488 -------------------------------------------------LCAQECLMLFISCNNWPSHLSQSKFCNLKLW 518 (553)
Q Consensus 488 -------------------------------------------------~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l 518 (553)
.....+.+|+..|+..||++|.|..|.|++-
T Consensus 668 HFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~Hp 747 (752)
T KOG0670|consen 668 HFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALKHP 747 (752)
T ss_pred hcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhcCC
Confidence 5567789999999999999999999999864
|
|
| >PHA02642 C-type lectin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.8e-27 Score=217.60 Aligned_cols=120 Identities=22% Similarity=0.511 Sum_probs=102.2
Q ss_pred CCCCCCCcCCcccCCCCeEEEEecCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHhhCCCCCCeEeeeeecCCCCCCc
Q 008785 48 DWKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLS 127 (553)
Q Consensus 48 ~~~~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~ 127 (553)
..+.+||.||. .|+++||+|+.+.++|.+|+.+|+++||+||+|+|++|++||+++.. ...|||||+ +...++.
T Consensus 83 ~k~~~CP~gW~--~~~~kCYyfs~~~ksW~eA~~~C~s~ga~La~I~seeE~~FL~~~~~--~~~yWIGLs--d~~~e~~ 156 (216)
T PHA02642 83 IKYVTCPKGWI--GFGYKCFYFSEDSKNWTFGNTFCTSLGATLVKVETEEELNFLKRYKD--SSDHWIGLN--RESSNHP 156 (216)
T ss_pred cccCCCCCcCE--EECCEEEEEeCcccCHHHHHHHHhhCCCeEeeECCHHHHHHHHHhhc--CCeEEEEeE--eCCCCCc
Confidence 44679999999 99999999999999999999999999999999999999999999875 457999999 6567799
Q ss_pred eEEcCCCCCCcCcccccCccCCCCCCCCCCCCCCCCeeEEEeCCCCceecccCCCCCCccceecc
Q 008785 128 WKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVEH 192 (553)
Q Consensus 128 w~W~dg~~~~~~~~~~~~~~~~~~~~~~C~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~~~ 192 (553)
|+|+|||++.+..| ..+ .++|+.++. ..+.+..|.....|||..+.
T Consensus 157 W~WvDGS~~n~~~~-i~G----------------~g~CAyLs~--~~i~s~~C~~~~~wIC~K~l 202 (216)
T PHA02642 157 WKWADNSNYNASFV-ITG----------------TGECAYLND--IRISSSRVYANRKWICSKTY 202 (216)
T ss_pred eEECCCCccCccee-ccC----------------CCceEEEeC--CceEccCcCCCceEEeeeec
Confidence 99999998765543 222 126776644 48999999999999998754
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-27 Score=244.18 Aligned_cols=188 Identities=22% Similarity=0.294 Sum_probs=158.2
Q ss_pred eeecccCceeEEEEEeCC-CCEEEEEEeccCChhhH---HHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCC
Q 008785 275 RLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRK---KEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 350 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~~-g~~vAvK~~~~~~~~~~---~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 350 (553)
+-||-|+||.|..+...| ...||.|.+++.+.-.+ ..+..|-.||..-+.+-||+||-.|.+.+.+|+||+|++||
T Consensus 635 k~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGG 714 (1034)
T KOG0608|consen 635 KTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGG 714 (1034)
T ss_pred eeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCc
Confidence 346999999999998544 66899999987754333 44678999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcc-----
Q 008785 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE----- 425 (553)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~----- 425 (553)
++-.+|-. -..+++..+..++.++..|+++.|.. |+|||||||+|||||.+|.+||+|||++.-+...
T Consensus 715 DmMSLLIr----mgIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskY 787 (1034)
T KOG0608|consen 715 DMMSLLIR----MGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 787 (1034)
T ss_pred cHHHHHHH----hccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccceecccccc
Confidence 99998864 24578888889999999999999999 9999999999999999999999999998533210
Q ss_pred ---ccc------------------------------c--eeeecCccccccccccccCCCCCcccchHhHHHHHHHHhc
Q 008785 426 ---VMQ------------------------------E--RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL 469 (553)
Q Consensus 426 ---~~~------------------------------~--~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~ 469 (553)
..+ . ......||+.|+|||++....|+..+|.||.|||||||+-
T Consensus 788 Yq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~ 866 (1034)
T KOG0608|consen 788 YQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLV 866 (1034)
T ss_pred ccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhh
Confidence 000 0 0011239999999999999999999999999999999995
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-27 Score=226.97 Aligned_cols=230 Identities=20% Similarity=0.243 Sum_probs=175.3
Q ss_pred ecccCceeEEEEEe-CCCCEEEEEEeccC--ChhhHHHHHHHHHHhhccCCCceeeEeeEEeeC------CceEEEEEcc
Q 008785 277 LGDSKTGGTYSGIL-PDGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH------GDRYIVYEFV 347 (553)
Q Consensus 277 iG~G~~g~Vy~~~~-~~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~------~~~~lV~E~~ 347 (553)
+|.|.- .|..+.. -.+++||+|++... .....++..+|...+..++|+||++++.++.-. .+.|+|||||
T Consensus 25 ~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m 103 (369)
T KOG0665|consen 25 IGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMELM 103 (369)
T ss_pred cCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHhh
Confidence 477766 4544442 24889999988643 223356778999999999999999999998744 3569999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccc
Q 008785 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM 427 (553)
Q Consensus 348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 427 (553)
.++|...+. ..++-..+..|..|++.|++|||+. +|+||||||+||++..+..+||.|||+|+..... .
T Consensus 104 -~~nl~~vi~------~elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~-~ 172 (369)
T KOG0665|consen 104 -DANLCQVIL------MELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD-F 172 (369)
T ss_pred -hhHHHHHHH------HhcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhhcccCcc-c
Confidence 568988876 2477788999999999999999999 9999999999999999999999999999865544 1
Q ss_pred cceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhc---Ccc----------------cccchHHH-HHhcCC-
Q 008785 428 QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL---VLC----------------RRWWTLYT-LVHSMS- 486 (553)
Q Consensus 428 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~---~~~----------------~~~~~l~~-~~~~~~- 486 (553)
.. +.. ..|..|.|||++.+..+.+.+||||.||++.||+. ..+ ..+.+..+ +...++
T Consensus 173 ~m-tpy-VvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~ 250 (369)
T KOG0665|consen 173 MM-TPY-VVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRN 250 (369)
T ss_pred cc-Cch-hheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHH
Confidence 11 111 26888999999999889999999999999999994 111 11111111 000000
Q ss_pred ------------H-----------------HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 008785 487 ------------L-----------------LCAQECLMLFISCNNWPSHLSQSKFCNLKLWVF 520 (553)
Q Consensus 487 ------------~-----------------~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~ 520 (553)
+ .....+.+++.+||-.||++|.|+.++|++--.
T Consensus 251 yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~ 313 (369)
T KOG0665|consen 251 YVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYI 313 (369)
T ss_pred HhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCee
Confidence 0 234457889999999999999999999987433
|
|
| >cd03599 CLECT_DGCR2_like C-type lectin-like domain (CTLD) of the type found in DGCR2, an integral membrane protein deleted in DiGeorge Syndrome (DGS) | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=206.99 Aligned_cols=128 Identities=17% Similarity=0.334 Sum_probs=101.9
Q ss_pred CCcCCcccCCCC--eEEEEecCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHhhCCC---------CCCeEeeee---
Q 008785 53 CPPDWIINEEKS--KCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKN---------VNGCWVGGR--- 118 (553)
Q Consensus 53 Cp~~w~~~~~~~--~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~---------~~~~WiGl~--- 118 (553)
||+||. .|++ +||+++.+.+||.+|+.+|+++|||||+|+|.+|++||.+++... ...+||||+
T Consensus 1 CP~gw~--~~~~~~~CYk~~~~~~tw~dA~~~C~~~Gg~Lasi~s~~e~~fl~~l~~~~~~~~~~~~~~~~~WIGL~~~~ 78 (153)
T cd03599 1 CPSGWH--HYEGTASCYKVYLSGENYWDAVQTCQKVNGSLATFTTDQELQFILAQEWDFDERVFGRKDQCKFWVGYQYVI 78 (153)
T ss_pred CCCchh--ccCCCCeEEEEeCCcCCHHHHHHHHHHcCCEEcCCCCHHHHHHHHHHHHhhcccccccccCCCEEEeecccc
Confidence 999999 8998 899999999999999999999999999999999999999988421 246999995
Q ss_pred -ecCCCCCCceEEc-CCCCCCcCcccccCccCCCCCCCCCCCCCCCCeeEEEe---------CCCCceecccCCCCCCcc
Q 008785 119 -SINTTVGLSWKWS-DNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVS---------NGSRSLVTERCNTSHPFI 187 (553)
Q Consensus 119 -~~~~~~~~~w~W~-dg~~~~~~~~~~~~~~~~~~~~~~C~~~~~~~~C~~~~---------~~~~~w~~~~C~~~~~~i 187 (553)
++|..++|.|+|+ |||++.+..|...-+ + ++ +++ ++++|+.+. .....|+|..|....+|+
T Consensus 79 ~~~~~~~eg~w~WsddGs~~~y~~w~~~w~-~----ge--Pn~-~~e~C~~~~~~~~~~~~~~~~~~W~d~~C~~~~~fi 150 (153)
T cd03599 79 TNRNHSLEGRWEVAYKGSMEVFLPPEPIFA-T----GM--STN-DNVFCAQLQCFQIPSLRERGLHSWHAENCYEKSSFL 150 (153)
T ss_pred cccCcccCCeEEEecCCccceecCccccCC-C----CC--CCC-CCCCCeEEEeeccccccccccCeeeCccCCCCCcce
Confidence 3366788999999 599987655532211 1 11 122 446787775 234579999999999999
Q ss_pred cee
Q 008785 188 CMV 190 (553)
Q Consensus 188 C~~ 190 (553)
|+.
T Consensus 151 Cq~ 153 (153)
T cd03599 151 CKR 153 (153)
T ss_pred eCC
Confidence 973
|
CLECT_DGCR2_like: C-type lectin-like domain (CTLD) of the type found in DGCR2, an integral membrane protein deleted in DiGeorge Syndrome (DGS). CTLD refers to a domain homologous to the carbohydrate-recognition domains (CRDs) of the C-type lectins. DGS is also known velo-cardio-facial syndrome (VCFS). DGS is a genetic abnormality that results in malformations of the heart, face, and limbs and is associated with schizophrenia and depressive disorders. DGCR2 is a candidate for involvement in the pathogenesis of DGS since the DGCR2 gene lies within the minimal DGS critical region (MDGRC) of 22q11, which when deleted gives rise to DGS, and the DGCR2 gene is in close proximity to the balanced translocation breakpoint in a DGS patient having a balanced translocation. |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.9e-26 Score=227.56 Aligned_cols=124 Identities=19% Similarity=0.273 Sum_probs=105.4
Q ss_pred eecccCceeEEEEEeC-CCCEEEEEEeccCChhhHHHHHHHHHHhhccC-----C---CceeeEeeEEeeC----CceEE
Q 008785 276 LLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLH-----H---PNLVAVKGCCYDH----GDRYI 342 (553)
Q Consensus 276 ~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-----H---pnIv~l~~~~~~~----~~~~l 342 (553)
.||-|-|++||.+... +.+.||+|+.+.. ..-.+..+.||++|++++ | .+||+|++.|... .++++
T Consensus 85 KLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~HVCM 163 (590)
T KOG1290|consen 85 KLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNGQHVCM 163 (590)
T ss_pred eccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCCCcEEEE
Confidence 3499999999999854 4678999999865 344567789999999983 3 3699999999754 46799
Q ss_pred EEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEe
Q 008785 343 VYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL 405 (553)
Q Consensus 343 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl 405 (553)
|+|++ |.+|..+|.. ..-+.++...+.+|++||+.||.|||..| ||||-||||+|||+
T Consensus 164 VfEvL-GdnLLklI~~--s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 164 VFEVL-GDNLLKLIKY--SNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred Eehhh-hhHHHHHHHH--hCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 99999 7789898876 34566999999999999999999999987 99999999999998
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-25 Score=215.49 Aligned_cols=189 Identities=29% Similarity=0.434 Sum_probs=162.1
Q ss_pred eeecccCceeEEEEEeCC-CCEEEEEEeccCChh-hHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCCH
Q 008785 275 RLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQ-RKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~~-g~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL 352 (553)
..||+|++|.||++...+ ++.+|+|.+...... ..+.+.+|++.+.+++|+|++++++++......++++||+++++|
T Consensus 5 ~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L 84 (225)
T smart00221 5 KKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGGDL 84 (225)
T ss_pred eEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCCCH
Confidence 345999999999999875 899999999876554 677899999999999999999999999998999999999999999
Q ss_pred HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccceee
Q 008785 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV 432 (553)
Q Consensus 353 ~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~ 432 (553)
.+++.... ..+++..+..++.+++.++.|||+. +++|+||+|.||+++.++.++|+|||.+.......... ..
T Consensus 85 ~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~-~~ 157 (225)
T smart00221 85 FDYLRKKG---GKLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAAL-LK 157 (225)
T ss_pred HHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccc-cc
Confidence 99986521 1178999999999999999999999 99999999999999999999999999998765442111 11
Q ss_pred ecCccccccccccc-cCCCCCcccchHhHHHHHHHHhcC
Q 008785 433 MAGGTYGYLAPEFV-YRNELTTKSDVYSFGVLLLEIRLV 470 (553)
Q Consensus 433 ~~~gt~~y~aPE~~-~~~~~t~ksDVwSlGvil~ell~~ 470 (553)
...++..|++||.+ ....++.++||||||++++||++.
T Consensus 158 ~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g 196 (225)
T smart00221 158 TVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWG 196 (225)
T ss_pred ceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHC
Confidence 12277889999998 666788899999999999999973
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-26 Score=263.64 Aligned_cols=192 Identities=19% Similarity=0.152 Sum_probs=138.4
Q ss_pred ccCC-CceeeEeeEE-------eeCCceEEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 008785 321 RLHH-PNLVAVKGCC-------YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPH 392 (553)
Q Consensus 321 ~l~H-pnIv~l~~~~-------~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ 392 (553)
.++| +||.++++++ .....++.++||+ +++|.++|.. ....+++.+++.++.||+.||.|||++ +
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---g 100 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN---PDRSVDAFECFHVFRQIVEIVNAAHSQ---G 100 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc---ccccccHHHHHHHHHHHHHHHHHHHhC---C
Confidence 4556 6888888877 2334567889987 6699999964 235689999999999999999999999 9
Q ss_pred ceecCCCCCcEEecC-------------------CCCeEEeeccccccCCcccc--------------cceeeecCcccc
Q 008785 393 VVHRDIRASNVLLDE-------------------EFGAHLMGVGLSKFVPWEVM--------------QERTVMAGGTYG 439 (553)
Q Consensus 393 ivHrDlkp~NILl~~-------------------~~~~kl~Dfgla~~~~~~~~--------------~~~~~~~~gt~~ 439 (553)
|+||||||+||||+. ++.+|++|||+++....... ........||+.
T Consensus 101 IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 180 (793)
T PLN00181 101 IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSW 180 (793)
T ss_pred eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcc
Confidence 999999999999954 34556666666653211000 000011237888
Q ss_pred ccccccccCCCCCcccchHhHHHHHHHHhcCcccccc--hHHHHHhcCC-----HHHHHHHHHHHhhccCCCCCCCCCHH
Q 008785 440 YLAPEFVYRNELTTKSDVYSFGVLLLEIRLVLCRRWW--TLYTLVHSMS-----LLCAQECLMLFISCNNWPSHLSQSKF 512 (553)
Q Consensus 440 y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~~~~~~--~l~~~~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~ 512 (553)
|||||++.+..++.++|||||||+||||++..+.... .....+.... ........+++.+||+.+|.+||++.
T Consensus 181 Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~ 260 (793)
T PLN00181 181 YTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRTMSSLRHRVLPPQILLNWPKEASFCLWLLHPEPSCRPSMS 260 (793)
T ss_pred eEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHHHHHHHHhhcChhhhhcCHHHHHHHHHhCCCChhhCcChH
Confidence 9999999999999999999999999999973332221 1111111111 12344567888999999999999999
Q ss_pred HHHHHHH
Q 008785 513 CNLKLWV 519 (553)
Q Consensus 513 evl~~l~ 519 (553)
|++++-.
T Consensus 261 eil~h~~ 267 (793)
T PLN00181 261 ELLQSEF 267 (793)
T ss_pred HHhhchh
Confidence 9998744
|
|
| >cd03588 CLECT_CSPGs C-type lectin-like domain (CTLD) of the type found in chondroitin sulfate proteoglycan core proteins | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.4e-26 Score=196.86 Aligned_cols=122 Identities=23% Similarity=0.451 Sum_probs=103.6
Q ss_pred CCcCCcccCCCCeEEEEecCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHhhCCCCCCeEeeeeecCCCCCCceEEcC
Q 008785 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSD 132 (553)
Q Consensus 53 Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~d 132 (553)
||+||+ .|+++||+|+.++++|.+|++.|+.+||+||+|+|++|++||.++.. ..+||||+ +...++.|+|+|
T Consensus 1 Cp~gw~--~~~~~Cy~~~~~~~sw~~A~~~C~~~gg~La~i~s~~e~~fl~~~~~---~~~WIGl~--~~~~~~~~~W~d 73 (124)
T cd03588 1 CEEGWD--KFQGHCYRHFPDRETWEDAERRCREQQGHLSSIVTPEEQEFVNNNAQ---DYQWIGLN--DRTIEGDFRWSD 73 (124)
T ss_pred CCccce--ecCCEEEEEECCccCHHHHHHHHHhcCCEEeccCCHHHHHHHHHhcc---CcEEecce--ecCCCCceEeCC
Confidence 999999 99999999999999999999999999999999999999999998764 46899999 767779999999
Q ss_pred CCCCCcCcccccCccCCCCCCCCCCCCCCCCeeEEEeC-CCCceecccCCCCCCcccee
Q 008785 133 NMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSN-GSRSLVTERCNTSHPFICMV 190 (553)
Q Consensus 133 g~~~~~~~~~~~~~~~~~~~~~~C~~~~~~~~C~~~~~-~~~~w~~~~C~~~~~~iC~~ 190 (553)
|+++.+.+|..++|.+.. .+.++|+.+.. ....|++..|....+|||+.
T Consensus 74 g~~~~~~~W~~~~p~~~~---------~~~~~Cv~~~~~~~~~W~d~~C~~~~~fICe~ 123 (124)
T cd03588 74 GHPLQFENWRPNQPDNFF---------ATGEDCVVMIWHEEGEWNDVPCNYHLPFTCKK 123 (124)
T ss_pred CCcccccCcCCCCCCCCC---------CCCCCeEEEecCCCCeEcCCCCCCCCeeeeeC
Confidence 999888777766652110 12357877643 45679999999999999974
|
CLECT_CSPGs: C-type lectin-like domain (CTLD) of the type found in chondroitin sulfate proteoglycan core proteins (CSPGs) in human and chicken aggrecan, frog brevican, and zebra fish dermacan. CTLD refers to a domain homologous to the carbohydrate-recognition domains (CRDs) of the C-type lectins. In cartilage, aggrecan forms cartilage link protein stabilized aggregates with hyaluronan (HA). These aggregates contribute to the tissue's load bearing properties. Aggregates having other CSPGs substituting for aggrecan may contribute to the structural integrity of many different tissues. Xenopus brevican is expressed in the notochord and the brain during early embryogenesis. Zebra fish dermacan is expressed in dermal bones and may play a role in dermal bone development. CSPGs do contain LINK domain(s) which bind HA. These LINK domains are considered by one classif |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=7e-26 Score=223.80 Aligned_cols=245 Identities=23% Similarity=0.285 Sum_probs=188.2
Q ss_pred HHHhhcccCCCCeeecccCceeEEEEEeC----CCCEEEEEEeccCChhhHHHHHHHHHHhhcc-CCCceeeEeeEEeeC
Q 008785 263 LRSITKNFSEGNRLLGDSKTGGTYSGILP----DGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDH 337 (553)
Q Consensus 263 l~~~~~~~~~~~~~iG~G~~g~Vy~~~~~----~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~ 337 (553)
+..+.+.|...+++ |+|.|++||+++.. ..+.||+|.+...+ ....+.+|++.|..+ -+.||+++.+++...
T Consensus 31 ~p~~~~~~~~v~ki-geGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnn 107 (418)
T KOG1167|consen 31 IPFISNAYKVVNKI-GEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNN 107 (418)
T ss_pred hhhhhhhhhhhccc-cccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccC
Confidence 34455566666666 99999999999853 36789999997653 345688999999999 599999999999999
Q ss_pred CceEEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCC-CCeEEeec
Q 008785 338 GDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE-FGAHLMGV 416 (553)
Q Consensus 338 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~-~~~kl~Df 416 (553)
+...+|+||++.....+++.. ++...+..+++.+..||+++|.+ |||||||||+|+|.+.. ++-.|.||
T Consensus 108 d~v~ivlp~~~H~~f~~l~~~-------l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDF 177 (418)
T KOG1167|consen 108 DQVAIVLPYFEHDRFRDLYRS-------LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDF 177 (418)
T ss_pred CeeEEEecccCccCHHHHHhc-------CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEec
Confidence 999999999999999998864 77889999999999999999999 99999999999999864 56789999
Q ss_pred cccccCCccc------------------------------------------ccceeeecCccccccccccccCC-CCCc
Q 008785 417 GLSKFVPWEV------------------------------------------MQERTVMAGGTYGYLAPEFVYRN-ELTT 453 (553)
Q Consensus 417 gla~~~~~~~------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~-~~t~ 453 (553)
|+|....... .........||++|.|||++... .-++
T Consensus 178 gLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qtt 257 (418)
T KOG1167|consen 178 GLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTT 257 (418)
T ss_pred hhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCC
Confidence 9996211000 00000112399999999999764 4688
Q ss_pred ccchHhHHHHHHHHhc-Cc-----ccccchHHH-------------HHhcCC--------H-------------------
Q 008785 454 KSDVYSFGVLLLEIRL-VL-----CRRWWTLYT-------------LVHSMS--------L------------------- 487 (553)
Q Consensus 454 ksDVwSlGvil~ell~-~~-----~~~~~~l~~-------------~~~~~~--------~------------------- 487 (553)
++||||.|||++-+++ .. +.+-..+.+ ..-.|. .
T Consensus 258 aiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~ 337 (418)
T KOG1167|consen 258 AIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIY 337 (418)
T ss_pred ccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcc
Confidence 9999999999999995 11 111112221 000011 0
Q ss_pred --------------HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 008785 488 --------------LCAQECLMLFISCNNWPSHLSQSKFCNLKLWVF 520 (553)
Q Consensus 488 --------------~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~ 520 (553)
..+..+++++.+|++.||.+|.|+++.|++-.+
T Consensus 338 ~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF 384 (418)
T KOG1167|consen 338 KSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFF 384 (418)
T ss_pred cccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCC
Confidence 234478999999999999999999999987544
|
|
| >cd03596 CLECT_tetranectin_like C-type lectin-like domain (CTLD) of the type found in the tetranectin (TN), cartilage derived C-type lectin (CLECSF1), and stem cell growth factor (SCGF) | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.9e-25 Score=192.82 Aligned_cols=122 Identities=16% Similarity=0.291 Sum_probs=103.2
Q ss_pred CCcCCcccCCCCeEEEEecCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHhhCCC---CCCeEeeeeecCCCCCCceE
Q 008785 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKN---VNGCWVGGRSINTTVGLSWK 129 (553)
Q Consensus 53 Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~---~~~~WiGl~~~~~~~~~~w~ 129 (553)
||+||. ++++||+|+.+++||.+|+.+|..+||+||+|+|.+|++||.+++... ...+||||+ |...++.|.
T Consensus 1 c~~g~~---~~~~CY~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~~WiGl~--~~~~~~~w~ 75 (129)
T cd03596 1 CLKGTK---IHKKCYLVSEETKHYHEASEDCIARGGTLATPRDSDENDALRDYVKASVPGNWEVWLGIN--DMVAEGKWV 75 (129)
T ss_pred CCCCcE---ECCEEEEEecccCCHHHHHHHHHhcCCeEecCCCHHHHHHHHHHHHhccCCCCcEEEecc--ccCccCeEE
Confidence 999998 789999999999999999999999999999999999999999876432 457999999 777889999
Q ss_pred EcCCCCCCcCcccc---cCccCCCCCCCCCCCCCCCCeeEEEeCC-CCceecccCCCCCCcccee
Q 008785 130 WSDNMSKWNESIHA---VGSFNSSCTSLPCHVHATVDLCTLVSNG-SRSLVTERCNTSHPFICMV 190 (553)
Q Consensus 130 W~dg~~~~~~~~~~---~~~~~~~~~~~~C~~~~~~~~C~~~~~~-~~~w~~~~C~~~~~~iC~~ 190 (553)
|+||+++.+.+|.. +.| ++...++|+.+... ...|++..|....+|||++
T Consensus 76 w~dG~~~~~~~W~~~~~~~p-----------~~~~~~~Cv~l~~~~~~~W~d~~C~~~~~fICe~ 129 (129)
T cd03596 76 DVNGSPISYFNWEREITAQP-----------DGGKRENCVALSSSAQGKWFDEDCRREKPYVCEF 129 (129)
T ss_pred eCCCCCccccccCCCCCCCC-----------CCCCCCCCEEEccCCCCcCcCccCCCCCceeccC
Confidence 99999988877776 232 12234578888654 5579999999999999974
|
CLECT_tetranectin_like: C-type lectin-like domain (CTLD) of the type found in the tetranectin (TN), cartilage derived C-type lectin (CLECSF1), and stem cell growth factor (SCGF). CTLD refers to a domain homologous to the carbohydrate-recognition domains (CRDs) of the C-type lectins. TN binds to plasminogen and stimulates activation of plasminogen, playing a key role in the regulation of proteolytic processes. The TN CTLD binds two calcium ions. Its calcium free form binds to various kringle-like protein ligands. Two residues involved in the coordination of calcium are critical for the binding of TN to the fourth kringle (K4) domain of plasminogen (Plg K4). TN binds the kringle 1-4 form of angiostatin (AST K1-4). AST K1-4 is a fragment of Plg, commonly found in cancer tissues. TN inhibits the bin |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.1e-25 Score=208.10 Aligned_cols=229 Identities=21% Similarity=0.246 Sum_probs=173.2
Q ss_pred CeeecccCceeEEEEEeCC-CCEEEEEEeccCChhhHHHHHHHHHHhhcc-CCCceeeEeeE-EeeCCceEEEEEccCCC
Q 008785 274 NRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGC-CYDHGDRYIVYEFVVNG 350 (553)
Q Consensus 274 ~~~iG~G~~g~Vy~~~~~~-g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~-~~~~~~~~lV~E~~~~g 350 (553)
++.+|+|.||.+-.+.++. .+.+++|.+... .....+|.+|...--.| .|.||+.-|++ |++.+..+.++||++.|
T Consensus 29 ~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~aP~g 107 (378)
T KOG1345|consen 29 NKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEFAPRG 107 (378)
T ss_pred HHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeeccCccc
Confidence 3456999999999999764 678999999765 34567899998765556 59999988765 45566778899999999
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEec--CCCCeEEeeccccccCCccccc
Q 008785 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD--EEFGAHLMGVGLSKFVPWEVMQ 428 (553)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~--~~~~~kl~Dfgla~~~~~~~~~ 428 (553)
+|..-+.. ..+.+.....++.|+++|+.|||++ ++||||||.+||||- +..++||+|||+.+..+.....
T Consensus 108 dL~snv~~-----~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV~~ 179 (378)
T KOG1345|consen 108 DLRSNVEA-----AGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTVKY 179 (378)
T ss_pred hhhhhcCc-----ccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccccccCceehh
Confidence 99876643 4578888899999999999999999 999999999999993 3457999999999765433211
Q ss_pred ceeeecCccccccccccccC---C--CCCcccchHhHHHHHHHHhcC-ccccc-----chHHH--HHhcCCH--------
Q 008785 429 ERTVMAGGTYGYLAPEFVYR---N--ELTTKSDVYSFGVLLLEIRLV-LCRRW-----WTLYT--LVHSMSL-------- 487 (553)
Q Consensus 429 ~~~~~~~gt~~y~aPE~~~~---~--~~t~ksDVwSlGvil~ell~~-~~~~~-----~~l~~--~~~~~~~-------- 487 (553)
. .-+..|.+||.... + ...+.+|||.||++++.++++ .|.+. ....+ .+.++..
T Consensus 180 ~-----~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F~ 254 (378)
T KOG1345|consen 180 L-----EYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKFN 254 (378)
T ss_pred h-----hhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchhhc
Confidence 1 13556889997643 2 347889999999999999973 33322 22222 3333322
Q ss_pred HHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 008785 488 LCAQECLMLFISCNNWPSHLSQSKFCNLK 516 (553)
Q Consensus 488 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 516 (553)
...+.+.++.++-+.++|++|-.+.++-+
T Consensus 255 ~fs~~a~r~Fkk~lt~~~~drcki~~~kk 283 (378)
T KOG1345|consen 255 PFSEKALRLFKKSLTPRFKDRCKIWTAKK 283 (378)
T ss_pred ccCHHHHHHHHHhcCCcccccchhHHHHH
Confidence 56777888899999999999955555443
|
|
| >cd03597 CLECT_attractin_like C-type lectin-like domain (CTLD) of the type found in human and mouse attractin (AtrN) and attractin-like protein (ALP) | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.1e-25 Score=192.70 Aligned_cols=119 Identities=20% Similarity=0.364 Sum_probs=98.3
Q ss_pred CCcCCcccCCCCeEEEEecCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHhhCCC-----CCCeEeeeeecCCCCCCc
Q 008785 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKN-----VNGCWVGGRSINTTVGLS 127 (553)
Q Consensus 53 Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~-----~~~~WiGl~~~~~~~~~~ 127 (553)
||+||. .|+++||+|+.+.++|.+|+.+|+++|||||+|+|++|++||.+++... ...+||||+ |.. +|.
T Consensus 1 Cp~gw~--~~~~~Cy~~~~~~~tw~~A~~~C~~~g~~La~i~~~~E~~fi~~~~~~~~~~~~~~~~WIGl~--d~~-~g~ 75 (129)
T cd03597 1 CGEGWH--LVGNSCLKINTARESYDNAKLYCRNLNAVLASLTTQKKVEFVLKELQKHQMTKQKLTPWVGLR--KIN-VSY 75 (129)
T ss_pred CCCcCE--EcCCEEEEEEcCCCCHHHHHHHHHHcCCEEcCCCCHHHHHHHHHHHHhhcccCCCCceEEeee--cCC-CCc
Confidence 999999 8999999999999999999999999999999999999999999877432 247899999 654 589
Q ss_pred eEEcCCCCCC--cCcccccCccCCCCCCCCCCCCCCCCeeEEEeCC-CCceecccCCCC-CCccce
Q 008785 128 WKWSDNMSKW--NESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNG-SRSLVTERCNTS-HPFICM 189 (553)
Q Consensus 128 w~W~dg~~~~--~~~~~~~~~~~~~~~~~~C~~~~~~~~C~~~~~~-~~~w~~~~C~~~-~~~iC~ 189 (553)
|.|+|||++. +..|.+++|++ .++|+.+..+ ...|+|..|... .+|||+
T Consensus 76 w~W~Dgs~~~~~~~~W~~geP~~-------------~~~C~~~~~~~~~~w~d~~C~~~~~~~iCe 128 (129)
T cd03597 76 WCWEDMSPFTNTTLQWLPGEPSD-------------AGFCGYLEEPAVSGLKANPCTNPVNGSVCE 128 (129)
T ss_pred eEECCCCCCCCccccCCCCCCCC-------------cccEEEEcccccCccccCCcCCCCcceeec
Confidence 9999999974 34555555421 1478887544 446999999998 699996
|
CLECT_attractin_like: C-type lectin-like domain (CTLD) of the type found in human and mouse attractin (AtrN) and attractin-like protein (ALP). CTLD refers to a domain homologous to the carbohydrate-recognition domains (CRDs) of the C-type lectins. Mouse AtrN (the product of the mahogany gene) has been shown to bind Agouti protein and to function in agouti-induced pigmentation and obesity. Mutations in AtrN have also been shown to cause spongiform encephalopathy and hypomyelination in rats and hamsters. The cytoplasmic region of mouse ALP has been shown to binds to melanocortin receptor (MCR4). Signaling through MCR4 plays a role in appetite suppression. Attractin may have therapeutic potential in the treatment of obesity. Human attractin (hAtrN) has been shown to be expressed on activated T cells and released extracellularly. The |
| >PHA03097 C-type lectin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.5e-24 Score=191.74 Aligned_cols=114 Identities=16% Similarity=0.414 Sum_probs=94.6
Q ss_pred CCCCCcCCcccCCCCeEEEEecCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHhhCCCCCCeEeeeeecCCCCCCceE
Q 008785 50 KAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWK 129 (553)
Q Consensus 50 ~~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~ 129 (553)
...||.||+ .|+++||+|+.++++|.+|+.+|+++||+||+|++++|++||+++.. ...|||||+ |.. .
T Consensus 43 ~~~CP~gW~--~~~~~CY~~s~~~~sW~~A~~~C~~~g~~La~I~~~~E~~fi~~~~~--~~~~WIGL~--d~~--~--- 111 (157)
T PHA03097 43 GLNCRSGWV--GYNNKCYTFSENITNKHLAIERCADMDGILTLIDDQKEVLFVSRYKG--GQDLWIGIE--KKK--G--- 111 (157)
T ss_pred CCCCCCCce--eeCCEEEEEecCCCcHHHHHHHHHhCCCEEeeeCCHHHHHHHHHhcC--CCCEEEeee--cCC--C---
Confidence 457999999 99999999999999999999999999999999999999999999876 567999999 644 2
Q ss_pred EcCCCCCCcCcccccCccCCCCCCCCCCCCCCCCeeEEEeCCCCceecccCCCCCCccceecc
Q 008785 130 WSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVEH 192 (553)
Q Consensus 130 W~dg~~~~~~~~~~~~~~~~~~~~~~C~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~~~ 192 (553)
|+||++...+ ++. + ...++|+.+..+ .|++..|.....|||+.+.
T Consensus 112 W~dgs~~~~~-~~~--~-------------~~~e~Cv~i~~~--~w~d~~C~~~~~~ICek~~ 156 (157)
T PHA03097 112 DDDDREVLDK-VVK--P-------------PKSGKCAYLKDK--TIISSNCNATKGWICFDRL 156 (157)
T ss_pred ccCCCccccc-ccC--C-------------CCCCCEEEEECC--cEEeCCCCCCeeEEEeecC
Confidence 9999875432 111 0 124588877554 5999999999999998753
|
|
| >cd03589 CLECT_CEL-1_like C-type lectin-like domain (CTLD) of the type found in CEL-1 from Cucumaria echinata and Echinoidin from Anthocidaris crassispina | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-24 Score=193.43 Aligned_cols=123 Identities=23% Similarity=0.468 Sum_probs=104.4
Q ss_pred CCcCCcccCCCCeEEEEecCCCChHHHHHHHhhc-----CCEEeeeCCHHHHHHHHHhhCCC-----CCCeEeeeeecCC
Q 008785 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI-----GGHLAALTSYEEEHSAQKLCGKN-----VNGCWVGGRSINT 122 (553)
Q Consensus 53 Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~-----~~~L~~i~~~~e~~f~~~~~~~~-----~~~~WiGl~~~~~ 122 (553)
||+||+ .|+++||+|+.+.++|.+|+.+|+.+ ||+||+|+|++|++||.+++... ...+||||+ +.
T Consensus 1 Cp~gw~--~~~~~Cy~~~~~~~~w~~A~~~C~~~~~~g~~~~La~i~s~~e~~~l~~~~~~~~~~~~~~~~WiGl~--~~ 76 (137)
T cd03589 1 CPTFWT--AFGGYCYRFFGDRLTWEEAELRCRSFSIPGLIAHLVSIHSQEENDFVYDLFESSRGPDTPYGLWIGLH--DR 76 (137)
T ss_pred CCcchh--hhCCEEEEEeCCCcCHHHHHHHHHhhcCCCCCceEcccCCHHHHHHHHHHHhhccccCCCCcEEEeee--cC
Confidence 999999 99999999999999999999999997 69999999999999999987532 467999999 66
Q ss_pred CCCCceEEcCCCCCCcCcccccCccCCCCCCCCCCCCCCCCeeEEEeCC---CCceecccCCCCCCccce
Q 008785 123 TVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNG---SRSLVTERCNTSHPFICM 189 (553)
Q Consensus 123 ~~~~~w~W~dg~~~~~~~~~~~~~~~~~~~~~~C~~~~~~~~C~~~~~~---~~~w~~~~C~~~~~~iC~ 189 (553)
..++.|+|+||+++.+.+|.+++|.+. .+.++|+.+... ...|++..|....+|||+
T Consensus 77 ~~~~~~~W~dG~~~~~~~W~~~~P~~~----------~~~~~C~~~~~~~~~~~~W~d~~C~~~~~fIC~ 136 (137)
T cd03589 77 TSEGPFEWTDGSPVDFTKWAGGQPDNY----------GGNEDCVQMWRRGDAGQSWNDMPCDAVFPYICK 136 (137)
T ss_pred CccCceEeCCcCcCCcCCcCCCCCCCC----------CCCCCceeeecCCCCCCeecCCCCCCCcceeee
Confidence 678999999999988888877665321 134577777543 346999999999999997
|
CLECT_CEL-1_like: C-type lectin-like domain (CTLD) of the type found in CEL-1 from Cucumaria echinata and Echinoidin from Anthocidaris crassispina. CTLD refers to a domain homologous to the carbohydrate-recognition domains (CRDs) of the C-type lectins. The CEL-1 CTLD binds three calcium ions and has a high specificity for N-acteylgalactosamine (GalNAc). CEL-1 exhibits strong cytotoxicity which is inhibited by GalNAc. This protein may play a role as a toxin defending against predation. Echinoidin is found in the coelomic fluid of the sea urchin and is specific for GalBeta1-3GalNAc. Echinoidin has a cell adhesive activity towards human cancer cells which is not mediated through the CTLD. Both CEL-1 and Echinoidin are multimeric proteins comprised of multiple dimers linked by disulfide bonds. |
| >cd03590 CLECT_DC-SIGN_like C-type lectin-like domain (CTLD) of the type found in human dendritic cell (DC)-specific intercellular adhesion molecule 3-grabbing non-integrin (DC-SIGN) and the related receptor, DC-SIGN receptor (DC-SIGNR) | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.2e-24 Score=187.01 Aligned_cols=123 Identities=25% Similarity=0.525 Sum_probs=104.8
Q ss_pred CCcCCcccCCCCeEEEEecCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHhhCCCCCCeEeeeeecCCCCCCceEEcC
Q 008785 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSD 132 (553)
Q Consensus 53 Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~d 132 (553)
||.||. .|+++||+|+...+||.+|+.+|+.+||+||+|+|.+|++||.+++. ....+||||+ +...++.|+|+|
T Consensus 1 Cp~~w~--~~~~~Cy~~~~~~~tw~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~-~~~~~WiGl~--~~~~~~~~~W~d 75 (126)
T cd03590 1 CPTNWK--SFQSSCYFFSTEKKSWEESRQFCEDMGAHLVIINSQEEQEFISKILS-GNRSYWIGLS--DEETEGEWKWVD 75 (126)
T ss_pred CCCCce--EeCCEEEEEeCCCcCHHHHHHHHHhCCCEEEeeCCHHHHHHHHHHhC-CCCCEEEeee--cCCCcCCeEecC
Confidence 999999 89999999999999999999999999999999999999999999985 3568999999 666779999999
Q ss_pred CCCC--CcCcccccCccCCCCCCCCCCCCCCCCeeEEEeCCCCceecccCCCCCCccce
Q 008785 133 NMSK--WNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICM 189 (553)
Q Consensus 133 g~~~--~~~~~~~~~~~~~~~~~~~C~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~ 189 (553)
|+++ .+..|..+.|..... ..++|+.+......|.+..|....+|||+
T Consensus 76 g~~~~~~~~~W~~~~p~~~~~---------~~~~C~~~~~~~~~w~~~~C~~~~~fiCe 125 (126)
T cd03590 76 GTPLNSSKTFWHPGEPNNWGG---------GGEDCAELVYDSGGWNDVPCNLEYRWICE 125 (126)
T ss_pred CCCCCCccCCcCCCcCCCCCC---------CCCCCEEEECCCCcEeCcCCCCCEeeeee
Confidence 9998 566666555421110 24688888765468999999999999997
|
CLECT_DC-SIGN_like: C-type lectin-like domain (CTLD) of the type found in human dendritic cell (DC)-specific intercellular adhesion molecule 3-grabbing non-integrin (DC-SIGN) and the related receptor, DC-SIGN receptor (DC-SIGNR). This group also contains proteins similar to hepatic asialoglycoprotein receptor (ASGP-R) and langerin in human. These proteins are type II membrane proteins with a CTLD ectodomain. CTLD refers to a domain homologous to the carbohydrate-recognition domains (CRDs) of the C-type lectins. DC-SIGN is thought to mediate the initial contact between dendritic cells and resting T cells, and may also mediate the rolling of DCs on epithelium. DC-SIGN and DC-SIGNR bind to oligosaccharides present on human tissues, as well as, on path |
| >cd03593 CLECT_NK_receptors_like C-type lectin-like domain (CTLD) of the type found in natural killer cell receptors (NKRs) | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.2e-24 Score=184.99 Aligned_cols=115 Identities=25% Similarity=0.561 Sum_probs=99.0
Q ss_pred CCcCCcccCCCCeEEEEecCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHhhCCCCCCeEeeeeecCCCCCCceEEcC
Q 008785 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSD 132 (553)
Q Consensus 53 Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~d 132 (553)
||+||+ .|+++||+|+.+.++|.+|+..|+.+||+||+|+|++|++||++++. ...+||||+ +...++.|+|+|
T Consensus 1 Cp~gw~--~~~~~Cy~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~--~~~~WiGl~--~~~~~~~~~W~d 74 (116)
T cd03593 1 CPKDWI--CYGNKCYYFSMEKKTWNESKEACSSKNSSLLKIDDEEELEFLQSQIG--SSSYWIGLS--REKSEKPWKWID 74 (116)
T ss_pred CCCcCE--EeCCEEEEEEcCCCCHHHHHHHHHhCCCcEEEECCHHHHHHHHHhcC--CCceEEEEe--ecCCCCCeEccC
Confidence 999999 89999999999999999999999999999999999999999999874 568999999 666679999999
Q ss_pred CCCCCcCcccccCccCCCCCCCCCCCCCCCCeeEEEeCCCCceecccCCCCCCccce
Q 008785 133 NMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICM 189 (553)
Q Consensus 133 g~~~~~~~~~~~~~~~~~~~~~~C~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~ 189 (553)
|+++. .|+...+.+ ..++|+.+... .|.+..|....+|||+
T Consensus 75 g~~~~--~~~~~~~~~------------~~~~C~~~~~~--~w~~~~C~~~~~~IC~ 115 (116)
T cd03593 75 GSPLN--NLFNIRGST------------KSGNCAYLSST--GIYSEDCSTKKRWICE 115 (116)
T ss_pred CCccc--ccccccCCC------------CCCCceEEcCC--cEEcccCCcCceeeee
Confidence 99876 444433311 33578877654 7999999999999996
|
CLECT_NK_receptors_like: C-type lectin-like domain (CTLD) of the type found in natural killer cell receptors (NKRs), including proteins similar to oxidized low density lipoprotein (OxLDL) receptor (LOX-1), CD94, CD69, NKG2-A and -D, osteoclast inhibitory lectin (OCIL), dendritic cell-associated C-type lectin-1 (dectin-1), human myeloid inhibitory C-type lectin-like receptor (MICL), mast cell-associated functional antigen (MAFA), killer cell lectin-like receptors: subfamily F, member 1 (KLRF1) and subfamily B, member 1 (KLRB1), and lys49 receptors. CTLD refers to a domain homologous to the carbohydrate-recognition domains (CRDs) of the C-type lectins. NKRs are variously associated with activation or inhibition of natural killer (NK) cells. Activating NKRs stimulate cytolysis by NK cells of virally infected or transformed cells; inhibitory NKRs block cytolysis up |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.5e-24 Score=197.95 Aligned_cols=154 Identities=19% Similarity=0.148 Sum_probs=120.9
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccc
Q 008785 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE 429 (553)
Q Consensus 350 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 429 (553)
|+|.+++.. .+..+++.++..++.||+.||.|||+. + ||+|||++.++.+|+ ||++........
T Consensus 1 GsL~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~~-- 64 (176)
T smart00750 1 VSLADILEV---RGRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQS-- 64 (176)
T ss_pred CcHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeeccccC--
Confidence 789999964 235699999999999999999999998 6 999999999999999 999876543221
Q ss_pred eeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcCc-ccccc----hHHH-HHh---cC------CH-HHHH--
Q 008785 430 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVL-CRRWW----TLYT-LVH---SM------SL-LCAQ-- 491 (553)
Q Consensus 430 ~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~-~~~~~----~l~~-~~~---~~------~~-~~~~-- 491 (553)
.||+.|+|||++.+..++.++|||||||++|||++.. |.... .... ... .. .. ....
T Consensus 65 -----~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 139 (176)
T smart00750 65 -----RVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAAR 139 (176)
T ss_pred -----CCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhh
Confidence 3889999999999999999999999999999999733 22211 1111 111 11 01 2222
Q ss_pred HHHHHHhhccCCCCCCCCCHHHHHHHHHHHHhh
Q 008785 492 ECLMLFISCNNWPSHLSQSKFCNLKLWVFAILT 524 (553)
Q Consensus 492 ~l~~l~~~Cl~~dP~~RPs~~evl~~l~~~~~~ 524 (553)
.+.+++.+||+.||++||++.|++++......+
T Consensus 140 ~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~ 172 (176)
T smart00750 140 SFADFMRVCASRLPQRREAANHYLAHCRALFAE 172 (176)
T ss_pred hHHHHHHHHHhcccccccCHHHHHHHHHHHHHH
Confidence 689999999999999999999999988665433
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PHA02953 IEV and EEV membrane glycoprotein; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.6e-24 Score=192.65 Aligned_cols=117 Identities=15% Similarity=0.209 Sum_probs=93.3
Q ss_pred CCCCcCCcccCCCCeEEEEecCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHhhCCCCCCeEeeeeecCCCCCCceEE
Q 008785 51 APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKW 130 (553)
Q Consensus 51 ~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W 130 (553)
.+||+||. .|+++||+|+.+.+||.+|+++|+.+||||++++ +|+.|+..+.. ...+||||+ | ++|.|.|
T Consensus 45 ~~CP~GW~--~~~~~CYk~f~~~~tW~~A~~~C~~~Gg~L~~~~--~e~~fv~~~~~--~~~~WIGL~--d--~eg~W~w 114 (170)
T PHA02953 45 SACAKGWI--PYDNYCYLDTNIQLSTYGAVYLCNKYRARLPKPN--FRHLKVLSLTY--GKDFWVSLK--K--KNNRWLD 114 (170)
T ss_pred CcCcccCh--hhCCEEEEEECCcCCHHHHHHHHHhcCCCCCCCc--HHHHHHHHhcc--CCCEEEeEE--C--CCCceEe
Confidence 46999999 9999999999999999999999999999998877 67899988765 557999999 7 6699999
Q ss_pred cCCC-CCCcCcc-----cccCccCCCCCCCCCCCCCCCCeeEEEeCCCCceecccCCCCCCccceec
Q 008785 131 SDNM-SKWNESI-----HAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVE 191 (553)
Q Consensus 131 ~dg~-~~~~~~~-----~~~~~~~~~~~~~~C~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~~ 191 (553)
.||+ ...+.+| |.+++ ++ +.++|+.+.. ..|+|..|....+|||+.+
T Consensus 115 ~Dggs~~~y~~~~~~~~w~~~~-----------~~-~~e~C~~~~~--~~W~d~~C~~~~~fICqk~ 167 (170)
T PHA02953 115 INTNKTVDMNKNTELKKIKSKT-----------KN-DNEACYIYKS--GELKETVCNSVNYIICVKR 167 (170)
T ss_pred CCCCeeeccccccccccccCCC-----------CC-CCCCceEEeC--CeEEeccCCCCcEEEEEEe
Confidence 9964 4444332 11111 11 3457887753 4799999999999999763
|
|
| >cd03594 CLECT_REG-1_like C-type lectin-like domain (CTLD) of the type found in Human REG-1 (lithostathine), REG-4, and avian eggshell-specific proteins: ansocalcin, structhiocalcin-1(SCA-1), and -2(SCA-2) | Back alignment and domain information |
|---|
Probab=99.90 E-value=9.6e-24 Score=185.61 Aligned_cols=122 Identities=27% Similarity=0.625 Sum_probs=102.1
Q ss_pred CCcCCcccCCCCeEEEEecCCCChHHHHHHHhhc--CCEEeeeCCHHHHHHHHHhhCCC---CCCeEeeeeecCCCCCCc
Q 008785 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI--GGHLAALTSYEEEHSAQKLCGKN---VNGCWVGGRSINTTVGLS 127 (553)
Q Consensus 53 Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~--~~~L~~i~~~~e~~f~~~~~~~~---~~~~WiGl~~~~~~~~~~ 127 (553)
||.||+ .|+++||+|+.+.+||.+|+.+|+.+ ||+||+|+|.+|++||.+++... ...+||||+ +...++.
T Consensus 1 Cp~gw~--~~~~~Cy~~~~~~~tw~~A~~~C~~~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~~WiGl~--~~~~~~~ 76 (129)
T cd03594 1 CPKGWL--PYKGNCYGYFRQPLSWSDAELFCQKYGPGAHLASIHSPAEAAAIASLISSYQKAYQPVWIGLH--DPQQSRG 76 (129)
T ss_pred CCCCCE--ecCCEeeeEeccCcCHHHHHHHHHhcCCCceEcccCCHHHHHHHHHHHHhhccCCccEEEeec--cCCCCCc
Confidence 999999 89999999999999999999999999 59999999999999999887432 357999999 6666789
Q ss_pred eEEcCCCCCCcCcccccCccCCCCCCCCCCCCCCCCeeEEEeCCC--CceecccCCCCCCcccee
Q 008785 128 WKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS--RSLVTERCNTSHPFICMV 190 (553)
Q Consensus 128 w~W~dg~~~~~~~~~~~~~~~~~~~~~~C~~~~~~~~C~~~~~~~--~~w~~~~C~~~~~~iC~~ 190 (553)
|+|+||+++.+..|..++|. ...++|+.+...+ ..|.+..|....+|||++
T Consensus 77 ~~W~dg~~~~~~~W~~~~p~------------~~~~~Cv~~~~~~~~~~W~~~~C~~~~~fICe~ 129 (129)
T cd03594 77 WEWSDGSKLDYRSWDRNPPY------------ARGGYCAELSRSTGFLKWNDANCEERNPFICKY 129 (129)
T ss_pred eEeCCCCcceecccCCCCCC------------CCCCCceEEEecCCCCeEECCCCCCCceeeeeC
Confidence 99999999877776655541 1235787775443 369999999999999974
|
CLECT_REG-1_like: C-type lectin-like domain (CTLD) of the type found in Human REG-1 (lithostathine), REG-4, and avian eggshell-specific proteins: ansocalcin, structhiocalcin-1(SCA-1), and -2(SCA-2). CTLD refers to a domain homologous to the carbohydrate-recognition domains (CRDs) of the C-type lectins. REG-1 is a proliferating factor which participates in various kinds of tissue regeneration including pancreatic beta-cell regeneration, regeneration of intestinal mucosa, regeneration of motor neurons, and perhaps in tissue regeneration of damaged heart. REG-1 may play a role on the pathophysiology of Alzheimer's disease and in the development of gastric cancers. Its expression is correlated with reduced survival from early-stage colorectal cancer. REG-1 also binds and aggregates |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.3e-23 Score=211.35 Aligned_cols=165 Identities=16% Similarity=0.131 Sum_probs=125.4
Q ss_pred HhhcccCCCCeeecccCceeEEEEEeC--CCCEEEEEEeccC-----ChhhHHHHHHHHHHhhccCCCceee-EeeEEee
Q 008785 265 SITKNFSEGNRLLGDSKTGGTYSGILP--DGSRVAVKRLKRS-----SFQRKKEFYSEIGRFARLHHPNLVA-VKGCCYD 336 (553)
Q Consensus 265 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~--~g~~vAvK~~~~~-----~~~~~~~~~~E~~~l~~l~HpnIv~-l~~~~~~ 336 (553)
.+..+|..... ||+|+||+||+|... +++.||||++... .......+.+|+++|++++|+||+. +++
T Consensus 15 ~~~~~Y~~~~~-IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---- 89 (365)
T PRK09188 15 ALSARFVETAV-LKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---- 89 (365)
T ss_pred cccCCceEccE-EeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE----
Confidence 34455666555 599999999999864 4778899987533 1223567899999999999999985 443
Q ss_pred CCceEEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCC-CCCcEEecCCCCeEEee
Q 008785 337 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDI-RASNVLLDEEFGAHLMG 415 (553)
Q Consensus 337 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDl-kp~NILl~~~~~~kl~D 415 (553)
.+..++||||++|++|.. +.. . . ...++.|+++||.|||+. ||+|||| ||+|||++.++.+||+|
T Consensus 90 ~~~~~LVmE~~~G~~L~~-~~~---~----~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiD 155 (365)
T PRK09188 90 TGKDGLVRGWTEGVPLHL-ARP---H----G---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVID 155 (365)
T ss_pred cCCcEEEEEccCCCCHHH-hCc---c----c---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEE
Confidence 246799999999999963 211 1 1 146789999999999999 9999999 99999999999999999
Q ss_pred ccccccCCcccccce------eeecCccccccccccccC
Q 008785 416 VGLSKFVPWEVMQER------TVMAGGTYGYLAPEFVYR 448 (553)
Q Consensus 416 fgla~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~ 448 (553)
||+|+.......... .....+++.|+|||.+..
T Consensus 156 FGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 156 FQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred CccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 999987654321111 012237888999998864
|
|
| >PHA02867 C-type lectin protein; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.7e-23 Score=182.72 Aligned_cols=111 Identities=19% Similarity=0.433 Sum_probs=90.7
Q ss_pred CCCCCcCCcccCCCCeEEEEecCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHhhCCCCCCeEeeeeecCCCCCCceE
Q 008785 50 KAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWK 129 (553)
Q Consensus 50 ~~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~ 129 (553)
+.+||+||. .|+++||+|++++++|.+|+.+|.++||+||+|+|++|++|++++.. ..|||||+ +.. .|.
T Consensus 46 ~~~CP~gWi--~~~~~CY~fs~~~~tW~~A~~~C~~~ga~La~I~s~eE~~Fl~~~~~---~~~WIGLs--~~~---~~~ 115 (167)
T PHA02867 46 SKVCPDEWI--GYNSKCYYFTINETNWNDSKKLCDVMDSSLIRFDNIETLNFVSRYGK---GSYWIDIN--QNR---KIP 115 (167)
T ss_pred CCCCCCCCE--EECCEEEEEeccccCHHHHHHHHhhCCCEECCcCCHHHHHHHHHcCC---CCEEEEEE--eCC---CCC
Confidence 468999999 99999999999999999999999999999999999999999998753 57999999 432 356
Q ss_pred EcCCCCCCcCcccccCccCCCCCCCCCCCCCCCCeeEEEeCCCCceecccCCCCCCccceecc
Q 008785 130 WSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVEH 192 (553)
Q Consensus 130 W~dg~~~~~~~~~~~~~~~~~~~~~~C~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~~~ 192 (553)
|.+++.++ .. .+.++|+.++.+ .+.+..|.....|||+.+.
T Consensus 116 ~~~~s~~~-----~~---------------~~~~~Ca~i~~~--~i~s~~C~~~~~wIC~K~~ 156 (167)
T PHA02867 116 GINFSLYY-----EQ---------------GVNDICLLFDTS--NIIEMSCIFHERTICVKED 156 (167)
T ss_pred CccCceee-----ec---------------CCCCcEEEEeCC--eEEeecccCCcEEEEEccC
Confidence 66654431 10 123378877654 7999999999999998754
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.7e-23 Score=195.23 Aligned_cols=234 Identities=21% Similarity=0.319 Sum_probs=178.7
Q ss_pred ecccCceeEEEEEeCCCCEEEEEEeccC--ChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCCHHH
Q 008785 277 LGDSKTGGTYSGILPDGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR 354 (553)
Q Consensus 277 iG~G~~g~Vy~~~~~~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~ 354 (553)
|.+...|..|+|++ .|..+++|+++.. .....++|..|.-.|+-+.||||+.++|.|.....+.++..||+.|+|+.
T Consensus 198 l~e~hsgelwrgrw-qgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gslyn 276 (448)
T KOG0195|consen 198 LAESHSGELWRGRW-QGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLYN 276 (448)
T ss_pred hccCCCcccccccc-cCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHHHH
Confidence 37778899999999 5666777887654 23334778899999999999999999999999999999999999999999
Q ss_pred HhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccceeeec
Q 008785 355 WLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA 434 (553)
Q Consensus 355 ~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 434 (553)
.|++ ..+-..+..++.+++.+||+|++|||+. .|-|.---|.+..++||++.+++|. .+-+++.. +....
T Consensus 277 vlhe--~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltaris-mad~kfsf----qe~gr-- 346 (448)
T KOG0195|consen 277 VLHE--QTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARIS-MADTKFSF----QEVGR-- 346 (448)
T ss_pred HHhc--CccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhhee-cccceeee----ecccc--
Confidence 9987 3445577889999999999999999986 4445555788999999999988874 12122111 11111
Q ss_pred CccccccccccccCCCCC---cccchHhHHHHHHHHhc-CcccccchHHH-----HHhcCCH----HHHHHHHHHHhhcc
Q 008785 435 GGTYGYLAPEFVYRNELT---TKSDVYSFGVLLLEIRL-VLCRRWWTLYT-----LVHSMSL----LCAQECLMLFISCN 501 (553)
Q Consensus 435 ~gt~~y~aPE~~~~~~~t---~ksDVwSlGvil~ell~-~~~~~~~~l~~-----~~~~~~~----~~~~~l~~l~~~Cl 501 (553)
.-.|.||+||.+...+.+ .++|+|||++++||+.+ ..|..+.+..+ .++.-+. ..+..+.+|+.-|+
T Consensus 347 ~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgis~hm~klm~icm 426 (448)
T KOG0195|consen 347 AYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGISRHMNKLMNICM 426 (448)
T ss_pred ccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCccHHHHHHHHHHh
Confidence 146789999999876643 57899999999999997 33444433333 2222222 56677889999999
Q ss_pred CCCCCCCCCHHHHHHHHHHH
Q 008785 502 NWPSHLSQSKFCNLKLWVFA 521 (553)
Q Consensus 502 ~~dP~~RPs~~evl~~l~~~ 521 (553)
+.||.+||.+..|+-.|+.+
T Consensus 427 nedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 427 NEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred cCCCCcCCCcceehhhHHHh
Confidence 99999999999988776554
|
|
| >cd03591 CLECT_collectin_like C-type lectin-like domain (CTLD) of the type found in human collectins including lung surfactant proteins A and D, mannose- or mannan binding lectin (MBL), and CL-L1 (collectin liver 1) | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.2e-22 Score=170.56 Aligned_cols=114 Identities=18% Similarity=0.247 Sum_probs=97.5
Q ss_pred CeEEEEecCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHhhCCCCCCeEeeeeecCCCCCCceEEcCCCCCCcCcccc
Q 008785 64 SKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSDNMSKWNESIHA 143 (553)
Q Consensus 64 ~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~dg~~~~~~~~~~ 143 (553)
.+||+++.+++||.+|+.+|+.+||+||+|+|.+|++||.+++......+||||+ |...++.|.|+||+++.+.+|..
T Consensus 1 ~k~y~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~~~~~~~WiGl~--~~~~~~~~~w~dg~~~~y~~W~~ 78 (114)
T cd03591 1 EKIFVTNGEEKNFDDAQKLCSEAGGTLAMPRNAAENAAIASYVKKGNTYAFIGIT--DLETEGQFVYLDGGPLTYTNWKP 78 (114)
T ss_pred CcEEEeCCceeCHHHHHHHHhhcCCEEecCCCHHHHHHHHHHHhcCCccEEEecc--cCCcCCcEEeCCCCCcccCCcCC
Confidence 3799999999999999999999999999999999999999998644567999999 77778999999999998888777
Q ss_pred cCccCCCCCCCCCCCCCCCCeeEEEeCCCCceecccCCCCCCcccee
Q 008785 144 VGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMV 190 (553)
Q Consensus 144 ~~~~~~~~~~~~C~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~ 190 (553)
++|.+ ..+.++|+.+. .+..|.+..|....+|||++
T Consensus 79 ~ep~~----------~~~~~~Cv~~~-~~~~W~~~~C~~~~~fICe~ 114 (114)
T cd03591 79 GEPNN----------AGGGEDCVEMY-TSGKWNDVACNLTRLFVCEF 114 (114)
T ss_pred CCCCC----------CCCCCCeEEEC-CCCcCcCccCCCCeeEEeeC
Confidence 66521 11245888886 45689999999999999974
|
CLECT_collectin_like: C-type lectin-like domain (CTLD) of the type found in human collectins including lung surfactant proteins A and D, mannose- or mannan binding lectin (MBL), and CL-L1 (collectin liver 1). CTLD refers to a domain homologous to the carbohydrate-recognition domains (CRDs) of the C-type lectins. The CTLDs of these collectins bind carbohydrates on surfaces (e.g. pathogens, allergens, necrotic, or apoptotic cells) and mediate functions associated with killing and phagocytosis. MBPs recognize high mannose oligosaccharides in a calcium dependent manner, bind to a broad range of pathogens, and trigger cell killing by activating the complement pathway. MBP also acts directly as an opsonin. SP-A and SP-D in addition to functioning as host defense components, a |
| >cd03598 CLECT_EMBP_like C-type lectin-like domain (CTLD) of the type found in the human proteins, eosinophil major basic protein (EMBP) and prepro major basic protein homolog (MBPH) | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.1e-21 Score=169.30 Aligned_cols=115 Identities=18% Similarity=0.395 Sum_probs=95.6
Q ss_pred CeEEEEecCCCChHHHHHHHhhc-CCEEeeeCCHHHHHHHHHhhCCC-CCCeEeeeeecCCCCCCceEEcCCCCCCcCcc
Q 008785 64 SKCFGYIGNFRSWDESETYCKEI-GGHLAALTSYEEEHSAQKLCGKN-VNGCWVGGRSINTTVGLSWKWSDNMSKWNESI 141 (553)
Q Consensus 64 ~~Cy~~~~~~~~w~~a~~~C~~~-~~~L~~i~~~~e~~f~~~~~~~~-~~~~WiGl~~~~~~~~~~w~W~dg~~~~~~~~ 141 (553)
++||+|+.+.+||.+|+..|..+ ||+||+|+|++|++||.+++... ...+||||++.+...++.|.|+||+++.+.+|
T Consensus 1 ~~Cy~~~~~~~t~~~A~~~C~~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~WiGl~~~~~~~~~~~~W~dg~~~~y~~W 80 (117)
T cd03598 1 GRCYRFVKSPRTFRDAQVICRRCYRGNLASIHSFAFNYRVQRLVSTLNQAQVWIGGIITGKGRCRRFSWVDGSVWNYAYW 80 (117)
T ss_pred CceEEEecCCCCHHHHHHHhhcCCCceEeeecChhHhHHHHHHHhCCCCCCEEEeeEcCCCCcCCeeEeCCCCccCcCCC
Confidence 47999999999999999999995 99999999999999999988532 46799999943225679999999999888877
Q ss_pred cccCccCCCCCCCCCCCCCCCCeeEEEeCCCCceecccCCCCCCcccee
Q 008785 142 HAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMV 190 (553)
Q Consensus 142 ~~~~~~~~~~~~~~C~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~ 190 (553)
.+++|.+ +.++|+.+..+...|++..|....+|||++
T Consensus 81 ~~g~p~~------------~~~~Cv~~~~~~g~W~~~~C~~~~~fiC~~ 117 (117)
T cd03598 81 APGQPGN------------RRGHCVELCTRGGHWRRAHCKLRRPFICSY 117 (117)
T ss_pred CCCCCCC------------CCCCcEEEeCCCCeECCCcCCCCceeeecC
Confidence 7666522 234787776656689999999999999963
|
CLECT_EMBP_like: C-type lectin-like domain (CTLD) of the type found in the human proteins, eosinophil major basic protein (EMBP) and prepro major basic protein homolog (MBPH). CTLD refers to a domain homologous to the carbohydrate-recognition domains (CRDs) of the C-type lectins. Eosinophils and basophils carry out various functions in allergic, parasitic, and inflammatory diseases. EMBP is stored in eosinophil crystalloid granules and is released upon degranulation. EMBP is also expressed in basophils. The proform of EMBP is expressed in placental X cells and breast tissue and increases significantly during human pregnancy. EMBP has cytotoxic properties and damages bacteria and mammalian cells, in vitro, as well as, helminth parasites. EMBP deposition has been observed in the inflamed tissue of all |
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.7e-21 Score=182.71 Aligned_cols=138 Identities=17% Similarity=0.165 Sum_probs=107.3
Q ss_pred eecccCceeEEEEEeCCCCEEEEEEeccCChh--h------------------------HHHHHHHHHHhhccCCCceee
Q 008785 276 LLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQ--R------------------------KKEFYSEIGRFARLHHPNLVA 329 (553)
Q Consensus 276 ~iG~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~--~------------------------~~~~~~E~~~l~~l~HpnIv~ 329 (553)
.||+|++|.||+|..++|+.||||+++..... . .....+|+..+.++.++++..
T Consensus 4 ~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~~ 83 (190)
T cd05147 4 CISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIPC 83 (190)
T ss_pred ccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCCC
Confidence 46999999999999888999999999754211 1 012245999999998777644
Q ss_pred EeeEEeeCCceEEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCceecCCCCCcEEecCC
Q 008785 330 VKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFL-HDKVKPHVVHRDIRASNVLLDEE 408 (553)
Q Consensus 330 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yL-H~~~~~~ivHrDlkp~NILl~~~ 408 (553)
...+.. ...+|||||++++++...... ...++...+..++.|++.+|.|+ |+. ||+||||||+|||+++
T Consensus 84 p~~~~~--~~~~iVmE~i~g~~l~~~~~~----~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~~- 153 (190)
T cd05147 84 PEPILL--KSHVLVMEFIGDDGWAAPRLK----DAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYHD- 153 (190)
T ss_pred CcEEEe--cCCEEEEEEeCCCCCcchhhh----cCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEEC-
Confidence 333222 234899999998877654321 24588899999999999999999 688 9999999999999984
Q ss_pred CCeEEeeccccccCC
Q 008785 409 FGAHLMGVGLSKFVP 423 (553)
Q Consensus 409 ~~~kl~Dfgla~~~~ 423 (553)
+.++|+|||+|....
T Consensus 154 ~~v~LiDFG~a~~~~ 168 (190)
T cd05147 154 GKLYIIDVSQSVEHD 168 (190)
T ss_pred CcEEEEEccccccCC
Confidence 789999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd03603 CLECT_VCBS A bacterial subgroup of the C-type lectin-like (CTLD) domain; a subgroup of bacterial protein domains homologous to the carbohydrate-recognition domains (CRDs) of the C-type lectins | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.8e-21 Score=166.06 Aligned_cols=113 Identities=17% Similarity=0.339 Sum_probs=94.5
Q ss_pred eEEEEecCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHhhCCCCCCeEeeeeecCCCCCCceEEcCCCCCCcCccccc
Q 008785 65 KCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAV 144 (553)
Q Consensus 65 ~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~dg~~~~~~~~~~~ 144 (553)
+||+|+.++++|.+|+..|+++||+||+|+|++|++||.+++. ....+||||+ +...++.|+|+||++..+.+|..+
T Consensus 1 ~~Y~~~~~~~sw~~A~~~C~~~g~~La~I~s~~E~~fv~~~~~-~~~~~WiG~~--~~~~~~~w~W~dg~~~~~~~W~~~ 77 (118)
T cd03603 1 HFYKFVDGGMTWEAAQTLAESLGGHLVTINSAEENDWLLSNFG-GYGASWIGAS--DAATEGTWKWSDGEESTYTNWGSG 77 (118)
T ss_pred CeEEEeCCCcCHHHHHHHHHHcCCEEcccCCHHHHHHHHHHhc-cCCCEEEeee--cCCCCCceEeCCCCcCCCCCcCCC
Confidence 5999999999999999999999999999999999999999985 3568999999 666679999999999888777776
Q ss_pred CccCCCCCCCCCCCCCCCCeeEEEeC---CCCceecccCC-CCCCccce
Q 008785 145 GSFNSSCTSLPCHVHATVDLCTLVSN---GSRSLVTERCN-TSHPFICM 189 (553)
Q Consensus 145 ~~~~~~~~~~~C~~~~~~~~C~~~~~---~~~~w~~~~C~-~~~~~iC~ 189 (553)
+|.++ ..+.++|+.+.. +...|+|..|. ....|||.
T Consensus 78 eP~~~---------~~~~~~Cv~~~~~~~~~~~W~d~~C~~~~~~~iCe 117 (118)
T cd03603 78 EPHNN---------GGGNEDYAAINHFPGISGKWNDLANSYNTLGYVIE 117 (118)
T ss_pred CCCCC---------CCCCcCeEEeecCCCCCCcCccCCCCccccceEEe
Confidence 65111 123357877754 45679999999 99999995
|
CLECT_VCBS: A bacterial subgroup of the C-type lectin-like (CTLD) domain; a subgroup of bacterial protein domains homologous to the carbohydrate-recognition domains (CRDs) of the C-type lectins. Many CTLDs are calcium-dependent carbohydrate binding modules; other CTLDs bind protein ligands, lipids, and inorganic surfaces including CaCO3 and ice. Bacterial CTLDs within this group are functionally uncharacterized. Animal C-type lectins are involved in such functions as extracellular matrix organization, endocytosis, complement activation, pathogen recognition, and cell-cell interactions. CTLDs may bind a variety of carbohydrate ligands including mannose, N-acetylglucosamine, galactose, N-acetylgalactosamine, and fucose. CTLDs associate with each other through several different surface |
| >cd03601 CLECT_TC14_like C-type lectin-like domain (CTLD) of the type found in lectins TC14, TC14-2, TC14-3, and TC14-4 from the budding tunicate Polyandrocarpa misakiensis and PfG6 from the Acorn worm | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.2e-21 Score=166.78 Aligned_cols=111 Identities=19% Similarity=0.319 Sum_probs=87.2
Q ss_pred EEEecCCCChHHHHHHHhhcCCEEeeeCCHHH--HHHHHHhhCCCCCCeEeeeeecCC-CCCCceEEcCCCCC--CcCcc
Q 008785 67 FGYIGNFRSWDESETYCKEIGGHLAALTSYEE--EHSAQKLCGKNVNGCWVGGRSINT-TVGLSWKWSDNMSK--WNESI 141 (553)
Q Consensus 67 y~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e--~~f~~~~~~~~~~~~WiGl~~~~~-~~~~~w~W~dg~~~--~~~~~ 141 (553)
|||+.+.+||.+|+.+|..+|||||+|+|++| .+++..........+||||+ |. ..+|.|.|+||+++ .+..|
T Consensus 3 ~~~~~~~~~w~~A~~~C~~~G~~La~i~s~~e~~~~~i~~~~~~~~~~~WIGl~--d~~~~~g~~~W~dG~~~~~~y~~W 80 (119)
T cd03601 3 ILCSDETMNYAKAGAFCRSRGMRLASLAMRDSEMRDAILAFTLVKGHGYWVGAD--NLQDGEYDFLWNDGVSLPTDSDLW 80 (119)
T ss_pred EEEcCCcCCHHHHHHHHHhcCCEEeeecCHHHHHHHHHHhccccCCccEEEEec--cCCCCCCCeEeCCCCCcCCCCCcc
Confidence 89999999999999999999999999999988 33333322112356999999 87 78899999999997 46666
Q ss_pred cccCccCCCCCCCCCCCCCCCCeeEEEeCCCCceecccCCCCCCccce
Q 008785 142 HAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICM 189 (553)
Q Consensus 142 ~~~~~~~~~~~~~~C~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~ 189 (553)
.+++|++ ..+.++|+.+......|+|..|....+|||+
T Consensus 81 ~~geP~~----------~~~~e~Cv~~~~~~~~W~d~~C~~~~~fICe 118 (119)
T cd03601 81 APNEPSN----------PQSRQLCVQLWSKYNLLDDEYCGRAKRVICE 118 (119)
T ss_pred CCCcCcC----------cCCCcCCeEEeCCCCCEeCccCCCCceeeec
Confidence 6666521 1123678877665568999999999999996
|
CLECT_TC14_like: C-type lectin-like domain (CTLD) of the type found in lectins TC14, TC14-2, TC14-3, and TC14-4 from the budding tunicate Polyandrocarpa misakiensis and PfG6 from the Acorn worm. CTLD refers to a domain homologous to the carbohydrate-recognition domains (CRDs) of the C-type lectins. TC14 is homodimeric. The CTLD of TC14 binds D-galactose and D-fucose. TC14 is expressed constitutively by multipotent epithelial and mesenchymal cells and plays in role during budding, in inducing the aggregation of undifferentiated mesenchymal cells to give rise to epithelial forming tissue. TC14-2 and TC14-3 shows calcium-dependent galactose binding activity. TC14-3 is a cytostatic factor which blocks cell growth and dedifferentiation of the atrial epithelium during asexual reproducti |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=2e-20 Score=190.72 Aligned_cols=250 Identities=16% Similarity=0.119 Sum_probs=186.6
Q ss_pred ccCCCCeeecccCceeEEEEEeCCC--CEEEEEEeccCChhhHHHHHHHHHHhhccCC----CceeeEeeEE-eeCCceE
Q 008785 269 NFSEGNRLLGDSKTGGTYSGILPDG--SRVAVKRLKRSSFQRKKEFYSEIGRFARLHH----PNLVAVKGCC-YDHGDRY 341 (553)
Q Consensus 269 ~~~~~~~~iG~G~~g~Vy~~~~~~g--~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H----pnIv~l~~~~-~~~~~~~ 341 (553)
.|.... .||+|+||.||.+...+. ..+|+|............+..|..++..+.. +++..+++.. ......+
T Consensus 19 ~~~i~~-~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~ 97 (322)
T KOG1164|consen 19 RYKLGK-KIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNF 97 (322)
T ss_pred ceEEee-eccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeE
Confidence 444444 459999999999997553 4789998876533333367788888888863 6888998888 4777889
Q ss_pred EEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCC-----CCeEEeec
Q 008785 342 IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE-----FGAHLMGV 416 (553)
Q Consensus 342 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~-----~~~kl~Df 416 (553)
+||+.+ |.+|.++..... ...++..+.+.|+.|++.+|.+||+. |++||||||+|+++... ..+.|.||
T Consensus 98 iVM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDf 171 (322)
T KOG1164|consen 98 IVMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDF 171 (322)
T ss_pred EEEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEec
Confidence 999988 889999876532 56799999999999999999999999 99999999999999865 46899999
Q ss_pred cccccCC--cccc----cc-e-eeecCccccccccccccCCCCCcccchHhHHHHHHHHhcC-cccccch---HHHHHhc
Q 008785 417 GLSKFVP--WEVM----QE-R-TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLV-LCRRWWT---LYTLVHS 484 (553)
Q Consensus 417 gla~~~~--~~~~----~~-~-~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~-~~~~~~~---l~~~~~~ 484 (553)
|+++... .... .. . .....||..|+++.+..+.+.+.+.|+||++.++.|++.. .|..... ....+.+
T Consensus 172 Glar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~ 251 (322)
T KOG1164|consen 172 GLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEK 251 (322)
T ss_pred CCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHH
Confidence 9998322 1111 11 1 1223499999999999999999999999999999999953 3432211 1111111
Q ss_pred ---CC------HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHhhc
Q 008785 485 ---MS------LLCAQECLMLFISCNNWPSHLSQSKFCNLKLWVFAILTI 525 (553)
Q Consensus 485 ---~~------~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~~~~~~ 525 (553)
.. ...+..+.++...+-+.+..++|....+.+.+...+.+.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 252 DPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred HhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 00 023456666766666789999999999998876666654
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.9e-21 Score=184.83 Aligned_cols=173 Identities=10% Similarity=0.114 Sum_probs=131.3
Q ss_pred HhhcccCCCCeeecccCceeEEEEEeCCCCEEEEEEeccCChhhHH---H------HHHHHHHhhccCCCceeeEeeEEe
Q 008785 265 SITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKK---E------FYSEIGRFARLHHPNLVAVKGCCY 335 (553)
Q Consensus 265 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~---~------~~~E~~~l~~l~HpnIv~l~~~~~ 335 (553)
.+.++-....+++|+|+||.||.... ++..+|||.+......... . +.+|+..+.+++||+|..+.+++.
T Consensus 27 ~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~ 105 (232)
T PRK10359 27 DFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL 105 (232)
T ss_pred HHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence 34444445566779999999999655 6778999999754322222 2 678999999999999999998866
Q ss_pred eC--------CceEEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecC
Q 008785 336 DH--------GDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE 407 (553)
Q Consensus 336 ~~--------~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~ 407 (553)
.. +..+|+|||++|.+|.++.. ++. ....+++.+|..+|+. |++|||+||+||++++
T Consensus 106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~ 170 (232)
T PRK10359 106 LAERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSK 170 (232)
T ss_pred ecccccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeC
Confidence 43 35799999999999988642 222 2456999999999999 9999999999999999
Q ss_pred CCCeEEeeccccccCCcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHh
Q 008785 408 EFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIR 468 (553)
Q Consensus 408 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell 468 (553)
++ ++|+|||........... ..+.....++.++|+||||+++.-..
T Consensus 171 ~g-i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 171 NG-LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CC-EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence 88 999999988654322111 11334455678999999999987553
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.3e-20 Score=186.85 Aligned_cols=237 Identities=27% Similarity=0.370 Sum_probs=186.1
Q ss_pred eeecccCceeEEEEEeCCCCEEEEEEeccCChh---hHHHHHHHHHHhhccCCC-ceeeEeeEEeeCCceEEEEEccCCC
Q 008785 275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQ---RKKEFYSEIGRFARLHHP-NLVAVKGCCYDHGDRYIVYEFVVNG 350 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~---~~~~~~~E~~~l~~l~Hp-nIv~l~~~~~~~~~~~lV~E~~~~g 350 (553)
+.+|.|+||.||++... ..+|+|.+...... ....+.+|+.+++.+.|+ +|+++++.+......+++++++.++
T Consensus 6 ~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 83 (384)
T COG0515 6 RKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGG 83 (384)
T ss_pred EeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCCCC
Confidence 34599999999999986 88999999765332 367899999999999988 7999999997777789999999999
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCC-CeEEeeccccccCCcccccc
Q 008785 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF-GAHLMGVGLSKFVPWEVMQE 429 (553)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~-~~kl~Dfgla~~~~~~~~~~ 429 (553)
++.+++...... ..++......++.|++.++.|+|+. +++|||+||+||+++... .++++|||.++.........
T Consensus 84 ~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~ 159 (384)
T COG0515 84 SLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTS 159 (384)
T ss_pred cHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCccc
Confidence 999777542111 3688899999999999999999999 999999999999999988 69999999998554433221
Q ss_pred ----eeeecCccccccccccccC---CCCCcccchHhHHHHHHHHhcCc-ccccc-------hHHHHHhcCC---H----
Q 008785 430 ----RTVMAGGTYGYLAPEFVYR---NELTTKSDVYSFGVLLLEIRLVL-CRRWW-------TLYTLVHSMS---L---- 487 (553)
Q Consensus 430 ----~~~~~~gt~~y~aPE~~~~---~~~t~ksDVwSlGvil~ell~~~-~~~~~-------~l~~~~~~~~---~---- 487 (553)
......|+..|+|||.+.+ ..++...|+||+|++++++++.. |.... ...+.+.... .
T Consensus 160 ~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (384)
T COG0515 160 SIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPL 239 (384)
T ss_pred cccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCccccccc
Confidence 1223338999999999987 57889999999999999988622 22111 1122111111 1
Q ss_pred HH------HHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008785 488 LC------AQECLMLFISCNNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 488 ~~------~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 517 (553)
.. ...+.+++..|+..+|..|.+..+....
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 240 SPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred CccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 11 2578899999999999999999998876
|
|
| >smart00034 CLECT C-type lectin (CTL) or carbohydrate-recognition domain (CRD) | Back alignment and domain information |
|---|
Probab=99.84 E-value=9.8e-21 Score=164.93 Aligned_cols=121 Identities=23% Similarity=0.586 Sum_probs=101.3
Q ss_pred CCcCCcccCCCCeEEEEecCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHhhCCC---CCCeEeeeeecCCCCCCceE
Q 008785 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKN---VNGCWVGGRSINTTVGLSWK 129 (553)
Q Consensus 53 Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~---~~~~WiGl~~~~~~~~~~w~ 129 (553)
||.+|. .++++||+++....+|.+|+.+|..+||+||+|++.+|++||.+++... ...+||||+ +...++.|+
T Consensus 1 Cp~~w~--~~~~~Cy~~~~~~~~~~~A~~~C~~~~~~La~i~~~~e~~~i~~~~~~~~~~~~~~WiG~~--~~~~~~~~~ 76 (126)
T smart00034 1 CPSGWI--SYGGKCYKFSTEKKTWADAQAFCQSLGAHLASIHSEAENDFVASLLKNSGSNSDYYWIGLS--DPDSNGSWQ 76 (126)
T ss_pred CCcchh--hhCCEEEEEECCccCHHHHHHHHHhcCCEEcccCCHHHHHHHHHHHHhhcCCCCCEEEecC--ccCcCCCeE
Confidence 999999 8999999999999999999999999999999999999999999988653 568999999 555679999
Q ss_pred EcCCCC-CCcCcccccCccCCCCCCCCCCCCCCCCeeEEEeCCC-CceecccCCCCCCccce
Q 008785 130 WSDNMS-KWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS-RSLVTERCNTSHPFICM 189 (553)
Q Consensus 130 W~dg~~-~~~~~~~~~~~~~~~~~~~~C~~~~~~~~C~~~~~~~-~~w~~~~C~~~~~~iC~ 189 (553)
|+||++ ..+..|.++ + .....++|+.+.... ..|.+..|....+|+|+
T Consensus 77 W~dg~~~~~~~~w~~~-~-----------~~~~~~~C~~~~~~~~~~w~~~~C~~~~~~ICe 126 (126)
T smart00034 77 WSDGSGPVNYSNWAPG-E-----------PNGGSGDCVVLSTSGGGKWNDVSCTSKLPFVCE 126 (126)
T ss_pred ECCCCCCCCccccCCC-C-----------CCCCCCCCEEEecCCCCcccCCCCCCCcccccC
Confidence 999998 445555544 2 122345788876654 47999999999999995
|
Many of these domains function as calcium-dependent carbohydrate binding modules. |
| >TIGR00864 PCC polycystin cation channel protein | Back alignment and domain information |
|---|
Probab=99.84 E-value=8.6e-21 Score=223.33 Aligned_cols=130 Identities=18% Similarity=0.335 Sum_probs=105.5
Q ss_pred CCCCCcCCcccCCCCeEEEEecCCCChHHHHHHHhhc-CCEEeeeCCHHHHHHHHHhhCCC-CCCeEeeeeecCCCCCCc
Q 008785 50 KAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI-GGHLAALTSYEEEHSAQKLCGKN-VNGCWVGGRSINTTVGLS 127 (553)
Q Consensus 50 ~~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~-~~~L~~i~~~~e~~f~~~~~~~~-~~~~WiGl~~~~~~~~~~ 127 (553)
...||+||....|+++||+|+.+.++|.+|+.+|+++ |||||+|+|++|++||.+++... ...+||||+ |...+|.
T Consensus 315 ~~~CP~GW~~f~~~g~CYk~~~e~~TW~dAe~~C~s~GGAhLAsI~S~eEn~FL~~lv~~s~~~~vWIGLs--D~~~EG~ 392 (2740)
T TIGR00864 315 HPHCPKDGEIFEENGHCFQIVPEEAAWLDAQEQCLARAGAALAIVDNDALQNFLARKVTHSLDRGVWIGFS--DVNGAEK 392 (2740)
T ss_pred CCCCCCCCeecCCCCEEEEEeCCccCHHHHHHHhhccCCeEEecCCCHHHHHHHHHHhhccCCccEEEeee--CCCCCCc
Confidence 3589999972245899999999999999999999999 69999999999999999988543 346999999 8777775
Q ss_pred --eEEcCCCCC-CcCcccccCccCCCCCCCCCCCCCCCCeeEEEeCCCCceecccCCCCCCccceeccc
Q 008785 128 --WKWSDNMSK-WNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVEHE 193 (553)
Q Consensus 128 --w~W~dg~~~-~~~~~~~~~~~~~~~~~~~C~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~~~~ 193 (553)
|+|+||+++ .+.+|..++|+ +.+.|+|+.+... ..|+|..|....+|+|+.+..
T Consensus 393 g~WvWsDGS~l~~YtnW~pGEPN-----------n~~~EdCV~l~~~-g~WND~~Cs~~~~FICE~~~~ 449 (2740)
T TIGR00864 393 GPAHQGEAFEAEECEEGLAGEPH-----------PARAEHCVRLDPR-GQCNSDLCNAPHAYVCELNPG 449 (2740)
T ss_pred eeeEECCCCcccCccCcCCCCCC-----------CCCCCCCEEEcCC-CCEEccCCCCCeeEEeEECCC
Confidence 999999998 56666666653 2223577776433 469999999999999987533
|
Note: this model has been restricted to the amino half because for technical reasons. |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.9e-20 Score=174.83 Aligned_cols=138 Identities=17% Similarity=0.174 Sum_probs=109.8
Q ss_pred eecccCceeEEEEEeCCCCEEEEEEeccCChh--h------------------------HHHHHHHHHHhhccCCCceee
Q 008785 276 LLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQ--R------------------------KKEFYSEIGRFARLHHPNLVA 329 (553)
Q Consensus 276 ~iG~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~--~------------------------~~~~~~E~~~l~~l~HpnIv~ 329 (553)
.||+|++|.||+|...+|+.||||+++..... . ...+.+|...+.++.|++|..
T Consensus 4 ~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (190)
T cd05145 4 CISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGVPV 83 (190)
T ss_pred eeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCCCC
Confidence 56999999999999878999999999864211 0 122357899999999998755
Q ss_pred EeeEEeeCCceEEEEEccCCCCHHHH-hccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCceecCCCCCcEEecC
Q 008785 330 VKGCCYDHGDRYIVYEFVVNGPLDRW-LHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD-KVKPHVVHRDIRASNVLLDE 407 (553)
Q Consensus 330 l~~~~~~~~~~~lV~E~~~~gsL~~~-l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~ivHrDlkp~NILl~~ 407 (553)
...+... ..++||||++++++... +.. ..++......++.|++.+|.+||+ . ||+||||||+|||++
T Consensus 84 p~~~~~~--~~~lVmE~~~g~~~~~~~l~~-----~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~- 152 (190)
T cd05145 84 PEPILLK--KNVLVMEFIGDDGSPAPRLKD-----VPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH- 152 (190)
T ss_pred ceEEEec--CCEEEEEEecCCCchhhhhhh-----ccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE-
Confidence 4444333 34899999998865433 322 346788899999999999999999 8 999999999999999
Q ss_pred CCCeEEeeccccccCCc
Q 008785 408 EFGAHLMGVGLSKFVPW 424 (553)
Q Consensus 408 ~~~~kl~Dfgla~~~~~ 424 (553)
++.++|+|||++.....
T Consensus 153 ~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 153 DGKPYIIDVSQAVELDH 169 (190)
T ss_pred CCCEEEEEcccceecCC
Confidence 78999999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.4e-21 Score=210.22 Aligned_cols=240 Identities=18% Similarity=0.187 Sum_probs=178.0
Q ss_pred cCCCCeeecccCceeEEEEEeC-CCCEEEEEEec----cC-Chhh-HHHHHHHHHHhhccCCCceeeEeeEEeeCCceEE
Q 008785 270 FSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLK----RS-SFQR-KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYI 342 (553)
Q Consensus 270 ~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~----~~-~~~~-~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 342 (553)
|.....++|.|++|.|+..... ..+.++.|..+ .. .... ...+..|+.+-..++|||++..+....+....+-
T Consensus 319 y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~ 398 (601)
T KOG0590|consen 319 YGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQ 398 (601)
T ss_pred cCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchh
Confidence 4445677899999977776633 34444544433 21 1111 1226668888888999999888777776666666
Q ss_pred EEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccC
Q 008785 343 VYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV 422 (553)
Q Consensus 343 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~ 422 (553)
+||||++ +|..++.. ...++..++-.++.|+..|++|||+. ||.|||+|++|+++..++.+||+|||.+...
T Consensus 399 ~mE~~~~-Dlf~~~~~----~~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf 470 (601)
T KOG0590|consen 399 SMEYCPY-DLFSLVMS----NGKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVF 470 (601)
T ss_pred hhhcccH-HHHHHHhc----ccccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceee
Confidence 6999999 99998854 23588888999999999999999999 9999999999999999999999999999766
Q ss_pred Cccccc--ceeeecCccccccccccccCCCCCc-ccchHhHHHHHHHHhcC-ccc----ccch-HHH-------HHhcCC
Q 008785 423 PWEVMQ--ERTVMAGGTYGYLAPEFVYRNELTT-KSDVYSFGVLLLEIRLV-LCR----RWWT-LYT-------LVHSMS 486 (553)
Q Consensus 423 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~t~-ksDVwSlGvil~ell~~-~~~----~~~~-l~~-------~~~~~~ 486 (553)
...... .......|+..|+|||.+.+..|++ ..||||.|+++..|+.. .+. ..+. ..+ .+..|.
T Consensus 471 ~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~ 550 (601)
T KOG0590|consen 471 RYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGP 550 (601)
T ss_pred ccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccCh
Confidence 544332 2222334899999999999999975 57999999999999961 111 1111 111 111111
Q ss_pred H----HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008785 487 L----LCAQECLMLFISCNNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 487 ~----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 517 (553)
. ..+.....++.++|+.||.+|-|+.+|++.
T Consensus 551 ~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 551 NRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred HHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence 1 566778889999999999999999999986
|
|
| >cd03592 CLECT_selectins_like C-type lectin-like domain (CTLD) of the type found in the type 1 transmembrane proteins: P(platlet)-, E(endothelial)-, and L(leukocyte)- selectins (sels) | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.6e-20 Score=161.61 Aligned_cols=110 Identities=19% Similarity=0.309 Sum_probs=92.2
Q ss_pred EEEecCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHhhCCC-CCCeEeeeeecCCCCCCceEEcCCCCCCcCcccccC
Q 008785 67 FGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKN-VNGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVG 145 (553)
Q Consensus 67 y~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~-~~~~WiGl~~~~~~~~~~w~W~dg~~~~~~~~~~~~ 145 (553)
|+|+.+.++|.+|+.+|+.+|||||+|+|++|++||.+++... ...|||||+ +...++.|.|+||++..+..|.+++
T Consensus 3 Y~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~~i~~~~~~~~~~~~WiG~~--~~~~~~~W~~~dg~~~~y~~W~~ge 80 (115)
T cd03592 3 YHYSTEKMTFNEAVKYCKSRGTDLVAIQNAEENALLNGFALKYNLGYYWIDGN--DINNEGTWVDTDKKELEYKNWAPGE 80 (115)
T ss_pred EEEcCCccCHHHHHHHHHHcCCeEeecCCHHHHHHHHHHHHhcCCCCEEEeCc--cCCccCeEEeCCCCcccccccCCCC
Confidence 9999999999999999999999999999999999999976433 447999999 6667799999999988788877766
Q ss_pred ccCCCCCCCCCCCCCCCCeeEEEeCC-CCceecccCCCCCCccce
Q 008785 146 SFNSSCTSLPCHVHATVDLCTLVSNG-SRSLVTERCNTSHPFICM 189 (553)
Q Consensus 146 ~~~~~~~~~~C~~~~~~~~C~~~~~~-~~~w~~~~C~~~~~~iC~ 189 (553)
|.++ ..++|+.+... +..|++..|....+|||+
T Consensus 81 P~~~-----------~~~~Cv~~~~~~~g~W~d~~C~~~~~fICe 114 (115)
T cd03592 81 PNNG-----------RNENCLEIYIKDNGKWNDEPCSKKKSAICY 114 (115)
T ss_pred CCCC-----------CCCCceEEccCCCCCCcCcCCCCCccceeC
Confidence 5321 13477777553 567999999999999996
|
CLECT_selectins_like: C-type lectin-like domain (CTLD) of the type found in the type 1 transmembrane proteins: P(platlet)-, E(endothelial)-, and L(leukocyte)- selectins (sels). CTLD refers to a domain homologous to the carbohydrate-recognition domains (CRDs) of the C-type lectins. P- E- and L-sels are cell adhesion receptors that mediate the initial attachment, tethering, and rolling of lymphocytes on inflamed vascular walls enabling subsequent lymphocyte adhesion and transmigration. L- sel is expressed constitutively on most leukocytes. P-sel is stored in the Weibel-Palade bodies of endothelial cells and in the alpha granules of platlets. E- sels are present on endothelial cells. Following platelet and/or endothelial cell activation P- sel is rapidly translocated to the cell surface and E-sel exp |
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=3.7e-20 Score=170.44 Aligned_cols=246 Identities=17% Similarity=0.224 Sum_probs=179.4
Q ss_pred ccCCCCeeecccCceeEEEEE-eCCCCEEEEEEeccCChhhHHHHHHHHHHhhccCC-CceeeEeeEEeeCCceEEEEEc
Q 008785 269 NFSEGNRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHH-PNLVAVKGCCYDHGDRYIVYEF 346 (553)
Q Consensus 269 ~~~~~~~~iG~G~~g~Vy~~~-~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H-pnIv~l~~~~~~~~~~~lV~E~ 346 (553)
+|....++ |.|+||.+|.|. ..+|+.||||+-+.. ....++.-|..+...|+| ..|..+..+..+.....+||+.
T Consensus 16 ky~lvrki-GsGSFGdIy~~~~i~~ge~VAiK~Es~~--a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdL 92 (341)
T KOG1163|consen 16 KYKLVRKI-GSGSFGDIYLGISITSGEEVAIKLESSK--AKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDL 92 (341)
T ss_pred ceEEEEee-cCCchhheeeeeeccCCceEEEEeeccc--CCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeeec
Confidence 44444445 999999999998 567999999987644 233457788888888865 6788888888888889999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecC---CCCeEEeeccccccCC
Q 008785 347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE---EFGAHLMGVGLSKFVP 423 (553)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~---~~~~kl~Dfgla~~~~ 423 (553)
+ |.||.+++.- ..+.++..+++-++-|++.-++|+|.+ +++||||||+|+|..- ..++.++|||+|+...
T Consensus 93 L-GPsLEdLfnf---C~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~ 165 (341)
T KOG1163|consen 93 L-GPSLEDLFNF---CSRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR 165 (341)
T ss_pred c-CccHHHHHHH---HhhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchhhhc
Confidence 8 8899998864 335689999999999999999999999 9999999999999964 3568999999998765
Q ss_pred cccccce-----eeecCccccccccccccCCCCCcccchHhHHHHHHHHhc-Cccccc------chHHHHHhcCCH----
Q 008785 424 WEVMQER-----TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-VLCRRW------WTLYTLVHSMSL---- 487 (553)
Q Consensus 424 ~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-~~~~~~------~~l~~~~~~~~~---- 487 (553)
+..+... .....||.+|.+--...+..-+.+.|+=|+|.+|...-- ..|.+. ..-.+.+.+.+.
T Consensus 166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~i 245 (341)
T KOG1163|consen 166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPI 245 (341)
T ss_pred cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCH
Confidence 4322211 111228999999888877788899999999998876642 222221 122223322222
Q ss_pred -----HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHhhc
Q 008785 488 -----LCAQECLMLFISCNNWPSHLSQSKFCNLKLWVFAILTI 525 (553)
Q Consensus 488 -----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~~~~~~ 525 (553)
..+.++...+.-|-..-=++-|.-.= ++++...+...
T Consensus 246 e~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~y-lrqlFriLfr~ 287 (341)
T KOG1163|consen 246 EVLCKGFPAEFAMYLNYCRGLGFEEKPDYMY-LRQLFRILFRT 287 (341)
T ss_pred HHHhCCCcHHHHHHHHHHhhcCCCCCCcHHH-HHHHHHHHHhh
Confidence 45667777777887777777777643 33344444333
|
|
| >cd03602 CLECT_1 C-type lectin (CTL)/C-type lectin-like (CTLD) domain subgroup 1; a subgroup of protein domains homologous to the carbohydrate-recognition domains (CRDs) of the C-type lectins | Back alignment and domain information |
|---|
Probab=99.82 E-value=4.2e-20 Score=157.11 Aligned_cols=107 Identities=21% Similarity=0.469 Sum_probs=90.1
Q ss_pred eEEEEecCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHhhCCCCCCeEeeeeecCCCCCCceEEcCCCCCCcCccccc
Q 008785 65 KCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAV 144 (553)
Q Consensus 65 ~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~dg~~~~~~~~~~~ 144 (553)
+||+|+..+++|.+|+.+|+.+||+||+|+|++|++||++++......+||||+ +. ++.|.|+||++..+..|..+
T Consensus 1 ~~y~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~~~~~~~WiGl~--~~--~~~~~W~dg~~~~~~~w~~~ 76 (108)
T cd03602 1 RTFYLVNESKTWSEAQQYCRENYTDLATVQNQEDNALLSNLSRVSNSAAWIGLY--RD--VDSWRWSDGSESSFRNWNTF 76 (108)
T ss_pred CceEEeccccCHHHHHHHHHHHCCccCeecCHHHHHHHHHHHhccCCcEEEEEE--CC--CCceEEcCCCCCccCccCCC
Confidence 489999999999999999999999999999999999999988533568999999 44 68999999999777766554
Q ss_pred CccCCCCCCCCCCCCCCCCeeEEEeCCCCceecccCCCCCCccce
Q 008785 145 GSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICM 189 (553)
Q Consensus 145 ~~~~~~~~~~~C~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~ 189 (553)
+| . ..++|+.+... ..|++..|....+|||.
T Consensus 77 ~~----~---------~~~~C~~~~~~-~~w~~~~C~~~~~fIC~ 107 (108)
T cd03602 77 QP----F---------GQGDCATMYSS-GRWYAALCSALKPFICY 107 (108)
T ss_pred CC----C---------CCCCeeEECcC-CeECcccCCCCcCEecc
Confidence 32 1 23578877654 68999999999999996
|
CLECT_1: C-type lectin (CTL)/C-type lectin-like (CTLD) domain subgroup 1; a subgroup of protein domains homologous to the carbohydrate-recognition domains (CRDs) of the C-type lectins. Many CTLDs are calcium-dependent carbohydrate binding modules; other CTLDs bind protein ligands, lipids, and inorganic surfaces including CaCO3 and ice. Animal C-type lectins are involved in such functions as extracellular matrix organization, endocytosis, complement activation, pathogen recognition, and cell-cell interactions. CTLDs may bind a variety of carbohydrate ligands including mannose, N-acetylglucosamine, galactose, N-acetylgalactosamine, and fucose. CTLDs associate with each other through several different surfaces to form dimers, trimers, or tetramers from which ligand-binding sites project in differe |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.3e-19 Score=171.82 Aligned_cols=134 Identities=16% Similarity=0.223 Sum_probs=105.5
Q ss_pred CeeecccCceeEEEEEeCCCCEEEEEEeccCChhhHHHHHHHHHHhhcc-----CCCceeeEeeEEeeCC---ceE-EEE
Q 008785 274 NRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-----HHPNLVAVKGCCYDHG---DRY-IVY 344 (553)
Q Consensus 274 ~~~iG~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-----~HpnIv~l~~~~~~~~---~~~-lV~ 344 (553)
..+||+|++|.||. .++....+||++........+.+.+|+.+++.+ +||||++++|++.++. ..+ +|+
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~ 84 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIA 84 (210)
T ss_pred cceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEe
Confidence 45679999999996 443333479998765455567899999999999 5799999999999874 333 789
Q ss_pred Ec--cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHH-HHHHhCCCCCceecCCCCCcEEecC----CCCeEEeecc
Q 008785 345 EF--VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGI-AFLHDKVKPHVVHRDIRASNVLLDE----EFGAHLMGVG 417 (553)
Q Consensus 345 E~--~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL-~yLH~~~~~~ivHrDlkp~NILl~~----~~~~kl~Dfg 417 (553)
|| +.+|+|.+++.+ ..+++. ..++.|++.++ +|||++ +|+||||||+|||++. +..++|+||+
T Consensus 85 e~~G~~~~tL~~~l~~-----~~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 85 DFDGKPSITLTEFAEQ-----CRYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred cCCCCcchhHHHHHHc-----ccccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 99 557999999964 125544 35678888887 999999 9999999999999974 3479999954
Q ss_pred cc
Q 008785 418 LS 419 (553)
Q Consensus 418 la 419 (553)
.+
T Consensus 155 G~ 156 (210)
T PRK10345 155 GE 156 (210)
T ss_pred CC
Confidence 33
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=5.6e-20 Score=190.99 Aligned_cols=198 Identities=23% Similarity=0.286 Sum_probs=154.0
Q ss_pred hhccCCCceeeEeeEEeeCCceEEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCc-eecC
Q 008785 319 FARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHV-VHRD 397 (553)
Q Consensus 319 l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~i-vHrD 397 (553)
|+.+.|.|+.+++|.+.+++..++|.+||..|+|.+.+.. ....+++.....++++|+.||+|||+. .| .|+.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~---~~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~ 74 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN---EDIKLDYFFILSFIRDISKGLAYLHNS---PIGYHGA 74 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc---cccCccHHHHHHHHHHHHHHHHHHhcC---cceeeee
Confidence 4678999999999999999999999999999999999975 456789999999999999999999987 55 9999
Q ss_pred CCCCcEEecCCCCeEEeeccccccCCcccccceeeecCccccccccccccCC-------CCCcccchHhHHHHHHHHhc-
Q 008785 398 IRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRN-------ELTTKSDVYSFGVLLLEIRL- 469 (553)
Q Consensus 398 lkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~t~ksDVwSlGvil~ell~- 469 (553)
++++|+++|..+.+|++|||+.................-..-|.|||.+... ..+.+.||||||++++|++.
T Consensus 75 l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r 154 (484)
T KOG1023|consen 75 LKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFR 154 (484)
T ss_pred eccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhc
Confidence 9999999999999999999999876531111111111134569999998753 14678999999999999996
Q ss_pred Ccccc-------cchHHHHHhc-CCH----------HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 008785 470 VLCRR-------WWTLYTLVHS-MSL----------LCAQECLMLFISCNNWPSHLSQSKFCNLKLWVFAI 522 (553)
Q Consensus 470 ~~~~~-------~~~l~~~~~~-~~~----------~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~~~ 522 (553)
..+.. ..++...+++ +.. ...+.+..++.+||..+|.+||++.+|-..+....
T Consensus 155 ~~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~ 225 (484)
T KOG1023|consen 155 SGPFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTIN 225 (484)
T ss_pred cCccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhc
Confidence 11111 1233334444 221 33446899999999999999999999887654433
|
|
| >cd03595 CLECT_chondrolectin_like C-type lectin-like domain (CTLD) of the type found in the human type-1A transmembrane proteins chondrolectin (CHODL) and layilin | Back alignment and domain information |
|---|
Probab=99.81 E-value=9.3e-20 Score=164.01 Aligned_cols=116 Identities=17% Similarity=0.348 Sum_probs=92.9
Q ss_pred CCCCeEEEEe-----cCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHhhCCC---CCCeEeeeeecCCCC--------
Q 008785 61 EEKSKCFGYI-----GNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKN---VNGCWVGGRSINTTV-------- 124 (553)
Q Consensus 61 ~~~~~Cy~~~-----~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~---~~~~WiGl~~~~~~~-------- 124 (553)
+|+++||+++ ..++||.+|+..|+.+||+||+|+|++|++||.+++... ...+||||+ +...
T Consensus 7 ~~~~~Cy~~~~~~~~~~~~tw~~A~~~C~~~g~~LasI~s~~E~~~i~~~i~~~~~~~~~~WIGl~--~~~~~~~~~~~~ 84 (149)
T cd03595 7 GTEKPCYKIAYFQDSRRRLNFEEARQACREDGGELLSIESENEQKLIERFIQTLRASDGDFWIGLR--RSSQYNVTSSAC 84 (149)
T ss_pred CCCCccEEEEEEeccccccCHHHHHHHHHHcCCEECccCCHHHHHHHHHHHHhhcCCCCcEEEEeE--CCCCcccccccc
Confidence 5778999864 789999999999999999999999999999999877422 457999999 5443
Q ss_pred CCceEEcCCCCCCcCcccccCccCCCCCCCCCCCCCCCCeeEEEeCC-----------CCceecccCCCCCCcccee
Q 008785 125 GLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNG-----------SRSLVTERCNTSHPFICMV 190 (553)
Q Consensus 125 ~~~w~W~dg~~~~~~~~~~~~~~~~~~~~~~C~~~~~~~~C~~~~~~-----------~~~w~~~~C~~~~~~iC~~ 190 (553)
++.|.|+||+++.+.+|.++.|.+ +.++|+.+... ...|++..|....+|||++
T Consensus 85 ~~~~~W~dG~~~~y~~W~~~eP~~------------~~~~Cv~l~~~~~~~~~~~~~~~~~W~d~~C~~~~~fICe~ 149 (149)
T cd03595 85 SSLYYWLDGSISTFRNWYVDEPSC------------GSEVCVVMYHQPSAPAGQGGPYLFQWNDDNCNMKNNFICKY 149 (149)
T ss_pred CCccEEcCCCccCccCCCCCCCCC------------cccCCEEEEecCCCCcCcCcccCCCccCCCCCCCcccccCC
Confidence 356999999998888877766531 23467766532 2369999999999999974
|
CLECT_chondrolectin_like: C-type lectin-like domain (CTLD) of the type found in the human type-1A transmembrane proteins chondrolectin (CHODL) and layilin. CTLD refers to a domain homologous to the carbohydrate-recognition domains (CRDs) of the C-type lectins. CHODL is predominantly expressed in muscle cells and is associated with T-cell maturation. Various alternatively spliced isoforms have been of CHODL have been identified. The transmembrane form of CHODL is localized in the ER-Golgi apparatus. Layilin is widely expressed in different cell types. The extracellular CTLD of layilin binds hyaluronan (HA), a major constituent of the extracellular matrix (ECM). The cytoplasmic tail of layilin binds various members of the band 4.1/ERM superfamily (talin, radixin, and merlin). The ERM proteins are cytoskeleton-membrane l |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=7e-19 Score=169.02 Aligned_cols=191 Identities=18% Similarity=0.288 Sum_probs=157.5
Q ss_pred cccCCCCeeecccCceeEEEEE-eCCCCEEEEEEeccCChhhHHHHHHHHHHhhcc-CCCceeeEeeEEeeCCceEEEEE
Q 008785 268 KNFSEGNRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYE 345 (553)
Q Consensus 268 ~~~~~~~~~iG~G~~g~Vy~~~-~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E 345 (553)
-+|..+.+| |+|+||..+.|+ +-+++.||||.-...+ ...++..|.+..+.| ..++|..++-+-.++.+..||+|
T Consensus 28 ~hyrVGkKI-GeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVid 104 (449)
T KOG1165|consen 28 PHYRVGKKI-GEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVID 104 (449)
T ss_pred ccceecccc-ccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhh
Confidence 356676666 999999999998 5579999999876542 334566788888877 47899999888888888899999
Q ss_pred ccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCC-----CCeEEeeccccc
Q 008785 346 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE-----FGAHLMGVGLSK 420 (553)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~-----~~~kl~Dfgla~ 420 (553)
++ |.||.|+..- .++.++..++..+|.|++.-++|+|++ .+|.|||||+|+||... ..+.++|||+|+
T Consensus 105 LL-GPSLEDLFD~---CgR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK 177 (449)
T KOG1165|consen 105 LL-GPSLEDLFDL---CGRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAK 177 (449)
T ss_pred hh-CcCHHHHHHH---hcCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchh
Confidence 98 8899998764 456799999999999999999999999 99999999999999754 358999999998
Q ss_pred cCCccccccee-----eecCccccccccccccCCCCCcccchHhHHHHHHHHh
Q 008785 421 FVPWEVMQERT-----VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIR 468 (553)
Q Consensus 421 ~~~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell 468 (553)
...+..+.... ....||.+||+-....+.+-+.+.|+=|+|-++...+
T Consensus 178 ~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFL 230 (449)
T KOG1165|consen 178 EYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFL 230 (449)
T ss_pred hhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhc
Confidence 77654332211 1223999999999999999999999999999988877
|
|
| >cd03600 CLECT_thrombomodulin_like C-type lectin-like domain (CTLD) of the type found in human thrombomodulin(TM), Endosialin, C14orf27, and C1qR | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.7e-19 Score=159.69 Aligned_cols=118 Identities=18% Similarity=0.310 Sum_probs=90.7
Q ss_pred CCCeEEEEecCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHhhCCC-------CCCeEeeeeecCC------CCCCce
Q 008785 62 EKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKN-------VNGCWVGGRSINT------TVGLSW 128 (553)
Q Consensus 62 ~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~-------~~~~WiGl~~~~~------~~~~~w 128 (553)
.+++||+++...+||.+|+.+|+.+|||||+|+|.+|++||++++... ...+||||++... ..++.|
T Consensus 2 ~~~~Cy~~~~~~~sw~~A~~~C~~~gg~La~i~s~~E~~~v~~~l~~~~~~~~~~~~~~WIGl~~~~~~~~~~~~~~~~f 81 (141)
T cd03600 2 VSDACYTLHPQKLTFLEAQRSCIELGGNLATVRSGEEADVVSLLLAAGPGRHGRGSLRLWIGLQREPRQCSDPSLPLRGF 81 (141)
T ss_pred CCCceEEEeCCccCHHHHHHHHHhhCCEeeecCCHHHHHHHHHHHhhccccccCCCccEEEeEecCcccCccccccCCcc
Confidence 468999999999999999999999999999999999999999988543 3479999994211 235789
Q ss_pred EEcCCCC-CCcCcccccCccCCCCCCCCCCCCCCCCeeEEEeCC-----CCceecccCCCC-CCcccee
Q 008785 129 KWSDNMS-KWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNG-----SRSLVTERCNTS-HPFICMV 190 (553)
Q Consensus 129 ~W~dg~~-~~~~~~~~~~~~~~~~~~~~C~~~~~~~~C~~~~~~-----~~~w~~~~C~~~-~~~iC~~ 190 (553)
.|+||+. ..+..|.++ | ++.. ..++|+.+... ...|++..|... .+|||++
T Consensus 82 ~W~d~~~~~~y~~W~~~-p-~n~~---------~~~~Cv~l~~~~~~~~~~~W~d~~C~~~~~~fIC~~ 139 (141)
T cd03600 82 SWVTGDQDTDFSNWLQE-P-AGTC---------TSPRCVALSAAGSTPDNLKWKDGPCSARADGYLCKF 139 (141)
T ss_pred EECCCCCCCCccccccC-C-CCCC---------CCCccEEEEccCCCCCCCccccCCcCCCCCCeEEee
Confidence 9999865 445555443 4 2222 23578777553 246999999998 4799986
|
CLECT_thrombomodulin_like: C-type lectin-like domain (CTLD) of the type found in human thrombomodulin(TM), Endosialin, C14orf27, and C1qR. CTLD refers to a domain homologous to the carbohydrate-recognition domains (CRDs) of the C-type lectins. In these thrombomodulin-like proteins the residues involved in coordinating Ca2+ in the classical MBP-A CTLD are not conserved. TM exerts anti-fibrinolytic and anti-inflammatory activity. TM also regulates blood coagulation in the anticoagulant protein C pathway. In this pathway, the procoagulant properties of thrombin (T) are lost when it binds TM. TM also plays a key role in tumor biology. It is expressed on endothelial cells and on several type of tumor cell including squamous cell carcinoma. Loss of TM expression correlates with advanced stage and poor prognosis. Loss of function of TM func |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.7e-18 Score=159.94 Aligned_cols=176 Identities=11% Similarity=-0.008 Sum_probs=131.5
Q ss_pred eeecccCceeEEEEEeCCCCEEEEEEeccCChhh----HHHHHHHHHHhhccC-CCceeeEeeEEeeCCceEEEEEccCC
Q 008785 275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQR----KKEFYSEIGRFARLH-HPNLVAVKGCCYDHGDRYIVYEFVVN 349 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~----~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lV~E~~~~ 349 (553)
..|++|+||+||.+.- ++.+++.+.+....... ...+.+|+++|++|+ |++|++++++ +..+++|||+.|
T Consensus 8 ~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~G 82 (218)
T PRK12274 8 EPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLAG 82 (218)
T ss_pred eeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeecC
Confidence 4569999999997665 78888888887653311 235789999999995 5889999886 456999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCC-CCCcEEecCCCCeEEeeccccccCCccccc
Q 008785 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDI-RASNVLLDEEFGAHLMGVGLSKFVPWEVMQ 428 (553)
Q Consensus 350 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDl-kp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 428 (553)
.+|.+.+.. ....++.|++.+|.++|+. ||+|||| ||+|||++.++.++|+|||++.........
T Consensus 83 ~~L~~~~~~-----------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~ 148 (218)
T PRK12274 83 AAMYQRPPR-----------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARW 148 (218)
T ss_pred ccHHhhhhh-----------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchH
Confidence 998654311 1135778999999999999 9999999 799999999999999999999855433210
Q ss_pred ----c-------eeeecCccccccccccccCC-CCC-cccchHhHHHHHHHHhc
Q 008785 429 ----E-------RTVMAGGTYGYLAPEFVYRN-ELT-TKSDVYSFGVLLLEIRL 469 (553)
Q Consensus 429 ----~-------~~~~~~gt~~y~aPE~~~~~-~~t-~ksDVwSlGvil~ell~ 469 (553)
. .......++.|++|+...-. ..+ ...+.++.|.-+|.++|
T Consensus 149 ~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~ 202 (218)
T PRK12274 149 MRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVT 202 (218)
T ss_pred HHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHh
Confidence 0 00111256777788754322 223 45688899999999998
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=6.9e-20 Score=190.23 Aligned_cols=220 Identities=25% Similarity=0.241 Sum_probs=173.4
Q ss_pred ecccCceeEEEEE----eCCCCEEEEEEeccCChhh--HHHHHHHHHHhhccC-CCceeeEeeEEeeCCceEEEEEccCC
Q 008785 277 LGDSKTGGTYSGI----LPDGSRVAVKRLKRSSFQR--KKEFYSEIGRFARLH-HPNLVAVKGCCYDHGDRYIVYEFVVN 349 (553)
Q Consensus 277 iG~G~~g~Vy~~~----~~~g~~vAvK~~~~~~~~~--~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lV~E~~~~ 349 (553)
+|+|+||.|+... ...|..+|.|++++..... ......|..++..++ ||.+|++.-.++.+...+++++|..+
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 5999999998754 2347789999887653221 124456777888886 99999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccc
Q 008785 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE 429 (553)
Q Consensus 350 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 429 (553)
|+|...+.+ ...+++.....+...++-+++++|+. +|+|||+|++||+++.+|.+++.|||+++..-.....
T Consensus 82 g~lft~l~~----~~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~- 153 (612)
T KOG0603|consen 82 GDLFTRLSK----EVMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA- 153 (612)
T ss_pred chhhhcccc----CCchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhhc-
Confidence 999887754 34467777778888999999999999 9999999999999999999999999999865543322
Q ss_pred eeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcCcccccchHHHHHhcCCH----HHHHHHHHHHhhccCCCC
Q 008785 430 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVLCRRWWTLYTLVHSMSL----LCAQECLMLFISCNNWPS 505 (553)
Q Consensus 430 ~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~~~~~~~l~~~~~~~~~----~~~~~l~~l~~~Cl~~dP 505 (553)
+||..|||||++. .....+|.||||++++||++.......+....+...++ .......+++...+..+|
T Consensus 154 -----cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~~~~~~Il~~~~~~p~~l~~~a~~~~~~l~~r~p 226 (612)
T KOG0603|consen 154 -----CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGGDTMKRILKAELEMPRELSAEARSLFRQLFKRNP 226 (612)
T ss_pred -----ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCchHHHHHHhhhccCCchhhhHHHHHHHHHHHhhCH
Confidence 5999999999987 67889999999999999998433333344443333232 555666777778888889
Q ss_pred CCCCCH
Q 008785 506 HLSQSK 511 (553)
Q Consensus 506 ~~RPs~ 511 (553)
.+|--.
T Consensus 227 ~nrLg~ 232 (612)
T KOG0603|consen 227 ENRLGA 232 (612)
T ss_pred HHHhcc
Confidence 888655
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=2e-19 Score=195.35 Aligned_cols=232 Identities=20% Similarity=0.156 Sum_probs=170.4
Q ss_pred eecccCceeEEEEEeCCCCEEEEEEeccCC-hhhHHHHHHHHHH--hhccCCCceeeEeeEEeeCCceEEEEEccCCCCH
Q 008785 276 LLGDSKTGGTYSGILPDGSRVAVKRLKRSS-FQRKKEFYSEIGR--FARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352 (553)
Q Consensus 276 ~iG~G~~g~Vy~~~~~~g~~vAvK~~~~~~-~~~~~~~~~E~~~--l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL 352 (553)
-+|++.|=+|.+++.+.|. |+||++-+.+ .-..+.|.++++- ...++|||++.+.-+-......|||=+|..+ +|
T Consensus 30 ~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqyvkh-nL 107 (1431)
T KOG1240|consen 30 NLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQYVKH-NL 107 (1431)
T ss_pred ccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHHHhh-hh
Confidence 3599999999999997777 9999986553 3334444443333 4455899999988776677777888888854 88
Q ss_pred HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccC--Ccccccce
Q 008785 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV--PWEVMQER 430 (553)
Q Consensus 353 ~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~--~~~~~~~~ 430 (553)
+|-|.. +..+...+.+-|+.|++.||.-+|.. ||.|||||.+||||+.-+-+.|+||..-+.. +.+.....
T Consensus 108 yDRlST----RPFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPadf 180 (1431)
T KOG1240|consen 108 YDRLST----RPFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPADF 180 (1431)
T ss_pred hhhhcc----chHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCCCCcccc
Confidence 888853 34577788889999999999999999 9999999999999999889999999765432 22211111
Q ss_pred ee---ecCccccccccccccCC----------C-CCcccchHhHHHHHHHHhc-Cccc-ccchHHHHHhcC-CH------
Q 008785 431 TV---MAGGTYGYLAPEFVYRN----------E-LTTKSDVYSFGVLLLEIRL-VLCR-RWWTLYTLVHSM-SL------ 487 (553)
Q Consensus 431 ~~---~~~gt~~y~aPE~~~~~----------~-~t~ksDVwSlGvil~ell~-~~~~-~~~~l~~~~~~~-~~------ 487 (553)
.. +...-..|.|||.+... + .+++.||||+||++.||+. ..|. +-.++.. ++.| ..
T Consensus 181 ~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~a-Yr~~~~~~~e~~L 259 (1431)
T KOG1240|consen 181 TFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLA-YRSGNADDPEQLL 259 (1431)
T ss_pred eEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHh-HhccCccCHHHHH
Confidence 11 11123469999987531 2 6788999999999999997 3333 3333333 2222 21
Q ss_pred --HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008785 488 --LCAQECLMLFISCNNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 488 --~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 517 (553)
-....+.+++..|++.||+.|-|+.+.|+.
T Consensus 260 e~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 260 EKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred HhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 233468899999999999999999999987
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=9.5e-18 Score=160.35 Aligned_cols=133 Identities=19% Similarity=0.300 Sum_probs=112.9
Q ss_pred eecccCceeEEEEEeCCCCEEEEEEeccCCh--------hhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEcc
Q 008785 276 LLGDSKTGGTYSGILPDGSRVAVKRLKRSSF--------QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV 347 (553)
Q Consensus 276 ~iG~G~~g~Vy~~~~~~g~~vAvK~~~~~~~--------~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 347 (553)
.||+|++|.||+|.. +|..|++|+...... .....+.+|+.++..++|++|+....++.+.+..+++|||+
T Consensus 3 ~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 81 (211)
T PRK14879 3 LIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYI 81 (211)
T ss_pred ccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEe
Confidence 469999999999988 778899998654321 11245788999999999999888777777778889999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeecccccc
Q 008785 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF 421 (553)
Q Consensus 348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~ 421 (553)
+|++|.+++... .. .+..++.+++.+|.+||+. +++|||++|+|||++ ++.++|+|||.+..
T Consensus 82 ~G~~L~~~~~~~-------~~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 82 EGEPLKDLINSN-------GM-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred CCcCHHHHHHhc-------cH-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 999999998541 12 7789999999999999999 999999999999999 78899999998864
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.75 E-value=7.9e-18 Score=159.40 Aligned_cols=129 Identities=19% Similarity=0.306 Sum_probs=106.6
Q ss_pred ecccCceeEEEEEeCCCCEEEEEEeccCCh--------hhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccC
Q 008785 277 LGDSKTGGTYSGILPDGSRVAVKRLKRSSF--------QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV 348 (553)
Q Consensus 277 iG~G~~g~Vy~~~~~~g~~vAvK~~~~~~~--------~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 348 (553)
||+|++|.||+|.+ +|..|++|....... ....++.+|++++..++|+++.....++...+..++||||++
T Consensus 2 ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~ 80 (199)
T TIGR03724 2 IAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIE 80 (199)
T ss_pred CCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEEC
Confidence 69999999999996 678999998654211 123567889999999998876655555566677899999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeecccccc
Q 008785 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF 421 (553)
Q Consensus 349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~ 421 (553)
|++|.+++... . . .++.+++.+|.+||+. +++|||++|+||+++ ++.++++|||++..
T Consensus 81 g~~l~~~~~~~----~----~---~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 81 GKPLKDVIEEG----N----D---ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CccHHHHHhhc----H----H---HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999887531 0 0 7899999999999999 999999999999999 78999999999875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.3e-17 Score=161.83 Aligned_cols=138 Identities=15% Similarity=0.152 Sum_probs=107.0
Q ss_pred CeeecccCceeEEEEE--eCCCCEEEEEEeccCChh------------------------hHHHHHHHHHHhhccCCC--
Q 008785 274 NRLLGDSKTGGTYSGI--LPDGSRVAVKRLKRSSFQ------------------------RKKEFYSEIGRFARLHHP-- 325 (553)
Q Consensus 274 ~~~iG~G~~g~Vy~~~--~~~g~~vAvK~~~~~~~~------------------------~~~~~~~E~~~l~~l~Hp-- 325 (553)
...||+|++|.||+|. ..+|+.||||+++..... ....+.+|+..+.++.+.
T Consensus 33 ~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~~~i 112 (237)
T smart00090 33 GGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYEAGV 112 (237)
T ss_pred CCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 3456999999999998 568999999998754210 112356899999999753
Q ss_pred ceeeEeeEEeeCCceEEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC-ceecCCCCCcEE
Q 008785 326 NLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPH-VVHRDIRASNVL 404 (553)
Q Consensus 326 nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~-ivHrDlkp~NIL 404 (553)
.++++++. ...++||||+++++|...+.. ...+.......++.||+.+|.+||+. + ++||||||+||+
T Consensus 113 ~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp~NIl 181 (237)
T smart00090 113 PVPKPIAW----RRNVLVMEFIGGDGLPAPRLK----DVEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSEYNIL 181 (237)
T ss_pred CCCeeeEe----cCceEEEEEecCCcccccccc----cCCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCChhhEE
Confidence 34455443 235899999999888665422 22355666789999999999999999 9 999999999999
Q ss_pred ecCCCCeEEeeccccccCC
Q 008785 405 LDEEFGAHLMGVGLSKFVP 423 (553)
Q Consensus 405 l~~~~~~kl~Dfgla~~~~ 423 (553)
++ ++.++|+|||.+....
T Consensus 182 i~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 182 VH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred EE-CCCEEEEEChhhhccC
Confidence 99 7899999999987543
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.74 E-value=1e-17 Score=164.19 Aligned_cols=225 Identities=15% Similarity=0.136 Sum_probs=140.6
Q ss_pred CeeecccCceeEEEEEeCC-CCEEEEEEeccCC---hhhHHHHHHHHHHhhccCC----------CceeeEeeEEe----
Q 008785 274 NRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHH----------PNLVAVKGCCY---- 335 (553)
Q Consensus 274 ~~~iG~G~~g~Vy~~~~~~-g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H----------pnIv~l~~~~~---- 335 (553)
..+||.|+++.||.++... |+.+|||++.... ....+++.+|.-....+.+ -.++-.++...
T Consensus 17 ~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~ 96 (288)
T PF14531_consen 17 GRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGK 96 (288)
T ss_dssp EEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS
T ss_pred ccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCC
Confidence 4567999999999999865 8999999985432 2335667776655544322 12222222221
Q ss_pred -----eCC--------ceEEEEEccCCCCHHHHhccC---CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCC
Q 008785 336 -----DHG--------DRYIVYEFVVNGPLDRWLHHI---PRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIR 399 (553)
Q Consensus 336 -----~~~--------~~~lV~E~~~~gsL~~~l~~~---~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlk 399 (553)
... ..+++|+-+ .+||.+++... ......+....++.+..|+++.+++||+. |++|+||+
T Consensus 97 ~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHgdi~ 172 (288)
T PF14531_consen 97 PPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHGDIK 172 (288)
T ss_dssp -SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEEST-S
T ss_pred CcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEecccc
Confidence 111 236778877 56888876421 11122244455667779999999999999 99999999
Q ss_pred CCcEEecCCCCeEEeeccccccCCcccccceeeecCccccccccccccC--------CCCCcccchHhHHHHHHHHhc-C
Q 008785 400 ASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYR--------NELTTKSDVYSFGVLLLEIRL-V 470 (553)
Q Consensus 400 p~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~t~ksDVwSlGvil~ell~-~ 470 (553)
|+|++++.+|.+.|+||+........... ...+..|.+||.... -.++.+.|.|++|+++|.|.. .
T Consensus 173 ~~nfll~~~G~v~Lg~F~~~~r~g~~~~~-----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~ 247 (288)
T PF14531_consen 173 PENFLLDQDGGVFLGDFSSLVRAGTRYRC-----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGR 247 (288)
T ss_dssp GGGEEE-TTS-EEE--GGGEEETTEEEEG-----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS
T ss_pred eeeEEEcCCCCEEEcChHHHeecCceeec-----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHcc
Confidence 99999999999999999877654432211 114577999997643 247889999999999999996 2
Q ss_pred cccccchH---HH-HHhcCCHHHHHHHHHHHhhccCCCCCCC
Q 008785 471 LCRRWWTL---YT-LVHSMSLLCAQECLMLFISCNNWPSHLS 508 (553)
Q Consensus 471 ~~~~~~~l---~~-~~~~~~~~~~~~l~~l~~~Cl~~dP~~R 508 (553)
.|.+.... .+ .+..-. ..++.+..||...|++||.+|
T Consensus 248 lPf~~~~~~~~~~~~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 248 LPFGLSSPEADPEWDFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp -STCCCGGGSTSGGGGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred CCCCCCCccccccccchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 22221111 00 222223 888899999999999999988
|
|
| >PHA02911 C-type lectin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.9e-17 Score=147.48 Aligned_cols=106 Identities=23% Similarity=0.561 Sum_probs=81.6
Q ss_pred CCCCCcCCcccCCCCeEEEEecCCCCh--HHHHHHHhhcCCEEeeeCCHHHHHHHHHhhCCCCCCeEeeeeecCCCCCCc
Q 008785 50 KAPCPPDWIINEEKSKCFGYIGNFRSW--DESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLS 127 (553)
Q Consensus 50 ~~~Cp~~w~~~~~~~~Cy~~~~~~~~w--~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~ 127 (553)
..+||.+|. .|+++||+|+.+.++| .+|+++|..+||+|+. ++.||++||+. +|.|+. +.
T Consensus 100 ~~pC~~nW~--~H~nkCYlFS~~s~sWsW~~Srr~C~~kGATLLk-~sdEELeFIqn--------~wkGks-------~~ 161 (213)
T PHA02911 100 EPICSRDWI--NHMGICLLSLGEEVGFRMEIAKRFCEKKDADLIG-KIDEEKKALEN--------IWTGND-------HS 161 (213)
T ss_pred CCCCchhhH--hhCCEEEEEeccccccchhHHHHHHHhcCCEecc-CcHHHHHHHHH--------HHhccc-------cc
Confidence 348999999 8999999999996665 8899999999999999 88899999994 578875 68
Q ss_pred eEEcCCCCCCcCcccccCccCCCCCCCCCCCCCCCCeeEEEeCC----CCceecccCCCCCCccceecc
Q 008785 128 WKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNG----SRSLVTERCNTSHPFICMVEH 192 (553)
Q Consensus 128 w~W~dg~~~~~~~~~~~~~~~~~~~~~~C~~~~~~~~C~~~~~~----~~~w~~~~C~~~~~~iC~~~~ 192 (553)
|.|+||.. .+.. . .....|+..... ........|.....|||+...
T Consensus 162 ~fWID~r~--------ngSt------~-----n~s~sCA~Is~~~~~~~~~V~sesCs~~~~wICqK~~ 211 (213)
T PHA02911 162 RFWIDNRA--------AAST------F-----DPVNECAIGTQNHIPEVPEVLKSPCDERHSFICIKKD 211 (213)
T ss_pred eEEecCcc--------ccce------e-----cCCCCeEEEEcccccCCCceEccccCCCceEEEEecc
Confidence 88888721 0110 0 001267777652 236788899999999998754
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.3e-18 Score=177.63 Aligned_cols=168 Identities=18% Similarity=0.280 Sum_probs=128.4
Q ss_pred ceEEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccc
Q 008785 339 DRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGL 418 (553)
Q Consensus 339 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgl 418 (553)
.+||.|++|...+|.++|... +.....++...+.++.|++.|+.| + +.+|||+||.||+...+..+||.|||+
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr-~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRR-RTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCC-CcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhh
Confidence 478999999999999999753 334457788899999999999999 6 999999999999999999999999999
Q ss_pred cccCCccc----ccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhc--CcccccchHHHHHhcCCH-----
Q 008785 419 SKFVPWEV----MQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL--VLCRRWWTLYTLVHSMSL----- 487 (553)
Q Consensus 419 a~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~--~~~~~~~~l~~~~~~~~~----- 487 (553)
........ .........||..||+||.+.+..|+.|+||||||++|+|++. ..+.......+-++.|.+
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~t~~d~r~g~ip~~~~ 482 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIATLTDIRDGIIPPEFL 482 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHHhhhhhhcCCCChHHh
Confidence 87655443 0111111229999999999999999999999999999999996 222211112223444443
Q ss_pred HHHHHHHHHHhhccCCCCCCCCCHHH
Q 008785 488 LCAQECLMLFISCNNWPSHLSQSKFC 513 (553)
Q Consensus 488 ~~~~~l~~l~~~Cl~~dP~~RPs~~e 513 (553)
..-+.-..++.++++..|.+||++.+
T Consensus 483 ~d~p~e~~ll~~lls~~p~~RP~~~~ 508 (516)
T KOG1033|consen 483 QDYPEEYTLLQQLLSPSPEERPSAIE 508 (516)
T ss_pred hcCcHHHHHHHHhcCCCcccCchHHH
Confidence 22233467889999999999995444
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.73 E-value=6.5e-17 Score=176.01 Aligned_cols=132 Identities=18% Similarity=0.256 Sum_probs=108.0
Q ss_pred CeeecccCceeEEEEEeCCCCEEEEEE-eccC-C------hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEE
Q 008785 274 NRLLGDSKTGGTYSGILPDGSRVAVKR-LKRS-S------FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYE 345 (553)
Q Consensus 274 ~~~iG~G~~g~Vy~~~~~~g~~vAvK~-~~~~-~------~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 345 (553)
.++||+|+||.||+|.+.+.. +++|+ +.+. . ....+.+.+|++++.+++|++++....++.+....++|||
T Consensus 338 ~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~E 416 (535)
T PRK09605 338 DHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVME 416 (535)
T ss_pred cceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEEE
Confidence 456699999999999985443 44443 2221 1 1123568899999999999999988888777778899999
Q ss_pred ccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccC
Q 008785 346 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV 422 (553)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~ 422 (553)
|+++++|.+++. ....++.+++.+|.|||+. +++||||||+|||+ +++.++|+|||+++..
T Consensus 417 ~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 417 YIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred ecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 999999998874 3467899999999999999 99999999999999 5778999999999754
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.73 E-value=3.2e-17 Score=181.81 Aligned_cols=240 Identities=16% Similarity=0.115 Sum_probs=165.8
Q ss_pred CeeecccCceeEEEEEeCCCCEEEEEEeccCChhhHHHHHHHHHHhhccC---CCceeeEeeEEeeCCceEEEEEccCCC
Q 008785 274 NRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLH---HPNLVAVKGCCYDHGDRYIVYEFVVNG 350 (553)
Q Consensus 274 ~~~iG~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~---HpnIv~l~~~~~~~~~~~lV~E~~~~g 350 (553)
.+.+|+|+||.||+|...+|+.||+|+-+...... |.-=.+++.+|+ -+-|..+...+.-.+.-+||+||.+.|
T Consensus 703 ~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ey~~~G 779 (974)
T KOG1166|consen 703 SKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVSEYSPYG 779 (974)
T ss_pred EeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCCcceeeeeccccc
Confidence 34569999999999998889999999988764332 111222333443 234455555555667779999999999
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecC-------CCCeEEeeccccccCC
Q 008785 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE-------EFGAHLMGVGLSKFVP 423 (553)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~-------~~~~kl~Dfgla~~~~ 423 (553)
+|.+++. ..+.+++.....++.|++..+++||.. +|||+||||+|.||.. +..++|+|||.+-.+.
T Consensus 780 tlld~~N----~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~ 852 (974)
T KOG1166|consen 780 TLLDLIN----TNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMK 852 (974)
T ss_pred cHHHhhc----cCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceEEEecccceeee
Confidence 9999996 456789999999999999999999999 9999999999999943 3568999999986543
Q ss_pred cccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcCcccc--cchHHHHHhcC--CHHHHHHHHHHHhh
Q 008785 424 WEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVLCRR--WWTLYTLVHSM--SLLCAQECLMLFIS 499 (553)
Q Consensus 424 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~~~~--~~~l~~~~~~~--~~~~~~~l~~l~~~ 499 (553)
.-.....-....+|-.+-.+|...+.+++.+.|.|.|+.+++-|+-+.... ..... .+..+ +...-.-.-++...
T Consensus 853 lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q~~~g~~~-~~~~~~~Ry~~~~~W~~~F~~ 931 (974)
T KOG1166|consen 853 LFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYMEVKNGSSW-MVKTNFPRYWKRDMWNKFFDL 931 (974)
T ss_pred EcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHHhcCCcce-eccccchhhhhHHHHHHHHHH
Confidence 322222222333788899999999999999999999999999998411110 00000 11111 11111112334444
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHhh
Q 008785 500 CNNWPSHLSQSKFCNLKLWVFAILT 524 (553)
Q Consensus 500 Cl~~dP~~RPs~~evl~~l~~~~~~ 524 (553)
.|+.|-..=|...++...+...+.+
T Consensus 932 lLN~~~~~~p~l~~lr~~~~~~~~~ 956 (974)
T KOG1166|consen 932 LLNPDCDTLPNLQELRTELEEVLAE 956 (974)
T ss_pred HhCcCcccchhHHHHHHHHHHHHHH
Confidence 5566666667777766665555443
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.72 E-value=4.8e-17 Score=154.01 Aligned_cols=134 Identities=16% Similarity=0.157 Sum_probs=105.7
Q ss_pred CeeecccCceeEEEEEeCCCCEEEEEEeccCCh----------------------hhHHHHHHHHHHhhccCCCc--eee
Q 008785 274 NRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSF----------------------QRKKEFYSEIGRFARLHHPN--LVA 329 (553)
Q Consensus 274 ~~~iG~G~~g~Vy~~~~~~g~~vAvK~~~~~~~----------------------~~~~~~~~E~~~l~~l~Hpn--Iv~ 329 (553)
.+.||+|+||.||++..++|+.||||+++.... .....+.+|..++.++.|++ ++.
T Consensus 20 ~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~v~~ 99 (198)
T cd05144 20 GNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFPVPK 99 (198)
T ss_pred CCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCCCCc
Confidence 345699999999999988899999998764320 01123677899999998774 444
Q ss_pred EeeEEeeCCceEEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCC
Q 008785 330 VKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF 409 (553)
Q Consensus 330 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~ 409 (553)
.++ ....++||||+++++|.+.... .....++.+++.++.++|+. +++||||||+||++++++
T Consensus 100 ~~~----~~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p~Nill~~~~ 162 (198)
T cd05144 100 PID----WNRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAYKH---GIIHGDLSEFNILVDDDE 162 (198)
T ss_pred eee----cCCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHHHC---CCCcCCCCcccEEEcCCC
Confidence 443 3456899999999998765320 23467889999999999999 999999999999999999
Q ss_pred CeEEeeccccccCCc
Q 008785 410 GAHLMGVGLSKFVPW 424 (553)
Q Consensus 410 ~~kl~Dfgla~~~~~ 424 (553)
.++|+|||++.....
T Consensus 163 ~~~liDfg~~~~~~~ 177 (198)
T cd05144 163 KIYIIDWPQMVSTDH 177 (198)
T ss_pred cEEEEECCccccCCC
Confidence 999999999965443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=7.2e-17 Score=158.54 Aligned_cols=187 Identities=21% Similarity=0.209 Sum_probs=132.5
Q ss_pred CCCceeeEeeEEeeC---------------------------CceEEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHH
Q 008785 323 HHPNLVAVKGCCYDH---------------------------GDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVA 375 (553)
Q Consensus 323 ~HpnIv~l~~~~~~~---------------------------~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~ 375 (553)
+|||||++.++|.++ ..+|+||.-++ .+|..++.. ...+.....-|+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~-----~~~s~r~~~~~l 347 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWT-----RHRSYRTGRVIL 347 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhc-----CCCchHHHHHHH
Confidence 699999999887542 23589999884 589999965 345667778899
Q ss_pred HHHHHHHHHHHhCCCCCceecCCCCCcEEe--cCCC--CeEEeeccccccCCccc----ccceeeecCcccccccccccc
Q 008785 376 TTLAQGIAFLHDKVKPHVVHRDIRASNVLL--DEEF--GAHLMGVGLSKFVPWEV----MQERTVMAGGTYGYLAPEFVY 447 (553)
Q Consensus 376 ~qia~gL~yLH~~~~~~ivHrDlkp~NILl--~~~~--~~kl~Dfgla~~~~~~~----~~~~~~~~~gt~~y~aPE~~~ 447 (553)
.|+++|+.|||.+ ||.|||+|++|||+ |+|. .+.|+|||.+-.-.... ......-..|...-||||+..
T Consensus 348 aQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t 424 (598)
T KOG4158|consen 348 AQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT 424 (598)
T ss_pred HHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence 9999999999999 99999999999999 3443 46889999874332211 111112233777899999875
Q ss_pred CCC--C----CcccchHhHHHHHHHHhcC-ccccc---chHHH-HHhcCCH-----HHHHHHHHHHhhccCCCCCCCCCH
Q 008785 448 RNE--L----TTKSDVYSFGVLLLEIRLV-LCRRW---WTLYT-LVHSMSL-----LCAQECLMLFISCNNWPSHLSQSK 511 (553)
Q Consensus 448 ~~~--~----t~ksDVwSlGvil~ell~~-~~~~~---~~l~~-~~~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPs~ 511 (553)
..+ . -.|+|.|+.|.+.||++.. .|+.. ..+.. -+.+.++ .+++.+.+++...|++||++|||.
T Consensus 425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp 504 (598)
T KOG4158|consen 425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSP 504 (598)
T ss_pred cCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCc
Confidence 322 1 2589999999999999962 22211 11111 2222222 667778889999999999999997
Q ss_pred HHHHHHH
Q 008785 512 FCNLKLW 518 (553)
Q Consensus 512 ~evl~~l 518 (553)
.-..+.+
T Consensus 505 ~iAANvl 511 (598)
T KOG4158|consen 505 NIAANVL 511 (598)
T ss_pred cHHHhHH
Confidence 6544443
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.8e-15 Score=147.16 Aligned_cols=137 Identities=21% Similarity=0.217 Sum_probs=107.0
Q ss_pred CCeeec-ccCceeEEEEEeCCCCEEEEEEeccCC-------------hhhHHHHHHHHHHhhccCCCce--eeEeeEEee
Q 008785 273 GNRLLG-DSKTGGTYSGILPDGSRVAVKRLKRSS-------------FQRKKEFYSEIGRFARLHHPNL--VAVKGCCYD 336 (553)
Q Consensus 273 ~~~~iG-~G~~g~Vy~~~~~~g~~vAvK~~~~~~-------------~~~~~~~~~E~~~l~~l~HpnI--v~l~~~~~~ 336 (553)
...++| .|+.|+||.... ++..++||.+.... ......+.+|+.++.+|+|++| ++.+++...
T Consensus 35 ~~~~lg~~~g~gtv~~v~~-~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~ 113 (239)
T PRK01723 35 QARVVGSAKGRGTTWFVQT-PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVV 113 (239)
T ss_pred cCceeecCCCCccEEEEEe-CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeee
Confidence 345668 899999999988 47889999885421 1223567889999999998775 677776543
Q ss_pred CCc----eEEEEEccCC-CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCe
Q 008785 337 HGD----RYIVYEFVVN-GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGA 411 (553)
Q Consensus 337 ~~~----~~lV~E~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~ 411 (553)
... .++|||++++ .+|.+++.. ..++.. .+.+|+.+|.+||+. ||+||||||+|||++.++.+
T Consensus 114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~-----~~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v 181 (239)
T PRK01723 114 RHGLFYRADILIERIEGARDLVALLQE-----APLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKF 181 (239)
T ss_pred ecCcceeeeEEEEecCCCCCHHHHHhc-----CCCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCE
Confidence 322 3599999997 699988853 234443 357899999999999 99999999999999998899
Q ss_pred EEeeccccccC
Q 008785 412 HLMGVGLSKFV 422 (553)
Q Consensus 412 kl~Dfgla~~~ 422 (553)
+|+|||.+...
T Consensus 182 ~LIDfg~~~~~ 192 (239)
T PRK01723 182 WLIDFDRGELR 192 (239)
T ss_pred EEEECCCcccC
Confidence 99999988754
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.1e-15 Score=137.04 Aligned_cols=133 Identities=18% Similarity=0.147 Sum_probs=112.5
Q ss_pred eecccCceeEEEEEeCCCCEEEEEEeccCChhhHHHHHHHHHHhhccCC--CceeeEeeEEeeCCceEEEEEccCCCCHH
Q 008785 276 LLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHH--PNLVAVKGCCYDHGDRYIVYEFVVNGPLD 353 (553)
Q Consensus 276 ~iG~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H--pnIv~l~~~~~~~~~~~lV~E~~~~gsL~ 353 (553)
.+|+|.++.||++... +..+++|....... ...+.+|+.++..++| +++++++++....+..+++|||++++++.
T Consensus 5 ~i~~g~~~~v~~~~~~-~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~~ 81 (155)
T cd05120 5 LLKGGLTNRVYLLGTK-DEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLD 81 (155)
T ss_pred ecccccccceEEEEec-CCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeecc
Confidence 4599999999999984 47899999876533 5678899999999976 58999999888888899999999887764
Q ss_pred HHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccC
Q 008785 354 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV 422 (553)
Q Consensus 354 ~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~ 422 (553)
.+ +......++.+++.+|++||.....+++|+|++|+||++++.+.++++|||.+...
T Consensus 82 ~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 82 EV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred cC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence 32 45667788999999999999864447999999999999999889999999998753
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.4e-15 Score=142.39 Aligned_cols=134 Identities=19% Similarity=0.251 Sum_probs=97.2
Q ss_pred eecccCceeEEEEEeCCCCEEEEEEeccCChh--hHHHH----------------------HHHHHHhhccCCCc--eee
Q 008785 276 LLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQ--RKKEF----------------------YSEIGRFARLHHPN--LVA 329 (553)
Q Consensus 276 ~iG~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~--~~~~~----------------------~~E~~~l~~l~Hpn--Iv~ 329 (553)
.||+|+||.||++...+|+.||||+++..... ....+ ..|...+.++.+.. +.+
T Consensus 4 ~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~ 83 (187)
T cd05119 4 PIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPVPK 83 (187)
T ss_pred ccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCCCc
Confidence 46999999999999888999999998754211 11111 34666666664432 444
Q ss_pred EeeEEeeCCceEEEEEccCCCCHHH-HhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCceecCCCCCcEEecC
Q 008785 330 VKGCCYDHGDRYIVYEFVVNGPLDR-WLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD-KVKPHVVHRDIRASNVLLDE 407 (553)
Q Consensus 330 l~~~~~~~~~~~lV~E~~~~gsL~~-~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~ivHrDlkp~NILl~~ 407 (553)
.++. ...++||||++++++.. .+... ... .....++.+++.++.++|. . +|+||||||+||+++
T Consensus 84 ~~~~----~~~~lv~e~~~g~~~~~~~l~~~-----~~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili~- 149 (187)
T cd05119 84 PIDL----NRHVLVMEFIGGDGIPAPRLKDV-----RLL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILVD- 149 (187)
T ss_pred eEec----CCCEEEEEEeCCCCccChhhhhh-----hhc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEEE-
Confidence 4443 34689999999855421 12110 011 5678899999999999999 8 999999999999999
Q ss_pred CCCeEEeeccccccCC
Q 008785 408 EFGAHLMGVGLSKFVP 423 (553)
Q Consensus 408 ~~~~kl~Dfgla~~~~ 423 (553)
++.++++|||.+....
T Consensus 150 ~~~~~liDfg~a~~~~ 165 (187)
T cd05119 150 DGKVYIIDVPQAVEID 165 (187)
T ss_pred CCcEEEEECccccccc
Confidence 8899999999996543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.62 E-value=3.2e-16 Score=170.73 Aligned_cols=199 Identities=20% Similarity=0.238 Sum_probs=138.0
Q ss_pred cccCCCCeeecccCceeEEEEEeCC-CCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEc
Q 008785 268 KNFSEGNRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF 346 (553)
Q Consensus 268 ~~~~~~~~~iG~G~~g~Vy~~~~~~-g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 346 (553)
.+|... ++|..|++|.||..+++. .+++|+|+-+.. . +.+- ++.....|.+|
T Consensus 83 ~df~~I-klisngAygavylvrh~~trqrfa~kiNkq~-l-----ilRn--ilt~a~npfvv------------------ 135 (1205)
T KOG0606|consen 83 SDFNTI-KLISNGAYGAVYLVRHKETRQRFAMKINKQN-L-----ILRN--ILTFAGNPFVV------------------ 135 (1205)
T ss_pred ccccee-EeeccCCCCceeeeeccccccchhhcccccc-h-----hhhc--cccccCCccee------------------
Confidence 344443 466999999999998764 667888433222 1 1111 22222333333
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCccc
Q 008785 347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV 426 (553)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 426 (553)
|+-...++. -..++.. ++.+++|||+. +|+|||+||+|.+|+.-|.+|+.|||+++......
T Consensus 136 ---gDc~tllk~----~g~lPvd--------mvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~ 197 (1205)
T KOG0606|consen 136 ---GDCATLLKN----IGPLPVD--------MVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSL 197 (1205)
T ss_pred ---chhhhhccc----CCCCcch--------hhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhc
Confidence 555555543 2233332 27889999999 99999999999999999999999999987543211
Q ss_pred -------------ccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhc----CcccccchHHH-------HH
Q 008785 427 -------------MQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL----VLCRRWWTLYT-------LV 482 (553)
Q Consensus 427 -------------~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~----~~~~~~~~l~~-------~~ 482 (553)
.+......+||+.|+|||++....|+..+|.|++|+|+||.+- +..+...+++. .+
T Consensus 198 atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~w 277 (1205)
T KOG0606|consen 198 ATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEW 277 (1205)
T ss_pred cchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccc
Confidence 0111223459999999999999999999999999999999984 33343344444 23
Q ss_pred hcCCHHHHHHHHHHHhhccCCCCCCCCCH
Q 008785 483 HSMSLLCAQECLMLFISCNNWPSHLSQSK 511 (553)
Q Consensus 483 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 511 (553)
.++....+.++.+++.+.|..+|..|---
T Consensus 278 pE~dea~p~Ea~dli~~LL~qnp~~Rlgt 306 (1205)
T KOG0606|consen 278 PEEDEALPPEAQDLIEQLLRQNPLCRLGT 306 (1205)
T ss_pred cccCcCCCHHHHHHHHHHHHhChHhhccc
Confidence 33444677888999999999999999433
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.55 E-value=2e-15 Score=145.25 Aligned_cols=199 Identities=17% Similarity=0.221 Sum_probs=142.6
Q ss_pred HhhccCCCceeeEeeEEeeCC-----ceEEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 008785 318 RFARLHHPNLVAVKGCCYDHG-----DRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPH 392 (553)
Q Consensus 318 ~l~~l~HpnIv~l~~~~~~~~-----~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ 392 (553)
-|-++-|.|||+++.++.+.. ...++.|||..|+|..+|++.++....+......+++.||+.||.|||+ +.|.
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~Pp 198 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CDPP 198 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cCCc
Confidence 344567999999999987643 4688999999999999999887777888999999999999999999999 5899
Q ss_pred ceecCCCCCcEEecCCCCeEEeeccccccCCcc--cccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhc-
Q 008785 393 VVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE--VMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL- 469 (553)
Q Consensus 393 ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~- 469 (553)
|+|+++..+-|++..++-+|+.--.-....... ..........+-++|.|||+-.....+.++|||+||...+||.-
T Consensus 199 iihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemail 278 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAIL 278 (458)
T ss_pred cccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHh
Confidence 999999999999999988887432111111100 00111112226789999998776677889999999999999873
Q ss_pred -CcccccchHH--H-HHhcCCH-HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008785 470 -VLCRRWWTLY--T-LVHSMSL-LCAQECLMLFISCNNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 470 -~~~~~~~~l~--~-~~~~~~~-~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 517 (553)
..+.+..+-+ + .+..-.+ .....=.+++..|++..|..||+|.+++.+
T Consensus 279 Eiq~tnseS~~~~ee~ia~~i~~len~lqr~~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 279 EIQSTNSESKVEVEENIANVIIGLENGLQRGSITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred eeccCCCcceeehhhhhhhheeeccCccccCcCcccccCCCCCCcchhhhhcC
Confidence 1111111111 1 1111111 112223567889999999999999998754
|
|
| >cd00037 CLECT C-type lectin (CTL)/C-type lectin-like (CTLD) domain | Back alignment and domain information |
|---|
Probab=99.54 E-value=4.7e-14 Score=120.14 Aligned_cols=112 Identities=26% Similarity=0.563 Sum_probs=89.6
Q ss_pred eEEEEecCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHhhCC-CCCCeEeeeeecCCCCCCceEEcCCCC-CCcCccc
Q 008785 65 KCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGK-NVNGCWVGGRSINTTVGLSWKWSDNMS-KWNESIH 142 (553)
Q Consensus 65 ~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~-~~~~~WiGl~~~~~~~~~~w~W~dg~~-~~~~~~~ 142 (553)
.||+++....+|.+|+..|..+||+|+.|++.+|.+||.+++.. ....+|||+++ ....+.|.|+||++ ..+..|.
T Consensus 1 ~Cy~~~~~~~~~~~A~~~C~~~~~~L~~~~~~~e~~~i~~~~~~~~~~~~wvg~~~--~~~~~~~~~~~~~~~~~~~~w~ 78 (116)
T cd00037 1 SCYKFSTEKLTWEEAQEYCRSLGGHLASIHSEEENDFLASLLKKSSSSDVWIGLND--LSSEGTWKWSDGSPLVDYTNWA 78 (116)
T ss_pred CCEEEcCCccCHHHHHHHHHHcCCEEcccCCHHHHHHHHHHHhCCCCCCEEEcccc--cCcCCCeEecCCCccccccCCC
Confidence 49999999999999999999999999999999999999998742 25689999994 33568999999988 4555555
Q ss_pred ccCccCCCCCCCCCCCCCCCCeeEEEeCC-CCceecccCCCCCCccce
Q 008785 143 AVGSFNSSCTSLPCHVHATVDLCTLVSNG-SRSLVTERCNTSHPFICM 189 (553)
Q Consensus 143 ~~~~~~~~~~~~~C~~~~~~~~C~~~~~~-~~~w~~~~C~~~~~~iC~ 189 (553)
...+ .....++|+.+... ...|.+..|....+++|.
T Consensus 79 ~~~~-----------~~~~~~~C~~~~~~~~~~~~~~~C~~~~~~iC~ 115 (116)
T cd00037 79 PGEP-----------NPGGSEDCVVLSSSSDGKWNDVSCSSKLPFICE 115 (116)
T ss_pred CCCc-----------CCCCCCCeeEEccCCCCCccCCCCCCCceeeec
Confidence 5443 12234577777654 357999999999999985
|
CLECT: C-type lectin (CTL)/C-type lectin-like (CTLD) domain; protein domains homologous to the carbohydrate-recognition domains (CRDs) of the C-type lectins. This group is chiefly comprised of eukaryotic CTLDs, but contains some, as yet functionally uncharacterized, bacterial CTLDs. Many CTLDs are calcium-dependent carbohydrate binding modules; other CTLDs bind protein ligands, lipids, and inorganic surfaces, including CaCO3 and ice. Animal C-type lectins are involved in such functions as extracellular matrix organization, endocytosis, complement activation, pathogen recognition, and cell-cell interactions. For example: mannose-binding lectin and lung surfactant proteins A and D bind carbohydrates on surfaces (e.g. pathogens, allergens, necrotic, and apoptotic cells) and mediate functions associated with killing and phagocytosis; P (platlet)-, E (endothelial)-, and L (leukocyte)- selectins (sels) mediate the initia |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.52 E-value=1.1e-15 Score=166.26 Aligned_cols=236 Identities=17% Similarity=0.125 Sum_probs=178.5
Q ss_pred ecccCceeEEEEEeCC--CCEEEEEEeccCC--hhhHHHHHHHHHHhhccC-CCceeeEeeEEeeCCceEEEEEccCCCC
Q 008785 277 LGDSKTGGTYSGILPD--GSRVAVKRLKRSS--FQRKKEFYSEIGRFARLH-HPNLVAVKGCCYDHGDRYIVYEFVVNGP 351 (553)
Q Consensus 277 iG~G~~g~Vy~~~~~~--g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lV~E~~~~gs 351 (553)
||+|+|+.|-...... ...+|+|.+.... .........|..+-+.+. |+|++++++...+.+..+++++|..+++
T Consensus 28 ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~s~g~~ 107 (601)
T KOG0590|consen 28 IGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSYSDGGS 107 (601)
T ss_pred ccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccCcccccc
Confidence 5999999998776533 4567777765442 223344555787777886 9999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCceecCCCCCcEEecCCC-CeEEeeccccccCCc-cccc
Q 008785 352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLH-DKVKPHVVHRDIRASNVLLDEEF-GAHLMGVGLSKFVPW-EVMQ 428 (553)
Q Consensus 352 L~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH-~~~~~~ivHrDlkp~NILl~~~~-~~kl~Dfgla~~~~~-~~~~ 428 (553)
+.+.+.. ......+......++.|+..++.|+| .. ++.|||+||+|.+++..+ ..+++|||+|..... ....
T Consensus 108 ~f~~i~~--~~~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~g~~ 182 (601)
T KOG0590|consen 108 LFSKISH--PDSTGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLATAYRNKNGAE 182 (601)
T ss_pred ccccccc--CCccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhccccccCCcc
Confidence 9887732 12224566677789999999999999 87 999999999999999999 999999999987776 4444
Q ss_pred ceeeecCc-cccccccccccCC-CCCcccchHhHHHHHHHHhcCc-cccc-----chHHHHHhc-CCH------HHHHHH
Q 008785 429 ERTVMAGG-TYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIRLVL-CRRW-----WTLYTLVHS-MSL------LCAQEC 493 (553)
Q Consensus 429 ~~~~~~~g-t~~y~aPE~~~~~-~~t~ksDVwSlGvil~ell~~~-~~~~-----~~l~~~~~~-~~~------~~~~~l 493 (553)
......+| ++.|+|||...+. ...+..|+||.|+++.-+++.. +... ......... +.. ......
T Consensus 183 ~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (601)
T KOG0590|consen 183 RSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNSISDQA 262 (601)
T ss_pred eeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCccccCChhh
Confidence 44444458 9999999998874 4467899999999999999621 1111 111111211 111 556677
Q ss_pred HHHHhhccCCCCCCCCCHHHHHHH
Q 008785 494 LMLFISCNNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 494 ~~l~~~Cl~~dP~~RPs~~evl~~ 517 (553)
.+++..++..+|+.|.+..++-..
T Consensus 263 ~~~l~k~l~~~~~~r~s~~~~~~d 286 (601)
T KOG0590|consen 263 HDLLHKILKENPSNRLSIEELKLD 286 (601)
T ss_pred hhcccccccCCchhcccccccccc
Confidence 888889999999999999997665
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.51 E-value=7.9e-14 Score=147.17 Aligned_cols=140 Identities=19% Similarity=0.197 Sum_probs=100.7
Q ss_pred eeecccCceeEEEEEeCCCCEEEEEEeccCChhhH----------------------------------------HHHHH
Q 008785 275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRK----------------------------------------KEFYS 314 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~----------------------------------------~~~~~ 314 (553)
+.||.|++|.||+|++++|+.||||+.++...... -+|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 35699999999999999999999999876421110 12445
Q ss_pred HHHHhhcc----C-CCceeeEeeEE-eeCCceEEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHH-HHHHHHh
Q 008785 315 EIGRFARL----H-HPNLVAVKGCC-YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQ-GIAFLHD 387 (553)
Q Consensus 315 E~~~l~~l----~-HpnIv~l~~~~-~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~-gL~yLH~ 387 (553)
|+..+.++ + +++| .+-.++ ......+|||||++|++|.++..... ... ....++.+++. .+..+|.
T Consensus 203 Ea~n~~~~~~~~~~~~~v-~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~---~~~---~~~~ia~~~~~~~l~ql~~ 275 (437)
T TIGR01982 203 EAANASELGENFKNDPGV-YVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE---AGL---DRKALAENLARSFLNQVLR 275 (437)
T ss_pred HHHHHHHHHHhcCCCCCE-EeCCEehhhcCCceEEEEeECCcccccHHHHHh---cCC---CHHHHHHHHHHHHHHHHHh
Confidence 66666555 2 3443 332232 22445799999999999988764311 112 23456666666 4788898
Q ss_pred CCCCCceecCCCCCcEEecCCCCeEEeeccccccCCc
Q 008785 388 KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW 424 (553)
Q Consensus 388 ~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~ 424 (553)
. |++|+|++|.||+++++++++++|||++...+.
T Consensus 276 ~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 276 D---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred C---CceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 8 999999999999999999999999999987654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PF00059 Lectin_C: Lectin C-type domain; InterPro: IPR001304 Lectins occur in plants, animals, bacteria and viruses | Back alignment and domain information |
|---|
Probab=99.47 E-value=8.1e-14 Score=117.04 Aligned_cols=104 Identities=25% Similarity=0.537 Sum_probs=79.2
Q ss_pred CCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHhhCCCCCCeEeeeeecCCCCCCceEEcCCCCCCcCcccccCccCCCC
Q 008785 72 NFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSC 151 (553)
Q Consensus 72 ~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~dg~~~~~~~~~~~~~~~~~~ 151 (553)
++++|.+|+.+|+.+||+||.|++.+|++||.+.+. ....+|||+ +....+.|.|.||++.....+. .++
T Consensus 1 e~~~~~~A~~~C~~~~~~L~~i~~~~e~~~i~~~~~-~~~~~Wig~---~~~~~~~~~w~~~~~~~~~~~~------~~w 70 (105)
T PF00059_consen 1 EPMTWEEAQQYCQSMGAHLASINSEEENDFIQSQLK-SNESYWIGL---DSDNNGTWKWIDGSPNSPENFY------TNW 70 (105)
T ss_dssp EEEEHHHHHHHHHHTTSEEB-GSSHHHHHHHHHHHH-SSSEEEEEE---ESSSTSEEEETTSSBSSSTTBS------GCB
T ss_pred CCCCHHHHHHHHhcCCCEEeEeCCHHHhhhhhhccc-ccceeeeee---eccccceeccccCCCccccccc------ccc
Confidence 357999999999999999999999999999999974 367899999 2234589999999886543220 000
Q ss_pred CCCCCCCCCCCCeeEEE-eCCCCceecccCCCCCCcccee
Q 008785 152 TSLPCHVHATVDLCTLV-SNGSRSLVTERCNTSHPFICMV 190 (553)
Q Consensus 152 ~~~~C~~~~~~~~C~~~-~~~~~~w~~~~C~~~~~~iC~~ 190 (553)
......++|+.+ ......|.+..|....+|+|..
T Consensus 71 -----~~~~~~~~C~~~~~~~~~~w~~~~C~~~~~fiCek 105 (105)
T PF00059_consen 71 -----NPPNDSENCAYIYYSSSGKWNDVPCSEKYPFICEK 105 (105)
T ss_dssp -----SSGGSSEEEEEEGCSTTTEEEEEETTSEEEEEEEE
T ss_pred -----ccCCCCCCeEEEEEcCCCeEEeeCCCCCeeEEeeC
Confidence 112234589888 4455689999999999999963
|
Initially described for their carbohydrate-binding activity [], they are now recognised as a more diverse group of proteins, some of which are involved in protein-protein, protein-lipid or protein-nucleic acid interactions []. There are at least twelve structural families of lectins: C-type lectins, which are Ca+-dependent. S-type (galectins), a widespread family of glycan-binding proteins []. I-type, which have an immunoglobulin-like fold and can recognise sialic acids, other sugars and glycosaminoglycans []. P-type, which bind phosphomannosyl receptors []. Pentraxins []. (Trout) egg lectins. Calreticulin and calnexin, which act as molecular chaperones of the endoplasmic reticulum []. ERGIC-53 and VIP-36 []. Discoidins []. Eel aggutinins (fucolectins) []. Annexin lectins []. Fibrinogen-type lectins, which includes ficolins, tachylectins 5A and 5B, and Limax flavus (Spotted garden slug) agglutinin (these proteins have clear distinctions from one another, but they share a homologous fibrinogen-like domain used for carbohydrate binding). Also unclassified orphan lectins, including amphoterin, Cel-II, complement factor H, thrombospondin, sailic acid-binding lectins, adherence lectin, and cytokins (such as tumour necrosis factor and several interleukins). C-type lectins can be further divided into seven subgroups based on additional non-lectin domains and gene structure: (I) hyalectans, (II) asialoglycoprotein receptors, (III) collectins, (IV) selectins, (V) NK group transmembrane receptors, (VI) macrophage mannose receptors, and (VII) simple (single domain) lectins []. Therefore, lectins are a diverse group of proteins, both in terms of structure and activity. Carbohydrate binding ability may have evolved independently and sporadically in numerous unrelated families, where each evolved a structure that was conserved to fulfil some other activity and function. In general, animal lectins act as recognition molecules within the immune system, their functions involving defence against pathogens, cell trafficking, immune regulation and the prevention of autoimmunity [].; GO: 0005488 binding; PDB: 1T8D_A 2H2T_B 1T8C_A 2H2R_A 1TN3_A 1RJH_A 1HTN_A 3G8K_B 2E3X_B 1UMR_D .... |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.37 E-value=4.1e-13 Score=140.13 Aligned_cols=237 Identities=19% Similarity=0.182 Sum_probs=174.6
Q ss_pred ecc--cCceeEEEEEe---CCCCEEEEEEecc--CChhhHHHHHHHHHHhhcc-CCCceeeEeeEEeeCCceEEEEEccC
Q 008785 277 LGD--SKTGGTYSGIL---PDGSRVAVKRLKR--SSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVV 348 (553)
Q Consensus 277 iG~--G~~g~Vy~~~~---~~g~~vAvK~~~~--~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~ 348 (553)
+|. |.+|.+|.+.. .++..+|+|.-+. ........=.+|+....++ .|+|.++.+..+.+.+..++-+|++
T Consensus 122 ~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfiqtE~~- 200 (524)
T KOG0601|consen 122 TGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILFIQTELC- 200 (524)
T ss_pred cccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcceeeeccc-
Confidence 499 99999999986 3588899998433 2223333445677777777 5999999999999999999999998
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHH----HHHHHHhCCCCCceecCCCCCcEEecCC-CCeEEeeccccccCC
Q 008785 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQ----GIAFLHDKVKPHVVHRDIRASNVLLDEE-FGAHLMGVGLSKFVP 423 (553)
Q Consensus 349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~----gL~yLH~~~~~~ivHrDlkp~NILl~~~-~~~kl~Dfgla~~~~ 423 (553)
+.+|..+.+. ....++...+..+..+... ||.++|+. +++|-|+||.||+...+ ...+++|||+...+.
T Consensus 201 ~~sl~~~~~~---~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i~ 274 (524)
T KOG0601|consen 201 GESLQSYCHT---PCNFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTDFGLVSKIS 274 (524)
T ss_pred cchhHHhhhc---ccccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCCcceeEEcc
Confidence 5788887764 3344777788888888888 99999999 99999999999999999 889999999998776
Q ss_pred ccccccee---eecCccccccccccccCCCCCcccchHhHHHHHHHHhcCc-------ccccchHHHHHhcCCH--HHHH
Q 008785 424 WEVMQERT---VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVL-------CRRWWTLYTLVHSMSL--LCAQ 491 (553)
Q Consensus 424 ~~~~~~~~---~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~-------~~~~~~l~~~~~~~~~--~~~~ 491 (553)
........ ....|...|++||.. ++.++..+|+||+|.+..+..... ...+..+.......++ ....
T Consensus 275 ~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~~~s~ 353 (524)
T KOG0601|consen 275 DGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCEGGSS 353 (524)
T ss_pred CCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhhhcCcch
Confidence 65422211 111377789999976 567899999999999999988411 1112222211111111 2233
Q ss_pred HHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 008785 492 ECLMLFISCNNWPSHLSQSKFCNLKLWVFA 521 (553)
Q Consensus 492 ~l~~l~~~Cl~~dP~~RPs~~evl~~l~~~ 521 (553)
++...+..+++.+|..|++.+.+...-...
T Consensus 354 ~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~ 383 (524)
T KOG0601|consen 354 SLRSVTSQMLDEDPRLRLTAQILTALNVIH 383 (524)
T ss_pred hhhhHHHHhcCcchhhhhHHHHHhcccccc
Confidence 344478889999999999999988764333
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.37 E-value=6.4e-13 Score=141.99 Aligned_cols=148 Identities=16% Similarity=0.169 Sum_probs=95.7
Q ss_pred hhcccCCCCeeecccCceeEEEEEeCC-CCEEEEEEeccCChhh----------------------------------H-
Q 008785 266 ITKNFSEGNRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQR----------------------------------K- 309 (553)
Q Consensus 266 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~-g~~vAvK~~~~~~~~~----------------------------------~- 309 (553)
+..+|+. +.+|.|++|.||+|++++ |+.||||+.++.-... .
T Consensus 118 ~F~~fd~--~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~ 195 (537)
T PRK04750 118 WFDDFDI--KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEK 195 (537)
T ss_pred HHHhcCh--hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHH
Confidence 3345555 356999999999999988 9999999997542110 0
Q ss_pred -----HHHHHHHHHhhccC----CCceeeEeeEEee-CCceEEEEEccCCCCHHHHh--ccCCCCCCCCCHHHHHHHHHH
Q 008785 310 -----KEFYSEIGRFARLH----HPNLVAVKGCCYD-HGDRYIVYEFVVNGPLDRWL--HHIPRGGRSLDWAMRMKVATT 377 (553)
Q Consensus 310 -----~~~~~E~~~l~~l~----HpnIv~l~~~~~~-~~~~~lV~E~~~~gsL~~~l--~~~~~~~~~l~~~~~~~i~~q 377 (553)
-++.+|+..+.+++ +.+.+.+-.++.+ ....+|||||++|+++.++- .........+....+..++.|
T Consensus 196 ~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q 275 (537)
T PRK04750 196 TLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ 275 (537)
T ss_pred HHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH
Confidence 12344555554442 4433443333333 45678999999999998742 210000011222233333444
Q ss_pred HHHHHHHHHhCCCCCceecCCCCCcEEecCCC----CeEEeeccccccCCcc
Q 008785 378 LAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF----GAHLMGVGLSKFVPWE 425 (553)
Q Consensus 378 ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~----~~kl~Dfgla~~~~~~ 425 (553)
+ +.. |++|+|+||.||+++.++ ++++.|||++..++..
T Consensus 276 i-------f~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~ 317 (537)
T PRK04750 276 V-------FRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE 317 (537)
T ss_pred H-------HhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence 3 345 999999999999999888 8999999999877553
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.31 E-value=8.5e-12 Score=114.65 Aligned_cols=129 Identities=14% Similarity=0.043 Sum_probs=94.7
Q ss_pred eecccCceeEEEEEeCCCCEEEEEEeccCChhhHHHHHHHHHHhhccCCCce-eeEeeEEeeCCceEEEEEccCCCCHHH
Q 008785 276 LLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNL-VAVKGCCYDHGDRYIVYEFVVNGPLDR 354 (553)
Q Consensus 276 ~iG~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnI-v~l~~~~~~~~~~~lV~E~~~~gsL~~ 354 (553)
.++.|.++.||++.. ++..|++|....... ....+.+|+.+++.+.+.++ .+++.+. ....++||||++|.++.+
T Consensus 5 ~l~~G~~~~vy~~~~-~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~~ 80 (170)
T cd05151 5 PLKGGMTNKNYRVEV-ANKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELLT 80 (170)
T ss_pred ecCCcccCceEEEEE-CCeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcccc
Confidence 358999999999987 478899999765432 22346789999988865443 4555543 334589999999988753
Q ss_pred HhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCceecCCCCCcEEecCCCCeEEeecccccc
Q 008785 355 WLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV--KPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF 421 (553)
Q Consensus 355 ~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~--~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~ 421 (553)
.. . ....++.+++.+|+.||+.. ..+++|+|++|.||+++ ++.++++||+.+..
T Consensus 81 ~~---------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 81 ED---------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cc---------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 20 1 11345679999999999881 11259999999999999 56899999998864
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.29 E-value=3.9e-11 Score=111.90 Aligned_cols=135 Identities=15% Similarity=0.117 Sum_probs=98.1
Q ss_pred eecccCceeEEEEEeCC-------CCEEEEEEeccCC----------------------hhhHHHH----HHHHHHhhcc
Q 008785 276 LLGDSKTGGTYSGILPD-------GSRVAVKRLKRSS----------------------FQRKKEF----YSEIGRFARL 322 (553)
Q Consensus 276 ~iG~G~~g~Vy~~~~~~-------g~~vAvK~~~~~~----------------------~~~~~~~----~~E~~~l~~l 322 (553)
.||.|.-+.||.|.-.+ +..+|||+.+... ......+ .+|++.|+++
T Consensus 4 ~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~rl 83 (197)
T cd05146 4 CISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKRM 83 (197)
T ss_pred ccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 45999999999998653 4799999876320 0012223 3799999998
Q ss_pred C--CCceeeEeeEEeeCCceEEEEEccCCCCHHH-HhccCCCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCceecCC
Q 008785 323 H--HPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR-WLHHIPRGGRSLDWAMRMKVATTLAQGIAFL-HDKVKPHVVHRDI 398 (553)
Q Consensus 323 ~--HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~-~l~~~~~~~~~l~~~~~~~i~~qia~gL~yL-H~~~~~~ivHrDl 398 (553)
. .-++.+++++ ...+|||||+.++.+.. .+++ ..++..+...+..+++.+|..| |.. +++||||
T Consensus 84 ~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd-----~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGDL 151 (197)
T cd05146 84 QKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD-----AKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHADL 151 (197)
T ss_pred HHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc-----cccCHHHHHHHHHHHHHHHHHHHHhC---CeecCCC
Confidence 4 3466666654 46789999997654321 2221 2345556678889999999999 788 9999999
Q ss_pred CCCcEEecCCCCeEEeeccccccCC
Q 008785 399 RASNVLLDEEFGAHLMGVGLSKFVP 423 (553)
Q Consensus 399 kp~NILl~~~~~~kl~Dfgla~~~~ 423 (553)
++.|||+++ +.+.|+|||.+-...
T Consensus 152 s~~NIL~~~-~~v~iIDF~qav~~~ 175 (197)
T cd05146 152 SEYNMLWHD-GKVWFIDVSQSVEPT 175 (197)
T ss_pred CHHHEEEEC-CcEEEEECCCceeCC
Confidence 999999974 689999999886443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.25 E-value=8e-11 Score=124.25 Aligned_cols=165 Identities=22% Similarity=0.252 Sum_probs=126.0
Q ss_pred eCCCCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCCHHHHhccCCCCCCCCCHH
Q 008785 290 LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWA 369 (553)
Q Consensus 290 ~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~ 369 (553)
..++.+|.|...+...........+-++.|+.++||||+++++.+...+..|||+|-+. .|..++++ +...
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~-------l~~~ 104 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE-------LGKE 104 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH-------hHHH
Confidence 44688999998887655445567788899999999999999999999999999999884 68888865 3456
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccceeeecCccccccccccccCC
Q 008785 370 MRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRN 449 (553)
Q Consensus 370 ~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 449 (553)
.....+.||+.||.|||+.+ +++|++|.-+.|+++..|..||++|.++............. .---.|..|+.+...
T Consensus 105 ~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~--~~~~s~~~P~~~~~s 180 (690)
T KOG1243|consen 105 EVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSL--YLIESFDDPEEIDPS 180 (690)
T ss_pred HHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccc--hhhhcccChhhcCcc
Confidence 67778899999999998654 99999999999999999999999998875443222100000 011235666644222
Q ss_pred CCCcccchHhHHHHHHHHhc
Q 008785 450 ELTTKSDVYSFGVLLLEIRL 469 (553)
Q Consensus 450 ~~t~ksDVwSlGvil~ell~ 469 (553)
+-..|.|-||++++|++.
T Consensus 181 --~~s~D~~~Lg~li~el~n 198 (690)
T KOG1243|consen 181 --EWSIDSWGLGCLIEELFN 198 (690)
T ss_pred --ccchhhhhHHHHHHHHhC
Confidence 134699999999999995
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.17 E-value=1.4e-11 Score=128.74 Aligned_cols=241 Identities=16% Similarity=0.088 Sum_probs=172.7
Q ss_pred HHhhcccCCCCeeecccCceeEEEEEeC--CCCEEEEEEeccCChhhHHH--HHHHHHHhhcc-CCCceeeEeeEEeeCC
Q 008785 264 RSITKNFSEGNRLLGDSKTGGTYSGILP--DGSRVAVKRLKRSSFQRKKE--FYSEIGRFARL-HHPNLVAVKGCCYDHG 338 (553)
Q Consensus 264 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~--~g~~vAvK~~~~~~~~~~~~--~~~E~~~l~~l-~HpnIv~l~~~~~~~~ 338 (553)
...+.+|.....+ |.|.|+.|+....+ ++..|++|.+.+.......+ -..|+.+...+ .|.++++++..+....
T Consensus 261 s~~~~df~~v~~i-~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r 339 (524)
T KOG0601|consen 261 SCKLTDFGLVSKI-SDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLR 339 (524)
T ss_pred eeecCCcceeEEc-cCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccc
Confidence 3445566666666 99999999987744 57899999887654333322 24566666666 5899999888888888
Q ss_pred ceEEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCC-CCeEEeecc
Q 008785 339 DRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE-FGAHLMGVG 417 (553)
Q Consensus 339 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~-~~~kl~Dfg 417 (553)
..|+-.||++++++...+. -...+++..++++..|++.++.++|+. .++|+|+||+||++..+ +..++.|||
T Consensus 340 ~~~ip~e~~~~~s~~l~~~----~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~ 412 (524)
T KOG0601|consen 340 QGYIPLEFCEGGSSSLRSV----TSQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFG 412 (524)
T ss_pred cccCchhhhcCcchhhhhH----HHHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhccccc
Confidence 8899999999998876552 224467778899999999999999998 99999999999999886 778999999
Q ss_pred ccccCCcccccceeeecCcccccc--ccccccCCCCCcccchHhHHHHHHHHhcCccccc--chHHHHHhcCCH----HH
Q 008785 418 LSKFVPWEVMQERTVMAGGTYGYL--APEFVYRNELTTKSDVYSFGVLLLEIRLVLCRRW--WTLYTLVHSMSL----LC 489 (553)
Q Consensus 418 la~~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~t~ksDVwSlGvil~ell~~~~~~~--~~l~~~~~~~~~----~~ 489 (553)
....+.... ....+.-++. +|+......+..+.|++|||..+.|.++..+... .... .+..+.. ..
T Consensus 413 ~~t~~~~~~-----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~-~i~~~~~p~~~~~ 486 (524)
T KOG0601|consen 413 CWTRLAFSS-----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQSL-TIRSGDTPNLPGL 486 (524)
T ss_pred cccccceec-----ccccccccccccchhhccccccccccccccccccccccccCcccCcccccce-eeecccccCCCch
Confidence 886422111 1111223333 5555566778899999999999999887332221 1111 2222222 22
Q ss_pred HHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008785 490 AQECLMLFISCNNWPSHLSQSKFCNLKLW 518 (553)
Q Consensus 490 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~l 518 (553)
...+..+.+.+...++..||.+.++..+.
T Consensus 487 ~~~~q~~~kv~~~~~~~~~~l~~~l~~~~ 515 (524)
T KOG0601|consen 487 KLQLQVLLKVMINPDRKRRPSAVELSLHS 515 (524)
T ss_pred HHhhhhhhhhhcCCccccchhhhhhcccc
Confidence 26677788888899999999998876554
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.16 E-value=2.5e-10 Score=109.51 Aligned_cols=142 Identities=24% Similarity=0.260 Sum_probs=109.6
Q ss_pred eecccCceeEEEEEeCCCCEEEEEEeccCCh-hhHHHHHHHHHHhhccCC--CceeeEeeEEeeC---CceEEEEEccCC
Q 008785 276 LLGDSKTGGTYSGILPDGSRVAVKRLKRSSF-QRKKEFYSEIGRFARLHH--PNLVAVKGCCYDH---GDRYIVYEFVVN 349 (553)
Q Consensus 276 ~iG~G~~g~Vy~~~~~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H--pnIv~l~~~~~~~---~~~~lV~E~~~~ 349 (553)
.++.|..+.+|++...+|+.+++|....... .....+.+|+++++.+++ .++.+++.+.... +..++||||++|
T Consensus 5 ~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~G 84 (223)
T cd05154 5 QLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVDG 84 (223)
T ss_pred ecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeCC
Confidence 4599999999999987778999999765432 134578899999999865 4457777776553 256899999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------------
Q 008785 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV---------------------------------------- 389 (553)
Q Consensus 350 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~---------------------------------------- 389 (553)
.++.+.+.. ..++..+...++.+++.+|..||+..
T Consensus 85 ~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 85 RVLRDRLLR-----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred EecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 888665421 24677788888999999999998521
Q ss_pred -------------CCCceecCCCCCcEEecC--CCCeEEeeccccccC
Q 008785 390 -------------KPHVVHRDIRASNVLLDE--EFGAHLMGVGLSKFV 422 (553)
Q Consensus 390 -------------~~~ivHrDlkp~NILl~~--~~~~kl~Dfgla~~~ 422 (553)
...++|+|+.|.||++++ ++.+.|+||+.+...
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~g 207 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATLG 207 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccccC
Confidence 246799999999999998 566899999988643
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.16 E-value=4.4e-10 Score=100.96 Aligned_cols=142 Identities=19% Similarity=0.221 Sum_probs=104.6
Q ss_pred CeeecccCceeEEEEEeCCCCEEEEEEe-ccC-------ChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEE
Q 008785 274 NRLLGDSKTGGTYSGILPDGSRVAVKRL-KRS-------SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYE 345 (553)
Q Consensus 274 ~~~iG~G~~g~Vy~~~~~~g~~vAvK~~-~~~-------~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 345 (553)
-.++-+|+-+.|+++.+ +|+...||.- .+. ..-...+..+|+++|.+++--.|.-..-++.+...-.|+||
T Consensus 12 l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME 90 (229)
T KOG3087|consen 12 LELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYME 90 (229)
T ss_pred ceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEE
Confidence 34679999999999998 7888777753 221 11224667889999999865455444445566667789999
Q ss_pred ccCC-CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCC---CeEEeecccccc
Q 008785 346 FVVN-GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF---GAHLMGVGLSKF 421 (553)
Q Consensus 346 ~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~---~~kl~Dfgla~~ 421 (553)
|++| -++.+++... .......+....++.+|-+.+.-||.+ +|+|+||..+||++..++ .+.++|||++..
T Consensus 91 ~~~g~~~vk~~i~~~--~~~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 91 FIDGASTVKDFILST--MEDESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred eccchhHHHHHHHHH--ccCcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchhc
Confidence 9976 3788887652 222233334478899999999999999 999999999999997654 358999999853
|
|
| >PF05473 Herpes_UL45: UL45 protein; InterPro: IPR008646 This family consists several UL45 proteins and homologues found in the herpes simplex virus family | Back alignment and domain information |
|---|
Probab=99.11 E-value=4.9e-10 Score=104.52 Aligned_cols=57 Identities=19% Similarity=0.539 Sum_probs=51.4
Q ss_pred CCCCCCcCCcccCCCCeEEEEecCCC-ChHHHHHHHhhcCCEEeeeCCHHHHHHHHHhhC
Q 008785 49 WKAPCPPDWIINEEKSKCFGYIGNFR-SWDESETYCKEIGGHLAALTSYEEEHSAQKLCG 107 (553)
Q Consensus 49 ~~~~Cp~~w~~~~~~~~Cy~~~~~~~-~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~ 107 (553)
.+.+||+||. +|+++||+|+...+ ||++|+.+|.+++++|+.+++.+..-++.+...
T Consensus 81 ~~~~CP~~Wi--~~~~~Cy~~~~~~~~t~~eA~~~C~~~~s~L~~~~~~~~L~~ll~~~~ 138 (200)
T PF05473_consen 81 GCGPCPKGWI--GYNNSCYRFSNSPKKTWEEARNICAAYNSTLANVNNAKSLLELLDVLN 138 (200)
T ss_pred cCCCCCccce--eeCCEEEEEeCCCCcCHHHHHHHHHhcCCcCCCchhHHHHHHHHHHhc
Confidence 3578999999 99999999999999 999999999999999999999888877776654
|
The herpes simplex virus UL45 gene encodes an 18 kDa virion envelope protein whose function remains unknown. It has been suggested that the 18 kDa UL45 gene product is required for efficient growth in the central nervous system at low doses and may play an important role under the conditions of a naturally acquired infection []. The Equine herpesvirus 1 UL45 protein represents a type II membrane glycoprotein which has found to be non-essential for EHV-1 growth in vitro but deletion reduces the viruses' replication efficiency []. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.11 E-value=8.6e-10 Score=99.62 Aligned_cols=130 Identities=20% Similarity=0.242 Sum_probs=97.6
Q ss_pred eecccCceeEEEEEeCCCCEEEEEEe-ccC-------ChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEcc
Q 008785 276 LLGDSKTGGTYSGILPDGSRVAVKRL-KRS-------SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV 347 (553)
Q Consensus 276 ~iG~G~~g~Vy~~~~~~g~~vAvK~~-~~~-------~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 347 (553)
++++|+-+.+|.+.+ -|..+++|.= ++. ..-....-.+|+.++.+++--.|....=+..+.+...|+|||+
T Consensus 3 ~i~~GAEa~i~~~~~-~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I 81 (204)
T COG3642 3 LIKQGAEAIIYLTDF-LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI 81 (204)
T ss_pred hhhCCcceeEEeeec-cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence 458999999999977 3445666643 222 1112355678999999986544444444556677778999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeecccccc
Q 008785 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF 421 (553)
Q Consensus 348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~ 421 (553)
+|-.|.+++... ...++..+-.-+.-||.. ||+|+||.++||++..+. +.++|||++.+
T Consensus 82 ~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 82 EGELLKDALEEA-----------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred CChhHHHHHHhc-----------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 999999888641 245677777888889999 999999999999998764 99999999974
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.99 E-value=8.3e-09 Score=101.64 Aligned_cols=141 Identities=13% Similarity=0.131 Sum_probs=100.4
Q ss_pred eeecccCceeEEEEEeCCCCEEEEEEeccCChhh-----------HHHHHHHHHHhhccCCCc--eeeEeeEEee-----
Q 008785 275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQR-----------KKEFYSEIGRFARLHHPN--LVAVKGCCYD----- 336 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~-----------~~~~~~E~~~l~~l~Hpn--Iv~l~~~~~~----- 336 (553)
+++-+.....|++..+ +|+.|.||......... ...+.+|...+.++..-+ .+.++++...
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 3445445556777766 78899999775433111 114778888888874323 2334444433
Q ss_pred CCceEEEEEccCCC-CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecC-------C
Q 008785 337 HGDRYIVYEFVVNG-PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE-------E 408 (553)
Q Consensus 337 ~~~~~lV~E~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~-------~ 408 (553)
....+||+|++++. +|.+++.... ....+......++.+++..+.-||.. ||+|+|+++.|||++. +
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~ 181 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREED 181 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCC
Confidence 23468999999876 8999885321 23345667788999999999999999 9999999999999975 4
Q ss_pred CCeEEeecccccc
Q 008785 409 FGAHLMGVGLSKF 421 (553)
Q Consensus 409 ~~~kl~Dfgla~~ 421 (553)
..+.++||+.+..
T Consensus 182 ~~~~LIDl~r~~~ 194 (268)
T PRK15123 182 LKLSVIDLHRAQI 194 (268)
T ss_pred ceEEEEECCcccc
Confidence 6789999998854
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.96 E-value=2.5e-08 Score=102.57 Aligned_cols=219 Identities=14% Similarity=0.126 Sum_probs=153.6
Q ss_pred CceeEEEEEe-CCCCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeEEee----CCceEEEEEccCC-CCHHH
Q 008785 281 KTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD----HGDRYIVYEFVVN-GPLDR 354 (553)
Q Consensus 281 ~~g~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~----~~~~~lV~E~~~~-gsL~~ 354 (553)
-..+.|++.. .||..|++|++.............-++.++++.|+|||++..++.. +..+++|++|.++ ++|.+
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 3457788874 4799999999944322222233455778999999999999998873 3457999999985 56766
Q ss_pred HhccCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCC
Q 008785 355 WLHHIP-----------RGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVP 423 (553)
Q Consensus 355 ~l~~~~-----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~ 423 (553)
+-.... ..+...++..++.++.|+..||.++|+. |+.-+-|.|.+||++.+.+++|+..|......
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeeec
Confidence 543221 1234578899999999999999999999 99999999999999999999998887766544
Q ss_pred cccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcCcccccc-hHHH--HHhcCCHHHHHHHHHHHhhc
Q 008785 424 WEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVLCRRWW-TLYT--LVHSMSLLCAQECLMLFISC 500 (553)
Q Consensus 424 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~~~~~~-~l~~--~~~~~~~~~~~~l~~l~~~C 500 (553)
.+.. |-+.. -.+-|.=.||.+++-|.+....... +..+ .++.-....+.++.+++.-.
T Consensus 445 ~d~~----------------~~le~---~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I~~~yS~D~rn~v~yl 505 (655)
T KOG3741|consen 445 EDPT----------------EPLES---QQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRITTTYSTDLRNVVEYL 505 (655)
T ss_pred CCCC----------------cchhH---HhhhhHHHHHHHHHHHhhcccccccccchHHHHHHHhhhhhhHHHHHHHHHH
Confidence 3320 11111 2356888999999999984332211 1111 11111226666777777777
Q ss_pred cCCCCCCCCCHHHHHHHHHHHH
Q 008785 501 NNWPSHLSQSKFCNLKLWVFAI 522 (553)
Q Consensus 501 l~~dP~~RPs~~evl~~l~~~~ 522 (553)
...++.+ -++.+++.+....|
T Consensus 506 ~s~~~~~-ksI~~llp~~~~~f 526 (655)
T KOG3741|consen 506 ESLNFRE-KSIQDLLPMIGSRF 526 (655)
T ss_pred HhcCccc-ccHHHHHHHHHHHH
Confidence 7888887 68888887665544
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.94 E-value=5.6e-09 Score=97.08 Aligned_cols=125 Identities=23% Similarity=0.303 Sum_probs=82.9
Q ss_pred eEEEEEeCCCCEEEEEEeccCC-------------h-------------hhHHHHHHHHHHhhccCCC--ceeeEeeEEe
Q 008785 284 GTYSGILPDGSRVAVKRLKRSS-------------F-------------QRKKEFYSEIGRFARLHHP--NLVAVKGCCY 335 (553)
Q Consensus 284 ~Vy~~~~~~g~~vAvK~~~~~~-------------~-------------~~~~~~~~E~~~l~~l~Hp--nIv~l~~~~~ 335 (553)
.||.|...+|..+|||+.+... . .......+|.+.|.++..- ++.+++++
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-- 78 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-- 78 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence 3899999899999999876320 0 0023457899999999755 56677654
Q ss_pred eCCceEEEEEccC--CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHH-HHhCCCCCceecCCCCCcEEecCCCCeE
Q 008785 336 DHGDRYIVYEFVV--NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAF-LHDKVKPHVVHRDIRASNVLLDEEFGAH 412 (553)
Q Consensus 336 ~~~~~~lV~E~~~--~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~y-LH~~~~~~ivHrDlkp~NILl~~~~~~k 412 (553)
....|||||++ |..+..+... .++......++.+++..+.. +|.. ||+|+||.+.|||++++ .+.
T Consensus 79 --~~~~ivME~I~~~G~~~~~l~~~------~~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~ 146 (188)
T PF01163_consen 79 --NRNVIVMEYIGEDGVPLPRLKDV------DLSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVY 146 (188)
T ss_dssp --ETTEEEEE--EETTEEGGCHHHC------GGGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEE
T ss_pred --eCCEEEEEecCCCccchhhHHhc------cccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEE
Confidence 24579999998 5555443321 11133456677888886666 4677 99999999999999988 999
Q ss_pred EeeccccccC
Q 008785 413 LMGVGLSKFV 422 (553)
Q Consensus 413 l~Dfgla~~~ 422 (553)
++|||.+...
T Consensus 147 iIDf~qav~~ 156 (188)
T PF01163_consen 147 IIDFGQAVDS 156 (188)
T ss_dssp E--GTTEEET
T ss_pred EEecCcceec
Confidence 9999987644
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.77 E-value=1.7e-09 Score=119.03 Aligned_cols=230 Identities=16% Similarity=0.085 Sum_probs=153.6
Q ss_pred eecccCceeEEEEEeC-CCCEEEEEEeccCCh---hhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCC
Q 008785 276 LLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF---QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP 351 (553)
Q Consensus 276 ~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gs 351 (553)
-+-+|.++.++...-. .|...++|....... .+.+....+-.++-..+||-+++..--+......+|+++|+.+++
T Consensus 811 p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~~~~ 890 (1205)
T KOG0606|consen 811 PSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYLNGGD 890 (1205)
T ss_pred cccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHHhccCC
Confidence 3477888888766532 243444444433211 112222333333333456777766555555677899999999999
Q ss_pred HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcc------
Q 008785 352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE------ 425 (553)
Q Consensus 352 L~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~------ 425 (553)
|...|+... ..+..-.......+..+++|||+. .+.|||++|.|+++..++..+++|||.......-
T Consensus 891 ~~Skl~~~~----~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~ 963 (1205)
T KOG0606|consen 891 LPSKLHNSG----CLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTDL 963 (1205)
T ss_pred chhhhhcCC----CcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCccccccccccccCcCCc
Confidence 999987532 344445556677788999999998 8999999999999999999999999843221100
Q ss_pred -------------------ccc----ceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcCcccccc----hH
Q 008785 426 -------------------VMQ----ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVLCRRWW----TL 478 (553)
Q Consensus 426 -------------------~~~----~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~~~~~~----~l 478 (553)
... .......||+.|.+||...+......+|.|++|++++|.++..+.... ..
T Consensus 964 sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~~ 1043 (1205)
T KOG0606|consen 964 SGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQQI 1043 (1205)
T ss_pred ccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchhhh
Confidence 000 011122389999999999999999999999999999999974433332 23
Q ss_pred HHHHh-------cCCHHHHHHHHHHHhhccCCCCCCCCCHH
Q 008785 479 YTLVH-------SMSLLCAQECLMLFISCNNWPSHLSQSKF 512 (553)
Q Consensus 479 ~~~~~-------~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ 512 (553)
.+-+- .|.........+++..-+..+|..|-.+.
T Consensus 1044 f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1044 FENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred hhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 33222 22225566677777788888999998776
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.72 E-value=1.3e-07 Score=90.60 Aligned_cols=130 Identities=19% Similarity=0.207 Sum_probs=95.0
Q ss_pred eeecccCceeEEEEEeCCCCEEEEEEeccCCh----------------------hhHHHHHHHHHHhhccCCC--ceeeE
Q 008785 275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSF----------------------QRKKEFYSEIGRFARLHHP--NLVAV 330 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~~g~~vAvK~~~~~~~----------------------~~~~~~~~E~~~l~~l~Hp--nIv~l 330 (553)
..||-|.-+.||.|..++|.++|||.-+.... ..+....+|.++|.+|... .|.+.
T Consensus 97 ~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~VP~P 176 (304)
T COG0478 97 TKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKVPKP 176 (304)
T ss_pred cccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCCCCc
Confidence 34599999999999999999999997543210 1123457899999999654 67776
Q ss_pred eeEEeeCCceEEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCC
Q 008785 331 KGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG 410 (553)
Q Consensus 331 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~ 410 (553)
+++ +...+||||++|-.|...- ++....-.++..|+.-+.-+-.. |+||+|+.+=||+++++|.
T Consensus 177 ~~~----nRHaVvMe~ieG~eL~~~r---------~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~~dg~ 240 (304)
T COG0478 177 IAW----NRHAVVMEYIEGVELYRLR---------LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVTEDGD 240 (304)
T ss_pred ccc----ccceeeeehcccceeeccc---------CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEecCCC
Confidence 654 5668999999886664321 12333444555555555555566 9999999999999999999
Q ss_pred eEEeeccccc
Q 008785 411 AHLMGVGLSK 420 (553)
Q Consensus 411 ~kl~Dfgla~ 420 (553)
+.++||--+.
T Consensus 241 ~~vIDwPQ~v 250 (304)
T COG0478 241 IVVIDWPQAV 250 (304)
T ss_pred EEEEeCcccc
Confidence 9999996554
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.64 E-value=2.8e-07 Score=87.61 Aligned_cols=108 Identities=24% Similarity=0.282 Sum_probs=82.9
Q ss_pred HHHHHHHHHHhhccCC--CceeeEeeEEeeCC----ceEEEEEccCCC-CHHHHhccCCCCCCCCCHHHHHHHHHHHHHH
Q 008785 309 KKEFYSEIGRFARLHH--PNLVAVKGCCYDHG----DRYIVYEFVVNG-PLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 381 (553)
Q Consensus 309 ~~~~~~E~~~l~~l~H--pnIv~l~~~~~~~~----~~~lV~E~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~qia~g 381 (553)
.....+|...+..|.. =.+++.+++..... ..++|+|++++. +|.+++.... ..+......++.+++..
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~----~~~~~~~~~ll~~l~~~ 130 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE----QLDPSQRRELLRALARL 130 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc----ccchhhHHHHHHHHHHH
Confidence 3467788887777742 23445556555432 348999999874 7999886421 25666778999999999
Q ss_pred HHHHHhCCCCCceecCCCCCcEEecCCC---CeEEeeccccccCC
Q 008785 382 IAFLHDKVKPHVVHRDIRASNVLLDEEF---GAHLMGVGLSKFVP 423 (553)
Q Consensus 382 L~yLH~~~~~~ivHrDlkp~NILl~~~~---~~kl~Dfgla~~~~ 423 (553)
++-||.. ||+|+|+++.|||++.+. .+.++||+.++...
T Consensus 131 i~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~ 172 (206)
T PF06293_consen 131 IAKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP 172 (206)
T ss_pred HHHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence 9999999 999999999999999887 79999999876543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.63 E-value=2.1e-07 Score=99.31 Aligned_cols=142 Identities=16% Similarity=0.183 Sum_probs=94.1
Q ss_pred eeecccCceeEEEEEeCCCCEEEEEEeccCChhh------------------------------HH----------HHHH
Q 008785 275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQR------------------------------KK----------EFYS 314 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~------------------------------~~----------~~~~ 314 (553)
.-++.++-|.||+|++++|+.||||+.+++-... .+ ++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 3469999999999999999999999987541110 01 1334
Q ss_pred HHHHhhcc-----CCCceeeEeeEEeeCCceEEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHH-HHHHHhC
Q 008785 315 EIGRFARL-----HHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG-IAFLHDK 388 (553)
Q Consensus 315 E~~~l~~l-----~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~g-L~yLH~~ 388 (553)
|+..+.++ +.|+|.-..=+..-.+...|+|||++|-.+.+...-. ....+...+ +..++.+ +..+-..
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~---~~g~d~k~i---a~~~~~~f~~q~~~d 284 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALK---SAGIDRKEL---AELLVRAFLRQLLRD 284 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHH---hcCCCHHHH---HHHHHHHHHHHHHhc
Confidence 55555555 2344332222333456779999999999888874321 123443333 2222222 2222234
Q ss_pred CCCCceecCCCCCcEEecCCCCeEEeeccccccCCcc
Q 008785 389 VKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE 425 (553)
Q Consensus 389 ~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~ 425 (553)
|++|.|..|.||+++.++++.+.|||+...++..
T Consensus 285 ---gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 285 ---GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK 318 (517)
T ss_pred ---CccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence 9999999999999999999999999999876653
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.60 E-value=1.8e-06 Score=81.00 Aligned_cols=155 Identities=12% Similarity=0.084 Sum_probs=109.4
Q ss_pred HHHHHHhhcccCCCCeeecccCceeEEEEEeCCCCEEEEEEeccC---C---hhhHHHHHHHHHHhhccCC--CceeeEe
Q 008785 260 TEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRS---S---FQRKKEFYSEIGRFARLHH--PNLVAVK 331 (553)
Q Consensus 260 ~~el~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~vAvK~~~~~---~---~~~~~~~~~E~~~l~~l~H--pnIv~l~ 331 (553)
++.+-....+.-+.-.. |+||-+.|++-.+ +|..+=+|.-... + +.....|.+|+..+.+|.. -.+.+..
T Consensus 10 f~~~w~~~~~wve~pN~-~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv 87 (216)
T PRK09902 10 FNHWWATEGDWVEEPNY-RRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV 87 (216)
T ss_pred HHHHHhCCCceecCCCc-CCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc
Confidence 33344444443333334 8899999999877 5557888876521 1 3356789999999999843 2244444
Q ss_pred eEEeeC----CceEEEEEccCC-CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEec
Q 008785 332 GCCYDH----GDRYIVYEFVVN-GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD 406 (553)
Q Consensus 332 ~~~~~~----~~~~lV~E~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~ 406 (553)
...... -..+||+|-+++ -||.+++.+. .-...+...+..++.+++..++-||+. |+.|+|+-+.||+++
T Consensus 88 f~~~~k~~~~~rA~LVTe~L~g~~~L~~~l~~~--~~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~ 162 (216)
T PRK09902 88 FGEAVKIEGEWRALLVTEDMAGFISIADWYAQH--AVSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVK 162 (216)
T ss_pred eeeeeccCCceEEEEEEEeCCCCccHHHHHhcC--CcCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeec
Confidence 221121 125899997753 5898888542 223457777889999999999999999 999999999999998
Q ss_pred CCCC--eEEeecccccc
Q 008785 407 EEFG--AHLMGVGLSKF 421 (553)
Q Consensus 407 ~~~~--~kl~Dfgla~~ 421 (553)
.++. ++++||.-++.
T Consensus 163 ~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 163 TEGKAEAGFLDLEKSRR 179 (216)
T ss_pred CCCCeeEEEEEhhccch
Confidence 6667 89999987654
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.54 E-value=2.5e-08 Score=106.04 Aligned_cols=140 Identities=22% Similarity=0.229 Sum_probs=100.6
Q ss_pred HHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccc-------eeeecCccccccccccccC
Q 008785 376 TTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE-------RTVMAGGTYGYLAPEFVYR 448 (553)
Q Consensus 376 ~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~ 448 (553)
.+++.||.|+|.. +++||++|.|++|.++.++..||+.|+.+.......... ..........|.|||++..
T Consensus 106 ~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 4455999999977 599999999999999999999999999875443311100 0001114567999999988
Q ss_pred CCCCcccchHhHHHHHHHHhc-Ccc---cccchHHH-----HHhcCCH----HHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 008785 449 NELTTKSDVYSFGVLLLEIRL-VLC---RRWWTLYT-----LVHSMSL----LCAQECLMLFISCNNWPSHLSQSKFCNL 515 (553)
Q Consensus 449 ~~~t~ksDVwSlGvil~ell~-~~~---~~~~~l~~-----~~~~~~~----~~~~~l~~l~~~Cl~~dP~~RPs~~evl 515 (553)
...+.++|+||+|+++|-+.. +.+ .....+.. ..+.+.. ..+.++.+=+.+.++.++.-||++.+++
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~ 263 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLL 263 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhh
Confidence 888999999999999998873 111 11111111 1111222 6778899999999999999999888876
Q ss_pred HH
Q 008785 516 KL 517 (553)
Q Consensus 516 ~~ 517 (553)
..
T Consensus 264 ~~ 265 (700)
T KOG2137|consen 264 SI 265 (700)
T ss_pred cc
Confidence 54
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.42 E-value=4.1e-06 Score=80.78 Aligned_cols=139 Identities=14% Similarity=0.209 Sum_probs=84.4
Q ss_pred eecccCceeEEEEEeCCCCEEEEEEeccCChhhHHHHHHHHHHhhccCCCc--eeeEeeEEeeCCceEEEEEccCCCC-H
Q 008785 276 LLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPN--LVAVKGCCYDHGDRYIVYEFVVNGP-L 352 (553)
Q Consensus 276 ~iG~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpn--Iv~l~~~~~~~~~~~lV~E~~~~gs-L 352 (553)
.||+|..+.||+. .|..+++|...... ......+|.++++.+..-. +.+.+++....+...+|||+++|.+ +
T Consensus 8 ~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~ 82 (226)
T TIGR02172 8 QTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSF 82 (226)
T ss_pred eecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccch
Confidence 4599999999983 35567889886543 3345688999998885333 4667777777777889999998863 2
Q ss_pred HHHh---------------------ccCCCCCCCCCHHHHHHHHHH----------HHH-HHHHHHhC-CCCCceecCCC
Q 008785 353 DRWL---------------------HHIPRGGRSLDWAMRMKVATT----------LAQ-GIAFLHDK-VKPHVVHRDIR 399 (553)
Q Consensus 353 ~~~l---------------------~~~~~~~~~l~~~~~~~i~~q----------ia~-gL~yLH~~-~~~~ivHrDlk 399 (553)
...+ +........++.. ...+..+ +.. ...+|... ..+.++|+|+.
T Consensus 83 ~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~-~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~ 161 (226)
T TIGR02172 83 SRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSY-KEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ 161 (226)
T ss_pred hhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHH-HHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence 1111 1110011111100 0000000 001 11222211 13367899999
Q ss_pred CCcEEecCCCCeEEeecccccc
Q 008785 400 ASNVLLDEEFGAHLMGVGLSKF 421 (553)
Q Consensus 400 p~NILl~~~~~~kl~Dfgla~~ 421 (553)
|.||++++++ +.++||+.+..
T Consensus 162 ~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 162 IGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCcEEEcCCC-cEEEechhcCc
Confidence 9999999887 99999998764
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.26 E-value=1.1e-05 Score=76.76 Aligned_cols=155 Identities=18% Similarity=0.150 Sum_probs=102.1
Q ss_pred cccCHHHHHHhhcccCC--CCeeecccCceeEEEEEeCCCCEEEEEEeccCChhh-------------------HH----
Q 008785 256 KVFTTEELRSITKNFSE--GNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQR-------------------KK---- 310 (553)
Q Consensus 256 ~~~~~~el~~~~~~~~~--~~~~iG~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~-------------------~~---- 310 (553)
...+.+.+..+...... ....|+.|.-+.||+|.-.++..||||+.+...... ..
T Consensus 33 D~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~ 112 (268)
T COG1718 33 DKRTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVF 112 (268)
T ss_pred hhHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHH
Confidence 33455666665544332 223457788889999998889999999987532111 01
Q ss_pred -HHHHHHHHhhccC--CCceeeEeeEEeeCCceEEEEEccCCCCH-HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHH
Q 008785 311 -EFYSEIGRFARLH--HPNLVAVKGCCYDHGDRYIVYEFVVNGPL-DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLH 386 (553)
Q Consensus 311 -~~~~E~~~l~~l~--HpnIv~l~~~~~~~~~~~lV~E~~~~gsL-~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH 386 (553)
-..+|..-|.++. +=.+.+.+++. ...|||||+..... .-.|+ ...+...+...+..++++.+.-|-
T Consensus 113 ~W~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~Lk-----Dv~~e~~e~~~~~~~~v~~~~~l~ 183 (268)
T COG1718 113 AWARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLK-----DVPLELEEAEGLYEDVVEYMRRLY 183 (268)
T ss_pred HHHHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCcc-----cCCcCchhHHHHHHHHHHHHHHHH
Confidence 1245777777773 44444555442 34799999954311 11111 122333356777888888888887
Q ss_pred h-CCCCCceecCCCCCcEEecCCCCeEEeeccccccCC
Q 008785 387 D-KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVP 423 (553)
Q Consensus 387 ~-~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~ 423 (553)
. . ++||+||+.=|||+. ++.+.++|+|-|....
T Consensus 184 ~~a---~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 184 KEA---GLVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred Hhc---CcccccchhhheEEE-CCeEEEEECccccccC
Confidence 6 5 999999999999999 7799999999886544
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.24 E-value=8.9e-06 Score=86.68 Aligned_cols=141 Identities=16% Similarity=0.107 Sum_probs=90.5
Q ss_pred eeecccCceeEEEEEeCCCCEEEEEEeccCChhh-------------------------------------HHHHHHHHH
Q 008785 275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQR-------------------------------------KKEFYSEIG 317 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~-------------------------------------~~~~~~E~~ 317 (553)
+-||.-+.|.||+|++++|+.||||+-++.-... +-+|.+|++
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 3469999999999999999999999876531111 011344544
Q ss_pred Hhhcc----CCCc------eeeEeeEEeeCCceEEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 008785 318 RFARL----HHPN------LVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD 387 (553)
Q Consensus 318 ~l~~l----~Hpn------Iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~ 387 (553)
-..++ .|-+ |.+++- .-.....|+||||+|..+.+.-.- ....++...+..-+.++..-+-+-
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~--~~st~RVLtME~~~G~~i~Dl~~i---~~~gi~~~~i~~~l~~~~~~qIf~-- 319 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYW--DLSTKRVLTMEYVDGIKINDLDAI---DKRGISPHDILNKLVEAYLEQIFK-- 319 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehh--hcCcceEEEEEecCCccCCCHHHH---HHcCCCHHHHHHHHHHHHHHHHHh--
Confidence 43333 3444 333332 223467899999999877665322 112355554443333332222222
Q ss_pred CCCCCceecCCCCCcEEecC----CCCeEEeeccccccCCcc
Q 008785 388 KVKPHVVHRDIRASNVLLDE----EFGAHLMGVGLSKFVPWE 425 (553)
Q Consensus 388 ~~~~~ivHrDlkp~NILl~~----~~~~kl~Dfgla~~~~~~ 425 (553)
.|++|+|-.|.||+++. ++.+.+-|||+...+...
T Consensus 320 ---~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~ 358 (538)
T KOG1235|consen 320 ---TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK 358 (538)
T ss_pred ---cCCccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence 29999999999999984 678999999999876544
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.23 E-value=1.3e-05 Score=78.20 Aligned_cols=140 Identities=17% Similarity=0.153 Sum_probs=85.1
Q ss_pred cccCc-eeEEEEEeCCCCEEEEEEeccCChhhHHHHHHHHHHhhccC-CCceeeEeeEEeeCCceEEEEEccCCCCHHHH
Q 008785 278 GDSKT-GGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLH-HPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRW 355 (553)
Q Consensus 278 G~G~~-g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~ 355 (553)
-.|.+ ..||+.... +..+.||...... ...+.+|+++++.+. +--+.+++++....+..++|||+++|.+|...
T Consensus 7 ~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~ 82 (244)
T cd05150 7 TEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAAL 82 (244)
T ss_pred CCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHh
Confidence 33444 788998764 5788889886543 345667888888773 44466778877766678999999998877643
Q ss_pred h-------------------ccCCCCCCCCCHH--HHHHHHH--------------------HHHHHHHHHHh----CCC
Q 008785 356 L-------------------HHIPRGGRSLDWA--MRMKVAT--------------------TLAQGIAFLHD----KVK 390 (553)
Q Consensus 356 l-------------------~~~~~~~~~l~~~--~~~~i~~--------------------qia~gL~yLH~----~~~ 390 (553)
. +............ ....... .+...+..|-. ...
T Consensus 83 ~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 162 (244)
T cd05150 83 WEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEED 162 (244)
T ss_pred hcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcCc
Confidence 2 1111111111100 0000000 01111222211 123
Q ss_pred CCceecCCCCCcEEecCCCCeEEeecccccc
Q 008785 391 PHVVHRDIRASNVLLDEEFGAHLMGVGLSKF 421 (553)
Q Consensus 391 ~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~ 421 (553)
+.++|+|+.|.|||++++....|+||+.+..
T Consensus 163 ~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 163 LVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred eEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 4699999999999999987788999997754
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.23 E-value=1.3e-05 Score=81.05 Aligned_cols=232 Identities=15% Similarity=0.099 Sum_probs=141.3
Q ss_pred eeecccCceeEEEEEeCCCCEEEEEEeccCChhhHHHHHHHHHHhhcc-CCCceeeEeeEE------eeCCc-eEEEEEc
Q 008785 275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCC------YDHGD-RYIVYEF 346 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~------~~~~~-~~lV~E~ 346 (553)
+-||+|+-+.+|.--- -+. -+-|+..........+.. ..|.+. .||-+-.-+.+= -+.+. .-+.|..
T Consensus 17 r~LgqGgea~ly~l~e-~~d-~VAKIYh~Pppa~~aqk~---a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP~ 91 (637)
T COG4248 17 RPLGQGGEADLYTLGE-VRD-QVAKIYHAPPPAAQAQKV---AELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMPK 91 (637)
T ss_pred ccccCCccceeeecch-hhc-hhheeecCCCchHHHHHH---HHhccCCCCcchhhhhcccHHHhhCCCccceeEEeccc
Confidence 3459999999985331 112 234666544333222222 223333 466443311111 11222 4567777
Q ss_pred cCCCC-HHHHhcc--CCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCC
Q 008785 347 VVNGP-LDRWLHH--IPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVP 423 (553)
Q Consensus 347 ~~~gs-L~~~l~~--~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~ 423 (553)
+++.- ...+++- .++.-...+|...++.++.+|.+.+-||.. |.+-+|+.++|+|+.+++.+.|.|-..-....
T Consensus 92 v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~~ 168 (637)
T COG4248 92 VSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSFQINA 168 (637)
T ss_pred CCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcccceeecc
Confidence 76532 2233321 122334578999999999999999999999 99999999999999999999998854332222
Q ss_pred cccccceeeecCcccccccccccc-----CCCCCcccchHhHHHHHHHHhc--Cccccc--------chHHHHHhcCCH-
Q 008785 424 WEVMQERTVMAGGTYGYLAPEFVY-----RNELTTKSDVYSFGVLLLEIRL--VLCRRW--------WTLYTLVHSMSL- 487 (553)
Q Consensus 424 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDVwSlGvil~ell~--~~~~~~--------~~l~~~~~~~~~- 487 (553)
.+.. .....|...|.+||.-. +..-+...|.|.||+++++++- ..|... ..+...+..|.+
T Consensus 169 ng~~---~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~ 245 (637)
T COG4248 169 NGTL---HLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFA 245 (637)
T ss_pred CCce---EecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceee
Confidence 1111 12233888999999654 3345778999999999999994 111111 111112222222
Q ss_pred -------------------HHHHHHHHHHhhccCC--CCCCCCCHHHHHHH
Q 008785 488 -------------------LCAQECLMLFISCNNW--PSHLSQSKFCNLKL 517 (553)
Q Consensus 488 -------------------~~~~~l~~l~~~Cl~~--dP~~RPs~~evl~~ 517 (553)
..++.+..+..+|+.. +|.-|||+..=+..
T Consensus 246 ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aA 296 (637)
T COG4248 246 YASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAA 296 (637)
T ss_pred echhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Confidence 5566777888889864 46789999875444
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.23 E-value=1.5e-05 Score=75.19 Aligned_cols=130 Identities=13% Similarity=0.215 Sum_probs=83.5
Q ss_pred eeecccCceeEEEEEeCCCCEEEEEEeccCChhhHHH---------HHHHHHHhhccCCC---ceeeEeeEEee-----C
Q 008785 275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKE---------FYSEIGRFARLHHP---NLVAVKGCCYD-----H 337 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~---------~~~E~~~l~~l~Hp---nIv~l~~~~~~-----~ 337 (553)
+++-......|.+-.. +|+.+.+|..+.......+. ..+++..+.+++.. ..+.++.+... .
T Consensus 37 kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ekk~~~~~ 115 (229)
T PF06176_consen 37 KVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEKKIFRYT 115 (229)
T ss_pred EeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeeeeeccce
Confidence 4445556566666555 78999999887653322222 22344444444322 22222222221 2
Q ss_pred CceEEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeecc
Q 008785 338 GDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVG 417 (553)
Q Consensus 338 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg 417 (553)
...+++|||++|..|.++.. +++ .++..+.+++.-||.. |++|+|..|.|++++++ .++++||+
T Consensus 116 ~~~~ll~EYIeG~~l~d~~~--------i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~~-~i~iID~~ 179 (229)
T PF06176_consen 116 SSYVLLMEYIEGVELNDIED--------IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSNN-GIRIIDTQ 179 (229)
T ss_pred eEEEEEEEEecCeecccchh--------cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEECC-cEEEEECc
Confidence 34468999999988866432 222 2456677889999999 99999999999999865 59999998
Q ss_pred cccc
Q 008785 418 LSKF 421 (553)
Q Consensus 418 la~~ 421 (553)
..+.
T Consensus 180 ~k~~ 183 (229)
T PF06176_consen 180 GKRM 183 (229)
T ss_pred cccc
Confidence 7654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.21 E-value=3.2e-05 Score=72.55 Aligned_cols=133 Identities=17% Similarity=0.279 Sum_probs=94.4
Q ss_pred CeeecccCceeEEEEEeCCCCEEEEEEeccCC----------------hhhHHHHHHHHHHhhccC------CCceeeEe
Q 008785 274 NRLLGDSKTGGTYSGILPDGSRVAVKRLKRSS----------------FQRKKEFYSEIGRFARLH------HPNLVAVK 331 (553)
Q Consensus 274 ~~~iG~G~~g~Vy~~~~~~g~~vAvK~~~~~~----------------~~~~~~~~~E~~~l~~l~------HpnIv~l~ 331 (553)
..+||+|+.-.||. +++.....||+..... ....++..+|+.....+. +.+|.+++
T Consensus 6 ~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 6 SDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred CcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 34679999999996 5566778889887654 122455667776665555 88999999
Q ss_pred eEEeeCCceEEEEEccCC------CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEe
Q 008785 332 GCCYDHGDRYIVYEFVVN------GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL 405 (553)
Q Consensus 332 ~~~~~~~~~~lV~E~~~~------gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl 405 (553)
|+..++...-+|+|.+.+ -+|.+++.+ ..++. .....+. .-..||-+. +|+.+|++|.||++
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~-----~~~~~-~~~~~L~---~f~~~l~~~---~Iv~~dl~~~NIv~ 151 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKE-----GGLTE-ELRQALD---EFKRYLLDH---HIVIRDLNPHNIVV 151 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHHc-----CCccH-HHHHHHH---HHHHHHHHc---CCeecCCCcccEEE
Confidence 999999999999998753 358888853 23554 3333333 345677777 99999999999999
Q ss_pred cCCC----CeEEee-ccccc
Q 008785 406 DEEF----GAHLMG-VGLSK 420 (553)
Q Consensus 406 ~~~~----~~kl~D-fgla~ 420 (553)
.... .+.|+| ||...
T Consensus 152 ~~~~~~~~~lvlIDG~G~~~ 171 (199)
T PF10707_consen 152 QRRDSGEFRLVLIDGLGEKE 171 (199)
T ss_pred EecCCCceEEEEEeCCCCcc
Confidence 6432 577777 55443
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.15 E-value=2.8e-05 Score=74.84 Aligned_cols=142 Identities=17% Similarity=0.200 Sum_probs=82.7
Q ss_pred eecccCceeEEEEEeCCCCEEEEEEeccCChhhHHHHHHHHHHhhccCC--CceeeEeeEEee---CCceEEEEEccCCC
Q 008785 276 LLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHH--PNLVAVKGCCYD---HGDRYIVYEFVVNG 350 (553)
Q Consensus 276 ~iG~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H--pnIv~l~~~~~~---~~~~~lV~E~~~~g 350 (553)
.++.|..+.||+....+ ..+++|..... .....+.+|..++..+.. ..+.+++..... ....+++|+++++.
T Consensus 4 ~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~ 80 (239)
T PF01636_consen 4 PLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGR 80 (239)
T ss_dssp EEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSE
T ss_pred cCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEeccc
Confidence 35899999999999866 69999997654 455677788888888742 235666664433 23468999999998
Q ss_pred CHHH----------------Hhc---cCCCCCCCCCHHH---------HHHH------------HHHHHH-HHHHHHh--
Q 008785 351 PLDR----------------WLH---HIPRGGRSLDWAM---------RMKV------------ATTLAQ-GIAFLHD-- 387 (553)
Q Consensus 351 sL~~----------------~l~---~~~~~~~~l~~~~---------~~~i------------~~qia~-gL~yLH~-- 387 (553)
++.. .+. ............. .... ...+.. .+..+++
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (239)
T PF01636_consen 81 PLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEALL 160 (239)
T ss_dssp EHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhhh
Confidence 7777 111 1100111111100 0000 111222 2333332
Q ss_pred --CCCCCceecCCCCCcEEec-CCCCeEEeeccccc
Q 008785 388 --KVKPHVVHRDIRASNVLLD-EEFGAHLMGVGLSK 420 (553)
Q Consensus 388 --~~~~~ivHrDlkp~NILl~-~~~~~kl~Dfgla~ 420 (553)
.....++|+|+.|.|||++ +++.+.|+||+.+.
T Consensus 161 ~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 161 PKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred ccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 1234799999999999999 55666799998764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.15 E-value=5.7e-07 Score=94.91 Aligned_cols=221 Identities=15% Similarity=0.045 Sum_probs=144.0
Q ss_pred cccCceeEEEEEeCCCCEEEEEEeccCChhhHHHHHHHHHHhhccCCCc-eeeEeeEEeeCCceEEEEEccCCC-CHHHH
Q 008785 278 GDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPN-LVAVKGCCYDHGDRYIVYEFVVNG-PLDRW 355 (553)
Q Consensus 278 G~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpn-Iv~l~~~~~~~~~~~lV~E~~~~g-sL~~~ 355 (553)
++|+++++|+.+-...+....+.+... ....-++++|.+++||| .+..++-+..+...+++++++.++ +-..-
T Consensus 251 vK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~~ 325 (829)
T KOG0576|consen 251 VKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSALE 325 (829)
T ss_pred HHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCcccccc
Confidence 889999999887544444445555433 33445788999999999 777777777778889999999877 22111
Q ss_pred hccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccceeeecC
Q 008785 356 LHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG 435 (553)
Q Consensus 356 l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~ 435 (553)
. ......+...+...+.+.-+++++++|+. .=+||| ||+..+ +..+..||+....+.... ......
T Consensus 326 ~---~~se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~---~~~t~~ 391 (829)
T KOG0576|consen 326 M---TVSEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM---KPRTAI 391 (829)
T ss_pred C---ChhhHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCcccCccc---ccccCC
Confidence 1 11222344445556777788899999987 568998 777766 578999999887665543 222334
Q ss_pred ccccccccccccCCCCCcccchHhHHHHHHHHhcCcccccchHHH--HHhcCC--------HHHHHHH-HHHHhhccCCC
Q 008785 436 GTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVLCRRWWTLYT--LVHSMS--------LLCAQEC-LMLFISCNNWP 504 (553)
Q Consensus 436 gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~~~~~~~l~~--~~~~~~--------~~~~~~l-~~l~~~Cl~~d 504 (553)
+++.++|||+...+.+..+.|+||+|+--.++.+..+........ .+..+. ....... .++...|+...
T Consensus 392 ~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~P~~~~~~~g~~p~s~~L~~~~aw~~~~~~~~~~~~~~g~ 471 (829)
T KOG0576|consen 392 GTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSSPPAVLPMIGNGPNSPMLTDKSAWSPVFHRDFPAPCLNGL 471 (829)
T ss_pred CCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCCCccccCCCCCCCCccccchhhhcCcccccCCcccccCCC
Confidence 899999999999999999999999998666665421111100000 000000 0000001 13556788888
Q ss_pred CCCCCCHHHHHHH
Q 008785 505 SHLSQSKFCNLKL 517 (553)
Q Consensus 505 P~~RPs~~evl~~ 517 (553)
|..|+.....+..
T Consensus 472 P~~pkv~mgacfs 484 (829)
T KOG0576|consen 472 PPTPKVHMGACFS 484 (829)
T ss_pred CCCCcchhhHHHH
Confidence 8888887776644
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.05 E-value=6e-05 Score=86.58 Aligned_cols=148 Identities=18% Similarity=0.286 Sum_probs=91.7
Q ss_pred eecccCceeEEEEEeCCC---CEEEEEEeccCC-hhhHHHHHHHHHHhhccC-CCce--eeEeeEEeeC---CceEEEEE
Q 008785 276 LLGDSKTGGTYSGILPDG---SRVAVKRLKRSS-FQRKKEFYSEIGRFARLH-HPNL--VAVKGCCYDH---GDRYIVYE 345 (553)
Q Consensus 276 ~iG~G~~g~Vy~~~~~~g---~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~-HpnI--v~l~~~~~~~---~~~~lV~E 345 (553)
.++.|.++.+|+....++ ..+++|+..... ......+.+|+++|+.+. |++| .++++++.+. +..|+|||
T Consensus 45 ~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVME 124 (822)
T PLN02876 45 QFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIME 124 (822)
T ss_pred EeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEEE
Confidence 358999999999877554 467888765432 223457889999999995 6665 7888887764 46799999
Q ss_pred ccCCCCHHH--------------------H---hccCCCC-------CCCCCH--HHHHHHH---------------HHH
Q 008785 346 FVVNGPLDR--------------------W---LHHIPRG-------GRSLDW--AMRMKVA---------------TTL 378 (553)
Q Consensus 346 ~~~~gsL~~--------------------~---l~~~~~~-------~~~l~~--~~~~~i~---------------~qi 378 (553)
|++|..+.+ . |+..... +..... .++..+. ..+
T Consensus 125 ~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~~~ 204 (822)
T PLN02876 125 YLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNPKM 204 (822)
T ss_pred ecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCChhH
Confidence 998764321 1 1111100 001011 1111111 112
Q ss_pred HHHHHHHHhCCC--------CCceecCCCCCcEEecCC-CC-eEEeeccccccCC
Q 008785 379 AQGIAFLHDKVK--------PHVVHRDIRASNVLLDEE-FG-AHLMGVGLSKFVP 423 (553)
Q Consensus 379 a~gL~yLH~~~~--------~~ivHrDlkp~NILl~~~-~~-~kl~Dfgla~~~~ 423 (553)
...+.+|..+.. +.++|+|+++.|||++.+ .. .-|.||.++...+
T Consensus 205 ~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~Gd 259 (822)
T PLN02876 205 LELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLGN 259 (822)
T ss_pred HHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccCC
Confidence 334566644321 359999999999999853 33 5789999887544
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.01 E-value=2.1e-05 Score=73.36 Aligned_cols=104 Identities=18% Similarity=0.171 Sum_probs=80.4
Q ss_pred HHHHHhhccCC-CceeeEeeEEeeCCceEEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 008785 314 SEIGRFARLHH-PNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPH 392 (553)
Q Consensus 314 ~E~~~l~~l~H-pnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ 392 (553)
+|.-+|..+++ +++++++|+|- .++|.||...+++...-... ..-...+|..+.+|+.++++.+.+|++...-.
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l-~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPL-SQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCcccccccccc-ccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 57888888875 69999999983 36799999877653210000 01123689999999999999999999854436
Q ss_pred ceecCCCCCcEEecCCCCeEEeeccccccC
Q 008785 393 VVHRDIRASNVLLDEEFGAHLMGVGLSKFV 422 (553)
Q Consensus 393 ivHrDlkp~NILl~~~~~~kl~Dfgla~~~ 422 (553)
+.-.|++|+|+-+++++++|++|.......
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 788999999999999999999999876543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.90 E-value=0.00024 Score=71.59 Aligned_cols=74 Identities=9% Similarity=0.042 Sum_probs=54.6
Q ss_pred eecccCceeEEEEEeCCCCEEEEEEeccCChhhHHHHHHHHHHhhccCC---CceeeEeeEEee---CCceEEEEEccCC
Q 008785 276 LLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHH---PNLVAVKGCCYD---HGDRYIVYEFVVN 349 (553)
Q Consensus 276 ~iG~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H---pnIv~l~~~~~~---~~~~~lV~E~~~~ 349 (553)
-||.|..+.||+-...++ .+.+|..+.. .....+.+|...|+.|.- -.+.++++++.. .+..+||||++++
T Consensus 21 ~i~~G~~~~vy~~~~~~~-~~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~G 97 (297)
T PRK10593 21 CISEQPYAALWALYDSQG-NPMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLRG 97 (297)
T ss_pred ecCCccceeEEEEEcCCC-CEEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccCC
Confidence 459999999999877555 4677775431 123578899999988842 367888887754 3668999999998
Q ss_pred CCH
Q 008785 350 GPL 352 (553)
Q Consensus 350 gsL 352 (553)
+++
T Consensus 98 ~~~ 100 (297)
T PRK10593 98 VSV 100 (297)
T ss_pred Eec
Confidence 754
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.81 E-value=0.00025 Score=64.16 Aligned_cols=127 Identities=17% Similarity=0.198 Sum_probs=86.2
Q ss_pred eeecccCceeEEEEEeCCCCEEEEEEeccCChhhHHHHHHHHHHhhccCCCcee-eEeeEEeeCCceEEEEEccCCCCHH
Q 008785 275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLV-AVKGCCYDHGDRYIVYEFVVNGPLD 353 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv-~l~~~~~~~~~~~lV~E~~~~gsL~ 353 (553)
+.|++|.+|.||.|.+ .|..+|+|+-+..+ .+..+..|+++|..+.-.++. +++.+. ..++.|||+.|-+|.
T Consensus 28 ~~L~KG~~s~Vyl~~~-~~~~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i~G~~L~ 100 (201)
T COG2112 28 KELAKGTTSVVYLGEW-RGGEVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYIDGRPLG 100 (201)
T ss_pred hhhhcccccEEEEeec-cCceEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhhcCcchh
Confidence 3469999999999999 56689999877653 456788999999998765553 444442 334669999988887
Q ss_pred HHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCC-CCcEEecCCCCeEEeeccccccC
Q 008785 354 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIR-ASNVLLDEEFGAHLMGVGLSKFV 422 (553)
Q Consensus 354 ~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlk-p~NILl~~~~~~kl~Dfgla~~~ 422 (553)
+.-.. .+...+. .+++.---|-.. ||-|+.|. |..++|..+..+.|+||.-|.+.
T Consensus 101 ~~~~~-------~~rk~l~----~vlE~a~~LD~~---GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k 156 (201)
T COG2112 101 KLEIG-------GDRKHLL----RVLEKAYKLDRL---GIEHGELSRPWKNVLVNDRDVYIIDFDSATFK 156 (201)
T ss_pred hhhhc-------ccHHHHH----HHHHHHHHHHHh---ccchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence 65432 1223333 344442233334 89999886 44445555558999999988743
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.69 E-value=0.00055 Score=71.18 Aligned_cols=74 Identities=15% Similarity=-0.006 Sum_probs=53.3
Q ss_pred eecccCceeEEEEEeCCC-CEEEEEEeccC-----C--hhhHHHHHHHHHHhhccC---CCceeeEeeEEeeCCceEEEE
Q 008785 276 LLGDSKTGGTYSGILPDG-SRVAVKRLKRS-----S--FQRKKEFYSEIGRFARLH---HPNLVAVKGCCYDHGDRYIVY 344 (553)
Q Consensus 276 ~iG~G~~g~Vy~~~~~~g-~~vAvK~~~~~-----~--~~~~~~~~~E~~~l~~l~---HpnIv~l~~~~~~~~~~~lV~ 344 (553)
-+|.|.+..||+....+| +.|+||.-... . ....++...|.+.|..+. ..++++++.+ +.+..++||
T Consensus 33 elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lVM 110 (401)
T PRK09550 33 EIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTVM 110 (401)
T ss_pred EcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEEE
Confidence 359999999999998877 48999985421 1 123456677888877762 3567788776 445578999
Q ss_pred EccCCCC
Q 008785 345 EFVVNGP 351 (553)
Q Consensus 345 E~~~~gs 351 (553)
||+++..
T Consensus 111 E~L~~~~ 117 (401)
T PRK09550 111 EDLSDHK 117 (401)
T ss_pred ecCCCcc
Confidence 9998643
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.67 E-value=0.00035 Score=67.83 Aligned_cols=70 Identities=14% Similarity=0.102 Sum_probs=42.5
Q ss_pred cccCce-eEEEEEeCCCCEEEEEEeccCChhhHHHHHHHHHHhhccCCC---ceeeEeeEEeeC---CceEEEEEccCCC
Q 008785 278 GDSKTG-GTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHP---NLVAVKGCCYDH---GDRYIVYEFVVNG 350 (553)
Q Consensus 278 G~G~~g-~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hp---nIv~l~~~~~~~---~~~~lV~E~~~~g 350 (553)
+.|+.. .||+. +..+++|..+.. .....+.+|.+++..+... .+.++++..... +..+++|++++|.
T Consensus 6 ~~gG~~n~vy~~----~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i~G~ 79 (235)
T cd05155 6 DSGGTDNATFRL----GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWLEGE 79 (235)
T ss_pred cCCCcccceEEc----CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEeecCC
Confidence 655555 58874 235777875542 2345788899888877421 234444433322 2358899999987
Q ss_pred CHH
Q 008785 351 PLD 353 (553)
Q Consensus 351 sL~ 353 (553)
++.
T Consensus 80 ~l~ 82 (235)
T cd05155 80 TAT 82 (235)
T ss_pred CCC
Confidence 663
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.63 E-value=0.00078 Score=62.90 Aligned_cols=118 Identities=27% Similarity=0.404 Sum_probs=83.3
Q ss_pred eecccCc-eeEEEEEeCCCCEEEEEEeccC---C-------h-----------hhHHHHHHHHHHhhccC---CCce--e
Q 008785 276 LLGDSKT-GGTYSGILPDGSRVAVKRLKRS---S-------F-----------QRKKEFYSEIGRFARLH---HPNL--V 328 (553)
Q Consensus 276 ~iG~G~~-g~Vy~~~~~~g~~vAvK~~~~~---~-------~-----------~~~~~~~~E~~~l~~l~---HpnI--v 328 (553)
.||.|.- |.||+..+ +|+.+|+|+++.- . . .....|..|.+...+|+ +.++ |
T Consensus 44 fLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~e~~~Av 122 (207)
T PF13095_consen 44 FLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGREGLWAV 122 (207)
T ss_pred ecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccccCceEE
Confidence 4599999 99999999 7889999994320 0 0 11235778888888773 5566 8
Q ss_pred eEeeEEeeCC------------------ceEEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 008785 329 AVKGCCYDHG------------------DRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVK 390 (553)
Q Consensus 329 ~l~~~~~~~~------------------~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~ 390 (553)
+.+|+..-.. ...||.||++... .+.. .-+.+|.+-|..+|..
T Consensus 123 kc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------~~~~----~~~~~~~~dl~~~~k~-- 183 (207)
T PF13095_consen 123 KCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------PLQI----RDIPQMLRDLKILHKL-- 183 (207)
T ss_pred EeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------ccch----hHHHHHHHHHHHHHHC--
Confidence 9999874221 1256777765432 1222 2345677778889999
Q ss_pred CCceecCCCCCcEEecCCCCeEEeecccc
Q 008785 391 PHVVHRDIRASNVLLDEEFGAHLMGVGLS 419 (553)
Q Consensus 391 ~~ivHrDlkp~NILl~~~~~~kl~Dfgla 419 (553)
||+-+|+++.|.. .-||+|||.+
T Consensus 184 -gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 184 -GIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred -CeeeccCcccccc-----CCEEEecccC
Confidence 9999999999986 3589999854
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.61 E-value=0.00023 Score=80.61 Aligned_cols=196 Identities=19% Similarity=0.107 Sum_probs=133.5
Q ss_pred HHHHHHHhhccCCCceeeEeeEEeeCCce----EEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 008785 312 FYSEIGRFARLHHPNLVAVKGCCYDHGDR----YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD 387 (553)
Q Consensus 312 ~~~E~~~l~~l~HpnIv~l~~~~~~~~~~----~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~ 387 (553)
..-|+..+.++.|+|+++++++-...... .+..|++..-++...+++ -..++....+.+..++..||.|+|+
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~----v~~i~~~~~r~~~~~~~~GL~~~h~ 304 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQS----VGSIPLETLRILHQKLLEGLAYLHS 304 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhh----ccccCHHHHHHHHHHHhhhHHHHHH
Confidence 34567778888999999999987754332 355678888888887764 2457888888999999999999999
Q ss_pred CCCCCceecCCCCC---cEEecCCCCeEEe--eccccccCCcccccceeeecCccccccccccccCCCCCcc--cchHhH
Q 008785 388 KVKPHVVHRDIRAS---NVLLDEEFGAHLM--GVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTK--SDVYSF 460 (553)
Q Consensus 388 ~~~~~ivHrDlkp~---NILl~~~~~~kl~--Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k--sDVwSl 460 (553)
. ...|.-+..+ +--.+..+...++ ||+.++............ -+..+.+||......++.+ .|+|.+
T Consensus 305 ~---~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~---~~~~~~~~e~~~~~~~~~~r~~dL~~l 378 (1351)
T KOG1035|consen 305 L---SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDL---LAEIRNADEDLKENTAKKSRLTDLWCL 378 (1351)
T ss_pred h---ccceeEEecccccccccCccceeecchhhhcccccCCCcccchhhc---CccccccccccccccchhhhhhHHHHH
Confidence 8 6666555554 4444555666666 888776655433222111 3456778888776665544 799999
Q ss_pred HHHHHHHhcCccccc--chHHHHHhcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 008785 461 GVLLLEIRLVLCRRW--WTLYTLVHSMSLLCAQECLMLFISCNNWPSHLSQSKFCNLKLWVF 520 (553)
Q Consensus 461 Gvil~ell~~~~~~~--~~l~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~ 520 (553)
|.....+....+... ......+.. .......+....|+..++++|+++.+++.+...
T Consensus 379 gll~~~~~~~~~i~~~~~~~~~~l~~---~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~ 437 (1351)
T KOG1035|consen 379 GLLLLQLSQGEDISEKSAVPVSLLDV---LSTSELLDALPKCLDEDSEERLSALELLTHPFL 437 (1351)
T ss_pred HHHHhhhhhcCcccccccchhhhhcc---ccchhhhhhhhhhcchhhhhccchhhhhhchhc
Confidence 999998875222211 111112211 111156778889999999999999999987644
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.60 E-value=0.00057 Score=68.71 Aligned_cols=142 Identities=18% Similarity=0.191 Sum_probs=83.3
Q ss_pred eecccCceeEEEEEeCCCCEEEEEEeccCChhhHHHHHHHHHHhhccCCC--ceeeEeeE------EeeCCceEEEEEcc
Q 008785 276 LLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHP--NLVAVKGC------CYDHGDRYIVYEFV 347 (553)
Q Consensus 276 ~iG~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hp--nIv~l~~~------~~~~~~~~lV~E~~ 347 (553)
.+..|....+|+... ++..+++|+.... .......|++++..+.+. .+.+++.. ....+..++|++|+
T Consensus 21 ~i~~G~~n~~y~v~~-~~~~~vLr~~~~~---~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i 96 (296)
T cd05153 21 GISAGIENTNYFVTT-DSGRYVLTLFEKV---SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEFL 96 (296)
T ss_pred cccCccccceEEEEe-CCCcEEEEEcCCC---ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEeC
Confidence 357777789999876 4457888987652 334566777777777432 24444431 12345568999999
Q ss_pred CCCCHHH-----------Hh---cc----CCCC---CCCCCHHHHH----------HHHHHHHHHHHHHHh----CCCCC
Q 008785 348 VNGPLDR-----------WL---HH----IPRG---GRSLDWAMRM----------KVATTLAQGIAFLHD----KVKPH 392 (553)
Q Consensus 348 ~~gsL~~-----------~l---~~----~~~~---~~~l~~~~~~----------~i~~qia~gL~yLH~----~~~~~ 392 (553)
+|.++.. .| +. .... .....|.... .....+..++.++.. ....+
T Consensus 97 ~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~ 176 (296)
T cd05153 97 AGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPRG 176 (296)
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCCc
Confidence 8866422 01 10 0000 0111111110 011123334445443 12347
Q ss_pred ceecCCCCCcEEecCCCCeEEeecccccc
Q 008785 393 VVHRDIRASNVLLDEEFGAHLMGVGLSKF 421 (553)
Q Consensus 393 ivHrDlkp~NILl~~~~~~kl~Dfgla~~ 421 (553)
++|+|+.|.||+++++..+.|+||+.+..
T Consensus 177 l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 177 VIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 99999999999999987778999988754
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.59 E-value=0.00065 Score=65.81 Aligned_cols=72 Identities=14% Similarity=0.040 Sum_probs=47.2
Q ss_pred eecccCceeEEEEEeCC--CCEEEEEEeccCChhhHHHHHHHHHHhhccC-CCceeeEeeEEeeCCceEEEEEccCCCCH
Q 008785 276 LLGDSKTGGTYSGILPD--GSRVAVKRLKRSSFQRKKEFYSEIGRFARLH-HPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352 (553)
Q Consensus 276 ~iG~G~~g~Vy~~~~~~--g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lV~E~~~~gsL 352 (553)
.+..|-...+|+....+ +..|++|+....... ..+..+|+.+++.+. +.-.+++++... ..++|||++|.++
T Consensus 5 ~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~l 79 (235)
T cd05157 5 RFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRTL 79 (235)
T ss_pred EcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCcC
Confidence 34788888999988764 678999987643221 123346888888874 333445554332 2489999988765
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.54 E-value=0.00092 Score=67.71 Aligned_cols=160 Identities=15% Similarity=0.195 Sum_probs=88.8
Q ss_pred CHHHHHHhhcccCCC----CeeecccCceeEEEEEeCCCCEEEEEEeccCChhhHHHHHHHHHHhhccCC--CceeeEee
Q 008785 259 TTEELRSITKNFSEG----NRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHH--PNLVAVKG 332 (553)
Q Consensus 259 ~~~el~~~~~~~~~~----~~~iG~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H--pnIv~l~~ 332 (553)
+.+++..+...|... -+.++.|....+|+....+| .+++|+..... ..+....|++++..|.. -.+++++.
T Consensus 8 ~~~~l~~~l~~y~~~~~~~i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~ 84 (307)
T TIGR00938 8 SDEEMSSFLDGYDLGELLSLKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVK 84 (307)
T ss_pred CHHHHHHHHHhcCCCCceeccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCcccc
Confidence 445666665555432 23457777789998876444 67789875532 13344556666666632 12344433
Q ss_pred E------EeeCCceEEEEEccCCCCHH-----------HH---hccCCC----CC----CCCCHHHHH------------
Q 008785 333 C------CYDHGDRYIVYEFVVNGPLD-----------RW---LHHIPR----GG----RSLDWAMRM------------ 372 (553)
Q Consensus 333 ~------~~~~~~~~lV~E~~~~gsL~-----------~~---l~~~~~----~~----~~l~~~~~~------------ 372 (553)
. ....+..++++||++|.++. .. ++.... .. ..-.|....
T Consensus 85 t~~g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~ 164 (307)
T TIGR00938 85 SRDGRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEA 164 (307)
T ss_pred CCCCCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCH
Confidence 1 11235678999999885431 11 111000 00 001111100
Q ss_pred HHHHHHHHHHHHHHh----CCCCCceecCCCCCcEEecCCCCeEEeecccccc
Q 008785 373 KVATTLAQGIAFLHD----KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF 421 (553)
Q Consensus 373 ~i~~qia~gL~yLH~----~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~ 421 (553)
.....+...++++.. ....+++|+|+.+.||++++++...|+||+.+..
T Consensus 165 ~~~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 165 HMGAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred HHHHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 011223344555542 2245899999999999999887678999998753
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 553 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-35 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 3e-34 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-29 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-29 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-29 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 4e-29 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 4e-29 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-26 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-22 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-22 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 5e-18 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-16 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-16 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-16 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-16 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-16 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-16 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-16 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-16 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-16 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-16 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-16 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-16 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-16 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-16 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-16 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-16 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 3e-16 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 3e-16 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 3e-16 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-16 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 3e-16 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 4e-16 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-15 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-15 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-15 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 4e-15 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 5e-15 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 5e-15 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 5e-15 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 6e-15 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 6e-15 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 7e-15 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 7e-15 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 7e-15 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 7e-15 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 8e-15 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 8e-15 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 8e-15 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 8e-15 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 9e-15 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-14 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-14 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-14 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-14 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-14 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-14 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-14 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-14 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-14 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-14 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-14 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-14 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-14 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-14 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-14 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-14 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 3e-14 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 5e-14 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 7e-14 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 9e-14 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-13 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-13 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-13 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-13 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-13 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-13 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 3e-13 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 3e-13 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 4e-13 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 5e-13 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-13 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 6e-13 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 6e-13 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 7e-13 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 7e-13 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 8e-13 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-12 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-12 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-12 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-12 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-12 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-12 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-12 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-12 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-12 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-12 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-12 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-12 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-12 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-12 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-12 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-12 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-12 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-12 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-12 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 3e-12 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-12 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 4e-12 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 4e-12 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 5e-12 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 5e-12 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 5e-12 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 5e-12 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 5e-12 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 6e-12 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 6e-12 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 6e-12 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-12 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 6e-12 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 7e-12 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 7e-12 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 7e-12 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 7e-12 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 7e-12 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 7e-12 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 9e-12 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-12 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-11 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-11 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-11 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-11 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-11 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-11 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-11 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-11 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-11 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-11 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-11 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-11 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-11 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-11 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-11 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-11 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-11 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-11 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-11 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 3e-11 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-11 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-11 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 4e-11 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 4e-11 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-11 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 4e-11 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 4e-11 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 4e-11 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 4e-11 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 4e-11 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 4e-11 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 5e-11 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-11 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-11 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-11 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 5e-11 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 6e-11 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 7e-11 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 7e-11 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 8e-11 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 9e-11 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-10 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-10 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-10 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-10 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-10 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-10 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-10 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-10 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-10 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-10 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-10 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-10 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-10 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-10 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-10 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-10 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-10 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-10 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-10 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-10 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-10 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-10 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 3e-10 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-10 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-10 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-10 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 3e-10 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 3e-10 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-10 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-10 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-10 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-10 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 4e-10 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 4e-10 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 4e-10 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 4e-10 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-10 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 4e-10 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-10 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 5e-10 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-10 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-10 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 5e-10 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 5e-10 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 5e-10 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 5e-10 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-10 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 6e-10 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-10 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 6e-10 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 6e-10 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 6e-10 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 7e-10 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-10 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 7e-10 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 7e-10 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 7e-10 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 7e-10 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 8e-10 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 9e-10 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 9e-10 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 9e-10 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 9e-10 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-09 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-09 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-09 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-09 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-09 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-09 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-09 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-09 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-09 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-09 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-09 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-09 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-09 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-09 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-09 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-09 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-09 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-09 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-09 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-09 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-09 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-09 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-09 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-09 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-09 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-09 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-09 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 3e-09 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 3e-09 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-09 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-09 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-09 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-09 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-09 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-09 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 4e-09 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 4e-09 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 4e-09 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 4e-09 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 4e-09 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 5e-09 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 5e-09 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-09 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 5e-09 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 5e-09 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 5e-09 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-09 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-09 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 6e-09 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 6e-09 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 6e-09 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 6e-09 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 6e-09 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-09 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 6e-09 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 6e-09 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 6e-09 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-09 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 7e-09 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 7e-09 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 7e-09 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 7e-09 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 7e-09 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 7e-09 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-09 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 7e-09 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 7e-09 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 7e-09 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 7e-09 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 8e-09 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 8e-09 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 8e-09 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 8e-09 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 8e-09 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 9e-09 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 9e-09 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-08 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-08 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-08 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-08 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-08 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-08 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-08 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-08 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-08 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-08 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-08 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-08 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-08 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-08 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-08 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-08 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-08 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-08 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-08 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-08 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-08 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-08 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-08 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-08 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-08 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-08 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-08 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-08 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-08 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-08 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-08 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-08 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-08 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-08 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-08 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-08 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-08 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-08 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-08 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-08 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-08 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-08 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-08 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-08 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-08 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-08 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-08 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-08 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-08 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-08 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-08 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-08 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 3e-08 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-08 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 3e-08 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-08 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 3e-08 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 3e-08 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 3e-08 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 3e-08 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 3e-08 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-08 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 4e-08 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 4e-08 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 4e-08 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 4e-08 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 5e-08 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 5e-08 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 6e-08 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-08 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 6e-08 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 6e-08 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 6e-08 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-08 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 6e-08 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 6e-08 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 7e-08 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 7e-08 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-08 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 7e-08 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-08 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 7e-08 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-08 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 7e-08 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 7e-08 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 7e-08 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 8e-08 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 8e-08 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-08 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 8e-08 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 8e-08 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 8e-08 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 8e-08 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 8e-08 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 8e-08 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 8e-08 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 8e-08 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 9e-08 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 9e-08 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 9e-08 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-07 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-07 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-07 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-07 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-07 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-07 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-07 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-07 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-07 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-07 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-07 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-07 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-07 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-07 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-07 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-07 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-07 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-07 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-07 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-07 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-07 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-07 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-07 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-07 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-07 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-07 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-07 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-07 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-07 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-07 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-07 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-07 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-07 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-07 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 3e-07 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-07 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 4e-07 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 4e-07 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 4e-07 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 4e-07 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-07 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-07 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 4e-07 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-07 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 4e-07 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 4e-07 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 4e-07 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 4e-07 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 4e-07 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 5e-07 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 5e-07 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 5e-07 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-07 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-07 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 5e-07 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 5e-07 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 5e-07 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 6e-07 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 6e-07 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 6e-07 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 6e-07 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 6e-07 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-07 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 6e-07 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-07 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-07 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 7e-07 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 7e-07 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 8e-07 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 8e-07 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 8e-07 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-07 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-06 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 1e-06 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-06 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-06 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-06 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-06 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-06 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-06 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-06 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-06 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-06 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-06 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-06 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-06 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-06 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-06 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-06 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-06 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-06 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-06 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-06 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 3e-06 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 3e-06 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 3e-06 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 3e-06 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-06 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-06 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-06 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-06 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 3e-06 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-06 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 4e-06 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 4e-06 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 4e-06 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 4e-06 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 4e-06 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 4e-06 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 5e-06 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 5e-06 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 5e-06 | ||
| 1jwi_A | 131 | Crystal Structure Of Bitiscetin, A Von Willeband Fa | 5e-06 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-06 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 5e-06 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-06 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 5e-06 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 5e-06 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 6e-06 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 6e-06 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 6e-06 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 6e-06 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-06 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-06 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 6e-06 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 6e-06 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 6e-06 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 6e-06 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 6e-06 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 6e-06 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 6e-06 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 6e-06 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 7e-06 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-06 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 7e-06 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 7e-06 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 7e-06 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 8e-06 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-06 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 8e-06 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 8e-06 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 8e-06 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 8e-06 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 8e-06 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 8e-06 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 8e-06 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 8e-06 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 8e-06 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 8e-06 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 9e-06 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 9e-06 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-06 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 9e-06 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 9e-06 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 9e-06 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 9e-06 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 9e-06 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 9e-06 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-05 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-05 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-05 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-05 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-05 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-05 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-05 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-05 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-05 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-05 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-05 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-05 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-05 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-05 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-05 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-05 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-05 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-05 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-05 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-05 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-05 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-05 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-05 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-05 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-05 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-05 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-05 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-05 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-05 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-05 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-05 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-05 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-05 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-05 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-05 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-05 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-05 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-05 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-05 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-05 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-05 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-05 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-05 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-05 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-05 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-05 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-05 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-05 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-05 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-05 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-05 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-05 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-05 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-05 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-05 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-05 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-05 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-05 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-05 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-05 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-05 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-05 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-05 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-05 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-05 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-05 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-05 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-05 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-05 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-05 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-05 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-05 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-05 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-05 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-05 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-05 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-05 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-05 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-05 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-05 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-05 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-05 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-05 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-05 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-05 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 3e-05 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-05 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-05 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-05 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 4e-05 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 4e-05 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 4e-05 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 4e-05 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 4e-05 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 4e-05 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 4e-05 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 4e-05 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 4e-05 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 4e-05 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 4e-05 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 4e-05 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-05 | ||
| 2afp_A | 129 | The Solution Structure Of Type Ii Antifreeze Protei | 4e-05 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-05 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 4e-05 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 4e-05 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 5e-05 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 5e-05 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-05 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-05 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 5e-05 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 5e-05 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 5e-05 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 5e-05 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 5e-05 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 5e-05 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 5e-05 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-05 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 5e-05 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 5e-05 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-05 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 6e-05 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 6e-05 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 6e-05 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 6e-05 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 6e-05 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 6e-05 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 6e-05 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 6e-05 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 6e-05 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 6e-05 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 6e-05 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-05 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 8e-05 | ||
| 2zib_A | 133 | Crystal Structure Analysis Of Calcium-Independent T | 8e-05 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-04 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-04 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-04 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-04 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-04 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-04 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-04 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-04 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-04 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-04 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-04 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-04 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-04 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-04 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-04 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-04 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-04 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-04 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-04 | ||
| 1fvu_B | 125 | Crystal Structure Of Botrocetin Length = 125 | 2e-04 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-04 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-04 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-04 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-04 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-04 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-04 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-04 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-04 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-04 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-04 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-04 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-04 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-04 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-04 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-04 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-04 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 3e-04 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-04 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 3e-04 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-04 | ||
| 1dv8_A | 128 | Crystal Structure Of The Carbohydrate Recognition D | 3e-04 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 3e-04 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-04 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-04 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-04 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 3e-04 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 4e-04 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 4e-04 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 4e-04 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-04 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-04 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 4e-04 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 4e-04 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 4e-04 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 4e-04 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 4e-04 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 4e-04 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 5e-04 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 5e-04 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 5e-04 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 5e-04 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 5e-04 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 5e-04 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 5e-04 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 5e-04 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 6e-04 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 6e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1JWI|A Chain A, Crystal Structure Of Bitiscetin, A Von Willeband Factor- Dependent Platelet Aggregation Inducer. Length = 131 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2AFP|A Chain A, The Solution Structure Of Type Ii Antifreeze Protein Reveals A New Member Of The Lectin Family Length = 129 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2ZIB|A Chain A, Crystal Structure Analysis Of Calcium-Independent Type Ii Antifreeze Protein Length = 133 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1FVU|B Chain B, Crystal Structure Of Botrocetin Length = 125 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|1DV8|A Chain A, Crystal Structure Of The Carbohydrate Recognition Domain Of The H1 Subunit Of The Asialoglycoprotein Receptor Length = 128 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 262 bits (671), Expect = 2e-83
Identities = 81/216 (37%), Positives = 126/216 (58%), Gaps = 5/216 (2%)
Query: 254 SWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQ-RKKEF 312
K F+ EL+ + NFS N +LG G Y G L DG+ VAVKRLK Q + +F
Sbjct: 16 QLKRFSLRELQVASDNFSNKN-ILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQF 74
Query: 313 YSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRM 372
+E+ + H NL+ ++G C +R +VY ++ NG + L P LDW R
Sbjct: 75 QTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQ 134
Query: 373 KVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT- 431
++A A+G+A+LHD P ++HRD++A+N+LLDEEF A + GL+K + ++ T
Sbjct: 135 RIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA 194
Query: 432 VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEI 467
V GT G++APE++ + + K+DV+ +GV+LLE+
Sbjct: 195 VR--GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLEL 228
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 251 bits (644), Expect = 1e-79
Identities = 78/241 (32%), Positives = 128/241 (53%), Gaps = 15/241 (6%)
Query: 233 SKRRRKSRKLSNPAASALVPPSW-KVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILP 291
SK + + +++ +S+ + P +L T NF L+G G Y G+L
Sbjct: 3 SKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKF-LIGHGVFGKVYKGVLR 61
Query: 292 DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP 351
DG++VA+KR S Q +EF +EI + HP+LV++ G C + + ++Y+++ NG
Sbjct: 62 DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGN 121
Query: 352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGA 411
L R L+ S+ W R+++ A+G+ +LH ++HRD+++ N+LLDE F
Sbjct: 122 LKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVP 178
Query: 412 HLMGVGLSKFVPWEVMQERT-----VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLE 466
+ G+SK ++T V GT GY+ PE+ + LT KSDVYSFGV+L E
Sbjct: 179 KITDFGISKKGTEL---DQTHLSTVVK--GTLGYIDPEYFIKGRLTEKSDVYSFGVVLFE 233
Query: 467 I 467
+
Sbjct: 234 V 234
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 237 bits (608), Expect = 2e-74
Identities = 85/223 (38%), Positives = 122/223 (54%), Gaps = 19/223 (8%)
Query: 256 KVFTTEELRSITKNFSEGNRLLGDSKTG----GT-YSGILPDGSRVAVKRLK----RSSF 306
F+ EL+++T NF E +G +K G G Y G + + + VAVK+L ++
Sbjct: 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTE 71
Query: 307 QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSL 366
+ K++F EI A+ H NLV + G D D +VY ++ NG L L G L
Sbjct: 72 ELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSC-LDGTPPL 130
Query: 367 DWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV 426
W MR K+A A GI FLH+ H +HRDI+++N+LLDE F A + GL++
Sbjct: 131 SWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARASEKFA 187
Query: 427 MQERT--VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEI 467
T ++ GT Y+APE + R E+T KSD+YSFGV+LLEI
Sbjct: 188 QTVMTSRIV--GTTAYMAPEAL-RGEITPKSDIYSFGVVLLEI 227
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 2e-45
Identities = 55/229 (24%), Positives = 89/229 (38%), Gaps = 30/229 (13%)
Query: 258 FTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLK---RSSFQRKKEFYS 314
TE L + + G + VAVK + S+Q + E YS
Sbjct: 14 LGTENLYFQSMPLQLLEVK-ARGRFGCVWKAQ-LLNEYVAVKIFPIQDKQSWQNEYEVYS 71
Query: 315 EIGRFARLHHPNLVAVKGCC----YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAM 370
+ H N++ G D +++ F G L +L + W
Sbjct: 72 ----LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA-----NVVSWNE 122
Query: 371 RMKVATTLAQGIAFLH-------DKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVP 423
+A T+A+G+A+LH D KP + HRDI++ NVLL A + GL+
Sbjct: 123 LCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFE 182
Query: 424 WEVMQERTVMAGGTYGYLAPE-----FVYRNELTTKSDVYSFGVLLLEI 467
T GT Y+APE ++ + + D+Y+ G++L E+
Sbjct: 183 AGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWEL 231
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 1e-43
Identities = 58/199 (29%), Positives = 97/199 (48%), Gaps = 26/199 (13%)
Query: 283 GGTYSGILPDGSRVAVKRLKRSSFQ----RKKEFYSEIGRFARLHHPNLVAVKGCCYDHG 338
G Y G VAVK + + + E FA L HPN++A++G C
Sbjct: 21 GKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEP 79
Query: 339 DRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDI 398
+ +V EF GPL+R L G+ + + + A +A+G+ +LHD+ ++HRD+
Sbjct: 80 NLCLVMEFARGGPLNRVLS-----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDL 134
Query: 399 RASNVLLDEEFGAHLMGV--------GLSKFVPWEVMQERTVMAG-GTYGYLAPEFVYRN 449
++SN+L+ ++ + GL++ T M+ G Y ++APE V R
Sbjct: 135 KSSNILILQKVENGDLSNKILKITDFGLAR-----EWHRTTKMSAAGAYAWMAPE-VIRA 188
Query: 450 EL-TTKSDVYSFGVLLLEI 467
+ + SDV+S+GVLL E+
Sbjct: 189 SMFSKGSDVWSYGVLLWEL 207
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 1e-42
Identities = 64/179 (35%), Positives = 98/179 (54%), Gaps = 10/179 (5%)
Query: 293 GSRVAVKRLKRSSF--QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 350
GS VAVK L F +R EF E+ RL HPN+V G + IV E++ G
Sbjct: 60 GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRG 119
Query: 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG 410
L R LH LD R+ +A +A+G+ +LH++ P +VHR++++ N+L+D+++
Sbjct: 120 SLYRLLHK-SGAREQLDERRRLSMAYDVAKGMNYLHNR-NPPIVHRNLKSPNLLVDKKYT 177
Query: 411 AHLMGVGLSKFVPWEVMQERTVMAG-GTYGYLAPEFVYRNEL-TTKSDVYSFGVLLLEI 467
+ GLS+ + + + GT ++APE V R+E KSDVYSFGV+L E+
Sbjct: 178 VKVCDFGLSRL---KASTFLSSKSAAGTPEWMAPE-VLRDEPSNEKSDVYSFGVILWEL 232
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 151 bits (385), Expect = 2e-42
Identities = 47/199 (23%), Positives = 88/199 (44%), Gaps = 20/199 (10%)
Query: 277 LGDSKTGGTYSGILPDGSRVAVKRLKRSSF--QRKKEFYSEIGRFARLHHPNLVAVKGCC 334
L ++ +G + G G+ + VK LK + ++ ++F E R HPN++ V G C
Sbjct: 18 LNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGAC 76
Query: 335 YD--HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPH 392
++ ++ G L LH +D + +K A +A+G+AFLH +P
Sbjct: 77 QSPPAPHPTLITHWMPYGSLYNVLHE--GTNFVVDQSQAVKFALDMARGMAFLHTL-EPL 133
Query: 393 VVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNE-- 450
+ + + +V++DE+ A + + Q M ++APE + +
Sbjct: 134 IPRHALNSRSVMIDEDMTARISMADVKFS-----FQSPGRM--YAPAWVAPE-ALQKKPE 185
Query: 451 --LTTKSDVYSFGVLLLEI 467
+D++SF VLL E+
Sbjct: 186 DTNRRSADMWSFAVLLWEL 204
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 1e-40
Identities = 52/198 (26%), Positives = 91/198 (45%), Gaps = 28/198 (14%)
Query: 286 YSGI-LPDGSRVAVKRLKRSSFQ-------RKKEFYSEIGRFARLHHPNLVAVKGCCYDH 337
+ G + D S VA+K L + + +EF E+ + L+HPN+V + G ++
Sbjct: 36 HKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHN- 94
Query: 338 GDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRD 397
+V EFV G L L + W++++++ +A GI ++ ++ P +VHRD
Sbjct: 95 -PPRMVMEFVPCGDLYHRLL---DKAHPIKWSVKLRLMLDIALGIEYMQNQ-NPPIVHRD 149
Query: 398 IRASNVLLDEEFGAHLMGV-----GLSKFVPWEVMQERTVMAG-GTYGYLAPE-FVYRNE 450
+R+ N+ L + GLS+ +V G + ++APE E
Sbjct: 150 LRSPNIFLQSLDENAPVCAKVADFGLSQ------QSVHSVSGLLGNFQWMAPETIGAEEE 203
Query: 451 L-TTKSDVYSFGVLLLEI 467
T K+D YSF ++L I
Sbjct: 204 SYTEKADTYSFAMILYTI 221
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 4e-40
Identities = 48/191 (25%), Positives = 83/191 (43%), Gaps = 28/191 (14%)
Query: 286 YSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYE 345
VA+K+++ S +K F E+ + +R++HPN+V + G C + +V E
Sbjct: 25 CKAKW-RAKDVAIKQIESESE--RKAFIVELRQLSRVNHPNIVKLYGACLNP--VCLVME 79
Query: 346 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL 405
+ G L LH A M +QG+A+LH ++HRD++ N+LL
Sbjct: 80 YAEGGSLYNVLHG-AEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLL 138
Query: 406 DEE--------FGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNEL-TTKSD 456
F G + +Q G+ ++APE V+ + K D
Sbjct: 139 VAGGTVLKICDF-------GTACD-----IQTHMTNNKGSAAWMAPE-VFEGSNYSEKCD 185
Query: 457 VYSFGVLLLEI 467
V+S+G++L E+
Sbjct: 186 VFSWGIILWEV 196
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 3e-37
Identities = 47/198 (23%), Positives = 88/198 (44%), Gaps = 23/198 (11%)
Query: 284 GTYSGILPDGSRVAVKRLKRSSF--QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRY 341
G + G VAVK L ++ Q+ + F +E+G + H N++ G
Sbjct: 43 GKWHG------DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAP-QLA 95
Query: 342 IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRAS 401
IV ++ L LH + + +A A+G+ +LH K ++HRD++++
Sbjct: 96 IVTQWCEGSSLYHHLH---ASETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSN 149
Query: 402 NVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNEL----TTKSDV 457
N+ L E+ + GL+ + G+ ++APE V R + + +SDV
Sbjct: 150 NIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPE-VIRMQDSNPYSFQSDV 208
Query: 458 YSFGVLLLEIRLVLCRRW 475
Y+FG++L E+ + +
Sbjct: 209 YAFGIVLYEL---MTGQL 223
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 1e-36
Identities = 42/213 (19%), Positives = 75/213 (35%), Gaps = 44/213 (20%)
Query: 284 GTYSGILPDGSRVAVKRLKRSSF--QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRY 341
G + G VA++ + + K F E+ + + H N+V G C
Sbjct: 52 GRWHG------EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLA 105
Query: 342 IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRAS 401
I+ L + LD ++A + +G+ +LH K ++H+D+++
Sbjct: 106 IITSLCKGRTLYSVVR---DAKIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSK 159
Query: 402 NVLLDEE------FGAHLMGVGLSKFV-PWEVMQERTVMAG--GTYGYLAPEFVYRNEL- 451
NV D F GL + + + G +LAPE + R
Sbjct: 160 NVFYDNGKVVITDF-------GLFSISGVLQAGRREDKLRIQNGWLCHLAPE-IIRQLSP 211
Query: 452 ---------TTKSDVYSFGVLLLEIRLVLCRRW 475
+ SDV++ G + E+ R W
Sbjct: 212 DTEEDKLPFSKHSDVFALGTIWYEL---HAREW 241
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-35
Identities = 47/196 (23%), Positives = 83/196 (42%), Gaps = 21/196 (10%)
Query: 284 GTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIV 343
T+ G + +K L R + ++ F E+ L HPN++ G Y +
Sbjct: 29 VTHRE---TGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFI 85
Query: 344 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNV 403
E++ G L + W+ R+ A +A G+A+LH +++HRD+ + N
Sbjct: 86 TEYIKGGTLRGIIK---SMDSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNC 139
Query: 404 LLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG------------GTYGYLAPEFVYRNEL 451
L+ E + GL++ + E Q + + G ++APE +
Sbjct: 140 LVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSY 199
Query: 452 TTKSDVYSFGVLLLEI 467
K DV+SFG++L EI
Sbjct: 200 DEKVDVFSFGIVLCEI 215
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-32
Identities = 45/202 (22%), Positives = 84/202 (41%), Gaps = 30/202 (14%)
Query: 286 YSGILPDGSRVAVKRLK---RSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR-- 340
+ G G +VAVK +S+ R+ E Y + H N++
Sbjct: 54 WMGKW-RGEKVAVKVFFTTEEASWFRETEIYQ----TVLMRHENILGFIAADIKGTGSWT 108
Query: 341 --YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV-----KPHV 393
Y++ ++ NG L +L +LD +K+A + G+ LH ++ KP +
Sbjct: 109 QLYLITDYHENGSLYDYLKS-----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAI 163
Query: 394 VHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPE------F 445
HRD+++ N+L+ + + +GL+ + + GT Y+ PE
Sbjct: 164 AHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLN 223
Query: 446 VYRNELTTKSDVYSFGVLLLEI 467
+ +D+YSFG++L E+
Sbjct: 224 RNHFQSYIMADMYSFGLILWEV 245
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-32
Identities = 45/203 (22%), Positives = 84/203 (41%), Gaps = 32/203 (15%)
Query: 286 YSGILPDGSRVAVKRLK---RSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR-- 340
+ G G VAVK S+ R+ E Y L H N++
Sbjct: 59 WRGKW-RGEEVAVKIFSSREERSWFREAEIYQT----VMLRHENILGFIAADNKDNGTWT 113
Query: 341 --YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV-----KPHV 393
++V ++ +G L +L+ ++ +K+A + A G+A LH ++ KP +
Sbjct: 114 QLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAI 168
Query: 394 VHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYRNEL 451
HRD+++ N+L+ + + +GL+ GT Y+APE V + +
Sbjct: 169 AHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE-VLDDSI 227
Query: 452 -------TTKSDVYSFGVLLLEI 467
++D+Y+ G++ EI
Sbjct: 228 NMKHFESFKRADIYAMGLVFWEI 250
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 6e-32
Identities = 48/225 (21%), Positives = 95/225 (42%), Gaps = 33/225 (14%)
Query: 264 RSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLK---RSSFQRKKEFYSEIGRFA 320
R++ ++ + + G + G + G G VAVK S+ R+ E Y+
Sbjct: 4 RTVARDITLLECV-GKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRETELYNT----V 57
Query: 321 RLHHPNLV----AVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVAT 376
L H N++ + + +++ + G L +L +LD +++
Sbjct: 58 MLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQL-----TTLDTVSCLRIVL 112
Query: 377 TLAQGIAFLH-----DKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT 431
++A G+A LH + KP + HRD+++ N+L+ + + +GL+ Q
Sbjct: 113 SIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDV 172
Query: 432 VMAG--GTYGYLAPEFVYRNEL-------TTKSDVYSFGVLLLEI 467
GT Y+APE V + + D+++FG++L E+
Sbjct: 173 GNNPRVGTKRYMAPE-VLDETIQVDCFDSYKRVDIWAFGLVLWEV 216
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 55/237 (23%), Positives = 88/237 (37%), Gaps = 38/237 (16%)
Query: 258 FTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLK---RSSFQRKKEFYS 314
E N + G + G Y G L D VAVK R +F +K Y
Sbjct: 3 AAASEPSLDLDNLKLLELI-GRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEKNIY- 59
Query: 315 EIGRFARLHHPNLVAVKGCCY-----DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWA 369
R + H N+ + +V E+ NG L ++L + DW
Sbjct: 60 ---RVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL-----HTSDWV 111
Query: 370 MRMKVATTLAQGIAFLH------DKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVP 423
++A ++ +G+A+LH D KP + HRD+ + NVL+ + + GLS +
Sbjct: 112 SSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLT 171
Query: 424 WEVMQERTVMAG------GTYGYLAPE-------FVYRNELTTKSDVYSFGVLLLEI 467
+ GT Y+APE + D+Y+ G++ EI
Sbjct: 172 GNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEI 228
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 3e-28
Identities = 53/196 (27%), Positives = 96/196 (48%), Gaps = 26/196 (13%)
Query: 284 GTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR-- 340
Y + + G VAVK+L+ S+ + ++F EI L H N+V KG CY G R
Sbjct: 29 CRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88
Query: 341 YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRA 400
++ E++ G L +L + +D ++ + + +G+ +L K +HRD+
Sbjct: 89 KLIMEYLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLAT 142
Query: 401 SNVLLDEEFGAHLMGV---GLSKFVPWEVMQERTVMAGGT------YGYLAPEFVYRNEL 451
N+L++ E + + + GL+K +P + +E + Y APE + ++
Sbjct: 143 RNILVENE---NRVKIGDFGLTKVLPQD--KEFFKVKEPGESPIFWY---APESLTESKF 194
Query: 452 TTKSDVYSFGVLLLEI 467
+ SDV+SFGV+L E+
Sbjct: 195 SVASDVWSFGVVLYEL 210
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 5e-28
Identities = 53/196 (27%), Positives = 96/196 (48%), Gaps = 26/196 (13%)
Query: 284 GTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR-- 340
Y + + G VAVK+L+ S+ + ++F EI L H N+V KG CY G R
Sbjct: 60 CRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119
Query: 341 YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRA 400
++ E++ G L +L + +D ++ + + +G+ +L K +HRD+
Sbjct: 120 KLIMEYLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLAT 173
Query: 401 SNVLLDEEFGAHLMGV---GLSKFVPWEVMQERTVMAGGT------YGYLAPEFVYRNEL 451
N+L++ E + + + GL+K +P + +E + Y APE + ++
Sbjct: 174 RNILVENE---NRVKIGDFGLTKVLPQD--KEYYKVKEPGESPIFWY---APESLTESKF 225
Query: 452 TTKSDVYSFGVLLLEI 467
+ SDV+SFGV+L E+
Sbjct: 226 SVASDVWSFGVVLYEL 241
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-27
Identities = 55/200 (27%), Positives = 84/200 (42%), Gaps = 18/200 (9%)
Query: 275 RLLGDSKTGGTYSGIL-PDGSRVAVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLVAVKG 332
+G G +SG L D + VAVK + K +F E + HPN+V + G
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 179
Query: 333 CCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPH 392
C YIV E V G +L G L +++ A G+ +L K
Sbjct: 180 VCTQKQPIYIVMELVQGGDFLTFLR---TEGARLRVKTLLQMVGDAAAGMEYLESK---C 233
Query: 393 VVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL-----APEFVY 447
+HRD+ A N L+ E+ + G+S+ + A G + APE +
Sbjct: 234 CIHRDLAARNCLVTEKNVLKISDFGMSR-----EEADGVYAASGGLRQVPVKWTAPEALN 288
Query: 448 RNELTTKSDVYSFGVLLLEI 467
+++SDV+SFG+LL E
Sbjct: 289 YGRYSSESDVWSFGILLWET 308
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 1e-27
Identities = 57/194 (29%), Positives = 91/194 (46%), Gaps = 8/194 (4%)
Query: 275 RLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGC 333
LG + G Y G+ VAVK LK + + + EF E + HPNLV + G
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGV 284
Query: 334 CYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHV 393
C YI+ EF+ G L +L + + + + +AT ++ + +L K +
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLEKK---NF 339
Query: 394 VHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTT 453
+HR++ A N L+ E + GLS+ + + A + APE + N+ +
Sbjct: 340 IHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA-GAKFPIKWTAPESLAYNKFSI 398
Query: 454 KSDVYSFGVLLLEI 467
KSDV++FGVLL EI
Sbjct: 399 KSDVWAFGVLLWEI 412
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 5e-27
Identities = 46/207 (22%), Positives = 76/207 (36%), Gaps = 45/207 (21%)
Query: 284 GTYSGILPDGS----RVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGD 339
G + G V +K L ++ + F+ ++L H +LV G C +
Sbjct: 27 GVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86
Query: 340 RYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIR 399
+V EFV G LD +L + ++ +++VA LA + FL + ++H ++
Sbjct: 87 NILVQEFVKFGSLDTYLK---KNKNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVC 140
Query: 400 ASNVLLDEEFGAHLMGV--------GLSKF----------VPWEVMQERTVMAGGTYGYL 441
A N+LL E G+S +PW +
Sbjct: 141 AKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPW----------------V 184
Query: 442 APE-FVYRNELTTKSDVYSFGVLLLEI 467
PE L +D +SFG L EI
Sbjct: 185 PPECIENPKNLNLATDKWSFGTTLWEI 211
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 8e-27
Identities = 56/197 (28%), Positives = 93/197 (47%), Gaps = 27/197 (13%)
Query: 284 GTYSGILPD-GSRVAVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR- 340
Y + G +VAVK LK S + EI L+H N+V KG C + G
Sbjct: 40 CRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99
Query: 341 -YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIR 399
++ EF+ +G L +L P+ ++ ++K A + +G+ +L + VHRD+
Sbjct: 100 IKLIMEFLPSGSLKEYL---PKNKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLA 153
Query: 400 ASNVLLDEEFGAHLMGV---GLSKFVPWEVMQERTVMAGGT------YGYLAPEFVYRNE 450
A NVL++ E H + + GL+K + + +E + Y APE + +++
Sbjct: 154 ARNVLVESE---HQVKIGDFGLTKAIETD--KEYYTVKDDRDSPVFWY---APECLMQSK 205
Query: 451 LTTKSDVYSFGVLLLEI 467
SDV+SFGV L E+
Sbjct: 206 FYIASDVWSFGVTLHEL 222
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 54/196 (27%), Positives = 98/196 (50%), Gaps = 26/196 (13%)
Query: 284 GTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR-- 340
Y + + G+ VAVK+L+ S ++++F EI LH +V +G Y G +
Sbjct: 42 CRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101
Query: 341 YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRA 400
+V E++ +G L +L R LD + + ++ + +G+ +L + VHRD+ A
Sbjct: 102 RLVMEYLPSGCLRDFL---QRHRARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAA 155
Query: 401 SNVLLDEEFGAHLMGV---GLSKFVPWEVMQERTVMAGGT------YGYLAPEFVYRNEL 451
N+L++ E + + GL+K +P + ++ V+ Y APE + N
Sbjct: 156 RNILVESE---AHVKIADFGLAKLLPLD--KDYYVVREPGQSPIFWY---APESLSDNIF 207
Query: 452 TTKSDVYSFGVLLLEI 467
+ +SDV+SFGV+L E+
Sbjct: 208 SRQSDVWSFGVVLYEL 223
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-26
Identities = 63/243 (25%), Positives = 105/243 (43%), Gaps = 16/243 (6%)
Query: 227 LLAYRRSKRRRKSRKLSNPAASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTY 286
L+ + + +KLS P S+ W+ E I + + + LG + G +
Sbjct: 150 LVDHYKKGNDGLCQKLSVPCMSSKPQKPWEKDAWE----IPRESLKLEKKLGAGQFGEVW 205
Query: 287 SGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF 346
++VAVK +K S + F +E L H LV + YI+ EF
Sbjct: 206 MATYNKHTKVAVKTMKPGSMSVE-AFLAEANVMKTLQHDKLVKLHAVVTKEP-IYIITEF 263
Query: 347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD 406
+ G L +L G + + +A+G+AF+ + + +HRD+RA+N+L+
Sbjct: 264 MAKGSLLDFLKS--DEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVS 318
Query: 407 EEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGY--LAPEFVYRNELTTKSDVYSFGVLL 464
+ GL++ + E T G + APE + T KSDV+SFG+LL
Sbjct: 319 ASLVCKIADFGLARVIEDN---EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILL 375
Query: 465 LEI 467
+EI
Sbjct: 376 MEI 378
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 4e-26
Identities = 65/214 (30%), Positives = 95/214 (44%), Gaps = 28/214 (13%)
Query: 284 GTYSGILPD-GSRVAVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR- 340
Y G VAVK LK + Q + + EI L+H +++ KGCC D G
Sbjct: 50 YCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAAS 109
Query: 341 -YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIR 399
+V E+V G L +L S+ A + A + +G+A+LH + H +HRD+
Sbjct: 110 LQLVMEYVPLGSLRDYLP-----RHSIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLA 161
Query: 400 ASNVLLDEEFGAHLMGV---GLSKFVPWEVMQERTVMAGGTYGYL-----APEFVYRNEL 451
A NVLLD + L+ + GL+K VP E + G APE + +
Sbjct: 162 ARNVLLDND---RLVKIGDFGLAKAVPEG--HEYYRVRED--GDSPVFWYAPECLKEYKF 214
Query: 452 TTKSDVYSFGVLLLEIRLVLCRRWWTLYTLVHSM 485
SDV+SFGV L E+ L C + T +
Sbjct: 215 YYASDVWSFGVTLYEL-LTHCDSSQSPPTKFLEL 247
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 6e-26
Identities = 58/196 (29%), Positives = 92/196 (46%), Gaps = 18/196 (9%)
Query: 275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCC 334
+ +G + G G G++VAVK +K + + F +E +L H NLV + G
Sbjct: 199 QTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVI 255
Query: 335 YDHGDR-YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHV 393
+ YIV E++ G L +L RG L +K + + + + +L +
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLRS--RGRSVLGGDCLLKFSLDVCEAMEYLEGN---NF 310
Query: 394 VHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGY--LAPEFVYRNEL 451
VHRD+ A NVL+ E+ A + GL+K + + G APE + +
Sbjct: 311 VHRDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEALREKKF 363
Query: 452 TTKSDVYSFGVLLLEI 467
+TKSDV+SFG+LL EI
Sbjct: 364 STKSDVWSFGILLWEI 379
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 6e-26
Identities = 53/208 (25%), Positives = 86/208 (41%), Gaps = 37/208 (17%)
Query: 284 GTYSGILPDGS--RVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRY 341
+ P VAVK LK + +K+F E L H ++V G C D
Sbjct: 34 AECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLI 93
Query: 342 IVYEFVVNGPLDRWL------------HHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV 389
+V+E++ +G L+++L + L + + +A+ +A G+ +L +
Sbjct: 94 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ- 152
Query: 390 KPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY-----GYL--- 441
H VHRD+ N L+ + G+S R V + Y L
Sbjct: 153 --HFVHRDLATRNCLVGANLLVKIGDFGMS----------RDVYSTDYYRVGGHTMLPIR 200
Query: 442 --APEFVYRNELTTKSDVYSFGVLLLEI 467
PE + + TT+SDV+SFGV+L EI
Sbjct: 201 WMPPESIMYRKFTTESDVWSFGVILWEI 228
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 7e-26
Identities = 62/200 (31%), Positives = 94/200 (47%), Gaps = 20/200 (10%)
Query: 275 RLLGDSKTGGTYSGILPDGS-RVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGC 333
LG + G Y G+ S VAVK LK + + + EF E + HPNLV + G
Sbjct: 19 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGV 77
Query: 334 CYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHV 393
C YI+ EF+ G L +L + + + + +AT ++ + +L K +
Sbjct: 78 CTREPPFYIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLEKK---NF 132
Query: 394 VHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGG------TYGYLAPEFVY 447
+HRD+ A N L+ E + GLS+ + + T AG T APE +
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGD---TYTAHAGAKFPIKWT----APESLA 185
Query: 448 RNELTTKSDVYSFGVLLLEI 467
N+ + KSDV++FGVLL EI
Sbjct: 186 YNKFSIKSDVWAFGVLLWEI 205
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 9e-26
Identities = 58/198 (29%), Positives = 86/198 (43%), Gaps = 22/198 (11%)
Query: 284 GTYSGILPDGS--RVAVKRLK-RSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR 340
G SG+ D S +VAVK L S Q + +F E ++ +H N+V G R
Sbjct: 49 GQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108
Query: 341 YIVYEFVVNGPLDRWL-HHIPRGGRSLDWAMR--MKVATTLAQGIAFLHDKVKPHVVHRD 397
+I+ E + G L +L PR + AM + VA +A G +L + H +HRD
Sbjct: 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRD 165
Query: 398 IRASNVLLDEEFGAHLMGV---GLSKFVPWEVMQERTVMAGGTYGYL-----APEFVYRN 449
I A N LL + + G+++ + + G L PE
Sbjct: 166 IAARNCLLTCPGPGRVAKIGDFGMARDI-----YRASYYRKGGCAMLPVKWMPPEAFMEG 220
Query: 450 ELTTKSDVYSFGVLLLEI 467
T+K+D +SFGVLL EI
Sbjct: 221 IFTSKTDTWSFGVLLWEI 238
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 1e-25
Identities = 55/193 (28%), Positives = 86/193 (44%), Gaps = 8/193 (4%)
Query: 275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCC 334
LG G + G +RVA+K LK + + F E +L H LV +
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVV 248
Query: 335 YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVV 394
+ YIV E++ G L +L G+ L + +A +A G+A++ + V
Sbjct: 249 SEEP-IYIVTEYMSKGSLLDFLKG--ETGKYLRLPQLVDMAAQIASGMAYVERM---NYV 302
Query: 395 HRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTK 454
HRD+RA+N+L+ E + GL++ + R + APE T K
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIK 361
Query: 455 SDVYSFGVLLLEI 467
SDV+SFG+LL E+
Sbjct: 362 SDVWSFGILLTEL 374
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 45/184 (24%), Positives = 79/184 (42%), Gaps = 29/184 (15%)
Query: 295 RVAVKRLKRSSFQRKKEFYSEIGRF-------ARLHHPNLVAVKGCCYDHGD----RYIV 343
+VA+K + + K+E + RF ++L H N+V++ D + Y+V
Sbjct: 38 KVAIKAI-FIPPREKEET---LKRFEREVHNSSQLSHQNIVSM----IDVDEEDDCYYLV 89
Query: 344 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNV 403
E++ L ++ G L + + GI HD +VHRDI+ N+
Sbjct: 90 MEYIEGPTLSEYIE---SHGP-LSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNI 142
Query: 404 LLDEEFGAHLMGVGLSKFVPWEVM-QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGV 462
L+D + G++K + + Q V+ GT Y +PE +D+YS G+
Sbjct: 143 LIDSNKTLKIFDFGIAKALSETSLTQTNHVL--GTVQYFSPEQAKGEATDECTDIYSIGI 200
Query: 463 LLLE 466
+L E
Sbjct: 201 VLYE 204
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 58/198 (29%), Positives = 85/198 (42%), Gaps = 22/198 (11%)
Query: 284 GTYSGILPDGS--RVAVKRLK-RSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR 340
G SG+ D S +VAVK L S Q + +F E ++ +H N+V G R
Sbjct: 90 GQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149
Query: 341 YIVYEFVVNGPLDRWL-HHIPRGGRSLDWAMR--MKVATTLAQGIAFLHDKVKPHVVHRD 397
+I+ E + G L +L PR + AM + VA +A G +L + H +HRD
Sbjct: 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRD 206
Query: 398 IRASNVLLDEEFGAHLMGV---GLSKFVPWEVMQERTVMAGGTYGYL-----APEFVYRN 449
I A N LL + + G+++ + G L PE
Sbjct: 207 IAARNCLLTCPGPGRVAKIGDFGMARDI-----YRAGYYRKGGCAMLPVKWMPPEAFMEG 261
Query: 450 ELTTKSDVYSFGVLLLEI 467
T+K+D +SFGVLL EI
Sbjct: 262 IFTSKTDTWSFGVLLWEI 279
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-25
Identities = 49/199 (24%), Positives = 92/199 (46%), Gaps = 20/199 (10%)
Query: 275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCC 334
+ +G + G + G + +VA+K ++ + +++F E +L HP LV + G C
Sbjct: 14 QEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVC 72
Query: 335 YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVV 394
+ +V EF+ +G L +L + + + +G+A+L + V+
Sbjct: 73 LEQAPICLVTEFMEHGCLSDYLR---TQRGLFAAETLLGMCLDVCEGMAYLEEA---CVI 126
Query: 395 HRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGG------TYGYLAPEFVYR 448
HRD+ A N L+ E + G+++FV + + T G +PE
Sbjct: 127 HRDLAARNCLVGENQVIKVSDFGMTRFVLDD---QYTSSTGTKFPVKWA----SPEVFSF 179
Query: 449 NELTTKSDVYSFGVLLLEI 467
+ ++KSDV+SFGVL+ E+
Sbjct: 180 SRYSSKSDVWSFGVLMWEV 198
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-25
Identities = 55/199 (27%), Positives = 94/199 (47%), Gaps = 20/199 (10%)
Query: 275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCC 334
+ LG + G G VAVK +K S + EF+ E +L HP LV G C
Sbjct: 14 KELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVC 72
Query: 335 YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVV 394
YIV E++ NG L +L G+ L+ + +++ + +G+AFL +
Sbjct: 73 SKEYPIYIVTEYISNGCLLNYLR---SHGKGLEPSQLLEMCYDVCEGMAFLESH---QFI 126
Query: 395 HRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGG------TYGYLAPEFVYR 448
HRD+ A N L+D + + G++++V + + G + APE +
Sbjct: 127 HRDLAARNCLVDRDLCVKVSDFGMTRYVLDD---QYVSSVGTKFPVKWS----APEVFHY 179
Query: 449 NELTTKSDVYSFGVLLLEI 467
+ ++KSDV++FG+L+ E+
Sbjct: 180 FKYSSKSDVWAFGILMWEV 198
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-25
Identities = 55/193 (28%), Positives = 86/193 (44%), Gaps = 8/193 (4%)
Query: 275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCC 334
LG G + G +RVA+K LK + + F E +L H LV +
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVV 331
Query: 335 YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVV 394
+ YIV E++ G L +L G+ L + +A +A G+A++ + V
Sbjct: 332 SEEP-IYIVTEYMSKGSLLDFLKG--ETGKYLRLPQLVDMAAQIASGMAYVERM---NYV 385
Query: 395 HRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTK 454
HRD+RA+N+L+ E + GL++ + R + APE T K
Sbjct: 386 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIK 444
Query: 455 SDVYSFGVLLLEI 467
SDV+SFG+LL E+
Sbjct: 445 SDVWSFGILLTEL 457
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 2e-25
Identities = 59/199 (29%), Positives = 93/199 (46%), Gaps = 20/199 (10%)
Query: 275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCC 334
LG + G + G ++VAVK LK+ S F +E +L H LV +
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 335 YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVV 394
YI+ E++ NG L +L G L + +A +A+G+AF+ ++ + +
Sbjct: 78 TQEP-IYIITEYMENGSLVDFLKT--PSGIKLTINKLLDMAAQIAEGMAFIEER---NYI 131
Query: 395 HRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGG------TYGYLAPEFVYR 448
HRD+RA+N+L+ + + GL++ + E T G T APE +
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDN---EYTAREGAKFPIKWT----APEAINY 184
Query: 449 NELTTKSDVYSFGVLLLEI 467
T KSDV+SFG+LL EI
Sbjct: 185 GTFTIKSDVWSFGILLTEI 203
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 4e-25
Identities = 32/283 (11%), Positives = 68/283 (24%), Gaps = 46/283 (16%)
Query: 227 LLAYRRSKRRRKSRKLSNPAASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTY 286
L+ Y R + ++ + + + P + + L + L +
Sbjct: 21 LIGYCREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLV-EPLRVGDRSVVF 79
Query: 287 SGI-LPDGSRVAVKRLKRSSFQRKKE---FYSEIGRFARLHHPNLVAVKGCC-------- 334
+ A+K + + E + ARL + +
Sbjct: 80 LVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDA 139
Query: 335 ------------------YDHGDRYIVYEFVV--NGPLDRWLHHIPRGGRSLDWAMRMKV 374
Y + ++ L L + +
Sbjct: 140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHIL 199
Query: 375 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA 434
L + A L K +VH N+ + + L V V R +
Sbjct: 200 TAQLIRLAANLQSK---GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVG-----TRGPAS 251
Query: 435 GGTYGYLAPEFVYRNEL--TTKSDVYSFGVLLLEIRLVLCRRW 475
Y EF+ + T + + G+ + + C
Sbjct: 252 SVPVTYAPREFLNASTATFTHALNAWQLGLSIYRV---WCLFL 291
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 5e-25
Identities = 59/200 (29%), Positives = 93/200 (46%), Gaps = 26/200 (13%)
Query: 275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCC 334
+ +G + G G G++VAVK +K + + F +E +L H NLV + G
Sbjct: 27 QTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVI 83
Query: 335 YDHGDR-YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHV 393
+ YIV E++ G L +L RG L +K + + + + +L +
Sbjct: 84 VEEKGGLYIVTEYMAKGSLVDYLRS--RGRSVLGGDCLLKFSLDVCEAMEYLEGN---NF 138
Query: 394 VHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGG------TYGYLAPEFVY 447
VHRD+ A NVL+ E+ A + GL+K + + G T APE +
Sbjct: 139 VHRDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWT----APEALR 187
Query: 448 RNELTTKSDVYSFGVLLLEI 467
+ +TKSDV+SFG+LL EI
Sbjct: 188 EKKFSTKSDVWSFGILLWEI 207
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 6e-25
Identities = 50/199 (25%), Positives = 87/199 (43%), Gaps = 20/199 (10%)
Query: 275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCC 334
+ LG + G G VA+K +K S EF E L H LV + G C
Sbjct: 30 KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED-EFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 335 YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVV 394
+I+ E++ NG L +L +++ + + + +L K +
Sbjct: 89 TKQRPIFIITEYMANGCLLNYLR---EMRHRFQTQQLLEMCKDVCEAMEYLESK---QFL 142
Query: 395 HRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGG------TYGYLAPEFVYR 448
HRD+ A N L++++ + GLS++V + E T G + PE +
Sbjct: 143 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDD---EYTSSVGSKFPVRWS----PPEVLMY 195
Query: 449 NELTTKSDVYSFGVLLLEI 467
++ ++KSD+++FGVL+ EI
Sbjct: 196 SKFSSKSDIWAFGVLMWEI 214
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 7e-25
Identities = 50/190 (26%), Positives = 83/190 (43%), Gaps = 16/190 (8%)
Query: 284 GTYSGILPDGSRVAVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYI 342
G VA+K LK + +++++F SE + HPN++ ++G I
Sbjct: 68 GRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127
Query: 343 VYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASN 402
V E++ NG LD +L + + + G+ +L D VHRD+ A N
Sbjct: 128 VTEYMENGSLDTFLR---THDGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARN 181
Query: 403 VLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGG-----TYGYLAPEFVYRNELTTKSDV 457
VL+D + GLS+ + + T G T APE + ++ SDV
Sbjct: 182 VLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWT----APEAIAFRTFSSASDV 237
Query: 458 YSFGVLLLEI 467
+SFGV++ E+
Sbjct: 238 WSFGVVMWEV 247
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 8e-25
Identities = 54/207 (26%), Positives = 87/207 (42%), Gaps = 36/207 (17%)
Query: 284 GTYSGILPDGS--RVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRY 341
+LP+ VAVK LK +S +++F E L H ++V G C +
Sbjct: 60 AECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLL 119
Query: 342 IVYEFVVNGPLDRWL-----------HHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVK 390
+V+E++ +G L+R+L L + VA+ +A G+ +L
Sbjct: 120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL-- 177
Query: 391 PHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY-----GYL---- 441
H VHRD+ N L+ + + G+S R + + Y L
Sbjct: 178 -HFVHRDLATRNCLVGQGLVVKIGDFGMS----------RDIYSTDYYRVGGRTMLPIRW 226
Query: 442 -APEFVYRNELTTKSDVYSFGVLLLEI 467
PE + + TT+SDV+SFGV+L EI
Sbjct: 227 MPPESILYRKFTTESDVWSFGVVLWEI 253
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 8e-25
Identities = 49/203 (24%), Positives = 85/203 (41%), Gaps = 32/203 (15%)
Query: 284 GTYSGILPDGS--RVAVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR 340
G G++ D RVA+K + +S + + EF +E + ++V + G
Sbjct: 44 GVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 103
Query: 341 YIVYEFVVNGPLDRWL------HHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVV 394
++ E + G L +L + +++A +A G+A+L+ V
Sbjct: 104 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFV 160
Query: 395 HRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY-----GYL-----APE 444
HRD+ A N ++ E+F + G++ R + Y G L +PE
Sbjct: 161 HRDLAARNCMVAEDFTVKIGDFGMT----------RDIYETDYYRKGGKGLLPVRWMSPE 210
Query: 445 FVYRNELTTKSDVYSFGVLLLEI 467
+ TT SDV+SFGV+L EI
Sbjct: 211 SLKDGVFTTYSDVWSFGVVLWEI 233
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 47/204 (23%), Positives = 78/204 (38%), Gaps = 33/204 (16%)
Query: 284 GTYSGILPDGSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR- 340
+VAVK LK + +EF E HP++ + G +
Sbjct: 42 AQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG 101
Query: 341 -----YIVYEFVVNGPLDRWL--HHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHV 393
++ F+ +G L +L I +L ++ +A G+ +L + +
Sbjct: 102 RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NF 158
Query: 394 VHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY-----GYL-----AP 443
+HRD+ A N +L E+ + GLS R + +G Y L A
Sbjct: 159 IHRDLAARNCMLAEDMTVCVADFGLS----------RKIYSGDYYRQGCASKLPVKWLAL 208
Query: 444 EFVYRNELTTKSDVYSFGVLLLEI 467
E + N T SDV++FGV + EI
Sbjct: 209 ESLADNLYTVHSDVWAFGVTMWEI 232
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 49/203 (24%), Positives = 87/203 (42%), Gaps = 32/203 (15%)
Query: 284 GTYSGILPDGSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR- 340
G +VAVK +K SS + +EF SE HPN++ + G C + +
Sbjct: 53 GNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQG 112
Query: 341 ----YIVYEFVVNGPLDRWL--HHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVV 394
++ F+ G L +L + G + + +K +A G+ +L ++ + +
Sbjct: 113 IPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFL 169
Query: 395 HRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY-----GYL-----APE 444
HRD+ A N +L ++ + GLS + + +G Y + A E
Sbjct: 170 HRDLAARNCMLRDDMTVCVADFGLS----------KKIYSGDYYRQGRIAKMPVKWIAIE 219
Query: 445 FVYRNELTTKSDVYSFGVLLLEI 467
+ T+KSDV++FGV + EI
Sbjct: 220 SLADRVYTSKSDVWAFGVTMWEI 242
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 54/203 (26%), Positives = 90/203 (44%), Gaps = 18/203 (8%)
Query: 273 GNRLLGDSKTGGTYSGILPDGSR---VAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNL 327
++ LG G G VAVK LK + K E +E +L +P +
Sbjct: 21 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 80
Query: 328 VAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD 387
V + G C +V E GPL+++L + R + +++ ++ G+ +L +
Sbjct: 81 VRMIGICEAES-WMLVMEMAELGPLNKYL----QQNRHVKDKNIIELVHQVSMGMKYLEE 135
Query: 388 KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT---YGYLAPE 444
+ VHRD+ A NVLL + A + GLSK + + + + APE
Sbjct: 136 S---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD--ENYYKAQTHGKWPVKWYAPE 190
Query: 445 FVYRNELTTKSDVYSFGVLLLEI 467
+ + ++KSDV+SFGVL+ E
Sbjct: 191 CINYYKFSSKSDVWSFGVLMWEA 213
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 51/201 (25%), Positives = 94/201 (46%), Gaps = 16/201 (7%)
Query: 275 RLLGDSKTGGTYSGILPDGSR----VAVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLVA 329
+++G + G SG L S+ VA+K LK + +++++F E + HPN++
Sbjct: 51 KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 330 VKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV 389
++G IV E++ NG LD +L + + + +A G+ +L D
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFLR---KHDAQFTVIQLVGMLRGIASGMKYLSDM- 166
Query: 390 KPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT---YGYLAPEFV 446
VHRD+ A N+L++ + GL + + E E G + +PE +
Sbjct: 167 --GYVHRDLAARNILINSNLVCKVSDFGLGRVL--EDDPEAAYTTRGGKIPIRWTSPEAI 222
Query: 447 YRNELTTKSDVYSFGVLLLEI 467
+ T+ SDV+S+G++L E+
Sbjct: 223 AYRKFTSASDVWSYGIVLWEV 243
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 4e-24
Identities = 38/184 (20%), Positives = 72/184 (39%), Gaps = 29/184 (15%)
Query: 295 RVAVKRLKRSSFQRKKEFYSEIGRF-------ARLHHPNLVAVKGCCYDHGD----RYIV 343
VA+K + + F R RL P++V + +D G+ Y+
Sbjct: 61 IVALKLM-SETLSSDPVF---RTRMQREARTAGRLQEPHVVPI----HDFGEIDGQLYVD 112
Query: 344 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNV 403
+ L L +G + A+ + + + H HRD++ N+
Sbjct: 113 MRLINGVDLAAMLRR--QGPLAPPRAVA--IVRQIGSALDAAHAA---GATHRDVKPENI 165
Query: 404 LLDEEFGAHLMGVGLSKFVPWEVM-QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGV 462
L+ + A+L+ G++ E + Q + GT Y+APE + T ++D+Y+
Sbjct: 166 LVSADDFAYLVDFGIASATTDEKLTQLGNTV--GTLYYMAPERFSESHATYRADIYALTC 223
Query: 463 LLLE 466
+L E
Sbjct: 224 VLYE 227
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 4e-24
Identities = 46/210 (21%), Positives = 84/210 (40%), Gaps = 18/210 (8%)
Query: 265 SITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRK--KEFYSEIGRFAR 321
S F + + +G Y G+ VA L+ + + F E
Sbjct: 22 SNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKG 81
Query: 322 LHHPNLVAVKGCCYDHGDR----YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATT 377
L HPN+V +V E + +G L + + + +
Sbjct: 82 LQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTL----KTYLKRFKVMKIKVLRSWCRQ 137
Query: 378 LAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMG-VGLSKFVPWEVMQERTVMAGG 436
+ +G+ FLH + P ++HRD++ N+ + G+ +G +GL+ + V+ G
Sbjct: 138 ILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK--RASFAKAVI--G 192
Query: 437 TYGYLAPEFVYRNELTTKSDVYSFGVLLLE 466
T ++APE +Y + DVY+FG+ +LE
Sbjct: 193 TPEFMAPE-MYEEKYDESVDVYAFGMCMLE 221
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 5e-24
Identities = 51/212 (24%), Positives = 85/212 (40%), Gaps = 44/212 (20%)
Query: 284 GTYSGILPDGS--RVAVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR 340
G G P VA+K LK + ++EF E ARL HPN+V + G
Sbjct: 28 GHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPL 87
Query: 341 YIVYEFVVNGPLDRWL------------HHIPRGGRSLDWAMRMKVATTLAQGIAFLHDK 388
+++ + +G L +L +L+ + + +A G+ +L
Sbjct: 88 SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH 147
Query: 389 VKPHVVHRDIRASNVLLDEEFGAHLMGV---GLSKFVPWEVMQERTVMAGGTY-----GY 440
HVVH+D+ NVL+ ++ + + GL R V A Y
Sbjct: 148 ---HVVHKDLATRNVLVYDK---LNVKISDLGLF----------REVYAADYYKLLGNSL 191
Query: 441 L-----APEFVYRNELTTKSDVYSFGVLLLEI 467
L APE + + + SD++S+GV+L E+
Sbjct: 192 LPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEV 223
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 5e-24
Identities = 55/190 (28%), Positives = 84/190 (44%), Gaps = 35/190 (18%)
Query: 295 RVAVKRLKRSSFQRKKEFYSEIGRF-------ARLHHPNLVAVKGCCYDHGD-------- 339
VAVK L R+ R F RF A L+HP +VAV YD G+
Sbjct: 39 DVAVKVL-RADLARDPSF---YLRFRREAQNAAALNHPAIVAV----YDTGEAETPAGPL 90
Query: 340 RYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIR 399
YIV E+V L +H G + ++V Q + F H ++HRD++
Sbjct: 91 PYIVMEYVDGVTLRDIVH---TEGP-MTPKRAIEVIADACQALNFSHQN---GIIHRDVK 143
Query: 400 ASNVLLDEEFGAHLMGVGLSKFVPWE---VMQERTVMAGGTYGYLAPEFVYRNELTTKSD 456
+N+++ +M G+++ + V Q V+ GT YL+PE + + +SD
Sbjct: 144 PANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVI--GTAQYLSPEQARGDSVDARSD 201
Query: 457 VYSFGVLLLE 466
VYS G +L E
Sbjct: 202 VYSLGCVLYE 211
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 8e-24
Identities = 57/208 (27%), Positives = 89/208 (42%), Gaps = 37/208 (17%)
Query: 284 GTYSGILPDGS--RVAVKRLKRS-SFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGD 339
T G+ + + +VAVK LK + K+ SE+ + L H N+V + G C G
Sbjct: 65 ATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP 124
Query: 340 RYIVYEFVVNGPLDRWL----------HHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV 389
++ E+ G L +L + + ++ +AQG+AFL K
Sbjct: 125 VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK- 183
Query: 390 KPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY-----GYL--- 441
+ +HRD+ A NVLL A + GL+ R +M Y L
Sbjct: 184 --NCIHRDVAARNVLLTNGHVAKIGDFGLA----------RDIMNDSNYIVKGNARLPVK 231
Query: 442 --APEFVYRNELTTKSDVYSFGVLLLEI 467
APE ++ T +SDV+S+G+LL EI
Sbjct: 232 WMAPESIFDCVYTVQSDVWSYGILLWEI 259
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 8e-24
Identities = 49/193 (25%), Positives = 91/193 (47%), Gaps = 21/193 (10%)
Query: 286 YSGIL--PDGSR---VAVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGD 339
Y G+L G + VA+K LK + +++ +F E G + H N++ ++G +
Sbjct: 61 YKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP 120
Query: 340 RYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIR 399
I+ E++ NG LD++L + + +A G+ +L + + VHRD+
Sbjct: 121 MMIITEYMENGALDKFLR---EKDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLA 174
Query: 400 ASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGG-----TYGYLAPEFVYRNELTTK 454
A N+L++ + GLS+ + + T G T APE + + T+
Sbjct: 175 ARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT----APEAISYRKFTSA 230
Query: 455 SDVYSFGVLLLEI 467
SDV+SFG+++ E+
Sbjct: 231 SDVWSFGIVMWEV 243
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 66/288 (22%), Positives = 109/288 (37%), Gaps = 32/288 (11%)
Query: 200 HCHREYLITLGVVSGLILLTTFAIVIWLLAYRRSKRRRKSRKLSNPAASAL------VPP 253
H R + G++ I ++ S L A+ + + P
Sbjct: 14 HGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSALNP 73
Query: 254 SWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGS----RVAVKRLKR-SSFQR 308
+ + N ++G G Y G L D AVK L R +
Sbjct: 74 ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 133
Query: 309 KKEFYSEIGRFARLHHPNLVAVKGCCYDHGD-RYIVYEFVVNGPLDRWLHHIPRGGRSLD 367
+F +E HPN++++ G C +V ++ +G L ++ +
Sbjct: 134 VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR---NETHNPT 190
Query: 368 WAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGV---GLSKFVPW 424
+ +A+G+ FL K VHRD+ A N +LDE+F + V GL++ +
Sbjct: 191 VKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKF---TVKVADFGLARDM-- 242
Query: 425 EVMQERTVMAGGTYGYL-----APEFVYRNELTTKSDVYSFGVLLLEI 467
+E + T L A E + + TTKSDV+SFGVLL E+
Sbjct: 243 -YDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWEL 289
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 47/178 (26%), Positives = 82/178 (46%), Gaps = 8/178 (4%)
Query: 292 DGSRVAVKRLK---RSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV 348
DG VA+K+++ + + + EI +L+HPN++ + + IV E
Sbjct: 56 DGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELAD 115
Query: 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE 408
G L R + H + R + K L + +H + V+HRDI+ +NV +
Sbjct: 116 AGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITAT 172
Query: 409 FGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLE 466
L +GL +F + +++ GT Y++PE ++ N KSD++S G LL E
Sbjct: 173 GVVKLGDLGLGRFFSSKTTAAHSLV--GTPYYMSPERIHENGYNFKSDIWSLGCLLYE 228
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 2e-23
Identities = 51/191 (26%), Positives = 91/191 (47%), Gaps = 16/191 (8%)
Query: 284 GTYSGILPDGSRVAVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD-HGDRY 341
G Y + + A+K L R + Q+ + F E L+HPN++A+ G G +
Sbjct: 40 GEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPH 99
Query: 342 IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRAS 401
++ ++ +G L +++ R+ + +A+G+ +L ++ VHRD+ A
Sbjct: 100 VLLPYMCHGDLLQFIR---SPQRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAAR 153
Query: 402 NVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL-----APEFVYRNELTTKSD 456
N +LDE F + GL++ + + +E + + L A E + TTKSD
Sbjct: 154 NCMLDESFTVKVADFGLARDI---LDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSD 210
Query: 457 VYSFGVLLLEI 467
V+SFGVLL E+
Sbjct: 211 VWSFGVLLWEL 221
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 49/205 (23%), Positives = 94/205 (45%), Gaps = 25/205 (12%)
Query: 275 RLLGDSKTGGTYSGIL-PDGSR----VAVKRLKRSSFQR-KKEFYSEIGRFARLHHPNLV 328
++LG G Y G+ P+G + VA+K L+ ++ + KE E A + +P++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 329 AVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDK 388
+ G C ++ + + G L ++ ++ + +A+G+ +L D+
Sbjct: 81 RLLGICLTS-TVQLITQLMPFGCLLDYVR---EHKDNIGSQYLLNWCVQIAKGMNYLEDR 136
Query: 389 VKPHVVHRDIRASNVLLDEEFGAHLMGV---GLSKFVPWEVMQERTVMAGGT---YGYLA 442
+VHRD+ A NVL+ + + GL+K + E E+ A G ++A
Sbjct: 137 ---RLVHRDLAARNVLVKTP---QHVKITDFGLAKLLGAE---EKEYHAEGGKVPIKWMA 187
Query: 443 PEFVYRNELTTKSDVYSFGVLLLEI 467
E + T +SDV+S+GV + E+
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWEL 212
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 3e-23
Identities = 53/194 (27%), Positives = 85/194 (43%), Gaps = 22/194 (11%)
Query: 284 GTYSGILPDGSRVAVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD-HGDRY 341
GT AVK L R + +F +E HPN++++ G C G
Sbjct: 44 GTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103
Query: 342 IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRAS 401
+V ++ +G L ++ + + +A+G+ +L K VHRD+ A
Sbjct: 104 VVLPYMKHGDLRNFIR---NETHNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAAR 157
Query: 402 NVLLDEEFGAHLMGV---GLSKFVPWEVMQERTVMAGGTYGYL-----APEFVYRNELTT 453
N +LDE+F + V GL++ + +E + T L A E + + TT
Sbjct: 158 NCMLDEKF---TVKVADFGLARDM---YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTT 211
Query: 454 KSDVYSFGVLLLEI 467
KSDV+SFGVLL E+
Sbjct: 212 KSDVWSFGVLLWEL 225
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 4e-23
Identities = 42/188 (22%), Positives = 75/188 (39%), Gaps = 37/188 (19%)
Query: 292 DGSRVAVKRLKRS---SFQRKKEFYSEIGRF-ARLHHPNLVAVKGCCYDHGDR------- 340
+G V +K L S Q +E +F A + HP++V + ++ +
Sbjct: 105 NGRPVVLKGLVHSGDAEAQAM--AMAE-RQFLAEVVHPSIVQI----FNFVEHTDRHGDP 157
Query: 341 --YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDI 398
YIV E+V L R + A+ + +++LH +V+ D+
Sbjct: 158 VGYIVMEYVGGQSLKRSK----GQKLPVAEAIA--YLLEILPALSYLHSI---GLVYNDL 208
Query: 399 RASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVY 458
+ N++L EE L+ +G + + GT G+ APE + R T +D+Y
Sbjct: 209 KPENIMLTEE-QLKLIDLGAVS----RINSFGYLY--GTPGFQAPE-IVRTGPTVATDIY 260
Query: 459 SFGVLLLE 466
+ G L
Sbjct: 261 TVGRTLAA 268
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 4e-23
Identities = 47/190 (24%), Positives = 73/190 (38%), Gaps = 15/190 (7%)
Query: 284 GTYSGILPDGSRVAVKRLKR---SSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR 340
G + VAVK LK S + +F E+ L H NL+ + G
Sbjct: 37 GEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95
Query: 341 YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRA 400
+V E G L L + + A +A+G+ +L K +HRD+ A
Sbjct: 96 KMVTELAPLGSLLDRLR---KHQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAA 149
Query: 401 SNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT---YGYLAPEFVYRNELTTKSDV 457
N+LL + GL + +P + VM + + APE + + SD
Sbjct: 150 RNLLLATRDLVKIGDFGLMRALPQN--DDHYVMQEHRKVPFAWCAPESLKTRTFSHASDT 207
Query: 458 YSFGVLLLEI 467
+ FGV L E+
Sbjct: 208 WMFGVTLWEM 217
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 4e-23
Identities = 50/182 (27%), Positives = 81/182 (44%), Gaps = 8/182 (4%)
Query: 292 DGSRVAVK--RLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR--YIVYEFV 347
DG + K + K+ SE+ L HPN+V D + YIV E+
Sbjct: 30 DGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYC 89
Query: 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDK--VKPHVVHRDIRASNVLL 405
G L + + + LD ++V T L + H + V+HRD++ +NV L
Sbjct: 90 EGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL 149
Query: 406 DEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLL 465
D + L GL++ + + +T + GT Y++PE + R KSD++S G LL
Sbjct: 150 DGKQNVKLGDFGLARILNHDTSFAKTFV--GTPYYMSPEQMNRMSYNEKSDIWSLGCLLY 207
Query: 466 EI 467
E+
Sbjct: 208 EL 209
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 6e-23
Identities = 46/189 (24%), Positives = 82/189 (43%), Gaps = 16/189 (8%)
Query: 286 YSGILPDGSR---VAVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRY 341
G+ + VA+K LK+ + +E E +L +P +V + G C
Sbjct: 27 RQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEA-LM 85
Query: 342 IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRAS 401
+V E GPL ++L + + ++ ++ G+ +L +K + VHRD+ A
Sbjct: 86 LVMEMAGGGPLHKFLV---GKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAAR 139
Query: 402 NVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT---YGYLAPEFVYRNELTTKSDVY 458
NVLL A + GLSK + + + APE + + +++SDV+
Sbjct: 140 NVLLVNRHYAKISDFGLSKALGAD--DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVW 197
Query: 459 SFGVLLLEI 467
S+GV + E
Sbjct: 198 SYGVTMWEA 206
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 6e-23
Identities = 52/215 (24%), Positives = 86/215 (40%), Gaps = 47/215 (21%)
Query: 284 GTYSGILPDGS--RVAVKRLKRS-SFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGD 339
T G++ + VAVK LK S ++ SE+ + L +H N+V + G C G
Sbjct: 42 ATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101
Query: 340 RYIVYEFVVNGPLDRWL-HHIPRGGRSLDWAMR-------------MKVATTLAQGIAFL 385
++ E+ G L +L S + + +A+G+AFL
Sbjct: 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL 161
Query: 386 HDKVKPHVVHRDIRASNVLLDEEFGAHLMGV---GLSKFVPWEVMQERTVMAGGTY---- 438
K + +HRD+ A N+LL + + GL+ R + Y
Sbjct: 162 ASK---NCIHRDLAARNILLTHG---RITKICDFGLA----------RDIKNDSNYVVKG 205
Query: 439 -GYL-----APEFVYRNELTTKSDVYSFGVLLLEI 467
L APE ++ T +SDV+S+G+ L E+
Sbjct: 206 NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWEL 240
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 8e-23
Identities = 43/178 (24%), Positives = 84/178 (47%), Gaps = 9/178 (5%)
Query: 292 DGSRVAVK--RLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 349
DG + +K + R S + ++E E+ A + HPN+V + ++G YIV ++
Sbjct: 48 DGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEG 107
Query: 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF 409
G L + ++ + G + + + +HD+ ++HRDI++ N+ L ++
Sbjct: 108 GDLFKRINA--QKGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDG 162
Query: 410 GAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEI 467
L G+++ + V R + GT YL+PE KSD+++ G +L E+
Sbjct: 163 TVQLGDFGIARVLNSTVELARACI--GTPYYLSPEICENKPYNNKSDIWALGCVLYEL 218
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 8e-23
Identities = 52/209 (24%), Positives = 84/209 (40%), Gaps = 36/209 (17%)
Query: 284 GTYSGILPDGS--RVAVKRLKR-SSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGD 339
GI + VAVK LK ++ + SE+ + HH N+V + G C G
Sbjct: 46 ADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 105
Query: 340 -RYIVYEFVVNGPL------------DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLH 386
++ EF G L + L + + +A+G+ FL
Sbjct: 106 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA 165
Query: 387 DKVKPHVVHRDIRASNVLLDEEFGAHLMGV---GLSKFVPWEVMQERTVMAGGTYGYL-- 441
+ +HRD+ A N+LL E+ ++ + GL++ + + L
Sbjct: 166 SR---KCIHRDLAARNILLSEKN---VVKICDFGLAR-----DIYKDPDYVRKGDARLPL 214
Query: 442 ---APEFVYRNELTTKSDVYSFGVLLLEI 467
APE ++ T +SDV+SFGVLL EI
Sbjct: 215 KWMAPETIFDRVYTIQSDVWSFGVLLWEI 243
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 1e-22
Identities = 52/210 (24%), Positives = 86/210 (40%), Gaps = 37/210 (17%)
Query: 284 GTYSGILPDGS----RVAVKRLKR-SSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDH 337
GI D VAVK LK ++ + + SE+ + H N++ + G C
Sbjct: 54 AEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113
Query: 338 GDRYIVYEFVVNGPL------------DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFL 385
G Y++ E+ G L + + + + LA+G+ +L
Sbjct: 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL 173
Query: 386 HDKVKPHVVHRDIRASNVLLDEEFGAHLMGV---GLSKFVPWEVMQERTVMAGGTYGYL- 441
+ +HRD+ A NVL+ E ++M + GL++ + T G L
Sbjct: 174 ASQ---KCIHRDLAARNVLVTEN---NVMKIADFGLAR-----DINNIDYYKKTTNGRLP 222
Query: 442 ----APEFVYRNELTTKSDVYSFGVLLLEI 467
APE ++ T +SDV+SFGVL+ EI
Sbjct: 223 VKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 2e-22
Identities = 55/220 (25%), Positives = 92/220 (41%), Gaps = 52/220 (23%)
Query: 284 GTYSGILPDGS--RVAVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR 340
G+LP VAVK LK +S + +F E A +PN+V + G C
Sbjct: 66 ARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPM 125
Query: 341 YIVYEFVVNGPLDRWL--------------------HHIPRGGRSLDWAMRMKVATTLAQ 380
+++E++ G L+ +L G L A ++ +A +A
Sbjct: 126 CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAA 185
Query: 381 GIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGV---GLSKFVPWEVMQERTVMAGGT 437
G+A+L ++ VHRD+ N L+ E ++ + GLS R + +
Sbjct: 186 GMAYLSER---KFVHRDLATRNCLVGEN---MVVKIADFGLS----------RNIYSADY 229
Query: 438 Y-----GYL-----APEFVYRNELTTKSDVYSFGVLLLEI 467
Y + PE ++ N TT+SDV+++GV+L EI
Sbjct: 230 YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEI 269
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 2e-22
Identities = 56/220 (25%), Positives = 90/220 (40%), Gaps = 52/220 (23%)
Query: 284 GTYSGILPDGS--RVAVKRLK-RSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR 340
T + VAVK LK +S ++ SE +++HP+++ + G C G
Sbjct: 42 ATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101
Query: 341 YIVYEFVVNGPLDRWL--------------------HHIPRGGRSLDWAMRMKVATTLAQ 380
++ E+ G L +L R+L + A ++Q
Sbjct: 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQ 161
Query: 381 GIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGV---GLSKFVPWEVMQERTVMAGGT 437
G+ +L + +VHRD+ A N+L+ E M + GLS R V +
Sbjct: 162 GMQYLAEM---KLVHRDLAARNILVAEG---RKMKISDFGLS----------RDVYEEDS 205
Query: 438 Y-----GYL-----APEFVYRNELTTKSDVYSFGVLLLEI 467
Y G + A E ++ + TT+SDV+SFGVLL EI
Sbjct: 206 YVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEI 245
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 95.3 bits (238), Expect = 4e-22
Identities = 51/190 (26%), Positives = 80/190 (42%), Gaps = 19/190 (10%)
Query: 284 GTYSGILPDGSRVAVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYI 342
G Y+ + VAVK K+ + K++F SE L HP++V + G + +I
Sbjct: 31 GVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWI 89
Query: 343 VYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASN 402
+ E G L +L R SL + + + + +A+L + VHRDI N
Sbjct: 90 IMELYPYGELGHYLE---RNKNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRN 143
Query: 403 VLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL-----APEFVYRNELTTKSDV 457
+L+ L GLS+++ E A L +PE + TT SDV
Sbjct: 144 ILVASPECVKLGDFGLSRYI----EDEDYYKASV--TRLPIKWMSPESINFRRFTTASDV 197
Query: 458 YSFGVLLLEI 467
+ F V + EI
Sbjct: 198 WMFAVCMWEI 207
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 5e-22
Identities = 53/215 (24%), Positives = 86/215 (40%), Gaps = 47/215 (21%)
Query: 284 GTYSGILPDGS----RVAVKRLKR-SSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDH 337
GI D VAVK LK ++ + + SE+ + H N++ + G C
Sbjct: 100 AEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159
Query: 338 GDRYIVYEFVVNGPL------------DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFL 385
G Y++ E+ G L + + + + LA+G+ +L
Sbjct: 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL 219
Query: 386 HDKVKPHVVHRDIRASNVLLDEEFGAHLMGV---GLSKFVPWEVMQERTVMAGGTY---- 438
+ +HRD+ A NVL+ E ++M + GL+ R + Y
Sbjct: 220 ASQ---KCIHRDLAARNVLVTEN---NVMKIADFGLA----------RDINNIDYYKKTT 263
Query: 439 -GYL-----APEFVYRNELTTKSDVYSFGVLLLEI 467
G L APE ++ T +SDV+SFGVL+ EI
Sbjct: 264 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 298
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 5e-22
Identities = 50/202 (24%), Positives = 93/202 (46%), Gaps = 19/202 (9%)
Query: 275 RLLGDSKTGGTYSGIL-PDGSR----VAVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLV 328
++LG G Y G+ P+G + VA+K L+ +S + KE E A + +P++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 329 AVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDK 388
+ G C ++ + + G L ++ ++ + +A+G+ +L D+
Sbjct: 81 RLLGICLTS-TVQLITQLMPFGCLLDYVR---EHKDNIGSQYLLNWCVQIAKGMNYLEDR 136
Query: 389 VKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT---YGYLAPEF 445
+VHRD+ A NVL+ + GL+K + E E+ A G ++A E
Sbjct: 137 ---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE---EKEYHAEGGKVPIKWMALES 190
Query: 446 VYRNELTTKSDVYSFGVLLLEI 467
+ T +SDV+S+GV + E+
Sbjct: 191 ILHRIYTHQSDVWSYGVTVWEL 212
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 5e-22
Identities = 40/202 (19%), Positives = 88/202 (43%), Gaps = 19/202 (9%)
Query: 275 RLLGDSKTGGTYSGILPDGSR-----VAVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLV 328
++LG G + G+ V +K ++ S Q + + L H ++V
Sbjct: 19 KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 329 AVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDK 388
+ G C +V +++ G L + + +L + + +A+G+ +L +
Sbjct: 79 RLLGLCPGSS-LQLVTQYLPLGSLLDHVR---QHRGALGPQLLLNWGVQIAKGMYYLEEH 134
Query: 389 VKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT---YGYLAPEF 445
+VHR++ A NVLL + G++ +P + ++ ++ ++A E
Sbjct: 135 ---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPD---DKQLLYSEAKTPIKWMALES 188
Query: 446 VYRNELTTKSDVYSFGVLLLEI 467
++ + T +SDV+S+GV + E+
Sbjct: 189 IHFGKYTHQSDVWSYGVTVWEL 210
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 98.9 bits (246), Expect = 5e-22
Identities = 64/302 (21%), Positives = 112/302 (37%), Gaps = 35/302 (11%)
Query: 192 HENKCYYLHCHREYL--ITLGVVSGLILLTTFAIVIWLLAYRRSKRRRKSRKLSNPAASA 249
++C +E + SG T A L +R S + A
Sbjct: 240 KLKADGLIYCLKEACPNSSASNASGAAAPTLPAHPSTLTHPQRRIDTLNSDGYTPEPARI 299
Query: 250 LVPPSWKVFTT------------EELRSITKNFSEGNRLLGDSKTG----GT-YSGILPD 292
P + EEL+ N L+ D + G G+ G+
Sbjct: 300 TSPDKPRPMPMDTSVFESPFSDPEELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRM 359
Query: 293 GSR---VAVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV 348
+ VA+K LK+ + +E E +L +P +V + G C +V E
Sbjct: 360 RKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAG 418
Query: 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE 408
GPL ++L + + ++ ++ G+ +L +K + VHR++ A NVLL
Sbjct: 419 GGPLHKFLV---GKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNR 472
Query: 409 FGAHLMGVGLSKFVPWEVMQERTVMAGGT---YGYLAPEFVYRNELTTKSDVYSFGVLLL 465
A + GLSK + + + APE + + +++SDV+S+GV +
Sbjct: 473 HYAKISDFGLSKALGAD--DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMW 530
Query: 466 EI 467
E
Sbjct: 531 EA 532
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 5e-22
Identities = 58/203 (28%), Positives = 88/203 (43%), Gaps = 23/203 (11%)
Query: 275 RLLGDSKTGGTYSGILPDGSR----VAVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLVA 329
R +G+ + G + GI VA+K K +S +++F E + HP++V
Sbjct: 21 RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 80
Query: 330 VKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV 389
+ G ++ +I+ E G L +L SLD A + A L+ +A+L K
Sbjct: 81 LIGVITEN-PVWIIMELCTLGELRSFLQ---VRKYSLDLASLILYAYQLSTALAYLESK- 135
Query: 390 KPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL-----APE 444
VHRDI A NVL+ L GLS+++ A G L APE
Sbjct: 136 --RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM----EDSTYYKASK--GKLPIKWMAPE 187
Query: 445 FVYRNELTTKSDVYSFGVLLLEI 467
+ T+ SDV+ FGV + EI
Sbjct: 188 SINFRRFTSASDVWMFGVCMWEI 210
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 6e-22
Identities = 55/215 (25%), Positives = 89/215 (41%), Gaps = 47/215 (21%)
Query: 284 GTYSGILPDGS----RVAVKRLKR-SSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDH 337
G+ D +VAVK LK ++ + + SE+ + H N++ + G C
Sbjct: 88 AEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147
Query: 338 GDRYIVYEFVVNGPL------------DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFL 385
G Y++ E+ G L + + L + A +A+G+ +L
Sbjct: 148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL 207
Query: 386 HDKVKPHVVHRDIRASNVLLDEEFGAHLMGV---GLSKFVPWEVMQERTVMAGGTY---- 438
K +HRD+ A NVL+ E+ ++M + GL+ R + Y
Sbjct: 208 ASK---KCIHRDLAARNVLVTED---NVMKIADFGLA----------RDIHHIDYYKKTT 251
Query: 439 -GYL-----APEFVYRNELTTKSDVYSFGVLLLEI 467
G L APE ++ T +SDV+SFGVLL EI
Sbjct: 252 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 286
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 1e-21
Identities = 59/220 (26%), Positives = 89/220 (40%), Gaps = 52/220 (23%)
Query: 284 GTYSGILPDGS--RVAVKRLKRS-SFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGD 339
T GI G +VAVK LK ++ SE+ +L H N+V + G C G
Sbjct: 64 ATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 123
Query: 340 RYIVYEFVVNGPLDRWL-------------------HHIPRGGRSLDWAMRMKVATTLAQ 380
Y+++E+ G L +L L + + A +A+
Sbjct: 124 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAK 183
Query: 381 GIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGV---GLSKFVPWEVMQERTVMAGGT 437
G+ FL K VHRD+ A NVL+ ++ + GL+ R +M+
Sbjct: 184 GMEFLEFK---SCVHRDLAARNVLVTHG---KVVKICDFGLA----------RDIMSDSN 227
Query: 438 Y-----GYL-----APEFVYRNELTTKSDVYSFGVLLLEI 467
Y L APE ++ T KSDV+S+G+LL EI
Sbjct: 228 YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEI 267
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 2e-21
Identities = 50/240 (20%), Positives = 92/240 (38%), Gaps = 19/240 (7%)
Query: 233 SKRRRKSRKLSNPAASALVPPSWKVFTTEELRSITKNFSEG---NRLLGDSKTGGTYSGI 289
SK R K WK + + + + + LG G + +
Sbjct: 12 SKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCV 71
Query: 290 -LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV 348
G K + K +EI +LHHP L+ + D + ++ EF+
Sbjct: 72 EKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLS 131
Query: 349 NGPL-DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE 407
G L DR I + A + +G+ +H+ +VH DI+ N++ +
Sbjct: 132 GGELFDR----IAAEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCET 184
Query: 408 EFGAHLMGV--GLSKFV-PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLL 464
+ + + + GL+ + P E+++ T T + APE V R + +D+++ GVL
Sbjct: 185 KKASSVKIIDFGLATKLNPDEIVKVTT----ATAEFAAPEIVDREPVGFYTDMWAIGVLG 240
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 96.1 bits (239), Expect = 5e-21
Identities = 59/203 (29%), Positives = 89/203 (43%), Gaps = 23/203 (11%)
Query: 275 RLLGDSKTGGTYSGILPDGSR----VAVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLVA 329
R +G+ + G + GI VA+K K +S +++F E + HP++V
Sbjct: 396 RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 455
Query: 330 VKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV 389
+ G ++ +I+ E G L +L SLD A + A L+ +A+L K
Sbjct: 456 LIGVITEN-PVWIIMELCTLGELRSFLQ---VRKFSLDLASLILYAYQLSTALAYLESK- 510
Query: 390 KPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL-----APE 444
VHRDI A NVL+ L GLS+ M++ T G L APE
Sbjct: 511 --RFVHRDIAARNVLVSSNDCVKLGDFGLSR-----YMEDSTYYKASK-GKLPIKWMAPE 562
Query: 445 FVYRNELTTKSDVYSFGVLLLEI 467
+ T+ SDV+ FGV + EI
Sbjct: 563 SINFRRFTSASDVWMFGVCMWEI 585
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 5e-21
Identities = 54/207 (26%), Positives = 88/207 (42%), Gaps = 39/207 (18%)
Query: 286 YSGILPDGS---RVAVKRLKR-SSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDR 340
+ A+KR+K +S ++F E+ +L HHPN++ + G C G
Sbjct: 42 LKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL 101
Query: 341 YIVYEFVVNGPLDRWL------------HHIPRGGRSLDWAMRMKVATTLAQGIAFLHDK 388
Y+ E+ +G L +L +L + A +A+G+ +L K
Sbjct: 102 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK 161
Query: 389 VKPHVVHRDIRASNVLLDEEFGAHLMGV---GLSKFVPWEVMQERTVMAGGTYGYL---- 441
+HRD+ A N+L+ E ++ + GLS+ + V T G L
Sbjct: 162 ---QFIHRDLAARNILVGEN---YVAKIADFGLSR--------GQEVYVKKTMGRLPVRW 207
Query: 442 -APEFVYRNELTTKSDVYSFGVLLLEI 467
A E + + TT SDV+S+GVLL EI
Sbjct: 208 MAIESLNYSVYTTNSDVWSYGVLLWEI 234
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 5e-21
Identities = 39/204 (19%), Positives = 83/204 (40%), Gaps = 37/204 (18%)
Query: 292 DGSRVAVKRLKRSSFQR-KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR---------- 340
D A+KR++ + + +++ E+ A+L HP +V +
Sbjct: 29 DDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKV 88
Query: 341 --YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDI 398
YI + L W++ + ++ + + +A+ + FLH K ++HRD+
Sbjct: 89 YLYIQMQLCRKENLKDWMNGR-CTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDL 144
Query: 399 RASNVLLDEEFGAHLMGV-----GLSKFVPWEVMQERTVMAG----------GTYGYLAP 443
+ SN+ + V GL + + ++ + GT Y++P
Sbjct: 145 KPSNIFFTMD-----DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSP 199
Query: 444 EFVYRNELTTKSDVYSFGVLLLEI 467
E ++ N + K D++S G++L E+
Sbjct: 200 EQIHGNSYSHKVDIFSLGLILFEL 223
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 1e-20
Identities = 51/256 (19%), Positives = 91/256 (35%), Gaps = 38/256 (14%)
Query: 231 RRSKRRRKSRKLSNPAASALVPPSW---KVFTTEELRSITKNFSEGNR------LLGDSK 281
K+ + L P + V TE+L+ + + E +G
Sbjct: 11 HSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGS 70
Query: 282 TGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR 340
G + G + AVK+++ F+ + E+ A L P +V + G +
Sbjct: 71 FGEVHRMKDKQTGFQCAVKKVRLEVFRVE-----ELVACAGLSSPRIVPLYGAVREGPWV 125
Query: 341 YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRA 400
I E + G L + + L + +G+ +LH + ++H D++A
Sbjct: 126 NIFMELLEGGS----LGQLIKQMGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKA 178
Query: 401 SNVLLDEE--------FG--AHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNE 450
NVLL + FG L GL K + + G ++APE V
Sbjct: 179 DNVLLSSDGSRAALCDFGHALCLQPDGLGK-----SLLTGDYIPGTET-HMAPEVVMGKP 232
Query: 451 LTTKSDVYSFGVLLLE 466
K D++S ++L
Sbjct: 233 CDAKVDIWSSCCMMLH 248
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 4e-20
Identities = 44/177 (24%), Positives = 75/177 (42%), Gaps = 14/177 (7%)
Query: 293 GSRVAVKRLKRSSFQRKK---EFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 349
+A+K L +S +++ + EI + L HPN++ + +D Y++ EF
Sbjct: 39 KFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPR 98
Query: 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF 409
G L + + GR + + LA + + H++ V+HRDI+ N+L+ +
Sbjct: 99 GEL---YKELQKHGRFDEQRSATFMEE-LADALHYCHER---KVIHRDIKPENLLMGYKG 151
Query: 410 GAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLE 466
+ G S P R GT YL PE + K D++ GVL E
Sbjct: 152 ELKIADFGWSVHAP----SLRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYE 204
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 6e-20
Identities = 55/252 (21%), Positives = 90/252 (35%), Gaps = 36/252 (14%)
Query: 230 YRRSKRRRKSRKLSNPAASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGI 289
Y +S + + R++S ++ S + ++F LG G+Y +
Sbjct: 19 YFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRL-SRLGH----GSYGEV 73
Query: 290 L-----PDGSRVAVKRLKRSSFQRK--KEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRY 341
DG AVKR K +E+G ++ HP V ++ + G Y
Sbjct: 74 FKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILY 133
Query: 342 IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRAS 401
+ E L H G SL A +A LH + +VH D++ +
Sbjct: 134 LQTELC-GPSL---QQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPA 186
Query: 402 NVLLDEEFGAHLMGV------GLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKS 455
N+ L G GL V G Y+APE + + T +
Sbjct: 187 NIFLGPR------GRCKLGDFGLLVE--LGTAGAGEVQEGDPR-YMAPE-LLQGSYGTAA 236
Query: 456 DVYSFGVLLLEI 467
DV+S G+ +LE+
Sbjct: 237 DVFSLGLTILEV 248
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 7e-20
Identities = 42/177 (23%), Positives = 74/177 (41%), Gaps = 14/177 (7%)
Query: 293 GSRVAVKRLKRSSFQRKK---EFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 349
+A+K L ++ ++ + E+ + L HPN++ + G +D Y++ E+
Sbjct: 34 KFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPL 93
Query: 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF 409
G + + + + + + LA +++ H K V+HRDI+ N+LL
Sbjct: 94 GTV---YRELQKLSKFDEQRTATYITE-LANALSYCHSK---RVIHRDIKPENLLLGSAG 146
Query: 410 GAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLE 466
+ G S P R GT YL PE + K D++S GVL E
Sbjct: 147 ELKIADFGWSVHAP----SSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYE 199
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 9e-20
Identities = 45/197 (22%), Positives = 87/197 (44%), Gaps = 38/197 (19%)
Query: 292 DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR----------- 340
DG +KR+K + ++ E+ A+L H N+V GC
Sbjct: 35 DGKTYVIKRVKYN----NEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRS 90
Query: 341 -----YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 395
+I EF G L++W+ R G LD + +++ + +G+ ++H K +++
Sbjct: 91 KTKCLFIQMEFCDKGTLEQWIEK--RRGEKLDKVLALELFEQITKGVDYIHSK---KLIN 145
Query: 396 RDIRASNVLLDEEFGAHLMGV-----GLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNE 450
RD++ SN+ L + V GL + + + R+ GT Y++PE + +
Sbjct: 146 RDLKPSNIFLVDT-----KQVKIGDFGLVTSLKNDGKRTRSK---GTLRYMSPEQISSQD 197
Query: 451 LTTKSDVYSFGVLLLEI 467
+ D+Y+ G++L E+
Sbjct: 198 YGKEVDLYALGLILAEL 214
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 1e-19
Identities = 51/243 (20%), Positives = 96/243 (39%), Gaps = 21/243 (8%)
Query: 232 RSKRRRKSRKLSNPAASALVPPSWKVFTTEELRSITKNFSE-----GNRLLGDSKTGGTY 286
R + A + +P F + + + +LG + G +
Sbjct: 47 DLTERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVH 106
Query: 287 SGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYE 345
G ++A K +K + K+E +EI +L H NL+ + D +V E
Sbjct: 107 KCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVME 166
Query: 346 FVVNGPL-DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 404
+V G L DR I +L + + +GI +H +++H D++ N+L
Sbjct: 167 YVDGGELFDR----IIDESYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENIL 219
Query: 405 LDEEFGAHLMGV--GLSKFV-PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFG 461
+ + GL++ P E ++ GT +LAPE V + ++ +D++S G
Sbjct: 220 CVNRDAKQIKIIDFGLARRYKPREKLKVNF----GTPEFLAPEVVNYDFVSFPTDMWSVG 275
Query: 462 VLL 464
V+
Sbjct: 276 VIA 278
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 2e-19
Identities = 36/203 (17%), Positives = 89/203 (43%), Gaps = 43/203 (21%)
Query: 292 DGSRVAVKRLKRSSFQRKKEFYS-----------------EIGRFARLHHPNLVAVKGCC 334
D A+K+ ++S ++K++F E+ + + + +G
Sbjct: 53 DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGII 112
Query: 335 YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQ----GIAFLHDKVK 390
++ + YI+YE++ N + ++ + ++ + ++V + + +++H++
Sbjct: 113 TNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK- 171
Query: 391 PHVVHRDIRASNVLLDEE-------FGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAP 443
++ HRD++ SN+L+D+ F G S+++ + + + GTY ++ P
Sbjct: 172 -NICHRDVKPSNILMDKNGRVKLSDF-------GESEYMVDKKI--KGSR--GTYEFMPP 219
Query: 444 EFVYRNELT--TKSDVYSFGVLL 464
EF K D++S G+ L
Sbjct: 220 EFFSNESSYNGAKVDIWSLGICL 242
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 2e-19
Identities = 41/187 (21%), Positives = 73/187 (39%), Gaps = 17/187 (9%)
Query: 292 DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR----YIVYEFV 347
DG A+KR+ Q ++E E +HPN++ + C +++ F
Sbjct: 53 DGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFF 112
Query: 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE 407
G L + + G L + + + +G+ +H HRD++ +N+LL +
Sbjct: 113 KRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGD 169
Query: 408 EFGAHLMGVGLSKFVPWEVMQERTVMAG-------GTYGYLAPEFV--YRNE-LTTKSDV 457
E LM +G V R + T Y APE + + ++DV
Sbjct: 170 EGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDV 229
Query: 458 YSFGVLL 464
+S G +L
Sbjct: 230 WSLGCVL 236
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 2e-19
Identities = 37/202 (18%), Positives = 75/202 (37%), Gaps = 35/202 (17%)
Query: 292 DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR----------- 340
D A+K+++ + ++ SE+ A L+H +V + +
Sbjct: 30 DSRYYAIKKIRHTE-EKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKS 88
Query: 341 --YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDI 398
+I E+ NG L I + ++ + + ++++H + ++HRD+
Sbjct: 89 TLFIQMEYCENGTL---YDLIHSENLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDL 142
Query: 399 RASNVLLDEE-------FG---AHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFV 446
+ N+ +DE FG + + K + + GT Y+A E V
Sbjct: 143 KPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATE-V 201
Query: 447 YRNELT--TKSDVYSFGVLLLE 466
K D+YS G++ E
Sbjct: 202 LDGTGHYNEKIDMYSLGIIFFE 223
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 2e-19
Identities = 53/201 (26%), Positives = 85/201 (42%), Gaps = 20/201 (9%)
Query: 275 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGC 333
+LG G Y+G L + R+A+K + + + + EI L H N+V G
Sbjct: 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGS 87
Query: 334 CYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATT-LAQGIAFLHDKVKPH 392
++G I E V G L L + G D + T + +G+ +LHD
Sbjct: 88 FSENGFIKIFMEQVPGGSLSALLRS--KWGPLKDNEQTIGFYTKQILEGLKYLHDN---Q 142
Query: 393 VVHRDIRASNVLLDEEFGAHLMGV-----GLSKFVPWEVMQERTVMAGGTYGYLAPEFVY 447
+VHRDI+ NVL++ G + G SK + T GT Y+APE +
Sbjct: 143 IVHRDIKGDNVLINTYSGV----LKISDFGTSKRLAGINPCTETFT--GTLQYMAPEIID 196
Query: 448 RNEL--TTKSDVYSFGVLLLE 466
+ +D++S G ++E
Sbjct: 197 KGPRGYGKAADIWSLGCTIIE 217
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 90.3 bits (224), Expect = 3e-19
Identities = 44/241 (18%), Positives = 92/241 (38%), Gaps = 19/241 (7%)
Query: 232 RSKRRRKSRKLSNPAASALVPPSWKVFTTEELRSITKNFSEG---NRLLGDSKTGGTYSG 288
+ + + + V WK + + + + + + LG G +
Sbjct: 117 EQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRV 176
Query: 289 I-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV 347
G+ A K + K+ EI + L HP LV + D + ++YEF+
Sbjct: 177 TERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 236
Query: 348 VNGPL-DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD 406
G L ++ + + ++ + +G+ +H+ + VH D++ N++
Sbjct: 237 SGGELFEK----VADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFT 289
Query: 407 EEFGAHLMGV--GLSKFV-PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVL 463
+ L + GL+ + P + ++ T GT + APE + +D++S GVL
Sbjct: 290 TKRSNELKLIDFGLTAHLDPKQSVKVTT----GTAEFAAPEVAEGKPVGYYTDMWSVGVL 345
Query: 464 L 464
Sbjct: 346 S 346
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 3e-19
Identities = 49/243 (20%), Positives = 87/243 (35%), Gaps = 27/243 (11%)
Query: 235 RRRKSRKLSNPAASALVPPSWKVFTTEELRSITKNFSEGN----RLLGDSKTGGTYSGI- 289
K P +A P+ E + S R LG +
Sbjct: 3 APADPGKAGVPGVAAPGAPAAAPPAKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISD 62
Query: 290 LPDGSRVAVKRLKRSSFQRKK---EFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF 346
A K + +S + + EI L H ++V G D+ ++V E
Sbjct: 63 ADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLEL 122
Query: 347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD 406
L L R + R + G +LH V+HRD++ N+ L+
Sbjct: 123 CRRRSL---LELHKRRKALTEPEAR-YYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLN 175
Query: 407 EEFGAHLMGV-----GLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFG 461
E+ + V GL+ V ++ +++ + GT Y+APE + + + + DV+S G
Sbjct: 176 ED-----LEVKIGDFGLATKVEYDGERKKVL--CGTPNYIAPEVLSKKGHSFEVDVWSIG 228
Query: 462 VLL 464
++
Sbjct: 229 CIM 231
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 87.2 bits (217), Expect = 4e-19
Identities = 52/212 (24%), Positives = 89/212 (41%), Gaps = 22/212 (10%)
Query: 260 TEELRSITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGR 318
+ + +I K F +LG + G A+K +K+S R +EI
Sbjct: 1 SMQTTNIRKTFIFM-EVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAV 59
Query: 319 FARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL-DRWLHHIPRGGR--SLDWAMRMKVA 375
++ H N+V ++ Y+V + V G L DR I G D ++ ++
Sbjct: 60 LKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDR----ILERGVYTEKDASLVIQ-- 113
Query: 376 TTLAQGIAFLHDKVKPHVVHRDIRASNVLL-DEEFGAHLMGV--GLSKFVPWEVMQERTV 432
+ + +LH+ +VHRD++ N+L E + +M GLSK +M
Sbjct: 114 -QVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTAC- 168
Query: 433 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLL 464
GT GY+APE + + + D +S GV+
Sbjct: 169 ---GTPGYVAPEVLAQKPYSKAVDCWSIGVIT 197
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 89.1 bits (221), Expect = 4e-19
Identities = 41/192 (21%), Positives = 68/192 (35%), Gaps = 23/192 (11%)
Query: 292 DGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNG 350
D VAVKR+ F E+ HPN++ D +YI E
Sbjct: 47 DNRDVAVKRILPECFSFAD---REVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC-AA 102
Query: 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG 410
L + + + + + + G+A LH ++VHRD++ N+L+
Sbjct: 103 TLQEY---VEQKDFAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNA 156
Query: 411 AHLMGV-----GLSK-FVPWEVMQERTVMAGGTYGYLAPEFVYRNE---LTTKSDVYSFG 461
+ GL K R GT G++APE + + T D++S G
Sbjct: 157 HGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAG 216
Query: 462 VLLLEIRLVLCR 473
+ V+
Sbjct: 217 CVFYY---VISE 225
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 5e-19
Identities = 55/209 (26%), Positives = 90/209 (43%), Gaps = 21/209 (10%)
Query: 265 SITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKE-FYSEIGRFARL 322
+I F R LG G + G +K + + Q E +EI L
Sbjct: 19 TIDDLFIFK-RKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSL 77
Query: 323 HHPNLVAVKGCCYDHGDRYIVYEFVVNGPL-DRWLHHIPRGGR--SLDWAMRMKVATTLA 379
HPN++ + D+ + YIV E G L +R + RG A MK +
Sbjct: 78 DHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMK---QMM 134
Query: 380 QGIAFLHDKVKPHVVHRDIRASNVLL-DEEFGAHLMGV--GLSKFV-PWEVMQERTVMAG 435
+A+ H + HVVH+D++ N+L D + + + GL++ E
Sbjct: 135 NALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAA---- 187
Query: 436 GTYGYLAPEFVYRNELTTKSDVYSFGVLL 464
GT Y+APE V++ ++T K D++S GV++
Sbjct: 188 GTALYMAPE-VFKRDVTFKCDIWSAGVVM 215
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 5e-19
Identities = 53/217 (24%), Positives = 88/217 (40%), Gaps = 21/217 (9%)
Query: 256 KVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKE--- 311
+F + + R+LG G G AVK + + ++K +
Sbjct: 14 GMFVQHSTAIFSDRYKGQ-RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKES 72
Query: 312 FYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMR 371
E+ +L HPN++ + D G Y+V E G L I R
Sbjct: 73 LLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGEL---FDEIISRKR-FSEVDA 128
Query: 372 MKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL-DEEFGAHLMGV--GLSKFV-PWEVM 427
++ + GI ++H +VHRD++ N+LL + A++ + GLS + M
Sbjct: 129 ARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM 185
Query: 428 QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLL 464
+++ GT Y+APE V K DV+S GV+L
Sbjct: 186 KDKI----GTAYYIAPE-VLHGTYDEKCDVWSTGVIL 217
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 6e-19
Identities = 56/241 (23%), Positives = 93/241 (38%), Gaps = 22/241 (9%)
Query: 231 RRSKRRRKSRKLSNPAASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGI- 289
R+ P F T + +++ + + LG G
Sbjct: 2 HHHHHHSSGRENLYFQGDLQATPGM--FITSKKGHLSEMYQRV-KKLGSGAYGEVLLCRD 58
Query: 290 LPDGSRVAVKRLKRSSFQRKKE--FYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV 347
A+K ++++S E+ L HPN++ + D + Y+V E
Sbjct: 59 KVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECY 118
Query: 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL-D 406
G L I + + + + G+ +LH ++VHRD++ N+LL
Sbjct: 119 KGGEL---FDEIIHRMK-FNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLES 171
Query: 407 EEFGAHLMGV--GLSKFV-PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVL 463
+E A + V GLS + M+ER GT Y+APE V R + K DV+S GV+
Sbjct: 172 KEKDALIKIVDFGLSAVFENQKKMKERL----GTAYYIAPE-VLRKKYDEKCDVWSIGVI 226
Query: 464 L 464
L
Sbjct: 227 L 227
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 9e-19
Identities = 61/249 (24%), Positives = 102/249 (40%), Gaps = 33/249 (13%)
Query: 234 KRRRKSRKLSNPAASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGI-LPD 292
S + + + P + ++ I +++ + R LG G
Sbjct: 4 HHHHSSGRENLYFQGIAINPGM--YVRKKEGKIGESYFKV-RKLGSGAYGEVLLCKEKNG 60
Query: 293 GSRVAVKRLKRSSF-------------QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGD 339
S A+K +K+S F + +E Y+EI L HPN++ + D
Sbjct: 61 HSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKY 120
Query: 340 RYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIR 399
Y+V EF G L I + D + + GI +LH ++VHRDI+
Sbjct: 121 FYLVTEFYEGGEL---FEQIINRHK-FDECDAANIMKQILSGICYLHKH---NIVHRDIK 173
Query: 400 ASNVLL-DEEFGAHLMGV--GLSKFV-PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKS 455
N+LL ++ ++ V GLS F +++R GT Y+APE V + + K
Sbjct: 174 PENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRL----GTAYYIAPE-VLKKKYNEKC 228
Query: 456 DVYSFGVLL 464
DV+S GV++
Sbjct: 229 DVWSCGVIM 237
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 9e-19
Identities = 30/179 (16%), Positives = 66/179 (36%), Gaps = 22/179 (12%)
Query: 293 GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352
K +K + EI H N++ + + +++EF+ +
Sbjct: 30 KKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDI 88
Query: 353 -DRWLHHIPRGGRSL---DWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE 408
+R I L + + + + + FLH ++ H DIR N++
Sbjct: 89 FER----INTSAFELNEREIVSYVH---QVCEALQFLHSH---NIGHFDIRPENIIYQTR 138
Query: 409 FGAHLMGV--GLSKFV-PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLL 464
+ + + G ++ + P + + Y APE + ++T +D++S G L+
Sbjct: 139 RSSTIKIIEFGQARQLKPGDNFRLLF----TAPEYYAPEVHQHDVVSTATDMWSLGTLV 193
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 1e-18
Identities = 48/203 (23%), Positives = 83/203 (40%), Gaps = 30/203 (14%)
Query: 275 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQR---KKEFYSEIGRFARLHHPNLVAV 330
LLG G Y + G VA+K + + + + + +E+ +L HP+++ +
Sbjct: 17 NLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILEL 76
Query: 331 KGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVK 390
D Y+V E NG ++R+L + R + R + + G+ +LH
Sbjct: 77 YNYFEDSNYVYLVLEMCHNGEMNRYLKN--RVKPFSENEARHFMH-QIITGMLYLHSH-- 131
Query: 391 PHVVHRDIRASNVLLDEE-------FG--AHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 441
++HRD+ SN+LL FG L T+ GT Y+
Sbjct: 132 -GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKH---------YTLC--GTPNYI 179
Query: 442 APEFVYRNELTTKSDVYSFGVLL 464
+PE R+ +SDV+S G +
Sbjct: 180 SPEIATRSAHGLESDVWSLGCMF 202
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 2e-18
Identities = 34/213 (15%), Positives = 72/213 (33%), Gaps = 26/213 (12%)
Query: 292 DGSRVAVKRLKR--SSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVV 348
DG A+KR K+ + ++ E+ A L H ++V + I E+
Sbjct: 35 DGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCN 94
Query: 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE 408
G L + R A + + +G+ ++H +VH DI+ SN+ +
Sbjct: 95 GGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRT 151
Query: 409 --------------FGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNEL--T 452
+ ++ + + + V G + +LA E V +
Sbjct: 152 SIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEEGDSR-FLANE-VLQENYTHL 209
Query: 453 TKSDVYSFGVLLLEIRLVLCRRWWTLYTLVHSM 485
K+D+++ + ++ H +
Sbjct: 210 PKADIFALALTVVC--AAGAEPLPRNGDQWHEI 240
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 86.2 bits (213), Expect = 2e-18
Identities = 24/190 (12%), Positives = 55/190 (28%), Gaps = 19/190 (10%)
Query: 292 DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP 351
+ + +K K ++ + R + +V E G
Sbjct: 94 NKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGT 153
Query: 352 L-DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG 410
L + + + + + + A + I +HD ++H DI+ N +L F
Sbjct: 154 LLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFL 210
Query: 411 AHLMGV-----------GLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYRNELTTKSDV 457
G S + ++ + T+ T G+ E + + D
Sbjct: 211 EQDDEDDLSAGLALIDLGQSIDM--KLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDY 268
Query: 458 YSFGVLLLEI 467
+ + +
Sbjct: 269 FGVAATVYCM 278
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 86.3 bits (213), Expect = 2e-18
Identities = 40/284 (14%), Positives = 75/284 (26%), Gaps = 52/284 (18%)
Query: 232 RSKRRRKSRKLSNPAASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGI-L 290
R+ + +++L EL + G +LG
Sbjct: 42 RTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRG-TVLGQEDPYAYLEATDQ 100
Query: 291 PDGSRVAVKRL---KRSSFQRKKEFYSEIGRFARL----------------------HHP 325
G V +R K+ E+ R L P
Sbjct: 101 ETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDP 160
Query: 326 NLVAVKGCCYDHGDRYIVYEFVV-------NGPLDRWLHHIPRGGRSLDWAMRMKVATTL 378
+ D D +++ F + L +SL R+++ +
Sbjct: 161 QKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQV 220
Query: 379 AQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY 438
+ +A LH +VH +R +++LD+ G L G G +
Sbjct: 221 IRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLV----RDGASAVSPIGRGF 273
Query: 439 G---YLAPEFVY-----RNELTTKSDVYSFGVLLLEIRLVLCRR 474
A + +T D ++ G+ + I C
Sbjct: 274 APPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWI---WCAD 314
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 4e-18
Identities = 47/208 (22%), Positives = 84/208 (40%), Gaps = 24/208 (11%)
Query: 265 SITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLH 323
I + ++ +G G + R A K++ + + F EI L
Sbjct: 6 DINQYYTLE-NTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLD 64
Query: 324 HPNLVAVKGCCYDHGDRYIVYEFVVNGPL-DRWLHHIPRGGR--SLDWAMRMKVATTLAQ 380
HPN++ + D+ D Y+V E G L +R + D A MK +
Sbjct: 65 HPNIIRLYETFEDNTDIYLVMELCTGGELFER----VVHKRVFRESDAARIMK---DVLS 117
Query: 381 GIAFLHDKVKPHVVHRDIRASNVLL-DEEFGAHLMGV--GLSKFV-PWEVMQERTVMAGG 436
+A+ H +V HRD++ N L + + L + GL+ P ++M+ + G
Sbjct: 118 AVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKV----G 170
Query: 437 TYGYLAPEFVYRNELTTKSDVYSFGVLL 464
T Y++P+ V + D +S GV++
Sbjct: 171 TPYYVSPQ-VLEGLYGPECDEWSAGVMM 197
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 84.3 bits (208), Expect = 8e-18
Identities = 40/287 (13%), Positives = 76/287 (26%), Gaps = 57/287 (19%)
Query: 232 RSKRRRKSRKLSNPAASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGI-L 290
R+ + +++L EL + G +LG
Sbjct: 37 RTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRG-TVLGQEDPYAYLEATDQ 95
Query: 291 PDGSRVAVKRLKRSSFQRKKE----------------------------FYSEIGRFARL 322
G V + F
Sbjct: 96 ETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDP 155
Query: 323 HHPNLVAVKGCCYDHG--DRYIVYEFVV--NGPLDRWLHHIPRGGRSLDWAMRMKVATTL 378
++ V+ D R+ +Y + L +SL R+++ +
Sbjct: 156 QKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQV 215
Query: 379 AQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY 438
+ +A LH +VH +R +++LD+ G L G V V++ +
Sbjct: 216 IRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHL------VRDGARVVSSVSR 266
Query: 439 GYLAPEFVYRNEL-----------TTKSDVYSFGVLLLEIRLVLCRR 474
G+ PE R T D ++ G+++ I C
Sbjct: 267 GFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWI---WCAD 310
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 9e-18
Identities = 64/241 (26%), Positives = 102/241 (42%), Gaps = 25/241 (10%)
Query: 231 RRSKRRRKSRKLSNPAASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGI- 289
+ + P ++LVP W + + +++ F LG T Y
Sbjct: 18 LYFQSMSSVTASAAPGTASLVPDYWIDGSNRD--ALSDFFEVE-SELGRGATSIVYRCKQ 74
Query: 290 LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 349
A+K LK++ KK +EIG RL HPN++ +K + +V E V
Sbjct: 75 KGTQKPYALKVLKKT--VDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTG 132
Query: 350 GPL-DRWLHHIPRGGRS-LDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL-D 406
G L DR + +G S D A +K + + +A+LH+ +VHRD++ N+L
Sbjct: 133 GELFDRI---VEKGYYSERDAADAVK---QILEAVAYLHEN---GIVHRDLKPENLLYAT 183
Query: 407 EEFGAHLMGV--GLSKFV-PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVL 463
A L GLSK V +M+ GT GY APE + + D++S G++
Sbjct: 184 PAPDAPLKIADFGLSKIVEHQVLMKTVC----GTPGYCAPEILRGCAYGPEVDMWSVGII 239
Query: 464 L 464
Sbjct: 240 T 240
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 2e-17
Identities = 57/210 (27%), Positives = 89/210 (42%), Gaps = 26/210 (12%)
Query: 265 SITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKE--FYSEIGRFAR 321
+ + ++ +LG G AVK + ++S + K E+ +
Sbjct: 19 TFAERYNIV-CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKK 77
Query: 322 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL-DRWLHHIPRGGR--SLDWAMRMKVATTL 378
L HPN++ + D YIV E G L D I + R D A +K +
Sbjct: 78 LDHPNIMKLFEILEDSSSFYIVGELYTGGELFDE----IIKRKRFSEHDAARIIK---QV 130
Query: 379 AQGIAFLHDKVKPHVVHRDIRASNVLL-DEEFGAHLMGV--GLSKFV-PWEVMQERTVMA 434
GI ++H ++VHRD++ N+LL +E + + GLS M++R
Sbjct: 131 FSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI--- 184
Query: 435 GGTYGYLAPEFVYRNELTTKSDVYSFGVLL 464
GT Y+APE V R K DV+S GV+L
Sbjct: 185 -GTAYYIAPE-VLRGTYDEKCDVWSAGVIL 212
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 84.1 bits (208), Expect = 2e-17
Identities = 44/199 (22%), Positives = 64/199 (32%), Gaps = 33/199 (16%)
Query: 292 DGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNG 350
G VAVKR+ EI HPN++ YI E N
Sbjct: 38 QGRPVAVKRMLIDFCDIAL---MEIKLLTESDDHPNVIRYYCSETTDRFLYIALEL-CNL 93
Query: 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQ---GIAFLHDKVKPHVVHRDIRASNVLLDE 407
L + +L + L Q G+A LH ++HRD++ N+L+
Sbjct: 94 NLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVST 150
Query: 408 EFGAHLMGV-------------GLSKFVPWEVMQERTVM--AGGTYGYLAPE-------F 445
GL K + RT + GT G+ APE
Sbjct: 151 SSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNL 210
Query: 446 VYRNELTTKSDVYSFGVLL 464
+ LT D++S G +
Sbjct: 211 QTKRRLTRSIDIFSMGCVF 229
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 2e-17
Identities = 53/208 (25%), Positives = 86/208 (41%), Gaps = 20/208 (9%)
Query: 264 RSITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRK--KEFYSEIGRFA 320
+ + ++ +LG G AVK + ++S + K E+
Sbjct: 18 GTFAERYNIV-CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLK 76
Query: 321 RLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQ 380
+L HPN++ + D YIV E G L I + R ++ +
Sbjct: 77 KLDHPNIMKLFEILEDSSSFYIVGELYTGGEL---FDEIIKRKR-FSEHDAARIIKQVFS 132
Query: 381 GIAFLHDKVKPHVVHRDIRASNVLL-DEEFGAHLMGV--GLSKFV-PWEVMQERTVMAGG 436
GI ++H ++VHRD++ N+LL +E + + GLS M++R G
Sbjct: 133 GITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI----G 185
Query: 437 TYGYLAPEFVYRNELTTKSDVYSFGVLL 464
T Y+APE V R K DV+S GV+L
Sbjct: 186 TAYYIAPE-VLRGTYDEKCDVWSAGVIL 212
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 2e-17
Identities = 40/180 (22%), Positives = 74/180 (41%), Gaps = 22/180 (12%)
Query: 293 GSRVAVKRLKRSSFQRKK---EFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 349
A K + +S + + EI L H ++V G D+ ++V E
Sbjct: 40 KEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRR 99
Query: 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF 409
L L R + R + G +LH V+HRD++ N+ L+E+
Sbjct: 100 RSL---LELHKRRKALTEPEAR-YYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNED- 151
Query: 410 GAHLMGV-----GLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLL 464
+ V GL+ V ++ +++ + GT Y+APE + + + + DV+S G ++
Sbjct: 152 ----LEVKIGDFGLATKVEYDGERKKVL--CGTPNYIAPEVLSKKGHSFEVDVWSIGCIM 205
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 3e-17
Identities = 47/238 (19%), Positives = 85/238 (35%), Gaps = 35/238 (14%)
Query: 245 PAASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRVAVK---- 299
P S + ++ + ++G I G + AVK
Sbjct: 3 PGISGGGGGILDM--ADDDVLFEDVYELC-EVIGKGPFSVVRRCINRETGQQFAVKIVDV 59
Query: 300 -RLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL-DRWLH 357
+ S ++ E L HP++V + G Y+V+EF+ L
Sbjct: 60 AKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFE--- 116
Query: 358 HIPRGGRSLDW------AMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL-DEEFG 410
I + + + M+ + + + + HD +++HRD++ VLL +E
Sbjct: 117 -IVKRADAGFVYSEAVASHYMR---QILEALRYCHDN---NIIHRDVKPHCVLLASKENS 169
Query: 411 AHLMGV--GLSKFV--PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLL 464
A + G++ + V R GT ++APE V R DV+ GV+L
Sbjct: 170 APVKLGGFGVAIQLGESGLVAGGRV----GTPHFMAPEVVKREPYGKPVDVWGCGVIL 223
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 6e-17
Identities = 47/200 (23%), Positives = 84/200 (42%), Gaps = 29/200 (14%)
Query: 277 LGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY 335
+G +G Y+ + + G VA++++ +K+ +EI +PN+V
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 336 DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 395
+ ++V E++ G L + +D V Q + FLH V+H
Sbjct: 88 VGDELWVVMEYLAGGSLTDVVTETC-----MDEGQIAAVCRECLQALEFLHSN---QVIH 139
Query: 396 RDIRASNVLLDEE-------FG--AHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFV 446
RDI++ N+LL + FG A + +R+ M G Y ++APE V
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQIT----------PEQSKRSTMVGTPY-WMAPEVV 188
Query: 447 YRNELTTKSDVYSFGVLLLE 466
R K D++S G++ +E
Sbjct: 189 TRKAYGPKVDIWSLGIMAIE 208
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 6e-17
Identities = 46/200 (23%), Positives = 91/200 (45%), Gaps = 29/200 (14%)
Query: 277 LGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY 335
+G+ TG G +VAVK + QR++ ++E+ H N+V +
Sbjct: 53 IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL 112
Query: 336 DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 395
+ +++ EF+ G L + + L+ V + Q +A+LH + V+H
Sbjct: 113 VGEELWVLMEFLQGGALTDIVSQVR-----LNEEQIATVCEAVLQALAYLHAQ---GVIH 164
Query: 396 RDIRASNVLLDEE-------FG--AHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFV 446
RDI++ ++LL + FG A + + + +R + G Y ++APE +
Sbjct: 165 RDIKSDSILLTLDGRVKLSDFGFCAQIS----------KDVPKRKSLVGTPY-WMAPEVI 213
Query: 447 YRNELTTKSDVYSFGVLLLE 466
R+ T+ D++S G++++E
Sbjct: 214 SRSLYATEVDIWSLGIMVIE 233
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 6e-17
Identities = 42/221 (19%), Positives = 87/221 (39%), Gaps = 25/221 (11%)
Query: 256 KVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRK--KEF 312
+ + + + + ++ LG K I G A K LK+ + E
Sbjct: 16 ENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEI 75
Query: 313 YSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNGPL-DRWLHHIPRGGRSL---D 367
EI P ++ + + + ++ E+ G + +P + D
Sbjct: 76 LHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLC---LPELAEMVSEND 132
Query: 368 WAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL-DEEFGAHLMGV--GLSKFV-P 423
+K + +G+ +LH ++VH D++ N+LL + V G+S+ +
Sbjct: 133 VIRLIK---QILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGH 186
Query: 424 WEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLL 464
++E GT YLAPE + + +TT +D+++ G++
Sbjct: 187 ACELREIM----GTPEYLAPEILNYDPITTATDMWNIGIIA 223
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 81.5 bits (201), Expect = 7e-17
Identities = 41/203 (20%), Positives = 78/203 (38%), Gaps = 21/203 (10%)
Query: 278 GDSKTGGTYSGI-LPDGSRVAVKR--LKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCC 334
G P G V V+R L+ S + E+ +HPN+V +
Sbjct: 36 GFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATF 95
Query: 335 YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLA---QGIAFLHDKVKP 391
+ ++V F+ G + G + +A L + + ++H
Sbjct: 96 IADNELWVVTSFMAYGSAKDLICTHFMDGMNELA-----IAYILQGVLKALDYIHHM--- 147
Query: 392 HVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG-----GTYGYLAPEFV 446
VHR ++AS++L+ + +L G+ + + ++R V +L+PE +
Sbjct: 148 GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVL 207
Query: 447 YRNEL--TTKSDVYSFGVLLLEI 467
+N KSD+YS G+ E+
Sbjct: 208 QQNLQGYDAKSDIYSVGITACEL 230
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 7e-17
Identities = 47/209 (22%), Positives = 83/209 (39%), Gaps = 23/209 (11%)
Query: 267 TKNFSEG---NRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRK--KEFYSEIGRFA 320
+ FS+ LG + G A K + + ++ E
Sbjct: 1 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60
Query: 321 RLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL-DRWLHHIPRGGRSLDWAMRMKVATTLA 379
+L HPN+V + + Y+V++ V G L + + R S A +
Sbjct: 61 KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDI---VAREFYSEADAS--HCIQQIL 115
Query: 380 QGIAFLHDKVKPHVVHRDIRASNVLL-DEEFGAHLMGV--GLSKFV-PWEVMQERTVMAG 435
+ IA+ H +VHR+++ N+LL + GA + GL+ V E
Sbjct: 116 ESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA---- 168
Query: 436 GTYGYLAPEFVYRNELTTKSDVYSFGVLL 464
GT GYL+PE + ++ + D+++ GV+L
Sbjct: 169 GTPGYLSPEVLKKDPYSKPVDIWACGVIL 197
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 3e-16
Identities = 44/210 (20%), Positives = 81/210 (38%), Gaps = 25/210 (11%)
Query: 265 SITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL- 322
++T ++ ++LG G G + A+K L S R+ E+ +
Sbjct: 25 AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQ-----EVDHHWQAS 79
Query: 323 HHPNLVAVKGCCYDHGDR----YIVYEFVVNGPLDRWLHHI-PRGGRSLDWAMRMKVATT 377
P++V + + I+ E + G L I RG ++ ++
Sbjct: 80 GGPHIVCILDVYENMHHGKRCLLIIMECMEGGEL---FSRIQERGDQAFTEREAAEIMRD 136
Query: 378 LAQGIAFLHDKVKPHVVHRDIRASNVLL-DEEFGAHLMGV--GLSKFVPWEVMQERTVMA 434
+ I FLH ++ HRD++ N+L +E A L G +K +Q
Sbjct: 137 IGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPC--- 190
Query: 435 GGTYGYLAPEFVYRNELTTKSDVYSFGVLL 464
T Y+APE + + D++S GV++
Sbjct: 191 -YTPYYVAPEVLGPEKYDKSCDMWSLGVIM 219
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 3e-16
Identities = 47/216 (21%), Positives = 86/216 (39%), Gaps = 23/216 (10%)
Query: 258 FTTEELRSITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRK--KEFYS 314
F + N+ LG + G A K + + ++
Sbjct: 19 FMMNASTKFSDNYDVK-EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLER 77
Query: 315 EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL-DRWLHHIPRGGRS-LDWAMRM 372
E +L HPN+V + + Y+V++ V G L + + R S D + +
Sbjct: 78 EARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDI---VAREFYSEADASHCI 134
Query: 373 KVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL-DEEFGAHLMGV--GLSKFV-PWEVMQ 428
+ + + IA+ H +VHR+++ N+LL + GA + GL+ V E
Sbjct: 135 Q---QILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH 188
Query: 429 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLL 464
GT GYL+PE + ++ + D+++ GV+L
Sbjct: 189 GFA----GTPGYLSPEVLKKDPYSKPVDIWACGVIL 220
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 3e-16
Identities = 46/214 (21%), Positives = 83/214 (38%), Gaps = 20/214 (9%)
Query: 259 TTEELRSITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKE--FYSE 315
T T+ + LG + + G A + + E
Sbjct: 2 ATITCTRFTEEYQLF-EELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLERE 60
Query: 316 IGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL-DRWLHHIPRGGRS-LDWAMRMK 373
L HPN+V + + G Y++++ V G L + + R S D + ++
Sbjct: 61 ARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDI---VAREYYSEADASHCIQ 117
Query: 374 VATTLAQGIAFLHDKVKPHVVHRDIRASNVLL-DEEFGAHLMGV--GLSKFVPWEVMQER 430
+ + + H VVHR+++ N+LL + GA + GL+ V E Q+
Sbjct: 118 ---QILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE--QQA 169
Query: 431 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLL 464
GT GYL+PE + ++ D+++ GV+L
Sbjct: 170 WFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVIL 203
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 5e-16
Identities = 38/185 (20%), Positives = 75/185 (40%), Gaps = 26/185 (14%)
Query: 293 GSRVAVKRLKRSSFQR------KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF 346
G A K +K+ + ++E E+ ++ H N++ + + D ++ E
Sbjct: 37 GLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILEL 96
Query: 347 VVNGPL-DRWLHHIPRGGRS-LDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 404
V G L D + S + +K + G+ +LH K + H D++ N++
Sbjct: 97 VSGGELFDFL---AQKESLSEEEATSFIK---QILDGVNYLHTK---KIAHFDLKPENIM 147
Query: 405 LD--EEFGAHLMGV--GLSKFV-PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYS 459
L H+ + GL+ + + GT ++APE V L ++D++S
Sbjct: 148 LLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF----GTPEFVAPEIVNYEPLGLEADMWS 203
Query: 460 FGVLL 464
GV+
Sbjct: 204 IGVIT 208
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 5e-16
Identities = 38/185 (20%), Positives = 72/185 (38%), Gaps = 26/185 (14%)
Query: 293 GSRVAVK-----RLKRSSFQRKKE-FYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF 346
G A K RL S +E E+ + HPN++ + + D ++ E
Sbjct: 30 GKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILEL 89
Query: 347 VVNGPL-DRWLHHIPRGGRS-LDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 404
V G L D + + + +K + G+ +LH K + H D++ N++
Sbjct: 90 VSGGELFDFL---AEKESLTEDEATQFLK---QILDGVHYLHSK---RIAHFDLKPENIM 140
Query: 405 LD--EEFGAHLMGV--GLSKFV-PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYS 459
L + + G++ + + GT ++APE V L ++D++S
Sbjct: 141 LLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIF----GTPEFVAPEIVNYEPLGLEADMWS 196
Query: 460 FGVLL 464
GV+
Sbjct: 197 IGVIT 201
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 5e-16
Identities = 62/255 (24%), Positives = 99/255 (38%), Gaps = 40/255 (15%)
Query: 236 RRKSRKLSNPAASALVPPSWKVFTTEELRSITKNFSEGN--------RLLGDSKTGGTYS 287
+ K R L+N + AL KVF +L ++ + LG G
Sbjct: 94 KGKRRPLNNNSEIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKL 153
Query: 288 GI-LPDGSRVAVKRLKRSSFQRKKE--------FYSEIGRFARLHHPNLVAVKGCCYDHG 338
+VA++ + + F +EI +L+HP ++ +K +D
Sbjct: 154 AFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF-FDAE 212
Query: 339 DRYIVYEFVVNGPL-DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRD 397
D YIV E + G L D+ + R L A + + +LH+ ++HRD
Sbjct: 213 DYYIVLELMEGGELFDK----VVGNKR-LKEATCKLYFYQMLLAVQYLHEN---GIIHRD 264
Query: 398 IRASNVLLD-EEFGAHLMGV--GLSKFVPWEVMQERTVMAG--GTYGYLAPE---FVYRN 449
++ NVLL +E + G SK + E ++M GT YLAPE V
Sbjct: 265 LKPENVLLSSQEEDCLIKITDFGHSKI-----LGETSLMRTLCGTPTYLAPEVLVSVGTA 319
Query: 450 ELTTKSDVYSFGVLL 464
D +S GV+L
Sbjct: 320 GYNRAVDCWSLGVIL 334
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 6e-16
Identities = 39/185 (21%), Positives = 75/185 (40%), Gaps = 26/185 (14%)
Query: 293 GSRVAVKRLKRSS------FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF 346
G A K +K+ ++E E+ ++ HPN++ + + D ++ E
Sbjct: 37 GLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILEL 96
Query: 347 VVNGPL-DRWLHHIPRGGRS-LDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 404
V G L D + S + +K + G+ +LH K + H D++ N++
Sbjct: 97 VSGGELFDFL---AQKESLSEEEATSFIK---QILDGVNYLHTK---KIAHFDLKPENIM 147
Query: 405 LD--EEFGAHLMGV--GLSKFV-PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYS 459
L H+ + GL+ + + GT ++APE V L ++D++S
Sbjct: 148 LLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF----GTPEFVAPEIVNYEPLGLEADMWS 203
Query: 460 FGVLL 464
GV+
Sbjct: 204 IGVIT 208
|
| >1fm5_A Early activation antigen CD69; C-type lectin-like domain, natural killer cell receptor, lectin, C-type lectin, immune system; 2.27A {Homo sapiens} SCOP: d.169.1.1 Length = 199 | Back alignment and structure |
|---|
Score = 75.0 bits (184), Expect = 8e-16
Identities = 37/182 (20%), Positives = 69/182 (37%), Gaps = 29/182 (15%)
Query: 10 VPLQCFLLLVAYY---VLQLVASDTISNQSSNGQLAASMNKDWKAPCPPDWIINEEKSKC 66
VP+ C ++ V + ++ L+A + + + C DW+ + KC
Sbjct: 39 VPVLCAVMNVVFITILIIALIALSVGQYNCPGQYTFSMPSDSHVSSCSEDWVGYQ--RKC 96
Query: 67 FGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGL 126
+ RSW ++ C E G LA + S ++ + ++ G+ WVG + G
Sbjct: 97 YFISTVKRSWTSAQNACSEHGATLAVIDSEKDMNFLKRYAGR--EEHWVG---LKKEPGH 151
Query: 127 SWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPF 186
WKWS+ ++N + GS C + N + + C + +
Sbjct: 152 PWKWSNG-KEFNNWFNVTGSDK----------------CVFLKNT--EVSSMECEKNLYW 192
Query: 187 IC 188
IC
Sbjct: 193 IC 194
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 9e-16
Identities = 47/193 (24%), Positives = 88/193 (45%), Gaps = 32/193 (16%)
Query: 291 PDGSRVAVKRLKR-SSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVV 348
P G +AVKR++ + Q +K ++ R P V G + GD +I E +
Sbjct: 30 PSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELM- 88
Query: 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE 408
+ LD++ + G+++ + K+A ++ + + LH K+ V+HRD++ SNVL++
Sbjct: 89 DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINAL 146
Query: 409 -------FG--AHLMG-VGLSKFVPWEVMQERTVMAGGTYGYLAPE----FVYRNELTTK 454
FG +L+ V G Y+APE + + + K
Sbjct: 147 GQVKMCDFGISGYLVDDVAKDIDA-------------GCKPYMAPERINPELNQKGYSVK 193
Query: 455 SDVYSFGVLLLEI 467
SD++S G+ ++E+
Sbjct: 194 SDIWSLGITMIEL 206
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 79.3 bits (195), Expect = 9e-16
Identities = 39/184 (21%), Positives = 80/184 (43%), Gaps = 21/184 (11%)
Query: 293 GSRVAVKRLKRSSFQRKKE-FYSEIGRFARLHHPNLVAV------KGCCYDHGDRYIVYE 345
G +VA+K+ ++ + +E + EI +L+HPN+V+ + + E
Sbjct: 39 GEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAME 98
Query: 346 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL 405
+ G L ++L+ L + + ++ + +LH+ ++HRD++ N++L
Sbjct: 99 YCEGGDLRKYLNQFENCCG-LKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVL 154
Query: 406 DEEFGAHLMGV---GLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYRNELTTKSDVYSF 460
+ + G +K + + + GT YLAPE + + + T D +SF
Sbjct: 155 QPGPQRLIHKIIDLGYAKE-----LDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSF 209
Query: 461 GVLL 464
G L
Sbjct: 210 GTLA 213
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 9e-16
Identities = 26/178 (14%), Positives = 42/178 (23%), Gaps = 49/178 (27%)
Query: 296 VAVKRLKRSSF---QRKKEFYSEIGRFARLHHPNLVAVKGCCYD---HGDR-YIVYEFVV 348
VA+ + +E S R +R+ P + V D +V E++
Sbjct: 59 VALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV----LDVVHTRAGGLVVAEWIR 114
Query: 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE 408
G L S A+R +LA H V S V + +
Sbjct: 115 GGSLQEVA----DTSPSPVGAIR--AMQSLAAAADAAHRA---GVALSIDHPSRVRVSID 165
Query: 409 FGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLE 466
L + + D+ G L
Sbjct: 166 GDVVL----------------------AYPATMPDA-------NPQDDIRGIGASLYA 194
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 1e-15
Identities = 44/176 (25%), Positives = 77/176 (43%), Gaps = 16/176 (9%)
Query: 297 AVKRLKRSSFQRKKEF---YSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 353
A+K L++ ++ + E +RL HP V + D Y + NG L
Sbjct: 59 AIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGEL- 117
Query: 354 RWLHHIPRGGRSLDWAMRMKVAT-TLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAH 412
L +I + G + R A A + +LH K ++HRD++ N+LL+E+ H
Sbjct: 118 --LKYIRKIGSFDETCTRFYTAEIVSA--LEYLHGK---GIIHRDLKPENILLNED--MH 168
Query: 413 LMGV--GLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLE 466
+ G +K + E Q R GT Y++PE + SD+++ G ++ +
Sbjct: 169 IQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQ 224
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 1e-15
Identities = 45/247 (18%), Positives = 86/247 (34%), Gaps = 32/247 (12%)
Query: 232 RSKRRRKSRKLSNPAASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGI-L 290
+ P K + +I ++ +++LG G
Sbjct: 25 TPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNK 84
Query: 291 PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDR----YIVYE 345
+ A+K L+ R+ E+ R P++V + + IV E
Sbjct: 85 RTQEKFALKMLQDCPKARR-----EVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVME 139
Query: 346 FVVNGPLDRWLHHI-PRGGRSL---DWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRAS 401
+ G L I RG ++ + + MK ++ + I +LH ++ HRD++
Sbjct: 140 CLDGGEL---FSRIQDRGDQAFTEREASEIMK---SIGEAIQYLHSI---NIAHRDVKPE 190
Query: 402 NVLL-DEEFGAHLMGV--GLSKFV-PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDV 457
N+L + A L G +K + T Y+APE + + D+
Sbjct: 191 NLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPC----YTPYYVAPEVLGPEKYDKSCDM 246
Query: 458 YSFGVLL 464
+S GV++
Sbjct: 247 WSLGVIM 253
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 1e-15
Identities = 35/185 (18%), Positives = 73/185 (39%), Gaps = 26/185 (14%)
Query: 293 GSRVAVKRLKRS------SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF 346
G + A K +K+ +++ E+ + HPN++ + + D ++ E
Sbjct: 36 GLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILEL 95
Query: 347 VVNGPL-DRWLHHIPRGGRS-LDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 404
V G L D + + + +K + G+ +LH + H D++ N++
Sbjct: 96 VAGGELFDFL---AEKESLTEEEATEFLK---QILNGVYYLHSL---QIAHFDLKPENIM 146
Query: 405 L--DEEFGAHLMGV--GLSKFV-PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYS 459
L + + GL+ + + GT ++APE V L ++D++S
Sbjct: 147 LLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF----GTPEFVAPEIVNYEPLGLEADMWS 202
Query: 460 FGVLL 464
GV+
Sbjct: 203 IGVIT 207
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 77.5 bits (191), Expect = 1e-15
Identities = 38/257 (14%), Positives = 87/257 (33%), Gaps = 37/257 (14%)
Query: 231 RRSKRRRKSRKLSNPAASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGIL 290
+ + + + + +P E + + +S + +G + + +
Sbjct: 19 ETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSIL-KQIGSGGSSKVFQVLN 77
Query: 291 PDGSRVAVKRLKRSSFQRK--KEFYSEIGRFARLHHPNLVAVK--GCCYDHGDRYIVYEF 346
A+K + + + +EI +L + ++ Y+V E
Sbjct: 78 EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC 137
Query: 347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD 406
N L+ WL +S+D R + + + +H +VH D++ +N L+
Sbjct: 138 G-NIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV 189
Query: 407 EE------FGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPE-----------FVYRN 449
+ F G++ + + G Y+ PE ++
Sbjct: 190 DGMLKLIDF-------GIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKS 242
Query: 450 ELTTKSDVYSFGVLLLE 466
+++ KSDV+S G +L
Sbjct: 243 KISPKSDVWSLGCILYY 259
|
| >1mpu_A NKG2-D type II integral membrane protein; C-type lectin-like domain, immune system; 2.50A {Homo sapiens} SCOP: d.169.1.1 PDB: 1hyr_B Length = 138 | Back alignment and structure |
|---|
Score = 72.5 bits (178), Expect = 2e-15
Identities = 31/155 (20%), Positives = 58/155 (37%), Gaps = 23/155 (14%)
Query: 34 NQSSNGQLAASMNKDWKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAAL 93
N N ++ + + + PCP +WI + + C+ + ++W ES+ C L +
Sbjct: 2 NSLFNQEVQIPLTESYCGPCPKNWICYK--NNCYQFFDESKNWYESQASCMSQNASLLKV 59
Query: 94 TSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTS 153
S E+ Q L + W+G + SW+W D S + ++ +
Sbjct: 60 YSKED----QDLLKLVKSYHWMGLV--HIPTNGSWQWEDG-SILSPNLLTIIEMQKG--- 109
Query: 154 LPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFIC 188
D S+ E C+T + +IC
Sbjct: 110 ---------DCALYASSF--KGYIENCSTPNTYIC 133
|
| >1ypq_A Oxidised low density lipoprotein (lectin-like) receptor 1; oxidized low density lipoprotein receptor, LOX-1, CTLD, C- type lectin like domain; 1.40A {Homo sapiens} SCOP: d.169.1.1 PDB: 1ypu_A 1yxk_A 3vlg_A 1ypo_A 1yxj_A Length = 135 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 3e-15
Identities = 28/139 (20%), Positives = 48/139 (34%), Gaps = 17/139 (12%)
Query: 51 APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNV 110
APCP DWI + C+ + +W++S+ C + L + S + Q+ +
Sbjct: 7 APCPQDWIWHG--ENCYLFSSGSFNWEKSQEKCLSLDAKLLKINSTADLDFIQQAISYSS 64
Query: 111 NGCWVGGRSINTTVGLSWKWSDNMSKWNESI-HAVGSFNSSCTSLPCHVHATVDLCTLVS 169
W+G N W W D S + G+ + + S C
Sbjct: 65 FPFWMGLSRRNP--SYPWLWEDG-SPLMPHLFRVRGAVSQTYPSGTC-----------AY 110
Query: 170 NGSRSLVTERCNTSHPFIC 188
++ E C + IC
Sbjct: 111 IQRGAVYAENCILAAFSIC 129
|
| >3rs1_A C-type lectin domain family 2 member I; C-type lectin-like, ligand of NK receptor, natural killer CE receptors, surface of activated T lymphocytes; 1.94A {Mus musculus} Length = 122 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 3e-15
Identities = 30/144 (20%), Positives = 56/144 (38%), Gaps = 26/144 (18%)
Query: 45 MNKDWKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQK 104
MNK + A C +W +KCF + G R+W ++ +C LA + EE ++
Sbjct: 1 MNKTY-AACSKNWTGVG--NKCFYFSGYPRNWTFAQAFCMAQEAQLARFDNEEELIFLKR 57
Query: 105 LCGKNVNGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDL 164
G W+G ++ WKW++N +++N +G
Sbjct: 58 FKGD--FDSWIGLHRESS--EHPWKWTNN-TEYNNMNPILGVGR---------------- 96
Query: 165 CTLVSNGSRSLVTERCNTSHPFIC 188
+S+ + + R + +IC
Sbjct: 97 YAYLSSD--RISSSRSYINRMWIC 118
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 75.6 bits (186), Expect = 4e-15
Identities = 45/238 (18%), Positives = 76/238 (31%), Gaps = 51/238 (21%)
Query: 275 RLLGDSKTGGTYSGI-LPDGSRVAVK-----RLKRSSFQRKKEFYSEIGRFARLHHPNLV 328
+G G I + A+K ++++ + + + +E+ +LHHPN+
Sbjct: 32 GAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIA 91
Query: 329 AVKGCCYDHGDRYIVYEFVVNGPL-DRWLHHIPRGGRSLDWAMRM--------------- 372
+ D +V E G L D+ I +
Sbjct: 92 RLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAIN 151
Query: 373 --------------------KVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAH 412
+ + + +LH++ + HRDI+ N L
Sbjct: 152 GSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFE 208
Query: 413 LMGV--GLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYRNEL--TTKSDVYSFGVLL 464
+ V GLSK E M GT ++APE + K D +S GVLL
Sbjct: 209 IKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 5e-15
Identities = 35/202 (17%), Positives = 73/202 (36%), Gaps = 36/202 (17%)
Query: 286 YSGILPDGSRVAVKRLKRSSFQRK--KEFYSEIGRFARLHHPNLVAVK--GCCYDHGDRY 341
+ + A+K + + + +EI +L + ++ Y
Sbjct: 45 FQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 104
Query: 342 IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRAS 401
+V E N L+ WL +S+D R + + + +H +VH D++ +
Sbjct: 105 MVMECG-NIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPA 156
Query: 402 NVLLDEEFGAHLMGV------GLSKFVPWEVMQERTVMAGGTYGYLAPE----------- 444
N L+ + G+ G++ + + GT Y+ PE
Sbjct: 157 NFLIVD-------GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSREN 209
Query: 445 FVYRNELTTKSDVYSFGVLLLE 466
+++++ KSDV+S G +L
Sbjct: 210 GKSKSKISPKSDVWSLGCILYY 231
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 5e-15
Identities = 49/202 (24%), Positives = 88/202 (43%), Gaps = 15/202 (7%)
Query: 277 LGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQ-RKKEFYSEIGRFARLHHPNLVAVKGCC 334
+G T + P +VA+KR+ Q E EI ++ HHPN+V+
Sbjct: 23 IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSF 82
Query: 335 YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMR-MKVATTLAQ---GIAFLHDKVK 390
+ ++V + + G + + HI G + +AT L + G+ +LH
Sbjct: 83 VVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN-- 140
Query: 391 PHVVHRDIRASNVLLDEEFGAHLM--GVG--LSKFVPWEVMQERTVMAGGTYGYLAPEFV 446
+HRD++A N+LL E+ + GV L+ + R G ++APE +
Sbjct: 141 -GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC-WMAPEVM 198
Query: 447 YRNEL-TTKSDVYSFGVLLLEI 467
+ K+D++SFG+ +E+
Sbjct: 199 EQVRGYDFKADIWSFGITAIEL 220
|
| >1jwi_A Bitiscetin; domain swapping, C-type lectin, toxin; 2.00A {Bitis arietans} SCOP: d.169.1.1 PDB: 1uex_A Length = 131 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 7e-15
Identities = 36/144 (25%), Positives = 55/144 (38%), Gaps = 30/144 (20%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNG 112
C PDW + C+ +W+++E +C E GHLA++ S EE KL + +
Sbjct: 4 CLPDWSSYK--GHCYKVFKKVGTWEDAEKFCVENSGHLASIDSKEEADFVTKLASQTLTK 61
Query: 113 ----CWVGGRSINTTVGLSWKWSDNMS----KWNESIHAVGSFNSSCTSLPCHVHATVDL 164
W+G R + T S +W+D S +E + C L H
Sbjct: 62 FVYDAWIGLRDESKTQQCSPQWTDGSSVVYENVDE--------PTKCFGLDVHT------ 107
Query: 165 CTLVSNGSRSLVTERCNTSHPFIC 188
R+ C +PFIC
Sbjct: 108 ------EYRTWTDLPCGEKNPFIC 125
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 9e-15
Identities = 47/255 (18%), Positives = 97/255 (38%), Gaps = 37/255 (14%)
Query: 231 RRSKRRRKSRKLSNPAASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGI- 289
K K + + P ++ + + + ++G + +
Sbjct: 57 EAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPK-DVIGRGVSSVVRRCVH 115
Query: 290 LPDGSRVAVKRLKRSSFQRKKE--------FYSEIGRFARLH-HPNLVAVKGCCYDHGDR 340
G AVK ++ ++ + E E ++ HP+++ +
Sbjct: 116 RATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFM 175
Query: 341 YIVYEFVVNGPL-DRWLHHIPRGGR-SLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDI 398
++V++ + G L D + S + +L + ++FLH ++VHRD+
Sbjct: 176 FLVFDLMRKGELFDY----LTEKVALSEKET--RSIMRSLLEAVSFLHAN---NIVHRDL 226
Query: 399 RASNVLLDEEFGAHLMGV--GLSKFV-PWEVMQERTVMAGGTYGYLAPEFVYRNELTT-- 453
+ N+LLD+ + G S + P E ++E GT GYLAPE + + T
Sbjct: 227 KPENILLDDN--MQIRLSDFGFSCHLEPGEKLRELC----GTPGYLAPEILKCSMDETHP 280
Query: 454 ----KSDVYSFGVLL 464
+ D+++ GV+L
Sbjct: 281 GYGKEVDLWACGVIL 295
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 1e-14
Identities = 45/219 (20%), Positives = 78/219 (35%), Gaps = 27/219 (12%)
Query: 264 RSITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKE-FYSEIGRFAR 321
+S + + + +LG T + G G A+K SF R + E +
Sbjct: 4 QSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKK 63
Query: 322 LHHPNLVAVKGCCYDHGDR--YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLA 379
L+H N+V + + R ++ EF G L L P L + + V +
Sbjct: 64 LNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEE-PSNAYGLPESEFLIVLRDVV 122
Query: 380 QGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAH----LMGVGLSKFVPWEVMQERTVMAG 435
G+ L + +VHR+I+ N++ L G ++ +++
Sbjct: 123 GGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE-----LEDDEQFVS 174
Query: 436 --GTYGYLAPEFVYRNELTT--------KSDVYSFGVLL 464
GT YL P+ R L D++S GV
Sbjct: 175 LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTF 213
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 1e-14
Identities = 40/201 (19%), Positives = 75/201 (37%), Gaps = 31/201 (15%)
Query: 292 DGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDH-----------GD 339
G A+KRL + ++ + E+ +L HPN+V
Sbjct: 52 SGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQ----FCSAASIGKEESDTGQA 107
Query: 340 RYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIR 399
+++ + G L +L + G L +K+ + + +H + KP ++HRD++
Sbjct: 108 EFLLLTELCKGQLVEFLKKMESRGP-LSCDTVLKIFYQTCRAVQHMHRQ-KPPIIHRDLK 165
Query: 400 ASNVLLDEE-------FG---AHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFV--Y 447
N+LL + FG S + E + T Y PE + Y
Sbjct: 166 VENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLY 225
Query: 448 RNE-LTTKSDVYSFGVLLLEI 467
N + K D+++ G +L +
Sbjct: 226 SNFPIGEKQDIWALGCILYLL 246
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 2e-14
Identities = 44/194 (22%), Positives = 81/194 (41%), Gaps = 33/194 (17%)
Query: 291 PDGSRVAVKRLKR-SSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVV 348
P G +AVKR++ + +K+ ++ R P +V G + GD +I E +
Sbjct: 45 PSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELM- 103
Query: 349 NGPLDRWLHHI-PRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE 407
+ D++ ++ + + K+ + + L + +K ++HRDI+ SN+LLD
Sbjct: 104 STSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK--IIHRDIKPSNILLDR 161
Query: 408 E-------FG--AHLMG-VGLSKFVPWEVMQERTVMAGGTYGYLAPE----FVYRNELTT 453
FG L+ + ++ G Y+APE R
Sbjct: 162 SGNIKLCDFGISGQLVDSIAKTRDA-------------GCRPYMAPERIDPSASRQGYDV 208
Query: 454 KSDVYSFGVLLLEI 467
+SDV+S G+ L E+
Sbjct: 209 RSDVWSLGITLYEL 222
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 2e-14
Identities = 36/203 (17%), Positives = 74/203 (36%), Gaps = 38/203 (18%)
Query: 286 YSGILPDGSRVAVKRLKRSSFQRK--KEFYSEIGRFARLHHPNLVAVK--GCCYDHGDRY 341
+ + A+K + + + +EI +L + ++ Y
Sbjct: 26 FQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 85
Query: 342 IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRAS 401
+V E N L+ WL +S+D R + + + +H +VH D++ +
Sbjct: 86 MVMECG-NIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPA 137
Query: 402 NVLLDEEFGAHLMGV------GLSKFV-PWEVMQERTVMAGGTYGYLAPE---------- 444
N L+ + G+ G++ + P + GT Y+ PE
Sbjct: 138 NFLIVD-------GMLKLIDFGIANQMQPDTTSVVKDSQV-GTVNYMPPEAIKDMSSSRE 189
Query: 445 -FVYRNELTTKSDVYSFGVLLLE 466
+++++ KSDV+S G +L
Sbjct: 190 NGKSKSKISPKSDVWSLGCILYY 212
|
| >1hq8_A NKG2-D; homodimer, CIS-proline, apoptosis; 1.95A {Mus musculus} SCOP: d.169.1.1 PDB: 1jsk_A 1kcg_A* Length = 123 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 2e-14
Identities = 27/137 (19%), Positives = 47/137 (34%), Gaps = 23/137 (16%)
Query: 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVN 111
PCP +WI + + C+ + ++W++S+ C L + S EE Q +
Sbjct: 5 PCPNNWICHR--NNCYQFFNEEKTWNQSQASCLSQNSSLLKIYSKEE----QDFLKLVKS 58
Query: 112 GCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNG 171
W+G SW+W D S + + + S+
Sbjct: 59 YHWMGLV--QIPANGSWQWEDG-SSLSYNQLTLVEIPKG------------SCAVYGSSF 103
Query: 172 SRSLVTERCNTSHPFIC 188
TE C + +IC
Sbjct: 104 --KAYTEDCANLNTYIC 118
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 74.1 bits (182), Expect = 2e-14
Identities = 41/223 (18%), Positives = 76/223 (34%), Gaps = 35/223 (15%)
Query: 264 RSITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKE-FYSEIGRFAR 321
+S + + + +LG T + G G A+K SF R + E +
Sbjct: 4 QSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKK 63
Query: 322 LHHPNLVAVKGCCYDHGDR--YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATT-- 377
L+H N+V + + R ++ EF G L + + + +
Sbjct: 64 LNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSL---YTVLEEPSNA--YGLPESEFLIVL 118
Query: 378 --LAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAH----LMGVGLSKFVPWEVMQERT 431
+ G+ L + +VHR+I+ N++ L G ++ +++
Sbjct: 119 RDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE-----LEDDE 170
Query: 432 VMAG--GTYGYLAPEFVYRNELTT--------KSDVYSFGVLL 464
GT YL P+ R L D++S GV
Sbjct: 171 QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTF 213
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 2e-14
Identities = 44/203 (21%), Positives = 80/203 (39%), Gaps = 21/203 (10%)
Query: 269 NFSEGNRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPN 326
+ ++ LG+ + AVK + + ++ EI HPN
Sbjct: 11 DLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK---EITALKLCEGHPN 67
Query: 327 LVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGR--SLDWAMRMKVATTLAQGIAF 384
+V + +D ++V E + G L I + + + M+ L ++
Sbjct: 68 IVKLHEVFHDQLHTFLVMELLNGGEL---FERIKKKKHFSETEASYIMR---KLVSAVSH 121
Query: 385 LHDKVKPHVVHRDIRASNVLL-DEEFGAHLMGV--GLSKFVPWEVMQERTVMAGGTYGYL 441
+HD VVHRD++ N+L DE + + G ++ P + +T T Y
Sbjct: 122 MHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC--FTLHYA 176
Query: 442 APEFVYRNELTTKSDVYSFGVLL 464
APE + +N D++S GV+L
Sbjct: 177 APELLNQNGYDESCDLWSLGVIL 199
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 2e-14
Identities = 56/205 (27%), Positives = 90/205 (43%), Gaps = 32/205 (15%)
Query: 277 LGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY 335
LGD G Y G+ A K ++ S + +++ EI A HP +V + G Y
Sbjct: 27 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86
Query: 336 DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 395
G +I+ EF G +D + + RG L V + + + FLH K ++H
Sbjct: 87 HDGKLWIMIEFCPGGAVDAIMLELDRG---LTEPQIQVVCRQMLEALNFLHSK---RIIH 140
Query: 396 RDIRASNVLLDEE-------FG--AHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFV 446
RD++A NVL+ E FG A + + +Q+R G Y ++APE V
Sbjct: 141 RDLKAGNVLMTLEGDIRLADFGVSAKNL----------KTLQKRDSFIGTPY-WMAPEVV 189
Query: 447 YRNELT-----TKSDVYSFGVLLLE 466
+ K+D++S G+ L+E
Sbjct: 190 MCETMKDTPYDYKADIWSLGITLIE 214
|
| >2yhf_A C-type lectin domain family 5 member A; immune system; 1.90A {Homo sapiens} Length = 118 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 2e-14
Identities = 29/136 (21%), Positives = 55/136 (40%), Gaps = 23/136 (16%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNG 112
CP DW + ++CF + SW+ES +CK G LA + + E+ Q + +
Sbjct: 2 CPKDWEFYQ--ARCFFLSTSESSWNESRDFCKGKGSTLAIVNTPEKLKFLQDI--TDAEK 57
Query: 113 CWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS 172
++G W+W +N S +N ++ N +C ++ +
Sbjct: 58 YFIGLIYHRE--EKRWRWINN-SVFNGNVTNQNQ-NFNCATI---------------GLT 98
Query: 173 RSLVTERCNTSHPFIC 188
++ C+ S+ IC
Sbjct: 99 KTFDAASCDISYRRIC 114
|
| >3hup_A Early activation antigen CD69; C-type lectin-like domain, disulfide bond, glycoprotein, LEC membrane, phosphoprotein, signal-anchor, transmembrane; 1.37A {Homo sapiens} PDB: 1e87_A 1e8i_A 3cck_A Length = 130 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 3e-14
Identities = 31/138 (22%), Positives = 54/138 (39%), Gaps = 26/138 (18%)
Query: 51 APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNV 110
+ C DW+ + KC+ RSW ++ C E G LA + S ++ + ++ G+
Sbjct: 14 SSCSEDWVGYQ--RKCYFISTVKRSWTSAQNACSEHGATLAVIDSEKDMNFLKRYAGR-- 69
Query: 111 NGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSN 170
WVG + G WKWS+ ++N + GS C + N
Sbjct: 70 EEHWVG---LKKEPGHPWKWSNG-KEFNNWFNVTGSDK----------------CVFLKN 109
Query: 171 GSRSLVTERCNTSHPFIC 188
+ + C + +IC
Sbjct: 110 T--EVSSMECEKNLYWIC 125
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 73.0 bits (179), Expect = 3e-14
Identities = 35/173 (20%), Positives = 62/173 (35%), Gaps = 14/173 (8%)
Query: 304 SSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGG 363
SS +I R N V YI + L W++
Sbjct: 100 SSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRR-CSL 158
Query: 364 RSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE-------FG---AHL 413
+ + + + +A+ + FLH K ++HRD++ SN+ + FG A
Sbjct: 159 EDREHGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMD 215
Query: 414 MGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLE 466
+ GT Y++PE ++ N + K D++S G++L E
Sbjct: 216 QDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFE 268
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 73.0 bits (179), Expect = 4e-14
Identities = 44/187 (23%), Positives = 82/187 (43%), Gaps = 29/187 (15%)
Query: 291 PDGSRVAVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 349
P G +A K + + + E+ + P +V G Y G+ I E +
Sbjct: 56 PSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDG 115
Query: 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE- 408
G LD+ L + + + KV+ + +G+ +L +K K ++HRD++ SN+L++
Sbjct: 116 GSLDQVL----KKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRG 169
Query: 409 ------FG--AHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSF 460
FG L+ + FV GT Y++PE + + +SD++S
Sbjct: 170 EIKLCDFGVSGQLIDSMANSFV-------------GTRSYMSPERLQGTHYSVQSDIWSM 216
Query: 461 GVLLLEI 467
G+ L+E+
Sbjct: 217 GLSLVEM 223
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 5e-14
Identities = 42/221 (19%), Positives = 84/221 (38%), Gaps = 30/221 (13%)
Query: 265 SITKNFSE----GNRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRF 319
S + F + +LG+ + I L AVK +++ + + E+
Sbjct: 5 SFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEML 64
Query: 320 ARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGR--SLDWAMRMKVAT 376
+ H N++ + + Y+V+E + G + L HI + L+ ++ ++
Sbjct: 65 YQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSI---LSHIHKRRHFNELEASVVVQ--- 118
Query: 377 TLAQGIAFLHDKVKPHVVHRDIRASNVLL-DEEFGAHLMGV--GLSKFVPWE---VMQER 430
+A + FLH+K + HRD++ N+L + + L +
Sbjct: 119 DVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPIST 175
Query: 431 TVMAG--GTYGYLAPEFVYRNELTTKS-----DVYSFGVLL 464
+ G+ Y+APE V D++S GV+L
Sbjct: 176 PELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 5e-14
Identities = 39/176 (22%), Positives = 78/176 (44%), Gaps = 16/176 (9%)
Query: 297 AVKRLKRSSFQRKKEF---YSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 353
A+K + + + E + E+ L HP LV + D D ++V + ++ G L
Sbjct: 44 AMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDL- 102
Query: 354 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHL 413
+H+ + + +++ + L + +L ++ ++HRD++ N+LLDE H+
Sbjct: 103 --RYHLQQNVHFKEETVKLFICE-LVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHI 156
Query: 414 MGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELT--TKS-DVYSFGVLLLE 466
++ +P E + GT Y+APE + + + D +S GV E
Sbjct: 157 TDFNIAAMLPRE---TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYE 209
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 5e-14
Identities = 46/200 (23%), Positives = 83/200 (41%), Gaps = 29/200 (14%)
Query: 277 LGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY 335
LG+ G Y I G VA+K++ +E EI + P++V G +
Sbjct: 37 LGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSYF 94
Query: 336 DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 395
+ D +IV E+ G + + + +L + + +G+ +LH +H
Sbjct: 95 KNTDLWIVMEYCGAGSVSDIIRLRNK---TLTEDEIATILQSTLKGLEYLHFM---RKIH 148
Query: 396 RDIRASNVLLDEE-------FG--AHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFV 446
RDI+A N+LL+ E FG L + M +R + G + ++APE +
Sbjct: 149 RDIKAGNILLNTEGHAKLADFGVAGQLT----------DTMAKRNTVIGTPF-WMAPEVI 197
Query: 447 YRNELTTKSDVYSFGVLLLE 466
+D++S G+ +E
Sbjct: 198 QEIGYNCVADIWSLGITAIE 217
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 5e-14
Identities = 44/193 (22%), Positives = 84/193 (43%), Gaps = 12/193 (6%)
Query: 277 LGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYS-EIGRFARLHHPNLVAVKGCC 334
+G G + GI VA+K + + + E EI ++ P + G
Sbjct: 30 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 89
Query: 335 YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVV 394
+I+ E++ G L P LD + + +G+ +LH + +
Sbjct: 90 LKDTKLWIIMEYLGGGSALDLLEPGP-----LDETQIATILREILKGLDYLHSE---KKI 141
Query: 395 HRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTK 454
HRDI+A+NVLL E L G++ + + +R G + ++APE + ++ +K
Sbjct: 142 HRDIKAANVLLSEHGEVKLADFGVAGQL-TDTQIKRNTFVGTPF-WMAPEVIKQSAYDSK 199
Query: 455 SDVYSFGVLLLEI 467
+D++S G+ +E+
Sbjct: 200 ADIWSLGITAIEL 212
|
| >3vpp_A C-type lectin domain family 9 member A; dendritic cell, C-type lectin-like domain, membrane, immune; 1.64A {Homo sapiens} Length = 132 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 8e-14
Identities = 34/142 (23%), Positives = 44/142 (30%), Gaps = 24/142 (16%)
Query: 51 APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNV 110
+PCP +WI N C+ + W S+ C + G L + S EE K
Sbjct: 2 SPCPNNWIQNR--ESCYYVSEIWSIWHTSQENCLKEGSTLLQIESKEEMDFITGSLRKIK 59
Query: 111 NG--CWVGGRSINTTVGLSWKWSDN--MSKWNESIHAVGSFNSSCTSLPCHVHATVDLCT 166
WVG W W D S S N C
Sbjct: 60 GSYDYWVGLSQDGH--SGRWLWQDGSSPSPGLLPAERSQSANQVC--------------- 102
Query: 167 LVSNGSRSLVTERCNTSHPFIC 188
S SL++ C+T FIC
Sbjct: 103 -GYVKSNSLLSSNCDTWKYFIC 123
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 73.0 bits (179), Expect = 1e-13
Identities = 38/177 (21%), Positives = 79/177 (44%), Gaps = 18/177 (10%)
Query: 297 AVKRLKRSSFQRKKEFYSEIG------RFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 350
A+K L + + K+ + + P +V + + + + + G
Sbjct: 218 AMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGG 277
Query: 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG 410
L +H+ + G + MR A + G+ +H++ VV+RD++ +N+LLDE
Sbjct: 278 DL---HYHLSQHGVFSEADMRFYAAE-IILGLEHMHNR---FVVYRDLKPANILLDEHGH 330
Query: 411 AHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKS-DVYSFGVLLLE 466
+ +GL+ + +++ + GT+GY+APE + + S D +S G +L +
Sbjct: 331 VRISDLGLAC----DFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFK 383
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 1e-13
Identities = 42/192 (21%), Positives = 78/192 (40%), Gaps = 34/192 (17%)
Query: 293 GSRVAVKRLKRSSFQ---------RKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYI 342
AVK + + ++ E+ ++ HPN++ +K + ++
Sbjct: 42 CKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFL 101
Query: 343 VYEFVVNGPL-DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRAS 401
V++ + G L D + S K+ L + I LH ++VHRD++
Sbjct: 102 VFDLMKKGELFDYL---TEKVTLSEKET--RKIMRALLEVICALHKL---NIVHRDLKPE 153
Query: 402 NVLLDEEFGAHLMGV--GLSKFV-PWEVMQERTVMAGGTYGYLAPE------FVYRNELT 452
N+LLD++ ++ G S + P E ++E GT YLAPE
Sbjct: 154 NILLDDD--MNIKLTDFGFSCQLDPGEKLREVC----GTPSYLAPEIIECSMNDNHPGYG 207
Query: 453 TKSDVYSFGVLL 464
+ D++S GV++
Sbjct: 208 KEVDMWSTGVIM 219
|
| >3m9z_A Killer cell lectin-like receptor subfamily B MEMB; C-type lectin-like domain, domain swapping, disulfide bond, transmembrane protein; 1.70A {Mus musculus} PDB: 3t3a_A Length = 139 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 1e-13
Identities = 30/136 (22%), Positives = 49/136 (36%), Gaps = 19/136 (13%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNG 112
CP DW+ + KCF +W+E C G L + EE + N
Sbjct: 6 CPQDWLSHR--DKCFHVSQVSNTWEEGLVDCDGKGATLMLIQDQEELRFLLDSIKEKYNS 63
Query: 113 CWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS 172
W+G R ++WKW + S N + + + + C +S
Sbjct: 64 FWIGLRYTLP--DMNWKWING-STLNSDVLKITGDTENDS------------CAAISGD- 107
Query: 173 RSLVTERCNTSHPFIC 188
+ E CN+ + +IC
Sbjct: 108 -KVTFESCNSDNRWIC 122
|
| >1egg_A Macrophage mannose receptor; C-type lectin, sugar binding protein; 2.30A {Homo sapiens} SCOP: d.169.1.1 PDB: 1egi_A Length = 147 | Back alignment and structure |
|---|
Score = 67.5 bits (165), Expect = 1e-13
Identities = 32/148 (21%), Positives = 56/148 (37%), Gaps = 26/148 (17%)
Query: 52 PCPPDWIINEEKSKCFGYIGNF----RSWDESETYCKEIGGHLAALTSYEEEHSAQKLCG 107
CP DW + S CF ++W ES +C+ +GG LA++ + EE+ + +L
Sbjct: 4 KCPEDWGASSRTSLCFKLYAKGKHEKKTWFESRDFCRALGGDLASINNKEEQQTIWRLIT 63
Query: 108 KNVNG---CWVGGRSINTTVGLSWKWSD----NMSKWNESIHAVGSFNSSCTSLPCHVHA 160
+ + W+G + + + WSD + W G N+ C
Sbjct: 64 ASGSYHKLFWLGLTYGSPS-E-GFTWSDGSPVSYENWAY-----GEPNNYQNVEYC-GE- 114
Query: 161 TVDLCTLVSNGSRSLVTERCNTSHPFIC 188
L + + S C + +IC
Sbjct: 115 ------LKGDPTMSWNDINCEHLNNWIC 136
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 1e-13
Identities = 50/189 (26%), Positives = 79/189 (41%), Gaps = 31/189 (16%)
Query: 293 GSRVAVKRLKRSSFQRKKE--------FYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVY 344
+VA+K + + F +EI +L+HP ++ +K +D D YIV
Sbjct: 35 CKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF-FDAEDYYIVL 93
Query: 345 EFVVNGPL-DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNV 403
E + G L D+ + R L A + + +LH+ ++HRD++ NV
Sbjct: 94 ELMEGGELFDK----VVGNKR-LKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENV 145
Query: 404 LLD-EEFGAHLMGV--GLSKFVPWEVMQERTVMAG--GTYGYLAPE---FVYRNELTTKS 455
LL +E + G SK + E ++M GT YLAPE V
Sbjct: 146 LLSSQEEDCLIKITDFGHSKI-----LGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAV 200
Query: 456 DVYSFGVLL 464
D +S GV+L
Sbjct: 201 DCWSLGVIL 209
|
| >1sb2_A Rhodocetin alpha subunit; C-type lectin, domain swapping, toxin; 1.90A {Calloselasma rhodostoma} SCOP: d.169.1.1 PDB: 3gpr_A Length = 133 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 2e-13
Identities = 27/146 (18%), Positives = 48/146 (32%), Gaps = 30/146 (20%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKNV 110
CP W + S C+ ++W+E+E +C E HL ++ + E + N
Sbjct: 2 CPDGWSSTK--SYCYRPFKEKKTWEEAERFCTEQEKEAHLVSMENRLEAVFVDMVMENNF 59
Query: 111 NG----CWVGGRSINTTVGLSWKWSD----NMSKWNESIHAVGSFNSSCTSLPCHVHATV 162
W+G + N + +WSD + E + C +
Sbjct: 60 ENKIYRSWIGLKIENKGQRSNLEWSDGSSISYENLYE------PYMEKCFLM-------- 105
Query: 163 DLCTLVSNGSRSLVTERCNTSHPFIC 188
+G T C + F+C
Sbjct: 106 ----DHQSGLPKWHTADCEEKNVFMC 127
|
| >2bpd_A Dectin-1; receptor, beta-glucan, fungal recognition, C-type lectin-like domain, CTLD, carbohydrate; 1.5A {Mus musculus} PDB: 2bph_A 2bpe_A 2cl8_A* Length = 142 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 2e-13
Identities = 28/139 (20%), Positives = 50/139 (35%), Gaps = 18/139 (12%)
Query: 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHS--AQKLCGKN 109
C P+WI++ C+ + + SW S+ +C ++G HL + + +E +
Sbjct: 16 SCLPNWIMHG--KSCYLFSFSGNSWYGSKRHCSQLGAHLLKIDN-SKEFEFIESQTSSHR 72
Query: 110 VNGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVS 169
+N W+G + W W D + + S + C V
Sbjct: 73 INAFWIGLSRNQS--EGPWFWEDGSAFFPNSFQVRNAVPQESLLHNC-----------VW 119
Query: 170 NGSRSLVTERCNTSHPFIC 188
+ + CNTS IC
Sbjct: 120 IHGSEVYNQICNTSSYSIC 138
|
| >1oz7_A Echicetin A-chain; platelet aggregation, dimer, toxin; 2.40A {Echis carinatus} SCOP: d.169.1.1 Length = 131 | Back alignment and structure |
|---|
Score = 66.4 bits (162), Expect = 2e-13
Identities = 34/145 (23%), Positives = 53/145 (36%), Gaps = 30/145 (20%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIG--GHLAALTSYEEEHSAQKLCGKNV 110
CPP W N C+ ++WDE+E +C + G GHL ++ S +EE + +N+
Sbjct: 2 CPPGWSSNG--VYCYMLFKEPKTWDEAEKFCNKQGKDGHLLSIESKKEEILVDIVVSENI 59
Query: 111 NG---CWVGGRSINTTVGLSWKWSDNMS----KWNESIHAVGSFNSSCTSLPCHVHATVD 163
W G + S +WSD + S C L
Sbjct: 60 GKMYKIWTGLSERSKEQHCSSRWSDGSFFRSYEIAIR-------YSECFVL--------- 103
Query: 164 LCTLVSNGSRSLVTERCNTSHPFIC 188
+ R+ V C + PF+C
Sbjct: 104 ---EKQSVFRTWVATPCENTFPFMC 125
|
| >3c8j_A Natural killer cell receptor LY49C; MHC, virus, immune system; 2.60A {Mus musculus} SCOP: d.169.1.1 PDB: 3c8k_D 1p4l_D 1ja3_A 1p1z_D Length = 203 | Back alignment and structure |
|---|
Score = 68.0 bits (166), Expect = 2e-13
Identities = 25/152 (16%), Positives = 43/152 (28%), Gaps = 25/152 (16%)
Query: 47 KDWKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLC 106
W +KC+ +I N +W + C+ G + + +E Q+
Sbjct: 74 SRDTGRGVKYWFCYS--TKCYYFIMNKTTWSGCKANCQHYGVPILKIEDEDELKFLQRHV 131
Query: 107 GKNVNGCWVGGRSINTTVGLSWKWSDN-MSKWNESIHAVGSFNSSCTSLPCHVHATVDLC 165
W+G W W DN SK + I + + C
Sbjct: 132 IP--GNYWIGLSYDKK--KKEWAWIDNGPSKLDMKIKKMNFKSRGC-------------- 173
Query: 166 TLVSNGSRSLVTERCNTSHPFICMVEHENKCY 197
V + CN + IC + +
Sbjct: 174 --VFLSKARIEDIDCNIPYYCIC--GKKLDKF 201
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 4e-13
Identities = 45/179 (25%), Positives = 77/179 (43%), Gaps = 22/179 (12%)
Query: 293 GSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNGP 351
AVK + + K++ EI R HPN++ +K D Y+V E + G
Sbjct: 47 NMEFAVKIIDK----SKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGE 102
Query: 352 L-DRWLHHIPRGGRS-LDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL--DE 407
L D+ + + S + + + T+ + + +LH + VVHRD++ SN+L +
Sbjct: 103 LLDKI---LRQKFFSEREASAVLF---TITKTVEYLHAQ---GVVHRDLKPSNILYVDES 153
Query: 408 EFGAHLMGV--GLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLL 464
+ G +K + E T T ++APE + R D++S GVLL
Sbjct: 154 GNPESIRICDFGFAKQLRAENGLLMTPC--YTANFVAPEVLERQGYDAACDIWSLGVLL 210
|
| >3ff9_A Killer cell lectin-like receptor subfamily G member 1; natural killer cell receptor KLTG1, glycoprotein, membrane, phosphoprotein, signal-anchor; 1.80A {Mus musculus} PDB: 3ff8_C Length = 115 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 4e-13
Identities = 25/136 (18%), Positives = 44/136 (32%), Gaps = 27/136 (19%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNG 112
CP W N S C+ + + W+ S +C + G HL + + G+ +
Sbjct: 2 CPILWTRNG--SHCYYFSMEKKDWNSSLKFCADKGSHLLTFPDNQGVKLFGEYLGQ--DF 57
Query: 113 CWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS 172
W+G R+I+ W+W + I C ++
Sbjct: 58 YWIGLRNID-----GWRWEGG-PALSLRILTNSL-IQRCGAI----------------HR 94
Query: 173 RSLVTERCNTSHPFIC 188
L C + +IC
Sbjct: 95 NGLQASSCEVALQWIC 110
|
| >3bdw_B NKG2-A/NKG2-B type II integral membrane protein; NK cells, receptor, glycoprotein, lectin, signal-A transmembrane, immune system receptor; 2.50A {Homo sapiens} PDB: 3cdg_K 3cii_H Length = 120 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 4e-13
Identities = 24/137 (17%), Positives = 43/137 (31%), Gaps = 25/137 (18%)
Query: 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVN 111
CP +WI + C+ R+W+ES C L ++ + EE K
Sbjct: 6 HCPEEWITYS--NSCYYIGKERRTWEESLLACTSKNSSLLSIDNEEE----MKFLSIISP 59
Query: 112 GCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNG 171
W+G ++ W + + I + +C L
Sbjct: 60 SSWIGVFRNSS--HHPWVTMNG-LAFKHEIKDSDNAELNCAVL----------------Q 100
Query: 172 SRSLVTERCNTSHPFIC 188
L + +C +S + C
Sbjct: 101 VNRLKSAQCGSSIIYHC 117
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 70.6 bits (173), Expect = 5e-13
Identities = 44/176 (25%), Positives = 80/176 (45%), Gaps = 17/176 (9%)
Query: 297 AVKRLKRSSFQRKKEF---YSEIGRFARLHHPNLVAVKGCCYDHGDR-YIVYEFVVNGPL 352
A K+L++ +++K +E +++ +V++ Y+ D +V + G L
Sbjct: 213 ACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA-YAYETKDALCLVLTLMNGGDL 271
Query: 353 DRWLHHIPRGGRSLDWAMRMKV-ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGA 411
HI G++ R A + G+ LH + +V+RD++ N+LLD+
Sbjct: 272 ---KFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHI 325
Query: 412 HLMGVGLSKFVPWEVMQERTVMA-GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLE 466
+ +GL+ V + +T+ GT GY+APE V T D ++ G LL E
Sbjct: 326 RISDLGLAV----HVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYE 377
|
| >3bdw_A Natural killer cells antigen CD94; NK cells, receptor, glycoprotein, lectin, signal-A transmembrane, immune system receptor; 2.50A {Homo sapiens} SCOP: d.169.1.1 PDB: 3cdg_J 1b6e_A 3cii_G Length = 123 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 5e-13
Identities = 22/139 (15%), Positives = 42/139 (30%), Gaps = 26/139 (18%)
Query: 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVN 111
C W+ C+ ++W+ES C L L + +E +
Sbjct: 4 SCQEKWVGYR--CNCYFISSEQKTWNESRHLCASQKSSLLQLQNTDE----LDFMSSSQQ 57
Query: 112 GCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSS--CTSLPCHVHATVDLCTLVS 169
W+G +W W + S ++ + ++ C
Sbjct: 58 FYWIGLSYSEE--HTAWLWENG-SALSQYLFPSFETFNTKNC-------------IAYNP 101
Query: 170 NGSRSLVTERCNTSHPFIC 188
NG + + E C + +IC
Sbjct: 102 NG--NALDESCEDKNRYIC 118
|
| >1c3a_A Flavocetin-A: alpha subunit; C-type lectin-like domains, membrane protein; 2.50A {Trimeresurus flavoviridis} SCOP: d.169.1.1 PDB: 1v4l_A Length = 135 | Back alignment and structure |
|---|
Score = 65.2 bits (159), Expect = 6e-13
Identities = 29/146 (19%), Positives = 52/146 (35%), Gaps = 30/146 (20%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI--GGHLAALTSYEEEHSAQKLCGKNV 110
C P W + C+ ++W+++E++C+E HL ++ S E +L + +
Sbjct: 4 CIPGWSAYD--RYCYQAFSKPKNWEDAESFCEEGVKTSHLVSIESSGEGDFVAQLVAEKI 61
Query: 111 NG----CWVGGRSINTTVGLSWKWSD----NMSKWNESIHAVGSFNSSCTSLPCHVHATV 162
W+G R N +WSD N + F+ C +L
Sbjct: 62 KTSFQYVWIGLRIQNKEQQCRSEWSDASSVNYENLVK------QFSKKCYAL-------- 107
Query: 163 DLCTLVSNGSRSLVTERCNTSHPFIC 188
R+ C T +P +C
Sbjct: 108 ----KKGTELRTWFNVYCGTENPEVC 129
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 7e-13
Identities = 47/175 (26%), Positives = 75/175 (42%), Gaps = 15/175 (8%)
Query: 297 AVKRLKRSSFQRKKEF---YSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 353
A+K LK+ K E +E HP L A+K H V E+ G L
Sbjct: 177 AMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGEL- 235
Query: 354 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHL 413
H+ R + R A + + +LH + +VV+RD++ N++LD++ +
Sbjct: 236 --FFHLSRERVFSEDRARFYGAE-IVSALDYLHSEK--NVVYRDLKLENLMLDKDGHIKI 290
Query: 414 MGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYRNELTTKSDVYSFGVLLLE 466
GL K E +++ M GT YLAPE + N+ D + GV++ E
Sbjct: 291 TDFGLCK----EGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYE 341
|
| >2c6u_A CLEC1B protein; lectin, rhodocytin, aggretin, C-type lectin-like, platelets, thrombosis; 1.6A {Homo sapiens} Length = 122 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 7e-13
Identities = 26/142 (18%), Positives = 45/142 (31%), Gaps = 29/142 (20%)
Query: 51 APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNV 110
+PC +W C+G+ + +W+ES+ YC ++ L + + +
Sbjct: 1 SPCDTNWRYYG--DSCYGFFRHNLTWEESKQYCTDMNATLLKIDNRNIVEYIKARTHLIR 58
Query: 111 NGCWVGGRSINTTVGLSWKWSD----NMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCT 166
WVG WKW D + + + G+ N C
Sbjct: 59 ---WVGLS--RQKSNEVWKWEDGSVISENMFEFLEDGKGNMN----------------CA 97
Query: 167 LVSNGSRSLVTERCNTSHPFIC 188
NG + C H +C
Sbjct: 98 YFHNG--KMHPTFCENKHYLMC 117
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 9e-13
Identities = 43/185 (23%), Positives = 70/185 (37%), Gaps = 27/185 (14%)
Query: 297 AVKRLKRSSFQRKKE---FYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 353
A+K + + ++ E F E + + D Y+V E+ V G L
Sbjct: 90 AMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDL- 148
Query: 354 RWLHHIPRGGR--SLDWAMRMKVA-TTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG 410
L + + G + A R +A +A I +H VHRDI+ N+LLD
Sbjct: 149 --LTLLSKFGERIPAEMA-RFYLAEIVMA--IDSVHRL---GYVHRDIKPDNILLDRC-- 198
Query: 411 AHLMGV--GLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVY-------SFG 461
H+ G + + R+++A GT YL+PE + + Y + G
Sbjct: 199 GHIRLADFGSCLKLRAD-GTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALG 257
Query: 462 VLLLE 466
V E
Sbjct: 258 VFAYE 262
|
| >3ff7_C Killer cell lectin-like receptor subfamily G member 1; KLRG1-cadherin complex, calcium, cell adhesion, cell junction, cell membrane; 1.80A {Homo sapiens} Length = 112 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 1e-12
Identities = 27/136 (19%), Positives = 47/136 (34%), Gaps = 26/136 (19%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNG 112
CP W+ + C+ + + W+ S +C HL +T +E Q +
Sbjct: 1 CPDRWMKYG--NHCYYFSVEEKDWNSSLEFCLARDSHLLVITDNQEMSLLQVFLSE--AF 56
Query: 113 CWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS 172
W+G R+ + W+W D S N S + SF +C ++
Sbjct: 57 SWIGLRNNS-----GWRWEDG-SPLNFSRISSNSFVQTCGAI----------------NK 94
Query: 173 RSLVTERCNTSHPFIC 188
L C ++C
Sbjct: 95 NGLQASSCEVPLHWVC 110
|
| >1ukm_B EMS16 B chain, EMS16 subunit B; domain swapping, C-type lectin, toxin; HET: NAG; 1.90A {Echis multisquamatus} SCOP: d.169.1.1 PDB: 1v7p_B* Length = 128 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 1e-12
Identities = 34/144 (23%), Positives = 49/144 (34%), Gaps = 32/144 (22%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKNV 110
CP W + C+ ++W E+E C + G LA++ S EEE KL K +
Sbjct: 1 CPLGWSSFD--QHCYKVFEPVKNWTEAEEICMQQHKGSRLASIHSSEEEAFVSKLASKAL 58
Query: 111 NG--CWVGGRSINTTVGLSWKWSD----NMSKWNESIHAVGSFNSSCTSLPCHVHATVDL 164
W+G N W+WSD + W CT +
Sbjct: 59 KFTSMWIGLN--NPWKDCKWEWSDNARFDYKAWKR--------RPYCTVM---------- 98
Query: 165 CTLVSNGSRSLVTERCNTSHPFIC 188
+V T C S F+C
Sbjct: 99 --VVKPDRIFWFTRGCEKSVSFVC 120
|
| >1umr_C Convulxin beta, CVX beta; lectin, C-type lectin, platelet, sugar-binding protein, activator, snake venom; 2.40A {Crotalus durissus terrificus} SCOP: d.169.1.1 PDB: 1uos_B Length = 125 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 1e-12
Identities = 27/144 (18%), Positives = 51/144 (35%), Gaps = 34/144 (23%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKNV 110
CP W + C+ +W ++E +C + G HL + S EE K+ +++
Sbjct: 4 CPSHWSSYD--RYCYKVFKQEMTWADAEKFCTQQHTGSHLVSFHSTEEVDFVVKMTHQSL 61
Query: 111 NG--CWVGGRSINTTVGLSWKWSD----NMSKWNESIHAVGSFNSSCTSLPCHVHATVDL 164
W+G N +W+WSD +W+E
Sbjct: 62 KSTFFWIGAN--NIWNKCNWQWSDGTKPEYKEWHEEFE---------------------- 97
Query: 165 CTLVSNGSRSLVTERCNTSHPFIC 188
C + ++ C+ ++ F+C
Sbjct: 98 CLISRTFDNQWLSAPCSDTYSFVC 121
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 1e-12
Identities = 43/180 (23%), Positives = 77/180 (42%), Gaps = 23/180 (12%)
Query: 293 GSRVAVKRLKRSSFQRK--KEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 350
G VA+K + ++ ++ + E+ L+HPN+V + Y++ E+ G
Sbjct: 40 GREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGG 99
Query: 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQ----GIAFLHDKVKPHVVHRDIRASNVLLD 406
+ ++ GR M+ K A + + + + H K +VHRD++A N+LLD
Sbjct: 100 EV---FDYLVAHGR-----MKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLD 148
Query: 407 EEFGAHLMGVGLS-KFVPWEVMQERTVMAGGTYGYLAPEFVYRNELT-TKSDVYSFGVLL 464
+ + G S +F + G Y APE + + DV+S GV+L
Sbjct: 149 ADMNIKIADFGFSNEFTVGGKLDA----FCGAPPYAAPELFQGKKYDGPEVDVWSLGVIL 204
|
| >2py2_A Antifreeze protein type II; type II antifreeze protein; 1.70A {Clupea harengus} Length = 136 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 1e-12
Identities = 21/81 (25%), Positives = 38/81 (46%), Gaps = 4/81 (4%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNG 112
CP DW + +CF + W +++ C + G +LA++ S EE ++L ++
Sbjct: 4 CPTDWKMFN--GRCFLFNPLQLHWADAQESCMKEGANLASIHSLEESTFVKELTSADLIP 61
Query: 113 CWVGGRSINTTVGLSWKWSDN 133
W+GG + W W D+
Sbjct: 62 SWIGGTDCQVS-T-RWFWMDS 80
|
| >3ubu_A Agglucetin subunit alpha-1; platelet inhibiting, agkisacucetin, dimer, toxin, C-type LEC GPIB inhibitor, GPIB binding; 1.91A {Deinagkistrodon acutus} Length = 131 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 1e-12
Identities = 30/145 (20%), Positives = 56/145 (38%), Gaps = 28/145 (19%)
Query: 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKN 109
C P W + C+ ++WD++E +C E GGHL ++ S E +L +N
Sbjct: 3 DCLPGWSAYD--QSCYRVFKLLKTWDDAEKFCTERPKGGHLVSIESAGERDFVAQLVSEN 60
Query: 110 VNG--CWVGGRSINTTVGLSWKWSD----NMSKWNESIHAVGSFNSSCTSLPCHVHATVD 163
W+G + + S +W+D + ++E + C L
Sbjct: 61 KQTDNVWLGLKIQSKGQQCSTEWTDGSSVSYENFSE------YQSKKCFVL--------- 105
Query: 164 LCTLVSNGSRSLVTERCNTSHPFIC 188
+ G R+ + C + + F+C
Sbjct: 106 ---EKNTGFRTWLNLNCGSEYSFVC 127
|
| >1sb2_B Rhodocetin beta subunit; C-type lectin, domain swapping, toxin; 1.90A {Calloselasma rhodostoma} SCOP: d.169.1.1 PDB: 3gpr_B Length = 129 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 1e-12
Identities = 25/146 (17%), Positives = 43/146 (29%), Gaps = 36/146 (24%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKNV 110
CP W ++ C+ ++W E+E +C + GHL ++ S E + N
Sbjct: 4 CPTTWSASK--LYCYKPFKEKKTWIEAERFCAKQAENGHLVSIGSAAEADFLDLVIVVNF 61
Query: 111 NGC----WVGGRSINTTVGLSWKWSD----NMSKWNESIHAVGSFNSSCTSLPCHVHATV 162
+ W G N KW++ + E + C
Sbjct: 62 DKQRYRAWTGLTERN------LKWTNGASVSYENLYE------PYIRKC----------- 98
Query: 163 DLCTLVSNGSRSLVTERCNTSHPFIC 188
G C + F+C
Sbjct: 99 -FVVQPWEGKSKWYKADCEEKNAFLC 123
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 1e-12
Identities = 51/179 (28%), Positives = 69/179 (38%), Gaps = 22/179 (12%)
Query: 293 GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352
VAVK ++R + + EI L HPN+V K I+ E+ G L
Sbjct: 45 KELVAVKYIERGAAIDEN-VQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGEL 103
Query: 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQ----GIAFLHDKVKPHVVHRDIRASNVLLDEE 408
I GR A Q G+++ H + HRD++ N LLD
Sbjct: 104 ---YERICNAGR-----FSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGS 152
Query: 409 FGAHLMGV--GLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELT-TKSDVYSFGVLL 464
L G SK + TV GT Y+APE + R E +DV+S GV L
Sbjct: 153 PAPRLKICDFGYSKSSVLHSQPKSTV---GTPAYIAPEVLLRQEYDGKIADVWSCGVTL 208
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 1e-12
Identities = 47/202 (23%), Positives = 81/202 (40%), Gaps = 21/202 (10%)
Query: 275 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEF----YSEIGRFARLHHPNLVA 329
LLG+ G + R AVK LK+ +R EI RL H N++
Sbjct: 11 DLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQ 70
Query: 330 VKGCCYDHGDR--YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQ---GIAF 384
+ Y+ + Y+V E+ V G + L +P + A Q G+ +
Sbjct: 71 LVDVLYNEEKQKMYMVMEYCVCGMQEM-LDSVPEKRFPVCQAHGY-----FCQLIDGLEY 124
Query: 385 LHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPE 444
LH + +VH+DI+ N+LL + +G+++ + + + G+ + PE
Sbjct: 125 LHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPE 181
Query: 445 FVYRNEL--TTKSDVYSFGVLL 464
+ K D++S GV L
Sbjct: 182 IANGLDTFSGFKVDIWSAGVTL 203
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 2e-12
Identities = 48/198 (24%), Positives = 84/198 (42%), Gaps = 20/198 (10%)
Query: 277 LGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYS---EIGRFARLHHPNLVAVKG 332
+G G Y + + VA+K++ S Q +++ E+ +L HPN + +G
Sbjct: 62 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 121
Query: 333 CCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPH 392
C ++V E+ + D H + L V QG+A+LH +
Sbjct: 122 CYLREHTAWLVMEYCLGSASDLLEVH----KKPLQEVEIAAVTHGALQGLAYLHSH---N 174
Query: 393 VVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY---RN 449
++HRD++A N+LL E L G + +M G Y ++APE +
Sbjct: 175 MIHRDVKAGNILLSEPGLVKLGDFGSA-----SIMAPANSFVGTPY-WMAPEVILAMDEG 228
Query: 450 ELTTKSDVYSFGVLLLEI 467
+ K DV+S G+ +E+
Sbjct: 229 QYDGKVDVWSLGITCIEL 246
|
| >1tdq_B Aggrecan core protein; extracellular matrix, lecticans, tenascins, protein-protein interactions, C-type lectin domain; 2.60A {Rattus norvegicus} SCOP: d.169.1.1 Length = 130 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 2e-12
Identities = 29/142 (20%), Positives = 50/142 (35%), Gaps = 25/142 (17%)
Query: 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVN 111
C W + C+ + + +W ++E C+E HL+++ + EE+ K
Sbjct: 6 QCEEGWTKFQ--GHCYRHFPDRETWVDAERRCREQQSHLSSIVTPEEQEFVNKNAQDYQ- 62
Query: 112 GCWVGGRSINTTVGLSWKWSD----NMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTL 167
W+G ++WSD KW + P + AT + C +
Sbjct: 63 --WIGLNDRTIEG--DFRWSDGHSLQFEKWRP-------------NQPDNFFATGEDCVV 105
Query: 168 VSNGSRSL-VTERCNTSHPFIC 188
+ R CN PF C
Sbjct: 106 MIWHERGEWNDVPCNYQLPFTC 127
|
| >2e3x_C Coagulation factor X-activating enzyme light CHAI; disintegrin, metalloproteinase, C-type lectin, hydrolase, BL clotting, toxin; HET: NAG MAN GM6; 2.91A {Daboia russellii siamensis} Length = 122 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 2e-12
Identities = 32/144 (22%), Positives = 49/144 (34%), Gaps = 34/144 (23%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKNV 110
CP W+ E C+ + ++W ++E +C E G HL +L S EEE L +N+
Sbjct: 3 CPSGWLSYE--QHCYKGFNDLKNWTDAEKFCTEQKKGSHLVSLHSREEEKFVVNLISENL 60
Query: 111 N--GCWVGGRSINTTVGLSWKWSD----NMSKWNESIHAVGSFNSSCTSLPCHVHATVDL 164
W+G N +WSD E S C +
Sbjct: 61 EYPATWIGLG--NMWKDCRMEWSDRGNVKYKALAE--------ESYCLIM---------- 100
Query: 165 CTLVSNGSRSLVTERCNTSHPFIC 188
+ + CN P +C
Sbjct: 101 ----ITHEKVWKSMTCNFIAPVVC 120
|
| >1umr_A Convulxin alpha, CVX alpha; lectin, C-type lectin, platelet, sugar-binding protein, activator, snake venom; 2.40A {Crotalus durissus terrificus} SCOP: d.169.1.1 PDB: 1uos_A Length = 135 | Back alignment and structure |
|---|
Score = 63.3 bits (154), Expect = 2e-12
Identities = 30/146 (20%), Positives = 51/146 (34%), Gaps = 30/146 (20%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKNV 110
CP DW + C+ +W+++E +C + G HL ++ S +E + +N+
Sbjct: 4 CPSDWYYYD--QHCYRIFNEEMNWEDAEWFCTKQAKGAHLVSIKSAKEADFVAWMVTQNI 61
Query: 111 NG----CWVGGRSINTTVGLSWKWSD----NMSKWNESIHAVGSFNSSCTSLPCHVHATV 162
+G R N S KWSD + + + + C+ L
Sbjct: 62 EESFSHVSIGLRVQNKEKQCSTKWSDGSSVSYDNLLD------LYITKCSLL-------- 107
Query: 163 DLCTLVSNGSRSLVTERCNTSHPFIC 188
G R C PF+C
Sbjct: 108 ----KKETGFRKWFVASCIGKIPFVC 129
|
| >3gpr_D Rhodocetin subunit delta; disulfide bond, lectin, secreted, toxin, cell adhesion; 3.20A {Calloselasma rhodostoma} Length = 124 | Back alignment and structure |
|---|
Score = 62.9 bits (153), Expect = 2e-12
Identities = 29/144 (20%), Positives = 49/144 (34%), Gaps = 32/144 (22%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKNV 110
CP W C+ ++W+++E++C G LA++ S EEE KL + +
Sbjct: 1 CPLHWSSYN--GYCYRVFSELKTWEDAESFCYAQHKGSRLASIHSREEEAFVGKLASQTL 58
Query: 111 N--GCWVGGRSINTTVGLSWKWSD----NMSKWNESIHAVGSFNSSCTSLPCHVHATVDL 164
W+G N W+WSD + W + C +
Sbjct: 59 KYTSMWLGLN--NAWAACKWEWSDDAKLDYKVWLR--------RAYCAVM---------- 98
Query: 165 CTLVSNGSRSLVTERCNTSHPFIC 188
+V C + F+C
Sbjct: 99 --VVKTDRIFWYNRGCEKTVSFLC 120
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 67.9 bits (166), Expect = 3e-12
Identities = 38/177 (21%), Positives = 79/177 (44%), Gaps = 16/177 (9%)
Query: 297 AVKRLKRSSFQRKKEF---YSEIGRFARLHHPNLVAVKGCCYDHGDR-YIVYEFVVNGPL 352
A K+L + +++K + E A++H +V++ ++ +V + G +
Sbjct: 214 ACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDI 272
Query: 353 DRWLHHIPRGGRSLDWAMRMKV-ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGA 411
++++ R + G+ LH + ++++RD++ NVLLD++
Sbjct: 273 RYHIYNVDEDNPGFQEP-RAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNV 328
Query: 412 HLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYRNELTTKSDVYSFGVLLLE 466
+ +GL+ E+ +T G GT G++APE + E D ++ GV L E
Sbjct: 329 RISDLGLAV----ELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYE 381
|
| >1oz7_B Echicetin B-chain; platelet aggregation, dimer, toxin; 2.40A {Echis carinatus} SCOP: d.169.1.1 Length = 123 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 3e-12
Identities = 27/144 (18%), Positives = 47/144 (32%), Gaps = 34/144 (23%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKNV 110
C PDW + E C+ +W ++E +C + GHL + + +E L +
Sbjct: 2 CLPDWSVYE--GYCYKVFKERMNWADAEKFCTKQHKDGHLVSFRNSKEVDFVISLAFPML 59
Query: 111 NG--CWVGGRSINTTVGLSWKWSD----NMSKWNESIHAVGSFNSSCTSLPCHVHATVDL 164
W+G + +W+WSD + W+ H
Sbjct: 60 KNDLVWIGLT--DYWRDCNWEWSDGAQLDYKAWDNERH---------------------- 95
Query: 165 CTLVSNGSRSLVTERCNTSHPFIC 188
C + N C + F+C
Sbjct: 96 CFIYKNTDNQWTRRDCTWTFSFVC 119
|
| >1jwi_B Platelet aggregation inducer; domain swapping, C-type lectin, toxin; 2.00A {Bitis arietans} SCOP: d.169.1.1 PDB: 1uex_B Length = 125 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 3e-12
Identities = 29/144 (20%), Positives = 52/144 (36%), Gaps = 34/144 (23%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI--GGHLAALTSYEEEHSAQKLCGKNV 110
C PDW + C+ ++W ++E +CKE+ GGHL ++ S EE KL + +
Sbjct: 4 CLPDWSSYK--GHCYKVFKVEKTWADAEKFCKELVNGGHLMSVNSREEGEFISKLALEKM 61
Query: 111 NG--CWVGGRSINTTVGLSWKWSD----NMSKWNESIHAVGSFNSSCTSLPCHVHATVDL 164
W+G + +W+D + ++ P
Sbjct: 62 RIVLVWIGLS--HFWRICPLRWTDGARLDYRALSDE--------------PI-------- 97
Query: 165 CTLVSNGSRSLVTERCNTSHPFIC 188
C + + + CN F+C
Sbjct: 98 CFVAESFHNKWIQWTCNRKKSFVC 121
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 4e-12
Identities = 41/190 (21%), Positives = 74/190 (38%), Gaps = 30/190 (15%)
Query: 290 LPDGSRVAVKRLKRS--------SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRY 341
V VK +K+ + + EI +R+ H N++ V + G
Sbjct: 46 KEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQ 105
Query: 342 IVYEFVVNGP--LDRWLHHIPRGGRSLDWAMRMKVATT----LAQGIAFLHDKVKPHVVH 395
+V E +G I R R + +A+ L + +L K ++H
Sbjct: 106 LVMEKHGSGLDLFA----FIDRHPR-----LDEPLASYIFRQLVSAVGYLRLK---DIIH 153
Query: 396 RDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELT-TK 454
RDI+ N+++ E+F L+ G + ++ + GT Y APE + N +
Sbjct: 154 RDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFC---GTIEYCAPEVLMGNPYRGPE 210
Query: 455 SDVYSFGVLL 464
+++S GV L
Sbjct: 211 LEMWSLGVTL 220
|
| >1fvu_A Botrocetin alpha chain; VON WILLBRAND factor modulator, C-type lectin, metal- binding, loop exchanged dimer, toxin; 1.80A {Bothrops jararaca} SCOP: d.169.1.1 PDB: 1ijk_B 1u0n_B 1u0o_A Length = 133 | Back alignment and structure |
|---|
Score = 62.9 bits (153), Expect = 4e-12
Identities = 34/147 (23%), Positives = 51/147 (34%), Gaps = 31/147 (21%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHS-AQKLCGKN 109
CP W E C+ + +W ++E +C E GGHL ++ Y +E L KN
Sbjct: 2 CPSGWSSYE--GNCYKFFQQKMNWADAERFCSEQAKGGHLVSIKIYSKEKDFVGDLVTKN 59
Query: 110 VNG----CWVGGRSINTTVGLSWKWSD----NMSKWNESIHAVGSFNSSCTSLPCHVHAT 161
+ W+G R N S +WSD + E C +L
Sbjct: 60 IQSSDLYAWIGLRVENKEKQCSSEWSDGSSVSYENVVE------RTVKKCFAL------- 106
Query: 162 VDLCTLVSNGSRSLVTERCNTSHPFIC 188
G + C +PF+C
Sbjct: 107 -----EKDLGFVLWINLYCAQKNPFVC 128
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 4e-12
Identities = 44/176 (25%), Positives = 77/176 (43%), Gaps = 21/176 (11%)
Query: 297 AVKRLKRSSFQRKKEF---YSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 353
A+K L + + K+ +E ++ P LV ++ D+ + Y+V E+V G +
Sbjct: 70 AMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM- 128
Query: 354 RWLHHIPRGGRSLDWAMRMKVA-TTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAH 412
H+ R GR + R A L +LH +++RD++ N+L+D++ +
Sbjct: 129 --FSHLRRIGRFSEPHARFYAAQIVLT--FEYLHSL---DLIYRDLKPENLLIDQQ--GY 179
Query: 413 LMGV--GLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLE 466
+ G +K V RT GT LAPE + D ++ GVL+ E
Sbjct: 180 IQVTDFGFAKRVK-----GRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYE 230
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 5e-12
Identities = 48/176 (27%), Positives = 75/176 (42%), Gaps = 18/176 (10%)
Query: 297 AVKRLKRSSFQRKKEF---YSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 353
A+K L++ K E +E HP L A+K H V E+ G L
Sbjct: 34 AMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGEL- 92
Query: 354 RWLHHIPRGGR-SLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAH 412
H+ R + + A R A + + +LH + VV+RDI+ N++LD++
Sbjct: 93 --FFHLSRERVFTEERA-RFYGAE-IVSALEYLHSR---DVVYRDIKLENLMLDKDGHIK 145
Query: 413 LMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYRNELTTKSDVYSFGVLLLE 466
+ GL K E + + M GT YLAPE + N+ D + GV++ E
Sbjct: 146 ITDFGLCK----EGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYE 197
|
| >3bx4_B Aggretin beta chain; toxin; 1.70A {Agkistrodon rhodostoma} PDB: 2vrp_B Length = 146 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 5e-12
Identities = 33/146 (22%), Positives = 50/146 (34%), Gaps = 34/146 (23%)
Query: 51 APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGK 108
A CP W E C+ ++W ++E +CK HL + S EE KL
Sbjct: 23 ADCPSGWSSYE--GHCYKPFNEPKNWADAERFCKLQPKHSHLVSFQSAEEADFVVKLTRP 80
Query: 109 NVNG--CWVGGRSINTTVGLSWKWSD----NMSKWNESIHAVGSFNSSCTSLPCHVHATV 162
+ W+G N G +W+WSD N W E S C +
Sbjct: 81 RLKANLVWMGLS--NIWHGCNWQWSDGARLNYKDWQE--------QSECLAF-------- 122
Query: 163 DLCTLVSNGSRSLVTERCNTSHPFIC 188
+ C+++ F+C
Sbjct: 123 ------RGVHTEWLNMDCSSTCSFVC 142
|
| >2kv3_A Regenerating islet-derived protein 4; GISP, C-type lectin, REG IV, disulfide bond, glycoPro lectin, secreted, sugar binding protein; NMR {Homo sapiens} Length = 131 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 5e-12
Identities = 30/147 (20%), Positives = 52/147 (35%), Gaps = 31/147 (21%)
Query: 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI--GGHLAALTSYEEEHSAQKLCGKN 109
C P W ++ S C+GY R+W ++E C+ G HLA++ S +E + +
Sbjct: 2 SCAPGWFYHK--SNCYGYFRKLRNWSDAELECQSYGNGAHLASILSLKEASTIAEYISGY 59
Query: 110 VNG--CWVGGRSINTTVGLSWKWSD----NMSKWNESIHAVGSFNSS--CTSLPCHVHAT 161
W+G + W+W D W+ S + C +
Sbjct: 60 QRSQSIWIGLH--DPQKRQQWQWIDGAMYLYRSWSG-----KSMGGNKHCAEM------- 105
Query: 162 VDLCTLVSNGSRSLVTERCNTSHPFIC 188
+N + + CN F+C
Sbjct: 106 -----SSNNNFLTWSSNECNKRQHFLC 127
|
| >1pwb_A SP-D, PSP-D, pulmonary surfactant-associated protein D; collectin, C-type lectin, alpha-helical coiled coil, carbohydrate recognition domain; HET: GLC; 1.40A {Homo sapiens} SCOP: d.169.1.1 h.1.1.1 PDB: 1pw9_A* 3ikn_A* 3ikp_A* 3ikq_A* 3ikr_A* 2rie_A* 2ggx_A* 2ggu_A* 2ork_A* 2orj_A* 2ria_A* 2rib_A* 2ric_A* 2rid_A* 2os9_A* 3dbz_A 3g81_A* 3g83_A* 1b08_A 3g84_A* ... Length = 177 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 6e-12
Identities = 22/104 (21%), Positives = 38/104 (36%), Gaps = 8/104 (7%)
Query: 40 QLAASMNKDWKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEE 99
L A+ ++ K P+ EK F G + + E++ C + GG LA+ S E
Sbjct: 42 HLQAAFSQYKKVELFPNGQSVGEK--IFKTAGFVKPFTEAQLLCTQAGGQLASPRSAAEN 99
Query: 100 HSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSD----NMSKWNE 139
+ Q+L ++ T G + + S W
Sbjct: 100 AALQQLVVAKNEAAFLSMTDSKTE-G-KFTYPTGESLVYSNWAP 141
|
| >3g8l_A Lectin-related NK cell receptor LY49L1; natural killer cell receptor, immune system; 2.50A {Mus musculus} Length = 190 | Back alignment and structure |
|---|
Score = 63.4 bits (154), Expect = 7e-12
Identities = 23/140 (16%), Positives = 43/140 (30%), Gaps = 27/140 (19%)
Query: 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVN 111
W KC+ ++ + ++W + C+ L + + +E + L +
Sbjct: 66 GFEKYWFCYG--IKCYYFVMDRKTWSGCKQTCQISSLSLLKIDNEDELKFLKLLVPS--D 121
Query: 112 GCWVGGRSINTTVGLSWKWSDN---MSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLV 168
W+G N W W +N N + + C L+
Sbjct: 122 SYWIGLSYDNK--KKDWAWINNGPSKLALNTMKYNIRDGG----------------CMLL 163
Query: 169 SNGSRSLVTERCNTSHPFIC 188
S L + C+ S IC
Sbjct: 164 SKT--RLDNDNCDKSFICIC 181
|
| >2xr6_A CD209 antigen; sugar binding protein, carbohydrate binding, mannose; HET: MAN 07B; 1.35A {Homo sapiens} PDB: 1sl4_A* 2it6_A* 1k9i_A* 2xr5_A* 1sl5_A* 2it5_A* 1xph_A 1k9j_A* Length = 170 | Back alignment and structure |
|---|
Score = 62.9 bits (153), Expect = 9e-12
Identities = 24/81 (29%), Positives = 40/81 (49%), Gaps = 4/81 (4%)
Query: 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVN 111
PCP +W + C+ + R+W +S T CKE+G L + S EE++ Q ++
Sbjct: 21 PCPWEWTFFQ--GNCYFMSNSQRNWHDSITACKEVGAQLVVIKSAEEQNFLQLQSSRSNR 78
Query: 112 GCWVGGRSINTTVGLSWKWSD 132
W+G +N +W+W D
Sbjct: 79 FTWMGLSDLNQE--GTWQWVD 97
|
| >1j34_A Coagulation factor IX-binding protein A chain; magnesium ION, calcium ION, GLA domain, protein binding/blood clotting complex; HET: CGU; 1.55A {Trimeresurus flavoviridis} SCOP: d.169.1.1 PDB: 1bj3_A* 1j35_A* 1x2t_A* 1x2w_A 1ixx_A 1y17_A 1wt9_A 1iod_A* Length = 129 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 9e-12
Identities = 37/148 (25%), Positives = 55/148 (37%), Gaps = 34/148 (22%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKNV 110
CP W E C+ +++WD++E +C E GGHL ++ S E +L +N+
Sbjct: 2 CPSGWSSYE--GHCYKPFKLYKTWDDAERFCTEQAKGGHLVSIESAGEADFVAQLVTENI 59
Query: 111 NGC----WVGGRSINTTVGLSWKWSD----NMSKW--NESIHAVGSFNSSCTSLPCHVHA 160
W+G R S +WSD + W ES +G T
Sbjct: 60 QNTKSYVWIGLRVQGKEKQCSSEWSDGSSVSYENWIEAESKTCLG--LEKET-------- 109
Query: 161 TVDLCTLVSNGSRSLVTERCNTSHPFIC 188
G R V C +PF+C
Sbjct: 110 ----------GFRKWVNIYCGQQNPFVC 127
|
| >2b6b_D CD209 antigen; cryo EM dengue CRD DC-SIGN, icosahedral virus, virus-recepto; 25.00A {Homo sapiens} SCOP: d.169.1.1 Length = 175 | Back alignment and structure |
|---|
Score = 62.9 bits (153), Expect = 1e-11
Identities = 26/101 (25%), Positives = 46/101 (45%), Gaps = 4/101 (3%)
Query: 33 SNQSSNGQLAASMNKDWKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAA 92
+ S+G + + PCP +W + C+ + R+W +S T CKE+G L
Sbjct: 7 HHHHSSGLVPRGSHMRLCHPCPWEWTFFQ--GNCYFMSNSQRNWHDSITACKEVGAQLVV 64
Query: 93 LTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSDN 133
+ S EE++ Q ++ W+G +N +W+W D
Sbjct: 65 IKSAEEQNFLQLQSSRSNRFTWMGLSDLNQE--GTWQWVDG 103
|
| >1sl6_A C-type lectin DC-signr; sugar binding protein; HET: GAL NDG FUC; 2.25A {Homo sapiens} SCOP: d.169.1.1 PDB: 1xar_A Length = 184 | Back alignment and structure |
|---|
Score = 63.0 bits (153), Expect = 1e-11
Identities = 33/166 (19%), Positives = 59/166 (35%), Gaps = 27/166 (16%)
Query: 29 SDTISNQSSNGQLAASMNKDWKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGG 88
S L + + + CP DW + C+ + R+W +S T C+E+
Sbjct: 30 SKQQQIYQELTDLKTAFERLCR-HCPKDWTFFQGN--CYFMSNSQRNWHDSVTACQEVRA 86
Query: 89 HLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSDN--MSKWNESIHAVGS 146
L + + EE++ Q ++ W+G +N G +W+W D +S + G
Sbjct: 87 QLVVIKTAEEQNFLQLQTSRSNRFSWMGLSDLNQE-G-TWQWVDGSPLSPSFQRYWNSGE 144
Query: 147 FNSS----CTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFIC 188
N+S C RC+ + +IC
Sbjct: 145 PNNSGNEDC----------------AEFSGSGWNDNRCDVDNYWIC 174
|
| >3c22_A C-type lectin domain family 4 member K; coiled coil, glycoprotein, membrane, signal-anchor, transmembrane, immune system, sugar binding protein; 1.50A {Homo sapiens} PDB: 3p5g_A* 3p5d_A* 3p5f_A* 3p5e_A* 3p5h_A* 3p5i_A* 3p7g_A* 3p7f_A* 3p7h_A* 3bc7_A* 3bbs_A* 3bc6_A* Length = 156 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 1e-11
Identities = 19/94 (20%), Positives = 33/94 (35%), Gaps = 6/94 (6%)
Query: 40 QLAASMNKDWKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEE 99
++ M D W + + + ++W +E +C HL ++TS E+
Sbjct: 10 KIEGRMQNDILQVVSQGWKYFK--GNFYYFSLIPKTWYSAEQFCVSRNSHLTSVTSESEQ 67
Query: 100 HSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSDN 133
K G W+G G W W D+
Sbjct: 68 EFLYKTAGG--LIYWIGLTKAGME-G-DWSWVDD 97
|
| >3gpr_C Rhodocetin subunit gamma; disulfide bond, lectin, secreted, toxin, cell adhesion; 3.20A {Calloselasma rhodostoma} Length = 134 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 1e-11
Identities = 33/148 (22%), Positives = 48/148 (32%), Gaps = 34/148 (22%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKNV 110
C P W + C+ ++WDE+E +C E GHL ++ S E +L N+
Sbjct: 3 CLPGWSAYD--QHCYQAFNEPKTWDEAERFCTEQAKRGHLVSIGSDGEADFVAQLVTNNI 60
Query: 111 NG----CWVGGRSINTTVGLSWKWSD----NMSKW--NESIHAVGSFNSSCTSLPCHVHA 160
W+G R S +WS W ES G +
Sbjct: 61 KRPELYVWIGLRDRRKEQQCSSEWSMSASIIYVNWNTGESQMCQGLARWT---------- 110
Query: 161 TVDLCTLVSNGSRSLVTERCNTSHPFIC 188
G R C +PF+C
Sbjct: 111 ----------GFRKWDYSDCQAKNPFVC 128
|
| >1fvu_B Botrocetin beta chain; VON WILLBRAND factor modulator, C-type lectin, metal- binding, loop exchanged dimer, toxin; 1.80A {Bothrops jararaca} SCOP: d.169.1.1 PDB: 1ijk_C 1u0n_C 1u0o_B Length = 125 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 1e-11
Identities = 28/144 (19%), Positives = 48/144 (33%), Gaps = 32/144 (22%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKNV 110
CPPDW E C+ + + WD++E +C E G HL + S EE + L + +
Sbjct: 2 CPPDWSSYE--GHCYRFFKEWMHWDDAEEFCTEQQTGAHLVSFQSKEEADFVRSLTSEML 59
Query: 111 NG--CWVGGRSINTTVGLSWKWSD----NMSKWNESIHAVGSFNSSCTSLPCHVHATVDL 164
G W+G + ++W+D + + +
Sbjct: 60 KGDVVWIGLS--DVWNKCRFEWTDGMEFDYDDYYLI----AEYE---------------- 97
Query: 165 CTLVSNGSRSLVTERCNTSHPFIC 188
C + C F+C
Sbjct: 98 CVASKPTNNKWWIIPCTRFKNFVC 121
|
| >1j34_B Coagulation factor IX-binding protein B chain; magnesium ION, calcium ION, GLA domain, protein binding/blood clotting complex; HET: CGU; 1.55A {Trimeresurus flavoviridis} SCOP: d.169.1.1 PDB: 1bj3_B 1ixx_B* 1j35_B* 1x2t_B* 1x2w_B 1wt9_B 1iod_B 1y17_B Length = 123 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 2e-11
Identities = 30/144 (20%), Positives = 48/144 (33%), Gaps = 34/144 (23%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKNV 110
CP DW E C+ ++W ++E +C + GGHL + S EE KL +
Sbjct: 2 CPSDWSSYE--GHCYKPFSEPKNWADAENFCTQQHAGGHLVSFQSSEEADFVVKLAFQTF 59
Query: 111 NGC--WVGGRSINTTVGLSWKWSD----NMSKWNESIHAVGSFNSSCTSLPCHVHATVDL 164
W+G N +W+WS+ W E +
Sbjct: 60 GHSIFWMGLS--NVWNQCNWQWSNAAMLRYKAWAEESY---------------------- 95
Query: 165 CTLVSNGSRSLVTERCNTSHPFIC 188
C + + + C F+C
Sbjct: 96 CVYFKSTNNKWRSRACRMMAQFVC 119
|
| >1c3a_B Flavocetin-A: beta subunit; C-type lectin-like domains, membrane protein; 2.50A {Trimeresurus flavoviridis} SCOP: d.169.1.1 PDB: 1v4l_B Length = 125 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 2e-11
Identities = 23/144 (15%), Positives = 45/144 (31%), Gaps = 34/144 (23%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKNV 110
CP W + C+ +W+++E +C + G HL + S EE +
Sbjct: 4 CPLGWSSYD--EHCYQVFQQKMNWEDAEKFCTQQHKGSHLVSFHSSEEVDFVTSKTFPIL 61
Query: 111 NG--CWVGGRSINTTVGLSWKWSD----NMSKWNESIHAVGSFNSSCTSLPCHVHATVDL 164
W+G N + +WSD + W+
Sbjct: 62 KYDFVWIGLS--NVWNECTKEWSDGTKLDYKAWSGGSD---------------------- 97
Query: 165 CTLVSNGSRSLVTERCNTSHPFIC 188
C + ++ C++ + +C
Sbjct: 98 CIVSKTTDNQWLSMDCSSKYYVVC 121
|
| >3bx4_A Aggretin alpha chain; toxin; 1.70A {Agkistrodon rhodostoma} PDB: 2vrp_A Length = 136 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 2e-11
Identities = 33/150 (22%), Positives = 51/150 (34%), Gaps = 35/150 (23%)
Query: 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCK--EIGGHLAALTSYEE-----EHSAQK 104
C W + C+ ++WDE+E +C+ E G HLA++ S E +QK
Sbjct: 4 DCDFGWSPYD--QHCYQAFNEQKTWDEAEKFCRAQENGAHLASIESNGEADFVSWLISQK 61
Query: 105 LCGKNVNGCWVGGRSINTTVGLSWKWSD----NMSKW--NESIHAVGSFNSSCTSLPCHV 158
+ + W+G R+ N S +WSD + + T
Sbjct: 62 DELADEDYVWIGLRAQNKEQQCSSEWSDGSSVSYENLIDLHTKKCGA--LEKLT------ 113
Query: 159 HATVDLCTLVSNGSRSLVTERCNTSHPFIC 188
G R V C H F+C
Sbjct: 114 ------------GFRKWVNYYCEQMHAFVC 131
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 64.5 bits (158), Expect = 2e-11
Identities = 48/182 (26%), Positives = 84/182 (46%), Gaps = 31/182 (17%)
Query: 297 AVKRLKRSSFQRKKEFYSEIGR--FARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR 354
A+K LK+++ + + +++ R ++HP +V + G Y++ +F+ G L
Sbjct: 56 AMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDL-- 113
Query: 355 WLHHIPRGGR-SLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE----- 408
+ + + + + +A LA + LH +++RD++ N+LLDEE
Sbjct: 114 -FTRLSKEVMFTEEDV-KFYLAE-LALALDHLHSL---GIIYRDLKPENILLDEEGHIKL 167
Query: 409 --FGAHLMGVGLSKFVPWEVMQE--RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLL 464
FG LSK E + + GT Y+APE V R T +D +SFGVL+
Sbjct: 168 TDFG-------LSK----ESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLM 216
Query: 465 LE 466
E
Sbjct: 217 FE 218
|
| >2afp_A Protein (SEA raven type II antifreeze protein); recombinant SEA raven protein, solution backbone fold, C- type lectin; NMR {Hemitripterus americanus} SCOP: d.169.1.1 Length = 129 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 2e-11
Identities = 35/145 (24%), Positives = 51/145 (35%), Gaps = 33/145 (22%)
Query: 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVN 111
CP W +C Y +W +ET C ++GGHLA++ S EE Q L V
Sbjct: 6 NCPAGWQPLG--DRCIYYETTAMTWALAETNCMKLGGHLASIHSQEEHSFIQTLNAGVV- 62
Query: 112 GCWVGGRSINTTVGLSWKWSD----NMSKWNESIHAVG----SFNSSCTSLPCHVHATVD 163
W+GG + G +W WSD N W + C +
Sbjct: 63 --WIGGSACLQA-G-AWTWSDGTPMNFRSWCS-----TKPDDVLAACC------MQ---- 103
Query: 164 LCTLVSNGSRSLVTERCNTSHPFIC 188
+ + + C SH +C
Sbjct: 104 ---MTAAADQCWDDLPCPASHKSVC 125
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 2e-11
Identities = 40/194 (20%), Positives = 79/194 (40%), Gaps = 36/194 (18%)
Query: 291 PDGSRVAVKRLKR-SSFQRKKEFYSEIGRFARLH-HPNLVAVKGCCYDHGDRYIVYEFVV 348
G +AVK+++R + + K ++ + H P +V G + D +I E +
Sbjct: 48 KTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM- 106
Query: 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE 408
++ + + + K+ + + + +L +K V+HRD++ SN+LLDE
Sbjct: 107 GTCAEKLKKRMQGP---IPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDER 161
Query: 409 -------FG--AHLMG-VGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNEL-----TT 453
FG L+ + G Y+APE + +
Sbjct: 162 GQIKLCDFGISGRLVDDKAKDRSA-------------GCAAYMAPERIDPPDPTKPDYDI 208
Query: 454 KSDVYSFGVLLLEI 467
++DV+S G+ L+E+
Sbjct: 209 RADVWSLGISLVEL 222
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 2e-11
Identities = 44/180 (24%), Positives = 73/180 (40%), Gaps = 22/180 (12%)
Query: 297 AVKRLKRSSFQRKKE---FYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 353
A+K L + ++ + F+ E A + P +V + D Y+V E++ G L
Sbjct: 98 AMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDL- 156
Query: 354 RWLHHIPRGGRSLDWAMRMKVA-TTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAH 412
++ + WA R A LA + +H +HRD++ N+LLD+ H
Sbjct: 157 --VNLMSNYDVPEKWA-RFYTAEVVLA--LDAIHSM---GFIHRDVKPDNMLLDKS--GH 206
Query: 413 LMGV--GLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELT---TKS-DVYSFGVLLLE 466
L G + + R A GT Y++PE + + D +S GV L E
Sbjct: 207 LKLADFGTCMKMN-KEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYE 265
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 64.1 bits (157), Expect = 3e-11
Identities = 46/176 (26%), Positives = 81/176 (46%), Gaps = 21/176 (11%)
Query: 297 AVKRLKRSSFQRKKEF---YSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 353
A+K LK+ R K+ E + + HP ++ + G D +++ +++ G L
Sbjct: 35 AMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGEL- 93
Query: 354 RWLHHIPRGGRSLDWAMRMKVA-TTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAH 412
+ + R + + A LA + +LH K +++RD++ N+LLD+ G H
Sbjct: 94 --FSLLRKSQRFPNPVAKFYAAEVCLA--LEYLHSK---DIIYRDLKPENILLDKN-G-H 144
Query: 413 LMGV--GLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLE 466
+ G +K+VP + T GT Y+APE V D +SFG+L+ E
Sbjct: 145 IKITDFGFAKYVP-----DVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYE 195
|
| >1qdd_A Lithostathine; pancreatic stone inhibitor, metal binding protein; HET: SIA NDG GAL; 1.30A {Homo sapiens} SCOP: d.169.1.1 PDB: 1lit_A Length = 144 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 3e-11
Identities = 25/140 (17%), Positives = 50/140 (35%), Gaps = 17/140 (12%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI-GGHLAALTSYEEEHSAQKLCGKNVN 111
CP S C+ + + +W +++ YC+ + G+L ++ + E L ++
Sbjct: 14 CPEGTNAYR--SYCYYFNEDRETWVDADLYCQNMNSGNLVSVLTQAEGAFVASLIKESGT 71
Query: 112 G---CWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLV 168
W+G + +W WS ++ S+ S P V+ +
Sbjct: 72 DDFNVWIGLH--DPKKNRAWHWSSG---------SLVSYKSWGIGAPSSVNPGYCVSLTS 120
Query: 169 SNGSRSLVTERCNTSHPFIC 188
S G + C F+C
Sbjct: 121 STGFQKWKDVPCEDKFSFVC 140
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 3e-11
Identities = 45/186 (24%), Positives = 75/186 (40%), Gaps = 31/186 (16%)
Query: 297 AVKRLKRSSFQRKKE---FYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 353
A+K L + ++ E F E + + D + Y+V ++ V G L
Sbjct: 103 AMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDL- 161
Query: 354 RWLHHIPRGGRSL--DWAMRMKVA-TTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG 410
L + + L + A R +A +A I +H H VHRDI+ N+L+D
Sbjct: 162 --LTLLSKFEDRLPEEMA-RFYLAEMVIA--IDSVHQL---HYVHRDIKPDNILMDMN-- 211
Query: 411 AHLMGV--GLSKFVPWEVMQERTVMAG---GTYGYLAPEFVYRNELTTKS-----DVYSF 460
H+ G ++M++ TV + GT Y++PE + E D +S
Sbjct: 212 GHIRLADFGSCL----KLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSL 267
Query: 461 GVLLLE 466
GV + E
Sbjct: 268 GVCMYE 273
|
| >3kqg_A Langerin, C-type lectin domain family 4 member K; trimer, NECK and CRD, coiled coil, immune system; 2.30A {Homo sapiens} Length = 182 | Back alignment and structure |
|---|
Score = 61.4 bits (149), Expect = 3e-11
Identities = 19/101 (18%), Positives = 35/101 (34%), Gaps = 7/101 (6%)
Query: 33 SNQSSNGQLAASMNKDWKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAA 92
+ + +L N + W + + + ++W +E +C HL +
Sbjct: 30 GSLENMSKLLKRQNDILQ-VVSQGWKYFK--GNFYYFSLIPKTWYSAEQFCVSRNSHLTS 86
Query: 93 LTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSDN 133
+TS E+ K G W+G G W W D+
Sbjct: 87 VTSESEQEFLYKTAGG--LIYWIGLTKAGME-G-DWSWVDD 123
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 3e-11
Identities = 46/178 (25%), Positives = 67/178 (37%), Gaps = 17/178 (9%)
Query: 293 GSRVAVKRLKRSSFQRKKE-FYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP 351
VAVK + E EI L+H N+V G + +Y+ E+ G
Sbjct: 32 EEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGE 91
Query: 352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQ----GIAFLHDKVKPHVVHRDIRASNVLLDE 407
L I M A G+ +LH + HRDI+ N+LLDE
Sbjct: 92 L---FDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDE 140
Query: 408 EFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELT-TKSDVYSFGVLL 464
+ GL+ + + GT Y+APE + R E DV+S G++L
Sbjct: 141 RDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVL 198
|
| >3ubu_B Agglucetin subunit beta-2; platelet inhibiting, agkisacucetin, dimer, toxin, C-type LEC GPIB inhibitor, GPIB binding; 1.91A {Deinagkistrodon acutus} Length = 126 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 4e-11
Identities = 32/144 (22%), Positives = 52/144 (36%), Gaps = 33/144 (22%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKNV 110
CP W E C+ + ++WD++E +C E GGHL ++ S EE L +
Sbjct: 4 CPLRWSAYE--GHCYLVVKEKKTWDDAEKFCTEQRKGGHLVSVHSREEADFLVHLAYPIL 61
Query: 111 NG--CWVGGRSINTTVGLSWKWSD----NMSKWNESIHAVGSFNSSCTSLPCHVHATVDL 164
+ W+G N +WSD + W + S C
Sbjct: 62 DLSLIWMGLS--NMWNDCKREWSDGTKLDFKSWAK--------TSDC------------- 98
Query: 165 CTLVSNGSRSLVTERCNTSHPFIC 188
++G + C+ H F+C
Sbjct: 99 LIGKTDGDNQWLNMDCSKKHYFVC 122
|
| >2e3x_B Coagulation factor X-activating enzyme light CHAI; disintegrin, metalloproteinase, C-type lectin, hydrolase, BL clotting, toxin; HET: NAG MAN GM6; 2.91A {Daboia russellii siamensis} Length = 134 | Back alignment and structure |
|---|
Score = 59.8 bits (145), Expect = 4e-11
Identities = 32/146 (21%), Positives = 49/146 (33%), Gaps = 30/146 (20%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKNV 110
CPPD + C+ ++W+ +E +C E GHL ++ S EE KL
Sbjct: 3 CPPDSSLYR--YFCYRVFKEHKTWEAAERFCMEHPNNGHLVSIESMEEAEFVAKLLSNTT 60
Query: 111 NGC----WVGGRSINTTVGLSWKWSD----NMSKWNESIHAVGSFNSSCTSLPCHVHATV 162
W+G + S +WSD + K + F C L
Sbjct: 61 GKFITHFWIGLMIKDKEQECSSEWSDGSSVSYDKLGK-----QEFR-KCFVL-------- 106
Query: 163 DLCTLVSNGSRSLVTERCNTSHPFIC 188
+G R C + F+C
Sbjct: 107 ----EKESGYRMWFNRNCEERYLFVC 128
|
| >1jzn_A Galactose-specific lectin; C-type lectin, protein-disaccharide complex, sugar binding P; HET: BGC GAL; 2.20A {Crotalus atrox} SCOP: d.169.1.1 PDB: 1muq_A* Length = 135 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 4e-11
Identities = 32/147 (21%), Positives = 54/147 (36%), Gaps = 29/147 (19%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI--GGHLAALTSYEEEHSAQKLCGKNV 110
CP DW+ C+ ++W+++E +C++ G HLA+ Y E +
Sbjct: 3 CPLDWLPMN--GLCYKIFNQLKTWEDAEMFCRKYKPGCHLASFHRYGESLEIAEYISDYH 60
Query: 111 NG---CWVGGRSINTTVGLSWKWSD----NMSKW--NESIHAVGSFNSSCTSLPCHVHAT 161
G W+G R + SW+W+D + W N+ H C L
Sbjct: 61 KGQENVWIGLR--DKKKDFSWEWTDRSCTDYLTWDKNQPDHYQN--KEFCVEL------- 109
Query: 162 VDLCTLVSNGSRSLVTERCNTSHPFIC 188
+ G R + C + F+C
Sbjct: 110 -----VSLTGYRLWNDQVCESKDAFLC 131
|
| >2h2t_B Low affinity immunoglobulin epsilon FC receptor ( IGE receptor) (FC-epsilon-RII)...; C-type lectin, calcium-bound, lectin domain; 1.30A {Homo sapiens} PDB: 2h2r_A 1t8c_A 1t8d_A Length = 175 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 4e-11
Identities = 22/92 (23%), Positives = 38/92 (41%), Gaps = 10/92 (10%)
Query: 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVN 111
CP WI + KC+ + + W + C ++ G L ++ S EE+ K
Sbjct: 16 TCPEKWINFQ--RKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKRASH--T 71
Query: 112 GCWVGGRSINTTVGLSWKWSD----NMSKWNE 139
G W+G R+++ + W D + S W
Sbjct: 72 GSWIGLRNLDLK--GEFIWVDGSHVDYSNWAP 101
|
| >2ox9_A Collectin placenta 1; C-type lectin, sugar binding protein; HET: GAL NAG FUC; 1.95A {Mus musculus} PDB: 2ox8_A Length = 140 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 5e-11
Identities = 26/140 (18%), Positives = 49/140 (35%), Gaps = 20/140 (14%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNG 112
CPP W KC+ + +++++ +C++ HL + S EE+ +K
Sbjct: 5 CPPHWKNFT--DKCYYFSLEKEIFEDAKLFCEDKSSHLVFINSREEQQWIKKHTVGR-ES 61
Query: 113 CWVGGRSINTTVGLSWKWSD----NMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLV 168
W+G WKW D + W G ++ + C +
Sbjct: 62 HWIGLTDSEQE-S-EWKWLDGSPVDYKNWKA-----GQPDNWGSGHGPGED-----CAGL 109
Query: 169 SNGSRSLVTERCNTSHPFIC 188
+ +C+ + FIC
Sbjct: 110 IYAGQ-WNDFQCDEINNFIC 128
|
| >2ls8_A C-type lectin domain family 4 member D; structural genomics, NEW YORK structural genomics research consortium, nysgrc, PSI-biology, immune system; NMR {Homo sapiens} Length = 156 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 6e-11
Identities = 22/81 (27%), Positives = 41/81 (50%), Gaps = 5/81 (6%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNG 112
CP DW + S C+ + + ++W ESE C +G HL +++ E++ + + ++
Sbjct: 3 CPIDWRAFQ--SNCYFPLTDNKTWAESERNCSGMGAHLMTISTEAEQNFIIQFLDRRLS- 59
Query: 113 CWVGGRSINTTVGLSWKWSDN 133
++G R N G W+W D
Sbjct: 60 YFLGLRDENAK-G-QWRWVDQ 78
|
| >1ukm_A EMS16 A chain, EMS16 subunit A; domain swapping, C-type lectin, toxin; HET: NAG; 1.90A {Echis multisquamatus} SCOP: d.169.1.1 PDB: 1v7p_A* Length = 134 | Back alignment and structure |
|---|
Score = 59.4 bits (144), Expect = 6e-11
Identities = 33/148 (22%), Positives = 52/148 (35%), Gaps = 34/148 (22%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKNV 110
CP DW + C+ IG ++W E+E +C E GHL ++ S EE + +L +
Sbjct: 4 CPSDWTAYD--QHCYLAIGEPQNWYEAERFCTEQAKDGHLVSIQSREEGNFVAQLVSGFM 61
Query: 111 NG----CWVGGRSINTTVGLSWKWSD----NMSKW--NESIHAVGSFNSSCTSLPCHVHA 160
+ W+G R + +W+D W ES G + T
Sbjct: 62 HRSEIYVWIGLRDRREEQQCNPEWNDGSKIIYVNWKEGESKMCQG--LTKWT-------- 111
Query: 161 TVDLCTLVSNGSRSLVTERCNTSHPFIC 188
C +PF+C
Sbjct: 112 ----------NFHDWNNINCEDLYPFVC 129
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 6e-11
Identities = 46/178 (25%), Positives = 67/178 (37%), Gaps = 17/178 (9%)
Query: 293 GSRVAVKRLKRSSFQRKKE-FYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP 351
VAVK + E EI L+H N+V G + +Y+ E+ G
Sbjct: 32 EEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGE 91
Query: 352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQ----GIAFLHDKVKPHVVHRDIRASNVLLDE 407
L I M A G+ +LH + HRDI+ N+LLDE
Sbjct: 92 L---FDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDE 140
Query: 408 EFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELT-TKSDVYSFGVLL 464
+ GL+ + + GT Y+APE + R E DV+S G++L
Sbjct: 141 RDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVL 198
|
| >1dv8_A Asialoglycoprotein receptor 1; C-type lectin CRD, signaling protein; 2.30A {Homo sapiens} SCOP: d.169.1.1 Length = 128 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 7e-11
Identities = 27/147 (18%), Positives = 49/147 (33%), Gaps = 34/147 (23%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNG 112
CP +W+ +E C+ + + ++W +++ YC+ HL +TS+EE+ Q G
Sbjct: 1 CPVNWVEHE--RSCYWFSRSGKAWADADNYCRLEDAHLVVVTSWEEQKFVQHHIGP--VN 56
Query: 113 CWVGGRSINTTVGLSWKWSD------NMSKW-----NESIHAVGSFNSSCTSLPCHVHAT 161
W+G N WKW D W ++ C
Sbjct: 57 TWMGLHDQNGP----WKWVDGTDYETGFKNWRPEQPDDWYGHGLGGGEDCAHF------- 105
Query: 162 VDLCTLVSNGSRSLVTERCNTSHPFIC 188
+ C + ++C
Sbjct: 106 --------TDDGRWNDDVCQRPYRWVC 124
|
| >1uv0_A Pancreatitis-associated protein 1; lectin, C-type, secreted, inflammatory response, acute phase; 1.78A {Homo sapiens} SCOP: d.169.1.1 PDB: 2go0_A Length = 149 | Back alignment and structure |
|---|
Score = 59.4 bits (144), Expect = 8e-11
Identities = 29/149 (19%), Positives = 49/149 (32%), Gaps = 30/149 (20%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKE-IGGHLAALTSYEEEHSAQKLCGKNVN 111
CP S C+ + +SW +++ C++ G+L ++ S E L N
Sbjct: 14 CPKGSKAYG--SHCYALFLSPKSWTDADLACQKRPSGNLVSVLSGAEGSFVSSLVKSIGN 71
Query: 112 G---CWVGGRSIN---TTVGLSWKWSD----NMSKWNESIHAVGSFNSSCTSLPCHVHAT 161
W+G G W+WS N W + P + +
Sbjct: 72 SYSYVWIGLHDPTQGTEPNGEGWEWSSSDVMNYFAWERN--------------PSTISSP 117
Query: 162 VDLCTLVSNGSRSL--VTERCNTSHPFIC 188
C +S + L CN P++C
Sbjct: 118 GH-CASLSRSTAFLRWKDYNCNVRLPYVC 145
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 1e-10
Identities = 50/240 (20%), Positives = 80/240 (33%), Gaps = 47/240 (19%)
Query: 252 PPSWKVFTTEELRSITKNFSEGN----RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSF 306
PP+ T + E LLG G ++G L D +VA+K + R+
Sbjct: 10 PPAPPGTPTPPPGGKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRV 69
Query: 307 QRKKEF------YSEIGRFARLH----HPNLVAVKGCCYDHGDRYIVYEFVVNGP-LDRW 355
E+ ++ HP ++ + +V E + L
Sbjct: 70 LGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDL--- 126
Query: 356 LHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE------- 408
+I G L + I H + VVHRDI+ N+L+D
Sbjct: 127 FDYITEKGP-LGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAKLI 182
Query: 409 ---FGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELT-TKSDVYSFGVLL 464
GA L + F GT Y PE++ R++ + V+S G+LL
Sbjct: 183 DFGSGALLHDEPYTDFD-------------GTRVYSPPEWISRHQYHALPATVWSLGILL 229
|
| >2zib_A Type II antifreeze protein; thermal hysteresis, lectin; 1.34A {Brachyopsis rostratus} Length = 133 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 1e-10
Identities = 25/81 (30%), Positives = 39/81 (48%), Gaps = 7/81 (8%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNG 112
CP W ++ +CF +WD +E C GGHLA++ S EE+ + + V
Sbjct: 10 CPAGWTLHG--QRCFYSEATAMTWDLAEANCVNKGGHLASIHSLEEQLYIKDIVAGIV-- 65
Query: 113 CWVGGRSINTTVGLSWKWSDN 133
W+GG + G +W W+D
Sbjct: 66 -WIGGSACKVA-G-AWSWTDG 83
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 1e-10
Identities = 58/247 (23%), Positives = 95/247 (38%), Gaps = 41/247 (16%)
Query: 237 RKSRKLSNPAASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGI-LPDGSR 295
+R L SAL P+ +F EL +G+ G Y G + G
Sbjct: 6 SPARSLDEIDLSALRDPA-GIFELVEL-------------VGNGTYGQVYKGRHVKTGQL 51
Query: 296 VAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRY------IVYEFVV 348
A+K + + ++E EI + HH N+ G +V EF
Sbjct: 52 AAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCG 110
Query: 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQ---GIAFLHDKVKPHVVHRDIRASNVLL 405
G + + + +W +A + G++ LH V+HRDI+ NVLL
Sbjct: 111 AGSVTDLIKNTKGNTLKEEW-----IAYICREILRGLSHLHQH---KVIHRDIKGQNVLL 162
Query: 406 DEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELT-----TKSDVYSF 460
E L+ G+S + + R G Y ++APE + +E KSD++S
Sbjct: 163 TENAEVKLVDFGVSAQLD-RTVGRRNTFIGTPY-WMAPEVIACDENPDATYDFKSDLWSL 220
Query: 461 GVLLLEI 467
G+ +E+
Sbjct: 221 GITAIEM 227
|
| >1gz2_A Ovocleidin-17, OC-17 ovocleidin; structural protein, CTLD, eggshell structural protein, phosphoprotein, sugar-binding protein, glycoprotein; HET: SEP; 1.5A {Gallus gallus} SCOP: d.169.1.1 Length = 142 | Back alignment and structure |
|---|
Score = 57.9 bits (140), Expect = 2e-10
Identities = 32/153 (20%), Positives = 50/153 (32%), Gaps = 36/153 (23%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI--GGHLAALTSYEEEHSAQKLCGKNV 110
C P W+ C G+ SW +E++C+ G HLAA+ S E +L +
Sbjct: 5 CGPGWVPTP--GGCLGFFSRELSWSRAESFCRRWGPGSHLAAVRSAAELRLLAELLNASR 62
Query: 111 NGCWVGGRSINTT-VGLS-------WKWSD----NMSKWNESIHAVGSFNSS---CTSLP 155
G G + +GL W+WSD + W+ + C +L
Sbjct: 63 GGDGSGEGADGRVWIGLHRPAGSRSWRWSDGTAPRFASWHR-----TAKARRGGRCAAL- 116
Query: 156 CHVHATVDLCTLVSNGSRSLVTERCNTSHPFIC 188
S C + F+C
Sbjct: 117 -----------RDEEAFTSWAARPCTERNAFVC 138
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 3e-10
Identities = 48/199 (24%), Positives = 86/199 (43%), Gaps = 37/199 (18%)
Query: 286 YSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR----- 340
+ L + VA+K++ Q K+ E+ + HPN+V +K Y +GD+
Sbjct: 57 FQAKLVESDEVAIKKV----LQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVF 112
Query: 341 -YIVYEFVVNGPLD--RWLHHIPRGGRSLDWAMRMKVAT-TLAQGIAFLHDKVKPHVVHR 396
+V E+V P R H + +++ + +K+ L + +A++H + HR
Sbjct: 113 LNLVLEYV---PETVYRASRHYAKLKQTMP-MLLIKLYMYQLLRSLAYIHSI---GICHR 165
Query: 397 DIRASNVLLDEEFGAHLMGV------GLSK-FVPWEVMQERTVMAGGTYGYLAPEFVYR- 448
DI+ N+LLD GV G +K + E + Y APE ++
Sbjct: 166 DIKPQNLLLDPP-----SGVLKLIDFGSAKILIAGEPNVSYIC----SRYYRAPELIFGA 216
Query: 449 NELTTKSDVYSFGVLLLEI 467
TT D++S G ++ E+
Sbjct: 217 TNYTTNIDIWSTGCVMAEL 235
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 3e-10
Identities = 47/257 (18%), Positives = 80/257 (31%), Gaps = 45/257 (17%)
Query: 233 SKRRRKSRKLSNPAASALVPPSWKVFTTEELRSITKNFSEGN----RLLGDSKTGGTYSG 288
S + + P + T+ K E LLG G YSG
Sbjct: 3 SSHHHHHHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSG 62
Query: 289 I-LPDGSRVAVKRLKRSSFQRKKEF------YSEIGRFARLHH--PNLVAVKGCCYDHGD 339
I + D VA+K +++ E E+ ++ ++ +
Sbjct: 63 IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 122
Query: 340 RYIVYEFVVN-GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDI 398
++ E L I G L + + + + H+ V+HRDI
Sbjct: 123 FVLILERPEPVQDL---FDFITERGA-LQEELARSFFWQVLEAVRHCHNC---GVLHRDI 175
Query: 399 RASNVLLDEE----------FGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYR 448
+ N+L+D GA L + F GT Y PE++
Sbjct: 176 KDENILIDLNRGELKLIDFGSGALLKDTVYTDFD-------------GTRVYSPPEWIRY 222
Query: 449 NELT-TKSDVYSFGVLL 464
+ + V+S G+LL
Sbjct: 223 HRYHGRSAAVWSLGILL 239
|
| >2vuv_A Codakine; sugar-binding protein, C-type, lectin, mannose, invertebrate; HET: CIT; 1.3A {Codakia orbicularis} PDB: 2vuz_A* Length = 129 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 4e-10
Identities = 21/87 (24%), Positives = 38/87 (43%), Gaps = 10/87 (11%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNG 112
CP W C+ Y SW +++ C+ +GG LA + E +C +N +
Sbjct: 2 CPDGWTQFL--DLCYIYQSAKASWASAQSSCQALGGILAEPDTACENEVLIHMCKENGDA 59
Query: 113 ----CWVGGRSINTTVGLSWKWSDNMS 135
W+GG+ + +W+WS + +
Sbjct: 60 GSFGPWLGGQKVGG----AWQWSSSGA 82
|
| >1tn3_A Tetranectin; plasminogen binding, kringle 4, C-type lectin, carbohydrate recognition domain; 2.00A {Homo sapiens} SCOP: d.169.1.1 PDB: 1rjh_A 3l9j_C Length = 137 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 4e-10
Identities = 15/85 (17%), Positives = 30/85 (35%), Gaps = 8/85 (9%)
Query: 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVN 111
C ++ KCF +++ E+ C GG L+ + E + + ++V
Sbjct: 5 VCLKGTKVHM---KCFLAFTQTKTFHEASEDCISRGGTLSTPQTGSENDALYEYLRQSVG 61
Query: 112 G---CWVGGRSINTTVGLSWKWSDN 133
W+G + G +W
Sbjct: 62 NEAEIWLGLNDMAAE-G-TWVDMTG 84
|
| >3pbf_A Pulmonary surfactant-associated protein A; collectin, carbohydrate binding, lectin, mannose, sugar BIND protein; 1.80A {Rattus norvegicus} PDB: 1r14_A* 1r13_A* 3paq_A* 3par_A 3pak_A Length = 148 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 5e-10
Identities = 16/81 (19%), Positives = 30/81 (37%), Gaps = 4/81 (4%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNG 112
+ +K F G ++D + C GG++A + EE + + K N
Sbjct: 27 LQGSMLSVGDK--VFSTNGQSVNFDTIKEMCTRAGGNIAVPRTPEENEAIASIAKKYNNY 84
Query: 113 CWVGGRSINTTVGLSWKWSDN 133
++G T G + + D
Sbjct: 85 VYLGMIEDQTP-G-DFHYLDG 103
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 5e-10
Identities = 46/180 (25%), Positives = 84/180 (46%), Gaps = 25/180 (13%)
Query: 297 AVKRLKRSSFQRKKEF---YSEIGRFAR-LHHPNLVAVKGCCYDHGDR-YIVYEFVVNGP 351
A+K +K+ ++ +E F + +HP LV + C+ R + V E+V G
Sbjct: 38 AMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH-SCFQTESRLFFVIEYVNGGD 96
Query: 352 LDRWLHHIPRGGR-SLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG 410
L + H+ R + + A R A ++ + +LH++ +++RD++ NVLLD E
Sbjct: 97 L---MFHMQRQRKLPEEHA-RFYSAE-ISLALNYLHER---GIIYRDLKLDNVLLDSE-- 146
Query: 411 AHLMGV--GLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYRNELTTKSDVYSFGVLLLE 466
H+ G+ K E ++ + GT Y+APE + + D ++ GVL+ E
Sbjct: 147 GHIKLTDYGMCK----EGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFE 202
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 6e-10
Identities = 45/180 (25%), Positives = 84/180 (46%), Gaps = 25/180 (13%)
Query: 297 AVKRLKRSSFQRKKEF---YSEIGRFAR-LHHPNLVAVKGCCYDHGDR-YIVYEFVVNGP 351
A++ +K+ ++ +E F + +HP LV + C+ R + V E+V G
Sbjct: 81 AMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH-SCFQTESRLFFVIEYVNGGD 139
Query: 352 LDRWLHHIPRGGR-SLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG 410
L + H+ R + + A R A ++ + +LH++ +++RD++ NVLLD E
Sbjct: 140 L---MFHMQRQRKLPEEHA-RFYSAE-ISLALNYLHER---GIIYRDLKLDNVLLDSE-- 189
Query: 411 AHLMGV--GLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYRNELTTKSDVYSFGVLLLE 466
H+ G+ K E ++ + GT Y+APE + + D ++ GVL+ E
Sbjct: 190 GHIKLTDYGMCK----EGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFE 245
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 59.1 bits (144), Expect = 6e-10
Identities = 50/186 (26%), Positives = 76/186 (40%), Gaps = 34/186 (18%)
Query: 293 GSRVAVKRLKRSSFQRKKEF---YSEIGRFARLHHPNLVAVKGCCYD----HGDRYIVYE 345
G +VAVK L R + EI HP+++ + Y D ++V E
Sbjct: 36 GHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL----YQVISTPTDFFMVME 91
Query: 346 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQ----GIAFLHDKVKPHVVHRDIRAS 401
+V G L +I + GR + A L Q + + H VVHRD++
Sbjct: 92 YVSGGEL---FDYICKHGR-----VEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPE 140
Query: 402 NVLLDEEFGAHLMGVGLSKFVPWEVMQERTVM--AGGTYGYLAPEFVYRNELT-TKSDVY 458
NVLLD A + GLS M + + + G+ Y APE + + D++
Sbjct: 141 NVLLDAHMNAKIADFGLSNM-----MSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIW 195
Query: 459 SFGVLL 464
S GV+L
Sbjct: 196 SCGVIL 201
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 8e-10
Identities = 41/153 (26%), Positives = 69/153 (45%), Gaps = 24/153 (15%)
Query: 323 HHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGR-SLDWAMRMKVA-TTLAQ 380
P LV + +++ +++ G L H+ + R + ++ V LA
Sbjct: 117 QSPFLVTLHYAFQTETKLHLILDYINGGEL---FTHLSQRERFTEHEV-QIYVGEIVLA- 171
Query: 381 GIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGV--GLSKFVPWEVMQERTVMAG--- 435
+ LH +++RDI+ N+LLD G H++ GLSK E + + T A
Sbjct: 172 -LEHLHKL---GIIYRDIKLENILLDSN-G-HVVLTDFGLSK----EFVADETERAYDFC 221
Query: 436 GTYGYLAPEFVYRNEL-TTKS-DVYSFGVLLLE 466
GT Y+AP+ V + K+ D +S GVL+ E
Sbjct: 222 GTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYE 254
|
| >1rtm_1 Mannose-binding protein-A; lectin; 1.80A {Rattus norvegicus} SCOP: d.169.1.1 h.1.1.1 PDB: 1kwu_A* 1kwv_A* 1kwt_A* 1kwx_A* 1kwy_A* 1kx1_A* 1kww_A 1kwz_A* 1kx0_A* 3kmb_1* 1kmb_1* 2kmb_1* 4kmb_1* 1afb_1* 1afa_1* 1afd_1 1bch_1* 1bcj_1* 1fif_A 1fih_A* Length = 149 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 8e-10
Identities = 16/104 (15%), Positives = 34/104 (32%), Gaps = 11/104 (10%)
Query: 40 QLAASMNKDWKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEE 99
L + + K + K F + + + C E+ G +A + EE
Sbjct: 15 TLKSKLELTNKLHAFSMG--KKSGKKFFVTNHERMPFSKVKALCSELRGTVAIPRNAEEN 72
Query: 100 HSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSD----NMSKWNE 139
+ Q++ + ++G T G + + S W +
Sbjct: 73 KAIQEVAKTSA---FLGITDEVTE-G-QFMYVTGGRLTYSNWKK 111
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 9e-10
Identities = 52/179 (29%), Positives = 75/179 (41%), Gaps = 23/179 (12%)
Query: 297 AVKRLKRSSFQRKKEF---YSEIGRFAR-LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352
AVK LK+ + + +E + +HP L + C + V EFV G L
Sbjct: 52 AVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDL 111
Query: 353 DRWLHHIPRGGR-SLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGA 411
+ HI + R A R A + + FLHDK +++RD++ NVLLD E
Sbjct: 112 ---MFHIQKSRRFDEARA-RFYAAE-IISALMFLHDK---GIIYRDLKLDNVLLDHE--G 161
Query: 412 HLMGV--GLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYRNELTTKSDVYSFGVLLLE 466
H G+ K E + A GT Y+APE + D ++ GVLL E
Sbjct: 162 HCKLADFGMCK----EGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYE 216
|
| >1htn_A Tetranectin; plasminogen binding, kringle 4, alpha-helical coiled coil, C-type lectin, carbohydrate recognition domain; 2.80A {Homo sapiens} SCOP: d.169.1.1 h.1.1.1 Length = 182 | Back alignment and structure |
|---|
Score = 57.1 bits (138), Expect = 1e-09
Identities = 15/86 (17%), Positives = 30/86 (34%), Gaps = 8/86 (9%)
Query: 51 APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNV 110
C ++ KCF +++ E+ C GG L+ + E + + ++V
Sbjct: 49 TVCLKGTKVHM---KCFLAFTQTKTFHEASEDCISRGGTLSTPQTGSENDALYEYLRQSV 105
Query: 111 NG---CWVGGRSINTTVGLSWKWSDN 133
W+G + G +W
Sbjct: 106 GNEAEIWLGLNDMAAE-G-TWVDMTG 129
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 1e-09
Identities = 54/180 (30%), Positives = 79/180 (43%), Gaps = 25/180 (13%)
Query: 297 AVKRLKRSSFQRKKEF---YSEIGRFAR-LHHPNLVAVKGCCYDHGDR-YIVYEFVVNGP 351
AVK LK+ + + E A P L + C+ DR Y V E+V G
Sbjct: 49 AVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGD 107
Query: 352 LDRWLHHIPRGGR-SLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG 410
L ++HI + GR A A +A G+ FL K +++RD++ NV+LD E G
Sbjct: 108 L---MYHIQQVGRFKEPHA-VFYAAE-IAIGLFFLQSK---GIIYRDLKLDNVMLDSE-G 158
Query: 411 AHLMGV--GLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYRNELTTKSDVYSFGVLLLE 466
H+ G+ K E + + GT Y+APE + D ++FGVLL E
Sbjct: 159 -HIKIADFGMCK----ENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYE 213
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 58.7 bits (143), Expect = 1e-09
Identities = 43/184 (23%), Positives = 78/184 (42%), Gaps = 33/184 (17%)
Query: 297 AVKRLKRSS-FQRKKEFY---SEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352
A+K LK++ + K+ +E + HP +V + G Y++ E++ G L
Sbjct: 49 AMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGEL 108
Query: 353 DRWLHHIPRGGR-SLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE--- 408
+ R G D A +A ++ + LH K +++RD++ N++L+ +
Sbjct: 109 ---FMQLEREGIFMEDTA-CFYLAE-ISMALGHLHQK---GIIYRDLKPENIMLNHQGHV 160
Query: 409 ----FGAHLMGVGLSKFVPWEVMQE--RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGV 462
FG L K E + + T GT Y+APE + R+ D +S G
Sbjct: 161 KLTDFG-------LCK----ESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGA 209
Query: 463 LLLE 466
L+ +
Sbjct: 210 LMYD 213
|
| >1buu_A Protein (mannose-binding protein A); lectin, HOST defense, metalloprotein, sugar binding protein; 1.90A {Rattus norvegicus} SCOP: d.169.1.1 h.1.1.1 Length = 168 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 1e-09
Identities = 16/109 (14%), Positives = 36/109 (33%), Gaps = 11/109 (10%)
Query: 35 QSSNGQLAASMNKDWKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALT 94
++ L + + K + K F + + + C E+ G +A
Sbjct: 29 EAEINTLKSKLELTNKLHAFSMG--KKSGKKFFVTNHERMPFSKVKALCSELRGTVAIPR 86
Query: 95 SYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSD----NMSKWNE 139
+ EE + Q++ + ++G T G + + S W +
Sbjct: 87 NAEENKAIQEVAKTSA---FLGITDEVTE-G-QFMYVTGGRLTYSNWKK 130
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 58.8 bits (142), Expect = 2e-09
Identities = 32/103 (31%), Positives = 48/103 (46%), Gaps = 23/103 (22%)
Query: 375 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA 434
+ +A+G+ FL + +HRD+ A N+LL E+ + GL+ R +
Sbjct: 199 SFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLA----------RDIYK 245
Query: 435 GGTY-----GYL-----APEFVYRNELTTKSDVYSFGVLLLEI 467
Y L APE ++ T +SDV+SFGVLL EI
Sbjct: 246 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 288
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 48.0 bits (114), Expect = 4e-06
Identities = 30/155 (19%), Positives = 49/155 (31%), Gaps = 16/155 (10%)
Query: 284 GTYSGILPDGS--RVAVKRLKRSSFQR-KKEFYSEIGRFARL-HHPNLVAVKGCCYDHGD 339
GI + VAVK LK + + SE+ + HH N+V + G C G
Sbjct: 41 ADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 100
Query: 340 R-YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDI 398
++ EF G L +L R + +G F K + D+
Sbjct: 101 PLMVIVEFCKFGNLSTYLRS-----------KRNEFVPYKTKGARFRQGKDYVGAIPVDL 149
Query: 399 RASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVM 433
+ + + G K + +E
Sbjct: 150 KRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPED 184
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 50/176 (28%), Positives = 75/176 (42%), Gaps = 17/176 (9%)
Query: 297 AVKRLKRSSFQRKKEF---YSEIGRFAR-LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352
AVK LK+ + + E A P L + C Y V E+V G L
Sbjct: 370 AVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDL 429
Query: 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAH 412
++HI + GR + A +A G+ FL K +++RD++ NV+LD E
Sbjct: 430 ---MYHIQQVGRFKEPHAVFYAAE-IAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIK 482
Query: 413 LMGVGLSKFVPWEVMQE--RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLE 466
+ G+ K E + + T GT Y+APE + D ++FGVLL E
Sbjct: 483 IADFGMCK----ENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYE 534
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 2e-09
Identities = 49/185 (26%), Positives = 82/185 (44%), Gaps = 35/185 (18%)
Query: 297 AVKRLKRSSFQRKKEF---YSEIGRFAR-LHHPNLVAVKGCCYDHGDR-YIVYEFVVNGP 351
AVK L++ + +KKE SE + + HP LV + + D+ Y V +++ G
Sbjct: 67 AVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH-FSFQTADKLYFVLDYINGGE 125
Query: 352 LDRWLHHIPRGGR-SLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE-- 408
L +H+ R A R A +A + +LH ++V+RD++ N+LLD +
Sbjct: 126 L---FYHLQRERCFLEPRA-RFYAAE-IASALGYLHSL---NIVYRDLKPENILLDSQGH 177
Query: 409 -----FGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYRNELTTKSDVYSFG 461
FG L K E ++ + + GT YLAPE +++ D + G
Sbjct: 178 IVLTDFG-------LCK----ENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLG 226
Query: 462 VLLLE 466
+L E
Sbjct: 227 AVLYE 231
|
| >1hup_A Mannose-binding protein; alpha-helical coiled-coil, C-type lectin; 2.50A {Homo sapiens} SCOP: d.169.1.1 h.1.1.1 Length = 141 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 2e-09
Identities = 17/104 (16%), Positives = 34/104 (32%), Gaps = 11/104 (10%)
Query: 40 QLAASMNKDWKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEE 99
L M + K + +K F G ++++ + C + +A + E
Sbjct: 7 ALQTEMARIKKWLTFSLG--KQVGNKFFLTNGEIMTFEKVKALCVKFQASVATPRNAAEN 64
Query: 100 HSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSDNM----SKWNE 139
+ Q L + ++G T G + + WNE
Sbjct: 65 GAIQNLIKEEA---FLGITDEK-TEG-QFVDLTGNRLTYTNWNE 103
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 3e-09
Identities = 48/184 (26%), Positives = 74/184 (40%), Gaps = 33/184 (17%)
Query: 297 AVKRLKRSSFQRKKEF---YSEIGRFAR-LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352
A+K LK+ + E + HP L + + + V E++ G L
Sbjct: 46 AIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDL 105
Query: 353 DRWLHHIPRGGR-SLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE--- 408
++HI + L A A + G+ FLH K +V+RD++ N+LLD++
Sbjct: 106 ---MYHIQSCHKFDLSRA-TFYAAE-IILGLQFLHSK---GIVYRDLKLDNILLDKDGHI 157
Query: 409 ----FGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYRNELTTKSDVYSFGV 462
FG + K E M GT Y+APE + + D +SFGV
Sbjct: 158 KIADFG-------MCK----ENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGV 206
Query: 463 LLLE 466
LL E
Sbjct: 207 LLYE 210
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 3e-09
Identities = 50/207 (24%), Positives = 89/207 (42%), Gaps = 44/207 (21%)
Query: 284 GTYSGI------LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH 337
G++ G+ G VA+K++ Q K+ E+ +L H N+V ++ Y
Sbjct: 65 GSF-GVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRYFFYSS 119
Query: 338 GDR------YIVYEFVVNGPLD--RWLHHIPRGGRSLDWAMRMKVAT-TLAQGIAFLHDK 388
G++ +V ++V P R H R ++L + +K+ L + +A++H
Sbjct: 120 GEKKDEVYLNLVLDYV---PETVYRVARHYSRAKQTLP-VIYVKLYMYQLFRSLAYIHSF 175
Query: 389 VKPHVVHRDIRASNVLLDEEFGAHLMGV------GLSK-FVPWEVMQERTVMAGGTYGYL 441
+ HRDI+ N+LLD + V G +K V E + Y
Sbjct: 176 ---GICHRDIKPQNLLLDPD-----TAVLKLCDFGSAKQLVRGEPNVSYIC----SRYYR 223
Query: 442 APEFVYR-NELTTKSDVYSFGVLLLEI 467
APE ++ + T+ DV+S G +L E+
Sbjct: 224 APELIFGATDYTSSIDVWSAGCVLAEL 250
|
| >1byf_A TC14, protein (polyandrocarpa lectin); C-type lectin, galactose-specific, sugar binding protein; 2.00A {Polyandrocarpa misakiensis} SCOP: d.169.1.1 PDB: 1tlg_A* Length = 125 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 3e-09
Identities = 10/71 (14%), Positives = 25/71 (35%), Gaps = 3/71 (4%)
Query: 65 KCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEE--HSAQKLCGKNVNGCWVGGRSINT 122
+ ++ ++ TYC+ G L + + + + WVG ++
Sbjct: 3 YEILFSDETMNYADAGTYCQSRGMALVSSAMRDSTMVKAILAFTEVKGHDYWVGADNLQD 62
Query: 123 TVGLSWKWSDN 133
++ W+D
Sbjct: 63 G-AYNFLWNDG 72
|
| >3cfw_A L-selectin; EGF, cell adhesion, EGF-like domain, glycoprotein, membrane, sushi, transmembrane; HET: NAG MAN BMA; 2.20A {Homo sapiens} Length = 164 | Back alignment and structure |
|---|
Score = 55.2 bits (133), Expect = 3e-09
Identities = 18/123 (14%), Positives = 41/123 (33%), Gaps = 7/123 (5%)
Query: 66 CFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVG 125
+ Y +W + +C++ L A+ + E +K + + W+G R I
Sbjct: 2 TYHYSEKPMNWQRARRFCRDNYTDLVAIQNKAEIEYLEKTLPFSRSYYWIGIRKIGGI-- 59
Query: 126 LSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHP 185
+W ++ G N+ C V++ + + + C+
Sbjct: 60 WTWVGTNKSLTEEAENWGDGEPNNKKNKEDC-----VEIYIKRNKDAGKWNDDACHKLKA 114
Query: 186 FIC 188
+C
Sbjct: 115 ALC 117
|
| >1h8u_A MBP, eosinophil granule major basic protein 1; lectin, eosinophil granule protein, EMBP; 1.8A {Homo sapiens} SCOP: d.169.1.1 PDB: 2brs_A* Length = 117 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 4e-09
Identities = 22/125 (17%), Positives = 43/125 (34%), Gaps = 14/125 (11%)
Query: 66 CFGYIGNFRSWDESETYCKEI-GGHLAALTSYEEEHSAQKLCGK-NVNGCWVGGRSINTT 123
+ + + +++ ++ C+ G+L ++ ++ + Q N W+GGR +
Sbjct: 3 RYLLVRSLQTFSQAWFTCRRCYRGNLVSIHNFNINYRIQCSVSALNQGQVWIGGRITGSG 62
Query: 124 VGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTS 183
++W D S+WN F P C + C
Sbjct: 63 RCRRFQWVDG-SRWN--------FAYWAAHQPWSRGGH---CVALCTRGGYWRRAHCLRR 110
Query: 184 HPFIC 188
PFIC
Sbjct: 111 LPFIC 115
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 57.5 bits (139), Expect = 5e-09
Identities = 29/145 (20%), Positives = 60/145 (41%), Gaps = 32/145 (22%)
Query: 284 GTYSGI-------LPDGSRVAVKRLKRSSF----QRKKEFYSEIGRFARLHHPNLVAVKG 332
GTY + D A+K+++ + R EI L HPN+++++
Sbjct: 32 GTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACR------EIALLRELKHPNVISLQK 85
Query: 333 CCYDHGDR--YIVYEFVVNGPLD-RWLHHIPRGGRSLDWAMRMKVATT------LAQGIA 383
H DR ++++++ D + R ++ +++ + GI
Sbjct: 86 VFLSHADRKVWLLFDYA---EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIH 142
Query: 384 FLHDKVKPHVVHRDIRASNVLLDEE 408
+LH V+HRD++ +N+L+ E
Sbjct: 143 YLHAN---WVLHRDLKPANILVMGE 164
|
| >3alu_A Lectin CEL-IV, C-type; C-type lectin, raffinose, sugar binding protein; HET: RAF; 1.65A {Cucumaria echinata} PDB: 3als_A* 3alt_A* Length = 157 | Back alignment and structure |
|---|
Score = 54.5 bits (131), Expect = 5e-09
Identities = 29/155 (18%), Positives = 52/155 (33%), Gaps = 29/155 (18%)
Query: 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIG-----------GHLAALTSYEEEH 100
CPP W KCF N ++D +E C++ G GHLA++ S E +
Sbjct: 4 SCPPLWTGFN--GKCFRLFHNHLNFDNAENACRQFGLASCSGDELATGHLASIHSAESQA 61
Query: 101 SAQKLCGKNVNGCWVGGRSINTTVGLS-------WKWSDNMSKWNESIHAVGSFNSSCTS 153
+L ++ GG + +G+ W+D S + ++ +
Sbjct: 62 FLTELVKTSLPDLITGGWAPQVYIGMKVGSTNSDQTWTDG-SSVD--------YDGWVSG 112
Query: 154 LPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFIC 188
P + + N + +IC
Sbjct: 113 EPNNGPNSRGAIAAGDYSRGFWADVYSNNNFKYIC 147
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 5e-09
Identities = 51/216 (23%), Positives = 81/216 (37%), Gaps = 65/216 (30%)
Query: 292 DGSRVAVKRLKRSSFQRKKEFYS--------------------------EIGRFARLHHP 325
D + A+K L + R+ F EI +L HP
Sbjct: 37 DNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHP 96
Query: 326 NLVAVKGCCYDHGDR--YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQ--- 380
N+V + D + Y+V+E V GP+ +P + A Q
Sbjct: 97 NVVKLVEVLDDPNEDHLYMVFELVNQGPV----MEVPTLKP-----LSEDQARFYFQDLI 147
Query: 381 -GIAFLHDKVKPHVVHRDIRASNVLLDEE-------FGAHLMGVGLS-KFVPWEVMQERT 431
GI +LH + ++HRDI+ SN+L+ E+ F G+S +F + + T
Sbjct: 148 KGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADF-------GVSNEFKGSDALLSNT 197
Query: 432 VMAGGTYGYLAPEFVYRNELT---TKSDVYSFGVLL 464
V GT ++APE + DV++ GV L
Sbjct: 198 V---GTPAFMAPESLSETRKIFSGKALDVWAMGVTL 230
|
| >1g1s_A P-selectin; selectin, lectin, EGF, sulphated, SLEX, immune system, membr protein; HET: TYS SIA GAL NAG FUC NGA; 1.90A {Homo sapiens} SCOP: d.169.1.1 g.3.11.1 PDB: 1g1r_A* 1g1q_A* 1fsb_A Length = 162 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 8e-09
Identities = 16/67 (23%), Positives = 25/67 (37%), Gaps = 4/67 (5%)
Query: 66 CFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVG 125
+ Y SW+ S YC+ L A+ + E K+ + W+G R N
Sbjct: 2 TYHYSTKAYSWNISRKYCQNRYTDLVAIQNKNEIDYLNKVLPYYSSYYWIGIRKNNK--- 58
Query: 126 LSWKWSD 132
+W W
Sbjct: 59 -TWTWVG 64
|
| >1g1t_A E-selectin; EGF, adhesion molecule, SLEX, immune system, membrane protein; HET: SIA GAL MAG FUC; 1.50A {Homo sapiens} SCOP: d.169.1.1 g.3.11.1 PDB: 1esl_A Length = 157 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 8e-09
Identities = 24/130 (18%), Positives = 42/130 (32%), Gaps = 21/130 (16%)
Query: 66 CFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVG 125
+ ++DE+ YC++ HL A+ + EE + + + W+G R +N
Sbjct: 2 SYNTSTEAMTYDEASAYCQQRYTHLVAIQNKEEIEYLNSILSYSPSYYWIGIRKVNNV-- 59
Query: 126 LSWKWSD-------NMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTE 178
W W W G N+ C V++ E
Sbjct: 60 --WVWVGTQKPLTEEAKNWAP-----GEPNNRQKDEDC-----VEIYIKREKDVGMWNDE 107
Query: 179 RCNTSHPFIC 188
RC+ +C
Sbjct: 108 RCSKKKLALC 117
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 53/188 (28%), Positives = 79/188 (42%), Gaps = 38/188 (20%)
Query: 293 GSRVAVKRLKRSSFQRKKEF---YSEIGRFARLHHPNLVAVKGCCYD----HGDRYIVYE 345
G +VAVK L R + EI HP+++ + Y D ++V E
Sbjct: 41 GHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL----YQVISTPSDIFMVME 96
Query: 346 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQ----GIAFLHDKVKPHVVHRDIRAS 401
+V G L +I + GR + K + L Q G+ + H VVHRD++
Sbjct: 97 YVSGGEL---FDYICKNGR-----LDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPE 145
Query: 402 NVLLDEEFGAHLMGVGLSKFVPWEVMQE----RTVMAGGTYGYLAPEFVYRNELT-TKSD 456
NVLLD A + GLS M + RT + G+ Y APE + + D
Sbjct: 146 NVLLDAHMNAKIADFGLSNM-----MSDGEFLRT--SCGSPNYAAPEVISGRLYAGPEVD 198
Query: 457 VYSFGVLL 464
++S GV+L
Sbjct: 199 IWSSGVIL 206
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 1e-08
Identities = 41/213 (19%), Positives = 77/213 (36%), Gaps = 51/213 (23%)
Query: 265 SITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL- 322
+I ++ +++LG G + A+K L+ R+ E+ R
Sbjct: 14 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR-----EVELHWRAS 68
Query: 323 HHPNLVAVKGCCYDHGDR----YIVYEFVVNGPL-DRWLHHIPRGGRSL---DWAMRMKV 374
P++V + + IV E + G L R RG ++ + + MK
Sbjct: 69 QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI---QDRGDQAFTEREASEIMK- 124
Query: 375 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLL-DEEFGAHLMGV--GLSKFVPWEVMQERT 431
++ + I +LH ++ HRD++ N+L + A L G +K E E+
Sbjct: 125 --SIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK----ETTGEK- 174
Query: 432 VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLL 464
Y D++S GV++
Sbjct: 175 ------YD-------------KSCDMWSLGVIM 188
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 2e-08
Identities = 54/213 (25%), Positives = 80/213 (37%), Gaps = 50/213 (23%)
Query: 284 GTYSGI------LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH 337
GT+ G G VA+K++ + + + A LHHPN+V ++ Y
Sbjct: 34 GTF-GTVQLGKEKSTGMSVAIKKV-IQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTL 91
Query: 338 GDR-------YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATT----LAQGIAFLH 386
G+R +V E+V P LH R A + L + I LH
Sbjct: 92 GERDRRDIYLNVVMEYV---PDT--LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLH 146
Query: 387 DKVKPHVVHRDIRASNVLLDEEFGAHLMGV------GLSK-FVPWEVMQERTVMAGGTYG 439
+V HRDI+ NVL++E G G +K P E +
Sbjct: 147 LPSV-NVCHRDIKPHNVLVNEA-----DGTLKLCDFGSAKKLSPSEPNVAYIC----SRY 196
Query: 440 YLAPEFV-----YRNELTTKSDVYSFGVLLLEI 467
Y APE + Y TT D++S G + E+
Sbjct: 197 YRAPELIFGNQHY----TTAVDIWSVGCIFAEM 225
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 55.3 bits (134), Expect = 2e-08
Identities = 35/120 (29%), Positives = 53/120 (44%), Gaps = 13/120 (10%)
Query: 293 GSRVAVKRLKRSSFQRKKEFYS----EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV 348
G VA+K+ S K EI +L H NLV + C Y+V+EF V
Sbjct: 50 GRIVAIKKFLESDD--DKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEF-V 106
Query: 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE 408
+ + L P G LD+ + K + GI F H +++HRDI+ N+L+ +
Sbjct: 107 DHTILDDLELFPNG---LDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQS 160
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 54.9 bits (133), Expect = 3e-08
Identities = 31/146 (21%), Positives = 55/146 (37%), Gaps = 39/146 (26%)
Query: 284 GTYSGI------LPDGSRVAVKRLKRSSFQRKKE-FYS----EIGRFARLHHPNLVAVKG 332
G + VA+K++K K+ EI L HPN++ +
Sbjct: 21 GQF-ATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLD 79
Query: 333 CCYDHGDRYIVYEFV----------VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGI 382
+ +V++F+ + L HI ++ M M QG+
Sbjct: 80 AFGHKSNISLVFDFMETDLEVIIKDNSLVLT--PSHI----KAY---MLM-----TLQGL 125
Query: 383 AFLHDKVKPHVVHRDIRASNVLLDEE 408
+LH ++HRD++ +N+LLDE
Sbjct: 126 EYLHQH---WILHRDLKPNNLLLDEN 148
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 3e-08
Identities = 44/186 (23%), Positives = 72/186 (38%), Gaps = 35/186 (18%)
Query: 293 GSRVAVKRLKRSSFQRKKEF---YSEIGRFARLHHPNLVAVKGCCYD----HGDRYIVYE 345
+VA+K + R ++ EI L HP+++ + YD D +V E
Sbjct: 34 QQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL----YDVITTPTDIVMVIE 89
Query: 346 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQ----GIAFLHDKVKPHVVHRDIRAS 401
+ G L +I R M Q I + H +VHRD++
Sbjct: 90 YA-GGEL---FDYIVEKKR-----MTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPE 137
Query: 402 NVLLDEEFGAHLMGVGLSKFVPWEVMQERTVM--AGGTYGYLAPEFVYRNELT-TKSDVY 458
N+LLD+ + GLS M + + + G+ Y APE + + DV+
Sbjct: 138 NLLLDDNLNVKIADFGLSNI-----MTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVW 192
Query: 459 SFGVLL 464
S G++L
Sbjct: 193 SCGIVL 198
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 54.5 bits (132), Expect = 3e-08
Identities = 27/119 (22%), Positives = 50/119 (42%), Gaps = 11/119 (9%)
Query: 293 GSRVAVKRLKRSSFQRKKEFYS--EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 350
G VA+K+ S + + EI +L HPNLV + ++V+E+
Sbjct: 28 GQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEY---- 83
Query: 351 PLDRWL-HHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE 408
D + H + R R + + + Q + F H + +HRD++ N+L+ +
Sbjct: 84 -CDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKH 138
|
| >1wmz_A Lectin CEL-I, N-acetyl-D-galactosamine-specific C-type; C-type lectin, N-acetylgalactosamine, invertebrate, sugar binding protein; HET: NGA A2G; 1.70A {Cucumaria echinata} SCOP: d.169.1.1 PDB: 1wmy_A* Length = 140 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 3e-08
Identities = 19/155 (12%), Positives = 40/155 (25%), Gaps = 31/155 (20%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIG-------GHLAALTSYEEEHSAQKL 105
CP DW C+ + +W+ + C L ++ S E+
Sbjct: 3 CPTDWEAEG--DHCYRFFNTLTTWENAHHECVSYSCSTLNVRSDLVSVHSAAEQAYVFNY 60
Query: 106 CGKNVNG---CWVGGRSINTTVGLSWKWSD----NMSKWNESIHAVGSFNSSCTSLPCHV 158
+ W+G + + W+D +KW G ++ +
Sbjct: 61 WRGIDSQAGQLWIGLY--DKYNEGDFIWTDGSKVGYTKWAG-----GQPDNWNNAEDY-- 111
Query: 159 HATVDLCTLVSNGSRSLVTERCNTSHPFICMVEHE 193
+ ++C + E
Sbjct: 112 ------GQFRHTEGGAWNDNSAAAQAKYMCKLTFE 140
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 53.3 bits (129), Expect = 7e-08
Identities = 36/142 (25%), Positives = 61/142 (42%), Gaps = 33/142 (23%)
Query: 284 GTYSGI------LPDGSRVAVKRLKRSSFQ--------RKKEFYSEIGRFARLHHPNLVA 329
GTY G+ G VA+K+++ + R EI L+HPN+V
Sbjct: 14 GTY-GVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR------EISLLKELNHPNIVK 66
Query: 330 VKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWA---MRMKVATTLAQGIAFLH 386
+ + Y+V+EF ++ L +++ G L + L QG+AF H
Sbjct: 67 LLDVIHTENKLYLVFEF-LHQDLKKFMDASALTGIPLPLIKSYLFQ-----LLQGLAFCH 120
Query: 387 DKVKPHVVHRDIRASNVLLDEE 408
V+HRD++ N+L++ E
Sbjct: 121 SH---RVLHRDLKPQNLLINTE 139
|
| >2msb_A Mannose-binding protein-A; lectin; HET: BMA MAN; 1.70A {Rattus rattus} SCOP: d.169.1.1 PDB: 1msb_A 1ytt_A* Length = 115 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 7e-08
Identities = 14/80 (17%), Positives = 29/80 (36%), Gaps = 9/80 (11%)
Query: 64 SKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTT 123
K F + + + C E+ G +A + EE + Q++ + ++G T
Sbjct: 3 KKFFVTNHERMPFSKVKALCSELRGTVAIPRNAEENKAIQEVAKTSA---FLGITDEVTE 59
Query: 124 VGLSWKWSD----NMSKWNE 139
G + + S W +
Sbjct: 60 -G-QFMYVTGGRLTYSNWKK 77
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 7e-08
Identities = 31/138 (22%), Positives = 57/138 (41%), Gaps = 22/138 (15%)
Query: 284 GTYSGI------LPDGSRVAVKRLKRSSFQRKKEFYS----EIGRFARLHHPNLVAVKGC 333
GTY G VA+K +K ++ S EI L H N+V +
Sbjct: 16 GTY-ATVYKGLNKTTGVYVALKEVK---LDSEEGTPSTAIREISLMKELKHENIVRLYDV 71
Query: 334 CYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQ---GIAFLHDKVK 390
+ +V+EF ++ L +++ G + + V Q G+AF H+
Sbjct: 72 IHTENKLTLVFEF-MDNDLKKYMDSRTVGNTPRGLELNL-VKYFQWQLLQGLAFCHEN-- 127
Query: 391 PHVVHRDIRASNVLLDEE 408
++HRD++ N+L+++
Sbjct: 128 -KILHRDLKPQNLLINKR 144
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 2e-07
Identities = 28/149 (18%), Positives = 56/149 (37%), Gaps = 41/149 (27%)
Query: 284 GTYSGI------LPDGSRVAVKRLKRSSFQRKKE-FYS----EIGRFARLHHPNLVAVKG 332
GTY G VA+KR++ + ++E E+ L H N++ +K
Sbjct: 45 GTY-GEVYKAIDTVTNETVAIKRIR---LEHEEEGVPGTAIREVSLLKELQHRNIIELKS 100
Query: 333 CCYDHGDRYIVYEFV---------VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIA 383
+ + ++++E+ N + + I +S + L G+
Sbjct: 101 VIHHNHRLHLIFEYAENDLKKYMDKNPDVS--MRVI----KSF---LYQ-----LINGVN 146
Query: 384 FLHDKVKPHVVHRDIRASNVLLDEEFGAH 412
F H + +HRD++ N+LL +
Sbjct: 147 FCHSR---RCLHRDLKPQNLLLSVSDASE 172
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 2e-07
Identities = 47/200 (23%), Positives = 82/200 (41%), Gaps = 24/200 (12%)
Query: 275 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKG 332
R LG K + I + + +V VK LK +KK+ EI L PN++ +
Sbjct: 42 RKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLAD 98
Query: 333 CCYDHGDR--YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVK 390
D R +V+E V N + + D+ +R + L + + + H
Sbjct: 99 IVKDPVSRTPALVFEHVNNTDFKQLYQTLT------DYDIRFYMYEIL-KALDYCHSM-- 149
Query: 391 PHVVHRDIRASNVLLDEEFGA-HLMGVGLSKF-VPWEVMQERTVMAGGTYGYLAPE-FVY 447
++HRD++ NV++D E L+ GL++F P + R + + PE V
Sbjct: 150 -GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVA----SRYFKGPELLVD 204
Query: 448 RNELTTKSDVYSFGVLLLEI 467
D++S G +L +
Sbjct: 205 YQMYDYSLDMWSLGCMLASM 224
|
| >1rdl_1 SUB-MBP-C, mannose-binding protein-C; C-type lectin, calcium-binding protein; HET: MMA; 1.70A {Rattus rattus} SCOP: d.169.1.1 PDB: 1rdj_1* 1rdk_1* 1rdi_1* 1rdm_1* 1rdn_1* 1rdo_1 1bv4_A 1kza_1* 1kzb_1* 1kzc_1* 1kzd_1* 1kze_1* Length = 113 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 3e-07
Identities = 14/79 (17%), Positives = 27/79 (34%), Gaps = 9/79 (11%)
Query: 65 KCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTV 124
K F + ++ C E+ G +A + EE + Q + ++G T
Sbjct: 2 KYFMSSVRRMPLNRAKALCSELQGTVATPRNAEENRAIQNVAKDVA---FLGITDQRTE- 57
Query: 125 GLSWKWSD----NMSKWNE 139
++ + WNE
Sbjct: 58 N-VFEDLTGNRVRYTNWNE 75
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 51.0 bits (123), Expect = 3e-07
Identities = 31/139 (22%), Positives = 53/139 (38%), Gaps = 28/139 (20%)
Query: 284 GTYSGI------LPDGSRVAVKRLKRSSFQ--------RKKEFYSEIGRFARLHHPNLVA 329
GTY G VA+KR++ R EI L H N+V
Sbjct: 13 GTY-GTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR------EICLLKELKHKNIVR 65
Query: 330 VKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV 389
+ + +V+EF + L ++ LD + L +G+ F H +
Sbjct: 66 LHDVLHSDKKLTLVFEF-CDQDLKKYFDSCNGD---LDPEIVKSFLFQLLKGLGFCHSR- 120
Query: 390 KPHVVHRDIRASNVLLDEE 408
+V+HRD++ N+L++
Sbjct: 121 --NVLHRDLKPQNLLINRN 137
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 51.8 bits (124), Expect = 4e-07
Identities = 41/189 (21%), Positives = 79/189 (41%), Gaps = 33/189 (17%)
Query: 293 GSRVAVKRLKRSSFQRK---KEFYSEIGRFARLHHPNLVAVK------GCCYDHGDRYIV 343
VA+K+L R FQ + K Y E+ ++H N++++ + D Y+V
Sbjct: 87 DRNVAIKKLSRP-FQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLV 145
Query: 344 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQ---GIAFLHDKVKPHVVHRDIRA 400
E +D L + + + +++ L Q GI LH ++HRD++
Sbjct: 146 MEL-----MDANLCQVIQMELDHE-----RMSYLLYQMLCGIKHLHSA---GIIHRDLKP 192
Query: 401 SNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYRNELTTKSDVY 458
SN+++ + ++ GL++ +M T Y APE + D++
Sbjct: 193 SNIVVKSDCTLKILDFGLAR-----TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIW 247
Query: 459 SFGVLLLEI 467
S G ++ E+
Sbjct: 248 SVGCIMGEM 256
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 50.6 bits (122), Expect = 5e-07
Identities = 30/124 (24%), Positives = 53/124 (42%), Gaps = 21/124 (16%)
Query: 293 GSRVAVKRLKRSSFQ--------RKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVY 344
G VA+KR++ + R EI LHHPN+V++ + +V+
Sbjct: 45 GRIVALKRIRLDAEDEGIPSTAIR------EISLLKELHHPNIVSLIDVIHSERCLTLVF 98
Query: 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 404
EF + L + L G L + L +G+A H ++HRD++ N+L
Sbjct: 99 EF-MEKDLKKVLDENKTG---LQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLL 151
Query: 405 LDEE 408
++ +
Sbjct: 152 INSD 155
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 6e-07
Identities = 23/120 (19%), Positives = 53/120 (44%), Gaps = 14/120 (11%)
Query: 293 GSRVAVKRLKRSSFQRKKEFYS----EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV 348
+ VA+K ++ + ++ E+ L H N+V + + +V+E++
Sbjct: 27 DNLVALKEIR---LEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL- 82
Query: 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE 408
+ L ++L ++ L +G+A+ H + V+HRD++ N+L++E
Sbjct: 83 DKDLKQYLDDCGNI---INMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINER 136
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 50.2 bits (121), Expect = 6e-07
Identities = 29/131 (22%), Positives = 53/131 (40%), Gaps = 35/131 (26%)
Query: 293 GSRVAVKRLKRSSFQRKKE-FYS----EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV 347
G A+K+++ +++ E S EI L H N+V + + +V+E +
Sbjct: 26 GETFALKKIR---LEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHL 82
Query: 348 ----------VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRD 397
G L+ +S + L GIA+ HD+ V+HRD
Sbjct: 83 DQDLKKLLDVCEGGLE--SVTA----KSF---LLQ-----LLNGIAYCHDR---RVLHRD 125
Query: 398 IRASNVLLDEE 408
++ N+L++ E
Sbjct: 126 LKPQNLLINRE 136
|
| >1wk1_A Hypothetical protein YK1067A12; lectin C-type domain, structural genomics, riken structural genomics/proteomics initiative, RSGI; NMR {Caenorhabditis elegans} SCOP: d.169.1.1 Length = 150 | Back alignment and structure |
|---|
Score = 47.9 bits (114), Expect = 9e-07
Identities = 11/70 (15%), Positives = 23/70 (32%), Gaps = 5/70 (7%)
Query: 64 SKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTT 123
K + S ++ +C GG+LA ++ + + W+G +
Sbjct: 8 VKFLTVNDDILSMPQARNFCASAGGYLADDLGDDKNNFYSSIAAN--TQFWIGLF--KNS 63
Query: 124 VGLSWKWSDN 133
G + W
Sbjct: 64 DG-QFYWDRG 72
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 1e-06
Identities = 42/189 (22%), Positives = 78/189 (41%), Gaps = 33/189 (17%)
Query: 293 GSRVAVKRLKRSSFQRK---KEFYSEIGRFARLHHPNLVAVK------GCCYDHGDRYIV 343
VA+K+L R FQ + K Y E+ ++H N++ + + D YIV
Sbjct: 50 ERNVAIKKLSRP-FQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIV 108
Query: 344 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQ---GIAFLHDKVKPHVVHRDIRA 400
E +D L + + + +++ L Q GI LH ++HRD++
Sbjct: 109 MEL-----MDANLCQVIQMELDHE-----RMSYLLYQMLCGIKHLHSA---GIIHRDLKP 155
Query: 401 SNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYRNELTTKSDVY 458
SN+++ + ++ GL++ +M T Y APE + D++
Sbjct: 156 SNIVVKSDCTLKILDFGLAR-----TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIW 210
Query: 459 SFGVLLLEI 467
S G ++ E+
Sbjct: 211 SVGCIMGEM 219
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 49.9 bits (120), Expect = 1e-06
Identities = 34/153 (22%), Positives = 60/153 (39%), Gaps = 48/153 (31%)
Query: 284 GTYSGI-----LPDGSRVAVKRLKRSSFQRKKE-FYS----EIGRFARLHHPNLVAVKGC 333
GT+ + G +VA+K++ + +KE F EI L H N+V +
Sbjct: 28 GTFGEVFKARHRKTGQKVALKKVL---MENEKEGFPITALREIKILQLLKHENVVNLIEI 84
Query: 334 CYDHGDR--------YIVYEFV----------VNGPLDRWLHHIPRGGRSLDWAMRMKVA 375
C Y+V++F V L I + + M+M
Sbjct: 85 CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFT--LSEI----KRV---MQM--- 132
Query: 376 TTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE 408
L G+ ++H ++HRD++A+NVL+ +
Sbjct: 133 --LLNGLYYIHRN---KILHRDMKAANVLITRD 160
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 47.2 bits (113), Expect = 6e-06
Identities = 25/94 (26%), Positives = 39/94 (41%), Gaps = 17/94 (18%)
Query: 323 HHPNLVAVKGCCYDHGDR-----YIVYEFVVNGPLDRWLHHIPRGGRSLDWA---MRMKV 374
HPN+V + C +V+E V + L +L +P G + M
Sbjct: 72 EHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQ-- 128
Query: 375 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE 408
L +G+ FLH VVHRD++ N+L+
Sbjct: 129 ---LLRGLDFLHSH---RVVHRDLKPQNILVTSS 156
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 7e-06
Identities = 49/243 (20%), Positives = 97/243 (39%), Gaps = 49/243 (20%)
Query: 249 ALVPPSWKVFTTEELRSITKNFSEGNR-----LLGDSKTGGTYSGI-LPDGSRVAVKRLK 302
+ PP+ F +E+ + +G G S + G++VA+K+L
Sbjct: 2 SSPPPARSGFYRQEVTKTA--WEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLY 59
Query: 303 RSSFQRK---KEFYSEIGRFARLHHPNLVAVK------GCCYDHGDRYIVYEFVVNGPLD 353
R FQ + K Y E+ + H N++ + D D Y+V F +
Sbjct: 60 RP-FQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPF-----MG 113
Query: 354 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE----- 408
L + + + + ++ V L +G+ ++H ++HRD++ N+ ++E+
Sbjct: 114 TDLGKLMKHEKLGEDRIQFLVYQML-KGLRYIHAA---GIIHRDLKPGNLAVNEDCELKI 169
Query: 409 --FG-AHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKS-DVYSFGVLL 464
FG A ++ +V T Y APE + T++ D++S G ++
Sbjct: 170 LDFGLARQADSEMTGYV-------------VTRWYRAPEVILNWMRYTQTVDIWSVGCIM 216
Query: 465 LEI 467
E+
Sbjct: 217 AEM 219
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 46.8 bits (112), Expect = 8e-06
Identities = 34/150 (22%), Positives = 52/150 (34%), Gaps = 38/150 (25%)
Query: 284 GTYSGI------LPDGSRVAVKRLKRSSFQRKKEFYS--------EIGRFARLH---HPN 326
G Y G G VA+K ++ E+ RL HPN
Sbjct: 20 GAY-GTVYKARDPHSGHFVALKSVR---VPNGGGGGGGLPISTVREVALLRRLEAFEHPN 75
Query: 327 LVAVKGCCYDHGDR-----YIVYEFVVNGPLDRWLHHIPRGGRSLDWA---MRMKVATTL 378
+V + C +V+E V + L +L P G + MR
Sbjct: 76 VVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDLMRQ-----F 129
Query: 379 AQGIAFLHDKVKPHVVHRDIRASNVLLDEE 408
+G+ FLH +VHRD++ N+L+
Sbjct: 130 LRGLDFLHAN---CIVHRDLKPENILVTSG 156
|
| >3fd4_A Glycoprotein GP42; C type lectin, virus entry, membrane fusion, HOST-virus interaction, lectin, membrane, transmembrane, viral protein; 2.40A {Human herpesvirus 4} PDB: 1kg0_C Length = 191 | Back alignment and structure |
|---|
Score = 45.3 bits (106), Expect = 1e-05
Identities = 21/146 (14%), Positives = 36/146 (24%), Gaps = 25/146 (17%)
Query: 50 KAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKN 109
+ CF + +W+ C E+ +
Sbjct: 69 YCNTREYTFSYK--GCCFYFTKKKHTWNGCFQACAELYPCTYFYGPTPDILPVVTRNLNA 126
Query: 110 VNGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVS 169
+ WVG + +W D + I CT VS
Sbjct: 127 IESLWVG---VYRVGEGNWTSLDGGTFKVYQIFGSH-------------------CTYVS 164
Query: 170 NGSRSLVTE-RCNTSHPFICMVEHEN 194
S V+ C+ P +C+ + N
Sbjct: 165 KFSTVPVSHHECSFLKPCLCVSQRSN 190
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 45.6 bits (108), Expect = 3e-05
Identities = 31/142 (21%), Positives = 57/142 (40%), Gaps = 30/142 (21%)
Query: 284 GTYSGI------LPDGSRVAVKRLKRSSFQRK---KEFYSEIGRFARLHHPNLVAVKGCC 334
G+Y G + VA+K++ R F+ K EI RL+H ++V V
Sbjct: 64 GSY-GHVCEAYDKLEKRVVAIKKILRV-FEDLIDCKRILREIAILNRLNHDHVVKVLDIV 121
Query: 335 YDHG-----DRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQ---GIAFLH 386
+ Y+V E D + R L + + T L G+ ++H
Sbjct: 122 IPKDVEKFDELYVVLEI-----ADSDFKKLFRTPVYLT---ELHIKTLLYNLLVGVKYVH 173
Query: 387 DKVKPHVVHRDIRASNVLLDEE 408
++HRD++ +N L++++
Sbjct: 174 SA---GILHRDLKPANCLVNQD 192
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 44.4 bits (105), Expect = 7e-05
Identities = 28/127 (22%), Positives = 49/127 (38%), Gaps = 23/127 (18%)
Query: 293 GSRVAVKRLKRSSFQRK---KEFYSEIGRFARLHHPNLVAVKGCCY-----DHGDRYIVY 344
VA+K++ R F+ K EI RL ++ + + YIV
Sbjct: 51 EKNVAIKKVNRM-FEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVL 109
Query: 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQ---GIAFLHDKVKPHVVHRDIRAS 401
E D L + + L + T L G F+H+ ++HRD++ +
Sbjct: 110 EI-----ADSDLKKLFKTPIFLT---EEHIKTILYNLLLGENFIHES---GIIHRDLKPA 158
Query: 402 NVLLDEE 408
N LL+++
Sbjct: 159 NCLLNQD 165
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 48/215 (22%), Positives = 84/215 (39%), Gaps = 49/215 (22%)
Query: 275 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRK---KEFYSEIGRFARLHHPNLVAV 330
+G G S I G +VA+K+L R FQ + K Y E+ + H N++ +
Sbjct: 30 THVGSGAYGSVCSAIDKRSGEKVAIKKLSRP-FQSEIFAKRAYRELLLLKHMQHENVIGL 88
Query: 331 K------GCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQ---G 381
+ D Y+V F + L I S + K+ + Q G
Sbjct: 89 LDVFTPASSLRNFYDFYLVMPF-----MQTDLQKIMGLKFSEE-----KIQYLVYQMLKG 138
Query: 382 IAFLHDKVKPHVVHRDIRASNVLLDEE-------FG-AHLMGVGLSKFVPWEVMQERTVM 433
+ ++H VVHRD++ N+ ++E+ FG A ++ +V
Sbjct: 139 LKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYV----------- 184
Query: 434 AGGTYGYLAPEFVYRNELTTKS-DVYSFGVLLLEI 467
T Y APE + ++ D++S G ++ E+
Sbjct: 185 --VTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEM 217
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 4e-04
Identities = 32/139 (23%), Positives = 61/139 (43%), Gaps = 24/139 (17%)
Query: 284 GTYSGIL-----PDGSRVAVKRLKRSSFQRK---KEFYSEIGRFARLHHPNLVAVK---- 331
G Y + G RVAVK+L R FQ K Y E+ + H N++ +
Sbjct: 40 GAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT 98
Query: 332 --GCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV 389
+ D Y+V + L++I + + D ++ + L +G+ ++H
Sbjct: 99 PARSLEEFNDVYLVTHL-----MGADLNNIVKCQKLTDDHVQFLIYQIL-RGLKYIHSA- 151
Query: 390 KPHVVHRDIRASNVLLDEE 408
++HRD++ SN+ ++E+
Sbjct: 152 --DIIHRDLKPSNLAVNED 168
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 6e-04
Identities = 31/133 (23%), Positives = 56/133 (42%), Gaps = 29/133 (21%)
Query: 293 GSRVAVKRLKRSSFQRK---KEFYSEIGRFARLHHPNLVAVK--------------GCCY 335
RVA+K++ K EI RL H N+V V G
Sbjct: 36 DKRVAIKKI---VLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLT 92
Query: 336 DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 395
+ YIV E+ ++ L ++ G L+ R+ + L +G+ ++H +V+H
Sbjct: 93 ELNSVYIVQEY-----METDLANVLEQGPLLEEHARLFMYQLL-RGLKYIHSA---NVLH 143
Query: 396 RDIRASNVLLDEE 408
RD++ +N+ ++ E
Sbjct: 144 RDLKPANLFINTE 156
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 40.9 bits (96), Expect = 7e-04
Identities = 47/241 (19%), Positives = 82/241 (34%), Gaps = 80/241 (33%)
Query: 284 GTYSGI------LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH 337
G++ GI + G R A+K++ Q + E+ L H N++ + Y
Sbjct: 18 GSF-GIVCEVFDIESGKRFALKKV----LQDPRYKNRELDIMKVLDHVNIIKLVDYFYTT 72
Query: 338 GDR--------------------------------------YIVYEFVVNGPLD--RWLH 357
GD ++ E+V P + L
Sbjct: 73 GDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV---PDTLHKVLK 129
Query: 358 HIPRGGRSLDWAMRMKVAT-TLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE-------- 408
R GRS+ + + L + + F+H + HRDI+ N+L++ +
Sbjct: 130 SFIRSGRSIP-MNLISIYIYQLFRAVGFIHSL---GICHRDIKPQNLLVNSKDNTLKLCD 185
Query: 409 FGAHLMGVGLSK-FVPWEVMQERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLE 466
F G +K +P E + Y APE + E T D++S G + E
Sbjct: 186 F-------GSAKKLIPSEPSVAYIC----SRFYRAPELMLGATEYTPSIDLWSIGCVFGE 234
Query: 467 I 467
+
Sbjct: 235 L 235
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 553 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 3vpp_A | 132 | C-type lectin domain family 9 member A; dendritic | 99.94 | |
| 3rs1_A | 122 | C-type lectin domain family 2 member I; C-type lec | 99.94 | |
| 2py2_A | 136 | Antifreeze protein type II; type II antifreeze pro | 99.94 | |
| 1ypq_A | 135 | Oxidised low density lipoprotein (lectin-like) rec | 99.94 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.94 | |
| 3bx4_B | 146 | Aggretin beta chain; toxin; 1.70A {Agkistrodon rho | 99.93 | |
| 3bdw_B | 120 | NKG2-A/NKG2-B type II integral membrane protein; N | 99.93 | |
| 3bdw_A | 123 | Natural killer cells antigen CD94; NK cells, recep | 99.93 | |
| 2b6b_D | 175 | CD209 antigen; cryo EM dengue CRD DC-SIGN, icosahe | 99.93 | |
| 2c6u_A | 122 | CLEC1B protein; lectin, rhodocytin, aggretin, C-ty | 99.93 | |
| 1fm5_A | 199 | Early activation antigen CD69; C-type lectin-like | 99.93 | |
| 1hq8_A | 123 | NKG2-D; homodimer, CIS-proline, apoptosis; 1.95A { | 99.93 | |
| 2bpd_A | 142 | Dectin-1; receptor, beta-glucan, fungal recognitio | 99.93 | |
| 2afp_A | 129 | Protein (SEA raven type II antifreeze protein); re | 99.93 | |
| 1sl6_A | 184 | C-type lectin DC-signr; sugar binding protein; HET | 99.93 | |
| 3g8k_A | 130 | Lectin-related NK cell receptor LY49L1; natural ki | 99.93 | |
| 3kqg_A | 182 | Langerin, C-type lectin domain family 4 member K; | 99.93 | |
| 1dv8_A | 128 | Asialoglycoprotein receptor 1; C-type lectin CRD, | 99.93 | |
| 2kv3_A | 131 | Regenerating islet-derived protein 4; GISP, C-type | 99.93 | |
| 1gz2_A | 142 | Ovocleidin-17, OC-17 ovocleidin; structural protei | 99.93 | |
| 1tdq_B | 130 | Aggrecan core protein; extracellular matrix, lecti | 99.92 | |
| 3m9z_A | 139 | Killer cell lectin-like receptor subfamily B MEMB; | 99.92 | |
| 2ox9_A | 140 | Collectin placenta 1; C-type lectin, sugar binding | 99.92 | |
| 1fvu_B | 125 | Botrocetin beta chain; VON WILLBRAND factor modula | 99.92 | |
| 1wmz_A | 140 | Lectin CEL-I, N-acetyl-D-galactosamine-specific C- | 99.92 | |
| 2yhf_A | 118 | C-type lectin domain family 5 member A; immune sys | 99.92 | |
| 1qdd_A | 144 | Lithostathine; pancreatic stone inhibitor, metal b | 99.92 | |
| 3hup_A | 130 | Early activation antigen CD69; C-type lectin-like | 99.92 | |
| 1mpu_A | 138 | NKG2-D type II integral membrane protein; C-type l | 99.92 | |
| 1egg_A | 147 | Macrophage mannose receptor; C-type lectin, sugar | 99.92 | |
| 1jwi_B | 125 | Platelet aggregation inducer; domain swapping, C-t | 99.92 | |
| 1umr_C | 125 | Convulxin beta, CVX beta; lectin, C-type lectin, p | 99.92 | |
| 3c22_A | 156 | C-type lectin domain family 4 member K; coiled coi | 99.92 | |
| 1j34_B | 123 | Coagulation factor IX-binding protein B chain; mag | 99.92 | |
| 1oz7_B | 123 | Echicetin B-chain; platelet aggregation, dimer, to | 99.92 | |
| 2e3x_C | 122 | Coagulation factor X-activating enzyme light CHAI; | 99.92 | |
| 3ff7_C | 112 | Killer cell lectin-like receptor subfamily G membe | 99.92 | |
| 1uv0_A | 149 | Pancreatitis-associated protein 1; lectin, C-type, | 99.92 | |
| 2h2t_B | 175 | Low affinity immunoglobulin epsilon FC receptor ( | 99.92 | |
| 1jzn_A | 135 | Galactose-specific lectin; C-type lectin, protein- | 99.92 | |
| 3gpr_C | 134 | Rhodocetin subunit gamma; disulfide bond, lectin, | 99.92 | |
| 1c3a_B | 125 | Flavocetin-A: beta subunit; C-type lectin-like dom | 99.92 | |
| 1tn3_A | 137 | Tetranectin; plasminogen binding, kringle 4, C-typ | 99.92 | |
| 3ubu_B | 126 | Agglucetin subunit beta-2; platelet inhibiting, ag | 99.92 | |
| 1c3a_A | 135 | Flavocetin-A: alpha subunit; C-type lectin-like do | 99.91 | |
| 2xr6_A | 170 | CD209 antigen; sugar binding protein, carbohydrate | 99.91 | |
| 3ff9_A | 115 | Killer cell lectin-like receptor subfamily G membe | 99.91 | |
| 1sb2_A | 133 | Rhodocetin alpha subunit; C-type lectin, domain sw | 99.91 | |
| 3ubu_A | 131 | Agglucetin subunit alpha-1; platelet inhibiting, a | 99.91 | |
| 3bx4_A | 136 | Aggretin alpha chain; toxin; 1.70A {Agkistrodon rh | 99.91 | |
| 3gpr_D | 124 | Rhodocetin subunit delta; disulfide bond, lectin, | 99.91 | |
| 1jwi_A | 131 | Bitiscetin; domain swapping, C-type lectin, toxin; | 99.91 | |
| 2zib_A | 133 | Type II antifreeze protein; thermal hysteresis, le | 99.91 | |
| 1ukm_B | 128 | EMS16 B chain, EMS16 subunit B; domain swapping, C | 99.91 | |
| 1ukm_A | 134 | EMS16 A chain, EMS16 subunit A; domain swapping, C | 99.91 | |
| 1fvu_A | 133 | Botrocetin alpha chain; VON WILLBRAND factor modul | 99.91 | |
| 3alu_A | 157 | Lectin CEL-IV, C-type; C-type lectin, raffinose, s | 99.91 | |
| 1umr_A | 135 | Convulxin alpha, CVX alpha; lectin, C-type lectin, | 99.91 | |
| 1hup_A | 141 | Mannose-binding protein; alpha-helical coiled-coil | 99.91 | |
| 1j34_A | 129 | Coagulation factor IX-binding protein A chain; mag | 99.91 | |
| 1oz7_A | 131 | Echicetin A-chain; platelet aggregation, dimer, to | 99.91 | |
| 2e3x_B | 134 | Coagulation factor X-activating enzyme light CHAI; | 99.91 | |
| 1rtm_1 | 149 | Mannose-binding protein-A; lectin; 1.80A {Rattus n | 99.91 | |
| 1sb2_B | 129 | Rhodocetin beta subunit; C-type lectin, domain swa | 99.91 | |
| 3c8j_A | 203 | Natural killer cell receptor LY49C; MHC, virus, im | 99.91 | |
| 1buu_A | 168 | Protein (mannose-binding protein A); lectin, HOST | 99.9 | |
| 2vuv_A | 129 | Codakine; sugar-binding protein, C-type, lectin, m | 99.9 | |
| 1htn_A | 182 | Tetranectin; plasminogen binding, kringle 4, alpha | 99.9 | |
| 3g8l_A | 190 | Lectin-related NK cell receptor LY49L1; natural ki | 99.9 | |
| 2ls8_A | 156 | C-type lectin domain family 4 member D; structural | 99.84 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.9 | |
| 2msb_A | 115 | Mannose-binding protein-A; lectin; HET: BMA MAN; 1 | 99.89 | |
| 1h8u_A | 117 | MBP, eosinophil granule major basic protein 1; lec | 99.88 | |
| 1rdl_1 | 113 | SUB-MBP-C, mannose-binding protein-C; C-type lecti | 99.88 | |
| 1pwb_A | 177 | SP-D, PSP-D, pulmonary surfactant-associated prote | 99.88 | |
| 1wk1_A | 150 | Hypothetical protein YK1067A12; lectin C-type doma | 99.88 | |
| 3pbf_A | 148 | Pulmonary surfactant-associated protein A; collect | 99.88 | |
| 1byf_A | 125 | TC14, protein (polyandrocarpa lectin); C-type lect | 99.86 | |
| 1g1t_A | 157 | E-selectin; EGF, adhesion molecule, SLEX, immune s | 99.8 | |
| 1g1s_A | 162 | P-selectin; selectin, lectin, EGF, sulphated, SLEX | 99.8 | |
| 3cfw_A | 164 | L-selectin; EGF, cell adhesion, EGF-like domain, g | 99.8 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.8 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.66 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.34 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.17 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.07 | |
| 3k7b_A | 96 | Protein A33; C-type lectin-like domain, homodimer, | 98.81 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.76 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.63 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.55 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.46 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.45 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.28 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.21 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.02 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.94 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.87 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.83 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.53 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.4 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.35 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.24 | |
| 3fd4_A | 191 | Glycoprotein GP42; C type lectin, virus entry, mem | 97.16 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.08 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.99 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.95 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.75 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.75 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.51 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.44 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 96.15 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.06 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 95.87 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 94.82 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.46 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 91.55 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 84.13 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 83.86 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-54 Score=433.86 Aligned_cols=243 Identities=25% Similarity=0.343 Sum_probs=204.3
Q ss_pred eeecccCceeEEEEEeC------CCCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccC
Q 008785 275 RLLGDSKTGGTYSGILP------DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV 348 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~------~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 348 (553)
+.||+|+||+||+|.+. ++..||||+++..+....++|.+|+++|++++|||||+++|++.+.+..+||||||+
T Consensus 19 ~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~ 98 (299)
T 4asz_A 19 RELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMK 98 (299)
T ss_dssp EEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred eEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEcCC
Confidence 45699999999999864 377899999998777778899999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCC---------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeecccc
Q 008785 349 NGPLDRWLHHIP---------RGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLS 419 (553)
Q Consensus 349 ~gsL~~~l~~~~---------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla 419 (553)
+|+|.++|+... .....+++.+++.|+.|||.||+|||++ +|+||||||+|||+++++.+||+|||+|
T Consensus 99 ~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~Ki~DFGla 175 (299)
T 4asz_A 99 HGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMS 175 (299)
T ss_dssp TCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCSCH
T ss_pred CCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcEEECCcccc
Confidence 999999997532 2345699999999999999999999999 9999999999999999999999999999
Q ss_pred ccCCcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhc--Cccccc---chHHHHHhcCCH-----HH
Q 008785 420 KFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL--VLCRRW---WTLYTLVHSMSL-----LC 489 (553)
Q Consensus 420 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~--~~~~~~---~~l~~~~~~~~~-----~~ 489 (553)
+...............||+.|||||++.+..|+.++|||||||++|||++ ..|... .++...+..+.. .+
T Consensus 176 ~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~ 255 (299)
T 4asz_A 176 RDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQRPRTC 255 (299)
T ss_dssp HHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTCCCCCCTTC
T ss_pred eecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCccc
Confidence 87654433322222338999999999999999999999999999999997 334333 234444544443 56
Q ss_pred HHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 008785 490 AQECLMLFISCNNWPSHLSQSKFCNLKLWVF 520 (553)
Q Consensus 490 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~ 520 (553)
+.++.+|+.+||+.||++|||+.||++.|..
T Consensus 256 ~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~ 286 (299)
T 4asz_A 256 PQEVYELMLGCWQREPHMRKNIKGIHTLLQN 286 (299)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred hHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 7889999999999999999999999877654
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-54 Score=434.93 Aligned_cols=243 Identities=23% Similarity=0.296 Sum_probs=198.4
Q ss_pred eecccCceeEEEEEeC------CCCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCC
Q 008785 276 LLGDSKTGGTYSGILP------DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 349 (553)
Q Consensus 276 ~iG~G~~g~Vy~~~~~------~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 349 (553)
.||+|+||.||+|.+. +++.||||+++..+....++|.+|+++|++++|||||+++|+|.+.+..+||||||++
T Consensus 48 ~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~ 127 (329)
T 4aoj_A 48 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRH 127 (329)
T ss_dssp EEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCTT
T ss_pred EEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCC
Confidence 4599999999999864 4788999999987777788999999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccc
Q 008785 350 GPLDRWLHHIPR-----------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGL 418 (553)
Q Consensus 350 gsL~~~l~~~~~-----------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgl 418 (553)
|+|.++|+.... ....+++.+++.|+.|||.||+|||++ +|+||||||+|||+++++.+||+|||+
T Consensus 128 G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~~Ki~DFGl 204 (329)
T 4aoj_A 128 GDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGM 204 (329)
T ss_dssp CBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC-
T ss_pred CcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCcEEEccccc
Confidence 999999975322 124689999999999999999999999 999999999999999999999999999
Q ss_pred cccCCcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhc--Ccccccc---hHHHHHhcCCH-----H
Q 008785 419 SKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL--VLCRRWW---TLYTLVHSMSL-----L 488 (553)
Q Consensus 419 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~--~~~~~~~---~l~~~~~~~~~-----~ 488 (553)
|+...............||+.|||||++.+..|+.++|||||||++|||++ ..|.... .+...+..+.. .
T Consensus 205 a~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g~~~~~p~~ 284 (329)
T 4aoj_A 205 SRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRA 284 (329)
T ss_dssp ---------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHHTCCCCCCTT
T ss_pred ceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCccc
Confidence 987654433333333449999999999999999999999999999999997 3343332 33444444432 5
Q ss_pred HHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 008785 489 CAQECLMLFISCNNWPSHLSQSKFCNLKLWVFA 521 (553)
Q Consensus 489 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~~ 521 (553)
+++++.+|+.+||+.||++|||+.||+++|...
T Consensus 285 ~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l 317 (329)
T 4aoj_A 285 CPPEVYAIMRGCWQREPQQRHSIKDVHARLQAL 317 (329)
T ss_dssp CCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHH
T ss_pred ccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 678899999999999999999999999987553
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-54 Score=430.53 Aligned_cols=241 Identities=23% Similarity=0.297 Sum_probs=202.5
Q ss_pred eecccCceeEEEEEeC------CCCEEEEEEeccCC-hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccC
Q 008785 276 LLGDSKTGGTYSGILP------DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV 348 (553)
Q Consensus 276 ~iG~G~~g~Vy~~~~~------~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 348 (553)
.||+|+||+||+|.+. +++.||||+++... ....++|.+|+.+|++++|||||+++|+|.+.+..+||||||+
T Consensus 33 ~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV~Ey~~ 112 (308)
T 4gt4_A 33 ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCS 112 (308)
T ss_dssp EEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCS
T ss_pred EeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEEEEcCC
Confidence 4699999999999963 46789999997543 3346789999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeec
Q 008785 349 NGPLDRWLHHIPR------------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGV 416 (553)
Q Consensus 349 ~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Df 416 (553)
+|+|.++|..... ....+++.+++.|+.|||.||+|||++ +||||||||+||||++++.+||+||
T Consensus 113 ~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~~~Ki~DF 189 (308)
T 4gt4_A 113 HGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDL 189 (308)
T ss_dssp SCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCS
T ss_pred CCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECCCCCEEECCc
Confidence 9999999965321 124589999999999999999999999 9999999999999999999999999
Q ss_pred cccccCCcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhc--Cccccc---chHHHHHhcCCH----
Q 008785 417 GLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL--VLCRRW---WTLYTLVHSMSL---- 487 (553)
Q Consensus 417 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~--~~~~~~---~~l~~~~~~~~~---- 487 (553)
|+|+...............||+.|||||++.++.|+.++|||||||++|||++ ..|... .++.+.+..+..
T Consensus 190 Glar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p 269 (308)
T 4gt4_A 190 GLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQVLPCP 269 (308)
T ss_dssp CCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHHTTCCCCCC
T ss_pred ccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCc
Confidence 99987654433333333448999999999999999999999999999999997 234333 344445555543
Q ss_pred -HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 008785 488 -LCAQECLMLFISCNNWPSHLSQSKFCNLKLWV 519 (553)
Q Consensus 488 -~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~ 519 (553)
.++..+.+|+.+||+.||++||||.||+++|.
T Consensus 270 ~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~ 302 (308)
T 4gt4_A 270 DDCPAWVYALMIECWNEFPSRRPRFKDIHSRLR 302 (308)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 67788999999999999999999999999874
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-52 Score=420.17 Aligned_cols=237 Identities=23% Similarity=0.317 Sum_probs=190.9
Q ss_pred eeecccCceeEEEEEeCCCCEEEEEEeccC--ChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCCH
Q 008785 275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL 352 (553)
+.||+|+||+||+|++++ .||||+++.. +....+.|.+|+.+|++++|||||+++|++.+ +..+||||||++|+|
T Consensus 42 ~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~~gGsL 118 (307)
T 3omv_A 42 TRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWCEGSSL 118 (307)
T ss_dssp EECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCSSCBH
T ss_pred eEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcCCCCCH
Confidence 346999999999999743 6999999754 34456789999999999999999999998764 568999999999999
Q ss_pred HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccceee
Q 008785 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV 432 (553)
Q Consensus 353 ~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~ 432 (553)
.++|+. ....+++.++..|+.|||.||+|||++ +||||||||+|||+++++.+||+|||+|+............
T Consensus 119 ~~~l~~---~~~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~ 192 (307)
T 3omv_A 119 YKHLHV---QETKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVE 192 (307)
T ss_dssp HHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC-----------
T ss_pred HHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceecccCCcceeec
Confidence 999974 334699999999999999999999999 99999999999999999999999999998765443333333
Q ss_pred ecCccccccccccccC---CCCCcccchHhHHHHHHHHhcC-cccccc----hHHHHHhcCCH---------HHHHHHHH
Q 008785 433 MAGGTYGYLAPEFVYR---NELTTKSDVYSFGVLLLEIRLV-LCRRWW----TLYTLVHSMSL---------LCAQECLM 495 (553)
Q Consensus 433 ~~~gt~~y~aPE~~~~---~~~t~ksDVwSlGvil~ell~~-~~~~~~----~l~~~~~~~~~---------~~~~~l~~ 495 (553)
...||+.|||||++.+ ++|+.++|||||||++|||++. .|.... .+...+..+.. .++..+.+
T Consensus 193 ~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~ 272 (307)
T 3omv_A 193 QPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKR 272 (307)
T ss_dssp -CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTSCHHHHH
T ss_pred ccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccccchHHHHH
Confidence 3459999999999863 4689999999999999999983 333221 22223333211 56788999
Q ss_pred HHhhccCCCCCCCCCHHHHHHHHHH
Q 008785 496 LFISCNNWPSHLSQSKFCNLKLWVF 520 (553)
Q Consensus 496 l~~~Cl~~dP~~RPs~~evl~~l~~ 520 (553)
|+.+||+.||++|||+.||++.+..
T Consensus 273 li~~cl~~dP~~RPs~~ei~~~Le~ 297 (307)
T 3omv_A 273 LVADCVKKVKEERPLFPQILSSIEL 297 (307)
T ss_dssp HHHHHTCSSSTTSCCHHHHHHHHHH
T ss_pred HHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 9999999999999999999998743
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-52 Score=423.73 Aligned_cols=242 Identities=20% Similarity=0.277 Sum_probs=197.7
Q ss_pred ccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccC--ChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEE
Q 008785 269 NFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYE 345 (553)
Q Consensus 269 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 345 (553)
+|.... .||+|+||+||+|+.. +|+.||||+++.. .....+.+.+|+.+|++|+|||||++++++.+++..|||||
T Consensus 25 ~Y~~~~-~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 25 KYVRLQ-KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CEEEEE-EC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ceEEeE-EEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 444434 4599999999999964 5999999999764 33446789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcc
Q 008785 346 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE 425 (553)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~ 425 (553)
||+||+|.++|.. +....+++.++..|+.||+.||+|||++ +|+||||||+||||++++.+||+|||+|+.....
T Consensus 104 y~~gg~L~~~i~~--~~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 178 (350)
T 4b9d_A 104 YCEGGDLFKRINA--QKGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST 178 (350)
T ss_dssp CCTTCBHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred CCCCCcHHHHHHH--cCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence 9999999999975 3345679999999999999999999999 9999999999999999999999999999877543
Q ss_pred cccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhc-CcccccchH---HHHHhcCCH-----HHHHHHHHH
Q 008785 426 VMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-VLCRRWWTL---YTLVHSMSL-----LCAQECLML 496 (553)
Q Consensus 426 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-~~~~~~~~l---~~~~~~~~~-----~~~~~l~~l 496 (553)
.... ....||+.|||||++.+..|+.++|||||||++|||++ ..|+...+. ...+..+.. ..+.++.+|
T Consensus 179 ~~~~--~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~l 256 (350)
T 4b9d_A 179 VELA--RACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSL 256 (350)
T ss_dssp HHHH--HHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHH
T ss_pred cccc--cccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccCCHHHHHH
Confidence 2221 12239999999999999999999999999999999998 334433333 333333333 567789999
Q ss_pred HhhccCCCCCCCCCHHHHHHHH
Q 008785 497 FISCNNWPSHLSQSKFCNLKLW 518 (553)
Q Consensus 497 ~~~Cl~~dP~~RPs~~evl~~l 518 (553)
+.+||+.||++|||+.|++++-
T Consensus 257 i~~~L~~dP~~R~s~~e~l~hp 278 (350)
T 4b9d_A 257 VSQLFKRNPRDRPSVNSILEKG 278 (350)
T ss_dssp HHHHTCSSGGGSCCHHHHHTSH
T ss_pred HHHHccCChhHCcCHHHHhcCH
Confidence 9999999999999999999873
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-52 Score=421.77 Aligned_cols=237 Identities=21% Similarity=0.263 Sum_probs=201.7
Q ss_pred cCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccC
Q 008785 270 FSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV 348 (553)
Q Consensus 270 ~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 348 (553)
|....+ ||+|+||.||+|... +|+.||||+++.......+.+.+|+.+|++++|||||++++++.+.+..|||||||+
T Consensus 76 y~~~~~-iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~ 154 (346)
T 4fih_A 76 LDNFIK-IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE 154 (346)
T ss_dssp EEEEEE-EEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred cEEeEE-eecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCC
Confidence 433344 599999999999975 599999999986655556778999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCccccc
Q 008785 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ 428 (553)
Q Consensus 349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 428 (553)
+|+|.+++.. ..+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+........
T Consensus 155 gg~L~~~l~~-----~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~ 226 (346)
T 4fih_A 155 GGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR 226 (346)
T ss_dssp TEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC
T ss_pred CCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCCCc
Confidence 9999999975 3589999999999999999999999 9999999999999999999999999999876544322
Q ss_pred ceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcC-cccccch---HHHHHhcCC---H----HHHHHHHHHH
Q 008785 429 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLV-LCRRWWT---LYTLVHSMS---L----LCAQECLMLF 497 (553)
Q Consensus 429 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~-~~~~~~~---l~~~~~~~~---~----~~~~~l~~l~ 497 (553)
. ...+||+.|||||++.+..|+.++|||||||++|||++. .|+...+ +...+..+. + ..+.++.+|+
T Consensus 227 ~--~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli 304 (346)
T 4fih_A 227 R--KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFL 304 (346)
T ss_dssp B--CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHH
T ss_pred c--cccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHHH
Confidence 2 223499999999999999999999999999999999983 3333332 233333321 1 5677899999
Q ss_pred hhccCCCCCCCCCHHHHHHH
Q 008785 498 ISCNNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 498 ~~Cl~~dP~~RPs~~evl~~ 517 (553)
.+||..||++|||+.|++++
T Consensus 305 ~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 305 DRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp HHHSCSSTTTSCCHHHHTTC
T ss_pred HHHcCCChhHCcCHHHHhcC
Confidence 99999999999999999986
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-51 Score=411.98 Aligned_cols=244 Identities=19% Similarity=0.169 Sum_probs=200.1
Q ss_pred eeecccCceeEEEEEeC-CCCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCCHH
Q 008785 275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 353 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~ 353 (553)
+.||+|+||.||+|+.. +|+.||||+++.... ..+|+.+|++++|||||++++++.+.+..|||||||+||+|.
T Consensus 64 ~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~ 138 (336)
T 4g3f_A 64 PRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLG 138 (336)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCBHH
T ss_pred cEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHH
Confidence 34599999999999965 589999999976532 247999999999999999999999999999999999999999
Q ss_pred HHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCC-CeEEeeccccccCCcccccc---
Q 008785 354 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF-GAHLMGVGLSKFVPWEVMQE--- 429 (553)
Q Consensus 354 ~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~-~~kl~Dfgla~~~~~~~~~~--- 429 (553)
++|+. ...+++..+..++.||+.||+|||++ +|+||||||+||||+.++ .+||+|||+|+.........
T Consensus 139 ~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~ 211 (336)
T 4g3f_A 139 QLIKQ----MGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLL 211 (336)
T ss_dssp HHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC----------
T ss_pred HHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccccee
Confidence 99975 24599999999999999999999999 999999999999999987 69999999998775443221
Q ss_pred eeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcCc-ccc---cchHHHHHhcCCH-------HHHHHHHHHHh
Q 008785 430 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVL-CRR---WWTLYTLVHSMSL-------LCAQECLMLFI 498 (553)
Q Consensus 430 ~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~-~~~---~~~l~~~~~~~~~-------~~~~~l~~l~~ 498 (553)
.....+||+.|||||++.+..|+.++|||||||++|||++.. |+. ...+...+..+.. ..+..+.+++.
T Consensus 212 ~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~li~ 291 (336)
T 4g3f_A 212 TGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQ 291 (336)
T ss_dssp --CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSCHHHHHHHH
T ss_pred cCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccCCHHHHHHHH
Confidence 122235999999999999999999999999999999999733 322 2223333322221 56778999999
Q ss_pred hccCCCCCCCCCHHHHHHHHHHHHhhcccccc
Q 008785 499 SCNNWPSHLSQSKFCNLKLWVFAILTIRKVQF 530 (553)
Q Consensus 499 ~Cl~~dP~~RPs~~evl~~l~~~~~~~~~~~~ 530 (553)
+||+.||++|||+.|+++++...+.+......
T Consensus 292 ~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~h 323 (336)
T 4g3f_A 292 EGLRKEPVHRASAMELRRKVGKALQEVGGLKS 323 (336)
T ss_dssp HHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCS
T ss_pred HHccCCHhHCcCHHHHHHHHHHHHhhhhhccC
Confidence 99999999999999999999888876654433
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-51 Score=404.88 Aligned_cols=232 Identities=20% Similarity=0.285 Sum_probs=191.2
Q ss_pred CeeecccCceeEEEEEeC-CCCEEEEEEeccC--ChhhHHHHHHHHHHhhccCCCceeeEeeEEee----CCceEEEEEc
Q 008785 274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD----HGDRYIVYEF 346 (553)
Q Consensus 274 ~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~----~~~~~lV~E~ 346 (553)
.+.||+|+||+||+|... +++.||||++... .....+.|.+|+.+|++++|||||++++++.+ .+..||||||
T Consensus 31 ~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmEy 110 (290)
T 3fpq_A 31 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTEL 110 (290)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEEEC
T ss_pred eeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEEeC
Confidence 344799999999999975 4889999999754 33446789999999999999999999999875 2457999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--ceecCCCCCcEEecC-CCCeEEeeccccccCC
Q 008785 347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPH--VVHRDIRASNVLLDE-EFGAHLMGVGLSKFVP 423 (553)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~--ivHrDlkp~NILl~~-~~~~kl~Dfgla~~~~ 423 (553)
|++|+|.+++.. ...+++..+..++.||+.||+|||++ + |+||||||+|||++. ++.+||+|||+|+...
T Consensus 111 ~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~ylH~~---~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~ 183 (290)
T 3fpq_A 111 MTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp CCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred CCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence 999999999975 24689999999999999999999998 6 999999999999985 7899999999998644
Q ss_pred cccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcC-ccccc----chHHHHHhcCCH------HHHHH
Q 008785 424 WEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLV-LCRRW----WTLYTLVHSMSL------LCAQE 492 (553)
Q Consensus 424 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~-~~~~~----~~l~~~~~~~~~------~~~~~ 492 (553)
... .....||+.|||||++. ++|+.++|||||||++|||++. .|... ..+...+..+.. ..+++
T Consensus 184 ~~~----~~~~~GTp~YmAPE~~~-~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 258 (290)
T 3fpq_A 184 ASF----AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPE 258 (290)
T ss_dssp TTS----BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHH
T ss_pred CCc----cCCcccCccccCHHHcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCCHH
Confidence 322 22334999999999886 4699999999999999999983 33322 123334443322 34567
Q ss_pred HHHHHhhccCCCCCCCCCHHHHHHH
Q 008785 493 CLMLFISCNNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 493 l~~l~~~Cl~~dP~~RPs~~evl~~ 517 (553)
+.+|+.+||+.||++|||+.|++++
T Consensus 259 ~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 259 VKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHccCChhHCcCHHHHhcC
Confidence 8999999999999999999999875
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-51 Score=411.76 Aligned_cols=240 Identities=19% Similarity=0.247 Sum_probs=203.1
Q ss_pred ccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCC---hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEE
Q 008785 269 NFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVY 344 (553)
Q Consensus 269 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 344 (553)
+|... +.||+|+||+||+++.. +|+.||||++++.. ....+.+.+|+++|++++|||||++++++.+++..||||
T Consensus 33 dy~i~-~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 33 DFKFG-KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GEEEE-EEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEE-EEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 45443 45699999999999964 58999999997542 234577999999999999999999999999999999999
Q ss_pred EccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCc
Q 008785 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW 424 (553)
Q Consensus 345 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~ 424 (553)
||++||+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+....
T Consensus 112 Ey~~gG~L~~~i~~----~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~ 184 (311)
T 4aw0_A 112 SYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 184 (311)
T ss_dssp CCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred ecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence 99999999999975 24699999999999999999999999 999999999999999999999999999998765
Q ss_pred ccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhc-Ccccccc---hHHHHHhcCCH----HHHHHHHHH
Q 008785 425 EVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-VLCRRWW---TLYTLVHSMSL----LCAQECLML 496 (553)
Q Consensus 425 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-~~~~~~~---~l~~~~~~~~~----~~~~~l~~l 496 (553)
..........+||+.|||||++.+..|+.++||||+||++|||++ ..|+... .+...+..+.. ..+.++.+|
T Consensus 185 ~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dl 264 (311)
T 4aw0_A 185 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKARDL 264 (311)
T ss_dssp TTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTCCHHHHHH
T ss_pred CCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcccCHHHHHH
Confidence 443333344459999999999999999999999999999999998 3333333 33344444444 556788999
Q ss_pred HhhccCCCCCCCCCHHHHHH
Q 008785 497 FISCNNWPSHLSQSKFCNLK 516 (553)
Q Consensus 497 ~~~Cl~~dP~~RPs~~evl~ 516 (553)
+.+||..||++|||+.|++.
T Consensus 265 i~~lL~~dp~~R~t~~e~~~ 284 (311)
T 4aw0_A 265 VEKLLVLDATKRLGCEEMEG 284 (311)
T ss_dssp HHHHSCSSGGGSTTSGGGTC
T ss_pred HHHHccCCHhHCcChHHHcC
Confidence 99999999999999999754
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-51 Score=423.01 Aligned_cols=237 Identities=20% Similarity=0.260 Sum_probs=201.9
Q ss_pred cCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccC
Q 008785 270 FSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV 348 (553)
Q Consensus 270 ~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 348 (553)
|....+ ||+|+||.||+|... +|+.||||++........+.+.+|+.+|++++|||||++++++.+.+..|||||||+
T Consensus 153 y~~~~~-iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~ 231 (423)
T 4fie_A 153 LDNFIK-IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE 231 (423)
T ss_dssp EEEEEE-EEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred cEeeeE-eccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCC
Confidence 434344 599999999999975 599999999987665666778999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCccccc
Q 008785 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ 428 (553)
Q Consensus 349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 428 (553)
||+|.+++.. ..+++.++..++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+|+........
T Consensus 232 gG~L~~~i~~-----~~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~ 303 (423)
T 4fie_A 232 GGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR 303 (423)
T ss_dssp TEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCC
T ss_pred CCcHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCCCcc
Confidence 9999999965 3489999999999999999999999 9999999999999999999999999999876544332
Q ss_pred ceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcC-cccccch---HHHHHhcCCH-------HHHHHHHHHH
Q 008785 429 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLV-LCRRWWT---LYTLVHSMSL-------LCAQECLMLF 497 (553)
Q Consensus 429 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~-~~~~~~~---l~~~~~~~~~-------~~~~~l~~l~ 497 (553)
.. ..+||+.|||||++.+..|+.++|||||||++|||++. .|+...+ +...+..+.. ..+..+.+|+
T Consensus 304 ~~--~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli 381 (423)
T 4fie_A 304 RK--SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFL 381 (423)
T ss_dssp BC--CCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHH
T ss_pred cc--ccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHHH
Confidence 22 23499999999999999999999999999999999983 3333332 3333333211 4677899999
Q ss_pred hhccCCCCCCCCCHHHHHHH
Q 008785 498 ISCNNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 498 ~~Cl~~dP~~RPs~~evl~~ 517 (553)
.+||..||++|||+.|+|++
T Consensus 382 ~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 382 DRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp HHHSCSSTTTSCCHHHHTTC
T ss_pred HHHcCCChhHCcCHHHHhcC
Confidence 99999999999999999986
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-51 Score=415.96 Aligned_cols=249 Identities=22% Similarity=0.256 Sum_probs=204.4
Q ss_pred CeeecccCceeEEEEEeCC------CCEEEEEEeccCC-hhhHHHHHHHHHHhhccCC-CceeeEeeEEeeC-CceEEEE
Q 008785 274 NRLLGDSKTGGTYSGILPD------GSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHH-PNLVAVKGCCYDH-GDRYIVY 344 (553)
Q Consensus 274 ~~~iG~G~~g~Vy~~~~~~------g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H-pnIv~l~~~~~~~-~~~~lV~ 344 (553)
.+.||+|+||+||+|.+.. ++.||||.++... ....++|.+|+++|++++| ||||+++|+|.+. +..+|||
T Consensus 69 ~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~~~iV~ 148 (353)
T 4ase_A 69 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIV 148 (353)
T ss_dssp EEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEE
T ss_pred eeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCEEEEEE
Confidence 3456999999999998642 3589999998653 3445789999999999965 9999999999765 5689999
Q ss_pred EccCCCCHHHHhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeE
Q 008785 345 EFVVNGPLDRWLHHIPR------------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAH 412 (553)
Q Consensus 345 E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~k 412 (553)
|||++|+|.++|+.... ....+++..+..++.|||.||+|||++ +||||||||+|||+++++.+|
T Consensus 149 Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~~vK 225 (353)
T 4ase_A 149 EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVK 225 (353)
T ss_dssp ECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEE
T ss_pred EcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCccCccceeeCCCCCEE
Confidence 99999999999975321 134589999999999999999999999 999999999999999999999
Q ss_pred EeeccccccCCcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhc--Cccccc----chHHHHHhcCC
Q 008785 413 LMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL--VLCRRW----WTLYTLVHSMS 486 (553)
Q Consensus 413 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~--~~~~~~----~~l~~~~~~~~ 486 (553)
|+|||+|+...............||+.|||||++.+..|+.++|||||||++|||++ ..|... ..+...+..+.
T Consensus 226 i~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~i~~g~ 305 (353)
T 4ase_A 226 ICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT 305 (353)
T ss_dssp ECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTC
T ss_pred ECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHHcCC
Confidence 999999987765443333333348999999999999999999999999999999997 333332 22334454443
Q ss_pred H-----HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHhhc
Q 008785 487 L-----LCAQECLMLFISCNNWPSHLSQSKFCNLKLWVFAILTI 525 (553)
Q Consensus 487 ~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~~~~~~ 525 (553)
. ..++++.+++.+||+.||++|||+.||+++|...+...
T Consensus 306 ~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~ 349 (353)
T 4ase_A 306 RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 349 (353)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred CCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHh
Confidence 2 56778999999999999999999999999987765443
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-50 Score=406.01 Aligned_cols=241 Identities=21% Similarity=0.246 Sum_probs=189.1
Q ss_pred CeeecccCceeEEEEEeCCCCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCC----ceEEEEEccCC
Q 008785 274 NRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHG----DRYIVYEFVVN 349 (553)
Q Consensus 274 ~~~iG~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~----~~~lV~E~~~~ 349 (553)
.+.||+|+||+||+|++ +|+.||||+++.... ....+..|+..+.+++|||||+++|++.+++ ..|||||||++
T Consensus 8 ~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~ 85 (303)
T 3hmm_A 8 QESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEH 85 (303)
T ss_dssp EEEEEECSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTT
T ss_pred EEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCCCC
Confidence 34569999999999998 689999999976432 2233456777778899999999999998764 47999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-----CCCCceecCCCCCcEEecCCCCeEEeeccccccCCc
Q 008785 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDK-----VKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW 424 (553)
Q Consensus 350 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~-----~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~ 424 (553)
|+|.++|+. ..+++..+.+++.|++.||+|||++ .+++|+||||||+|||+++++.+||+|||+|+....
T Consensus 86 gsL~~~l~~-----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~ 160 (303)
T 3hmm_A 86 GSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS 160 (303)
T ss_dssp CBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEET
T ss_pred CcHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccC
Confidence 999999975 3589999999999999999999975 246999999999999999999999999999986644
Q ss_pred ccccc--eeeecCccccccccccccCC------CCCcccchHhHHHHHHHHhcCcccc-----------c--------ch
Q 008785 425 EVMQE--RTVMAGGTYGYLAPEFVYRN------ELTTKSDVYSFGVLLLEIRLVLCRR-----------W--------WT 477 (553)
Q Consensus 425 ~~~~~--~~~~~~gt~~y~aPE~~~~~------~~t~ksDVwSlGvil~ell~~~~~~-----------~--------~~ 477 (553)
..... ......||+.|||||++.+. .++.++|||||||++|||++..+.. . ..
T Consensus 161 ~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~ 240 (303)
T 3hmm_A 161 ATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE 240 (303)
T ss_dssp TTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHH
T ss_pred CCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHHH
Confidence 32221 11223499999999998754 4678999999999999999732210 0 11
Q ss_pred HHHHHhcCCH-----------HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 008785 478 LYTLVHSMSL-----------LCAQECLMLFISCNNWPSHLSQSKFCNLKLWVFA 521 (553)
Q Consensus 478 l~~~~~~~~~-----------~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~~ 521 (553)
+...+..+.. ..+..+.+|+.+||+.||++||||.||++.|...
T Consensus 241 ~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l 295 (303)
T 3hmm_A 241 MRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295 (303)
T ss_dssp HHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 1222221111 4667889999999999999999999999987553
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-50 Score=396.95 Aligned_cols=240 Identities=18% Similarity=0.228 Sum_probs=188.7
Q ss_pred cccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCC---hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEE
Q 008785 268 KNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIV 343 (553)
Q Consensus 268 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 343 (553)
++|... +.||+|+||+||+|... +|+.||||++++.. ......+.+|+++|++++|||||++++++.+.+..|+|
T Consensus 13 g~Y~i~-~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (275)
T 3hyh_A 13 GNYQIV-KTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV 91 (275)
T ss_dssp -CCEEE-EEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred eCeEEE-EEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 455554 45599999999999964 59999999997642 23356799999999999999999999999999999999
Q ss_pred EEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCC
Q 008785 344 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVP 423 (553)
Q Consensus 344 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~ 423 (553)
|||+ +|+|.+++.. ...+++.++..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+|+...
T Consensus 92 mEy~-~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~ 163 (275)
T 3hyh_A 92 IEYA-GNELFDYIVQ----RDKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMT 163 (275)
T ss_dssp EECC-CEEHHHHHHH----SCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC----
T ss_pred EeCC-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecC
Confidence 9999 7899999975 24599999999999999999999999 99999999999999999999999999998765
Q ss_pred cccccceeeecCccccccccccccCCCC-CcccchHhHHHHHHHHhc-Ccccccch---HHHHHhcCCH----HHHHHHH
Q 008785 424 WEVMQERTVMAGGTYGYLAPEFVYRNEL-TTKSDVYSFGVLLLEIRL-VLCRRWWT---LYTLVHSMSL----LCAQECL 494 (553)
Q Consensus 424 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDVwSlGvil~ell~-~~~~~~~~---l~~~~~~~~~----~~~~~l~ 494 (553)
..... ....||+.|||||++.+..+ +.++||||+||++|||++ ..|....+ +.+.+..+.. ..++.+.
T Consensus 164 ~~~~~---~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~ 240 (275)
T 3hyh_A 164 DGNFL---KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAA 240 (275)
T ss_dssp --------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTSCHHHH
T ss_pred CCCcc---CCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 43222 22349999999999988876 589999999999999998 33443333 3334444443 4567889
Q ss_pred HHHhhccCCCCCCCCCHHHHHHHHH
Q 008785 495 MLFISCNNWPSHLSQSKFCNLKLWV 519 (553)
Q Consensus 495 ~l~~~Cl~~dP~~RPs~~evl~~l~ 519 (553)
+++.+||+.||++|||+.|++++-.
T Consensus 241 ~li~~~L~~dP~~R~s~~eil~hpw 265 (275)
T 3hyh_A 241 GLIKRMLIVNPLNRISIHEIMQDDW 265 (275)
T ss_dssp HHHHHHSCSSGGGSCCHHHHHHCHH
T ss_pred HHHHHHccCChhHCcCHHHHHcCcc
Confidence 9999999999999999999998743
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-50 Score=400.22 Aligned_cols=242 Identities=18% Similarity=0.264 Sum_probs=185.8
Q ss_pred ccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCC-hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCc-------
Q 008785 269 NFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGD------- 339 (553)
Q Consensus 269 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~------- 339 (553)
+|...+ .||+|+||+||+|+.. +|+.||||+++... ....+.+.+|+.+|++++|||||++++++.+.+.
T Consensus 6 dy~~~~-~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 6 DFEPIQ-CLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HEEEEE-EEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hCEEee-EEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 454444 4599999999999964 58999999997543 3445789999999999999999999999876543
Q ss_pred -----eEEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEe
Q 008785 340 -----RYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLM 414 (553)
Q Consensus 340 -----~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~ 414 (553)
.|+|||||++|+|.+++.... .....++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~ 160 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRC-TIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVG 160 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCC-SGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcC-CCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEc
Confidence 699999999999999997522 122356677889999999999999999 99999999999999999999999
Q ss_pred eccccccCCcccccce----------eeecCccccccccccccCCCCCcccchHhHHHHHHHHhcCcccccc-h---HHH
Q 008785 415 GVGLSKFVPWEVMQER----------TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVLCRRWW-T---LYT 480 (553)
Q Consensus 415 Dfgla~~~~~~~~~~~----------~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~~~~~~-~---l~~ 480 (553)
|||+|+.......... ....+||+.|||||++.+..|+.++|||||||++|||++ |.... + ...
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~--Pf~~~~~~~~~~~ 238 (299)
T 4g31_A 161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY--PFSTQMERVRTLT 238 (299)
T ss_dssp CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS--CCSSHHHHHHHHH
T ss_pred cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc--CCCCccHHHHHHH
Confidence 9999987654322111 112349999999999999999999999999999999996 22211 1 111
Q ss_pred HHhcCCH-----HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008785 481 LVHSMSL-----LCAQECLMLFISCNNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 481 ~~~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 517 (553)
.+..... ...+.+.+++.+||+.||++|||+.|++++
T Consensus 239 ~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 280 (299)
T 4g31_A 239 DVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280 (299)
T ss_dssp HHHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 3333333 344567889999999999999999999875
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-50 Score=403.37 Aligned_cols=239 Identities=23% Similarity=0.239 Sum_probs=191.1
Q ss_pred ccCCCCeeecccCceeEEEEEeC----CCCEEEEEEeccCC--hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEE
Q 008785 269 NFSEGNRLLGDSKTGGTYSGILP----DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYI 342 (553)
Q Consensus 269 ~~~~~~~~iG~G~~g~Vy~~~~~----~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 342 (553)
+|... +.||+|+||+||+++.. .++.||||++++.. ......+.+|+++|++++|||||++++++.+++..||
T Consensus 25 ~Y~i~-~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 25 QFELL-KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GEEEE-EEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred ccEEE-EEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 34443 45699999999999852 47899999997642 2233468899999999999999999999999999999
Q ss_pred EEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccC
Q 008785 343 VYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV 422 (553)
Q Consensus 343 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~ 422 (553)
||||++||+|.+++.. ...+++.++..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+|+..
T Consensus 104 vmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 176 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKES 176 (304)
T ss_dssp EECCCTTCEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred EEEcCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceec
Confidence 9999999999999975 24699999999999999999999999 9999999999999999999999999999865
Q ss_pred CcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhc-Ccccccc---hHHHHHhcCCH----HHHHHHH
Q 008785 423 PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-VLCRRWW---TLYTLVHSMSL----LCAQECL 494 (553)
Q Consensus 423 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-~~~~~~~---~l~~~~~~~~~----~~~~~l~ 494 (553)
...... .....||+.|||||++.+..|+.++|||||||++|||++ ..|.... .+...+..+.. ..++++.
T Consensus 177 ~~~~~~--~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~ 254 (304)
T 3ubd_A 177 IDHEKK--AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQ 254 (304)
T ss_dssp ----CC--CCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHH
T ss_pred cCCCcc--ccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCcCCHHHH
Confidence 433222 122349999999999999999999999999999999998 3343333 33334444443 5677899
Q ss_pred HHHhhccCCCCCCCCC-----HHHHHHH
Q 008785 495 MLFISCNNWPSHLSQS-----KFCNLKL 517 (553)
Q Consensus 495 ~l~~~Cl~~dP~~RPs-----~~evl~~ 517 (553)
+|+.+||+.||++||| +.|++++
T Consensus 255 ~li~~~L~~dP~~R~ta~~~~~~eil~H 282 (304)
T 3ubd_A 255 SLLRMLFKRNPANRLGAGPDGVEEIKRH 282 (304)
T ss_dssp HHHHHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred HHHHHHcccCHHHCCCCCcCCHHHHHcC
Confidence 9999999999999999 4688775
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=382.15 Aligned_cols=242 Identities=19% Similarity=0.237 Sum_probs=191.0
Q ss_pred ccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccC--ChhhHHHHHHHHHHhhccCCCceeeEeeEEeeC------Cc
Q 008785 269 NFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH------GD 339 (553)
Q Consensus 269 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~------~~ 339 (553)
+|... +.||+|+||+||+|... +|+.||||+++.. .....+.+.+|+++|++++|||||++++++... +.
T Consensus 55 ~Y~~~-~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 55 EYEII-ETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SEEEE-EEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CeEEE-EEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 34443 45699999999999964 5999999999754 234456789999999999999999999987643 57
Q ss_pred eEEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeecccc
Q 008785 340 RYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLS 419 (553)
Q Consensus 340 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla 419 (553)
+|||||||+ |+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|
T Consensus 134 ~~ivmE~~~-g~L~~~i~~----~~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla 205 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHS----SQPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMA 205 (398)
T ss_dssp EEEEEECCS-EEHHHHHTS----SSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEeCCC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeeccee
Confidence 899999995 789999964 35699999999999999999999999 9999999999999999999999999999
Q ss_pred ccCCccccc--ceeeecCccccccccccccCC-CCCcccchHhHHHHHHHHhcCc-ccccch---HHHHHh--cCC----
Q 008785 420 KFVPWEVMQ--ERTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIRLVL-CRRWWT---LYTLVH--SMS---- 486 (553)
Q Consensus 420 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwSlGvil~ell~~~-~~~~~~---l~~~~~--~~~---- 486 (553)
+........ .......||+.|||||++.+. .++.++||||+||++|||++.. |....+ ....+. .+.
T Consensus 206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~ 285 (398)
T 4b99_A 206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPA 285 (398)
T ss_dssp BCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGG
T ss_pred eecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChH
Confidence 876543221 122234599999999998875 4699999999999999999833 332222 221111 000
Q ss_pred ------------------------H-----HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 008785 487 ------------------------L-----LCAQECLMLFISCNNWPSHLSQSKFCNLKLWV 519 (553)
Q Consensus 487 ------------------------~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~ 519 (553)
+ ..+.++.+|+.+||..||++|||+.|+|++-.
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~ 347 (398)
T 4b99_A 286 VIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPF 347 (398)
T ss_dssp GTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGG
T ss_pred HhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHh
Confidence 0 12567899999999999999999999999843
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-45 Score=398.44 Aligned_cols=240 Identities=18% Similarity=0.190 Sum_probs=203.6
Q ss_pred cccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEc
Q 008785 268 KNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF 346 (553)
Q Consensus 268 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 346 (553)
++|.... .||+|+||.||++... +|+.||||++........+.+.+|+.+|++++|||||++++++.+.+..||||||
T Consensus 157 ~~Y~i~~-~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 157 DHYDIHE-ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GTEEEEE-EEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred cccEEEE-EEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 4555444 4599999999999975 5999999999887767778899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCC--CCeEEeeccccccCCc
Q 008785 347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE--FGAHLMGVGLSKFVPW 424 (553)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~--~~~kl~Dfgla~~~~~ 424 (553)
|+||+|.++|.. ....+++.++..++.||+.||+|||++ +|+||||||+|||++.+ +.+||+|||+|+....
T Consensus 236 ~~gg~L~~~i~~---~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~ 309 (573)
T 3uto_A 236 MSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 309 (573)
T ss_dssp CCCCBHHHHHTC---TTSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCT
T ss_pred cCCCcHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccC
Confidence 999999999964 234689999999999999999999999 99999999999999854 7899999999988764
Q ss_pred ccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcC-ccccc---chHHHHHhcCCH--------HHHHH
Q 008785 425 EVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLV-LCRRW---WTLYTLVHSMSL--------LCAQE 492 (553)
Q Consensus 425 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~-~~~~~---~~l~~~~~~~~~--------~~~~~ 492 (553)
.... ...+||+.|||||++.+..|+.++|||||||++|||++. .|+.. ......+..+.. ..+..
T Consensus 310 ~~~~---~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 386 (573)
T 3uto_A 310 KQSV---KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISED 386 (573)
T ss_dssp TSEE---EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHH
T ss_pred CCce---eeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHH
Confidence 4322 233499999999999999999999999999999999973 33332 233334443332 45778
Q ss_pred HHHHHhhccCCCCCCCCCHHHHHHH
Q 008785 493 CLMLFISCNNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 493 l~~l~~~Cl~~dP~~RPs~~evl~~ 517 (553)
+.+|+.+||..||++|||+.|+|++
T Consensus 387 ~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 387 GKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHHccCChhHCcCHHHHhcC
Confidence 8999999999999999999999986
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-45 Score=376.10 Aligned_cols=240 Identities=19% Similarity=0.220 Sum_probs=189.5
Q ss_pred HhhcccCCCCeeecccCceeEEEEEeC----CCCEEEEEEeccCChhhHHHHHHHHHHhhcc-CCCceeeEeeEEeeCCc
Q 008785 265 SITKNFSEGNRLLGDSKTGGTYSGILP----DGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGD 339 (553)
Q Consensus 265 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~----~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~ 339 (553)
.+.+.|.... .||+|+||+||+|+.+ .++.||||.+.... ....+.+|+++|+.+ +|||||++++++.+.+.
T Consensus 18 ~l~~~Y~i~~-~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~ 94 (361)
T 4f9c_A 18 QLSNVFKIED-KIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDH 94 (361)
T ss_dssp GGGGTCEEEE-EEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTE
T ss_pred CccCcEEEEE-EEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCE
Confidence 3455565544 4599999999999853 46789999987653 345688999999998 69999999999999999
Q ss_pred eEEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCC-CCeEEeeccc
Q 008785 340 RYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE-FGAHLMGVGL 418 (553)
Q Consensus 340 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~-~~~kl~Dfgl 418 (553)
.|+||||+++|+|.+++. .+++.++..++.||+.||+|||++ ||+||||||+|||++.+ +.+||+|||+
T Consensus 95 ~~lvmE~~~g~~L~~~~~-------~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGl 164 (361)
T 4f9c_A 95 VVIAMPYLEHESFLDILN-------SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGL 164 (361)
T ss_dssp EEEEEECCCCCCHHHHHT-------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEEEEeCCCcccHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCC
Confidence 999999999999999984 389999999999999999999999 99999999999999877 7999999999
Q ss_pred cccCCccccc--------------------------ceeeecCccccccccccccCC-CCCcccchHhHHHHHHHHhcCc
Q 008785 419 SKFVPWEVMQ--------------------------ERTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIRLVL 471 (553)
Q Consensus 419 a~~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwSlGvil~ell~~~ 471 (553)
|+........ .......||+.|+|||++.+. .|+.++||||+||++|||++..
T Consensus 165 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~ 244 (361)
T 4f9c_A 165 AQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGR 244 (361)
T ss_dssp CEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTC
T ss_pred CcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCC
Confidence 9765432111 011123499999999999875 4899999999999999999733
Q ss_pred -cccc--chH--HHHH--------------------------------------hcCC--------------------HH
Q 008785 472 -CRRW--WTL--YTLV--------------------------------------HSMS--------------------LL 488 (553)
Q Consensus 472 -~~~~--~~l--~~~~--------------------------------------~~~~--------------------~~ 488 (553)
|... .+. ...+ .... ..
T Consensus 245 ~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~ 324 (361)
T 4f9c_A 245 YPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNE 324 (361)
T ss_dssp SSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTT
T ss_pred CCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhcccccccccccccccccccccccccc
Confidence 3311 111 0000 0000 02
Q ss_pred HHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008785 489 CAQECLMLFISCNNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 489 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 517 (553)
.+.++.+|+.+||..||++|||+.|+|++
T Consensus 325 is~~a~DLl~~lL~~dP~~R~ta~eaL~H 353 (361)
T 4f9c_A 325 VPDEAYDLLDKLLDLNPASRITAEEALLH 353 (361)
T ss_dssp CCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred CCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 34568899999999999999999999986
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-44 Score=361.44 Aligned_cols=263 Identities=29% Similarity=0.443 Sum_probs=215.8
Q ss_pred cCHHHHHHhhcccCCCCeeecccCceeEEEEEeCCCCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeEEeeC
Q 008785 258 FTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH 337 (553)
Q Consensus 258 ~~~~el~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 337 (553)
++..++...+++|.....+ |+|+||.||+|...+|+.||||++........+.+.+|+.++++++||||+++++++.+.
T Consensus 29 ~~~~~~~~~~~~y~~~~~l-g~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 107 (321)
T 2qkw_B 29 VPLVDLEEATNNFDHKFLI-GHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDER 107 (321)
T ss_dssp -CCSCCCCCCCCCSCCCCS-CBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCT
T ss_pred ecHHHHHHHHhccCcccee-ecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence 3444555677788776655 999999999999888999999999877666778899999999999999999999999999
Q ss_pred CceEEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeecc
Q 008785 338 GDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVG 417 (553)
Q Consensus 338 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg 417 (553)
+..++||||+++|+|.+++.........+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg 184 (321)
T 2qkw_B 108 NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFG 184 (321)
T ss_dssp TCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCT
T ss_pred CeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeecc
Confidence 999999999999999999976444445699999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcCccc-c------cchHHH----HHhcC-
Q 008785 418 LSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVLCR-R------WWTLYT----LVHSM- 485 (553)
Q Consensus 418 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~~~-~------~~~l~~----~~~~~- 485 (553)
+++...............||+.|+|||++.+..++.++||||||+++|||++..+. . ...... ....+
T Consensus 185 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 264 (321)
T 2qkw_B 185 ISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQ 264 (321)
T ss_dssp TCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTC
T ss_pred cccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcccccc
Confidence 99865433222222222389999999999989999999999999999999973221 1 111111 11111
Q ss_pred -------------CHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHhh
Q 008785 486 -------------SLLCAQECLMLFISCNNWPSHLSQSKFCNLKLWVFAILT 524 (553)
Q Consensus 486 -------------~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~~~~~ 524 (553)
....+..+.+++.+||+.||++|||+.|+++++...+..
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~ 316 (321)
T 2qkw_B 265 LEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316 (321)
T ss_dssp CCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence 126788899999999999999999999999998776543
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-44 Score=362.03 Aligned_cols=266 Identities=31% Similarity=0.513 Sum_probs=220.2
Q ss_pred CCcccCHHHHHHhhcccCCCCeeecccCceeEEEEEeCCCCEEEEEEeccCChh-hHHHHHHHHHHhhccCCCceeeEee
Q 008785 254 SWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQ-RKKEFYSEIGRFARLHHPNLVAVKG 332 (553)
Q Consensus 254 ~~~~~~~~el~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~ 332 (553)
....++.+++....++|.....+ |+|+||.||+|...+|+.||||+++..... ....+.+|+.++++++||||+++++
T Consensus 16 ~~~~~~~~~~~~~~~~y~~~~~l-g~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 94 (326)
T 3uim_A 16 QLKRFSLRELQVASDNFSNKNIL-GRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG 94 (326)
T ss_dssp CCEECCTHHHHTTTTSSCSTTEE-ECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCE
T ss_pred ccceecHHHHHHHhhccccceeE-ecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEE
Confidence 34667889999999999887766 999999999999888999999999765322 2346899999999999999999999
Q ss_pred EEeeCCceEEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeE
Q 008785 333 CCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAH 412 (553)
Q Consensus 333 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~k 412 (553)
++.+.+..++||||+++|+|.+++.........+++..+..++.|++.||+|||+.+.++|+||||||+|||+++++.+|
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~k 174 (326)
T 3uim_A 95 FCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV 174 (326)
T ss_dssp EECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEE
T ss_pred EEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEE
Confidence 99999999999999999999999987555556799999999999999999999998778999999999999999999999
Q ss_pred EeeccccccCCcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcCc-cccc--------chHHHHH-
Q 008785 413 LMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVL-CRRW--------WTLYTLV- 482 (553)
Q Consensus 413 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~-~~~~--------~~l~~~~- 482 (553)
|+|||++............ ...||+.|+|||++.+..++.++||||||+++|||++.. |... ..+.+.+
T Consensus 175 l~Dfg~~~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 253 (326)
T 3uim_A 175 VGDFGLAKLMDYKDTHVTT-AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 253 (326)
T ss_dssp ECCCSSCEECCSSSSCEEC-CCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHT
T ss_pred eccCccccccCcccccccc-cccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHH
Confidence 9999999876544332222 233899999999998889999999999999999999733 2221 1111111
Q ss_pred ---hcC--------------CHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 008785 483 ---HSM--------------SLLCAQECLMLFISCNNWPSHLSQSKFCNLKLWVFA 521 (553)
Q Consensus 483 ---~~~--------------~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~~ 521 (553)
... ....+..+.+++.+||+.||++|||+.|++++|...
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 254 GLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp TTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred HHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 111 116678899999999999999999999999988653
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-44 Score=387.30 Aligned_cols=239 Identities=19% Similarity=0.208 Sum_probs=193.6
Q ss_pred ccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCCh---hhHHHH---HHHHHHhhccCCCceeeEeeEEeeCCceE
Q 008785 269 NFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF---QRKKEF---YSEIGRFARLHHPNLVAVKGCCYDHGDRY 341 (553)
Q Consensus 269 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~---~~~~~~---~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 341 (553)
+|.. .++||+|+||.||+++.. +|+.||||++++... .....+ ..++.+++.++|||||++++++.+.+.+|
T Consensus 190 df~i-~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 190 DFSV-HRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GEEE-EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HeEE-EEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 4444 356699999999999975 599999999975421 112223 34467778889999999999999999999
Q ss_pred EEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeecccccc
Q 008785 342 IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF 421 (553)
Q Consensus 342 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~ 421 (553)
|||||++||+|.++|.. ...+++..+..++.||+.||+|||++ |||||||||+||||+.+|.+||+|||+|+.
T Consensus 269 lVmEy~~GGdL~~~l~~----~~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~~ 341 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACD 341 (689)
T ss_dssp EEECCCCSCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceeee
Confidence 99999999999999975 24599999999999999999999999 999999999999999999999999999987
Q ss_pred CCcccccceeeecCccccccccccccC-CCCCcccchHhHHHHHHHHhcCc-cccc---ch---HHHHHhcCCH----HH
Q 008785 422 VPWEVMQERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIRLVL-CRRW---WT---LYTLVHSMSL----LC 489 (553)
Q Consensus 422 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwSlGvil~ell~~~-~~~~---~~---l~~~~~~~~~----~~ 489 (553)
...... ...+||+.|||||++.+ ..|+.++|+|||||++|||+++. |... .. +...+..... ..
T Consensus 342 ~~~~~~----~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p~~~ 417 (689)
T 3v5w_A 342 FSKKKP----HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSF 417 (689)
T ss_dssp CSSCCC----CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCCTTS
T ss_pred cCCCCC----CCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCCccC
Confidence 654332 23359999999999975 57999999999999999999833 3322 11 2222322322 56
Q ss_pred HHHHHHHHhhccCCCCCCCCC-----HHHHHHHHH
Q 008785 490 AQECLMLFISCNNWPSHLSQS-----KFCNLKLWV 519 (553)
Q Consensus 490 ~~~l~~l~~~Cl~~dP~~RPs-----~~evl~~l~ 519 (553)
+.++.+|+.+||..||++|++ +.||+++-.
T Consensus 418 S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~Hpf 452 (689)
T 3v5w_A 418 SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPF 452 (689)
T ss_dssp CHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGG
T ss_pred CHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCcc
Confidence 778999999999999999998 789988743
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=349.05 Aligned_cols=240 Identities=20% Similarity=0.274 Sum_probs=200.7
Q ss_pred cccCCCCeeecccCceeEEEEEe-CCCCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEc
Q 008785 268 KNFSEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF 346 (553)
Q Consensus 268 ~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 346 (553)
+.|.... .||+|+||.||+|.. .+|+.||||++........+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 20 ~~y~~~~-~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 20 KKYTRFE-KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GTBCCCE-EEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hceeeee-eeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 3454444 459999999999995 46899999999876556677899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCccc
Q 008785 347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV 426 (553)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 426 (553)
+++|+|.+++.. ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++.......
T Consensus 99 ~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (297)
T 3fxz_A 99 LAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (297)
T ss_dssp CTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred CCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence 999999999975 3589999999999999999999999 99999999999999999999999999998765443
Q ss_pred ccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcC-cccccchHHH----HHhcCCH------HHHHHHHH
Q 008785 427 MQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLV-LCRRWWTLYT----LVHSMSL------LCAQECLM 495 (553)
Q Consensus 427 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~-~~~~~~~l~~----~~~~~~~------~~~~~l~~ 495 (553)
.... ...||+.|+|||++.+..++.++||||||+++|||++. .|........ ....+.. ..+..+.+
T Consensus 171 ~~~~--~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (297)
T 3fxz_A 171 SKRS--TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRD 248 (297)
T ss_dssp CCBC--CCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHH
T ss_pred cccC--CccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHH
Confidence 3222 23389999999999999999999999999999999983 3332222211 2222111 55677899
Q ss_pred HHhhccCCCCCCCCCHHHHHHHH
Q 008785 496 LFISCNNWPSHLSQSKFCNLKLW 518 (553)
Q Consensus 496 l~~~Cl~~dP~~RPs~~evl~~l 518 (553)
++.+||+.||++|||+.|++++-
T Consensus 249 li~~~l~~dp~~Rps~~ell~h~ 271 (297)
T 3fxz_A 249 FLNRCLEMDVEKRGSAKELLQHQ 271 (297)
T ss_dssp HHHHHSCSSTTTSCCHHHHTTCG
T ss_pred HHHHHccCChhHCcCHHHHhhCh
Confidence 99999999999999999999864
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=351.68 Aligned_cols=253 Identities=19% Similarity=0.226 Sum_probs=209.0
Q ss_pred cccCHHHHHHhhcccCC---------CCeeecccCceeEEEEEeC-CCCEEEEEEeccCChhhHHHHHHHHHHhhccCCC
Q 008785 256 KVFTTEELRSITKNFSE---------GNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHP 325 (553)
Q Consensus 256 ~~~~~~el~~~~~~~~~---------~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hp 325 (553)
..++.+++..+++.... ..+.||+|+||.||+|... +|+.||||+++.......+.+.+|+.++++++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 45778888887765321 2245699999999999976 6999999999877666678899999999999999
Q ss_pred ceeeEeeEEeeCCceEEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEe
Q 008785 326 NLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL 405 (553)
Q Consensus 326 nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl 405 (553)
||+++++++...+..++||||+++|+|.+++.. ..+++..+..++.|++.||.|||+. +|+||||||+|||+
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-----~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll 174 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ-----VRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILL 174 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEE
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEE
Confidence 999999999999999999999999999999864 3589999999999999999999999 99999999999999
Q ss_pred cCCCCeEEeeccccccCCcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcCc-ccccch---HHHH
Q 008785 406 DEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVL-CRRWWT---LYTL 481 (553)
Q Consensus 406 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~-~~~~~~---l~~~ 481 (553)
+.++.+||+|||++.......... ....||+.|+|||++.+..++.++||||||+++|||++.. |..... ....
T Consensus 175 ~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~ 252 (321)
T 2c30_A 175 TLDGRVKLSDFGFCAQISKDVPKR--KSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKR 252 (321)
T ss_dssp CTTCCEEECCCTTCEECCSSSCCB--CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH
T ss_pred CCCCcEEEeeeeeeeecccCcccc--ccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 999999999999998765432221 1223899999999999999999999999999999999733 332222 2222
Q ss_pred HhcCC-------HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008785 482 VHSMS-------LLCAQECLMLFISCNNWPSHLSQSKFCNLKLW 518 (553)
Q Consensus 482 ~~~~~-------~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l 518 (553)
+.... ...+..+.+++.+||+.||++|||+.|++++-
T Consensus 253 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp 296 (321)
T 2c30_A 253 LRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHP 296 (321)
T ss_dssp HHHSSCCCCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred HhcCCCCCcCccccCCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 22211 14567789999999999999999999999864
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-43 Score=352.35 Aligned_cols=244 Identities=21% Similarity=0.332 Sum_probs=199.8
Q ss_pred eeecccCceeEEEEEeC-CCCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCCHH
Q 008785 275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 353 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~ 353 (553)
+.||+|+||.||++... +++.||+|.+...+....+.+.+|+.++++++||||+++++++.+.+..++||||+++|+|.
T Consensus 16 ~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 95 (310)
T 3s95_A 16 EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLR 95 (310)
T ss_dssp EEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHH
T ss_pred ceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecCCCcHH
Confidence 45699999999999975 58999999998777777889999999999999999999999999999999999999999999
Q ss_pred HHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccce---
Q 008785 354 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER--- 430 (553)
Q Consensus 354 ~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~--- 430 (553)
+++.. ....+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++..........
T Consensus 96 ~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 169 (310)
T 3s95_A 96 GIIKS---MDSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLR 169 (310)
T ss_dssp HHHHH---CCTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC----------
T ss_pred HHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceecccccccccccc
Confidence 99975 235689999999999999999999999 999999999999999999999999999987654322111
Q ss_pred ---------eeecCccccccccccccCCCCCcccchHhHHHHHHHHhcCcccccc----------hHHHHHhc-CCHHHH
Q 008785 431 ---------TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVLCRRWW----------TLYTLVHS-MSLLCA 490 (553)
Q Consensus 431 ---------~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~~~~~~----------~l~~~~~~-~~~~~~ 490 (553)
.....||+.|+|||++.+..++.++||||||+++|||++..+.... ........ .....+
T Consensus 170 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (310)
T 3s95_A 170 SLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPPNCP 249 (310)
T ss_dssp ----------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHHTCCTTCC
T ss_pred cccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccccCCCCCC
Confidence 0123489999999999999999999999999999999963221111 11111111 111445
Q ss_pred HHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHhh
Q 008785 491 QECLMLFISCNNWPSHLSQSKFCNLKLWVFAILT 524 (553)
Q Consensus 491 ~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~~~~~ 524 (553)
..+.+++.+||+.||++|||+.|+++.+......
T Consensus 250 ~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~ 283 (310)
T 3s95_A 250 PSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH 283 (310)
T ss_dssp TTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 6789999999999999999999999877554433
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=358.49 Aligned_cols=248 Identities=23% Similarity=0.310 Sum_probs=203.3
Q ss_pred CeeecccCceeEEEEEeC--------CCCEEEEEEeccCC-hhhHHHHHHHHHHhhcc-CCCceeeEeeEEeeCCceEEE
Q 008785 274 NRLLGDSKTGGTYSGILP--------DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIV 343 (553)
Q Consensus 274 ~~~iG~G~~g~Vy~~~~~--------~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV 343 (553)
.+.||+|+||.||+|... ++..||||+++... ....+.+.+|+.+++++ +||||+++++++.+.+..|+|
T Consensus 86 ~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv 165 (370)
T 2psq_A 86 GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVI 165 (370)
T ss_dssp EEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSSCEEE
T ss_pred eeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCCEEEE
Confidence 345699999999999852 35579999997653 34457899999999999 899999999999999999999
Q ss_pred EEccCCCCHHHHhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCe
Q 008785 344 YEFVVNGPLDRWLHHIPR------------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGA 411 (553)
Q Consensus 344 ~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~ 411 (553)
|||+++|+|.+++..... ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+
T Consensus 166 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~ 242 (370)
T 2psq_A 166 VEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVM 242 (370)
T ss_dssp EECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCE
T ss_pred EEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEEECCCCCE
Confidence 999999999999976321 124589999999999999999999999 99999999999999999999
Q ss_pred EEeeccccccCCcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhc-Cc-cc---ccchHHHHHhcCC
Q 008785 412 HLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-VL-CR---RWWTLYTLVHSMS 486 (553)
Q Consensus 412 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-~~-~~---~~~~l~~~~~~~~ 486 (553)
||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ .. |. ....+...+..+.
T Consensus 243 kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~~~~~~~ 322 (370)
T 2psq_A 243 KIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGH 322 (370)
T ss_dssp EECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC
T ss_pred EEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC
Confidence 9999999986654332222222237889999999999999999999999999999997 32 22 2233444444332
Q ss_pred H-----HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHhh
Q 008785 487 L-----LCAQECLMLFISCNNWPSHLSQSKFCNLKLWVFAILT 524 (553)
Q Consensus 487 ~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~~~~~ 524 (553)
. ..+..+.+++.+||+.||++|||+.|+++.+...+..
T Consensus 323 ~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~ 365 (370)
T 2psq_A 323 RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 365 (370)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 2 5667899999999999999999999999998776543
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=350.62 Aligned_cols=248 Identities=23% Similarity=0.309 Sum_probs=201.5
Q ss_pred CeeecccCceeEEEEEeC----CCCEEEEEEeccC-ChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccC
Q 008785 274 NRLLGDSKTGGTYSGILP----DGSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV 348 (553)
Q Consensus 274 ~~~iG~G~~g~Vy~~~~~----~g~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 348 (553)
.+.||+|+||.||+|... .+..||||+++.. .....+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 54 ~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 133 (325)
T 3kul_A 54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYME 133 (325)
T ss_dssp EEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEEEECCT
T ss_pred eeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEEeeCCC
Confidence 356799999999999974 3456999999865 34456789999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCccccc
Q 008785 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ 428 (553)
Q Consensus 349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 428 (553)
+|+|.+++.. ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 134 ~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 207 (325)
T 3kul_A 134 NGSLDTFLRT---HDGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDA 207 (325)
T ss_dssp TCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEECC----C
T ss_pred CCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCcccccccCccc
Confidence 9999999964 334699999999999999999999999 9999999999999999999999999999876544222
Q ss_pred ce-eeecCccccccccccccCCCCCcccchHhHHHHHHHHhc-C-ccccc---chHHHHHhcCCH-----HHHHHHHHHH
Q 008785 429 ER-TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-V-LCRRW---WTLYTLVHSMSL-----LCAQECLMLF 497 (553)
Q Consensus 429 ~~-~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-~-~~~~~---~~l~~~~~~~~~-----~~~~~l~~l~ 497 (553)
.. .....+|+.|+|||++.+..++.++||||||+++|||++ . .|... ..+...+..+.. ..+..+.+++
T Consensus 208 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 287 (325)
T 3kul_A 208 AYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGCPHALHQLM 287 (325)
T ss_dssp CEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred eeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCCCCCcCHHHHHHH
Confidence 21 112226778999999998899999999999999999997 3 23222 233333333321 5677899999
Q ss_pred hhccCCCCCCCCCHHHHHHHHHHHHhhccc
Q 008785 498 ISCNNWPSHLSQSKFCNLKLWVFAILTIRK 527 (553)
Q Consensus 498 ~~Cl~~dP~~RPs~~evl~~l~~~~~~~~~ 527 (553)
.+||+.||++|||+.|+++.+...+.....
T Consensus 288 ~~~l~~dp~~Rps~~eil~~L~~l~~~~~~ 317 (325)
T 3kul_A 288 LDCWHKDRAQRPRFSQIVSVLDALIRSPES 317 (325)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHHHHHSCC-
T ss_pred HHHccCChhhCcCHHHHHHHHHHHHhCccc
Confidence 999999999999999999998776655443
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-43 Score=362.67 Aligned_cols=242 Identities=25% Similarity=0.319 Sum_probs=199.7
Q ss_pred eeecccCceeEEEEEeC-CCCEEEEEEeccCC-hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCCH
Q 008785 275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL 352 (553)
+.||+|+||.||+|... +++.||||.++... ....+.+.+|+.+|++++||||+++++++.+.+..++||||+++|+|
T Consensus 120 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L 199 (377)
T 3cbl_A 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 199 (377)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBH
T ss_pred eEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcCCCCCH
Confidence 45699999999999986 68999999997652 33456789999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccceee
Q 008785 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV 432 (553)
Q Consensus 353 ~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~ 432 (553)
.+++.. ....+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++............
T Consensus 200 ~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~~ 273 (377)
T 3cbl_A 200 LTFLRT---EGARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGG 273 (377)
T ss_dssp HHHHHH---HGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECCSS
T ss_pred HHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecCCCceeecCC
Confidence 999974 234589999999999999999999999 99999999999999999999999999998654332221111
Q ss_pred ecCccccccccccccCCCCCcccchHhHHHHHHHHhc-C-ccccc---chHHHHHhcCCH-----HHHHHHHHHHhhccC
Q 008785 433 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-V-LCRRW---WTLYTLVHSMSL-----LCAQECLMLFISCNN 502 (553)
Q Consensus 433 ~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-~-~~~~~---~~l~~~~~~~~~-----~~~~~l~~l~~~Cl~ 502 (553)
...+++.|+|||++.+..++.++||||||+++|||++ . .|... ....+.+..+.. ..+..+.+++.+||+
T Consensus 274 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 353 (377)
T 3cbl_A 274 LRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAVFRLMEQCWA 353 (377)
T ss_dssp CCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTC
T ss_pred CCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcC
Confidence 1225778999999998899999999999999999997 2 23222 223333433321 456789999999999
Q ss_pred CCCCCCCCHHHHHHHHHHHH
Q 008785 503 WPSHLSQSKFCNLKLWVFAI 522 (553)
Q Consensus 503 ~dP~~RPs~~evl~~l~~~~ 522 (553)
.||++|||+.++++.+....
T Consensus 354 ~dP~~Rps~~~i~~~L~~i~ 373 (377)
T 3cbl_A 354 YEPGQRPSFSTIYQELQSIR 373 (377)
T ss_dssp SSGGGSCCHHHHHHHHHHHH
T ss_pred CCchhCcCHHHHHHHHHHHH
Confidence 99999999999999886644
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=340.63 Aligned_cols=241 Identities=21% Similarity=0.306 Sum_probs=201.7
Q ss_pred eeecccCceeEEEEEeCCCCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCCHHH
Q 008785 275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR 354 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~ 354 (553)
+.||+|+||.||++...+++.||+|++.... ...+++.+|+.++++++||||+++++++.+.+..++||||+++|+|.+
T Consensus 16 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 94 (269)
T 4hcu_A 16 QEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSD 94 (269)
T ss_dssp EEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHH
T ss_pred heecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCCCcHHH
Confidence 3459999999999999889999999998653 335679999999999999999999999999999999999999999999
Q ss_pred HhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccceeeec
Q 008785 355 WLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA 434 (553)
Q Consensus 355 ~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 434 (553)
++.. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++............ ..
T Consensus 95 ~l~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~-~~ 167 (269)
T 4hcu_A 95 YLRT---QRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST-GT 167 (269)
T ss_dssp HHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTT-ST
T ss_pred HHHh---cCcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEecccccccccccccccccc-Cc
Confidence 9964 334689999999999999999999999 9999999999999999999999999999876544322222 22
Q ss_pred CccccccccccccCCCCCcccchHhHHHHHHHHhc-Cc-ccccc---hHHHHHhcCCH-----HHHHHHHHHHhhccCCC
Q 008785 435 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-VL-CRRWW---TLYTLVHSMSL-----LCAQECLMLFISCNNWP 504 (553)
Q Consensus 435 ~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-~~-~~~~~---~l~~~~~~~~~-----~~~~~l~~l~~~Cl~~d 504 (553)
.+|+.|+|||.+.+..++.++||||||+++|||++ .. |.... .+...+..+.. ..+..+.+++.+||+.|
T Consensus 168 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 247 (269)
T 4hcu_A 168 KFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWRER 247 (269)
T ss_dssp TCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSS
T ss_pred ccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCCCCcCCHHHHHHHHHHccCC
Confidence 26788999999998999999999999999999997 33 33222 22233333211 45678999999999999
Q ss_pred CCCCCCHHHHHHHHHHHHh
Q 008785 505 SHLSQSKFCNLKLWVFAIL 523 (553)
Q Consensus 505 P~~RPs~~evl~~l~~~~~ 523 (553)
|++|||+.|+++++.....
T Consensus 248 p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 248 PEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp GGGSCCHHHHHHHHHHHHH
T ss_pred cccCcCHHHHHHHHHHHHH
Confidence 9999999999999876543
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=352.45 Aligned_cols=240 Identities=19% Similarity=0.234 Sum_probs=200.2
Q ss_pred cccCCCCeeecccCceeEEEEEe-CCCCEEEEEEeccC--ChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEE
Q 008785 268 KNFSEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVY 344 (553)
Q Consensus 268 ~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 344 (553)
++|.... .||+|+||.||+|.. .+|+.||||++... .....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 15 ~~y~~~~-~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 15 GNYRLLK-TIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp TTEEEEE-EEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEE-EEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 3454444 459999999999997 56999999999754 3345677899999999999999999999999999999999
Q ss_pred EccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCc
Q 008785 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW 424 (553)
Q Consensus 345 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~ 424 (553)
||+++|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 94 e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 166 (328)
T 3fe3_A 94 EYASGGEVFDYLVA----HGRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTV 166 (328)
T ss_dssp CCCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSS
T ss_pred ECCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCC
Confidence 99999999999964 24589999999999999999999999 999999999999999999999999999986554
Q ss_pred ccccceeeecCccccccccccccCCCCC-cccchHhHHHHHHHHhc-Ccccccch---HHHHHhcCCH----HHHHHHHH
Q 008785 425 EVMQERTVMAGGTYGYLAPEFVYRNELT-TKSDVYSFGVLLLEIRL-VLCRRWWT---LYTLVHSMSL----LCAQECLM 495 (553)
Q Consensus 425 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t-~ksDVwSlGvil~ell~-~~~~~~~~---l~~~~~~~~~----~~~~~l~~ 495 (553)
.... ....||+.|+|||++.+..++ .++||||||+++|||++ ..|....+ +.+.+..+.. ..+..+.+
T Consensus 167 ~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~ 243 (328)
T 3fe3_A 167 GGKL---DAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCEN 243 (328)
T ss_dssp SCGG---GTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHH
T ss_pred CCcc---ccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 3222 123499999999999888765 79999999999999997 33333333 3334444433 45678899
Q ss_pred HHhhccCCCCCCCCCHHHHHHHH
Q 008785 496 LFISCNNWPSHLSQSKFCNLKLW 518 (553)
Q Consensus 496 l~~~Cl~~dP~~RPs~~evl~~l 518 (553)
++.+||+.||.+|||+.|++++-
T Consensus 244 li~~~L~~dP~~R~t~~eil~h~ 266 (328)
T 3fe3_A 244 LLKRFLVLNPIKRGTLEQIMKDR 266 (328)
T ss_dssp HHHHHCCSSTTTSCCHHHHTTCT
T ss_pred HHHHHCCCChhHCcCHHHHhcCH
Confidence 99999999999999999999873
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=348.62 Aligned_cols=248 Identities=27% Similarity=0.396 Sum_probs=193.8
Q ss_pred ccCCCCeeecccCceeEEEEEeCCCCEEEEEEeccCC--hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEc
Q 008785 269 NFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF 346 (553)
Q Consensus 269 ~~~~~~~~iG~G~~g~Vy~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 346 (553)
+|... +.||+|+||.||+|.. +|+.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 38 ~y~i~-~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 115 (309)
T 3p86_A 38 DLNIK-EKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEY 115 (309)
T ss_dssp GEEEE-EEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEEC
T ss_pred Hceee-eEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEec
Confidence 44443 4569999999999987 68899999997653 34457899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--ceecCCCCCcEEecCCCCeEEeeccccccCCc
Q 008785 347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPH--VVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW 424 (553)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~--ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~ 424 (553)
+++|+|.+++.... ....+++..+..++.||+.||+|||+. + |+||||||+|||++.++.+||+|||+++....
T Consensus 116 ~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~ 191 (309)
T 3p86_A 116 LSRGSLYRLLHKSG-AREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS 191 (309)
T ss_dssp CTTCBHHHHHHSTT-HHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC-------
T ss_pred CCCCcHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCCCCccccc
Confidence 99999999997521 112389999999999999999999999 8 99999999999999999999999999976543
Q ss_pred ccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhc-Ccccccch---HHHHH--hcCCH----HHHHHHH
Q 008785 425 EVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-VLCRRWWT---LYTLV--HSMSL----LCAQECL 494 (553)
Q Consensus 425 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-~~~~~~~~---l~~~~--~~~~~----~~~~~l~ 494 (553)
..... ....||+.|+|||++.+..++.++||||||+++|||++ ..|..... ....+ ..... ..+..+.
T Consensus 192 ~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 269 (309)
T 3p86_A 192 TFLSS--KSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVA 269 (309)
T ss_dssp ------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHH
T ss_pred ccccc--ccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHH
Confidence 32211 12238999999999999999999999999999999997 33333222 22222 11111 5677899
Q ss_pred HHHhhccCCCCCCCCCHHHHHHHHHHHHhh
Q 008785 495 MLFISCNNWPSHLSQSKFCNLKLWVFAILT 524 (553)
Q Consensus 495 ~l~~~Cl~~dP~~RPs~~evl~~l~~~~~~ 524 (553)
+++.+||+.||++|||+.|+++.+...+..
T Consensus 270 ~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 270 AIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 999999999999999999999987665543
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-41 Score=338.12 Aligned_cols=262 Identities=32% Similarity=0.454 Sum_probs=213.1
Q ss_pred CCcccCHHHHHHhhcccCCC-----CeeecccCceeEEEEEeCCCCEEEEEEeccC----ChhhHHHHHHHHHHhhccCC
Q 008785 254 SWKVFTTEELRSITKNFSEG-----NRLLGDSKTGGTYSGILPDGSRVAVKRLKRS----SFQRKKEFYSEIGRFARLHH 324 (553)
Q Consensus 254 ~~~~~~~~el~~~~~~~~~~-----~~~iG~G~~g~Vy~~~~~~g~~vAvK~~~~~----~~~~~~~~~~E~~~l~~l~H 324 (553)
....|+++++..++++|... .+.||+|+||.||+|.. +++.||||++... .....+.+.+|+.++++++|
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 34678999999999999876 24459999999999997 7899999998753 23346789999999999999
Q ss_pred CceeeEeeEEeeCCceEEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEE
Q 008785 325 PNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 404 (553)
Q Consensus 325 pnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NIL 404 (553)
|||+++++++.+.+..++||||+++|+|.+++... .....+++..+..++.||+.||.|||+. +|+||||||+||+
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil 165 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL-DGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANIL 165 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTG-GGCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEE
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhc-cCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEE
Confidence 99999999999999999999999999999998642 2235689999999999999999999999 9999999999999
Q ss_pred ecCCCCeEEeeccccccCCcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcCcc-ccc---c----
Q 008785 405 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVLC-RRW---W---- 476 (553)
Q Consensus 405 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~~-~~~---~---- 476 (553)
+++++.+||+|||++................||+.|+|||.+.+ .++.++||||||+++|||++..+ ... .
T Consensus 166 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~ 244 (307)
T 2nru_A 166 LDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLL 244 (307)
T ss_dssp ECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTT
T ss_pred EcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHH
Confidence 99999999999999986654332222222348999999998754 58999999999999999997322 111 1
Q ss_pred hHHHHHhc---------------CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 008785 477 TLYTLVHS---------------MSLLCAQECLMLFISCNNWPSHLSQSKFCNLKLWVFA 521 (553)
Q Consensus 477 ~l~~~~~~---------------~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~~ 521 (553)
.+.+.+.. .....+..+.+++.+||+.||.+|||+.++++++...
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l 304 (307)
T 2nru_A 245 DIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM 304 (307)
T ss_dssp HHHHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred HHHHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 11111111 1125677899999999999999999999999987653
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=358.70 Aligned_cols=257 Identities=25% Similarity=0.294 Sum_probs=206.3
Q ss_pred CeeecccCceeEEEEEeC------CCCEEEEEEeccC-ChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEc
Q 008785 274 NRLLGDSKTGGTYSGILP------DGSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF 346 (553)
Q Consensus 274 ~~~iG~G~~g~Vy~~~~~------~g~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 346 (553)
.+.||+|+||.||+|.+. +++.||||+++.. .......+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 76 ~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 155 (367)
T 3l9p_A 76 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLEL 155 (367)
T ss_dssp EEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred eeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCEEEEEe
Confidence 345699999999999953 3668999999754 344556789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCC---CeEEeeccccc
Q 008785 347 VVNGPLDRWLHHIPR---GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF---GAHLMGVGLSK 420 (553)
Q Consensus 347 ~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~---~~kl~Dfgla~ 420 (553)
+++|+|.+++..... ....+++..++.++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+++
T Consensus 156 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~ 232 (367)
T 3l9p_A 156 MAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 232 (367)
T ss_dssp CTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECCCHHHH
T ss_pred CCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEECCCcccc
Confidence 999999999975321 224589999999999999999999999 999999999999999554 59999999997
Q ss_pred cCCcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhc-C-ccccc---chHHHHHhcCCH-----HHH
Q 008785 421 FVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-V-LCRRW---WTLYTLVHSMSL-----LCA 490 (553)
Q Consensus 421 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-~-~~~~~---~~l~~~~~~~~~-----~~~ 490 (553)
...............||+.|+|||++.+..++.++||||||+++|||++ . .|... ..+.+.+..+.. ..+
T Consensus 233 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 312 (367)
T 3l9p_A 233 DIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCP 312 (367)
T ss_dssp HHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCC
T ss_pred ccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccCC
Confidence 5433322222223337899999999999999999999999999999996 3 23322 233333433322 566
Q ss_pred HHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHhhccccccccc
Q 008785 491 QECLMLFISCNNWPSHLSQSKFCNLKLWVFAILTIRKVQFEFP 533 (553)
Q Consensus 491 ~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~~~~~~~~~~~~~p 533 (553)
..+.+++.+||+.||++|||+.|+++++..............|
T Consensus 313 ~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~~~~~~~~p 355 (367)
T 3l9p_A 313 GPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTALP 355 (367)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHHHHTCCCC
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhChhhccCCCc
Confidence 7899999999999999999999999999877766554444443
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-42 Score=354.77 Aligned_cols=250 Identities=22% Similarity=0.320 Sum_probs=194.1
Q ss_pred ccCCCCeeecccCceeEEEEEeC----CCCEEEEEEeccC-ChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEE
Q 008785 269 NFSEGNRLLGDSKTGGTYSGILP----DGSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIV 343 (553)
Q Consensus 269 ~~~~~~~~iG~G~~g~Vy~~~~~----~g~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 343 (553)
+|.. .+.||+|+||.||+|... ++..||||+++.. .....+++.+|+.++++++||||+++++++.+.+..++|
T Consensus 46 ~~~~-~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 124 (373)
T 2qol_A 46 NISI-DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV 124 (373)
T ss_dssp GCCC-CEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hcee-eeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence 3443 456699999999999865 4778999999865 344567899999999999999999999999999999999
Q ss_pred EEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCC
Q 008785 344 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVP 423 (553)
Q Consensus 344 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~ 423 (553)
|||+++|+|.+++.. ....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 125 ~e~~~~~sL~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 198 (373)
T 2qol_A 125 TEYMENGSLDSFLRK---HDAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLE 198 (373)
T ss_dssp EECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence 999999999999974 335689999999999999999999999 99999999999999999999999999998765
Q ss_pred cccccc-eeeecCccccccccccccCCCCCcccchHhHHHHHHHHhc--Cccccc---chHHHHHhcCC-----HHHHHH
Q 008785 424 WEVMQE-RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL--VLCRRW---WTLYTLVHSMS-----LLCAQE 492 (553)
Q Consensus 424 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~--~~~~~~---~~l~~~~~~~~-----~~~~~~ 492 (553)
...... ......+++.|+|||++.+..++.++||||||+++|||++ ..|... ..+...+..+. ...+..
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 278 (373)
T 2qol_A 199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAA 278 (373)
T ss_dssp ---------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCCCTTCBHH
T ss_pred cCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccccHH
Confidence 432211 1111125778999999999999999999999999999986 233322 22333333321 156678
Q ss_pred HHHHHhhccCCCCCCCCCHHHHHHHHHHHHhhc
Q 008785 493 CLMLFISCNNWPSHLSQSKFCNLKLWVFAILTI 525 (553)
Q Consensus 493 l~~l~~~Cl~~dP~~RPs~~evl~~l~~~~~~~ 525 (553)
+.+++.+||+.||++|||+.|+++.+...+...
T Consensus 279 l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 311 (373)
T 2qol_A 279 LYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311 (373)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred HHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence 999999999999999999999999987776544
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=346.04 Aligned_cols=246 Identities=18% Similarity=0.279 Sum_probs=195.0
Q ss_pred hcccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCC-hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCc-----
Q 008785 267 TKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGD----- 339 (553)
Q Consensus 267 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~----- 339 (553)
.++|.... .||+|+||.||+|... +|+.||||+++... ....+.+.+|+.++++++||||+++++++.+.+.
T Consensus 5 ~~~y~~~~-~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 83 (332)
T 3qd2_B 5 LTDFEPIQ-CMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE 83 (332)
T ss_dssp HHHEEEEE-EEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred hhcCceee-EecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence 34454444 4599999999999976 69999999997543 3356789999999999999999999999876542
Q ss_pred ----------------------------------------------------eEEEEEccCCCCHHHHhccCCCCCCCCC
Q 008785 340 ----------------------------------------------------RYIVYEFVVNGPLDRWLHHIPRGGRSLD 367 (553)
Q Consensus 340 ----------------------------------------------------~~lV~E~~~~gsL~~~l~~~~~~~~~l~ 367 (553)
.++||||+++|+|.+++.... .....+
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~ 162 (332)
T 3qd2_B 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC-SLEDRE 162 (332)
T ss_dssp HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCC-SGGGSC
T ss_pred hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhccc-Cccchh
Confidence 799999999999999997632 233457
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccc----------eeeecCcc
Q 008785 368 WAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE----------RTVMAGGT 437 (553)
Q Consensus 368 ~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~----------~~~~~~gt 437 (553)
+..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++......... ......||
T Consensus 163 ~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt 239 (332)
T 3qd2_B 163 HGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT 239 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-C
T ss_pred hHHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCC
Confidence 778899999999999999999 99999999999999999999999999998765442111 11122389
Q ss_pred ccccccccccCCCCCcccchHhHHHHHHHHhcCcccccc--hHHHHHhcCCH-----HHHHHHHHHHhhccCCCCCCCCC
Q 008785 438 YGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVLCRRWW--TLYTLVHSMSL-----LCAQECLMLFISCNNWPSHLSQS 510 (553)
Q Consensus 438 ~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~~~~~~--~l~~~~~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPs 510 (553)
+.|+|||++.+..++.++||||||+++|||++....... ........+.. .....+.+++.+||+.||++|||
T Consensus 240 ~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 319 (332)
T 3qd2_B 240 KLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPE 319 (332)
T ss_dssp GGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHHCSSGGGSCC
T ss_pred cCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHHHHHHHhhccCCCcccccCChhHHHHHHHHccCCCCcCCC
Confidence 999999999999999999999999999999974332221 12223333332 45567899999999999999999
Q ss_pred HHHHHHH
Q 008785 511 KFCNLKL 517 (553)
Q Consensus 511 ~~evl~~ 517 (553)
+.|++++
T Consensus 320 ~~~~l~~ 326 (332)
T 3qd2_B 320 ATDIIEN 326 (332)
T ss_dssp HHHHHHS
T ss_pred HHHHhhc
Confidence 9999975
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-42 Score=346.65 Aligned_cols=243 Identities=13% Similarity=0.106 Sum_probs=201.0
Q ss_pred cccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEc
Q 008785 268 KNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF 346 (553)
Q Consensus 268 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 346 (553)
++|.... .||+|+||.||++... +++.||+|.++... .....+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~-~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 5 EKYMIAE-DLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTEEEEE-EEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hceEeee-EEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 3444444 4599999999999975 48899999997653 4456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecC--CCCeEEeeccccccCCc
Q 008785 347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE--EFGAHLMGVGLSKFVPW 424 (553)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~--~~~~kl~Dfgla~~~~~ 424 (553)
+++|+|.+++.. ....+++..+..++.||+.||.|||++ +|+||||||+|||++. ++.+||+|||++.....
T Consensus 83 ~~g~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~ 156 (321)
T 1tki_A 83 ISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp CCCCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred CCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC
Confidence 999999999964 334689999999999999999999999 9999999999999987 78999999999987654
Q ss_pred ccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcC-ccccc---chHHHHHhcCCH--------HHHHH
Q 008785 425 EVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLV-LCRRW---WTLYTLVHSMSL--------LCAQE 492 (553)
Q Consensus 425 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~-~~~~~---~~l~~~~~~~~~--------~~~~~ 492 (553)
.... ....||+.|+|||++.+..++.++||||||+++|||++. .|... ..+.+.+..+.. ..+..
T Consensus 157 ~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 233 (321)
T 1tki_A 157 GDNF---RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIE 233 (321)
T ss_dssp TCEE---EEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHH
T ss_pred CCcc---ccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHH
Confidence 3322 122389999999999988899999999999999999973 33322 233333333322 34678
Q ss_pred HHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 008785 493 CLMLFISCNNWPSHLSQSKFCNLKLWVFA 521 (553)
Q Consensus 493 l~~l~~~Cl~~dP~~RPs~~evl~~l~~~ 521 (553)
+.+++.+||+.||++|||+.|++++-...
T Consensus 234 ~~~li~~~L~~dp~~Rpt~~e~l~hp~~~ 262 (321)
T 1tki_A 234 AMDFVDRLLVKERKSRMTASEALQHPWLK 262 (321)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHHSHHHH
T ss_pred HHHHHHHHcCCChhHCcCHHHHhcChhhc
Confidence 89999999999999999999999985543
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-42 Score=340.06 Aligned_cols=242 Identities=21% Similarity=0.287 Sum_probs=199.8
Q ss_pred eeecccCceeEEEEEeCCCCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCCHHH
Q 008785 275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR 354 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~ 354 (553)
+.||+|+||.||++...++..||||+++... ...+++.+|+.++++++||||+++++++.+.+..++||||+++|+|.+
T Consensus 30 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 108 (283)
T 3gen_A 30 KELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLN 108 (283)
T ss_dssp EECC---CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTTCBHHH
T ss_pred hhcCCCCCceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCCCcHHH
Confidence 4569999999999999888899999998653 235678999999999999999999999999999999999999999999
Q ss_pred HhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccceeeec
Q 008785 355 WLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA 434 (553)
Q Consensus 355 ~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 434 (553)
++.. ....+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||++............ ..
T Consensus 109 ~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~-~~ 181 (283)
T 3gen_A 109 YLRE---MRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV-GS 181 (283)
T ss_dssp HHHC---GGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHSTT-ST
T ss_pred HHHH---hccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEcccccccccccccccccc-CC
Confidence 9964 234589999999999999999999999 9999999999999999999999999999876544322221 22
Q ss_pred CccccccccccccCCCCCcccchHhHHHHHHHHhc-Cc-cccc---chHHHHHhcCCH-----HHHHHHHHHHhhccCCC
Q 008785 435 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-VL-CRRW---WTLYTLVHSMSL-----LCAQECLMLFISCNNWP 504 (553)
Q Consensus 435 ~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-~~-~~~~---~~l~~~~~~~~~-----~~~~~l~~l~~~Cl~~d 504 (553)
.+|+.|+|||++.+..++.++||||||+++|||++ .. |... ......+..+.. ..+..+.+++.+||+.|
T Consensus 182 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 261 (283)
T 3gen_A 182 KFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEK 261 (283)
T ss_dssp TSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSS
T ss_pred ccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCCCcCCHHHHHHHHHHccCC
Confidence 26788999999998899999999999999999997 33 3222 222333333321 45678999999999999
Q ss_pred CCCCCCHHHHHHHHHHHHhh
Q 008785 505 SHLSQSKFCNLKLWVFAILT 524 (553)
Q Consensus 505 P~~RPs~~evl~~l~~~~~~ 524 (553)
|++|||+.|+++++...+.+
T Consensus 262 p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 262 ADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp GGGSCCHHHHHHHHHHHHHH
T ss_pred hhHCcCHHHHHHHHHHHhhc
Confidence 99999999999999877654
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-42 Score=345.10 Aligned_cols=247 Identities=25% Similarity=0.330 Sum_probs=204.1
Q ss_pred eeecccCceeEEEEEe------CCCCEEEEEEeccC-ChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEcc
Q 008785 275 RLLGDSKTGGTYSGIL------PDGSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV 347 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~------~~g~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 347 (553)
+.||+|+||.||++.. .+++.||||+++.. .....+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 29 ~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 108 (314)
T 2ivs_A 29 KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYA 108 (314)
T ss_dssp EEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred eeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceEEEEeec
Confidence 4569999999999985 24578999999764 3445678999999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecC
Q 008785 348 VNGPLDRWLHHIPR--------------------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE 407 (553)
Q Consensus 348 ~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~ 407 (553)
++|+|.+++..... ....+++..+..++.||+.||.|||++ +|+||||||+||++++
T Consensus 109 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dikp~NIli~~ 185 (314)
T 2ivs_A 109 KYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAARNILVAE 185 (314)
T ss_dssp TTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEET
T ss_pred CCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccccchheEEEcC
Confidence 99999999976432 123488999999999999999999999 9999999999999999
Q ss_pred CCCeEEeeccccccCCcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhc-Cc-cc---ccchHHHHH
Q 008785 408 EFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-VL-CR---RWWTLYTLV 482 (553)
Q Consensus 408 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-~~-~~---~~~~l~~~~ 482 (553)
++.+||+|||++................+|+.|+|||.+.+..++.++||||||+++|||++ .. |. ....+.+.+
T Consensus 186 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~ 265 (314)
T 2ivs_A 186 GRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLL 265 (314)
T ss_dssp TTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH
T ss_pred CCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHh
Confidence 99999999999987654433222222337889999999998889999999999999999997 32 22 223344444
Q ss_pred hcCCH-----HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHhh
Q 008785 483 HSMSL-----LCAQECLMLFISCNNWPSHLSQSKFCNLKLWVFAILT 524 (553)
Q Consensus 483 ~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~~~~~ 524 (553)
..+.. ..+..+.+++.+||+.||++|||+.|+++++...+.+
T Consensus 266 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 266 KTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred hcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 44322 5677899999999999999999999999998877654
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=349.77 Aligned_cols=239 Identities=19% Similarity=0.214 Sum_probs=198.6
Q ss_pred cccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCChh------hHHHHHHHHHHhhccCCCceeeEeeEEeeCCce
Q 008785 268 KNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQ------RKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR 340 (553)
Q Consensus 268 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~~------~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 340 (553)
+.|... +.||+|+||.||++... +|+.||+|+++..... ..+.+.+|+.++++++||||+++++++.+.+..
T Consensus 12 ~~y~~~-~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 12 DFYDIG-EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GTEEEE-EEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hceEEe-eEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 344443 45699999999999975 5899999999765322 357899999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCC----CeEEeec
Q 008785 341 YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF----GAHLMGV 416 (553)
Q Consensus 341 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~----~~kl~Df 416 (553)
++||||+++|+|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||+++++ .+||+||
T Consensus 91 ~lv~e~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DF 163 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (361)
T ss_dssp EEEEECCCSCBHHHHHTT----CSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEec
Confidence 999999999999999964 34699999999999999999999999 999999999999998876 7999999
Q ss_pred cccccCCcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcCc-ccc---cchHHHHHhcCCH-----
Q 008785 417 GLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVL-CRR---WWTLYTLVHSMSL----- 487 (553)
Q Consensus 417 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~-~~~---~~~l~~~~~~~~~----- 487 (553)
|++......... ....||+.|+|||++.+..++.++||||||+++|||++.. |.. ...+...+..+..
T Consensus 164 G~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~ 240 (361)
T 2yab_A 164 GLAHEIEDGVEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEE 240 (361)
T ss_dssp SSCEECCTTCCC---CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHH
T ss_pred CCceEcCCCCcc---ccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCch
Confidence 999876543221 1233999999999999889999999999999999999733 322 2233334443332
Q ss_pred ---HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008785 488 ---LCAQECLMLFISCNNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 488 ---~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 517 (553)
..+..+.+++.+||..||++|||+.|++++
T Consensus 241 ~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 241 FFSQTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hccCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 345678999999999999999999999975
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=366.57 Aligned_cols=240 Identities=23% Similarity=0.331 Sum_probs=199.1
Q ss_pred CeeecccCceeEEEEEeCCCCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCCHH
Q 008785 274 NRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 353 (553)
Q Consensus 274 ~~~iG~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~ 353 (553)
.+.||+|+||.||+|.+.++..||||+++... ...+.+.+|+.+|++++||||+++++++. .+..++||||+++|+|.
T Consensus 193 ~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~L~ 270 (454)
T 1qcf_A 193 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLL 270 (454)
T ss_dssp EEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHH
T ss_pred EEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecCCCcHH
Confidence 34569999999999999888999999998653 45678999999999999999999999986 56789999999999999
Q ss_pred HHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccceeee
Q 008785 354 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVM 433 (553)
Q Consensus 354 ~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 433 (553)
+++.. .....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++........... .
T Consensus 271 ~~l~~--~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~-~ 344 (454)
T 1qcf_A 271 DFLKS--DEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTARE-G 344 (454)
T ss_dssp HHHHS--HHHHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHTTC-S
T ss_pred HHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceeccC-C
Confidence 99974 2223588999999999999999999999 9999999999999999999999999999876543322222 1
Q ss_pred cCccccccccccccCCCCCcccchHhHHHHHHHHhc-Cc-cccc---chHHHHHhcCCH-----HHHHHHHHHHhhccCC
Q 008785 434 AGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-VL-CRRW---WTLYTLVHSMSL-----LCAQECLMLFISCNNW 503 (553)
Q Consensus 434 ~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-~~-~~~~---~~l~~~~~~~~~-----~~~~~l~~l~~~Cl~~ 503 (553)
..+|+.|+|||++....++.++||||||+++|||++ .. |... ..+...+..+.. ..+..+.+++.+||+.
T Consensus 345 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~ 424 (454)
T 1qcf_A 345 AKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMRCWKN 424 (454)
T ss_dssp SSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCS
T ss_pred CcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccC
Confidence 226789999999998999999999999999999997 32 3322 223333333221 5677899999999999
Q ss_pred CCCCCCCHHHHHHHHHHH
Q 008785 504 PSHLSQSKFCNLKLWVFA 521 (553)
Q Consensus 504 dP~~RPs~~evl~~l~~~ 521 (553)
||++|||+.+|++.|...
T Consensus 425 dp~~RPt~~~i~~~L~~~ 442 (454)
T 1qcf_A 425 RPEERPTFEYIQSVLDDF 442 (454)
T ss_dssp SGGGSCCHHHHHHHHHTS
T ss_pred ChhHCcCHHHHHHHHHHH
Confidence 999999999999887543
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-42 Score=352.95 Aligned_cols=260 Identities=22% Similarity=0.264 Sum_probs=205.7
Q ss_pred HHHHhhcccCCCCeeecccCceeEEEEEe------CCCCEEEEEEeccCC-hhhHHHHHHHHHHhhcc-CCCceeeEeeE
Q 008785 262 ELRSITKNFSEGNRLLGDSKTGGTYSGIL------PDGSRVAVKRLKRSS-FQRKKEFYSEIGRFARL-HHPNLVAVKGC 333 (553)
Q Consensus 262 el~~~~~~~~~~~~~iG~G~~g~Vy~~~~------~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~l~~~ 333 (553)
+.....++|... +.||+|+||.||+|.+ .+++.||||+++... ....+.+.+|+.++.++ +||||++++++
T Consensus 16 ~~~~~~~~y~~~-~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~ 94 (359)
T 3vhe_A 16 KWEFPRDRLKLG-KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 94 (359)
T ss_dssp HHBCCGGGEEEE-EEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccccccceeec-eeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeee
Confidence 333344555554 4559999999999973 246789999998653 34457799999999999 89999999999
Q ss_pred EeeCCc-eEEEEEccCCCCHHHHhccCCCC--------------------------------------------------
Q 008785 334 CYDHGD-RYIVYEFVVNGPLDRWLHHIPRG-------------------------------------------------- 362 (553)
Q Consensus 334 ~~~~~~-~~lV~E~~~~gsL~~~l~~~~~~-------------------------------------------------- 362 (553)
+.+.+. .++||||+++|+|.+++......
T Consensus 95 ~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (359)
T 3vhe_A 95 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLS 174 (359)
T ss_dssp ECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------------
T ss_pred eecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccc
Confidence 987655 89999999999999999763221
Q ss_pred ------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccce
Q 008785 363 ------------GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER 430 (553)
Q Consensus 363 ------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 430 (553)
...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++...........
T Consensus 175 ~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 251 (359)
T 3vhe_A 175 DVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 251 (359)
T ss_dssp ---------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEE
T ss_pred hhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecccccchh
Confidence 12288999999999999999999999 999999999999999999999999999987654433222
Q ss_pred eeecCccccccccccccCCCCCcccchHhHHHHHHHHhc-Cc-cccc----chHHHHHhcCCH-----HHHHHHHHHHhh
Q 008785 431 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-VL-CRRW----WTLYTLVHSMSL-----LCAQECLMLFIS 499 (553)
Q Consensus 431 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-~~-~~~~----~~l~~~~~~~~~-----~~~~~l~~l~~~ 499 (553)
.....||+.|+|||++.+..++.++||||||+++|||++ .. |... ..+...+..+.. ..+..+.+++.+
T Consensus 252 ~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 331 (359)
T 3vhe_A 252 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLD 331 (359)
T ss_dssp C--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHH
T ss_pred ccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHHHH
Confidence 223338899999999999999999999999999999996 33 3222 122223332221 456789999999
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHhhc
Q 008785 500 CNNWPSHLSQSKFCNLKLWVFAILTI 525 (553)
Q Consensus 500 Cl~~dP~~RPs~~evl~~l~~~~~~~ 525 (553)
||+.||++|||+.|+++++...+...
T Consensus 332 ~l~~dP~~Rps~~ell~~L~~~~~~~ 357 (359)
T 3vhe_A 332 CWHGEPSQRPTFSELVEHLGNLLQAN 357 (359)
T ss_dssp HTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HccCChhhCCCHHHHHHHHHHHHHHh
Confidence 99999999999999999998776543
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=352.11 Aligned_cols=251 Identities=24% Similarity=0.308 Sum_probs=206.0
Q ss_pred CeeecccCceeEEEEEeC--------CCCEEEEEEeccC-ChhhHHHHHHHHHHhhcc-CCCceeeEeeEEeeCCceEEE
Q 008785 274 NRLLGDSKTGGTYSGILP--------DGSRVAVKRLKRS-SFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIV 343 (553)
Q Consensus 274 ~~~iG~G~~g~Vy~~~~~--------~g~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV 343 (553)
.+.||+|+||.||+|... ++..||||+++.. .......+.+|+++++++ +||||+++++++.+.+..++|
T Consensus 74 ~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv 153 (382)
T 3tt0_A 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVI 153 (382)
T ss_dssp EEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred eeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCCceEEE
Confidence 345699999999999852 2457999999765 334457899999999999 999999999999999999999
Q ss_pred EEccCCCCHHHHhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCe
Q 008785 344 YEFVVNGPLDRWLHHIPR------------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGA 411 (553)
Q Consensus 344 ~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~ 411 (553)
|||+++|+|.+++..... ....+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+
T Consensus 154 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~ 230 (382)
T 3tt0_A 154 VEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVM 230 (382)
T ss_dssp EECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCE
T ss_pred EEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceEEEcCCCcE
Confidence 999999999999976331 124589999999999999999999999 99999999999999999999
Q ss_pred EEeeccccccCCcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhc-Cc-cccc---chHHHHHhcCC
Q 008785 412 HLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-VL-CRRW---WTLYTLVHSMS 486 (553)
Q Consensus 412 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-~~-~~~~---~~l~~~~~~~~ 486 (553)
||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ .. |... ..+.+.+..+.
T Consensus 231 kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~~~~~~~~ 310 (382)
T 3tt0_A 231 KIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGH 310 (382)
T ss_dssp EECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC
T ss_pred EEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence 9999999987654332222222337889999999999999999999999999999997 32 3322 23333444332
Q ss_pred H-----HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHhhccc
Q 008785 487 L-----LCAQECLMLFISCNNWPSHLSQSKFCNLKLWVFAILTIRK 527 (553)
Q Consensus 487 ~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~~~~~~~~ 527 (553)
. ..+..+.+++.+||+.||++|||+.|+++.+...+.....
T Consensus 311 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~ 356 (382)
T 3tt0_A 311 RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSN 356 (382)
T ss_dssp CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCS
T ss_pred CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhc
Confidence 2 5677899999999999999999999999998877755543
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=336.34 Aligned_cols=238 Identities=25% Similarity=0.351 Sum_probs=198.8
Q ss_pred eeecccCceeEEEEEeCCCCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCCHHH
Q 008785 275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR 354 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~ 354 (553)
+.||+|+||.||++...++..||||+++... ...+++.+|+.++.+++||||+++++++.+.+..++||||+++++|.+
T Consensus 14 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 92 (268)
T 3sxs_A 14 KELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLN 92 (268)
T ss_dssp EEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHH
T ss_pred eeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCCCcHHH
Confidence 4569999999999999888899999998653 345678999999999999999999999999999999999999999999
Q ss_pred HhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccceeeec
Q 008785 355 WLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA 434 (553)
Q Consensus 355 ~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 434 (553)
++.. ....+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++............ ..
T Consensus 93 ~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~-~~ 165 (268)
T 3sxs_A 93 YLRS---HGKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSV-GT 165 (268)
T ss_dssp HHHH---HGGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEECC-SC
T ss_pred HHHH---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchhhhhccc-CC
Confidence 9975 234589999999999999999999999 9999999999999999999999999999876544332222 22
Q ss_pred CccccccccccccCCCCCcccchHhHHHHHHHHhc-Cc-ccccc---hHHHHHhcCCH-----HHHHHHHHHHhhccCCC
Q 008785 435 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-VL-CRRWW---TLYTLVHSMSL-----LCAQECLMLFISCNNWP 504 (553)
Q Consensus 435 ~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-~~-~~~~~---~l~~~~~~~~~-----~~~~~l~~l~~~Cl~~d 504 (553)
.+|+.|+|||.+.+..++.++||||||+++|||++ .. |.... .....+..+.. ..+..+.+++.+||+.|
T Consensus 166 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 245 (268)
T 3sxs_A 166 KFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDTIYQIMYSCWHEL 245 (268)
T ss_dssp CCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHTTCSS
T ss_pred CcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCCCcChHHHHHHHHHHcCCC
Confidence 26778999999998899999999999999999997 33 32222 22222333221 45678999999999999
Q ss_pred CCCCCCHHHHHHHHHH
Q 008785 505 SHLSQSKFCNLKLWVF 520 (553)
Q Consensus 505 P~~RPs~~evl~~l~~ 520 (553)
|++|||+.|+++++..
T Consensus 246 p~~Rps~~~ll~~L~~ 261 (268)
T 3sxs_A 246 PEKRPTFQQLLSSIEP 261 (268)
T ss_dssp GGGSCCHHHHHHHHGG
T ss_pred hhhCcCHHHHHHHHHH
Confidence 9999999999998743
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=349.92 Aligned_cols=246 Identities=18% Similarity=0.178 Sum_probs=199.4
Q ss_pred ccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCC-----hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEE
Q 008785 269 NFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS-----FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYI 342 (553)
Q Consensus 269 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~-----~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 342 (553)
.|.. .+.||+|+||.||++... +|+.||||+++... ....+.+.+|+.++++++||||+++++++.+.+..|+
T Consensus 25 ~y~~-~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 103 (351)
T 3c0i_A 25 VYEL-CEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM 103 (351)
T ss_dssp HEEE-EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred ceEE-eeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 3443 345699999999999965 58999999986432 1235789999999999999999999999999999999
Q ss_pred EEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCC---eEEeecccc
Q 008785 343 VYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG---AHLMGVGLS 419 (553)
Q Consensus 343 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~---~kl~Dfgla 419 (553)
||||+++|+|.+++.........+++..+..++.||+.||.|||++ +|+||||||+|||++.++. +||+|||++
T Consensus 104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a 180 (351)
T 3c0i_A 104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVA 180 (351)
T ss_dssp EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCcce
Confidence 9999999999988865333345689999999999999999999999 9999999999999987654 999999999
Q ss_pred ccCCcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcCc-cccc--chHHHHHhcCCH--------H
Q 008785 420 KFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVL-CRRW--WTLYTLVHSMSL--------L 488 (553)
Q Consensus 420 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~-~~~~--~~l~~~~~~~~~--------~ 488 (553)
.......... ....||+.|+|||++.+..++.++||||||+++|||++.. |... ..+...+..+.. .
T Consensus 181 ~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~i~~~~~~~~~~~~~~ 258 (351)
T 3c0i_A 181 IQLGESGLVA--GGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKYKMNPRQWSH 258 (351)
T ss_dssp EECCTTSCBC--CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHHHHHHHHHTCCCCCHHHHTT
T ss_pred eEecCCCeee--cCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHHHHHHHHcCCCCCCcccccc
Confidence 8765433211 1223999999999999999999999999999999999833 2222 223333333322 3
Q ss_pred HHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 008785 489 CAQECLMLFISCNNWPSHLSQSKFCNLKLWVF 520 (553)
Q Consensus 489 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~ 520 (553)
.+..+.+++.+||+.||++|||+.|++++-..
T Consensus 259 ~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~ 290 (351)
T 3c0i_A 259 ISESAKDLVRRMLMLDPAERITVYEALNHPWL 290 (351)
T ss_dssp SCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred CCHHHHHHHHHHCCCChhHCcCHHHHhcChhh
Confidence 46788999999999999999999999987544
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=341.58 Aligned_cols=244 Identities=25% Similarity=0.348 Sum_probs=195.1
Q ss_pred CeeecccCceeEEEEEe-----CCCCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeEEeeC--CceEEEEEc
Q 008785 274 NRLLGDSKTGGTYSGIL-----PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH--GDRYIVYEF 346 (553)
Q Consensus 274 ~~~iG~G~~g~Vy~~~~-----~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~~lV~E~ 346 (553)
.+.||+|+||.||++.+ .+++.||||++........+.+.+|+.++++++||||+++++++... ...++||||
T Consensus 15 ~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~ 94 (295)
T 3ugc_A 15 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEY 94 (295)
T ss_dssp EEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEEEEEC
T ss_pred hheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceEEEEEe
Confidence 34569999999999984 25889999999887777778899999999999999999999998654 558999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCccc
Q 008785 347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV 426 (553)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 426 (553)
+++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 95 ~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 168 (295)
T 3ugc_A 95 LPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 168 (295)
T ss_dssp CTTCBHHHHHHHC---GGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSCC------
T ss_pred CCCCCHHHHHHhc---ccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCcccccccCCc
Confidence 9999999999752 34589999999999999999999999 99999999999999999999999999998765432
Q ss_pred ccc-eeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcCcccccch--------------------HHHHHhcC
Q 008785 427 MQE-RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVLCRRWWT--------------------LYTLVHSM 485 (553)
Q Consensus 427 ~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~~~~~~~--------------------l~~~~~~~ 485 (553)
... ......++..|+|||++.+..++.++||||||+++|||++........ +.+.+..+
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (295)
T 3ugc_A 169 EFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN 248 (295)
T ss_dssp -------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHHTT
T ss_pred ceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHhcc
Confidence 221 112223777899999999999999999999999999999732221111 11111111
Q ss_pred -CH----HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHh
Q 008785 486 -SL----LCAQECLMLFISCNNWPSHLSQSKFCNLKLWVFAIL 523 (553)
Q Consensus 486 -~~----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~~~~ 523 (553)
.. ..+..+.+++.+||+.||++|||+.|+++.+.....
T Consensus 249 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~ 291 (295)
T 3ugc_A 249 GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 291 (295)
T ss_dssp CCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence 11 456789999999999999999999999998876544
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=345.56 Aligned_cols=246 Identities=21% Similarity=0.258 Sum_probs=193.9
Q ss_pred ccCCCCeeecccCceeEEEEEeCCCCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCc----eEEEE
Q 008785 269 NFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGD----RYIVY 344 (553)
Q Consensus 269 ~~~~~~~~iG~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~----~~lV~ 344 (553)
+|... +.||+|+||.||+|.. .++.||||+++... .....+.+|+.++++++||||+++++++.+... .++||
T Consensus 25 ~y~~~-~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~ 101 (322)
T 3soc_A 25 PLQLL-EVKARGRFGCVWKAQL-LNEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLIT 101 (322)
T ss_dssp EEEEE-EEEECSTTCEEEEEEE-TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred hchhh-heecccCceEEEEEEE-CCCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEE
Confidence 34443 4569999999999998 48999999997653 334556779999999999999999999987553 69999
Q ss_pred EccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-------CCCCceecCCCCCcEEecCCCCeEEeecc
Q 008785 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDK-------VKPHVVHRDIRASNVLLDEEFGAHLMGVG 417 (553)
Q Consensus 345 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~-------~~~~ivHrDlkp~NILl~~~~~~kl~Dfg 417 (553)
||+++|+|.++++. ..+++..+..++.|++.||+|||+. ++++|+||||||+|||++.++.+||+|||
T Consensus 102 e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg 176 (322)
T 3soc_A 102 AFHEKGSLSDFLKA-----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFG 176 (322)
T ss_dssp ECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCT
T ss_pred ecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCC
Confidence 99999999999975 3489999999999999999999975 23489999999999999999999999999
Q ss_pred ccccCCcccccceeeecCccccccccccccC-----CCCCcccchHhHHHHHHHHhcCcc-ccc----------------
Q 008785 418 LSKFVPWEVMQERTVMAGGTYGYLAPEFVYR-----NELTTKSDVYSFGVLLLEIRLVLC-RRW---------------- 475 (553)
Q Consensus 418 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~t~ksDVwSlGvil~ell~~~~-~~~---------------- 475 (553)
+++...............||+.|+|||++.+ ..++.++||||||+++|||++..+ ...
T Consensus 177 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~ 256 (322)
T 3soc_A 177 LALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQH 256 (322)
T ss_dssp TCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSS
T ss_pred cccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccC
Confidence 9977654433222222348999999999976 356778999999999999997321 110
Q ss_pred ---chHHHHHhcCCH-----------HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 008785 476 ---WTLYTLVHSMSL-----------LCAQECLMLFISCNNWPSHLSQSKFCNLKLWVFAI 522 (553)
Q Consensus 476 ---~~l~~~~~~~~~-----------~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~~~ 522 (553)
..+.+.+..... ..+..+.+++.+||+.||++|||+.|+++.+....
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~ 317 (322)
T 3soc_A 257 PSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQ 317 (322)
T ss_dssp CCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 111111111111 45667999999999999999999999999876543
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=346.58 Aligned_cols=241 Identities=21% Similarity=0.200 Sum_probs=199.3
Q ss_pred ccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCC---hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEE
Q 008785 269 NFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVY 344 (553)
Q Consensus 269 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 344 (553)
+|... +.||+|+||.||++... +|+.||+|++++.. ......+.+|+.++++++||||+++++++.+.+..++||
T Consensus 6 ~y~~~-~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 6 DFDYL-KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GEEEE-EEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HeEEE-EEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 44443 45699999999999975 58999999997642 234567889999999999999999999999999999999
Q ss_pred EccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCc
Q 008785 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW 424 (553)
Q Consensus 345 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~ 424 (553)
||+++|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 85 E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 157 (337)
T 1o6l_A 85 EYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp ECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred eCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence 99999999999864 24589999999999999999999999 999999999999999999999999999986433
Q ss_pred ccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcCc-cccc---chHHHHHhcCCH----HHHHHHHHH
Q 008785 425 EVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVL-CRRW---WTLYTLVHSMSL----LCAQECLML 496 (553)
Q Consensus 425 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~-~~~~---~~l~~~~~~~~~----~~~~~l~~l 496 (553)
..... ....||+.|+|||++.+..++.++||||||+++|||++.. |... ..+.+.+..+.. ..+..+.++
T Consensus 158 ~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l 235 (337)
T 1o6l_A 158 DGATM--KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSL 235 (337)
T ss_dssp TTCCB--CCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHH
T ss_pred CCCcc--cccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 22211 2233899999999999999999999999999999999733 3322 233333333332 456788999
Q ss_pred HhhccCCCCCCCC-----CHHHHHHHHH
Q 008785 497 FISCNNWPSHLSQ-----SKFCNLKLWV 519 (553)
Q Consensus 497 ~~~Cl~~dP~~RP-----s~~evl~~l~ 519 (553)
+.+||+.||++|| ++.|++++-.
T Consensus 236 i~~lL~~dP~~R~g~~~~~~~ei~~h~~ 263 (337)
T 1o6l_A 236 LAGLLKKDPKQRLGGGPSDAKEVMEHRF 263 (337)
T ss_dssp HHHHTCSSTTTSTTCSTTTHHHHHTSGG
T ss_pred HHHHhhcCHHHhcCCCCCCHHHHHcCCC
Confidence 9999999999999 9999998743
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=348.12 Aligned_cols=252 Identities=24% Similarity=0.331 Sum_probs=204.2
Q ss_pred hcccCCCCeeecccCceeEEEEEeC------CCCEEEEEEeccCC-hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCc
Q 008785 267 TKNFSEGNRLLGDSKTGGTYSGILP------DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGD 339 (553)
Q Consensus 267 ~~~~~~~~~~iG~G~~g~Vy~~~~~------~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 339 (553)
.++|... +.||+|+||.||+|... +++.||||+++... ....+.+.+|+.++++++||||+++++++.+.+.
T Consensus 46 ~~~~~~~-~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 124 (343)
T 1luf_A 46 RNNIEYV-RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 124 (343)
T ss_dssp GGGCEEE-EEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred HHHCeee-eeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCc
Confidence 3445444 45699999999999974 34789999998653 3446789999999999999999999999999999
Q ss_pred eEEEEEccCCCCHHHHhccCCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCC
Q 008785 340 RYIVYEFVVNGPLDRWLHHIPRG--------------------GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIR 399 (553)
Q Consensus 340 ~~lV~E~~~~gsL~~~l~~~~~~--------------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlk 399 (553)
.++||||+++|+|.+++...... ...+++..++.++.||+.||.|||++ +|+|||||
T Consensus 125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlk 201 (343)
T 1luf_A 125 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLA 201 (343)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCS
T ss_pred eEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCC
Confidence 99999999999999999763211 25689999999999999999999999 99999999
Q ss_pred CCcEEecCCCCeEEeeccccccCCcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhc-Cc-ccccc-
Q 008785 400 ASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-VL-CRRWW- 476 (553)
Q Consensus 400 p~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-~~-~~~~~- 476 (553)
|+|||++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ .. |....
T Consensus 202 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 281 (343)
T 1luf_A 202 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 281 (343)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred cceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCC
Confidence 9999999999999999999976554332222223347899999999998899999999999999999997 33 33322
Q ss_pred --hHHHHHhcCCH-----HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 008785 477 --TLYTLVHSMSL-----LCAQECLMLFISCNNWPSHLSQSKFCNLKLWVFAI 522 (553)
Q Consensus 477 --~l~~~~~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~~~ 522 (553)
.+...+..+.. ..+..+.+++.+||+.||++|||+.++++.+....
T Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~ 334 (343)
T 1luf_A 282 HEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 334 (343)
T ss_dssp HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred hHHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHH
Confidence 23334444332 55678999999999999999999999999876544
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=343.22 Aligned_cols=239 Identities=17% Similarity=0.202 Sum_probs=197.1
Q ss_pred ccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCChh------hHHHHHHHHHHhhccCCCceeeEeeEEeeCCceE
Q 008785 269 NFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQ------RKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRY 341 (553)
Q Consensus 269 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~~------~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 341 (553)
.|... +.||+|+||.||++... +|+.||+|+++..... ..+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 12 ~y~~~-~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 12 YYDTG-EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HEEEE-EEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ceEec-eEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 34443 45699999999999975 5899999999764321 3678999999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCC----CeEEeecc
Q 008785 342 IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF----GAHLMGVG 417 (553)
Q Consensus 342 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~----~~kl~Dfg 417 (553)
+||||+++|+|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++ .+||+|||
T Consensus 91 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 163 (326)
T 2y0a_A 91 LILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFG 163 (326)
T ss_dssp EEEECCCSCBHHHHHTT----SSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEcCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence 99999999999999964 34689999999999999999999999 999999999999999887 79999999
Q ss_pred ccccCCcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcCc-ccccc---hHHHHHhcCCH------
Q 008785 418 LSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVL-CRRWW---TLYTLVHSMSL------ 487 (553)
Q Consensus 418 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~-~~~~~---~l~~~~~~~~~------ 487 (553)
+++........ ....||+.|+|||++.+..++.++||||||+++|||++.. |.... .....+.....
T Consensus 164 ~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 240 (326)
T 2y0a_A 164 LAHKIDFGNEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY 240 (326)
T ss_dssp TCEECCTTSCC---CCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHH
T ss_pred CCeECCCCCcc---ccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccc
Confidence 99876543221 1223899999999999889999999999999999999733 33222 22222222221
Q ss_pred --HHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008785 488 --LCAQECLMLFISCNNWPSHLSQSKFCNLKLW 518 (553)
Q Consensus 488 --~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l 518 (553)
..+..+.+++.+||+.||++|||+.|++++-
T Consensus 241 ~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp 273 (326)
T 2y0a_A 241 FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHP 273 (326)
T ss_dssp HTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHST
T ss_pred cccCCHHHHHHHHHHccCChhhCCCHHHHhcCC
Confidence 3456789999999999999999999999863
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=340.76 Aligned_cols=238 Identities=22% Similarity=0.238 Sum_probs=192.0
Q ss_pred cccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccC--ChhhHHHHHHHHHHhhcc-CCCceeeEeeEEeeCCceEEE
Q 008785 268 KNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS--SFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIV 343 (553)
Q Consensus 268 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV 343 (553)
++|....+ ||+|+||+||+|... +|+.||||++... .......+..|+..+.++ +||||+++++++.+.+..++|
T Consensus 57 ~~y~~~~~-LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 57 QSFQRLSR-LGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHEEEEEE-EEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hheeeehe-eccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 45655444 599999999999976 6999999998654 233445566677666666 899999999999999999999
Q ss_pred EEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCC
Q 008785 344 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVP 423 (553)
Q Consensus 344 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~ 423 (553)
|||+ +++|.+++.. ....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++....
T Consensus 136 ~e~~-~~~L~~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~ 208 (311)
T 3p1a_A 136 TELC-GPSLQQHCEA---WGASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELG 208 (311)
T ss_dssp EECC-CCBHHHHHHH---HCSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEECC
T ss_pred Eecc-CCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeecc
Confidence 9999 7799998875 234699999999999999999999999 99999999999999999999999999997665
Q ss_pred cccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcC-cccccchHHHHHhcCCH------HHHHHHHHH
Q 008785 424 WEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLV-LCRRWWTLYTLVHSMSL------LCAQECLML 496 (553)
Q Consensus 424 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~-~~~~~~~l~~~~~~~~~------~~~~~l~~l 496 (553)
..... ....||+.|+|||++.+ .++.++||||||+++|||++. .+.......+.+..+.. ..+..+.++
T Consensus 209 ~~~~~---~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 284 (311)
T 3p1a_A 209 TAGAG---EVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEFTAGLSSELRSV 284 (311)
T ss_dssp ---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHHHHTTTCCCHHHHTTSCHHHHHH
T ss_pred cCCCC---cccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHhccCCCcccccCCCHHHHHH
Confidence 43221 22338999999998875 799999999999999999984 33333333333333332 346789999
Q ss_pred HhhccCCCCCCCCCHHHHHHH
Q 008785 497 FISCNNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 497 ~~~Cl~~dP~~RPs~~evl~~ 517 (553)
+.+||+.||++|||+.|++++
T Consensus 285 i~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 285 LVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp HHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHcCCChhhCcCHHHHHhC
Confidence 999999999999999999874
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=347.99 Aligned_cols=242 Identities=21% Similarity=0.249 Sum_probs=200.2
Q ss_pred hhcccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccC--ChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEE
Q 008785 266 ITKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYI 342 (553)
Q Consensus 266 ~~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 342 (553)
+.++|.... .||+|+||.||++... +|+.||+|+++.. .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 27 ~~~~y~~~~-~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l 105 (362)
T 2bdw_A 27 FSDNYDVKE-ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 105 (362)
T ss_dssp HHHHEEEEE-EEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cccCeEEee-EEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 344565544 4599999999999975 5899999999754 33445778999999999999999999999999999999
Q ss_pred EEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCC---CCeEEeecccc
Q 008785 343 VYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE---FGAHLMGVGLS 419 (553)
Q Consensus 343 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~---~~~kl~Dfgla 419 (553)
||||+++|+|.+++.. ...+++..+..++.||+.||.|||++ +|+||||||+|||++.+ +.+||+|||++
T Consensus 106 v~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a 178 (362)
T 2bdw_A 106 VFDLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLA 178 (362)
T ss_dssp EECCCCSCBHHHHHTT----CSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcc
Confidence 9999999999999864 34689999999999999999999999 99999999999999865 45999999999
Q ss_pred ccCCcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcCc-ccc---cchHHHHHhcCCH--------
Q 008785 420 KFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVL-CRR---WWTLYTLVHSMSL-------- 487 (553)
Q Consensus 420 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~-~~~---~~~l~~~~~~~~~-------- 487 (553)
......... ....||+.|+|||++.+..++.++||||||+++|||++.. |.. ...+...+..+..
T Consensus 179 ~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 255 (362)
T 2bdw_A 179 IEVNDSEAW---HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWD 255 (362)
T ss_dssp BCCTTCCSC---CCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGG
T ss_pred eEecCCccc---ccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCccccc
Confidence 876533221 1233999999999999989999999999999999999733 322 2233334443332
Q ss_pred HHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008785 488 LCAQECLMLFISCNNWPSHLSQSKFCNLKLW 518 (553)
Q Consensus 488 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l 518 (553)
..+..+.+++.+||+.||++|||+.|++++-
T Consensus 256 ~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 286 (362)
T 2bdw_A 256 TVTPEAKSLIDSMLTVNPKKRITADQALKVP 286 (362)
T ss_dssp GSCHHHHHHHHHHSCSSGGGSCCHHHHTTSH
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHhcCc
Confidence 4567899999999999999999999999874
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=347.68 Aligned_cols=254 Identities=25% Similarity=0.318 Sum_probs=199.4
Q ss_pred ccCCCCeeecccCceeEEEEEe------CCCCEEEEEEeccCC-hhhHHHHHHHHHHhhcc-CCCceeeEeeEEeeCCce
Q 008785 269 NFSEGNRLLGDSKTGGTYSGIL------PDGSRVAVKRLKRSS-FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDR 340 (553)
Q Consensus 269 ~~~~~~~~iG~G~~g~Vy~~~~------~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~ 340 (553)
+|.. .+.||+|+||.||+|.. .++..||||+++... ....+.+.+|+.+++++ +||||+++++++...+..
T Consensus 46 ~y~~-~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 124 (344)
T 1rjb_A 46 NLEF-GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 124 (344)
T ss_dssp GEEE-EEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred Hcee-eeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCcc
Confidence 3433 34569999999999995 235689999997542 33457789999999999 899999999999999999
Q ss_pred EEEEEccCCCCHHHHhccCCCC-------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCC
Q 008785 341 YIVYEFVVNGPLDRWLHHIPRG-------------------GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRAS 401 (553)
Q Consensus 341 ~lV~E~~~~gsL~~~l~~~~~~-------------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~ 401 (553)
++||||+++|+|.+++...... ...+++..+..++.||+.||.|||++ +|+||||||+
T Consensus 125 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~ 201 (344)
T 1rjb_A 125 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAAR 201 (344)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGG
T ss_pred EEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChh
Confidence 9999999999999999753211 13479999999999999999999999 9999999999
Q ss_pred cEEecCCCCeEEeeccccccCCcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhc-Cc-cccc----
Q 008785 402 NVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-VL-CRRW---- 475 (553)
Q Consensus 402 NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-~~-~~~~---- 475 (553)
|||++.++.+||+|||++................||+.|+|||++.+..++.++||||||+++|||++ .. |...
T Consensus 202 NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~ 281 (344)
T 1rjb_A 202 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 281 (344)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred hEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcH
Confidence 99999999999999999986654332222222237889999999999999999999999999999997 33 2222
Q ss_pred chHHHHHhcCCH-----HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHhhcc
Q 008785 476 WTLYTLVHSMSL-----LCAQECLMLFISCNNWPSHLSQSKFCNLKLWVFAILTIR 526 (553)
Q Consensus 476 ~~l~~~~~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~~~~~~~ 526 (553)
..+...+..+.. ..+..+.+++.+||+.||.+|||+.|+++++...+....
T Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~ 337 (344)
T 1rjb_A 282 ANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAE 337 (344)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC----
T ss_pred HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHH
Confidence 122233333211 457789999999999999999999999999877655443
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=335.34 Aligned_cols=244 Identities=24% Similarity=0.299 Sum_probs=190.1
Q ss_pred CeeecccCceeEEEEEeCC----CCEEEEEEeccC-ChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccC
Q 008785 274 NRLLGDSKTGGTYSGILPD----GSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV 348 (553)
Q Consensus 274 ~~~iG~G~~g~Vy~~~~~~----g~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 348 (553)
.+.||+|+||.||+|.... +..||+|.++.. .....+.+.+|+.++++++||||+++++++. .+..++||||++
T Consensus 20 ~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv~e~~~ 98 (281)
T 1mp8_A 20 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCT 98 (281)
T ss_dssp EEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECCT
T ss_pred EeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEEEEecCC
Confidence 3456999999999999743 457999998764 3344678999999999999999999999974 567899999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCccccc
Q 008785 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ 428 (553)
Q Consensus 349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 428 (553)
+|+|.+++.. ....+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++........
T Consensus 99 ~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 172 (281)
T 1mp8_A 99 LGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY 172 (281)
T ss_dssp TEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-------------
T ss_pred CCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECccccccccCccccc
Confidence 9999999975 234689999999999999999999999 9999999999999999999999999999876543322
Q ss_pred ceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhc-Cc-cc---ccchHHHHHhcCCH-----HHHHHHHHHHh
Q 008785 429 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-VL-CR---RWWTLYTLVHSMSL-----LCAQECLMLFI 498 (553)
Q Consensus 429 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-~~-~~---~~~~l~~~~~~~~~-----~~~~~l~~l~~ 498 (553)
... ...+|+.|+|||++.+..++.++||||||+++|||++ .. |. ....+...+..+.. ..+..+.+++.
T Consensus 173 ~~~-~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~ 251 (281)
T 1mp8_A 173 KAS-KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMT 251 (281)
T ss_dssp -------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred ccc-cCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Confidence 211 2226789999999998899999999999999999995 22 32 22334444433321 56778999999
Q ss_pred hccCCCCCCCCCHHHHHHHHHHHHhhc
Q 008785 499 SCNNWPSHLSQSKFCNLKLWVFAILTI 525 (553)
Q Consensus 499 ~Cl~~dP~~RPs~~evl~~l~~~~~~~ 525 (553)
+||+.||++|||+.|+++.+...+.+.
T Consensus 252 ~~l~~~p~~Rps~~~l~~~l~~~~~~~ 278 (281)
T 1mp8_A 252 KCWAYDPSRRPRFTELKAQLSTILEEE 278 (281)
T ss_dssp HHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 999999999999999999987766554
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=356.48 Aligned_cols=243 Identities=19% Similarity=0.223 Sum_probs=199.5
Q ss_pred hhcccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCC--hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEE
Q 008785 266 ITKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYI 342 (553)
Q Consensus 266 ~~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 342 (553)
+.++|.... .||+|+||.||++... +|+.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 9 ~~~~Y~i~~-~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 87 (444)
T 3soa_A 9 FTEEYQLFE-ELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL 87 (444)
T ss_dssp HHHHEEEEE-EEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred ccCCeEEEE-EeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence 344555544 4599999999999864 68999999997653 3345678999999999999999999999999999999
Q ss_pred EEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEec---CCCCeEEeecccc
Q 008785 343 VYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD---EEFGAHLMGVGLS 419 (553)
Q Consensus 343 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~---~~~~~kl~Dfgla 419 (553)
||||+++|+|.+++.. ...+++..+..++.||+.||.|||++ +|+||||||+|||++ +++.+||+|||++
T Consensus 88 v~E~~~gg~L~~~i~~----~~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a 160 (444)
T 3soa_A 88 IFDLVTGGELFEDIVA----REYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLA 160 (444)
T ss_dssp EECCCBCCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSC
T ss_pred EEEeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCcee
Confidence 9999999999999875 24589999999999999999999999 999999999999998 4578999999999
Q ss_pred ccCCcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcCc-cc---ccchHHHHHhcCCH--------
Q 008785 420 KFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVL-CR---RWWTLYTLVHSMSL-------- 487 (553)
Q Consensus 420 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~-~~---~~~~l~~~~~~~~~-------- 487 (553)
.......... ....||+.|+|||++.+..++.++||||||+++|+|++.. |. ....+...+..+..
T Consensus 161 ~~~~~~~~~~--~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 238 (444)
T 3soa_A 161 IEVEGEQQAW--FGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWD 238 (444)
T ss_dssp BCCCTTCCBC--CCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTT
T ss_pred EEecCCCcee--ecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccc
Confidence 8765433221 1233999999999999989999999999999999999733 32 22333444444432
Q ss_pred HHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008785 488 LCAQECLMLFISCNNWPSHLSQSKFCNLKLW 518 (553)
Q Consensus 488 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l 518 (553)
..+..+.+++.+||+.||++|||+.|++++-
T Consensus 239 ~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp 269 (444)
T 3soa_A 239 TVTPEAKDLINKMLTINPSKRITAAEALKHP 269 (444)
T ss_dssp TSCHHHHHHHHHHSCSSTTTSCCHHHHHHSC
T ss_pred cCCHHHHHHHHHHcCCChhHCCCHHHHhcCc
Confidence 4567899999999999999999999999873
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-41 Score=348.99 Aligned_cols=240 Identities=17% Similarity=0.188 Sum_probs=200.2
Q ss_pred cccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEc
Q 008785 268 KNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF 346 (553)
Q Consensus 268 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 346 (553)
+.|... +.||+|+||.||+|... +|+.||+|++..........+.+|+.+|++++||||+++++++.+.+..++||||
T Consensus 51 ~~y~i~-~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 51 DYYDIL-EELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GTEEEE-EEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred cceEEE-EEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 344443 45699999999999975 5899999999877666677899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecC--CCCeEEeeccccccCCc
Q 008785 347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE--EFGAHLMGVGLSKFVPW 424 (553)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~--~~~~kl~Dfgla~~~~~ 424 (553)
+++|+|.+++.. ....+++..+..++.||+.||+|||++ +|+||||||+|||++. ++.+||+|||+++....
T Consensus 130 ~~gg~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~ 203 (387)
T 1kob_A 130 LSGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 203 (387)
T ss_dssp CCCCBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred CCCCcHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecCC
Confidence 999999999864 334689999999999999999999999 9999999999999974 46799999999987654
Q ss_pred ccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcC-cccccc---hHHHHHhcCCH--------HHHHH
Q 008785 425 EVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLV-LCRRWW---TLYTLVHSMSL--------LCAQE 492 (553)
Q Consensus 425 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~-~~~~~~---~l~~~~~~~~~--------~~~~~ 492 (553)
.... ....||+.|+|||++.+..++.++||||||+++|||++. .|.... .....+..+.. ..+..
T Consensus 204 ~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 280 (387)
T 1kob_A 204 DEIV---KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPE 280 (387)
T ss_dssp TSCE---EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHH
T ss_pred Ccce---eeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHH
Confidence 3322 122399999999999999999999999999999999973 333222 22222322221 45778
Q ss_pred HHHHHhhccCCCCCCCCCHHHHHHH
Q 008785 493 CLMLFISCNNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 493 l~~l~~~Cl~~dP~~RPs~~evl~~ 517 (553)
+.+++.+||+.||++|||+.|++++
T Consensus 281 ~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 281 AKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHcCCChhHCcCHHHHhhC
Confidence 9999999999999999999999986
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-41 Score=355.39 Aligned_cols=235 Identities=26% Similarity=0.343 Sum_probs=196.2
Q ss_pred eeecccCceeEEEEEeCCCCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCC-ceEEEEEccCCCCHH
Q 008785 275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHG-DRYIVYEFVVNGPLD 353 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~-~~~lV~E~~~~gsL~ 353 (553)
+.||+|+||.||+|.+ .|+.||||+++... ..+.|.+|+.+|++++||||+++++++.+.+ ..++||||+++|+|.
T Consensus 199 ~~lG~G~fg~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L~ 275 (450)
T 1k9a_A 199 QTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLV 275 (450)
T ss_dssp EEEEECSSEEEEEEEE-TTEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCBHH
T ss_pred eeecCcCCeeEEEEEe-cCCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCcHH
Confidence 4569999999999998 47899999998653 4578999999999999999999999987765 789999999999999
Q ss_pred HHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccceeee
Q 008785 354 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVM 433 (553)
Q Consensus 354 ~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 433 (553)
+++.. .....+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++....... .
T Consensus 276 ~~l~~--~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~-----~ 345 (450)
T 1k9a_A 276 DYLRS--RGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD-----T 345 (450)
T ss_dssp HHHHH--HCTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC----------
T ss_pred HHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCccccccccc-----C
Confidence 99976 2334479999999999999999999999 999999999999999999999999999985432211 1
Q ss_pred cCccccccccccccCCCCCcccchHhHHHHHHHHhc-Cc-ccc---cchHHHHHhcCCH-----HHHHHHHHHHhhccCC
Q 008785 434 AGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-VL-CRR---WWTLYTLVHSMSL-----LCAQECLMLFISCNNW 503 (553)
Q Consensus 434 ~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-~~-~~~---~~~l~~~~~~~~~-----~~~~~l~~l~~~Cl~~ 503 (553)
..+++.|+|||++.+..++.++||||||+++|||++ .. |.. ...+...+..+.. ..+..+.+++.+||+.
T Consensus 346 ~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~ 425 (450)
T 1k9a_A 346 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYDVMKNCWHL 425 (450)
T ss_dssp -CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred CCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCC
Confidence 137889999999999999999999999999999997 22 222 2334444444321 5678899999999999
Q ss_pred CCCCCCCHHHHHHHHHHHH
Q 008785 504 PSHLSQSKFCNLKLWVFAI 522 (553)
Q Consensus 504 dP~~RPs~~evl~~l~~~~ 522 (553)
||++|||+.++++.+....
T Consensus 426 dp~~Rpt~~~l~~~L~~i~ 444 (450)
T 1k9a_A 426 DAATRPTFLQLREQLEHIR 444 (450)
T ss_dssp SGGGSCCHHHHHHHHHHHH
T ss_pred ChhHCcCHHHHHHHHHHHH
Confidence 9999999999999876543
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=363.39 Aligned_cols=240 Identities=27% Similarity=0.404 Sum_probs=200.8
Q ss_pred eeecccCceeEEEEEeCC-CCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCCHH
Q 008785 275 RLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 353 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~~-g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~ 353 (553)
+.||+|+||.||+|.+.+ +..||||.++... ...++|.+|+.+|++++||||+++++++.+.+..++||||+++|+|.
T Consensus 226 ~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g~L~ 304 (495)
T 1opk_A 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 304 (495)
T ss_dssp EESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHH
T ss_pred eEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccCCCCHH
Confidence 456999999999999865 8899999998653 34678999999999999999999999999999999999999999999
Q ss_pred HHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccceeee
Q 008785 354 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVM 433 (553)
Q Consensus 354 ~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 433 (553)
+++... ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++........... .
T Consensus 305 ~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~-~ 378 (495)
T 1opk_A 305 DYLREC--NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA-G 378 (495)
T ss_dssp HHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEECCT-T
T ss_pred HHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceeccCCceeecC-C
Confidence 999762 335689999999999999999999999 9999999999999999999999999999876543222111 1
Q ss_pred cCccccccccccccCCCCCcccchHhHHHHHHHHhc-C-cccc---cchHHHHHhcCCH-----HHHHHHHHHHhhccCC
Q 008785 434 AGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-V-LCRR---WWTLYTLVHSMSL-----LCAQECLMLFISCNNW 503 (553)
Q Consensus 434 ~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-~-~~~~---~~~l~~~~~~~~~-----~~~~~l~~l~~~Cl~~ 503 (553)
..+++.|+|||++.+..++.++||||||+++|||++ . .|.. ...+.+.+..+.. ..+..+.+|+.+||+.
T Consensus 379 ~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 458 (495)
T 1opk_A 379 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQW 458 (495)
T ss_dssp CCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred CcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCc
Confidence 226789999999998899999999999999999997 2 2222 2233444433321 5677899999999999
Q ss_pred CCCCCCCHHHHHHHHHHH
Q 008785 504 PSHLSQSKFCNLKLWVFA 521 (553)
Q Consensus 504 dP~~RPs~~evl~~l~~~ 521 (553)
||++|||+.++++.+...
T Consensus 459 dP~~RPs~~el~~~L~~~ 476 (495)
T 1opk_A 459 NPSDRPSFAEIHQAFETM 476 (495)
T ss_dssp SGGGSCCHHHHHHHHHTS
T ss_pred ChhHCcCHHHHHHHHHHH
Confidence 999999999999987543
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-41 Score=347.50 Aligned_cols=237 Identities=19% Similarity=0.196 Sum_probs=194.1
Q ss_pred eeecccCceeEEEEEeC-CCCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCCHH
Q 008785 275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 353 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~ 353 (553)
++||+|+||.||+|... +|+.||+|+++.......+.+.+|+.++++++||||+++++++.+.+..++||||+++|+|.
T Consensus 95 ~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L~ 174 (373)
T 2x4f_A 95 EILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELF 174 (373)
T ss_dssp EECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEEH
T ss_pred eEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHH
Confidence 45799999999999964 58999999998876677788999999999999999999999999999999999999999999
Q ss_pred HHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEe--cCCCCeEEeeccccccCCccccccee
Q 008785 354 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL--DEEFGAHLMGVGLSKFVPWEVMQERT 431 (553)
Q Consensus 354 ~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl--~~~~~~kl~Dfgla~~~~~~~~~~~~ 431 (553)
+++.. ....+++..+..++.||+.||+|||+. +|+||||||+|||+ ++++.+||+|||+++.........
T Consensus 175 ~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~-- 246 (373)
T 2x4f_A 175 DRIID---ESYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLK-- 246 (373)
T ss_dssp HHHHH---TGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCC--
T ss_pred HHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccccc--
Confidence 98864 234589999999999999999999999 99999999999999 567889999999998765433221
Q ss_pred eecCccccccccccccCCCCCcccchHhHHHHHHHHhcC-ccccc---chHHHHHhcCCH--------HHHHHHHHHHhh
Q 008785 432 VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLV-LCRRW---WTLYTLVHSMSL--------LCAQECLMLFIS 499 (553)
Q Consensus 432 ~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~-~~~~~---~~l~~~~~~~~~--------~~~~~l~~l~~~ 499 (553)
...||+.|+|||++.+..++.++||||||+++|||++. .|... ......+..... ..+..+.+++.+
T Consensus 247 -~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~ 325 (373)
T 2x4f_A 247 -VNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISK 325 (373)
T ss_dssp -CCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHHHT
T ss_pred -cccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHHHHH
Confidence 22389999999999988999999999999999999973 33322 222222222111 456789999999
Q ss_pred ccCCCCCCCCCHHHHHHHHHH
Q 008785 500 CNNWPSHLSQSKFCNLKLWVF 520 (553)
Q Consensus 500 Cl~~dP~~RPs~~evl~~l~~ 520 (553)
||+.||.+|||+.|++++-..
T Consensus 326 ~L~~dp~~Rps~~e~l~hp~~ 346 (373)
T 2x4f_A 326 LLIKEKSWRISASEALKHPWL 346 (373)
T ss_dssp TSCSSGGGSCCHHHHHHSHHH
T ss_pred HcCCChhhCCCHHHHhcCcCc
Confidence 999999999999999997443
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=343.21 Aligned_cols=243 Identities=20% Similarity=0.309 Sum_probs=192.8
Q ss_pred eeecccCceeEEEEEeC-CCC----EEEEEEeccC-ChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccC
Q 008785 275 RLLGDSKTGGTYSGILP-DGS----RVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV 348 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~-~g~----~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 348 (553)
+.||+|+||.||+|... +++ .||+|.++.. .....+.+.+|+.++++++||||+++++++.+. ..++|+||++
T Consensus 21 ~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~v~e~~~ 99 (327)
T 3poz_A 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMP 99 (327)
T ss_dssp EEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-SEEEEEECCT
T ss_pred eEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-CeEEEEEecC
Confidence 45699999999999964 344 3688887644 234567899999999999999999999999875 4789999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCccccc
Q 008785 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ 428 (553)
Q Consensus 349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 428 (553)
+|+|.+++.. ....+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++........
T Consensus 100 ~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 173 (327)
T 3poz_A 100 FGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 173 (327)
T ss_dssp TCBHHHHHHH---STTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC-
T ss_pred CCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeEccCCccc
Confidence 9999999975 234689999999999999999999999 9999999999999999999999999999876544333
Q ss_pred ceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhc-Cc-ccc---cchHHHHHhcCCH-----HHHHHHHHHHh
Q 008785 429 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-VL-CRR---WWTLYTLVHSMSL-----LCAQECLMLFI 498 (553)
Q Consensus 429 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-~~-~~~---~~~l~~~~~~~~~-----~~~~~l~~l~~ 498 (553)
.......+|+.|+|||++.+..++.++||||||+++|||++ .. |.. ...+...+..+.. ..+..+.+++.
T Consensus 174 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 253 (327)
T 3poz_A 174 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMV 253 (327)
T ss_dssp ------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHHHHHHHH
T ss_pred ccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHH
Confidence 32223337889999999999999999999999999999997 33 222 2334444443322 56678999999
Q ss_pred hccCCCCCCCCCHHHHHHHHHHHHhh
Q 008785 499 SCNNWPSHLSQSKFCNLKLWVFAILT 524 (553)
Q Consensus 499 ~Cl~~dP~~RPs~~evl~~l~~~~~~ 524 (553)
+||+.||++|||+.|+++++......
T Consensus 254 ~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 254 KCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp HHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred HHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 99999999999999999998766543
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=343.41 Aligned_cols=243 Identities=21% Similarity=0.207 Sum_probs=194.5
Q ss_pred cccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCCh-hhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEE
Q 008785 268 KNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF-QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYE 345 (553)
Q Consensus 268 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 345 (553)
++|.... .||+|+||.||+|... +++.||||++..... ...+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 7 ~~y~i~~-~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 7 EDWDLVQ-TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TCEEEEE-EEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhceeee-EEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 3444444 4599999999999975 689999999975432 234678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcc
Q 008785 346 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE 425 (553)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~ 425 (553)
|+++|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 86 ~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 158 (323)
T 3tki_A 86 YCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (323)
T ss_dssp CCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred cCCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccC
Confidence 9999999999864 34589999999999999999999999 9999999999999999999999999999865433
Q ss_pred cccceeeecCccccccccccccCCCC-CcccchHhHHHHHHHHhcCc-ccccc----hHHHH-HhcCCH-----HHHHHH
Q 008785 426 VMQERTVMAGGTYGYLAPEFVYRNEL-TTKSDVYSFGVLLLEIRLVL-CRRWW----TLYTL-VHSMSL-----LCAQEC 493 (553)
Q Consensus 426 ~~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDVwSlGvil~ell~~~-~~~~~----~l~~~-~~~~~~-----~~~~~l 493 (553)
..........||+.|+|||++.+..+ +.++||||||+++|||++.. |.... ..... ...... ..+..+
T Consensus 159 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (323)
T 3tki_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP 238 (323)
T ss_dssp TEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHH
T ss_pred CcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHH
Confidence 32222223348999999999987775 78999999999999999732 22111 11222 222111 456788
Q ss_pred HHHHhhccCCCCCCCCCHHHHHHHH
Q 008785 494 LMLFISCNNWPSHLSQSKFCNLKLW 518 (553)
Q Consensus 494 ~~l~~~Cl~~dP~~RPs~~evl~~l 518 (553)
.+++.+||+.||++|||+.|++++-
T Consensus 239 ~~li~~~L~~dP~~R~t~~eil~h~ 263 (323)
T 3tki_A 239 LALLHKILVENPSARITIPDIKKDR 263 (323)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHTTCT
T ss_pred HHHHHHHccCChhhCcCHHHHhhCh
Confidence 9999999999999999999999864
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=359.58 Aligned_cols=241 Identities=25% Similarity=0.326 Sum_probs=194.5
Q ss_pred CeeecccCceeEEEEEeCCCCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCCHH
Q 008785 274 NRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 353 (553)
Q Consensus 274 ~~~iG~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~ 353 (553)
.+.||+|+||.||+|.+.++..||||+++... ...++|.+|+.+|++++||||+++++++.+ +..++||||+++|+|.
T Consensus 189 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gsL~ 266 (452)
T 1fmk_A 189 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLL 266 (452)
T ss_dssp EEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHH
T ss_pred eeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcCCCHH
Confidence 34569999999999999888889999998653 345789999999999999999999999876 6789999999999999
Q ss_pred HHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccceeee
Q 008785 354 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVM 433 (553)
Q Consensus 354 ~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 433 (553)
+++.. .....+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++........... .
T Consensus 267 ~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~-~ 340 (452)
T 1fmk_A 267 DFLKG--ETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ-G 340 (452)
T ss_dssp HHHSH--HHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC-------------
T ss_pred HHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCCCceeccc-C
Confidence 99964 1234589999999999999999999999 9999999999999999999999999999876543222211 2
Q ss_pred cCccccccccccccCCCCCcccchHhHHHHHHHHhc-Cc-cccc---chHHHHHhcCCH-----HHHHHHHHHHhhccCC
Q 008785 434 AGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-VL-CRRW---WTLYTLVHSMSL-----LCAQECLMLFISCNNW 503 (553)
Q Consensus 434 ~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-~~-~~~~---~~l~~~~~~~~~-----~~~~~l~~l~~~Cl~~ 503 (553)
..+++.|+|||++.+..++.++||||||+++|||++ .. |... ..+.+.+..+.. ..+..+.+++.+||+.
T Consensus 341 ~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~ 420 (452)
T 1fmk_A 341 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRK 420 (452)
T ss_dssp --CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCS
T ss_pred CcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccC
Confidence 226789999999998999999999999999999998 32 3322 233334433321 5677899999999999
Q ss_pred CCCCCCCHHHHHHHHHHHH
Q 008785 504 PSHLSQSKFCNLKLWVFAI 522 (553)
Q Consensus 504 dP~~RPs~~evl~~l~~~~ 522 (553)
||++|||+.++++.+...+
T Consensus 421 dP~~Rpt~~~l~~~L~~~~ 439 (452)
T 1fmk_A 421 EPEERPTFEYLQAFLEDYF 439 (452)
T ss_dssp SGGGSCCHHHHHHHHHTTT
T ss_pred ChhhCcCHHHHHHHHHHHh
Confidence 9999999999998775433
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-41 Score=336.56 Aligned_cols=240 Identities=19% Similarity=0.229 Sum_probs=191.9
Q ss_pred eeecccCceeEEEEEeC-CCCEEEEEEeccC---ChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCC
Q 008785 275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRS---SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 350 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 350 (553)
+.||+|+||.||++... +++.||+|.+... .....+.+.+|+.++++++||||+++++++.+.+..++||||+++|
T Consensus 17 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~ 96 (294)
T 4eqm_A 17 DKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGP 96 (294)
T ss_dssp EEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEECCCSC
T ss_pred EEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEeCCCCC
Confidence 45699999999999964 5899999998643 2344578899999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccce
Q 008785 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER 430 (553)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 430 (553)
+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++...........
T Consensus 97 ~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 169 (294)
T 4eqm_A 97 TLSEYIES----HGPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQT 169 (294)
T ss_dssp BHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC--------
T ss_pred CHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCcccccccccccc
Confidence 99999965 23589999999999999999999999 999999999999999999999999999987654332222
Q ss_pred eeecCccccccccccccCCCCCcccchHhHHHHHHHHhcC-cccccchHHH----HHhcCCH--------HHHHHHHHHH
Q 008785 431 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLV-LCRRWWTLYT----LVHSMSL--------LCAQECLMLF 497 (553)
Q Consensus 431 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~-~~~~~~~l~~----~~~~~~~--------~~~~~l~~l~ 497 (553)
. ...||+.|+|||++.+..++.++||||||+++|||++. .|.......+ .+..... ..+..+.+++
T Consensus 170 ~-~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 248 (294)
T 4eqm_A 170 N-HVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSNVI 248 (294)
T ss_dssp ------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHHHHHH
T ss_pred C-ccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHHHHHHH
Confidence 2 22389999999999999999999999999999999983 3333222221 2222111 3567899999
Q ss_pred hhccCCCCCCCC-CHHHHHHHHHHHH
Q 008785 498 ISCNNWPSHLSQ-SKFCNLKLWVFAI 522 (553)
Q Consensus 498 ~~Cl~~dP~~RP-s~~evl~~l~~~~ 522 (553)
.+||+.||++|| ++.++.+.|...+
T Consensus 249 ~~~l~~dp~~R~~~~~~l~~~l~~~~ 274 (294)
T 4eqm_A 249 LRATEKDKANRYKTIQEMKDDLSSVL 274 (294)
T ss_dssp HHHSCSSGGGSCSSHHHHHHHHHTSS
T ss_pred HHHhcCCHhHccccHHHHHHHHHHHH
Confidence 999999999999 7777766664433
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-41 Score=339.88 Aligned_cols=253 Identities=23% Similarity=0.311 Sum_probs=189.2
Q ss_pred ccCCCCeeecccCceeEEEEEeCCC----CEEEEEEeccC--ChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCce--
Q 008785 269 NFSEGNRLLGDSKTGGTYSGILPDG----SRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR-- 340 (553)
Q Consensus 269 ~~~~~~~~iG~G~~g~Vy~~~~~~g----~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~-- 340 (553)
+|.. .+.||+|+||.||+|..... ..||||+++.. .....+.+.+|+.++++++||||+++++++......
T Consensus 24 ~y~~-~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 102 (323)
T 3qup_A 24 QFTL-GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGR 102 (323)
T ss_dssp -CEE-EEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-----
T ss_pred HeEE-eceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccC
Confidence 3443 34569999999999997543 27999999764 334567899999999999999999999999877655
Q ss_pred ----EEEEEccCCCCHHHHhccCC--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEe
Q 008785 341 ----YIVYEFVVNGPLDRWLHHIP--RGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLM 414 (553)
Q Consensus 341 ----~lV~E~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~ 414 (553)
++||||+++|+|.+++.... .....+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+
T Consensus 103 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~kl~ 179 (323)
T 3qup_A 103 LPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVA 179 (323)
T ss_dssp --CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEEC
T ss_pred CCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCEEEe
Confidence 99999999999999986422 2223589999999999999999999999 99999999999999999999999
Q ss_pred eccccccCCcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhc-Cc-cc---ccchHHHHHhcCC-H-
Q 008785 415 GVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-VL-CR---RWWTLYTLVHSMS-L- 487 (553)
Q Consensus 415 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-~~-~~---~~~~l~~~~~~~~-~- 487 (553)
|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ .. |. ....+...+..+. .
T Consensus 180 Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~ 259 (323)
T 3qup_A 180 DFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRLK 259 (323)
T ss_dssp CCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC
T ss_pred eccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCCCCC
Confidence 9999987654433222222337889999999999999999999999999999997 32 22 2233333333222 1
Q ss_pred ---HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHhhc
Q 008785 488 ---LCAQECLMLFISCNNWPSHLSQSKFCNLKLWVFAILTI 525 (553)
Q Consensus 488 ---~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~~~~~~ 525 (553)
..+..+.+++.+||+.||++|||+.++++.+...+...
T Consensus 260 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~ 300 (323)
T 3qup_A 260 QPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL 300 (323)
T ss_dssp CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred CCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 56678999999999999999999999999987766544
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-41 Score=337.89 Aligned_cols=249 Identities=23% Similarity=0.283 Sum_probs=203.1
Q ss_pred CeeecccCceeEEEEEe------CCCCEEEEEEeccCC-hhhHHHHHHHHHHhhcc-CCCceeeEeeEEeeCCceEEEEE
Q 008785 274 NRLLGDSKTGGTYSGIL------PDGSRVAVKRLKRSS-FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYE 345 (553)
Q Consensus 274 ~~~iG~G~~g~Vy~~~~------~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E 345 (553)
.+.||+|+||.||+|.. .+++.||||+++... ....+.+.+|+.+++++ +||||+++++++.+.+..++|||
T Consensus 28 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 107 (313)
T 1t46_A 28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITE 107 (313)
T ss_dssp EEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred HHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCcEEEEe
Confidence 34569999999999984 246789999998653 34467899999999999 99999999999999999999999
Q ss_pred ccCCCCHHHHhccCCC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCe
Q 008785 346 FVVNGPLDRWLHHIPR--------------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGA 411 (553)
Q Consensus 346 ~~~~gsL~~~l~~~~~--------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~ 411 (553)
|+++|+|.+++..... ....+++..+..++.||+.||.|||++ +|+||||||+||+++.++.+
T Consensus 108 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~ 184 (313)
T 1t46_A 108 YCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRIT 184 (313)
T ss_dssp CCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEETTTEE
T ss_pred cCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEcCCCCE
Confidence 9999999999976321 123589999999999999999999999 99999999999999999999
Q ss_pred EEeeccccccCCcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhc-Cc-cccc----chHHHHHhcC
Q 008785 412 HLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-VL-CRRW----WTLYTLVHSM 485 (553)
Q Consensus 412 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-~~-~~~~----~~l~~~~~~~ 485 (553)
||+|||++................+|+.|+|||++.+..++.++||||||+++|||++ .. |... ..+...+..+
T Consensus 185 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~ 264 (313)
T 1t46_A 185 KICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEG 264 (313)
T ss_dssp EECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHT
T ss_pred EEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHHHHhccC
Confidence 9999999987665433222222337789999999999999999999999999999997 32 2221 1222233222
Q ss_pred C-----HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHhhc
Q 008785 486 S-----LLCAQECLMLFISCNNWPSHLSQSKFCNLKLWVFAILTI 525 (553)
Q Consensus 486 ~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~~~~~~ 525 (553)
. ...+..+.+++.+||+.||.+|||+.|+++.+...+.+.
T Consensus 265 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 309 (313)
T 1t46_A 265 FRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309 (313)
T ss_dssp CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred CCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHh
Confidence 1 146678999999999999999999999999987776543
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-41 Score=330.36 Aligned_cols=241 Identities=21% Similarity=0.300 Sum_probs=200.9
Q ss_pred eeecccCceeEEEEEeCCCCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCCHHH
Q 008785 275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR 354 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~ 354 (553)
+.||+|+||.||++...+++.||+|+++.... ..+.+.+|+.++++++||||+++++++.+.+..++||||+++++|.+
T Consensus 14 ~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 92 (267)
T 3t9t_A 14 QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSD 92 (267)
T ss_dssp EEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHH
T ss_pred eEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCCcHHH
Confidence 45699999999999998889999999986533 34678999999999999999999999999999999999999999999
Q ss_pred HhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccceeeec
Q 008785 355 WLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA 434 (553)
Q Consensus 355 ~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 434 (553)
++.. ....+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||++............ ..
T Consensus 93 ~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~-~~ 165 (267)
T 3t9t_A 93 YLRT---QRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST-GT 165 (267)
T ss_dssp HHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTT-ST
T ss_pred HHhh---CcccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEcccccccccccccccccc-cc
Confidence 9975 234689999999999999999999999 9999999999999999999999999999876543222111 12
Q ss_pred CccccccccccccCCCCCcccchHhHHHHHHHHhc-Cc-ccccc---hHHHHHhcCCH-----HHHHHHHHHHhhccCCC
Q 008785 435 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-VL-CRRWW---TLYTLVHSMSL-----LCAQECLMLFISCNNWP 504 (553)
Q Consensus 435 ~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-~~-~~~~~---~l~~~~~~~~~-----~~~~~l~~l~~~Cl~~d 504 (553)
.+++.|+|||++.+..++.++||||||+++|||++ .. |.... ...+.+..+.. ..+..+.+++.+||+.|
T Consensus 166 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~ 245 (267)
T 3t9t_A 166 KFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWRER 245 (267)
T ss_dssp TCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSS
T ss_pred cccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCCCccCcHHHHHHHHHHccCC
Confidence 27788999999998899999999999999999997 33 33222 22223333211 45678899999999999
Q ss_pred CCCCCCHHHHHHHHHHHHh
Q 008785 505 SHLSQSKFCNLKLWVFAIL 523 (553)
Q Consensus 505 P~~RPs~~evl~~l~~~~~ 523 (553)
|++|||+.|+++.+.....
T Consensus 246 p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 246 PEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp GGGSCCHHHHHHHHHHHHH
T ss_pred hhhCcCHHHHHHHHHHHHh
Confidence 9999999999998866543
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=345.65 Aligned_cols=255 Identities=25% Similarity=0.304 Sum_probs=203.0
Q ss_pred cccCCCCeeecccCceeEEEEEeCC------CCEEEEEEeccCC-hhhHHHHHHHHHHhhcc-CCCceeeEeeEEeeCCc
Q 008785 268 KNFSEGNRLLGDSKTGGTYSGILPD------GSRVAVKRLKRSS-FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGD 339 (553)
Q Consensus 268 ~~~~~~~~~iG~G~~g~Vy~~~~~~------g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~ 339 (553)
++|.. .+.||+|+||.||+|.... +..||+|.++... ....+.+.+|+.+++++ +||||+++++++.+.+.
T Consensus 46 ~~~~~-~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 124 (333)
T 2i1m_A 46 NNLQF-GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP 124 (333)
T ss_dssp TSEEE-EEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHcee-eeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCc
Confidence 33433 3456999999999999643 2489999997653 34567799999999999 89999999999999999
Q ss_pred eEEEEEccCCCCHHHHhccCCC----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCC
Q 008785 340 RYIVYEFVVNGPLDRWLHHIPR----------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF 409 (553)
Q Consensus 340 ~~lV~E~~~~gsL~~~l~~~~~----------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~ 409 (553)
.++||||+++|+|.+++..... ....+++..+..++.||+.||.|||++ +|+||||||+|||++.++
T Consensus 125 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~ 201 (333)
T 2i1m_A 125 VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGH 201 (333)
T ss_dssp CEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEEEGGG
T ss_pred eEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEECCCC
Confidence 9999999999999999864210 134589999999999999999999999 999999999999999999
Q ss_pred CeEEeeccccccCCcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhc-Cc-cccc----chHHHHHh
Q 008785 410 GAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-VL-CRRW----WTLYTLVH 483 (553)
Q Consensus 410 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-~~-~~~~----~~l~~~~~ 483 (553)
.+||+|||++................+|+.|+|||++.+..++.++||||||+++|||++ .. |... ..+...+.
T Consensus 202 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~ 281 (333)
T 2i1m_A 202 VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVK 281 (333)
T ss_dssp EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHH
T ss_pred eEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHHh
Confidence 999999999986544332222222236789999999998899999999999999999997 32 2222 11222332
Q ss_pred cCCH-----HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHhhcc
Q 008785 484 SMSL-----LCAQECLMLFISCNNWPSHLSQSKFCNLKLWVFAILTIR 526 (553)
Q Consensus 484 ~~~~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~~~~~~~ 526 (553)
.+.. ..+..+.+++.+||+.||.+|||+.|+++.+.....+.+
T Consensus 282 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~ 329 (333)
T 2i1m_A 282 DGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQEDR 329 (333)
T ss_dssp HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred cCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhhh
Confidence 2211 456789999999999999999999999999877665543
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=348.28 Aligned_cols=242 Identities=24% Similarity=0.259 Sum_probs=196.9
Q ss_pred cccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccC---ChhhHHHHHHHHHHhhcc-CCCceeeEeeEEeeCCceEE
Q 008785 268 KNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS---SFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYI 342 (553)
Q Consensus 268 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~l 342 (553)
++|... +.||+|+||.||++... +|+.||||++++. .....+.+.+|..+++.+ +||||+++++++.+.+..|+
T Consensus 23 ~~y~~~-~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 23 DNFEFI-RVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp CCEEEE-EEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hheEEE-EEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 345443 45699999999999975 4899999999764 223456688999999988 79999999999999999999
Q ss_pred EEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccC
Q 008785 343 VYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV 422 (553)
Q Consensus 343 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~ 422 (553)
||||+++|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 102 v~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~~ 174 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQK----SRRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEG 174 (353)
T ss_dssp EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred EEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceeec
Confidence 9999999999999965 24589999999999999999999999 9999999999999999999999999999864
Q ss_pred CcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcC-cccc---cchHHHHHhcCCH----HHHHHHH
Q 008785 423 PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLV-LCRR---WWTLYTLVHSMSL----LCAQECL 494 (553)
Q Consensus 423 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~-~~~~---~~~l~~~~~~~~~----~~~~~l~ 494 (553)
...... .....||+.|+|||++.+..++.++|||||||++|||++. .|.. ...+.+.+..+.. ..+..+.
T Consensus 175 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 252 (353)
T 3txo_A 175 ICNGVT--TATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDAT 252 (353)
T ss_dssp CC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHH
T ss_pred ccCCcc--ccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 333222 2223499999999999988999999999999999999973 3332 2333444444433 4567789
Q ss_pred HHHhhccCCCCCCCCCH------HHHHHHHH
Q 008785 495 MLFISCNNWPSHLSQSK------FCNLKLWV 519 (553)
Q Consensus 495 ~l~~~Cl~~dP~~RPs~------~evl~~l~ 519 (553)
+++.+||+.||++||++ .|++++-.
T Consensus 253 ~li~~lL~~dP~~R~~~~~~~~~~~il~hp~ 283 (353)
T 3txo_A 253 GILKSFMTKNPTMRLGSLTQGGEHAILRHPF 283 (353)
T ss_dssp HHHHHHTCSSGGGSTTSGGGTCTHHHHTSGG
T ss_pred HHHHHHhhhCHHHccCCcccCCHHHHhhCCc
Confidence 99999999999999999 88887643
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=337.10 Aligned_cols=239 Identities=21% Similarity=0.211 Sum_probs=188.8
Q ss_pred ccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCChh--------------------------hHHHHHHHHHHhhc
Q 008785 269 NFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQ--------------------------RKKEFYSEIGRFAR 321 (553)
Q Consensus 269 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~~--------------------------~~~~~~~E~~~l~~ 321 (553)
+|... +.||+|+||.||+|... +|+.||||++...... ..+.+.+|+.++++
T Consensus 14 ~y~~~-~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 92 (298)
T 2zv2_A 14 QYTLK-DEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK 92 (298)
T ss_dssp TEEEE-EEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred ceEEE-eEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence 44443 44599999999999964 5889999999754321 13568899999999
Q ss_pred cCCCceeeEeeEEee--CCceEEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCC
Q 008785 322 LHHPNLVAVKGCCYD--HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIR 399 (553)
Q Consensus 322 l~HpnIv~l~~~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlk 399 (553)
++||||+++++++.+ .+..++||||+++++|.+++. ...+++..+..++.||+.||+|||++ +|+|||||
T Consensus 93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlk 164 (298)
T 2zv2_A 93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-----LKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIK 164 (298)
T ss_dssp CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-----SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCC
T ss_pred CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCC
Confidence 999999999999987 567899999999999987653 24689999999999999999999999 99999999
Q ss_pred CCcEEecCCCCeEEeeccccccCCcccccceeeecCccccccccccccCCC---CCcccchHhHHHHHHHHhcC-ccccc
Q 008785 400 ASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNE---LTTKSDVYSFGVLLLEIRLV-LCRRW 475 (553)
Q Consensus 400 p~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~t~ksDVwSlGvil~ell~~-~~~~~ 475 (553)
|+|||++.++.+||+|||+++......... ....||+.|+|||++.+.. ++.++||||||+++|||++. .|...
T Consensus 165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 242 (298)
T 2zv2_A 165 PSNLLVGEDGHIKIADFGVSNEFKGSDALL--SNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD 242 (298)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSSSCEE--CCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred HHHEEECCCCCEEEecCCCccccccccccc--cCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 999999999999999999998765432211 1223899999999997655 47889999999999999973 33333
Q ss_pred chH---HHHHhcCCH------HHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008785 476 WTL---YTLVHSMSL------LCAQECLMLFISCNNWPSHLSQSKFCNLKLW 518 (553)
Q Consensus 476 ~~l---~~~~~~~~~------~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l 518 (553)
... ...+..+.. ..+..+.+++.+||+.||++|||+.|++++-
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp 294 (298)
T 2zv2_A 243 ERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHP 294 (298)
T ss_dssp SSHHHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCH
T ss_pred ccHHHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCc
Confidence 322 222322222 4567899999999999999999999998763
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-41 Score=334.10 Aligned_cols=241 Identities=19% Similarity=0.216 Sum_probs=197.4
Q ss_pred hcccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccC--ChhhHHHHHHHHHHhhcc-CCCceeeEeeEEeeCCceEE
Q 008785 267 TKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS--SFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYI 342 (553)
Q Consensus 267 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~l 342 (553)
.++|.... .||+|+||.||+|... +++.||||+++.. ......++.+|+..+.++ +||||+++++++.+.+..++
T Consensus 10 ~~~y~~~~-~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 10 TTEFHELE-KIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHEEEEE-EEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred cchhhhhh-hhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 34555544 4599999999999976 6999999999864 234457788999999999 99999999999999999999
Q ss_pred EEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecC---------------
Q 008785 343 VYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE--------------- 407 (553)
Q Consensus 343 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~--------------- 407 (553)
||||+++|+|.+++.........+++..+..++.||+.||.|||++ +|+||||||+|||++.
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC----------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCccccccccccc
Confidence 9999999999999975322235689999999999999999999999 9999999999999984
Q ss_pred ----CCCeEEeeccccccCCcccccceeeecCccccccccccccCC-CCCcccchHhHHHHHHHHhcCcc-cccchHHHH
Q 008785 408 ----EFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIRLVLC-RRWWTLYTL 481 (553)
Q Consensus 408 ----~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwSlGvil~ell~~~~-~~~~~l~~~ 481 (553)
...+||+|||.+........ ..||+.|+|||++.+. .++.++||||||+++|||++..+ .........
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~~~------~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~ 239 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSPQV------EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHE 239 (289)
T ss_dssp ----CCCEEECCCTTCEETTCSCC------CCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHHHH
T ss_pred ccCCceEEEEcccccccccCCccc------cCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHHHH
Confidence 44799999999987654322 2289999999999766 56789999999999999998443 233333333
Q ss_pred HhcCCH-----HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008785 482 VHSMSL-----LCAQECLMLFISCNNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 482 ~~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 517 (553)
+..+.. ..+..+.+++.+||+.||++|||+.|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 240 IRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp HHTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred HHcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 333332 456789999999999999999999999875
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=339.66 Aligned_cols=250 Identities=22% Similarity=0.312 Sum_probs=202.6
Q ss_pred CeeecccCceeEEEEEeC--------CCCEEEEEEeccCC-hhhHHHHHHHHHHhhcc-CCCceeeEeeEEeeCCceEEE
Q 008785 274 NRLLGDSKTGGTYSGILP--------DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIV 343 (553)
Q Consensus 274 ~~~iG~G~~g~Vy~~~~~--------~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV 343 (553)
.+.||+|+||.||+|... ++..||||+++... ....+.+.+|+.+++++ +||||+++++++.+.+..++|
T Consensus 40 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 119 (334)
T 2pvf_A 40 GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVI 119 (334)
T ss_dssp EEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCCEEE
T ss_pred eeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCCceEEE
Confidence 345699999999999863 46789999997653 34467899999999999 899999999999999999999
Q ss_pred EEccCCCCHHHHhccCCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCe
Q 008785 344 YEFVVNGPLDRWLHHIPRG------------GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGA 411 (553)
Q Consensus 344 ~E~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~ 411 (553)
|||+++|+|.+++...... ...+++..+..++.||+.||.|||+. +|+||||||+||+++.++.+
T Consensus 120 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~ 196 (334)
T 2pvf_A 120 VEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVM 196 (334)
T ss_dssp EECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCE
T ss_pred EECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceEEEcCCCCE
Confidence 9999999999999763221 23489999999999999999999999 99999999999999999999
Q ss_pred EEeeccccccCCcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhc-Cc-ccccc---hHHHHHhcCC
Q 008785 412 HLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-VL-CRRWW---TLYTLVHSMS 486 (553)
Q Consensus 412 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-~~-~~~~~---~l~~~~~~~~ 486 (553)
||+|||++................+|+.|+|||++.+..++.++||||||+++|||++ .. |.... .+...+..+.
T Consensus 197 kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~ 276 (334)
T 2pvf_A 197 KIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGH 276 (334)
T ss_dssp EECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTC
T ss_pred EEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHHHHhcCC
Confidence 9999999987654432222222337889999999988889999999999999999997 32 32222 2333333322
Q ss_pred H-----HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHhhcc
Q 008785 487 L-----LCAQECLMLFISCNNWPSHLSQSKFCNLKLWVFAILTIR 526 (553)
Q Consensus 487 ~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~~~~~~~ 526 (553)
. ..+..+.+++.+||+.||.+|||+.|+++.+...+....
T Consensus 277 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~ 321 (334)
T 2pvf_A 277 RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT 321 (334)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccc
Confidence 1 556789999999999999999999999999887765443
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=336.13 Aligned_cols=242 Identities=20% Similarity=0.247 Sum_probs=191.6
Q ss_pred hhcccCCCCeeecccCceeEEEEEeCCCCEEEEEEeccCCh--hhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEE
Q 008785 266 ITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSF--QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIV 343 (553)
Q Consensus 266 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 343 (553)
+.++|..... ||+|+||.||++...+|+.||+|+++.... .....+.+|+.++++++||||+++++++.+.+..++|
T Consensus 19 l~~~y~~~~~-lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 97 (311)
T 3niz_A 19 LMEKYQKLEK-VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLV 97 (311)
T ss_dssp SSCEEEEEEE-EEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEE
T ss_pred hHhhhHhhhh-ccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEE
Confidence 3445555444 599999999999998899999999975422 2346788999999999999999999999999999999
Q ss_pred EEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCC
Q 008785 344 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVP 423 (553)
Q Consensus 344 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~ 423 (553)
|||++ |+|.+++.. ....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 98 ~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 170 (311)
T 3niz_A 98 FEFME-KDLKKVLDE---NKTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFG 170 (311)
T ss_dssp EECCS-EEHHHHHHT---CTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETT
T ss_pred EcCCC-CCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecC
Confidence 99997 588888864 334589999999999999999999999 99999999999999999999999999998764
Q ss_pred cccccceeeecCccccccccccccC-CCCCcccchHhHHHHHHHHhcCc-cc---ccchHHH-HH---hcC---------
Q 008785 424 WEVMQERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIRLVL-CR---RWWTLYT-LV---HSM--------- 485 (553)
Q Consensus 424 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwSlGvil~ell~~~-~~---~~~~l~~-~~---~~~--------- 485 (553)
....... ...||+.|+|||++.+ ..++.++||||||+++|||++.. |. ....... .. ...
T Consensus 171 ~~~~~~~--~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 248 (311)
T 3niz_A 171 IPVRSYT--HEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQ 248 (311)
T ss_dssp SCCC-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGT
T ss_pred CCccccc--CCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhh
Confidence 3322211 2238999999999876 56899999999999999999732 22 1111111 11 000
Q ss_pred ----------------CH-----HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008785 486 ----------------SL-----LCAQECLMLFISCNNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 486 ----------------~~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 517 (553)
.. ..+.++.+++.+||+.||++|||+.|++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 249 ELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp TSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred ccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 00 234578899999999999999999999975
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=333.47 Aligned_cols=240 Identities=19% Similarity=0.287 Sum_probs=187.7
Q ss_pred cccCCCCeeecccCceeEEEEEeCCCCEEEEEEeccCChhhHHHHHHHHHHhhc--cCCCceeeEeeEEeeC----CceE
Q 008785 268 KNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFAR--LHHPNLVAVKGCCYDH----GDRY 341 (553)
Q Consensus 268 ~~~~~~~~~iG~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~--l~HpnIv~l~~~~~~~----~~~~ 341 (553)
++|.... .||+|+||.||+|.. +|+.||||++... ....+.+|.+++.. ++||||+++++++... ...+
T Consensus 8 ~~y~~~~-~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 8 RDITLLE-CVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp GGCEEEE-EEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred CcEEEEE-eeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 3444444 559999999999998 7899999999754 34455566666665 7999999999987653 4579
Q ss_pred EEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCceecCCCCCcEEecCCCCeEE
Q 008785 342 IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLH--------DKVKPHVVHRDIRASNVLLDEEFGAHL 413 (553)
Q Consensus 342 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH--------~~~~~~ivHrDlkp~NILl~~~~~~kl 413 (553)
+||||+++|+|.++++. ..+++..+..++.||+.||+||| +. +|+||||||+|||++.++.+||
T Consensus 83 lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~kl 154 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQL-----TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCCI 154 (301)
T ss_dssp EEECCCTTCBHHHHHTT-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEEE
T ss_pred EehhhccCCCHHHHHhh-----cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEEE
Confidence 99999999999999953 35899999999999999999999 77 9999999999999999999999
Q ss_pred eeccccccCCcccccce--eeecCccccccccccccCC------CCCcccchHhHHHHHHHHhcC----------cccc-
Q 008785 414 MGVGLSKFVPWEVMQER--TVMAGGTYGYLAPEFVYRN------ELTTKSDVYSFGVLLLEIRLV----------LCRR- 474 (553)
Q Consensus 414 ~Dfgla~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~------~~t~ksDVwSlGvil~ell~~----------~~~~- 474 (553)
+|||+++.......... .....||+.|+|||++.+. .++.++||||||+++|||++. .+..
T Consensus 155 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~ 234 (301)
T 3q4u_A 155 ADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY 234 (301)
T ss_dssp CCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred eeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccc
Confidence 99999976543322211 1122489999999999876 456799999999999999974 1111
Q ss_pred c--------chHHHHHhc-CCH----------HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 008785 475 W--------WTLYTLVHS-MSL----------LCAQECLMLFISCNNWPSHLSQSKFCNLKLWVF 520 (553)
Q Consensus 475 ~--------~~l~~~~~~-~~~----------~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~ 520 (553)
. ..+...... +.. ..+..+.+++.+||+.||++|||+.|+++.|..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~ 299 (301)
T 3q4u_A 235 DVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK 299 (301)
T ss_dssp TTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred ccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhc
Confidence 1 111111111 110 467889999999999999999999999998754
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=342.12 Aligned_cols=255 Identities=20% Similarity=0.305 Sum_probs=204.3
Q ss_pred HhhcccCCCCeeecccCceeEEEEEeC------CCCEEEEEEeccCC-hhhHHHHHHHHHHhhccCCCceeeEeeEEeeC
Q 008785 265 SITKNFSEGNRLLGDSKTGGTYSGILP------DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH 337 (553)
Q Consensus 265 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~------~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 337 (553)
...++|.... .||+|+||.||+|... +++.||||.+.... ......+.+|+.++++++||||+++++++.+.
T Consensus 22 ~~~~~y~~~~-~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 100 (322)
T 1p4o_A 22 VAREKITMSR-ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 100 (322)
T ss_dssp CCGGGEEEEE-EEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred chhhheeeee-EeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccC
Confidence 3444555544 4599999999999864 36789999997643 34456789999999999999999999999999
Q ss_pred CceEEEEEccCCCCHHHHhccCC------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCe
Q 008785 338 GDRYIVYEFVVNGPLDRWLHHIP------RGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGA 411 (553)
Q Consensus 338 ~~~~lV~E~~~~gsL~~~l~~~~------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~ 411 (553)
+..++||||+++|+|.+++.... .....+++..+..++.||+.||.|||++ +|+||||||+||+++.++.+
T Consensus 101 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~~~~~ 177 (322)
T 1p4o_A 101 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTV 177 (322)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCE
T ss_pred CccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcCCCeE
Confidence 99999999999999999986421 1124578999999999999999999999 99999999999999999999
Q ss_pred EEeeccccccCCcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhc-C-ccccc---chHHHHHhcCC
Q 008785 412 HLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-V-LCRRW---WTLYTLVHSMS 486 (553)
Q Consensus 412 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-~-~~~~~---~~l~~~~~~~~ 486 (553)
||+|||++................+|+.|+|||++.+..++.++||||||+++|||++ . .|... ..+...+..+.
T Consensus 178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~ 257 (322)
T 1p4o_A 178 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG 257 (322)
T ss_dssp EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTC
T ss_pred EECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcCC
Confidence 9999999986544332222222226889999999998899999999999999999997 3 23322 22333333332
Q ss_pred H-----HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHh
Q 008785 487 L-----LCAQECLMLFISCNNWPSHLSQSKFCNLKLWVFAIL 523 (553)
Q Consensus 487 ~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~~~~ 523 (553)
. ..+..+.+++.+||+.||.+|||+.|+++++...+.
T Consensus 258 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 258 LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 2 566789999999999999999999999998866544
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-41 Score=333.16 Aligned_cols=250 Identities=26% Similarity=0.391 Sum_probs=206.1
Q ss_pred cccCCCCeeecccCceeEEEEEeCC-CCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEc
Q 008785 268 KNFSEGNRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF 346 (553)
Q Consensus 268 ~~~~~~~~~iG~G~~g~Vy~~~~~~-g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 346 (553)
++|... +.||+|+||.||+|...+ +..||+|.++.. ....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 13 ~~~~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 90 (288)
T 3kfa_A 13 TDITMK-HKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 90 (288)
T ss_dssp GGEEEE-EESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred cceeEE-eecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEc
Confidence 344443 345999999999999765 889999999765 34567899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCccc
Q 008785 347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV 426 (553)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 426 (553)
+++++|.+++.. .....+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 91 ~~~~~L~~~~~~--~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 165 (288)
T 3kfa_A 91 MTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165 (288)
T ss_dssp CTTEEHHHHHHH--CCTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS
T ss_pred CCCCcHHHHHHh--cccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceeccCCc
Confidence 999999999976 2345689999999999999999999999 99999999999999999999999999998765443
Q ss_pred ccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhc-Cc-cc---ccchHHHHHhcCCH-----HHHHHHHHH
Q 008785 427 MQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-VL-CR---RWWTLYTLVHSMSL-----LCAQECLML 496 (553)
Q Consensus 427 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-~~-~~---~~~~l~~~~~~~~~-----~~~~~l~~l 496 (553)
...... ..+|+.|+|||++.+..++.++||||||+++|+|++ .. |. ....+.+.+..+.. ..+..+.++
T Consensus 166 ~~~~~~-~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 244 (288)
T 3kfa_A 166 YTAHAG-AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYEL 244 (288)
T ss_dssp SEEETT-EEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred cccccC-CccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCCCCCCCCHHHHHH
Confidence 222211 226788999999998999999999999999999997 32 22 22233333333211 567789999
Q ss_pred HhhccCCCCCCCCCHHHHHHHHHHHHhhc
Q 008785 497 FISCNNWPSHLSQSKFCNLKLWVFAILTI 525 (553)
Q Consensus 497 ~~~Cl~~dP~~RPs~~evl~~l~~~~~~~ 525 (553)
+.+||+.||.+|||+.|+++.+...+.+.
T Consensus 245 i~~~l~~dp~~Rps~~~~~~~l~~~~~~~ 273 (288)
T 3kfa_A 245 MRACWQWNPSDRPSFAEIHQAFETMFQES 273 (288)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHhCCChhhCcCHHHHHHHHHHHHHhc
Confidence 99999999999999999999887766543
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-41 Score=332.62 Aligned_cols=243 Identities=25% Similarity=0.340 Sum_probs=199.1
Q ss_pred eeecccCceeEEEEEeCCCCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCCHHH
Q 008785 275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR 354 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~ 354 (553)
+.||+|+||.||+|...++..||||.++... ...+.+.+|+.++++++||||+++++++. .+..++||||+++++|.+
T Consensus 19 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~ 96 (279)
T 1qpc_A 19 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLVD 96 (279)
T ss_dssp EEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBHHH
T ss_pred eeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecCCCCCHHH
Confidence 3559999999999999888899999997653 34678999999999999999999999876 456899999999999999
Q ss_pred HhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccceeeec
Q 008785 355 WLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA 434 (553)
Q Consensus 355 ~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 434 (553)
++.. .....+++..+..++.|++.||.|||++ +|+||||||+||++++++.+||+|||++............ ..
T Consensus 97 ~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~-~~ 170 (279)
T 1qpc_A 97 FLKT--PSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE-GA 170 (279)
T ss_dssp HTTS--HHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCT-TC
T ss_pred HHhc--CCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccCccccccc-CC
Confidence 9964 1223589999999999999999999999 9999999999999999999999999999876543322211 12
Q ss_pred CccccccccccccCCCCCcccchHhHHHHHHHHhc-Cc-cccc---chHHHHHhcCCH-----HHHHHHHHHHhhccCCC
Q 008785 435 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-VL-CRRW---WTLYTLVHSMSL-----LCAQECLMLFISCNNWP 504 (553)
Q Consensus 435 ~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-~~-~~~~---~~l~~~~~~~~~-----~~~~~l~~l~~~Cl~~d 504 (553)
.+++.|+|||.+.+..++.++||||||+++|||++ .. |... ..+...+..+.. ..+..+.+++.+||+.|
T Consensus 171 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 250 (279)
T 1qpc_A 171 KFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKER 250 (279)
T ss_dssp CCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSS
T ss_pred CCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCCCcccccHHHHHHHHHHhccC
Confidence 26788999999988889999999999999999997 33 3222 223333333211 55678999999999999
Q ss_pred CCCCCCHHHHHHHHHHHHhhc
Q 008785 505 SHLSQSKFCNLKLWVFAILTI 525 (553)
Q Consensus 505 P~~RPs~~evl~~l~~~~~~~ 525 (553)
|++|||+.++++.+...+...
T Consensus 251 p~~Rps~~~l~~~l~~~~~~~ 271 (279)
T 1qpc_A 251 PEDRPTFDYLRSVLEDFFTAT 271 (279)
T ss_dssp GGGSCCHHHHHHHHHHHHHHC
T ss_pred hhhCCCHHHHHHHHHHHHHhc
Confidence 999999999999887665543
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=330.02 Aligned_cols=251 Identities=22% Similarity=0.281 Sum_probs=204.4
Q ss_pred ccCCCCeeecccCceeEEEEEeC---CCCEEEEEEeccC-ChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEE
Q 008785 269 NFSEGNRLLGDSKTGGTYSGILP---DGSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVY 344 (553)
Q Consensus 269 ~~~~~~~~iG~G~~g~Vy~~~~~---~g~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 344 (553)
++....+.||+|+||.||+|... ++..||||+++.. .....+.+.+|+.++++++||||+++++++ ..+..++||
T Consensus 10 ~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~ 88 (287)
T 1u59_A 10 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVM 88 (287)
T ss_dssp GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEE
T ss_pred HhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEE
Confidence 34444546799999999999854 5778999999875 344567899999999999999999999998 556789999
Q ss_pred EccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCc
Q 008785 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW 424 (553)
Q Consensus 345 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~ 424 (553)
||+++++|.+++.. ....+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 89 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 162 (287)
T 1u59_A 89 EMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGA 162 (287)
T ss_dssp ECCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EeCCCCCHHHHHHh---CCccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence 99999999999964 335689999999999999999999999 999999999999999999999999999987654
Q ss_pred ccccc-eeeecCccccccccccccCCCCCcccchHhHHHHHHHHhc-Cc-ccc---cchHHHHHhcCCH-----HHHHHH
Q 008785 425 EVMQE-RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-VL-CRR---WWTLYTLVHSMSL-----LCAQEC 493 (553)
Q Consensus 425 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-~~-~~~---~~~l~~~~~~~~~-----~~~~~l 493 (553)
..... ......+|+.|+|||++.+..++.++||||||+++|||++ .. |.. ...+...+..+.. ..+..+
T Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l 242 (287)
T 1u59_A 163 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPEL 242 (287)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHHH
T ss_pred CcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCCCCCCcCHHH
Confidence 32221 1122236889999999988889999999999999999997 33 322 2233334443322 567789
Q ss_pred HHHHhhccCCCCCCCCCHHHHHHHHHHHHhhcc
Q 008785 494 LMLFISCNNWPSHLSQSKFCNLKLWVFAILTIR 526 (553)
Q Consensus 494 ~~l~~~Cl~~dP~~RPs~~evl~~l~~~~~~~~ 526 (553)
.+++.+||+.||++|||+.++++++...+.+..
T Consensus 243 ~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 275 (287)
T 1u59_A 243 YALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 275 (287)
T ss_dssp HHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence 999999999999999999999999877665543
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=335.72 Aligned_cols=235 Identities=23% Similarity=0.319 Sum_probs=194.9
Q ss_pred CeeecccCceeEEEEEeCC-C-------CEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEE
Q 008785 274 NRLLGDSKTGGTYSGILPD-G-------SRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYE 345 (553)
Q Consensus 274 ~~~iG~G~~g~Vy~~~~~~-g-------~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 345 (553)
.+.||+|+||.||+|.... + ..||+|++........+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 13 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 92 (289)
T 4fvq_A 13 NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQE 92 (289)
T ss_dssp EEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCCEEEEE
T ss_pred eeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCCEEEEE
Confidence 3456999999999998643 3 4799999987766777889999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCC--------eEEeecc
Q 008785 346 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG--------AHLMGVG 417 (553)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~--------~kl~Dfg 417 (553)
|+++|+|.+++.. ....+++..+..++.||+.||.|||++ +|+||||||+|||++.++. +||+|||
T Consensus 93 ~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg 166 (289)
T 4fvq_A 93 FVKFGSLDTYLKK---NKNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPG 166 (289)
T ss_dssp CCTTCBHHHHHHH---TGGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCEEEECCCC
T ss_pred CCCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccceeeeccCc
Confidence 9999999999975 234489999999999999999999999 9999999999999998887 9999999
Q ss_pred ccccCCcccccceeeecCccccccccccccC-CCCCcccchHhHHHHHHHHhc-Ccccc-cchH---HHHHhcC-CH--H
Q 008785 418 LSKFVPWEVMQERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIRL-VLCRR-WWTL---YTLVHSM-SL--L 488 (553)
Q Consensus 418 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwSlGvil~ell~-~~~~~-~~~l---~~~~~~~-~~--~ 488 (553)
++........ ..||+.|+|||++.+ ..++.++||||||+++|||++ ..+.. .... ....... .. .
T Consensus 167 ~~~~~~~~~~------~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (289)
T 4fvq_A 167 ISITVLPKDI------LQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLPAP 240 (289)
T ss_dssp SCTTTSCHHH------HHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCC
T ss_pred ccccccCccc------cCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhccCCCCCC
Confidence 9976543321 127889999999987 678999999999999999998 22222 1111 1122111 11 4
Q ss_pred HHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 008785 489 CAQECLMLFISCNNWPSHLSQSKFCNLKLWVF 520 (553)
Q Consensus 489 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~ 520 (553)
.+..+.+++.+||+.||++|||+.|+++++..
T Consensus 241 ~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~ 272 (289)
T 4fvq_A 241 KAAELANLINNCMDYEPDHRPSFRAIIRDLNS 272 (289)
T ss_dssp SSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHT
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 45678999999999999999999999998754
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-40 Score=328.69 Aligned_cols=246 Identities=23% Similarity=0.304 Sum_probs=202.1
Q ss_pred eeecccCceeEEEEEeCC-C---CEEEEEEeccCC-hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCce-EEEEEccC
Q 008785 275 RLLGDSKTGGTYSGILPD-G---SRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR-YIVYEFVV 348 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~~-g---~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~-~lV~E~~~ 348 (553)
+.||+|+||.||+|...+ + ..||+|.++... ....+.+.+|+.++++++||||+++++++.+.+.. ++||||+.
T Consensus 27 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~ 106 (298)
T 3pls_A 27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMC 106 (298)
T ss_dssp EEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECCCT
T ss_pred ceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEeccc
Confidence 567999999999998533 2 379999997643 34567899999999999999999999999876665 99999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCccccc
Q 008785 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ 428 (553)
Q Consensus 349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 428 (553)
+|+|.+++.. ....+++..+..++.|++.||+|||++ +|+||||||+||++++++.+||+|||+++........
T Consensus 107 ~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 180 (298)
T 3pls_A 107 HGDLLQFIRS---PQRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYY 180 (298)
T ss_dssp TCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGG
T ss_pred CCCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCcccccCCccc
Confidence 9999999975 345689999999999999999999999 9999999999999999999999999999866543221
Q ss_pred --ceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhc-Cccc----ccchHHHHHhcCCH-----HHHHHHHHH
Q 008785 429 --ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-VLCR----RWWTLYTLVHSMSL-----LCAQECLML 496 (553)
Q Consensus 429 --~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-~~~~----~~~~l~~~~~~~~~-----~~~~~l~~l 496 (553)
.......+|+.|+|||.+.+..++.++||||||+++|||++ ..+. ....+...+..+.. ..+..+.++
T Consensus 181 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 260 (298)
T 3pls_A 181 SVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCPDSLYQV 260 (298)
T ss_dssp CSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred ccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCCCccchHHHHHH
Confidence 11122337889999999999999999999999999999997 3332 22233333333322 456789999
Q ss_pred HhhccCCCCCCCCCHHHHHHHHHHHHhhcc
Q 008785 497 FISCNNWPSHLSQSKFCNLKLWVFAILTIR 526 (553)
Q Consensus 497 ~~~Cl~~dP~~RPs~~evl~~l~~~~~~~~ 526 (553)
+.+||+.||.+|||+.++++.+...+....
T Consensus 261 i~~~l~~~p~~Rps~~~ll~~l~~~~~~l~ 290 (298)
T 3pls_A 261 MQQCWEADPAVRPTFRVLVGEVEQIVSALL 290 (298)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHHHHHHCC
T ss_pred HHHHccCChhhCcCHHHHHHHHHHHHHHHh
Confidence 999999999999999999999887776654
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=343.77 Aligned_cols=248 Identities=24% Similarity=0.348 Sum_probs=192.6
Q ss_pred eeecccCceeEEEEEeCC--C--CEEEEEEeccC-ChhhHHHHHHHHHHhhccCCCceeeEeeEEee-CCceEEEEEccC
Q 008785 275 RLLGDSKTGGTYSGILPD--G--SRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD-HGDRYIVYEFVV 348 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~~--g--~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~~lV~E~~~ 348 (553)
+.||+|+||.||+|...+ + ..||||.++.. .....+.+.+|+.++++++||||+++++++.+ .+..++||||++
T Consensus 95 ~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e~~~ 174 (373)
T 3c1x_A 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMK 174 (373)
T ss_dssp EEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEECCT
T ss_pred cEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEECCC
Confidence 467999999999998642 2 36899998754 33456789999999999999999999998765 457899999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCccccc
Q 008785 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ 428 (553)
Q Consensus 349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 428 (553)
+|+|.+++.. ....+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++........
T Consensus 175 ~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~ 248 (373)
T 3c1x_A 175 HGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 248 (373)
T ss_dssp TCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC------------
T ss_pred CCCHHHHHhh---cccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeeccccccccccccc
Confidence 9999999974 334688999999999999999999999 9999999999999999999999999999865433211
Q ss_pred c--eeeecCccccccccccccCCCCCcccchHhHHHHHHHHhc-Cccc----ccchHHHHHhcCCH-----HHHHHHHHH
Q 008785 429 E--RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-VLCR----RWWTLYTLVHSMSL-----LCAQECLML 496 (553)
Q Consensus 429 ~--~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-~~~~----~~~~l~~~~~~~~~-----~~~~~l~~l 496 (553)
. ......+|+.|+|||++.+..++.++||||||+++|||++ ..+. ....+...+..+.. ..+..+.++
T Consensus 249 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~l 328 (373)
T 3c1x_A 249 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEV 328 (373)
T ss_dssp ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred cccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 1 1112237789999999999999999999999999999997 3322 12233333333322 466789999
Q ss_pred HhhccCCCCCCCCCHHHHHHHHHHHHhhcccc
Q 008785 497 FISCNNWPSHLSQSKFCNLKLWVFAILTIRKV 528 (553)
Q Consensus 497 ~~~Cl~~dP~~RPs~~evl~~l~~~~~~~~~~ 528 (553)
+.+||+.||++|||+.|+++.+...+......
T Consensus 329 i~~cl~~dp~~RPs~~ell~~L~~i~~~~~~~ 360 (373)
T 3c1x_A 329 MLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 360 (373)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSC
T ss_pred HHHHcCCChhhCcCHHHHHHHHHHHHHhcccc
Confidence 99999999999999999999998877655433
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=329.30 Aligned_cols=245 Identities=24% Similarity=0.340 Sum_probs=197.9
Q ss_pred eeecccCceeEEEEEeCC----CCEEEEEEeccC-ChhhHHHHHHHHHHhhccCCCceeeEeeEEee-CCceEEEEEccC
Q 008785 275 RLLGDSKTGGTYSGILPD----GSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD-HGDRYIVYEFVV 348 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~~----g~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~~lV~E~~~ 348 (553)
+.||+|+||.||+|...+ +..||+|.++.. .....+.+.+|+.++++++||||+++++++.+ .+..++||||++
T Consensus 31 ~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~ 110 (298)
T 3f66_A 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMK 110 (298)
T ss_dssp EEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEECCT
T ss_pred ceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEEeCCC
Confidence 457999999999999643 236899999764 33456789999999999999999999998654 567899999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCccccc
Q 008785 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ 428 (553)
Q Consensus 349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 428 (553)
+|+|.+++.. ....+++..+..++.|++.||+|||++ +|+||||||+||++++++.+||+|||++.........
T Consensus 111 ~~~L~~~l~~---~~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~ 184 (298)
T 3f66_A 111 HGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYY 184 (298)
T ss_dssp TCBHHHHHHC---TTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGGC
T ss_pred CCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECcccccccccccchh
Confidence 9999999974 345689999999999999999999999 9999999999999999999999999999876543321
Q ss_pred c--eeeecCccccccccccccCCCCCcccchHhHHHHHHHHhc-Cccc----ccchHHHHHhcCCH-----HHHHHHHHH
Q 008785 429 E--RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-VLCR----RWWTLYTLVHSMSL-----LCAQECLML 496 (553)
Q Consensus 429 ~--~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-~~~~----~~~~l~~~~~~~~~-----~~~~~l~~l 496 (553)
. ......+|+.|+|||.+.+..++.++||||||+++|||++ ..+. ........+..+.. ..+..+.++
T Consensus 185 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 264 (298)
T 3f66_A 185 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEV 264 (298)
T ss_dssp BC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred ccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHHHH
Confidence 1 1122237889999999999999999999999999999997 3322 22223333332222 456789999
Q ss_pred HhhccCCCCCCCCCHHHHHHHHHHHHhhc
Q 008785 497 FISCNNWPSHLSQSKFCNLKLWVFAILTI 525 (553)
Q Consensus 497 ~~~Cl~~dP~~RPs~~evl~~l~~~~~~~ 525 (553)
+.+||+.||++|||+.|+++.+...+...
T Consensus 265 i~~~l~~~p~~Rps~~ell~~L~~~~~~~ 293 (298)
T 3f66_A 265 MLKCWHPKAEMRPSFSELVSRISAIFSTF 293 (298)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHHHHHTS
T ss_pred HHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 99999999999999999999987776544
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=333.99 Aligned_cols=250 Identities=23% Similarity=0.335 Sum_probs=190.9
Q ss_pred CeeecccCceeEEEEEeCC----CCEEEEEEeccC--ChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCc-----eEE
Q 008785 274 NRLLGDSKTGGTYSGILPD----GSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGD-----RYI 342 (553)
Q Consensus 274 ~~~iG~G~~g~Vy~~~~~~----g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~-----~~l 342 (553)
.+.||+|+||.||+|.... +..||||.++.. .....+.+.+|+.++++++||||+++++++.+.+. .++
T Consensus 39 ~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 118 (313)
T 3brb_A 39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMV 118 (313)
T ss_dssp EEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------CEEE
T ss_pred ccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCcccEE
Confidence 3456999999999998642 458999998754 33445779999999999999999999999987653 499
Q ss_pred EEEccCCCCHHHHhccCC--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccc
Q 008785 343 VYEFVVNGPLDRWLHHIP--RGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSK 420 (553)
Q Consensus 343 V~E~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~ 420 (553)
||||+++|+|.+++.... .....+++..+..++.||+.||.|||++ +|+||||||+||+++.++.+||+|||++.
T Consensus 119 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kl~Dfg~~~ 195 (313)
T 3brb_A 119 ILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSK 195 (313)
T ss_dssp EEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSCEEECSCSCC-
T ss_pred EEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEEeecCcce
Confidence 999999999999985422 2345699999999999999999999999 99999999999999999999999999998
Q ss_pred cCCcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhc-Cc-cc---ccchHHHHHhcCCH-----HHH
Q 008785 421 FVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-VL-CR---RWWTLYTLVHSMSL-----LCA 490 (553)
Q Consensus 421 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-~~-~~---~~~~l~~~~~~~~~-----~~~ 490 (553)
...............+++.|+|||.+.+..++.++||||||+++|||++ .. |. ....+.+.+..+.. ..+
T Consensus 196 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (313)
T 3brb_A 196 KIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQPEDCL 275 (313)
T ss_dssp ---------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCBTTCC
T ss_pred ecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCCCCCCcccc
Confidence 7654432222223337889999999999999999999999999999997 32 22 22233333333221 566
Q ss_pred HHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHhhcc
Q 008785 491 QECLMLFISCNNWPSHLSQSKFCNLKLWVFAILTIR 526 (553)
Q Consensus 491 ~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~~~~~~~ 526 (553)
..+.+++.+||+.||++|||+.++++++...+....
T Consensus 276 ~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp 311 (313)
T 3brb_A 276 DELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP 311 (313)
T ss_dssp HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence 789999999999999999999999999877765543
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-41 Score=340.58 Aligned_cols=243 Identities=19% Similarity=0.268 Sum_probs=195.3
Q ss_pred eeecccCceeEEEEEeC-CCCE----EEEEEeccCC-hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccC
Q 008785 275 RLLGDSKTGGTYSGILP-DGSR----VAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV 348 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~-~g~~----vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 348 (553)
+.||+|+||.||+|... +++. ||+|.+.... ......+.+|+.++++++||||+++++++. .+..++||||++
T Consensus 19 ~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~ 97 (325)
T 3kex_A 19 KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVTQYLP 97 (325)
T ss_dssp EEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEEEECCT
T ss_pred eeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEEEEeCC
Confidence 45699999999999964 3443 8888875432 223456788999999999999999999886 567899999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCccccc
Q 008785 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ 428 (553)
Q Consensus 349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 428 (553)
+|+|.+++.. ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 98 ~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~ 171 (325)
T 3kex_A 98 LGSLLDHVRQ---HRGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQ 171 (325)
T ss_dssp TCBSHHHHHS---SGGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCTTC
T ss_pred CCCHHHHHHH---ccccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcccccCccccc
Confidence 9999999975 234688899999999999999999999 9999999999999999999999999999877654333
Q ss_pred ceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhc-Cc-cccc---chHHHHHhcCCH-----HHHHHHHHHHh
Q 008785 429 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-VL-CRRW---WTLYTLVHSMSL-----LCAQECLMLFI 498 (553)
Q Consensus 429 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-~~-~~~~---~~l~~~~~~~~~-----~~~~~l~~l~~ 498 (553)
.......||+.|+|||++.+..++.++||||||+++|||++ .. |... ..+.+.+..+.. ..+..+.+++.
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 251 (325)
T 3kex_A 172 LLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQICTIDVYMVMV 251 (325)
T ss_dssp CC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCCTTBCTTTTHHHH
T ss_pred ccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCCCcCcHHHHHHHH
Confidence 32333347889999999998999999999999999999997 33 2222 233344444322 45667889999
Q ss_pred hccCCCCCCCCCHHHHHHHHHHHHhh
Q 008785 499 SCNNWPSHLSQSKFCNLKLWVFAILT 524 (553)
Q Consensus 499 ~Cl~~dP~~RPs~~evl~~l~~~~~~ 524 (553)
+||+.||.+|||+.|+++++......
T Consensus 252 ~~l~~dp~~Rps~~el~~~l~~~~~~ 277 (325)
T 3kex_A 252 KCWMIDENIRPTFKELANEFTRMARD 277 (325)
T ss_dssp HHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred HHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 99999999999999999998766543
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=347.44 Aligned_cols=241 Identities=20% Similarity=0.210 Sum_probs=195.6
Q ss_pred ccCCCCeeecccCceeEEEEEeCC-CCEEEEEEeccCCh---hhHHHHHHHHHHhhcc-CCCceeeEeeEEeeCCceEEE
Q 008785 269 NFSEGNRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSF---QRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIV 343 (553)
Q Consensus 269 ~~~~~~~~iG~G~~g~Vy~~~~~~-g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV 343 (553)
+|... ++||+|+||.||+++..+ ++.||+|++++... ...+.+.+|..++.++ +||||+++++++.+.+..++|
T Consensus 53 ~y~~~-~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV 131 (396)
T 4dc2_A 53 DFDLL-RVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 131 (396)
T ss_dssp GEEEE-EEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred HcEEE-EEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEE
Confidence 44443 456999999999999764 78999999986522 2234578899999887 899999999999999999999
Q ss_pred EEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCC
Q 008785 344 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVP 423 (553)
Q Consensus 344 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~ 423 (553)
|||+++|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 132 ~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~~ 204 (396)
T 4dc2_A 132 IEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 204 (396)
T ss_dssp EECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEcCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence 999999999999964 24589999999999999999999999 99999999999999999999999999998633
Q ss_pred cccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcCccccc-------------chHHHHHhcCCH---
Q 008785 424 WEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVLCRRW-------------WTLYTLVHSMSL--- 487 (553)
Q Consensus 424 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~~~~~-------------~~l~~~~~~~~~--- 487 (553)
..... ....+||+.|+|||++.+..++.++|||||||++|||++..+... ..+.+.+..+..
T Consensus 205 ~~~~~--~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p 282 (396)
T 4dc2_A 205 RPGDT--TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP 282 (396)
T ss_dssp CTTCC--BCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCC
T ss_pred cCCCc--cccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCC
Confidence 22221 223349999999999999999999999999999999997332221 112233333332
Q ss_pred -HHHHHHHHHHhhccCCCCCCCCCH------HHHHHHHH
Q 008785 488 -LCAQECLMLFISCNNWPSHLSQSK------FCNLKLWV 519 (553)
Q Consensus 488 -~~~~~l~~l~~~Cl~~dP~~RPs~------~evl~~l~ 519 (553)
..+..+.+++.+||+.||++||++ .|++++-.
T Consensus 283 ~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpf 321 (396)
T 4dc2_A 283 RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPF 321 (396)
T ss_dssp TTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTT
T ss_pred CcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCcc
Confidence 456788999999999999999995 78887643
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=341.34 Aligned_cols=239 Identities=22% Similarity=0.254 Sum_probs=182.5
Q ss_pred hcccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEE
Q 008785 267 TKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYE 345 (553)
Q Consensus 267 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 345 (553)
.+.|... +.||+|+||.||+|... +++.||||+++... ..+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 52 ~~~y~~~-~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 52 SDFFEVE-SELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GGTEEEE-EEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cCcEEEe-eEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 3344443 45699999999999976 47899999998653 34678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecC---CCCeEEeeccccccC
Q 008785 346 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE---EFGAHLMGVGLSKFV 422 (553)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~---~~~~kl~Dfgla~~~ 422 (553)
|+++|+|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++. ++.+||+|||+++..
T Consensus 129 ~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~ 201 (349)
T 2w4o_A 129 LVTGGELFDRIVE----KGYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV 201 (349)
T ss_dssp CCCSCBHHHHHTT----CSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC-----
T ss_pred eCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCcccccc
Confidence 9999999999964 34589999999999999999999999 9999999999999975 889999999999865
Q ss_pred CcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcC-cccccc----hHHHHHhcCCH--------HH
Q 008785 423 PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLV-LCRRWW----TLYTLVHSMSL--------LC 489 (553)
Q Consensus 423 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~-~~~~~~----~l~~~~~~~~~--------~~ 489 (553)
...... ....||+.|+|||++.+..++.++||||||+++|||++. .|.... .+...+..+.. ..
T Consensus 202 ~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 278 (349)
T 2w4o_A 202 EHQVLM---KTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEV 278 (349)
T ss_dssp --------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTS
T ss_pred Cccccc---ccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhC
Confidence 433211 122389999999999998999999999999999999973 232221 12332322221 45
Q ss_pred HHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008785 490 AQECLMLFISCNNWPSHLSQSKFCNLKLW 518 (553)
Q Consensus 490 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~l 518 (553)
+..+.+++.+||+.||++|||+.|++++-
T Consensus 279 ~~~~~~li~~~L~~dP~~Rpt~~e~l~hp 307 (349)
T 2w4o_A 279 SLNAKDLVRKLIVLDPKKRLTTFQALQHP 307 (349)
T ss_dssp CHHHHHHHHTTSCSSGGGSCCHHHHHHST
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence 67889999999999999999999999863
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-41 Score=339.94 Aligned_cols=232 Identities=19% Similarity=0.233 Sum_probs=178.5
Q ss_pred CeeecccCceeEEEEEeC-CCCEEEEEEeccCChhhHHHHHHHHHHhhccC-CCceeeEeeEEeeCCceEEEEEccCCCC
Q 008785 274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLH-HPNLVAVKGCCYDHGDRYIVYEFVVNGP 351 (553)
Q Consensus 274 ~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lV~E~~~~gs 351 (553)
.+.||+|+||.||++... +|+.||||++... ....+.+|+.++++++ ||||+++++++.+.+..++||||+++|+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 456799999999999975 5899999999754 3466788999999997 9999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCC---CeEEeeccccccCCccccc
Q 008785 352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF---GAHLMGVGLSKFVPWEVMQ 428 (553)
Q Consensus 352 L~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~---~~kl~Dfgla~~~~~~~~~ 428 (553)
|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+++........
T Consensus 93 L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~ 165 (325)
T 3kn6_A 93 LFERIKK----KKHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP 165 (325)
T ss_dssp HHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC----
T ss_pred HHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCc
Confidence 9999975 24689999999999999999999999 999999999999997765 7999999999865543222
Q ss_pred ceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcCc-cccc----------chHHHHHhcCCH--------HH
Q 008785 429 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVL-CRRW----------WTLYTLVHSMSL--------LC 489 (553)
Q Consensus 429 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~-~~~~----------~~l~~~~~~~~~--------~~ 489 (553)
.. ...||+.|+|||++.+..++.++||||||+++|||++.. |... ..+.+.+..+.. ..
T Consensus 166 ~~--~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 243 (325)
T 3kn6_A 166 LK--TPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNV 243 (325)
T ss_dssp --------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHTS
T ss_pred cc--ccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccccCC
Confidence 21 223899999999999999999999999999999999732 2221 123334444443 35
Q ss_pred HHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008785 490 AQECLMLFISCNNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 490 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 517 (553)
+..+.+++.+||+.||++|||+.|++++
T Consensus 244 s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 244 SQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp CHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred CHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 6789999999999999999999999876
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=331.51 Aligned_cols=243 Identities=21% Similarity=0.369 Sum_probs=198.2
Q ss_pred hcccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeEEee---------
Q 008785 267 TKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD--------- 336 (553)
Q Consensus 267 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--------- 336 (553)
..+|.... .||+|+||.||++... +|+.||+|.++... +.+.+|+.++++++||||+++++++..
T Consensus 10 ~~~y~~~~-~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 10 GMDFKEIE-LIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHEEEEE-EEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred ccccceee-eeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 34455444 4599999999999976 69999999997653 346789999999999999999998864
Q ss_pred -------CCceEEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCC
Q 008785 337 -------HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF 409 (553)
Q Consensus 337 -------~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~ 409 (553)
....++||||+++|+|.+++... ....+++..+..++.||+.||.|||++ +|+||||||+||++++++
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~ 159 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKR--RGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTK 159 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHG--GGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETT
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCCC
Confidence 34579999999999999999752 235689999999999999999999999 999999999999999999
Q ss_pred CeEEeeccccccCCcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcCccccc--chHHHHHhcCCH
Q 008785 410 GAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVLCRRW--WTLYTLVHSMSL 487 (553)
Q Consensus 410 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~~~~~--~~l~~~~~~~~~ 487 (553)
.+||+|||++.......... ...||+.|+|||++.+..++.++||||||+++|||++...... ......+..+..
T Consensus 160 ~~kl~Dfg~~~~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T 2a19_B 160 QVKIGDFGLVTSLKNDGKRT---RSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGII 236 (284)
T ss_dssp EEEECCCTTCEESSCCSCCC---CCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHHHHHHHHTTCC
T ss_pred CEEECcchhheecccccccc---ccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHHHHHHhhcccc
Confidence 99999999998765432211 2238999999999999999999999999999999997433221 222223333333
Q ss_pred --HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 008785 488 --LCAQECLMLFISCNNWPSHLSQSKFCNLKLWVFAI 522 (553)
Q Consensus 488 --~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~~~ 522 (553)
..+..+.+++.+||+.||.+|||+.|+++++....
T Consensus 237 ~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 237 SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 45667889999999999999999999999876543
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=330.40 Aligned_cols=241 Identities=17% Similarity=0.153 Sum_probs=195.6
Q ss_pred CeeecccCceeEEEEEeCC-CCEEEEEEeccCC-hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCC--ceEEEEEccCC
Q 008785 274 NRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHG--DRYIVYEFVVN 349 (553)
Q Consensus 274 ~~~iG~G~~g~Vy~~~~~~-g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~--~~~lV~E~~~~ 349 (553)
.++||+|+||.||+|.... |+.||||+++... ....+.+.+|+.++++++||||+++++++...+ ..++||||+++
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~ 93 (319)
T 4euu_A 14 SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPC 93 (319)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEECCTT
T ss_pred EEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeCCCC
Confidence 4456999999999999764 8999999997643 234577889999999999999999999988765 67999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEe----cCCCCeEEeeccccccCCcc
Q 008785 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL----DEEFGAHLMGVGLSKFVPWE 425 (553)
Q Consensus 350 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl----~~~~~~kl~Dfgla~~~~~~ 425 (553)
|+|.+++.... ....+++..+..++.||+.||+|||+. +|+||||||+|||+ +.++.+||+|||+++.....
T Consensus 94 ~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~ 169 (319)
T 4euu_A 94 GSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD 169 (319)
T ss_dssp CBHHHHHHSGG-GTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCTT
T ss_pred CCHHHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCceecCCC
Confidence 99999997532 223489999999999999999999999 99999999999999 77888999999999876544
Q ss_pred cccceeeecCcccccccccccc--------CCCCCcccchHhHHHHHHHHhcCc-ccc-------cchHHH-HHhcCC--
Q 008785 426 VMQERTVMAGGTYGYLAPEFVY--------RNELTTKSDVYSFGVLLLEIRLVL-CRR-------WWTLYT-LVHSMS-- 486 (553)
Q Consensus 426 ~~~~~~~~~~gt~~y~aPE~~~--------~~~~t~ksDVwSlGvil~ell~~~-~~~-------~~~l~~-~~~~~~-- 486 (553)
.... ...||+.|+|||++. +..++.++||||||+++|||++.. |.. ...+.. .+....
T Consensus 170 ~~~~---~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~ 246 (319)
T 4euu_A 170 EQFV---SLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSG 246 (319)
T ss_dssp CCBC---CCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTT
T ss_pred Ccee---ecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCcc
Confidence 3222 223899999999986 577899999999999999999732 221 111111 221110
Q ss_pred --------------------------HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 008785 487 --------------------------LLCAQECLMLFISCNNWPSHLSQSKFCNLKLWVFA 521 (553)
Q Consensus 487 --------------------------~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~~ 521 (553)
......+.+++.+||+.||++|||+.|++++....
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 247 AISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp CCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred cchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 16677899999999999999999999999987544
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=335.63 Aligned_cols=242 Identities=17% Similarity=0.212 Sum_probs=192.5
Q ss_pred ccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCChhhHHHHHHHHHHhhcc-CCCceeeEeeEEeeCCceEEEEEc
Q 008785 269 NFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEF 346 (553)
Q Consensus 269 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E~ 346 (553)
.|....++||+|+||.||++... +++.||||+++.......+.+.+|+.++.++ +||||+++++++.+.+..++||||
T Consensus 13 ~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~ 92 (316)
T 2ac3_A 13 VYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEK 92 (316)
T ss_dssp SCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred eEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEc
Confidence 34333456799999999999954 6899999999876656678899999999985 799999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCC---eEEeeccccccCC
Q 008785 347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG---AHLMGVGLSKFVP 423 (553)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~---~kl~Dfgla~~~~ 423 (553)
+++|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++. +||+|||++....
T Consensus 93 ~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 165 (316)
T 2ac3_A 93 MRGGSILSHIHK----RRHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK 165 (316)
T ss_dssp CTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred CCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence 999999999975 24589999999999999999999999 9999999999999998766 9999999997654
Q ss_pred ccccc-----ceeeecCccccccccccccC-----CCCCcccchHhHHHHHHHHhcCc-cccc-----------------
Q 008785 424 WEVMQ-----ERTVMAGGTYGYLAPEFVYR-----NELTTKSDVYSFGVLLLEIRLVL-CRRW----------------- 475 (553)
Q Consensus 424 ~~~~~-----~~~~~~~gt~~y~aPE~~~~-----~~~t~ksDVwSlGvil~ell~~~-~~~~----------------- 475 (553)
..... .......||+.|+|||++.+ ..++.++||||||+++|||++.. |...
T Consensus 166 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 245 (316)
T 2ac3_A 166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPAC 245 (316)
T ss_dssp ----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHH
T ss_pred cCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhH
Confidence 32111 11112338999999999875 56889999999999999999732 2211
Q ss_pred -chHHHHHhcCCH--------HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008785 476 -WTLYTLVHSMSL--------LCAQECLMLFISCNNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 476 -~~l~~~~~~~~~--------~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 517 (553)
..+.+.+..+.. ..+..+.+++.+||+.||++|||+.|++++
T Consensus 246 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 246 QNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 112333333332 245678999999999999999999999986
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=333.59 Aligned_cols=243 Identities=24% Similarity=0.328 Sum_probs=195.6
Q ss_pred CeeecccCceeEEEEEe-----CCCCEEEEEEeccCC-hhhHHHHHHHHHHhhccCCCceeeEeeEEeeC--CceEEEEE
Q 008785 274 NRLLGDSKTGGTYSGIL-----PDGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH--GDRYIVYE 345 (553)
Q Consensus 274 ~~~iG~G~~g~Vy~~~~-----~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~~lV~E 345 (553)
.+.||+|+||.||++.+ .+++.||||+++... ....+.+.+|+.++++++||||+++++++.+. ...++|||
T Consensus 26 ~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e 105 (302)
T 4e5w_A 26 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIME 105 (302)
T ss_dssp EEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEEEEEE
T ss_pred hhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEEEEEE
Confidence 45669999999999984 358899999997543 33457889999999999999999999999876 66899999
Q ss_pred ccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcc
Q 008785 346 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE 425 (553)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~ 425 (553)
|+++|+|.+++.. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++......
T Consensus 106 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 179 (302)
T 4e5w_A 106 FLPSGSLKEYLPK---NKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD 179 (302)
T ss_dssp CCTTCBHHHHHHH---HTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTT
T ss_pred eCCCCcHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECcccccccccCC
Confidence 9999999999964 234589999999999999999999999 9999999999999999999999999999876544
Q ss_pred cccc-eeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcCcccccchH-------------------HHHHhcC
Q 008785 426 VMQE-RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVLCRRWWTL-------------------YTLVHSM 485 (553)
Q Consensus 426 ~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~~~~~~~l-------------------~~~~~~~ 485 (553)
.... ......||..|+|||++.+..++.++||||||+++|||++......... ...+..+
T Consensus 180 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (302)
T 4e5w_A 180 KEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEG 259 (302)
T ss_dssp CCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHHTT
T ss_pred CcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHhcc
Confidence 3221 1222337888999999999999999999999999999998433211111 1122221
Q ss_pred CH-----HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 008785 486 SL-----LCAQECLMLFISCNNWPSHLSQSKFCNLKLWVFAI 522 (553)
Q Consensus 486 ~~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~~~ 522 (553)
.. ..+..+.+++.+||+.||.+|||+.|+++.+...+
T Consensus 260 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 260 KRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 11 45678999999999999999999999999986543
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=329.85 Aligned_cols=250 Identities=23% Similarity=0.304 Sum_probs=198.6
Q ss_pred ccCCCCeeecccCceeEEEEEeCC----CCEEEEEEeccC-ChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEE
Q 008785 269 NFSEGNRLLGDSKTGGTYSGILPD----GSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIV 343 (553)
Q Consensus 269 ~~~~~~~~iG~G~~g~Vy~~~~~~----g~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 343 (553)
+|.. .+.||+|+||.||+|...+ +..||+|.++.. .....+.+.+|+.++++++||||+++++++.+ +..++|
T Consensus 13 ~y~~-~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v 90 (281)
T 3cc6_A 13 DVVL-NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWII 90 (281)
T ss_dssp GEEE-EEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEEE
T ss_pred ceEE-EEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEEE
Confidence 3433 3456999999999998643 336999999865 34456789999999999999999999999765 467999
Q ss_pred EEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCC
Q 008785 344 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVP 423 (553)
Q Consensus 344 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~ 423 (553)
|||+++++|.+++.. ....+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||++....
T Consensus 91 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 164 (281)
T 3cc6_A 91 MELYPYGELGHYLER---NKNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYIE 164 (281)
T ss_dssp EECCTTCBHHHHHHH---HTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred EecCCCCCHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCcccc
Confidence 999999999999975 234589999999999999999999999 99999999999999999999999999998765
Q ss_pred cccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhc-Cc-cc---ccchHHHHHhcCCH-----HHHHHH
Q 008785 424 WEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-VL-CR---RWWTLYTLVHSMSL-----LCAQEC 493 (553)
Q Consensus 424 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-~~-~~---~~~~l~~~~~~~~~-----~~~~~l 493 (553)
....... ....+|+.|+|||++.+..++.++||||||+++|||++ .. |. ........+..+.. ..+..+
T Consensus 165 ~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 243 (281)
T 3cc6_A 165 DEDYYKA-SVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPPVL 243 (281)
T ss_dssp ---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCCCTTCCHHH
T ss_pred ccccccc-ccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCCCCCCCHHH
Confidence 4332221 22237889999999988899999999999999999997 33 32 22333443333221 456779
Q ss_pred HHHHhhccCCCCCCCCCHHHHHHHHHHHHhhccc
Q 008785 494 LMLFISCNNWPSHLSQSKFCNLKLWVFAILTIRK 527 (553)
Q Consensus 494 ~~l~~~Cl~~dP~~RPs~~evl~~l~~~~~~~~~ 527 (553)
.+++.+||+.||++|||+.|+++.+.......+.
T Consensus 244 ~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~ 277 (281)
T 3cc6_A 244 YTLMTRCWDYDPSDRPRFTELVCSLSDVYQMEKD 277 (281)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHccCCchhCcCHHHHHHHHHHHHHhhhh
Confidence 9999999999999999999999998776654443
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=325.46 Aligned_cols=233 Identities=21% Similarity=0.263 Sum_probs=192.0
Q ss_pred eeecccCceeEEEEEeCCCCEEEEEEeccC--ChhhHHHHHHHHHHhhccCCCceeeEeeEEeeC--CceEEEEEccCCC
Q 008785 275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH--GDRYIVYEFVVNG 350 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~~lV~E~~~~g 350 (553)
+.||+|+||.||+|.. +|+.||||+++.. .....+.+.+|+.++++++||||+++++++.+. +..++||||+++|
T Consensus 16 ~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~ 94 (271)
T 3kmu_A 16 TKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYG 94 (271)
T ss_dssp EEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEECCTTC
T ss_pred HHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeecccCCC
Confidence 4569999999999998 5899999999765 334457899999999999999999999999887 7789999999999
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--ceecCCCCCcEEecCCCCeEEeeccccccCCccccc
Q 008785 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPH--VVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ 428 (553)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~--ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 428 (553)
+|.+++.. .....+++..+..++.|++.||+|||+. + ++||||||+||++++++.++|.|||++.......
T Consensus 95 ~L~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~~~-- 167 (271)
T 3kmu_A 95 SLYNVLHE--GTNFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPG-- 167 (271)
T ss_dssp BHHHHHHS--CSSCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSCTT--
T ss_pred cHHHHHhh--cccCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceeeecccC--
Confidence 99999975 2334689999999999999999999998 8 9999999999999999999999998875432221
Q ss_pred ceeeecCccccccccccccCCCCCc---ccchHhHHHHHHHHhcC-cccccchHH---H-HHhcCCH-----HHHHHHHH
Q 008785 429 ERTVMAGGTYGYLAPEFVYRNELTT---KSDVYSFGVLLLEIRLV-LCRRWWTLY---T-LVHSMSL-----LCAQECLM 495 (553)
Q Consensus 429 ~~~~~~~gt~~y~aPE~~~~~~~t~---ksDVwSlGvil~ell~~-~~~~~~~l~---~-~~~~~~~-----~~~~~l~~ 495 (553)
..||+.|+|||++.+..++. ++||||||+++|||++. .|....... . ....+.. ..+..+.+
T Consensus 168 -----~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (271)
T 3kmu_A 168 -----RMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPHVSK 242 (271)
T ss_dssp -----CBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCCTTCCHHHHH
T ss_pred -----ccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCCCCCCHHHHH
Confidence 12899999999998765544 79999999999999973 333222221 1 2222211 56778999
Q ss_pred HHhhccCCCCCCCCCHHHHHHHHHH
Q 008785 496 LFISCNNWPSHLSQSKFCNLKLWVF 520 (553)
Q Consensus 496 l~~~Cl~~dP~~RPs~~evl~~l~~ 520 (553)
++.+||+.||++|||+.|+++.+..
T Consensus 243 li~~~l~~~p~~Rps~~~il~~L~~ 267 (271)
T 3kmu_A 243 LMKICMNEDPAKRPKFDMIVPILEK 267 (271)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHcCCChhhCcCHHHHHHHHHH
Confidence 9999999999999999999998754
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=337.25 Aligned_cols=250 Identities=20% Similarity=0.226 Sum_probs=193.8
Q ss_pred cccCCCCeeecccCceeEEEEEe-CCCCEEEEEEeccCC---hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCce---
Q 008785 268 KNFSEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR--- 340 (553)
Q Consensus 268 ~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~--- 340 (553)
++|... +.||+|+||.||++.. .+++.||||+++... ......+.+|+.++++++||||+++++++......
T Consensus 12 ~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 12 DRYELG-EILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTEEEE-EEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred CcEEEE-EEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 344443 4569999999999996 568899999997652 33356789999999999999999999998876543
Q ss_pred -EEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeecccc
Q 008785 341 -YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLS 419 (553)
Q Consensus 341 -~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla 419 (553)
++||||+++|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 91 ~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a 163 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIA 163 (311)
T ss_dssp EEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred cEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence 999999999999999964 23589999999999999999999999 9999999999999999999999999999
Q ss_pred ccCCcccccc-eeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcC-cccccchHHH----HHhcCCH------
Q 008785 420 KFVPWEVMQE-RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLV-LCRRWWTLYT----LVHSMSL------ 487 (553)
Q Consensus 420 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~-~~~~~~~l~~----~~~~~~~------ 487 (553)
.......... ......||+.|+|||++.+..++.++||||||+++|||++. .|.......+ .......
T Consensus 164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 243 (311)
T 3ork_A 164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARH 243 (311)
T ss_dssp ------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHS
T ss_pred ccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCccccc
Confidence 8665432211 11223389999999999999999999999999999999983 3333222222 2222221
Q ss_pred -HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHhhc
Q 008785 488 -LCAQECLMLFISCNNWPSHLSQSKFCNLKLWVFAILTI 525 (553)
Q Consensus 488 -~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~~~~~~ 525 (553)
..+..+.+++.+||+.||++||+..+++++-.......
T Consensus 244 ~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~ 282 (311)
T 3ork_A 244 EGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNG 282 (311)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTT
T ss_pred CCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcC
Confidence 25677999999999999999999999888766665544
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=331.46 Aligned_cols=234 Identities=19% Similarity=0.222 Sum_probs=188.0
Q ss_pred eeecccCceeEEEEEeCCCCEEEEEEeccCChh--hHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCCH
Q 008785 275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQ--RKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL 352 (553)
+.||+|+||.||+|...+|+.||+|+++..... ..+.+.+|+.++++++||||+++++++.+.+..++||||+++ +|
T Consensus 8 ~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l 86 (288)
T 1ob3_A 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DL 86 (288)
T ss_dssp EEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSE-EH
T ss_pred hhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecCC-CH
Confidence 346999999999999988999999999755322 246788999999999999999999999999999999999975 99
Q ss_pred HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccceee
Q 008785 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV 432 (553)
Q Consensus 353 ~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~ 432 (553)
.+++.. ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++.......... .
T Consensus 87 ~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~--~ 158 (288)
T 1ob3_A 87 KKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY--T 158 (288)
T ss_dssp HHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--------
T ss_pred HHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCcccccc--c
Confidence 998864 235689999999999999999999999 99999999999999999999999999997654322111 1
Q ss_pred ecCccccccccccccCC-CCCcccchHhHHHHHHHHhcCc-ccccchHH----HHHh---cCC-----------------
Q 008785 433 MAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIRLVL-CRRWWTLY----TLVH---SMS----------------- 486 (553)
Q Consensus 433 ~~~gt~~y~aPE~~~~~-~~t~ksDVwSlGvil~ell~~~-~~~~~~l~----~~~~---~~~----------------- 486 (553)
...||+.|+|||++.+. .++.++||||||+++|||++.. |.....-. .... ...
T Consensus 159 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T 1ob3_A 159 HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238 (288)
T ss_dssp ---CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTC
T ss_pred cccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccccccc
Confidence 12389999999998764 5899999999999999999733 22221111 1111 000
Q ss_pred ------------HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008785 487 ------------LLCAQECLMLFISCNNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 487 ------------~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 517 (553)
...+..+.+++.+||+.||++|||+.|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp CCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0245678899999999999999999999875
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=345.08 Aligned_cols=241 Identities=17% Similarity=0.173 Sum_probs=189.2
Q ss_pred hcccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCChhhHHHHHHHHHHhhc-cCCCceeeEeeEEee----CCce
Q 008785 267 TKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFAR-LHHPNLVAVKGCCYD----HGDR 340 (553)
Q Consensus 267 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~-l~HpnIv~l~~~~~~----~~~~ 340 (553)
.++|....++||+|+||.||++... +|+.||||+++.. ..+.+|+.++.+ .+||||+++++++.. .+..
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~ 134 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 134 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence 3455554456799999999999975 5889999999743 346678888754 489999999999876 5568
Q ss_pred EEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecC---CCCeEEeecc
Q 008785 341 YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE---EFGAHLMGVG 417 (553)
Q Consensus 341 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~---~~~~kl~Dfg 417 (553)
|+||||+++|+|.+++.. .....+++..+..++.||+.||.|||+. +|+||||||+|||++. ++.+||+|||
T Consensus 135 ~lv~E~~~gg~L~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG 209 (400)
T 1nxk_A 135 LIVMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFG 209 (400)
T ss_dssp EEEEECCCSEEHHHHHHC--C---CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred EEEEEeCCCCcHHHHHHH--hCCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEecc
Confidence 999999999999999975 2335699999999999999999999999 9999999999999998 7889999999
Q ss_pred ccccCCcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcCc-ccccc-------hHHHHHhcCCH--
Q 008785 418 LSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVL-CRRWW-------TLYTLVHSMSL-- 487 (553)
Q Consensus 418 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~-~~~~~-------~l~~~~~~~~~-- 487 (553)
+++........ ....||+.|+|||++.+..++.++|||||||++|||++.. |.... .+...+..+..
T Consensus 210 ~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~ 286 (400)
T 1nxk_A 210 FAKETTSHNSL---TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF 286 (400)
T ss_dssp TCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCC
T ss_pred cccccCCCCcc---ccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccC
Confidence 99865433221 2233899999999999999999999999999999999732 22111 12233333322
Q ss_pred ------HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 008785 488 ------LCAQECLMLFISCNNWPSHLSQSKFCNLKLWVF 520 (553)
Q Consensus 488 ------~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~ 520 (553)
..+..+.+|+.+||+.||++|||+.|++++-..
T Consensus 287 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~ 325 (400)
T 1nxk_A 287 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 325 (400)
T ss_dssp CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHH
T ss_pred CCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccc
Confidence 456789999999999999999999999998554
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=327.78 Aligned_cols=232 Identities=28% Similarity=0.417 Sum_probs=183.1
Q ss_pred eeecccCceeEEEEEeCCCCEEEEEEeccCCh----hhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCC
Q 008785 275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSF----QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 350 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~~g~~vAvK~~~~~~~----~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 350 (553)
+.||+|+||.||+|.. .|+.||||+++.... ...+.+.+|+.+++.++||||+++++++.+.+..++||||++++
T Consensus 13 ~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 91 (271)
T 3dtc_A 13 EIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGG 91 (271)
T ss_dssp EEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEECCTTE
T ss_pred eeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEEcCCCC
Confidence 4569999999999998 589999999875432 23467899999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC---ceecCCCCCcEEecC--------CCCeEEeecccc
Q 008785 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPH---VVHRDIRASNVLLDE--------EFGAHLMGVGLS 419 (553)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~---ivHrDlkp~NILl~~--------~~~~kl~Dfgla 419 (553)
+|.+++.. ..+++..+..++.|++.||.|||++ + |+||||||+||+++. ++.+||+|||++
T Consensus 92 ~L~~~~~~-----~~~~~~~~~~i~~~l~~~l~~lH~~---~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~ 163 (271)
T 3dtc_A 92 PLNRVLSG-----KRIPPDILVNWAVQIARGMNYLHDE---AIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLA 163 (271)
T ss_dssp EHHHHHTS-----SCCCHHHHHHHHHHHHHHHHHHHHS---SSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC-
T ss_pred CHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CCCceeecCCchHHEEEecccccccccCcceEEccCCcc
Confidence 99999853 4689999999999999999999999 7 999999999999986 678999999999
Q ss_pred ccCCcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcC-cccccch---HHHHHhcCC------HHH
Q 008785 420 KFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLV-LCRRWWT---LYTLVHSMS------LLC 489 (553)
Q Consensus 420 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~-~~~~~~~---l~~~~~~~~------~~~ 489 (553)
......... ...||+.|+|||.+.+..++.++||||||+++|||++. .|..... .......+. ...
T Consensus 164 ~~~~~~~~~----~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (271)
T 3dtc_A 164 REWHRTTKM----SAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTC 239 (271)
T ss_dssp ----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCCCTTC
T ss_pred ccccccccc----CCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCCCccc
Confidence 865433221 22389999999999988999999999999999999973 3332222 111222111 155
Q ss_pred HHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 008785 490 AQECLMLFISCNNWPSHLSQSKFCNLKLWV 519 (553)
Q Consensus 490 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~ 519 (553)
+..+.+++.+||+.||++|||+.|+++++.
T Consensus 240 ~~~~~~li~~~l~~~p~~Rps~~e~l~~L~ 269 (271)
T 3dtc_A 240 PEPFAKLMEDCWNPDPHSRPSFTNILDQLT 269 (271)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CHHHHHHHHHHhcCCcccCcCHHHHHHHHh
Confidence 678999999999999999999999999874
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-40 Score=333.87 Aligned_cols=247 Identities=21% Similarity=0.330 Sum_probs=196.4
Q ss_pred eeecccCceeEEEEEeCC-----CCEEEEEEeccC-ChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccC
Q 008785 275 RLLGDSKTGGTYSGILPD-----GSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV 348 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~~-----g~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 348 (553)
++||+|+||.||+|.... +..||||.++.. .......+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 50 ~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 129 (333)
T 1mqb_A 50 KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYME 129 (333)
T ss_dssp EEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred cEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEeCCC
Confidence 567999999999998643 236999999865 33445679999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCccccc
Q 008785 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ 428 (553)
Q Consensus 349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 428 (553)
+|+|.+++.. ....+++..+..++.||+.||.|||++ +|+||||||+||+++.++.+||+|||+++........
T Consensus 130 ~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 203 (333)
T 1mqb_A 130 NGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA 203 (333)
T ss_dssp TEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC----------
T ss_pred CCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchhhcccccc
Confidence 9999999975 234689999999999999999999999 9999999999999999999999999999876543221
Q ss_pred c-eeeecCccccccccccccCCCCCcccchHhHHHHHHHHhc-Cc-cccc---chHHHHHhcCC-H----HHHHHHHHHH
Q 008785 429 E-RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-VL-CRRW---WTLYTLVHSMS-L----LCAQECLMLF 497 (553)
Q Consensus 429 ~-~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-~~-~~~~---~~l~~~~~~~~-~----~~~~~l~~l~ 497 (553)
. ......+|+.|+|||++.+..++.++||||||+++|||++ .. |... ..+...+..+. . ..+..+.+++
T Consensus 204 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 283 (333)
T 1mqb_A 204 TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQLM 283 (333)
T ss_dssp -------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBHHHHHHH
T ss_pred ccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCCCcccCCHHHHHHH
Confidence 1 1111226788999999998999999999999999999987 32 3222 23333443332 1 5667899999
Q ss_pred hhccCCCCCCCCCHHHHHHHHHHHHhhccc
Q 008785 498 ISCNNWPSHLSQSKFCNLKLWVFAILTIRK 527 (553)
Q Consensus 498 ~~Cl~~dP~~RPs~~evl~~l~~~~~~~~~ 527 (553)
.+||+.||++||++.++++.+...+.....
T Consensus 284 ~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~ 313 (333)
T 1mqb_A 284 MQCWQQERARRPKFADIVSILDKLIRAPDS 313 (333)
T ss_dssp HHHTCSSTTTSCCHHHHHHHHHHHHHSGGG
T ss_pred HHHcCCChhhCcCHHHHHHHHHHHHhcchh
Confidence 999999999999999999998777655443
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=330.53 Aligned_cols=234 Identities=18% Similarity=0.206 Sum_probs=188.6
Q ss_pred eeecccCceeEEEEEeC-CCCEEEEEEeccCC--hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCC
Q 008785 275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP 351 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gs 351 (553)
+.||+|+||+||+|... +|+.||||+++... ......+.+|+.++++++||||+++++++.+.+..++||||+++ +
T Consensus 8 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~ 86 (292)
T 3o0g_A 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-D 86 (292)
T ss_dssp EEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE-E
T ss_pred eEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecCCC-C
Confidence 34599999999999975 58999999997543 33357788999999999999999999999999999999999975 6
Q ss_pred HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCccccccee
Q 008785 352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT 431 (553)
Q Consensus 352 L~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~ 431 (553)
|.+++.. ....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.........
T Consensus 87 l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~-- 158 (292)
T 3o0g_A 87 LKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY-- 158 (292)
T ss_dssp HHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSCC--
T ss_pred HHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCccccc--
Confidence 6666653 235699999999999999999999999 99999999999999999999999999998764332221
Q ss_pred eecCccccccccccccCCC-CCcccchHhHHHHHHHHhc-Cccc-ccchH---HH-HHhc-CC-----------------
Q 008785 432 VMAGGTYGYLAPEFVYRNE-LTTKSDVYSFGVLLLEIRL-VLCR-RWWTL---YT-LVHS-MS----------------- 486 (553)
Q Consensus 432 ~~~~gt~~y~aPE~~~~~~-~t~ksDVwSlGvil~ell~-~~~~-~~~~l---~~-~~~~-~~----------------- 486 (553)
....||+.|+|||++.+.. ++.++||||||+++|||++ ..|. ...+. .. .... +.
T Consensus 159 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 238 (292)
T 3o0g_A 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238 (292)
T ss_dssp CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCC
T ss_pred cCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccc
Confidence 1223899999999998766 7999999999999999996 3332 11111 11 1110 00
Q ss_pred --------------HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008785 487 --------------LLCAQECLMLFISCNNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 487 --------------~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 517 (553)
...+..+.+++.+||+.||++|||+.|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp CCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0245678899999999999999999999975
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=339.23 Aligned_cols=241 Identities=20% Similarity=0.207 Sum_probs=196.5
Q ss_pred ccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccC---ChhhHHHHHHHHHHhhcc-CCCceeeEeeEEeeCCceEEE
Q 008785 269 NFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS---SFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIV 343 (553)
Q Consensus 269 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV 343 (553)
+|... +.||+|+||.||++... +|+.||+|++++. .....+.+.+|..++.++ +||||+++++++.+.+..|+|
T Consensus 10 ~y~~~-~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 10 DFDLL-RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GEEEE-EEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred heEEE-EEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 34333 45699999999999975 4889999999764 233456788999999988 899999999999999999999
Q ss_pred EEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCC
Q 008785 344 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVP 423 (553)
Q Consensus 344 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~ 423 (553)
|||+++|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 89 ~e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~ 161 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 161 (345)
T ss_dssp ECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred EeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEecccccccc
Confidence 999999999999964 24589999999999999999999999 99999999999999999999999999998643
Q ss_pred cccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcCccccc-------------chHHHHHhcCCH---
Q 008785 424 WEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVLCRRW-------------WTLYTLVHSMSL--- 487 (553)
Q Consensus 424 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~~~~~-------------~~l~~~~~~~~~--- 487 (553)
..... .....||+.|+|||++.+..++.++||||||+++|||++..+... ..+.+.+..+..
T Consensus 162 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p 239 (345)
T 3a8x_A 162 RPGDT--TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP 239 (345)
T ss_dssp CTTCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCC
T ss_pred CCCCc--ccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCC
Confidence 22211 222349999999999999999999999999999999997332221 112223333322
Q ss_pred -HHHHHHHHHHhhccCCCCCCCCCH------HHHHHHHH
Q 008785 488 -LCAQECLMLFISCNNWPSHLSQSK------FCNLKLWV 519 (553)
Q Consensus 488 -~~~~~l~~l~~~Cl~~dP~~RPs~------~evl~~l~ 519 (553)
..+..+.+++.+||+.||++||++ .|++++-.
T Consensus 240 ~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~ 278 (345)
T 3a8x_A 240 RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPF 278 (345)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGG
T ss_pred CCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCc
Confidence 456788999999999999999995 78887643
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-41 Score=344.21 Aligned_cols=240 Identities=21% Similarity=0.235 Sum_probs=197.5
Q ss_pred cccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCC---hhhHHHHHHHHHHhhcc-CCCceeeEeeEEeeCCceEE
Q 008785 268 KNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYI 342 (553)
Q Consensus 268 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~l 342 (553)
++|... ++||+|+||.||++... +|+.||||++++.. ....+.+..|..++..+ +||||+++++++.+.+..|+
T Consensus 17 ~~y~~~-~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~l 95 (345)
T 1xjd_A 17 EDFILH-KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF 95 (345)
T ss_dssp TTEEEE-EEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred HHeEEE-EEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEE
Confidence 445443 45699999999999975 58899999997642 23356678899999887 99999999999999999999
Q ss_pred EEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccC
Q 008785 343 VYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV 422 (553)
Q Consensus 343 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~ 422 (553)
||||+++|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 96 v~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 168 (345)
T 1xjd_A 96 VMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKEN 168 (345)
T ss_dssp EEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhhhc
Confidence 9999999999999964 23589999999999999999999999 9999999999999999999999999999864
Q ss_pred CcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcCc-cccc---chHHHHHhcCCH----HHHHHHH
Q 008785 423 PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVL-CRRW---WTLYTLVHSMSL----LCAQECL 494 (553)
Q Consensus 423 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~-~~~~---~~l~~~~~~~~~----~~~~~l~ 494 (553)
...... .....||+.|+|||++.+..++.++||||||+++|||++.. |... ..+...+..+.. ..+..+.
T Consensus 169 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~ 246 (345)
T 1xjd_A 169 MLGDAK--TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAK 246 (345)
T ss_dssp CCTTCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHH
T ss_pred ccCCCc--ccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccCHHHH
Confidence 332221 22334999999999999999999999999999999999733 3322 233333333332 4567889
Q ss_pred HHHhhccCCCCCCCCCHH-HHHHH
Q 008785 495 MLFISCNNWPSHLSQSKF-CNLKL 517 (553)
Q Consensus 495 ~l~~~Cl~~dP~~RPs~~-evl~~ 517 (553)
+++.+||..||++||++. |++++
T Consensus 247 ~li~~lL~~dp~~R~~~~~~i~~h 270 (345)
T 1xjd_A 247 DLLVKLFVREPEKRLGVRGDIRQH 270 (345)
T ss_dssp HHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred HHHHHHhcCCHhHcCCChHHHHcC
Confidence 999999999999999998 77765
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=327.72 Aligned_cols=241 Identities=18% Similarity=0.217 Sum_probs=199.0
Q ss_pred hcccCCCCeeecccCceeEEEEEeCC-CCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEE
Q 008785 267 TKNFSEGNRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYE 345 (553)
Q Consensus 267 ~~~~~~~~~~iG~G~~g~Vy~~~~~~-g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 345 (553)
.+.|.... .||+|+||.||+|.... +..||+|++........+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 8 ~~~y~~~~-~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 8 NQYYTLEN-TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHEEEEE-EEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhEEeee-EEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 34454444 45999999999999754 77999999987655667889999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEe---cCCCCeEEeeccccccC
Q 008785 346 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL---DEEFGAHLMGVGLSKFV 422 (553)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl---~~~~~~kl~Dfgla~~~ 422 (553)
|+++++|.+++.. ...+++..+..++.|++.||.|||++ +|+||||||+||++ +.++.+||+|||++...
T Consensus 87 ~~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~ 159 (277)
T 3f3z_A 87 LCTGGELFERVVH----KRVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF 159 (277)
T ss_dssp CCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred ccCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceec
Confidence 9999999998864 24589999999999999999999999 99999999999999 78889999999999866
Q ss_pred CcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcC-cccc---cchHHHHHhcCCH--------HHH
Q 008785 423 PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLV-LCRR---WWTLYTLVHSMSL--------LCA 490 (553)
Q Consensus 423 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~-~~~~---~~~l~~~~~~~~~--------~~~ 490 (553)
....... ...||+.|+|||++.+ .++.++||||||+++|||++. .|.. .......+..+.. ..+
T Consensus 160 ~~~~~~~---~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (277)
T 3f3z_A 160 KPGKMMR---TKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVS 235 (277)
T ss_dssp CTTSCBC---CCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSC
T ss_pred cCccchh---ccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCC
Confidence 5433221 2238999999998865 489999999999999999973 2322 2223333333332 346
Q ss_pred HHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 008785 491 QECLMLFISCNNWPSHLSQSKFCNLKLWV 519 (553)
Q Consensus 491 ~~l~~l~~~Cl~~dP~~RPs~~evl~~l~ 519 (553)
..+.+++.+||+.||++|||+.|++++-.
T Consensus 236 ~~~~~li~~~l~~dp~~R~s~~~~l~h~~ 264 (277)
T 3f3z_A 236 PQAESLIRRLLTKSPKQRITSLQALEHEW 264 (277)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHTTSHH
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcCHH
Confidence 78999999999999999999999998743
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=343.74 Aligned_cols=236 Identities=19% Similarity=0.224 Sum_probs=194.6
Q ss_pred eeecccCceeEEEEEe-CCCCEEEEEEeccCCh---hhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCC
Q 008785 275 RLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSF---QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 350 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~-~~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 350 (553)
+.||+|+||.||+|.. .+|+.||||++..... .....+.+|+.+++.++||||+++++++.+.+..++||||+ +|
T Consensus 15 ~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~-~g 93 (336)
T 3h4j_B 15 ETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GG 93 (336)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCC-CE
T ss_pred EEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEECC-CC
Confidence 4569999999999996 4689999999975421 22357889999999999999999999999999999999999 78
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccce
Q 008785 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER 430 (553)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 430 (553)
+|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||+++++.+||+|||++..........
T Consensus 94 ~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~~~- 165 (336)
T 3h4j_B 94 ELFDYIVE----KKRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLK- 165 (336)
T ss_dssp EHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBTTC-
T ss_pred cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccCCcccc-
Confidence 99998864 24589999999999999999999999 99999999999999999999999999998765443222
Q ss_pred eeecCccccccccccccCCCC-CcccchHhHHHHHHHHhcC-cccccchHHH---HHhcCCH----HHHHHHHHHHhhcc
Q 008785 431 TVMAGGTYGYLAPEFVYRNEL-TTKSDVYSFGVLLLEIRLV-LCRRWWTLYT---LVHSMSL----LCAQECLMLFISCN 501 (553)
Q Consensus 431 ~~~~~gt~~y~aPE~~~~~~~-t~ksDVwSlGvil~ell~~-~~~~~~~l~~---~~~~~~~----~~~~~l~~l~~~Cl 501 (553)
...||+.|+|||++.+..+ +.++||||||+++|||++. .|.......+ .+..+.. ..+..+.+++.+||
T Consensus 166 --~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L 243 (336)
T 3h4j_B 166 --TSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQSLIRRMI 243 (336)
T ss_dssp --CCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCCCCTTSCHHHHHHHHTTS
T ss_pred --cccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCcccCCHHHHHHHHHHc
Confidence 2349999999999988776 7899999999999999973 3333222221 2222211 45678899999999
Q ss_pred CCCCCCCCCHHHHHHHHHHH
Q 008785 502 NWPSHLSQSKFCNLKLWVFA 521 (553)
Q Consensus 502 ~~dP~~RPs~~evl~~l~~~ 521 (553)
+.||.+|||+.|++++-...
T Consensus 244 ~~dP~~Rpt~~eil~hp~~~ 263 (336)
T 3h4j_B 244 VADPMQRITIQEIRRDPWFN 263 (336)
T ss_dssp CSSGGGSCCHHHHTTCHHHH
T ss_pred CCChhHCcCHHHHHhChhhc
Confidence 99999999999999986554
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=335.76 Aligned_cols=237 Identities=20% Similarity=0.251 Sum_probs=197.8
Q ss_pred ccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCC---hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEE
Q 008785 269 NFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVY 344 (553)
Q Consensus 269 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 344 (553)
+|... +.||+|+||.||++... +|+.||+|++++.. ....+.+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus 7 ~y~~~-~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 7 DFQIL-RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GEEEE-EEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HcEEE-EEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 34443 45699999999999975 58999999997642 234567889999999999999999999999999999999
Q ss_pred EccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCc
Q 008785 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW 424 (553)
Q Consensus 345 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~ 424 (553)
||+++|+|.+++.. ...+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 86 e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~ 158 (318)
T 1fot_A 86 DYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 158 (318)
T ss_dssp CCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred eCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence 99999999999975 24589999999999999999999999 999999999999999999999999999986543
Q ss_pred ccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcC-cccccc---hHHHHHhcCCH----HHHHHHHHH
Q 008785 425 EVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLV-LCRRWW---TLYTLVHSMSL----LCAQECLML 496 (553)
Q Consensus 425 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~-~~~~~~---~l~~~~~~~~~----~~~~~l~~l 496 (553)
.. ....||+.|+|||++.+..++.++||||||+++|||++. .|.... .....+..+.. ..+..+.++
T Consensus 159 ~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~l 233 (318)
T 1fot_A 159 VT-----YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDL 233 (318)
T ss_dssp CB-----CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHH
T ss_pred cc-----ccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 21 223499999999999999999999999999999999973 333222 22333333322 456788999
Q ss_pred HhhccCCCCCCCC-----CHHHHHHHH
Q 008785 497 FISCNNWPSHLSQ-----SKFCNLKLW 518 (553)
Q Consensus 497 ~~~Cl~~dP~~RP-----s~~evl~~l 518 (553)
+.+||..||++|| ++.|++++-
T Consensus 234 i~~lL~~dp~~R~~~~~~~~~~i~~hp 260 (318)
T 1fot_A 234 LSRLITRDLSQRLGNLQNGTEDVKNHP 260 (318)
T ss_dssp HHHHTCSCTTTCTTSSTTTTHHHHTSG
T ss_pred HHHHhccCHHHcCCCcCCCHHHHhcCc
Confidence 9999999999999 999999873
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=331.22 Aligned_cols=239 Identities=24% Similarity=0.323 Sum_probs=184.2
Q ss_pred CeeecccCceeEEEEEeCCCCEEEEEEeccC--ChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCC
Q 008785 274 NRLLGDSKTGGTYSGILPDGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP 351 (553)
Q Consensus 274 ~~~iG~G~~g~Vy~~~~~~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gs 351 (553)
.+.||+|+||.||+|... ..||||+++.. .....+.+.+|+.++++++||||++++++. ..+..++||||+++++
T Consensus 29 ~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~~~~~~ 105 (289)
T 3og7_A 29 GQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSS 105 (289)
T ss_dssp EEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEECCCEEE
T ss_pred eeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEEecCCCc
Confidence 445699999999999864 36999999754 344567899999999999999999999964 5567899999999999
Q ss_pred HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCccccccee
Q 008785 352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT 431 (553)
Q Consensus 352 L~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~ 431 (553)
|.+++.. ....+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++............
T Consensus 106 L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 179 (289)
T 3og7_A 106 LYHHLHA---SETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQF 179 (289)
T ss_dssp HHHHHTT---C---CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC--------------
T ss_pred HHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceeccccccccccccc
Confidence 9999964 345689999999999999999999999 9999999999999999999999999999765432222222
Q ss_pred eecCcccccccccccc---CCCCCcccchHhHHHHHHHHhcC-ccccc----chHHHHHhcCCH---------HHHHHHH
Q 008785 432 VMAGGTYGYLAPEFVY---RNELTTKSDVYSFGVLLLEIRLV-LCRRW----WTLYTLVHSMSL---------LCAQECL 494 (553)
Q Consensus 432 ~~~~gt~~y~aPE~~~---~~~~t~ksDVwSlGvil~ell~~-~~~~~----~~l~~~~~~~~~---------~~~~~l~ 494 (553)
....||+.|+|||++. +..++.++||||||+++|||++. .|... ..+.+.+..+.. ..+..+.
T Consensus 180 ~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 259 (289)
T 3og7_A 180 EQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMK 259 (289)
T ss_dssp ----CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTTSCHHHH
T ss_pred cccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhccccCCHHHH
Confidence 2233899999999986 56788999999999999999973 23222 223333333222 4567899
Q ss_pred HHHhhccCCCCCCCCCHHHHHHHHHHH
Q 008785 495 MLFISCNNWPSHLSQSKFCNLKLWVFA 521 (553)
Q Consensus 495 ~l~~~Cl~~dP~~RPs~~evl~~l~~~ 521 (553)
+++.+||+.||++|||+.|+++.+...
T Consensus 260 ~li~~~l~~~p~~Rps~~ell~~L~~l 286 (289)
T 3og7_A 260 RLMAECLKKKRDERPSFPRILAEIEEL 286 (289)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred HHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 999999999999999999999987653
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=334.66 Aligned_cols=256 Identities=23% Similarity=0.269 Sum_probs=203.9
Q ss_pred hhcccCCCCeeecccCceeEEEEEe------CCCCEEEEEEeccCC-hhhHHHHHHHHHHhhcc-CCCceeeEeeEEeeC
Q 008785 266 ITKNFSEGNRLLGDSKTGGTYSGIL------PDGSRVAVKRLKRSS-FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDH 337 (553)
Q Consensus 266 ~~~~~~~~~~~iG~G~~g~Vy~~~~------~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~ 337 (553)
..++|... +.||+|+||.||+|.. .+++.||||+++... ....+.+.+|+.++.++ +||||+++++++...
T Consensus 25 ~~~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 103 (316)
T 2xir_A 25 PRDRLKLG-KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 103 (316)
T ss_dssp CGGGEEEE-EEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred chhheeee-eEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecC
Confidence 34455444 4569999999999984 346799999998653 33456789999999999 799999999998876
Q ss_pred C-ceEEEEEccCCCCHHHHhccCCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEE
Q 008785 338 G-DRYIVYEFVVNGPLDRWLHHIPRG------------GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 404 (553)
Q Consensus 338 ~-~~~lV~E~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NIL 404 (553)
+ ..++||||+++|+|.+++...... ...+++..+..++.||+.||.|||++ +|+||||||+||+
T Consensus 104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil 180 (316)
T 2xir_A 104 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNIL 180 (316)
T ss_dssp TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEE
Confidence 5 489999999999999999763221 12388999999999999999999999 9999999999999
Q ss_pred ecCCCCeEEeeccccccCCcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhc-Cc-cccc----chH
Q 008785 405 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-VL-CRRW----WTL 478 (553)
Q Consensus 405 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-~~-~~~~----~~l 478 (553)
++.++.+||+|||+++...............||+.|+|||++.+..++.++||||||+++|||++ .. |... ..+
T Consensus 181 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~ 260 (316)
T 2xir_A 181 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 260 (316)
T ss_dssp ECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHH
T ss_pred ECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHH
Confidence 99999999999999987654433222222237889999999999999999999999999999997 32 2222 222
Q ss_pred HHHHhcCCH-----HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHhhc
Q 008785 479 YTLVHSMSL-----LCAQECLMLFISCNNWPSHLSQSKFCNLKLWVFAILTI 525 (553)
Q Consensus 479 ~~~~~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~~~~~~ 525 (553)
...+..+.. ..+..+.+++.+||+.||.+|||+.|+++++...+...
T Consensus 261 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 312 (316)
T 2xir_A 261 CRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 312 (316)
T ss_dssp HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 333333221 45678999999999999999999999999988776544
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=338.61 Aligned_cols=254 Identities=25% Similarity=0.300 Sum_probs=199.1
Q ss_pred CeeecccCceeEEEEEe------CCCCEEEEEEeccC-ChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEc
Q 008785 274 NRLLGDSKTGGTYSGIL------PDGSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF 346 (553)
Q Consensus 274 ~~~iG~G~~g~Vy~~~~------~~g~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 346 (553)
.+.||+|+||.||+|.. .+++.||||.+... ......++.+|+.++++++||||+++++++.+.+..++||||
T Consensus 35 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 114 (327)
T 2yfx_A 35 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMEL 114 (327)
T ss_dssp EEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred EEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcEEEEec
Confidence 45569999999999984 24778999999754 344567889999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecC---CCCeEEeeccccc
Q 008785 347 VVNGPLDRWLHHIPR---GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE---EFGAHLMGVGLSK 420 (553)
Q Consensus 347 ~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~---~~~~kl~Dfgla~ 420 (553)
+++|+|.+++..... ....+++..+..++.||+.||.|||+. +|+||||||+|||++. +..+||+|||++.
T Consensus 115 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~ 191 (327)
T 2yfx_A 115 MAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 191 (327)
T ss_dssp CTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECCCHHHH
T ss_pred CCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEEECcccccc
Confidence 999999999986432 124589999999999999999999999 9999999999999984 4569999999987
Q ss_pred cCCcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhc-C-ccccc---chHHHHHhcCCH-----HHH
Q 008785 421 FVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-V-LCRRW---WTLYTLVHSMSL-----LCA 490 (553)
Q Consensus 421 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-~-~~~~~---~~l~~~~~~~~~-----~~~ 490 (553)
...............||+.|+|||++.+..++.++||||||+++|||++ . .|... ..+.+.+..+.. ..+
T Consensus 192 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (327)
T 2yfx_A 192 DIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCP 271 (327)
T ss_dssp HHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCC
T ss_pred ccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCCCCCCCCCCC
Confidence 5433322222222337889999999998999999999999999999997 3 23322 223333333321 566
Q ss_pred HHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHhhcccccc
Q 008785 491 QECLMLFISCNNWPSHLSQSKFCNLKLWVFAILTIRKVQF 530 (553)
Q Consensus 491 ~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~~~~~~~~~~~ 530 (553)
..+.+++.+||+.||.+|||+.|+++++............
T Consensus 272 ~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~~~~ 311 (327)
T 2yfx_A 272 GPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINT 311 (327)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHHHHTC
T ss_pred HHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCHHHhcc
Confidence 7899999999999999999999999998776655443333
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=362.75 Aligned_cols=243 Identities=21% Similarity=0.285 Sum_probs=198.0
Q ss_pred eecccCceeEEEEEeC---CCCEEEEEEeccCC-hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCC
Q 008785 276 LLGDSKTGGTYSGILP---DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP 351 (553)
Q Consensus 276 ~iG~G~~g~Vy~~~~~---~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gs 351 (553)
.||+|+||.||+|.+. ++..||||+++... ....+++.+|+.+|++++|||||++++++.+ +..++||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 4699999999999864 45679999998653 3456889999999999999999999999876 56899999999999
Q ss_pred HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccce-
Q 008785 352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER- 430 (553)
Q Consensus 352 L~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~- 430 (553)
|.+++.. ....+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++..........
T Consensus 422 L~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 495 (613)
T 2ozo_A 422 LHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTA 495 (613)
T ss_dssp HHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--------
T ss_pred HHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeee
Confidence 9999964 345689999999999999999999999 999999999999999999999999999987654322111
Q ss_pred eeecCccccccccccccCCCCCcccchHhHHHHHHHHhc-C-ccc---ccchHHHHHhcCCH-----HHHHHHHHHHhhc
Q 008785 431 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-V-LCR---RWWTLYTLVHSMSL-----LCAQECLMLFISC 500 (553)
Q Consensus 431 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-~-~~~---~~~~l~~~~~~~~~-----~~~~~l~~l~~~C 500 (553)
.....+|+.|+|||++.+..++.++|||||||++|||++ . .|. ....+.+.+..+.. ..+..+.+++.+|
T Consensus 496 ~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~c 575 (613)
T 2ozo_A 496 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDC 575 (613)
T ss_dssp ------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHT
T ss_pred ccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHH
Confidence 112225689999999998999999999999999999997 2 222 22344445554432 5678899999999
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHhhc
Q 008785 501 NNWPSHLSQSKFCNLKLWVFAILTI 525 (553)
Q Consensus 501 l~~dP~~RPs~~evl~~l~~~~~~~ 525 (553)
|+.||++|||+.++++.|.......
T Consensus 576 l~~dP~~RPs~~~l~~~L~~~~~~~ 600 (613)
T 2ozo_A 576 WIYKWEDRPDFLTVEQRMRACYYSL 600 (613)
T ss_dssp TCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred cCCChhHCcCHHHHHHHHHHHHHHh
Confidence 9999999999999999887665544
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-40 Score=332.23 Aligned_cols=250 Identities=27% Similarity=0.340 Sum_probs=200.4
Q ss_pred ccCCCCeeecccCceeEEEEEeC-----CCCEEEEEEeccCC-hhhHHHHHHHHHHhhccCCCceeeEeeEEeeC--Cce
Q 008785 269 NFSEGNRLLGDSKTGGTYSGILP-----DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH--GDR 340 (553)
Q Consensus 269 ~~~~~~~~iG~G~~g~Vy~~~~~-----~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~ 340 (553)
++....+.||+|+||.||++.+. +|+.||||+++... ....+.+.+|+.++++++||||+++++++.+. ...
T Consensus 31 r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 110 (318)
T 3lxp_A 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASL 110 (318)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEE
T ss_pred HHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceE
Confidence 34333456799999999998753 57899999998653 34467799999999999999999999999884 567
Q ss_pred EEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccc
Q 008785 341 YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSK 420 (553)
Q Consensus 341 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~ 420 (553)
++||||+++|+|.+++.. ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++.
T Consensus 111 ~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~ 182 (318)
T 3lxp_A 111 QLVMEYVPLGSLRDYLPR-----HSIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAK 182 (318)
T ss_dssp EEEECCCTTCBHHHHGGG-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred EEEEecccCCcHHHHHhh-----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCccccc
Confidence 999999999999999965 2489999999999999999999999 99999999999999999999999999998
Q ss_pred cCCcccccc-eeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcCcccccch-------------------HHH
Q 008785 421 FVPWEVMQE-RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVLCRRWWT-------------------LYT 480 (553)
Q Consensus 421 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~~~~~~~-------------------l~~ 480 (553)
......... ......+|+.|+|||++.+..++.++||||||+++|||++........ +.+
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (318)
T 3lxp_A 183 AVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTE 262 (318)
T ss_dssp ECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHH
T ss_pred cccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHH
Confidence 765443211 122233788899999999889999999999999999999833221111 111
Q ss_pred HHhcCCH-----HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHhhcc
Q 008785 481 LVHSMSL-----LCAQECLMLFISCNNWPSHLSQSKFCNLKLWVFAILTIR 526 (553)
Q Consensus 481 ~~~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~~~~~~~ 526 (553)
.+..+.. ..+..+.+++.+||+.||++|||+.|+++.+.......+
T Consensus 263 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~ 313 (318)
T 3lxp_A 263 LLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQ 313 (318)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred HHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhc
Confidence 2222211 456789999999999999999999999998876554443
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=337.81 Aligned_cols=241 Identities=20% Similarity=0.184 Sum_probs=188.5
Q ss_pred ccCCCCeeecccCceeEEEEEe----CCCCEEEEEEeccCC----hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCce
Q 008785 269 NFSEGNRLLGDSKTGGTYSGIL----PDGSRVAVKRLKRSS----FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR 340 (553)
Q Consensus 269 ~~~~~~~~iG~G~~g~Vy~~~~----~~g~~vAvK~~~~~~----~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 340 (553)
+|... +.||+|+||.||++.. .+|+.||+|+++... ......+.+|+.++++++||||+++++++.+.+..
T Consensus 18 ~y~~~-~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 96 (327)
T 3a62_A 18 CFELL-RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKL 96 (327)
T ss_dssp GEEEE-EEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCE
T ss_pred HeEEE-EEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEE
Confidence 34443 4569999999999996 468999999998652 23345678999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccc
Q 008785 341 YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSK 420 (553)
Q Consensus 341 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~ 420 (553)
++||||+++|+|.+++.. ...+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 97 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 97 YLILEYLSGGELFMQLER----EGIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp EEEEECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred EEEEeCCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 999999999999999964 24588999999999999999999999 99999999999999999999999999997
Q ss_pred cCCcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcC-cccccc---hHHHHHhcCCH----HHHHH
Q 008785 421 FVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLV-LCRRWW---TLYTLVHSMSL----LCAQE 492 (553)
Q Consensus 421 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~-~~~~~~---~l~~~~~~~~~----~~~~~ 492 (553)
........ .....||+.|+|||++.+..++.++||||||+++|||++. .|.... .....+..+.. ..+..
T Consensus 170 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~ 247 (327)
T 3a62_A 170 ESIHDGTV--THTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQE 247 (327)
T ss_dssp -----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTSCHH
T ss_pred ccccCCcc--ccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHH
Confidence 54332211 1223489999999999999999999999999999999973 333222 22333322222 45678
Q ss_pred HHHHHhhccCCCCCCCC-----CHHHHHHHHH
Q 008785 493 CLMLFISCNNWPSHLSQ-----SKFCNLKLWV 519 (553)
Q Consensus 493 l~~l~~~Cl~~dP~~RP-----s~~evl~~l~ 519 (553)
+.+++.+||+.||++|| ++.|++++-.
T Consensus 248 ~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~ 279 (327)
T 3a62_A 248 ARDLLKKLLKRNAASRLGAGPGDAGEVQAHPF 279 (327)
T ss_dssp HHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGG
T ss_pred HHHHHHHHHhcCHhhccCCCCCCHHHHHcCCc
Confidence 89999999999999999 8889998743
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=342.68 Aligned_cols=239 Identities=15% Similarity=0.149 Sum_probs=191.9
Q ss_pred eeeccc--CceeEEEEEeC-CCCEEEEEEeccCC--hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCC
Q 008785 275 RLLGDS--KTGGTYSGILP-DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 349 (553)
Q Consensus 275 ~~iG~G--~~g~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 349 (553)
+.||+| +||.||++... +|+.||||+++... ....+.+.+|+.++++++||||+++++++.+.+..++||||+++
T Consensus 31 ~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 110 (389)
T 3gni_B 31 TVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAY 110 (389)
T ss_dssp EEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred ecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEEEccCC
Confidence 456999 99999999976 59999999997543 34457788999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccc
Q 008785 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE 429 (553)
Q Consensus 350 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 429 (553)
|+|.+++... ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||.+..........
T Consensus 111 ~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~~~ 185 (389)
T 3gni_B 111 GSAKDLICTH--FMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQ 185 (389)
T ss_dssp CBHHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEECEETTEEC
T ss_pred CCHHHHHhhh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceeeccccccc
Confidence 9999999762 334589999999999999999999999 99999999999999999999999999986543221111
Q ss_pred -----eeeecCccccccccccccC--CCCCcccchHhHHHHHHHHhcCc-cccc---chHHHHHhcCC------------
Q 008785 430 -----RTVMAGGTYGYLAPEFVYR--NELTTKSDVYSFGVLLLEIRLVL-CRRW---WTLYTLVHSMS------------ 486 (553)
Q Consensus 430 -----~~~~~~gt~~y~aPE~~~~--~~~t~ksDVwSlGvil~ell~~~-~~~~---~~l~~~~~~~~------------ 486 (553)
......||+.|+|||++.+ ..++.++|||||||++|||++.. |... .........+.
T Consensus 186 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (389)
T 3gni_B 186 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPA 265 (389)
T ss_dssp SCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC----------------
T ss_pred cccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccccccccc
Confidence 1111248899999999987 57899999999999999999732 2211 11111000000
Q ss_pred --------------------------------------HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008785 487 --------------------------------------LLCAQECLMLFISCNNWPSHLSQSKFCNLKLW 518 (553)
Q Consensus 487 --------------------------------------~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l 518 (553)
...+..+.+|+.+||+.||++|||+.|++++-
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp 335 (389)
T 3gni_B 266 EELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHS 335 (389)
T ss_dssp ----------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSG
T ss_pred ccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCH
Confidence 02345689999999999999999999999873
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=336.96 Aligned_cols=245 Identities=24% Similarity=0.303 Sum_probs=198.2
Q ss_pred eeecccCceeEEEEEe-----CCCCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeEEee--CCceEEEEEcc
Q 008785 275 RLLGDSKTGGTYSGIL-----PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD--HGDRYIVYEFV 347 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~-----~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--~~~~~lV~E~~ 347 (553)
+.||+|+||.||++.+ .+++.||||++........+.+.+|+.++++++||||+++++++.. ....++||||+
T Consensus 29 ~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~ 108 (327)
T 3lxl_A 29 SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYL 108 (327)
T ss_dssp EEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEEEEECC
T ss_pred hhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEEEEeec
Confidence 4569999999999984 3588999999988777777889999999999999999999999874 45689999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccc
Q 008785 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM 427 (553)
Q Consensus 348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 427 (553)
++|+|.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++........
T Consensus 109 ~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 182 (327)
T 3lxl_A 109 PSGCLRDFLQR---HRARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKD 182 (327)
T ss_dssp TTCBHHHHHHH---HGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCEECCTTCS
T ss_pred CCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccceecccCCc
Confidence 99999999975 223589999999999999999999999 999999999999999999999999999987654332
Q ss_pred cc-eeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcCcccccchH-------------------HHHHhcCCH
Q 008785 428 QE-RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVLCRRWWTL-------------------YTLVHSMSL 487 (553)
Q Consensus 428 ~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~~~~~~~l-------------------~~~~~~~~~ 487 (553)
.. ......||+.|+|||++.+..++.++||||||+++|||++......... .+.+..+..
T Consensus 183 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (327)
T 3lxl_A 183 YYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQR 262 (327)
T ss_dssp EEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHTTCC
T ss_pred cceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhcccC
Confidence 21 1122237888999999998889999999999999999998332221111 111111111
Q ss_pred -----HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHhhc
Q 008785 488 -----LCAQECLMLFISCNNWPSHLSQSKFCNLKLWVFAILTI 525 (553)
Q Consensus 488 -----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~~~~~~ 525 (553)
..+..+.+++.+||+.||++|||+.|+++++.......
T Consensus 263 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 305 (327)
T 3lxl_A 263 LPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS 305 (327)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 45678999999999999999999999999887655444
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=331.74 Aligned_cols=242 Identities=21% Similarity=0.253 Sum_probs=192.0
Q ss_pred cccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCC-hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEE
Q 008785 268 KNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYE 345 (553)
Q Consensus 268 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 345 (553)
+.|.... .||+|+||.||++... ++..||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 22 ~~y~~~~-~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 22 DLFIFKR-KLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHEEEEE-EEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hheeecc-eeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 3454444 4599999999999964 58899999997653 3346789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEe---cCCCCeEEeeccccccC
Q 008785 346 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL---DEEFGAHLMGVGLSKFV 422 (553)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl---~~~~~~kl~Dfgla~~~ 422 (553)
|+++|+|.+++.........+++..+..++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||++...
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 9999999999864322345699999999999999999999999 99999999999999 45678999999999865
Q ss_pred CcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhc-CcccccchHHH---HHhcCC--H-----HHHH
Q 008785 423 PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-VLCRRWWTLYT---LVHSMS--L-----LCAQ 491 (553)
Q Consensus 423 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-~~~~~~~~l~~---~~~~~~--~-----~~~~ 491 (553)
...... ....||+.|+|||++. ..++.++||||||+++|||++ ..|.......+ ...... . ..+.
T Consensus 178 ~~~~~~---~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (285)
T 3is5_A 178 KSDEHS---TNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTP 253 (285)
T ss_dssp ------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--CCCCH
T ss_pred CCcccC---cCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccCcCCH
Confidence 543222 1223899999999875 578999999999999999997 33333322222 221111 1 3467
Q ss_pred HHHHHHhhccCCCCCCCCCHHHHHHH
Q 008785 492 ECLMLFISCNNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 492 ~l~~l~~~Cl~~dP~~RPs~~evl~~ 517 (553)
.+.+++.+||+.||++|||+.|++++
T Consensus 254 ~~~~li~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 254 QAVDLLKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp HHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcC
Confidence 88999999999999999999999875
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=333.61 Aligned_cols=238 Identities=19% Similarity=0.202 Sum_probs=196.9
Q ss_pred ccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCChh------hHHHHHHHHHHhhccCCCceeeEeeEEeeCCceE
Q 008785 269 NFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQ------RKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRY 341 (553)
Q Consensus 269 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~~------~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 341 (553)
.|... +.||+|+||.||++... +|+.||||.++..... ..+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 13 ~y~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (321)
T 2a2a_A 13 FYDIG-EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV 91 (321)
T ss_dssp HEEEE-EEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cEEEe-eEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 34443 45699999999999975 5899999999764321 3678999999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCC----CeEEeecc
Q 008785 342 IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF----GAHLMGVG 417 (553)
Q Consensus 342 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~----~~kl~Dfg 417 (553)
+||||+++++|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++ .+||+|||
T Consensus 92 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg 164 (321)
T 2a2a_A 92 LILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (321)
T ss_dssp EEECCCCSCBHHHHHHT----CSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred EEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccCc
Confidence 99999999999999964 34689999999999999999999999 999999999999999887 79999999
Q ss_pred ccccCCcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcC-ccccc---chHHHHHhcCCH------
Q 008785 418 LSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLV-LCRRW---WTLYTLVHSMSL------ 487 (553)
Q Consensus 418 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~-~~~~~---~~l~~~~~~~~~------ 487 (553)
++......... ....||+.|+|||++.+..++.++||||||+++|||++. .|... ......+..+..
T Consensus 165 ~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 241 (321)
T 2a2a_A 165 LAHEIEDGVEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEF 241 (321)
T ss_dssp TCEECCTTCCC---CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHH
T ss_pred cceecCccccc---cccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhh
Confidence 99876543221 122389999999999989999999999999999999973 33322 222223333221
Q ss_pred --HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008785 488 --LCAQECLMLFISCNNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 488 --~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 517 (553)
..+..+.+++.+||+.||++|||+.|++++
T Consensus 242 ~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 242 FSHTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp HTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred hcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 345678999999999999999999999986
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=360.81 Aligned_cols=239 Identities=25% Similarity=0.336 Sum_probs=198.7
Q ss_pred CeeecccCceeEEEEEeCCCCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCCHH
Q 008785 274 NRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 353 (553)
Q Consensus 274 ~~~iG~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~ 353 (553)
.+.||+|+||.||+|.+.++..||||+++... ...++|.+|+.+|++++||||+++++++.+ +..+|||||+++|+|.
T Consensus 272 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~gsL~ 349 (535)
T 2h8h_A 272 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLL 349 (535)
T ss_dssp EEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTEEHH
T ss_pred heecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhcCCcHH
Confidence 34569999999999999888899999998654 345789999999999999999999999876 6789999999999999
Q ss_pred HHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccceeee
Q 008785 354 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVM 433 (553)
Q Consensus 354 ~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 433 (553)
++|.. .....+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++........... .
T Consensus 350 ~~l~~--~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~-~ 423 (535)
T 2h8h_A 350 DFLKG--ETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ-G 423 (535)
T ss_dssp HHHSH--HHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHTTC-S
T ss_pred HHHhh--cCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecCCCceeccc-C
Confidence 99964 1224589999999999999999999999 9999999999999999999999999999876543222211 2
Q ss_pred cCccccccccccccCCCCCcccchHhHHHHHHHHhc-C-ccccc---chHHHHHhcCCH-----HHHHHHHHHHhhccCC
Q 008785 434 AGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-V-LCRRW---WTLYTLVHSMSL-----LCAQECLMLFISCNNW 503 (553)
Q Consensus 434 ~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-~-~~~~~---~~l~~~~~~~~~-----~~~~~l~~l~~~Cl~~ 503 (553)
..++..|+|||++.+..++.++||||||+++|||++ . .|... ..+.+.+..+.. ..+..+.+|+.+||+.
T Consensus 424 ~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~ 503 (535)
T 2h8h_A 424 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRK 503 (535)
T ss_dssp TTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred CcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCC
Confidence 226789999999998999999999999999999998 2 23322 233334443321 5677899999999999
Q ss_pred CCCCCCCHHHHHHHHHH
Q 008785 504 PSHLSQSKFCNLKLWVF 520 (553)
Q Consensus 504 dP~~RPs~~evl~~l~~ 520 (553)
||++|||+.+|++.|..
T Consensus 504 dP~~RPt~~~l~~~L~~ 520 (535)
T 2h8h_A 504 EPEERPTFEYLQAFLED 520 (535)
T ss_dssp SGGGSCCHHHHHHHHHT
T ss_pred ChhHCcCHHHHHHHHHH
Confidence 99999999999987754
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=352.22 Aligned_cols=252 Identities=19% Similarity=0.173 Sum_probs=202.3
Q ss_pred HHHHHhhcccCCCCeeecccCceeEEEEEeCC-CCEEEEEEeccCChh---hHHHHHHHHHHhhccCCCceeeEeeEEee
Q 008785 261 EELRSITKNFSEGNRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQ---RKKEFYSEIGRFARLHHPNLVAVKGCCYD 336 (553)
Q Consensus 261 ~el~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~-g~~vAvK~~~~~~~~---~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 336 (553)
.++....++|.... +||+|+||+||++...+ ++.||+|++++.... ....+.+|..++..++||||+++++++.+
T Consensus 67 ~~~~~~~~~y~~~~-~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 145 (437)
T 4aw2_A 67 KQMRLHREDFEILK-VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD 145 (437)
T ss_dssp HHHSCCGGGEEEEE-EEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hcccCChhheEEEE-EEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence 34444556676654 45999999999999765 789999999753221 22348899999999999999999999999
Q ss_pred CCceEEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeec
Q 008785 337 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGV 416 (553)
Q Consensus 337 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Df 416 (553)
.+..|+||||+++|+|.+++.. ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+||
T Consensus 146 ~~~~~lV~Ey~~gg~L~~~l~~---~~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DF 219 (437)
T 4aw2_A 146 DNNLYLVMDYYVGGDLLTLLSK---FEDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADF 219 (437)
T ss_dssp SSEEEEEECCCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred CCEEEEEEecCCCCcHHHHHHH---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcch
Confidence 9999999999999999999974 235699999999999999999999999 9999999999999999999999999
Q ss_pred cccccCCcccccceeeecCcccccccccccc-----CCCCCcccchHhHHHHHHHHhcC-cccccch---HHHHHhcC--
Q 008785 417 GLSKFVPWEVMQERTVMAGGTYGYLAPEFVY-----RNELTTKSDVYSFGVLLLEIRLV-LCRRWWT---LYTLVHSM-- 485 (553)
Q Consensus 417 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDVwSlGvil~ell~~-~~~~~~~---l~~~~~~~-- 485 (553)
|+++.......... ....||+.|+|||++. ...++.++|||||||++|||++. .|....+ ....+...
T Consensus 220 Gla~~~~~~~~~~~-~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~ 298 (437)
T 4aw2_A 220 GSCLKLMEDGTVQS-SVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE 298 (437)
T ss_dssp TTCEECCTTSCEEC-CSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH
T ss_pred hhhhhcccCCCccc-ccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccc
Confidence 99976654332221 2234999999999987 56789999999999999999973 3333322 22222111
Q ss_pred --CH-----HHHHHHHHHHhhccCCCCCC--CCCHHHHHHHHHH
Q 008785 486 --SL-----LCAQECLMLFISCNNWPSHL--SQSKFCNLKLWVF 520 (553)
Q Consensus 486 --~~-----~~~~~l~~l~~~Cl~~dP~~--RPs~~evl~~l~~ 520 (553)
.+ ..+..+.+|+.+||..+|++ ||++.|++++-..
T Consensus 299 ~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff 342 (437)
T 4aw2_A 299 RFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFF 342 (437)
T ss_dssp HCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGG
T ss_pred cccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCcc
Confidence 11 35778999999999988888 9999999988544
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=328.15 Aligned_cols=243 Identities=21% Similarity=0.243 Sum_probs=199.0
Q ss_pred hcccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccC--ChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEE
Q 008785 267 TKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIV 343 (553)
Q Consensus 267 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 343 (553)
.++|.... .||+|+||.||+|... +|+.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 5 ~~~y~~~~-~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 5 SDNYDVKE-ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTEEEEE-EEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhh-hhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 34454444 4599999999999975 4899999999754 334457788999999999999999999999999999999
Q ss_pred EEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCC---eEEeeccccc
Q 008785 344 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG---AHLMGVGLSK 420 (553)
Q Consensus 344 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~---~kl~Dfgla~ 420 (553)
|||+++|+|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++. +||+|||++.
T Consensus 84 ~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~ 156 (284)
T 3kk8_A 84 FDLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAI 156 (284)
T ss_dssp ECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeE
Confidence 999999999988864 24589999999999999999999999 9999999999999987655 9999999997
Q ss_pred cCCcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcC-cccc---cchHHHHHhcCCH--------H
Q 008785 421 FVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLV-LCRR---WWTLYTLVHSMSL--------L 488 (553)
Q Consensus 421 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~-~~~~---~~~l~~~~~~~~~--------~ 488 (553)
......... ...||+.|+|||++.+..++.++||||||+++|+|++. .|.. ...+...+..+.. .
T Consensus 157 ~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T 3kk8_A 157 EVNDSEAWH---GFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDT 233 (284)
T ss_dssp ECCSSCBCC---CSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTT
T ss_pred EcccCcccc---CCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcc
Confidence 665433221 22389999999999999999999999999999999973 3322 2223333333322 4
Q ss_pred HHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 008785 489 CAQECLMLFISCNNWPSHLSQSKFCNLKLWVF 520 (553)
Q Consensus 489 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~ 520 (553)
.+..+.+++.+||+.||++|||+.|++++-..
T Consensus 234 ~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~ 265 (284)
T 3kk8_A 234 VTPEAKSLIDSMLTVNPKKRITADQALKVPWI 265 (284)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHH
T ss_pred cCHHHHHHHHHHcccChhhCCCHHHHhcCccc
Confidence 56789999999999999999999999997543
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=339.87 Aligned_cols=238 Identities=19% Similarity=0.196 Sum_probs=199.4
Q ss_pred ccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCC---hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEE
Q 008785 269 NFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVY 344 (553)
Q Consensus 269 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 344 (553)
+|... +.||+|+||.||++... +|+.||||+++... ....+.+.+|+.++++++||||+++++++.+.+..|+||
T Consensus 42 ~y~~~-~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 42 QFDRI-KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GEEEE-EEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HCEEE-EEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 34443 45699999999999975 58999999997542 234567889999999999999999999999999999999
Q ss_pred EccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCc
Q 008785 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW 424 (553)
Q Consensus 345 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~ 424 (553)
||+++|+|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 121 e~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~ 193 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRI----GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp ECCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred cCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccC
Confidence 999999999999752 3589999999999999999999999 999999999999999999999999999986543
Q ss_pred ccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcCc-cccc---chHHHHHhcCCH----HHHHHHHHH
Q 008785 425 EVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVL-CRRW---WTLYTLVHSMSL----LCAQECLML 496 (553)
Q Consensus 425 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~-~~~~---~~l~~~~~~~~~----~~~~~l~~l 496 (553)
.. ....||+.|+|||++.+..++.++||||||+++|||++.. |... ..+.+.+..+.. ..+..+.++
T Consensus 194 ~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~l 268 (350)
T 1rdq_E 194 RT-----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL 268 (350)
T ss_dssp CB-----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHH
T ss_pred Cc-----ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 21 1223899999999999999999999999999999999733 3222 233334444433 456789999
Q ss_pred HhhccCCCCCCCCC-----HHHHHHHHH
Q 008785 497 FISCNNWPSHLSQS-----KFCNLKLWV 519 (553)
Q Consensus 497 ~~~Cl~~dP~~RPs-----~~evl~~l~ 519 (553)
+.+||+.||++||+ +.|++++-.
T Consensus 269 i~~lL~~dp~~R~~~~~~~~~ei~~h~~ 296 (350)
T 1rdq_E 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKW 296 (350)
T ss_dssp HHHHSCSCTTTCTTSSTTTTHHHHTSGG
T ss_pred HHHHhhcCHHhccCCccCCHHHHHhCcC
Confidence 99999999999999 999998743
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=353.89 Aligned_cols=242 Identities=22% Similarity=0.207 Sum_probs=189.8
Q ss_pred cccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccC---ChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEE
Q 008785 268 KNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS---SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIV 343 (553)
Q Consensus 268 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 343 (553)
++|... +.||+|+||.||++... +|+.||||+++.. .......+.+|+.++++++||||+++++++.+.+..++|
T Consensus 148 ~~y~~~-~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 148 NEFEYL-KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGEEEE-EEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred HHcEEe-EEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 345443 45699999999999964 5899999999754 223346678999999999999999999999999999999
Q ss_pred EEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCceecCCCCCcEEecCCCCeEEeeccccccC
Q 008785 344 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD-KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV 422 (553)
Q Consensus 344 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~ 422 (553)
|||+++|+|.+++.. ...+++..+..++.||+.||+|||+ . +|+||||||+|||++.++.+||+|||+++..
T Consensus 227 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 299 (446)
T 4ejn_A 227 MEYANGGELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEG 299 (446)
T ss_dssp ECCCSSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTT
T ss_pred EeeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceec
Confidence 999999999999964 2468999999999999999999998 8 9999999999999999999999999999864
Q ss_pred CcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcC-ccccc---chHHHHHhcCCH----HHHHHHH
Q 008785 423 PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLV-LCRRW---WTLYTLVHSMSL----LCAQECL 494 (553)
Q Consensus 423 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~-~~~~~---~~l~~~~~~~~~----~~~~~l~ 494 (553)
....... ....||+.|+|||++.+..++.++||||||+++|||++. .|... ..+.+.+..+.. ..+..+.
T Consensus 300 ~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 377 (446)
T 4ejn_A 300 IKDGATM--KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAK 377 (446)
T ss_dssp CC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHH
T ss_pred cCCCccc--ccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHH
Confidence 4332221 223499999999999999999999999999999999973 33322 233333333322 5667889
Q ss_pred HHHhhccCCCCCCCC-----CHHHHHHHHH
Q 008785 495 MLFISCNNWPSHLSQ-----SKFCNLKLWV 519 (553)
Q Consensus 495 ~l~~~Cl~~dP~~RP-----s~~evl~~l~ 519 (553)
+++.+||+.||++|| |+.|++++-.
T Consensus 378 ~li~~~L~~dP~~R~~~~~~t~~ell~hp~ 407 (446)
T 4ejn_A 378 SLLSGLLKKDPKQRLGGGSEDAKEIMQHRF 407 (446)
T ss_dssp HHHHHHTCSSTTTSTTCSTTTHHHHHTSGG
T ss_pred HHHHHHcccCHHHhCCCCCCCHHHHHhCcc
Confidence 999999999999999 9999998743
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=338.55 Aligned_cols=254 Identities=20% Similarity=0.194 Sum_probs=197.1
Q ss_pred HHHhhcccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccC-----ChhhHHHHHHHHHHhhccCCCceeeEeeEEee
Q 008785 263 LRSITKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS-----SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD 336 (553)
Q Consensus 263 l~~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~-----~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 336 (553)
+..+.++|.....+ |+|+||.||+|... +++.||+|++... .....+.+.+|+.++++++||||+++++++.+
T Consensus 21 ~~~~~~~y~~~~~l-G~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 99 (345)
T 3hko_A 21 LLELQKKYHLKGAI-GQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED 99 (345)
T ss_dssp HHHHHHHEEEEEEE-EECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhhhhheeeccee-eecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence 44566677665554 99999999999974 5889999998754 23445789999999999999999999999999
Q ss_pred CCceEEEEEccCCCCHHHHhccCCCC------------------------------------CCCCCHHHHHHHHHHHHH
Q 008785 337 HGDRYIVYEFVVNGPLDRWLHHIPRG------------------------------------GRSLDWAMRMKVATTLAQ 380 (553)
Q Consensus 337 ~~~~~lV~E~~~~gsL~~~l~~~~~~------------------------------------~~~l~~~~~~~i~~qia~ 380 (553)
.+..++||||+++|+|.+++...... ...+++..+..++.||+.
T Consensus 100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 179 (345)
T 3hko_A 100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179 (345)
T ss_dssp SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence 99999999999999999998521100 122357778899999999
Q ss_pred HHHHHHhCCCCCceecCCCCCcEEecCCC--CeEEeeccccccCCcccccc--eeeecCccccccccccccC--CCCCcc
Q 008785 381 GIAFLHDKVKPHVVHRDIRASNVLLDEEF--GAHLMGVGLSKFVPWEVMQE--RTVMAGGTYGYLAPEFVYR--NELTTK 454 (553)
Q Consensus 381 gL~yLH~~~~~~ivHrDlkp~NILl~~~~--~~kl~Dfgla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~--~~~t~k 454 (553)
||+|||+. +|+||||||+|||++.++ .+||+|||++.......... ......||+.|+|||++.+ ..++.+
T Consensus 180 ~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 256 (345)
T 3hko_A 180 ALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK 256 (345)
T ss_dssp HHHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred HHHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence 99999999 999999999999998766 89999999998653321111 1122348999999999865 678999
Q ss_pred cchHhHHHHHHHHhcC-cccccc---hHHHHHhcCCH--------HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 008785 455 SDVYSFGVLLLEIRLV-LCRRWW---TLYTLVHSMSL--------LCAQECLMLFISCNNWPSHLSQSKFCNLKLWVF 520 (553)
Q Consensus 455 sDVwSlGvil~ell~~-~~~~~~---~l~~~~~~~~~--------~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~ 520 (553)
+||||||+++|||++. .|.... .....+..+.. ..+..+.+++.+||+.||.+|||+.|++++-..
T Consensus 257 ~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~ 334 (345)
T 3hko_A 257 CDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWI 334 (345)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHH
T ss_pred HHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhh
Confidence 9999999999999973 333222 22222222221 356789999999999999999999999997543
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=351.09 Aligned_cols=237 Identities=23% Similarity=0.285 Sum_probs=198.4
Q ss_pred CeeecccCceeEEEEEeC-CCCEEEEEEeccCCh---hhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCC
Q 008785 274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF---QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 349 (553)
Q Consensus 274 ~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 349 (553)
.+.||+|+||.||+|... +|+.||||+++.... .....+.+|+.+++.++||||+++++++.+.+..++||||+++
T Consensus 21 ~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~g 100 (476)
T 2y94_A 21 GDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSG 100 (476)
T ss_dssp EEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSS
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCC
Confidence 345699999999999975 699999999975422 2356789999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccc
Q 008785 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE 429 (553)
Q Consensus 350 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 429 (553)
|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++.........
T Consensus 101 g~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~~- 172 (476)
T 2y94_A 101 GELFDYICK----NGRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFL- 172 (476)
T ss_dssp EEHHHHTTS----SSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECCTTCCB-
T ss_pred CcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhccccccc-
Confidence 999999964 34689999999999999999999999 9999999999999999999999999999876543221
Q ss_pred eeeecCccccccccccccCCCC-CcccchHhHHHHHHHHhcC-cccccc---hHHHHHhcCCH----HHHHHHHHHHhhc
Q 008785 430 RTVMAGGTYGYLAPEFVYRNEL-TTKSDVYSFGVLLLEIRLV-LCRRWW---TLYTLVHSMSL----LCAQECLMLFISC 500 (553)
Q Consensus 430 ~~~~~~gt~~y~aPE~~~~~~~-t~ksDVwSlGvil~ell~~-~~~~~~---~l~~~~~~~~~----~~~~~l~~l~~~C 500 (553)
....||+.|+|||++.+..+ +.++||||||+++|||++. .|.... .+...+..+.. ..+..+.+++.+|
T Consensus 173 --~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~ 250 (476)
T 2y94_A 173 --RTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVISLLKHM 250 (476)
T ss_dssp --CCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCCTTCCHHHHHHHHHH
T ss_pred --cccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCCccCCHHHHHHHHHH
Confidence 22349999999999988765 7899999999999999973 333332 33334444433 4567889999999
Q ss_pred cCCCCCCCCCHHHHHHHHHH
Q 008785 501 NNWPSHLSQSKFCNLKLWVF 520 (553)
Q Consensus 501 l~~dP~~RPs~~evl~~l~~ 520 (553)
|+.||++|||+.|++++-..
T Consensus 251 L~~dP~~Rpt~~eil~hp~~ 270 (476)
T 2y94_A 251 LQVDPMKRATIKDIREHEWF 270 (476)
T ss_dssp TCSSTTTSCCHHHHHTCHHH
T ss_pred cCCCchhCcCHHHHHhCHHh
Confidence 99999999999999997443
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-41 Score=350.42 Aligned_cols=248 Identities=19% Similarity=0.171 Sum_probs=200.2
Q ss_pred HHHhhcccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCCh---hhHHHHHHHHHHhhccCCCceeeEeeEEeeCC
Q 008785 263 LRSITKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF---QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHG 338 (553)
Q Consensus 263 l~~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 338 (553)
+....++|.... .||+|+||.||++... +++.||+|++++... ...+.+.+|+.+++.++||||+++++++.+.+
T Consensus 64 ~~~~~~~y~~~~-~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 142 (410)
T 3v8s_A 64 LRMKAEDYEVVK-VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 142 (410)
T ss_dssp HSCCGGGEEEEE-EEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred cccCccccEEEE-EEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence 333445665544 4599999999999976 488999999975321 12345789999999999999999999999999
Q ss_pred ceEEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccc
Q 008785 339 DRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGL 418 (553)
Q Consensus 339 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgl 418 (553)
..|+||||+++|+|.++++. ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 143 ~~~lV~E~~~gg~L~~~l~~-----~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG~ 214 (410)
T 3v8s_A 143 YLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGT 214 (410)
T ss_dssp EEEEEECCCTTEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred EEEEEEeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccce
Confidence 99999999999999999975 3489999999999999999999999 999999999999999999999999999
Q ss_pred cccCCcccccceeeecCccccccccccccCCC----CCcccchHhHHHHHHHHhcC-cccccch---HHHHHhcC----C
Q 008785 419 SKFVPWEVMQERTVMAGGTYGYLAPEFVYRNE----LTTKSDVYSFGVLLLEIRLV-LCRRWWT---LYTLVHSM----S 486 (553)
Q Consensus 419 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~t~ksDVwSlGvil~ell~~-~~~~~~~---l~~~~~~~----~ 486 (553)
++......... .....||+.|+|||++.+.. ++.++|||||||++|||++. .|....+ ....+..+ .
T Consensus 215 a~~~~~~~~~~-~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~ 293 (410)
T 3v8s_A 215 CMKMNKEGMVR-CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLT 293 (410)
T ss_dssp CEECCTTSEEE-CCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCC
T ss_pred eEeeccCCccc-ccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhcccccc
Confidence 98765443221 12334999999999998665 78999999999999999973 3333322 22222221 1
Q ss_pred H----HHHHHHHHHHhhccCCCCCC--CCCHHHHHHHHHH
Q 008785 487 L----LCAQECLMLFISCNNWPSHL--SQSKFCNLKLWVF 520 (553)
Q Consensus 487 ~----~~~~~l~~l~~~Cl~~dP~~--RPs~~evl~~l~~ 520 (553)
+ ..+..+.+|+.+||..+|.+ ||++.||+++-.+
T Consensus 294 ~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f 333 (410)
T 3v8s_A 294 FPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFF 333 (410)
T ss_dssp CCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGG
T ss_pred CCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccc
Confidence 1 35678999999999999988 9999999998544
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-40 Score=331.02 Aligned_cols=241 Identities=22% Similarity=0.290 Sum_probs=189.0
Q ss_pred eeecccCceeEEEEEeCCCCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCCHHH
Q 008785 275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR 354 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~ 354 (553)
+.||+|+||.||++.. .++.||||.+... ...+.+.+|+.++++++||||+++++++. +..++||||+++|+|.+
T Consensus 14 ~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~~~~L~~ 88 (307)
T 2eva_A 14 EVVGRGAFGVVCKAKW-RAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAEGGSLYN 88 (307)
T ss_dssp EEEECCSSSEEEEEEE-TTEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCTTCBHHH
T ss_pred eEeecCCCceEEEEEE-CCeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCCCCCHHH
Confidence 4569999999999998 5789999999754 34578999999999999999999999876 45899999999999999
Q ss_pred HhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCC-eEEeeccccccCCcccccceeee
Q 008785 355 WLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG-AHLMGVGLSKFVPWEVMQERTVM 433 (553)
Q Consensus 355 ~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~-~kl~Dfgla~~~~~~~~~~~~~~ 433 (553)
++.... ....+++..++.++.|++.||+|||+....+|+||||||+|||++.++. +||+|||++........ .
T Consensus 89 ~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~~-----~ 162 (307)
T 2eva_A 89 VLHGAE-PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMT-----N 162 (307)
T ss_dssp HHHCSS-SEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---------------
T ss_pred HHhccC-CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccccc-----c
Confidence 997521 2234788999999999999999999921129999999999999998886 79999999975543211 1
Q ss_pred cCccccccccccccCCCCCcccchHhHHHHHHHHhcCc-cccc---c--hHHHHHhcCCH-----HHHHHHHHHHhhccC
Q 008785 434 AGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVL-CRRW---W--TLYTLVHSMSL-----LCAQECLMLFISCNN 502 (553)
Q Consensus 434 ~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~-~~~~---~--~l~~~~~~~~~-----~~~~~l~~l~~~Cl~ 502 (553)
..||+.|+|||++.+..++.++||||||+++|||++.. |... . .+......+.. ..+..+.+++.+||+
T Consensus 163 ~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 242 (307)
T 2eva_A 163 NKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESLMTRCWS 242 (307)
T ss_dssp --CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCBTTCCHHHHHHHHHHTC
T ss_pred CCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCcccccCHHHHHHHHHHhc
Confidence 23899999999999989999999999999999999733 2221 1 11112222221 556788999999999
Q ss_pred CCCCCCCCHHHHHHHHHHHHhhcc
Q 008785 503 WPSHLSQSKFCNLKLWVFAILTIR 526 (553)
Q Consensus 503 ~dP~~RPs~~evl~~l~~~~~~~~ 526 (553)
.||++|||+.|+++.+........
T Consensus 243 ~dp~~Rps~~ell~~L~~~~~~~~ 266 (307)
T 2eva_A 243 KDPSQRPSMEEIVKIMTHLMRYFP 266 (307)
T ss_dssp SSGGGSCCHHHHHHHHHHHGGGCC
T ss_pred CChhhCcCHHHHHHHHHHHHHhcc
Confidence 999999999999999877665443
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=328.53 Aligned_cols=241 Identities=22% Similarity=0.312 Sum_probs=176.7
Q ss_pred cccCCCCeeecccCceeEEEEEe-CCCCEEEEEEeccCCh---hhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEE
Q 008785 268 KNFSEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSF---QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIV 343 (553)
Q Consensus 268 ~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 343 (553)
++|... +.||+|+||.||+|.. .+|+.||||.+..... ...+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 11 ~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 11 EDFKVG-NLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGEEEE-EEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceee-eeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 345444 4569999999999996 4689999999975422 2246789999999999999999999999999999999
Q ss_pred EEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCC
Q 008785 344 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVP 423 (553)
Q Consensus 344 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~ 423 (553)
|||+++++|.+++.. ....+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||++....
T Consensus 90 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 163 (278)
T 3cok_A 90 LEMCHNGEMNRYLKN---RVKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLK 163 (278)
T ss_dssp EECCTTEEHHHHHHT---CSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeecc
Confidence 999999999999974 335689999999999999999999999 99999999999999999999999999998665
Q ss_pred cccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcCc-ccccchH---HHHHhcCCH----HHHHHHHH
Q 008785 424 WEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVL-CRRWWTL---YTLVHSMSL----LCAQECLM 495 (553)
Q Consensus 424 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~-~~~~~~l---~~~~~~~~~----~~~~~l~~ 495 (553)
...... ....||+.|+|||.+.+..++.++||||||+++|||++.. |...... ...+..... ..+..+.+
T Consensus 164 ~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (278)
T 3cok_A 164 MPHEKH--YTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKD 241 (278)
T ss_dssp ------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCCCCCTTSCHHHHH
T ss_pred CCCCcc--eeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcccCCccccCHHHHH
Confidence 332211 1223899999999999888999999999999999999732 3222221 111111111 45677899
Q ss_pred HHhhccCCCCCCCCCHHHHHHH
Q 008785 496 LFISCNNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 496 l~~~Cl~~dP~~RPs~~evl~~ 517 (553)
++.+||+.||++|||+.+++++
T Consensus 242 li~~~l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 242 LIHQLLRRNPADRLSLSSVLDH 263 (278)
T ss_dssp HHHHHSCSSGGGSCCHHHHTTS
T ss_pred HHHHHcccCHhhCCCHHHHhcC
Confidence 9999999999999999999875
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=341.87 Aligned_cols=238 Identities=19% Similarity=0.246 Sum_probs=194.3
Q ss_pred ccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCC---hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEE
Q 008785 269 NFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVY 344 (553)
Q Consensus 269 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 344 (553)
+|... +.||+|+||.||++... +++.||+|++.... ....+.+.+|+.+|++++||||+++++++.+.+..++||
T Consensus 16 ~y~i~-~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 16 HFEIL-RAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GEEEE-EEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HeEEE-EEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 34443 45699999999999965 48899999997542 233567889999999999999999999999999999999
Q ss_pred EccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCc
Q 008785 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW 424 (553)
Q Consensus 345 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~ 424 (553)
||+.+|+|.+++.. ...+++..+..++.||+.||.|||+. ||+||||||+|||++.++.+||+|||++.....
T Consensus 95 e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 167 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQ----NVHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR 167 (384)
T ss_dssp CCCTTEEHHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred ecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence 99999999999964 34589999999999999999999999 999999999999999999999999999987654
Q ss_pred ccccceeeecCccccccccccccC---CCCCcccchHhHHHHHHHHhcCc-ccc---cc---hHHHHHhcCCH----HHH
Q 008785 425 EVMQERTVMAGGTYGYLAPEFVYR---NELTTKSDVYSFGVLLLEIRLVL-CRR---WW---TLYTLVHSMSL----LCA 490 (553)
Q Consensus 425 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~t~ksDVwSlGvil~ell~~~-~~~---~~---~l~~~~~~~~~----~~~ 490 (553)
.... ....||+.|+|||++.. ..++.++|||||||++|||++.. |.. .. .+...+..... ..+
T Consensus 168 ~~~~---~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p~~~s 244 (384)
T 4fr4_A 168 ETQI---TTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWS 244 (384)
T ss_dssp TCCB---CCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCCTTSC
T ss_pred CCce---eccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCCCcCC
Confidence 3221 22349999999999864 45899999999999999999732 221 11 22222222222 556
Q ss_pred HHHHHHHhhccCCCCCCCCC-HHHHHHH
Q 008785 491 QECLMLFISCNNWPSHLSQS-KFCNLKL 517 (553)
Q Consensus 491 ~~l~~l~~~Cl~~dP~~RPs-~~evl~~ 517 (553)
..+.+++.+||+.||++||+ +.+++++
T Consensus 245 ~~~~~li~~lL~~dP~~R~s~~~~l~~h 272 (384)
T 4fr4_A 245 QEMVSLLKKLLEPNPDQRFSQLSDVQNF 272 (384)
T ss_dssp HHHHHHHHHHSCSSGGGSCCSHHHHHTS
T ss_pred HHHHHHHHHHhcCCHhHhcccHHHHHcC
Confidence 78999999999999999999 7777664
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=334.50 Aligned_cols=243 Identities=20% Similarity=0.301 Sum_probs=191.2
Q ss_pred eeecccCceeEEEEEeC-CCC----EEEEEEeccC-ChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccC
Q 008785 275 RLLGDSKTGGTYSGILP-DGS----RVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV 348 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~-~g~----~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 348 (553)
+.||+|+||.||+|... +++ +||+|.+... .....+.+.+|+.++++++||||+++++++... ..++|+||+.
T Consensus 21 ~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~~v~~~~~ 99 (327)
T 3lzb_A 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMP 99 (327)
T ss_dssp EEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS-SEEEEECCCS
T ss_pred EEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC-CceEEEEecC
Confidence 45699999999999964 344 3678877543 334567899999999999999999999998875 4889999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCccccc
Q 008785 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ 428 (553)
Q Consensus 349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 428 (553)
+|+|.+++.. ....+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++........
T Consensus 100 ~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~~ 173 (327)
T 3lzb_A 100 FGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 173 (327)
T ss_dssp SCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC----------
T ss_pred CCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeEccCcccc
Confidence 9999999975 234689999999999999999999999 9999999999999999999999999999876544333
Q ss_pred ceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhc-Cc-cc---ccchHHHHHhcCCH-----HHHHHHHHHHh
Q 008785 429 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-VL-CR---RWWTLYTLVHSMSL-----LCAQECLMLFI 498 (553)
Q Consensus 429 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-~~-~~---~~~~l~~~~~~~~~-----~~~~~l~~l~~ 498 (553)
.......+|+.|+|||++.+..++.++||||||+++|||++ .. |. ....+...+..+.. ..+..+.+++.
T Consensus 174 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 253 (327)
T 3lzb_A 174 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMR 253 (327)
T ss_dssp ------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHHHHHHHH
T ss_pred ccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHH
Confidence 22223337889999999999999999999999999999997 33 22 22334444443332 56678999999
Q ss_pred hccCCCCCCCCCHHHHHHHHHHHHhh
Q 008785 499 SCNNWPSHLSQSKFCNLKLWVFAILT 524 (553)
Q Consensus 499 ~Cl~~dP~~RPs~~evl~~l~~~~~~ 524 (553)
+||+.||.+|||+.|+++.+......
T Consensus 254 ~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 254 KCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp HHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred HHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 99999999999999999988776543
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=326.87 Aligned_cols=243 Identities=23% Similarity=0.281 Sum_probs=196.8
Q ss_pred cccCCCCeeecccCceeEEEEEeCC-CCEEEEEEeccCC---hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEE
Q 008785 268 KNFSEGNRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIV 343 (553)
Q Consensus 268 ~~~~~~~~~iG~G~~g~Vy~~~~~~-g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 343 (553)
++|.... .||+|+||.||++.... ++.||||++.... ......+.+|+.++++++||||+++++++.+.+..++|
T Consensus 9 ~~y~~~~-~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 9 EDFEIGR-PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGEEEEE-EEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccEEEee-EEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 3444433 45999999999998654 7799999996542 22356789999999999999999999999999999999
Q ss_pred EEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCC
Q 008785 344 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVP 423 (553)
Q Consensus 344 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~ 423 (553)
|||+++|+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 88 ~e~~~~~~l~~~l~~~----~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~ 160 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKL----SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP 160 (279)
T ss_dssp ECCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred EecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCC
Confidence 9999999999998652 4589999999999999999999999 99999999999999999999999999986544
Q ss_pred cccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcC-cccccch---HHHHHhcCCH----HHHHHHHH
Q 008785 424 WEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLV-LCRRWWT---LYTLVHSMSL----LCAQECLM 495 (553)
Q Consensus 424 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~-~~~~~~~---l~~~~~~~~~----~~~~~l~~ 495 (553)
.... ....||+.|+|||.+.+..++.++||||||+++|||++. .|..... ....+..... ..+..+.+
T Consensus 161 ~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (279)
T 3fdn_A 161 SSRR----TDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 236 (279)
T ss_dssp -----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHH
T ss_pred cccc----cccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCCCcCCHHHHH
Confidence 3321 122389999999999998999999999999999999973 3333222 2223332222 45677899
Q ss_pred HHhhccCCCCCCCCCHHHHHHHHHHHH
Q 008785 496 LFISCNNWPSHLSQSKFCNLKLWVFAI 522 (553)
Q Consensus 496 l~~~Cl~~dP~~RPs~~evl~~l~~~~ 522 (553)
++.+||+.||++|||+.|++++-....
T Consensus 237 li~~~l~~~p~~Rps~~e~l~h~~~~~ 263 (279)
T 3fdn_A 237 LISRLLKHNPSQRPMLREVLEHPWITA 263 (279)
T ss_dssp HHHHHCCSSGGGSCCHHHHHHCHHHHH
T ss_pred HHHHHhccChhhCCCHHHHhhCccccC
Confidence 999999999999999999999865543
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=339.88 Aligned_cols=241 Identities=22% Similarity=0.221 Sum_probs=197.8
Q ss_pred cccCCCCeeecccCceeEEEEEeCC-CCEEEEEEeccCC---hhhHHHHHHHHHHhhcc-CCCceeeEeeEEeeCCceEE
Q 008785 268 KNFSEGNRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSS---FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYI 342 (553)
Q Consensus 268 ~~~~~~~~~iG~G~~g~Vy~~~~~~-g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~l 342 (553)
++|... ++||+|+||.||++.... |+.||||++++.. ....+.+.+|..++..+ +||||+++++++.+.+..|+
T Consensus 20 ~~y~~~-~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 98 (353)
T 2i0e_A 20 TDFNFL-MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 98 (353)
T ss_dssp TTEEEE-EEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred HHcEEE-EEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence 344443 456999999999999765 7899999997642 23456788999999988 89999999999999999999
Q ss_pred EEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccC
Q 008785 343 VYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV 422 (553)
Q Consensus 343 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~ 422 (553)
||||+++|+|.+++.. ...+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 99 v~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~ 171 (353)
T 2i0e_A 99 VMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 171 (353)
T ss_dssp EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence 9999999999999974 23589999999999999999999999 9999999999999999999999999999864
Q ss_pred CcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcCc-cccc---chHHHHHhcCCH----HHHHHHH
Q 008785 423 PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVL-CRRW---WTLYTLVHSMSL----LCAQECL 494 (553)
Q Consensus 423 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~-~~~~---~~l~~~~~~~~~----~~~~~l~ 494 (553)
...... .....||+.|+|||++.+..++.++||||||+++|||++.. |... ..+.+.+..+.. ..+..+.
T Consensus 172 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~ 249 (353)
T 2i0e_A 172 IWDGVT--TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAV 249 (353)
T ss_dssp CCTTCC--BCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHH
T ss_pred ccCCcc--cccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 332221 22334999999999999999999999999999999999733 3322 233333333333 4567899
Q ss_pred HHHhhccCCCCCCCCC-----HHHHHHHH
Q 008785 495 MLFISCNNWPSHLSQS-----KFCNLKLW 518 (553)
Q Consensus 495 ~l~~~Cl~~dP~~RPs-----~~evl~~l 518 (553)
+++.+||+.||.+||+ +.|++++-
T Consensus 250 ~li~~lL~~dP~~R~~~~~~~~~~i~~h~ 278 (353)
T 2i0e_A 250 AICKGLMTKHPGKRLGCGPEGERDIKEHA 278 (353)
T ss_dssp HHHHHHTCSCTTSCTTCSTTHHHHHHTSG
T ss_pred HHHHHHhhcCHHHcCCCCCCCHHHHhcCc
Confidence 9999999999999995 58888764
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-40 Score=330.10 Aligned_cols=247 Identities=23% Similarity=0.310 Sum_probs=191.8
Q ss_pred cccCCCCeeecccCceeEEEEEe-CCCCEEEEEEeccC---ChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEE
Q 008785 268 KNFSEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRS---SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIV 343 (553)
Q Consensus 268 ~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 343 (553)
.+|... +.||+|+||.||+|.. .+|+.||||+++.. .......+.+|+.++++++||||+++++++.+.+..++|
T Consensus 32 ~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 32 ANFRIE-KKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGEEEE-EEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cceEEE-EeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 345444 4569999999999996 46899999999753 344567889999999999999999999999999999999
Q ss_pred EEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCC
Q 008785 344 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVP 423 (553)
Q Consensus 344 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~ 423 (553)
|||+++|+|.+++.........+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++....
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 999999999999875333445689999999999999999999999 99999999999999999999999999997654
Q ss_pred cccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcCc-cccc-----chHHHHHhcCCH------HHHH
Q 008785 424 WEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVL-CRRW-----WTLYTLVHSMSL------LCAQ 491 (553)
Q Consensus 424 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~-~~~~-----~~l~~~~~~~~~------~~~~ 491 (553)
...... ....|++.|+|||++.+..++.++||||||+++|||++.. |... ..+...+..+.. ..+.
T Consensus 188 ~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (310)
T 2wqm_A 188 SKTTAA--HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSE 265 (310)
T ss_dssp -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCH
T ss_pred CCCccc--cccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccCH
Confidence 432211 1223899999999999999999999999999999999733 2221 122233333322 4567
Q ss_pred HHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 008785 492 ECLMLFISCNNWPSHLSQSKFCNLKLWVF 520 (553)
Q Consensus 492 ~l~~l~~~Cl~~dP~~RPs~~evl~~l~~ 520 (553)
.+.+++.+||+.||++|||+.++++.+..
T Consensus 266 ~l~~li~~~l~~dp~~Rps~~~il~~l~~ 294 (310)
T 2wqm_A 266 ELRQLVNMCINPDPEKRPDVTYVYDVAKR 294 (310)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence 89999999999999999999999987644
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-40 Score=336.47 Aligned_cols=237 Identities=22% Similarity=0.302 Sum_probs=193.4
Q ss_pred cCCCCeeecccCceeEEEEEe-CCCCEEEEEEeccCC---hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEE
Q 008785 270 FSEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYE 345 (553)
Q Consensus 270 ~~~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 345 (553)
|.... .||+|+||.||+|.. .+|+.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 56 y~~~~-~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 134 (348)
T 1u5q_A 56 FSDLR-EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 134 (348)
T ss_dssp EEEEE-EEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eeeee-EEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEe
Confidence 43333 459999999999996 468999999997542 2334678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcc
Q 008785 346 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE 425 (553)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~ 425 (553)
|+. |+|.+++.. ....+++..+..++.|++.||.|||++ +|+||||||+|||+++++.+||+|||++......
T Consensus 135 ~~~-g~l~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~ 207 (348)
T 1u5q_A 135 YCL-GSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 207 (348)
T ss_dssp CCS-EEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred cCC-CCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCCC
Confidence 996 688888754 235689999999999999999999999 9999999999999999999999999999865432
Q ss_pred cccceeeecCcccccccccccc---CCCCCcccchHhHHHHHHHHhcCc-ccccchHHH----HHhcCCH-----HHHHH
Q 008785 426 VMQERTVMAGGTYGYLAPEFVY---RNELTTKSDVYSFGVLLLEIRLVL-CRRWWTLYT----LVHSMSL-----LCAQE 492 (553)
Q Consensus 426 ~~~~~~~~~~gt~~y~aPE~~~---~~~~t~ksDVwSlGvil~ell~~~-~~~~~~l~~----~~~~~~~-----~~~~~ 492 (553)
. ...||+.|+|||++. ...++.++||||||+++|||++.. |.......+ ....... ..+..
T Consensus 208 ~------~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (348)
T 1u5q_A 208 N------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEY 281 (348)
T ss_dssp C------CCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHH
T ss_pred C------cccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHH
Confidence 2 123899999999984 567899999999999999999833 322222111 2222111 45677
Q ss_pred HHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 008785 493 CLMLFISCNNWPSHLSQSKFCNLKLWVF 520 (553)
Q Consensus 493 l~~l~~~Cl~~dP~~RPs~~evl~~l~~ 520 (553)
+.+++.+||+.||++|||+.+++++...
T Consensus 282 l~~li~~~l~~dP~~Rps~~~ll~h~~~ 309 (348)
T 1u5q_A 282 FRNFVDSCLQKIPQDRPTSEVLLKHRFV 309 (348)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHTTCHHH
T ss_pred HHHHHHHHcccChhhCcCHHHHhhChhh
Confidence 8999999999999999999999987543
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=333.85 Aligned_cols=243 Identities=21% Similarity=0.254 Sum_probs=183.7
Q ss_pred cccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCCh-hhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEE
Q 008785 268 KNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF-QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYE 345 (553)
Q Consensus 268 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 345 (553)
.+|..... ||+|+||.||+|... +|+.||||+++.... ...+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 5 ~~y~~~~~-lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 5 SQFKQLEK-LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred cceeEeeE-ECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 34555444 499999999999965 589999999976532 234678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhccCC--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCC
Q 008785 346 FVVNGPLDRWLHHIP--RGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVP 423 (553)
Q Consensus 346 ~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~ 423 (553)
|++ |+|.+++.... .....+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 997 69999886421 2234589999999999999999999999 99999999999999999999999999998664
Q ss_pred cccccceeeecCccccccccccccC-CCCCcccchHhHHHHHHHHhcCc-ccccc---hHHHHH-hc-C-----------
Q 008785 424 WEVMQERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIRLVL-CRRWW---TLYTLV-HS-M----------- 485 (553)
Q Consensus 424 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwSlGvil~ell~~~-~~~~~---~l~~~~-~~-~----------- 485 (553)
...... ....||+.|+|||++.+ ..++.++||||||+++|||++.. |.... .....+ .. +
T Consensus 160 ~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (317)
T 2pmi_A 160 IPVNTF--SSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVT 237 (317)
T ss_dssp SCCCCC--CCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGG
T ss_pred CCcccC--CCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhh
Confidence 332211 12238999999999876 46899999999999999999733 22221 111111 00 0
Q ss_pred -------------------------CHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008785 486 -------------------------SLLCAQECLMLFISCNNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 486 -------------------------~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 517 (553)
....+..+.+++.+||+.||++|||+.|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 238 KLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp GCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 00235678999999999999999999999986
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=330.96 Aligned_cols=245 Identities=23% Similarity=0.269 Sum_probs=196.6
Q ss_pred cccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccC--ChhhHHHHHHHHHHhhccCCCceeeEeeEEee--CCceEE
Q 008785 268 KNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD--HGDRYI 342 (553)
Q Consensus 268 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--~~~~~l 342 (553)
++|... +.||+|+||.||++... +|+.||+|.+... .....+.+.+|+.++++++||||+++++++.+ .+..++
T Consensus 6 ~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 6 EDYEVL-YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGEEEE-EEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hheeee-hhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 344443 45599999999999975 5899999999754 33456789999999999999999999998854 567899
Q ss_pred EEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC-----ceecCCCCCcEEecCCCCeEEeecc
Q 008785 343 VYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPH-----VVHRDIRASNVLLDEEFGAHLMGVG 417 (553)
Q Consensus 343 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~-----ivHrDlkp~NILl~~~~~~kl~Dfg 417 (553)
||||+++|+|.+++.........+++..+..++.|++.||.|||+. + |+||||||+||+++.++.+||+|||
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg 161 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 161 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence 9999999999999975333345689999999999999999999998 8 9999999999999999999999999
Q ss_pred ccccCCcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcCc-ccc---cchHHHHHhcCCH-----H
Q 008785 418 LSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVL-CRR---WWTLYTLVHSMSL-----L 488 (553)
Q Consensus 418 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~-~~~---~~~l~~~~~~~~~-----~ 488 (553)
++........... ...||+.|+|||++.+..++.++||||||+++|||++.. |.. ...+.+.+..+.. .
T Consensus 162 ~~~~~~~~~~~~~--~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~ 239 (279)
T 2w5a_A 162 LARILNHDTSFAK--TFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYR 239 (279)
T ss_dssp HHHHC---CHHHH--HHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCCTT
T ss_pred hheeecccccccc--ccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccccCCcc
Confidence 9976654322111 123899999999999989999999999999999999732 322 2233334444433 4
Q ss_pred HHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008785 489 CAQECLMLFISCNNWPSHLSQSKFCNLKLW 518 (553)
Q Consensus 489 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l 518 (553)
.+..+.+++.+||+.||++|||+.|++++.
T Consensus 240 ~~~~l~~li~~~l~~~p~~Rps~~~ll~~~ 269 (279)
T 2w5a_A 240 YSDELNEIITRMLNLKDYHRPSVEEILENP 269 (279)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred cCHHHHHHHHHHcCCCcccCCCHHHHHhCh
Confidence 567899999999999999999999999753
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=328.89 Aligned_cols=251 Identities=24% Similarity=0.297 Sum_probs=201.0
Q ss_pred ccCCCCeeecccCceeEEEEEeC---CCCEEEEEEeccCC--hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEE
Q 008785 269 NFSEGNRLLGDSKTGGTYSGILP---DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIV 343 (553)
Q Consensus 269 ~~~~~~~~iG~G~~g~Vy~~~~~---~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 343 (553)
.|....+.||+|+||.||+|.+. +++.||||+++... ....+++.+|+.++++++||||+++++++ ..+..++|
T Consensus 17 ~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv 95 (291)
T 1xbb_A 17 LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLV 95 (291)
T ss_dssp GEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEE
T ss_pred hhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEE
Confidence 34444446799999999999642 36789999997653 23357899999999999999999999998 66778999
Q ss_pred EEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCC
Q 008785 344 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVP 423 (553)
Q Consensus 344 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~ 423 (553)
|||+++++|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 96 ~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 168 (291)
T 1xbb_A 96 MEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALR 168 (291)
T ss_dssp EECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEeCCCCCHHHHHHh----CcCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcceeec
Confidence 999999999999975 24589999999999999999999999 99999999999999999999999999998765
Q ss_pred cccccce-eeecCccccccccccccCCCCCcccchHhHHHHHHHHhc-Cc-cccc---chHHHHHhcCCH-----HHHHH
Q 008785 424 WEVMQER-TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-VL-CRRW---WTLYTLVHSMSL-----LCAQE 492 (553)
Q Consensus 424 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-~~-~~~~---~~l~~~~~~~~~-----~~~~~ 492 (553)
....... .....+++.|+|||.+.+..++.++||||||+++|||++ .. |... ..+...+..+.. ..+..
T Consensus 169 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (291)
T 1xbb_A 169 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPRE 248 (291)
T ss_dssp TTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHH
T ss_pred cCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHH
Confidence 4432211 112226788999999988889999999999999999997 33 3222 223334443322 56778
Q ss_pred HHHHHhhccCCCCCCCCCHHHHHHHHHHHHhhccc
Q 008785 493 CLMLFISCNNWPSHLSQSKFCNLKLWVFAILTIRK 527 (553)
Q Consensus 493 l~~l~~~Cl~~dP~~RPs~~evl~~l~~~~~~~~~ 527 (553)
+.+++.+||+.||++|||+.++++.+...+.....
T Consensus 249 l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~ 283 (291)
T 1xbb_A 249 MYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN 283 (291)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhh
Confidence 99999999999999999999999998777665543
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=326.04 Aligned_cols=247 Identities=17% Similarity=0.202 Sum_probs=199.0
Q ss_pred ccCCCCeeecccCceeEEEEEe-CCCCEEEEEEeccCChhhHHHHHHHHHHhhcc-CCCceeeEeeEEeeCCceEEEEEc
Q 008785 269 NFSEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEF 346 (553)
Q Consensus 269 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E~ 346 (553)
+|... +.||+|+||.||+|.. .+|+.||||++.... ..+.+.+|+.+++++ +||||+++++++.+....++||||
T Consensus 11 ~y~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 87 (298)
T 1csn_A 11 HYKVG-RRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 87 (298)
T ss_dssp TEEEE-EEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred ceEEE-EEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEe
Confidence 34443 4569999999999995 568999999987543 234578899999999 899999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCC-----eEEeecccccc
Q 008785 347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG-----AHLMGVGLSKF 421 (553)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~-----~kl~Dfgla~~ 421 (553)
+ +++|.+++.. ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++. +||+|||++..
T Consensus 88 ~-~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~ 160 (298)
T 1csn_A 88 L-GPSLEDLLDL---CGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160 (298)
T ss_dssp C-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred c-CCCHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence 9 9999999975 234589999999999999999999999 9999999999999987766 99999999987
Q ss_pred CCcccccc-----eeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcC-ccccc------chHHHHHhc----C
Q 008785 422 VPWEVMQE-----RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLV-LCRRW------WTLYTLVHS----M 485 (553)
Q Consensus 422 ~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~-~~~~~------~~l~~~~~~----~ 485 (553)
........ ......||+.|+|||++.+..++.++||||||+++|||++. .|... ......+.. .
T Consensus 161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (298)
T 1csn_A 161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 240 (298)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred cccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCc
Confidence 65432211 11223489999999999999999999999999999999973 22222 111111111 1
Q ss_pred CH-----HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHhhc
Q 008785 486 SL-----LCAQECLMLFISCNNWPSHLSQSKFCNLKLWVFAILTI 525 (553)
Q Consensus 486 ~~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~~~~~~ 525 (553)
.. ..+..+.+++.+||+.||++|||+.+|++.+...+.+.
T Consensus 241 ~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~ 285 (298)
T 1csn_A 241 PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 285 (298)
T ss_dssp CHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred cHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhc
Confidence 11 34678999999999999999999999999988776654
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-40 Score=334.27 Aligned_cols=246 Identities=17% Similarity=0.127 Sum_probs=197.9
Q ss_pred ccCCCCeeecccCceeEEEEEe-CCCCEEEEEEeccCChhhHHHHHHHHHHhhcc-CCCceeeEeeEEeeCCceEEEEEc
Q 008785 269 NFSEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEF 346 (553)
Q Consensus 269 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E~ 346 (553)
+|... +.||+|+||.||+|.. .+|+.||||++.... ..+.+.+|+.+++++ +||||+++++++.+.+..++||||
T Consensus 10 ~y~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~ 86 (330)
T 2izr_A 10 NFRVG-KKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLEL 86 (330)
T ss_dssp TEEEE-EECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEEC
T ss_pred CeEEE-EEeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEe
Confidence 44443 4569999999999996 468999999987543 234688999999999 999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCC-----eEEeecccccc
Q 008785 347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG-----AHLMGVGLSKF 421 (553)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~-----~kl~Dfgla~~ 421 (553)
+ +++|.+++... ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++. +||+|||+++.
T Consensus 87 ~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 87 L-GPSLEDLFDLC---DRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp C-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred C-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 9 99999999752 35699999999999999999999999 9999999999999998887 99999999986
Q ss_pred CCcccccc-----eeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcC-ccccc---chHHH---HHhcCCH--
Q 008785 422 VPWEVMQE-----RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLV-LCRRW---WTLYT---LVHSMSL-- 487 (553)
Q Consensus 422 ~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~-~~~~~---~~l~~---~~~~~~~-- 487 (553)
........ ......||+.|+|||++.+..++.++||||||+++|||++. .|... ..+.+ .+.....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~ 239 (330)
T 2izr_A 160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRAT 239 (330)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHS
T ss_pred eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccC
Confidence 54332211 11233499999999999999999999999999999999973 23222 22222 2211111
Q ss_pred -------HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHhhc
Q 008785 488 -------LCAQECLMLFISCNNWPSHLSQSKFCNLKLWVFAILTI 525 (553)
Q Consensus 488 -------~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~~~~~~ 525 (553)
..+ .+.+++..||+.||.+||++.+|++.+...+...
T Consensus 240 ~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~ 283 (330)
T 2izr_A 240 PIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRK 283 (330)
T ss_dssp CHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred CHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHc
Confidence 133 8999999999999999999999999887666543
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=324.04 Aligned_cols=242 Identities=18% Similarity=0.208 Sum_probs=195.9
Q ss_pred ccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCCh------hhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceE
Q 008785 269 NFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF------QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRY 341 (553)
Q Consensus 269 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~------~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 341 (553)
+|... +.||+|+||.||++... +|+.||+|.++.... ...+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 6 ~y~~~-~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 6 HYEMG-EELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HEEEE-EEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhH-HhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 34443 34599999999999976 589999999875422 13678999999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCC----CeEEeecc
Q 008785 342 IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF----GAHLMGVG 417 (553)
Q Consensus 342 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~----~~kl~Dfg 417 (553)
+||||+++++|.+++.. ...+++..+..++.||+.||.|||+. +++||||||+||+++.++ .+||+|||
T Consensus 85 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg 157 (283)
T 3bhy_A 85 LILELVSGGELFDFLAE----KESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFG 157 (283)
T ss_dssp EEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEeecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEecc
Confidence 99999999999999964 24589999999999999999999999 999999999999998877 79999999
Q ss_pred ccccCCcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcC-cccccc---hHHHHHhcCCH------
Q 008785 418 LSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLV-LCRRWW---TLYTLVHSMSL------ 487 (553)
Q Consensus 418 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~-~~~~~~---~l~~~~~~~~~------ 487 (553)
++......... ....|++.|+|||++.+..++.++||||||+++|||++. .|.... .....+.....
T Consensus 158 ~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T 3bhy_A 158 IAHKIEAGNEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEY 234 (283)
T ss_dssp TCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHH
T ss_pred cceeccCCCcc---cccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchh
Confidence 99866543221 122389999999999988999999999999999999973 332222 22222222221
Q ss_pred --HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 008785 488 --LCAQECLMLFISCNNWPSHLSQSKFCNLKLWVFA 521 (553)
Q Consensus 488 --~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~~ 521 (553)
..+..+.+++.+||+.||++|||+.|++++-...
T Consensus 235 ~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~ 270 (283)
T 3bhy_A 235 FSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIK 270 (283)
T ss_dssp HTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHH
T ss_pred cccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHH
Confidence 3456789999999999999999999999975443
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=339.03 Aligned_cols=240 Identities=22% Similarity=0.208 Sum_probs=187.9
Q ss_pred ccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEcc
Q 008785 269 NFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV 347 (553)
Q Consensus 269 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 347 (553)
+|... +.||+|+||.||++... +++.||||++.... ...+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 21 ~y~~~-~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 98 (361)
T 3uc3_A 21 RYDFV-KDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYA 98 (361)
T ss_dssp TEEEE-EEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred cEEEE-EEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeC
Confidence 34443 34699999999999976 68999999997653 23466889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCC--eEEeeccccccCCcc
Q 008785 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG--AHLMGVGLSKFVPWE 425 (553)
Q Consensus 348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~--~kl~Dfgla~~~~~~ 425 (553)
++|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++. +||+|||+++.....
T Consensus 99 ~~~~L~~~l~~----~~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~ 171 (361)
T 3uc3_A 99 SGGELYERICN----AGRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 171 (361)
T ss_dssp CSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred CCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence 99999999864 23589999999999999999999999 9999999999999987765 999999999754322
Q ss_pred cccceeeecCccccccccccccCCCCCcc-cchHhHHHHHHHHhcCc-cccc----c---hHHHHHhcCCH------HHH
Q 008785 426 VMQERTVMAGGTYGYLAPEFVYRNELTTK-SDVYSFGVLLLEIRLVL-CRRW----W---TLYTLVHSMSL------LCA 490 (553)
Q Consensus 426 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~k-sDVwSlGvil~ell~~~-~~~~----~---~l~~~~~~~~~------~~~ 490 (553)
... ....||+.|+|||++.+..++.+ +||||||+++|||++.. |... . .....+..... ..+
T Consensus 172 ~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s 248 (361)
T 3uc3_A 172 SQP---KSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRIS 248 (361)
T ss_dssp ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCC
T ss_pred CCC---CCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCC
Confidence 211 12238999999999988887655 89999999999999732 2222 1 11122222211 356
Q ss_pred HHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 008785 491 QECLMLFISCNNWPSHLSQSKFCNLKLWVF 520 (553)
Q Consensus 491 ~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~ 520 (553)
..+.+++.+||+.||++|||+.|++++-..
T Consensus 249 ~~~~~li~~~L~~dP~~Rps~~ell~hp~f 278 (361)
T 3uc3_A 249 PECCHLISRIFVADPATRISIPEIKTHSWF 278 (361)
T ss_dssp HHHHHHHHHHSCSCTTTSCCHHHHHTSHHH
T ss_pred HHHHHHHHHHccCChhHCcCHHHHHhCcch
Confidence 788999999999999999999999998544
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=338.92 Aligned_cols=247 Identities=18% Similarity=0.186 Sum_probs=196.2
Q ss_pred cCHHHHHHhhcccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCChhhHHHHHHHHHHhhccC-----CCceeeEe
Q 008785 258 FTTEELRSITKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLH-----HPNLVAVK 331 (553)
Q Consensus 258 ~~~~el~~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-----HpnIv~l~ 331 (553)
++.++...+.++|..... ||+|+||.||+|... +++.||||+++.. ....+.+..|+.++++++ ||||++++
T Consensus 25 ~~~~~g~~~~~~y~~~~~-lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~ 102 (360)
T 3llt_A 25 FSWKKGMLLNNAFLVIRK-MGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYH 102 (360)
T ss_dssp CCCCTTCEETTTEEEEEE-EEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEE
T ss_pred eeeecceEecCEEEEEEE-EcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeeccc
Confidence 334444445566666554 599999999999974 5889999999754 344566788999999986 99999999
Q ss_pred eEEeeCCceEEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecC----
Q 008785 332 GCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE---- 407 (553)
Q Consensus 332 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~---- 407 (553)
+++...+..++||||+ +++|.+++.. .....+++..+..++.||+.||+|||++ +|+||||||+|||++.
T Consensus 103 ~~~~~~~~~~lv~e~~-~~~L~~~~~~--~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~ 176 (360)
T 3llt_A 103 GKFMYYDHMCLIFEPL-GPSLYEIITR--NNYNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFE 176 (360)
T ss_dssp EEEEETTEEEEEECCC-CCBHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTCC
T ss_pred ceeeECCeeEEEEcCC-CCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEcccccc
Confidence 9999999999999999 9999999976 2334589999999999999999999999 9999999999999975
Q ss_pred ---------------------CCCeEEeeccccccCCcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHH
Q 008785 408 ---------------------EFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLE 466 (553)
Q Consensus 408 ---------------------~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~e 466 (553)
++.+||+|||++....... ....||+.|+|||++.+..++.++||||||+++||
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e 251 (360)
T 3llt_A 177 KSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH-----GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAE 251 (360)
T ss_dssp EEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC-----CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHH
T ss_pred ccccchhcccccccccccccCCCCEEEEeccCceecCCCC-----cCccCcccccCcHHHcCCCCCCccchHHHHHHHHH
Confidence 7889999999998644322 12238999999999999999999999999999999
Q ss_pred HhcCc-ccccch---HHHHHhc--CCH------------------------------------------------HHHHH
Q 008785 467 IRLVL-CRRWWT---LYTLVHS--MSL------------------------------------------------LCAQE 492 (553)
Q Consensus 467 ll~~~-~~~~~~---l~~~~~~--~~~------------------------------------------------~~~~~ 492 (553)
|++.. |..... ....+.. +.. .....
T Consensus 252 ll~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (360)
T 3llt_A 252 LYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHEL 331 (360)
T ss_dssp HHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHH
T ss_pred HHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHH
Confidence 99732 222211 1111100 000 01156
Q ss_pred HHHHHhhccCCCCCCCCCHHHHHHH
Q 008785 493 CLMLFISCNNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 493 l~~l~~~Cl~~dP~~RPs~~evl~~ 517 (553)
+.+++.+||+.||++|||+.|+|++
T Consensus 332 l~~li~~~L~~dP~~Rpta~elL~h 356 (360)
T 3llt_A 332 FCDFLYSILQIDPTLRPSPAELLKH 356 (360)
T ss_dssp HHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HHHHHHHHhcCChhhCCCHHHHhcC
Confidence 7799999999999999999999875
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=338.32 Aligned_cols=242 Identities=19% Similarity=0.235 Sum_probs=195.5
Q ss_pred hhcccCCCCeeecccCceeEEEEEe-CCCCEEEEEEeccCCh--------hhHHHHHHHHHHhhccCCCceeeEeeEEee
Q 008785 266 ITKNFSEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSF--------QRKKEFYSEIGRFARLHHPNLVAVKGCCYD 336 (553)
Q Consensus 266 ~~~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~~~~~~~--------~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 336 (553)
..++|.... .||+|+||.||+|.. .+|+.||||+++.... ...+.+.+|+.++++++||||+++++++.+
T Consensus 22 ~~~~y~~~~-~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~ 100 (335)
T 3dls_A 22 YSQKYSTMS-PLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN 100 (335)
T ss_dssp HHHHEEEEE-ECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred cccceEEEe-EEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence 344555544 459999999999995 4588999999976531 123457789999999999999999999999
Q ss_pred CCceEEEEEccCCC-CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEee
Q 008785 337 HGDRYIVYEFVVNG-PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMG 415 (553)
Q Consensus 337 ~~~~~lV~E~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~D 415 (553)
.+..++||||+.+| +|.+++.. ...+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|
T Consensus 101 ~~~~~lv~e~~~~g~~l~~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~D 173 (335)
T 3dls_A 101 QGFFQLVMEKHGSGLDLFAFIDR----HPRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLID 173 (335)
T ss_dssp SSEEEEEEECCTTSCBHHHHHHT----CCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECC
T ss_pred CCEEEEEEEeCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEee
Confidence 99999999999777 99999964 34589999999999999999999999 999999999999999999999999
Q ss_pred ccccccCCcccccceeeecCccccccccccccCCCC-CcccchHhHHHHHHHHhcCc-ccccc-hHHHHHhcCCHHHHHH
Q 008785 416 VGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNEL-TTKSDVYSFGVLLLEIRLVL-CRRWW-TLYTLVHSMSLLCAQE 492 (553)
Q Consensus 416 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDVwSlGvil~ell~~~-~~~~~-~l~~~~~~~~~~~~~~ 492 (553)
||++.......... ...||+.|+|||++.+..+ +.++||||||+++|||++.. |.... .............+..
T Consensus 174 fg~a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 250 (335)
T 3dls_A 174 FGSAAYLERGKLFY---TFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEAAIHPPYLVSKE 250 (335)
T ss_dssp CTTCEECCTTCCBC---EECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGTTTCCCCSSCCCHH
T ss_pred cccceECCCCCcee---ccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHHhhccCCCcccCHH
Confidence 99998765443222 2238999999999988776 88999999999999999733 32221 1111000111145678
Q ss_pred HHHHHhhccCCCCCCCCCHHHHHHHH
Q 008785 493 CLMLFISCNNWPSHLSQSKFCNLKLW 518 (553)
Q Consensus 493 l~~l~~~Cl~~dP~~RPs~~evl~~l 518 (553)
+.+++.+||+.||++|||+.|++++-
T Consensus 251 l~~li~~~L~~dP~~Rps~~ell~hp 276 (335)
T 3dls_A 251 LMSLVSGLLQPVPERRTTLEKLVTDP 276 (335)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHCT
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCc
Confidence 89999999999999999999999873
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=322.17 Aligned_cols=242 Identities=21% Similarity=0.214 Sum_probs=195.9
Q ss_pred cccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCC-hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEE
Q 008785 268 KNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYE 345 (553)
Q Consensus 268 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 345 (553)
++|.... .||+|+||.||++... +++.||||+++... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 7 ~~y~~~~-~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 7 EDWDLVQ-TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHEEEEE-EEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEEE-EeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 3454444 4599999999999975 58999999997543 3445788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcc
Q 008785 346 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE 425 (553)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~ 425 (553)
|+++++|.+++.. ...+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||++......
T Consensus 86 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 158 (276)
T 2yex_A 86 YCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (276)
T ss_dssp CCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred ecCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCC
Confidence 9999999999863 34589999999999999999999999 9999999999999999999999999999765433
Q ss_pred cccceeeecCccccccccccccCCCC-CcccchHhHHHHHHHHhcCc-cccc----chHHHHHhcCCH------HHHHHH
Q 008785 426 VMQERTVMAGGTYGYLAPEFVYRNEL-TTKSDVYSFGVLLLEIRLVL-CRRW----WTLYTLVHSMSL------LCAQEC 493 (553)
Q Consensus 426 ~~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDVwSlGvil~ell~~~-~~~~----~~l~~~~~~~~~------~~~~~l 493 (553)
..........||+.|+|||.+.+..+ +.++||||||+++|||++.. |... ......+..... ..+..+
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (276)
T 2yex_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP 238 (276)
T ss_dssp TEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHH
T ss_pred cchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHH
Confidence 22222222348999999999987765 78999999999999999732 2211 111222222111 456788
Q ss_pred HHHHhhccCCCCCCCCCHHHHHHH
Q 008785 494 LMLFISCNNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 494 ~~l~~~Cl~~dP~~RPs~~evl~~ 517 (553)
.+++.+||+.||++|||+.|++++
T Consensus 239 ~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 239 LALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHHHHHCCCCchhCCCHHHHhcC
Confidence 999999999999999999998874
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-40 Score=329.10 Aligned_cols=242 Identities=20% Similarity=0.228 Sum_probs=197.3
Q ss_pred hcccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEE
Q 008785 267 TKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYE 345 (553)
Q Consensus 267 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 345 (553)
.++|... +.||+|+||.||++... +|+.||+|.++.......+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 8 ~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 8 RKTFIFM-EVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHHEEEE-EEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hccceee-eeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 3445443 45699999999999975 689999999987655556778999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEe---cCCCCeEEeeccccccC
Q 008785 346 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL---DEEFGAHLMGVGLSKFV 422 (553)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl---~~~~~~kl~Dfgla~~~ 422 (553)
|+++++|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+||++ ++++.+||+|||++...
T Consensus 87 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~ 159 (304)
T 2jam_A 87 LVSGGELFDRILE----RGVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKME 159 (304)
T ss_dssp CCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCC
T ss_pred cCCCccHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceec
Confidence 9999999999864 23589999999999999999999999 99999999999999 77889999999999765
Q ss_pred CcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcCc-ccc---cchHHHHHhcCCH--------HHH
Q 008785 423 PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVL-CRR---WWTLYTLVHSMSL--------LCA 490 (553)
Q Consensus 423 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~-~~~---~~~l~~~~~~~~~--------~~~ 490 (553)
...... ...||+.|+|||++.+..++.++||||||+++|||++.. |.. ...+.+.+..+.. ..+
T Consensus 160 ~~~~~~----~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 235 (304)
T 2jam_A 160 QNGIMS----TACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDIS 235 (304)
T ss_dssp CCBTTH----HHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSC
T ss_pred CCCccc----cccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCC
Confidence 433211 122899999999999999999999999999999999733 222 2233333333321 456
Q ss_pred HHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 008785 491 QECLMLFISCNNWPSHLSQSKFCNLKLWVF 520 (553)
Q Consensus 491 ~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~ 520 (553)
..+.+++.+||+.||++|||+.|++++-..
T Consensus 236 ~~~~~li~~~l~~dp~~Rps~~~~l~h~~~ 265 (304)
T 2jam_A 236 ESAKDFICHLLEKDPNERYTCEKALSHPWI 265 (304)
T ss_dssp HHHHHHHHHHHCSSTTTSCCHHHHHTSHHH
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHhcCccc
Confidence 789999999999999999999999987544
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-40 Score=335.77 Aligned_cols=240 Identities=17% Similarity=0.230 Sum_probs=188.9
Q ss_pred CeeecccCceeEEEEEeCCCCEEEEEEeccC--ChhhHHHHHHHHHHhhccCC--CceeeEeeEEeeCCceEEEEEccCC
Q 008785 274 NRLLGDSKTGGTYSGILPDGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHH--PNLVAVKGCCYDHGDRYIVYEFVVN 349 (553)
Q Consensus 274 ~~~iG~G~~g~Vy~~~~~~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H--pnIv~l~~~~~~~~~~~lV~E~~~~ 349 (553)
.+.||+|+||.||++...+++.||||++... .....+.+.+|+.++.+++| |||+++++++.+.+..++|||+ .+
T Consensus 14 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e~-~~ 92 (343)
T 3dbq_A 14 LKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GN 92 (343)
T ss_dssp EEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECC-CS
T ss_pred EEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEeC-CC
Confidence 3456999999999999988999999999754 33445788999999999976 9999999999999999999994 58
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccc
Q 008785 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE 429 (553)
Q Consensus 350 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 429 (553)
|+|.+++.. ...+++..+..++.||+.||.|||++ +|+||||||+|||++ ++.+||+|||+++.........
T Consensus 93 ~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~~ 164 (343)
T 3dbq_A 93 IDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSV 164 (343)
T ss_dssp EEHHHHHHH----SCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-------
T ss_pred CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccCcccccc
Confidence 899999975 24589999999999999999999999 999999999999997 5789999999998765443322
Q ss_pred eeeecCccccccccccccC-----------CCCCcccchHhHHHHHHHHhcCcc-ccc--chH---HHHHhcC-CH----
Q 008785 430 RTVMAGGTYGYLAPEFVYR-----------NELTTKSDVYSFGVLLLEIRLVLC-RRW--WTL---YTLVHSM-SL---- 487 (553)
Q Consensus 430 ~~~~~~gt~~y~aPE~~~~-----------~~~t~ksDVwSlGvil~ell~~~~-~~~--~~l---~~~~~~~-~~---- 487 (553)
......||+.|+|||++.+ ..++.++||||||+++|||++..+ ... ... ...+... ..
T Consensus 165 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 244 (343)
T 3dbq_A 165 VKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD 244 (343)
T ss_dssp -----CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCCCC
T ss_pred cCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcccCCcc
Confidence 2223349999999999864 678999999999999999997433 221 111 1122111 11
Q ss_pred HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 008785 488 LCAQECLMLFISCNNWPSHLSQSKFCNLKLWVFAI 522 (553)
Q Consensus 488 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~~~ 522 (553)
..+..+.+++.+||+.||.+|||+.|++++.....
T Consensus 245 ~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~ 279 (343)
T 3dbq_A 245 IPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 279 (343)
T ss_dssp CSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHS
T ss_pred cCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccc
Confidence 34467899999999999999999999999866543
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=332.11 Aligned_cols=247 Identities=27% Similarity=0.373 Sum_probs=197.9
Q ss_pred CeeecccCceeEEEEEeC-CCCE--EEEEEeccC-ChhhHHHHHHHHHHhhcc-CCCceeeEeeEEeeCCceEEEEEccC
Q 008785 274 NRLLGDSKTGGTYSGILP-DGSR--VAVKRLKRS-SFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVV 348 (553)
Q Consensus 274 ~~~iG~G~~g~Vy~~~~~-~g~~--vAvK~~~~~-~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~ 348 (553)
.+.||+|+||.||++... +|.. ||||.++.. .....+.+.+|+.+++++ +||||+++++++.+.+..++||||++
T Consensus 30 ~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~ 109 (327)
T 1fvr_A 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 109 (327)
T ss_dssp EEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred eeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEEecCC
Confidence 345699999999999964 4554 599998754 233456789999999999 89999999999999999999999999
Q ss_pred CCCHHHHhccCC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeec
Q 008785 349 NGPLDRWLHHIP------------RGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGV 416 (553)
Q Consensus 349 ~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Df 416 (553)
+|+|.+++.... .....+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+||
T Consensus 110 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kL~Df 186 (327)
T 1fvr_A 110 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADF 186 (327)
T ss_dssp TCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCT
T ss_pred CCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCeEEEccc
Confidence 999999997532 1234689999999999999999999999 9999999999999999999999999
Q ss_pred cccccCCcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhc-Cc-ccccc---hHHHHHhcCC-----
Q 008785 417 GLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-VL-CRRWW---TLYTLVHSMS----- 486 (553)
Q Consensus 417 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-~~-~~~~~---~l~~~~~~~~----- 486 (553)
|+++........ ....+++.|+|||++.+..++.++||||||+++|||++ .. |.... .+.+.+..+.
T Consensus 187 g~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~ 263 (327)
T 1fvr_A 187 GLSRGQEVYVKK---TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKP 263 (327)
T ss_dssp TCEESSCEECCC-------CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCCCCCC
T ss_pred CcCccccccccc---cCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcCCCCCCC
Confidence 999754322211 12227889999999988889999999999999999997 33 32222 2333333332
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHhhcc
Q 008785 487 LLCAQECLMLFISCNNWPSHLSQSKFCNLKLWVFAILTIR 526 (553)
Q Consensus 487 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~~~~~~~ 526 (553)
...+..+.+++.+||+.||++|||+.|+++.+...+.+..
T Consensus 264 ~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 303 (327)
T 1fvr_A 264 LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 303 (327)
T ss_dssp TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhc
Confidence 1556789999999999999999999999999877665543
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-39 Score=327.10 Aligned_cols=249 Identities=21% Similarity=0.323 Sum_probs=190.4
Q ss_pred HhhcccCCCCeeecccCceeEEEEEeCCCCEEEEEEeccCChhhHHHHHHHHHHhhc--cCCCceeeEeeEEeeC----C
Q 008785 265 SITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFAR--LHHPNLVAVKGCCYDH----G 338 (553)
Q Consensus 265 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~--l~HpnIv~l~~~~~~~----~ 338 (553)
.+.++|.... .||+|+||.||+|.. .|+.||||++.... ...+.+|.+++.. ++||||+++++++... .
T Consensus 34 ~~~~~y~~~~-~lg~G~~g~V~~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 108 (337)
T 3mdy_A 34 TIAKQIQMVK-QIGKGRYGEVWMGKW-RGEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWT 108 (337)
T ss_dssp THHHHCEEEE-EEEEETTEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGC
T ss_pred ccccceEEEe-EeecCCCeEEEEEEE-CCceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCC
Confidence 3445565544 459999999999998 48999999996542 3344455555544 4999999999999887 6
Q ss_pred ceEEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCceecCCCCCcEEecCCCCeEE
Q 008785 339 DRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV-----KPHVVHRDIRASNVLLDEEFGAHL 413 (553)
Q Consensus 339 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~-----~~~ivHrDlkp~NILl~~~~~~kl 413 (553)
..++||||+++|+|.++++. ..+++..+..++.|++.||.|||+.. +++|+||||||+|||++.++.+||
T Consensus 109 ~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl 183 (337)
T 3mdy_A 109 QLYLITDYHENGSLYDYLKS-----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCI 183 (337)
T ss_dssp EEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEE
T ss_pred ceEEEEeccCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEE
Confidence 78999999999999999965 35899999999999999999999752 348999999999999999999999
Q ss_pred eeccccccCCcccccce--eeecCccccccccccccCCCCCcc------cchHhHHHHHHHHhcC----------c-ccc
Q 008785 414 MGVGLSKFVPWEVMQER--TVMAGGTYGYLAPEFVYRNELTTK------SDVYSFGVLLLEIRLV----------L-CRR 474 (553)
Q Consensus 414 ~Dfgla~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~t~k------sDVwSlGvil~ell~~----------~-~~~ 474 (553)
+|||++........... .....||+.|+|||++.+...+.+ +||||||+++|||++. . |..
T Consensus 184 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~ 263 (337)
T 3mdy_A 184 ADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYH 263 (337)
T ss_dssp CCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred EeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHh
Confidence 99999976654332211 112348999999999987766655 9999999999999964 1 111
Q ss_pred c--------chHHHHHhcCCH-----------HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHh
Q 008785 475 W--------WTLYTLVHSMSL-----------LCAQECLMLFISCNNWPSHLSQSKFCNLKLWVFAIL 523 (553)
Q Consensus 475 ~--------~~l~~~~~~~~~-----------~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~~~~ 523 (553)
. ..+...+..... ..+..+.+++.+||+.||++|||+.|+++++.....
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 331 (337)
T 3mdy_A 264 DLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSE 331 (337)
T ss_dssp TTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHh
Confidence 0 111112211111 677889999999999999999999999999866544
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=324.08 Aligned_cols=247 Identities=21% Similarity=0.253 Sum_probs=196.2
Q ss_pred hcccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCC----hhhHHHHHHHHHHhhccCCCceeeEeeEEe--eCCc
Q 008785 267 TKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS----FQRKKEFYSEIGRFARLHHPNLVAVKGCCY--DHGD 339 (553)
Q Consensus 267 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~----~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~--~~~~ 339 (553)
.++|.....+ |+|+||.||++... +++.||+|+++... ......+.+|+.++++++||||+++++++. +.+.
T Consensus 4 ~~~y~i~~~l-g~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 4 IGKYLMGDLL-GEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp -CCBCCCCEE-EECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred ccceeEeeEE-ecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 4566665554 99999999999974 58899999997542 234578999999999999999999999984 4457
Q ss_pred eEEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeecccc
Q 008785 340 RYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLS 419 (553)
Q Consensus 340 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla 419 (553)
.++||||++++ |.+++... ....+++..+..++.||+.||.|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 83 ~~lv~e~~~~~-l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~ 156 (305)
T 2wtk_C 83 MYMVMEYCVCG-MQEMLDSV--PEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVA 156 (305)
T ss_dssp EEEEEECCSEE-HHHHHHHS--TTCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred EEEEehhccCC-HHHHHHhC--cccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeeccccc
Confidence 89999999876 77777653 345689999999999999999999999 9999999999999999999999999999
Q ss_pred ccCCcccccceeeecCccccccccccccCCC--CCcccchHhHHHHHHHHhcC-cccccch---HHHHHhcCCH----HH
Q 008785 420 KFVPWEVMQERTVMAGGTYGYLAPEFVYRNE--LTTKSDVYSFGVLLLEIRLV-LCRRWWT---LYTLVHSMSL----LC 489 (553)
Q Consensus 420 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~t~ksDVwSlGvil~ell~~-~~~~~~~---l~~~~~~~~~----~~ 489 (553)
................||+.|+|||++.+.. ++.++||||||+++|||++. .|..... +.+.+..+.. ..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~ 236 (305)
T 2wtk_C 157 EALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDC 236 (305)
T ss_dssp EECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCCSSS
T ss_pred cccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCCCCcc
Confidence 8765433222333344899999999987644 37899999999999999973 3333332 2333333332 45
Q ss_pred HHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 008785 490 AQECLMLFISCNNWPSHLSQSKFCNLKLWVF 520 (553)
Q Consensus 490 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~ 520 (553)
+..+.+++.+||+.||++|||+.|++++-..
T Consensus 237 ~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~ 267 (305)
T 2wtk_C 237 GPPLSDLLKGMLEYEPAKRFSIRQIRQHSWF 267 (305)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHHSHHH
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHhcCccc
Confidence 6788999999999999999999999998544
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=331.58 Aligned_cols=243 Identities=25% Similarity=0.377 Sum_probs=197.8
Q ss_pred CeeecccCceeEEEEEe-----CCCCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCC--ceEEEEEc
Q 008785 274 NRLLGDSKTGGTYSGIL-----PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHG--DRYIVYEF 346 (553)
Q Consensus 274 ~~~iG~G~~g~Vy~~~~-----~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~--~~~lV~E~ 346 (553)
.+.||+|+||.||++.+ .+|+.||||++........+.+.+|+.++++++||||+++++++...+ ..++||||
T Consensus 46 ~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~ 125 (326)
T 2w1i_A 46 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEY 125 (326)
T ss_dssp EEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEEEECC
T ss_pred eeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEEEEC
Confidence 34569999999999984 358899999998876667788999999999999999999999987654 68999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCccc
Q 008785 347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV 426 (553)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 426 (553)
+++|+|.+++.. ....+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 126 ~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~ 199 (326)
T 2w1i_A 126 LPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 199 (326)
T ss_dssp CTTCBHHHHHHH---STTSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCSSC
T ss_pred CCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcchhhccccc
Confidence 999999999975 234589999999999999999999999 99999999999999999999999999998765443
Q ss_pred ccce-eeecCccccccccccccCCCCCcccchHhHHHHHHHHhcCcccccch--------------------HHHHHhcC
Q 008785 427 MQER-TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVLCRRWWT--------------------LYTLVHSM 485 (553)
Q Consensus 427 ~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~~~~~~~--------------------l~~~~~~~ 485 (553)
.... .....++..|+|||.+.+..++.++||||||+++|||++........ +.+.+..+
T Consensus 200 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (326)
T 2w1i_A 200 EYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN 279 (326)
T ss_dssp SEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHHTT
T ss_pred cccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhhcC
Confidence 2111 11223677899999999888999999999999999999733221111 11122221
Q ss_pred C-H----HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 008785 486 S-L----LCAQECLMLFISCNNWPSHLSQSKFCNLKLWVFAI 522 (553)
Q Consensus 486 ~-~----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~~~ 522 (553)
. . ..+..+.+++.+||+.||++|||+.|+++.+....
T Consensus 280 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~ 321 (326)
T 2w1i_A 280 GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 321 (326)
T ss_dssp CCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1 1 45678999999999999999999999999876543
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=325.01 Aligned_cols=241 Identities=21% Similarity=0.271 Sum_probs=188.0
Q ss_pred hcccCCCCeeecccCceeEEEEEe-CCCCEEEEEEeccCCh-----hhHHHHHHHHHHhhcc---CCCceeeEeeEEeeC
Q 008785 267 TKNFSEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSF-----QRKKEFYSEIGRFARL---HHPNLVAVKGCCYDH 337 (553)
Q Consensus 267 ~~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~~~~~~~-----~~~~~~~~E~~~l~~l---~HpnIv~l~~~~~~~ 337 (553)
.++|.... .||+|+||.||+|.. .+|+.||||+++.... .....+.+|+.+++++ +||||+++++++...
T Consensus 8 ~~~y~~~~-~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 8 TSRYEPVA-EIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp --CCEEEE-EECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred ccceEEEE-EEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 34554444 459999999999996 4689999999874321 1134566777777666 599999999999876
Q ss_pred C-----ceEEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeE
Q 008785 338 G-----DRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAH 412 (553)
Q Consensus 338 ~-----~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~k 412 (553)
. ..++||||+. |+|.+++.. .....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+|
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~k 160 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDK--APPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVK 160 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHT--CCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCEE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhh--ccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEE
Confidence 5 4799999996 699999976 2334589999999999999999999999 999999999999999999999
Q ss_pred EeeccccccCCcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcCc-ccccch---HHH-HHhc-C-
Q 008785 413 LMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVL-CRRWWT---LYT-LVHS-M- 485 (553)
Q Consensus 413 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~-~~~~~~---l~~-~~~~-~- 485 (553)
|+|||+++......... ...||+.|+|||++.+..++.++||||||+++|||++.. +..... ... .... +
T Consensus 161 l~Dfg~a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~ 237 (308)
T 3g33_A 161 LADFGLARIYSYQMALT---PVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGL 237 (308)
T ss_dssp ECSCSCTTTSTTCCCSG---GGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred EeeCccccccCCCcccC---CccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 99999998665332221 223899999999999999999999999999999999733 222221 111 1110 0
Q ss_pred -----------------------CH-----HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008785 486 -----------------------SL-----LCAQECLMLFISCNNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 486 -----------------------~~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 517 (553)
.. ..+..+.+++.+||+.||++|||+.|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 238 PPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp CCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 00 245678999999999999999999999975
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-40 Score=360.86 Aligned_cols=241 Identities=24% Similarity=0.295 Sum_probs=195.8
Q ss_pred eeecccCceeEEEEEeC---CCCEEEEEEeccCC--hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCC
Q 008785 275 RLLGDSKTGGTYSGILP---DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 349 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~---~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 349 (553)
+.||+|+||.||+|.+. .++.||||+++... ....+++.+|+.+|++++|||||++++++. .+..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccCC
Confidence 35799999999999753 36789999998643 334678999999999999999999999986 4568999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccc
Q 008785 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE 429 (553)
Q Consensus 350 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 429 (553)
|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.........
T Consensus 454 g~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 526 (635)
T 4fl3_A 454 GPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 526 (635)
T ss_dssp EEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred CCHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence 999999964 24589999999999999999999999 99999999999999999999999999998765433211
Q ss_pred -eeeecCccccccccccccCCCCCcccchHhHHHHHHHHhc-C-ccccc---chHHHHHhcCCH-----HHHHHHHHHHh
Q 008785 430 -RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-V-LCRRW---WTLYTLVHSMSL-----LCAQECLMLFI 498 (553)
Q Consensus 430 -~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-~-~~~~~---~~l~~~~~~~~~-----~~~~~l~~l~~ 498 (553)
......+|+.|+|||++.+..++.++||||||+++|||++ . .|... ..+.+.+..+.. ..+..+.+++.
T Consensus 527 ~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~ 606 (635)
T 4fl3_A 527 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMN 606 (635)
T ss_dssp --------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Confidence 1122236789999999999999999999999999999997 3 23322 234444444432 56788999999
Q ss_pred hccCCCCCCCCCHHHHHHHHHHHHh
Q 008785 499 SCNNWPSHLSQSKFCNLKLWVFAIL 523 (553)
Q Consensus 499 ~Cl~~dP~~RPs~~evl~~l~~~~~ 523 (553)
+||+.||++|||+.+|++.|...+.
T Consensus 607 ~cl~~dP~~RPs~~~l~~~L~~~~~ 631 (635)
T 4fl3_A 607 LCWTYDVENRPGFAAVELRLRNYYY 631 (635)
T ss_dssp HHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 9999999999999999998876543
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=335.74 Aligned_cols=249 Identities=13% Similarity=0.086 Sum_probs=193.6
Q ss_pred ccCCCCeeecccCceeEEEEEeCC------CCEEEEEEeccCChhhH-----------HHHHHHHHHhhccCCCceeeEe
Q 008785 269 NFSEGNRLLGDSKTGGTYSGILPD------GSRVAVKRLKRSSFQRK-----------KEFYSEIGRFARLHHPNLVAVK 331 (553)
Q Consensus 269 ~~~~~~~~iG~G~~g~Vy~~~~~~------g~~vAvK~~~~~~~~~~-----------~~~~~E~~~l~~l~HpnIv~l~ 331 (553)
+|... +.||+|+||.||+|.+.+ ++.||||++........ ..+.+|+..+..++||||++++
T Consensus 36 ~y~~~-~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~ 114 (364)
T 3op5_A 36 AWKVG-LPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYW 114 (364)
T ss_dssp EEEEE-EECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEE
T ss_pred eEEEE-EEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEE
Confidence 45444 456999999999999765 47899999876542211 2244566777888999999999
Q ss_pred eEEeeC----CceEEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEec-
Q 008785 332 GCCYDH----GDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD- 406 (553)
Q Consensus 332 ~~~~~~----~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~- 406 (553)
+++... ...++||||+ +++|.+++.. ....+++..+..++.||+.||+|||++ +|+||||||+|||++
T Consensus 115 ~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~---~~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~~ 187 (364)
T 3op5_A 115 GSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA---NAKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNY 187 (364)
T ss_dssp EEEEEEETTEEEEEEEEECE-EEEHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEES
T ss_pred eeeeeccCCcceEEEEEeCC-CCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEec
Confidence 998875 4479999999 9999999975 335699999999999999999999999 999999999999999
Q ss_pred -CCCCeEEeeccccccCCcccccce-----eeecCccccccccccccCCCCCcccchHhHHHHHHHHhcCc-cccc----
Q 008785 407 -EEFGAHLMGVGLSKFVPWEVMQER-----TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVL-CRRW---- 475 (553)
Q Consensus 407 -~~~~~kl~Dfgla~~~~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~-~~~~---- 475 (553)
.++.+||+|||+++.......... .....||+.|+|||++.+..++.++||||||+++|||++.. |...
T Consensus 188 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~ 267 (364)
T 3op5_A 188 KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD 267 (364)
T ss_dssp SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccC
Confidence 889999999999987654422211 11223899999999999999999999999999999999833 3221
Q ss_pred chHHHHHh---cCCH-----------HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHhhc
Q 008785 476 WTLYTLVH---SMSL-----------LCAQECLMLFISCNNWPSHLSQSKFCNLKLWVFAILTI 525 (553)
Q Consensus 476 ~~l~~~~~---~~~~-----------~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~~~~~~ 525 (553)
........ ...+ ..+..+.+++..||+.||++||++.++++.+...+.+.
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~ 331 (364)
T 3op5_A 268 PKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAI 331 (364)
T ss_dssp HHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Confidence 11111111 0111 12667899999999999999999999999887777544
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-40 Score=333.32 Aligned_cols=248 Identities=17% Similarity=0.202 Sum_probs=199.3
Q ss_pred HHHhhcccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCC--hhhHHHHHHHHHHhhcc-CCCceeeEeeEEeeCC
Q 008785 263 LRSITKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHG 338 (553)
Q Consensus 263 l~~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~ 338 (553)
...+.+.|....+.||+|+||.||++... +|+.||||+++... ......+.+|+.++.++ +||||+++++++.+.+
T Consensus 23 ~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~ 102 (327)
T 3lm5_A 23 MENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTS 102 (327)
T ss_dssp HHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred HHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCC
Confidence 34455556555567799999999999975 58999999997642 23467889999999999 5799999999999999
Q ss_pred ceEEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecC---CCCeEEee
Q 008785 339 DRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE---EFGAHLMG 415 (553)
Q Consensus 339 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~---~~~~kl~D 415 (553)
..++||||+++|+|.+++.. .....+++..+..++.|++.||+|||++ +|+||||||+|||++. ++.+||+|
T Consensus 103 ~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~kL~D 177 (327)
T 3lm5_A 103 EIILILEYAAGGEIFSLCLP--ELAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVD 177 (327)
T ss_dssp EEEEEEECCTTEEGGGGGSS--CC-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEEECC
T ss_pred eEEEEEEecCCCcHHHHHHH--hcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEEEee
Confidence 99999999999999999864 3345699999999999999999999999 9999999999999988 78999999
Q ss_pred ccccccCCcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcC-cccccch---HHHHHhcCCH----
Q 008785 416 VGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLV-LCRRWWT---LYTLVHSMSL---- 487 (553)
Q Consensus 416 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~-~~~~~~~---l~~~~~~~~~---- 487 (553)
||+++......... ...||+.|+|||++.+..++.++||||||+++|||++. .|..... ....+.....
T Consensus 178 fg~a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 254 (327)
T 3lm5_A 178 FGMSRKIGHACELR---EIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSE 254 (327)
T ss_dssp GGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT
T ss_pred CccccccCCccccc---cccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCc
Confidence 99998765432211 22389999999999999999999999999999999973 3332222 2222221111
Q ss_pred ----HHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008785 488 ----LCAQECLMLFISCNNWPSHLSQSKFCNLKLW 518 (553)
Q Consensus 488 ----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l 518 (553)
..+..+.+++.+||+.||++|||+.|++++-
T Consensus 255 ~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~ 289 (327)
T 3lm5_A 255 ETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHS 289 (327)
T ss_dssp TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCG
T ss_pred hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCH
Confidence 4567789999999999999999999999874
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=329.85 Aligned_cols=248 Identities=19% Similarity=0.188 Sum_probs=196.5
Q ss_pred ccCCCCeeecccCceeEEEEEe-CCCCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeEEee----CCceEEE
Q 008785 269 NFSEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD----HGDRYIV 343 (553)
Q Consensus 269 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~----~~~~~lV 343 (553)
+|... +.||+|+||.||++.. .+|+.||||++........+.+.+|+.++++++||||+++++++.. ....++|
T Consensus 30 ~y~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv 108 (317)
T 2buj_A 30 HYLFI-QKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLL 108 (317)
T ss_dssp EEEEE-EEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEE
T ss_pred EEEEE-EEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEE
Confidence 34443 4569999999999996 5689999999987766777889999999999999999999999873 3467999
Q ss_pred EEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCC
Q 008785 344 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVP 423 (553)
Q Consensus 344 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~ 423 (553)
|||+++|+|.+++.........+++..+..++.||+.||.|||++ +|+||||||+||+++.++.+||+|||++....
T Consensus 109 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~ 185 (317)
T 2buj_A 109 LPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQAC 185 (317)
T ss_dssp EECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCEESC
T ss_pred EEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcchhcc
Confidence 999999999999976434456799999999999999999999999 99999999999999999999999999987654
Q ss_pred cccccc-------eeeecCccccccccccccCCC---CCcccchHhHHHHHHHHhcCccccc------chHHHHHhcCC-
Q 008785 424 WEVMQE-------RTVMAGGTYGYLAPEFVYRNE---LTTKSDVYSFGVLLLEIRLVLCRRW------WTLYTLVHSMS- 486 (553)
Q Consensus 424 ~~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~t~ksDVwSlGvil~ell~~~~~~~------~~l~~~~~~~~- 486 (553)
...... ......||+.|+|||++.+.. ++.++||||||+++|||++...... ..+...+....
T Consensus 186 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 265 (317)
T 2buj_A 186 IHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLS 265 (317)
T ss_dssp EEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHCC--
T ss_pred cccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhccCC
Confidence 321110 001122789999999987544 6899999999999999997433221 11222222211
Q ss_pred ----HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 008785 487 ----LLCAQECLMLFISCNNWPSHLSQSKFCNLKLWVF 520 (553)
Q Consensus 487 ----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~ 520 (553)
...+..+.+++.+||+.||.+|||+.++++++..
T Consensus 266 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 303 (317)
T 2buj_A 266 IPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEA 303 (317)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhh
Confidence 1456789999999999999999999999998743
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=323.29 Aligned_cols=233 Identities=24% Similarity=0.342 Sum_probs=188.0
Q ss_pred CeeecccCceeEEEEEeC-CCCEEEEEEeccCChhh-------HHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEE
Q 008785 274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQR-------KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYE 345 (553)
Q Consensus 274 ~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~~~-------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 345 (553)
.+.||+|+||.||+|... +++.||||++....... .+.+.+|+.++++++||||+++++++.+.. ++|||
T Consensus 24 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~lv~e 101 (287)
T 4f0f_A 24 EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--RMVME 101 (287)
T ss_dssp EEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--EEEEE
T ss_pred hhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--eEEEE
Confidence 345699999999999974 68999999986543221 167899999999999999999999986554 79999
Q ss_pred ccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--ceecCCCCCcEEecCCCC-----eEEeeccc
Q 008785 346 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPH--VVHRDIRASNVLLDEEFG-----AHLMGVGL 418 (553)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~--ivHrDlkp~NILl~~~~~-----~kl~Dfgl 418 (553)
|+++|+|.+++.. ....+++..+..++.|++.||+|||++ + |+||||||+|||++.++. +||+|||+
T Consensus 102 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~ 175 (287)
T 4f0f_A 102 FVPCGDLYHRLLD---KAHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGL 175 (287)
T ss_dssp CCTTCBHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTT
T ss_pred ecCCCCHHHHHhc---ccCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEEeCCCCc
Confidence 9999999998864 345699999999999999999999999 8 999999999999988776 99999999
Q ss_pred cccCCcccccceeeecCcccccccccccc--CCCCCcccchHhHHHHHHHHhcC-ccccc---chH--HHHHhcCCH---
Q 008785 419 SKFVPWEVMQERTVMAGGTYGYLAPEFVY--RNELTTKSDVYSFGVLLLEIRLV-LCRRW---WTL--YTLVHSMSL--- 487 (553)
Q Consensus 419 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~t~ksDVwSlGvil~ell~~-~~~~~---~~l--~~~~~~~~~--- 487 (553)
++..... .....||+.|+|||++. ...++.++||||||+++|||++. .|... ... ...+.....
T Consensus 176 ~~~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 250 (287)
T 4f0f_A 176 SQQSVHS-----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPT 250 (287)
T ss_dssp CBCCSSC-----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCCC
T ss_pred ccccccc-----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCCCC
Confidence 9754332 11233899999999983 45678999999999999999973 22221 111 222221111
Q ss_pred ---HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 008785 488 ---LCAQECLMLFISCNNWPSHLSQSKFCNLKLWV 519 (553)
Q Consensus 488 ---~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~ 519 (553)
..+..+.+++.+||+.||++|||+.|+++.+.
T Consensus 251 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~ 285 (287)
T 4f0f_A 251 IPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELS 285 (287)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHH
Confidence 56778999999999999999999999999874
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=344.80 Aligned_cols=251 Identities=20% Similarity=0.168 Sum_probs=200.2
Q ss_pred HHHHHhhcccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCCh---hhHHHHHHHHHHhhccCCCceeeEeeEEee
Q 008785 261 EELRSITKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF---QRKKEFYSEIGRFARLHHPNLVAVKGCCYD 336 (553)
Q Consensus 261 ~el~~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 336 (553)
++.....++|.... .||+|+||.||++... +|+.||||++++... ...+.+.+|..++.+++||||+++++++.+
T Consensus 54 ~~~~~~~~~f~~~~-~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 132 (412)
T 2vd5_A 54 KEVRLQRDDFEILK-VIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD 132 (412)
T ss_dssp HHHSCCGGGEEEEE-EEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhccCChhhEEEEE-EEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence 34444456666544 4599999999999975 589999999975422 223457899999999999999999999999
Q ss_pred CCceEEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeec
Q 008785 337 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGV 416 (553)
Q Consensus 337 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Df 416 (553)
.+..|+||||+++|+|.+++.. .+..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+||
T Consensus 133 ~~~~~lVmE~~~gg~L~~~l~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DF 206 (412)
T 2vd5_A 133 ENYLYLVMEYYVGGDLLTLLSK---FGERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADF 206 (412)
T ss_dssp SSEEEEEECCCCSCBHHHHHHH---HSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred CCEEEEEEcCCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeec
Confidence 9999999999999999999975 224689999999999999999999999 9999999999999999999999999
Q ss_pred cccccCCcccccceeeecCcccccccccccc-------CCCCCcccchHhHHHHHHHHhcC-cccccc---hHHHHHhc-
Q 008785 417 GLSKFVPWEVMQERTVMAGGTYGYLAPEFVY-------RNELTTKSDVYSFGVLLLEIRLV-LCRRWW---TLYTLVHS- 484 (553)
Q Consensus 417 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~t~ksDVwSlGvil~ell~~-~~~~~~---~l~~~~~~- 484 (553)
|+++......... .....||+.|+|||++. ...++.++|||||||++|||++. .|.... .....+..
T Consensus 207 Gla~~~~~~~~~~-~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~ 285 (412)
T 2vd5_A 207 GSCLKLRADGTVR-SLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHY 285 (412)
T ss_dssp TTCEECCTTSCEE-CSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTH
T ss_pred hhheeccCCCccc-cceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Confidence 9998765433211 12234999999999987 35689999999999999999973 333222 22222211
Q ss_pred ---CCH-----HHHHHHHHHHhhccCCCCCCC---CCHHHHHHHHHH
Q 008785 485 ---MSL-----LCAQECLMLFISCNNWPSHLS---QSKFCNLKLWVF 520 (553)
Q Consensus 485 ---~~~-----~~~~~l~~l~~~Cl~~dP~~R---Ps~~evl~~l~~ 520 (553)
..+ ..+..+.+++.+||. +|.+| |++.|++++-.+
T Consensus 286 ~~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff 331 (412)
T 2vd5_A 286 KEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFF 331 (412)
T ss_dssp HHHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGG
T ss_pred ccCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCc
Confidence 111 356789999999999 99998 699999988544
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=324.10 Aligned_cols=243 Identities=22% Similarity=0.241 Sum_probs=198.9
Q ss_pred ccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCC---hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEE
Q 008785 269 NFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVY 344 (553)
Q Consensus 269 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 344 (553)
+|... +.||+|+||.||+|... +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 15 ~y~~~-~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 15 DFDIG-RPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GEEEE-EEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hceee-heecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 34443 45699999999999975 47789999997542 223467899999999999999999999999999999999
Q ss_pred EccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCc
Q 008785 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW 424 (553)
Q Consensus 345 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~ 424 (553)
||+++|+|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||++.....
T Consensus 94 e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (284)
T 2vgo_A 94 EFAPRGELYKELQKH----GRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPS 166 (284)
T ss_dssp CCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred EeCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence 999999999999752 3589999999999999999999999 999999999999999999999999999875543
Q ss_pred ccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcC-cccccc---hHHHHHhcCCH----HHHHHHHHH
Q 008785 425 EVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLV-LCRRWW---TLYTLVHSMSL----LCAQECLML 496 (553)
Q Consensus 425 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~-~~~~~~---~l~~~~~~~~~----~~~~~l~~l 496 (553)
... ....|++.|+|||++.+..++.++||||||+++|||++. .|.... .....+..... ..+..+.++
T Consensus 167 ~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 242 (284)
T 2vgo_A 167 LRR----RTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDL 242 (284)
T ss_dssp SCB----CCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHH
T ss_pred ccc----ccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCCCcCCHHHHHH
Confidence 221 122389999999999998999999999999999999973 233222 22222322222 456788999
Q ss_pred HhhccCCCCCCCCCHHHHHHHHHHHHh
Q 008785 497 FISCNNWPSHLSQSKFCNLKLWVFAIL 523 (553)
Q Consensus 497 ~~~Cl~~dP~~RPs~~evl~~l~~~~~ 523 (553)
+.+||+.||.+|||+.|++++-.....
T Consensus 243 i~~~l~~~p~~Rps~~~ll~h~~~~~~ 269 (284)
T 2vgo_A 243 ISKLLRYHPPQRLPLKGVMEHPWVKAN 269 (284)
T ss_dssp HHHHSCSSGGGSCCHHHHHTCHHHHHH
T ss_pred HHHHhhcCHhhCCCHHHHhhCHHHHhh
Confidence 999999999999999999998655433
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=323.96 Aligned_cols=238 Identities=19% Similarity=0.221 Sum_probs=198.1
Q ss_pred CeeecccCceeEEEEEeCC-CCEEEEEEeccC---ChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCC
Q 008785 274 NRLLGDSKTGGTYSGILPD-GSRVAVKRLKRS---SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 349 (553)
Q Consensus 274 ~~~iG~G~~g~Vy~~~~~~-g~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 349 (553)
.+.||+|+||.||++...+ ++.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++||||+++
T Consensus 20 ~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 99 (294)
T 2rku_A 20 GRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRR 99 (294)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred EEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEecCCC
Confidence 3456999999999999764 889999998754 234567789999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccc
Q 008785 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE 429 (553)
Q Consensus 350 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 429 (553)
++|.+++.. ...+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||++..........
T Consensus 100 ~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 172 (294)
T 2rku_A 100 RSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK 172 (294)
T ss_dssp CBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTCCB
T ss_pred CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceecccCcccc
Confidence 999998864 24589999999999999999999999 99999999999999999999999999998765332221
Q ss_pred eeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcC-cccccchHH---HHHhcCCH----HHHHHHHHHHhhcc
Q 008785 430 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLV-LCRRWWTLY---TLVHSMSL----LCAQECLMLFISCN 501 (553)
Q Consensus 430 ~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~-~~~~~~~l~---~~~~~~~~----~~~~~l~~l~~~Cl 501 (553)
....||+.|+|||.+.+..++.++||||||+++|||++. .+....... ..+..+.. ..+..+.+++.+||
T Consensus 173 --~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 250 (294)
T 2rku_A 173 --KVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKML 250 (294)
T ss_dssp --CCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHHHT
T ss_pred --ccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCccccCHHHHHHHHHHc
Confidence 123389999999999988899999999999999999973 333322222 23333222 45677899999999
Q ss_pred CCCCCCCCCHHHHHHHHHH
Q 008785 502 NWPSHLSQSKFCNLKLWVF 520 (553)
Q Consensus 502 ~~dP~~RPs~~evl~~l~~ 520 (553)
+.||++|||+.|++++-..
T Consensus 251 ~~~p~~Rps~~~ll~~~~~ 269 (294)
T 2rku_A 251 QTDPTARPTINELLNDEFF 269 (294)
T ss_dssp CSSGGGSCCGGGGGGSHHH
T ss_pred ccChhhCcCHHHHhhChhe
Confidence 9999999999999998544
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=327.73 Aligned_cols=240 Identities=19% Similarity=0.201 Sum_probs=189.0
Q ss_pred ccCCCCeeecccCceeEEEEEeCC-CCEEEEEEeccCC--hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEE
Q 008785 269 NFSEGNRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYE 345 (553)
Q Consensus 269 ~~~~~~~~iG~G~~g~Vy~~~~~~-g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 345 (553)
+|.... .||+|+||.||+|.... |+.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 4 ~y~~~~-~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 4 KYEKIG-KIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CEEEEE-EEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEee-EEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 344434 45999999999999754 8999999986543 2335678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcc
Q 008785 346 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE 425 (553)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~ 425 (553)
|+++++|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++......
T Consensus 83 ~~~~~~l~~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 155 (311)
T 4agu_A 83 YCDHTVLHELDRY----QRGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGP 155 (311)
T ss_dssp CCSEEHHHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred eCCCchHHHHHhh----hcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCc
Confidence 9999999998753 34589999999999999999999999 9999999999999999999999999999876533
Q ss_pred cccceeeecCccccccccccccC-CCCCcccchHhHHHHHHHHhcCc-ccccchHHH---HHhc--CC------------
Q 008785 426 VMQERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIRLVL-CRRWWTLYT---LVHS--MS------------ 486 (553)
Q Consensus 426 ~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwSlGvil~ell~~~-~~~~~~l~~---~~~~--~~------------ 486 (553)
..... ...||+.|+|||++.+ ..++.++||||||+++|||++.. |.......+ .+.. +.
T Consensus 156 ~~~~~--~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (311)
T 4agu_A 156 SDYYD--DEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTN 233 (311)
T ss_dssp ------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTC
T ss_pred ccccC--CCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccc
Confidence 22211 2238999999999876 56899999999999999999732 222211111 1100 00
Q ss_pred ---------------------HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008785 487 ---------------------LLCAQECLMLFISCNNWPSHLSQSKFCNLKLW 518 (553)
Q Consensus 487 ---------------------~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l 518 (553)
...+..+.+++.+||+.||++|||+.|++++-
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 286 (311)
T 4agu_A 234 QYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHP 286 (311)
T ss_dssp GGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSG
T ss_pred cccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcCh
Confidence 02355688999999999999999999999863
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=342.79 Aligned_cols=240 Identities=21% Similarity=0.253 Sum_probs=187.0
Q ss_pred hhcccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCCh--------hhHHHHHHHHHHhhccCCCceeeEeeEEee
Q 008785 266 ITKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF--------QRKKEFYSEIGRFARLHHPNLVAVKGCCYD 336 (553)
Q Consensus 266 ~~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~--------~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 336 (553)
+.++|.... .||+|+||.||+|... +++.||||++..... .....+.+|+.+|++++||||+++++++.
T Consensus 133 ~~~~y~~~~-~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~- 210 (419)
T 3i6u_A 133 LRDEYIMSK-TLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD- 210 (419)
T ss_dssp HHTTEEEEE-EEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred hhccEEEEe-EEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 445565544 5599999999999965 489999999975421 11235789999999999999999999975
Q ss_pred CCceEEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCC---CCeEE
Q 008785 337 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE---FGAHL 413 (553)
Q Consensus 337 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~---~~~kl 413 (553)
.+..++||||+++|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.+ ..+||
T Consensus 211 ~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl 283 (419)
T 3i6u_A 211 AEDYYIVLELMEGGELFDKVVG----NKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKI 283 (419)
T ss_dssp SSEEEEEEECCTTCBGGGGTSS----SCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEE
T ss_pred cCceEEEEEcCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEE
Confidence 4568999999999999998854 34689999999999999999999999 99999999999999754 45999
Q ss_pred eeccccccCCcccccceeeecCccccccccccccC---CCCCcccchHhHHHHHHHHhcCc-ccc----cchHHHHHhcC
Q 008785 414 MGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYR---NELTTKSDVYSFGVLLLEIRLVL-CRR----WWTLYTLVHSM 485 (553)
Q Consensus 414 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~t~ksDVwSlGvil~ell~~~-~~~----~~~l~~~~~~~ 485 (553)
+|||+++........ ....||+.|+|||++.+ ..++.++||||||+++|||++.. |.. ...+.+.+..+
T Consensus 284 ~DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~ 360 (419)
T 3i6u_A 284 TDFGHSKILGETSLM---RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSG 360 (419)
T ss_dssp CCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTT
T ss_pred eecccceecCCCccc---cccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcC
Confidence 999999876543221 12338999999999853 67889999999999999999732 221 22344444444
Q ss_pred CH--------HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008785 486 SL--------LCAQECLMLFISCNNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 486 ~~--------~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 517 (553)
.. ..+..+.+++.+||+.||++|||+.|++++
T Consensus 361 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 361 KYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp CCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 33 346789999999999999999999999986
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-40 Score=353.47 Aligned_cols=238 Identities=21% Similarity=0.205 Sum_probs=198.3
Q ss_pred CeeecccCceeEEEEEeC-CCCEEEEEEeccCC---hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCC
Q 008785 274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 349 (553)
Q Consensus 274 ~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 349 (553)
.++||+|+||.||++... +|+.||||++.... ......+.+|+.+|++++||||+++++++.+.+..++||||+++
T Consensus 189 ~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~g 268 (576)
T 2acx_A 189 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNG 268 (576)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred EEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEcCCC
Confidence 345699999999999975 59999999997542 23356788999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccc
Q 008785 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE 429 (553)
Q Consensus 350 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 429 (553)
|+|.+++... ....+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++........
T Consensus 269 g~L~~~l~~~--~~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~~~- 342 (576)
T 2acx_A 269 GDLKFHIYHM--GQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTI- 342 (576)
T ss_dssp CBHHHHHHSS--SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCCE-
T ss_pred CcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceecccCccc-
Confidence 9999999752 334589999999999999999999999 9999999999999999999999999999876543221
Q ss_pred eeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcCc-cccc-------chHHHHHhcCCH----HHHHHHHHHH
Q 008785 430 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVL-CRRW-------WTLYTLVHSMSL----LCAQECLMLF 497 (553)
Q Consensus 430 ~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~-~~~~-------~~l~~~~~~~~~----~~~~~l~~l~ 497 (553)
....||+.|+|||++.+..++.++|||||||++|||++.. |... ..+...+..... ..+..+.+++
T Consensus 343 --~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p~~~s~~~~dLI 420 (576)
T 2acx_A 343 --KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLC 420 (576)
T ss_dssp --ECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCCTTSCHHHHHHH
T ss_pred --cccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCCccCCHHHHHHH
Confidence 2234999999999999989999999999999999999733 2221 123333333222 4677899999
Q ss_pred hhccCCCCCCCC-----CHHHHHHHHH
Q 008785 498 ISCNNWPSHLSQ-----SKFCNLKLWV 519 (553)
Q Consensus 498 ~~Cl~~dP~~RP-----s~~evl~~l~ 519 (553)
.+||+.||.+|| ++.|++++-.
T Consensus 421 ~~lL~~dP~~R~g~~~~sa~eil~Hpf 447 (576)
T 2acx_A 421 SQLLCKDPAERLGCRGGSAREVKEHPL 447 (576)
T ss_dssp HHHTCSSGGGSTTCSSSHHHHHHTSGG
T ss_pred HHhccCCHHHcCCCCCCCHHHHHhChh
Confidence 999999999999 7899998743
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=337.14 Aligned_cols=239 Identities=17% Similarity=0.222 Sum_probs=188.9
Q ss_pred CeeecccCceeEEEEEeCCCCEEEEEEeccC--ChhhHHHHHHHHHHhhccC--CCceeeEeeEEeeCCceEEEEEccCC
Q 008785 274 NRLLGDSKTGGTYSGILPDGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLH--HPNLVAVKGCCYDHGDRYIVYEFVVN 349 (553)
Q Consensus 274 ~~~iG~G~~g~Vy~~~~~~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~--HpnIv~l~~~~~~~~~~~lV~E~~~~ 349 (553)
.+.||+|+||.||++...+++.||||++... .....+.+.+|+.+|++++ ||||+++++++...+..++||| +.+
T Consensus 61 ~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E-~~~ 139 (390)
T 2zmd_A 61 LKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGN 139 (390)
T ss_dssp EEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE-CCS
T ss_pred EEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe-cCC
Confidence 3456999999999999888999999999754 3445678999999999996 5999999999999999999999 568
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccc
Q 008785 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE 429 (553)
Q Consensus 350 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 429 (553)
++|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+|||++ ++.+||+|||+++.........
T Consensus 140 ~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~ 211 (390)
T 2zmd_A 140 IDLNSWLKKK----KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSV 211 (390)
T ss_dssp EEHHHHHHHC----SSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC-------
T ss_pred CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccccCCCccc
Confidence 8999999752 3688999999999999999999999 999999999999996 5789999999998765443222
Q ss_pred eeeecCccccccccccccC-----------CCCCcccchHhHHHHHHHHhcCcc-ccc--ch---HHHHHhcC-CH----
Q 008785 430 RTVMAGGTYGYLAPEFVYR-----------NELTTKSDVYSFGVLLLEIRLVLC-RRW--WT---LYTLVHSM-SL---- 487 (553)
Q Consensus 430 ~~~~~~gt~~y~aPE~~~~-----------~~~t~ksDVwSlGvil~ell~~~~-~~~--~~---l~~~~~~~-~~---- 487 (553)
......||+.|+|||++.+ ..++.++|||||||++|||++..+ ... .. +...+... ..
T Consensus 212 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 291 (390)
T 2zmd_A 212 VKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD 291 (390)
T ss_dssp --CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCCCCC
T ss_pred cCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCCCCc
Confidence 2223349999999999865 468999999999999999997333 221 11 11122211 11
Q ss_pred HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 008785 488 LCAQECLMLFISCNNWPSHLSQSKFCNLKLWVFA 521 (553)
Q Consensus 488 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~~ 521 (553)
..+..+.+++.+||+.||++|||+.|++++-...
T Consensus 292 ~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~ 325 (390)
T 2zmd_A 292 IPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 325 (390)
T ss_dssp CSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred cchHHHHHHHHHHcccChhhCCCHHHHhhCcCcc
Confidence 3356789999999999999999999999886554
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=349.66 Aligned_cols=239 Identities=18% Similarity=0.211 Sum_probs=198.5
Q ss_pred eeecccCceeEEEEEeC-CCCEEEEEEeccCCh---hhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCC
Q 008785 275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF---QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 350 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 350 (553)
++||+|+||.||++... +|+.||+|++++... ...+.+.+|+.++++++||||+++++++.+.+..|+||||+++|
T Consensus 191 ~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~gg 270 (543)
T 3c4z_A 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGG 270 (543)
T ss_dssp EEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTC
T ss_pred EEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEeccCC
Confidence 45799999999999975 599999999975422 23467889999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccce
Q 008785 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER 430 (553)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 430 (553)
+|.+++.........+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++.........
T Consensus 271 ~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~~~- 346 (543)
T 3c4z_A 271 DIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKT- 346 (543)
T ss_dssp BHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCCCB-
T ss_pred CHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeeccCCCccc-
Confidence 99999976444455799999999999999999999999 99999999999999999999999999998765433221
Q ss_pred eeecCccccccccccccCCCCCcccchHhHHHHHHHHhcCc-cccc-------chHHHHHhcCCH----HHHHHHHHHHh
Q 008785 431 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVL-CRRW-------WTLYTLVHSMSL----LCAQECLMLFI 498 (553)
Q Consensus 431 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~-~~~~-------~~l~~~~~~~~~----~~~~~l~~l~~ 498 (553)
....||+.|+|||++.+..++.++|||||||++|||++.. |... ..+...+..+.. ..+..+.+++.
T Consensus 347 -~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~ 425 (543)
T 3c4z_A 347 -KGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKDFCE 425 (543)
T ss_dssp -CCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCCTTSCHHHHHHHH
T ss_pred -ccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCCcccCHHHHHHHH
Confidence 2224999999999999999999999999999999999733 2221 123333322222 56778899999
Q ss_pred hccCCCCCCCCCH-----HHHHHHH
Q 008785 499 SCNNWPSHLSQSK-----FCNLKLW 518 (553)
Q Consensus 499 ~Cl~~dP~~RPs~-----~evl~~l 518 (553)
+||+.||++||++ .+++++-
T Consensus 426 ~lL~~dP~~R~~~~~~~a~ei~~Hp 450 (543)
T 3c4z_A 426 ALLQKDPEKRLGFRDGSCDGLRTHP 450 (543)
T ss_dssp HHSCSSGGGSCCCBTTBSHHHHTSG
T ss_pred HhccCCHhHCCCCcccCHHHHHcCc
Confidence 9999999999965 7888753
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=327.91 Aligned_cols=249 Identities=17% Similarity=0.130 Sum_probs=191.7
Q ss_pred cccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCC---hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEE
Q 008785 268 KNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIV 343 (553)
Q Consensus 268 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 343 (553)
++|... +.||+|+||.||++... +++.||||+++... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 34 ~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 34 GPYRLR-RLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp CCEEEE-EEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccEEEE-EEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 445444 45599999999999975 58899999997642 23347789999999999999999999999999999999
Q ss_pred EEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCC
Q 008785 344 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVP 423 (553)
Q Consensus 344 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~ 423 (553)
|||+++++|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 113 ~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 185 (309)
T 2h34_A 113 MRLINGVDLAAMLRR----QGPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATT 185 (309)
T ss_dssp EECCCCEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred EEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence 999999999999975 23589999999999999999999999 99999999999999999999999999997665
Q ss_pred cccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcCc-ccccchH---HHHHhcCCH-------HHHHH
Q 008785 424 WEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVL-CRRWWTL---YTLVHSMSL-------LCAQE 492 (553)
Q Consensus 424 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~-~~~~~~l---~~~~~~~~~-------~~~~~ 492 (553)
........ ...|++.|+|||++.+..++.++||||||+++|||++.. |...... ...+..... ..+..
T Consensus 186 ~~~~~~~~-~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (309)
T 2h34_A 186 DEKLTQLG-NTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVA 264 (309)
T ss_dssp ------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTSTTCCTH
T ss_pred cccccccc-ccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCCCCCHH
Confidence 43222211 223899999999999999999999999999999999833 3322222 112222111 45677
Q ss_pred HHHHHhhccCCCCCCCC-CHHHHHHHHHHHHhhc
Q 008785 493 CLMLFISCNNWPSHLSQ-SKFCNLKLWVFAILTI 525 (553)
Q Consensus 493 l~~l~~~Cl~~dP~~RP-s~~evl~~l~~~~~~~ 525 (553)
+.+++.+||+.||++|| |+.++++.+...+...
T Consensus 265 l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~ 298 (309)
T 2h34_A 265 FDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA 298 (309)
T ss_dssp HHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred HHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence 99999999999999999 9999998876655444
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=325.12 Aligned_cols=243 Identities=19% Similarity=0.286 Sum_probs=189.6
Q ss_pred hcccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeEEee---------
Q 008785 267 TKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD--------- 336 (553)
Q Consensus 267 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--------- 336 (553)
.++|.... .||+|+||.||+|... +|+.||||+++.. ....+.+.+|+.++++++||||+++++++.+
T Consensus 5 ~~~y~~~~-~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 5 ASDFEEIA-VLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHHEEEEE-EEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred cccchhhh-eeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 34555444 4599999999999964 6899999999754 3456788999999999999999999998865
Q ss_pred ----CCceEEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeE
Q 008785 337 ----HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAH 412 (553)
Q Consensus 337 ----~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~k 412 (553)
.+..++||||+++|+|.+++.. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+|
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~k 156 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHS---ENLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVK 156 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHH---SCGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEE
T ss_pred ccccCCceEEEEecCCCCCHHHhhhc---cccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEE
Confidence 3457999999999999999975 234578899999999999999999999 999999999999999999999
Q ss_pred EeeccccccCCcccc------------cceeeecCccccccccccccCC-CCCcccchHhHHHHHHHHhcCccc--ccch
Q 008785 413 LMGVGLSKFVPWEVM------------QERTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIRLVLCR--RWWT 477 (553)
Q Consensus 413 l~Dfgla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwSlGvil~ell~~~~~--~~~~ 477 (553)
|+|||++........ ........||+.|+|||++.+. .++.++||||||+++|||++.... ....
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~p~~~~~~~~~ 236 (303)
T 1zy4_A 157 IGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVN 236 (303)
T ss_dssp ECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHH
T ss_pred EeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHhccCCchhHHH
Confidence 999999986543210 0111223389999999999764 689999999999999999972111 1112
Q ss_pred HHHHHhcCCH--------HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008785 478 LYTLVHSMSL--------LCAQECLMLFISCNNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 478 l~~~~~~~~~--------~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 517 (553)
+...+..... ..+..+.+++.+||+.||++|||+.|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 237 ILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp HHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred HHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 2223322221 445678999999999999999999999975
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=349.83 Aligned_cols=242 Identities=21% Similarity=0.269 Sum_probs=199.9
Q ss_pred ccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCC---hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEE
Q 008785 269 NFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVY 344 (553)
Q Consensus 269 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 344 (553)
.|.. .+.||+|+||.||++... +|+.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 27 ~y~~-~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 105 (484)
T 3nyv_A 27 RYKG-QRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVG 105 (484)
T ss_dssp HEEE-EEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ceEE-eeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 4444 345699999999999975 68999999996542 345678999999999999999999999999999999999
Q ss_pred EccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEe---cCCCCeEEeecccccc
Q 008785 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL---DEEFGAHLMGVGLSKF 421 (553)
Q Consensus 345 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl---~~~~~~kl~Dfgla~~ 421 (553)
||+.+|+|.+++.. ...+++..+..++.||+.||.|||++ +|+||||||+|||+ +.++.+||+|||+++.
T Consensus 106 e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 178 (484)
T 3nyv_A 106 EVYTGGELFDEIIS----RKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTH 178 (484)
T ss_dssp CCCCSCBHHHHHHT----CSCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred ecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence 99999999999864 24589999999999999999999999 99999999999999 5678999999999986
Q ss_pred CCcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcC-ccccc---chHHHHHhcCCH--------HH
Q 008785 422 VPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLV-LCRRW---WTLYTLVHSMSL--------LC 489 (553)
Q Consensus 422 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~-~~~~~---~~l~~~~~~~~~--------~~ 489 (553)
........ ...||+.|+|||++.+ .++.++||||||+++|+|++. .|... ..+...+..+.. ..
T Consensus 179 ~~~~~~~~---~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 254 (484)
T 3nyv_A 179 FEASKKMK---DKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKV 254 (484)
T ss_dssp BCCCCSHH---HHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGS
T ss_pred cccccccc---cCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccC
Confidence 65433211 1238999999999865 699999999999999999973 33322 233334444432 45
Q ss_pred HHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 008785 490 AQECLMLFISCNNWPSHLSQSKFCNLKLWVFAI 522 (553)
Q Consensus 490 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~~~ 522 (553)
+..+.+++.+||+.||.+|||+.|++++-...-
T Consensus 255 s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~ 287 (484)
T 3nyv_A 255 SESAKDLIRKMLTYVPSMRISARDALDHEWIQT 287 (484)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHH
T ss_pred CHHHHHHHHHHCCCChhHCcCHHHHhhChhhcc
Confidence 678999999999999999999999999855443
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=333.65 Aligned_cols=245 Identities=17% Similarity=0.247 Sum_probs=198.6
Q ss_pred HHHHhhcccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCCh--------hhHHHHHHHHHHhhcc-CCCceeeEe
Q 008785 262 ELRSITKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF--------QRKKEFYSEIGRFARL-HHPNLVAVK 331 (553)
Q Consensus 262 el~~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~--------~~~~~~~~E~~~l~~l-~HpnIv~l~ 331 (553)
....+..+|.... .||+|+||.||+|... +|+.||||+++.... ...+.+.+|+.+++++ +||||++++
T Consensus 88 ~~~~~~~~y~~~~-~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 166 (365)
T 2y7j_A 88 AAKEFYQKYDPKD-VIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLI 166 (365)
T ss_dssp HHHHHHHHEEEEE-EEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred hhhhhhhhcccce-EEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence 3344555666544 4599999999999985 699999999875431 1245678999999999 799999999
Q ss_pred eEEeeCCceEEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCe
Q 008785 332 GCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGA 411 (553)
Q Consensus 332 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~ 411 (553)
+++...+..++||||+++++|.+++.. ...+++..+..++.||+.||.|||+. ||+||||||+|||+++++.+
T Consensus 167 ~~~~~~~~~~lv~e~~~g~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~i 239 (365)
T 2y7j_A 167 DSYESSSFMFLVFDLMRKGELFDYLTE----KVALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQI 239 (365)
T ss_dssp EEEEBSSEEEEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCE
T ss_pred EEEeeCCEEEEEEEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCE
Confidence 999999999999999999999999964 24589999999999999999999999 99999999999999999999
Q ss_pred EEeeccccccCCcccccceeeecCccccccccccccC------CCCCcccchHhHHHHHHHHhcCc-cccc---chHHHH
Q 008785 412 HLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYR------NELTTKSDVYSFGVLLLEIRLVL-CRRW---WTLYTL 481 (553)
Q Consensus 412 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~t~ksDVwSlGvil~ell~~~-~~~~---~~l~~~ 481 (553)
||+|||++......... ....||+.|+|||++.+ ..++.++||||||+++|||++.. |... ......
T Consensus 240 kl~DfG~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~ 316 (365)
T 2y7j_A 240 RLSDFGFSCHLEPGEKL---RELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRM 316 (365)
T ss_dssp EECCCTTCEECCTTCCB---CCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred EEEecCcccccCCCccc---ccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence 99999999876543221 12338999999999863 35889999999999999999833 3222 222233
Q ss_pred HhcCCH--------HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008785 482 VHSMSL--------LCAQECLMLFISCNNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 482 ~~~~~~--------~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 517 (553)
+..+.. ..+..+.+++.+||+.||++|||+.|++++
T Consensus 317 i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 317 IMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp HHHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 333332 234568999999999999999999999985
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=324.60 Aligned_cols=236 Identities=20% Similarity=0.269 Sum_probs=197.2
Q ss_pred eeecccCceeEEEEEeC-CCCEEEEEEeccCC-hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCCH
Q 008785 275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL 352 (553)
+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++||||+++++|
T Consensus 28 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 107 (303)
T 3a7i_A 28 EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSA 107 (303)
T ss_dssp EEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEH
T ss_pred hhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCCCCcH
Confidence 45699999999999864 58999999997653 34467899999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccceee
Q 008785 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV 432 (553)
Q Consensus 353 ~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~ 432 (553)
.+++.. ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++.......... .
T Consensus 108 ~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~--~ 177 (303)
T 3a7i_A 108 LDLLEP-----GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR--N 177 (303)
T ss_dssp HHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCCB--C
T ss_pred HHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCcccccc--C
Confidence 999853 4589999999999999999999999 99999999999999999999999999997654432221 2
Q ss_pred ecCccccccccccccCCCCCcccchHhHHHHHHHHhcCc-ccccch---HHHHHhcCCH-----HHHHHHHHHHhhccCC
Q 008785 433 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVL-CRRWWT---LYTLVHSMSL-----LCAQECLMLFISCNNW 503 (553)
Q Consensus 433 ~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~-~~~~~~---l~~~~~~~~~-----~~~~~l~~l~~~Cl~~ 503 (553)
...||+.|+|||++.+..++.++||||||+++|||++.. |..... ....+..+.. ..+..+.+++.+||+.
T Consensus 178 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 257 (303)
T 3a7i_A 178 TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNK 257 (303)
T ss_dssp CCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCSSCCHHHHHHHHHHCCS
T ss_pred ccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCCCccccCHHHHHHHHHHcCC
Confidence 223899999999999999999999999999999999733 322221 2222222221 4567789999999999
Q ss_pred CCCCCCCHHHHHHHHHH
Q 008785 504 PSHLSQSKFCNLKLWVF 520 (553)
Q Consensus 504 dP~~RPs~~evl~~l~~ 520 (553)
||++|||+.|++++...
T Consensus 258 dp~~Rps~~~ll~~~~~ 274 (303)
T 3a7i_A 258 EPSFRPTAKELLKHKFI 274 (303)
T ss_dssp SGGGSCCHHHHTTCHHH
T ss_pred ChhhCcCHHHHhhChhh
Confidence 99999999999997554
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=336.25 Aligned_cols=241 Identities=21% Similarity=0.216 Sum_probs=195.0
Q ss_pred hhcccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCChhhHHHHHHHHHHhhcc-CCCceeeEeeEEeeCCceEEE
Q 008785 266 ITKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIV 343 (553)
Q Consensus 266 ~~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV 343 (553)
+.++|.... .||+|+||.||++... +|+.||||+++.... ...+|++++.++ +||||+++++++.+.+..|+|
T Consensus 20 ~~~~y~~~~-~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv 94 (342)
T 2qr7_A 20 FTDGYEVKE-DIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVV 94 (342)
T ss_dssp HHHHEEEEE-EEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred ccccEEEEE-EEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEE
Confidence 344555544 4599999999999975 588999999976532 235688888888 799999999999999999999
Q ss_pred EEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCC----CCeEEeecccc
Q 008785 344 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE----FGAHLMGVGLS 419 (553)
Q Consensus 344 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~----~~~kl~Dfgla 419 (553)
|||+++|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||+.++ +.+||+|||++
T Consensus 95 ~E~~~gg~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a 167 (342)
T 2qr7_A 95 TELMKGGELLDKILR----QKFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFA 167 (342)
T ss_dssp ECCCCSCBHHHHHHT----CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTC
T ss_pred EeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCc
Confidence 999999999999864 24589999999999999999999999 99999999999998543 34999999999
Q ss_pred ccCCcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcCc-ccc------cchHHHHHhcCCH-----
Q 008785 420 KFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVL-CRR------WWTLYTLVHSMSL----- 487 (553)
Q Consensus 420 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~-~~~------~~~l~~~~~~~~~----- 487 (553)
+........ .....||+.|+|||++.+..++.++||||||+++|||++.. |.. ...+...+..+..
T Consensus 168 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 245 (342)
T 2qr7_A 168 KQLRAENGL--LMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGG 245 (342)
T ss_dssp EECBCTTCC--BCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCST
T ss_pred ccCcCCCCc--eeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCcc
Confidence 865433221 12234899999999998888999999999999999999732 221 1233344444433
Q ss_pred ---HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 008785 488 ---LCAQECLMLFISCNNWPSHLSQSKFCNLKLWVF 520 (553)
Q Consensus 488 ---~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~ 520 (553)
..+..+.+++.+||+.||++|||+.|++++-..
T Consensus 246 ~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~ 281 (342)
T 2qr7_A 246 YWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWI 281 (342)
T ss_dssp TTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHH
T ss_pred ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCee
Confidence 357789999999999999999999999998544
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=322.45 Aligned_cols=232 Identities=20% Similarity=0.283 Sum_probs=189.3
Q ss_pred CeeecccCceeEEEEEeC-CCCEEEEEEeccC--ChhhHHHHHHHHHHhhccCCCceeeEeeEEeeC----CceEEEEEc
Q 008785 274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH----GDRYIVYEF 346 (553)
Q Consensus 274 ~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~----~~~~lV~E~ 346 (553)
.+.||+|+||.||+|... ++..||+|.+... .....+.+.+|+.++++++||||+++++++... ...++||||
T Consensus 31 ~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~ 110 (290)
T 1t4h_A 31 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTEL 110 (290)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEEC
T ss_pred eeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEEEe
Confidence 345799999999999975 4789999998754 344567899999999999999999999998763 457999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--ceecCCCCCcEEec-CCCCeEEeeccccccCC
Q 008785 347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPH--VVHRDIRASNVLLD-EEFGAHLMGVGLSKFVP 423 (553)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~--ivHrDlkp~NILl~-~~~~~kl~Dfgla~~~~ 423 (553)
+++|+|.+++.. ...+++..+..++.||+.||.|||+. + |+||||||+|||++ +++.+||+|||++....
T Consensus 111 ~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~ 183 (290)
T 1t4h_A 111 MTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp CCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred cCCCCHHHHHHH----ccCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCCccccc
Confidence 999999999964 24589999999999999999999998 8 99999999999997 78899999999997554
Q ss_pred cccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcC-ccccc----chHHHHHhcCCH------HHHHH
Q 008785 424 WEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLV-LCRRW----WTLYTLVHSMSL------LCAQE 492 (553)
Q Consensus 424 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~-~~~~~----~~l~~~~~~~~~------~~~~~ 492 (553)
.... ....||+.|+|||++. +.++.++||||||+++|+|++. .|... ..+...+..+.. ..+..
T Consensus 184 ~~~~----~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (290)
T 1t4h_A 184 ASFA----KAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPE 258 (290)
T ss_dssp TTSB----EESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHH
T ss_pred cccc----ccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCCCHH
Confidence 3322 1223899999999876 5689999999999999999973 23222 122223332221 33467
Q ss_pred HHHHHhhccCCCCCCCCCHHHHHHH
Q 008785 493 CLMLFISCNNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 493 l~~l~~~Cl~~dP~~RPs~~evl~~ 517 (553)
+.+++.+||+.||++|||+.|++++
T Consensus 259 l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 259 VKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHccCChhhCCCHHHHhhC
Confidence 9999999999999999999999975
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=348.96 Aligned_cols=240 Identities=20% Similarity=0.235 Sum_probs=192.6
Q ss_pred cccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCC--hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEE
Q 008785 268 KNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVY 344 (553)
Q Consensus 268 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 344 (553)
+.|.... .||+|+||.||++... ++..||||+++... ......+.+|+.++++++||||+++++++.+.+..++||
T Consensus 37 ~~y~~~~-~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 37 EMYQRVK-KLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHEEEEE-EEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEee-EEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 3454444 4599999999999975 58899999997653 233577899999999999999999999999999999999
Q ss_pred EccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCC---CCeEEeecccccc
Q 008785 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE---FGAHLMGVGLSKF 421 (553)
Q Consensus 345 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~---~~~kl~Dfgla~~ 421 (553)
||+++|+|.+++.. ...+++..+..++.||+.||.|||++ +|+||||||+|||++.+ +.+||+|||++..
T Consensus 116 e~~~~g~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~ 188 (494)
T 3lij_A 116 ECYKGGELFDEIIH----RMKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAV 188 (494)
T ss_dssp ECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred ecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence 99999999998864 24589999999999999999999999 99999999999999764 4599999999987
Q ss_pred CCcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcC-cccc---cchHHHHHhcCCH--------HH
Q 008785 422 VPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLV-LCRR---WWTLYTLVHSMSL--------LC 489 (553)
Q Consensus 422 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~-~~~~---~~~l~~~~~~~~~--------~~ 489 (553)
....... ....||+.|+|||++. ..++.++|||||||++|+|++. .|.. ...+...+..+.. ..
T Consensus 189 ~~~~~~~---~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 264 (494)
T 3lij_A 189 FENQKKM---KERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNV 264 (494)
T ss_dssp CBTTBCB---CCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTS
T ss_pred CCCCccc---cccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccC
Confidence 6543221 1233999999999875 5799999999999999999973 3332 2333334444332 45
Q ss_pred HHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 008785 490 AQECLMLFISCNNWPSHLSQSKFCNLKLWV 519 (553)
Q Consensus 490 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~ 519 (553)
+..+.+++.+||+.||.+|||+.|++++-.
T Consensus 265 s~~~~~li~~~L~~dp~~R~s~~e~l~hp~ 294 (494)
T 3lij_A 265 SEGAKDLIKQMLQFDSQRRISAQQALEHPW 294 (494)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHTCHH
T ss_pred CHHHHHHHHHHCCCChhhCccHHHHhcCcc
Confidence 678999999999999999999999998833
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=322.74 Aligned_cols=238 Identities=21% Similarity=0.258 Sum_probs=191.4
Q ss_pred eeecccCceeEEEEEeC-CCCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCCHH
Q 008785 275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 353 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~ 353 (553)
.+||+|+||.||+|... +++.||||.++.......+.+.+|+.++++++||||+++++++.+.+..++||||+++++|.
T Consensus 28 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 107 (295)
T 2clq_A 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLS 107 (295)
T ss_dssp CEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHH
T ss_pred EEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHH
Confidence 36799999999999964 58899999998776666788999999999999999999999999999999999999999999
Q ss_pred HHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecC-CCCeEEeeccccccCCcccccceee
Q 008785 354 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE-EFGAHLMGVGLSKFVPWEVMQERTV 432 (553)
Q Consensus 354 ~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~-~~~~kl~Dfgla~~~~~~~~~~~~~ 432 (553)
+++... .....+++..+..++.|++.||.|||++ +|+||||||+||+++. ++.+||+|||++.......... .
T Consensus 108 ~~l~~~-~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~--~ 181 (295)
T 2clq_A 108 ALLRSK-WGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCT--E 181 (295)
T ss_dssp HHHHHT-TCCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-------C
T ss_pred HHHHhh-ccCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCCCCcc--c
Confidence 999763 2234567899999999999999999999 9999999999999987 8999999999998664332111 1
Q ss_pred ecCccccccccccccCCC--CCcccchHhHHHHHHHHhcCc-ccccc--h---HHHH-Hhc--CCH--HHHHHHHHHHhh
Q 008785 433 MAGGTYGYLAPEFVYRNE--LTTKSDVYSFGVLLLEIRLVL-CRRWW--T---LYTL-VHS--MSL--LCAQECLMLFIS 499 (553)
Q Consensus 433 ~~~gt~~y~aPE~~~~~~--~t~ksDVwSlGvil~ell~~~-~~~~~--~---l~~~-~~~--~~~--~~~~~l~~l~~~ 499 (553)
...||+.|+|||++.+.. ++.++||||||+++|||++.. |.... . .... ... ... ..+..+.+++.+
T Consensus 182 ~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 261 (295)
T 2clq_A 182 TFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILK 261 (295)
T ss_dssp CCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCHHHHHHHHH
T ss_pred ccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCHHHHHHHHH
Confidence 223899999999987654 789999999999999999733 32211 1 1111 111 111 456788999999
Q ss_pred ccCCCCCCCCCHHHHHHHH
Q 008785 500 CNNWPSHLSQSKFCNLKLW 518 (553)
Q Consensus 500 Cl~~dP~~RPs~~evl~~l 518 (553)
||+.||++|||+.|++++-
T Consensus 262 ~l~~dp~~Rps~~~ll~~~ 280 (295)
T 2clq_A 262 CFEPDPDKRACANDLLVDE 280 (295)
T ss_dssp TTCSSTTTSCCHHHHHTSG
T ss_pred HccCChhhCCCHHHHhcCh
Confidence 9999999999999998753
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=330.41 Aligned_cols=242 Identities=19% Similarity=0.238 Sum_probs=199.7
Q ss_pred ccCCCCeeecccCceeEEEEEeCC-CCEEEEEEeccC---ChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEE
Q 008785 269 NFSEGNRLLGDSKTGGTYSGILPD-GSRVAVKRLKRS---SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVY 344 (553)
Q Consensus 269 ~~~~~~~~iG~G~~g~Vy~~~~~~-g~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 344 (553)
+|.. .+.||+|+||.||++...+ ++.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 42 ~y~~-~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 120 (335)
T 2owb_A 42 RYVR-GRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 120 (335)
T ss_dssp EEEE-EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ceEE-EEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 3433 3456999999999999754 789999998754 2345677899999999999999999999999999999999
Q ss_pred EccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCc
Q 008785 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW 424 (553)
Q Consensus 345 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~ 424 (553)
||+++++|.+++.. ...+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 121 e~~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 193 (335)
T 2owb_A 121 ELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 193 (335)
T ss_dssp CCCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred ecCCCCCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence 99999999998864 24589999999999999999999999 999999999999999999999999999987653
Q ss_pred ccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcC-cccccchH---HHHHhcCCH----HHHHHHHHH
Q 008785 425 EVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLV-LCRRWWTL---YTLVHSMSL----LCAQECLML 496 (553)
Q Consensus 425 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~-~~~~~~~l---~~~~~~~~~----~~~~~l~~l 496 (553)
..... ....||+.|+|||++.+..++.++||||||+++|||++. .+...... ...+..+.. ..+..+.++
T Consensus 194 ~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 271 (335)
T 2owb_A 194 DGERK--KVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASL 271 (335)
T ss_dssp TTCCB--CCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHH
T ss_pred Ccccc--cccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHH
Confidence 32221 223389999999999998999999999999999999973 33332222 222322222 456678999
Q ss_pred HhhccCCCCCCCCCHHHHHHHHHH
Q 008785 497 FISCNNWPSHLSQSKFCNLKLWVF 520 (553)
Q Consensus 497 ~~~Cl~~dP~~RPs~~evl~~l~~ 520 (553)
+.+||+.||++|||+.|++++-..
T Consensus 272 i~~~l~~dp~~Rps~~ell~~~~~ 295 (335)
T 2owb_A 272 IQKMLQTDPTARPTINELLNDEFF 295 (335)
T ss_dssp HHHHTCSSGGGSCCGGGGGGSHHH
T ss_pred HHHHccCChhHCcCHHHHhcCccc
Confidence 999999999999999999987544
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=334.36 Aligned_cols=244 Identities=15% Similarity=0.105 Sum_probs=189.1
Q ss_pred eeecccCceeEEEEE------eCCCCEEEEEEeccCChhhHHHHHHHHHHhhccC---CCceeeEeeEEeeCCceEEEEE
Q 008785 275 RLLGDSKTGGTYSGI------LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLH---HPNLVAVKGCCYDHGDRYIVYE 345 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~------~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~---HpnIv~l~~~~~~~~~~~lV~E 345 (553)
+.||+|+||.||+|. ..+++.||||+++... ..++.+|+.++.+++ |+||+++++++...+..++|||
T Consensus 71 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~lv~e 147 (365)
T 3e7e_A 71 HLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGE 147 (365)
T ss_dssp EEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEEEEEC
T ss_pred EEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcEEEEe
Confidence 456999999999994 4468899999998653 445677777777775 9999999999999999999999
Q ss_pred ccCCCCHHHHhccCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecC-----------CCCeEE
Q 008785 346 FVVNGPLDRWLHHIPR-GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE-----------EFGAHL 413 (553)
Q Consensus 346 ~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~-----------~~~~kl 413 (553)
|+++|+|.+++..... ....+++..+..++.||+.||+|||++ +|+||||||+|||++. ++.+||
T Consensus 148 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl 224 (365)
T 3e7e_A 148 LYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLAL 224 (365)
T ss_dssp CCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC------CTTEEE
T ss_pred ccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCccccccccCCEEE
Confidence 9999999999964221 345699999999999999999999999 9999999999999998 899999
Q ss_pred eeccccccCCcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcCcccccchHHH--HHh--cCCHHH
Q 008785 414 MGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVLCRRWWTLYT--LVH--SMSLLC 489 (553)
Q Consensus 414 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~~~~~~~l~~--~~~--~~~~~~ 489 (553)
+|||+|+...............||+.|+|||++.+..++.++|||||||++|||++........-.. .+. ......
T Consensus 225 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~ 304 (365)
T 3e7e_A 225 IDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPH 304 (365)
T ss_dssp CCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEEECSCCTTCSS
T ss_pred eeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCceeechhccccCc
Confidence 9999997544222222223344999999999999999999999999999999999843221111000 000 011134
Q ss_pred HHHHHHHHhhccCCCCCCC-CCHHHHHHHHHHHHhh
Q 008785 490 AQECLMLFISCNNWPSHLS-QSKFCNLKLWVFAILT 524 (553)
Q Consensus 490 ~~~l~~l~~~Cl~~dP~~R-Ps~~evl~~l~~~~~~ 524 (553)
...+.+++..|++.+|.+| |++.++.+.+...+..
T Consensus 305 ~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~ 340 (365)
T 3e7e_A 305 LDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ 340 (365)
T ss_dssp HHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHH
Confidence 5667889999999999999 5566665555554443
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=328.02 Aligned_cols=246 Identities=22% Similarity=0.347 Sum_probs=185.9
Q ss_pred eeecccCceeEEEEEeCCCCEEEEEEeccCChhhHHHHH--HHHHHhhccCCCceeeEeeEEee-----CCceEEEEEcc
Q 008785 275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFY--SEIGRFARLHHPNLVAVKGCCYD-----HGDRYIVYEFV 347 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~--~E~~~l~~l~HpnIv~l~~~~~~-----~~~~~lV~E~~ 347 (553)
+.||+|+||.||+|.. +++.||||+++... ...+. .|+..+..++||||+++++.+.. ....++||||+
T Consensus 19 ~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~ 94 (336)
T 3g2f_A 19 ELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYY 94 (336)
T ss_dssp EEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEECCC
T ss_pred eecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEEecC
Confidence 4569999999999987 78999999997543 23333 44445566899999999986553 22468999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC------CCCceecCCCCCcEEecCCCCeEEeecccccc
Q 008785 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV------KPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF 421 (553)
Q Consensus 348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~------~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~ 421 (553)
++|+|.+++.. ...++..+..++.||+.||+|||+.+ +++|+||||||+|||++.++.+||+|||+++.
T Consensus 95 ~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a~~ 169 (336)
T 3g2f_A 95 PNGSLXKYLSL-----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMR 169 (336)
T ss_dssp TTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTTCEE
T ss_pred CCCcHHHHHhh-----cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeeccceee
Confidence 99999999965 23588999999999999999999863 34899999999999999999999999999987
Q ss_pred CCcccc------cceeeecCccccccccccccC-------CCCCcccchHhHHHHHHHHhcC-ccccc------------
Q 008785 422 VPWEVM------QERTVMAGGTYGYLAPEFVYR-------NELTTKSDVYSFGVLLLEIRLV-LCRRW------------ 475 (553)
Q Consensus 422 ~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~t~ksDVwSlGvil~ell~~-~~~~~------------ 475 (553)
...... ........||+.|+|||++.+ ..++.++||||||+++|||++. .+...
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~ 249 (336)
T 3g2f_A 170 LTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQ 249 (336)
T ss_dssp CSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTH
T ss_pred cccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhh
Confidence 653321 111122348999999999976 4567899999999999999962 11100
Q ss_pred ---------chHHHHHhcCC------------HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHhhccccc
Q 008785 476 ---------WTLYTLVHSMS------------LLCAQECLMLFISCNNWPSHLSQSKFCNLKLWVFAILTIRKVQ 529 (553)
Q Consensus 476 ---------~~l~~~~~~~~------------~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~~~~~~~~~~ 529 (553)
..+...+.... ...+..+.+++.+||+.||++|||+.|+++.+...+....+..
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~~~ 324 (336)
T 3g2f_A 250 TEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERNK 324 (336)
T ss_dssp HHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC--
T ss_pred cccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHHhcc
Confidence 00000111110 0466789999999999999999999999999888775554433
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=327.52 Aligned_cols=240 Identities=23% Similarity=0.293 Sum_probs=190.6
Q ss_pred ccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEcc
Q 008785 269 NFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV 347 (553)
Q Consensus 269 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 347 (553)
.|.... .||+|+||.||+|... +|+.||+|++........+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 20 ~y~i~~-~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (302)
T 2j7t_A 20 VWEIVG-ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFC 98 (302)
T ss_dssp TEEEEE-EEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECC
T ss_pred ceeecc-eeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeC
Confidence 344433 4599999999999976 48999999998776666788999999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccc
Q 008785 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM 427 (553)
Q Consensus 348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 427 (553)
++++|.+++.. ....+++..+..++.||+.||.|||+. +++||||||+||+++.++.+||+|||++........
T Consensus 99 ~~~~l~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 172 (302)
T 2j7t_A 99 PGGAVDAIMLE---LDRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQ 172 (302)
T ss_dssp TTEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHH
T ss_pred CCCcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCcccccccc
Confidence 99999999864 234589999999999999999999999 999999999999999999999999998754322111
Q ss_pred cceeeecCcccccccccccc-----CCCCCcccchHhHHHHHHHHhcCc-ccccch---HHHHHhcCC-------HHHHH
Q 008785 428 QERTVMAGGTYGYLAPEFVY-----RNELTTKSDVYSFGVLLLEIRLVL-CRRWWT---LYTLVHSMS-------LLCAQ 491 (553)
Q Consensus 428 ~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDVwSlGvil~ell~~~-~~~~~~---l~~~~~~~~-------~~~~~ 491 (553)
......||+.|+|||++. ...++.++||||||+++|||++.. |..... ....+..+. ...+.
T Consensus 173 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (302)
T 2j7t_A 173 --KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSV 250 (302)
T ss_dssp --C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCH
T ss_pred --ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCccccCH
Confidence 111223899999999983 667899999999999999999733 322222 111111111 14567
Q ss_pred HHHHHHhhccCCCCCCCCCHHHHHHH
Q 008785 492 ECLMLFISCNNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 492 ~l~~l~~~Cl~~dP~~RPs~~evl~~ 517 (553)
.+.+++.+||+.||++|||+.|++++
T Consensus 251 ~l~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 251 EFRDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp HHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred HHHHHHHHHcccChhhCCCHHHHhcC
Confidence 78999999999999999999999875
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=345.02 Aligned_cols=239 Identities=19% Similarity=0.209 Sum_probs=186.3
Q ss_pred hcccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccC--ChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCC-----
Q 008785 267 TKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHG----- 338 (553)
Q Consensus 267 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~----- 338 (553)
.++|.... .||+|+||.||++... +|+.||||++... .....+.+.+|+.+++.++||||+++++++...+
T Consensus 61 ~~~y~~~~-~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 61 LKRYQNLK-PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp ETTEEEEE-EEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred cCCeEEEE-EeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 34454444 4599999999999864 5889999999764 3445677899999999999999999999997653
Q ss_pred -ceEEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeecc
Q 008785 339 -DRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVG 417 (553)
Q Consensus 339 -~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg 417 (553)
..|+||||+++ +|.+.+.. .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||
T Consensus 140 ~~~~lv~E~~~~-~l~~~~~~------~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG 209 (464)
T 3ttj_A 140 QDVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 209 (464)
T ss_dssp CEEEEEEECCSE-EHHHHHTS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCC
T ss_pred CeEEEEEeCCCC-CHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEE
Confidence 46999999975 57666642 389999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcCc-ccccchHHH----HHh-cC------
Q 008785 418 LSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVL-CRRWWTLYT----LVH-SM------ 485 (553)
Q Consensus 418 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~-~~~~~~l~~----~~~-~~------ 485 (553)
+++........ ....||+.|+|||++.+..++.++|||||||++|||++.. +....+..+ .++ .|
T Consensus 210 ~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~ 286 (464)
T 3ttj_A 210 LARTAGTSFMM---TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF 286 (464)
T ss_dssp CC-----CCCC-------CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred eeeecCCCccc---CCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 99866543221 1223899999999999999999999999999999999732 222222111 100 00
Q ss_pred ---------------------CH-----------------HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 008785 486 ---------------------SL-----------------LCAQECLMLFISCNNWPSHLSQSKFCNLKLWV 519 (553)
Q Consensus 486 ---------------------~~-----------------~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~ 519 (553)
.+ ..+..+.+|+.+||..||++|||+.|++++-.
T Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~ 358 (464)
T 3ttj_A 287 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPY 358 (464)
T ss_dssp HTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTT
T ss_pred HHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChh
Confidence 00 12567899999999999999999999998743
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=337.99 Aligned_cols=240 Identities=21% Similarity=0.204 Sum_probs=186.5
Q ss_pred cccCCCCeeecccCceeEEEEEeCC-CCEEEEEEeccCCh---hhHHHHHHHHHH-hhccCCCceeeEeeEEeeCCceEE
Q 008785 268 KNFSEGNRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSF---QRKKEFYSEIGR-FARLHHPNLVAVKGCCYDHGDRYI 342 (553)
Q Consensus 268 ~~~~~~~~~iG~G~~g~Vy~~~~~~-g~~vAvK~~~~~~~---~~~~~~~~E~~~-l~~l~HpnIv~l~~~~~~~~~~~l 342 (553)
++|... ++||+|+||.||+++... ++.||||++++... .....+.+|..+ ++.++||||+++++++.+.+..|+
T Consensus 38 ~~y~~~-~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 38 SDFHFL-KVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGEEEE-EEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hheEEE-EEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 344443 456999999999999754 88999999976532 234556777776 577899999999999999999999
Q ss_pred EEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccC
Q 008785 343 VYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV 422 (553)
Q Consensus 343 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~ 422 (553)
||||+++|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 117 v~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~ 189 (373)
T 2r5t_A 117 VLDYINGGELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKEN 189 (373)
T ss_dssp EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGG
T ss_pred EEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCcccccc
Confidence 9999999999999964 24588999999999999999999999 9999999999999999999999999999753
Q ss_pred CcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcC-ccccc---chHHHHHhcCCH----HHHHHHH
Q 008785 423 PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLV-LCRRW---WTLYTLVHSMSL----LCAQECL 494 (553)
Q Consensus 423 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~-~~~~~---~~l~~~~~~~~~----~~~~~l~ 494 (553)
..... ......||+.|+|||++.+..++.++||||||+++|||++. .|... ..+.+.+..+.. ..+..+.
T Consensus 190 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 267 (373)
T 2r5t_A 190 IEHNS--TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSAR 267 (373)
T ss_dssp BCCCC--CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCCSSSCHHHH
T ss_pred ccCCC--ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHH
Confidence 32211 12223499999999999999999999999999999999973 33322 233333333322 4567889
Q ss_pred HHHhhccCCCCCCCCCHH----HHHHH
Q 008785 495 MLFISCNNWPSHLSQSKF----CNLKL 517 (553)
Q Consensus 495 ~l~~~Cl~~dP~~RPs~~----evl~~ 517 (553)
+++.+||+.||.+||++. +++++
T Consensus 268 ~li~~lL~~dp~~R~~~~~~~~~i~~h 294 (373)
T 2r5t_A 268 HLLEGLLQKDRTKRLGAKDDFMEIKSH 294 (373)
T ss_dssp HHHHHHTCSSGGGSTTTTTTHHHHHTS
T ss_pred HHHHHHcccCHHhCCCCCCCHHHHhCC
Confidence 999999999999999984 55554
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=323.40 Aligned_cols=240 Identities=25% Similarity=0.339 Sum_probs=190.0
Q ss_pred ccCCCCeeecccCceeEEEEEeCCCCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeEEeeC-CceEEEEEcc
Q 008785 269 NFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH-GDRYIVYEFV 347 (553)
Q Consensus 269 ~~~~~~~~iG~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~-~~~~lV~E~~ 347 (553)
+|... +.||+|+||.||++.. +|+.||||.++... ..+.+.+|+.++++++||||+++++++.+. +..++||||+
T Consensus 22 ~y~~~-~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 97 (278)
T 1byg_A 22 ELKLL-QTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 97 (278)
T ss_dssp GEEEE-EEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred hceEE-eEEecCCCceEEEEEE-cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecC
Confidence 34443 4469999999999988 58899999997653 457789999999999999999999997654 4789999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccc
Q 008785 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM 427 (553)
Q Consensus 348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 427 (553)
++|+|.+++... ....+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||++........
T Consensus 98 ~~~~L~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 172 (278)
T 1byg_A 98 AKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD 172 (278)
T ss_dssp TTEEHHHHHHHH--HHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred CCCCHHHHHHhc--ccccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeecccccccccccc
Confidence 999999999751 222378899999999999999999999 999999999999999999999999999875543211
Q ss_pred cceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhc-Cc-ccc---cchHHHHHhcCCH-----HHHHHHHHHH
Q 008785 428 QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-VL-CRR---WWTLYTLVHSMSL-----LCAQECLMLF 497 (553)
Q Consensus 428 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-~~-~~~---~~~l~~~~~~~~~-----~~~~~l~~l~ 497 (553)
...+++.|+|||.+.+..++.++||||||+++|||++ .. |.. ...+...+..+.. ..+..+.+++
T Consensus 173 -----~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 247 (278)
T 1byg_A 173 -----TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVM 247 (278)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHHHHH
T ss_pred -----CCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCcccCCHHHHHHH
Confidence 1227889999999998899999999999999999997 32 222 2233333333311 5677899999
Q ss_pred hhccCCCCCCCCCHHHHHHHHHHHH
Q 008785 498 ISCNNWPSHLSQSKFCNLKLWVFAI 522 (553)
Q Consensus 498 ~~Cl~~dP~~RPs~~evl~~l~~~~ 522 (553)
.+||+.||++|||+.|+++.+....
T Consensus 248 ~~~l~~~p~~Rps~~~l~~~L~~i~ 272 (278)
T 1byg_A 248 KNCWHLDAAMRPSFLQLREQLEHIK 272 (278)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHhcCChhhCCCHHHHHHHHHHHH
Confidence 9999999999999999999876543
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-39 Score=341.50 Aligned_cols=193 Identities=21% Similarity=0.338 Sum_probs=151.1
Q ss_pred cccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccC--ChhhHHHHHHHHHHhhccCCCceeeEeeEEeeC-----Cc
Q 008785 268 KNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH-----GD 339 (553)
Q Consensus 268 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~-----~~ 339 (553)
++|..... ||+|+||.||+|... +|+.||||++... .....+.+.+|+.+|++++||||+++++++... ..
T Consensus 53 ~~y~~~~~-lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 53 DRYEIRHL-IGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp TTEEECCC--------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCeEEeeE-eeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 45555444 599999999999865 5899999999753 344567899999999999999999999998543 56
Q ss_pred eEEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeecccc
Q 008785 340 RYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLS 419 (553)
Q Consensus 340 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla 419 (553)
.|+||||+ +|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 132 ~~lv~e~~-~~~L~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla 203 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRT----PVYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLA 203 (458)
T ss_dssp EEEEECCC-SEEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEecc-ccchhhhccc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccc
Confidence 89999998 5799999864 34699999999999999999999999 9999999999999999999999999999
Q ss_pred ccCCccccc-------------------------ceeeecCccccccccccc-cCCCCCcccchHhHHHHHHHHhc
Q 008785 420 KFVPWEVMQ-------------------------ERTVMAGGTYGYLAPEFV-YRNELTTKSDVYSFGVLLLEIRL 469 (553)
Q Consensus 420 ~~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~t~ksDVwSlGvil~ell~ 469 (553)
+........ .......||+.|+|||++ ....++.++|||||||++|||++
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ellt 279 (458)
T 3rp9_A 204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN 279 (458)
T ss_dssp BCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHT
T ss_pred hhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHH
Confidence 876432110 011122389999999986 45679999999999999999995
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=326.34 Aligned_cols=248 Identities=20% Similarity=0.280 Sum_probs=196.8
Q ss_pred HHhhcccCCCCeeecccCceeEEEEEeCCCCEEEEEEeccCChhhHHHHHHHHHHhhc--cCCCceeeEeeEEeeCC---
Q 008785 264 RSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFAR--LHHPNLVAVKGCCYDHG--- 338 (553)
Q Consensus 264 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~--l~HpnIv~l~~~~~~~~--- 338 (553)
..+.++|.... .||+|+||.||+|.. +|+.||||++... ....+.+|++++.. ++||||+++++++....
T Consensus 38 ~~~~~~y~~~~-~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~ 112 (342)
T 1b6c_B 38 RTIARTIVLQE-SIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTW 112 (342)
T ss_dssp HHHHHHCEEEE-EEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSC
T ss_pred ccccccEEEEe-eecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcc
Confidence 34455665544 559999999999998 6899999999754 34567788888887 79999999999998876
Q ss_pred -ceEEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCceecCCCCCcEEecCCC
Q 008785 339 -DRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLH--------DKVKPHVVHRDIRASNVLLDEEF 409 (553)
Q Consensus 339 -~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH--------~~~~~~ivHrDlkp~NILl~~~~ 409 (553)
..++||||+++|+|.+++.. ..+++..+..++.|++.||.||| +. +|+||||||+|||++.++
T Consensus 113 ~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~~~~ 184 (342)
T 1b6c_B 113 TQLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVKKNG 184 (342)
T ss_dssp CCEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEECTTS
T ss_pred ceeEEEEeecCCCcHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEECCCC
Confidence 78999999999999999975 35899999999999999999999 77 999999999999999999
Q ss_pred CeEEeeccccccCCcccccc--eeeecCccccccccccccCC------CCCcccchHhHHHHHHHHhcC-----------
Q 008785 410 GAHLMGVGLSKFVPWEVMQE--RTVMAGGTYGYLAPEFVYRN------ELTTKSDVYSFGVLLLEIRLV----------- 470 (553)
Q Consensus 410 ~~kl~Dfgla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~t~ksDVwSlGvil~ell~~----------- 470 (553)
.+||+|||++.......... ......||+.|+|||++.+. .++.++||||||+++|||++.
T Consensus 185 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~ 264 (342)
T 1b6c_B 185 TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ 264 (342)
T ss_dssp CEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred CEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccc
Confidence 99999999997654332211 11222489999999998765 334789999999999999974
Q ss_pred ccccc--------chHHHHHhcCCH-----------HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHhh
Q 008785 471 LCRRW--------WTLYTLVHSMSL-----------LCAQECLMLFISCNNWPSHLSQSKFCNLKLWVFAILT 524 (553)
Q Consensus 471 ~~~~~--------~~l~~~~~~~~~-----------~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~~~~~ 524 (553)
.|... ..+...+..... ..+..+.+++.+||+.||++|||+.|+++++......
T Consensus 265 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~ 337 (342)
T 1b6c_B 265 LPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 337 (342)
T ss_dssp CTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred cCccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHH
Confidence 12211 112222222111 5667899999999999999999999999998765443
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=341.59 Aligned_cols=235 Identities=16% Similarity=0.143 Sum_probs=183.4
Q ss_pred eeecccCceeEEEEEe-CCCCEEEEEEeccC---ChhhHHHHHHHH---HHhhccCCCceeeEe-------eEEeeCCc-
Q 008785 275 RLLGDSKTGGTYSGIL-PDGSRVAVKRLKRS---SFQRKKEFYSEI---GRFARLHHPNLVAVK-------GCCYDHGD- 339 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~-~~g~~vAvK~~~~~---~~~~~~~~~~E~---~~l~~l~HpnIv~l~-------~~~~~~~~- 339 (553)
+.||+|+||.||+|.. .+|+.||||+++.. .....+.+.+|+ .++++++||||++++ +++.+.+.
T Consensus 79 ~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~ 158 (377)
T 3byv_A 79 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKK 158 (377)
T ss_dssp EEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTTSC
T ss_pred ceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccCCc
Confidence 4569999999999996 46999999999743 334567889999 556666899999998 66665532
Q ss_pred ----------------eEEEEEccCCCCHHHHhccCC---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCC
Q 008785 340 ----------------RYIVYEFVVNGPLDRWLHHIP---RGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRA 400 (553)
Q Consensus 340 ----------------~~lV~E~~~~gsL~~~l~~~~---~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp 400 (553)
.++||||+ +|+|.+++.... .....+++..+..|+.||+.||+|||++ +|+||||||
T Consensus 159 ~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDikp 234 (377)
T 3byv_A 159 KMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRP 234 (377)
T ss_dssp SEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TEECSCCCG
T ss_pred cccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCH
Confidence 78999999 689999997421 1112344688889999999999999999 999999999
Q ss_pred CcEEecCCCCeEEeeccccccCCcccccceeeecCccccccccccccCC-----------CCCcccchHhHHHHHHHHhc
Q 008785 401 SNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRN-----------ELTTKSDVYSFGVLLLEIRL 469 (553)
Q Consensus 401 ~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~t~ksDVwSlGvil~ell~ 469 (553)
+|||++.++.+||+|||+++..... .....| +.|+|||++.+. .++.++||||||+++|||++
T Consensus 235 ~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~ellt 308 (377)
T 3byv_A 235 VDIVLDQRGGVFLTGFEHLVRDGAR-----VVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWC 308 (377)
T ss_dssp GGEEECTTCCEEECCGGGCEETTCE-----EECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHH
T ss_pred HHEEEcCCCCEEEEechhheecCCc-----ccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHH
Confidence 9999999999999999999854321 122337 999999999887 89999999999999999998
Q ss_pred Cc-ccccchHH---HHHhcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 008785 470 VL-CRRWWTLY---TLVHSMSLLCAQECLMLFISCNNWPSHLSQSKFCNLKLWV 519 (553)
Q Consensus 470 ~~-~~~~~~l~---~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~ 519 (553)
.. |....... ..+.......+..+.+++.+||+.||++|||+.|++++-.
T Consensus 309 g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~ 362 (377)
T 3byv_A 309 ADLPITKDAALGGSEWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPE 362 (377)
T ss_dssp SSCCC------CCSGGGGSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHH
T ss_pred CCCCCcccccccchhhhhhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChH
Confidence 33 32222111 1222222255678999999999999999999999998643
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=333.86 Aligned_cols=244 Identities=17% Similarity=0.156 Sum_probs=196.8
Q ss_pred CeeecccCceeEEEEEeCC-CCEEEEEEeccCC-hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCC--ceEEEEEccCC
Q 008785 274 NRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHG--DRYIVYEFVVN 349 (553)
Q Consensus 274 ~~~iG~G~~g~Vy~~~~~~-g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~--~~~lV~E~~~~ 349 (553)
.++||+|+||.||+|.... |+.||||+++... ....+.+.+|++++++++||||+++++++.+.+ ..++||||+++
T Consensus 14 ~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~ 93 (396)
T 4eut_A 14 SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPC 93 (396)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECCCTT
T ss_pred EEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEecCCC
Confidence 4456999999999999764 8999999997643 234577889999999999999999999998765 67999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEe----cCCCCeEEeeccccccCCcc
Q 008785 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL----DEEFGAHLMGVGLSKFVPWE 425 (553)
Q Consensus 350 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl----~~~~~~kl~Dfgla~~~~~~ 425 (553)
|+|.+++.... ....+++..+..++.||+.||+|||+. +|+||||||+|||+ +.++.+||+|||+++.....
T Consensus 94 g~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~ 169 (396)
T 4eut_A 94 GSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD 169 (396)
T ss_dssp EEHHHHTTSGG-GTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCCG
T ss_pred CCHHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCceEccCC
Confidence 99999997522 223489999999999999999999999 99999999999999 77788999999999876544
Q ss_pred cccceeeecCccccccccccccC--------CCCCcccchHhHHHHHHHHhcCc-ccc-------cchHHH-HHhcCC--
Q 008785 426 VMQERTVMAGGTYGYLAPEFVYR--------NELTTKSDVYSFGVLLLEIRLVL-CRR-------WWTLYT-LVHSMS-- 486 (553)
Q Consensus 426 ~~~~~~~~~~gt~~y~aPE~~~~--------~~~t~ksDVwSlGvil~ell~~~-~~~-------~~~l~~-~~~~~~-- 486 (553)
.... ...||+.|+|||++.+ ..++.++||||||+++|||++.. |.. ...... .+....
T Consensus 170 ~~~~---~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~ 246 (396)
T 4eut_A 170 EQFV---SLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSG 246 (396)
T ss_dssp GGSS---CSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTT
T ss_pred Cccc---cccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCcc
Confidence 3221 2238999999999865 56788999999999999999732 211 112222 221110
Q ss_pred --------------------------HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHhh
Q 008785 487 --------------------------LLCAQECLMLFISCNNWPSHLSQSKFCNLKLWVFAILT 524 (553)
Q Consensus 487 --------------------------~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~~~~~ 524 (553)
......+.+++.+||+.||++|||+.|+++.+...+..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 247 AISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp CCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred cchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 15777889999999999999999999999988666544
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=347.13 Aligned_cols=243 Identities=24% Similarity=0.293 Sum_probs=197.0
Q ss_pred hhcccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCCh-------------hhHHHHHHHHHHhhccCCCceeeEe
Q 008785 266 ITKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF-------------QRKKEFYSEIGRFARLHHPNLVAVK 331 (553)
Q Consensus 266 ~~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~-------------~~~~~~~~E~~~l~~l~HpnIv~l~ 331 (553)
+.+.|.... .||+|+||.||++... +++.||||+++.... ...+.+.+|+.++++++||||++++
T Consensus 34 i~~~Y~~~~-~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~ 112 (504)
T 3q5i_A 34 IGESYFKVR-KLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF 112 (504)
T ss_dssp GGGTEEEEE-EEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred cccceEEEe-EecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 445565544 4599999999999975 478999999976431 2356789999999999999999999
Q ss_pred eEEeeCCceEEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCC--
Q 008785 332 GCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF-- 409 (553)
Q Consensus 332 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~-- 409 (553)
+++.+.+..++||||+++|+|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++
T Consensus 113 ~~~~~~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~ 185 (504)
T 3q5i_A 113 DVFEDKKYFYLVTEFYEGGELFEQIIN----RHKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSL 185 (504)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCC
T ss_pred EEEEcCCEEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCC
Confidence 999999999999999999999998864 24589999999999999999999999 999999999999998775
Q ss_pred -CeEEeeccccccCCcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcC-cccc---cchHHHHHhc
Q 008785 410 -GAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLV-LCRR---WWTLYTLVHS 484 (553)
Q Consensus 410 -~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~-~~~~---~~~l~~~~~~ 484 (553)
.+||+|||++......... ....||+.|+|||++. +.++.++||||||+++|+|++. .|.. ...+...+..
T Consensus 186 ~~~kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~ 261 (504)
T 3q5i_A 186 LNIKIVDFGLSSFFSKDYKL---RDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEK 261 (504)
T ss_dssp SSEEECCCTTCEECCTTSCB---CCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred ccEEEEECCCCEEcCCCCcc---ccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc
Confidence 6999999999876543221 1223999999999886 5699999999999999999973 3332 2334444444
Q ss_pred CCH--------HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 008785 485 MSL--------LCAQECLMLFISCNNWPSHLSQSKFCNLKLWVF 520 (553)
Q Consensus 485 ~~~--------~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~ 520 (553)
+.. ..+..+.+++.+||+.||.+|||+.|++++-..
T Consensus 262 ~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~ 305 (504)
T 3q5i_A 262 GKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWI 305 (504)
T ss_dssp CCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred CCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhh
Confidence 443 346789999999999999999999999988543
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-39 Score=334.50 Aligned_cols=244 Identities=23% Similarity=0.262 Sum_probs=183.7
Q ss_pred hhcccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccC--ChhhHHHHHHHHHHhhccC-CCceeeEeeEEeeCC--c
Q 008785 266 ITKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLH-HPNLVAVKGCCYDHG--D 339 (553)
Q Consensus 266 ~~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~--~ 339 (553)
+.++|.... .||+|+||.||+|... +|+.||||++... .......+.+|+.++.++. ||||+++++++...+ .
T Consensus 7 ~~~~y~~~~-~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 7 VLRKYELVK-KLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHTTEEEEE-C-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred ccCceEEEE-EeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 345555544 4599999999999964 5899999998653 3445677889999999997 999999999997654 6
Q ss_pred eEEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeecccc
Q 008785 340 RYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLS 419 (553)
Q Consensus 340 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla 419 (553)
.|+||||++ |+|.+++.. ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 86 ~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a 156 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRA-----NILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLS 156 (388)
T ss_dssp EEEEEECCS-EEHHHHHHH-----TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEecccC-cCHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCccc
Confidence 899999997 699999865 3589999999999999999999999 9999999999999999999999999999
Q ss_pred ccCCcccc-------------------cceeeecCccccccccccccC-CCCCcccchHhHHHHHHHHhcCcc-cccchH
Q 008785 420 KFVPWEVM-------------------QERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIRLVLC-RRWWTL 478 (553)
Q Consensus 420 ~~~~~~~~-------------------~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwSlGvil~ell~~~~-~~~~~l 478 (553)
+....... ........||+.|+|||++.+ ..++.++|||||||++|||++..+ ....+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~ 236 (388)
T 3oz6_A 157 RSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSST 236 (388)
T ss_dssp EESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 86532100 011112348999999999976 678999999999999999997332 222111
Q ss_pred HH----HH---hcCC---------------------------------H--------------HHHHHHHHHHhhccCCC
Q 008785 479 YT----LV---HSMS---------------------------------L--------------LCAQECLMLFISCNNWP 504 (553)
Q Consensus 479 ~~----~~---~~~~---------------------------------~--------------~~~~~l~~l~~~Cl~~d 504 (553)
.+ .+ .... + ..+..+.+|+.+||..|
T Consensus 237 ~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~d 316 (388)
T 3oz6_A 237 MNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFN 316 (388)
T ss_dssp HHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSS
T ss_pred HHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccC
Confidence 11 10 0000 0 12457899999999999
Q ss_pred CCCCCCHHHHHHHHH
Q 008785 505 SHLSQSKFCNLKLWV 519 (553)
Q Consensus 505 P~~RPs~~evl~~l~ 519 (553)
|++|||+.|++++-.
T Consensus 317 P~~R~t~~e~l~Hp~ 331 (388)
T 3oz6_A 317 PNKRISANDALKHPF 331 (388)
T ss_dssp GGGSCCHHHHTTSTT
T ss_pred cccCCCHHHHhCCHH
Confidence 999999999998843
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-39 Score=324.09 Aligned_cols=237 Identities=21% Similarity=0.279 Sum_probs=192.1
Q ss_pred CeeecccCceeEEEEEeC-CCCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCCH
Q 008785 274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352 (553)
Q Consensus 274 ~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL 352 (553)
.+.||+|+||.||+|... +|+.||||.+.... ..+.+.+|+.++++++||||+++++++.+.+..++||||+++|+|
T Consensus 34 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 111 (314)
T 3com_A 34 LEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSV 111 (314)
T ss_dssp EEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEH
T ss_pred heeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCCCCCH
Confidence 345699999999999975 48999999997643 346789999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccceee
Q 008785 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV 432 (553)
Q Consensus 353 ~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~ 432 (553)
.+++.. ....+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++.......... .
T Consensus 112 ~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~--~ 183 (314)
T 3com_A 112 SDIIRL---RNKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKR--N 183 (314)
T ss_dssp HHHHHH---HTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBSCB--C
T ss_pred HHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcccc--C
Confidence 999863 234689999999999999999999999 99999999999999999999999999997654332211 1
Q ss_pred ecCccccccccccccCCCCCcccchHhHHHHHHHHhcCc-ccccchHHH---HHhcCC---H----HHHHHHHHHHhhcc
Q 008785 433 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVL-CRRWWTLYT---LVHSMS---L----LCAQECLMLFISCN 501 (553)
Q Consensus 433 ~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~-~~~~~~l~~---~~~~~~---~----~~~~~l~~l~~~Cl 501 (553)
...||+.|+|||.+.+..++.++||||||+++|||++.. |........ .+.... . ..+..+.+++.+||
T Consensus 184 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 263 (314)
T 3com_A 184 TVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVKQCL 263 (314)
T ss_dssp CCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHT
T ss_pred ccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHHHHHHHHHc
Confidence 223899999999999989999999999999999999733 332222111 111111 1 34678999999999
Q ss_pred CCCCCCCCCHHHHHHHHHH
Q 008785 502 NWPSHLSQSKFCNLKLWVF 520 (553)
Q Consensus 502 ~~dP~~RPs~~evl~~l~~ 520 (553)
+.||.+|||+.+++++-..
T Consensus 264 ~~dp~~Rpt~~~ll~~~~~ 282 (314)
T 3com_A 264 VKSPEQRATATQLLQHPFV 282 (314)
T ss_dssp CSCTTTSCCHHHHTTSHHH
T ss_pred cCChhhCcCHHHHHhCHHH
Confidence 9999999999999987544
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-40 Score=332.48 Aligned_cols=238 Identities=18% Similarity=0.242 Sum_probs=184.9
Q ss_pred eeecccCceeEEEEEeC-CCCEEEEEEeccCChhh-HHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCCH
Q 008785 275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQR-KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~~~-~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL 352 (553)
+.||+|+||.||+|... +++.||||+++...... ...+.+|+.++++++||||+++++++.+.+..++||||++ |+|
T Consensus 8 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l 86 (324)
T 3mtl_A 8 DKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDL 86 (324)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCS-EEH
T ss_pred EEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecccc-cCH
Confidence 34599999999999975 68999999997543222 2245679999999999999999999999999999999996 699
Q ss_pred HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccceee
Q 008785 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV 432 (553)
Q Consensus 353 ~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~ 432 (553)
.+++.. ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++...........
T Consensus 87 ~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~-- 158 (324)
T 3mtl_A 87 KQYLDD---CGNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYD-- 158 (324)
T ss_dssp HHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC----------
T ss_pred HHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCccccc--
Confidence 998875 334689999999999999999999999 999999999999999999999999999976543322211
Q ss_pred ecCccccccccccccC-CCCCcccchHhHHHHHHHHhcCc-ccccchHHH---HH-h---cC------------------
Q 008785 433 MAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIRLVL-CRRWWTLYT---LV-H---SM------------------ 485 (553)
Q Consensus 433 ~~~gt~~y~aPE~~~~-~~~t~ksDVwSlGvil~ell~~~-~~~~~~l~~---~~-~---~~------------------ 485 (553)
...||+.|+|||++.+ ..++.++||||||+++|||++.. |.......+ .+ . ..
T Consensus 159 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (324)
T 3mtl_A 159 NEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYN 238 (324)
T ss_dssp ----CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTC
T ss_pred cccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcccc
Confidence 1238999999999876 56899999999999999999733 322222111 11 0 00
Q ss_pred -------CH-----HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 008785 486 -------SL-----LCAQECLMLFISCNNWPSHLSQSKFCNLKLWVFA 521 (553)
Q Consensus 486 -------~~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~~ 521 (553)
.. ..+..+.+++.+||+.||++|||+.|++++-...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~ 286 (324)
T 3mtl_A 239 YPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFL 286 (324)
T ss_dssp CCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGG
T ss_pred cccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhh
Confidence 00 2356788999999999999999999999985443
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=319.56 Aligned_cols=240 Identities=21% Similarity=0.276 Sum_probs=190.5
Q ss_pred ccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCC---hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEE
Q 008785 269 NFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVY 344 (553)
Q Consensus 269 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 344 (553)
+|... +.||+|+||.||+|... +|+.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 12 ~y~i~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (276)
T 2h6d_A 12 HYVLG-DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM 90 (276)
T ss_dssp TEEEE-EEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cEEEE-eeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEE
Confidence 34343 45699999999999976 68999999997542 223567899999999999999999999999999999999
Q ss_pred EccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCc
Q 008785 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW 424 (553)
Q Consensus 345 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~ 424 (553)
||+++++|.+++... ..+++..+..++.||+.||.|||++ +++||||||+||+++.++.+||+|||++.....
T Consensus 91 e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 163 (276)
T 2h6d_A 91 EYVSGGELFDYICKH----GRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 163 (276)
T ss_dssp ECCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred eccCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccCC
Confidence 999999999999652 3589999999999999999999999 999999999999999999999999999987654
Q ss_pred ccccceeeecCccccccccccccCCCC-CcccchHhHHHHHHHHhcC-cccccc---hHHHHHhcCCH----HHHHHHHH
Q 008785 425 EVMQERTVMAGGTYGYLAPEFVYRNEL-TTKSDVYSFGVLLLEIRLV-LCRRWW---TLYTLVHSMSL----LCAQECLM 495 (553)
Q Consensus 425 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDVwSlGvil~ell~~-~~~~~~---~l~~~~~~~~~----~~~~~l~~ 495 (553)
..... ...|++.|+|||.+.+..+ +.++||||||+++|||++. .|.... .+.+.+..+.. ..+..+.+
T Consensus 164 ~~~~~---~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 240 (276)
T 2h6d_A 164 GEFLR---TSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVAT 240 (276)
T ss_dssp ----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHH
T ss_pred Cccee---cccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCchhcCHHHHH
Confidence 32211 2238999999999987765 6899999999999999973 333222 22333333322 34677899
Q ss_pred HHhhccCCCCCCCCCHHHHHHHHH
Q 008785 496 LFISCNNWPSHLSQSKFCNLKLWV 519 (553)
Q Consensus 496 l~~~Cl~~dP~~RPs~~evl~~l~ 519 (553)
++.+||+.||++|||+.|++++-.
T Consensus 241 li~~~l~~~p~~Rps~~~~l~h~~ 264 (276)
T 2h6d_A 241 LLMHMLQVDPLKRATIKDIREHEW 264 (276)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHSHH
T ss_pred HHHHHccCChhhCCCHHHHHhChh
Confidence 999999999999999999998743
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=346.54 Aligned_cols=242 Identities=20% Similarity=0.256 Sum_probs=197.3
Q ss_pred hcccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCC--hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEE
Q 008785 267 TKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIV 343 (553)
Q Consensus 267 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 343 (553)
.+.|.... .||+|+||.||++... +|+.||||++.... ......+.+|+.++++++||||+++++++.+.+..++|
T Consensus 21 ~~~y~~~~-~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 21 AERYNIVC-MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHEEEEE-EEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hcceEEeE-EEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 34455544 5599999999999975 68999999996532 23467889999999999999999999999999999999
Q ss_pred EEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEec---CCCCeEEeeccccc
Q 008785 344 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD---EEFGAHLMGVGLSK 420 (553)
Q Consensus 344 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~---~~~~~kl~Dfgla~ 420 (553)
|||+++|+|.+++.. ...+++..+..++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||+++
T Consensus 100 ~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 172 (486)
T 3mwu_A 100 GELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (486)
T ss_dssp ECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTT
T ss_pred EEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCe
Confidence 999999999998864 24589999999999999999999999 999999999999995 45679999999998
Q ss_pred cCCcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcC-ccccc---chHHHHHhcCCH--------H
Q 008785 421 FVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLV-LCRRW---WTLYTLVHSMSL--------L 488 (553)
Q Consensus 421 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~-~~~~~---~~l~~~~~~~~~--------~ 488 (553)
........ ....||+.|+|||++.+ .++.++||||||+++|+|++. .|... ..+...+..+.. .
T Consensus 173 ~~~~~~~~---~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 248 (486)
T 3mwu_A 173 CFQQNTKM---KDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRT 248 (486)
T ss_dssp TBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGG
T ss_pred ECCCCCcc---CCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCC
Confidence 66543221 12239999999999865 699999999999999999973 33322 233334444432 4
Q ss_pred HHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 008785 489 CAQECLMLFISCNNWPSHLSQSKFCNLKLWVF 520 (553)
Q Consensus 489 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~ 520 (553)
.+..+.+++.+||+.||.+|||+.|++++-..
T Consensus 249 ~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~ 280 (486)
T 3mwu_A 249 ISDDAKDLIRKMLTFHPSLRITATQCLEHPWI 280 (486)
T ss_dssp SCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHH
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHhcCHhh
Confidence 56789999999999999999999999998544
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=332.06 Aligned_cols=241 Identities=19% Similarity=0.258 Sum_probs=184.7
Q ss_pred hhcccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCChh--hHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEE
Q 008785 266 ITKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQ--RKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYI 342 (553)
Q Consensus 266 ~~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 342 (553)
..++|..... ||+|+||.||++... +|+.||||+++..... ..+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 32 ~~~~y~~~~~-lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 110 (329)
T 3gbz_A 32 SIDRYRRITK-LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL 110 (329)
T ss_dssp CGGGEEEEEE-EEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred chhhEEEEEE-EEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence 4455655544 599999999999854 6889999999755322 24567899999999999999999999999999999
Q ss_pred EEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEec-----CCCCeEEeecc
Q 008785 343 VYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD-----EEFGAHLMGVG 417 (553)
Q Consensus 343 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~-----~~~~~kl~Dfg 417 (553)
||||++ |+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++ +++.+||+|||
T Consensus 111 v~e~~~-~~L~~~~~~----~~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg 182 (329)
T 3gbz_A 111 IFEYAE-NDLKKYMDK----NPDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFG 182 (329)
T ss_dssp EEECCS-EEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTT
T ss_pred EEecCC-CCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCC
Confidence 999997 599999975 23589999999999999999999999 999999999999994 45569999999
Q ss_pred ccccCCcccccceeeecCccccccccccccCC-CCCcccchHhHHHHHHHHhcCc-ccccchHHH----HHhc-------
Q 008785 418 LSKFVPWEVMQERTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIRLVL-CRRWWTLYT----LVHS------- 484 (553)
Q Consensus 418 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwSlGvil~ell~~~-~~~~~~l~~----~~~~------- 484 (553)
++.......... ....||+.|+|||++.+. .++.++||||||+++|||++.. +.......+ ....
T Consensus 183 ~a~~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 260 (329)
T 3gbz_A 183 LARAFGIPIRQF--THEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDT 260 (329)
T ss_dssp HHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTT
T ss_pred CccccCCccccc--CCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchh
Confidence 997654332221 112379999999999874 4899999999999999999732 222221111 1110
Q ss_pred --------------------CCH------HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008785 485 --------------------MSL------LCAQECLMLFISCNNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 485 --------------------~~~------~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 517 (553)
... ..+..+.+++.+||+.||++|||+.|++++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 319 (329)
T 3gbz_A 261 TWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH 319 (329)
T ss_dssp TSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence 000 145778999999999999999999999875
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=333.52 Aligned_cols=240 Identities=19% Similarity=0.226 Sum_probs=195.2
Q ss_pred eeecccCceeEEEEEeC-CCCEEEEEEeccC-ChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCCH
Q 008785 275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL 352 (553)
+.||+|+||.||++... +|+.||+|+++.. .....+.+.+|+.++++++||||+++++++.+.+..++||||+++|+|
T Consensus 39 ~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 118 (360)
T 3eqc_A 39 SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL 118 (360)
T ss_dssp EEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCCTTCBH
T ss_pred eeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECCCCCCH
Confidence 45699999999999975 5899999999865 344467899999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCceecCCCCCcEEecCCCCeEEeeccccccCCccccccee
Q 008785 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD-KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT 431 (553)
Q Consensus 353 ~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~ 431 (553)
.+++.. ...+++..+..++.|++.||.|||+ . +|+||||||+|||++.++.+||+|||++....... .
T Consensus 119 ~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~----~ 187 (360)
T 3eqc_A 119 DQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----A 187 (360)
T ss_dssp HHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHC-----
T ss_pred HHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHhC---CEEcCCccHHHEEECCCCCEEEEECCCCccccccc----c
Confidence 999975 2358999999999999999999998 5 89999999999999999999999999986543221 1
Q ss_pred eecCccccccccccccCCCCCcccchHhHHHHHHHHhcC-cccccch---HHHHH-------------------------
Q 008785 432 VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLV-LCRRWWT---LYTLV------------------------- 482 (553)
Q Consensus 432 ~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~-~~~~~~~---l~~~~------------------------- 482 (553)
....||+.|+|||++.+..++.++||||||+++|||++. .|..... +...+
T Consensus 188 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (360)
T 3eqc_A 188 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKF 267 (360)
T ss_dssp ---CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------------
T ss_pred cCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCccccc
Confidence 122389999999999999999999999999999999973 2322211 11100
Q ss_pred -----------------hcCCH------HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHhhc
Q 008785 483 -----------------HSMSL------LCAQECLMLFISCNNWPSHLSQSKFCNLKLWVFAILTI 525 (553)
Q Consensus 483 -----------------~~~~~------~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~~~~~~ 525 (553)
..+.. ..+..+.+++.+||+.||++|||+.|++++-...-...
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 333 (360)
T 3eqc_A 268 GMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDA 333 (360)
T ss_dssp ------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHHH
T ss_pred ccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcchH
Confidence 00000 23567899999999999999999999999865544433
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-39 Score=330.69 Aligned_cols=248 Identities=21% Similarity=0.255 Sum_probs=191.3
Q ss_pred HHHHHHhhcccCCCCeeecccCceeEEEEEeCCCCEEEEEEeccCCh-----------hhHHHHHHHHHHhhccCCCcee
Q 008785 260 TEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSF-----------QRKKEFYSEIGRFARLHHPNLV 328 (553)
Q Consensus 260 ~~el~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~vAvK~~~~~~~-----------~~~~~~~~E~~~l~~l~HpnIv 328 (553)
.+++..+.++|..... ||+|+||.||+|...+|+.||||++..... ...+.+.+|+.++++++||||+
T Consensus 14 ~~~~~~~~~~y~~~~~-lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 14 IAELHAMQSPYTVQRF-ISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHTTCSCEEEEE-EEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHhccceEEeEE-eccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 4567777778776554 599999999999988899999999864321 2237789999999999999999
Q ss_pred eEeeEEeeC-----CceEEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcE
Q 008785 329 AVKGCCYDH-----GDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNV 403 (553)
Q Consensus 329 ~l~~~~~~~-----~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NI 403 (553)
++++++... ...++||||++ |+|.+++.. ....+++..+..++.||+.||.|||++ +|+||||||+||
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NI 165 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD---QRIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNI 165 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGE
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHE
Confidence 999998643 35799999997 688888864 345689999999999999999999999 999999999999
Q ss_pred EecCCCCeEEeeccccccCCcccccceeeecCccccccccccccC-CCCCcccchHhHHHHHHHHhcCc-ccccchHHH-
Q 008785 404 LLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIRLVL-CRRWWTLYT- 480 (553)
Q Consensus 404 Ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwSlGvil~ell~~~-~~~~~~l~~- 480 (553)
|++.++.+||+|||++.......... ...||+.|+|||++.+ ..++.++||||||+++|||++.. |.......+
T Consensus 166 l~~~~~~~kl~Dfg~~~~~~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~ 242 (362)
T 3pg1_A 166 LLADNNDITICDFNLAREDTADANKT---HYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQ 242 (362)
T ss_dssp EECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred EEcCCCCEEEEecCcccccccccccc---eecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHH
Confidence 99999999999999997544332221 2238999999999876 67899999999999999999732 332222111
Q ss_pred ---HH---hcCCH--------------------------------HHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008785 481 ---LV---HSMSL--------------------------------LCAQECLMLFISCNNWPSHLSQSKFCNLKLW 518 (553)
Q Consensus 481 ---~~---~~~~~--------------------------------~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l 518 (553)
.. ..... ..+..+.+++.+||+.||++|||+.|++++-
T Consensus 243 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 318 (362)
T 3pg1_A 243 LNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHP 318 (362)
T ss_dssp HHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred HHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCc
Confidence 11 01000 2245689999999999999999999999874
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=339.67 Aligned_cols=245 Identities=19% Similarity=0.247 Sum_probs=189.6
Q ss_pred hcccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccC--ChhhHHHHHHHHHHhhccCCCceeeEeeEEeeC-----C
Q 008785 267 TKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH-----G 338 (553)
Q Consensus 267 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~-----~ 338 (553)
.++|... +.||+|+||.||+|... +|+.||||+++.. .....+.+.+|+.+|++++||||+++++++... +
T Consensus 25 ~~~y~~~-~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 103 (432)
T 3n9x_A 25 PDNYIIK-HLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103 (432)
T ss_dssp CTTEEEE-EEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred cCCEEEE-EEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence 3445443 45699999999999965 4889999999754 334557889999999999999999999998876 5
Q ss_pred ceEEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccc
Q 008785 339 DRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGL 418 (553)
Q Consensus 339 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgl 418 (553)
..|+||||+. |+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 104 ~~~lv~e~~~-~~L~~~~~~----~~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGl 175 (432)
T 3n9x_A 104 ELYIVLEIAD-SDLKKLFKT----PIFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGL 175 (432)
T ss_dssp CEEEEEECCS-EEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecCC-cCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCC
Confidence 6899999985 699999964 34589999999999999999999999 999999999999999999999999999
Q ss_pred cccCCccccc--------------------ceeeecCccccccccccc-cCCCCCcccchHhHHHHHHHHhc--------
Q 008785 419 SKFVPWEVMQ--------------------ERTVMAGGTYGYLAPEFV-YRNELTTKSDVYSFGVLLLEIRL-------- 469 (553)
Q Consensus 419 a~~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~t~ksDVwSlGvil~ell~-------- 469 (553)
++........ .......||+.|+|||++ ....++.++|||||||++|||++
T Consensus 176 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~ 255 (432)
T 3n9x_A 176 ARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHIND 255 (432)
T ss_dssp CEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSS
T ss_pred cccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccc
Confidence 9876543211 011223489999999986 45669999999999999999994
Q ss_pred ---Ccccccc----------------------hH---HHHHhcCC-------------------------------HHHH
Q 008785 470 ---VLCRRWW----------------------TL---YTLVHSMS-------------------------------LLCA 490 (553)
Q Consensus 470 ---~~~~~~~----------------------~l---~~~~~~~~-------------------------------~~~~ 490 (553)
..|.... .+ .+.+.... ...+
T Consensus 256 ~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s 335 (432)
T 3n9x_A 256 PTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSIS 335 (432)
T ss_dssp GGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSC
T ss_pred cccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCC
Confidence 1111100 00 00000000 0246
Q ss_pred HHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 008785 491 QECLMLFISCNNWPSHLSQSKFCNLKLWVF 520 (553)
Q Consensus 491 ~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~ 520 (553)
..+.+|+.+||..||++|||+.|++++-..
T Consensus 336 ~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f 365 (432)
T 3n9x_A 336 DDGINLLESMLKFNPNKRITIDQALDHPYL 365 (432)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHHTCGGG
T ss_pred HHHHHHHHHHhcCCcccCCCHHHHhcChhh
Confidence 778999999999999999999999998443
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=330.72 Aligned_cols=240 Identities=20% Similarity=0.208 Sum_probs=184.8
Q ss_pred cccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccC--ChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCC------
Q 008785 268 KNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHG------ 338 (553)
Q Consensus 268 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~------ 338 (553)
++|.... .||+|+||.||+|... +|+.||||++... .....+.+.+|+.+++.++||||+++++++...+
T Consensus 25 ~~y~~~~-~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 25 KRYQNLK-PIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp TTEEEEE-EEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hheeEee-eeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 3454444 4599999999999864 5889999999753 3344577889999999999999999999998665
Q ss_pred ceEEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccc
Q 008785 339 DRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGL 418 (553)
Q Consensus 339 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgl 418 (553)
..++||||++ |+|.+++.. .+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 104 ~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 173 (371)
T 2xrw_A 104 DVYIVMELMD-ANLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 173 (371)
T ss_dssp EEEEEEECCS-EEHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred ceEEEEEcCC-CCHHHHHhh------ccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeec
Confidence 6799999996 578888852 488999999999999999999999 999999999999999999999999999
Q ss_pred cccCCcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcCc-ccccchHHH----HHhc-C-------
Q 008785 419 SKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVL-CRRWWTLYT----LVHS-M------- 485 (553)
Q Consensus 419 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~-~~~~~~l~~----~~~~-~------- 485 (553)
++........ ....||+.|+|||++.+..++.++||||||+++|||++.. |....+..+ .+.. +
T Consensus 174 a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 250 (371)
T 2xrw_A 174 ARTAGTSFMM---TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM 250 (371)
T ss_dssp -------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHH
T ss_pred cccccccccc---CCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 9865433211 1223899999999999999999999999999999999732 222211111 1110 0
Q ss_pred --------------------CH-----------------HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 008785 486 --------------------SL-----------------LCAQECLMLFISCNNWPSHLSQSKFCNLKLWVFA 521 (553)
Q Consensus 486 --------------------~~-----------------~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~~ 521 (553)
.+ ..+..+.+|+.+||..||++|||+.|++++-...
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~ 323 (371)
T 2xrw_A 251 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYIN 323 (371)
T ss_dssp TTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHH
T ss_pred HHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchh
Confidence 00 2266789999999999999999999999986554
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=330.01 Aligned_cols=244 Identities=20% Similarity=0.259 Sum_probs=188.9
Q ss_pred hcccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCChhh-----HHHHHHHHHHhhccCCCceeeEeeEEeeCCce
Q 008785 267 TKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQR-----KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR 340 (553)
Q Consensus 267 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~~~-----~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 340 (553)
.++|.... .||+|+||.||+|... +|+.||||+++...... .+.+.+|+.++++++||||+++++++.+.+..
T Consensus 9 ~~~y~~~~-~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 9 AKRYEKLD-FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp ----CEEE-EEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred hcccEEEe-EEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 34555544 5599999999999975 58999999997542211 24678999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccc
Q 008785 341 YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSK 420 (553)
Q Consensus 341 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~ 420 (553)
++||||+++ +|.+++.. ....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 88 ~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAK 160 (346)
T ss_dssp EEEEECCSE-EHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred EEEEEcCCC-CHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccce
Confidence 999999975 89888864 335688899999999999999999999 99999999999999999999999999998
Q ss_pred cCCcccccceeeecCccccccccccccCC-CCCcccchHhHHHHHHHHhcCccc-ccch---HHH-HHhc-CC-------
Q 008785 421 FVPWEVMQERTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIRLVLCR-RWWT---LYT-LVHS-MS------- 486 (553)
Q Consensus 421 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwSlGvil~ell~~~~~-~~~~---l~~-~~~~-~~------- 486 (553)
......... ....||+.|+|||++.+. .++.++||||||+++|||++..+. .... ... .+.. +.
T Consensus 161 ~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 238 (346)
T 1ua2_A 161 SFGSPNRAY--THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWP 238 (346)
T ss_dssp TTTSCCCCC--CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSS
T ss_pred eccCCcccC--CcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhh
Confidence 764332211 122389999999998764 589999999999999999973332 1111 111 1110 00
Q ss_pred -----------------------HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 008785 487 -----------------------LLCAQECLMLFISCNNWPSHLSQSKFCNLKLWVF 520 (553)
Q Consensus 487 -----------------------~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~ 520 (553)
...+..+.+++.+||+.||++|||+.|++++-..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f 295 (346)
T 1ua2_A 239 DMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYF 295 (346)
T ss_dssp STTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGG
T ss_pred hhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhh
Confidence 0224679999999999999999999999987544
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=327.26 Aligned_cols=246 Identities=16% Similarity=0.185 Sum_probs=180.7
Q ss_pred CeeecccCceeEEEEEeC-CCCEEEEEEeccCChhhHHHHHHHHHHhhccC-CCceeeEeeEEee--------CCceEEE
Q 008785 274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLH-HPNLVAVKGCCYD--------HGDRYIV 343 (553)
Q Consensus 274 ~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~--------~~~~~lV 343 (553)
.+.||+|+||.||++... +|+.||||++........+.+.+|+.++.++. ||||+++++++.. ....++|
T Consensus 33 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~lv 112 (337)
T 3ll6_A 33 RRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLL 112 (337)
T ss_dssp EEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEEEEE
T ss_pred EEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCceEEEE
Confidence 345699999999999964 68999999998776677788999999999996 9999999999842 3347999
Q ss_pred EEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--ceecCCCCCcEEecCCCCeEEeecccccc
Q 008785 344 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPH--VVHRDIRASNVLLDEEFGAHLMGVGLSKF 421 (553)
Q Consensus 344 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~--ivHrDlkp~NILl~~~~~~kl~Dfgla~~ 421 (553)
|||+. |+|.+++.... ....+++..+..++.||+.||.|||+. + |+||||||+|||++.++.+||+|||++..
T Consensus 113 ~e~~~-g~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 187 (337)
T 3ll6_A 113 TELCK-GQLVEFLKKME-SRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKLCDFGSATT 187 (337)
T ss_dssp EECCS-EEHHHHHHHHH-TTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEBCCCTTCBC
T ss_pred EEecC-CCHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEEecCcccee
Confidence 99995 79999886422 234599999999999999999999998 8 99999999999999999999999999987
Q ss_pred CCcccccc----------eeeecCccccccccccc---cCCCCCcccchHhHHHHHHHHhcC-cccccchHHHHHhcCC-
Q 008785 422 VPWEVMQE----------RTVMAGGTYGYLAPEFV---YRNELTTKSDVYSFGVLLLEIRLV-LCRRWWTLYTLVHSMS- 486 (553)
Q Consensus 422 ~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~t~ksDVwSlGvil~ell~~-~~~~~~~l~~~~~~~~- 486 (553)
........ ......||+.|+|||++ .+..++.++||||||+++|||++. .|..............
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~ 267 (337)
T 3ll6_A 188 ISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNGKYS 267 (337)
T ss_dssp CSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------------CC
T ss_pred ccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhcCccc
Confidence 65432211 01122389999999998 566789999999999999999973 3333222222111110
Q ss_pred ----HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHhh
Q 008785 487 ----LLCAQECLMLFISCNNWPSHLSQSKFCNLKLWVFAILT 524 (553)
Q Consensus 487 ----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~~~~~ 524 (553)
...+..+.+++.+||+.||++|||+.|+++++......
T Consensus 268 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~ 309 (337)
T 3ll6_A 268 IPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAA 309 (337)
T ss_dssp CCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 03445688999999999999999999999998765543
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=328.98 Aligned_cols=248 Identities=22% Similarity=0.294 Sum_probs=192.0
Q ss_pred HHhhcccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCChhhHHHHHHHHHHhhcc-CCCceeeEeeEEee-----
Q 008785 264 RSITKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYD----- 336 (553)
Q Consensus 264 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~----- 336 (553)
....+.|.... .||+|+||.||+|... +|+.||||++.... ...+.+.+|+.+++++ +||||+++++++..
T Consensus 20 ~~~~~~y~~~~-~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~ 97 (326)
T 2x7f_A 20 RDPAGIFELVE-LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG 97 (326)
T ss_dssp CCCTTTEEEEE-EEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--C
T ss_pred cCCCCcEEEEE-EeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCcc
Confidence 33445555544 5599999999999974 68999999997653 3456788999999999 89999999999987
Q ss_pred -CCceEEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEee
Q 008785 337 -HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMG 415 (553)
Q Consensus 337 -~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~D 415 (553)
.+..++||||+++|+|.+++... ....+++..+..++.||+.||.|||+. +|+||||||+||+++.++.+||+|
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl~D 172 (326)
T 2x7f_A 98 MDDQLWLVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVD 172 (326)
T ss_dssp CCCEEEEEEECCTTEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECC
T ss_pred ccceEEEEEEcCCCCcHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEEee
Confidence 45789999999999999999762 235689999999999999999999999 999999999999999999999999
Q ss_pred ccccccCCcccccceeeecCcccccccccccc-----CCCCCcccchHhHHHHHHHHhcCc-ccccchHHH---HHhcCC
Q 008785 416 VGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY-----RNELTTKSDVYSFGVLLLEIRLVL-CRRWWTLYT---LVHSMS 486 (553)
Q Consensus 416 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDVwSlGvil~ell~~~-~~~~~~l~~---~~~~~~ 486 (553)
||++.......... ....||+.|+|||++. +..++.++||||||+++|||++.. |........ .+....
T Consensus 173 fg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~ 250 (326)
T 2x7f_A 173 FGVSAQLDRTVGRR--NTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP 250 (326)
T ss_dssp CTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC
T ss_pred CcCceecCcCcccc--ccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc
Confidence 99998654332111 1223899999999987 567899999999999999999733 322222111 222111
Q ss_pred H------HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 008785 487 L------LCAQECLMLFISCNNWPSHLSQSKFCNLKLWVF 520 (553)
Q Consensus 487 ~------~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~ 520 (553)
. ..+..+.+++.+||+.||.+|||+.|++++-..
T Consensus 251 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~ 290 (326)
T 2x7f_A 251 APRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFI 290 (326)
T ss_dssp CCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHH
T ss_pred cccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHH
Confidence 1 456789999999999999999999999987443
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-39 Score=325.78 Aligned_cols=239 Identities=21% Similarity=0.258 Sum_probs=188.8
Q ss_pred hcccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCCh--------hhHHHHHHHHHHhhccCCCceeeEeeEEeeC
Q 008785 267 TKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF--------QRKKEFYSEIGRFARLHHPNLVAVKGCCYDH 337 (553)
Q Consensus 267 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~--------~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 337 (553)
.++|.... .||+|+||.||+|... +++.||||++..... .....+.+|+.++++++||||+++++++...
T Consensus 9 ~~~y~~~~-~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 9 RDEYIMSK-TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHEEEEE-EEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhceeEee-EEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 34455444 4599999999999975 478999999975421 1234588999999999999999999998765
Q ss_pred CceEEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCC---eEEe
Q 008785 338 GDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG---AHLM 414 (553)
Q Consensus 338 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~---~kl~ 414 (553)
..++||||+++|+|.+++.. ...+++..+..++.||+.||.|||++ +|+||||||+|||++.++. +||+
T Consensus 88 -~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~ 159 (322)
T 2ycf_A 88 -DYYIVLELMEGGELFDKVVG----NKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKIT 159 (322)
T ss_dssp -SEEEEEECCTTEETHHHHST----TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEEC
T ss_pred -ceEEEEecCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEc
Confidence 48999999999999999864 34689999999999999999999999 9999999999999987654 9999
Q ss_pred eccccccCCcccccceeeecCcccccccccccc---CCCCCcccchHhHHHHHHHHhcCc-ccc----cchHHHHHhcCC
Q 008785 415 GVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY---RNELTTKSDVYSFGVLLLEIRLVL-CRR----WWTLYTLVHSMS 486 (553)
Q Consensus 415 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~t~ksDVwSlGvil~ell~~~-~~~----~~~l~~~~~~~~ 486 (553)
|||++.......... ...||+.|+|||++. ...++.++||||||+++|||++.. |.. ...+.+.+..+.
T Consensus 160 Dfg~~~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 236 (322)
T 2ycf_A 160 DFGHSKILGETSLMR---TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGK 236 (322)
T ss_dssp CCTTCEECCCCHHHH---HHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTC
T ss_pred cCccceecccccccc---cccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCc
Confidence 999998765432211 123899999999974 467899999999999999999732 221 123344444333
Q ss_pred H--------HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008785 487 L--------LCAQECLMLFISCNNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 487 ~--------~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 517 (553)
. ..+..+.+++.+||+.||++|||+.|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h 275 (322)
T 2ycf_A 237 YNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 275 (322)
T ss_dssp CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence 2 346778999999999999999999999964
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=332.34 Aligned_cols=239 Identities=16% Similarity=0.124 Sum_probs=184.1
Q ss_pred CeeecccCceeEEEEEeC----CCCEEEEEEeccCChh-----------hHHHHHHHHHHhhccCCCceeeEeeEEee--
Q 008785 274 NRLLGDSKTGGTYSGILP----DGSRVAVKRLKRSSFQ-----------RKKEFYSEIGRFARLHHPNLVAVKGCCYD-- 336 (553)
Q Consensus 274 ~~~iG~G~~g~Vy~~~~~----~g~~vAvK~~~~~~~~-----------~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-- 336 (553)
.+.||+|+||.||+|... ++..||||++...... ....+.+|+..++.++||||+++++++..
T Consensus 42 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~~~~~~ 121 (345)
T 2v62_A 42 GKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEF 121 (345)
T ss_dssp EEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEEEEEES
T ss_pred EeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeeccccccc
Confidence 345699999999999975 5788999999765321 11346678899999999999999999988
Q ss_pred --CCceEEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCC--CeE
Q 008785 337 --HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF--GAH 412 (553)
Q Consensus 337 --~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~--~~k 412 (553)
....++||||+ +++|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++ .+|
T Consensus 122 ~~~~~~~lv~e~~-~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~k 193 (345)
T 2v62_A 122 KGRSYRFMVMERL-GIDLQKISGQN----GTFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKNPDQVY 193 (345)
T ss_dssp SSCEEEEEEEECE-EEEHHHHCBGG----GBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESSSTTSEE
T ss_pred CCCcEEEEEEecc-CCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccCCCCcEE
Confidence 67789999999 99999999752 2689999999999999999999999 999999999999999877 999
Q ss_pred EeeccccccCCcccccce-----eeecCccccccccccccCCCCCcccchHhHHHHHHHHhcCc-cccc----ch-HHH-
Q 008785 413 LMGVGLSKFVPWEVMQER-----TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVL-CRRW----WT-LYT- 480 (553)
Q Consensus 413 l~Dfgla~~~~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~-~~~~----~~-l~~- 480 (553)
|+|||+++.......... .....||+.|+|||++.+..++.++||||||+++|||++.. |... .. +..
T Consensus 194 L~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~ 273 (345)
T 2v62_A 194 LADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTA 273 (345)
T ss_dssp ECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHH
T ss_pred EEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHHH
Confidence 999999987654322110 12234899999999999999999999999999999999833 3311 11 111
Q ss_pred ---HHhcCCH---------HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 008785 481 ---LVHSMSL---------LCAQECLMLFISCNNWPSHLSQSKFCNLKLWVF 520 (553)
Q Consensus 481 ---~~~~~~~---------~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~ 520 (553)
....-.. ..+..+.+++.+||+.||++|||+.++++.+..
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~ 325 (345)
T 2v62_A 274 KTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNP 325 (345)
T ss_dssp HHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCT
T ss_pred HHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 1111111 234589999999999999999999999997743
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=323.46 Aligned_cols=227 Identities=20% Similarity=0.264 Sum_probs=186.4
Q ss_pred eeecccCceeEEEEEe-CCCCEEEEEEeccCChhhHHHHHHHHHHhhccC-CCceeeEeeEEee--CCceEEEEEccCCC
Q 008785 275 RLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLH-HPNLVAVKGCCYD--HGDRYIVYEFVVNG 350 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~--~~~~~lV~E~~~~g 350 (553)
+.||+|+||.||+|.. .+++.||||+++.. ..+.+.+|+.++++++ ||||+++++++.+ ....++||||++++
T Consensus 42 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~ 118 (330)
T 3nsz_A 42 RKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNT 118 (330)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECCCCC
T ss_pred EEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEeccCch
Confidence 4569999999999986 46899999999754 3467889999999997 9999999999987 56789999999999
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCC-CeEEeeccccccCCcccccc
Q 008785 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF-GAHLMGVGLSKFVPWEVMQE 429 (553)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~-~~kl~Dfgla~~~~~~~~~~ 429 (553)
+|.+++.. +++..+..++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+++.........
T Consensus 119 ~l~~~~~~-------~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~ 188 (330)
T 3nsz_A 119 DFKQLYQT-------LTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYN 188 (330)
T ss_dssp CHHHHGGG-------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCC
T ss_pred hHHHHHHh-------CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCccc
Confidence 99998853 88999999999999999999999 999999999999999776 89999999998665433221
Q ss_pred eeeecCccccccccccccC-CCCCcccchHhHHHHHHHHhcCc-cccc-----chHHH------------HHhcCCH---
Q 008785 430 RTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIRLVL-CRRW-----WTLYT------------LVHSMSL--- 487 (553)
Q Consensus 430 ~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwSlGvil~ell~~~-~~~~-----~~l~~------------~~~~~~~--- 487 (553)
...||+.|+|||++.+ ..++.++||||||+++|||++.. |... ..+.. .+.....
T Consensus 189 ---~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 265 (330)
T 3nsz_A 189 ---VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 265 (330)
T ss_dssp ---SCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCC
T ss_pred ---cccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccc
Confidence 2238999999999877 67899999999999999999732 3211 01111 1111000
Q ss_pred -------------------------HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008785 488 -------------------------LCAQECLMLFISCNNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 488 -------------------------~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 517 (553)
..+..+.+++.+||+.||++|||+.|++++
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 266 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp THHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred cchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 146789999999999999999999999986
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-39 Score=320.26 Aligned_cols=241 Identities=20% Similarity=0.240 Sum_probs=195.8
Q ss_pred hhcccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCC---------hhhHHHHHHHHHHhhccC-CCceeeEeeEE
Q 008785 266 ITKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---------FQRKKEFYSEIGRFARLH-HPNLVAVKGCC 334 (553)
Q Consensus 266 ~~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~---------~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~ 334 (553)
..++|.... .||+|+||.||++... +|+.||||+++... ....+.+.+|+.+++++. ||||+++++++
T Consensus 15 ~~~~y~~~~-~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 15 FYENYEPKE-ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp CTTTEEEEE-EEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred hhhccceee-eecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 344554444 4599999999999975 58899999997542 122467889999999995 99999999999
Q ss_pred eeCCceEEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEe
Q 008785 335 YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLM 414 (553)
Q Consensus 335 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~ 414 (553)
.+.+..++||||+++++|.+++.. ...+++..+..++.||+.||.|||+. +++||||||+||+++.++.+||+
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~ 166 (298)
T 1phk_A 94 ETNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLT 166 (298)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEEC
T ss_pred ccCCeEEEEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEe
Confidence 999999999999999999999975 24589999999999999999999999 99999999999999999999999
Q ss_pred eccccccCCcccccceeeecCcccccccccccc------CCCCCcccchHhHHHHHHHHhcCc-cccc---chHHHHHhc
Q 008785 415 GVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY------RNELTTKSDVYSFGVLLLEIRLVL-CRRW---WTLYTLVHS 484 (553)
Q Consensus 415 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~t~ksDVwSlGvil~ell~~~-~~~~---~~l~~~~~~ 484 (553)
|||++......... ....|++.|+|||++. ...++.++||||||+++|||++.. |... ......+..
T Consensus 167 dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 243 (298)
T 1phk_A 167 DFGFSCQLDPGEKL---REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMS 243 (298)
T ss_dssp CCTTCEECCTTCCB---CCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred cccchhhcCCCccc---ccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhc
Confidence 99999876543221 1223899999999885 456889999999999999999732 2222 222223322
Q ss_pred CCH--------HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008785 485 MSL--------LCAQECLMLFISCNNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 485 ~~~--------~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 517 (553)
+.. ..+..+.+++.+||+.||++|||+.|++++
T Consensus 244 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (298)
T 1phk_A 244 GNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 284 (298)
T ss_dssp TCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred CCcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence 221 456789999999999999999999999874
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-39 Score=326.42 Aligned_cols=238 Identities=24% Similarity=0.259 Sum_probs=188.6
Q ss_pred eeecccCceeEEEEEeCC-CCEEEEEEeccCC--hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCC
Q 008785 275 RLLGDSKTGGTYSGILPD-GSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP 351 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~~-g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gs 351 (553)
+.||+|+||.||++.... |+.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++||||+++++
T Consensus 31 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 110 (331)
T 4aaa_A 31 GLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTI 110 (331)
T ss_dssp EEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEH
T ss_pred eEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEecCCcch
Confidence 456999999999999754 8999999986543 2335668899999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCccccccee
Q 008785 352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT 431 (553)
Q Consensus 352 L~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~ 431 (553)
|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++...........
T Consensus 111 l~~~~~~----~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~- 182 (331)
T 4aaa_A 111 LDDLELF----PNGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYD- 182 (331)
T ss_dssp HHHHHHS----TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC------------
T ss_pred HHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecCCccccC-
Confidence 9887653 24589999999999999999999999 999999999999999999999999999976544322211
Q ss_pred eecCccccccccccccCC-CCCcccchHhHHHHHHHHhcCc-ccccchHHH----HHh-cCCH-----------------
Q 008785 432 VMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIRLVL-CRRWWTLYT----LVH-SMSL----------------- 487 (553)
Q Consensus 432 ~~~~gt~~y~aPE~~~~~-~~t~ksDVwSlGvil~ell~~~-~~~~~~l~~----~~~-~~~~----------------- 487 (553)
...||+.|+|||++.+. .++.++||||||+++|||++.. |.....-.+ ... .+..
T Consensus 183 -~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (331)
T 4aaa_A 183 -DEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGV 261 (331)
T ss_dssp --CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTC
T ss_pred -CCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccc
Confidence 22389999999999775 6899999999999999999733 222211111 110 0000
Q ss_pred ----------------HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 008785 488 ----------------LCAQECLMLFISCNNWPSHLSQSKFCNLKLWVFA 521 (553)
Q Consensus 488 ----------------~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~~ 521 (553)
..+..+.+++.+||+.||++|||+.|++++-...
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~ 311 (331)
T 4aaa_A 262 RLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQ 311 (331)
T ss_dssp CCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHH
T ss_pred cCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhc
Confidence 2357799999999999999999999999985543
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=320.68 Aligned_cols=249 Identities=22% Similarity=0.319 Sum_probs=183.5
Q ss_pred ccCCCCeeecccCceeEEEEEe-CCCCEEEEEEeccCC-hhh-HHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEE
Q 008785 269 NFSEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSS-FQR-KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYE 345 (553)
Q Consensus 269 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~~~~~~-~~~-~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 345 (553)
+|... +.||+|+||.||++.. .+|+.||||+++... ... .+.+.++...++.++||||+++++++.+.+..++|||
T Consensus 8 ~y~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e 86 (290)
T 3fme_A 8 DLEPI-MELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICME 86 (290)
T ss_dssp GEEEE-EEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEE
T ss_pred hhhhH-HhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEe
Confidence 44443 3459999999999996 468999999997652 222 2334455556888899999999999999999999999
Q ss_pred ccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcc
Q 008785 346 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE 425 (553)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~ 425 (553)
|++ |+|.+++.........+++..+..++.|++.||+|||++ .+|+||||||+||+++.++.+||+|||++......
T Consensus 87 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 163 (290)
T 3fme_A 87 LMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK--LSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDD 163 (290)
T ss_dssp CCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH--SCCCCCCCSGGGCEECTTCCEEBCCC---------
T ss_pred hhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeecCCccccccc
Confidence 996 588888764333456799999999999999999999984 28999999999999999999999999999866543
Q ss_pred cccceeeecCccccccccccc----cCCCCCcccchHhHHHHHHHHhcCc-cccc-----chHHHHHhcCCH-----HHH
Q 008785 426 VMQERTVMAGGTYGYLAPEFV----YRNELTTKSDVYSFGVLLLEIRLVL-CRRW-----WTLYTLVHSMSL-----LCA 490 (553)
Q Consensus 426 ~~~~~~~~~~gt~~y~aPE~~----~~~~~t~ksDVwSlGvil~ell~~~-~~~~-----~~l~~~~~~~~~-----~~~ 490 (553)
.... ...||+.|+|||++ .+..++.++||||||+++|||++.. |... ..+...+..... ..+
T Consensus 164 ~~~~---~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (290)
T 3fme_A 164 VAKD---IDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFS 240 (290)
T ss_dssp ---------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTTTSC
T ss_pred cccc---ccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcccccCC
Confidence 2221 12389999999996 4567899999999999999999733 3221 112223332221 456
Q ss_pred HHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHhh
Q 008785 491 QECLMLFISCNNWPSHLSQSKFCNLKLWVFAILT 524 (553)
Q Consensus 491 ~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~~~~~ 524 (553)
..+.+++.+||+.||++|||+.|++++-......
T Consensus 241 ~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~~ 274 (290)
T 3fme_A 241 AEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHE 274 (290)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred HHHHHHHHHHhhcChhhCcCHHHHHhCcccccCc
Confidence 7899999999999999999999999986554443
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=318.02 Aligned_cols=249 Identities=17% Similarity=0.211 Sum_probs=192.6
Q ss_pred hcccCCCCeeecccCceeEEEEEe-CCCCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeEE-eeCCceEEEE
Q 008785 267 TKNFSEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCC-YDHGDRYIVY 344 (553)
Q Consensus 267 ~~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~-~~~~~~~lV~ 344 (553)
.++|... +.||+|+||.||+|.. .+++.||||++.... ..+.+.+|+.++++++|++++..++.+ .+.+..++||
T Consensus 8 ~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 8 GNRYRLG-RKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ---CEEE-EEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred CCceEEe-eeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 3455444 4559999999999996 468899999876542 224578899999999988877766665 5667789999
Q ss_pred EccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEe---cCCCCeEEeecccccc
Q 008785 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL---DEEFGAHLMGVGLSKF 421 (553)
Q Consensus 345 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl---~~~~~~kl~Dfgla~~ 421 (553)
||+ +++|.+++.. ....+++..+..++.||+.||.|||++ +|+||||||+|||+ ++++.+||+|||+++.
T Consensus 85 e~~-~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~ 157 (296)
T 4hgt_A 85 ELL-GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157 (296)
T ss_dssp ECC-CCBHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred Ecc-CCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCcccee
Confidence 999 9999999974 234599999999999999999999999 99999999999999 7889999999999987
Q ss_pred CCcccccc-----eeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcC-ccccc------chHHHHHhc----C
Q 008785 422 VPWEVMQE-----RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLV-LCRRW------WTLYTLVHS----M 485 (553)
Q Consensus 422 ~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~-~~~~~------~~l~~~~~~----~ 485 (553)
........ ......||+.|+|||++.+..++.++||||||+++|||++. .|... ......+.. .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 237 (296)
T 4hgt_A 158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST 237 (296)
T ss_dssp CBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS
T ss_pred ccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccc
Confidence 65432211 11123489999999999999999999999999999999972 22211 111111111 1
Q ss_pred CH-----HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHhhc
Q 008785 486 SL-----LCAQECLMLFISCNNWPSHLSQSKFCNLKLWVFAILTI 525 (553)
Q Consensus 486 ~~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~~~~~~ 525 (553)
.. ..+..+.+++.+||+.||++|||+.++++.+...+.+.
T Consensus 238 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~ 282 (296)
T 4hgt_A 238 PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 282 (296)
T ss_dssp CHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred hhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHh
Confidence 11 23678999999999999999999999999887766554
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=317.27 Aligned_cols=248 Identities=17% Similarity=0.196 Sum_probs=194.8
Q ss_pred cccCCCCeeecccCceeEEEEEe-CCCCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeEE-eeCCceEEEEE
Q 008785 268 KNFSEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCC-YDHGDRYIVYE 345 (553)
Q Consensus 268 ~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~-~~~~~~~lV~E 345 (553)
++|... +.||+|+||.||+|.. .+|+.||||++..... .+.+.+|+.++++++|++++..++.+ .+.+..++|||
T Consensus 9 ~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 9 NRYRLG-RKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTEEEE-EEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred cEEEEE-EEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 445444 4559999999999996 5689999999876532 34688999999999988866666655 55667799999
Q ss_pred ccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEe---cCCCCeEEeeccccccC
Q 008785 346 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL---DEEFGAHLMGVGLSKFV 422 (553)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl---~~~~~~kl~Dfgla~~~ 422 (553)
|+ +++|.+++.. ....+++..+..++.||+.||+|||++ +|+||||||+|||+ ++++.+||+|||++...
T Consensus 86 ~~-~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 158 (296)
T 3uzp_A 86 LL-GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp CC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred ec-CCCHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence 99 9999999974 234699999999999999999999999 99999999999999 47889999999999876
Q ss_pred Ccccccc-----eeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcCc-cccc------chHHHHHhcC----C
Q 008785 423 PWEVMQE-----RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVL-CRRW------WTLYTLVHSM----S 486 (553)
Q Consensus 423 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~-~~~~------~~l~~~~~~~----~ 486 (553)
....... ......||+.|+|||++.+..++.++||||||+++|||++.. |... ......+..+ .
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T 3uzp_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 238 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred cccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc
Confidence 5432211 112234899999999999999999999999999999999732 2221 1122211111 1
Q ss_pred H-----HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHhhc
Q 008785 487 L-----LCAQECLMLFISCNNWPSHLSQSKFCNLKLWVFAILTI 525 (553)
Q Consensus 487 ~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~~~~~~ 525 (553)
. ..+..+.+++.+||+.||++|||+.++++.+...+.+.
T Consensus 239 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 282 (296)
T 3uzp_A 239 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 282 (296)
T ss_dssp HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHT
T ss_pred hHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhc
Confidence 1 34678999999999999999999999999887766554
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=351.63 Aligned_cols=242 Identities=24% Similarity=0.298 Sum_probs=195.9
Q ss_pred eeecccCceeEEEEEeCC----CCEEEEEEeccC-ChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCC
Q 008785 275 RLLGDSKTGGTYSGILPD----GSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 349 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~~----g~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 349 (553)
+.||+|+||.||+|.... +..||||.++.. .....+.+.+|+.++++++||||+++++++. ++..++||||+++
T Consensus 396 ~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~lv~E~~~~ 474 (656)
T 2j0j_A 396 RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTL 474 (656)
T ss_dssp EEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTT
T ss_pred eEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEEEEEcCCC
Confidence 456999999999999743 457999998764 3344578999999999999999999999984 4678999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccc
Q 008785 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE 429 (553)
Q Consensus 350 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 429 (553)
|+|.+++.. ....+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++.........
T Consensus 475 g~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~~~~ 548 (656)
T 2j0j_A 475 GELRSFLQV---RKFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYK 548 (656)
T ss_dssp CBHHHHHHH---TTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC-----
T ss_pred CcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCCeecCCCccee
Confidence 999999975 234589999999999999999999999 99999999999999999999999999998765443222
Q ss_pred eeeecCccccccccccccCCCCCcccchHhHHHHHHHHhc-C-cccccc---hHHHHHhcCCH-----HHHHHHHHHHhh
Q 008785 430 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-V-LCRRWW---TLYTLVHSMSL-----LCAQECLMLFIS 499 (553)
Q Consensus 430 ~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-~-~~~~~~---~l~~~~~~~~~-----~~~~~l~~l~~~ 499 (553)
.. ...+|+.|+|||++.+..++.++||||||+++|||++ . .|.... .+...+..+.. ..+..+.+++.+
T Consensus 549 ~~-~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~ 627 (656)
T 2j0j_A 549 AS-KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTK 627 (656)
T ss_dssp ------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCCCTTCCHHHHHHHHH
T ss_pred cc-CCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCccccHHHHHHHHH
Confidence 21 2236789999999998899999999999999999996 3 233222 23333333321 556789999999
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHhh
Q 008785 500 CNNWPSHLSQSKFCNLKLWVFAILT 524 (553)
Q Consensus 500 Cl~~dP~~RPs~~evl~~l~~~~~~ 524 (553)
||+.||++|||+.|+++.+...+.+
T Consensus 628 ~l~~dP~~RPs~~el~~~L~~il~~ 652 (656)
T 2j0j_A 628 CWAYDPSRRPRFTELKAQLSTILEE 652 (656)
T ss_dssp HTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HcCCChhHCcCHHHHHHHHHHHHHH
Confidence 9999999999999999998776544
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=321.10 Aligned_cols=246 Identities=22% Similarity=0.249 Sum_probs=188.2
Q ss_pred ccCCCCeeecccCceeEEEEEeC--CCC--EEEEEEeccC---ChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceE
Q 008785 269 NFSEGNRLLGDSKTGGTYSGILP--DGS--RVAVKRLKRS---SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRY 341 (553)
Q Consensus 269 ~~~~~~~~iG~G~~g~Vy~~~~~--~g~--~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 341 (553)
+|... +.||+|+||.||+|.+. +++ .||||+++.. .....+.+.+|+.++++++||||+++++++.+.. .+
T Consensus 19 ~y~~~-~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~ 96 (291)
T 1u46_A 19 DLRLL-EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK 96 (291)
T ss_dssp GEEEE-EECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred Heeee-eeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence 34443 45699999999999853 233 6999998754 2344678999999999999999999999988754 89
Q ss_pred EEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeecccccc
Q 008785 342 IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF 421 (553)
Q Consensus 342 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~ 421 (553)
+||||+++|+|.+++.. ....+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||++..
T Consensus 97 ~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 97 MVTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRA 170 (291)
T ss_dssp EEEECCTTCBHHHHHHH---HGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeEecccCCCHHHHHHh---ccCCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEcccccccc
Confidence 99999999999999975 234589999999999999999999999 999999999999999999999999999987
Q ss_pred CCcccccc-eeeecCccccccccccccCCCCCcccchHhHHHHHHHHhc-Cc-ccccc---hHHHHHhcCC------HHH
Q 008785 422 VPWEVMQE-RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-VL-CRRWW---TLYTLVHSMS------LLC 489 (553)
Q Consensus 422 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-~~-~~~~~---~l~~~~~~~~------~~~ 489 (553)
........ ......+|+.|+|||++.+..++.++||||||+++|||++ .. |.... .+...+.... ...
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (291)
T 1u46_A 171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDC 250 (291)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTC
T ss_pred ccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCCcCc
Confidence 65433221 1122237888999999988889999999999999999997 33 32222 2222222211 156
Q ss_pred HHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 008785 490 AQECLMLFISCNNWPSHLSQSKFCNLKLWVFAI 522 (553)
Q Consensus 490 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~~~ 522 (553)
+..+.+++.+||+.||++|||+.++++.+....
T Consensus 251 ~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 283 (291)
T 1u46_A 251 PQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 283 (291)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred CHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence 678999999999999999999999999876543
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=330.75 Aligned_cols=246 Identities=15% Similarity=0.118 Sum_probs=195.6
Q ss_pred ccCCCCeeecccCceeEEEEEeCC---------CCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceee----------
Q 008785 269 NFSEGNRLLGDSKTGGTYSGILPD---------GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVA---------- 329 (553)
Q Consensus 269 ~~~~~~~~iG~G~~g~Vy~~~~~~---------g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~---------- 329 (553)
+|... +.||+|+||.||+|.... ++.||||.+... +.+.+|+.++++++||||++
T Consensus 43 ~y~~~-~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 116 (352)
T 2jii_A 43 QWKLK-SFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL 116 (352)
T ss_dssp EEEEE-EEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred eEEEE-EEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence 34443 456999999999999764 789999999754 35789999999999999987
Q ss_pred -----EeeEEee-CCceEEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcE
Q 008785 330 -----VKGCCYD-HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNV 403 (553)
Q Consensus 330 -----l~~~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NI 403 (553)
+++++.. .+..++||||+ +++|.+++... ....+++..+..++.||+.||.|||++ +|+||||||+||
T Consensus 117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NI 190 (352)
T 2jii_A 117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS--PKHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAENI 190 (352)
T ss_dssp CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGGE
T ss_pred cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC--CcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHE
Confidence 6777776 67789999999 99999999752 235699999999999999999999999 999999999999
Q ss_pred EecCCC--CeEEeeccccccCCcccccc-----eeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcCc-cccc
Q 008785 404 LLDEEF--GAHLMGVGLSKFVPWEVMQE-----RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVL-CRRW 475 (553)
Q Consensus 404 Ll~~~~--~~kl~Dfgla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~-~~~~ 475 (553)
|++.++ .+||+|||+++......... ......||+.|+|||++.+..++.++||||||+++|||++.. |...
T Consensus 191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 270 (352)
T 2jii_A 191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN 270 (352)
T ss_dssp EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 999998 89999999998765432211 111224899999999999989999999999999999999733 3322
Q ss_pred c-----hHHHHH---hcCCH----------HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHhhcc
Q 008785 476 W-----TLYTLV---HSMSL----------LCAQECLMLFISCNNWPSHLSQSKFCNLKLWVFAILTIR 526 (553)
Q Consensus 476 ~-----~l~~~~---~~~~~----------~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~~~~~~~ 526 (553)
. .+.... ..... ..+..+.+++.+||+.||++|||+.++++.+...+....
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~ 339 (352)
T 2jii_A 271 CLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLR 339 (352)
T ss_dssp GTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred CCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcC
Confidence 1 122211 11110 236889999999999999999999999999887776553
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-39 Score=356.18 Aligned_cols=235 Identities=22% Similarity=0.227 Sum_probs=196.6
Q ss_pred eeecccCceeEEEEEeC-CCCEEEEEEeccCC---hhhHHHHHHHHHHhhcc-CCCceeeEeeEEeeCCceEEEEEccCC
Q 008785 275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVN 349 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~~ 349 (553)
++||+|+||.||++... +++.||||++++.. ....+.+..|..++..+ +||||+++++++.+.+..|+||||+++
T Consensus 347 ~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E~~~g 426 (674)
T 3pfq_A 347 MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNG 426 (674)
T ss_dssp EESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEECCCS
T ss_pred EEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEeCcCC
Confidence 45699999999999975 48899999997542 23346778899999988 799999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccc
Q 008785 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE 429 (553)
Q Consensus 350 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 429 (553)
|+|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++........
T Consensus 427 g~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~~- 498 (674)
T 3pfq_A 427 GDLMYHIQQV----GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT- 498 (674)
T ss_dssp CBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEECCCTTCC-
T ss_pred CcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeeccccCCcc-
Confidence 9999999752 3589999999999999999999999 9999999999999999999999999999864333222
Q ss_pred eeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcC-ccc---ccchHHHHHhcCCH----HHHHHHHHHHhhcc
Q 008785 430 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLV-LCR---RWWTLYTLVHSMSL----LCAQECLMLFISCN 501 (553)
Q Consensus 430 ~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~-~~~---~~~~l~~~~~~~~~----~~~~~l~~l~~~Cl 501 (553)
.....||+.|+|||++.+..++.++||||||+++|||++. .|. +...+.+.+..+.. ..+.++.+|+.+||
T Consensus 499 -~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL 577 (674)
T 3pfq_A 499 -TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLM 577 (674)
T ss_dssp -BCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCCTTSCHHHHHHHHHHS
T ss_pred -cccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHc
Confidence 2233499999999999999999999999999999999973 233 22334444444433 56778999999999
Q ss_pred CCCCCCCCCH-----HHHHHHH
Q 008785 502 NWPSHLSQSK-----FCNLKLW 518 (553)
Q Consensus 502 ~~dP~~RPs~-----~evl~~l 518 (553)
+.||++||++ .||+++-
T Consensus 578 ~~dP~~R~~~~~~~~~ei~~h~ 599 (674)
T 3pfq_A 578 TKHPGKRLGCGPEGERDIKEHA 599 (674)
T ss_dssp CSSSTTCTTCSTTHHHHHHSSG
T ss_pred cCCHHHCCCCCCCcHHHHhcCc
Confidence 9999999998 8888763
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-39 Score=329.07 Aligned_cols=239 Identities=18% Similarity=0.284 Sum_probs=196.1
Q ss_pred cccCCCCeeecccCceeEEEEEeCCCCEEEEEEeccCChhh-----------------HHHHHHHHHHhhccCCCceeeE
Q 008785 268 KNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQR-----------------KKEFYSEIGRFARLHHPNLVAV 330 (553)
Q Consensus 268 ~~~~~~~~~iG~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~-----------------~~~~~~E~~~l~~l~HpnIv~l 330 (553)
++|.... .||+|+||.||++.. +|+.||||.+....... .+.+.+|+.++++++||||+++
T Consensus 31 ~~y~~~~-~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 31 NDYRIIR-TLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp TTEEEEE-EEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred CceEEEE-EEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 3444444 459999999999999 99999999997542211 1789999999999999999999
Q ss_pred eeEEeeCCceEEEEEccCCCCHHHH------hccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCceecCCCCCcE
Q 008785 331 KGCCYDHGDRYIVYEFVVNGPLDRW------LHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD-KVKPHVVHRDIRASNV 403 (553)
Q Consensus 331 ~~~~~~~~~~~lV~E~~~~gsL~~~------l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~ivHrDlkp~NI 403 (553)
++++.+.+..++||||+++|+|.++ +.. .....+++..+..++.||+.||.|||+ . +|+||||||+||
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Ni 183 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK--NYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNI 183 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCS--SSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh--ccccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhE
Confidence 9999999999999999999999998 543 225679999999999999999999999 8 999999999999
Q ss_pred EecCCCCeEEeeccccccCCcccccceeeecCccccccccccccCC-CCCc-ccchHhHHHHHHHHhcCc-cccc----c
Q 008785 404 LLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRN-ELTT-KSDVYSFGVLLLEIRLVL-CRRW----W 476 (553)
Q Consensus 404 Ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~-ksDVwSlGvil~ell~~~-~~~~----~ 476 (553)
+++.++.+||+|||.+....... .....||+.|+|||++.+. .++. ++||||||+++|||++.. |... .
T Consensus 184 l~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 259 (348)
T 2pml_X 184 LMDKNGRVKLSDFGESEYMVDKK----IKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV 259 (348)
T ss_dssp EECTTSCEEECCCTTCEECBTTE----ECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH
T ss_pred EEcCCCcEEEecccccccccccc----ccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH
Confidence 99999999999999998654331 1223389999999999877 6666 999999999999999732 2221 3
Q ss_pred hHHHHHhcCCH-----------------------HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008785 477 TLYTLVHSMSL-----------------------LCAQECLMLFISCNNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 477 ~l~~~~~~~~~-----------------------~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 517 (553)
.+.+.+..+.. ..+..+.+++.+||+.||.+|||+.|++++
T Consensus 260 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 260 ELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp HHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 33333333321 346788999999999999999999999986
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=332.95 Aligned_cols=244 Identities=18% Similarity=0.155 Sum_probs=194.0
Q ss_pred ccCCCCeeecccCceeEEEEEe----CCCCEEEEEEeccCC----hhhHHHHHHHHHHhhcc-CCCceeeEeeEEeeCCc
Q 008785 269 NFSEGNRLLGDSKTGGTYSGIL----PDGSRVAVKRLKRSS----FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGD 339 (553)
Q Consensus 269 ~~~~~~~~iG~G~~g~Vy~~~~----~~g~~vAvK~~~~~~----~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~ 339 (553)
+|... +.||+|+||.||++.. .+|+.||||+++... ....+.+.+|+.+++++ +||||+++++++...+.
T Consensus 55 ~y~~~-~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 55 NFELL-KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GEEEE-EEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred ceEEE-EEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 44443 4569999999999997 368999999987532 22345677899999999 79999999999999999
Q ss_pred eEEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeecccc
Q 008785 340 RYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLS 419 (553)
Q Consensus 340 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla 419 (553)
.++||||+++|+|.+++.. ...+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 134 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a 206 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLS 206 (355)
T ss_dssp EEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred EEEEeecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCCC
Confidence 9999999999999999975 23589999999999999999999999 9999999999999999999999999999
Q ss_pred ccCCcccccceeeecCccccccccccccC--CCCCcccchHhHHHHHHHHhcCc-ccc----c---chHHHHHhcCCH--
Q 008785 420 KFVPWEVMQERTVMAGGTYGYLAPEFVYR--NELTTKSDVYSFGVLLLEIRLVL-CRR----W---WTLYTLVHSMSL-- 487 (553)
Q Consensus 420 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~t~ksDVwSlGvil~ell~~~-~~~----~---~~l~~~~~~~~~-- 487 (553)
+........... ...||+.|+|||++.+ ..++.++||||||+++|||++.. |.. . ..+...+.....
T Consensus 207 ~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 285 (355)
T 1vzo_A 207 KEFVADETERAY-DFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY 285 (355)
T ss_dssp EECCGGGGGGGC-GGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCC
T ss_pred eecccCCCCccc-CcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCC
Confidence 866543332222 2238999999999985 34789999999999999999732 221 1 112222211111
Q ss_pred --HHHHHHHHHHhhccCCCCCCCC-----CHHHHHHHHHHH
Q 008785 488 --LCAQECLMLFISCNNWPSHLSQ-----SKFCNLKLWVFA 521 (553)
Q Consensus 488 --~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~l~~~ 521 (553)
..+..+.+++.+||+.||++|| |+.|++++....
T Consensus 286 ~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~ 326 (355)
T 1vzo_A 286 PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQ 326 (355)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGT
T ss_pred CcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchh
Confidence 4567789999999999999999 999999886543
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=326.04 Aligned_cols=237 Identities=19% Similarity=0.257 Sum_probs=185.2
Q ss_pred cccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccC--ChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCC------
Q 008785 268 KNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHG------ 338 (553)
Q Consensus 268 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~------ 338 (553)
+.|... +.||+|+||.||+|... +|+.||||++... .....+.+.+|+.++++++||||+++++++...+
T Consensus 25 ~~y~~~-~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 25 AVYRDL-QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp SSEEEE-EEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred ceEEEe-EEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 344443 45699999999999974 5999999999653 3334577899999999999999999999998653
Q ss_pred ceEEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccc
Q 008785 339 DRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGL 418 (553)
Q Consensus 339 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgl 418 (553)
..|+||||+ +++|.+++.. ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 174 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL 174 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeec
Confidence 459999999 8899999975 3589999999999999999999999 999999999999999999999999999
Q ss_pred cccCCcccccceeeecCccccccccccccC-CCCCcccchHhHHHHHHHHhcCc-ccccchHHH----HHh-cCC-----
Q 008785 419 SKFVPWEVMQERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIRLVL-CRRWWTLYT----LVH-SMS----- 486 (553)
Q Consensus 419 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwSlGvil~ell~~~-~~~~~~l~~----~~~-~~~----- 486 (553)
++...... ....+|+.|+|||++.+ ..++.++|||||||++|||++.. +....+..+ .+. .|.
T Consensus 175 a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~ 249 (367)
T 1cm8_A 175 ARQADSEM-----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEF 249 (367)
T ss_dssp CEECCSSC-----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred cccccccc-----CcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 98754321 11238999999999887 67999999999999999999733 222221111 110 000
Q ss_pred -----------------------H-----HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 008785 487 -----------------------L-----LCAQECLMLFISCNNWPSHLSQSKFCNLKLWV 519 (553)
Q Consensus 487 -----------------------~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~ 519 (553)
+ ..+..+.+++.+||..||++|||+.|++++-.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~ 310 (367)
T 1cm8_A 250 VQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPY 310 (367)
T ss_dssp HHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred HHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChH
Confidence 0 23567899999999999999999999999743
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=332.31 Aligned_cols=242 Identities=21% Similarity=0.252 Sum_probs=187.2
Q ss_pred hcccCCCCeeecccCceeEEEEEe-CCCCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeEEeeC--------
Q 008785 267 TKNFSEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH-------- 337 (553)
Q Consensus 267 ~~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~-------- 337 (553)
.++|.... .||+|+||.||+|.. .+|+.||||++..... ...+|+.+++.++||||+++++++...
T Consensus 6 ~~~y~~~~-~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~ 80 (383)
T 3eb0_A 6 SKKYSLGK-TLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPP 80 (383)
T ss_dssp CTTEEEEE-EEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC--------
T ss_pred cceEEEEE-EEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccccc
Confidence 34454444 559999999999986 4689999999875422 224799999999999999999998543
Q ss_pred ------------------------------CceEEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 008785 338 ------------------------------GDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD 387 (553)
Q Consensus 338 ------------------------------~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~ 387 (553)
...++||||++ |+|.+.+.........+++..+..++.||+.||+|||+
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~ 159 (383)
T 3eb0_A 81 QPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS 159 (383)
T ss_dssp -----------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT
T ss_pred ccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 23789999997 58888776433345679999999999999999999999
Q ss_pred CCCCCceecCCCCCcEEec-CCCCeEEeeccccccCCcccccceeeecCccccccccccccCC-CCCcccchHhHHHHHH
Q 008785 388 KVKPHVVHRDIRASNVLLD-EEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLL 465 (553)
Q Consensus 388 ~~~~~ivHrDlkp~NILl~-~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwSlGvil~ 465 (553)
. +|+||||||+|||++ .++.+||+|||+++......... ...||+.|+|||++.+. .++.++||||||+++|
T Consensus 160 ~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ 233 (383)
T 3eb0_A 160 L---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSV---AYICSRFYRAPELMLGATEYTPSIDLWSIGCVFG 233 (383)
T ss_dssp T---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCC---CCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHH
T ss_pred C---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCc---CcccCCCccCHHHhcCCCCCCcchhhhhHHHHHH
Confidence 9 999999999999998 67899999999998664433221 22389999999998765 4899999999999999
Q ss_pred HHhcCc-ccccch----HHHHHh---c-----------------------CCH------HHHHHHHHHHhhccCCCCCCC
Q 008785 466 EIRLVL-CRRWWT----LYTLVH---S-----------------------MSL------LCAQECLMLFISCNNWPSHLS 508 (553)
Q Consensus 466 ell~~~-~~~~~~----l~~~~~---~-----------------------~~~------~~~~~l~~l~~~Cl~~dP~~R 508 (553)
||++.. +..... +...+. . ... ..+..+.+++.+||+.||.+|
T Consensus 234 ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 313 (383)
T 3eb0_A 234 ELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLR 313 (383)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGS
T ss_pred HHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhC
Confidence 999733 222221 111111 0 000 245668999999999999999
Q ss_pred CCHHHHHHHHHH
Q 008785 509 QSKFCNLKLWVF 520 (553)
Q Consensus 509 Ps~~evl~~l~~ 520 (553)
||+.|++++-..
T Consensus 314 ~t~~e~l~hp~f 325 (383)
T 3eb0_A 314 INPYEAMAHPFF 325 (383)
T ss_dssp CCHHHHHTSGGG
T ss_pred CCHHHHhcCHHH
Confidence 999999987443
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-38 Score=331.34 Aligned_cols=236 Identities=16% Similarity=0.189 Sum_probs=188.9
Q ss_pred ccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCChhhHHHHHHHHHHhhcc------CCCceeeEeeEEeeCCceE
Q 008785 269 NFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARL------HHPNLVAVKGCCYDHGDRY 341 (553)
Q Consensus 269 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l------~HpnIv~l~~~~~~~~~~~ 341 (553)
.|... +.||+|+||.||+|... +++.||||+++.. ......+.+|+.+++.+ +|+||+++++++...+..+
T Consensus 98 ry~~~-~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~ 175 (429)
T 3kvw_A 98 RYEVL-KVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHIC 175 (429)
T ss_dssp TEEEE-EEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEE
T ss_pred cEEEE-EEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEE
Confidence 34443 45699999999999865 4889999999764 33456677888888777 6789999999999999999
Q ss_pred EEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCC--eEEeecccc
Q 008785 342 IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG--AHLMGVGLS 419 (553)
Q Consensus 342 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~--~kl~Dfgla 419 (553)
+||||+. ++|.+++.. .....+++..+..++.||+.||+|||+. +|+||||||+|||++.++. +||+|||++
T Consensus 176 lv~e~~~-~~L~~~l~~--~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG~a 249 (429)
T 3kvw_A 176 MTFELLS-MNLYELIKK--NKFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSS 249 (429)
T ss_dssp EEECCCC-CBHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred EEEeccC-CCHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeecccc
Confidence 9999995 699999876 2334589999999999999999999999 9999999999999999887 999999999
Q ss_pred ccCCcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcCcc-cccch---HHH-HHhc---CC-----
Q 008785 420 KFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVLC-RRWWT---LYT-LVHS---MS----- 486 (553)
Q Consensus 420 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~~-~~~~~---l~~-~~~~---~~----- 486 (553)
....... ....||+.|+|||++.+..++.++|||||||++|||++..+ ....+ ... .+.. ..
T Consensus 250 ~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~ 324 (429)
T 3kvw_A 250 CYEHQRV-----YTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLD 324 (429)
T ss_dssp EETTCCC-----CSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred eecCCcc-----cccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHH
Confidence 7544321 12238999999999999999999999999999999997332 22111 111 1100 00
Q ss_pred ------------------------------------------------H------HHHHHHHHHHhhccCCCCCCCCCHH
Q 008785 487 ------------------------------------------------L------LCAQECLMLFISCNNWPSHLSQSKF 512 (553)
Q Consensus 487 ------------------------------------------------~------~~~~~l~~l~~~Cl~~dP~~RPs~~ 512 (553)
. ..+..+.+|+.+||+.||++|||+.
T Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~ 404 (429)
T 3kvw_A 325 ASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPG 404 (429)
T ss_dssp TBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred hhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHH
Confidence 0 1146688999999999999999999
Q ss_pred HHHHH
Q 008785 513 CNLKL 517 (553)
Q Consensus 513 evl~~ 517 (553)
|+|++
T Consensus 405 e~L~H 409 (429)
T 3kvw_A 405 QALRH 409 (429)
T ss_dssp HHHTS
T ss_pred HHhCC
Confidence 99986
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=326.66 Aligned_cols=251 Identities=25% Similarity=0.275 Sum_probs=185.1
Q ss_pred HHHHHhhcccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCc
Q 008785 261 EELRSITKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGD 339 (553)
Q Consensus 261 ~el~~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 339 (553)
++.....++|.....+ |+|+||.||+|... +|+.||||++.... .....+.+|+..++.++||||+++++++...+.
T Consensus 16 ~~~~~~~~~y~~~~~l-g~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~ 93 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMA-GQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGE 93 (360)
T ss_dssp HHHHHHHTTEEEC-----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECS
T ss_pred hhchhhccceEEEEEE-ecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhcccc
Confidence 4455666777766555 99999999999975 58999999986542 233456788888999999999999999976544
Q ss_pred -------eEEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHH--hCCCCCceecCCCCCcEEecC-CC
Q 008785 340 -------RYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLH--DKVKPHVVHRDIRASNVLLDE-EF 409 (553)
Q Consensus 340 -------~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH--~~~~~~ivHrDlkp~NILl~~-~~ 409 (553)
.++||||+++ +|.+.+.........+++..+..++.|++.||.||| +. +|+||||||+|||++. ++
T Consensus 94 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~ 169 (360)
T 3e3p_A 94 RDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADG 169 (360)
T ss_dssp SCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTT
T ss_pred ccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCC
Confidence 7899999976 555544432234556899999999999999999999 88 9999999999999997 89
Q ss_pred CeEEeeccccccCCcccccceeeecCccccccccccccCCC-CCcccchHhHHHHHHHHhcCc-ccccch---HHH-HHh
Q 008785 410 GAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNE-LTTKSDVYSFGVLLLEIRLVL-CRRWWT---LYT-LVH 483 (553)
Q Consensus 410 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~t~ksDVwSlGvil~ell~~~-~~~~~~---l~~-~~~ 483 (553)
.+||+|||+++......... ...||+.|+|||++.+.. ++.++||||||+++|||++.. |..... ... ...
T Consensus 170 ~~kl~Dfg~a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~ 246 (360)
T 3e3p_A 170 TLKLCDFGSAKKLSPSEPNV---AYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVR 246 (360)
T ss_dssp EEEECCCTTCBCCCTTSCCC---STTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred cEEEeeCCCceecCCCCCcc---cccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHH
Confidence 99999999998765433221 223899999999987654 899999999999999999732 222221 111 111
Q ss_pred ---cCC--------------------------------HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 008785 484 ---SMS--------------------------------LLCAQECLMLFISCNNWPSHLSQSKFCNLKLWVF 520 (553)
Q Consensus 484 ---~~~--------------------------------~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~ 520 (553)
... ...+..+.+++.+||+.||.+|||+.|++++-..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f 318 (360)
T 3e3p_A 247 VLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYF 318 (360)
T ss_dssp HHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGG
T ss_pred HcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccc
Confidence 000 0146789999999999999999999999998443
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=324.64 Aligned_cols=243 Identities=19% Similarity=0.227 Sum_probs=189.3
Q ss_pred cccCCCCeeecccCceeEEEEEe-CCCCEEEEEEeccCCh--hhHHHHHHHHHHhhccCCCceeeEeeEEeeC-------
Q 008785 268 KNFSEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSF--QRKKEFYSEIGRFARLHHPNLVAVKGCCYDH------- 337 (553)
Q Consensus 268 ~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~------- 337 (553)
++|.... .||+|+||.||+|.. .+|+.||||++..... .....+.+|+.++++++||||+++++++...
T Consensus 17 ~~y~~~~-~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 17 SKYEKLA-KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGEEEEE-ECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred cceeEEE-EEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 3454444 459999999999997 4689999999865432 2346788999999999999999999999874
Q ss_pred -CceEEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeec
Q 008785 338 -GDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGV 416 (553)
Q Consensus 338 -~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Df 416 (553)
+..++||||+++ +|.+.+.. ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+||
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Df 168 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADF 168 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred CceEEEEEeccCC-CHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccc
Confidence 457999999974 77777764 334599999999999999999999999 9999999999999999999999999
Q ss_pred cccccCCcccccc--eeeecCccccccccccccC-CCCCcccchHhHHHHHHHHhcCccc-ccc---hHHHHHhc--CC-
Q 008785 417 GLSKFVPWEVMQE--RTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIRLVLCR-RWW---TLYTLVHS--MS- 486 (553)
Q Consensus 417 gla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwSlGvil~ell~~~~~-~~~---~l~~~~~~--~~- 486 (553)
|+++......... ......||+.|+|||++.+ ..++.++||||||+++|||++..+. ... .....+.. +.
T Consensus 169 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~ 248 (351)
T 3mi9_A 169 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 248 (351)
T ss_dssp TTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred hhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 9998665322111 1122338999999999876 4589999999999999999973322 111 11111100 00
Q ss_pred --------------------------H-------HHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008785 487 --------------------------L-------LCAQECLMLFISCNNWPSHLSQSKFCNLKLW 518 (553)
Q Consensus 487 --------------------------~-------~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l 518 (553)
. ..+..+.+|+.+||+.||++|||+.|++++-
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 313 (351)
T 3mi9_A 249 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD 313 (351)
T ss_dssp CTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred ChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCC
Confidence 0 1145688999999999999999999999874
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-39 Score=338.75 Aligned_cols=244 Identities=20% Similarity=0.187 Sum_probs=183.1
Q ss_pred hcccCCCCeeecccCceeEEEEEeCCCCEEEEEEeccCChhhHHHHHHHHHHhhcc-CCCceeeEeeEEeeCCceEEEEE
Q 008785 267 TKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYE 345 (553)
Q Consensus 267 ~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E 345 (553)
.+++....++||+|+||+||.+...+|+.||||++... ..+.+.+|+.++.++ +||||+++++++.+.+..++|||
T Consensus 13 l~~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E 89 (434)
T 2rio_A 13 LKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALE 89 (434)
T ss_dssp CSSCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred hhheeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEe
Confidence 34455556778999999998766668999999998754 345678999999987 89999999999999999999999
Q ss_pred ccCCCCHHHHhccCCCCCCC---CCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCC-------------C
Q 008785 346 FVVNGPLDRWLHHIPRGGRS---LDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE-------------F 409 (553)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~---l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~-------------~ 409 (553)
|+. |+|.+++......... .++..+..++.||+.||+|||++ +|+||||||+|||++.+ +
T Consensus 90 ~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~ 165 (434)
T 2rio_A 90 LCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENL 165 (434)
T ss_dssp CCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSC
T ss_pred cCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCce
Confidence 995 6999999753221111 13334578999999999999999 99999999999999754 4
Q ss_pred CeEEeeccccccCCcccccc--eeeecCccccccccccccC-------CCCCcccchHhHHHHHHHHhc-Cc-ccccchH
Q 008785 410 GAHLMGVGLSKFVPWEVMQE--RTVMAGGTYGYLAPEFVYR-------NELTTKSDVYSFGVLLLEIRL-VL-CRRWWTL 478 (553)
Q Consensus 410 ~~kl~Dfgla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-------~~~t~ksDVwSlGvil~ell~-~~-~~~~~~l 478 (553)
.+||+|||+++......... ......||+.|+|||++.+ ..++.++|||||||++|||++ .. |......
T Consensus 166 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~ 245 (434)
T 2rio_A 166 RILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS 245 (434)
T ss_dssp EEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTT
T ss_pred EEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchh
Confidence 79999999998765443221 1122349999999999965 568999999999999999997 33 3222111
Q ss_pred --HHHHhcC----------CHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008785 479 --YTLVHSM----------SLLCAQECLMLFISCNNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 479 --~~~~~~~----------~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 517 (553)
...+... ....+..+.+++.+||+.||++|||+.|++++
T Consensus 246 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 296 (434)
T 2rio_A 246 RESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH 296 (434)
T ss_dssp HHHHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hHHHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence 1111110 11567889999999999999999999999975
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=314.87 Aligned_cols=242 Identities=20% Similarity=0.257 Sum_probs=196.5
Q ss_pred hhcccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCC--hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEE
Q 008785 266 ITKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYI 342 (553)
Q Consensus 266 ~~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 342 (553)
+.++|.... .||+|+||.||++... +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 20 ~~~~y~i~~-~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (287)
T 2wei_A 20 FAERYNIVC-MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (287)
T ss_dssp HHHHEEEEE-EEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred HhhcceeeE-EEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence 445565544 5599999999999975 68999999997542 3346789999999999999999999999999999999
Q ss_pred EEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCC---CCeEEeecccc
Q 008785 343 VYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE---FGAHLMGVGLS 419 (553)
Q Consensus 343 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~---~~~kl~Dfgla 419 (553)
||||+++++|.+++.. ...+++..+..++.||+.||.|||++ +++||||||+||+++.+ +.+||+|||++
T Consensus 99 v~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~ 171 (287)
T 2wei_A 99 VGELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (287)
T ss_dssp EECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred EEEccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCcc
Confidence 9999999999998864 23589999999999999999999999 99999999999999764 46999999999
Q ss_pred ccCCcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcC-ccccc---chHHHHHhcCCH--------
Q 008785 420 KFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLV-LCRRW---WTLYTLVHSMSL-------- 487 (553)
Q Consensus 420 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~-~~~~~---~~l~~~~~~~~~-------- 487 (553)
.......... ...||+.|+|||.+.+ .++.++||||||+++|+|++. .|... ..+...+..+..
T Consensus 172 ~~~~~~~~~~---~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (287)
T 2wei_A 172 TCFQQNTKMK---DRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWR 247 (287)
T ss_dssp GTBCCCSSCS---CHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGT
T ss_pred eeecCCCccc---cccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhh
Confidence 8654332211 1127899999998865 589999999999999999973 23222 233334433332
Q ss_pred HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 008785 488 LCAQECLMLFISCNNWPSHLSQSKFCNLKLWV 519 (553)
Q Consensus 488 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~ 519 (553)
..+..+.+++.+||+.||++|||+.|++++-.
T Consensus 248 ~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~ 279 (287)
T 2wei_A 248 TISDDAKDLIRKMLTFHPSLRITATQCLEHPW 279 (287)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHH
T ss_pred hcCHHHHHHHHHHcccChhhCcCHHHHhcCHH
Confidence 35678999999999999999999999998743
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=323.64 Aligned_cols=242 Identities=17% Similarity=0.212 Sum_probs=172.7
Q ss_pred hhcccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeEEee----CCce
Q 008785 266 ITKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD----HGDR 340 (553)
Q Consensus 266 ~~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~----~~~~ 340 (553)
+.++|....++||+|+||.||++... +|+.||||++.... ....+ ....++.++||||+++++++.. ....
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~e---~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-KARQE---VDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-HHHHH---HHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-HHHHH---HHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 45667766677899999999999976 58999999997542 22222 2233556799999999999876 3457
Q ss_pred EEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecC---CCCeEEeecc
Q 008785 341 YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE---EFGAHLMGVG 417 (553)
Q Consensus 341 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~---~~~~kl~Dfg 417 (553)
++||||+++|+|.+++.. .....+++..+..++.||+.||.|||++ +|+||||||+|||++. ++.+||+|||
T Consensus 102 ~lv~e~~~gg~L~~~l~~--~~~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg 176 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQE--RGDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFG 176 (336)
T ss_dssp EEEEECCTTEEHHHHHHT--C-CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred EEEEeccCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEeccc
Confidence 999999999999999975 3335699999999999999999999999 9999999999999976 4559999999
Q ss_pred ccccCCcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcCcccc-cch---H----HHHHhcCCH--
Q 008785 418 LSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVLCRR-WWT---L----YTLVHSMSL-- 487 (553)
Q Consensus 418 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~~~~-~~~---l----~~~~~~~~~-- 487 (553)
++......... ...||+.|+|||++.+..++.++||||||+++|||++..... ... . ...+..+..
T Consensus 177 ~~~~~~~~~~~----~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 252 (336)
T 3fhr_A 177 FAKETTQNALQ----TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGF 252 (336)
T ss_dssp TCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CC
T ss_pred cceeccccccc----cCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhcccccc
Confidence 99765433221 223899999999998888999999999999999999733222 111 1 111111111
Q ss_pred ------HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 008785 488 ------LCAQECLMLFISCNNWPSHLSQSKFCNLKLWVF 520 (553)
Q Consensus 488 ------~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~ 520 (553)
..+..+.+++.+||+.||++|||+.|++++-..
T Consensus 253 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~ 291 (336)
T 3fhr_A 253 PNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWI 291 (336)
T ss_dssp CTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHH
T ss_pred CchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccc
Confidence 456789999999999999999999999998544
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-39 Score=335.42 Aligned_cols=247 Identities=17% Similarity=0.230 Sum_probs=178.3
Q ss_pred cccCCCCeeecccCceeEEEEEeC---CCCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeEEee--CCceEE
Q 008785 268 KNFSEGNRLLGDSKTGGTYSGILP---DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD--HGDRYI 342 (553)
Q Consensus 268 ~~~~~~~~~iG~G~~g~Vy~~~~~---~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--~~~~~l 342 (553)
+.|....+.||+|+||.||+|... +++.||||++.... ....+.+|+.+|++++||||+++++++.. ....++
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l 97 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWL 97 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence 334444556799999999999965 47899999997653 23467899999999999999999999965 567899
Q ss_pred EEEccCCCCHHHHhccCC-----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEe----cCCCCeEE
Q 008785 343 VYEFVVNGPLDRWLHHIP-----RGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL----DEEFGAHL 413 (553)
Q Consensus 343 V~E~~~~gsL~~~l~~~~-----~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl----~~~~~~kl 413 (553)
||||++ |+|.+++.... .....+++..+..++.||+.||+|||++ +|+||||||+|||+ +.++.+||
T Consensus 98 v~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl 173 (405)
T 3rgf_A 98 LFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKI 173 (405)
T ss_dssp EEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred EEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEEE
Confidence 999996 58888775311 1223589999999999999999999999 99999999999999 67789999
Q ss_pred eeccccccCCccccc-ceeeecCccccccccccccCC-CCCcccchHhHHHHHHHHhcCccccc--------------ch
Q 008785 414 MGVGLSKFVPWEVMQ-ERTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIRLVLCRRW--------------WT 477 (553)
Q Consensus 414 ~Dfgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwSlGvil~ell~~~~~~~--------------~~ 477 (553)
+|||+++........ .......||+.|+|||++.+. .++.++|||||||++|||++..+... ..
T Consensus 174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~ 253 (405)
T 3rgf_A 174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQ 253 (405)
T ss_dssp CCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHH
T ss_pred EECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHH
Confidence 999999876543211 111223489999999999874 58999999999999999997332211 01
Q ss_pred HHHHHh---------------------------cC-----CH---------HHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 008785 478 LYTLVH---------------------------SM-----SL---------LCAQECLMLFISCNNWPSHLSQSKFCNLK 516 (553)
Q Consensus 478 l~~~~~---------------------------~~-----~~---------~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 516 (553)
+...+. .. .. ..+..+.+|+.+||+.||++|||+.|+|+
T Consensus 254 l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~ 333 (405)
T 3rgf_A 254 LDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 333 (405)
T ss_dssp HHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 111000 00 00 11567889999999999999999999999
Q ss_pred HHHH
Q 008785 517 LWVF 520 (553)
Q Consensus 517 ~l~~ 520 (553)
+-..
T Consensus 334 hp~f 337 (405)
T 3rgf_A 334 DPYF 337 (405)
T ss_dssp SGGG
T ss_pred Chhh
Confidence 8544
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=318.61 Aligned_cols=237 Identities=21% Similarity=0.239 Sum_probs=183.4
Q ss_pred eeecccCceeEEEEEeCC-CCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeEEe--------------eCCc
Q 008785 275 RLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY--------------DHGD 339 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~~-g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~--------------~~~~ 339 (553)
+.||+|+||.||+|...+ |+.||||++...+....+.+.+|+.++++++||||+++++++. +.+.
T Consensus 17 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~ 96 (320)
T 2i6l_A 17 KPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNS 96 (320)
T ss_dssp EECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CCSCSE
T ss_pred EEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccccccCc
Confidence 456999999999999765 8999999998777777788999999999999999999999874 3356
Q ss_pred eEEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEec-CCCCeEEeeccc
Q 008785 340 RYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD-EEFGAHLMGVGL 418 (553)
Q Consensus 340 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~-~~~~~kl~Dfgl 418 (553)
.++||||++ |+|.+++.. ..+++..+..++.|++.||+|||++ +|+||||||+||+++ +++.+||+|||+
T Consensus 97 ~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl~Dfg~ 167 (320)
T 2i6l_A 97 VYIVQEYME-TDLANVLEQ-----GPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGL 167 (320)
T ss_dssp EEEEEECCS-EEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEEEECCCTT
T ss_pred eeEEeeccC-CCHHHHhhc-----CCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeEEEccCcc
Confidence 799999997 699999853 4589999999999999999999999 999999999999997 567899999999
Q ss_pred cccCCcccccc-eeeecCccccccccccccC-CCCCcccchHhHHHHHHHHhcCc-ccccchHH---H-HHhcC------
Q 008785 419 SKFVPWEVMQE-RTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIRLVL-CRRWWTLY---T-LVHSM------ 485 (553)
Q Consensus 419 a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwSlGvil~ell~~~-~~~~~~l~---~-~~~~~------ 485 (553)
++......... ......+|+.|+|||.+.+ ..++.++||||||+++|||++.. |....... . .....
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 247 (320)
T 2i6l_A 168 ARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEE 247 (320)
T ss_dssp CBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHH
T ss_pred ccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCchh
Confidence 98764332111 1112237889999998865 67899999999999999999732 32222111 1 11100
Q ss_pred ----------------------CH-----HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 008785 486 ----------------------SL-----LCAQECLMLFISCNNWPSHLSQSKFCNLKLWVF 520 (553)
Q Consensus 486 ----------------------~~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~ 520 (553)
.. ..+..+.+++.+||+.||++|||+.|++++-..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~ 309 (320)
T 2i6l_A 248 DRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYM 309 (320)
T ss_dssp HHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHH
T ss_pred hhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCccc
Confidence 00 246779999999999999999999999987544
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-39 Score=321.39 Aligned_cols=242 Identities=19% Similarity=0.285 Sum_probs=175.5
Q ss_pred CeeecccCceeEEEEEeC-CCCEEEEEEeccCC-hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCC
Q 008785 274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP 351 (553)
Q Consensus 274 ~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gs 351 (553)
.+.||+|+||.||++... +++.||||.+.... ....+++.+|+.++++++||||+++++++...+..++||||+++|+
T Consensus 20 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 99 (303)
T 2vwi_A 20 QEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGS 99 (303)
T ss_dssp EEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEECCTTCB
T ss_pred hheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhccCCc
Confidence 445699999999999964 68999999987543 2345678899999999999999999999999999999999999999
Q ss_pred HHHHhccC----CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccc
Q 008785 352 LDRWLHHI----PRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM 427 (553)
Q Consensus 352 L~~~l~~~----~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 427 (553)
|.+++... ......+++..+..++.||+.||.|||++ +|+||||||+||+++.++.+||+|||++........
T Consensus 100 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 176 (303)
T 2vwi_A 100 VLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGD 176 (303)
T ss_dssp HHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHHHHHCC----
T ss_pred hHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccchheeccCCC
Confidence 99998631 11234589999999999999999999999 999999999999999999999999999876543321
Q ss_pred cc---eeeecCccccccccccccC-CCCCcccchHhHHHHHHHHhcCc-cccc---chHHH-HHhcCCH-----------
Q 008785 428 QE---RTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIRLVL-CRRW---WTLYT-LVHSMSL----------- 487 (553)
Q Consensus 428 ~~---~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwSlGvil~ell~~~-~~~~---~~l~~-~~~~~~~----------- 487 (553)
.. ......||+.|+|||++.+ ..++.++||||||+++|||++.. |... ..... .......
T Consensus 177 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (303)
T 2vwi_A 177 ITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEM 256 (303)
T ss_dssp -----------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC-----CC
T ss_pred ccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCccccccccchh
Confidence 11 1112238999999999875 56899999999999999999732 2221 11111 1111110
Q ss_pred --HHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008785 488 --LCAQECLMLFISCNNWPSHLSQSKFCNLKLW 518 (553)
Q Consensus 488 --~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l 518 (553)
..+..+.+++.+||+.||++|||+.|++++-
T Consensus 257 ~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~ 289 (303)
T 2vwi_A 257 LKKYGKSFRKMISLCLQKDPEKRPTAAELLRHK 289 (303)
T ss_dssp CCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTST
T ss_pred hhhhhHHHHHHHHHHccCChhhCcCHHHHhhCh
Confidence 3456789999999999999999999999853
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=325.83 Aligned_cols=243 Identities=20% Similarity=0.226 Sum_probs=191.8
Q ss_pred hcccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCC-hhhHHHHHHHHHHhhccCCCceeeEeeEEeeC-----Cc
Q 008785 267 TKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH-----GD 339 (553)
Q Consensus 267 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~-----~~ 339 (553)
..+|.... .||+|+||.||++... +++.||||++.... ....+.+.+|+.++++++||||+++++++... ..
T Consensus 26 ~~~y~~~~-~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 26 GPRYTNLS-YIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp TTTEEEEE-EEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred cccEEEEE-EeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 34454444 4599999999999965 58899999997543 33457889999999999999999999998765 36
Q ss_pred eEEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeecccc
Q 008785 340 RYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLS 419 (553)
Q Consensus 340 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla 419 (553)
.++||||++ |+|.+++.. ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 105 ~~iv~e~~~-~~L~~~l~~-----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a 175 (364)
T 3qyz_A 105 VYIVQDLME-TDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLA 175 (364)
T ss_dssp EEEEEECCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEcccC-cCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcce
Confidence 799999996 699999865 3589999999999999999999999 9999999999999999999999999999
Q ss_pred ccCCcccccce-eeecCccccccccccccCC-CCCcccchHhHHHHHHHHhcCc-ccccc---hHHH-HH---hcCCH--
Q 008785 420 KFVPWEVMQER-TVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIRLVL-CRRWW---TLYT-LV---HSMSL-- 487 (553)
Q Consensus 420 ~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~-~~t~ksDVwSlGvil~ell~~~-~~~~~---~l~~-~~---~~~~~-- 487 (553)
........... .....||+.|+|||++.+. .++.++||||||+++|||++.. |.... .... .. .....
T Consensus 176 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 255 (364)
T 3qyz_A 176 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 255 (364)
T ss_dssp EECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHH
T ss_pred EecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 87654432211 1122489999999987654 5899999999999999999732 22211 1111 11 00000
Q ss_pred -----------------------------HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 008785 488 -----------------------------LCAQECLMLFISCNNWPSHLSQSKFCNLKLWV 519 (553)
Q Consensus 488 -----------------------------~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~ 519 (553)
..+..+.+++.+||+.||++|||+.|++++-.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 316 (364)
T 3qyz_A 256 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPY 316 (364)
T ss_dssp HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGG
T ss_pred HHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcc
Confidence 23567899999999999999999999998743
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=329.59 Aligned_cols=233 Identities=12% Similarity=0.004 Sum_probs=170.6
Q ss_pred eeecccCceeEEEEEeC-CCCEEEEEEeccCCh---hhHHHHHHHHHHhhcc--CCCceeeEe-------eEEeeCC---
Q 008785 275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF---QRKKEFYSEIGRFARL--HHPNLVAVK-------GCCYDHG--- 338 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l--~HpnIv~l~-------~~~~~~~--- 338 (553)
+.||+|+||.||+|... +|+.||||+++.... ...+.+.+|+.+++.+ +||||++++ +++...+
T Consensus 68 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~~~~~ 147 (371)
T 3q60_A 68 EPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPP 147 (371)
T ss_dssp EEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEETTSCS
T ss_pred eeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecCCCCC
Confidence 45699999999999965 689999999987542 3356677885444444 699988755 5554432
Q ss_pred --------------ceEEEEEccCCCCHHHHhccCCCCCCCCCHHHH------HHHHHHHHHHHHHHHhCCCCCceecCC
Q 008785 339 --------------DRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMR------MKVATTLAQGIAFLHDKVKPHVVHRDI 398 (553)
Q Consensus 339 --------------~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~------~~i~~qia~gL~yLH~~~~~~ivHrDl 398 (553)
..++||||++ |+|.+++... +..+++..+ ..++.||+.||+|||++ +|+||||
T Consensus 148 ~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~---~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~ivHrDi 220 (371)
T 3q60_A 148 FAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL---DFVYVFRGDEGILALHILTAQLIRLAANLQSK---GLVHGHF 220 (371)
T ss_dssp SSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH---HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---TEEETTC
T ss_pred eeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh---ccccchhhhhhhhhHHHHHHHHHHHHHHHHHC---CCccCcC
Confidence 3799999998 8999999752 223444555 67889999999999999 9999999
Q ss_pred CCCcEEecCCCCeEEeeccccccCCcccccceeeecCccccccccccccC--CCCCcccchHhHHHHHHHHhcCc-cccc
Q 008785 399 RASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYR--NELTTKSDVYSFGVLLLEIRLVL-CRRW 475 (553)
Q Consensus 399 kp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~t~ksDVwSlGvil~ell~~~-~~~~ 475 (553)
||+|||++.++.+||+|||+++....... ...+|+.|+|||++.+ ..++.++||||||+++|||++.. |...
T Consensus 221 kp~NIll~~~~~~kL~DFG~a~~~~~~~~-----~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~ 295 (371)
T 3q60_A 221 TPDNLFIMPDGRLMLGDVSALWKVGTRGP-----ASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGL 295 (371)
T ss_dssp SGGGEEECTTSCEEECCGGGEEETTCEEE-----GGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTB
T ss_pred CHHHEEECCCCCEEEEecceeeecCCCcc-----CccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999999986643221 2227799999999987 67999999999999999999732 2222
Q ss_pred ch--HHHHH------h--cCCH------HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 008785 476 WT--LYTLV------H--SMSL------LCAQECLMLFISCNNWPSHLSQSKFCNLKLWV 519 (553)
Q Consensus 476 ~~--l~~~~------~--~~~~------~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~ 519 (553)
.. ....+ . .... ..+..+.+++.+||+.||++|||+.|++++-.
T Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 355 (371)
T 3q60_A 296 VTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPE 355 (371)
T ss_dssp CCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHH
T ss_pred cCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHH
Confidence 10 00000 0 0010 45678999999999999999999999998743
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=317.96 Aligned_cols=236 Identities=19% Similarity=0.212 Sum_probs=190.2
Q ss_pred ccCCCCeeecccCceeEEEEEe--CCCCEEEEEEeccCChhhHHHHHHHHHHhhccCCC------ceeeEeeEEeeCCce
Q 008785 269 NFSEGNRLLGDSKTGGTYSGIL--PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHP------NLVAVKGCCYDHGDR 340 (553)
Q Consensus 269 ~~~~~~~~iG~G~~g~Vy~~~~--~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hp------nIv~l~~~~~~~~~~ 340 (553)
+|... +.||+|+||.||++.. .+|+.||||+++.. ....+.+.+|+.+++.++|+ +|+++++++.+.+..
T Consensus 15 ~y~~~-~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~ 92 (339)
T 1z57_A 15 RYEIV-DTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHI 92 (339)
T ss_dssp TEEEE-EEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEE
T ss_pred ceEEE-EEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcE
Confidence 44443 4459999999999986 35889999999764 34457788999999988665 499999999999999
Q ss_pred EEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecC-------------
Q 008785 341 YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE------------- 407 (553)
Q Consensus 341 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~------------- 407 (553)
++||||+ +++|.+++.. .....+++..+..++.||+.||+|||++ +|+||||||+|||++.
T Consensus 93 ~lv~e~~-~~~l~~~l~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~ 166 (339)
T 1z57_A 93 CIVFELL-GLSTYDFIKE--NGFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKR 166 (339)
T ss_dssp EEEEECC-CCBHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC----C
T ss_pred EEEEcCC-CCCHHHHHHh--cCCCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCcccc
Confidence 9999999 8999999976 2334689999999999999999999999 9999999999999987
Q ss_pred ------CCCeEEeeccccccCCcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcC-cccccch---
Q 008785 408 ------EFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLV-LCRRWWT--- 477 (553)
Q Consensus 408 ------~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~-~~~~~~~--- 477 (553)
++.+||+|||++....... ....||+.|+|||++.+..++.++||||||+++|||++. .|....+
T Consensus 167 ~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 241 (339)
T 1z57_A 167 DERTLINPDIKVVDFGSATYDDEHH-----STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE 241 (339)
T ss_dssp EEEEESCCCEEECCCSSCEETTSCC-----CSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH
T ss_pred ccccccCCCceEeeCcccccCcccc-----ccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH
Confidence 6689999999997644321 122389999999999999999999999999999999973 2222211
Q ss_pred HHHHHhc--C----------------------------------------------CHHHHHHHHHHHhhccCCCCCCCC
Q 008785 478 LYTLVHS--M----------------------------------------------SLLCAQECLMLFISCNNWPSHLSQ 509 (553)
Q Consensus 478 l~~~~~~--~----------------------------------------------~~~~~~~l~~l~~~Cl~~dP~~RP 509 (553)
....+.. + ....+..+.+++.+||+.||.+||
T Consensus 242 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp 321 (339)
T 1z57_A 242 HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRI 321 (339)
T ss_dssp HHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred HHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccccc
Confidence 1111100 0 003467899999999999999999
Q ss_pred CHHHHHHH
Q 008785 510 SKFCNLKL 517 (553)
Q Consensus 510 s~~evl~~ 517 (553)
|+.|++++
T Consensus 322 t~~ell~h 329 (339)
T 1z57_A 322 TLREALKH 329 (339)
T ss_dssp CHHHHTTS
T ss_pred CHHHHhcC
Confidence 99999876
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-38 Score=321.73 Aligned_cols=243 Identities=20% Similarity=0.233 Sum_probs=190.1
Q ss_pred hcccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCC-hhhHHHHHHHHHHhhccCCCceeeEeeEEeeC-----Cc
Q 008785 267 TKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH-----GD 339 (553)
Q Consensus 267 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~-----~~ 339 (553)
.++|.... .||+|+||.||+|... +|+.||||+++... ......+.+|+.++++++||||+++++++... ..
T Consensus 10 ~~~y~~~~-~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 10 SSDFQLKS-LLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp CTTEEEEE-EEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred ccceEEee-EEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 34454444 4599999999999975 58899999997543 34456788999999999999999999988764 67
Q ss_pred eEEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeecccc
Q 008785 340 RYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLS 419 (553)
Q Consensus 340 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla 419 (553)
.++||||+. |+|.+++.. ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 89 ~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a 159 (353)
T 2b9h_A 89 VYIIQELMQ-TDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLA 159 (353)
T ss_dssp EEEEECCCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEeccC-ccHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEecccc
Confidence 899999996 699999865 3589999999999999999999999 9999999999999999999999999999
Q ss_pred ccCCcccccce--------eeecCccccccccccccC-CCCCcccchHhHHHHHHHHhcCc-ccccchHHH----H----
Q 008785 420 KFVPWEVMQER--------TVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIRLVL-CRRWWTLYT----L---- 481 (553)
Q Consensus 420 ~~~~~~~~~~~--------~~~~~gt~~y~aPE~~~~-~~~t~ksDVwSlGvil~ell~~~-~~~~~~l~~----~---- 481 (553)
........... .....||+.|+|||++.+ ..++.++||||||+++|||++.. +....+..+ .
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 239 (353)
T 2b9h_A 160 RIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGII 239 (353)
T ss_dssp EECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred cccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHh
Confidence 87654321111 111238999999998765 67899999999999999999733 222221111 0
Q ss_pred --------------------Hhc------CCH-----HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 008785 482 --------------------VHS------MSL-----LCAQECLMLFISCNNWPSHLSQSKFCNLKLWV 519 (553)
Q Consensus 482 --------------------~~~------~~~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~ 519 (553)
+.. ... ..+..+.+++.+||+.||++|||+.|++++-.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 308 (353)
T 2b9h_A 240 GTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPY 308 (353)
T ss_dssp CCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred CCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCcc
Confidence 000 000 34567889999999999999999999998743
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=321.10 Aligned_cols=242 Identities=20% Similarity=0.278 Sum_probs=189.7
Q ss_pred hcccCCCCeeecccCceeEEEEEe--CCCCEEEEEEeccCCh--hhHHHHHHHHHHhhcc---CCCceeeEeeEEe----
Q 008785 267 TKNFSEGNRLLGDSKTGGTYSGIL--PDGSRVAVKRLKRSSF--QRKKEFYSEIGRFARL---HHPNLVAVKGCCY---- 335 (553)
Q Consensus 267 ~~~~~~~~~~iG~G~~g~Vy~~~~--~~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l---~HpnIv~l~~~~~---- 335 (553)
.++|.... .||+|+||.||++.. .+|+.||||+++.... .....+.+|+.+++.+ +||||+++++++.
T Consensus 10 ~~~y~~~~-~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 10 DQQYECVA-EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGTEEEEE-EEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred hhceeeee-eecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 34555544 459999999999997 3588999999875322 1223566777777666 8999999999987
Q ss_pred -eCCceEEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEe
Q 008785 336 -DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLM 414 (553)
Q Consensus 336 -~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~ 414 (553)
.....++||||++ |+|.+++... ....+++..+..++.||+.||.|||+. ||+||||||+||+++.++.+||+
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~ 162 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLA 162 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHS--CTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEe
Confidence 4566899999997 6999999763 334589999999999999999999999 99999999999999999999999
Q ss_pred eccccccCCcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcCc-ccccch---HHH-HHhc-C---
Q 008785 415 GVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVL-CRRWWT---LYT-LVHS-M--- 485 (553)
Q Consensus 415 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~-~~~~~~---l~~-~~~~-~--- 485 (553)
|||++......... ....||+.|+|||++.+..++.++||||||+++|||++.. +..... ... .+.. +
T Consensus 163 Dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~ 239 (326)
T 1blx_A 163 DFGLARIYSFQMAL---TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG 239 (326)
T ss_dssp SCCSCCCCCGGGGG---CCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred cCcccccccCCCCc---cccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence 99999876543221 1223899999999999999999999999999999999733 222211 111 1110 0
Q ss_pred ---------------------C-----HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008785 486 ---------------------S-----LLCAQECLMLFISCNNWPSHLSQSKFCNLKLW 518 (553)
Q Consensus 486 ---------------------~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l 518 (553)
. ...+..+.+++.+||+.||++|||+.|++++-
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp 298 (326)
T 1blx_A 240 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHP 298 (326)
T ss_dssp GGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred cccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCc
Confidence 0 03466788999999999999999999999864
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-38 Score=330.79 Aligned_cols=236 Identities=22% Similarity=0.263 Sum_probs=183.6
Q ss_pred CeeecccCceeEEEEEeC-CCCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCC------ceEEEEEc
Q 008785 274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHG------DRYIVYEF 346 (553)
Q Consensus 274 ~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~------~~~lV~E~ 346 (553)
.++||+|+||.||+|... +|+.||||++..... ...+|+++|++++||||+++++++...+ ..++||||
T Consensus 59 ~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~ 134 (420)
T 1j1b_A 59 TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDY 134 (420)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEEC
T ss_pred eeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehhc
Confidence 345699999999999975 589999999975422 2347999999999999999999986432 26799999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCC-CCeEEeeccccccCCcc
Q 008785 347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE-FGAHLMGVGLSKFVPWE 425 (553)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~-~~~kl~Dfgla~~~~~~ 425 (553)
+++ +|.+.+.........+++..+..++.||+.||+|||++ +|+||||||+|||++.+ +.+||+|||+++.....
T Consensus 135 ~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~ 210 (420)
T 1j1b_A 135 VPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 210 (420)
T ss_dssp CCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred ccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhhhhcccC
Confidence 975 67666653323446799999999999999999999999 99999999999999965 56899999999866443
Q ss_pred cccceeeecCccccccccccccCC-CCCcccchHhHHHHHHHHhcCc-ccccch----HHHHHhc-C-------------
Q 008785 426 VMQERTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIRLVL-CRRWWT----LYTLVHS-M------------- 485 (553)
Q Consensus 426 ~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwSlGvil~ell~~~-~~~~~~----l~~~~~~-~------------- 485 (553)
.... ...||+.|+|||++.+. .++.++|||||||++|||++.. +....+ +.+.++. |
T Consensus 211 ~~~~---~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~ 287 (420)
T 1j1b_A 211 EPNV---SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 287 (420)
T ss_dssp CCCC---SCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSC
T ss_pred CCce---eeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChh
Confidence 2211 22389999999998764 7899999999999999999733 222221 2221110 0
Q ss_pred ------------CH------HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 008785 486 ------------SL------LCAQECLMLFISCNNWPSHLSQSKFCNLKLWVF 520 (553)
Q Consensus 486 ------------~~------~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~ 520 (553)
.. ..+..+.+|+.+||..||++|||+.|++++-..
T Consensus 288 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f 340 (420)
T 1j1b_A 288 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 340 (420)
T ss_dssp CCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred hhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhh
Confidence 00 225679999999999999999999999988544
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=328.74 Aligned_cols=236 Identities=20% Similarity=0.269 Sum_probs=183.4
Q ss_pred CeeecccCceeEEEEEeCCCCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCc------eEEEEEcc
Q 008785 274 NRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGD------RYIVYEFV 347 (553)
Q Consensus 274 ~~~iG~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~------~~lV~E~~ 347 (553)
.++||+|+||.||+|...++..||+|++...... ..+|+.+++.++||||+++++++...+. .++||||+
T Consensus 45 ~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~ 120 (394)
T 4e7w_A 45 CKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYV 120 (394)
T ss_dssp EEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEECC
T ss_pred eEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEeecc
Confidence 3456999999999999877777999998654221 2369999999999999999999976543 78999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEec-CCCCeEEeeccccccCCccc
Q 008785 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD-EEFGAHLMGVGLSKFVPWEV 426 (553)
Q Consensus 348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~-~~~~~kl~Dfgla~~~~~~~ 426 (553)
+++ +.+.+.........+++..+..++.||+.||+|||++ +|+||||||+|||++ .++.+||+|||+++......
T Consensus 121 ~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~ 196 (394)
T 4e7w_A 121 PET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGE 196 (394)
T ss_dssp SEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTC
T ss_pred Ccc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCC
Confidence 765 4443332222345699999999999999999999999 999999999999999 78999999999998764433
Q ss_pred ccceeeecCccccccccccccCC-CCCcccchHhHHHHHHHHhcCc-ccccch----HHHHHhc-C--------------
Q 008785 427 MQERTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIRLVL-CRRWWT----LYTLVHS-M-------------- 485 (553)
Q Consensus 427 ~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwSlGvil~ell~~~-~~~~~~----l~~~~~~-~-------------- 485 (553)
... ...||+.|+|||++.+. .++.++|||||||++|||++.. |....+ +...++. |
T Consensus 197 ~~~---~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~ 273 (394)
T 4e7w_A 197 PNV---SYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNY 273 (394)
T ss_dssp CCC---SSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGG
T ss_pred CCc---ccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhh
Confidence 221 22389999999998765 5899999999999999999733 332222 1111110 0
Q ss_pred -----------CH------HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 008785 486 -----------SL------LCAQECLMLFISCNNWPSHLSQSKFCNLKLWVF 520 (553)
Q Consensus 486 -----------~~------~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~ 520 (553)
.+ ..+..+.+|+.+||+.||++|||+.|++++-..
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f 325 (394)
T 4e7w_A 274 MEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFF 325 (394)
T ss_dssp SSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGG
T ss_pred hhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhh
Confidence 00 245689999999999999999999999987443
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-38 Score=323.31 Aligned_cols=239 Identities=19% Similarity=0.269 Sum_probs=175.4
Q ss_pred hcccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccC--ChhhHHHHHHHHHHhhccCCCceeeEeeEEeeC------
Q 008785 267 TKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH------ 337 (553)
Q Consensus 267 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~------ 337 (553)
.++|... +.||+|+||.||+|... +|+.||||++... .....+.+.+|+.+++.++||||+++++++...
T Consensus 28 ~~~y~~~-~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 28 PERYQNL-SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp ETTEEEE-EECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CCceEEe-eEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence 3445444 44599999999999854 5889999999753 334567888999999999999999999998754
Q ss_pred CceEEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeecc
Q 008785 338 GDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVG 417 (553)
Q Consensus 338 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg 417 (553)
...++|+||+ +++|.+++.. ..+++..+..++.||+.||+|||+. ||+||||||+|||++.++.+||+|||
T Consensus 107 ~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG 177 (367)
T 2fst_X 107 NDVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFG 177 (367)
T ss_dssp CCCEEEEECC-CEECC----------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC--
T ss_pred CeEEEEeccc-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeecc
Confidence 5679999999 7899988853 4589999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCcccccceeeecCccccccccccccC-CCCCcccchHhHHHHHHHHhcCc-ccccchHH---HH-Hh---cC---
Q 008785 418 LSKFVPWEVMQERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIRLVL-CRRWWTLY---TL-VH---SM--- 485 (553)
Q Consensus 418 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwSlGvil~ell~~~-~~~~~~l~---~~-~~---~~--- 485 (553)
+++...... ....||+.|+|||++.+ ..++.++|||||||++|||++.. +....+.. .. .+ ..
T Consensus 178 ~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~ 252 (367)
T 2fst_X 178 LARHTADEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 252 (367)
T ss_dssp ------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHH
T ss_pred ccccccccC-----CCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 998654321 11238999999999877 67899999999999999999733 22222111 11 00 00
Q ss_pred -----------------------CH-----HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 008785 486 -----------------------SL-----LCAQECLMLFISCNNWPSHLSQSKFCNLKLWVF 520 (553)
Q Consensus 486 -----------------------~~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~ 520 (553)
.+ ..+..+.+|+.+||..||++|||+.|++++-..
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~ 315 (367)
T 2fst_X 253 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 315 (367)
T ss_dssp HHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred HHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhh
Confidence 00 124568999999999999999999999987443
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=319.65 Aligned_cols=244 Identities=17% Similarity=0.211 Sum_probs=189.5
Q ss_pred cccCCCCeeecccCceeEEEEEeCCCCEEEEEEeccC--ChhhHHHHHHHHHHhhccC--CCceeeEeeEEeeCCceEEE
Q 008785 268 KNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLH--HPNLVAVKGCCYDHGDRYIV 343 (553)
Q Consensus 268 ~~~~~~~~~iG~G~~g~Vy~~~~~~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~--HpnIv~l~~~~~~~~~~~lV 343 (553)
++|.... .||+|+||.||++...+++.||||++... .....+.+.+|+.++.+++ ||||+++++++.+.+..++|
T Consensus 28 ~~y~~~~-~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 106 (313)
T 3cek_A 28 RIYSILK-QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 106 (313)
T ss_dssp EEEEEEE-EEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEE
T ss_pred ceEEEEE-EecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEE
Confidence 3454444 55999999999999988999999999754 3445678899999999997 59999999999999999999
Q ss_pred EEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCC
Q 008785 344 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVP 423 (553)
Q Consensus 344 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~ 423 (553)
|| +.+++|.+++.. ...+++..+..++.||+.||.|||++ +|+||||||+|||+++ +.+||+|||++....
T Consensus 107 ~e-~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~ 177 (313)
T 3cek_A 107 ME-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDFGIANQMQ 177 (313)
T ss_dssp EC-CCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCCSSSCC--
T ss_pred Ee-cCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeecccccccc
Confidence 99 568899999975 24689999999999999999999999 9999999999999965 799999999998765
Q ss_pred cccccceeeecCccccccccccccC-----------CCCCcccchHhHHHHHHHHhcCc-cccc--ch---HHHHHhcCC
Q 008785 424 WEVMQERTVMAGGTYGYLAPEFVYR-----------NELTTKSDVYSFGVLLLEIRLVL-CRRW--WT---LYTLVHSMS 486 (553)
Q Consensus 424 ~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~t~ksDVwSlGvil~ell~~~-~~~~--~~---l~~~~~~~~ 486 (553)
............||+.|+|||.+.+ ..++.++||||||+++|||++.. |... .. +...+....
T Consensus 178 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 257 (313)
T 3cek_A 178 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNH 257 (313)
T ss_dssp ------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTS
T ss_pred CccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhccc
Confidence 4432222222348999999999865 46889999999999999999733 2221 11 111222111
Q ss_pred H-----HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 008785 487 L-----LCAQECLMLFISCNNWPSHLSQSKFCNLKLWVFA 521 (553)
Q Consensus 487 ~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~~ 521 (553)
. ..+..+.+++.+||+.||++|||+.|++++-...
T Consensus 258 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~ 297 (313)
T 3cek_A 258 EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 297 (313)
T ss_dssp CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred ccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCcccc
Confidence 1 3356789999999999999999999999876543
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=322.25 Aligned_cols=246 Identities=18% Similarity=0.264 Sum_probs=189.6
Q ss_pred cccCCCCeeecccCceeEEEEEeCCCCEEEEEEeccCC--hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEE
Q 008785 268 KNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYE 345 (553)
Q Consensus 268 ~~~~~~~~~iG~G~~g~Vy~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 345 (553)
++|.... .||+|+||.||+|...+ .||+|+++... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 33 ~~~~~~~-~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e 109 (319)
T 2y4i_B 33 EQLEIGE-LIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITS 109 (319)
T ss_dssp SCEECCC-BCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECB
T ss_pred HHeEEee-EeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEee
Confidence 3444444 45999999999999743 49999987542 2234567889999999999999999999999999999999
Q ss_pred ccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcc
Q 008785 346 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE 425 (553)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~ 425 (553)
|+++++|.+++.. ....+++..+..++.||+.||+|||++ +|+||||||+||+++ ++.+||+|||++......
T Consensus 110 ~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~ 182 (319)
T 2y4i_B 110 LCKGRTLYSVVRD---AKIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFSISGVL 182 (319)
T ss_dssp CCCSEEHHHHTTS---SCCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC-----
T ss_pred cccCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCccccccc
Confidence 9999999999964 334689999999999999999999999 999999999999998 679999999998765322
Q ss_pred cc---cceeeecCccccccccccccC---------CCCCcccchHhHHHHHHHHhcC-cccccc---hHHHHHhcCCH--
Q 008785 426 VM---QERTVMAGGTYGYLAPEFVYR---------NELTTKSDVYSFGVLLLEIRLV-LCRRWW---TLYTLVHSMSL-- 487 (553)
Q Consensus 426 ~~---~~~~~~~~gt~~y~aPE~~~~---------~~~t~ksDVwSlGvil~ell~~-~~~~~~---~l~~~~~~~~~-- 487 (553)
.. ........||+.|+|||++.+ ..++.++||||||+++|||++. .|.... .+...+..+..
T Consensus 183 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 262 (319)
T 2y4i_B 183 QAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPN 262 (319)
T ss_dssp -----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCC
T ss_pred cccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCC
Confidence 11 111122338999999999864 4578999999999999999973 333222 22222322221
Q ss_pred ----HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHh
Q 008785 488 ----LCAQECLMLFISCNNWPSHLSQSKFCNLKLWVFAIL 523 (553)
Q Consensus 488 ----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~~~~ 523 (553)
..+..+.+++.+||+.||++|||+.++++.+.....
T Consensus 263 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~ 302 (319)
T 2y4i_B 263 LSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPK 302 (319)
T ss_dssp CCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC--
T ss_pred CCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 356678999999999999999999999998755433
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=322.05 Aligned_cols=238 Identities=19% Similarity=0.266 Sum_probs=188.1
Q ss_pred hcccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccC--ChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCce---
Q 008785 267 TKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR--- 340 (553)
Q Consensus 267 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~--- 340 (553)
.++|... +.||+|+||.||+|... +|+.||||++... .....+.+.+|+.++++++||||+++++++...+..
T Consensus 41 ~~~y~~~-~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 41 PKTYVSP-THVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp ETTEEEE-EEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred cccEEEE-eEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 3445444 44699999999999965 5899999999764 333457889999999999999999999999877655
Q ss_pred ---EEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeecc
Q 008785 341 ---YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVG 417 (553)
Q Consensus 341 ---~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg 417 (553)
++||||+. ++|.+++. ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||
T Consensus 120 ~~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg 189 (371)
T 4exu_A 120 YDFYLVMPFMQ-TDLQKIMG------MEFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFG 189 (371)
T ss_dssp CCCEEEEECCC-EEHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTT
T ss_pred eeEEEEEcccc-ccHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecC
Confidence 99999996 68988774 2489999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCcccccceeeecCccccccccccccC-CCCCcccchHhHHHHHHHHhcC-cccccchHHH----HHh---c----
Q 008785 418 LSKFVPWEVMQERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIRLV-LCRRWWTLYT----LVH---S---- 484 (553)
Q Consensus 418 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwSlGvil~ell~~-~~~~~~~l~~----~~~---~---- 484 (553)
+++...... ....||+.|+|||++.+ ..++.++||||||+++|||++. .|....+..+ .+. .
T Consensus 190 ~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 264 (371)
T 4exu_A 190 LARHADAEM-----TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTE 264 (371)
T ss_dssp CC-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHH
T ss_pred cccccccCc-----CCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHH
Confidence 998654321 12238999999999887 6789999999999999999973 3332222111 110 0
Q ss_pred ----------------------CCH-----HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 008785 485 ----------------------MSL-----LCAQECLMLFISCNNWPSHLSQSKFCNLKLWVF 520 (553)
Q Consensus 485 ----------------------~~~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~ 520 (553)
..+ ..+..+.+|+.+||+.||++|||+.|++++-..
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f 327 (371)
T 4exu_A 265 FVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFF 327 (371)
T ss_dssp HHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGG
T ss_pred HHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCccc
Confidence 000 235788999999999999999999999988443
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=321.95 Aligned_cols=238 Identities=17% Similarity=0.152 Sum_probs=187.3
Q ss_pred cccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCChhhHHHHHHHHHHhhccC--------CCceeeEeeEEe---
Q 008785 268 KNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLH--------HPNLVAVKGCCY--- 335 (553)
Q Consensus 268 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~--------HpnIv~l~~~~~--- 335 (553)
++|... +.||+|+||.||+|... +++.||||+++.. ....+.+.+|+.++++++ ||||+++++++.
T Consensus 37 ~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 37 GRYHVI-RKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTEEEE-EEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CeEEEE-EEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 344443 44699999999999864 5889999999754 345677889999999985 788999999988
Q ss_pred -eCCceEEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCC-----
Q 008785 336 -DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF----- 409 (553)
Q Consensus 336 -~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~----- 409 (553)
+....++||||+ +++|.+++.. .....+++..+..++.||+.||+|||+++ +|+||||||+|||++.++
T Consensus 115 ~~~~~~~lv~e~~-~~~l~~~~~~--~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~~~ 189 (397)
T 1wak_A 115 VNGTHICMVFEVL-GHHLLKWIIK--SNYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRR 189 (397)
T ss_dssp TTEEEEEEEECCC-CCBHHHHHHH--TTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHHHH
T ss_pred CCCceEEEEEecc-CccHHHHHHh--cccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhhhh
Confidence 455789999999 6677676654 23356999999999999999999999852 899999999999998775
Q ss_pred --------------------------------------------CeEEeeccccccCCcccccceeeecCcccccccccc
Q 008785 410 --------------------------------------------GAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEF 445 (553)
Q Consensus 410 --------------------------------------------~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~ 445 (553)
.+||+|||++........ ...||+.|+|||+
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~~-----~~~gt~~y~aPE~ 264 (397)
T 1wak_A 190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFT-----EDIQTRQYRSLEV 264 (397)
T ss_dssp HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCSC-----SCCSCGGGCCHHH
T ss_pred hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccCc-----cCCCCCcccCChh
Confidence 799999999986643311 1238999999999
Q ss_pred ccCCCCCcccchHhHHHHHHHHhcCc-cccc---c------hHHH----HHhc---------------------------
Q 008785 446 VYRNELTTKSDVYSFGVLLLEIRLVL-CRRW---W------TLYT----LVHS--------------------------- 484 (553)
Q Consensus 446 ~~~~~~t~ksDVwSlGvil~ell~~~-~~~~---~------~l~~----~~~~--------------------------- 484 (553)
+.+..++.++|||||||++|||++.. |... . .... ....
T Consensus 265 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (397)
T 1wak_A 265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITK 344 (397)
T ss_dssp HHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCC
T ss_pred hcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccc
Confidence 99999999999999999999999732 2211 0 0000 0000
Q ss_pred ---------------CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008785 485 ---------------MSLLCAQECLMLFISCNNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 485 ---------------~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 517 (553)
.....+..+.+|+.+||+.||++|||+.|++++
T Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 345 LKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp CCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred cCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 011456778999999999999999999999975
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-37 Score=328.50 Aligned_cols=248 Identities=18% Similarity=0.214 Sum_probs=195.5
Q ss_pred cccCCCCeeecccCceeEEEEEe-CCCCEEEEEEeccCChhhHHHHHHHHHHhhccCC-CceeeEeeEEeeCCceEEEEE
Q 008785 268 KNFSEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHH-PNLVAVKGCCYDHGDRYIVYE 345 (553)
Q Consensus 268 ~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H-pnIv~l~~~~~~~~~~~lV~E 345 (553)
++|..... ||+|+||.||+|.. .+++.||||++..... ..++.+|+.+++.++| ++|..+..++.+.+..+||||
T Consensus 7 ~~y~i~~~-LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 7 NKFRLGRK-IGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTEECCCC-CEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CcEEEEEE-EeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 45555454 59999999999996 4689999999875432 2357889999999976 566666677777888899999
Q ss_pred ccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEe---cCCCCeEEeeccccccC
Q 008785 346 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL---DEEFGAHLMGVGLSKFV 422 (553)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl---~~~~~~kl~Dfgla~~~ 422 (553)
|+ +++|.+++.. ....+++..++.|+.||+.||.|||++ +|+||||||+|||+ +.++.+||+|||+++..
T Consensus 84 ~~-g~sL~~ll~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (483)
T 3sv0_A 84 LL-GPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (483)
T ss_dssp CC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred CC-CCCHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcceec
Confidence 99 9999999975 234699999999999999999999999 99999999999999 68899999999999876
Q ss_pred Ccccccc-----eeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcC-ccccc---c---hHHHHHhc----CC
Q 008785 423 PWEVMQE-----RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLV-LCRRW---W---TLYTLVHS----MS 486 (553)
Q Consensus 423 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~-~~~~~---~---~l~~~~~~----~~ 486 (553)
....... ......||+.|+|||++.+..++.++||||||+++|||++. .|... . .....+.. ..
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (483)
T 3sv0_A 157 RDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATS 236 (483)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSC
T ss_pred cCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccccc
Confidence 5433211 11123489999999999999999999999999999999972 22221 1 11111111 11
Q ss_pred H-----HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHhhc
Q 008785 487 L-----LCAQECLMLFISCNNWPSHLSQSKFCNLKLWVFAILTI 525 (553)
Q Consensus 487 ~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~~~~~~ 525 (553)
. ..+.++.+++..||+.||++||++.+|++.+...+...
T Consensus 237 ~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~ 280 (483)
T 3sv0_A 237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIRE 280 (483)
T ss_dssp HHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred HHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHc
Confidence 1 34568999999999999999999999999887776544
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=326.27 Aligned_cols=233 Identities=22% Similarity=0.233 Sum_probs=177.1
Q ss_pred eeecccCceeEEEEEeCCCCEEEEEEeccCChhhHHHHHHHHHHhhcc-CCCceeeEeeEEeeCCceEEEEEccCCCCHH
Q 008785 275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 353 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~ 353 (553)
++||+|+||+||.....+|+.||||++..... ..+.+|+.+|+++ +||||+++++++.+.+..|+||||+. |+|.
T Consensus 30 ~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g~L~ 105 (432)
T 3p23_A 30 DVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQ 105 (432)
T ss_dssp EEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-EEHH
T ss_pred CeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-CCHH
Confidence 45699999996655556899999999975432 2356899999999 79999999999999999999999995 6999
Q ss_pred HHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecC-----CCCeEEeeccccccCCccccc
Q 008785 354 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE-----EFGAHLMGVGLSKFVPWEVMQ 428 (553)
Q Consensus 354 ~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~-----~~~~kl~Dfgla~~~~~~~~~ 428 (553)
+++... .....+..+..++.||+.||.|||+. +|+||||||+|||++. ...+||+|||+++........
T Consensus 106 ~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~ 179 (432)
T 3p23_A 106 EYVEQK---DFAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHS 179 (432)
T ss_dssp HHHHSS---SCCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC------
T ss_pred HHHHhc---CCCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcc
Confidence 999752 22344456678999999999999999 9999999999999953 346889999999876543221
Q ss_pred -ceeeecCcccccccccccc---CCCCCcccchHhHHHHHHHHhc-CcccccchHHH----HHhcCCH-------HHHHH
Q 008785 429 -ERTVMAGGTYGYLAPEFVY---RNELTTKSDVYSFGVLLLEIRL-VLCRRWWTLYT----LVHSMSL-------LCAQE 492 (553)
Q Consensus 429 -~~~~~~~gt~~y~aPE~~~---~~~~t~ksDVwSlGvil~ell~-~~~~~~~~l~~----~~~~~~~-------~~~~~ 492 (553)
.......||+.|+|||++. ...++.++|||||||++|||++ ..+........ ....... .....
T Consensus 180 ~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (432)
T 3p23_A 180 FSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHEDVI 259 (432)
T ss_dssp ------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTTSCTTCHHHHH
T ss_pred eeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCccccCccccccHH
Confidence 1122234999999999997 4567889999999999999998 33332222111 1111111 55667
Q ss_pred HHHHHhhccCCCCCCCCCHHHHHHH
Q 008785 493 CLMLFISCNNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 493 l~~l~~~Cl~~dP~~RPs~~evl~~ 517 (553)
+.+++.+||+.||++|||+.|++++
T Consensus 260 ~~~li~~~L~~dP~~Rps~~evl~h 284 (432)
T 3p23_A 260 ARELIEKMIAMDPQKRPSAKHVLKH 284 (432)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHHhCCHhhCCCHHHHHhC
Confidence 8899999999999999999999965
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-37 Score=317.59 Aligned_cols=193 Identities=18% Similarity=0.245 Sum_probs=159.9
Q ss_pred hhcccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCChhhHHHHHHHHHHhhccC-CC-----ceeeEeeEEeeCC
Q 008785 266 ITKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLH-HP-----NLVAVKGCCYDHG 338 (553)
Q Consensus 266 ~~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-Hp-----nIv~l~~~~~~~~ 338 (553)
+.++|.... .||+|+||.||+|... +++.||||+++.. .....++.+|+.+++.++ |+ +|+++++++...+
T Consensus 52 ~~~~y~~~~-~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 129 (382)
T 2vx3_A 52 WMDRYEIDS-LIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN 129 (382)
T ss_dssp ETTTEEEEE-EEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT
T ss_pred eeeeEEEEE-EEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC
Confidence 445565544 4599999999999965 5789999999754 334567788888888884 55 4999999999999
Q ss_pred ceEEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEec--CCCCeEEeec
Q 008785 339 DRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD--EEFGAHLMGV 416 (553)
Q Consensus 339 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~--~~~~~kl~Df 416 (553)
..++||||++ |+|.+++... ....+++..+..++.|++.||.|||++ ..+|+||||||+|||++ .++.+||+||
T Consensus 130 ~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DF 205 (382)
T 2vx3_A 130 HLCLVFEMLS-YNLYDLLRNT--NFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDF 205 (382)
T ss_dssp EEEEEEECCC-CBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCC
T ss_pred ceEEEEecCC-CCHHHHHhhc--CcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEec
Confidence 9999999995 5999999762 334589999999999999999999952 22999999999999995 4778999999
Q ss_pred cccccCCcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhc
Q 008785 417 GLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL 469 (553)
Q Consensus 417 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~ 469 (553)
|+++...... ....||+.|+|||++.+..++.++|||||||++|||++
T Consensus 206 G~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt 253 (382)
T 2vx3_A 206 GSSCQLGQRI-----YQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHT 253 (382)
T ss_dssp TTCEETTCCC-----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHH
T ss_pred cCceeccccc-----ccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHh
Confidence 9998764321 12238999999999999999999999999999999997
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-38 Score=316.89 Aligned_cols=242 Identities=20% Similarity=0.238 Sum_probs=185.6
Q ss_pred HHhhcccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCChh------hHHHHHHHHHHhhcc----CCCceeeEee
Q 008785 264 RSITKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQ------RKKEFYSEIGRFARL----HHPNLVAVKG 332 (553)
Q Consensus 264 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~~------~~~~~~~E~~~l~~l----~HpnIv~l~~ 332 (553)
....++|.... .||+|+||.||+|... +|+.||||+++..... ....+.+|+.++.++ +||||+++++
T Consensus 27 ~~~~~~y~~~~-~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 27 EAFEAEYRLGP-LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp ------CEEEE-EEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhceEEee-EEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 34455666544 5599999999999864 5889999999765321 233456799999998 8999999999
Q ss_pred EEeeCCceEEEEEc-cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEec-CCCC
Q 008785 333 CCYDHGDRYIVYEF-VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD-EEFG 410 (553)
Q Consensus 333 ~~~~~~~~~lV~E~-~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~-~~~~ 410 (553)
++.+.+..++|||| +.+++|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+||+++ +++.
T Consensus 106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~ 178 (312)
T 2iwi_A 106 WFETQEGFMLVLERPLPAQDLFDYITE----KGPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGC 178 (312)
T ss_dssp EC-----CEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTE
T ss_pred EEecCCeEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCe
Confidence 99999999999999 789999999975 23589999999999999999999999 999999999999999 7899
Q ss_pred eEEeeccccccCCcccccceeeecCccccccccccccCCCC-CcccchHhHHHHHHHHhcCcccccchHHHHHhc-CC--
Q 008785 411 AHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNEL-TTKSDVYSFGVLLLEIRLVLCRRWWTLYTLVHS-MS-- 486 (553)
Q Consensus 411 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDVwSlGvil~ell~~~~~~~~~l~~~~~~-~~-- 486 (553)
+||+|||++......... ...||+.|+|||++.+..+ +.++||||||+++|||++........ .+.... ..
T Consensus 179 ~kl~dfg~~~~~~~~~~~----~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~-~~~~~~~~~~~ 253 (312)
T 2iwi_A 179 AKLIDFGSGALLHDEPYT----DFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD-QEILEAELHFP 253 (312)
T ss_dssp EEECCCSSCEECCSSCBC----CCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH-HHHHHTCCCCC
T ss_pred EEEEEcchhhhcccCccc----ccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh-HHHhhhccCCc
Confidence 999999999876543221 2238999999999887666 45899999999999999843322211 111111 11
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008785 487 LLCAQECLMLFISCNNWPSHLSQSKFCNLKLW 518 (553)
Q Consensus 487 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l 518 (553)
...+..+.+++.+||+.||++|||+.|++++-
T Consensus 254 ~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~ 285 (312)
T 2iwi_A 254 AHVSPDCCALIRRCLAPKPSSRPSLEEILLDP 285 (312)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSCCHHHHHHST
T ss_pred ccCCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 14567789999999999999999999999863
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-37 Score=313.76 Aligned_cols=238 Identities=17% Similarity=0.188 Sum_probs=188.9
Q ss_pred cccCCCCeeecccCceeEEEEEeC-CC-CEEEEEEeccCChhhHHHHHHHHHHhhccCCCc------eeeEeeEEeeCCc
Q 008785 268 KNFSEGNRLLGDSKTGGTYSGILP-DG-SRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPN------LVAVKGCCYDHGD 339 (553)
Q Consensus 268 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g-~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpn------Iv~l~~~~~~~~~ 339 (553)
++|.... .||+|+||.||++... ++ +.||||+++.. ....+.+.+|+.++++++|++ ++.+++++...+.
T Consensus 19 ~~y~~~~-~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 19 ERYEIVG-NLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTEEEEE-EEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred ccEEEEE-EeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 3444444 4599999999999964 34 68999999754 344577889999999997665 9999999999999
Q ss_pred eEEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEe--------------
Q 008785 340 RYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL-------------- 405 (553)
Q Consensus 340 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl-------------- 405 (553)
.++||||+ +++|.+++.. .....+++..+..++.||+.||+|||++ +|+||||||+|||+
T Consensus 97 ~~lv~e~~-~~~l~~~l~~--~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~ 170 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKE--NNFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKS 170 (355)
T ss_dssp EEEEEECC-CCBHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-C
T ss_pred EEEEEecc-CCChHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeccccccccccccc
Confidence 99999999 6777777765 2334689999999999999999999999 99999999999999
Q ss_pred -----cCCCCeEEeeccccccCCcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcC-cccccchH-
Q 008785 406 -----DEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLV-LCRRWWTL- 478 (553)
Q Consensus 406 -----~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~-~~~~~~~l- 478 (553)
+.++.+||+|||+++...... ....||+.|+|||++.+..++.++||||||+++|||++. .|......
T Consensus 171 ~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 245 (355)
T 2eu9_A 171 CEEKSVKNTSIRVADFGSATFDHEHH-----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENR 245 (355)
T ss_dssp CCEEEESCCCEEECCCTTCEETTSCC-----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred ccccccCCCcEEEeecCccccccccc-----cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH
Confidence 567899999999997644322 122389999999999999999999999999999999973 22222111
Q ss_pred --HHHHhc--CC----------------------------------------------HHHHHHHHHHHhhccCCCCCCC
Q 008785 479 --YTLVHS--MS----------------------------------------------LLCAQECLMLFISCNNWPSHLS 508 (553)
Q Consensus 479 --~~~~~~--~~----------------------------------------------~~~~~~l~~l~~~Cl~~dP~~R 508 (553)
...+.. +. ...+..+.+++.+||+.||++|
T Consensus 246 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 325 (355)
T 2eu9_A 246 EHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQR 325 (355)
T ss_dssp HHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred HHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhC
Confidence 110000 00 0335678999999999999999
Q ss_pred CCHHHHHHHH
Q 008785 509 QSKFCNLKLW 518 (553)
Q Consensus 509 Ps~~evl~~l 518 (553)
||+.|++++-
T Consensus 326 pt~~e~l~hp 335 (355)
T 2eu9_A 326 ITLAEALLHP 335 (355)
T ss_dssp CCHHHHTTSG
T ss_pred cCHHHHhcCh
Confidence 9999999863
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=317.74 Aligned_cols=236 Identities=19% Similarity=0.247 Sum_probs=186.7
Q ss_pred cccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccC--ChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCc-----
Q 008785 268 KNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGD----- 339 (553)
Q Consensus 268 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~----- 339 (553)
++|... +.||+|+||.||+|... +|+.||||++... .....+.+.+|+.++++++||||+++++++...+.
T Consensus 24 ~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 24 KTYVSP-THVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp TTEEEE-EEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred ceEEEe-eeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 344443 45699999999999975 5899999999754 23345778999999999999999999999987654
Q ss_pred -eEEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccc
Q 008785 340 -RYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGL 418 (553)
Q Consensus 340 -~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgl 418 (553)
.++||||+. |+|.+++. ..+++..+..++.||+.||.|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 103 ~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~ 172 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG------LKFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGL 172 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTC
T ss_pred eEEEEecccc-CCHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeeccc
Confidence 499999996 68887764 2489999999999999999999999 999999999999999999999999999
Q ss_pred cccCCcccccceeeecCccccccccccccC-CCCCcccchHhHHHHHHHHhcC-cccccchHHH----HHhc-C------
Q 008785 419 SKFVPWEVMQERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIRLV-LCRRWWTLYT----LVHS-M------ 485 (553)
Q Consensus 419 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwSlGvil~ell~~-~~~~~~~l~~----~~~~-~------ 485 (553)
+....... ....||+.|+|||++.+ ..++.++||||||+++|||++. .|....+..+ .... +
T Consensus 173 ~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 247 (353)
T 3coi_A 173 ARHADAEM-----TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEF 247 (353)
T ss_dssp TTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHH
T ss_pred ccCCCCCc-----cccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 98654321 11238999999999876 6789999999999999999973 2332222111 1100 0
Q ss_pred ----------------------C-----HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 008785 486 ----------------------S-----LLCAQECLMLFISCNNWPSHLSQSKFCNLKLWV 519 (553)
Q Consensus 486 ----------------------~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~ 519 (553)
. ...+..+.+++.+||+.||++|||+.|++++-.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~ 308 (353)
T 3coi_A 248 VQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPF 308 (353)
T ss_dssp HTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGG
T ss_pred HHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcc
Confidence 0 034677899999999999999999999998743
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=319.40 Aligned_cols=239 Identities=18% Similarity=0.225 Sum_probs=191.9
Q ss_pred hhcccCCCCeeecccCceeEEEEEe-CCCCEEEEEEeccCChh------hHHHHHHHHHHhhccC--CCceeeEeeEEee
Q 008785 266 ITKNFSEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQ------RKKEFYSEIGRFARLH--HPNLVAVKGCCYD 336 (553)
Q Consensus 266 ~~~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~~~~~~~~------~~~~~~~E~~~l~~l~--HpnIv~l~~~~~~ 336 (553)
+.++|... +.||+|+||.||+|.. .+|+.||||+++..... ..+.+.+|+.++++++ ||||+++++++.+
T Consensus 41 ~~~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~ 119 (320)
T 3a99_A 41 LESQYQVG-PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER 119 (320)
T ss_dssp CTTTEEEE-EECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred ccCceEEE-EEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec
Confidence 34445444 4569999999999986 45889999999764221 2245678999999996 5999999999999
Q ss_pred CCceEEEEEccCC-CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEec-CCCCeEEe
Q 008785 337 HGDRYIVYEFVVN-GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD-EEFGAHLM 414 (553)
Q Consensus 337 ~~~~~lV~E~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~-~~~~~kl~ 414 (553)
.+..++|||++.+ ++|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++ +++.+||+
T Consensus 120 ~~~~~lv~e~~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL~ 192 (320)
T 3a99_A 120 PDSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLI 192 (320)
T ss_dssp SSEEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEEC
T ss_pred CCcEEEEEEcCCCCccHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEEe
Confidence 9999999999976 899999965 24589999999999999999999999 999999999999999 77899999
Q ss_pred eccccccCCcccccceeeecCccccccccccccCCCC-CcccchHhHHHHHHHHhcCc-ccccchHHHHHhcCC---HHH
Q 008785 415 GVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNEL-TTKSDVYSFGVLLLEIRLVL-CRRWWTLYTLVHSMS---LLC 489 (553)
Q Consensus 415 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDVwSlGvil~ell~~~-~~~~~~l~~~~~~~~---~~~ 489 (553)
|||++......... ...||+.|+|||++.+..+ +.++||||||+++|||++.. |..... +...... ...
T Consensus 193 Dfg~~~~~~~~~~~----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~--~~~~~~~~~~~~~ 266 (320)
T 3a99_A 193 DFGSGALLKDTVYT----DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--EIIRGQVFFRQRV 266 (320)
T ss_dssp CCTTCEECCSSCBC----CCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--HHHHCCCCCSSCC
T ss_pred eCcccccccccccc----CCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh--hhhcccccccccC
Confidence 99999876543221 2238999999999987665 78899999999999999843 332221 1111111 145
Q ss_pred HHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008785 490 AQECLMLFISCNNWPSHLSQSKFCNLKLW 518 (553)
Q Consensus 490 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~l 518 (553)
+..+.+++.+||+.||++|||+.|++++-
T Consensus 267 ~~~~~~li~~~l~~dp~~Rps~~~ll~hp 295 (320)
T 3a99_A 267 SSECQHLIRWCLALRPSDRPTFEEIQNHP 295 (320)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcCH
Confidence 67889999999999999999999999863
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=313.39 Aligned_cols=248 Identities=19% Similarity=0.288 Sum_probs=174.7
Q ss_pred ccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCC-hhhHHHHHHHHH-HhhccCCCceeeEeeEEeeCCceEEEEE
Q 008785 269 NFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS-FQRKKEFYSEIG-RFARLHHPNLVAVKGCCYDHGDRYIVYE 345 (553)
Q Consensus 269 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~-~l~~l~HpnIv~l~~~~~~~~~~~lV~E 345 (553)
+|.... .||+|+||.||++... +|+.||||+++... .....++..|+. +++.++||||+++++++.+.+..++|||
T Consensus 23 ~y~~~~-~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e 101 (327)
T 3aln_A 23 DLKDLG-EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICME 101 (327)
T ss_dssp SEEC-C-EEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred Hhhehh-eeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEe
Confidence 444444 4599999999999975 58999999997653 334455666666 7777899999999999999999999999
Q ss_pred ccCCCCHHHHhccCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCc
Q 008785 346 FVVNGPLDRWLHHIP-RGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW 424 (553)
Q Consensus 346 ~~~~gsL~~~l~~~~-~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~ 424 (553)
|+++ +|.+++.... .....+++..+..++.|++.||.|||+. .+|+||||||+||+++.++.+||+|||+++....
T Consensus 102 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 178 (327)
T 3aln_A 102 LMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD 178 (327)
T ss_dssp CCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHH--HSCCCSCCCGGGEEEETTTEEEECCCSSSCC---
T ss_pred ecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhcc--CCEeECCCCHHHEEEcCCCCEEEccCCCceeccc
Confidence 9975 8887775311 1245689999999999999999999984 3899999999999999999999999999986654
Q ss_pred ccccceeeecCccccccccccc----cCCCCCcccchHhHHHHHHHHhcCc-ccccc-hHHHHH---hcCCH--------
Q 008785 425 EVMQERTVMAGGTYGYLAPEFV----YRNELTTKSDVYSFGVLLLEIRLVL-CRRWW-TLYTLV---HSMSL-------- 487 (553)
Q Consensus 425 ~~~~~~~~~~~gt~~y~aPE~~----~~~~~t~ksDVwSlGvil~ell~~~-~~~~~-~l~~~~---~~~~~-------- 487 (553)
..... ...||+.|+|||++ .+..++.++||||||+++|||++.. |.... ...+.+ ..+..
T Consensus 179 ~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (327)
T 3aln_A 179 SIAKT---RDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEE 255 (327)
T ss_dssp ------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCCCCCSS
T ss_pred ccccc---cCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCCCccc
Confidence 32211 12389999999998 4567899999999999999999733 33221 111111 11110
Q ss_pred -HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHh
Q 008785 488 -LCAQECLMLFISCNNWPSHLSQSKFCNLKLWVFAIL 523 (553)
Q Consensus 488 -~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~~~~ 523 (553)
..+..+.+++.+||+.||++|||+.|++++-.....
T Consensus 256 ~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 292 (327)
T 3aln_A 256 REFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMY 292 (327)
T ss_dssp CCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred ccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHh
Confidence 356789999999999999999999999987555443
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-37 Score=310.09 Aligned_cols=241 Identities=18% Similarity=0.260 Sum_probs=173.9
Q ss_pred ccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCCh-hhH-HHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEE
Q 008785 269 NFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF-QRK-KEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYE 345 (553)
Q Consensus 269 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~-~~~-~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 345 (553)
+|.... .||+|+||.||++... +|+.||||++..... ... +.+..+..+++.++||||+++++++.+.+..++|||
T Consensus 26 ~y~~~~-~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e 104 (318)
T 2dyl_A 26 DLENLG-EMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAME 104 (318)
T ss_dssp GEEEEE-EC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred cccccc-eeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEe
Confidence 344433 4599999999999975 689999999976532 222 334445557788899999999999999999999999
Q ss_pred ccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCceecCCCCCcEEecCCCCeEEeeccccccCCc
Q 008785 346 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD-KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW 424 (553)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~ 424 (553)
|+ ++.+..+... ....+++..+..++.|++.||.|||+ . +|+||||||+||+++.++.+||+|||++.....
T Consensus 105 ~~-~~~~~~l~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 177 (318)
T 2dyl_A 105 LM-GTCAEKLKKR---MQGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRLVD 177 (318)
T ss_dssp CC-SEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred cc-CCcHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence 99 5566555542 23568999999999999999999998 6 899999999999999999999999999976544
Q ss_pred ccccceeeecCcccccccccccc-----CCCCCcccchHhHHHHHHHHhcCc-cccc----chHHH-HHhcCCH------
Q 008785 425 EVMQERTVMAGGTYGYLAPEFVY-----RNELTTKSDVYSFGVLLLEIRLVL-CRRW----WTLYT-LVHSMSL------ 487 (553)
Q Consensus 425 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDVwSlGvil~ell~~~-~~~~----~~l~~-~~~~~~~------ 487 (553)
..... ...||+.|+|||++. ...++.++||||||+++|||++.. |... ..... .......
T Consensus 178 ~~~~~---~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (318)
T 2dyl_A 178 DKAKD---RSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHM 254 (318)
T ss_dssp ------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSSS
T ss_pred Ccccc---ccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCccC
Confidence 32221 223899999999984 456889999999999999999732 3221 12222 2222111
Q ss_pred HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 008785 488 LCAQECLMLFISCNNWPSHLSQSKFCNLKLWVF 520 (553)
Q Consensus 488 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~ 520 (553)
..+..+.+++.+||+.||.+|||+.|++++-..
T Consensus 255 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~ 287 (318)
T 2dyl_A 255 GFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFI 287 (318)
T ss_dssp CCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHH
T ss_pred CCCHHHHHHHHHHccCChhHCcCHHHHhhCHHH
Confidence 356789999999999999999999999987443
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-37 Score=315.63 Aligned_cols=238 Identities=15% Similarity=0.156 Sum_probs=188.5
Q ss_pred ccCCCCeeecccCceeEEEEEe-CCCCEEEEEEeccCChhhHHHHHHHHHHhhccC-----------CCceeeEeeEEee
Q 008785 269 NFSEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLH-----------HPNLVAVKGCCYD 336 (553)
Q Consensus 269 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-----------HpnIv~l~~~~~~ 336 (553)
+|... +.||+|+||.||+|.. .+++.||||++... ....+.+.+|+.++++++ ||||+++++++..
T Consensus 20 ~y~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~ 97 (373)
T 1q8y_A 20 RYILV-RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 97 (373)
T ss_dssp TEEEE-EEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred eEEEE-EeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence 34333 4569999999999996 46889999999754 344567889999999886 8999999999886
Q ss_pred CC----ceEEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEec------
Q 008785 337 HG----DRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD------ 406 (553)
Q Consensus 337 ~~----~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~------ 406 (553)
.+ ..++||||+ +++|.+++... ....+++..+..++.||+.||+|||+++ +|+||||||+|||++
T Consensus 98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~~~ 172 (373)
T 1q8y_A 98 KGPNGVHVVMVFEVL-GENLLALIKKY--EHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPE 172 (373)
T ss_dssp EETTEEEEEEEECCC-CEEHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTT
T ss_pred cCCCCceEEEEEecC-CCCHHHHHHHh--hccCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCCCc
Confidence 54 679999999 89999999763 3345899999999999999999999842 899999999999994
Q ss_pred CCCCeEEeeccccccCCcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcCc-ccccch--------
Q 008785 407 EEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVL-CRRWWT-------- 477 (553)
Q Consensus 407 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~-~~~~~~-------- 477 (553)
..+.+||+|||++........ ...||+.|+|||++.+..++.++||||||+++|||++.. |.....
T Consensus 173 ~~~~~kl~Dfg~a~~~~~~~~-----~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 247 (373)
T 1q8y_A 173 NLIQIKIADLGNACWYDEHYT-----NSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 247 (373)
T ss_dssp TEEEEEECCCTTCEETTBCCC-----SCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred CcceEEEcccccccccCCCCC-----CCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChH
Confidence 445799999999986643211 123899999999999999999999999999999999732 222110
Q ss_pred --HHHHHh-----------c----------------------------------CCHHHHHHHHHHHhhccCCCCCCCCC
Q 008785 478 --LYTLVH-----------S----------------------------------MSLLCAQECLMLFISCNNWPSHLSQS 510 (553)
Q Consensus 478 --l~~~~~-----------~----------------------------------~~~~~~~~l~~l~~~Cl~~dP~~RPs 510 (553)
+...+. . -....+..+.+|+.+||+.||++|||
T Consensus 248 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 327 (373)
T 1q8y_A 248 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD 327 (373)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred HHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCC
Confidence 111100 0 00155678999999999999999999
Q ss_pred HHHHHHHH
Q 008785 511 KFCNLKLW 518 (553)
Q Consensus 511 ~~evl~~l 518 (553)
+.|++++-
T Consensus 328 ~~ell~hp 335 (373)
T 1q8y_A 328 AGGLVNHP 335 (373)
T ss_dssp HHHHHTCG
T ss_pred HHHHhhCh
Confidence 99999874
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-37 Score=342.48 Aligned_cols=237 Identities=20% Similarity=0.214 Sum_probs=185.3
Q ss_pred cccCCCCeeecccCceeEEEEEeC--CCCEEEEEEeccC-ChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCc-----
Q 008785 268 KNFSEGNRLLGDSKTGGTYSGILP--DGSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGD----- 339 (553)
Q Consensus 268 ~~~~~~~~~iG~G~~g~Vy~~~~~--~g~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~----- 339 (553)
++|.... .||+|+||.||++... +|+.||||++... .......+.+|+.++++++||||+++++++...+.
T Consensus 80 ~~y~i~~-~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 80 GQYEVKG-CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTEEEEE-EEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CceEEEE-EEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 3444434 5599999999999975 5899999998654 34455678999999999999999999999988766
Q ss_pred eEEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeecccc
Q 008785 340 RYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLS 419 (553)
Q Consensus 340 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla 419 (553)
.||||||+++++|.+++.. .+++.++..++.||+.||.|||++ +|+||||||+|||++.+ .+||+|||++
T Consensus 159 ~~lv~E~~~g~~L~~~~~~------~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~a 228 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAV 228 (681)
T ss_dssp EEEEEECCCCEECC----C------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTTC
T ss_pred eEEEEEeCCCCcHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecccc
Confidence 6999999999999887642 589999999999999999999999 99999999999999986 8999999999
Q ss_pred ccCCcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcCcccccchHHHHHhcCCH--HHHHHHHHHH
Q 008785 420 KFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVLCRRWWTLYTLVHSMSL--LCAQECLMLF 497 (553)
Q Consensus 420 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~~~~~~~l~~~~~~~~~--~~~~~l~~l~ 497 (553)
+..... ....||+.|+|||++.+.. +.++||||||+++|||++..+.........+..... ..+..+.+++
T Consensus 229 ~~~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~l~~li 301 (681)
T 2pzi_A 229 SRINSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGLPEDDPVLKTYDSYGRLL 301 (681)
T ss_dssp EETTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSCCTTCHHHHHCHHHHHHH
T ss_pred hhcccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccccccccccccccCHHHHHHH
Confidence 866533 1223999999999987654 899999999999999997433221111110111111 3456789999
Q ss_pred hhccCCCCCCCCCHHHHHHHHHHHH
Q 008785 498 ISCNNWPSHLSQSKFCNLKLWVFAI 522 (553)
Q Consensus 498 ~~Cl~~dP~~RPs~~evl~~l~~~~ 522 (553)
.+||+.||++||+..+.+.+-+..+
T Consensus 302 ~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 302 RRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp HHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred hhhccCChhhCCCHHHHHHHHHHHH
Confidence 9999999999997666665544333
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=296.11 Aligned_cols=222 Identities=16% Similarity=0.177 Sum_probs=177.4
Q ss_pred hhcccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCChhhHHHHHHHHHHh-hccCCCceeeEeeEEee----CCc
Q 008785 266 ITKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRF-ARLHHPNLVAVKGCCYD----HGD 339 (553)
Q Consensus 266 ~~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l-~~l~HpnIv~l~~~~~~----~~~ 339 (553)
+.++|....++||+|+||.||++... +++.||||+++.. ..+.+|+.++ +.++||||+++++++.. ...
T Consensus 15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 89 (299)
T 3m2w_A 15 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 89 (299)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred cccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCce
Confidence 44556665567899999999999964 5899999999753 3567888887 55599999999999887 667
Q ss_pred eEEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecC---CCCeEEeec
Q 008785 340 RYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE---EFGAHLMGV 416 (553)
Q Consensus 340 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~---~~~~kl~Df 416 (553)
.++||||+++|+|.+++.. .....+++..+..++.|++.||.|||+. +|+||||||+|||++. ++.+||+||
T Consensus 90 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Df 164 (299)
T 3m2w_A 90 LLIVMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDF 164 (299)
T ss_dssp EEEEECCCCSCBHHHHHHH--CTTCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCC
T ss_pred EEEEEeecCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEecc
Confidence 8999999999999999986 3345699999999999999999999999 9999999999999998 788999999
Q ss_pred cccccCCcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcCc-ccccchHHH-------HHhcCCH-
Q 008785 417 GLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVL-CRRWWTLYT-------LVHSMSL- 487 (553)
Q Consensus 417 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~-~~~~~~l~~-------~~~~~~~- 487 (553)
|++.... +..++.++||||||+++|||++.. |........ .+..+..
T Consensus 165 g~a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 220 (299)
T 3m2w_A 165 GFAKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE 220 (299)
T ss_dssp TTCEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCS
T ss_pred ccccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhcccc
Confidence 9885422 234678999999999999999733 322211111 1111111
Q ss_pred -------HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 008785 488 -------LCAQECLMLFISCNNWPSHLSQSKFCNLKLWVFA 521 (553)
Q Consensus 488 -------~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~~ 521 (553)
..+..+.+++.+||+.||++|||+.|++++-...
T Consensus 221 ~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~ 261 (299)
T 3m2w_A 221 FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM 261 (299)
T ss_dssp SCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred CCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhc
Confidence 3467899999999999999999999999985443
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-36 Score=327.10 Aligned_cols=242 Identities=20% Similarity=0.283 Sum_probs=189.8
Q ss_pred cccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccC-ChhhHHHHHHHHHHhhccCCCceeeEeeEEee------CCc
Q 008785 268 KNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD------HGD 339 (553)
Q Consensus 268 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~------~~~ 339 (553)
++|.....+ |+|+||.||+|... +|+.||||+++.. .....+.+.+|+.++++++||||+++++++.. .+.
T Consensus 14 grY~i~~~L-G~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 14 GPWEMKERL-GTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ---CCCCCC-CBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCeEEEEEE-eeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 456665555 99999999999974 5899999998764 44456789999999999999999999998765 567
Q ss_pred eEEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCC---eEEeec
Q 008785 340 RYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG---AHLMGV 416 (553)
Q Consensus 340 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~---~kl~Df 416 (553)
.++||||+++|+|.+++.... ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++. +||+||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~-~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DF 168 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFE-NCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDL 168 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSS-CTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred EEEEEEeCCCCCHHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEccc
Confidence 799999999999999997632 233588899999999999999999999 9999999999999997665 899999
Q ss_pred cccccCCcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcC-cccccc-hHHH------------HH
Q 008785 417 GLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLV-LCRRWW-TLYT------------LV 482 (553)
Q Consensus 417 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~-~~~~~~-~l~~------------~~ 482 (553)
|++.......... ...||+.|+|||++.+..++.++||||||+++|||++. .|.... ...+ ..
T Consensus 169 G~a~~~~~~~~~~---~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~ 245 (676)
T 3qa8_A 169 GYAKELDQGELCT---EFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIV 245 (676)
T ss_dssp CCCCBTTSCCCCC---CCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CC
T ss_pred ccccccccccccc---cccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhh
Confidence 9998765443221 22389999999999999999999999999999999983 332211 1110 00
Q ss_pred ----hcCC--------------HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008785 483 ----HSMS--------------LLCAQECLMLFISCNNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 483 ----~~~~--------------~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 517 (553)
..+. ...+..+.+++.+||+.||++|||+.|++++
T Consensus 246 ~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~h 298 (676)
T 3qa8_A 246 VYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNV 298 (676)
T ss_dssp SCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCC
T ss_pred hhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcC
Confidence 0000 0467889999999999999999999986544
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=296.35 Aligned_cols=228 Identities=13% Similarity=0.029 Sum_probs=173.9
Q ss_pred ccCCCCeeecccCceeEEEEEeCC-CCEEEEEEeccCC---hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEE
Q 008785 269 NFSEGNRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVY 344 (553)
Q Consensus 269 ~~~~~~~~iG~G~~g~Vy~~~~~~-g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 344 (553)
.|... +.||+|+||.||+|.... |+.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..|+||
T Consensus 32 ~y~i~-~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 32 RYRLL-IFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TEEEE-EEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cEEEE-EEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 34444 456999999999999754 8999999997653 334578899999999999999999999999999999999
Q ss_pred EccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCc
Q 008785 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW 424 (553)
Q Consensus 345 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~ 424 (553)
||+++++|.++++. .....++..++.|++.||+|||++ ||+||||||+|||+++++.+||++++
T Consensus 111 e~~~g~~L~~~l~~------~~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~------- 174 (286)
T 3uqc_A 111 EWIRGGSLQEVADT------SPSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA------- 174 (286)
T ss_dssp ECCCEEEHHHHHTT------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC-------
T ss_pred EecCCCCHHHHHhc------CCChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc-------
Confidence 99999999999953 135567889999999999999999 99999999999999999999987432
Q ss_pred ccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcCc-ccccchHHH------HHhcCCH--------HH
Q 008785 425 EVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVL-CRRWWTLYT------LVHSMSL--------LC 489 (553)
Q Consensus 425 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~-~~~~~~l~~------~~~~~~~--------~~ 489 (553)
|++| ++.++||||||+++|||++.. |.......+ ....+.. ..
T Consensus 175 ---------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T 3uqc_A 175 ---------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDI 232 (286)
T ss_dssp ---------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTS
T ss_pred ---------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCC
Confidence 3333 688999999999999999722 222111100 0001110 45
Q ss_pred HHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHhhcccccccccccc
Q 008785 490 AQECLMLFISCNNWPSHLSQSKFCNLKLWVFAILTIRKVQFEFPLLR 536 (553)
Q Consensus 490 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~~~~~~~~~~~~~p~~~ 536 (553)
+..+.+++.+||+.||++| |+.|+++.|........+.....|...
T Consensus 233 ~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~~~~~~~p~~~ 278 (286)
T 3uqc_A 233 PFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVADRTEVLGPIDE 278 (286)
T ss_dssp CHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC-------------
T ss_pred CHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCCccCCCCCCCC
Confidence 6779999999999999999 999999998887766655554444433
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-36 Score=312.91 Aligned_cols=233 Identities=18% Similarity=0.158 Sum_probs=173.6
Q ss_pred eeecccCceeEEEEEe-CCCCEEEEEEeccCCh---hhHHHHHHHHHHhhccCC-Cce---------------ee-----
Q 008785 275 RLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSF---QRKKEFYSEIGRFARLHH-PNL---------------VA----- 329 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~-~~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~H-pnI---------------v~----- 329 (553)
++||+|+||.||+|.. .+|+.||||+++.... ...+.+.+|+.+++.++| +|. +.
T Consensus 84 ~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (413)
T 3dzo_A 84 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKK 163 (413)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC--
T ss_pred cccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCCCC
Confidence 4679999999999995 4699999999984322 235778999999999977 221 11
Q ss_pred -EeeEEee-----CCceEEEEEccCCCCHHHHhccC---CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCC
Q 008785 330 -VKGCCYD-----HGDRYIVYEFVVNGPLDRWLHHI---PRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRA 400 (553)
Q Consensus 330 -l~~~~~~-----~~~~~lV~E~~~~gsL~~~l~~~---~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp 400 (553)
+..+... ....+++|+++ +++|.+++... ......+++..++.++.||+.||+|||++ +|+||||||
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~iiHrDiKp 239 (413)
T 3dzo_A 164 KMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRP 239 (413)
T ss_dssp -------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEECSCCCG
T ss_pred ccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCccc
Confidence 1111111 12356777766 78999988521 12345578889999999999999999999 999999999
Q ss_pred CcEEecCCCCeEEeeccccccCCcccccceeeecCccccccccccc----------cCCCCCcccchHhHHHHHHHHhcC
Q 008785 401 SNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFV----------YRNELTTKSDVYSFGVLLLEIRLV 470 (553)
Q Consensus 401 ~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~t~ksDVwSlGvil~ell~~ 470 (553)
+|||++.++.+||+|||+++..... .....| +.|+|||++ .+..++.++|||||||++|||++.
T Consensus 240 ~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg 313 (413)
T 3dzo_A 240 VDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCA 313 (413)
T ss_dssp GGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHS
T ss_pred ceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHC
Confidence 9999999999999999998865433 222337 999999999 555688999999999999999973
Q ss_pred -cccccchH---HHHHhcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008785 471 -LCRRWWTL---YTLVHSMSLLCAQECLMLFISCNNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 471 -~~~~~~~l---~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 517 (553)
.|...... .+.+-......+..+.+++.+||+.||++|||+.|++++
T Consensus 314 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~ 364 (413)
T 3dzo_A 314 DLPNTDDAALGGSEWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMET 364 (413)
T ss_dssp SCCCCTTGGGSCSGGGGSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred CCCCCCcchhhhHHHHHhhcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 33322221 112222222556789999999999999999999998765
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-36 Score=305.80 Aligned_cols=226 Identities=15% Similarity=0.124 Sum_probs=174.6
Q ss_pred ccCCCCeeecccCceeEEEEEeCCCCEEEEEEeccCC--------hhhHHHHHHHHHHhhccC---------CCceeeEe
Q 008785 269 NFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSS--------FQRKKEFYSEIGRFARLH---------HPNLVAVK 331 (553)
Q Consensus 269 ~~~~~~~~iG~G~~g~Vy~~~~~~g~~vAvK~~~~~~--------~~~~~~~~~E~~~l~~l~---------HpnIv~l~ 331 (553)
+|... +.||+|+||.||+|+. +|+.||||+++... ....+.+.+|+.++++++ ||||+++.
T Consensus 21 ~y~~~-~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~ 98 (336)
T 2vuw_A 21 KLQRC-EKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLN 98 (336)
T ss_dssp HHHTC-EEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEE
T ss_pred cchhe-eeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhc
Confidence 34443 4569999999999998 78999999997652 223477889999988885 77777777
Q ss_pred eEEe-----------------e-------------CCceEEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHH
Q 008785 332 GCCY-----------------D-------------HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 381 (553)
Q Consensus 332 ~~~~-----------------~-------------~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~g 381 (553)
+++. + .+..++||||+++|++.+.+.. ..+++..+..++.||+.|
T Consensus 99 ~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-----~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 99 SVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-----KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp EEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-----TCCCHHHHHHHHHHHHHH
T ss_pred ceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-----cCCCHHHHHHHHHHHHHH
Confidence 6643 2 6788999999999977666632 458999999999999999
Q ss_pred HHHHH-hCCCCCceecCCCCCcEEecCCC--------------------CeEEeeccccccCCcccccceeeecCccccc
Q 008785 382 IAFLH-DKVKPHVVHRDIRASNVLLDEEF--------------------GAHLMGVGLSKFVPWEVMQERTVMAGGTYGY 440 (553)
Q Consensus 382 L~yLH-~~~~~~ivHrDlkp~NILl~~~~--------------------~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y 440 (553)
|+||| ++ +|+||||||+|||++.++ .+||+|||+|+..... ...||+.|
T Consensus 174 L~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~y 243 (336)
T 2vuw_A 174 LAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCDVS 243 (336)
T ss_dssp HHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCCCT
T ss_pred HHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEeecc
Confidence 99999 89 999999999999999887 8999999999865432 11399999
Q ss_pred cccccccCCCCCcccchHhHHHH-HHHHhcC-cccccc----hHHH-HHhcCCH----------HHHHHHHHHHhhccCC
Q 008785 441 LAPEFVYRNELTTKSDVYSFGVL-LLEIRLV-LCRRWW----TLYT-LVHSMSL----------LCAQECLMLFISCNNW 503 (553)
Q Consensus 441 ~aPE~~~~~~~t~ksDVwSlGvi-l~ell~~-~~~~~~----~l~~-~~~~~~~----------~~~~~l~~l~~~Cl~~ 503 (553)
+|||++.+.. +.++||||+|++ .+++++. .|.... .+.+ ....... ..+..+.+|+.+||+.
T Consensus 244 ~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~ 322 (336)
T 2vuw_A 244 MDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNF 322 (336)
T ss_dssp TCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGS
T ss_pred cChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhcc
Confidence 9999998666 899999998777 5666653 333221 1222 2211110 5778899999999997
Q ss_pred CCCCCCCHHHHH-HH
Q 008785 504 PSHLSQSKFCNL-KL 517 (553)
Q Consensus 504 dP~~RPs~~evl-~~ 517 (553)
| |+.|++ ++
T Consensus 323 d-----sa~e~l~~H 332 (336)
T 2vuw_A 323 S-----SATDLLCQH 332 (336)
T ss_dssp S-----SHHHHHHHC
T ss_pred C-----CHHHHHhcC
Confidence 6 999998 64
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.7e-30 Score=282.98 Aligned_cols=179 Identities=17% Similarity=0.096 Sum_probs=125.9
Q ss_pred cccCceeEEEEE-eCCCCEEEEEEeccCC----------hhhHHHHHHHHHHhhcc-CCCceeeEeeEEeeCCceEEEEE
Q 008785 278 GDSKTGGTYSGI-LPDGSRVAVKRLKRSS----------FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYE 345 (553)
Q Consensus 278 G~G~~g~Vy~~~-~~~g~~vAvK~~~~~~----------~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E 345 (553)
+.|++|.+..++ .--|+.||+|.+.... ....++|.+|+++|+++ +|+||+++++++++++..|||||
T Consensus 243 ~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVME 322 (569)
T 4azs_A 243 YAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVME 322 (569)
T ss_dssp C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEE
T ss_pred ccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEe
Confidence 445555444433 2248889999997541 22346799999999999 79999999999999999999999
Q ss_pred ccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcc
Q 008785 346 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE 425 (553)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~ 425 (553)
|++|++|.++|.. ...++.. .|+.||+.||+|+|++ |||||||||+|||+++++.+||+|||+|+.....
T Consensus 323 yv~G~~L~d~i~~----~~~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~ 392 (569)
T 4azs_A 323 KLPGRLLSDMLAA----GEEIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD 392 (569)
T ss_dssp CCCSEEHHHHHHT----TCCCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred cCCCCcHHHHHHh----CCCCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence 9999999999974 2346654 5889999999999999 9999999999999999999999999999876544
Q ss_pred cccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhc
Q 008785 426 VMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL 469 (553)
Q Consensus 426 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~ 469 (553)
..... ...||+.|||||++.+ .+..++|+||+|++++++.+
T Consensus 393 ~~~~~--t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~ 433 (569)
T 4azs_A 393 CSWPT--NLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQ 433 (569)
T ss_dssp -CCSH--HHHHHHHHHHHHHC------------------CCCCT
T ss_pred Ccccc--CceechhhccHHHhCC-CCCCcccccccccchhhhcc
Confidence 32222 2339999999999864 56788999999999988763
|
| >3vpp_A C-type lectin domain family 9 member A; dendritic cell, C-type lectin-like domain, membrane, immune; 1.64A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=4.4e-27 Score=206.42 Aligned_cols=126 Identities=26% Similarity=0.488 Sum_probs=104.5
Q ss_pred CCCCCcCCcccCCCCeEEEEecCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHhhCCC--CCCeEeeeeecCCCCCCc
Q 008785 50 KAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKN--VNGCWVGGRSINTTVGLS 127 (553)
Q Consensus 50 ~~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~--~~~~WiGl~~~~~~~~~~ 127 (553)
|.+||.||. .|+++||+|+.+.++|.+|+.+|+.+||+||+|+|++|++||.+++... ...+||||+ +...++.
T Consensus 1 c~~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~WIGl~--~~~~~~~ 76 (132)
T 3vpp_A 1 SSPCPNNWI--QNRESCYYVSEIWSIWHTSQENCLKEGSTLLQIESKEEMDFITGSLRKIKGSYDYWVGLS--QDGHSGR 76 (132)
T ss_dssp -CCSCTTCE--EETTEEEEECSSCBCHHHHHHHHHHTTCEECCCCSHHHHHHHHHHHTTSSSCCEEEEEEE--ECTTTCC
T ss_pred CCCCCccce--EeCCEEEEEECCccCHHHHHHHHHhcCCEEeEECCHHHHHHHHHHHhccCCCccEEEEec--ccCCCCc
Confidence 578999999 8999999999999999999999999999999999999999999987532 457999999 5556799
Q ss_pred eEEcCCCCCCcCcccccCccCCCCCCCCCCCCCCCCeeEEEeCCCCceecccCCCCCCccceeccc
Q 008785 128 WKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVEHE 193 (553)
Q Consensus 128 w~W~dg~~~~~~~~~~~~~~~~~~~~~~C~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~~~~ 193 (553)
|+|+||+++.+.+|..++| +.+.++|+.+.. ..|++..|....+|||+.+..
T Consensus 77 w~W~dg~~~~~~~w~~~~p------------~~~~~~C~~~~~--~~w~~~~C~~~~~fiCe~~~~ 128 (132)
T 3vpp_A 77 WLWQDGSSPSPGLLPAERS------------QSANQVCGYVKS--NSLLSSNCDTWKYFICEKYAL 128 (132)
T ss_dssp EEETTSCCCCTTSCCCC------------------CEEEEEET--TEEEEEESSSCBEEEEEEECC
T ss_pred eEecCCCcCChhhcccCCC------------CCCCCceEEEEC--CeEeccCCCCCceEECCcccc
Confidence 9999999987766544332 123568998875 469999999999999998653
|
| >3rs1_A C-type lectin domain family 2 member I; C-type lectin-like, ligand of NK receptor, natural killer CE receptors, surface of activated T lymphocytes; 1.94A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.7e-26 Score=199.78 Aligned_cols=118 Identities=23% Similarity=0.446 Sum_probs=103.5
Q ss_pred CCCCCCcCCcccCCCCeEEEEecCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHhhCCCCCCeEeeeeecCCCCCCce
Q 008785 49 WKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSW 128 (553)
Q Consensus 49 ~~~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w 128 (553)
.+.+||.||. .|+++||+|+.+.++|.+|+.+|+.+||+||+|+|++|++||.+++. ...+||||+ +...++.|
T Consensus 4 ~~~~Cp~gw~--~~~~~Cy~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~--~~~~WIGl~--~~~~~~~w 77 (122)
T 3rs1_A 4 TYAACSKNWT--GVGNKCFYFSGYPRNWTFAQAFCMAQEAQLARFDNEEELIFLKRFKG--DFDSWIGLH--RESSEHPW 77 (122)
T ss_dssp SSSSCCTTCE--EETTEEEEECSSCBCHHHHHHHHHHTTCEECCCSSHHHHHHHHHHTT--TSCEEEEEE--CSSTTSCC
T ss_pred ccCCCChhhe--ecCCEEEEEECCccCHHHHHHHHHhcCCEEeeeCCHHHHHHHHHhcC--CCCEEEEEE--ecCCCCce
Confidence 4678999999 99999999999999999999999999999999999999999999975 568999999 66667999
Q ss_pred EEcCCCCCCcCcccccCccCCCCCCCCCCCCCCCCeeEEEeCCCCceecccCCCCCCccceec
Q 008785 129 KWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVE 191 (553)
Q Consensus 129 ~W~dg~~~~~~~~~~~~~~~~~~~~~~C~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~~ 191 (553)
+|+||+++.+..|.. +.++|+.+..+ .|++..|....+|||+.+
T Consensus 78 ~W~dg~~~~~~~w~~-----------------~~~~C~~~~~~--~w~~~~C~~~~~fICekp 121 (122)
T 3rs1_A 78 KWTNNTEYNNMNPIL-----------------GVGRYAYLSSD--RISSSRSYINRMWICSKL 121 (122)
T ss_dssp EETTCCBCCCCSCCC-----------------SSCSEEEEETT--EEEEECSCSCBCBEEEEE
T ss_pred ECCCCCcCCccccCC-----------------CCCceEEEeCC--cEeccccCCCCCeeeecC
Confidence 999999987665521 23478888654 699999999999999875
|
| >2py2_A Antifreeze protein type II; type II antifreeze protein; 1.70A {Clupea harengus} | Back alignment and structure |
|---|
Probab=99.94 E-value=7e-27 Score=206.34 Aligned_cols=129 Identities=23% Similarity=0.494 Sum_probs=109.4
Q ss_pred CCCCcCCcccCCCCeEEEEecCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHhhCCCCCCeEeeeeecCCCCCCceEE
Q 008785 51 APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKW 130 (553)
Q Consensus 51 ~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W 130 (553)
..||.||. .|+++||+|+...++|.+|+.+|+.+||+||+|+|++|++||.+++......+||||+ +...++.|+|
T Consensus 2 ~~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~~~~~~~WIGl~--~~~~~~~w~W 77 (136)
T 2py2_A 2 DECPTDWK--MFNGRCFLFNPLQLHWADAQESCMKEGANLASIHSLEESTFVKELTSADLIPSWIGGT--DCQVSTRWFW 77 (136)
T ss_dssp --CCTTCE--EETTEEEEEEEEEECHHHHHHHHHTTTCEECCCCSHHHHHHHHTTSTTTTCCEEEEEE--CCSSTTCCEE
T ss_pred CCCCcCce--ecCCEEEEEECCCcCHHHHHHHHhhCCCEEeeeCCHHHHHHHHHHHHcCCCCEeEeeE--cCCCCCceEe
Confidence 36999999 8999999999999999999999999999999999999999999988643378999999 6667799999
Q ss_pred cCCCCCCcCcccccCccCCCCCCCCCCCCCCCCeeEEEeCC-CCceecccCCCCCCccceecccC
Q 008785 131 SDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNG-SRSLVTERCNTSHPFICMVEHEN 194 (553)
Q Consensus 131 ~dg~~~~~~~~~~~~~~~~~~~~~~C~~~~~~~~C~~~~~~-~~~w~~~~C~~~~~~iC~~~~~~ 194 (553)
+||+++.+.+|..++|+ +...++|+.+... ...|++..|....+|||+.+.++
T Consensus 78 ~dG~~~~y~~W~~geP~-----------~~~~~~Cv~~~~~~~~~W~d~~C~~~~~fIC~~~~~~ 131 (136)
T 2py2_A 78 MDSTSMDYADWCAAQPD-----------TTLTECCIQMNVGIGKCWNDTPCTHLHSSICAKPLKH 131 (136)
T ss_dssp TTCCCCCCCCBCTTCCC-----------CCGGGCEEEEEETTTTEEEEECTTSCEEEEEEEECC-
T ss_pred CCCCCcccCCCCCCCCC-----------CCCCCCCeEEccCCCCeEcCCCCCCCccEEeeECccc
Confidence 99999988877766652 2223689888664 46799999999999999986554
|
| >1ypq_A Oxidised low density lipoprotein (lectin-like) receptor 1; oxidized low density lipoprotein receptor, LOX-1, CTLD, C- type lectin like domain; 1.40A {Homo sapiens} SCOP: d.169.1.1 PDB: 1ypu_A 1yxk_A 3vlg_A 1ypo_A 1yxj_A | Back alignment and structure |
|---|
Probab=99.94 E-value=1.8e-26 Score=203.43 Aligned_cols=128 Identities=19% Similarity=0.390 Sum_probs=108.3
Q ss_pred CCCCCCcCCcccCCCCeEEEEecCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHhhCCCCCCeEeeeeecCCCCCCce
Q 008785 49 WKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSW 128 (553)
Q Consensus 49 ~~~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w 128 (553)
.+..||.||. .|+++||+|+.+.++|.+|+.+|+++||+||+|+|.+|++||.+++......+||||+ +...+|.|
T Consensus 5 ~~~~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~~~~~~~WIGl~--~~~~~~~w 80 (135)
T 1ypq_A 5 CSAPCPQDWI--WHGENCYLFSSGSFNWEKSQEKCLSLDAKLLKINSTADLDFIQQAISYSSFPFWMGLS--RRNPSYPW 80 (135)
T ss_dssp CCCSSCTTSE--EETTEEEEECSSCBCHHHHHHHHHHTTCEECCCCSHHHHHHHHHHHTTCCCCEEEEEE--ESSTTSCC
T ss_pred cCCcCCcccE--EcCCEEEEEECCccCHHHHHHHHHhCCCEEeEeCCHHHHHHHHHHHhccCCCEEEecc--ccCCCCCe
Confidence 3568999999 8999999999999999999999999999999999999999999998654678999999 66667999
Q ss_pred EEcCCCCCC-cCcccccCccCCCCCCCCCCCCCCCCeeEEEeCCCCceecccCCCCCCccceecc
Q 008785 129 KWSDNMSKW-NESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVEH 192 (553)
Q Consensus 129 ~W~dg~~~~-~~~~~~~~~~~~~~~~~~C~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~~~ 192 (553)
+|+||+++. +..|..++|++ ..+.++|+.+.. ..|++..|....+|||+.+.
T Consensus 81 ~W~dg~~~~~~~~w~~g~P~~----------~~~~~~Cv~~~~--~~w~~~~C~~~~~fICe~~~ 133 (135)
T 1ypq_A 81 LWEDGSPLMPHLFRVRGAVSQ----------TYPSGTCAYIQR--GAVYAENCILAAFSICQKKA 133 (135)
T ss_dssp EETTSCBCCTTSCCEEESCSC----------CCTTCEEEEEET--TEEEEEETTSCBEEEEEEEC
T ss_pred EeCCcCccCcccccccCCCCC----------CCCCCCeeEEeC--CcEEccCCCCCeeeEeeecC
Confidence 999999985 55555555421 123568998875 47999999999999998753
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.1e-26 Score=251.59 Aligned_cols=177 Identities=16% Similarity=0.164 Sum_probs=140.3
Q ss_pred CeeecccCceeEEEEEeCCCCEEEEEEeccCCh--------hhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEE
Q 008785 274 NRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSF--------QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYE 345 (553)
Q Consensus 274 ~~~iG~G~~g~Vy~~~~~~g~~vAvK~~~~~~~--------~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 345 (553)
.++||+|+||.||++.. .++.+|+|+...... ...+.+.+|++++++++||||+++..++...+..++|||
T Consensus 341 ~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE 419 (540)
T 3en9_A 341 EHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMS 419 (540)
T ss_dssp -------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEE
T ss_pred CCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEE
Confidence 44679999999999955 678899998654211 113558999999999999999976666677888899999
Q ss_pred ccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcc
Q 008785 346 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE 425 (553)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~ 425 (553)
|+++++|.+++.. +..++.|++.||.|||++ +|+||||||+|||+++ .+||+|||+++.....
T Consensus 420 ~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~ 482 (540)
T 3en9_A 420 YINGKLAKDVIED------------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLD 482 (540)
T ss_dssp CCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECCCH
T ss_pred CCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECCCc
Confidence 9999999999853 468999999999999999 9999999999999999 9999999999987654
Q ss_pred cccc-----eeeecCccccccccccccC--CCCCcccchHhHHHHHHHHh
Q 008785 426 VMQE-----RTVMAGGTYGYLAPEFVYR--NELTTKSDVYSFGVLLLEIR 468 (553)
Q Consensus 426 ~~~~-----~~~~~~gt~~y~aPE~~~~--~~~t~ksDVwSlGvil~ell 468 (553)
.... ......||+.|||||++.. ..|+..+|+||..+-..+-+
T Consensus 483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v 532 (540)
T 3en9_A 483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDV 532 (540)
T ss_dssp HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHH
T ss_pred cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHH
Confidence 3221 1112349999999999976 56888899999888777654
|
| >3bx4_B Aggretin beta chain; toxin; 1.70A {Agkistrodon rhodostoma} PDB: 2vrp_B | Back alignment and structure |
|---|
Probab=99.93 E-value=2.8e-26 Score=205.01 Aligned_cols=118 Identities=25% Similarity=0.541 Sum_probs=103.4
Q ss_pred CCCcCCcccCCCCeEEEEecCCCChHHHHHHHhh--cCCEEeeeCCHHHHHHHHHhhCCC--CCCeEeeeeecCCCCCCc
Q 008785 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKN--VNGCWVGGRSINTTVGLS 127 (553)
Q Consensus 52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~--~~~~L~~i~~~~e~~f~~~~~~~~--~~~~WiGl~~~~~~~~~~ 127 (553)
.||+||. .|+++||+|+.+++||.+|+.+|++ .|||||+|+|++|++||.+++... ...+||||+ +...++.
T Consensus 24 ~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~WIGl~--~~~~~~~ 99 (146)
T 3bx4_B 24 DCPSGWS--SYEGHCYKPFNEPKNWADAERFCKLQPKHSHLVSFQSAEEADFVVKLTRPRLKANLVWMGLS--NIWHGCN 99 (146)
T ss_dssp -CCTTCE--EETTEEEEEEEEEECHHHHHHHHHHSSSCCEECCCSSHHHHHHHHHHHTTTTTTSEEECSCC--CTTSSSC
T ss_pred CCCcCcE--eeCCEEEEEECCCcCHHHHHHHHhccCCCceEeccCCHHHHHHHHHHHhhcCCCCCEEEecc--cCCCCCc
Confidence 6999999 8999999999999999999999999 499999999999999999988643 467999999 6666799
Q ss_pred eEEcCCCCCCcCcccccCccCCCCCCCCCCCCCCCCeeEEEeCCCCceecccCCCCCCccceec
Q 008785 128 WKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVE 191 (553)
Q Consensus 128 w~W~dg~~~~~~~~~~~~~~~~~~~~~~C~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~~ 191 (553)
|+|+||+++.+.+|. ++| +|+.+....+.|++..|....+|+|+.+
T Consensus 100 ~~W~dg~~~~~~~W~-g~P-----------------~C~~~~~~~g~w~~~~C~~~~~~ICe~~ 145 (146)
T 3bx4_B 100 WQWSDGARLNYKDWQ-EQS-----------------ECLAFRGVHTEWLNMDCSSTCSFVCKFK 145 (146)
T ss_dssp EEETTCCCCCSCCBC-SCC-----------------EEEEEETTCCCEEEEETTSCEEEEEEEE
T ss_pred eEeCCCCcccccCcC-CCC-----------------CceEEECCCCeEecCCCCCCcceEEeec
Confidence 999999998777766 432 7888877656899999999999999864
|
| >3bdw_B NKG2-A/NKG2-B type II integral membrane protein; NK cells, receptor, glycoprotein, lectin, signal-A transmembrane, immune system receptor; 2.50A {Homo sapiens} PDB: 3cdg_K 3cii_H | Back alignment and structure |
|---|
Probab=99.93 E-value=5.5e-26 Score=196.02 Aligned_cols=118 Identities=19% Similarity=0.378 Sum_probs=100.8
Q ss_pred CCCCCCCcCCcccCCCCeEEEEecCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHhhCCCCCCeEeeeeecCCCCCCc
Q 008785 48 DWKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLS 127 (553)
Q Consensus 48 ~~~~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~ 127 (553)
..|..||.||. .|+++||+|+.+.++|.+|+.+|+++|||||+|+|++|++||.++. ..+||||+ +...++.
T Consensus 2 ~~c~~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~~l~~~~----~~~WIGl~--~~~~~~~ 73 (120)
T 3bdw_B 2 RHCGHCPEEWI--TYSNSCYYIGKERRTWEESLLACTSKNSSLLSIDNEEEMKFLSIIS----PSSWIGVF--RNSSHHP 73 (120)
T ss_dssp CCCTTSCTTCE--ESSSSEEEEEEEEECHHHHHHHHHHTTSEECCCCCHHHHHHHHHHC----SEEEEEEE--CSSTTSC
T ss_pred CcCCCCCCCce--EECCEEEEEECCccCHHHHHHHHHhCCCEEceeCCHHHHHHHHHcC----CCEeEEEE--ecCCCCc
Confidence 45789999999 8999999999999999999999999999999999999999999975 48999999 6667799
Q ss_pred eEEcCCCCCCcCcccccCccCCCCCCCCCCCCCCCCeeEEEeCCCCceecccCCCCCCcccee
Q 008785 128 WKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMV 190 (553)
Q Consensus 128 w~W~dg~~~~~~~~~~~~~~~~~~~~~~C~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~ 190 (553)
|+|+||+++.+..+ +|. + ..++|+.+... .|++..|....+|||+.
T Consensus 74 w~W~dg~~~~~~~~---~p~-----------~-~~~~C~~~~~~--~w~~~~C~~~~~fICe~ 119 (120)
T 3bdw_B 74 WVTMNGLAFKHEIK---DSD-----------N-AELNCAVLQVN--RLKSAQCGSSIIYHCKH 119 (120)
T ss_dssp CEETTSSBCCSCCC-------------------CCCCEEEEESS--SEEEECTTSCEEEEEEC
T ss_pred eEeCCCCccCccCc---CCC-----------C-CCCCccEEeCC--ceECCCCCCCcceeeee
Confidence 99999999765432 221 1 24589888765 59999999999999975
|
| >3bdw_A Natural killer cells antigen CD94; NK cells, receptor, glycoprotein, lectin, signal-A transmembrane, immune system receptor; 2.50A {Homo sapiens} SCOP: d.169.1.1 PDB: 3cdg_J 1b6e_A 3cii_G | Back alignment and structure |
|---|
Probab=99.93 E-value=1.6e-26 Score=200.34 Aligned_cols=121 Identities=16% Similarity=0.386 Sum_probs=104.0
Q ss_pred CCCCCCcCCcccCCCCeEEEEecCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHhhCCCCCCeEeeeeecCCCCCCce
Q 008785 49 WKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSW 128 (553)
Q Consensus 49 ~~~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w 128 (553)
+|.+||.||. .|+++||+|+.+.++|.+|+.+|+.+||+||+|+|++|++||.++ ...+||||+ +...++.|
T Consensus 1 ~c~~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~~l~~~----~~~~WIGl~--~~~~~~~w 72 (123)
T 3bdw_A 1 DCCSCQEKWV--GYRCNCYFISSEQKTWNESRHLCASQKSSLLQLQNTDELDFMSSS----QQFYWIGLS--YSEEHTAW 72 (123)
T ss_dssp CCCCCTTTCE--EETTEEEEECSSCBCHHHHHHHHHHTTCEECCCSCGGGGGGGTTC----CCCEECSEE--EETTTTEE
T ss_pred CCCCCCCCce--EECCEEEEEeCCCCCHHHHHHHHHHCCCeeEEECCHHHHHHHHhC----cCCEEeeee--cCCCCCcE
Confidence 3778999999 899999999999999999999999999999999999999999876 458999999 55567999
Q ss_pred EEcCCCCCCcCcccccCccCCCCCCCCCCCCCCCCeeEEEeCCCCceecccCCCCCCccceec
Q 008785 129 KWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVE 191 (553)
Q Consensus 129 ~W~dg~~~~~~~~~~~~~~~~~~~~~~C~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~~ 191 (553)
+|+||+++.+..|....+ .+.++|+.+... ..|++..|....+|||+.+
T Consensus 73 ~W~dg~~~~~~~w~~~~~-------------~~~~~C~~~~~~-~~w~d~~C~~~~~fICe~~ 121 (123)
T 3bdw_A 73 LWENGSALSQYLFPSFET-------------FNTKNCIAYNPN-GNALDESCEDKNRYICKQQ 121 (123)
T ss_dssp EETTSCBCCTTTSGGGGG-------------CCTTSEEEEETT-TEEEEECTTSCBEEEEEEC
T ss_pred EeeCCCcCCcccccccCC-------------CCCCCCcEEcCC-CcEEccCCCCCCeeeEeEe
Confidence 999999988776654332 124588887654 5799999999999999864
|
| >2b6b_D CD209 antigen; cryo EM dengue CRD DC-SIGN, icosahedral virus, virus-recepto; 25.00A {Homo sapiens} SCOP: d.169.1.1 | Back alignment and structure |
|---|
Probab=99.93 E-value=1.4e-25 Score=206.52 Aligned_cols=137 Identities=21% Similarity=0.423 Sum_probs=112.8
Q ss_pred cccccCCCCCCCCCcCCcccCCCCeEEEEecCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHhhCCCCCCeEeeeeec
Q 008785 41 LAASMNKDWKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSI 120 (553)
Q Consensus 41 ~~~~~~~~~~~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~ 120 (553)
.........|..||.||. .|+++||+|+.+.++|.+|+.+|+.+||+||+|+|.+|++||.++.......+||||+
T Consensus 15 ~~~~~~~~~~~~Cp~gw~--~~~~~CY~~~~~~~tw~~A~~~C~~~g~~La~i~s~~e~~fl~~~~~~~~~~~WIGl~-- 90 (175)
T 2b6b_D 15 VPRGSHMRLCHPCPWEWT--FFQGNCYFMSNSQRNWHDSITACKEVGAQLVVIKSAEEQNFLQLQSSRSNRFTWMGLS-- 90 (175)
T ss_pred ccccccccccCCCCcCcE--EeCCEEEEEECCccCHHHHHHHHhhCCCEEeeeCCHHHHHHHHHHhccCCCcEEEeeE--
Confidence 334445667789999999 8999999999999999999999999999999999999999999876544678999999
Q ss_pred CCCCCCceEEcCCCCCCc---CcccccCccCCCCCCCCCCCCCCCCeeEEEeCCCCceecccCCCCCCccceecccC
Q 008785 121 NTTVGLSWKWSDNMSKWN---ESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVEHEN 194 (553)
Q Consensus 121 ~~~~~~~w~W~dg~~~~~---~~~~~~~~~~~~~~~~~C~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~~~~~ 194 (553)
+...++.|+|+||+++.+ .+|..++|+ +.+.++|+.+... .|++..|....+|||+.....
T Consensus 91 ~~~~~~~w~W~dGs~~~~~~~~~W~~geP~-----------~~~~~~Cv~~~~~--gW~d~~C~~~~~fICe~~~~~ 154 (175)
T 2b6b_D 91 DLNQEGTWQWVDGSPLLPSFKQYWNRGEPN-----------NVGEEDCAEFSGN--GWNDDKCNLAKFWICKKSAAS 154 (175)
T ss_pred ccCCCCcEEeCCCCCcccccccCCCCCCCC-----------CCCCCCeeEEcCC--ceEccCCCCCeeEEEEECCCC
Confidence 666679999999999764 455554442 2234688887654 499999999999999987653
|
| >2c6u_A CLEC1B protein; lectin, rhodocytin, aggretin, C-type lectin-like, platelets, thrombosis; 1.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=3.6e-26 Score=197.78 Aligned_cols=120 Identities=19% Similarity=0.437 Sum_probs=104.3
Q ss_pred CCCcCCcccCCCCeEEEEecCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHhhCCCCCCeEeeeeecCCCCCCceEEc
Q 008785 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWS 131 (553)
Q Consensus 52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~ 131 (553)
+||.||. .|+++||+|+.++++|.+|+.+|+.+||+||+|+|.+|++||.+++. ..+||||+ +...++.|+|+
T Consensus 2 ~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~g~~L~~i~s~~e~~~l~~~~~---~~~WiGl~--~~~~~~~~~W~ 74 (122)
T 2c6u_A 2 PCDTNWR--YYGDSCYGFFRHNLTWEESKQYCTDMNATLLKIDNRNIVEYIKARTH---LIRWVGLS--RQKSNEVWKWE 74 (122)
T ss_dssp CSCTTEE--EETTEEEEEEEEEECHHHHHHHHHHTTCEECCCCSHHHHHHHHTTCC---SCEEEEEE--CSSTTSCCBCT
T ss_pred CCCccce--EeCCEEEEEECCcCCHHHHHHHHHhCCCeEeeECCHHHHHHHHHhhc---CCEEEEee--ecCCCCCeEeC
Confidence 6999999 89999999999999999999999999999999999999999999886 47899999 66667999999
Q ss_pred CCCCCCcCcccccCccCCCCCCCCCCCCCCCCeeEEEeCCCCceecccCCCCCCccceecc
Q 008785 132 DNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVEH 192 (553)
Q Consensus 132 dg~~~~~~~~~~~~~~~~~~~~~~C~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~~~ 192 (553)
||+++.+ +|..+.|. +.+.++|+.+.. ..|++..|....+|||+.+.
T Consensus 75 dg~~~~~-~W~~~~P~-----------~~~~~~C~~~~~--g~w~~~~C~~~~~~ICe~~~ 121 (122)
T 2c6u_A 75 DGSVISE-NMFEFLED-----------GKGNMNCAYFHN--GKMHPTFCENKHYLMCERKA 121 (122)
T ss_dssp TSCBCCG-GGGGGBCC-----------CCTTCCEEEEET--TEEEEECTTSCEEEEEEEEC
T ss_pred CCCccCc-CcccCCCC-----------CCCCCCeeEEcC--CeEEeccCCCCceEeeeecC
Confidence 9999887 66666552 113468888853 48999999999999998753
|
| >1fm5_A Early activation antigen CD69; C-type lectin-like domain, natural killer cell receptor, lectin, C-type lectin, immune system; 2.27A {Homo sapiens} SCOP: d.169.1.1 | Back alignment and structure |
|---|
Probab=99.93 E-value=8.1e-26 Score=212.54 Aligned_cols=120 Identities=24% Similarity=0.541 Sum_probs=99.8
Q ss_pred CCCCCCCCCcCCcccCCCCeEEEEecCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHhhCCCCCCeEeeeeecCCCCC
Q 008785 46 NKDWKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVG 125 (553)
Q Consensus 46 ~~~~~~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~ 125 (553)
....+..||.||. .|+++||+|+.+.++|.+|+.+|+.+||+||+|+|++|++||.++.. ...|||||+ +.. +
T Consensus 78 ~~~~~~~Cp~gW~--~~~~~CY~~~~~~~tw~~A~~~C~~~g~~La~i~s~~e~~fl~~~~~--~~~~WIGl~--~~~-~ 150 (199)
T 1fm5_A 78 SDSHVSSCSEDWV--GYQRKCYFISTVKRSWTSAQNACSEHGATLAVIDSEKDMNFLKRYAG--REEHWVGLK--KEP-G 150 (199)
T ss_dssp CCC----CCTTSE--EETTEEEEECSSCBCHHHHHHHHHHTTCEECCCCSHHHHHHHHHHHC--SSCEEEEEE--CCT-T
T ss_pred CCCCCCCCCCCcE--EECCEEEEEeCCccCHHHHHHHHhhcCCEEEecCCHHHHHHHHHhhC--CCCEEeeeE--ECC-C
Confidence 3455678999999 89999999999999999999999999999999999999999999987 568999999 554 7
Q ss_pred CceEEcCCCCCCcCcccccCccCCCCCCCCCCCCCCCCeeEEEeCCCCceecccCCCCCCccceec
Q 008785 126 LSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVE 191 (553)
Q Consensus 126 ~~w~W~dg~~~~~~~~~~~~~~~~~~~~~~C~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~~ 191 (553)
|.|+|+||+++. +|. + +.+.++|+.+.. ..|++..|....+|+|+.+
T Consensus 151 ~~w~W~DGs~~~--~W~---~------------~~~~~~Cv~l~~--~~W~d~~C~~~~~fICe~~ 197 (199)
T 1fm5_A 151 HPWKWSNGKEFN--NWF---N------------VTGSDKCVFLKN--TEVSSMECEKNLYWICNKP 197 (199)
T ss_dssp SCCEETTSCBCC--CSS---C------------CCSSSSEEEECS--SCEEEECTTSCBEEEEEEE
T ss_pred CCeEECCCCccc--ccc---C------------CCCCCCceEEEC--CCEEEecCCCCEEEEcccc
Confidence 999999999742 332 1 123468888865 4799999999999999864
|
| >1hq8_A NKG2-D; homodimer, CIS-proline, apoptosis; 1.95A {Mus musculus} SCOP: d.169.1.1 PDB: 1jsk_A 1kcg_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.6e-26 Score=200.27 Aligned_cols=120 Identities=23% Similarity=0.538 Sum_probs=104.6
Q ss_pred CCCCCCcCCcccCCCCeEEEEecCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHhhCCCCCCeEeeeeecCCCCCCce
Q 008785 49 WKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSW 128 (553)
Q Consensus 49 ~~~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w 128 (553)
.|.+||.||. .|+++||+|+.++++|.+|+.+|+++||+||+|+|++|++||..+. ..+||||+ +...++.|
T Consensus 2 ~c~~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~fl~~~~----~~~WIGl~--~~~~~~~w 73 (123)
T 1hq8_A 2 YCGPCPNNWI--CHRNNCYQFFNEEKTWNQSQASCLSQNSSLLKIYSKEEQDFLKLVK----SYHWMGLV--QIPANGSW 73 (123)
T ss_dssp CCCCCSTTCE--EETTEEEEEEEEEECHHHHHHHHHTTTCEECCCSCTTTTGGGGGCC----SCEEEEEE--ECTTTCCE
T ss_pred cCCCCCcccE--EcCCEEEEEeCCccCHHHHHHHHHhcCCEecccCCHHHHHHHHhcc----CCEEEEee--ecCCCCCe
Confidence 4788999999 8999999999999999999999999999999999999999998653 57999999 66667999
Q ss_pred EEcCCCCCCcCcccccCccCCCCCCCCCCCCCCCCeeEEEeCCCCceecccCCCCCCccceec
Q 008785 129 KWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVE 191 (553)
Q Consensus 129 ~W~dg~~~~~~~~~~~~~~~~~~~~~~C~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~~ 191 (553)
+|+||+++.+.+|..++|. .++|+.+... ..|++..|....+|||+.+
T Consensus 74 ~W~dg~~~~~~~w~~~~p~--------------~~~C~~~~~~-~~w~~~~C~~~~~fICe~~ 121 (123)
T 1hq8_A 74 QWEDGSSLSYNQLTLVEIP--------------KGSCAVYGSS-FKAYTEDCANLNTYICMKR 121 (123)
T ss_dssp EETTSCBCCTTTCEEECCT--------------TCCEEEECST-TEEEEECTTSCEEEEEEEC
T ss_pred EeCCCCCccccccccCCCC--------------CCCcEEEecc-CCEeccCCCCCceeEeeee
Confidence 9999999888777665541 2478887654 4799999999999999864
|
| >2bpd_A Dectin-1; receptor, beta-glucan, fungal recognition, C-type lectin-like domain, CTLD, carbohydrate; 1.5A {Mus musculus} PDB: 2bph_A 2bpe_A 2cl8_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=7.2e-26 Score=201.37 Aligned_cols=128 Identities=22% Similarity=0.494 Sum_probs=107.0
Q ss_pred CCCCCCcCCcccCCCCeEEEEecCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHhhCCC-CCCeEeeeeecCCCCCCc
Q 008785 49 WKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKN-VNGCWVGGRSINTTVGLS 127 (553)
Q Consensus 49 ~~~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~-~~~~WiGl~~~~~~~~~~ 127 (553)
....||.||. .|+++||+|+.+.++|.+|+.+|+++||+||+|+|++|++||.+++... ...+||||+ +...+|.
T Consensus 13 ~~~~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~WIGl~--~~~~~~~ 88 (142)
T 2bpd_A 13 FSQSCLPNWI--MHGKSCYLFSFSGNSWYGSKRHCSQLGAHLLKIDNSKEFEFIESQTSSHRINAFWIGLS--RNQSEGP 88 (142)
T ss_dssp --CCCCTTCE--EETTEEEEEEEEEECHHHHHHHHHHTTCEECCCCSHHHHHHHHHHHGGGTTSEEEEEEE--CSSTTSC
T ss_pred CCCCCCccce--ecCCEEEEEECCCCCHHHHHHHHHHcCCEEeeeCCHHHHHHHHHHHhccCCCCEEEEee--cCCCCCC
Confidence 3467999999 8999999999999999999999999999999999999999999988532 467999999 6667799
Q ss_pred eEEcCCCCCCcCcccccCccCCCCCCCCCCCCCCCCeeEEEeCCCCceecccCCCCCCccceec
Q 008785 128 WKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVE 191 (553)
Q Consensus 128 w~W~dg~~~~~~~~~~~~~~~~~~~~~~C~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~~ 191 (553)
|+|+||+++.+.+|..+.+.+. ..+.++|+.+.. ..|++..|....+|||+.+
T Consensus 89 w~W~dg~~~~~~~w~~~~~~~~---------~~~~~~Cv~~~~--~~W~d~~C~~~~~fICe~~ 141 (142)
T 2bpd_A 89 WFWEDGSAFFPNSFQVRNAVPQ---------ESLLHNCVWIHG--SEVYNQICNTSSYSICEKE 141 (142)
T ss_dssp CEETTSCBCCSSSCCEECCCCS---------CCSCCCEEEEET--TEEEEECTTSCEEEEEEEC
T ss_pred eEeCCCCccccccccccCCCCC---------CCCCCCCcEEcC--CeEECcCCCCCceeeeeee
Confidence 9999999988777765432111 124568998865 4799999999999999864
|
| >2afp_A Protein (SEA raven type II antifreeze protein); recombinant SEA raven protein, solution backbone fold, C- type lectin; NMR {Hemitripterus americanus} SCOP: d.169.1.1 | Back alignment and structure |
|---|
Probab=99.93 E-value=4.6e-26 Score=199.05 Aligned_cols=125 Identities=26% Similarity=0.500 Sum_probs=105.8
Q ss_pred CCCCCCcCCcccCCCCeEEEEecCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHhhCCCCCCeEeeeeecCCCCCCce
Q 008785 49 WKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSW 128 (553)
Q Consensus 49 ~~~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w 128 (553)
.+..||.||. .|+++||+|+.+.++|.+|+.+|+.+||+||+|+|++|++||.++ . ...+||||+ +...++.|
T Consensus 3 ~~~~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~~l~~~-~--~~~~WIGl~--~~~~~~~~ 75 (129)
T 2afp_A 3 AGPNCPAGWQ--PLGDRCIYYETTAMTWALAETNCMKLGGHLASIHSQEEHSFIQTL-N--AGVVWIGGS--ACLQAGAW 75 (129)
T ss_dssp CCCSSCSSSC--CCSSSEECCCCSCCCHHHHHHHHHHHSCEECCCSSSHHHHHHHHH-C--SSCBCCSCB--CSSSSSCC
T ss_pred ccCCCCcCcE--EcCCEEEEEECCcCCHHHHHHHHHHcCCEECCcCCHHHHHHHHhc-C--CCCEEEccc--ccCCCCce
Confidence 3568999999 999999999999999999999999999999999999999999999 3 578999999 66667999
Q ss_pred EEcCCCCCCcCcccccCccCCCCCCCCCCCCCCCCeeEEEeCCCC-ceecccCCCCCCccceec
Q 008785 129 KWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSR-SLVTERCNTSHPFICMVE 191 (553)
Q Consensus 129 ~W~dg~~~~~~~~~~~~~~~~~~~~~~C~~~~~~~~C~~~~~~~~-~w~~~~C~~~~~~iC~~~ 191 (553)
+|+||+++.+..|..++|.+. ..++|+.+..... .|++..|....+|||+.+
T Consensus 76 ~W~dg~~~~~~~W~~~~P~~~-----------~~~~C~~~~~~~~~~w~~~~C~~~~~~iCe~~ 128 (129)
T 2afp_A 76 TWSDGTPMNFRSWCSTKPDDV-----------LAACCMQMTAAADQCWDDLPCPASHKSVCAMT 128 (129)
T ss_dssp BSSSSCCCCCCCSSSCCSCCS-----------TTCCBCCBCCSSSSCBCCBCSCCCCCCCEEEC
T ss_pred EeCCCCccccCCcCCCccCCC-----------CCCCCeEEccCCCCEEeCCCCCCCcceEEeee
Confidence 999999998877776665321 1146666655443 599999999999999863
|
| >1sl6_A C-type lectin DC-signr; sugar binding protein; HET: GAL NDG FUC; 2.25A {Homo sapiens} SCOP: d.169.1.1 PDB: 1xar_A | Back alignment and structure |
|---|
Probab=99.93 E-value=9e-26 Score=209.74 Aligned_cols=128 Identities=20% Similarity=0.417 Sum_probs=107.9
Q ss_pred CCCCCCcCCcccCCCCeEEEEecCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHhhCCCCCCeEeeeeecCCCCCCce
Q 008785 49 WKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSW 128 (553)
Q Consensus 49 ~~~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w 128 (553)
.|..||.||. .|+++||+|+...++|.+|+.+|.++|||||+|+|.+|++||.++.......+||||+ +...+|.|
T Consensus 49 ~~~~Cp~gw~--~~~~~CY~~~~~~~tw~~A~~~C~~~g~~La~i~s~~e~~fl~~~~~~~~~~~WIGl~--~~~~~~~w 124 (184)
T 1sl6_A 49 LCRHCPKDWT--FFQGNCYFMSNSQRNWHDSVTACQEVRAQLVVIKTAEEQNFLQLQTSRSNRFSWMGLS--DLNQEGTW 124 (184)
T ss_dssp TCCBCCTTCE--EETTEEEEECSSCBCHHHHHHHHHTTTCEECCCCSHHHHHHHHHHHHHTTCCEEEEEE--CCSSTTCC
T ss_pred cCCCCCCCcE--EECCEEEEEECCCCCHHHHHHHHHhcCCEEEEeCCHHHHHHHHHHhccCCccEEEEEE--ccCCCCCe
Confidence 4678999999 8999999999999999999999999999999999999999999865333568999999 66677999
Q ss_pred EEcCCCCCCc---CcccccCccCCCCCCCCCCCCCCCCeeEEEeCCCCceecccCCCCCCccceeccc
Q 008785 129 KWSDNMSKWN---ESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVEHE 193 (553)
Q Consensus 129 ~W~dg~~~~~---~~~~~~~~~~~~~~~~~C~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~~~~ 193 (553)
.|+||+++.+ .+|..+.|+ +.+.++|+.+... .|++..|....+|||+.+..
T Consensus 125 ~W~DGs~~~~~~~~~W~~geP~-----------~~~~~~Cv~~~~~--gW~d~~C~~~~~fICe~~~~ 179 (184)
T 1sl6_A 125 QWVDGSPLSPSFQRYWNSGEPN-----------NSGNEDCAEFSGS--GWNDNRCDVDNYWICKKPAA 179 (184)
T ss_dssp EETTSCBCCGGGGGGBCTTCCC-----------CTTSCCEEEEETT--EEEEECTTSCBEEEEEEECB
T ss_pred EecCCCccCCcccCCCCCCCCC-----------CCCCCCceEEeCC--cEEccCCCCCeeEEEeECCc
Confidence 9999999864 345554442 2245689988764 49999999999999998754
|
| >3kqg_A Langerin, C-type lectin domain family 4 member K; trimer, NECK and CRD, coiled coil, immune system; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.3e-25 Score=208.42 Aligned_cols=126 Identities=18% Similarity=0.308 Sum_probs=107.6
Q ss_pred CCCcCCcccCCCCeEEEEecCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHhhCCCCCCeEeeeeecCCCCCCceEEc
Q 008785 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWS 131 (553)
Q Consensus 52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~ 131 (553)
.||.||. .|+++||+|+...++|.+|+.+|..+|||||+|+|.+|++||.++.. ...|||||+ +...+|.|.|+
T Consensus 48 ~Cp~gw~--~~~~~CY~~~~~~~tw~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~--~~~~WIGl~--~~~~~~~w~W~ 121 (182)
T 3kqg_A 48 VVSQGWK--YFKGNFYYFSLIPKTWYSAEQFCVSRNSHLTSVTSESEQEFLYKTAG--GLIYWIGLT--KAGMEGDWSWV 121 (182)
T ss_dssp HHTTTCE--EETTEEEEECSSCBCHHHHHHHHHHTTCEECCCCSHHHHHHHHHHHT--TCCEEEEEE--ECSTTCCEEET
T ss_pred cCCCCCE--EeCCEEEEEECCCCCHHHHHHHHHhCCCEEeeeCCHHHHHHHHHhcC--CCcEEEEeE--ccCCCCceEeC
Confidence 5999999 89999999999999999999999999999999999999999999886 468999999 65567999999
Q ss_pred CCCCCC----cCcccccCccCCCCCCCCCCCCCCCCeeEEEeCCC-CceecccCCCCCCccceeccc
Q 008785 132 DNMSKW----NESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS-RSLVTERCNTSHPFICMVEHE 193 (553)
Q Consensus 132 dg~~~~----~~~~~~~~~~~~~~~~~~C~~~~~~~~C~~~~~~~-~~w~~~~C~~~~~~iC~~~~~ 193 (553)
||+++. +.+|..+.|. + ..+.++|+.+.... ..|++..|....+|||+.+..
T Consensus 122 dG~~~~~~~~~~~W~~geP~-~---------~~~~~~Cv~~~~~~~~~W~d~~C~~~~~fICe~~~~ 178 (182)
T 3kqg_A 122 DDTPFNKVQSARFWIPGEPN-N---------AGNNEHCGNIKAPSLQAWNDAPCDKTFLFICKRPYV 178 (182)
T ss_dssp TCCCCCHHHHTTTBCTTCCC-C---------TTSCCCEEEECSSSSSCEEEECTTSCBEEEEEEECC
T ss_pred CCCccccccccCCCCCCCCC-C---------CCCCCCeeEEecCCCCCEeCcCCCCCeeEEeccCCC
Confidence 999987 5566655542 1 22356898886643 479999999999999998654
|
| >1dv8_A Asialoglycoprotein receptor 1; C-type lectin CRD, signaling protein; 2.30A {Homo sapiens} SCOP: d.169.1.1 | Back alignment and structure |
|---|
Probab=99.93 E-value=2.5e-25 Score=194.03 Aligned_cols=125 Identities=22% Similarity=0.516 Sum_probs=105.5
Q ss_pred CCcCCcccCCCCeEEEEecCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHhhCCCCCCeEeeeeecCCCCCCceEEcC
Q 008785 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSD 132 (553)
Q Consensus 53 Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~d 132 (553)
||.||. .|+++||+|+.+.++|.+|+.+|+.+||+||+|+|++|++||.+++. ...+||||+ +. ++.|+|+|
T Consensus 1 Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~--~~~~WIGl~--~~--~~~~~W~d 72 (128)
T 1dv8_A 1 CPVNWV--EHERSCYWFSRSGKAWADADNYCRLEDAHLVVVTSWEEQKFVQHHIG--PVNTWMGLH--DQ--NGPWKWVD 72 (128)
T ss_dssp CCTTCE--EETTEEEEECSSCBCHHHHHHHHHHTTCEECCCCSHHHHHHHHHHHC--SSCEEEEEE--CT--TSSCEETT
T ss_pred CCCcce--ecCCEEEEEECCCcCHHHHHHHHhhCCCEEcccCCHHHHHHHHHhhC--CCCEEeeEE--cC--CCcEEeCC
Confidence 999999 89999999999999999999999999999999999999999999986 568999999 54 69999999
Q ss_pred CCCC--CcCcccccCccCCCCCCCCCCCCCCCCeeEEEeCCCCceecccCCCCCCccceec
Q 008785 133 NMSK--WNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVE 191 (553)
Q Consensus 133 g~~~--~~~~~~~~~~~~~~~~~~~C~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~~ 191 (553)
|+++ .+.+|..++|.+... ....+.++|+.+.. ...|++..|....+|||+.+
T Consensus 73 g~~~~~~~~~W~~g~P~~~~~-----~~~~~~~~C~~~~~-~g~W~~~~C~~~~~fICe~~ 127 (128)
T 1dv8_A 73 GTDYETGFKNWRPEQPDDWYG-----HGLGGGEDCAHFTD-DGRWNDDVCQRPYRWVCETE 127 (128)
T ss_dssp CCCSTTSCCCBCTTCCCCCCT-----TSSSSCCCEEEECT-TSCEEEECTTSCBEEEEEEE
T ss_pred CCcCCcccccCCCCCCCCccc-----ccCCCCCcCceecC-CCcCCCccCCCCcceeeeeC
Confidence 9998 677777666532111 01134678998864 35899999999999999864
|
| >2kv3_A Regenerating islet-derived protein 4; GISP, C-type lectin, REG IV, disulfide bond, glycoPro lectin, secreted, sugar binding protein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.1e-25 Score=197.21 Aligned_cols=123 Identities=24% Similarity=0.617 Sum_probs=106.6
Q ss_pred CCCcCCcccCCCCeEEEEecCCCChHHHHHHHhhc--CCEEeeeCCHHHHHHHHHhhCCC--CCCeEeeeeecCCCCCCc
Q 008785 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI--GGHLAALTSYEEEHSAQKLCGKN--VNGCWVGGRSINTTVGLS 127 (553)
Q Consensus 52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~--~~~L~~i~~~~e~~f~~~~~~~~--~~~~WiGl~~~~~~~~~~ 127 (553)
.||.||. .|+++||+|+.+.++|.+|+.+|+++ |||||+|+|++|++||.+++... ...+||||+ +...++.
T Consensus 2 ~Cp~gw~--~~~~~CY~~~~~~~tw~~A~~~C~~~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~WIGl~--~~~~~~~ 77 (131)
T 2kv3_A 2 SCAPGWF--YHKSNCYGYFRKLRNWSDAELECQSYGNGAHLASILSLKEASTIAEYISGYQRSQSIWIGLH--DPQKRQQ 77 (131)
T ss_dssp CSCTTCC--EETTEEEEEEEEEECHHHHHHHHHTTSSSCEECCCSSHHHHHHHHHHHTCTTSCCCCBCSEE--CSSSSSC
T ss_pred cCCcccE--EcCCEeEEEECCCCCHHHHHHHHhccCCCceEeeeCCHHHHHHHHHHHHhcCCCCCEEEecc--CCCCCCC
Confidence 5999999 89999999999999999999999999 99999999999999999998753 467999999 6666799
Q ss_pred eEEcCCCCCCcCcccccCccCCCCCCCCCCCCCCCCeeEEEeCCCC--ceecccCCCCCCccceec
Q 008785 128 WKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSR--SLVTERCNTSHPFICMVE 191 (553)
Q Consensus 128 w~W~dg~~~~~~~~~~~~~~~~~~~~~~C~~~~~~~~C~~~~~~~~--~w~~~~C~~~~~~iC~~~ 191 (553)
|+|+||+++.+.+|..++| .+.++|+.+..... .|++..|....+|||+.+
T Consensus 78 ~~W~dg~~~~~~~W~~~~P-------------~~~~~C~~~~~~~~~~~W~~~~C~~~~~~iCe~~ 130 (131)
T 2kv3_A 78 WQWIDGAMYLYRSWSGKSM-------------GGNKHCAEMSSNNNFLTWSSNECNKRQHFLCKYR 130 (131)
T ss_dssp CEETTCCCCSSCCCSSCCC-------------TTCTTEEEECTTCTTCCEEEECTTCCEEEEEEEC
T ss_pred eEeCCcCcccccccCCCCC-------------CCCCCceEEECCCCcCceecCCCCCCceEEEeeC
Confidence 9999999997777766554 12458888866543 599999999999999864
|
| >1gz2_A Ovocleidin-17, OC-17 ovocleidin; structural protein, CTLD, eggshell structural protein, phosphoprotein, sugar-binding protein, glycoprotein; HET: SEP; 1.5A {Gallus gallus} SCOP: d.169.1.1 | Back alignment and structure |
|---|
Probab=99.93 E-value=8.8e-26 Score=200.54 Aligned_cols=126 Identities=25% Similarity=0.566 Sum_probs=107.6
Q ss_pred CCCCCcCCcccCCCCeEEEEecCCCChHHHHHHHhh--cCCEEeeeCCHHHHHHHHHhhCCC----------CCCeEeee
Q 008785 50 KAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKN----------VNGCWVGG 117 (553)
Q Consensus 50 ~~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~--~~~~L~~i~~~~e~~f~~~~~~~~----------~~~~WiGl 117 (553)
+..||.||. .|+++||+|+...++|.+|+.+|+. +||+||+|+|.+|++||.+++... ...+||||
T Consensus 2 ~~~Cp~gw~--~~~~~Cy~~~~~~~~w~~A~~~C~~~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~~~~~~~~~WIGl 79 (142)
T 1gz2_A 2 PDGCGPGWV--PTPGGCLGFFSRELSWSRAESFCRRWGPGSHLAAVRSAAELRLLAELLNASRGGDGSGEGADGRVWIGL 79 (142)
T ss_dssp --CCCTTCE--EETTEEEEEEEEEECHHHHHHHHHTTCTTEEECCCCSHHHHHHHHHHHHCSSCCSSSCCCCSSCEEEEE
T ss_pred CCCCCcccE--EcCCEEEEEcCCCcCHHHHHHHHhccCCCceECccCCHHHHHHHHHHHHhcccccccccccCCCEEEEe
Confidence 457999999 8999999999999999999999999 999999999999999999987542 35799999
Q ss_pred eecCCCCCCceEEcCCCCCCcCcccccCccCCCCCCCCCCCCCCCCeeEEEeCCCC--ceecccCCCCCCccceec
Q 008785 118 RSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSR--SLVTERCNTSHPFICMVE 191 (553)
Q Consensus 118 ~~~~~~~~~~w~W~dg~~~~~~~~~~~~~~~~~~~~~~C~~~~~~~~C~~~~~~~~--~w~~~~C~~~~~~iC~~~ 191 (553)
+ +...++.|+|+||+++.+..|..+.|.+. .++|+.+..... .|++..|....+|||+.+
T Consensus 80 ~--~~~~~~~w~W~dg~~~~~~~W~~~~P~~~------------~~~C~~~~~~~~~~~w~~~~C~~~~~fICe~~ 141 (142)
T 1gz2_A 80 H--RPAGSRSWRWSDGTAPRFASWHRTAKARR------------GGRCAALRDEEAFTSWAARPCTERNAFVCKAA 141 (142)
T ss_dssp E--CCTTCSSCEETTSCCCCCCCBCSSSGGGC------------SCSEEEECTTTTSSCEEEECTTCCEEEEEEEE
T ss_pred e--cCCCCCCcEeCCCCccCccCcCCCCCCCC------------CCCCeEEecCCCCCeEecCCCCCCceeEEeec
Confidence 9 66677999999999988887776665321 458888876543 799999999999999864
|
| >1tdq_B Aggrecan core protein; extracellular matrix, lecticans, tenascins, protein-protein interactions, C-type lectin domain; 2.60A {Rattus norvegicus} SCOP: d.169.1.1 | Back alignment and structure |
|---|
Probab=99.92 E-value=1.6e-25 Score=195.80 Aligned_cols=125 Identities=23% Similarity=0.437 Sum_probs=107.0
Q ss_pred CCCCCcCCcccCCCCeEEEEecCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHhhCCCCCCeEeeeeecCCCCCCceE
Q 008785 50 KAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWK 129 (553)
Q Consensus 50 ~~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~ 129 (553)
...||.||. .|+++||+|+.+.++|.+|+.+|+.+||+||+|+|.+|++||.+++. ..+||||+ +...++.|+
T Consensus 4 ~~~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~---~~~WIGl~--~~~~~~~~~ 76 (130)
T 1tdq_B 4 QEQCEEGWT--KFQGHCYRHFPDRETWVDAERRCREQQSHLSSIVTPEEQEFVNKNAQ---DYQWIGLN--DRTIEGDFR 76 (130)
T ss_dssp -CCCCTTCE--EETTEEEEEEEEEECHHHHHHHHHHTTCEECCCCSHHHHHHHHHHHC---SCEEEEEE--CSSSTTCCE
T ss_pred ccCCCcccE--EeCCEEEEEECCCCCHHHHHHHHHhcCCEEeeeCCHHHHHHHHhccC---CCEEEeee--cCCCCCEEE
Confidence 347999999 89999999999999999999999999999999999999999999885 57999999 666679999
Q ss_pred EcCCCCCCcCcccccCccCCCCCCCCCCCCCCCCeeEEEeC-CCCceecccCCCCCCcccee
Q 008785 130 WSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSN-GSRSLVTERCNTSHPFICMV 190 (553)
Q Consensus 130 W~dg~~~~~~~~~~~~~~~~~~~~~~C~~~~~~~~C~~~~~-~~~~w~~~~C~~~~~~iC~~ 190 (553)
|+||+++.+..|..++|.+. ..+.++|+.+.. ....|++..|....+|||+.
T Consensus 77 W~dg~~~~~~~W~~~~P~~~---------~~~~~~C~~~~~~~~~~w~~~~C~~~~~fICe~ 129 (130)
T 1tdq_B 77 WSDGHSLQFEKWRPNQPDNF---------FATGEDCVVMIWHERGEWNDVPCNYQLPFTCKK 129 (130)
T ss_dssp ETTCCCCCCCCBCTTCCCCC---------STTTEEEEEEETTTTTEEEEEETTSCEEEEEEE
T ss_pred ecCCCcCCccccCCCCCCCc---------cCCCCCeEEEccCCCCcccCcCCCCCeeeeeec
Confidence 99999998877776665211 024569998864 35679999999999999975
|
| >3m9z_A Killer cell lectin-like receptor subfamily B MEMB; C-type lectin-like domain, domain swapping, disulfide bond, transmembrane protein; 1.70A {Mus musculus} SCOP: d.169.1.0 PDB: 3t3a_A | Back alignment and structure |
|---|
Probab=99.92 E-value=1e-25 Score=199.60 Aligned_cols=125 Identities=26% Similarity=0.554 Sum_probs=107.2
Q ss_pred CCCCcCCcccCCCCeEEEEecCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHhhCCCCCCeEeeeeecCCCCCCceEE
Q 008785 51 APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKW 130 (553)
Q Consensus 51 ~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W 130 (553)
..||.||+ .|+++||+|+.+.++|.+|+.+|+++||+||+|+|.+|++||.+++......+||||+ +...++.|+|
T Consensus 4 ~~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~~~~~~~WIGl~--~~~~~~~w~W 79 (139)
T 3m9z_A 4 LECPQDWL--SHRDKCFHVSQVSNTWEEGLVDCDGKGATLMLIQDQEELRFLLDSIKEKYNSFWIGLR--YTLPDMNWKW 79 (139)
T ss_dssp CCCCTTCE--EETTEEEEECSSCBCHHHHHHHHHHTTCEECCCCCHHHHHHHHHHHTCSSSCEEEEEE--EECCCCCCBC
T ss_pred CCCCccce--ecCCEEEEEECCcCCHHHHHHHHHhcCCeEeeeCCHHHHHHHHHHhcccCccEEEEEe--ccCCCCCeEe
Confidence 57999999 8999999999999999999999999999999999999999999998754568999999 5556699999
Q ss_pred cCCCCCCcCcccccCccCCCCCCCCCCCCCCCCeeEEEeCCCCceecccCCCCCCccceecccC
Q 008785 131 SDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVEHEN 194 (553)
Q Consensus 131 ~dg~~~~~~~~~~~~~~~~~~~~~~C~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~~~~~ 194 (553)
+||+++.+..|+..++. ..++|+.+.. ..|++..|....+|||+.+...
T Consensus 80 ~dg~~~~~~~~~~~~~~-------------~~~~Cv~~~~--~~w~~~~C~~~~~fICe~~~~~ 128 (139)
T 3m9z_A 80 INGSTLNSDVLKITGDT-------------ENDSCAAISG--DKVTFESCNSDNRWICQKELYH 128 (139)
T ss_dssp TTSCBCCHHHHTTSSCT-------------TCEEEEEEET--TEEEEEETTSCBEEEEEEECC-
T ss_pred CCCCcCCcCccccCCCC-------------CCCCeeEEeC--CcEEeCCCCCCCceEeeecCcc
Confidence 99999887766644431 1358998875 4799999999999999986543
|
| >2ox9_A Collectin placenta 1; C-type lectin, sugar binding protein; HET: GAL NAG FUC; 1.95A {Mus musculus} PDB: 2ox8_A | Back alignment and structure |
|---|
Probab=99.92 E-value=2.7e-25 Score=197.12 Aligned_cols=131 Identities=22% Similarity=0.422 Sum_probs=109.9
Q ss_pred CCCCcCCcccCCCCeEEEEecCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHhhCCCCCCeEeeeeecCCCCCCceEE
Q 008785 51 APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKW 130 (553)
Q Consensus 51 ~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W 130 (553)
..||.||. .|+++||+|+...++|.+|+.+|+.+||+||+|+|++|++||.+++.. ...+||||+ +...++.|+|
T Consensus 3 ~~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~~-~~~~WIGl~--~~~~~~~~~W 77 (140)
T 2ox9_A 3 NGCPPHWK--NFTDKCYYFSLEKEIFEDAKLFCEDKSSHLVFINSREEQQWIKKHTVG-RESHWIGLT--DSEQESEWKW 77 (140)
T ss_dssp -CCCTTCE--EETTEEEEECSCCBCHHHHHHHHHHTTCEECCCCSHHHHHHHHHTCCS-SSCEEEEEE--CSSSTTCCEE
T ss_pred CCCCcCce--EcCCEEEEEECCCcCHHHHHHHHHhcCCEEeeeCCHHHHHHHHHHhcC-CCCEEeeeE--eCCCCCceEe
Confidence 36999999 899999999999999999999999999999999999999999998753 568999999 6666799999
Q ss_pred cCCCCCCcCcccccCccCCCCCCCCCCCCCCCCeeEEEeCCCCceecccCCCCCCccceeccc
Q 008785 131 SDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVEHE 193 (553)
Q Consensus 131 ~dg~~~~~~~~~~~~~~~~~~~~~~C~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~~~~ 193 (553)
+||+++.+.+|..++|++. . ....+.++|+.+.. ...|++..|....+|||+.+..
T Consensus 78 ~dg~~~~~~~W~~~~P~~~--~----~~~~~~~~Cv~~~~-~g~W~d~~C~~~~~fICe~~~~ 133 (140)
T 2ox9_A 78 LDGSPVDYKNWKAGQPDNW--G----SGHGPGEDCAGLIY-AGQWNDFQCDEINNFICEKERE 133 (140)
T ss_dssp TTSCBCCSCCBCTTCCCCT--T----TTTSSCCCEEEECG-GGCEEEECTTSCBEEEEEEECC
T ss_pred CCcCcCCccCcCCcCCCCc--c----cCCCCCCCCceECC-CCeEeccCCCCCceeEEeecCC
Confidence 9999988888877665321 0 01134578998864 3579999999999999998654
|
| >1fvu_B Botrocetin beta chain; VON WILLBRAND factor modulator, C-type lectin, metal- binding, loop exchanged dimer, toxin; 1.80A {Bothrops jararaca} SCOP: d.169.1.1 PDB: 1ijk_C 1u0n_C 1u0o_B | Back alignment and structure |
|---|
Probab=99.92 E-value=1.4e-25 Score=194.79 Aligned_cols=120 Identities=23% Similarity=0.576 Sum_probs=102.8
Q ss_pred CCCcCCcccCCCCeEEEEecCCCChHHHHHHHhh--cCCEEeeeCCHHHHHHHHHhhCCC--CCCeEeeeeecCCCCCCc
Q 008785 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKN--VNGCWVGGRSINTTVGLS 127 (553)
Q Consensus 52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~--~~~~L~~i~~~~e~~f~~~~~~~~--~~~~WiGl~~~~~~~~~~ 127 (553)
+||.||. .|+++||+|+.+.++|.+|+.+|+. .||+||+|+|.+|++||.+++... ...+||||+ +...++.
T Consensus 1 ~Cp~gw~--~~~~~Cy~~~~~~~~w~~A~~~C~~~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~WIGl~--~~~~~~~ 76 (125)
T 1fvu_B 1 DCPPDWS--SYEGHCYRFFKEWMHWDDAEEFCTEQQTGAHLVSFQSKEEADFVRSLTSEMLKGDVVWIGLS--DVWNKCR 76 (125)
T ss_dssp CCSTTCE--EETTEEEEEEEEEECHHHHHHHHHHHSTTCEECCCSSHHHHHHHHTTCTTSCTTCCEECSCC--CCSTTSC
T ss_pred CcCCccE--EcCCEEEEEeCCCCCHHHHHHHHhccCCCcEECccCCHHHHHHHHHHHHhcCCCCCEEEeee--ecCCCCc
Confidence 4999999 8999999999999999999999999 899999999999999999988643 468999999 6666799
Q ss_pred eEEcCCCCCCcCcccccCccCCCCCCCCCCCCCCCCeeEEEeCCCCceecccCCCCCCccceec
Q 008785 128 WKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVE 191 (553)
Q Consensus 128 w~W~dg~~~~~~~~~~~~~~~~~~~~~~C~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~~ 191 (553)
|+|+||+++.+.+|..+.|. +|+.+....+.|++..|....+|||+.+
T Consensus 77 ~~W~dg~~~~~~~w~~~~P~----------------~C~~~~~~~g~w~~~~C~~~~~~iCe~~ 124 (125)
T 1fvu_B 77 FEWTDGMEFDYDDYYLIAEY----------------ECVASKPTNNKWWIIPCTRFKNFVCEFQ 124 (125)
T ss_dssp EEETTSCCCCC----CCSCC----------------EEEEEETTTTEEEEEETTSCEEEEEEEC
T ss_pred eEecCCCccCccccCCCCCC----------------CceEEECCCCcEeCCcCCCCCcEEEeec
Confidence 99999999887777665541 7888877656899999999999999864
|
| >1wmz_A Lectin CEL-I, N-acetyl-D-galactosamine-specific C-type; C-type lectin, N-acetylgalactosamine, invertebrate, sugar binding protein; HET: NGA A2G; 1.70A {Cucumaria echinata} SCOP: d.169.1.1 PDB: 1wmy_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=9.9e-26 Score=199.87 Aligned_cols=126 Identities=13% Similarity=0.341 Sum_probs=108.5
Q ss_pred CCCcCCcccCCCCeEEEEecCCCChHHHHHHHh-------hcCCEEeeeCCHHHHHHHHHhhCC---CCCCeEeeeeecC
Q 008785 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCK-------EIGGHLAALTSYEEEHSAQKLCGK---NVNGCWVGGRSIN 121 (553)
Q Consensus 52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~-------~~~~~L~~i~~~~e~~f~~~~~~~---~~~~~WiGl~~~~ 121 (553)
+||.||+ .|+++||+|+.+.++|.+|+.+|+ .+|||||+|+|++|++||.+++.. ....+||||+ +
T Consensus 2 ~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~~~~~~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~~WiGl~--~ 77 (140)
T 1wmz_A 2 QCPTDWE--AEGDHCYRFFNTLTTWENAHHECVSYSCSTLNVRSDLVSVHSAAEQAYVFNYWRGIDSQAGQLWIGLY--D 77 (140)
T ss_dssp CCCTTCE--EETTEEEEEEEEEECHHHHHHHHHTTCBGGGTEEEEECCCCSHHHHHHHHHHHHHHCCSSCCEEEEEE--C
T ss_pred cCCCcce--ecCCEEEEEECCCcCHHHHHHhhhhhccCCCCCCcEEcccCCHHHHHHHHHHHhhccCCCCCEEEeee--e
Confidence 6999999 899999999999999999999999 999999999999999999988743 1468999999 6
Q ss_pred CCCCCceEEcCCCCCCcCcccccCccCCCCCCCCCCCCCCCCeeEEEeCCCC-ceecccCCCCCCccceec
Q 008785 122 TTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSR-SLVTERCNTSHPFICMVE 191 (553)
Q Consensus 122 ~~~~~~w~W~dg~~~~~~~~~~~~~~~~~~~~~~C~~~~~~~~C~~~~~~~~-~w~~~~C~~~~~~iC~~~ 191 (553)
...++.|.|+||+++.+.+|..+.|.+ ..+.++|+.+..... .|++..|....+|||+.+
T Consensus 78 ~~~~~~~~W~dg~~~~~~~W~~~~P~~----------~~~~~~Cv~~~~~~~~~W~~~~C~~~~~fICe~~ 138 (140)
T 1wmz_A 78 KYNEGDFIWTDGSKVGYTKWAGGQPDN----------WNNAEDYGQFRHTEGGAWNDNSAAAQAKYMCKLT 138 (140)
T ss_dssp SSSTTCCEETTCCCCCCCCBCTTCCCC----------GGGCEEEEEECSSTTTCEEEEETTCCEEEEEEEE
T ss_pred cCCCCeeEECCcCcccccCcCcccCCC----------CCCcCCcEEEccCCCCCEeCCCCCCCceEEEEEe
Confidence 666799999999999887777666521 124579999876644 799999999999999875
|
| >2yhf_A C-type lectin domain family 5 member A; immune system; 1.90A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=2e-25 Score=191.86 Aligned_cols=117 Identities=22% Similarity=0.405 Sum_probs=99.5
Q ss_pred CCCcCCcccCCCCeEEEEecCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHhhCCCCCCeEeeeeecCCCCCCceEEc
Q 008785 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWS 131 (553)
Q Consensus 52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~ 131 (553)
+||.||. .|+++||+|+.+.++|.+|+.+|+.+|||||+|+|++|++||.+++. ...+||||+ +...++.|+|+
T Consensus 1 ~Cp~gw~--~~~~~Cy~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~--~~~~WIGl~--~~~~~~~w~W~ 74 (118)
T 2yhf_A 1 MCPKDWE--FYQARCFFLSTSESSWNESRDFCKGKGSTLAIVNTPEKLKFLQDITD--AEKYFIGLI--YHREEKRWRWI 74 (118)
T ss_dssp CCCTTCE--EETTEEEEECSSCBCHHHHHHHHHTTTCEECCCCSHHHHHHHHHHHC--SSCEEEEEE--EETTTTEEEET
T ss_pred CCCCCcE--EeCCEEEEEeCCCCCHHHHHHHHhhcCCEEEEeCCHHHHHHHHHhhC--CCcEEEecc--ccCCCCcEEEe
Confidence 4999999 89999999999999999999999999999999999999999999986 568999999 55567999999
Q ss_pred CCCCCCcCcccccCccCCCCCCCCCCCCCCCCeeEEEeCCCCceecccCCCCCCccceec
Q 008785 132 DNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVE 191 (553)
Q Consensus 132 dg~~~~~~~~~~~~~~~~~~~~~~C~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~~ 191 (553)
||+++.+ |....| +.++|+.+... ..|++..|....+|||+.+
T Consensus 75 dg~~~~~--~~~~~~--------------~~~~C~~~~~~-~~w~~~~C~~~~~fICe~~ 117 (118)
T 2yhf_A 75 NNSVFNG--NVTNQN--------------QNFNCATIGLT-KTFDAASCDISYRRICEKN 117 (118)
T ss_dssp TTEECCS--CEESCC--------------TTCCEEEESSS-SSEEEECTTSCBEEEEEEE
T ss_pred CCCcCCC--CccCCC--------------CCCCeeEEcCC-CcCccccCCCCceeeeccc
Confidence 9988642 222111 23588888653 5799999999999999864
|
| >1qdd_A Lithostathine; pancreatic stone inhibitor, metal binding protein; HET: SIA NDG GAL; 1.30A {Homo sapiens} SCOP: d.169.1.1 PDB: 1lit_A | Back alignment and structure |
|---|
Probab=99.92 E-value=1.6e-25 Score=199.52 Aligned_cols=127 Identities=17% Similarity=0.429 Sum_probs=108.2
Q ss_pred CCCCCcCCcccCCCCeEEEEecCCCChHHHHHHHhhc-CCEEeeeCCHHHHHHHHHhhCCC---CCCeEeeeeecCCCCC
Q 008785 50 KAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI-GGHLAALTSYEEEHSAQKLCGKN---VNGCWVGGRSINTTVG 125 (553)
Q Consensus 50 ~~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~-~~~L~~i~~~~e~~f~~~~~~~~---~~~~WiGl~~~~~~~~ 125 (553)
...||.||. .|+++||+|+.+.++|.+|+.+|+.+ ||+||+|+|.+|++||.+++... ...+||||+ +...+
T Consensus 11 ~~~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~~gg~La~i~s~~e~~~l~~~~~~~~~~~~~~WIGl~--~~~~~ 86 (144)
T 1qdd_A 11 RISCPEGTN--AYRSYCYYFNEDRETWVDADLYCQNMNSGNLVSVLTQAEGAFVASLIKESGTDDFNVWIGLH--DPKKN 86 (144)
T ss_dssp GTSCCTTCE--EETTEEEEEEEEEECHHHHHHHHHHTTSCEECCCCSHHHHHHHHHHHHHTTCCCSEEEEEEE--CTTSS
T ss_pred CCCCCCCce--ecCCEeEEEeCCCcCHHHHHHHhhccCCceECccCCHHHHHHHHHHHHhcCCCCCCEEEeeE--cCCCC
Confidence 357999999 89999999999999999999999998 99999999999999999987532 457999999 66667
Q ss_pred CceEEcCCCCCCcCcccccCccCCCCCCCCCCCCCCCCeeEEEeCCC--CceecccCCCCCCccceec
Q 008785 126 LSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS--RSLVTERCNTSHPFICMVE 191 (553)
Q Consensus 126 ~~w~W~dg~~~~~~~~~~~~~~~~~~~~~~C~~~~~~~~C~~~~~~~--~~w~~~~C~~~~~~iC~~~ 191 (553)
+.|.|+||+++.+.+|..+.|. +.+.++|+.+.... ..|++..|....+|||+.+
T Consensus 87 ~~~~W~dg~~~~~~~W~~~~P~-----------~~~~~~Cv~~~~~~~~~~W~d~~C~~~~~fICe~~ 143 (144)
T 1qdd_A 87 RAWHWSSGSLVSYKSWGIGAPS-----------SVNPGYCVSLTSSTGFQKWKDVPCEDKFSFVCKFK 143 (144)
T ss_dssp SCCEETTCCCCCCCCBCTTCSC-----------SSSCCSEEEEEGGGTTCSEEEECTTSCEEEEEEEE
T ss_pred CeEEeCCCCCcCcCccCCCCcC-----------CCCCCCcEEEEecCCCCeEeCCCCCCCceeeeeec
Confidence 9999999999888877766652 12356898886643 4799999999999999864
|
| >3hup_A Early activation antigen CD69; C-type lectin-like domain, disulfide bond, glycoprotein, LEC membrane, phosphoprotein, signal-anchor, transmembrane; 1.37A {Homo sapiens} SCOP: d.169.1.1 PDB: 1e87_A 1e8i_A 3cck_A | Back alignment and structure |
|---|
Probab=99.92 E-value=4.3e-25 Score=193.23 Aligned_cols=118 Identities=25% Similarity=0.535 Sum_probs=100.5
Q ss_pred CCCCCCCcCCcccCCCCeEEEEecCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHhhCCCCCCeEeeeeecCCCCCCc
Q 008785 48 DWKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLS 127 (553)
Q Consensus 48 ~~~~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~ 127 (553)
..+..||.||+ .|+++||+|+.+.++|.+|+.+|+++|||||+|+|++|++||.+++. ...+||||+ + ..++.
T Consensus 11 ~~~~~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~--~~~~WIGl~--~-~~~~~ 83 (130)
T 3hup_A 11 SHVSSCSEDWV--GYQRKCYFISTVKRSWTSAQNACSEHGATLAVIDSEKDMNFLKRYAG--REEHWVGLK--K-EPGHP 83 (130)
T ss_dssp CCCBCCCTTCE--EETTEEEEECSSCBCHHHHHHHHHTTTCEECCCCSHHHHHHHHHHHT--TSCEEEEEE--E-CTTSC
T ss_pred CCCCCCChhhe--ecCCEEEEEECCccCHHHHHHHHHhcCCEEeecCCHHHHHHHHHhhC--CCCEEEEEE--e-CCCCe
Confidence 34578999999 89999999999999999999999999999999999999999999986 568999999 4 24689
Q ss_pred eEEcCCCCCCcCcccccCccCCCCCCCCCCCCCCCCeeEEEeCCCCceecccCCCCCCccceec
Q 008785 128 WKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVE 191 (553)
Q Consensus 128 w~W~dg~~~~~~~~~~~~~~~~~~~~~~C~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~~ 191 (553)
|+|+||+++. +|.. ..+.++|+.+..+ .|++..|....+|||+.+
T Consensus 84 w~W~dg~~~~--~w~~---------------~~~~~~Cv~~~~~--~w~~~~C~~~~~fICe~~ 128 (130)
T 3hup_A 84 WKWSNGKEFN--NWFN---------------VTGSDKCVFLKNT--EVSSMECEKNLYWICNKP 128 (130)
T ss_dssp EEETTSCBCC--CCSC---------------CCSSCSEEEEETT--EEEEECTTSCBEEEEEEE
T ss_pred EEeCCCCccc--CccC---------------CCCCCCceEEeCC--CcccCCCCCCccEEeccC
Confidence 9999999842 3321 1234689988764 699999999999999875
|
| >1mpu_A NKG2-D type II integral membrane protein; C-type lectin-like domain, immune system; 2.50A {Homo sapiens} SCOP: d.169.1.1 PDB: 1hyr_B | Back alignment and structure |
|---|
Probab=99.92 E-value=5.5e-26 Score=201.13 Aligned_cols=122 Identities=23% Similarity=0.512 Sum_probs=105.3
Q ss_pred CCCCCCCCcCCcccCCCCeEEEEecCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHhhCCCCCCeEeeeeecCCCCCC
Q 008785 47 KDWKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGL 126 (553)
Q Consensus 47 ~~~~~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~ 126 (553)
...|..||.||. .|+++||+|+.+.++|.+|+.+|+.+|||||+|+|++|++||..+. ..+||||+ +...++
T Consensus 15 ~~~~~~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~fl~~~~----~~~WIGl~--~~~~~~ 86 (138)
T 1mpu_A 15 ESYCGPCPKNWI--CYKNNCYQFFDESKNWYESQASCMSQNASLLKVYSKEDQDLLKLVK----SYHWMGLV--HIPTNG 86 (138)
T ss_dssp CCCCCCCCTTCE--ECSSCEEEEEEEEECHHHHHHHHHHTSCEECCCCCTTTCGGGGGCC----SEEEEEEE--ECTTTC
T ss_pred CCccCCCChhhe--EeCCEEEEEECCCCCHHHHHHHHHhcCCEEeeeCCHHHHHHHHhcc----CCEeEeee--ccCCCC
Confidence 345678999999 8999999999999999999999999999999999999999998653 58999999 666779
Q ss_pred ceEEcCCCCCCcCcccccCccCCCCCCCCCCCCCCCCeeEEEeCCCCceecccCCCCCCccceec
Q 008785 127 SWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVE 191 (553)
Q Consensus 127 ~w~W~dg~~~~~~~~~~~~~~~~~~~~~~C~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~~ 191 (553)
.|+|+||+++.+..|..+.|. .++|+.+... ..|++..|....+|+|+.+
T Consensus 87 ~w~W~dG~~~~~~~w~~~~p~--------------~~~C~~~~~~-~~w~~~~C~~~~~fICe~~ 136 (138)
T 1mpu_A 87 SWQWEDGSILSPNLLTIIEMQ--------------KGDCALYASS-FKGYIENCSTPNTYICMQR 136 (138)
T ss_dssp CEEETTSCBCCTTSCEEECSS--------------CCSEEEEETT-TEEEEECTTSCEEEEEEEC
T ss_pred ceEeCCCCcCCccccccCCCC--------------CCCCeEEECC-CcEEccCCCCCCeEcccCc
Confidence 999999999888777665541 2478888654 4799999999999999864
|
| >1egg_A Macrophage mannose receptor; C-type lectin, sugar binding protein; 2.30A {Homo sapiens} SCOP: d.169.1.1 PDB: 1egi_A | Back alignment and structure |
|---|
Probab=99.92 E-value=1.5e-25 Score=200.30 Aligned_cols=129 Identities=24% Similarity=0.504 Sum_probs=105.1
Q ss_pred CCCCcCC--cccCCCCeEEEEec----CCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHhhCCC---CCCeEeeeeecC
Q 008785 51 APCPPDW--IINEEKSKCFGYIG----NFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKN---VNGCWVGGRSIN 121 (553)
Q Consensus 51 ~~Cp~~w--~~~~~~~~Cy~~~~----~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~---~~~~WiGl~~~~ 121 (553)
..||.|| . .|+++||+|+. ..++|.+|+.+|+.+||+||+|+|.+|++||.+++... ...+||||+ +
T Consensus 3 ~~Cp~gw~~~--~~~~~CY~~~~~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~~WIGl~--~ 78 (147)
T 1egg_A 3 PKCPEDWGAS--SRTSLCFKLYAKGKHEKKTWFESRDFCRALGGDLASINNKEEQQTIWRLITASGSYHKLFWLGLT--Y 78 (147)
T ss_dssp --CCTTCEEC--SSSSCEEEEECSCGGGCBCHHHHHHHHHTTTCEECCCCSHHHHHHHHHHHHHHTCTTCEEEEEEE--C
T ss_pred CCCCCCCccc--cCCCEEEEEeccCCccccCHHHHHHHHHHcCCEECccCCHHHHHHHHHHHHhccCCCCcEEEeee--c
Confidence 4699999 8 99999999999 99999999999999999999999999999999877422 367999999 6
Q ss_pred CCCCCceEEcCCCCCCcCcccccCccCCCCCCCCCCCCCCCCeeEEEeCC-CCceecccCCCCCCccceeccc
Q 008785 122 TTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNG-SRSLVTERCNTSHPFICMVEHE 193 (553)
Q Consensus 122 ~~~~~~w~W~dg~~~~~~~~~~~~~~~~~~~~~~C~~~~~~~~C~~~~~~-~~~w~~~~C~~~~~~iC~~~~~ 193 (553)
...++.|+|+||+++.+.+|..++|.+ ..+.++|+.+... ...|++..|....+|||+.+..
T Consensus 79 ~~~~~~w~W~dg~~~~~~~W~~g~P~~----------~~~~~~Cv~~~~~~~~~W~d~~C~~~~~fICe~~~~ 141 (147)
T 1egg_A 79 GSPSEGFTWSDGSPVSYENWAYGEPNN----------YQNVEYCGELKGDPTMSWNDINCEHLNNWICQIQKG 141 (147)
T ss_dssp C----CCCCTTSCCCCCCCCCTTCSCG----------GGSCCEEEEEECSTTCCEEEEETTSCBEEEEECCC-
T ss_pred CCCCCcEEecCCCCcccCccCCCCCCC----------CCCCCCCeEECCCCCCceeccCCCCCccEEeeCCCC
Confidence 666799999999998887777666521 1245799998765 4689999999999999997643
|
| >1jwi_B Platelet aggregation inducer; domain swapping, C-type lectin, toxin; 2.00A {Bitis arietans} SCOP: d.169.1.1 PDB: 1uex_B | Back alignment and structure |
|---|
Probab=99.92 E-value=1.1e-25 Score=195.59 Aligned_cols=118 Identities=24% Similarity=0.506 Sum_probs=102.4
Q ss_pred CCCcCCcccCCCCeEEEEecCCCChHHHHHHHh--hcCCEEeeeCCHHHHHHHHHhhCCC--CCCeEeeeeecCCCCCCc
Q 008785 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCK--EIGGHLAALTSYEEEHSAQKLCGKN--VNGCWVGGRSINTTVGLS 127 (553)
Q Consensus 52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~--~~~~~L~~i~~~~e~~f~~~~~~~~--~~~~WiGl~~~~~~~~~~ 127 (553)
.||+||. .|+++||+|+.+.++|.+|+.+|+ .+|||||+|+|++|++||.+++... ...+||||+ +...++.
T Consensus 3 ~Cp~gw~--~~~~~CY~~~~~~~tw~~A~~~C~~~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~WiGl~--~~~~~~~ 78 (125)
T 1jwi_B 3 GCLPDWS--SYKGHCYKVFKVEKTWADAEKFCKELVNGGHLMSVNSREEGEFISKLALEKMRIVLVWIGLS--HFWRICP 78 (125)
T ss_dssp CCCTTCE--EETTEEEEEEEEEECHHHHHHHHHHHSTTCEECCCCSHHHHHHHHHHHHHTTCCCEEEEEEE--ECGGGSC
T ss_pred CCCCCCE--ecCCEEEEEECCCcCHHHHHHHhhccCCCceECccCCHHHHHHHHHHHHhcCCCCCEEEeee--cCCCCCc
Confidence 6999999 899999999999999999999999 8999999999999999999987532 468999999 6556799
Q ss_pred eEEcCCCCCCcCcccccCccCCCCCCCCCCCCCCCCeeEEEeCCCCceecccCCCCCCccceec
Q 008785 128 WKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVE 191 (553)
Q Consensus 128 w~W~dg~~~~~~~~~~~~~~~~~~~~~~C~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~~ 191 (553)
|+|+||+++.+.+|..++ .|+.+...+..|++..|....+|||+.+
T Consensus 79 ~~W~dg~~~~~~~W~~g~------------------pC~~~~~~~~~W~~~~C~~~~~~iCe~~ 124 (125)
T 1jwi_B 79 LRWTDGARLDYRALSDEP------------------ICFVAESFHNKWIQWTCNRKKSFVCKYR 124 (125)
T ss_dssp EEETTCCCCCSCCSCCSC------------------EEEEEETTTCCEEEEETTSCEEEEEEEE
T ss_pred eEeeCcCcCccCCcCCCC------------------CeEEEECCCCeEecCCCCCCCcEEEeEe
Confidence 999999998776665433 2777776557899999999999999864
|
| >1umr_C Convulxin beta, CVX beta; lectin, C-type lectin, platelet, sugar-binding protein, activator, snake venom; 2.40A {Crotalus durissus terrificus} SCOP: d.169.1.1 PDB: 1uos_B | Back alignment and structure |
|---|
Probab=99.92 E-value=2.1e-25 Score=193.77 Aligned_cols=118 Identities=23% Similarity=0.539 Sum_probs=103.7
Q ss_pred CCCcCCcccCCCCeEEEEecCCCChHHHHHHHhh--cCCEEeeeCCHHHHHHHHHhhCCC--CCCeEeeeeecCCCCCCc
Q 008785 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKN--VNGCWVGGRSINTTVGLS 127 (553)
Q Consensus 52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~--~~~~L~~i~~~~e~~f~~~~~~~~--~~~~WiGl~~~~~~~~~~ 127 (553)
+||+||+ .|+++||+|+.+.++|.+|+.+|++ +||+||+|+|.+|++||.+++... ...+||||+ +...++.
T Consensus 3 ~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~WIGl~--~~~~~~~ 78 (125)
T 1umr_C 3 CCPSHWS--SYDRYCYKVFKQEMTWADAEKFCTQQHTGSHLVSFHSTEEVDFVVKMTHQSLKSTFFWIGAN--NIWNKCN 78 (125)
T ss_dssp CCCTTCE--EETTEEEEEEEEEECHHHHHHHHHHHSTTCEECCCSSHHHHHHHHHHHHTTCSSSEEECSCC--CTTTSSC
T ss_pred CCCCCCE--EcCCEeEEEECCCcCHHHHHHHHhccCCcceECccCCHHHHHHHHHHHHhcCCCCCEEEeeE--eCCCCCe
Confidence 6999999 8999999999999999999999999 899999999999999999987543 367999999 6666799
Q ss_pred eEEcCCCCCCcCcccccCccCCCCCCCCCCCCCCCCeeEEEeCCCCceecccCCCCCCccceec
Q 008785 128 WKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVE 191 (553)
Q Consensus 128 w~W~dg~~~~~~~~~~~~~~~~~~~~~~C~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~~ 191 (553)
|+|+||+++.+.+|. +.| +|+.+....+.|++..|....+|||+.+
T Consensus 79 ~~W~dg~~~~~~~W~-g~P-----------------~C~~~~~~~g~w~~~~C~~~~~fICe~~ 124 (125)
T 1umr_C 79 WQWSDGTKPEYKEWH-EEF-----------------ECLISRTFDNQWLSAPCSDTYSFVCKFE 124 (125)
T ss_dssp EEETTSCCCSSCCBC-CCC-----------------EEEEEESSCSCEEEEETTSCEEEEEEEE
T ss_pred eEeCCcCccCcccCC-CCC-----------------CcEEEECCCCcEeCCCCCCCcceEEeec
Confidence 999999998777665 332 7888876556899999999999999864
|
| >3c22_A C-type lectin domain family 4 member K; coiled coil, glycoprotein, membrane, signal-anchor, transmembrane, immune system, sugar binding protein; 1.50A {Homo sapiens} PDB: 3p5g_A* 3p5d_A* 3p5f_A* 3p5e_A* 3p5h_A* 3p5i_A* 3p7g_A* 3p7f_A* 3p7h_A* 3bc7_A* 3bbs_A* 3bc6_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=3.2e-25 Score=200.49 Aligned_cols=128 Identities=19% Similarity=0.308 Sum_probs=105.0
Q ss_pred CCCCCcCCcccCCCCeEEEEecCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHhhCCCCCCeEeeeeecCCCCCCceE
Q 008785 50 KAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWK 129 (553)
Q Consensus 50 ~~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~ 129 (553)
+..||.||+ .|+++||+|+.+.++|.+|+.+|+.+||+||+|+|.+|++||.+++. ...+||||+ +...++.|+
T Consensus 20 ~~~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~--~~~~WIGl~--~~~~~~~w~ 93 (156)
T 3c22_A 20 LQVVSQGWK--YFKGNFYYFSLIPKTWYSAEQFCVSRNSHLTSVTSESEQEFLYKTAG--GLIYWIGLT--KAGMEGDWS 93 (156)
T ss_dssp ----CCCCE--EETTEEEEECSSCBCHHHHHHHHHHTTCEECCCCSHHHHHHHHHHHT--TCCEEEEEE--EETTTTEEE
T ss_pred hccCCCCCE--EcCCEEEEEECCCCCHHHHHHHHHhCCCEEeecCCHHHHHHHHHhhc--CCcEEEeee--ccCCCCceE
Confidence 467999999 89999999999999999999999999999999999999999999986 578999999 555679999
Q ss_pred EcCCCCCCc----CcccccCccCCCCCCCCCCCCCCCCeeEEEeCCC-CceecccCCCCCCccceeccc
Q 008785 130 WSDNMSKWN----ESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS-RSLVTERCNTSHPFICMVEHE 193 (553)
Q Consensus 130 W~dg~~~~~----~~~~~~~~~~~~~~~~~C~~~~~~~~C~~~~~~~-~~w~~~~C~~~~~~iC~~~~~ 193 (553)
|+||+++.+ ..|..++|.+ ..+.++|+.+.... ..|++..|....+|||+....
T Consensus 94 W~dG~~~~~~~~~~~W~~geP~~----------~~~~~~Cv~~~~~~~~~W~d~~C~~~~~fICe~~~~ 152 (156)
T 3c22_A 94 WVDDTPFNKVQSARFWIPGEPNN----------AGNNEHCGNIKAPSLQAWNDAPCDKTFLFICKRPYV 152 (156)
T ss_dssp ETTCCCCCHHHHGGGBCTTCCCC----------GGGCCCEEEECSSSSSCEEEECTTSCBEEEEEEECC
T ss_pred eCCCCccccccccCcCCCCCCCC----------CCCCCCceEECCCCCCcEECCCCCCCeeEEEeeCCc
Confidence 999999875 4555544421 12456888886643 579999999999999998654
|
| >1j34_B Coagulation factor IX-binding protein B chain; magnesium ION, calcium ION, GLA domain, protein binding/blood clotting complex; HET: CGU; 1.55A {Trimeresurus flavoviridis} SCOP: d.169.1.1 PDB: 1bj3_B 1ixx_B* 1j35_B* 1x2t_B* 1x2w_B 1wt9_B 1iod_B 1y17_B | Back alignment and structure |
|---|
Probab=99.92 E-value=1.5e-25 Score=194.03 Aligned_cols=118 Identities=24% Similarity=0.565 Sum_probs=103.3
Q ss_pred CCCcCCcccCCCCeEEEEecCCCChHHHHHHHhh--cCCEEeeeCCHHHHHHHHHhhCCC--CCCeEeeeeecCCCCCCc
Q 008785 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKN--VNGCWVGGRSINTTVGLS 127 (553)
Q Consensus 52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~--~~~~L~~i~~~~e~~f~~~~~~~~--~~~~WiGl~~~~~~~~~~ 127 (553)
+||+||. .|+++||+|+.+.++|.+|+.+|+. +||+||+|+|++|++||.+++... ...+||||+ +...++.
T Consensus 1 ~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~WIGl~--~~~~~~~ 76 (123)
T 1j34_B 1 DCPSDWS--SYEGHCYKPFSEPKNWADAENFCTQQHAGGHLVSFQSSEEADFVVKLAFQTFGHSIFWMGLS--NVWNQCN 76 (123)
T ss_dssp CCCTTSE--EETTEEEEEEEEEECHHHHHHHHHHHSTTCEECCCSSHHHHHHHHHHHHHHHCSCEEECSCC--SCSTTSC
T ss_pred CcCCccc--ccCCEEEEEECCCcCHHHHHHHHhccCCCcEEcccCCHHHHHHHHHHHHhcCCCCCEEEeeE--cCCCCCe
Confidence 4999999 8999999999999999999999999 899999999999999999887432 367999999 7666799
Q ss_pred eEEcCCCCCCcCcccccCccCCCCCCCCCCCCCCCCeeEEEeCCCCceecccCCCCCCccceec
Q 008785 128 WKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVE 191 (553)
Q Consensus 128 w~W~dg~~~~~~~~~~~~~~~~~~~~~~C~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~~ 191 (553)
|+|+||+++.+.+|. ++| +|+.+....+.|++..|....+|||+.+
T Consensus 77 ~~W~dg~~~~~~~W~-g~P-----------------~C~~~~~~~g~w~~~~C~~~~~~iCe~~ 122 (123)
T 1j34_B 77 WQWSNAAMLRYKAWA-EES-----------------YCVYFKSTNNKWRSRACRMMAQFVCEFQ 122 (123)
T ss_dssp EEETTCCCCCCCCBS-CSC-----------------EEEEEETTSCCBEEEETTSCEEEEEEEE
T ss_pred eEeCCCCCcCccCcC-CCC-----------------CcEEEECCCCCCcCCCCCCCCcEEEeec
Confidence 999999998777665 332 7888877656899999999999999864
|
| >1oz7_B Echicetin B-chain; platelet aggregation, dimer, toxin; 2.40A {Echis carinatus} SCOP: d.169.1.1 | Back alignment and structure |
|---|
Probab=99.92 E-value=1.6e-25 Score=193.89 Aligned_cols=118 Identities=20% Similarity=0.473 Sum_probs=103.3
Q ss_pred CCCcCCcccCCCCeEEEEecCCCChHHHHHHHhh--cCCEEeeeCCHHHHHHHHHhhCCC--CCCeEeeeeecCCCCCCc
Q 008785 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKN--VNGCWVGGRSINTTVGLS 127 (553)
Q Consensus 52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~--~~~~L~~i~~~~e~~f~~~~~~~~--~~~~WiGl~~~~~~~~~~ 127 (553)
+||+||. .|+++||+|+.+.++|.+|+.+|+. .||+||+|+|++|++||.+++... ...+||||+ +...++.
T Consensus 1 ~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~WIGl~--~~~~~~~ 76 (123)
T 1oz7_B 1 NCLPDWS--VYEGYCYKVFKERMNWADAEKFCTKQHKDGHLVSFRNSKEVDFVISLAFPMLKNDLVWIGLT--DYWRDCN 76 (123)
T ss_dssp CCCTTCE--EETTEEEEEEEEEECHHHHHHHHHHHSTTCEECCCCCSSHHHHHHHTSSTTTTCSEEEEEEE--CCCCGGG
T ss_pred CCCCCcE--EcCCEEEEEECCccCHHHHHHHHhccCCCcEECCcCCHHHHHHHHHHHHhcCCCCCEEEeee--eCCCCCC
Confidence 4999999 8999999999999999999999999 899999999999999999988643 367999999 6666799
Q ss_pred eEEcCCCCCCcCcccccCccCCCCCCCCCCCCCCCCeeEEEeCCCCceecccCCCCCCccceec
Q 008785 128 WKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVE 191 (553)
Q Consensus 128 w~W~dg~~~~~~~~~~~~~~~~~~~~~~C~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~~ 191 (553)
|.|+||+++.+.+|. +.| +|+.+....+.|++..|....+|||+.+
T Consensus 77 ~~W~dg~~~~~~~W~-g~P-----------------~C~~~~~~~g~w~~~~C~~~~~~ICe~~ 122 (123)
T 1oz7_B 77 WEWSDGAQLDYKAWD-NER-----------------HCFIYKNTDNQWTRRDCTWTFSFVCKCP 122 (123)
T ss_dssp EEETTCCCCCSCCBC-SST-----------------TEEEEEGGGTEEEEECTTSCEEEEEEEE
T ss_pred EEEcCCCcccccCCC-CCC-----------------CeEEEECCCCcEeCCCCCCCeeEEEeEe
Confidence 999999998777665 332 6777766555899999999999999864
|
| >2e3x_C Coagulation factor X-activating enzyme light CHAI; disintegrin, metalloproteinase, C-type lectin, hydrolase, BL clotting, toxin; HET: NAG MAN GM6; 2.91A {Daboia russellii siamensis} | Back alignment and structure |
|---|
Probab=99.92 E-value=2.5e-25 Score=192.35 Aligned_cols=117 Identities=26% Similarity=0.587 Sum_probs=101.9
Q ss_pred CCCcCCcccCCCCeEEEEecCCCChHHHHHHHhh--cCCEEeeeCCHHHHHHHHHhhCCC--CCCeEeeeeecCCCCCCc
Q 008785 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKN--VNGCWVGGRSINTTVGLS 127 (553)
Q Consensus 52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~--~~~~L~~i~~~~e~~f~~~~~~~~--~~~~WiGl~~~~~~~~~~ 127 (553)
+||+||. .|+++||+|+.+.++|.+|+.+|+. .||+||+|+|++|++||.+++... ...+||||+ +...++.
T Consensus 2 ~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~WIGl~--~~~~~~~ 77 (122)
T 2e3x_C 2 DCPSGWL--SYEQHCYKGFNDLKNWTDAEKFCTEQKKGSHLVSLHSREEEKFVVNLISENLEYPATWIGLG--NMWKDCR 77 (122)
T ss_dssp CCCSSCE--EETTEEEEECCCCBCHHHHHHHHHHHSTTCCBCCCSSHHHHHHHHHHHHHHCSSSEEEEEEE--STTSSSC
T ss_pred CCCcchh--hhCCEeEEEECCCcCHHHHHHHHhccCCCCEECccCCHHHHHHHHHHHHhcCCCCCEEEeee--ecCCCCc
Confidence 5999999 8999999999999999999999999 899999999999999999887432 367999999 7666799
Q ss_pred eEEcCCCCCCcCcccccCccCCCCCCCCCCCCCCCCeeEEEeCCCCceecccCCCCCCcccee
Q 008785 128 WKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMV 190 (553)
Q Consensus 128 w~W~dg~~~~~~~~~~~~~~~~~~~~~~C~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~ 190 (553)
|.|+||+++.+.+|. ++| +|+.+....+.|++..|....+|||+.
T Consensus 78 ~~W~dg~~~~~~~W~-~~P-----------------~C~~~~~~~g~w~~~~C~~~~~~ICe~ 122 (122)
T 2e3x_C 78 MEWSDRGNVKYKALA-EES-----------------YCLIMITHEKVWKSMTCNFIAPVVCKF 122 (122)
T ss_dssp EEETTSCCCCCCCBC-SCC-----------------EEEEEETTTCCEEEEETTSCBCCEEC-
T ss_pred eEeCCCCcccccccC-CCC-----------------CCEEEECCCCcEeCCCCCCCCceeecC
Confidence 999999998777665 332 788887665689999999999999963
|
| >3ff7_C Killer cell lectin-like receptor subfamily G member 1; KLRG1-cadherin complex, calcium, cell adhesion, cell junction, cell membrane; 1.80A {Homo sapiens} SCOP: d.169.1.0 | Back alignment and structure |
|---|
Probab=99.92 E-value=3.5e-25 Score=188.53 Aligned_cols=111 Identities=23% Similarity=0.554 Sum_probs=97.8
Q ss_pred CCcCCcccCCCCeEEEEecCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHhhCCCCCCeEeeeeecCCCCCCceEEcC
Q 008785 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSD 132 (553)
Q Consensus 53 Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~d 132 (553)
||+||. .|+++||+|+.+.+||.+|+.+|+++||+||+|+|.+|++||.+++. ...+||||+ + ++.|+|+|
T Consensus 1 Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~--~~~~WiGl~--~---~~~~~W~d 71 (112)
T 3ff7_C 1 CPDRWM--KYGNHCYYFSVEEKDWNSSLEFCLARDSHLLVITDNQEMSLLQVFLS--EAFSWIGLR--N---NSGWRWED 71 (112)
T ss_dssp CCTTCE--EETTEEEEECSSCBCHHHHHHHHHTTTCEECCCCSHHHHHHHHTTCC--SSCEEEEEE--E---SSSEEETT
T ss_pred CCccce--EeCCEEEEEeCCccCHHHHHHHHhhcCCeEeeECCHHHHHHHHHhcc--CCCEEEeee--c---CCceEeCC
Confidence 999999 89999999999999999999999999999999999999999999876 567999999 4 48899999
Q ss_pred CCCCCcCcccccCccCCCCCCCCCCCCCCCCeeEEEeCCCCceecccCCCCCCccce
Q 008785 133 NMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICM 189 (553)
Q Consensus 133 g~~~~~~~~~~~~~~~~~~~~~~C~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~ 189 (553)
|+++.+..|.+.. +.++|+.+..+ .|++..|....+|||+
T Consensus 72 g~~~~~~~w~~~~---------------~~~~C~~~~~~--~w~~~~C~~~~~fICe 111 (112)
T 3ff7_C 72 GSPLNFSRISSNS---------------FVQTCGAINKN--GLQASSCEVPLHWVCK 111 (112)
T ss_dssp SCBCCSSCEECSS---------------TTCCEEEEETT--EEEEECTTSCBEEEEE
T ss_pred CCccccceecCCC---------------CCCCCeEEeCC--CcccCCCCCCCceeec
Confidence 9998877664211 23588888764 5999999999999996
|
| >1uv0_A Pancreatitis-associated protein 1; lectin, C-type, secreted, inflammatory response, acute phase; 1.78A {Homo sapiens} SCOP: d.169.1.1 PDB: 2go0_A | Back alignment and structure |
|---|
Probab=99.92 E-value=4.4e-25 Score=197.83 Aligned_cols=126 Identities=21% Similarity=0.400 Sum_probs=107.6
Q ss_pred CCCCcCCcccCCCCeEEEEecCCCChHHHHHHHhhc-CCEEeeeCCHHHHHHHHHhhCCC---CCCeEeeeeecCCCCCC
Q 008785 51 APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI-GGHLAALTSYEEEHSAQKLCGKN---VNGCWVGGRSINTTVGL 126 (553)
Q Consensus 51 ~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~-~~~L~~i~~~~e~~f~~~~~~~~---~~~~WiGl~~~~~~~~~ 126 (553)
..||.||. .|+++||+|+.+.++|.+|+.+|+.+ ||+||+|+|++|++||.+++... ...+||||+ +...++
T Consensus 12 ~~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~~WiGl~--~~~~~~ 87 (149)
T 1uv0_A 12 IRCPKGSK--AYGSHCYALFLSPKSWTDADLACQKRPSGNLVSVLSGAEGSFVSSLVKSIGNSYSYVWIGLH--DPTQGT 87 (149)
T ss_dssp CCCCTTCE--EETTEEEEEEEEEECHHHHHHHHTTSTTCEECCCCSHHHHHHHHHHHTTSCTTCCEEEEEEE--CTTTTC
T ss_pred CCCCcccc--ccCCEEEEEECCCCCHHHHHHHhhcCCCccEeEeCCHHHHHHHHHHHHhhccCCCCEEEeeE--ccCCCC
Confidence 47999999 89999999999999999999999998 99999999999999999998643 457999999 655556
Q ss_pred c-----eEEcCCCCCCcCcccccCccCCCCCCCCCCCCCCCCeeEEEeCCC--CceecccCCCCCCccceec
Q 008785 127 S-----WKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS--RSLVTERCNTSHPFICMVE 191 (553)
Q Consensus 127 ~-----w~W~dg~~~~~~~~~~~~~~~~~~~~~~C~~~~~~~~C~~~~~~~--~~w~~~~C~~~~~~iC~~~ 191 (553)
. |.|+||+++.+.+|..++|.+ .+.++|+.+.... ..|++..|....+|||+.+
T Consensus 88 ~~~~~~w~W~dg~~~~~~~W~~~~P~~-----------~~~~~Cv~~~~~~~~~~W~d~~C~~~~~fICe~~ 148 (149)
T 1uv0_A 88 EPNGEGWEWSSSDVMNYFAWERNPSTI-----------SSPGHCASLSRSTAFLRWKDYNCNVRLPYVCKFT 148 (149)
T ss_dssp C--CCCCEETTCCCCCCCCBSSCGGGS-----------SSCCSEEEEEGGGTTCSEEEECTTSCEEEEEEEC
T ss_pred ccCCCccEECCCCccCccCcCCCCcCC-----------CCCCCCEEEEcCCCCCeEeCcCCCCCCceEEeec
Confidence 5 999999998888877766521 2456888886643 4799999999999999864
|
| >2h2t_B Low affinity immunoglobulin epsilon FC receptor ( IGE receptor) (FC-epsilon-RII)...; C-type lectin, calcium-bound, lectin domain; 1.30A {Homo sapiens} PDB: 2h2r_A 1t8c_A 1t8d_A | Back alignment and structure |
|---|
Probab=99.92 E-value=2.5e-25 Score=205.14 Aligned_cols=129 Identities=19% Similarity=0.397 Sum_probs=107.2
Q ss_pred CCCCCCCcCCcccCCCCeEEEEecCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHhhCCCCCCeEeeeeecCCCCCCc
Q 008785 48 DWKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLS 127 (553)
Q Consensus 48 ~~~~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~ 127 (553)
..+..||.||. .|+++||+|+.+.++|.+|+.+|+.+||+||+|+|++|++||.+++. ...+||||+ +...+|.
T Consensus 12 ~~~~~Cp~gw~--~~~~~CY~~~~~~~tw~~A~~~C~~~g~~La~i~s~~e~~fl~~~~~--~~~~WIGl~--~~~~~~~ 85 (175)
T 2h2t_B 12 FVCNTCPEKWI--NFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKRAS--HTGSWIGLR--NLDLKGE 85 (175)
T ss_dssp --CCBCCTTCE--EETTEEEEEEEEEECHHHHHHHHHHTTCEECCCCSHHHHHHHHTTCC--TTCEEEEEE--EETTTTE
T ss_pred ccCCCCCcccE--EeCCEEEEEeCCccCHHHHHHHHhhcCCEEeecCCHHHHHHHHHHhc--CCcEEecce--ecCCCCC
Confidence 44678999999 89999999999999999999999999999999999999999999876 568999999 5456699
Q ss_pred eEEcCCCCCCcCcccccCccCCCCCCCCCCCCCCCCeeEEEeCCCCceecccCCCCC-Cccceeccc
Q 008785 128 WKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSH-PFICMVEHE 193 (553)
Q Consensus 128 w~W~dg~~~~~~~~~~~~~~~~~~~~~~C~~~~~~~~C~~~~~~~~~w~~~~C~~~~-~~iC~~~~~ 193 (553)
|+|+||+++.+.+|..++|++ ..+.++|+.+.. ...|++..|.... +|||+....
T Consensus 86 w~W~dG~~~~y~~W~~geP~~----------~~~~~~Cv~~~~-~g~W~d~~C~~~~~~fICe~~~~ 141 (175)
T 2h2t_B 86 FIWVDGSHVDYSNWAPGEPTS----------RSQSEDCVMMRG-SGRWNDAFCDRKLGAWVCDRLAT 141 (175)
T ss_dssp EEETTSCCCSSCCBCTTCCCC---------------CEEEECT-TSCEEEECTTCCEEEEEEEEECB
T ss_pred eEeCCCCcccCcCcCCCCCCC----------CCCCCCceEEcC-CCcEEECCCCCcCcceEEeECCc
Confidence 999999999888777666521 124568988864 4579999999999 999998653
|
| >1jzn_A Galactose-specific lectin; C-type lectin, protein-disaccharide complex, sugar binding P; HET: BGC GAL; 2.20A {Crotalus atrox} SCOP: d.169.1.1 PDB: 1muq_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2e-25 Score=196.46 Aligned_cols=126 Identities=21% Similarity=0.579 Sum_probs=106.7
Q ss_pred CCCcCCcccCCCCeEEEEecCCCChHHHHHHHhh--cCCEEeeeCCHHHHHHHHHhhCCC---CCCeEeeeeecCCCCCC
Q 008785 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKN---VNGCWVGGRSINTTVGL 126 (553)
Q Consensus 52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~--~~~~L~~i~~~~e~~f~~~~~~~~---~~~~WiGl~~~~~~~~~ 126 (553)
+||.||. .|+++||+|+.+.++|.+|+.+|++ .||+||+|+|.+|++||.+++... ...+||||+ +...++
T Consensus 2 ~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~~WIGl~--~~~~~~ 77 (135)
T 1jzn_A 2 NCPLDWL--PMNGLCYKIFNQLKTWEDAEMFCRKYKPGCHLASFHRYGESLEIAEYISDYHKGQENVWIGLR--DKKKDF 77 (135)
T ss_dssp CSCTTSE--EETTEEEEEEEEEECHHHHHHHHHHHSSSEEECCCCSHHHHHHHHHHHHHHCCSSCCEEEEEE--CTTSSS
T ss_pred cCCCCce--eeCCEEEEEECCccCHHHHHHHHhccCCCCEECccCCHHHHHHHHHHHHhcccCCCCEEEeeE--cCCcCC
Confidence 5999999 8999999999999999999999999 599999999999999999877421 358999999 666679
Q ss_pred ceEEcCCCCCCcCcccccCccCCCCCCCCCCCCCCCCeeEEEeCCC--CceecccCCCCCCccceec
Q 008785 127 SWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS--RSLVTERCNTSHPFICMVE 191 (553)
Q Consensus 127 ~w~W~dg~~~~~~~~~~~~~~~~~~~~~~C~~~~~~~~C~~~~~~~--~~w~~~~C~~~~~~iC~~~ 191 (553)
.|+|+||+++.+..|..++|.+ ..+.++|+.+.... ..|++..|....+|||+.+
T Consensus 78 ~~~W~dg~~~~~~~W~~~~P~~----------~~~~~~C~~~~~~~~~~~w~~~~C~~~~~~ICe~~ 134 (135)
T 1jzn_A 78 SWEWTDRSCTDYLTWDKNQPDH----------YQNKEFCVELVSLTGYRLWNDQVCESKDAFLCQCK 134 (135)
T ss_dssp CCEETTCCCCCCCCBCTTCCCC----------GGGCCCEEEECGGGTTCSEEEECTTSCEEEEEEEC
T ss_pred ceEECCCCccCcCcCCcCCCCC----------CCCCCCceEEECCCCCCcCCCcCCCCCCceeeeec
Confidence 9999999998888777666521 12356888886543 4799999999999999864
|
| >3gpr_C Rhodocetin subunit gamma; disulfide bond, lectin, secreted, toxin, cell adhesion; 3.20A {Calloselasma rhodostoma} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.6e-25 Score=197.02 Aligned_cols=121 Identities=24% Similarity=0.501 Sum_probs=103.7
Q ss_pred CCCcCCcccCCCCeEEEEecCCCChHHHHHHHhhc--CCEEeeeCCHHHHHHHHHhhCCC----CCCeEeeeeecCCCCC
Q 008785 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI--GGHLAALTSYEEEHSAQKLCGKN----VNGCWVGGRSINTTVG 125 (553)
Q Consensus 52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~--~~~L~~i~~~~e~~f~~~~~~~~----~~~~WiGl~~~~~~~~ 125 (553)
.||+||+ .|+++||+|+.+.+||.+|+.+|+++ |||||+|+|++|++||.+++... ...+||||+ +...+
T Consensus 2 ~Cp~gw~--~~~~~CY~~~~~~~tw~~A~~~C~~~~~G~~La~i~s~~e~~~l~~~~~~~~~~~~~~~WIGl~--~~~~~ 77 (134)
T 3gpr_C 2 NCLPGWS--AYDQHCYQAFNEPKTWDEAERFCTEQAKRGHLVSIGSDGEADFVAQLVTNNIKRPELYVWIGLR--DRRKE 77 (134)
T ss_dssp CCCTTCE--ESSSCEEEECSCCBCSHHHHHHHTTSSSCCEECCCCCHHHHHHHHHHHHHHHCSSCCBCCCSCB--CCSST
T ss_pred cCCCcce--eeCCEEEEEeCCCcCHHHHHHHHHhhCCCceEeeeCCHHHHHHHHHHHHhhccCCCCcEEEeeE--ecCCC
Confidence 5999999 89999999999999999999999999 89999999999999999887532 167999999 66667
Q ss_pred Cc-e-EEcCCCCCCcCcccccCccCCCCCCCCCCCCCCCCeeEEEeCCCC--ceecccCCCCCCccceecc
Q 008785 126 LS-W-KWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSR--SLVTERCNTSHPFICMVEH 192 (553)
Q Consensus 126 ~~-w-~W~dg~~~~~~~~~~~~~~~~~~~~~~C~~~~~~~~C~~~~~~~~--~w~~~~C~~~~~~iC~~~~ 192 (553)
+. | +|+||+++.+.+|..++| ++|+.+..... .|++..|....+|||+.+.
T Consensus 78 ~~~w~~W~dG~~~~~~~W~~~~~----------------~~Cv~~~~~~~~~~W~~~~C~~~~~fICe~~~ 132 (134)
T 3gpr_C 78 QQCSSEWSMSASIIYVNWNTGES----------------QMCQGLARWTGFRKWDYSDCQAKNPFVCKFSS 132 (134)
T ss_dssp TSCSCEETTCCCSCCBCBSSCEE----------------CCEECCBCSSSSCBBCEECTTCCBCCEEEECC
T ss_pred CCcCCEeCCcCcccccccCCCCC----------------CcceEEeccCCCCcCcCCCCCCCCcEEeCcCC
Confidence 99 9 999999998777665432 36777665433 7999999999999999864
|
| >1c3a_B Flavocetin-A: beta subunit; C-type lectin-like domains, membrane protein; 2.50A {Trimeresurus flavoviridis} SCOP: d.169.1.1 PDB: 1v4l_B | Back alignment and structure |
|---|
Probab=99.92 E-value=2.6e-25 Score=193.16 Aligned_cols=118 Identities=20% Similarity=0.423 Sum_probs=103.1
Q ss_pred CCCcCCcccCCCCeEEEEecCCCChHHHHHHHhh--cCCEEeeeCCHHHHHHHHHhhCCC--CCCeEeeeeecCCCCCCc
Q 008785 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKN--VNGCWVGGRSINTTVGLS 127 (553)
Q Consensus 52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~--~~~~L~~i~~~~e~~f~~~~~~~~--~~~~WiGl~~~~~~~~~~ 127 (553)
.||.||+ .|+++||+|+.+.++|.+|+.+|+. +||+||+|+|++|++||.+++... ...+||||+ +...++.
T Consensus 3 ~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~WIGl~--~~~~~~~ 78 (125)
T 1c3a_B 3 CCPLGWS--SYDEHCYQVFQQKMNWEDAEKFCTQQHKGSHLVSFHSSEEVDFVTSKTFPILKYDFVWIGLS--NVWNECT 78 (125)
T ss_dssp CCCTTCE--EETTEEEEEEEEEECHHHHHHHHHHHSTTCEECCCSSHHHHHHHHHHHHHHHCSCEEECSCC--CTTTSSC
T ss_pred CCCCcce--ecCCEEEEEECCCCCHHHHHHHhhccCCCcEECccCCHHHHHHHHHHHHhcCCCCCEEEeeE--cCCCCCc
Confidence 6999999 8999999999999999999999999 899999999999999999877422 367999999 6666799
Q ss_pred eEEcCCCCCCcCcccccCccCCCCCCCCCCCCCCCCeeEEEeCCCCceecccCCCCCCccceec
Q 008785 128 WKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVE 191 (553)
Q Consensus 128 w~W~dg~~~~~~~~~~~~~~~~~~~~~~C~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~~ 191 (553)
|.|+||+++.+.+|. ++| +|+.+....+.|++..|....+|||+.+
T Consensus 79 ~~W~dg~~~~~~~w~-~~P-----------------~C~~~~~~~g~w~~~~C~~~~~fiCe~~ 124 (125)
T 1c3a_B 79 KEWSDGTKLDYKAWS-GGS-----------------DCIVSKTTDNQWLSMDCSSKYYVVCKFQ 124 (125)
T ss_dssp EEETTCCCCCSCCBC-CCC-----------------EEEEEESSSSCEEEEETTSCEEEEEEEE
T ss_pred eEeCCCCcccccccC-CCC-----------------CcEEEECCCCCEeCCCCCCCCeeEEeee
Confidence 999999998777665 332 7888876556899999999999999864
|
| >1tn3_A Tetranectin; plasminogen binding, kringle 4, C-type lectin, carbohydrate recognition domain; 2.00A {Homo sapiens} SCOP: d.169.1.1 PDB: 1rjh_A 3l9j_C | Back alignment and structure |
|---|
Probab=99.92 E-value=1.3e-25 Score=198.15 Aligned_cols=125 Identities=16% Similarity=0.310 Sum_probs=105.4
Q ss_pred CCCCcCCcccCCCCeEEEEecCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHhhCCC---CCCeEeeeeecCCCCCCc
Q 008785 51 APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKN---VNGCWVGGRSINTTVGLS 127 (553)
Q Consensus 51 ~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~---~~~~WiGl~~~~~~~~~~ 127 (553)
..||.||. |+++||+|+.+.++|.+|+.+|+++||+||+|+|++|++||.+++... ...+||||+ +...++.
T Consensus 4 ~~Cp~gw~---~~~~CY~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~~WIGl~--~~~~~~~ 78 (137)
T 1tn3_A 4 TVCLKGTK---VHMKCFLAFTQTKTFHEASEDCISRGGTLSTPQTGSENDALYEYLRQSVGNEAEIWLGLN--DMAAEGT 78 (137)
T ss_dssp CEEEECSS---SSEEEEEEEEEEECHHHHHHHHHHTTCEECCCCSHHHHHHHHHHHHHHTCTTCEEEEEEE--EEEETTE
T ss_pred CCCCCCeE---ECCEEEEEeCCCCCHHHHHHHHHhcCCEEcccCCHHHHHHHHHHHHhhcCCCCCEEEeeE--ccCCCce
Confidence 46999998 789999999999999999999999999999999999999999876421 467999999 5555799
Q ss_pred eEEcCCCCCCcCccc---ccCccCCCCCCCCCCCCCCCCeeEEEeC-CCCceecccCCCCCCccceec
Q 008785 128 WKWSDNMSKWNESIH---AVGSFNSSCTSLPCHVHATVDLCTLVSN-GSRSLVTERCNTSHPFICMVE 191 (553)
Q Consensus 128 w~W~dg~~~~~~~~~---~~~~~~~~~~~~~C~~~~~~~~C~~~~~-~~~~w~~~~C~~~~~~iC~~~ 191 (553)
|.|+||+++.+.+|. ++.|. +.+.++|+.+.. ....|++..|....+|||+.+
T Consensus 79 w~W~dg~~~~~~~W~~~~~g~P~-----------~~~~~~Cv~~~~~~~~~W~d~~C~~~~~fiCe~~ 135 (137)
T 1tn3_A 79 WVDMTGARIAYKNWETEITAQPD-----------GGKTENCAVLSGAANGKWFDKRCRDQLPYICQFG 135 (137)
T ss_dssp EEETTSCBCSCCCBCCTTTCSSC-----------CGGGCCEEEEETTTTTEEEEECTTSCEEEEEEEE
T ss_pred EEeCCcCCCcccccCcCCCCcCC-----------CCCccCCcEEccCCCCeEeCcCCCCCccceEeEe
Confidence 999999998887776 55542 234568998864 356799999999999999874
|
| >3ubu_B Agglucetin subunit beta-2; platelet inhibiting, agkisacucetin, dimer, toxin, C-type LEC GPIB inhibitor, GPIB binding; 1.91A {Deinagkistrodon acutus} | Back alignment and structure |
|---|
Probab=99.92 E-value=3.8e-25 Score=192.29 Aligned_cols=118 Identities=25% Similarity=0.500 Sum_probs=102.7
Q ss_pred CCCcCCcccCCCCeEEEEecCCCChHHHHHHHhh--cCCEEeeeCCHHHHHHHHHhhCCC--CCCeEeeeeecCCCCCCc
Q 008785 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKN--VNGCWVGGRSINTTVGLS 127 (553)
Q Consensus 52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~--~~~~L~~i~~~~e~~f~~~~~~~~--~~~~WiGl~~~~~~~~~~ 127 (553)
.||+||+ .|+++||+|+.+.+||.+|+.+|+. +||+||+|+|++|++||.+++... ...+||||+ +...++.
T Consensus 3 ~Cp~gw~--~~~~~CY~~~~~~~tw~~A~~~C~~~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~WIGl~--~~~~~~~ 78 (126)
T 3ubu_B 3 CCPLRWS--AYEGHCYLVVKEKKTWDDAEKFCTEQRKGGHLVSVHSREEADFLVHLAYPILDLSLIWMGLS--NMWNDCK 78 (126)
T ss_dssp SCCTTCE--EETTEEEEEEEEEECHHHHHHHHHHHSTTCEECCCCSHHHHHHHHHHHHHHHCSCEEEEEEE--CTTTSSE
T ss_pred CCCCCCe--EcCCEeEEEeCCCCCHHHHHHHHhccCCCcEECccCCHHHHHHHHHHHhhccCCCcEEEeEE--cCCCCCc
Confidence 6999999 9999999999999999999999999 999999999999999999986421 347999999 6666799
Q ss_pred eEEcCCCCCCcCcccccCccCCCCCCCCCCCCCCCCeeEEEeCCC-CceecccCCCCCCccceec
Q 008785 128 WKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS-RSLVTERCNTSHPFICMVE 191 (553)
Q Consensus 128 w~W~dg~~~~~~~~~~~~~~~~~~~~~~C~~~~~~~~C~~~~~~~-~~w~~~~C~~~~~~iC~~~ 191 (553)
|+|+||+++.+.+|.+ .++|+.+.... ..|++..|....+|||+.+
T Consensus 79 ~~W~dg~~~~~~~W~~------------------~~~Cv~~~~~~~~~W~~~~C~~~~~fICe~~ 125 (126)
T 3ubu_B 79 REWSDGTKLDFKSWAK------------------TSDCLIGKTDGDNQWLNMDCSKKHYFVCKFK 125 (126)
T ss_dssp EEETTCCCCCCCCBCC------------------CCCEEEEESSTTCCEEEECTTSCEEEEEEEE
T ss_pred eEecCCCeeeeeccCC------------------CCCeEEEecCCCCcCcCCCCCCCceeEEeee
Confidence 9999999987666543 24788887654 4799999999999999874
|
| >1c3a_A Flavocetin-A: alpha subunit; C-type lectin-like domains, membrane protein; 2.50A {Trimeresurus flavoviridis} SCOP: d.169.1.1 PDB: 1v4l_A | Back alignment and structure |
|---|
Probab=99.91 E-value=3.3e-25 Score=195.16 Aligned_cols=123 Identities=24% Similarity=0.481 Sum_probs=105.9
Q ss_pred CCCcCCcccCCCCeEEEEecCCCChHHHHHHHhh--cCCEEeeeCCHHHHHHHHHhhCCC---CC-CeEeeeeecCCCCC
Q 008785 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKN---VN-GCWVGGRSINTTVG 125 (553)
Q Consensus 52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~--~~~~L~~i~~~~e~~f~~~~~~~~---~~-~~WiGl~~~~~~~~ 125 (553)
+||+||. .|+++||+|+.+.++|.+|+.+|+. +|||||+|+|++|++||.+++... .. .+||||++.+...+
T Consensus 3 ~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~~~WIGl~~~~~~~~ 80 (135)
T 1c3a_A 3 DCIPGWS--AYDRYCYQAFSKPKNWEDAESFCEEGVKTSHLVSIESSGEGDFVAQLVAEKIKTSFQYVWIGLRIQNKEQQ 80 (135)
T ss_dssp CCCTTCE--EETTEEEEEEEEEECHHHHHHHHHHHSTTCEECCCCSHHHHHHHHHHHHHHCCSCCSEEEEEEEECCCSSS
T ss_pred CCCCcCE--ecCCeeEEEeCCCcCHHHHHHHHhhcCCCCEECeeCCHHHHHHHHHHHhhccccCCCcEEecccccCCCCC
Confidence 6999999 8999999999999999999999999 899999999999999999887532 24 79999985555567
Q ss_pred CceEEcCCCCCCcCcccccCccCCCCCCCCCCCCCCCCeeEEEeCCC--CceecccCCCCCCccceecc
Q 008785 126 LSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS--RSLVTERCNTSHPFICMVEH 192 (553)
Q Consensus 126 ~~w~W~dg~~~~~~~~~~~~~~~~~~~~~~C~~~~~~~~C~~~~~~~--~~w~~~~C~~~~~~iC~~~~ 192 (553)
+.|.|+||+++.+.+|..++|. +|+.+.... ..|++..|....+|||+.+.
T Consensus 81 ~~~~W~dg~~~~~~~W~~~~P~----------------~C~~~~~~~~~~~W~d~~C~~~~~fICe~~~ 133 (135)
T 1c3a_A 81 CRSEWSDASSVNYENLVKQFSK----------------KCYALKKGTELRTWFNVYCGTENPEVCKYTP 133 (135)
T ss_dssp CCCBCTTSCBCCCCCBCGGGCC----------------CEEEEETTSCSCSBEEECTTSCEEEEEEECC
T ss_pred CceEECCCCcccccccCCCCCC----------------cceEEeccCCCCeEccCCCCCCccEEcccCC
Confidence 9999999999888777765541 688876654 57999999999999999864
|
| >2xr6_A CD209 antigen; sugar binding protein, carbohydrate binding, mannose; HET: MAN 07B; 1.35A {Homo sapiens} PDB: 1sl4_A* 2it6_A* 1k9i_A* 2xr5_A* 1sl5_A* 2it5_A* 1xph_A 1k9j_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=3.4e-25 Score=203.23 Aligned_cols=130 Identities=22% Similarity=0.453 Sum_probs=105.0
Q ss_pred CCCCCCCCcCCcccCCCCeEEEEecCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHhhCCCCCCeEeeeeecCCCCCC
Q 008785 47 KDWKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGL 126 (553)
Q Consensus 47 ~~~~~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~ 126 (553)
...|..||.||. .|+++||+|+.+.++|.+|+.+|+.+|||||+|+|.+|++||.++.......+||||+ +...++
T Consensus 16 ~~~~~~Cp~gw~--~~~~~CY~~~~~~~tw~~A~~~C~~~g~~La~i~s~~e~~fl~~~~~~~~~~~WIGl~--~~~~~~ 91 (170)
T 2xr6_A 16 ERLSHPCPWEWT--FFQGNCYFMSNSQRNWHDSITACKEVGAQLVVIKSAEEQNFLQLQSSRSNRFTWMGLS--DLNQEG 91 (170)
T ss_dssp -----CCCTTCE--EETTEEEEECSSCBCHHHHHHHHHHTTCEECCCCSHHHHHHHHHHHHHHTCCEEEEEE--EEEETT
T ss_pred ccccCCCCcCcE--EeCCEEEEEECCcCCHHHHHHHHHhCCCEEeeeCCHHHHHHHHHHhccCCCCEEeccc--cCCCCC
Confidence 345678999999 8999999999999999999999999999999999999999999765323568999999 544569
Q ss_pred ceEEcCCCCCCc---CcccccCccCCCCCCCCCCCCCCCCeeEEEeCCCCceecccCCCCCCccceeccc
Q 008785 127 SWKWSDNMSKWN---ESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVEHE 193 (553)
Q Consensus 127 ~w~W~dg~~~~~---~~~~~~~~~~~~~~~~~C~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~~~~ 193 (553)
.|+|+||+++.+ .+|..++|+ +.+.++|+.+... .|++..|....+|||+....
T Consensus 92 ~w~W~dG~~~~~~~~~~W~~geP~-----------~~~~~~Cv~~~~~--gW~d~~C~~~~~fICe~~~~ 148 (170)
T 2xr6_A 92 TWQWVDGSPLLPSFKQYWNRGEPN-----------NVGEEDCAEFSGN--GWNDDKCNLAKFWICKKSAA 148 (170)
T ss_dssp EEEETTSCBCCGGGGGGBCTTCCC-----------CTTCCCEEEEETT--EEEEECTTSCBEEEEEEETT
T ss_pred eEEeCCCCCcccccccCCCCCCCC-----------CCCCCCCeEEeCC--cEEccccCCCccEEEEECCC
Confidence 999999999764 455554442 2245689988764 49999999999999998765
|
| >3ff9_A Killer cell lectin-like receptor subfamily G member 1; natural killer cell receptor KLTG1, glycoprotein, membrane, phosphoprotein, signal-anchor; 1.80A {Mus musculus} SCOP: d.169.1.0 PDB: 3ff8_C | Back alignment and structure |
|---|
Probab=99.91 E-value=4.1e-25 Score=189.05 Aligned_cols=113 Identities=21% Similarity=0.504 Sum_probs=97.7
Q ss_pred CCCcCCcccCCCCeEEEEecCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHhhCCCCCCeEeeeeecCCCCCCceEEc
Q 008785 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWS 131 (553)
Q Consensus 52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~ 131 (553)
.||.||. .|+++||+|+.+.++|.+|+.+|+++|||||+|+|++|++||.+++. ...+||||+ + ++.|+|+
T Consensus 1 ~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~--~~~~WIGl~--~---~~~w~W~ 71 (115)
T 3ff9_A 1 MCPILWT--RNGSHCYYFSMEKKDWNSSLKFCADKGSHLLTFPDNQGVKLFGEYLG--QDFYWIGLR--N---IDGWRWE 71 (115)
T ss_dssp CCCTTCE--EETTEEEEECSSCBCHHHHHHHHHHTTCEECCCTTSCCHHHHHTTCC--SSCEEEEEE--E---SSSEEET
T ss_pred CCCccce--ecCCEEEEEEcCCcCHHHHHHHHHhcCCeeeeeCCHHHHHHHHHhhC--CCcEEEeee--e---CCceEeC
Confidence 4999999 89999999999999999999999999999999999999999999886 468999999 4 4889999
Q ss_pred CCCCCCcCcccccCccCCCCCCCCCCCCCCCCeeEEEeCCCCceecccCCCCCCccceec
Q 008785 132 DNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVE 191 (553)
Q Consensus 132 dg~~~~~~~~~~~~~~~~~~~~~~C~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~~ 191 (553)
||+++.+. + .| + .+.++|+.+..+ .|++..|....+|||+.+
T Consensus 72 dg~~~~~~-~---~p-----------~-~~~~~C~~~~~~--~w~~~~C~~~~~fICe~~ 113 (115)
T 3ff9_A 72 GGPALSLR-I---LT-----------N-SLIQRCGAIHRN--GLQASSCEVALQWICKKV 113 (115)
T ss_dssp TSCBCCSC-C---BC-----------S-STTCCEEEEETT--EEEEECTTSCBEEEEEEE
T ss_pred CCCccccc-c---cC-----------C-CCCCCCeEEcCC--CcccccCCCCCceEEEEe
Confidence 99997662 1 11 1 134689888764 599999999999999875
|
| >1sb2_A Rhodocetin alpha subunit; C-type lectin, domain swapping, toxin; 1.90A {Calloselasma rhodostoma} SCOP: d.169.1.1 PDB: 3gpr_A | Back alignment and structure |
|---|
Probab=99.91 E-value=4.1e-25 Score=193.94 Aligned_cols=123 Identities=24% Similarity=0.514 Sum_probs=104.7
Q ss_pred CCCcCCcccCCCCeEEEEecCCCChHHHHHHHhh--cCCEEeeeCCHHHHHHHHHhhCCC----CCCeEeeeeecCCCCC
Q 008785 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKN----VNGCWVGGRSINTTVG 125 (553)
Q Consensus 52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~--~~~~L~~i~~~~e~~f~~~~~~~~----~~~~WiGl~~~~~~~~ 125 (553)
+||+||. .|+++||+|+.+.++|.+|+.+|+. .|||||+|+|++|++||.+++... ...+||||+..+...+
T Consensus 1 ~Cp~gw~--~~~~~Cy~~~~~~~~w~~A~~~C~~~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~~~WIGl~~~~~~~~ 78 (133)
T 1sb2_A 1 DCPDGWS--STKSYCYRPFKEKKTWEEAERFCTEQEKEAHLVSMENRLEAVFVDMVMENNFENKIYRSWIGLKIENKGQR 78 (133)
T ss_dssp CCCTTCE--ECSSEEEEEEEEEECHHHHHHHHHTSSSCCEECCCSSHHHHHHHHHHHHHHTTTCCEEEEEEEEEECSSTT
T ss_pred CcCCCcE--EcCCEeEEEECCcCCHHHHHHHHhhhCCCcEEeeECCHHHHHHHHHHHHhhccCccCCEEEeeeccCCCCC
Confidence 4999999 8999999999999999999999999 899999999999999999887432 3579999984344456
Q ss_pred CceEEcCCCCCCcCcccccCccCCCCCCCCCCCCCCCCeeEEEeCCC--CceecccCCCCCCccceecc
Q 008785 126 LSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS--RSLVTERCNTSHPFICMVEH 192 (553)
Q Consensus 126 ~~w~W~dg~~~~~~~~~~~~~~~~~~~~~~C~~~~~~~~C~~~~~~~--~~w~~~~C~~~~~~iC~~~~ 192 (553)
+.|.|+||+++.+.+|.. .| .++|+.+.... ..|++..|....+|||+.+.
T Consensus 79 ~~~~W~dg~~~~~~~W~~-~P---------------~~~C~~~~~~~~~~~w~~~~C~~~~~fICe~~~ 131 (133)
T 1sb2_A 79 SNLEWSDGSSISYENLYE-PY---------------MEKCFLMDHQSGLPKWHTADCEEKNVFMCKFQL 131 (133)
T ss_dssp SSEEETTCCCCCCCCBSS-CC---------------CEEEEEEEESSSSCEEEEECTTSCEEEEEEEEC
T ss_pred CceEECCCCcccccccCc-CC---------------CCCcEEEEecCCCCeEccCCCCCCceeEecccC
Confidence 999999999987777665 43 34888886654 57999999999999998754
|
| >3ubu_A Agglucetin subunit alpha-1; platelet inhibiting, agkisacucetin, dimer, toxin, C-type LEC GPIB inhibitor, GPIB binding; 1.91A {Deinagkistrodon acutus} | Back alignment and structure |
|---|
Probab=99.91 E-value=2.8e-25 Score=194.45 Aligned_cols=122 Identities=24% Similarity=0.568 Sum_probs=102.8
Q ss_pred CCCcCCcccCCCCeEEEEecCCCChHHHHHHHhhc--CCEEeeeCCHHHHHHHHHhhCCC--CCCeEeeeeecCCCCCCc
Q 008785 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI--GGHLAALTSYEEEHSAQKLCGKN--VNGCWVGGRSINTTVGLS 127 (553)
Q Consensus 52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~--~~~L~~i~~~~e~~f~~~~~~~~--~~~~WiGl~~~~~~~~~~ 127 (553)
.||.||. .|+++||+|+.+.+||.+|+.+|+.+ |||||+|+|++|++||.+++... ...+||||++.....++.
T Consensus 3 ~Cp~gw~--~~~~~CY~~~~~~~tw~~A~~~C~~~~~G~~La~i~s~~e~~~l~~~~~~~~~~~~~WIGl~~~~~~~~~~ 80 (131)
T 3ubu_A 3 DCLPGWS--AYDQSCYRVFKLLKTWDDAEKFCTERPKGGHLVSIESAGERDFVAQLVSENKQTDNVWLGLKIQSKGQQCS 80 (131)
T ss_dssp CCCTTCE--EETTEEEEEEEEEECHHHHHHHHHTSTTCCEECCCCSHHHHHHHHHHHHHTTCCSCEEEEEEEECSSSSSC
T ss_pred CCCccCE--ecCCEeeEEcCCCcCHHHHHHHHhccCCCceEceeCCHHHHHHHHHHHHhcCCCCCEEEeEecCCCCCCCc
Confidence 5999999 89999999999999999999999999 89999999999999999987532 347999999443222799
Q ss_pred eEEcCCCCCCcCcccccCccCCCCCCCCCCCCCCCCeeEEEeCCCC--ceecccCCCCCCccceec
Q 008785 128 WKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSR--SLVTERCNTSHPFICMVE 191 (553)
Q Consensus 128 w~W~dg~~~~~~~~~~~~~~~~~~~~~~C~~~~~~~~C~~~~~~~~--~w~~~~C~~~~~~iC~~~ 191 (553)
|+|+||+++.+.+|..+++ ++|+.+..... .|++..|....+|||+.+
T Consensus 81 ~~W~dg~~~~~~~w~~~~~----------------~~Cv~~~~~~~~~~W~~~~C~~~~~fiCe~~ 130 (131)
T 3ubu_A 81 TEWTDGSSVSYENFSEYQS----------------KKCFVLEKNTGFRTWLNLNCGSEYSFVCKSP 130 (131)
T ss_dssp CBCTTSCBCCCCCBCTTTC----------------CCEEEECGGGTSCSEEEECTTCCEEEEEEEC
T ss_pred eEeCCCCccceeccCCCCC----------------CCcEEEeCCCCCCeEcCCCCCCCceeEEecC
Confidence 9999999988777655332 47888865433 799999999999999875
|
| >3bx4_A Aggretin alpha chain; toxin; 1.70A {Agkistrodon rhodostoma} PDB: 2vrp_A | Back alignment and structure |
|---|
Probab=99.91 E-value=4.8e-25 Score=194.40 Aligned_cols=123 Identities=26% Similarity=0.528 Sum_probs=104.8
Q ss_pred CCCCcCCcccCCCCeEEEEecCCCChHHHHHHHhh--cCCEEeeeCCHHHHHHHHHhhCCC--C---CCeEeeeeecCCC
Q 008785 51 APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKN--V---NGCWVGGRSINTT 123 (553)
Q Consensus 51 ~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~--~~~~L~~i~~~~e~~f~~~~~~~~--~---~~~WiGl~~~~~~ 123 (553)
..||+||. .|+++||+|+.+.++|.+|+.+|+. .|||||+|+|++|++||.+++... . ..+||||++.+..
T Consensus 3 ~~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~~~~WIGl~~~~~~ 80 (136)
T 3bx4_A 3 EDCDFGWS--PYDQHCYQAFNEQKTWDEAEKFCRAQENGAHLASIESNGEADFVSWLISQKDELADEDYVWIGLRAQNKE 80 (136)
T ss_dssp -CCCTTCE--EETTEEEEEEEEEECHHHHHHHHHTSTTTCEECCCCSHHHHHHHHHHHHTCGGGTTCCEEEEEEEECCCS
T ss_pred CCCCCCCE--ecCCEEEEEECCCcCHHHHHHHHhccCCCcEEcccCCHHHHHHHHHHHHhhcccCccCCEEEeeeccCCC
Confidence 36999999 8999999999999999999999999 899999999999999999987543 2 5799999844555
Q ss_pred CCCceEEcCCCCCCcCcccccCccCCCCCCCCCCCCCCCCeeEEEeCCC--CceecccCCCCCCccceec
Q 008785 124 VGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS--RSLVTERCNTSHPFICMVE 191 (553)
Q Consensus 124 ~~~~w~W~dg~~~~~~~~~~~~~~~~~~~~~~C~~~~~~~~C~~~~~~~--~~w~~~~C~~~~~~iC~~~ 191 (553)
.++.|.|+||+++.+.+|..++|. +|+.+.... ..|++..|....+|||+.+
T Consensus 81 ~~~~~~W~dg~~~~~~~W~~~~P~----------------~C~~~~~~~~~~~W~~~~C~~~~~fICe~~ 134 (136)
T 3bx4_A 81 QQCSSEWSDGSSVSYENLIDLHTK----------------KCGALEKLTGFRKWVNYYCEQMHAFVCKLL 134 (136)
T ss_dssp SSSCCBCTTSCBCCCCCCTTCCCC----------------CEEEEEGGGTTTSEEEECTTSCEEEEEEEC
T ss_pred CCCceEeCCCCccCcccccCCCCC----------------ccEEEEecCCCCeEeCCCCCCCcceEEeec
Confidence 679999999999888777665541 677776643 5799999999999999874
|
| >3gpr_D Rhodocetin subunit delta; disulfide bond, lectin, secreted, toxin, cell adhesion; 3.20A {Calloselasma rhodostoma} | Back alignment and structure |
|---|
Probab=99.91 E-value=1.3e-25 Score=194.67 Aligned_cols=117 Identities=23% Similarity=0.571 Sum_probs=101.1
Q ss_pred CCcCCcccCCCCeEEEEecCCCChHHHHHHHhhc--CCEEeeeCCHHHHHHHHHhhCCC--CCCeEeeeeecCCCCCCce
Q 008785 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI--GGHLAALTSYEEEHSAQKLCGKN--VNGCWVGGRSINTTVGLSW 128 (553)
Q Consensus 53 Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~--~~~L~~i~~~~e~~f~~~~~~~~--~~~~WiGl~~~~~~~~~~w 128 (553)
||+||+ .|+++||+|+.+.++|.+|+.+|+++ ||+||+|+|++|++||.+++... ...+||||+ +...++.|
T Consensus 1 Cp~gw~--~~~~~CY~~~~~~~tw~~A~~~C~~~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~WIGl~--~~~~~~~~ 76 (124)
T 3gpr_D 1 CPLHWS--SYNGYCYRVFSELKTWEDAESFCYAQHKGSRLASIHSREEEAFVGKLASQTLKYTSMWLGLN--NAWAACKW 76 (124)
T ss_dssp CCSSCC--CSSSEEEEEEEEEEESHHHHHHHHHHSTTCBSCCCCSHHHHHHHHHHHHHSCSSCCBCCSEE--CCSSCSSC
T ss_pred CCCcce--ecCCEeEEEeCCCcCHHHHHHHHHhcCCCCEEcccCCHHHHHHHHHHHHhcCCCCCEEEEeE--cCCCCCce
Confidence 999999 99999999999999999999999999 99999999999999999987432 367999999 66677999
Q ss_pred EEcCCCCCCcCcccccCccCCCCCCCCCCCCCCCCeeEEEeCCC--CceecccCCCCCCccceec
Q 008785 129 KWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS--RSLVTERCNTSHPFICMVE 191 (553)
Q Consensus 129 ~W~dg~~~~~~~~~~~~~~~~~~~~~~C~~~~~~~~C~~~~~~~--~~w~~~~C~~~~~~iC~~~ 191 (553)
.|+||+++.+.+|.. +| +|+.+.... ..|++..|....+|||+.+
T Consensus 77 ~W~dg~~~~~~~W~~-~p-----------------~C~~~~~~~~~~~W~~~~C~~~~~fiCe~p 123 (124)
T 3gpr_D 77 EWSDDAKLDYKVWLR-RA-----------------YCAVMVVKTDRIFWYNRGCEKTVSFLCKFY 123 (124)
T ss_dssp SSSSCCCSCCBCCCS-CC-----------------CEECCBCCSSSCBBCEECTTSEEEEEEEEE
T ss_pred EECCCCcccccccCC-CC-----------------CcEEEEcCCCCCcEeCCCCCCCccEEeeec
Confidence 999999987776654 21 566665544 4799999999999999874
|
| >1jwi_A Bitiscetin; domain swapping, C-type lectin, toxin; 2.00A {Bitis arietans} SCOP: d.169.1.1 PDB: 1uex_A | Back alignment and structure |
|---|
Probab=99.91 E-value=3.1e-25 Score=194.26 Aligned_cols=121 Identities=29% Similarity=0.596 Sum_probs=101.1
Q ss_pred CCCcCCcccCCCCeEEEEecCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHhhCCC---CC-CeEeeeeecCCCCCCc
Q 008785 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKN---VN-GCWVGGRSINTTVGLS 127 (553)
Q Consensus 52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~---~~-~~WiGl~~~~~~~~~~ 127 (553)
.||+||+ .|+++||+|+.+.++|.+|+.+|+++||+||+|+|++|++||.+++... .. .+||||++.+...++.
T Consensus 3 ~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~~~WIGl~~~~~~~~~~ 80 (131)
T 1jwi_A 3 GCLPDWS--SYKGHCYKVFKKVGTWEDAEKFCVENSGHLASIDSKEEADFVTKLASQTLTKFVYDAWIGLRDESKTQQCS 80 (131)
T ss_dssp -CCTTSE--EETTEEEEEEEEEECHHHHHHHHHHTTCEECCCCSHHHHHHHHHHHHHHC--CCSCEEEEEEECCSSSSSC
T ss_pred CCCCCCE--EeCCEeEEEECCCcCHHHHHHHHHHcCCeECccCCHHHHHHHHHHHhhcccccCccEEEeeeecCCCCCCc
Confidence 5999999 8999999999999999999999999999999999999999999877432 24 8999998444445699
Q ss_pred eEEcCCCCCCcCcccccCccCCCCCCCCCCCCCCCCeeEEEeCCC--CceecccCCCCCCccceecc
Q 008785 128 WKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS--RSLVTERCNTSHPFICMVEH 192 (553)
Q Consensus 128 w~W~dg~~~~~~~~~~~~~~~~~~~~~~C~~~~~~~~C~~~~~~~--~~w~~~~C~~~~~~iC~~~~ 192 (553)
|+|+||+++.+.+|. +| + +|+.+.... ..|++..|....+|||+.+.
T Consensus 81 ~~W~dg~~~~~~~W~--~P--~--------------~C~~~~~~~~~~~w~~~~C~~~~~fICe~~~ 129 (131)
T 1jwi_A 81 PQWTDGSSVVYENVD--EP--T--------------KCFGLDVHTEYRTWTDLPCGEKNPFICKSRL 129 (131)
T ss_dssp SBCTTSCBCCSCCBS--SC--C--------------CEEEECGGGTTSSEEEECTTSCEEEEEEC--
T ss_pred eEEeCcCcccCcCCC--CC--C--------------CceEEecCCCCCeEcCcCCCCCcceeeCcCC
Confidence 999999998777665 43 1 677776543 57999999999999998754
|
| >2zib_A Type II antifreeze protein; thermal hysteresis, lectin; 1.34A {Brachyopsis rostratus} | Back alignment and structure |
|---|
Probab=99.91 E-value=1.7e-24 Score=190.17 Aligned_cols=123 Identities=25% Similarity=0.521 Sum_probs=107.0
Q ss_pred CCCCcCCcccCCCCeEEEEecCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHhhCCCCCCeEeeeeecCCCCCCceEE
Q 008785 51 APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKW 130 (553)
Q Consensus 51 ~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W 130 (553)
.++|.+|. .|+++||+|+.+.++|.+|+.+|+.+||+||+|+|++|++||.+++. ..+||||+ +...++.|+|
T Consensus 8 ~~~~~~~~--~~~~~CY~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~---~~~WIGl~--~~~~~~~w~W 80 (133)
T 2zib_A 8 LVCPAGWT--LHGQRCFYSEATAMTWDLAEANCVNKGGHLASIHSLEEQLYIKDIVA---GIVWIGGS--ACKVAGAWSW 80 (133)
T ss_dssp CCCCTTCE--EETTEEEEEEEEEECHHHHHHHHHHTTSEECCCCSHHHHHHHHHHCS---SCEEEEEE--CCSSTTCCEE
T ss_pred eeCCCCEE--EeCCEEEEEECCccCHHHHHHHHHHCCCEECccCCHHHHHHHHHhhc---cCEEEccE--ecCCCCceEE
Confidence 46899999 99999999999999999999999999999999999999999999985 68999999 6667799999
Q ss_pred cCCCCCCcCcccccCccCCCCCCCCCCCCCCCCeeEEEeCCCC-ceecccCCCCCCccceec
Q 008785 131 SDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSR-SLVTERCNTSHPFICMVE 191 (553)
Q Consensus 131 ~dg~~~~~~~~~~~~~~~~~~~~~~C~~~~~~~~C~~~~~~~~-~w~~~~C~~~~~~iC~~~ 191 (553)
+||+++.+.+|..+.|.+ ...++|+.+..... .|++..|....+|||+.+
T Consensus 81 ~dG~~~~y~~W~~g~P~~-----------~~~~~Cv~~~~~~~~~W~d~~C~~~~~fICe~~ 131 (133)
T 2zib_A 81 TDGTPVDYRTWCPTKPND-----------ILSDCCMQMTAAVDKCWDDLPCPASHASICAKA 131 (133)
T ss_dssp TTCCCCCCCCBCTTCCCC-----------CTTSCEEEECSSTTCCEEEECTTCCEEEEEEEE
T ss_pred CCCCCcccCCcCCCCCCC-----------CCCCCceEEecCCCCcEeCCCCCCCeeEEEeEc
Confidence 999999888877666521 11268988876544 599999999999999874
|
| >1ukm_B EMS16 B chain, EMS16 subunit B; domain swapping, C-type lectin, toxin; HET: NAG; 1.90A {Echis multisquamatus} SCOP: d.169.1.1 PDB: 1v7p_B* | Back alignment and structure |
|---|
Probab=99.91 E-value=5e-25 Score=192.19 Aligned_cols=119 Identities=28% Similarity=0.559 Sum_probs=102.3
Q ss_pred CCcCCcccCCCCeEEEEecCCCChHHHHHHHhh--cCCEEeeeCCHHHHHHHHHhhCCC--CCCeEeeeeecCCCCCCce
Q 008785 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKN--VNGCWVGGRSINTTVGLSW 128 (553)
Q Consensus 53 Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~--~~~~L~~i~~~~e~~f~~~~~~~~--~~~~WiGl~~~~~~~~~~w 128 (553)
||.||. .|+++||+|+.+.++|.+|+.+|++ .|||||+|+|++|++||.+++... ...+||||+ +...++.|
T Consensus 1 Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~WiGl~--~~~~~~~~ 76 (128)
T 1ukm_B 1 CPLGWS--SFDQHCYKVFEPVKNWTEAEEICMQQHKGSRLASIHSSEEEAFVSKLASKALKFTSMWIGLN--NPWKDCKW 76 (128)
T ss_dssp CCTTCE--EETTEEEEEEEEEECHHHHHHHHHHHSTTCEECCCCSHHHHHHHHHHHHHHCSSCEEEEEEE--CTTTTCCE
T ss_pred CCCcCE--ecCCEeEEEECCccCHHHHHHHHhccCCccEEcccCCHHHHHHHHHHHHhcCCcCcEEEecc--cCCCCCce
Confidence 999999 8999999999999999999999999 899999999999999999887432 367999999 66667999
Q ss_pred EEcCCCCCCcCcccccCccCCCCCCCCCCCCCCCCeeEEEeCC--CCceecccCCCCCCccceeccc
Q 008785 129 KWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNG--SRSLVTERCNTSHPFICMVEHE 193 (553)
Q Consensus 129 ~W~dg~~~~~~~~~~~~~~~~~~~~~~C~~~~~~~~C~~~~~~--~~~w~~~~C~~~~~~iC~~~~~ 193 (553)
+|+||+++.+.+|. ++| +|+.+... ...|++..|....+|||+.+..
T Consensus 77 ~W~dg~~~~~~~W~-g~P-----------------~C~~~~~~~~~~~w~~~~C~~~~~fICe~~~~ 125 (128)
T 1ukm_B 77 EWSDNARFDYKAWK-RRP-----------------YCTVMVVKPDRIFWFTRGCEKSVSFVCKFLTD 125 (128)
T ss_dssp EETTCCCCCCCCBC-CCC-----------------EEEEEEECSSCEEEEEEETTSCEEEEEEEEC-
T ss_pred EeCCCCccccCCCC-CCC-----------------CcEEEeCCCCCCeEeCCCCCCCcCeEeeecCC
Confidence 99999998777665 432 67777553 2579999999999999998654
|
| >1ukm_A EMS16 A chain, EMS16 subunit A; domain swapping, C-type lectin, toxin; HET: NAG; 1.90A {Echis multisquamatus} SCOP: d.169.1.1 PDB: 1v7p_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=4.6e-25 Score=193.89 Aligned_cols=120 Identities=25% Similarity=0.518 Sum_probs=104.2
Q ss_pred CCCcCCcccCCCCeEEEEecCCCChHHHHHHHhh--cCCEEeeeCCHHHHHHHHHhhCCC---CC-CeEeeeeecCC--C
Q 008785 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKN---VN-GCWVGGRSINT--T 123 (553)
Q Consensus 52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~--~~~~L~~i~~~~e~~f~~~~~~~~---~~-~~WiGl~~~~~--~ 123 (553)
+||+||+ .|+++||+|+.+.++|.+|+.+|++ .|||||+|+|++|++||.+++... .. .+||||+ +. .
T Consensus 3 ~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~~~WIGl~--~~~~~ 78 (134)
T 1ukm_A 3 DCPSDWT--AYDQHCYLAIGEPQNWYEAERFCTEQAKDGHLVSIQSREEGNFVAQLVSGFMHRSEIYVWIGLR--DRREE 78 (134)
T ss_dssp CCSTTCE--EETTEEEEEEEEEECHHHHHHHHHHHSTTCEECCCCSHHHHHHHHHHTGGGGGSSCCEEEEEEE--ECCSS
T ss_pred CCCCccE--ecCCEEEEEECCCcCHHHHHHHHhhcCCCcEECccCCHHHHHHHHHHHhhhccCCCCCEEEeee--cCCCC
Confidence 6999999 8999999999999999999999999 899999999999999999987543 25 7999999 55 5
Q ss_pred CCCceEEcCCCCCCcCcccccCccCCCCCCCCCCCCCCCCeeEEEeCCC--CceecccCCCCCCccceec
Q 008785 124 VGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS--RSLVTERCNTSHPFICMVE 191 (553)
Q Consensus 124 ~~~~w~W~dg~~~~~~~~~~~~~~~~~~~~~~C~~~~~~~~C~~~~~~~--~~w~~~~C~~~~~~iC~~~ 191 (553)
.++.|+|+||+++.+.+|.+++|. +|+.+.... ..|++..|....+|||+.+
T Consensus 79 ~~~~~~W~dg~~~~~~~W~~g~P~----------------~C~~~~~~~~~~~W~~~~C~~~~~~ICe~~ 132 (134)
T 1ukm_A 79 QQCNPEWNDGSKIIYVNWKEGESK----------------MCQGLTKWTNFHDWNNINCEDLYPFVCKFS 132 (134)
T ss_dssp SCSCCBCTTSCBCCCCCBCTTCCC----------------CEEEEEGGGTSCSEEEECTTSCEEEEEEEE
T ss_pred CCCceEEcCcCccccceECCCcCc----------------cceEEEecCCCCeeecCCCCCCceeEEeEc
Confidence 679999999999888777665541 677876654 5799999999999999875
|
| >1fvu_A Botrocetin alpha chain; VON WILLBRAND factor modulator, C-type lectin, metal- binding, loop exchanged dimer, toxin; 1.80A {Bothrops jararaca} SCOP: d.169.1.1 PDB: 1ijk_B 1u0n_B 1u0o_A | Back alignment and structure |
|---|
Probab=99.91 E-value=4.4e-25 Score=193.84 Aligned_cols=123 Identities=26% Similarity=0.557 Sum_probs=104.9
Q ss_pred CCCcCCcccCCCCeEEEEecCCCChHHHHHHHhh--cCCEEeeeCCHH-HHHHHHHhhCCC----CCCeEeeeeecCCCC
Q 008785 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYE-EEHSAQKLCGKN----VNGCWVGGRSINTTV 124 (553)
Q Consensus 52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~--~~~~L~~i~~~~-e~~f~~~~~~~~----~~~~WiGl~~~~~~~ 124 (553)
+||+||+ .|+++||+|+.+.++|.+|+.+|+. .|||||+|+|.+ |++||.+++... ...+||||+..+...
T Consensus 1 ~Cp~gw~--~~~~~CY~~~~~~~tw~~A~~~C~~~~~g~~La~i~s~~~e~~~l~~~~~~~~~~~~~~~WIGl~~~~~~~ 78 (133)
T 1fvu_A 1 DCPSGWS--SYEGNCYKFFQQKMNWADAERFCSEQAKGGHLVSIKIYSKEKDFVGDLVTKNIQSSDLYAWIGLRVENKEK 78 (133)
T ss_dssp CCCTTCE--EETTEEEEEEEEEECHHHHHHHHHHHSTTCEECCCCTTSTHHHHHHHHHHHHCCSSCCEEEEEEEECCSSS
T ss_pred CcCCCcE--EcCCeeEEEECCCcCHHHHHHHHhccCCCcEEeeecChHHHHHHHHHHHhhccccCCCCEEEeeecccCCC
Confidence 4999999 8999999999999999999999999 699999999999 999999887432 367999998334445
Q ss_pred CCceEEcCCCCCCcCcccccCccCCCCCCCCCCCCCCCCeeEEEeCCC--CceecccCCCCCCccceecc
Q 008785 125 GLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS--RSLVTERCNTSHPFICMVEH 192 (553)
Q Consensus 125 ~~~w~W~dg~~~~~~~~~~~~~~~~~~~~~~C~~~~~~~~C~~~~~~~--~~w~~~~C~~~~~~iC~~~~ 192 (553)
++.|+|+||+++.+.+|.. .|. ++|+.+.... ..|++..|....+|||+.+.
T Consensus 79 ~~~w~W~dg~~~~~~~W~~-~P~---------------~~C~~~~~~~~~~~w~~~~C~~~~~fICe~~~ 132 (133)
T 1fvu_A 79 QCSSEWSDGSSVSYENVVE-RTV---------------KKCFALEKDLGFVLWINLYCAQKNPFVCKSPP 132 (133)
T ss_dssp SSCCBCTTSCBCCCCCBCG-GGC---------------CCEEEEETTTTSCSEEEECTTCCEEEEEEECC
T ss_pred CCccEeCCCCcccccCccc-CCC---------------CCcEEEEecCCCCeEecCCCCCCCCEEeeecC
Confidence 6999999999988887776 542 4788887654 57999999999999998753
|
| >3alu_A Lectin CEL-IV, C-type; C-type lectin, raffinose, sugar binding protein; HET: RAF; 1.65A {Cucumaria echinata} PDB: 3als_A* 3alt_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=3.3e-25 Score=200.58 Aligned_cols=128 Identities=21% Similarity=0.358 Sum_probs=108.6
Q ss_pred CCCCcCCcccCCCCeEEEEecCCCChHHHHHHHhh--c---------CCEEeeeCCHHHHHHHHHhhCCC-------C--
Q 008785 51 APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--I---------GGHLAALTSYEEEHSAQKLCGKN-------V-- 110 (553)
Q Consensus 51 ~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~--~---------~~~L~~i~~~~e~~f~~~~~~~~-------~-- 110 (553)
..||.||. .|+++||+|+.+.++|.+|+.+|+. + |||||+|+|.+|++||.+++... .
T Consensus 3 ~~Cp~gw~--~~~~~CY~~~~~~~tw~~A~~~C~~~~~~~~~~~~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~~~~~ 80 (157)
T 3alu_A 3 TSCPPLWT--GFNGKCFRLFHNHLNFDNAENACRQFGLASCSGDELATGHLASIHSAESQAFLTELVKTSLPDLITGGWA 80 (157)
T ss_dssp CEECTTCE--EETTEEEEEEEEEECHHHHHHHHTTEEEEETTSCEEEECEECCCCSHHHHHHHHHHHHHHCGGGCCSSSC
T ss_pred CCCCCCcE--eeCCEEEEEECCccCHHHHHHHhhccccccccCCCCCCeEEcccCCHHHHHHHHHHHHhcccccccccCC
Confidence 46999999 8999999999999999999999999 8 99999999999999999887421 1
Q ss_pred CCeEeeeeecCCCCCCceEEcCCCCCCcCcccccCccCCCCCCCCCCCCCCCCeeEEEeCCC-CceecccCCCCCCccce
Q 008785 111 NGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS-RSLVTERCNTSHPFICM 189 (553)
Q Consensus 111 ~~~WiGl~~~~~~~~~~w~W~dg~~~~~~~~~~~~~~~~~~~~~~C~~~~~~~~C~~~~~~~-~~w~~~~C~~~~~~iC~ 189 (553)
..+||||+ +...++.|.|+||+++.+.+|..+.|.+ ..+.++|+.+.... ..|++..|....+|||+
T Consensus 81 ~~~WIGl~--~~~~~~~w~W~dG~~~~y~~W~~g~P~~----------~~~~~~Cv~~~~~~~~~W~d~~C~~~~~fICe 148 (157)
T 3alu_A 81 PQVYIGMK--VGSTNSDQTWTDGSSVDYDGWVSGEPNN----------GPNSRGAIAAGDYSRGFWADVYSNNNFKYICQ 148 (157)
T ss_dssp SEEEEEEE--ECSSTTCEEETTCCCCCCCCBCTTCCCS----------CSSEEEEEECSTTTTTCEEEECTTCCEEEEEE
T ss_pred CCEEEeee--eCCCCCCeEeCCCCCCCccCcCCCCCCC----------CCCCCCeEEEecCCCCeEcCCCCCCccceEec
Confidence 67999999 6666799999999998888877766521 12357899886543 67999999999999998
Q ss_pred ecc
Q 008785 190 VEH 192 (553)
Q Consensus 190 ~~~ 192 (553)
.+.
T Consensus 149 ~~~ 151 (157)
T 3alu_A 149 LPC 151 (157)
T ss_dssp CCC
T ss_pred ccc
Confidence 754
|
| >1umr_A Convulxin alpha, CVX alpha; lectin, C-type lectin, platelet, sugar-binding protein, activator, snake venom; 2.40A {Crotalus durissus terrificus} SCOP: d.169.1.1 PDB: 1uos_A | Back alignment and structure |
|---|
Probab=99.91 E-value=4.4e-25 Score=194.37 Aligned_cols=123 Identities=24% Similarity=0.479 Sum_probs=104.9
Q ss_pred CCCcCCcccCCCCeEEEEecCCCChHHHHHHHhh--cCCEEeeeCCHHHHHHHHHhhCCC---CC-CeEeeeeecCCCCC
Q 008785 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKN---VN-GCWVGGRSINTTVG 125 (553)
Q Consensus 52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~--~~~~L~~i~~~~e~~f~~~~~~~~---~~-~~WiGl~~~~~~~~ 125 (553)
.||+||+ .|+++||+|+.+.++|.+|+.+|++ .|||||+|+|++|++||.+++... .. .+||||+..+...+
T Consensus 3 ~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~~~WIGl~~~~~~~~ 80 (135)
T 1umr_A 3 HCPSDWY--YYDQHCYRIFNEEMNWEDAEWFCTKQAKGAHLVSIKSAKEADFVAWMVTQNIEESFSHVSIGLRVQNKEKQ 80 (135)
T ss_dssp SSCTTCE--EETTEEEEEEEEEECHHHHHHHHHHHSTTCEECCCCSHHHHHHHHHHHHHHSCTTCCEEECSEEECCSSSS
T ss_pred CCCCCCE--EcCCEeEEEECCCCCHHHHHHHHHccCCCceECccCCHHHHHHHHHHHHhhcccCCCCEEEeccccCCCCC
Confidence 6999999 8999999999999999999999999 899999999999999999887432 24 89999984344456
Q ss_pred CceEEcCCCCCCcCcccccCccCCCCCCCCCCCCCCCCeeEEEeCCC--CceecccCCCCCCccceecc
Q 008785 126 LSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS--RSLVTERCNTSHPFICMVEH 192 (553)
Q Consensus 126 ~~w~W~dg~~~~~~~~~~~~~~~~~~~~~~C~~~~~~~~C~~~~~~~--~~w~~~~C~~~~~~iC~~~~ 192 (553)
+.|.|+||+++.+.+|..++|. +|+.+.... ..|++..|....+|||+.+.
T Consensus 81 ~~w~W~dg~~~~~~~W~~g~P~----------------~C~~~~~~~~~g~W~~~~C~~~~~~ICe~~~ 133 (135)
T 1umr_A 81 CSTKWSDGSSVSYDNLLDLYIT----------------KCSLLKKETGFRKWFVASCIGKIPFVCKFPP 133 (135)
T ss_dssp SCCBCTTSCBCCCCCBCGGGCC----------------CEEEEEGGGTTCSBEEECTTCCEEEEEEECC
T ss_pred CccCcCCCCeecccccCCCCCC----------------ccEEEecCCCCCeEecCCCCCCCcEEeCccC
Confidence 9999999999888877765541 677776644 57999999999999999754
|
| >1hup_A Mannose-binding protein; alpha-helical coiled-coil, C-type lectin; 2.50A {Homo sapiens} SCOP: d.169.1.1 h.1.1.1 | Back alignment and structure |
|---|
Probab=99.91 E-value=6.5e-25 Score=194.92 Aligned_cols=122 Identities=14% Similarity=0.131 Sum_probs=106.6
Q ss_pred CCCcCCcccCCCCeEEEEecCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHhhCCCCCCeEeeeeecCCCCCCceEEc
Q 008785 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWS 131 (553)
Q Consensus 52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~ 131 (553)
.||++|. .|+++||+|+...++|.+|+.+|+.+||+||+|+|.+|++||.+++. ..+||||+ +...+|.|.|+
T Consensus 19 ~~~~~w~--~~~~~Cy~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~---~~~WIGl~--~~~~~~~w~W~ 91 (141)
T 1hup_A 19 LTFSLGK--QVGNKFFLTNGEIMTFEKVKALCVKFQASVATPRNAAENGAIQNLIK---EEAFLGIT--DEKTEGQFVDL 91 (141)
T ss_dssp HHHHTSE--EETTEEEEEEEEEEEHHHHHHHHHHTTCEECCCCSHHHHHHHHHHCS---SCEEEEEE--CSSSTTCCEET
T ss_pred hhcCCeE--EECCEEEEEeCCCcCHHHHHHHHHhCCCEECccCCHHHHHHHHHHhc---CCEEEeee--ecCcCCcEEEC
Confidence 4899999 99999999999999999999999999999999999999999999875 68999999 76677999999
Q ss_pred CCCCCCcCcccccCccCCCCCCCCCCCCCCCCeeEEEeCCCCceecccCCCCCCccceec
Q 008785 132 DNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVE 191 (553)
Q Consensus 132 dg~~~~~~~~~~~~~~~~~~~~~~C~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~~ 191 (553)
||+++.+.+|.++.|.+ ..+.++|+.+.. .+.|++..|....+|+|+.+
T Consensus 92 dG~~~~~~~W~~g~P~~----------~~~~~~Cv~~~~-~g~W~~~~C~~~~~fICe~~ 140 (141)
T 1hup_A 92 TGNRLTYTNWNEGEPNN----------AGSDEDCVLLLK-NGQWNDVPCSTSHLAVCEFP 140 (141)
T ss_dssp TSCBCSCCCBCTTCCCC----------GGGCCCEEEECT-TSCEEEECTTSEEEEEEEEE
T ss_pred CcCCCcCCCCCCCCCCC----------CCCCCCeEEECC-CCcEeccCCCCCccEEEEEE
Confidence 99999888877766521 124568998863 45899999999999999864
|
| >1j34_A Coagulation factor IX-binding protein A chain; magnesium ION, calcium ION, GLA domain, protein binding/blood clotting complex; HET: CGU; 1.55A {Trimeresurus flavoviridis} SCOP: d.169.1.1 PDB: 1bj3_A* 1j35_A* 1x2t_A* 1x2w_A 1ixx_A 1y17_A 1wt9_A 1iod_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=5.8e-25 Score=191.85 Aligned_cols=121 Identities=28% Similarity=0.584 Sum_probs=102.3
Q ss_pred CCCcCCcccCCCCeEEEEecCCCChHHHHHHHhh--cCCEEeeeCCHHHHHHHHHhhCCC---CC-CeEeeeeecCCCCC
Q 008785 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKN---VN-GCWVGGRSINTTVG 125 (553)
Q Consensus 52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~--~~~~L~~i~~~~e~~f~~~~~~~~---~~-~~WiGl~~~~~~~~ 125 (553)
+||+||+ .|+++||+|+.+.++|.+|+.+|+. .||+||+|+|++|++||.+++... .. .+||||+..+...+
T Consensus 1 ~Cp~gw~--~~~~~Cy~~~~~~~~w~~A~~~C~~~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~~~WIGl~~~~~~~~ 78 (129)
T 1j34_A 1 DCPSGWS--SYEGHCYKPFKLYKTWDDAERFCTEQAKGGHLVSIESAGEADFVAQLVTENIQNTKSYVWIGLRVQGKEKQ 78 (129)
T ss_dssp CCCTTCE--EETTEEEEEEEEEECHHHHHHHHHHHSTTCEECCCCSHHHHHHHHHHHHHHCCCTTCCEEEEEEECSSCSC
T ss_pred CCCCCcE--EeCCEEEEEECCCCCHHHHHHHHhccCCCCEECccCCHHHHHHHHHHHhhcccCCCCCEEEeeecCCCCCC
Confidence 4999999 8999999999999999999999999 799999999999999999877432 24 89999983344456
Q ss_pred CceEEcCCCCCCcCcccccCccCCCCCCCCCCCCCCCCeeEEEeCCC--CceecccCCCCCCcccee
Q 008785 126 LSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS--RSLVTERCNTSHPFICMV 190 (553)
Q Consensus 126 ~~w~W~dg~~~~~~~~~~~~~~~~~~~~~~C~~~~~~~~C~~~~~~~--~~w~~~~C~~~~~~iC~~ 190 (553)
+.|.|+||+++.+.+|..++|. +|+.+.... ..|++..|....+|||+.
T Consensus 79 ~~~~W~dg~~~~~~~W~~~~P~----------------~C~~~~~~~~~~~w~~~~C~~~~~fiCe~ 129 (129)
T 1j34_A 79 CSSEWSDGSSVSYENWIEAESK----------------TCLGLEKETGFRKWVNIYCGQQNPFVCEA 129 (129)
T ss_dssp SCCBCTTSCBCCCCCBCGGGSC----------------CEEEECGGGTTCSBEEECTTSCEEEEEEC
T ss_pred CceEECCcCccceeccCCCCCC----------------cceEEEccCCCCeEccCCCCCCCceEeeC
Confidence 9999999999888777665541 677775543 579999999999999973
|
| >1oz7_A Echicetin A-chain; platelet aggregation, dimer, toxin; 2.40A {Echis carinatus} SCOP: d.169.1.1 | Back alignment and structure |
|---|
Probab=99.91 E-value=5.3e-25 Score=192.79 Aligned_cols=120 Identities=27% Similarity=0.560 Sum_probs=103.7
Q ss_pred CCCcCCcccCCCCeEEEEecCCCChHHHHHHHhh--cCCEEeeeCCHHHHHHHHHhhCCC---CCCeEeeeeecCCC--C
Q 008785 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKN---VNGCWVGGRSINTT--V 124 (553)
Q Consensus 52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~--~~~~L~~i~~~~e~~f~~~~~~~~---~~~~WiGl~~~~~~--~ 124 (553)
+||+||. .|+++||+|+.+.++|.+|+.+|+. .||+||+|+|.+|++||.+++... ...+||||+ +.. .
T Consensus 1 ~Cp~gw~--~~~~~Cy~~~~~~~~w~~A~~~C~~~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~~WIGl~--~~~~~~ 76 (131)
T 1oz7_A 1 MCPPGWS--SNGVYCYMLFKEPKTWDEAEKFCNKQGKDGHLLSIESKKEEILVDIVVSENIGKMYKIWTGLS--ERSKEQ 76 (131)
T ss_dssp CCCTTCE--EETTEEEEEEEEEECHHHHHHHHHHHSTTCEECCCCSHHHHHHHHHHHHHHSCCCSEEEEEEE--ECCCGG
T ss_pred CcCCCcE--EeCCEEEEEECCCCCHHHHHHHHHhcCCCCEECccCCHHHHHHHHHHHHhhcCCCCCEEEeee--CCCCCC
Confidence 4999999 8999999999999999999999999 899999999999999999887432 367999999 555 6
Q ss_pred CCceEEcCCCCCCcCcccccCccCCCCCCCCCCCCCCCCeeEEEeCCC--CceecccCCCCCCccceecc
Q 008785 125 GLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS--RSLVTERCNTSHPFICMVEH 192 (553)
Q Consensus 125 ~~~w~W~dg~~~~~~~~~~~~~~~~~~~~~~C~~~~~~~~C~~~~~~~--~~w~~~~C~~~~~~iC~~~~ 192 (553)
++.|.|+||+++.+.+|.. +|. +|+.+.... ..|++..|....+|||+.+.
T Consensus 77 ~~~~~W~dg~~~~~~~W~~-~P~----------------~Cv~~~~~~~~~~w~~~~C~~~~~fICe~~~ 129 (131)
T 1oz7_A 77 HCSSRWSDGSFFRSYEIAI-RYS----------------ECFVLEKQSVFRTWVATPCENTFPFMCKYPV 129 (131)
T ss_dssp GSCCBCSSSBCCSCCCCCC-SCC----------------CEEEEEGGGTTCSEEEECTTSCEEEEEEECT
T ss_pred CCceEECCCCeeccccccC-CCC----------------CeEEEEccCCCCeEeecCCCCCCcEEeeecC
Confidence 7999999999988777766 541 688876654 57999999999999998754
|
| >2e3x_B Coagulation factor X-activating enzyme light CHAI; disintegrin, metalloproteinase, C-type lectin, hydrolase, BL clotting, toxin; HET: NAG MAN GM6; 2.91A {Daboia russellii siamensis} | Back alignment and structure |
|---|
Probab=99.91 E-value=6.6e-25 Score=192.97 Aligned_cols=123 Identities=25% Similarity=0.475 Sum_probs=104.7
Q ss_pred CCCcCCcccCCCCeEEEEecCCCChHHHHHHHhh--cCCEEeeeCCHHHHHHHHHhhCCCC---C-CeEeeeeecCCCCC
Q 008785 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKNV---N-GCWVGGRSINTTVG 125 (553)
Q Consensus 52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~--~~~~L~~i~~~~e~~f~~~~~~~~~---~-~~WiGl~~~~~~~~ 125 (553)
+||+||+ .|+++||+|+.+.++|.+|+.+|++ .||+||+|+|++|++||.+++.... . .+||||+..+...+
T Consensus 2 ~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~~~WIGl~~~~~~~~ 79 (134)
T 2e3x_B 2 DCPPDSS--LYRYFCYRVFKEHKTWEAAERFCMEHPNNGHLVSIESMEEAEFVAKLLSNTTGKFITHFWIGLMIKDKEQE 79 (134)
T ss_dssp CCTTTSE--EETTEEEEEEEEEEEHHHHHHHHTSTTTTCCBCCCCSHHHHHHHHHHHHTCC----CEEECCEEECSSCTT
T ss_pred CCCCCCE--EeCCEeeEEeCCCcCHHHHHHHHhccCCCcEEcccCCHHHHHHHHHHHHhhccCCCCCEEEeeeecCCCCC
Confidence 5999999 8999999999999999999999999 8999999999999999999876432 4 89999983344456
Q ss_pred CceEEcCCCCCCcCcccccCccCCCCCCCCCCCCCCCCeeEEEeCCC--CceecccCCCCCCccceecc
Q 008785 126 LSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS--RSLVTERCNTSHPFICMVEH 192 (553)
Q Consensus 126 ~~w~W~dg~~~~~~~~~~~~~~~~~~~~~~C~~~~~~~~C~~~~~~~--~~w~~~~C~~~~~~iC~~~~ 192 (553)
+.|.|+||+++.+.+|..++|. +|+.+.... ..|++..|....+|||+.+.
T Consensus 80 ~~~~W~dg~~~~~~~W~~~~P~----------------~C~~~~~~~~~~~w~~~~C~~~~~~ICe~~~ 132 (134)
T 2e3x_B 80 CSSEWSDGSSVSYDKLGKQEFR----------------KCFVLEKESGYRMWFNRNCEERYLFVCKVPP 132 (134)
T ss_dssp TTCCCTTSCCCCCCCBCGGGCC----------------CEEEEEGGGTTCCBEEECTTSEEEEEEEECC
T ss_pred CccEeCCCCcccccccCCCCCC----------------CeEEEEecCCCCcCCCCCCCCCcceEeCccC
Confidence 9999999999888777665541 677776644 57999999999999999754
|
| >1rtm_1 Mannose-binding protein-A; lectin; 1.80A {Rattus norvegicus} SCOP: d.169.1.1 h.1.1.1 PDB: 1kwu_A* 1kwv_A* 1kwt_A* 1kwx_A* 1kwy_A* 1kx1_A* 1kww_A 1kwz_A* 1kx0_A* 3kmb_1* 1kmb_1* 2kmb_1* 4kmb_1* 1afb_1* 1afa_1* 1afd_1 1bch_1* 1bcj_1* 1fif_A 1fih_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.2e-24 Score=195.10 Aligned_cols=122 Identities=13% Similarity=0.176 Sum_probs=106.4
Q ss_pred CCCcCCcccCCCCeEEEEecCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHhhCCCCCCeEeeeeecCCCCCCceEEc
Q 008785 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWS 131 (553)
Q Consensus 52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~ 131 (553)
.||++|. .|+++||+|+...+||.+|+.+|..+|||||+|+|.+|++||.+++. ..+||||+ +...+|.|.|+
T Consensus 27 ~~~~~w~--~~~~~Cy~~~~~~~tw~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~---~~~WIGl~--~~~~~~~w~W~ 99 (149)
T 1rtm_1 27 HAFSMGK--KSGKKFFVTNHERMPFSKVKALCSELRGTVAIPRNAEENKAIQEVAK---TSAFLGIT--DEVTEGQFMYV 99 (149)
T ss_dssp HHHHTTC--CTTSCEEEEEEEEEEHHHHHHHHHHTTCEECCCCSHHHHHHHHHHHS---SCEEEEEE--CSSSTTCCEET
T ss_pred hcCCCeE--EeCCEEEEEeCCCCCHHHHHHHHHhCCCEEeeeCCHHHHHHHHHHhc---CCEEEEee--ccCcCCeEEEC
Confidence 4899999 99999999999999999999999999999999999999999999985 68999999 77778999999
Q ss_pred CCCCCCcCcccccCccCCCCCCCCCCCCCCCCeeEEEeCCCCceecccCCCCCCccceec
Q 008785 132 DNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVE 191 (553)
Q Consensus 132 dg~~~~~~~~~~~~~~~~~~~~~~C~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~~ 191 (553)
||+++.+.+|.++.|.+ ..+.++|+.+.. .+.|++..|....+|||+.+
T Consensus 100 dg~~~~~~~W~~g~P~~----------~~~~~~Cv~~~~-~g~W~d~~C~~~~~fICe~~ 148 (149)
T 1rtm_1 100 TGGRLTYSNWKKDEPND----------HGSGEDCVTIVD-NGLWNDISCQASHTAVCEFP 148 (149)
T ss_dssp TSSBCCSCCBCTTCCCC----------CTTCCCEEEECG-GGCEEEECTTSEEEEEEEEC
T ss_pred CCCCccccCcCCCCCCC----------CCCCCCeEEECC-CCCEeCCCCCCCeeEEEEee
Confidence 99999888877666521 134568988863 35799999999999999864
|
| >1sb2_B Rhodocetin beta subunit; C-type lectin, domain swapping, toxin; 1.90A {Calloselasma rhodostoma} SCOP: d.169.1.1 PDB: 3gpr_B | Back alignment and structure |
|---|
Probab=99.91 E-value=1e-24 Score=190.52 Aligned_cols=118 Identities=22% Similarity=0.432 Sum_probs=101.7
Q ss_pred CCCCcCCcccCCCCeEEEEecCCCChHHHHHHHhh--cCCEEeeeCCHHHHHHHHHhhCCC----CCCeEeeeeecCCCC
Q 008785 51 APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKN----VNGCWVGGRSINTTV 124 (553)
Q Consensus 51 ~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~--~~~~L~~i~~~~e~~f~~~~~~~~----~~~~WiGl~~~~~~~ 124 (553)
..||.||. .|+++||+|+.+.++|.+|+.+|++ .|||||+|+|++|++||.+++... ...+||||+
T Consensus 2 ~~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~~~WiGl~------ 73 (129)
T 1sb2_B 2 FRCPTTWS--ASKLYCYKPFKEKKTWIEAERFCAKQAENGHLVSIGSAAEADFLDLVIVVNFDKQRYRAWTGLT------ 73 (129)
T ss_dssp CCCCTTCE--ECSSEEEEEEEEEECHHHHHHHHHHHSTTCEECCCCSHHHHHHHHHHHHHHC---CCCEEEEEE------
T ss_pred CCCCCCCE--EeCCEeEEEECCCcCHHHHHHHHhhcCCCceECccCCHHHHHHHHHHHHhhcccCCCCEeEeec------
Confidence 36999999 8999999999999999999999999 899999999999999999876421 468999997
Q ss_pred CCceEEcCCCCCCcCcccccCccCCCCCCCCCCCCCCCCeeEEEeCCCC--ceecccCCCCCCccceecc
Q 008785 125 GLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSR--SLVTERCNTSHPFICMVEH 192 (553)
Q Consensus 125 ~~~w~W~dg~~~~~~~~~~~~~~~~~~~~~~C~~~~~~~~C~~~~~~~~--~w~~~~C~~~~~~iC~~~~ 192 (553)
++.|+|+||+++.+.+|..++|. +|+.+..... .|++..|....+|||+.+.
T Consensus 74 ~~~~~W~dg~~~~~~~W~~~~P~----------------~C~~~~~~~~~~~W~~~~C~~~~~fICe~~~ 127 (129)
T 1sb2_B 74 ERNLKWTNGASVSYENLYEPYIR----------------KCFVVQPWEGKSKWYKADCEEKNAFLCKFPK 127 (129)
T ss_dssp ECCCBCTTSCBCCSCCBSSCCCC----------------CEEEEEEETTEEEEEEECTTSCEEEEEEEEC
T ss_pred CCccEECCCCcccccccCCCCCC----------------CeEEEEecCCCCeEeCcCCCCCcceEecccC
Confidence 48999999999887777665541 6777765544 7999999999999998754
|
| >3c8j_A Natural killer cell receptor LY49C; MHC, virus, immune system; 2.60A {Mus musculus} SCOP: d.169.1.1 PDB: 3c8k_D 1p4l_D 1ja3_A 1p1z_D | Back alignment and structure |
|---|
Probab=99.91 E-value=8.4e-25 Score=206.11 Aligned_cols=124 Identities=18% Similarity=0.300 Sum_probs=104.9
Q ss_pred CCCCCCCcCCcccCCCCeEEEEecCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHhhCCCCCCeEeeeeecCCCCCCc
Q 008785 48 DWKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLS 127 (553)
Q Consensus 48 ~~~~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~ 127 (553)
..+.+||.||. .|+++||+|+.+.++|.+|+.+|.++||+||+|+|.+|++||.+++. ...+||||+ +...+|.
T Consensus 75 ~~~~~Cp~gW~--~~~~~CY~~~~~~~tw~~A~~~C~~~g~~LasI~s~~E~~fl~~~~~--~~~~WIGl~--~~~~~~~ 148 (203)
T 3c8j_A 75 RDTGRGVKYWF--CYSTKCYYFIMNKTTWSGCKANCQHYGVPILKIEDEDELKFLQRHVI--PGNYWIGLS--YDKKKKE 148 (203)
T ss_dssp --CCCCCEEEE--EEETEEEEEEEEEECHHHHHHHHHHTTCCBCCCCSHHHHHHHHHHSC--SSCEEEEEE--EETTTTE
T ss_pred cCCCCCCCCcE--EeCCEEEEEECCCCCHHHHHHHHHhCCCEeeeeCCHHHHHHHHHhcC--CCCEEEeee--ecCCCCc
Confidence 34568999999 89999999999999999999999999999999999999999999986 568999999 5556799
Q ss_pred eEEcCCCCCCcCcccccCccCCCCCCCCCCCCCCCCeeEEEeCCCCceecccCCCCCCccceecc
Q 008785 128 WKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVEH 192 (553)
Q Consensus 128 w~W~dg~~~~~~~~~~~~~~~~~~~~~~C~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~~~ 192 (553)
|.|+||+++.+ .|..+.|+ .+.++|+.+..+ .|++..|....+|||+.+.
T Consensus 149 w~W~DGs~~~~-~w~~~~pn------------~~~~~Cv~l~~~--~W~d~~C~~~~~fICe~~~ 198 (203)
T 3c8j_A 149 WAWIDNGPSKL-DMKIKKMN------------FKSRGCVFLSKA--RIEDIDCNIPYYCICGKKL 198 (203)
T ss_dssp EEETTSCCCTT-HHHHHTTC------------CCSSSEEEECSS--CEEEECTTSCEEEEEEEEC
T ss_pred eEECCCCCCCC-CCCCCCCC------------CCCCCcEEEECC--cEECcCCCCCEEEEEeECC
Confidence 99999999874 45444331 234689888653 7999999999999998764
|
| >1buu_A Protein (mannose-binding protein A); lectin, HOST defense, metalloprotein, sugar binding protein; 1.90A {Rattus norvegicus} SCOP: d.169.1.1 h.1.1.1 | Back alignment and structure |
|---|
Probab=99.90 E-value=2.9e-24 Score=196.56 Aligned_cols=122 Identities=13% Similarity=0.171 Sum_probs=107.0
Q ss_pred CCCcCCcccCCCCeEEEEecCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHhhCCCCCCeEeeeeecCCCCCCceEEc
Q 008785 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWS 131 (553)
Q Consensus 52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~ 131 (553)
.||.+|. .|+++||+|+...+||.+|+.+|..+|||||+|+|.+|++||.+++. ..+||||+ |...+|.|.|+
T Consensus 46 ~~~~~~~--~~~~~Cy~~~~~~~tw~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~---~~~WIGl~--d~~~~g~w~W~ 118 (168)
T 1buu_A 46 HAFSMGK--KSGKKFFVTNHERMPFSKVKALCSELRGTVAIPRNAEENKAIQEVAK---TSAFLGIT--DEVTEGQFMYV 118 (168)
T ss_dssp HHHHTTC--CTTSCEEEEEEEEECHHHHHHHHHHTTSEECCCCSHHHHHHHHHHHC---SCEECSEE--CSSSTTCCEET
T ss_pred ccCCCeE--EECCEEEEEeCCccCHHHHHHHHHhCCCEEeeeCCHHHHHHHHHHhc---CCEEeeee--cCCcCCCEEeC
Confidence 4999999 99999999999999999999999999999999999999999999985 68999999 77778999999
Q ss_pred CCCCCCcCcccccCccCCCCCCCCCCCCCCCCeeEEEeCCCCceecccCCCCCCccceec
Q 008785 132 DNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVE 191 (553)
Q Consensus 132 dg~~~~~~~~~~~~~~~~~~~~~~C~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~~ 191 (553)
||+++.+.+|..+.|++ ..+.++|+.+. ....|++..|....+|||+.+
T Consensus 119 dG~~~~y~~W~~geP~~----------~~~~e~Cv~~~-~~g~W~d~~C~~~~~~ICe~~ 167 (168)
T 1buu_A 119 TGGRLTYSNWKKDEPND----------HGSGEDCVTIV-DNGLWNDISCQASHTAVCEFP 167 (168)
T ss_dssp TSSBCSCCCBSSSSCCC----------TTSCCCEEEEC-TTSCEEEECTTSCEEEEEEEC
T ss_pred CCCCcCCCCCCCCCCCC----------CCCCCCeEEEC-CCCCEEccCCCCCEEEEEEec
Confidence 99999888777666521 13456899886 345899999999999999864
|
| >2vuv_A Codakine; sugar-binding protein, C-type, lectin, mannose, invertebrate; HET: CIT; 1.3A {Codakia orbicularis} PDB: 2vuz_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.9e-24 Score=188.79 Aligned_cols=123 Identities=24% Similarity=0.493 Sum_probs=103.5
Q ss_pred CCCcCCcccCCCCeEEEEecCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHhhCCC--CCCe--EeeeeecCCCCCCc
Q 008785 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKN--VNGC--WVGGRSINTTVGLS 127 (553)
Q Consensus 52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~--~~~~--WiGl~~~~~~~~~~ 127 (553)
+||.||. .|+++||+|+.+.++|.+|+.+|+++|||||+|+|++|++||.+++... ...+ |||.. . .++.
T Consensus 1 ~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~~~WiG~~--~--~~~~ 74 (129)
T 2vuv_A 1 GCPDGWT--QFLDLCYIYQSAKASWASAQSSCQALGGILAEPDTACENEVLIHMCKENGDAGSFGPWLGGQ--K--VGGA 74 (129)
T ss_dssp CCCTTCE--EETTEEEEEEEEEECHHHHHHHHHHTTSEECCCCSHHHHHHHHHHHHHTTCCSSSCCEEEEE--E--ETTE
T ss_pred CCCcchh--hhCCEEEEEECCCcCHHHHHHHHHhcCCEECccCCHHHHHHHHHHHHhccCCCCcccccCCC--C--CCCe
Confidence 4999999 8999999999999999999999999999999999999999999987532 3467 99922 3 4599
Q ss_pred eEEcC-CCCCCcCcccccCccCCCCCCCCCCCCCCCCeeEEEeCCCCceecccCCCCCCccceecc
Q 008785 128 WKWSD-NMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVEH 192 (553)
Q Consensus 128 w~W~d-g~~~~~~~~~~~~~~~~~~~~~~C~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~~~ 192 (553)
|+|+| |+++.+..|..+.|.+ ..+.++|+.+.... |++..|....+|||+.+.
T Consensus 75 ~~W~d~g~~~~~~~W~~~~P~~----------~~~~~~C~~~~~~~--w~~~~C~~~~~~ICe~~~ 128 (129)
T 2vuv_A 75 WQWSSSGAAFDYLRWGPNEPNN----------SGGNEDCLHYNWLS--WNDLRCHYQASYLCQRAA 128 (129)
T ss_dssp EEETTTCCBCSSCCBCTTCSCC----------TTSCCCEEEEETTE--EEEECTTSCEEEEEEEEC
T ss_pred EEEcCCCCccccCCcCCCCCCC----------CCCCCCccEEcCCc--ccCCCCCCCcceEeeecC
Confidence 99999 9999887777666521 12456899987764 999999999999998753
|
| >1htn_A Tetranectin; plasminogen binding, kringle 4, alpha-helical coiled coil, C-type lectin, carbohydrate recognition domain; 2.80A {Homo sapiens} SCOP: d.169.1.1 h.1.1.1 | Back alignment and structure |
|---|
Probab=99.90 E-value=1.1e-24 Score=202.17 Aligned_cols=125 Identities=16% Similarity=0.310 Sum_probs=106.2
Q ss_pred CCCCcCCcccCCCCeEEEEecCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHhhCCC---CCCeEeeeeecCCCCCCc
Q 008785 51 APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKN---VNGCWVGGRSINTTVGLS 127 (553)
Q Consensus 51 ~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~---~~~~WiGl~~~~~~~~~~ 127 (553)
..||.||. |+++||+|+.+.++|.+|+.+|..+|||||+|+|.+|++||.+++... ...+||||+ +...+|.
T Consensus 49 ~~Cp~gw~---~~~~CY~~~~~~~tw~~A~~~C~~~gg~La~i~s~~e~~~l~~~~~~~~~~~~~~WIGl~--~~~~~g~ 123 (182)
T 1htn_A 49 TVCLKGTK---VHMKCFLAFTQTKTFHEASEDCISRGGTLSTPQTGSENDALYEYLRQSVGNEAEIWLGLN--DMAAEGT 123 (182)
T ss_dssp HHHHHSEE---ETTEEEEEEEEEECHHHHHHHHHTTTCEECCCCSHHHHHHHHHHHHHHTCSSCEEEEEEE--CSSSTTC
T ss_pred CCCCCCcE---ECCEEEEEECCCcCHHHHHHHHhhCCCEEeeeCCHHHHHHHHHHHHhccCCCCcEEEeeE--CCCCCCe
Confidence 36999998 789999999999999999999999999999999999999999876421 467999999 7667899
Q ss_pred eEEcCCCCCCcCccc---ccCccCCCCCCCCCCCCCCCCeeEEEeC-CCCceecccCCCCCCccceec
Q 008785 128 WKWSDNMSKWNESIH---AVGSFNSSCTSLPCHVHATVDLCTLVSN-GSRSLVTERCNTSHPFICMVE 191 (553)
Q Consensus 128 w~W~dg~~~~~~~~~---~~~~~~~~~~~~~C~~~~~~~~C~~~~~-~~~~w~~~~C~~~~~~iC~~~ 191 (553)
|.|+||+++.+.+|. .+.|+ +.+.++|+.+.. ....|++..|....+|||+.+
T Consensus 124 w~W~dG~~~~y~nW~~~~~geP~-----------~~~~~~Cv~l~~~~~g~W~d~~C~~~~~fICe~~ 180 (182)
T 1htn_A 124 WVDMTGARIAYKNWETEITAQPD-----------GGKTENCAVLSGAANGKWFDKRCRDQLPYICQFG 180 (182)
T ss_dssp CBCTTSCBCCCCCBCCSSSCSCC-----------CTTTCCEEEEETTTTTEEEEECTTSCEEEEEEEE
T ss_pred EEeCCCCCccCCCCCCCCCCcCC-----------CCCCCCCEEEccCCCCCEECCCCCCCeeEEEEEe
Confidence 999999999887777 55542 234568998864 456799999999999999874
|
| >3g8l_A Lectin-related NK cell receptor LY49L1; natural killer cell receptor, immune system; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.90 E-value=2e-24 Score=201.56 Aligned_cols=124 Identities=17% Similarity=0.293 Sum_probs=104.9
Q ss_pred CCCCCCCc-CCcccCCCCeEEEEecCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHhhCCCCCCeEeeeeecCCCCCC
Q 008785 48 DWKAPCPP-DWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGL 126 (553)
Q Consensus 48 ~~~~~Cp~-~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~ 126 (553)
..+..||+ ||. .|+++||+|+.+.++|.+|+.+|+++||+||+|+|.+|++||.+++. ...+||||+ +...+|
T Consensus 61 ~~~~~Cp~~gW~--~~~~~CY~~~~~~~tw~~A~~~C~~~g~~LasI~s~~e~~fl~~~~~--~~~~WIGl~--~~~~~~ 134 (190)
T 3g8l_A 61 QHTGRGFEKYWF--CYGIKCYYFVMDRKTWSGCKQTCQISSLSLLKIDNEDELKFLKLLVP--SDSYWIGLS--YDNKKK 134 (190)
T ss_dssp SSTTCEEEEEEE--EEETEEEEEEEEEECHHHHHHHHHHTTCEECCCCSHHHHHHHHHHSC--SSCEEEEEE--EETTTT
T ss_pred CCCCCCCCCCcE--EECCEEEEEEcccCCHHHHHHHHHhCCCEEeeeCCHHHHHHHHHhhC--cCCEEEEEE--cCCCCC
Confidence 44568999 999 89999999999999999999999999999999999999999999986 568999999 555679
Q ss_pred ceEEcCCCCCCcCcccccCccCCCCCCCCCCCCCCCCeeEEEeCCCCceecccCCCCCCccceecc
Q 008785 127 SWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVEH 192 (553)
Q Consensus 127 ~w~W~dg~~~~~~~~~~~~~~~~~~~~~~C~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~~~ 192 (553)
.|+|+||+++.+..|.+.. +.+.++|+.+.. ..|++..|....+|||+.+.
T Consensus 135 ~w~W~DGs~~~~~~~~~~~-------------~~~~~~Cv~l~~--~~W~d~~C~~~~~fICek~~ 185 (190)
T 3g8l_A 135 DWAWINNGPSKLALNTMKY-------------NIRDGGCMLLSK--TRLDNDNCDKSFICICGKRL 185 (190)
T ss_dssp EEEETTTBCCCCCCCGGGC-------------CGGGCSEEEECS--SCEEEECTTSCEEEEEEEEC
T ss_pred ceEeCCCCcccccccCCCC-------------CCCCCCeEEEeC--CcEECCCCCCCeeEEEeeCC
Confidence 9999999987665543321 123458888854 47999999999999998764
|
| >2ls8_A C-type lectin domain family 4 member D; structural genomics, NEW YORK structural genomics research consortium, nysgrc, PSI-biology, immune system; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.84 E-value=1.2e-25 Score=203.28 Aligned_cols=126 Identities=21% Similarity=0.442 Sum_probs=105.6
Q ss_pred CCCcCCcccCCCCeEEEEecCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHhhCCCCCCeEeeeeecCCCCCCceEEc
Q 008785 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWS 131 (553)
Q Consensus 52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~ 131 (553)
.||.||. .|+++||+|+.+.++|.+|+.+|+++||+||+|+|.+|++||.+++.. ...+||||+ +...+|.|+|+
T Consensus 2 ~Cp~gw~--~~~~~CY~~~~~~~tw~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~~-~~~~WIGl~--~~~~~~~w~W~ 76 (156)
T 2ls8_A 2 VCPIDWR--AFQSNCYFPLTDNKTWAESERNCSGMGAHLMTISTEAEQNFIIQFLDR-RLSYFLGLR--DENAKGQWRWV 76 (156)
Confidence 5999999 899999999999999999999999999999999999999999998853 457999999 66667999999
Q ss_pred CCCCC--CcCcccccCccCCCCCCCCCCCCCCCCeeEEEeCCC--CceecccCCCCCCccceeccc
Q 008785 132 DNMSK--WNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS--RSLVTERCNTSHPFICMVEHE 193 (553)
Q Consensus 132 dg~~~--~~~~~~~~~~~~~~~~~~~C~~~~~~~~C~~~~~~~--~~w~~~~C~~~~~~iC~~~~~ 193 (553)
||+++ .+.+|..++|++ .+.++|+.+.... ..|++..|....+|||+.+..
T Consensus 77 dG~~~~~~~~~W~~g~P~~-----------~~~~~Cv~l~~~~~~~~W~d~~C~~~~~fICe~~~~ 131 (156)
T 2ls8_A 77 DQTPFNPRRVFWHKNEPDN-----------SQGENCVVLVYNQDKWAWNDVPCNFEASRICKIPGT 131 (156)
Confidence 99997 456666555421 2345777775543 379999999999999998643
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=4.7e-24 Score=211.96 Aligned_cols=151 Identities=19% Similarity=0.197 Sum_probs=120.3
Q ss_pred eeecccCceeEEEEEeCCCCEEEEEEeccCCh------------------hhHHHHHHHHHHhhccCCCceeeEeeEEee
Q 008785 275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSF------------------QRKKEFYSEIGRFARLHHPNLVAVKGCCYD 336 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~~g~~vAvK~~~~~~~------------------~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 336 (553)
+.||+|+||.||+|...+|+.||||.++.... .....+.+|+.++++++ | +++.+++.
T Consensus 96 ~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~~~- 171 (282)
T 1zar_A 96 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKVYA- 171 (282)
T ss_dssp EEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCEEE-
T ss_pred CEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeEEe-
Confidence 56799999999999997799999999975321 13567899999999999 4 66666543
Q ss_pred CCceEEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeec
Q 008785 337 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGV 416 (553)
Q Consensus 337 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Df 416 (553)
.+..++||||+++|+|.+ +.. .....++.|++.||.|||+. ||+||||||+|||++ ++.+||+||
T Consensus 172 ~~~~~lvmE~~~g~~L~~-l~~----------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NILl~-~~~vkl~DF 236 (282)
T 1zar_A 172 WEGNAVLMELIDAKELYR-VRV----------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVS-EEGIWIIDF 236 (282)
T ss_dssp EETTEEEEECCCCEEGGG-CCC----------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE-TTEEEECCC
T ss_pred ccceEEEEEecCCCcHHH-cch----------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEEEE-CCcEEEEEC
Confidence 356799999999999988 521 12347999999999999999 999999999999999 999999999
Q ss_pred cccccCCcccccceeeecCccccccccccccC----------CCCCcccchHh
Q 008785 417 GLSKFVPWEVMQERTVMAGGTYGYLAPEFVYR----------NELTTKSDVYS 459 (553)
Q Consensus 417 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----------~~~t~ksDVwS 459 (553)
|+++ .+..++|||++.+ ..+...+|+|.
T Consensus 237 G~a~---------------~~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~ 274 (282)
T 1zar_A 237 PQSV---------------EVGEEGWREILERDVRNIITYFSRTYRTEKDINS 274 (282)
T ss_dssp TTCE---------------ETTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHH
T ss_pred CCCe---------------ECCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHH
Confidence 9986 3445789998753 33455566654
|
| >2msb_A Mannose-binding protein-A; lectin; HET: BMA MAN; 1.70A {Rattus rattus} SCOP: d.169.1.1 PDB: 1msb_A 1ytt_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=3.2e-23 Score=177.19 Aligned_cols=114 Identities=14% Similarity=0.223 Sum_probs=96.4
Q ss_pred CCCeEEEEecCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHhhCCCCCCeEeeeeecCCCCCCceEEcCCCCCCcCcc
Q 008785 62 EKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSDNMSKWNESI 141 (553)
Q Consensus 62 ~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~dg~~~~~~~~ 141 (553)
++++||+|+.+.++|.+|+.+|+.+||+||+|+|++|++||.+++. ..+||||+ +...++.|.|+||+++.+.+|
T Consensus 1 ig~~Cy~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~---~~~WiGl~--~~~~~~~w~W~dg~~~~~~~W 75 (115)
T 2msb_A 1 SGKKFFVTNHERMPFSKVKALCSELRGTVAIPRNAEENKAIQEVAK---TSAFLGIT--DEVTEGQFMYVTGGRLTYSNW 75 (115)
T ss_dssp ---CEEEEEEEEECHHHHHHHHHHTTCEECCCSSHHHHHHHHHHHS---SCEEEEEE--CSSSTTCCEETTSSBCCSCCB
T ss_pred CCCEEEEEeCCCcCHHHHHHHHHhCCCEEeccCCHHHHHHHHHhhc---CCEEEeeE--cCCCCCcEEECCCCEeeecCc
Confidence 3689999999999999999999999999999999999999999985 68999999 767789999999999988777
Q ss_pred cccCccCCCCCCCCCCCCCCCCeeEEEeCCCCceecccCCCCCCccceec
Q 008785 142 HAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVE 191 (553)
Q Consensus 142 ~~~~~~~~~~~~~~C~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~~ 191 (553)
.++.|.+ ..+.++|+.+.. ...|++..|....+|||+.+
T Consensus 76 ~~~~P~~----------~~~~~~C~~~~~-~g~W~~~~C~~~~~fiCe~~ 114 (115)
T 2msb_A 76 KKDEPND----------HGSGEDCVTIVD-NGLWNDISCQASHTAVCEFP 114 (115)
T ss_dssp CTTCCCC----------CTTCCCEEEECT-TSCEEEECTTSCEEEEEEEC
T ss_pred CCCCCCC----------CCCCCCeEEECC-CCCEECcCCCCCeEEEEeEc
Confidence 7666521 124568998863 45899999999999999864
|
| >1h8u_A MBP, eosinophil granule major basic protein 1; lectin, eosinophil granule protein, EMBP; 1.8A {Homo sapiens} SCOP: d.169.1.1 PDB: 2brs_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=6.8e-23 Score=175.67 Aligned_cols=114 Identities=16% Similarity=0.340 Sum_probs=96.2
Q ss_pred eE-EEEecCCCChHHHHHHHhh-cCCEEeeeCCHHHHHHHHHhhCCC-CCCeEeeeeecCCCCCCceEEcCCCCCCcCcc
Q 008785 65 KC-FGYIGNFRSWDESETYCKE-IGGHLAALTSYEEEHSAQKLCGKN-VNGCWVGGRSINTTVGLSWKWSDNMSKWNESI 141 (553)
Q Consensus 65 ~C-y~~~~~~~~w~~a~~~C~~-~~~~L~~i~~~~e~~f~~~~~~~~-~~~~WiGl~~~~~~~~~~w~W~dg~~~~~~~~ 141 (553)
+| |+|+.+.++|.+|+.+|+. +|||||+|+|++|++||.+++... ...+||||++.+...++.|+|+||+++.+.+|
T Consensus 1 ~C~Y~~~~~~~tw~~A~~~C~~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~WIGl~~~~~~~~~~~~W~dg~~~~y~~W 80 (117)
T 1h8u_A 1 TCRYLLVRSLQTFSQAWFTCRRCYRGNLVSIHNFNINYRIQCSVSALNQGQVWIGGRITGSGRCRRFQWVDGSRWNFAYW 80 (117)
T ss_dssp --CEEEEEEEECHHHHHHHHHHHHSSEECCCCSHHHHHHHHHHHTTCSSSEEEEEEEEECSSSCCEEEETTCCCCCCCCB
T ss_pred CeEEEEeCCccCHHHHHHHhccCCCCeEEeecCHHHHHHHHHHHhccCCCCEEEcccccCCCCCCccEeCCCCcCCccCc
Confidence 59 9999999999999999999 999999999999999999988643 35799999965556779999999999888887
Q ss_pred cccCccCCCCCCCCCCCCCCCCeeEEEeCCCCceecccCCCCCCcccee
Q 008785 142 HAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMV 190 (553)
Q Consensus 142 ~~~~~~~~~~~~~~C~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~ 190 (553)
.+++|.+ +.++|+.+....+.|++..|....+|||++
T Consensus 81 ~~~~P~~------------~~~~C~~~~~~~g~W~~~~C~~~~~fiCe~ 117 (117)
T 1h8u_A 81 AAHQPWS------------RGGHCVALCTRGGYWRRAHCLRRLPFICSY 117 (117)
T ss_dssp CSSSCCT------------TSCSEEEEETTTTCEEEECTTSCEEEEEEC
T ss_pred CCCCCCC------------CCCCCeEEECCCCcCCCCCCCCCcceeEeC
Confidence 7766532 236899988765689999999999999974
|
| >1rdl_1 SUB-MBP-C, mannose-binding protein-C; C-type lectin, calcium-binding protein; HET: MMA; 1.70A {Rattus rattus} SCOP: d.169.1.1 PDB: 1rdj_1* 1rdk_1* 1rdi_1* 1rdm_1* 1rdn_1* 1rdo_1 1bv4_A 1kza_1* 1kzb_1* 1kzc_1* 1kzd_1* 1kze_1* | Back alignment and structure |
|---|
Probab=99.88 E-value=1.3e-22 Score=172.91 Aligned_cols=112 Identities=13% Similarity=0.176 Sum_probs=96.0
Q ss_pred CeEEEEecCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHhhCCCCCCeEeeeeecCCCCCCceEEcCCCCCCcCcccc
Q 008785 64 SKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSDNMSKWNESIHA 143 (553)
Q Consensus 64 ~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~dg~~~~~~~~~~ 143 (553)
.+||+|+.+.++|.+|+.+|+++|||||+|+|++|++||.+++ ...+||||+ +...++.|.|+||+++.+.+|.+
T Consensus 1 ~~CY~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~~l~~~~---~~~~WIGl~--~~~~~~~~~W~dg~~~~y~~W~~ 75 (113)
T 1rdl_1 1 KKYFMSSVRRMPLNRAKALCSELQGTVATPRNAEENRAIQNVA---KDVAFLGIT--DQRTENVFEDLTGNRVRYTNWNE 75 (113)
T ss_dssp -CEEEECSSCBCHHHHHHHHHHTTCEECCCCSHHHHHHHHHHC---SSCEEEEEE--CSSSTTCCEETTSCBCCCCCBCT
T ss_pred CeEEEEeCCccCHHHHHHHHHhcCCEEcccCCHHHHHHHHHHh---cCCEEEEeE--CCCCCCcEEECCCCEeecCCCCC
Confidence 4799999999999999999999999999999999999999987 368999999 66677999999999998887776
Q ss_pred cCccCCCCCCCCCCCCCCCCeeEEEeCCCCceecccCCCCCCccceec
Q 008785 144 VGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVE 191 (553)
Q Consensus 144 ~~~~~~~~~~~~C~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~~ 191 (553)
++|.+ ..+.++|+.+.. ...|++..|....+|||+.+
T Consensus 76 ~~P~~----------~~~~~~Cv~~~~-~g~w~~~~C~~~~~~ICe~~ 112 (113)
T 1rdl_1 76 GEPNN----------VGSGENCVVLLT-NGKWNDVPCSDSFLVVCEFS 112 (113)
T ss_dssp TCCCC----------CTTCCCEEEECT-TSCEEEECTTSCBEEEEEEC
T ss_pred CcCCC----------CCCCCCeeEECC-CCcEeccCCCCCceEEEeeC
Confidence 66521 134568988864 35799999999999999874
|
| >1pwb_A SP-D, PSP-D, pulmonary surfactant-associated protein D; collectin, C-type lectin, alpha-helical coiled coil, carbohydrate recognition domain; HET: GLC; 1.40A {Homo sapiens} SCOP: d.169.1.1 h.1.1.1 PDB: 1pw9_A* 3ikn_A* 3ikp_A* 3ikq_A* 3ikr_A* 2rie_A* 2ggx_A* 2ggu_A* 2ork_A* 2orj_A* 2ria_A* 2rib_A* 2ric_A* 2rid_A* 2os9_A* 3dbz_A 3g81_A* 3g83_A* 1b08_A 3g84_A* ... | Back alignment and structure |
|---|
Probab=99.88 E-value=1.3e-23 Score=193.91 Aligned_cols=124 Identities=15% Similarity=0.220 Sum_probs=106.1
Q ss_pred CCCcCCcccCCCCeEEEEecCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHhhCCCCCCeEeeeeecCCCCCCceEEc
Q 008785 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWS 131 (553)
Q Consensus 52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~ 131 (553)
.|+.+|. .++++||+|+...++|.+|+.+|+.+|||||+|+|.+|++||.+++......+||||+ |...++.|.|+
T Consensus 54 ~~~~~~~--~~~~~Cy~~~~~~~~w~~A~~~C~~~gg~La~i~s~~e~~~l~~~~~~~~~~~WIGl~--~~~~~~~w~W~ 129 (177)
T 1pwb_A 54 ELFPNGQ--SVGEKIFKTAGFVKPFTEAQLLCTQAGGQLASPRSAAENAALQQLVVAKNEAAFLSMT--DSKTEGKFTYP 129 (177)
T ss_dssp HHTTTEE--EETTEEEEEEEEEEEHHHHHHHHHHTTSEECCCCSHHHHHHHHHHHHHHTCCEECSCB--CSSSTTCCBCT
T ss_pred hcCCCeE--EECCEEEEEcCCccCHHHHHHHHHhcCCEEcccCCHHHHHHHHHHHhcCCCcEEEEEe--ccCcCCceEeC
Confidence 4789999 8999999999999999999999999999999999999999999987433468999999 76678999999
Q ss_pred CCCCCCcCcccccCccCCCCCCCCCCCCCCCCeeEEEeCCCCceecccCCCCCCcccee
Q 008785 132 DNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMV 190 (553)
Q Consensus 132 dg~~~~~~~~~~~~~~~~~~~~~~C~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~ 190 (553)
||+++.+.+|..+.|++ ..+.++|+.+.. +..|++..|....+|||++
T Consensus 130 dG~~~~y~~W~~geP~~----------~~~~~~Cv~~~~-~g~W~d~~C~~~~~fICe~ 177 (177)
T 1pwb_A 130 TGESLVYSNWAPGEPND----------DGGSEDCVEIFT-NGKWNDRACGEKRLVVCEF 177 (177)
T ss_dssp TSCBCSCCCBCTTCCCC----------GGGCCCEEEECT-TSCEEEECTTSEEEEEEEC
T ss_pred CcCCcccCCcCCCcCCC----------CCCCCCcEEECC-CCcEeCCCCCCCeeEEEeC
Confidence 99999887777666521 124568998864 3579999999999999974
|
| >1wk1_A Hypothetical protein YK1067A12; lectin C-type domain, structural genomics, riken structural genomics/proteomics initiative, RSGI; NMR {Caenorhabditis elegans} SCOP: d.169.1.1 | Back alignment and structure |
|---|
Probab=99.88 E-value=1e-22 Score=182.71 Aligned_cols=116 Identities=16% Similarity=0.287 Sum_probs=99.2
Q ss_pred CCCCeEEEEecCC---CChHHHHHHHhhcCCEEeeeCCHHHHHHHHHhhCCCCCCeEeeeeecCCCCCCceEEcCCCCC-
Q 008785 61 EEKSKCFGYIGNF---RSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSDNMSK- 136 (553)
Q Consensus 61 ~~~~~Cy~~~~~~---~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~dg~~~- 136 (553)
.|+++||+|+... ++|.+|+.+|+.+|||||+|+|++|++||.+++. ...+||||+ + ..++.|+|+||+++
T Consensus 2 ~~~~~CY~~~~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~--~~~~WIGl~--~-~~~~~w~W~dg~~~~ 76 (150)
T 1wk1_A 2 SSGSSGVKFLTVNDDILSMPQARNFCASAGGYLADDLGDDKNNFYSSIAA--NTQFWIGLF--K-NSDGQFYWDRGQGIN 76 (150)
T ss_dssp CCSSCCCCSSSCCSSCBCHHHHHHHHHHHTCEECCCCSHHHHHHHHHHTT--TCEEEEEEE--E-CSSSCEEECCSSSSC
T ss_pred ccCCEEEEEEecCCCccCHHHHHHHHHhCCCEEeeeCCHHHHHHHHHhhc--cCCEEEEEE--e-CCCCcEEeCCCCccc
Confidence 5899999999999 9999999999999999999999999999999987 457999999 5 66799999999998
Q ss_pred ------CcCcccccCccCCCCCCCCCCCCCCCCeeEEEe----CCCCceecccCCCCCCccceecc
Q 008785 137 ------WNESIHAVGSFNSSCTSLPCHVHATVDLCTLVS----NGSRSLVTERCNTSHPFICMVEH 192 (553)
Q Consensus 137 ------~~~~~~~~~~~~~~~~~~~C~~~~~~~~C~~~~----~~~~~w~~~~C~~~~~~iC~~~~ 192 (553)
.+.+|..++|. +.+.++|+.+. .....|++..|....+|||+.+.
T Consensus 77 ~~~~~~~y~~W~~geP~-----------~~~~~~Cv~~~~~~~~~~~~W~d~~C~~~~~fICe~~~ 131 (150)
T 1wk1_A 77 PDLLNQPITYWANGEPS-----------NDPTRQCVYFDGRSGDKSKVWTTDTCATPRPFICQKHR 131 (150)
T ss_dssp CEECCCSCCCBCTTCSC-----------CCSSCCEEEEESSCSCGGGCEEEECTTSCBCCCEECCC
T ss_pred cccccCCcCCCCCCCCC-----------CCCCCCcEEEeCccCCCCCEEeCcCcCCCeeEEEeecC
Confidence 66666665542 13456899887 34467999999999999999754
|
| >3pbf_A Pulmonary surfactant-associated protein A; collectin, carbohydrate binding, lectin, mannose, sugar BIND protein; 1.80A {Rattus norvegicus} PDB: 1r14_A* 1r13_A* 3paq_A* 3par_A 3pak_A | Back alignment and structure |
|---|
Probab=99.88 E-value=6.6e-23 Score=183.52 Aligned_cols=122 Identities=15% Similarity=0.190 Sum_probs=102.5
Q ss_pred CCcCCcccCCCCeEEEEecCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHhhCCCCCCeEeeeeecCCCCCCceEEcC
Q 008785 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSD 132 (553)
Q Consensus 53 Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~d 132 (553)
+...+. .|+++||+|+...++|.+|+.+|+.+|||||+|+|.+|++||.+++......+||||+ +...++.|.|+|
T Consensus 27 ~~~~~~--~~~~~Cy~~~~~~~tw~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~~~~~~~WIGl~--~~~~~~~w~W~d 102 (148)
T 3pbf_A 27 LQGSML--SVGDKVFSTNGQSVNFDTIKEMCTRAGGNIAVPRTPEENEAIASIAKKYNNYVYLGMI--EDQTPGDFHYLD 102 (148)
T ss_dssp HTTSCE--EETTEEEEEEEEEECHHHHHHHHHHTTCEECCCCSHHHHHHHHHHHHHHTSCEEEEEE--ECSSTTCEEETT
T ss_pred HHhcce--eeCCEEEEEcCCccCHHHHHHHHhhcCCEEeeeCCHHHHHHHHHHHHhCCCCEEEEeE--ecCCCCceEeCC
Confidence 445556 8999999999999999999999999999999999999999999987533357999999 555679999999
Q ss_pred CCCCCcCcccccCccCCCCCCCCCCCCCCCCeeEEEeCCCCceecccCCCCCCcccee
Q 008785 133 NMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMV 190 (553)
Q Consensus 133 g~~~~~~~~~~~~~~~~~~~~~~C~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~ 190 (553)
|+++.+.+|.++.|.+ .+.++|+.+.. ...|++..|....+|+|++
T Consensus 103 g~~~~~~~W~~~~P~~-----------~~~~~Cv~~~~-~g~W~~~~C~~~~~fICe~ 148 (148)
T 3pbf_A 103 GASVSYTNWYPGEPRG-----------QGKEKCVEMYT-DGTWNDRGCLQYRLAVCEF 148 (148)
T ss_dssp SCBCCSCCBCTTCCCS-----------TTSCCEEEECT-TSCEEEECSCSCEEEEEEC
T ss_pred CCCcccCCcCCCccCc-----------CCCCCceEECC-CCcEecCCCCCCeeEeeeC
Confidence 9999888887766532 13458888865 3579999999999999974
|
| >1byf_A TC14, protein (polyandrocarpa lectin); C-type lectin, galactose-specific, sugar binding protein; 2.00A {Polyandrocarpa misakiensis} SCOP: d.169.1.1 PDB: 1tlg_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=8e-22 Score=171.11 Aligned_cols=117 Identities=16% Similarity=0.241 Sum_probs=95.3
Q ss_pred CCeEEEEecCCCChHHHHHHHhhcCCEEee--eCCHHHHHHHHHhhCCCCCCeEeeeeecCCCCCCc--eEEcCCCCC-C
Q 008785 63 KSKCFGYIGNFRSWDESETYCKEIGGHLAA--LTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLS--WKWSDNMSK-W 137 (553)
Q Consensus 63 ~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~--i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~--w~W~dg~~~-~ 137 (553)
+++||+|+.+.++|.+|+.+|+.+|||||+ |+|++|++||.++.......+|||| +.. .+|. |+|+||+++ .
T Consensus 1 g~~Cy~~~~~~~~w~~A~~~C~~~g~~La~~~i~s~~e~~~l~~~~~~~~~~~WIGl-~~~--~~~~~~w~W~dg~~~~~ 77 (125)
T 1byf_A 1 MDYEILFSDETMNYADAGTYCQSRGMALVSSAMRDSTMVKAILAFTEVKGHDYWVGA-DNL--QDGAYNFLWNDGVSLPT 77 (125)
T ss_dssp -CEEEEEEEEEECHHHHHHHHHTTTCEESCGGGGSHHHHHHHHHHHHHHTCCEEEEE-EST--TTCTTCCEETTSCBCCT
T ss_pred CCeEEEEeCCCCCHHHHHHHHHHcCCEeeecCCCCHHHHHHHHHhcCCCCCCEEEec-ccC--CCCceeEEECCCCCCcc
Confidence 578999999999999999999999999999 9999999999988211156899999 433 5588 999999998 6
Q ss_pred cC-cccccCccCCCCCCCCCCCCCCCCeeEEEeCCCCceecccCCCCCCccceecc
Q 008785 138 NE-SIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVEH 192 (553)
Q Consensus 138 ~~-~~~~~~~~~~~~~~~~C~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~~~ 192 (553)
+. +|..++|.+ ..+.++|+.+......|++..|....+|||+.+.
T Consensus 78 ~~~~W~~~~P~~----------~~~~~~Cv~~~~~~~~W~d~~C~~~~~fICe~~~ 123 (125)
T 1byf_A 78 DSDLWSPNEPSN----------PQSWQLCVQIWSKYNLLDDVGCGGARRVICEKEL 123 (125)
T ss_dssp TCTTBCTTCSCS----------CTTSCCEEEEETTTTEEEEECSCSCEEEEEEEEC
T ss_pred cccCcCCCcCCC----------CCCCCCceEEECCCCcEECcCCCCceeEEEeeeC
Confidence 66 676655521 1245689998854468999999999999998754
|
| >1g1t_A E-selectin; EGF, adhesion molecule, SLEX, immune system, membrane protein; HET: SIA GAL MAG FUC; 1.50A {Homo sapiens} SCOP: d.169.1.1 g.3.11.1 PDB: 1esl_A | Back alignment and structure |
|---|
Probab=99.80 E-value=1.3e-19 Score=163.65 Aligned_cols=113 Identities=18% Similarity=0.310 Sum_probs=92.7
Q ss_pred EEEEecCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHhhCCCCCCeEeeeeecCCCCCCceEEcCCCC-C--CcCccc
Q 008785 66 CFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSDNMS-K--WNESIH 142 (553)
Q Consensus 66 Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~dg~~-~--~~~~~~ 142 (553)
||+|+.+.++|.+|+.+|+++|||||+|+|++|++||.+++......+||||+ +. +|.|+|+||+. + .+.+|.
T Consensus 2 ~Y~~~~~~~tw~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~~~~~~~WIGl~--~~--~~~~~W~dg~~~~~~~y~~W~ 77 (157)
T 1g1t_A 2 SYNTSTEAMTYDEASAYCQQRYTHLVAIQNKEEIEYLNSILSYSPSYYWIGIR--KV--NNVWVWVGTQKPLTEEAKNWA 77 (157)
T ss_dssp EEEECSSCBCHHHHHHHHHHHSSEECCCCSHHHHHHHHHHSCCCTTCEEESEE--EE--TTEEEETTTCCBCCTTTCCBC
T ss_pred ceEeCCCccCHHHHHHHHHHCCCEEcccCCHHHHHHHHHHhccCCCCEEEEEE--CC--CCeeEEeCCCccCCcccCCCC
Confidence 79999999999999999999999999999999999999998754567999999 53 58999999984 3 255666
Q ss_pred ccCccCCCCCCCCCCCCCCCCeeEEEeC----CCCceecccCCCCCCccceecc
Q 008785 143 AVGSFNSSCTSLPCHVHATVDLCTLVSN----GSRSLVTERCNTSHPFICMVEH 192 (553)
Q Consensus 143 ~~~~~~~~~~~~~C~~~~~~~~C~~~~~----~~~~w~~~~C~~~~~~iC~~~~ 192 (553)
+++|.+ ..+.++|+.+.. ....|++..|....+|||+...
T Consensus 78 ~geP~~----------~~~~~~Cv~~~~~~~~~~~~W~d~~C~~~~~fICe~~~ 121 (157)
T 1g1t_A 78 PGEPNN----------RQKDEDCVEIYIKREKDVGMWNDERCSKKKLALCYTAA 121 (157)
T ss_dssp TTCCCC----------CSTTCCEEEECTTCSSSTTCEEEECTTSCBEEEEEECC
T ss_pred CCcCCC----------CCCCCCceEEeCcCCCCCCccccCCCCCCcceEeCcCC
Confidence 555421 123568888864 2467999999999999999753
|
| >1g1s_A P-selectin; selectin, lectin, EGF, sulphated, SLEX, immune system, membr protein; HET: TYS SIA GAL NAG FUC NGA; 1.90A {Homo sapiens} SCOP: d.169.1.1 g.3.11.1 PDB: 1g1r_A* 1g1q_A* 1fsb_A | Back alignment and structure |
|---|
Probab=99.80 E-value=1.2e-19 Score=164.82 Aligned_cols=112 Identities=19% Similarity=0.334 Sum_probs=92.7
Q ss_pred EEEEecCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHhhCCCCCCeEeeeeecCCCCCCceEEcCCC-CCC--cCccc
Q 008785 66 CFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSDNM-SKW--NESIH 142 (553)
Q Consensus 66 Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~dg~-~~~--~~~~~ 142 (553)
||+|+.+.++|.+|+.+|+.+|||||+|+|++|++||.+++......+||||+ +. ++.|+|+||+ ++. +.+|.
T Consensus 2 ~Y~~~~~~~tw~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~~~~~~~WIGl~--~~--~~~~~W~dg~~~~~~~~~~W~ 77 (162)
T 1g1s_A 2 TYHYSTKAYSWNISRKYCQNRYTDLVAIQNKNEIDYLNKVLPYYSSYYWIGIR--KN--NKTWTWVGTKKALTNEAENWA 77 (162)
T ss_dssp EEEEEEEEECHHHHHHHHHHHSSEECCCCCHHHHHHHHHHSCCCTTCEEEEEE--EE--TTEEEETTTCCBCCTTTCCBC
T ss_pred eEEEecCCcCHHHHHHHHHhcCCEEeeeCCHHHHHHHHHHhccCCCCEEEeEE--CC--CCCeEECCCCccCCcccCccC
Confidence 89999999999999999999999999999999999999998754578999999 43 5999999996 443 55666
Q ss_pred ccCccCCCCCCCCCCCCCCCCeeEEEeC----CCCceecccCCCCCCccceec
Q 008785 143 AVGSFNSSCTSLPCHVHATVDLCTLVSN----GSRSLVTERCNTSHPFICMVE 191 (553)
Q Consensus 143 ~~~~~~~~~~~~~C~~~~~~~~C~~~~~----~~~~w~~~~C~~~~~~iC~~~ 191 (553)
++.|.+ ..+.++|+.+.. ....|++..|....+|||+..
T Consensus 78 ~geP~~----------~~~~~~Cv~~~~~~~~~~~~W~d~~C~~~~~fICe~~ 120 (162)
T 1g1s_A 78 DNEPNN----------KRNNEDCVEIYIKSPSAPGKWNDEHCLKKKHALCYTA 120 (162)
T ss_dssp TTCCCC----------TTSCCCEEEECTTCSSSTTCEEEECTTSCEEEEEEEC
T ss_pred CCCCCC----------CCCCcceEEEeccCCCCCCeEECCCCCCCCCEEEEeC
Confidence 555521 123568988864 346799999999999999975
|
| >3cfw_A L-selectin; EGF, cell adhesion, EGF-like domain, glycoprotein, membrane, sushi, transmembrane; HET: NAG MAN BMA; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.80 E-value=1e-19 Score=165.70 Aligned_cols=114 Identities=16% Similarity=0.296 Sum_probs=93.5
Q ss_pred eEEEEecCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHhhCCCCCCeEeeeeecCCCCCCceEEcCCCC-C--CcCcc
Q 008785 65 KCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSDNMS-K--WNESI 141 (553)
Q Consensus 65 ~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~dg~~-~--~~~~~ 141 (553)
.||+|+..+++|.+|+.+|+.+|||||+|+|++|++||.+++......+||||+ +. ++.|+|+||+. + .+.+|
T Consensus 1 wcY~~~~~~~tw~~A~~~C~~~g~~La~i~s~~e~~fl~~~~~~~~~~~WIGl~--~~--~~~~~W~dg~~~~~~~y~~W 76 (164)
T 3cfw_A 1 WTYHYSEKPMNWQRARRFCRDNYTDLVAIQNKAEIEYLEKTLPFSRSYYWIGIR--KI--GGIWTWVGTNKSLTEEAENW 76 (164)
T ss_dssp CEEEEEEEEECHHHHHHHHHHHSSEECCCCSHHHHHHHHHHSCCCTTCEEESEE--EE--TTEEEETTTCCBCCTTTCCB
T ss_pred CeEEEecCCcCHHHHHHHHHHCCCEECccCCHHHHHHHHHHhccCCccEEEeEE--CC--CCEEEECCCCcccccccCCC
Confidence 399999999999999999999999999999999999999998654678999999 53 59999999985 3 25566
Q ss_pred cccCccCCCCCCCCCCCCCCCCeeEEEeC----CCCceecccCCCCCCccceecc
Q 008785 142 HAVGSFNSSCTSLPCHVHATVDLCTLVSN----GSRSLVTERCNTSHPFICMVEH 192 (553)
Q Consensus 142 ~~~~~~~~~~~~~~C~~~~~~~~C~~~~~----~~~~w~~~~C~~~~~~iC~~~~ 192 (553)
..++|.+ ..+.++|+.+.. ....|++..|....+|||+.+.
T Consensus 77 ~~geP~~----------~~~~~~Cv~~~~~~~~~~~~W~d~~C~~~~~fICe~~~ 121 (164)
T 3cfw_A 77 GDGEPNN----------KKNKEDCVEIYIKRNKDAGKWNDDACHKLKAALCYTAS 121 (164)
T ss_dssp CTTCCCC----------GGGCCCEEEECTTCSSSTTCEEEECTTSCEEEEEEECC
T ss_pred CCCCCCC----------CCCCccceeeeccCCCCCCceeCCCCCCCcEeEEccCC
Confidence 6555421 123568988864 3467999999999999999863
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.80 E-value=1.1e-19 Score=178.18 Aligned_cols=133 Identities=14% Similarity=0.126 Sum_probs=104.0
Q ss_pred CeeecccCceeEEEEEe-CCCCE--EEEEEeccCChh------------------------hHHHHHHHHHHhhccCCCc
Q 008785 274 NRLLGDSKTGGTYSGIL-PDGSR--VAVKRLKRSSFQ------------------------RKKEFYSEIGRFARLHHPN 326 (553)
Q Consensus 274 ~~~iG~G~~g~Vy~~~~-~~g~~--vAvK~~~~~~~~------------------------~~~~~~~E~~~l~~l~Hpn 326 (553)
...||+|+||.||+|.. .+|+. ||||+++..... ....+.+|+.+|.+++|++
T Consensus 52 ~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 131 (258)
T 1zth_A 52 GGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKEAG 131 (258)
T ss_dssp EEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHhCC
Confidence 45679999999999997 68888 999997643111 1236789999999998876
Q ss_pred e--eeEeeEEeeCCceEEEEEccCC-C----CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCceecCC
Q 008785 327 L--VAVKGCCYDHGDRYIVYEFVVN-G----PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLH-DKVKPHVVHRDI 398 (553)
Q Consensus 327 I--v~l~~~~~~~~~~~lV~E~~~~-g----sL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH-~~~~~~ivHrDl 398 (553)
+ +.+++. +..+|||||+.+ | +|.++... .++..+..++.|++.||.||| +. +|+||||
T Consensus 132 i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~~---givHrDl 197 (258)
T 1zth_A 132 VSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQEA---ELVHADL 197 (258)
T ss_dssp CCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHTS---CEECSSC
T ss_pred CCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHHC---CEEeCCC
Confidence 4 334432 357899999942 4 67766532 234467789999999999999 88 9999999
Q ss_pred CCCcEEecCCCCeEEeeccccccC
Q 008785 399 RASNVLLDEEFGAHLMGVGLSKFV 422 (553)
Q Consensus 399 kp~NILl~~~~~~kl~Dfgla~~~ 422 (553)
||+|||+++ .++|+|||+|...
T Consensus 198 kp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 198 SEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp STTSEEESS--SEEECCCTTCEET
T ss_pred CHHHEEEcC--cEEEEECcccccC
Confidence 999999998 8999999999754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.66 E-value=2.3e-17 Score=168.64 Aligned_cols=136 Identities=14% Similarity=0.080 Sum_probs=97.2
Q ss_pred CCCeeecccCceeEEEEEeCCCCEEEEEEeccCCh--------------hhHH--------HHHHHHHHhhccCCCceee
Q 008785 272 EGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSF--------------QRKK--------EFYSEIGRFARLHHPNLVA 329 (553)
Q Consensus 272 ~~~~~iG~G~~g~Vy~~~~~~g~~vAvK~~~~~~~--------------~~~~--------~~~~E~~~l~~l~HpnIv~ 329 (553)
.....||+|++|.||+|...+|+.||||+++.... .... ...+|...|.++.+.++.-
T Consensus 98 ~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~v 177 (397)
T 4gyi_A 98 SVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFPV 177 (397)
T ss_dssp EEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCSC
T ss_pred EecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 33455699999999999998999999999764210 0011 1235667777775544322
Q ss_pred EeeEEeeCCceEEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCC
Q 008785 330 VKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF 409 (553)
Q Consensus 330 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~ 409 (553)
..-+.. ...+|||||++|++|.++... .....++.|++.+|.|||+. |||||||||.|||+++++
T Consensus 178 p~p~~~--~~~~LVME~i~G~~L~~l~~~----------~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~~dg 242 (397)
T 4gyi_A 178 PEPIAQ--SRHTIVMSLVDALPMRQVSSV----------PDPASLYADLIALILRLAKH---GLIHGDFNEFNILIREEK 242 (397)
T ss_dssp CCEEEE--ETTEEEEECCSCEEGGGCCCC----------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEEEEE
T ss_pred Ceeeec--cCceEEEEecCCccHhhhccc----------HHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeCCC
Confidence 211111 234799999999988664321 12356789999999999999 999999999999998876
Q ss_pred ----------CeEEeeccccccC
Q 008785 410 ----------GAHLMGVGLSKFV 422 (553)
Q Consensus 410 ----------~~kl~Dfgla~~~ 422 (553)
.+.|+||+-+-..
T Consensus 243 d~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 243 DAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp CSSCTTSEEEEEEECCCTTCEET
T ss_pred CcccccccccceEEEEeCCcccC
Confidence 3899999977543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.34 E-value=2.7e-12 Score=125.40 Aligned_cols=146 Identities=11% Similarity=0.044 Sum_probs=110.0
Q ss_pred HHhhcccCCCCeeecccCceeEEEEEeCCCCEEEEEEeccCChhhHHHHHHHHHHhhccC-CCceeeEeeEEeeCCceEE
Q 008785 264 RSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLH-HPNLVAVKGCCYDHGDRYI 342 (553)
Q Consensus 264 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~l 342 (553)
.....++.. ...++.|+.+.||+... +++.+++|............+.+|+.+++.+. +.++.+++++..+.+..|+
T Consensus 10 ~~~l~~~~~-~~~~~g~s~~~v~~~~~-~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~l 87 (263)
T 3tm0_A 10 KKLIEKYRC-VKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL 87 (263)
T ss_dssp HHHHTTSEE-EECCSCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred HHHhcccee-EeeccCCCCCeEEEEEC-CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEE
Confidence 333444432 23447788899999986 47899999987532223346888999999884 6788899999988889999
Q ss_pred EEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------
Q 008785 343 VYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV--------------------------------- 389 (553)
Q Consensus 343 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~--------------------------------- 389 (553)
||||++|.+|.+.+.. ......++.+++.+|+.||+..
T Consensus 88 v~e~i~G~~l~~~~~~---------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T 3tm0_A 88 LMSEADGVLCSEEYED---------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EEECCSSEEHHHHCCT---------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGG
T ss_pred EEEecCCeehhhccCC---------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccc
Confidence 9999999999876421 1123478899999999999810
Q ss_pred -----------------------CCCceecCCCCCcEEecCCCCeEEeeccccc
Q 008785 390 -----------------------KPHVVHRDIRASNVLLDEEFGAHLMGVGLSK 420 (553)
Q Consensus 390 -----------------------~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~ 420 (553)
.+.++|+|++|.|||++++..+.|+||+.+.
T Consensus 159 ~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp STTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1358999999999999876556799998774
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.17 E-value=4.3e-11 Score=116.23 Aligned_cols=128 Identities=16% Similarity=0.141 Sum_probs=97.7
Q ss_pred cccCceeEEEEEeCCCCEEEEEEeccCChhhHHHHHHHHHHhhccCCCc--eeeEeeEEeeCCceEEEEEccCCCCHHHH
Q 008785 278 GDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPN--LVAVKGCCYDHGDRYIVYEFVVNGPLDRW 355 (553)
Q Consensus 278 G~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpn--Iv~l~~~~~~~~~~~lV~E~~~~gsL~~~ 355 (553)
+.|..+.||+....+|+.+++|..... ....+.+|+.+++.+.+.+ +.+++++....+..++||||++|.+|.
T Consensus 29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~-- 103 (264)
T 1nd4_A 29 IGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL-- 103 (264)
T ss_dssp CTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--
T ss_pred cCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--
Confidence 456669999998877889999997654 2245778999998885434 567888888878889999999998884
Q ss_pred hccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------------------
Q 008785 356 LHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV---------------------------------------------- 389 (553)
Q Consensus 356 l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~---------------------------------------------- 389 (553)
... .+ ...++.+++..|..||+..
T Consensus 104 ~~~-------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (264)
T 1nd4_A 104 SSH-------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFAR 173 (264)
T ss_dssp TSC-------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHH
T ss_pred cCc-------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHH
Confidence 211 12 2357788888888888751
Q ss_pred ---------CCCceecCCCCCcEEecCCCCeEEeeccccc
Q 008785 390 ---------KPHVVHRDIRASNVLLDEEFGAHLMGVGLSK 420 (553)
Q Consensus 390 ---------~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~ 420 (553)
.+.++|+|++|.|||++++..+.|+||+.+.
T Consensus 174 l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 174 LKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp HHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1129999999999999877666799999875
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.07 E-value=3.9e-10 Score=115.39 Aligned_cols=141 Identities=18% Similarity=0.217 Sum_probs=105.9
Q ss_pred eecccCceeEEEEEeCCCCEEEEEEec--cCC-hhhHHHHHHHHHHhhccC--CCceeeEeeEEeeC---CceEEEEEcc
Q 008785 276 LLGDSKTGGTYSGILPDGSRVAVKRLK--RSS-FQRKKEFYSEIGRFARLH--HPNLVAVKGCCYDH---GDRYIVYEFV 347 (553)
Q Consensus 276 ~iG~G~~g~Vy~~~~~~g~~vAvK~~~--~~~-~~~~~~~~~E~~~l~~l~--HpnIv~l~~~~~~~---~~~~lV~E~~ 347 (553)
.++.|.++.||+.... +..+++|+.. ... ......+.+|+.+++.+. +..++++++++.+. +..|+||||+
T Consensus 45 ~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~v 123 (359)
T 3dxp_A 45 QFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEFV 123 (359)
T ss_dssp ECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEECC
T ss_pred EcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEec
Confidence 4599999999998874 4688899876 332 123456788999999986 45688899888776 4589999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------------
Q 008785 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV-------------------------------------- 389 (553)
Q Consensus 348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~-------------------------------------- 389 (553)
+|.++.+.. ...++..++..++.+++..|+.||+..
T Consensus 124 ~G~~l~~~~------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (359)
T 3dxp_A 124 SGRVLWDQS------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAM 197 (359)
T ss_dssp CCBCCCCTT------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHH
T ss_pred CCeecCCCc------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHH
Confidence 988774311 123678888999999999999999731
Q ss_pred -----------------CCCceecCCCCCcEEecCCCC--eEEeeccccccCC
Q 008785 390 -----------------KPHVVHRDIRASNVLLDEEFG--AHLMGVGLSKFVP 423 (553)
Q Consensus 390 -----------------~~~ivHrDlkp~NILl~~~~~--~kl~Dfgla~~~~ 423 (553)
.+.++|||++|.|||+++++. +.|+||+.+....
T Consensus 198 ~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g~ 250 (359)
T 3dxp_A 198 DSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLGH 250 (359)
T ss_dssp HHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEEC
T ss_pred HHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccCC
Confidence 247999999999999997753 6899999987543
|
| >3k7b_A Protein A33; C-type lectin-like domain, homodimer, poxvirus, EEV, EV, VIR protein; 2.10A {Vaccinia virus WR} | Back alignment and structure |
|---|
Probab=98.81 E-value=4e-10 Score=89.20 Aligned_cols=46 Identities=7% Similarity=0.161 Sum_probs=43.6
Q ss_pred CCCCeEEEEecCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHhhC
Q 008785 61 EEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCG 107 (553)
Q Consensus 61 ~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~ 107 (553)
.|+++||+|+.+.++|.+|+.+|.++|+||++|++.++ .||..++.
T Consensus 15 ~f~~~CY~f~~~pkTW~eA~~~C~~~G~~Lpsi~s~~~-~wL~~YL~ 60 (96)
T 3k7b_A 15 YYQGSCYILHSDYQMFSDAAANCTAESSTLPNKSDVMI-TWLIDYVE 60 (96)
T ss_dssp EETTEEEEEEEEEECHHHHHHHHHHTTCBCCCHHHHTT-STTHHHHB
T ss_pred eeCCeeEEEeCCCCCHHHHHHHHHHcCCccCCcccchh-HHHHHHHh
Confidence 69999999999999999999999999999999999988 99998875
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.76 E-value=6.2e-09 Score=103.81 Aligned_cols=136 Identities=17% Similarity=0.211 Sum_probs=99.2
Q ss_pred eecccCceeEEEEEeCCCCEEEEEEeccCChhhHHHHHHHHHHhhcc-CCCc--eeeEeeEEeeCC---ceEEEEEccCC
Q 008785 276 LLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPN--LVAVKGCCYDHG---DRYIVYEFVVN 349 (553)
Q Consensus 276 ~iG~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~Hpn--Iv~l~~~~~~~~---~~~lV~E~~~~ 349 (553)
.++.|....||+.. ..+++|+.... .....+.+|+.+|+.+ .+.. +.+++......+ ..|+|||+++|
T Consensus 27 ~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G 100 (304)
T 3sg8_A 27 ISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKG 100 (304)
T ss_dssp EEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCC
T ss_pred ecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCC
Confidence 35899999999853 56889986533 3456788999999888 3332 345554433332 34899999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-----------------------------------------
Q 008785 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDK----------------------------------------- 388 (553)
Q Consensus 350 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~----------------------------------------- 388 (553)
.+|.+... ..++..++..++.+++..|+.||+.
T Consensus 101 ~~l~~~~~------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 174 (304)
T 3sg8_A 101 VPLTPLLL------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD 174 (304)
T ss_dssp EECCHHHH------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred eECCcccc------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence 88865332 2367788888999999999999961
Q ss_pred --------------CCCCceecCCCCCcEEecC--CCCeEEeeccccccCC
Q 008785 389 --------------VKPHVVHRDIRASNVLLDE--EFGAHLMGVGLSKFVP 423 (553)
Q Consensus 389 --------------~~~~ivHrDlkp~NILl~~--~~~~kl~Dfgla~~~~ 423 (553)
..+.++|+|++|.||++++ ...+.|+||+.+....
T Consensus 175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~ 225 (304)
T 3sg8_A 175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISD 225 (304)
T ss_dssp HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEEC
T ss_pred HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCC
Confidence 1135899999999999998 4567899999886543
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.46 E-value=1.3e-06 Score=87.01 Aligned_cols=136 Identities=17% Similarity=0.106 Sum_probs=97.0
Q ss_pred eecccCceeEEEEEeCCCCEEEEEEeccCChhhHHHHHHHHHHhhccCCC---ceeeEeeEEe-eCCceEEEEEccCCCC
Q 008785 276 LLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHP---NLVAVKGCCY-DHGDRYIVYEFVVNGP 351 (553)
Q Consensus 276 ~iG~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hp---nIv~l~~~~~-~~~~~~lV~E~~~~gs 351 (553)
.++.|....||+. |..+++|+-.. ......+.+|.++|..+.+. .+.+++.+.. ..+..++|||+++|.+
T Consensus 26 ~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~ 99 (306)
T 3tdw_A 26 SLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQI 99 (306)
T ss_dssp EEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEE
T ss_pred ecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeE
Confidence 4588888899987 57788888532 33456788999999999642 3566666664 4456799999999988
Q ss_pred HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-------------------------------------------
Q 008785 352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDK------------------------------------------- 388 (553)
Q Consensus 352 L~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~------------------------------------------- 388 (553)
|.+... ..++..+...++.+++..|+.||+.
T Consensus 100 l~~~~~------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~ 173 (306)
T 3tdw_A 100 LGEDGM------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT 173 (306)
T ss_dssp CHHHHH------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred Cchhhh------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence 876321 1245556666667777777666643
Q ss_pred --------------CCCCceecCCCCCcEEecC---CCC-eEEeeccccccCC
Q 008785 389 --------------VKPHVVHRDIRASNVLLDE---EFG-AHLMGVGLSKFVP 423 (553)
Q Consensus 389 --------------~~~~ivHrDlkp~NILl~~---~~~-~kl~Dfgla~~~~ 423 (553)
..+.++|+|++|.||++++ ++. ..|+||+.+....
T Consensus 174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~gd 226 (306)
T 3tdw_A 174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAISD 226 (306)
T ss_dssp HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEEC
T ss_pred HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCCC
Confidence 1235699999999999987 455 4899999886543
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.45 E-value=1.1e-06 Score=85.52 Aligned_cols=133 Identities=18% Similarity=0.140 Sum_probs=96.5
Q ss_pred cccCce-eEEEEEeC-CCCEEEEEEeccCChhhHHHHHHHHHHhhccC-CCceeeEeeEEeeCCceEEEEEccCCCCHHH
Q 008785 278 GDSKTG-GTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLH-HPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR 354 (553)
Q Consensus 278 G~G~~g-~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~ 354 (553)
..|..| .||+.... ++..+++|+-... ...++.+|...|+.+. +--+.++++++.+.+..++|||+++|.++.+
T Consensus 33 ~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~ 109 (272)
T 4gkh_A 33 NVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQ 109 (272)
T ss_dssp ECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHH
T ss_pred cCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccc
Confidence 455555 68987754 4668999987643 3456788999888874 3347788888888899999999999988877
Q ss_pred HhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------------------
Q 008785 355 WLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV--------------------------------------------- 389 (553)
Q Consensus 355 ~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~--------------------------------------------- 389 (553)
.... .......+..+++..|.-||+..
T Consensus 110 ~~~~--------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (272)
T 4gkh_A 110 VLEE--------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK 181 (272)
T ss_dssp HHHH--------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred cccC--------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence 6532 11223456667777777777430
Q ss_pred ----------CCCceecCCCCCcEEecCCCCeEEeecccccc
Q 008785 390 ----------KPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF 421 (553)
Q Consensus 390 ----------~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~ 421 (553)
.+.++|+|+.+.|||+++++.+-|+||+.+..
T Consensus 182 ~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 182 EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 12379999999999999877677999988753
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.21 E-value=2.7e-06 Score=86.49 Aligned_cols=79 Identities=5% Similarity=-0.051 Sum_probs=54.8
Q ss_pred eee-cccCceeEEEEEeC-------CCCEEEEEEeccCC---hhhHHHHHHHHHHhhccC-C--CceeeEeeEEeeC---
Q 008785 275 RLL-GDSKTGGTYSGILP-------DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLH-H--PNLVAVKGCCYDH--- 337 (553)
Q Consensus 275 ~~i-G~G~~g~Vy~~~~~-------~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~-H--pnIv~l~~~~~~~--- 337 (553)
+.| +.|....+|+.... +++.+++|...... ......+.+|+.+++.+. + -.+.++++++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 346 78888999988764 26789999865432 111245677888888773 2 3577788877655
Q ss_pred CceEEEEEccCCCCHH
Q 008785 338 GDRYIVYEFVVNGPLD 353 (553)
Q Consensus 338 ~~~~lV~E~~~~gsL~ 353 (553)
+..++||||++|.++.
T Consensus 106 g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPP 121 (357)
T ss_dssp SSCEEEEECCCCBCCC
T ss_pred CCceEEEEecCCCChh
Confidence 3568999999987664
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.02 E-value=2.7e-05 Score=80.31 Aligned_cols=74 Identities=14% Similarity=0.001 Sum_probs=48.8
Q ss_pred eeecccCceeEEEEEeC-CCCEEEEEEeccCCh-------hhHHHHHHHHHHhhccCC--C-ceeeEeeEEeeCCceEEE
Q 008785 275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF-------QRKKEFYSEIGRFARLHH--P-NLVAVKGCCYDHGDRYIV 343 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~-------~~~~~~~~E~~~l~~l~H--p-nIv~l~~~~~~~~~~~lV 343 (553)
+.+|.|..+.||++... +++.|+||....... ...+.+..|.++++.+.. | .+.+++.+ +.+..++|
T Consensus 36 ~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~lv 113 (397)
T 2olc_A 36 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 113 (397)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEEE
Confidence 34699999999999764 478999998654211 123456778888887732 3 34456654 44567899
Q ss_pred EEccCCC
Q 008785 344 YEFVVNG 350 (553)
Q Consensus 344 ~E~~~~g 350 (553)
||++++.
T Consensus 114 mE~l~g~ 120 (397)
T 2olc_A 114 MEDLSHL 120 (397)
T ss_dssp ECCCTTS
T ss_pred EEeCCCc
Confidence 9999764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.94 E-value=6.6e-05 Score=75.28 Aligned_cols=140 Identities=19% Similarity=0.271 Sum_probs=78.5
Q ss_pred ecccCceeEEEEEeCCCCEEEEEEeccCChhhHHHHHHHHHHhhcc-----CCCceeeEe-e--EEeeCCceEEEEEccC
Q 008785 277 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-----HHPNLVAVK-G--CCYDHGDRYIVYEFVV 348 (553)
Q Consensus 277 iG~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-----~HpnIv~l~-~--~~~~~~~~~lV~E~~~ 348 (553)
++.|..+.||+....+| .+++|+.... . ..+..|..++..| ..|.++... | +....+..+++|||++
T Consensus 40 l~gG~~n~~~~v~~~~~-~~vlk~~~~~-~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i~ 114 (346)
T 2q83_A 40 IQGNQMALVWKVHTDSG-AVCLKRIHRP-E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWIE 114 (346)
T ss_dssp CC----CEEEEEEETTE-EEEEEEECSC-H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECCC
T ss_pred ccccccCcEEEEEeCCC-CEEEEecCCC-H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEeec
Confidence 46677889999987554 5999998753 2 2333444444444 234444311 1 1234567899999999
Q ss_pred CCCHH-----------HH---hccCCC----C-C-----CCCCHHHH-------------------------------HH
Q 008785 349 NGPLD-----------RW---LHHIPR----G-G-----RSLDWAMR-------------------------------MK 373 (553)
Q Consensus 349 ~gsL~-----------~~---l~~~~~----~-~-----~~l~~~~~-------------------------------~~ 373 (553)
|.++. .. ++.... . . ....|... ..
T Consensus 115 G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (346)
T 2q83_A 115 GRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEIDG 194 (346)
T ss_dssp CBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHHHH
T ss_pred CccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHHHH
Confidence 86542 11 111000 0 0 01122211 11
Q ss_pred HHHHHHHHHHHHHh----------CCCCCceecCCCCCcEEecCCCCeEEeecccccc
Q 008785 374 VATTLAQGIAFLHD----------KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF 421 (553)
Q Consensus 374 i~~qia~gL~yLH~----------~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~ 421 (553)
+..++..++.+|+. ...+.++|+|+++.|||++.++.+.|+||+.+..
T Consensus 195 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 195 FIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 11234446667763 0235899999999999998888899999998754
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.87 E-value=4.7e-05 Score=74.78 Aligned_cols=72 Identities=26% Similarity=0.263 Sum_probs=53.4
Q ss_pred ecccCceeEEEEEeCCCCEEEEEEeccCChhhHHHHHHHHHHhhccC-C--CceeeEeeEEeeCCceEEEEEccCCCCH
Q 008785 277 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLH-H--PNLVAVKGCCYDHGDRYIVYEFVVNGPL 352 (553)
Q Consensus 277 iG~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-H--pnIv~l~~~~~~~~~~~lV~E~~~~gsL 352 (553)
+|.|..+.||+....||+.|.+|+-..........|..|+..|+.|. . --+++++++ +..++||||++++..
T Consensus 23 ~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e~l~~~~~ 97 (288)
T 3f7w_A 23 RGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAMEWVDERPP 97 (288)
T ss_dssp EEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEECCCCCCC
T ss_pred cCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEEeecccCC
Confidence 49999999999999999999999876554444456788998888873 2 224455554 234799999987653
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.83 E-value=0.00011 Score=73.07 Aligned_cols=137 Identities=19% Similarity=0.228 Sum_probs=91.0
Q ss_pred eecccCceeEEEEEeCCCCEEEEEEeccCChhhHHHHHHHHHHhhccC---CCceeeEeeEEeeCCceEEEEEccCCCCH
Q 008785 276 LLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLH---HPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352 (553)
Q Consensus 276 ~iG~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~---HpnIv~l~~~~~~~~~~~lV~E~~~~gsL 352 (553)
-++.|....+|+... ++..+++|+.... ....+..|...|+.|. ...+++++++....+..++||||+++.++
T Consensus 43 ~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~ 118 (312)
T 3jr1_A 43 KLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKN 118 (312)
T ss_dssp EECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCC
T ss_pred EeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCC
Confidence 359999999999886 5778999987643 3567888998888883 36688888888878889999999998764
Q ss_pred H--------H---HhccCCC-CC-----------------CCCCHHHHH---HHH----------------HHHHHHH-H
Q 008785 353 D--------R---WLHHIPR-GG-----------------RSLDWAMRM---KVA----------------TTLAQGI-A 383 (553)
Q Consensus 353 ~--------~---~l~~~~~-~~-----------------~~l~~~~~~---~i~----------------~qia~gL-~ 383 (553)
. . -|+.... .. ..-+|.... ++. .++...+ .
T Consensus 119 ~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l~~ 198 (312)
T 3jr1_A 119 KQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIVAD 198 (312)
T ss_dssp CTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHHHH
T ss_pred CchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHHHH
Confidence 2 1 1222111 00 012344321 111 1111111 2
Q ss_pred HHHh-CCCCCceecCCCCCcEEecCCCCeEEeecc
Q 008785 384 FLHD-KVKPHVVHRDIRASNVLLDEEFGAHLMGVG 417 (553)
Q Consensus 384 yLH~-~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg 417 (553)
.|.. ...+.++|+|+.+.|++++.++ +.|+|+.
T Consensus 199 ~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 199 TLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 3421 2357899999999999999887 8899973
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.53 E-value=0.0004 Score=72.08 Aligned_cols=76 Identities=9% Similarity=0.092 Sum_probs=46.1
Q ss_pred CCceecCCCCCcEEecCCCCeEEeeccccccCCcccccceeeecCccccccccccccCC---CCCcccchHhHHHHHHHH
Q 008785 391 PHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRN---ELTTKSDVYSFGVLLLEI 467 (553)
Q Consensus 391 ~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~t~ksDVwSlGvil~el 467 (553)
+.++|+|++|.|||+++++ ++++||+.+........-... ...-...|.+|+..... .-....++.+....+|+.
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAY-LGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL 309 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHH-HHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHH-HHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence 4899999999999998876 999999988764432111000 00012346666654311 112234555777777776
Q ss_pred h
Q 008785 468 R 468 (553)
Q Consensus 468 l 468 (553)
+
T Consensus 310 y 310 (420)
T 2pyw_A 310 F 310 (420)
T ss_dssp H
T ss_pred H
Confidence 6
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.40 E-value=0.0024 Score=63.38 Aligned_cols=162 Identities=14% Similarity=0.163 Sum_probs=88.7
Q ss_pred ccCHHHHHHhhcccCCCC----eeecccCceeEEEEEeCCCCEEEEEEeccCChhhHHHHHHHHHHhhccCCCc--eeeE
Q 008785 257 VFTTEELRSITKNFSEGN----RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPN--LVAV 330 (553)
Q Consensus 257 ~~~~~el~~~~~~~~~~~----~~iG~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpn--Iv~l 330 (553)
.++.+++..+...|.... +.++.|....+|+....+| .+++|...... ..+.+..|+.++..+...+ +.++
T Consensus 6 ~~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~ 82 (322)
T 2ppq_A 6 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLP 82 (322)
T ss_dssp CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred cCCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcc
Confidence 355677777777665422 2356788889999987555 68899887531 1234456777666653111 3333
Q ss_pred eeE------EeeCCceEEEEEccCCCCHHH-----------H---hcc----CCCCC-CCC---CHHHHHH---------
Q 008785 331 KGC------CYDHGDRYIVYEFVVNGPLDR-----------W---LHH----IPRGG-RSL---DWAMRMK--------- 373 (553)
Q Consensus 331 ~~~------~~~~~~~~lV~E~~~~gsL~~-----------~---l~~----~~~~~-~~l---~~~~~~~--------- 373 (553)
+.. ....+..+++|+|++|..+.. . ++. ..... ... .|.....
T Consensus 83 ~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~ 162 (322)
T 2ppq_A 83 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV 162 (322)
T ss_dssp CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred cCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhh
Confidence 321 122356789999998865311 0 111 00000 001 1221100
Q ss_pred ---HHHHHHHHHHHHHhC----CCCCceecCCCCCcEEecCCCCeEEeecccccc
Q 008785 374 ---VATTLAQGIAFLHDK----VKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF 421 (553)
Q Consensus 374 ---i~~qia~gL~yLH~~----~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~ 421 (553)
+...+...++.++.. ...+++|+|+.+.|||++++..+.|+||+.+..
T Consensus 163 ~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 163 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 011234455555532 234799999999999999875568999987753
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.35 E-value=0.0025 Score=63.41 Aligned_cols=162 Identities=15% Similarity=0.130 Sum_probs=90.4
Q ss_pred cccCHHHHHHhhcccCC----CCeeecccCceeEEEEEeCCCCEEEEEEeccCChhhHHHHHHHHHHhhccCC--Cceee
Q 008785 256 KVFTTEELRSITKNFSE----GNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHH--PNLVA 329 (553)
Q Consensus 256 ~~~~~~el~~~~~~~~~----~~~~iG~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H--pnIv~ 329 (553)
...+.+++..+...+.. .-..++ |....||+....+|+.+++|...... .....+..|..++..+.. -.+++
T Consensus 9 ~~l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~ 86 (328)
T 1zyl_A 9 QTLHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAA 86 (328)
T ss_dssp CCCCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCC
T ss_pred CCCCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecc
Confidence 34556666666555432 123356 88889999887778889999987431 134556677777777631 12444
Q ss_pred EeeE-----EeeCCceEEEEEccCCCCHH-----H------H---hcc----CCC-CCCCCCHHHH----HHH-------
Q 008785 330 VKGC-----CYDHGDRYIVYEFVVNGPLD-----R------W---LHH----IPR-GGRSLDWAMR----MKV------- 374 (553)
Q Consensus 330 l~~~-----~~~~~~~~lV~E~~~~gsL~-----~------~---l~~----~~~-~~~~l~~~~~----~~i------- 374 (553)
++.. ....+..+++||+++|.++. . . ++. ... .....++... ..+
T Consensus 87 ~~~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 166 (328)
T 1zyl_A 87 PVAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLI 166 (328)
T ss_dssp CCCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSS
T ss_pred eeecCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcC
Confidence 4442 12245568899999875431 1 1 111 000 0011222111 000
Q ss_pred --------HHHHHHHHHHHHhC----CCCCceecCCCCCcEEecCCCCeEEeecccccc
Q 008785 375 --------ATTLAQGIAFLHDK----VKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF 421 (553)
Q Consensus 375 --------~~qia~gL~yLH~~----~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~ 421 (553)
...+...++.+... ....++|+|+++.|||++ + .+.|+||+.+..
T Consensus 167 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 167 PSGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CTTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred CHHHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 11111223333221 234689999999999999 4 899999988764
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.24 E-value=0.0014 Score=65.59 Aligned_cols=141 Identities=11% Similarity=0.003 Sum_probs=72.4
Q ss_pred cccCcee-EEEEEeCCCCEEEEEEeccCChhhHHHHHHHHHHhhccC--CCceeeEeeEEeeCCceEEEEEccCCCCHHH
Q 008785 278 GDSKTGG-TYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLH--HPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR 354 (553)
Q Consensus 278 G~G~~g~-Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~--HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~ 354 (553)
+.|.... +|+....+|+.+++|....... .++..|+.++..+. .-.+.+++.+..+. -+++||++.+.++.+
T Consensus 27 ~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~--g~ll~e~l~~~~l~~ 101 (333)
T 3csv_A 27 AGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHAR--GLLLIEDLGDALFTE 101 (333)
T ss_dssp -------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTT--TEEEECCCCSCBHHH
T ss_pred CCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCC--CEEEEeeCCCcchHH
Confidence 4444443 6677654477888886554321 22345566665552 22355666653333 378999997766654
Q ss_pred HhccC---------------------CCC-CCCCCHHHHH-------H-H------------HHHHHHHHHHHH---hCC
Q 008785 355 WLHHI---------------------PRG-GRSLDWAMRM-------K-V------------ATTLAQGIAFLH---DKV 389 (553)
Q Consensus 355 ~l~~~---------------------~~~-~~~l~~~~~~-------~-i------------~~qia~gL~yLH---~~~ 389 (553)
++... ... ...++..... . + ...+...+..+. ...
T Consensus 102 ~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~~~~ 181 (333)
T 3csv_A 102 VINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQLEG 181 (333)
T ss_dssp HHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHHCCS
T ss_pred HhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhcccC
Confidence 43211 000 0111111100 0 0 001111222221 112
Q ss_pred CCCceecCCCCCcEEecCC----CCeEEeeccccccCC
Q 008785 390 KPHVVHRDIRASNVLLDEE----FGAHLMGVGLSKFVP 423 (553)
Q Consensus 390 ~~~ivHrDlkp~NILl~~~----~~~kl~Dfgla~~~~ 423 (553)
.+.++|||+.+.|||++.+ ..+.|+||+.+....
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~ 219 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGH 219 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEEC
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCC
Confidence 3489999999999999874 678999999886543
|
| >3fd4_A Glycoprotein GP42; C type lectin, virus entry, membrane fusion, HOST-virus interaction, lectin, membrane, transmembrane, viral protein; 2.40A {Human herpesvirus 4} PDB: 1kg0_C | Back alignment and structure |
|---|
Probab=97.16 E-value=0.0015 Score=56.12 Aligned_cols=122 Identities=18% Similarity=0.279 Sum_probs=84.3
Q ss_pred ccCCCCCCCCCcC-CcccCCCCeEEEEecCCCChHHHHHHHhhcCCEEeeeCCHH-HHHHHHHhhCCCCCCeEeeeeecC
Q 008785 44 SMNKDWKAPCPPD-WIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYE-EEHSAQKLCGKNVNGCWVGGRSIN 121 (553)
Q Consensus 44 ~~~~~~~~~Cp~~-w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~-e~~f~~~~~~~~~~~~WiGl~~~~ 121 (553)
..+...|.-|+.. -+| .|++.||||...+-+|+.--.+|++..-=---+.-+. .+-++++.++ .....|+|..+ +
T Consensus 61 ~~~k~~C~~C~~r~~tF-s~~~~CyYftp~kytf~~CF~aCa~ls~C~yfY~Pq~~~~PiV~~NLk-~~eslWVGifK-~ 137 (191)
T 3fd4_A 61 NYTKANCTYCNTREYTF-SYKGCCFYFTKKKHTWNGCFQACAELYPCTYFYGPTPDILPVVTRNLN-AIESLWVGVYR-V 137 (191)
T ss_dssp CCCCCCSCCCCTTTCSE-EETTEEEEECSSCBCTTHHHHHHHHHSTTEEECCCCTTTHHHHHTTSC-TTCEEEECCEE-C
T ss_pred ccCCCCCeecCcceeEE-EecceEEEeCcccccHHHHHHHHHhhcCeeEEecCCccCChhhhcccC-CcCcEEEEEEE-c
Confidence 3477888999987 223 5999999999999999999999999743333333333 5678887775 24689999984 3
Q ss_pred CCCCCceEEcCCCCCCcCcccccCccCCCCCCCCCCCCCCCCeeEEEeCCCC-ceecccCCCCCCccce
Q 008785 122 TTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSR-SLVTERCNTSHPFICM 189 (553)
Q Consensus 122 ~~~~~~w~W~dg~~~~~~~~~~~~~~~~~~~~~~C~~~~~~~~C~~~~~~~~-~w~~~~C~~~~~~iC~ 189 (553)
. ++.|.=.||. .+..|..-+ .+|..+..... .|....|+.+.+=.|.
T Consensus 138 ~--~~~W~sLDn~--n~~V~Di~g-----------------SyCaYvt~~S~~P~s~~eC~~~K~CLC~ 185 (191)
T 3fd4_A 138 G--EGNWTSLDGG--TFKVYQIFG-----------------SHCTYVSKFSTVPVSHHECSFLKPCLCV 185 (191)
T ss_dssp T--TCCEEETTEE--EECCBCSSS-----------------SSCEEEESSCSSCEECSCTTSCBCBEEE
T ss_pred C--ccceEEccCC--ceEEEEecc-----------------CeeeEEecccccccceeeccccceeEEe
Confidence 2 3899988985 344433322 26778766544 3666778777765554
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.08 E-value=0.0011 Score=65.19 Aligned_cols=70 Identities=7% Similarity=-0.022 Sum_probs=41.5
Q ss_pred eeecccCceeEEEEEeCCCCEEEEEEeccCChhhHHHHHHHHHHhhccCCCce-eeEeeEEeeCCceEEEEEcc-CCCCH
Q 008785 275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNL-VAVKGCCYDHGDRYIVYEFV-VNGPL 352 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnI-v~l~~~~~~~~~~~lV~E~~-~~gsL 352 (553)
+.++.|....+|+. ..+++|+....... .....+|+.+++.+...++ .+++++ +.+.-++++||+ ++.++
T Consensus 24 ~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~l 95 (301)
T 3dxq_A 24 LERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQTM 95 (301)
T ss_dssp EEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEEC
T ss_pred eEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCccC
Confidence 34588999999998 56888987653211 1122457766666632112 455543 344457899999 65444
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.99 E-value=0.0027 Score=58.79 Aligned_cols=140 Identities=12% Similarity=0.001 Sum_probs=85.3
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccce
Q 008785 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER 430 (553)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 430 (553)
||.+.|.. .+.++++++++.++.|.+.+|.-+-.+. .-..+=+.|..|++..+|.+.+.+ +.+. .
T Consensus 34 SL~eIL~~---~~~PlsEEqaWALc~Qc~~~L~~~~~~~--~~~~~i~~~~~i~l~~dG~V~f~~-~~s~--------~- 98 (229)
T 2yle_A 34 SLEEILRL---YNQPINEEQAWAVCYQCCGSLRAAARRR--QPRHRVRSAAQIRVWRDGAVTLAP-AADD--------A- 98 (229)
T ss_dssp EHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred cHHHHHHH---cCCCcCHHHHHHHHHHHHHHHHhhhhcc--cCCceecCCcceEEecCCceeccc-cccc--------c-
Confidence 78888875 4578999999999999999987762210 111233456889999999887653 1110 0
Q ss_pred eeecCccccccccccccCCCCCcccchHhHHHHHHHHhcCcccccchHHHHHhcCCHHHHHHHHHHHhhccCC-------
Q 008785 431 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVLCRRWWTLYTLVHSMSLLCAQECLMLFISCNNW------- 503 (553)
Q Consensus 431 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~~~~~~~l~~~~~~~~~~~~~~l~~l~~~Cl~~------- 503 (553)
....+.|||... ...+.+.=|||||+++|.-+-+.-..+... ..++.|-.|+..|++.
T Consensus 99 -----~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e~eE~---------eLS~~LE~LL~~Mt~~~~d~~~~ 163 (229)
T 2yle_A 99 -----GEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKENEER---------ELSPPLEQLIDHMANTVEADGSN 163 (229)
T ss_dssp -------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCTTEEE---------CCCHHHHHHHHHHTTCCC-----
T ss_pred -----cccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCcccch---------hhCHHHHHHHHHHHhcccccccc
Confidence 122466888763 345678899999999999986322221110 2223334444444433
Q ss_pred ------------------CCCCCCCHHHHHHHHHH
Q 008785 504 ------------------PSHLSQSKFCNLKLWVF 520 (553)
Q Consensus 504 ------------------dP~~RPs~~evl~~l~~ 520 (553)
.+..|++..+|++.-..
T Consensus 164 DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~~C~~ 198 (229)
T 2yle_A 164 DEGYEAAEEGLGDEDEKRKISAIRSYRDVMKLCAA 198 (229)
T ss_dssp ---------------CCSCCCCCCSHHHHHHHHHT
T ss_pred cccccccccccccccccccccCcCCHHHHHHHHHh
Confidence 45789999999986544
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.95 E-value=0.0016 Score=67.78 Aligned_cols=70 Identities=13% Similarity=0.114 Sum_probs=47.4
Q ss_pred ecccCceeEEEEEeCC--------CCEEEEEEeccCChhhHHHHHHHHHHhhccC-CCceeeEeeEEeeCCceEEEEEcc
Q 008785 277 LGDSKTGGTYSGILPD--------GSRVAVKRLKRSSFQRKKEFYSEIGRFARLH-HPNLVAVKGCCYDHGDRYIVYEFV 347 (553)
Q Consensus 277 iG~G~~g~Vy~~~~~~--------g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lV~E~~ 347 (553)
|+.|....+|+....+ ++.+++|+..... ..+.+.+|..+++.+. +.-.+++++.+.+ .+|+||+
T Consensus 81 l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e~l 154 (429)
T 1nw1_A 81 IKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYI 154 (429)
T ss_dssp ECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCC
T ss_pred eCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEEEe
Confidence 4888889999998753 5789999884421 1245567888888874 3223566765432 3899999
Q ss_pred CCCCH
Q 008785 348 VNGPL 352 (553)
Q Consensus 348 ~~gsL 352 (553)
+|.+|
T Consensus 155 ~G~~l 159 (429)
T 1nw1_A 155 PSRPL 159 (429)
T ss_dssp CEEEC
T ss_pred CCccc
Confidence 86443
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.75 E-value=0.0075 Score=63.08 Aligned_cols=72 Identities=10% Similarity=-0.092 Sum_probs=45.5
Q ss_pred eecccCceeEEEEEeCC-CCEEEEEEeccCChhhHHHHHHHHHHhhccCCCce-eeEeeEEeeCCceEEEEEccCCCCH
Q 008785 276 LLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNL-VAVKGCCYDHGDRYIVYEFVVNGPL 352 (553)
Q Consensus 276 ~iG~G~~g~Vy~~~~~~-g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnI-v~l~~~~~~~~~~~lV~E~~~~gsL 352 (553)
.|+.|-...+|+....+ +..+++|+........ -+-.+|..++..|...++ .++++.+. + .+||||++|.+|
T Consensus 115 ~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~-idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l 188 (458)
T 2qg7_A 115 IINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI-INREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYAL 188 (458)
T ss_dssp EECC--CEEEEEEEETTTTEEEEEEEECC-CCSC-SCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEEC
T ss_pred EcCCCeEeEEEEEEECCCCceEEEEECCCChhhh-cCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccC
Confidence 35888889999998865 4788999875432111 112478888888854333 56777652 2 359999987544
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.75 E-value=0.0047 Score=62.95 Aligned_cols=140 Identities=16% Similarity=0.166 Sum_probs=81.4
Q ss_pred ecccCceeEEEEEeC--------CCCEEEEEEeccCChhhHHHHHHHHHHhhccC-CCceeeEeeEEeeCCceEEEEEcc
Q 008785 277 LGDSKTGGTYSGILP--------DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLH-HPNLVAVKGCCYDHGDRYIVYEFV 347 (553)
Q Consensus 277 iG~G~~g~Vy~~~~~--------~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lV~E~~ 347 (553)
+..|-...+|+.... +++.|++|+.... ......+.+|..+++.|. +.-..++++.+.+ .+||||+
T Consensus 58 lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e~i 132 (379)
T 3feg_A 58 VSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQYI 132 (379)
T ss_dssp C-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEECC
T ss_pred cCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEEEe
Confidence 477888889998874 2578999986332 223456678998888873 3223566666543 2999999
Q ss_pred CCCCHHH--------------H---hccCC-CCCCCCC--HHHHHHHHHHHHH-------------------HHHHHH--
Q 008785 348 VNGPLDR--------------W---LHHIP-RGGRSLD--WAMRMKVATTLAQ-------------------GIAFLH-- 386 (553)
Q Consensus 348 ~~gsL~~--------------~---l~~~~-~~~~~l~--~~~~~~i~~qia~-------------------gL~yLH-- 386 (553)
+|.+|.. . |+... ....... +.++.++..++.. .+..|.
T Consensus 133 ~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~~ 212 (379)
T 3feg_A 133 PSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRKL 212 (379)
T ss_dssp SEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHHH
T ss_pred cCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHHH
Confidence 8765431 1 11111 1111122 3445555544322 223332
Q ss_pred --hC-CCCCceecCCCCCcEEecCC----CCeEEeecccccc
Q 008785 387 --DK-VKPHVVHRDIRASNVLLDEE----FGAHLMGVGLSKF 421 (553)
Q Consensus 387 --~~-~~~~ivHrDlkp~NILl~~~----~~~kl~Dfgla~~ 421 (553)
.. ....++|+|+.+.|||++++ +.+.++||..+..
T Consensus 213 L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 213 LESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 21 23378999999999999876 6899999998864
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.51 E-value=0.013 Score=58.72 Aligned_cols=33 Identities=27% Similarity=0.350 Sum_probs=28.5
Q ss_pred CCceecCCCCCcEEecCCCCeEEeeccccccCC
Q 008785 391 PHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVP 423 (553)
Q Consensus 391 ~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~ 423 (553)
..++|+|+.+.||++++++.+.|+||+.+....
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~~ 238 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLAP 238 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEEEC
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeCC
Confidence 479999999999999988889999998776543
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.44 E-value=0.0048 Score=62.60 Aligned_cols=71 Identities=13% Similarity=0.089 Sum_probs=41.9
Q ss_pred ecccCceeEEEEEeCC---------CCEEEEEEeccCChhhHHHHHHHHHHhhccCCCc-eeeEeeEEeeCCceEEEEEc
Q 008785 277 LGDSKTGGTYSGILPD---------GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPN-LVAVKGCCYDHGDRYIVYEF 346 (553)
Q Consensus 277 iG~G~~g~Vy~~~~~~---------g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpn-Iv~l~~~~~~~~~~~lV~E~ 346 (553)
++.|....+|+....+ ++.+++|+...... ...+...|..+++.+...+ +.++++.. . -++||||
T Consensus 41 l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~e~ 115 (369)
T 3c5i_A 41 ILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIEEW 115 (369)
T ss_dssp C----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEEC
T ss_pred eCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEEEE
Confidence 4778888999988754 26899998765321 1112356777777774222 44666543 2 3789999
Q ss_pred cCCCCH
Q 008785 347 VVNGPL 352 (553)
Q Consensus 347 ~~~gsL 352 (553)
++|.++
T Consensus 116 i~G~~l 121 (369)
T 3c5i_A 116 LYGDPL 121 (369)
T ss_dssp CCSEEC
T ss_pred ecCCcC
Confidence 987543
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=96.15 E-value=0.0032 Score=41.88 Aligned_cols=27 Identities=26% Similarity=0.486 Sum_probs=12.8
Q ss_pred EeehhHHHHHHHHHHHHHHHHHHHhhh
Q 008785 206 LITLGVVSGLILLTTFAIVIWLLAYRR 232 (553)
Q Consensus 206 ~i~~~~~~~~~~l~~~~~~~~~~~~~r 232 (553)
..+++.++|++++++++++++++.+||
T Consensus 12 ~~Ia~~vVGvll~vi~~l~~~~~~RRR 38 (44)
T 2jwa_A 12 TSIISAVVGILLVVVLGVVFGILIKRR 38 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred cchHHHHHHHHHHHHHHHHHHhheehh
Confidence 345555666554444444444433333
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=95.87 E-value=0.0071 Score=40.40 Aligned_cols=27 Identities=41% Similarity=0.520 Sum_probs=15.3
Q ss_pred EeehhHHHHHHHHHHHHHHHHHHHhhh
Q 008785 206 LITLGVVSGLILLTTFAIVIWLLAYRR 232 (553)
Q Consensus 206 ~i~~~~~~~~~~l~~~~~~~~~~~~~r 232 (553)
.|..++++|++++++++++++++.+||
T Consensus 12 ~IA~gVVgGv~~~~ii~~~~~~~~RRr 38 (44)
T 2ks1_B 12 SIATGMVGALLLLLVVALGIGLFMRRR 38 (44)
T ss_dssp SSTHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred eEEeehhHHHHHHHHHHHHHHHHhhhh
Confidence 456666666766666555544444443
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=94.82 E-value=0.02 Score=38.07 Aligned_cols=26 Identities=27% Similarity=0.552 Sum_probs=14.0
Q ss_pred eehhHHHHHHHHHHHHHHHHHHHhhh
Q 008785 207 ITLGVVSGLILLTTFAIVIWLLAYRR 232 (553)
Q Consensus 207 i~~~~~~~~~~l~~~~~~~~~~~~~r 232 (553)
|..++++|++++++++++++++.+||
T Consensus 12 IA~gVVgGv~~v~ii~~~~~~~~RRR 37 (44)
T 2l2t_A 12 IAAGVIGGLFILVIVGLTFAVYVRRK 37 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEeehHHHHHHHHHHHHHHHHhhhh
Confidence 55556666666655555544444443
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.46 E-value=0.042 Score=56.73 Aligned_cols=71 Identities=13% Similarity=0.048 Sum_probs=45.4
Q ss_pred ecccCceeEEEEEeCC--------CCEEEEEEeccCChhhHHHHHHHHHHhhccC-CCceeeEeeEEeeCCceEEEEEcc
Q 008785 277 LGDSKTGGTYSGILPD--------GSRVAVKRLKRSSFQRKKEFYSEIGRFARLH-HPNLVAVKGCCYDHGDRYIVYEFV 347 (553)
Q Consensus 277 iG~G~~g~Vy~~~~~~--------g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lV~E~~ 347 (553)
+..|-...+|+....+ ++.|++|+....... .-+..+|..+++.+. +.-..++++.+ . -++||||+
T Consensus 78 lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~-~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~efI 152 (424)
T 3mes_A 78 IFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK-FYDSKVELDVFRYLSNINIAPNIIADF--P--EGRIEEFI 152 (424)
T ss_dssp ECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C-CCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEECC
T ss_pred cCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch-hcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEEEEe
Confidence 4778888999988753 588999987543211 112346777777763 32244555533 2 37899999
Q ss_pred CCCCH
Q 008785 348 VNGPL 352 (553)
Q Consensus 348 ~~gsL 352 (553)
+|.+|
T Consensus 153 ~G~~l 157 (424)
T 3mes_A 153 DGEPL 157 (424)
T ss_dssp CSEEC
T ss_pred CCccC
Confidence 98653
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=91.55 E-value=0.52 Score=48.03 Aligned_cols=30 Identities=27% Similarity=0.414 Sum_probs=25.0
Q ss_pred CceecCCCCCcEEe------cCCCCeEEeecccccc
Q 008785 392 HVVHRDIRASNVLL------DEEFGAHLMGVGLSKF 421 (553)
Q Consensus 392 ~ivHrDlkp~NILl------~~~~~~kl~Dfgla~~ 421 (553)
.++|+|+.+.|||+ +++..+.++||..|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 35699999999999 4456799999998864
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=84.13 E-value=1.9 Score=39.63 Aligned_cols=84 Identities=12% Similarity=0.129 Sum_probs=60.2
Q ss_pred CCCceeeEeeEEeeCCceEEEEEccCCC-CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCC
Q 008785 323 HHPNLVAVKGCCYDHGDRYIVYEFVVNG-PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRAS 401 (553)
Q Consensus 323 ~HpnIv~l~~~~~~~~~~~lV~E~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~ 401 (553)
.||+.+.. .+-.+.+...+.++.-+.+ ++.. ++ .++...+++++..|+.-..+++.. +|--|.|+
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-ik-------~~~~~eKlr~l~ni~~l~~~~~~r-----~tf~L~P~ 108 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-IK-------SFTKNEKLRYLLNIKNLEEVNRTR-----YTFVLAPD 108 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-GG-------GSCHHHHHHHHHHGGGGGGGGGSS-----EECCCSGG
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-HH-------hcCHHHHHHHHHHHHHHHHHhcCc-----eEEEEecc
Confidence 68888866 4545556555555544322 2222 32 378889999999999988766644 78899999
Q ss_pred cEEecCCCCeEEeeccccc
Q 008785 402 NVLLDEEFGAHLMGVGLSK 420 (553)
Q Consensus 402 NILl~~~~~~kl~Dfgla~ 420 (553)
||+++.++.+++.--|+..
T Consensus 109 NL~f~~~~~p~i~~RGik~ 127 (215)
T 4ann_A 109 ELFFTRDGLPIAKTRGLQN 127 (215)
T ss_dssp GEEECTTSCEEESCCEETT
T ss_pred eEEEcCCCCEEEEEccCcc
Confidence 9999999999998776543
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=83.86 E-value=3.1 Score=38.36 Aligned_cols=83 Identities=11% Similarity=0.110 Sum_probs=59.0
Q ss_pred CCCceeeEeeEEeeCCceEEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHH-HHHhCCCCCceecCCCCC
Q 008785 323 HHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIA-FLHDKVKPHVVHRDIRAS 401 (553)
Q Consensus 323 ~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~-yLH~~~~~~ivHrDlkp~ 401 (553)
.||++ -...-.+++...+.++.-+++.=...++ .++...+++++..|+.-.. +++ .-+|--|.|+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~-------~~~~~eKlrll~nl~~L~~~~~~-----~r~tf~l~P~ 113 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR-------KTTLLSRIRAAIHLVSKVKHHSA-----RRLIFIVCPE 113 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH-------TSCHHHHHHHHHHHHHHHSSCCS-----SSEECCCCGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH-------hcCHHHHHHHHHHHHHHHHHhhh-----CceeEEEeCc
Confidence 68887 3333456666666666553433233343 3788899999999888766 555 4478889999
Q ss_pred cEEecCCCCeEEeecccc
Q 008785 402 NVLLDEEFGAHLMGVGLS 419 (553)
Q Consensus 402 NILl~~~~~~kl~Dfgla 419 (553)
||+++.++.+++.-.|+-
T Consensus 114 NL~f~~~~~p~i~hRGi~ 131 (219)
T 4ano_A 114 NLMFNRALEPFFLHVGVK 131 (219)
T ss_dssp GEEECTTCCEEESCCEET
T ss_pred eEEEeCCCcEEEEEcCCc
Confidence 999999999999877654
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 553 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 7e-43 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-42 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 7e-42 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 6e-41 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-40 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-40 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 9e-40 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-39 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-38 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-38 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-38 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 7e-38 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 8e-38 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-37 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 4e-37 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 6e-37 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 7e-37 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-36 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 6e-36 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-35 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-35 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-35 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-35 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-35 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 5e-35 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 8e-35 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-34 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 7e-34 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-33 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-33 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-32 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-31 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-31 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 4e-31 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 4e-31 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-30 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 9e-30 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-29 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-29 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 5e-29 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 6e-29 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-28 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-27 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-27 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 7e-27 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-26 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-26 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-25 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-25 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-25 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-25 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-25 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-25 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 7e-24 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-23 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-22 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 6e-22 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-21 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-20 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 7e-19 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-18 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 7e-18 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 8e-13 | |
| d1ypqa1 | 131 | d.169.1.1 (A:140-270) Oxidised low density lipopro | 2e-11 | |
| d1egga_ | 136 | d.169.1.1 (A:) Macrophage mannose receptor, CRD4 { | 2e-10 | |
| d1g1sa1 | 118 | d.169.1.1 (A:1-118) P-selectin, C-lectin domain {H | 9e-10 | |
| d1e87a_ | 117 | d.169.1.1 (A:) CD69 {Human (Homo sapiens) [TaxId: | 2e-09 | |
| d1wk1a_ | 150 | d.169.1.1 (A:) Hypothetical protein F28B4.3 {Caeno | 2e-09 | |
| d1xpha1 | 130 | d.169.1.1 (A:265-394) DC-SIGNR (DC-SIGN related re | 6e-09 | |
| d1hq8a_ | 123 | d.169.1.1 (A:) NK cell-activating receptor nkg2d { | 1e-08 | |
| d1qo3c_ | 133 | d.169.1.1 (C:) NK cell receptor {Mouse (Mus muscul | 1e-08 | |
| d3c8ja1 | 122 | d.169.1.1 (A:138-259) NK cell receptor {Mouse (Mus | 2e-08 | |
| d1g1ta1 | 118 | d.169.1.1 (A:1-118) E-selectin, C-lectin domain {H | 5e-08 | |
| d1tdqb_ | 126 | d.169.1.1 (B:) Aggrecan core protein {Rat (Rattus | 5e-08 | |
| d1dv8a_ | 128 | d.169.1.1 (A:) H1 subunit of the asialoglycoprotei | 1e-07 | |
| d1h8ua_ | 115 | d.169.1.1 (A:) Eosinophil major basic protein {Hum | 2e-07 | |
| d1kg0c_ | 136 | d.169.1.1 (C:) EBV gp42 {Epstein-Barr virus [TaxId | 6e-07 | |
| d1r13a1 | 119 | d.169.1.1 (A:110-228) Surfactant protein, lectin d | 2e-06 | |
| d2msba_ | 112 | d.169.1.1 (A:) Mannose-binding protein A, C-lectin | 2e-06 | |
| d1tn3a_ | 137 | d.169.1.1 (A:) Tetranectin {Human (Homo sapiens) [ | 3e-06 | |
| d1pwba1 | 121 | d.169.1.1 (A:235-355) Surfactant protein, lectin d | 3e-06 | |
| d1t8da1 | 143 | d.169.1.1 (A:1-143) Low affinity immunoglobulin ep | 3e-06 | |
| d1oz7b_ | 123 | d.169.1.1 (B:) Snake coagglutinin beta chain {Saw- | 3e-06 | |
| d1v7pb_ | 127 | d.169.1.1 (B:) Snake coagglutinin beta chain {Snak | 5e-06 | |
| d1hupa1 | 117 | d.169.1.1 (A:112-228) Mannose-binding protein A, C | 7e-06 | |
| d1wmza_ | 140 | d.169.1.1 (A:) Lectin CEL-I {Cucumaria echinata [T | 9e-06 | |
| d1c3ab_ | 125 | d.169.1.1 (B:) Snake coagglutinin beta chain {Habu | 1e-05 | |
| d3bdwa1 | 121 | d.169.1.1 (A:59-179) CD94 {Human (Homo sapiens) [T | 2e-05 | |
| d1jwia_ | 124 | d.169.1.1 (A:) Snake coagglutinin alpha chain {Puf | 2e-05 | |
| d1gz2a_ | 139 | d.169.1.1 (A:) Ovocleidin-17 {Chicken (Gallus gall | 2e-05 | |
| d1oz7a_ | 131 | d.169.1.1 (A:) Snake coagglutinin alpha chain {Saw | 2e-05 | |
| d1uv0a_ | 140 | d.169.1.1 (A:) Pancreatitis-associated protein 1 { | 3e-05 | |
| d1rdl1_ | 111 | d.169.1.1 (1:) Mannose-binding protein A, C-lectin | 4e-05 | |
| d1jwib_ | 123 | d.169.1.1 (B:) Snake coagglutinin beta chain {Puff | 7e-05 | |
| d1jzna_ | 135 | d.169.1.1 (A:) Galactose-specific C-type lectin {W | 8e-05 | |
| d1qdda_ | 144 | d.169.1.1 (A:) Lithostathine, inhibitor of stone f | 9e-05 | |
| d2afpa_ | 129 | d.169.1.1 (A:) Type II antifreeze protein {Sea rav | 1e-04 | |
| d1v7pa_ | 134 | d.169.1.1 (A:) Snake coagglutinin alpha chain {Sna | 2e-04 | |
| d1c3aa_ | 135 | d.169.1.1 (A:) Snake coagglutinin alpha chain {Hab | 2e-04 | |
| d1umrc_ | 125 | d.169.1.1 (C:) Snake coagglutinin beta chain {Sout | 3e-04 | |
| d1byfa_ | 123 | d.169.1.1 (A:) Lectin TC14 {Tunicate (Polyandrocar | 4e-04 | |
| d1j34b_ | 123 | d.169.1.1 (B:) Snake coagglutinin beta chain {Habu | 6e-04 | |
| d1umra_ | 135 | d.169.1.1 (A:) Snake coagglutinin alpha chain {Sou | 7e-04 | |
| d1fvua_ | 133 | d.169.1.1 (A:) Snake coagglutinin alpha chain {Jar | 7e-04 | |
| d1sb2a1 | 132 | d.169.1.1 (A:1-132) Snake coagglutinin alpha chain | 8e-04 | |
| d1fvub_ | 125 | d.169.1.1 (B:) Snake coagglutinin beta chain {Jara | 0.001 | |
| d1sb2b1 | 127 | d.169.1.1 (B:2-128) Snake coagglutinin beta chain | 0.002 | |
| d1j34a_ | 129 | d.169.1.1 (A:) Snake coagglutinin alpha chain {Hab | 0.003 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 7e-43
Identities = 49/198 (24%), Positives = 89/198 (44%), Gaps = 14/198 (7%)
Query: 275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSF--QRKKEFYSEIGRFARLHHPNLVAVKG 332
+ +G G Y G VAVK L ++ Q+ + F +E+G + H N++ G
Sbjct: 14 QRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71
Query: 333 CCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPH 392
IV ++ L LH + + +A AQG+ +LH K
Sbjct: 72 YS-TAPQLAIVTQWCEGSSLYHHLH---IIETKFEMIKLIDIARQTAQGMDYLHAK---S 124
Query: 393 VVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY---RN 449
++HRD++++N+ L E+ + GL+ + G+ ++APE + +N
Sbjct: 125 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 184
Query: 450 ELTTKSDVYSFGVLLLEI 467
+ +SDVY+FG++L E+
Sbjct: 185 PYSFQSDVYAFGIVLYEL 202
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 3e-42
Identities = 57/193 (29%), Positives = 92/193 (47%), Gaps = 8/193 (4%)
Query: 275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCC 334
LG + G + G ++VAVK LK+ S F +E +L H LV +
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 335 YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVV 394
YI+ E++ NG L +L G L + +A +A+G+AF+ ++ + +
Sbjct: 78 TQ-EPIYIITEYMENGSLVDFLKT--PSGIKLTINKLLDMAAQIAEGMAFIEER---NYI 131
Query: 395 HRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTK 454
HRD+RA+N+L+ + + GL++ + R A + APE + T K
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE-GAKFPIKWTAPEAINYGTFTIK 190
Query: 455 SDVYSFGVLLLEI 467
SDV+SFG+LL EI
Sbjct: 191 SDVWSFGILLTEI 203
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 7e-42
Identities = 50/215 (23%), Positives = 95/215 (44%), Gaps = 9/215 (4%)
Query: 275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCC 334
+ LG + G G VA+K +K S + EF E L H LV + G C
Sbjct: 10 KELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVC 68
Query: 335 YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVV 394
+I+ E++ NG L +L +++ + + + +L K +
Sbjct: 69 TKQRPIFIITEYMANGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLESK---QFL 122
Query: 395 HRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTK 454
HRD+ A N L++++ + GLS++V + +V + + PE + ++ ++K
Sbjct: 123 HRDLAARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLMYSKFSSK 181
Query: 455 SDVYSFGVLLLEIRLVLCRRWWTLYTLVHSMSLLC 489
SD+++FGVL+ EI L + + +T + +
Sbjct: 182 SDIWAFGVLMWEI-YSLGKMPYERFTNSETAEHIA 215
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 6e-41
Identities = 46/195 (23%), Positives = 85/195 (43%), Gaps = 12/195 (6%)
Query: 275 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQR-KKEFYSEIGRFARLHHPNLVAVKG 332
LG G + P G +A K + + + E+ + P +V G
Sbjct: 12 SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 71
Query: 333 CCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPH 392
Y G+ I E + G LD+ L R + + KV+ + +G+ +L +K K
Sbjct: 72 AFYSDGEISICMEHMDGGSLDQVLKKAGR----IPEQILGKVSIAVIKGLTYLREKHK-- 125
Query: 393 VVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELT 452
++HRD++ SN+L++ L G+S + + GT Y++PE + +
Sbjct: 126 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV----GTRSYMSPERLQGTHYS 181
Query: 453 TKSDVYSFGVLLLEI 467
+SD++S G+ L+E+
Sbjct: 182 VQSDIWSMGLSLVEM 196
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 2e-40
Identities = 47/193 (24%), Positives = 92/193 (47%), Gaps = 8/193 (4%)
Query: 275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCC 334
+ +G + G + G + +VA+K ++ + +++F E +L HP LV + G C
Sbjct: 11 QEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVC 69
Query: 335 YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVV 394
+ +V+EF+ +G L +L + + + +G+A+L + V+
Sbjct: 70 LEQAPICLVFEFMEHGCLSDYLR---TQRGLFAAETLLGMCLDVCEGMAYLEEA---CVI 123
Query: 395 HRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTK 454
HRD+ A N L+ E + G+++FV + + + +PE + ++K
Sbjct: 124 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFSRYSSK 182
Query: 455 SDVYSFGVLLLEI 467
SDV+SFGVL+ E+
Sbjct: 183 SDVWSFGVLMWEV 195
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 2e-40
Identities = 53/201 (26%), Positives = 84/201 (41%), Gaps = 9/201 (4%)
Query: 275 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQR--KKEFYSEIGRFARLHHPNLVAVK 331
+G G DG + K L S K+ SE+ L HPN+V
Sbjct: 10 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 69
Query: 332 GCCYDHGDR--YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDK- 388
D + YIV E+ G L + + + LD ++V T L + H +
Sbjct: 70 DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 129
Query: 389 -VKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY 447
V+HRD++ +NV LD + L GL++ + + + + GT Y++PE +
Sbjct: 130 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFV--GTPYYMSPEQMN 187
Query: 448 RNELTTKSDVYSFGVLLLEIR 468
R KSD++S G LL E+
Sbjct: 188 RMSYNEKSDIWSLGCLLYELC 208
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 9e-40
Identities = 51/213 (23%), Positives = 90/213 (42%), Gaps = 16/213 (7%)
Query: 261 EELRSITKNFSEGNR-----LLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYS 314
E+LRSI + +G +G Y+ + + G VA++++ +K+ +
Sbjct: 7 EKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIIN 66
Query: 315 EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKV 374
EI +PN+V + ++V E++ G L + +D V
Sbjct: 67 EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAV 121
Query: 375 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA 434
Q + FLH V+HRDI++ N+LL + L G + E Q +
Sbjct: 122 CRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKRSTM 176
Query: 435 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEI 467
GT ++APE V R K D++S G++ +E+
Sbjct: 177 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEM 209
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (360), Expect = 3e-39
Identities = 55/193 (28%), Positives = 85/193 (44%), Gaps = 8/193 (4%)
Query: 275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCC 334
LG G + G +RVA+K LK + + F E +L H LV +
Sbjct: 23 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVV 81
Query: 335 YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVV 394
YIV E++ G L +L G+ L + +A +A G+A++ + V
Sbjct: 82 S-EEPIYIVTEYMSKGSLLDFLKG--ETGKYLRLPQLVDMAAQIASGMAYVERM---NYV 135
Query: 395 HRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTK 454
HRD+RA+N+L+ E + GL++ + R + APE T K
Sbjct: 136 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAK-FPIKWTAPEAALYGRFTIK 194
Query: 455 SDVYSFGVLLLEI 467
SDV+SFG+LL E+
Sbjct: 195 SDVWSFGILLTEL 207
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 141 bits (355), Expect = 2e-38
Identities = 56/235 (23%), Positives = 106/235 (45%), Gaps = 22/235 (9%)
Query: 258 FTTEELRSITKNFSEGN--------RLLGDSKTGGTYSGILPDGSR----VAVKRLKRS- 304
FT E+ + F++ +++G + G SG L + VA+K LK
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 305 SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGR 364
+ +++++F SE + HPN++ ++G I+ EF+ NG LD +L
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ---NDG 123
Query: 365 SLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW 424
+ + +A G+ +L D + VHRD+ A N+L++ + GLS+F+
Sbjct: 124 QFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180
Query: 425 EVMQE---RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVLCRRWW 476
+ + + APE + + T+ SDV+S+G+++ E+ R +W
Sbjct: 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYW 235
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 3e-38
Identities = 49/199 (24%), Positives = 83/199 (41%), Gaps = 14/199 (7%)
Query: 275 RLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGC 333
LGD G Y + A K + S + +++ EI A HPN+V +
Sbjct: 18 GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77
Query: 334 CYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHV 393
Y + +I+ EF G +D + R L + V + +LHD +
Sbjct: 78 FYYENNLWILIEFCAGGAVD---AVMLELERPLTESQIQVVCKQTLDALNYLHDN---KI 131
Query: 394 VHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNEL-- 451
+HRD++A N+L + L G+S + + + + GT ++APE V
Sbjct: 132 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI--GTPYWMAPEVVMCETSKD 189
Query: 452 ---TTKSDVYSFGVLLLEI 467
K+DV+S G+ L+E+
Sbjct: 190 RPYDYKADVWSLGITLIEM 208
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (350), Expect = 4e-38
Identities = 57/194 (29%), Positives = 90/194 (46%), Gaps = 14/194 (7%)
Query: 275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCC 334
+ +G + G G G++VAVK +K + + F +E +L H NLV + G
Sbjct: 13 QTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVI 69
Query: 335 YDHGDR-YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHV 393
+ YIV E++ G L +L RG L +K + + + + +L +
Sbjct: 70 VEEKGGLYIVTEYMAKGSLVDYLRS--RGRSVLGGDCLLKFSLDVCEAMEYLE---GNNF 124
Query: 394 VHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTT 453
VHRD+ A NVL+ E+ A + GL+K + APE + + +T
Sbjct: 125 VHRDLAARNVLVSEDNVAKVSDFGLTKE-----ASSTQDTGKLPVKWTAPEALREKKFST 179
Query: 454 KSDVYSFGVLLLEI 467
KSDV+SFG+LL EI
Sbjct: 180 KSDVWSFGILLWEI 193
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 139 bits (350), Expect = 7e-38
Identities = 59/194 (30%), Positives = 92/194 (47%), Gaps = 8/194 (4%)
Query: 275 RLLGDSKTGGTYSGILPDGSR-VAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGC 333
LG + G Y G+ S VAVK LK + + + EF E + HPNLV + G
Sbjct: 23 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGV 81
Query: 334 CYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHV 393
C YI+ EF+ G L +L + + + + +AT ++ + +L K +
Sbjct: 82 CTREPPFYIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLE---KKNF 136
Query: 394 VHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTT 453
+HRD+ A N L+ E + GLS+ + + A + APE + N+ +
Sbjct: 137 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA-GAKFPIKWTAPESLAYNKFSI 195
Query: 454 KSDVYSFGVLLLEI 467
KSDV++FGVLL EI
Sbjct: 196 KSDVWAFGVLLWEI 209
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 8e-38
Identities = 51/212 (24%), Positives = 91/212 (42%), Gaps = 12/212 (5%)
Query: 261 EELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSR---VAVKRLKRSSFQR-KKEFYSEI 316
++L N + LG G G+ + VA+K LK+ + + +E E
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 317 GRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVAT 376
+L +P +V + G C +V E GPL ++L + + ++
Sbjct: 61 QIMHQLDNPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLV---GKREEIPVSNVAELLH 116
Query: 377 TLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV-PWEVMQERTVMAG 435
++ G+ +L +K + VHRD+ A NVLL A + GLSK + +
Sbjct: 117 QVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 173
Query: 436 GTYGYLAPEFVYRNELTTKSDVYSFGVLLLEI 467
+ APE + + +++SDV+S+GV + E
Sbjct: 174 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEA 205
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 138 bits (348), Expect = 2e-37
Identities = 52/224 (23%), Positives = 94/224 (41%), Gaps = 24/224 (10%)
Query: 252 PPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRK- 309
P ++F ++ K FS+ + G G Y + + VA+K++ S Q
Sbjct: 2 PDVAELFFKDD---PEKLFSDLREI-GHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNE 57
Query: 310 --KEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLD 367
++ E+ +L HPN + +GC ++V E+ + D H + L
Sbjct: 58 KWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVH----KKPLQ 113
Query: 368 WAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM 427
V QG+A+LH +++HRD++A N+LL E L G + +
Sbjct: 114 EVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMA---- 166
Query: 428 QERTVMAGGTYGYLAPEFV---YRNELTTKSDVYSFGVLLLEIR 468
+ + GT ++APE + + K DV+S G+ +E+
Sbjct: 167 PANSFV--GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA 208
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 4e-37
Identities = 52/197 (26%), Positives = 81/197 (41%), Gaps = 15/197 (7%)
Query: 275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRK---KEFYSEIGRFARLHHPNLVAV 330
R LG K G Y +A+K L ++ ++ + E+ + L HPN++ +
Sbjct: 12 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 71
Query: 331 KGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVK 390
G +D Y++ E+ G + R L + + D T LA +++ H K
Sbjct: 72 YGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANALSYCHSK-- 125
Query: 391 PHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNE 450
V+HRDI+ N+LL + G S P R GT YL PE +
Sbjct: 126 -RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLCGTLDYLPPEMIEGRM 180
Query: 451 LTTKSDVYSFGVLLLEI 467
K D++S GVL E
Sbjct: 181 HDEKVDLWSLGVLCYEF 197
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 6e-37
Identities = 57/257 (22%), Positives = 103/257 (40%), Gaps = 30/257 (11%)
Query: 238 KSRKLSNPAASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSR-- 295
+ +++ + + ++ + + + E ++LG G + S+
Sbjct: 6 QMVQVTGSSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTG 65
Query: 296 ----VAVKRLKRSSFQR-KKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVN 349
VAVK LK + ++ SE+ +L H N+V + G C G Y+++E+
Sbjct: 66 VSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCY 125
Query: 350 GPLDRWLH-------------------HIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVK 390
G L +L L + + A +A+G+ FL K
Sbjct: 126 GDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK-- 183
Query: 391 PHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNE 450
VHRD+ A NVL+ + GL++ + + A ++APE ++
Sbjct: 184 -SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGI 242
Query: 451 LTTKSDVYSFGVLLLEI 467
T KSDV+S+G+LL EI
Sbjct: 243 YTIKSDVWSYGILLWEI 259
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (342), Expect = 7e-37
Identities = 45/212 (21%), Positives = 84/212 (39%), Gaps = 18/212 (8%)
Query: 264 RSITKNFSEGNRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQR--KKEFYSEIGRFA 320
S F + + +G Y G+ + VA L+ + ++ F E
Sbjct: 4 MSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLK 63
Query: 321 RLHHPNLVAVKGCCYDHGDR----YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVAT 376
L HPN+V +V E + +G L +L + + +
Sbjct: 64 GLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR----FKVMKIKVLRSWCR 119
Query: 377 TLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG-AHLMGVGLSKFVPWEVMQERTVMAG 435
+ +G+ FLH + P ++HRD++ N+ + G + +GL+ +
Sbjct: 120 QILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVI---- 174
Query: 436 GTYGYLAPEFVYRNELTTKSDVYSFGVLLLEI 467
GT ++APE +Y + DVY+FG+ +LE+
Sbjct: 175 GTPEFMAPE-MYEEKYDESVDVYAFGMCMLEM 205
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 1e-36
Identities = 56/206 (27%), Positives = 93/206 (45%), Gaps = 14/206 (6%)
Query: 268 KNFSEGNRLLGDSKTGGTYSGILPD---GSRVAVKRLKRSSFQR--KKEFYSEIGRFARL 322
K + ++ LG G G VAVK LK + K E +E +L
Sbjct: 6 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL 65
Query: 323 HHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGI 382
+P +V + G C + +V E GPL+++L R + +++ ++ G+
Sbjct: 66 DNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGM 120
Query: 383 AFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG-GTYGYL 441
+L + + VHRD+ A NVLL + A + GLSK + + + G +
Sbjct: 121 KYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY 177
Query: 442 APEFVYRNELTTKSDVYSFGVLLLEI 467
APE + + ++KSDV+SFGVL+ E
Sbjct: 178 APECINYYKFSSKSDVWSFGVLMWEA 203
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (337), Expect = 6e-36
Identities = 52/215 (24%), Positives = 90/215 (41%), Gaps = 25/215 (11%)
Query: 275 RLLGDSKTGGTYSGIL------PDGSRVAVKRLKRSSFQR-KKEFYSEIGRFARL-HHPN 326
+ LG G VAVK LK S+ ++ SE+ + L +H N
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88
Query: 327 LVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHH--------------IPRGGRSLDWAMRM 372
+V + G C G ++ E+ G L +L + +LD +
Sbjct: 89 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148
Query: 373 KVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV 432
+ +A+G+AFL K + +HRD+ A N+LL + GL++ + +
Sbjct: 149 SFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 205
Query: 433 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEI 467
A ++APE ++ T +SDV+S+G+ L E+
Sbjct: 206 NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWEL 240
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 1e-35
Identities = 46/196 (23%), Positives = 77/196 (39%), Gaps = 10/196 (5%)
Query: 275 RLLGDSKTGGTYSGI-LPDGSRVAVKRL-KRSSFQRKKEFYSEIGRFARLHHPNLVAVKG 332
+ LG+ G + VAVK + + + + EI L+H N+V G
Sbjct: 11 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 70
Query: 333 CCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPH 392
+ +Y+ E+ G L + + + L G+ +LH
Sbjct: 71 HRREGNIQYLFLEYCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGI---G 123
Query: 393 VVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNEL- 451
+ HRDI+ N+LLDE + GL+ + + GT Y+APE + R E
Sbjct: 124 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 183
Query: 452 TTKSDVYSFGVLLLEI 467
DV+S G++L +
Sbjct: 184 AEPVDVWSCGIVLTAM 199
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 134 bits (337), Expect = 2e-35
Identities = 40/196 (20%), Positives = 77/196 (39%), Gaps = 12/196 (6%)
Query: 275 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGC 333
LG G + + G K + K +EI +LHHP L+ +
Sbjct: 35 EELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA 94
Query: 334 CYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHV 393
D + ++ EF+ G L I + A + +G+ +H+ +
Sbjct: 95 FEDKYEMVLILEFLSGGEL---FDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH---SI 148
Query: 394 VHRDIRASNVLLDEEFGAH--LMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNEL 451
VH DI+ N++ + + + ++ GL+ + + E + T + APE V R +
Sbjct: 149 VHLDIKPENIMCETKKASSVKIIDFGLATKLNPD---EIVKVTTATAEFAAPEIVDREPV 205
Query: 452 TTKSDVYSFGVLLLEI 467
+D+++ GVL +
Sbjct: 206 GFYTDMWAIGVLGYVL 221
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 132 bits (333), Expect = 2e-35
Identities = 53/220 (24%), Positives = 92/220 (41%), Gaps = 30/220 (13%)
Query: 275 RLLGDSKTGGTYSGILP------DGSRVAVKRLKRSSFQR-KKEFYSEIGRFARLHHPNL 327
R +G+ G + P + VAVK LK + + +F E A +PN+
Sbjct: 19 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 78
Query: 328 VAVKGCCYDHGDRYIVYEFVVNGPLDRWLH--------------------HIPRGGRSLD 367
V + G C +++E++ G L+ +L G L
Sbjct: 79 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 138
Query: 368 WAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM 427
A ++ +A +A G+A+L + VHRD+ N L+ E + GLS+ +
Sbjct: 139 CAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY 195
Query: 428 QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEI 467
+ ++ PE ++ N TT+SDV+++GV+L EI
Sbjct: 196 YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEI 235
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 2e-35
Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 17/211 (8%)
Query: 265 SITKNFSEGNRLLGDSKTGGTYSGILPDGSR----VAVKRLKRSSFQRK-KEFYSEIGRF 319
S+ +F+E ++G G Y G L D AVK L R + + +F +E
Sbjct: 26 SLIVHFNE---VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 82
Query: 320 ARLHHPNLVAVKGCCYDH-GDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTL 378
HPN++++ G C G +V ++ +G L ++ + + + +
Sbjct: 83 KDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQV 139
Query: 379 AQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--G 436
A+G+ FL K VHRD+ A N +LDE+F + GL++ + + G
Sbjct: 140 AKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKL 196
Query: 437 TYGYLAPEFVYRNELTTKSDVYSFGVLLLEI 467
++A E + + TTKSDV+SFGVLL E+
Sbjct: 197 PVKWMALESLQTQKFTTKSDVWSFGVLLWEL 227
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 3e-35
Identities = 41/197 (20%), Positives = 78/197 (39%), Gaps = 11/197 (5%)
Query: 275 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRK---KEFYSEIGRFARLHHPNLVAV 330
++LG+ L A+K L++ ++ E +RL HP V +
Sbjct: 14 KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 73
Query: 331 KGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVK 390
D Y + NG L +++ I D + + +LH
Sbjct: 74 YFTFQDDEKLYFGLSYAKNGELLKYIRKIGS----FDETCTRFYTAEIVSALEYLH---G 126
Query: 391 PHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNE 450
++HRD++ N+LL+E+ + G +K + E Q R GT Y++PE +
Sbjct: 127 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKS 186
Query: 451 LTTKSDVYSFGVLLLEI 467
SD+++ G ++ ++
Sbjct: 187 ACKSSDLWALGCIIYQL 203
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 132 bits (334), Expect = 5e-35
Identities = 39/196 (19%), Positives = 76/196 (38%), Gaps = 12/196 (6%)
Query: 275 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGC 333
LG G + G+ A K + K+ EI + L HP LV +
Sbjct: 32 EELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDA 91
Query: 334 CYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHV 393
D + ++YEF+ G L + + ++ + +G+ +H+ +
Sbjct: 92 FEDDNEMVMIYEFMSGGEL---FEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NY 145
Query: 394 VHRDIRASNVLLDEEFGAHLMGV--GLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNEL 451
VH D++ N++ + L + GL+ + ++ + GT + APE +
Sbjct: 146 VHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP---KQSVKVTTGTAEFAAPEVAEGKPV 202
Query: 452 TTKSDVYSFGVLLLEI 467
+D++S GVL +
Sbjct: 203 GYYTDMWSVGVLSYIL 218
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 8e-35
Identities = 56/227 (24%), Positives = 101/227 (44%), Gaps = 17/227 (7%)
Query: 259 TTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSR-----VAVKRLKRSSFQR-KKEF 312
TTE S + +++G + G Y G+L S VA+K LK ++ + +F
Sbjct: 1 TTEIHPS---CVTRQ-KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDF 56
Query: 313 YSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRM 372
E G + H N++ ++G + I+ E++ NG LD + +
Sbjct: 57 LGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALD---KFLREKDGEFSVLQLV 113
Query: 373 KVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV 432
+ +A G+ +L + VHRD+ A N+L++ + GLS+ + + T
Sbjct: 114 GMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTT 170
Query: 433 MAG-GTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVLCRRWWTL 478
G + APE + + T+ SDV+SFG+++ E+ R +W L
Sbjct: 171 SGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL 217
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 2e-34
Identities = 59/250 (23%), Positives = 104/250 (41%), Gaps = 25/250 (10%)
Query: 268 KNFSEGNRLLGDSKTGGTYSGILPDGSR---VAVKRLKR-SSFQRKKEFYSEIGRFARL- 322
+ + ++G+ G + A+KR+K +S ++F E+ +L
Sbjct: 10 NDIKFQD-VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLG 68
Query: 323 HHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLH------------HIPRGGRSLDWAM 370
HHPN++ + G C G Y+ E+ +G L +L +L
Sbjct: 69 HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 128
Query: 371 RMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER 430
+ A +A+G+ +L + +HRD+ A N+L+ E + A + GLS+ V +
Sbjct: 129 LLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV---K 182
Query: 431 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVLCRRWWTLYTLVHSMSLLCA 490
M ++A E + + TT SDV+S+GVLL EI + L + T L
Sbjct: 183 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEI-VSLGGTPYCGMTCAELYEKLPQ 241
Query: 491 QECLMLFISC 500
L ++C
Sbjct: 242 GYRLEKPLNC 251
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 7e-34
Identities = 46/210 (21%), Positives = 88/210 (41%), Gaps = 24/210 (11%)
Query: 275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCC 334
+G + G + G G VAVK +R +EI + L H N++
Sbjct: 9 ESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAAD 66
Query: 335 YDHGDR----YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV- 389
++V ++ +G L +L+ ++ +K+A + A G+A LH ++
Sbjct: 67 NKDNGTWTQLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIV 121
Query: 390 ----KPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAP 443
KP + HRD+++ N+L+ + + +GL+ GT Y+AP
Sbjct: 122 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 181
Query: 444 EFVYRN------ELTTKSDVYSFGVLLLEI 467
E + + E ++D+Y+ G++ EI
Sbjct: 182 EVLDDSINMKHFESFKRADIYAMGLVFWEI 211
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (321), Expect = 1e-33
Identities = 53/232 (22%), Positives = 101/232 (43%), Gaps = 14/232 (6%)
Query: 275 RLLGDSKTGGTYSGI-LPDGSR----VAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLV 328
++LG G Y G+ +P+G + VA+K L+ + S + KE E A + +P++
Sbjct: 15 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 74
Query: 329 AVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDK 388
+ G C ++ + + G L L ++ ++ + +A+G+ +L D+
Sbjct: 75 RLLGICLT-STVQLITQLMPFGCL---LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 130
Query: 389 VKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYR 448
+VHRD+ A NVL+ + GL+K + E + ++A E +
Sbjct: 131 ---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 187
Query: 449 NELTTKSDVYSFGVLLLEIRLVLCRRWWTLYTLVHSMSLLCAQECLMLFISC 500
T +SDV+S+GV + E+ + + + S+L E L C
Sbjct: 188 RIYTHQSDVWSYGVTVWEL-MTFGSKPYDGIPASEISSILEKGERLPQPPIC 238
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (316), Expect = 3e-33
Identities = 58/231 (25%), Positives = 96/231 (41%), Gaps = 14/231 (6%)
Query: 275 RLLGDSKTGGTYSGILPDGSR----VAVKRLKRSSFQRKKE-FYSEIGRFARLHHPNLVA 329
R +G+ + G + GI VA+K K + +E F E + HP++V
Sbjct: 13 RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 72
Query: 330 VKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV 389
+ G ++ +I+ E G L + SLD A + A L+ +A+L K
Sbjct: 73 LIGVITEN-PVWIIMELCTLGEL---RSFLQVRKYSLDLASLILYAYQLSTALAYLESK- 127
Query: 390 KPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRN 449
VHRDI A NVL+ L GLS+++ + ++APE +
Sbjct: 128 --RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY-KASKGKLPIKWMAPESINFR 184
Query: 450 ELTTKSDVYSFGVLLLEIRLVLCRRWWTLYTLVHSMSLLCAQECLMLFISC 500
T+ SDV+ FGV + EI L+ + + + + E L + +C
Sbjct: 185 RFTSASDVWMFGVCMWEI-LMHGVKPFQGVKNNDVIGRIENGERLPMPPNC 234
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (313), Expect = 1e-32
Identities = 52/198 (26%), Positives = 88/198 (44%), Gaps = 17/198 (8%)
Query: 284 GTYSGILPDGSRVAVKRLKRSSFQR-KKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRY 341
G ++VAVK LK + ++ + SE+ + H N++ + G C G Y
Sbjct: 36 GLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLY 95
Query: 342 IVYEFVVNGPLDRWLHHIPRGG------------RSLDWAMRMKVATTLAQGIAFLHDKV 389
++ E+ G L +L G L + A +A+G+ +L K
Sbjct: 96 VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK- 154
Query: 390 KPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRN 449
+HRD+ A NVL+ E+ + GL++ + ++T ++APE ++
Sbjct: 155 --KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR 212
Query: 450 ELTTKSDVYSFGVLLLEI 467
T +SDV+SFGVLL EI
Sbjct: 213 IYTHQSDVWSFGVLLWEI 230
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (305), Expect = 2e-31
Identities = 51/239 (21%), Positives = 99/239 (41%), Gaps = 17/239 (7%)
Query: 275 RLLGDSKTGGTYSGIL------PDGSRVAVKRLKRSSFQR-KKEFYSEIGRFARLHHPNL 327
R LG G Y G+ +RVA+K + ++ R + EF +E + ++
Sbjct: 26 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 85
Query: 328 VAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRS------LDWAMRMKVATTLAQG 381
V + G ++ E + G L +L + + + +++A +A G
Sbjct: 86 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 145
Query: 382 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 441
+A+L+ VHRD+ A N ++ E+F + G+++ + + ++
Sbjct: 146 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 202
Query: 442 APEFVYRNELTTKSDVYSFGVLLLEIRLVLCRRWWTLYTLVHSMSLLCAQECLMLFISC 500
+PE + TT SDV+SFGV+L EI L + + + + + L +C
Sbjct: 203 SPESLKDGVFTTYSDVWSFGVVLWEI-ATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNC 260
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (302), Expect = 2e-31
Identities = 44/188 (23%), Positives = 70/188 (37%), Gaps = 11/188 (5%)
Query: 284 GTYSGILPDGSRVAVKRLKRSSF---QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR 340
G + VAVK LK + +F E+ L H NL+ + G
Sbjct: 27 GEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM 85
Query: 341 YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRA 400
+V E G L L + + + A +A+G+ +L K +HRD+ A
Sbjct: 86 KMVTELAPLGSL---LDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAA 139
Query: 401 SNVLLDEEFGAHLMGVGLSKFVPWEV-MQERTVMAGGTYGYLAPEFVYRNELTTKSDVYS 459
N+LL + GL + +P + + APE + + SD +
Sbjct: 140 RNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWM 199
Query: 460 FGVLLLEI 467
FGV L E+
Sbjct: 200 FGVTLWEM 207
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 119 bits (300), Expect = 4e-31
Identities = 49/202 (24%), Positives = 81/202 (40%), Gaps = 16/202 (7%)
Query: 275 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRK---KEFYSEIGRFARLHHPNLVAV 330
+LG + L VAVK L+ + F E A L+HP +VAV
Sbjct: 13 EILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 72
Query: 331 KGCCYDHGDR----YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLH 386
YIV E+V L +H + ++V Q + F H
Sbjct: 73 YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP----MTPKRAIEVIADACQALNFSH 128
Query: 387 DKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV-MQERTVMAGGTYGYLAPEF 445
++HRD++ +N+++ +M G+++ + +T GT YL+PE
Sbjct: 129 QN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 185
Query: 446 VYRNELTTKSDVYSFGVLLLEI 467
+ + +SDVYS G +L E+
Sbjct: 186 ARGDSVDARSDVYSLGCVLYEV 207
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (303), Expect = 4e-31
Identities = 30/196 (15%), Positives = 71/196 (36%), Gaps = 13/196 (6%)
Query: 275 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGC 333
LG + G + + K +K + EI H N++ +
Sbjct: 11 EDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQV-LVKKEISILNIARHRNILHLHES 69
Query: 334 CYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHV 393
+ +++EF+ + ++ L+ + + + + FLH ++
Sbjct: 70 FESMEELVMIFEFISGLDIFERIN---TSAFELNEREIVSYVHQVCEALQFLHSH---NI 123
Query: 394 VHRDIRASNVLLDEEFGAH--LMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNEL 451
H DIR N++ + ++ G ++ + + + Y APE + +
Sbjct: 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP---GDNFRLLFTAPEYYAPEVHQHDVV 180
Query: 452 TTKSDVYSFGVLLLEI 467
+T +D++S G L+ +
Sbjct: 181 STATDMWSLGTLVYVL 196
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 120 bits (303), Expect = 1e-30
Identities = 44/216 (20%), Positives = 85/216 (39%), Gaps = 23/216 (10%)
Query: 269 NFSEGNRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRK------KEFYSEIGRFAR 321
+FS R++G G Y D G A+K L + + K + +
Sbjct: 5 DFSVH-RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 322 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 381
P +V + + + + + G L L A A + G
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILG 119
Query: 382 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 441
+ +H++ VV+RD++ +N+LLDE + +GL+ +++ + GT+GY+
Sbjct: 120 LEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFS----KKKPHASVGTHGYM 172
Query: 442 APEFVYRNE-LTTKSDVYSFGVLLLEIRLVLCRRWW 476
APE + + + +D +S G +L ++ L
Sbjct: 173 APEVLQKGVAYDSSADWFSLGCMLFKL---LRGHSP 205
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (294), Expect = 9e-30
Identities = 36/210 (17%), Positives = 78/210 (37%), Gaps = 16/210 (7%)
Query: 264 RSITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL 322
+I ++ +++LG G + A+K L+ + E+ R
Sbjct: 7 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRA 61
Query: 323 -HHPNLVAVKGCCYD----HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATT 377
P++V + + IV E + G L + RG ++ ++ +
Sbjct: 62 SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQD--RGDQAFTEREASEIMKS 119
Query: 378 LAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT 437
+ + I +LH ++ HRD++ N+L + ++ + F T
Sbjct: 120 IGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT 176
Query: 438 YGYLAPEFVYRNELTTKSDVYSFGVLLLEI 467
Y+APE + + D++S GV++ +
Sbjct: 177 PYYVAPEVLGPEKYDKSCDMWSLGVIMYIL 206
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 116 bits (291), Expect = 1e-29
Identities = 45/197 (22%), Positives = 78/197 (39%), Gaps = 16/197 (8%)
Query: 275 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKE---FYSEIGRFARLHHPNLVAV 330
R LG G + +G A+K LK+ R K+ E + + HP ++ +
Sbjct: 10 RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 69
Query: 331 KGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVK 390
G D +++ +++ G L L A+ L
Sbjct: 70 WGTFQDAQQIFMIMDYIEGGELFSLLRKSQ-------RFPNPVAKFYAAEVCLALEYLHS 122
Query: 391 PHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNE 450
+++RD++ N+LLD+ + G +K+VP + T GT Y+APE V
Sbjct: 123 KDIIYRDLKPENILLDKNGHIKITDFGFAKYVP-----DVTYTLCGTPDYIAPEVVSTKP 177
Query: 451 LTTKSDVYSFGVLLLEI 467
D +SFG+L+ E+
Sbjct: 178 YNKSIDWWSFGILIYEM 194
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (291), Expect = 2e-29
Identities = 46/198 (23%), Positives = 77/198 (38%), Gaps = 14/198 (7%)
Query: 275 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKE---FYSEIGRFAR-LHHPNLVA 329
++LG G + A+K LK+ + E + HP L
Sbjct: 8 KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 67
Query: 330 VKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV 389
+ + + V E++ G L + D + A + G+ FLH K
Sbjct: 68 MFCTFQTKENLFFVMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHSK- 122
Query: 390 KPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRN 449
+V+RD++ N+LLD++ + G+ K + T GT Y+APE +
Sbjct: 123 --GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC--GTPDYIAPEILLGQ 178
Query: 450 ELTTKSDVYSFGVLLLEI 467
+ D +SFGVLL E+
Sbjct: 179 KYNHSVDWWSFGVLLYEM 196
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (286), Expect = 5e-29
Identities = 55/214 (25%), Positives = 85/214 (39%), Gaps = 24/214 (11%)
Query: 275 RLLGDSKTGGTYSGI------LPDGSRVAVKRLKRSSFQ-RKKEFYSEIGRFAR-LHHPN 326
+ LG G VAVK LK + + SE+ HH N
Sbjct: 19 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 78
Query: 327 LVAVKGCCYDHGDR-YIVYEFVVNGPLDRWLHH------------IPRGGRSLDWAMRMK 373
+V + G C G ++ EF G L +L L +
Sbjct: 79 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 138
Query: 374 VATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVM 433
+ +A+G+ FL + +HRD+ A N+LL E+ + GL++ + + R
Sbjct: 139 YSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 195
Query: 434 AGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEI 467
A ++APE ++ T +SDV+SFGVLL EI
Sbjct: 196 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 229
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 114 bits (286), Expect = 6e-29
Identities = 42/195 (21%), Positives = 73/195 (37%), Gaps = 9/195 (4%)
Query: 275 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKE-FYSEIGRFARLHHPNLVAVKG 332
+LG VA+K + + + + K+ +EI ++ HPN+VA+
Sbjct: 15 DVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDD 74
Query: 333 CCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPH 392
G Y++ + V G L + ++ + + +LHD H
Sbjct: 75 IYESGGHLYLIMQLVSGGELFDRIVE----KGFYTERDASRLIFQVLDAVKYLHDLGIVH 130
Query: 393 VVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELT 452
+ LDE+ + GLSK E A GT GY+APE + + +
Sbjct: 131 RDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYVAPEVLAQKPYS 187
Query: 453 TKSDVYSFGVLLLEI 467
D +S GV+ +
Sbjct: 188 KAVDCWSIGVIAYIL 202
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (285), Expect = 2e-28
Identities = 49/270 (18%), Positives = 95/270 (35%), Gaps = 19/270 (7%)
Query: 275 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQR-KKEFYSEIGRFARLHHPNLVAVKG 332
+G+ G S + RVA+K++ Q + EI R H N++ +
Sbjct: 14 SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 73
Query: 333 CCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPH 392
+ ++V + L+ + + L + +G+ ++H +
Sbjct: 74 IIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH-LSNDHICYFLYQILRGLKYIHSA---N 129
Query: 393 VVHRDIRASNVLLDEEFGAHLMGVGLSKFV-PWEVMQERTVMAGGTYGYLAPEFVYRNEL 451
V+HRD++ SN+LL+ + GL++ P T Y APE + ++
Sbjct: 130 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 189
Query: 452 TTKS-DVYSFGVLLLEIRLVLCRRWWTLYTLVHSMSLLCAQECLMLFISCNNWPSHLSQS 510
TKS D++S G +L + + + L + PS +
Sbjct: 190 YTKSIDIWSVGCILA--------EMLSNRPIFPGKH---YLDQLNHILGILGSPSQEDLN 238
Query: 511 KFCNLKLWVFAILTIRKVQFEFPLLRLAVS 540
NLK + + K + + L
Sbjct: 239 CIINLKARNYLLSLPHKNKVPWNRLFPNAD 268
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (277), Expect = 2e-27
Identities = 48/213 (22%), Positives = 90/213 (42%), Gaps = 21/213 (9%)
Query: 264 RSITKNFSEGNRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARL 322
R ++++ +++G+ G Y L D G VA+K++ Q K+ E+ +L
Sbjct: 16 RPQEVSYTDT-KVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKL 70
Query: 323 HHPNLVAVKGCCYDHGDR------YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVAT 376
H N+V ++ Y G++ +V ++V H+ R ++L
Sbjct: 71 DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYS-RAKQTLPVIYVKLYMY 129
Query: 377 TLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAH-LMGVGLSKFVPWEVMQERTVMAG 435
L + +A++H + HRDI+ N+LLD + L G +K + +
Sbjct: 130 QLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC-- 184
Query: 436 GTYGYLAP-EFVYRNELTTKSDVYSFGVLLLEI 467
+ Y AP + T+ DV+S G +L E+
Sbjct: 185 -SRYYRAPELIFGATDYTSSIDVWSAGCVLAEL 216
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (273), Expect = 3e-27
Identities = 43/231 (18%), Positives = 85/231 (36%), Gaps = 28/231 (12%)
Query: 257 VFTTEELRSITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQR------K 309
VF E ++ + G LG + G + A K +K+ + +
Sbjct: 2 VFRQE---NVDDYYDTG-EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSR 57
Query: 310 KEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWA 369
++ E+ + HPN++ + + D ++ E V G L +L SL
Sbjct: 58 EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAE----KESLTEE 113
Query: 370 MRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGA----HLMGVGLSKFVPWE 425
+ + G+ +LH + H D++ N++L + ++ GL+ +
Sbjct: 114 EATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID-- 168
Query: 426 VMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVLCRRWW 476
GT ++APE V L ++D++S GV+ + L
Sbjct: 169 -FGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYIL---LSGASP 215
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 107 bits (269), Expect = 7e-27
Identities = 45/210 (21%), Positives = 85/210 (40%), Gaps = 27/210 (12%)
Query: 275 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSF---------QRKKEFYSEIGRFARLH- 323
+LG + I P AVK + + + ++ E+ ++
Sbjct: 9 EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 68
Query: 324 HPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIA 383
HPN++ +K + ++V++ + G L +L +L K+ L + I
Sbjct: 69 HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVIC 124
Query: 384 FLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAP 443
LH ++VHRD++ N+LLD++ L G S + E+ GT YLAP
Sbjct: 125 ALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLD---PGEKLREVCGTPSYLAP 178
Query: 444 EFVYRNEL------TTKSDVYSFGVLLLEI 467
E + + + D++S GV++ +
Sbjct: 179 EIIECSMNDNHPGYGKEVDMWSTGVIMYTL 208
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (269), Expect = 1e-26
Identities = 43/200 (21%), Positives = 76/200 (38%), Gaps = 16/200 (8%)
Query: 275 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKE-----FYSEIGRFARLHHPNLV 328
LG+ + Y VA+K++K K+ EI L HPN++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 329 AVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDK 388
+ + +V++F+ I L + QG+ +LH
Sbjct: 64 GLLDAFGHKSNISLVFDFMET----DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH 119
Query: 389 VKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYR 448
++HRD++ +N+LLDE L GL+K + T Y APE ++
Sbjct: 120 ---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV--VTRWYRAPELLFG 174
Query: 449 NEL-TTKSDVYSFGVLLLEI 467
+ D+++ G +L E+
Sbjct: 175 ARMYGVGVDMWAVGCILAEL 194
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (269), Expect = 2e-26
Identities = 48/197 (24%), Positives = 73/197 (37%), Gaps = 13/197 (6%)
Query: 275 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKE---FYSEIGRFARLHHPNLVAV 330
+LLG G G A+K L++ K E +E HP L A+
Sbjct: 11 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 331 KGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVK 390
K H V E+ G L L R + + +LH +
Sbjct: 71 KYAFQTHDRLCFVMEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSR-- 124
Query: 391 PHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNE 450
VV+RDI+ N++LD++ + GL K + GT YLAPE + N+
Sbjct: 125 -DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKTFCGTPEYLAPEVLEDND 181
Query: 451 LTTKSDVYSFGVLLLEI 467
D + GV++ E+
Sbjct: 182 YGRAVDWWGLGVVMYEM 198
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 104 bits (261), Expect = 1e-25
Identities = 35/202 (17%), Positives = 72/202 (35%), Gaps = 17/202 (8%)
Query: 275 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGC 333
R +G G Y G + G VA+K + + + + E + + +
Sbjct: 13 RKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRW 70
Query: 334 CYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHV 393
C GD ++ ++ L+ + R + +A + I ++H K +
Sbjct: 71 CGAEGDYNVMVMELLGPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSK---NF 124
Query: 394 VHRDIRASNVL---LDEEFGAHLMGVGLSKFVPWE-----VMQERTVMAGGTYGYLAPEF 445
+HRD++ N L + +++ GL+K + GT Y +
Sbjct: 125 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINT 184
Query: 446 VYRNELTTKSDVYSFGVLLLEI 467
E + + D+ S G +L+
Sbjct: 185 HLGIEQSRRDDLESLGYVLMYF 206
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (261), Expect = 1e-25
Identities = 40/202 (19%), Positives = 77/202 (38%), Gaps = 15/202 (7%)
Query: 275 RLLGDSKTGGTYSG--ILPDGSRVAVKRLKRSSFQRKKEFY-----SEIGRFARLHHPNL 327
+G+ G + + G VA+KR++ + + + + HPN+
Sbjct: 13 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72
Query: 328 VAVKGCCYDHGDRYIVYEFVVNGPLDRW--LHHIPRGGRSLDWAMRMKVATTLAQGIAFL 385
V + C +V +D+ + + + L +G+ FL
Sbjct: 73 VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 132
Query: 386 HDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEF 445
H VVHRD++ N+L+ L GL++ +++ V T Y APE
Sbjct: 133 HSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVV---VTLWYRAPEV 186
Query: 446 VYRNELTTKSDVYSFGVLLLEI 467
+ ++ T D++S G + E+
Sbjct: 187 LLQSSYATPVDLWSVGCIFAEM 208
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 104 bits (260), Expect = 1e-25
Identities = 33/214 (15%), Positives = 67/214 (31%), Gaps = 24/214 (11%)
Query: 275 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKG 332
R +G+ G + G L + +VA+K R S + E + L + V
Sbjct: 11 RRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYY 68
Query: 333 CCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPH 392
+ +V + + + GR A + + +H+K
Sbjct: 69 FGQEGLHNVLVIDLLGPS----LEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK---S 121
Query: 393 VVHRDIRASNVLLDEEFGAHLMGVGLSKF----------VPWEVMQERTVMAGGTYGYLA 442
+V+RDI+ N L+ + + + F + GT Y++
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 181
Query: 443 PEFVYRNELTTKSDVYSFGVLLLEIRLVLCRRWW 476
E + + D+ + G + + L
Sbjct: 182 INTHLGREQSRRDDLEALGHVFMYF---LRGSLP 212
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (258), Expect = 2e-25
Identities = 41/204 (20%), Positives = 75/204 (36%), Gaps = 21/204 (10%)
Query: 275 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKE------FYSEIGRFARLH--HP 325
LLG G YSGI + D VA+K +++ E E+ ++
Sbjct: 10 PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 69
Query: 326 NLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFL 385
++ + ++ E L +L + + + +
Sbjct: 70 GVIRLLDWFERPDSFVLILERPEPVQD---LFDFITERGALQEELARSFFWQVLEAVRHC 126
Query: 386 HDKVKPHVVHRDIRASNVLLDEEFG-AHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPE 444
H+ V+HRDI+ N+L+D G L+ G + V + GT Y PE
Sbjct: 127 HNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD----GTRVYSPPE 179
Query: 445 FVYRNELTTKS-DVYSFGVLLLEI 467
++ + +S V+S G+LL ++
Sbjct: 180 WIRYHRYHGRSAAVWSLGILLYDM 203
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (258), Expect = 3e-25
Identities = 46/197 (23%), Positives = 79/197 (40%), Gaps = 12/197 (6%)
Query: 275 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRK--KEFYSEIGRFARLHHPNLVAVK 331
+G+ G Y G VA+K+++ + EI L+HPN+V +
Sbjct: 8 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 67
Query: 332 GCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKP 391
+ Y+V+EF+ G + + L QG+AF H
Sbjct: 68 DVIHTENKLYLVFEFLHQDLKKFMDASALTG---IPLPLIKSYLFQLLQGLAFCHSH--- 121
Query: 392 HVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNE- 450
V+HRD++ N+L++ E L GL++ V + T Y APE + +
Sbjct: 122 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV--VTLWYRAPEILLGCKY 179
Query: 451 LTTKSDVYSFGVLLLEI 467
+T D++S G + E+
Sbjct: 180 YSTAVDIWSLGCIFAEM 196
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 104 bits (261), Expect = 3e-25
Identities = 44/197 (22%), Positives = 80/197 (40%), Gaps = 16/197 (8%)
Query: 275 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKE---FYSEIGRFARLHHPNLVAV 330
+ LG G G+ A+K L + + K+ +E ++ P LV +
Sbjct: 47 KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 331 KGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVK 390
+ D+ + Y+V E+V G + L I R A + +LH
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR----FSEPHARFYAAQIVLTFEYLHSL-- 160
Query: 391 PHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNE 450
+++RD++ N+L+D++ + G +K ++ RT GT LAPE +
Sbjct: 161 -DLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPEALAPEIILSKG 214
Query: 451 LTTKSDVYSFGVLLLEI 467
D ++ GVL+ E+
Sbjct: 215 YNKAVDWWALGVLIYEM 231
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (250), Expect = 7e-24
Identities = 36/216 (16%), Positives = 76/216 (35%), Gaps = 13/216 (6%)
Query: 258 FTTEELRSITKNFSEGNRL---LGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRK--KE 311
F +E+ R +G G S + G++VA+K+L R K
Sbjct: 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63
Query: 312 FYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMR 371
Y E+ + H N++ + +F + P L
Sbjct: 64 AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRI 123
Query: 372 MKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT 431
+ + +G+ ++H ++HRD++ N+ ++E+ ++ GL++ E T
Sbjct: 124 QFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQAD----SEMT 176
Query: 432 VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEI 467
+ + T D++S G ++ E+
Sbjct: 177 GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEM 212
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 98.4 bits (244), Expect = 1e-23
Identities = 40/196 (20%), Positives = 76/196 (38%), Gaps = 12/196 (6%)
Query: 275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRK--KEFYSEIGRFARLHHPNLVAVKG 332
+G+ G Y G A+K+++ EI L H N+V +
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 333 CCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPH 392
+ +V+E + + L+ L GIA+ HD+
Sbjct: 68 VIHTKKRLVLVFEHLDQ----DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR---R 120
Query: 393 VVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNE-L 451
V+HRD++ N+L++ E + GL++ V + + T Y AP+ + ++
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEI--VTLWYRAPDVLMGSKKY 178
Query: 452 TTKSDVYSFGVLLLEI 467
+T D++S G + E+
Sbjct: 179 STTIDIWSVGCIFAEM 194
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.5 bits (239), Expect = 1e-22
Identities = 46/281 (16%), Positives = 96/281 (34%), Gaps = 26/281 (9%)
Query: 275 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRK--KEFYSEIGRFARLHHPNLVAVK 331
+G G + G +VA+K++ + + EI L H N+V +
Sbjct: 16 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75
Query: 332 GCCYDH--------GDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIA 383
C G Y+V++F + + + + +L R+ + +
Sbjct: 76 EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK--FTLSEIKRV-----MQMLLN 128
Query: 384 FLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYL 441
L+ + ++HRD++A+NVL+ + L GL++ + T Y
Sbjct: 129 GLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYR 188
Query: 442 APEFV-YRNELTTKSDVYSFGVLLLEIRLVLCRRWWTLYTLVHSMSLLCAQECLMLFISC 500
PE + + D++ G ++ E+ R + L L I+
Sbjct: 189 PPELLLGERDYGPPIDLWGAGCIMAEM---WTRS--PIMQGNTEQHQLALISQLCGSITP 243
Query: 501 NNWPSHLSQSKFCNLKLWVFAILTIRKVQFEFPLLRLAVSF 541
WP+ + + L+L ++ + A+
Sbjct: 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDL 284
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.5 bits (234), Expect = 6e-22
Identities = 45/204 (22%), Positives = 76/204 (37%), Gaps = 19/204 (9%)
Query: 275 RLLGDSKTGGTYSGIL----PDGSRVAVKRLKRSSFQRK----KEFYSEIGRFARL-HHP 325
++LG G + G A+K LK+++ +K + +E + P
Sbjct: 30 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 89
Query: 326 NLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFL 385
LV + +++ +++ G L L R + + L
Sbjct: 90 FLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER----FTEHEVQIYVGEIVLALEHL 145
Query: 386 HDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEF 445
H +++RDI+ N+LLD L GLSK ER GT Y+AP+
Sbjct: 146 HKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEF-VADETERAYDFCGTIEYMAPDI 201
Query: 446 VYRNE--LTTKSDVYSFGVLLLEI 467
V + D +S GVL+ E+
Sbjct: 202 VRGGDSGHDKAVDWWSLGVLMYEL 225
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 92.7 bits (229), Expect = 2e-21
Identities = 42/247 (17%), Positives = 81/247 (32%), Gaps = 15/247 (6%)
Query: 275 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRK--KEFYSEIGRFARLHHPNLVAVK 331
+G+ G + VA+KR++ EI L H N+V +
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 332 GCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKP 391
+ +V+EF + LD + L +G+ F H +
Sbjct: 68 DVLHSDKKLTLVFEFCDQ----DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR--- 120
Query: 392 HVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNEL 451
+V+HRD++ N+L++ L GL++ ++ + +
Sbjct: 121 NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP-VRCYSAEVVTLWYRPPDVLFGAKLY 179
Query: 452 TTKSDVYSFGVLLLEIRLVLCRRWWTLYTLVHSMSLLCAQECLMLFISCNNWPSHLSQSK 511
+T D++S G + E L L+ L L+ + WPS
Sbjct: 180 STSIDMWSAGCIFAE----LANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235
Query: 512 FCNLKLW 518
+ ++
Sbjct: 236 YKPYPMY 242
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 90.3 bits (223), Expect = 2e-20
Identities = 45/198 (22%), Positives = 76/198 (38%), Gaps = 20/198 (10%)
Query: 275 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKG 332
R LG K + I + + +V VK LK +KK+ EI L PN++ +
Sbjct: 41 RKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLAD 97
Query: 333 CCYDHGDR--YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVK 390
D R +V+E V N + ++L + + + + H
Sbjct: 98 IVKDPVSRTPALVFEHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHSM-- 148
Query: 391 PHVVHRDIRASNVLLDEEFG-AHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRN 449
++HRD++ NV++D E L+ GL++F QE V Y V
Sbjct: 149 -GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG--QEYNVRVASRYFKGPELLVDYQ 205
Query: 450 ELTTKSDVYSFGVLLLEI 467
D++S G +L +
Sbjct: 206 MYDYSLDMWSLGCMLASM 223
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 86.1 bits (212), Expect = 7e-19
Identities = 34/196 (17%), Positives = 71/196 (36%), Gaps = 10/196 (5%)
Query: 275 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVK 331
+G G + G RVAVK+L R S K Y E+ + H N++ +
Sbjct: 24 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83
Query: 332 GCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKP 391
+ + L + + L + + +G+ ++H
Sbjct: 84 DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA--- 140
Query: 392 HVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNEL 451
++HRD++ SN+ ++E+ ++ GL++ E T + +
Sbjct: 141 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMTGYVATRWYRAPEIMLNWMHY 196
Query: 452 TTKSDVYSFGVLLLEI 467
D++S G ++ E+
Sbjct: 197 NQTVDIWSVGCIMAEL 212
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 85.4 bits (210), Expect = 1e-18
Identities = 38/202 (18%), Positives = 75/202 (37%), Gaps = 22/202 (10%)
Query: 275 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRK--KEFYSEIGRFARLHHPNLVAVK 331
+ +G G + VA+K+L R + K Y E+ ++H N++++
Sbjct: 23 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82
Query: 332 GCC------YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFL 385
+ D Y+V E + + + + GI L
Sbjct: 83 NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD-------HERMSYLLYQMLCGIKHL 135
Query: 386 HDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEF 445
H ++HRD++ SN+++ + ++ GL++ M V T Y APE
Sbjct: 136 H---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV---VTRYYRAPEV 189
Query: 446 VYRNELTTKSDVYSFGVLLLEI 467
+ D++S G ++ E+
Sbjct: 190 ILGMGYKENVDIWSVGCIMGEM 211
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 83.2 bits (204), Expect = 7e-18
Identities = 30/207 (14%), Positives = 72/207 (34%), Gaps = 17/207 (8%)
Query: 275 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGC 333
R LG + + + + VA+K ++ + EI R++ +
Sbjct: 19 RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTE-AAEDEIKLLQRVNDADNTKEDSM 77
Query: 334 CYDHGDRYIVYE------------FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 381
+H + + + + R + +++ L G
Sbjct: 78 GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLG 137
Query: 382 IAFLHDKVKPHVVHRDIRASNVLLDEE-FGAHLMGVGLSKFVPWEVMQERTVMAGGTYGY 440
+ ++H + ++H DI+ NVL++ +L+ + ++ E + T Y
Sbjct: 138 LDYMHRR--CGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREY 195
Query: 441 LAPEFVYRNELTTKSDVYSFGVLLLEI 467
+PE + +D++S L+ E+
Sbjct: 196 RSPEVLLGAPWGCGADIWSTACLIFEL 222
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 64.8 bits (157), Expect = 8e-13
Identities = 40/209 (19%), Positives = 71/209 (33%), Gaps = 40/209 (19%)
Query: 275 RLLGDSKTGGTYSGILPDGSRVAVK--RLKRSSFQ--------RKKEFYSEIGRFARLHH 324
+L+G+ K ++ VK ++ +SF+ F R AR
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 325 PNLVAVKGCC----YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQ 380
L ++G Y ++ E + L R P +V + +
Sbjct: 66 RALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPD-----------EVLDMILE 114
Query: 381 GIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVP---WEVMQERTVMAGGT 437
+A + + +VH D+ NVL+ E G ++ S V W + ER V T
Sbjct: 115 EVAKFYHR---GIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWREILERDVRNIIT 170
Query: 438 YGYLAPEFVYRNELTTKSDVYSFGVLLLE 466
Y + T+ D+ S +L+
Sbjct: 171 Y--------FSRTYRTEKDINSAIDRILQ 191
|
| >d1ypqa1 d.169.1.1 (A:140-270) Oxidised low density lipoprotein {Human (Homo sapiens) [TaxId: 9606]} Length = 131 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Oxidised low density lipoprotein species: Human (Homo sapiens) [TaxId: 9606]
Score = 59.5 bits (143), Expect = 2e-11
Identities = 28/138 (20%), Positives = 48/138 (34%), Gaps = 15/138 (10%)
Query: 51 APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNV 110
APCP DWI + C+ + +W++S+ C + L + S + Q+ +
Sbjct: 3 APCPQDWIWHG--ENCYLFSSGSFNWEKSQEKCLSLDAKLLKINSTADLDFIQQAISYSS 60
Query: 111 NGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSN 170
W+G N W W D G+ + + S C +
Sbjct: 61 FPFWMGLSRRNP--SYPWLWEDGSPLMPHLFRVRGAVSQTYPS---------GTCAYIQR 109
Query: 171 GSRSLVTERCNTSHPFIC 188
G ++ E C + IC
Sbjct: 110 G--AVYAENCILAAFSIC 125
|
| >d1egga_ d.169.1.1 (A:) Macrophage mannose receptor, CRD4 {Human (Homo sapiens) [TaxId: 9606]} Length = 136 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Macrophage mannose receptor, CRD4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.8 bits (135), Expect = 2e-10
Identities = 28/143 (19%), Positives = 53/143 (37%), Gaps = 12/143 (8%)
Query: 53 CPPDWIINEEKSKCFGYIGNF----RSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGK 108
CP DW + S CF ++W ES +C+ +GG LA++ + EE+ + +L
Sbjct: 1 CPEDWGASSRTSLCFKLYAKGKHEKKTWFESRDFCRALGGDLASINNKEEQQTIWRLITA 60
Query: 109 NVNGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLV 168
+ + + + + S + A G N+ C L
Sbjct: 61 SGSYHKLFWLGLTYGSPSEGFTWSDGSPVSYENWAYGEPNNYQNVEYC--------GELK 112
Query: 169 SNGSRSLVTERCNTSHPFICMVE 191
+ + S C + +IC ++
Sbjct: 113 GDPTMSWNDINCEHLNNWICQIQ 135
|
| >d1g1sa1 d.169.1.1 (A:1-118) P-selectin, C-lectin domain {Human (Homo sapiens) [TaxId: 9606]} Length = 118 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: P-selectin, C-lectin domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.3 bits (129), Expect = 9e-10
Identities = 23/123 (18%), Positives = 39/123 (31%), Gaps = 7/123 (5%)
Query: 66 CFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVG 125
+ Y SW+ S YC+ L A+ + E K+ + W+G R N T
Sbjct: 2 TYHYSTKAYSWNISRKYCQNRYTDLVAIQNKNEIDYLNKVLPYYSSYYWIGIRKNNKTW- 60
Query: 126 LSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHP 185
+W + A N+ + C V++ + E C
Sbjct: 61 -TWVGTKKALTNEAENWADNEPNNKRNNEDC-----VEIYIKSPSAPGKWNDEHCLKKKH 114
Query: 186 FIC 188
+C
Sbjct: 115 ALC 117
|
| >d1e87a_ d.169.1.1 (A:) CD69 {Human (Homo sapiens) [TaxId: 9606]} Length = 117 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: CD69 species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.3 bits (127), Expect = 2e-09
Identities = 28/138 (20%), Positives = 52/138 (37%), Gaps = 26/138 (18%)
Query: 51 APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNV 110
+ C DW+ + KC+ RSW ++ C E G LA + S ++ + ++ G+
Sbjct: 1 SSCSEDWV--GYQRKCYFISTVKRSWTSAQNACSEHGATLAVIDSEKDMNFLKRYAGREE 58
Query: 111 NGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSN 170
+ + G WKWS+ ++N + GS C + N
Sbjct: 59 HWVGL-----KKEPGHPWKWSNG-KEFNNWFNVTGSDK----------------CVFLKN 96
Query: 171 GSRSLVTERCNTSHPFIC 188
+ + C + +IC
Sbjct: 97 T--EVSSMECEKNLYWIC 112
|
| >d1wk1a_ d.169.1.1 (A:) Hypothetical protein F28B4.3 {Caenorhabditis elegans [TaxId: 6239]} Length = 150 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Hypothetical protein F28B4.3 species: Caenorhabditis elegans [TaxId: 6239]
Score = 53.9 bits (128), Expect = 2e-09
Identities = 19/126 (15%), Positives = 39/126 (30%), Gaps = 7/126 (5%)
Query: 64 SKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTT 123
K + S ++ +C GG+LA ++ + + + S
Sbjct: 8 VKFLTVNDDILSMPQARNFCASAGGYLADDLGDDKNNFYSSIAANTQFWIGLFKNSDGQF 67
Query: 124 VGLSW-KWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNT 182
+ ++ + A G ++ T + + S+ T+ C T
Sbjct: 68 YWDRGQGINPDLLNQPITYWANGEPSNDPTRQCVYFDGR------SGDKSKVWTTDTCAT 121
Query: 183 SHPFIC 188
PFIC
Sbjct: 122 PRPFIC 127
|
| >d1xpha1 d.169.1.1 (A:265-394) DC-SIGNR (DC-SIGN related receptor) {Human (Homo sapiens) [TaxId: 9606]} Length = 130 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: DC-SIGNR (DC-SIGN related receptor) species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.4 bits (124), Expect = 6e-09
Identities = 29/137 (21%), Positives = 51/137 (37%), Gaps = 14/137 (10%)
Query: 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVN 111
CP DW + C+ + R+W +S T C+E+ L + + EE++ Q ++
Sbjct: 3 HCPKDWTFFQ--GNCYFMSNSQRNWHDSVTACQEVRAQLVVIKTAEEQNFLQLQTSRSNR 60
Query: 112 GCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNG 171
W+G +N W +S + G N+S + C S
Sbjct: 61 FSWMGLSDLNQEGTWQWVDGSPLSPSFQRYWNSGEPNNSGN----------EDCAEFSGS 110
Query: 172 SRSLVTERCNTSHPFIC 188
RC+ + +IC
Sbjct: 111 --GWNDNRCDVDNYWIC 125
|
| >d1hq8a_ d.169.1.1 (A:) NK cell-activating receptor nkg2d {Mouse (Mus musculus) [TaxId: 10090]} Length = 123 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: NK cell-activating receptor nkg2d species: Mouse (Mus musculus) [TaxId: 10090]
Score = 51.4 bits (122), Expect = 1e-08
Identities = 27/137 (19%), Positives = 48/137 (35%), Gaps = 23/137 (16%)
Query: 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVN 111
PCP +WI + + C+ + ++W++S+ C L + S EE+ + +
Sbjct: 5 PCPNNWICHR--NNCYQFFNEEKTWNQSQASCLSQNSSLLKIYSKEEQDFLKLVK----- 57
Query: 112 GCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNG 171
+ + SW+W D S + V SC S+
Sbjct: 58 -SYHWMGLVQIPANGSWQWEDGSSLSYNQLTLVEIPKGSC-------------AVYGSSF 103
Query: 172 SRSLVTERCNTSHPFIC 188
TE C + +IC
Sbjct: 104 --KAYTEDCANLNTYIC 118
|
| >d1qo3c_ d.169.1.1 (C:) NK cell receptor {Mouse (Mus musculus), ly49-a [TaxId: 10090]} Length = 133 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: NK cell receptor species: Mouse (Mus musculus), ly49-a [TaxId: 10090]
Score = 51.4 bits (122), Expect = 1e-08
Identities = 20/137 (14%), Positives = 37/137 (27%), Gaps = 21/137 (15%)
Query: 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVN 111
W KC+ ++ + ++W + C+ L + +E Q + +
Sbjct: 13 GDKVYWF--CYGMKCYYFVMDRKTWSGCKQTCQSSSLSLLKIDDEDELKFLQLVVPSDSC 70
Query: 112 GCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNG 171
+ + W W DN S + C L+S
Sbjct: 71 WVGLSYDNKKK----DWAWIDNRP-------------SKLALNTRKYNIRDGGCMLLSKT 113
Query: 172 SRSLVTERCNTSHPFIC 188
L C+ IC
Sbjct: 114 --RLDNGNCDQVFICIC 128
|
| >d3c8ja1 d.169.1.1 (A:138-259) NK cell receptor {Mouse (Mus musculus), ly49-c [TaxId: 10090]} Length = 122 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: NK cell receptor species: Mouse (Mus musculus), ly49-c [TaxId: 10090]
Score = 50.6 bits (120), Expect = 2e-08
Identities = 22/136 (16%), Positives = 38/136 (27%), Gaps = 21/136 (15%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNG 112
W +KC+ +I N +W + C+ G + + +E Q+
Sbjct: 2 GVKYWFCYS--TKCYYFIMNKTTWSGCKANCQHYGVPILKIEDEDELKFLQRHVIPGNYW 59
Query: 113 CWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS 172
+ W W DN + +F S C +S
Sbjct: 60 IGLSYDKKKKE----WAWIDNGPSKLDMKIKKMNFKSRG-------------CVFLSKA- 101
Query: 173 RSLVTERCNTSHPFIC 188
+ CN + IC
Sbjct: 102 -RIEDIDCNIPYYCIC 116
|
| >d1g1ta1 d.169.1.1 (A:1-118) E-selectin, C-lectin domain {Human (Homo sapiens) [TaxId: 9606]} Length = 118 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: E-selectin, C-lectin domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.3 bits (116), Expect = 5e-08
Identities = 23/115 (20%), Positives = 41/115 (35%), Gaps = 7/115 (6%)
Query: 74 RSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSDN 133
++DE+ YC++ HL A+ + EE + + + W+G R +N W +
Sbjct: 10 MTYDEASAYCQQRYTHLVAIQNKEEIEYLNSILSYSPSYYWIGIRKVNNVW--VWVGTQK 67
Query: 134 MSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFIC 188
A G N+ C V++ ERC+ +C
Sbjct: 68 PLTEEAKNWAPGEPNNRQKDEDC-----VEIYIKREKDVGMWNDERCSKKKLALC 117
|
| >d1tdqb_ d.169.1.1 (B:) Aggrecan core protein {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 126 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Aggrecan core protein species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 49.7 bits (117), Expect = 5e-08
Identities = 26/137 (18%), Positives = 48/137 (35%), Gaps = 15/137 (10%)
Query: 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVN 111
C W + + C+ + + +W ++E C+E HL+++ + EE+ KN
Sbjct: 2 QCEEGWT--KFQGHCYRHFPDRETWVDAERRCREQQSHLSSIVTPEEQE----FVNKNAQ 55
Query: 112 GCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNG 171
G + T G ++WSD H++ D ++ +
Sbjct: 56 DYQWIGLNDRTIEG-DFRWSDG--------HSLQFEKWRPNQPDNFFATGEDCVVMIWHE 106
Query: 172 SRSLVTERCNTSHPFIC 188
CN PF C
Sbjct: 107 RGEWNDVPCNYQLPFTC 123
|
| >d1dv8a_ d.169.1.1 (A:) H1 subunit of the asialoglycoprotein receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 128 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: H1 subunit of the asialoglycoprotein receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.3 bits (113), Expect = 1e-07
Identities = 23/142 (16%), Positives = 45/142 (31%), Gaps = 18/142 (12%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNG 112
CP +W+ E + C+ + + ++W +++ YC+ HL +TS+EE+ Q G
Sbjct: 1 CPVNWV--EHERSCYWFSRSGKAWADADNYCRLEDAHLVVVTSWEEQKFVQHHIGPVNTW 58
Query: 113 CWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLP---CHVHATVDLCTLVS 169
+ KW + F + P
Sbjct: 59 MG-------------LHDQNGPWKWVDGTDYETGFKNWRPEQPDDWYGHGLGGGEDCAHF 105
Query: 170 NGSRSLVTERCNTSHPFICMVE 191
+ C + ++C E
Sbjct: 106 TDDGRWNDDVCQRPYRWVCETE 127
|
| >d1h8ua_ d.169.1.1 (A:) Eosinophil major basic protein {Human (Homo sapiens) [TaxId: 9606]} Length = 115 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Eosinophil major basic protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.6 bits (112), Expect = 2e-07
Identities = 18/117 (15%), Positives = 37/117 (31%), Gaps = 14/117 (11%)
Query: 74 RSWDESETYCKEI-GGHLAALTSYEEEHSAQKLCGK-NVNGCWVGGRSINTTVGLSWKWS 131
+++ ++ C+ G+L ++ ++ + Q N W+GGR + ++W
Sbjct: 9 QTFSQAWFTCRRCYRGNLVSIHNFNINYRIQCSVSALNQGQVWIGGRITGSGRCRRFQWV 68
Query: 132 DNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFIC 188
D A ++ C + C PFIC
Sbjct: 69 DGSRWNFAYWAAHQPWSRG------------GHCVALCTRGGYWRRAHCLRRLPFIC 113
|
| >d1kg0c_ d.169.1.1 (C:) EBV gp42 {Epstein-Barr virus [TaxId: 10376]} Length = 136 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: EBV gp42 species: Epstein-Barr virus [TaxId: 10376]
Score = 46.8 bits (110), Expect = 6e-07
Identities = 14/138 (10%), Positives = 28/138 (20%), Gaps = 23/138 (16%)
Query: 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVN 111
K CF + +W+ C E + +
Sbjct: 18 NTREYTF--SYKGCCFYFTKKKHTWNGCFQACAEKYPCTYFYGPTPDILPVVTRNLNAIE 75
Query: 112 GCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNG 171
WVG + +W D + +
Sbjct: 76 SLWVG---VYRVGEGNWTSLDG-GTFKVYQIFGSHC-----------------TYVSKFS 114
Query: 172 SRSLVTERCNTSHPFICM 189
+ + C+ P +C+
Sbjct: 115 TVPVSHHECSFLKPCLCV 132
|
| >d1r13a1 d.169.1.1 (A:110-228) Surfactant protein, lectin domain {Rat (Rattus norvegicus), SP-A [TaxId: 10116]} Length = 119 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Surfactant protein, lectin domain species: Rat (Rattus norvegicus), SP-A [TaxId: 10116]
Score = 44.6 bits (104), Expect = 2e-06
Identities = 18/125 (14%), Positives = 37/125 (29%), Gaps = 14/125 (11%)
Query: 64 SKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTT 123
K F G ++D + C GG++A + EE + + K N ++
Sbjct: 7 DKVFSTNGQSVNFDTIKEMCTRAGGNIAVPRTPEENEAIASIAKKYNNYVYL-------- 58
Query: 124 VGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTS 183
++ A S+ + P + ++G + C
Sbjct: 59 ---GMIEDQTPGDFHYLDGASVSYTNWYPGEPRG-QGKEKCVEMYTDG--TWNDRGCLQY 112
Query: 184 HPFIC 188
+C
Sbjct: 113 RLAVC 117
|
| >d2msba_ d.169.1.1 (A:) Mannose-binding protein A, C-lectin domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 112 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Mannose-binding protein A, C-lectin domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 44.6 bits (104), Expect = 2e-06
Identities = 17/125 (13%), Positives = 36/125 (28%), Gaps = 18/125 (14%)
Query: 65 KCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVN-GCWVGGRSINTT 123
K F + + + C E+ G +A + EE + Q++ + G
Sbjct: 2 KFFVTNHERMPFSKVKALCSELRGTVAIPRNAEENKAIQEVAKTSAFLGITDEVTEGQFM 61
Query: 124 VGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTS 183
+ + + K +E + C ++ + C S
Sbjct: 62 YVTGGRLTYSNWKKDEPNDHGSGED--CVTI---------------VDNGLWNDISCQAS 104
Query: 184 HPFIC 188
H +C
Sbjct: 105 HTAVC 109
|
| >d1tn3a_ d.169.1.1 (A:) Tetranectin {Human (Homo sapiens) [TaxId: 9606]} Length = 137 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Tetranectin species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.7 bits (104), Expect = 3e-06
Identities = 18/137 (13%), Positives = 39/137 (28%), Gaps = 11/137 (8%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVN- 111
C ++ KCF +++ E+ C GG L+ + E + + ++V
Sbjct: 6 CLKGTKVH---MKCFLAFTQTKTFHEASEDCISRGGTLSTPQTGSENDALYEYLRQSVGN 62
Query: 112 GCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNG 171
+ + +W ++ + L
Sbjct: 63 EAEIWLGLNDMAAEGTWVDMTGARIAYKNWETEITAQPDGGKTENCAV-------LSGAA 115
Query: 172 SRSLVTERCNTSHPFIC 188
+ +RC P+IC
Sbjct: 116 NGKWFDKRCRDQLPYIC 132
|
| >d1pwba1 d.169.1.1 (A:235-355) Surfactant protein, lectin domain {Human (Homo sapiens), SP-D [TaxId: 9606]} Length = 121 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Surfactant protein, lectin domain species: Human (Homo sapiens), SP-D [TaxId: 9606]
Score = 44.7 bits (104), Expect = 3e-06
Identities = 22/125 (17%), Positives = 40/125 (32%), Gaps = 13/125 (10%)
Query: 64 SKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTT 123
K F G + + E++ C + GG LA+ S E + Q+L ++
Sbjct: 8 EKIFKTAGFVKPFTEAQLLCTQAGGQLASPRSAAENAALQQLVVAKNEAAFL-------- 59
Query: 124 VGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTS 183
S S K+ +++ P + D + +NG C
Sbjct: 60 ---SMTDSKTEGKFTYPTGESLVYSNWAPGEPNDDGGSEDCVEIFTNG--KWNDRACGEK 114
Query: 184 HPFIC 188
+C
Sbjct: 115 RLVVC 119
|
| >d1t8da1 d.169.1.1 (A:1-143) Low affinity immunoglobulin epsilon Fc receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 143 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Low affinity immunoglobulin epsilon Fc receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.0 bits (105), Expect = 3e-06
Identities = 26/138 (18%), Positives = 46/138 (33%), Gaps = 18/138 (13%)
Query: 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVN 111
CP WI + KC+ + + W + C ++ G L ++ S EE+ K +
Sbjct: 7 TCPEKWI--NFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGS 64
Query: 112 GCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNG 171
+ + + W D S + S A G S C ++ G
Sbjct: 65 WIGLRNLDLKGE----FIWVDG-SHVDYSNWAPGEPTSRSQGEDC----------VMMRG 109
Query: 172 SRSLVTERCNTS-HPFIC 188
S C+ ++C
Sbjct: 110 SGRWNDAFCDRKLGAWVC 127
|
| >d1oz7b_ d.169.1.1 (B:) Snake coagglutinin beta chain {Saw-scaled viper (Echis carinatus), echicetin [TaxId: 40353]} Length = 123 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Snake coagglutinin beta chain species: Saw-scaled viper (Echis carinatus), echicetin [TaxId: 40353]
Score = 44.3 bits (103), Expect = 3e-06
Identities = 25/142 (17%), Positives = 43/142 (30%), Gaps = 30/142 (21%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI--GGHLAALTSYEEEHSAQKLCGKNV 110
C PDW + C+ +W ++E +C + GHL + + +E L +
Sbjct: 2 CLPDWS--VYEGYCYKVFKERMNWADAEKFCTKQHKDGHLVSFRNSKEVDFVISLAFPML 59
Query: 111 NGCWVGGRSINTTVGLSWKWSDNM----SKWNESIHAVGSFNSSCTSLPCHVHATVDLCT 166
V + +W+WSD W+ H C
Sbjct: 60 KNDLVWIGLTDYWRDCNWEWSDGAQLDYKAWDNERH----------------------CF 97
Query: 167 LVSNGSRSLVTERCNTSHPFIC 188
+ N C + F+C
Sbjct: 98 IYKNTDNQWTRRDCTWTFSFVC 119
|
| >d1v7pb_ d.169.1.1 (B:) Snake coagglutinin beta chain {Snake (Echis multisquamatus), Ems16 [TaxId: 93050]} Length = 127 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Snake coagglutinin beta chain species: Snake (Echis multisquamatus), Ems16 [TaxId: 93050]
Score = 43.9 bits (102), Expect = 5e-06
Identities = 33/142 (23%), Positives = 46/142 (32%), Gaps = 28/142 (19%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKNV 110
CP W C+ ++W E+E C + G LA++ S EEE KL K +
Sbjct: 1 CPLGWS--SFDQHCYKVFEPVKNWTEAEEICMQQHKGSRLASIHSSEEEAFVSKLASKAL 58
Query: 111 NGCWVGGRSINTTVGLSWKWSDNM----SKWNESIHAVGSFNSSCTSLPCHVHATVDLCT 166
+ N W+WSDN W CT +
Sbjct: 59 KFTSMWIGLNNPWKDCKWEWSDNARFDYKAWKR--------RPYCTVM------------ 98
Query: 167 LVSNGSRSLVTERCNTSHPFIC 188
+V T C S F+C
Sbjct: 99 VVKPDRIFWFTRGCEKSVSFVC 120
|
| >d1hupa1 d.169.1.1 (A:112-228) Mannose-binding protein A, C-lectin domain {Human (Homo sapiens) [TaxId: 9606]} Length = 117 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Mannose-binding protein A, C-lectin domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.1 bits (100), Expect = 7e-06
Identities = 17/125 (13%), Positives = 36/125 (28%), Gaps = 16/125 (12%)
Query: 64 SKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTT 123
+K F G ++++ + C + +A + E+ A + K +
Sbjct: 5 NKFFLTNGEIMTFEKVKALCVKFQASVATPRN-AAENGAIQNLIKEEAFLGITDEKTEGQ 63
Query: 124 VGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTS 183
+ WNE + C ++ + C+TS
Sbjct: 64 FVDLTGNRLTYTNWNEGEPNNAGSDEDC---------------VLLLKNGQWNDVPCSTS 108
Query: 184 HPFIC 188
H +C
Sbjct: 109 HLAVC 113
|
| >d1wmza_ d.169.1.1 (A:) Lectin CEL-I {Cucumaria echinata [TaxId: 40245]} Length = 140 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Lectin CEL-I species: Cucumaria echinata [TaxId: 40245]
Score = 43.3 bits (100), Expect = 9e-06
Identities = 17/148 (11%), Positives = 36/148 (24%), Gaps = 17/148 (11%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGG-------HLAALTSYEEEHSAQKL 105
CP DW E C+ + +W+ + C L ++ S E+
Sbjct: 3 CPTDWE--AEGDHCYRFFNTLTTWENAHHECVSYSCSTLNVRSDLVSVHSAAEQAYVFNY 60
Query: 106 CGKNVNGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLC 165
+ + + SK + A G ++ +
Sbjct: 61 WRGIDSQAGQLWIGLYDKYNEGDFIWTDGSKVGYTKWAGGQPDNWNNAEDY--------G 112
Query: 166 TLVSNGSRSLVTERCNTSHPFICMVEHE 193
+ ++C + E
Sbjct: 113 QFRHTEGGAWNDNSAAAQAKYMCKLTFE 140
|
| >d1c3ab_ d.169.1.1 (B:) Snake coagglutinin beta chain {Habu snake (Trimeresurus flavoviridis), flavocetin-A [TaxId: 88087]} Length = 125 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Snake coagglutinin beta chain species: Habu snake (Trimeresurus flavoviridis), flavocetin-A [TaxId: 88087]
Score = 42.8 bits (99), Expect = 1e-05
Identities = 22/142 (15%), Positives = 42/142 (29%), Gaps = 30/142 (21%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI--GGHLAALTSYEEEHSAQKLCGKNV 110
CP W C+ +W+++E +C + G HL + S EE +
Sbjct: 4 CPLGWS--SYDEHCYQVFQQKMNWEDAEKFCTQQHKGSHLVSFHSSEEVDFVTSKTFPIL 61
Query: 111 NGCWVGGRSINTTVGLSWKWSDNM----SKWNESIHAVGSFNSSCTSLPCHVHATVDLCT 166
+V N + +WSD W+ C
Sbjct: 62 KYDFVWIGLSNVWNECTKEWSDGTKLDYKAWSGGSD----------------------CI 99
Query: 167 LVSNGSRSLVTERCNTSHPFIC 188
+ ++ C++ + +C
Sbjct: 100 VSKTTDNQWLSMDCSSKYYVVC 121
|
| >d3bdwa1 d.169.1.1 (A:59-179) CD94 {Human (Homo sapiens) [TaxId: 9606]} Length = 121 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: CD94 species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.3 bits (98), Expect = 2e-05
Identities = 20/137 (14%), Positives = 40/137 (29%), Gaps = 22/137 (16%)
Query: 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVN 111
C W+ C+ ++W+ES C L L + +E
Sbjct: 2 SCQEKWVGYR--CNCYFISSEQKTWNESRHLCASQKSSLLQLQNTDELDFMSSSQQFYWI 59
Query: 112 GCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNG 171
G + +W W + S ++ + ++ + NG
Sbjct: 60 GLS------YSEEHTAWLWENG-SALSQYLFPSFETFNTK-----------NCIAYNPNG 101
Query: 172 SRSLVTERCNTSHPFIC 188
+ + E C + +IC
Sbjct: 102 --NALDESCEDKNRYIC 116
|
| >d1jwia_ d.169.1.1 (A:) Snake coagglutinin alpha chain {Puff adder (Bitis arietans), bitiscetin [TaxId: 8692]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Snake coagglutinin alpha chain species: Puff adder (Bitis arietans), bitiscetin [TaxId: 8692]
Score = 42.0 bits (97), Expect = 2e-05
Identities = 36/144 (25%), Positives = 54/144 (37%), Gaps = 30/144 (20%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVN- 111
C PDW K C+ +W+++E +C E GHLA++ S EE KL + +
Sbjct: 1 CLPDWS--SYKGHCYKVFKKVGTWEDAEKFCVENSGHLASIDSKEEADFVTKLASQTLTK 58
Query: 112 ---GCWVGGRSINTTVGLSWKWSDNM----SKWNESIHAVGSFNSSCTSLPCHVHATVDL 164
W+G R + T S +W+D +E + C L H
Sbjct: 59 FVYDAWIGLRDESKTQQCSPQWTDGSSVVYENVDE--------PTKCFGLDVH------- 103
Query: 165 CTLVSNGSRSLVTERCNTSHPFIC 188
R+ C +PFIC
Sbjct: 104 -----TEYRTWTDLPCGEKNPFIC 122
|
| >d1gz2a_ d.169.1.1 (A:) Ovocleidin-17 {Chicken (Gallus gallus) [TaxId: 9031]} Length = 139 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Ovocleidin-17 species: Chicken (Gallus gallus) [TaxId: 9031]
Score = 42.5 bits (98), Expect = 2e-05
Identities = 24/137 (17%), Positives = 35/137 (25%), Gaps = 4/137 (2%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIG-GHLAALTSYEEEHSAQKLCGKNVN 111
C P W+ C G+ SW +E++C+ G G A E
Sbjct: 2 CGPGWV--PTPGGCLGFFSRELSWSRAESFCRRWGPGSHLAAVRSAAELRLLAELLNASR 59
Query: 112 GCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNG 171
G G + V + W S F S +
Sbjct: 60 GGDGSGEGADGRVWIGLHRPAGSRSWRWSDGTAPRFASWHRTAKAR-RGGRCAALRDEEA 118
Query: 172 SRSLVTERCNTSHPFIC 188
S C + F+C
Sbjct: 119 FTSWAARPCTERNAFVC 135
|
| >d1oz7a_ d.169.1.1 (A:) Snake coagglutinin alpha chain {Saw-scaled viper (Echis carinatus), echicetin [TaxId: 40353]} Length = 131 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Snake coagglutinin alpha chain species: Saw-scaled viper (Echis carinatus), echicetin [TaxId: 40353]
Score = 42.0 bits (97), Expect = 2e-05
Identities = 26/136 (19%), Positives = 44/136 (32%), Gaps = 12/136 (8%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNG 112
CPP W N C+ ++WDE+E +C + G L+ ++
Sbjct: 2 CPPGWSSNG--VYCYMLFKEPKTWDEAEKFCNKQGKDGHLLSIESKKEEILVDI----VV 55
Query: 113 CWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS 172
G+ GLS + + S S S + + +
Sbjct: 56 SENIGKMYKIWTGLSERSKEQHCSSRW------SDGSFFRSYEIAIRYSECFVLEKQSVF 109
Query: 173 RSLVTERCNTSHPFIC 188
R+ V C + PF+C
Sbjct: 110 RTWVATPCENTFPFMC 125
|
| >d1uv0a_ d.169.1.1 (A:) Pancreatitis-associated protein 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 140 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Pancreatitis-associated protein 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.0 bits (97), Expect = 3e-05
Identities = 18/136 (13%), Positives = 38/136 (27%), Gaps = 4/136 (2%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNG 112
CP S C+ + +SW +++ C++ E S K++
Sbjct: 5 CPKGSK--AYGSHCYALFLSPKSWTDADLACQKRPSGNLVSVLSGAEGSFVSSLVKSIGN 62
Query: 113 CWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS 172
+ + + +W S V ++ + + S
Sbjct: 63 SYSYVWIGLHDPTQGTEPNGEGWEW--SSSDVMNYFAWERNPSTISSPGHCASLSRSTAF 120
Query: 173 RSLVTERCNTSHPFIC 188
CN P++C
Sbjct: 121 LRWKDYNCNVRLPYVC 136
|
| >d1rdl1_ d.169.1.1 (1:) Mannose-binding protein A, C-lectin domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 111 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Mannose-binding protein A, C-lectin domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 40.9 bits (94), Expect = 4e-05
Identities = 16/124 (12%), Positives = 34/124 (27%), Gaps = 16/124 (12%)
Query: 65 KCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTV 124
K F + ++ C E+ G +A +A++ V I
Sbjct: 1 KYFMSSVRRMPLNRAKALCSELQGTVATP------RNAEENRAIQNVAKDVAFLGITDQR 54
Query: 125 GLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSH 184
+ ++ + G N+ + C +V + C+ S
Sbjct: 55 TENVFEDLTGNRVRYTNWNEGEPNNVGSGENC----------VVLLTNGKWNDVPCSDSF 104
Query: 185 PFIC 188
+C
Sbjct: 105 LVVC 108
|
| >d1jwib_ d.169.1.1 (B:) Snake coagglutinin beta chain {Puff adder (Bitis arietans), bitiscetin [TaxId: 8692]} Length = 123 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Snake coagglutinin beta chain species: Puff adder (Bitis arietans), bitiscetin [TaxId: 8692]
Score = 40.4 bits (93), Expect = 7e-05
Identities = 29/138 (21%), Positives = 49/138 (35%), Gaps = 22/138 (15%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI--GGHLAALTSYEEEHSAQKLCGKNV 110
C PDW K C+ ++W ++E +CKE+ GGHL ++ S EE KL + +
Sbjct: 2 CLPDWS--SYKGHCYKVFKVEKTWADAEKFCKELVNGGHLMSVNSREEGEFISKLALEKM 59
Query: 111 NGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSN 170
V + +W+D L + +C + +
Sbjct: 60 RIVLVWIGLSHFWRICPLRWTDG------------------ARLDYRALSDEPICFVAES 101
Query: 171 GSRSLVTERCNTSHPFIC 188
+ CN F+C
Sbjct: 102 FHNKWIQWTCNRKKSFVC 119
|
| >d1jzna_ d.169.1.1 (A:) Galactose-specific C-type lectin {Western diamondback rattlesnake (Crotalus atrox) [TaxId: 8730]} Length = 135 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Galactose-specific C-type lectin species: Western diamondback rattlesnake (Crotalus atrox) [TaxId: 8730]
Score = 40.5 bits (93), Expect = 8e-05
Identities = 21/137 (15%), Positives = 44/137 (32%), Gaps = 9/137 (6%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNG 112
CP DW+ C+ ++W+++E +C++ + + S +
Sbjct: 3 CPLDWL--PMNGLCYKIFNQLKTWEDAEMFCRKYKPGCHLASFHRYGESLEIAE------ 54
Query: 113 CWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVS-NG 171
V + + W + + + + + P H LVS G
Sbjct: 55 YISDYHKGQENVWIGLRDKKKDFSWEWTDRSCTDYLTWDKNQPDHYQNKEFCVELVSLTG 114
Query: 172 SRSLVTERCNTSHPFIC 188
R + C + F+C
Sbjct: 115 YRLWNDQVCESKDAFLC 131
|
| >d1qdda_ d.169.1.1 (A:) Lithostathine, inhibitor of stone formation {Human (Homo sapiens) [TaxId: 9606]} Length = 144 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Lithostathine, inhibitor of stone formation species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.5 bits (93), Expect = 9e-05
Identities = 18/140 (12%), Positives = 41/140 (29%), Gaps = 11/140 (7%)
Query: 50 KAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKN 109
+ CP +S C+ + + +W +++ YC+ + + E + K
Sbjct: 11 RISCPEGTN--AYRSYCYYFNEDRETWVDADLYCQNMNSGNLVSVLTQAEGAFVASLIKE 68
Query: 110 VNGCWVGGRSINTTVGLSWKWSD-NMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLV 168
+ W + S + +G+ +S + +
Sbjct: 69 SGTDDFNVWIGLHDPKKNRAWHWSSGSLVSYKSWGIGAPSSVNPGYCVSLTS-------- 120
Query: 169 SNGSRSLVTERCNTSHPFIC 188
S G + C F+C
Sbjct: 121 STGFQKWKDVPCEDKFSFVC 140
|
| >d2afpa_ d.169.1.1 (A:) Type II antifreeze protein {Sea raven (Hemitripterus americanus) [TaxId: 8094]} Length = 129 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Type II antifreeze protein species: Sea raven (Hemitripterus americanus) [TaxId: 8094]
Score = 40.1 bits (92), Expect = 1e-04
Identities = 25/138 (18%), Positives = 40/138 (28%), Gaps = 17/138 (12%)
Query: 51 APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNV 110
CP W +C Y +W +ET C ++GGHLA++ S EE Q L V
Sbjct: 5 PNCPAGWQ--PLGDRCIYYETTAMTWALAETNCMKLGGHLASIHSQEEHSFIQTLNAGVV 62
Query: 111 NGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSN 170
+ + N + + + +
Sbjct: 63 WIGGSACLQAG------AWTWSDGTPMNFRSWCSTKPDDVLAA---------CCMQMTAA 107
Query: 171 GSRSLVTERCNTSHPFIC 188
+ C SH +C
Sbjct: 108 ADQCWDDLPCPASHKSVC 125
|
| >d1v7pa_ d.169.1.1 (A:) Snake coagglutinin alpha chain {Snake (Echis multisquamatus), Ems16 [TaxId: 93050]} Length = 134 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Snake coagglutinin alpha chain species: Snake (Echis multisquamatus), Ems16 [TaxId: 93050]
Score = 39.3 bits (90), Expect = 2e-04
Identities = 29/142 (20%), Positives = 47/142 (33%), Gaps = 22/142 (15%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI--GGHLAALTSYEEEHSAQKLCGK-- 108
CP DW C+ IG ++W E+E +C E GHL ++ S EE + +L
Sbjct: 4 CPSDWT--AYDQHCYLAIGEPQNWYEAERFCTEQAKDGHLVSIQSREEGNFVAQLVSGFM 61
Query: 109 --NVNGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCT 166
+ W+G R + +W+D + S +
Sbjct: 62 HRSEIYVWIGLRDRREEQQCNPEWNDGSKIIYVNWKEGESKMCQGLT------------- 108
Query: 167 LVSNGSRSLVTERCNTSHPFIC 188
C +PF+C
Sbjct: 109 -KWTNFHDWNNINCEDLYPFVC 129
|
| >d1c3aa_ d.169.1.1 (A:) Snake coagglutinin alpha chain {Habu snake (Trimeresurus flavoviridis), flavocetin-A [TaxId: 88087]} Length = 135 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Snake coagglutinin alpha chain species: Habu snake (Trimeresurus flavoviridis), flavocetin-A [TaxId: 88087]
Score = 39.3 bits (90), Expect = 2e-04
Identities = 15/136 (11%), Positives = 37/136 (27%), Gaps = 10/136 (7%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNG 112
C P W C+ ++W+++E++C+E ++
Sbjct: 4 CIPGWS--AYDRYCYQAFSKPKNWEDAESFCEEGVKTSHLVSIESSGEGDFVAQLVAEKI 61
Query: 113 CWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS 172
+ + + S + ++ + +A
Sbjct: 62 KTSFQYVWIGLR---IQNKEQQCRSEWSDASSVNYENLVKQFSKKCYALKK-----GTEL 113
Query: 173 RSLVTERCNTSHPFIC 188
R+ C T +P +C
Sbjct: 114 RTWFNVYCGTENPEVC 129
|
| >d1umrc_ d.169.1.1 (C:) Snake coagglutinin beta chain {South american rattlesnake (Crotalus durissus terrificus), convulxin [TaxId: 8732]} Length = 125 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Snake coagglutinin beta chain species: South american rattlesnake (Crotalus durissus terrificus), convulxin [TaxId: 8732]
Score = 39.0 bits (89), Expect = 3e-04
Identities = 25/142 (17%), Positives = 49/142 (34%), Gaps = 30/142 (21%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI--GGHLAALTSYEEEHSAQKLCGKNV 110
CP W C+ +W ++E +C + G HL + S EE K+ +++
Sbjct: 4 CPSHWS--SYDRYCYKVFKQEMTWADAEKFCTQQHTGSHLVSFHSTEEVDFVVKMTHQSL 61
Query: 111 NGCWVGGRSINTTVGLSWKWSDNM----SKWNESIHAVGSFNSSCTSLPCHVHATVDLCT 166
+ + N +W+WSD +W+E C
Sbjct: 62 KSTFFWIGANNIWNKCNWQWSDGTKPEYKEWHEEFE----------------------CL 99
Query: 167 LVSNGSRSLVTERCNTSHPFIC 188
+ ++ C+ ++ F+C
Sbjct: 100 ISRTFDNQWLSAPCSDTYSFVC 121
|
| >d1byfa_ d.169.1.1 (A:) Lectin TC14 {Tunicate (Polyandrocarpa misakiensis) [TaxId: 7723]} Length = 123 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Lectin TC14 species: Tunicate (Polyandrocarpa misakiensis) [TaxId: 7723]
Score = 38.3 bits (87), Expect = 4e-04
Identities = 19/124 (15%), Positives = 38/124 (30%), Gaps = 9/124 (7%)
Query: 66 CFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNV-NGCWVGGRSINTTV 124
+ ++ ++ TYC+ G L + + L V + G
Sbjct: 3 EILFSDETMNYADAGTYCQSRGMALVSSAMRDSTMVKAILAFTEVKGHDYWVGADNLQDG 62
Query: 125 GLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSH 184
++ W+D +S +S + S+ S V + + L C +
Sbjct: 63 AYNFLWNDGVSLPTDSDLWSPNEPSNPQSWQLCVQ--------IWSKYNLLDDVGCGGAR 114
Query: 185 PFIC 188
IC
Sbjct: 115 RVIC 118
|
| >d1j34b_ d.169.1.1 (B:) Snake coagglutinin beta chain {Habu snake (Trimeresurus flavoviridis) [TaxId: 88087]} Length = 123 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Snake coagglutinin beta chain species: Habu snake (Trimeresurus flavoviridis) [TaxId: 88087]
Score = 37.8 bits (86), Expect = 6e-04
Identities = 27/142 (19%), Positives = 45/142 (31%), Gaps = 30/142 (21%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI--GGHLAALTSYEEEHSAQKLCGKNV 110
CP DW + C+ ++W ++E +C + GGHL + S EE KL +
Sbjct: 2 CPSDWS--SYEGHCYKPFSEPKNWADAENFCTQQHAGGHLVSFQSSEEADFVVKLAFQTF 59
Query: 111 NGCWVGGRSINTTVGLSWKWSD----NMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCT 166
N +W+WS+ W E + C
Sbjct: 60 GHSIFWMGLSNVWNQCNWQWSNAAMLRYKAWAEESY----------------------CV 97
Query: 167 LVSNGSRSLVTERCNTSHPFIC 188
+ + + C F+C
Sbjct: 98 YFKSTNNKWRSRACRMMAQFVC 119
|
| >d1umra_ d.169.1.1 (A:) Snake coagglutinin alpha chain {South american rattlesnake (Crotalus durissus terrificus), convulxin [TaxId: 8732]} Length = 135 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Snake coagglutinin alpha chain species: South american rattlesnake (Crotalus durissus terrificus), convulxin [TaxId: 8732]
Score = 37.8 bits (86), Expect = 7e-04
Identities = 26/140 (18%), Positives = 48/140 (34%), Gaps = 18/140 (12%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI--GGHLAALTSYEEEHSAQKLCGKNV 110
CP DW C+ +W+++E +C + G HL ++ S +E + +N+
Sbjct: 4 CPSDWY--YYDQHCYRIFNEEMNWEDAEWFCTKQAKGAHLVSIKSAKEADFVAWMVTQNI 61
Query: 111 NGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVS- 169
+ S + E + + S S + + C+L+
Sbjct: 62 EESF------------SHVSIGLRVQNKEKQCSTKWSDGSSVSYDNLLDLYITKCSLLKK 109
Query: 170 -NGSRSLVTERCNTSHPFIC 188
G R C PF+C
Sbjct: 110 ETGFRKWFVASCIGKIPFVC 129
|
| >d1fvua_ d.169.1.1 (A:) Snake coagglutinin alpha chain {Jararaca (Bothrops jararaca), botrocetin [TaxId: 8724]} Length = 133 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Snake coagglutinin alpha chain species: Jararaca (Bothrops jararaca), botrocetin [TaxId: 8724]
Score = 37.8 bits (86), Expect = 7e-04
Identities = 24/138 (17%), Positives = 41/138 (29%), Gaps = 13/138 (9%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIG--GHLAALTSYEEEHSAQKLCGKNV 110
CP W + C+ + +W ++E +C E GHL ++ Y +E
Sbjct: 2 CPSGWS--SYEGNCYKFFQQKMNWADAERFCSEQAKGGHLVSIKIYSKEKDFVGDLVTKN 59
Query: 111 NGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSN 170
I V K + S+ S+ + A
Sbjct: 60 IQSSDLYAWIGLRVENKEKQCSSEWSDGSSV----SYENVVERTVKKCFALEK-----DL 110
Query: 171 GSRSLVTERCNTSHPFIC 188
G + C +PF+C
Sbjct: 111 GFVLWINLYCAQKNPFVC 128
|
| >d1sb2a1 d.169.1.1 (A:1-132) Snake coagglutinin alpha chain {Malayan pit viper (Calloselasma rhodostoma), rhodocetin [TaxId: 8717]} Length = 132 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Snake coagglutinin alpha chain species: Malayan pit viper (Calloselasma rhodostoma), rhodocetin [TaxId: 8717]
Score = 37.4 bits (85), Expect = 8e-04
Identities = 25/138 (18%), Positives = 41/138 (29%), Gaps = 14/138 (10%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI--GGHLAALTSYEEEHSAQKLCGKNV 110
CP W KS C+ ++W+E+E +C E HL ++ + E + N
Sbjct: 2 CPDGWS--STKSYCYRPFKEKKTWEEAERFCTEQEKEAHLVSMENRLEAVFVDMVMENNF 59
Query: 111 NGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSN 170
SW +K S +S + +
Sbjct: 60 ENKIYR----------SWIGLKIENKGQRSNLEWSDGSSISYENLYEPYMEKCFLMDHQS 109
Query: 171 GSRSLVTERCNTSHPFIC 188
G T C + F+C
Sbjct: 110 GLPKWHTADCEEKNVFMC 127
|
| >d1fvub_ d.169.1.1 (B:) Snake coagglutinin beta chain {Jararaca (Bothrops jararaca), botrocetin [TaxId: 8724]} Length = 125 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Snake coagglutinin beta chain species: Jararaca (Bothrops jararaca), botrocetin [TaxId: 8724]
Score = 37.1 bits (84), Expect = 0.001
Identities = 26/138 (18%), Positives = 44/138 (31%), Gaps = 20/138 (14%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKNV 110
CPPDW + C+ + + WD++E +C E G HL + S EE + L + +
Sbjct: 2 CPPDWS--SYEGHCYRFFKEWMHWDDAEEFCTEQQTGAHLVSFQSKEEADFVRSLTSEML 59
Query: 111 NGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSN 170
G V + ++W+D + T
Sbjct: 60 KGDVVWIGLSDVWNKCRFEWTDG------MEFDYDDYYLIAEYECVASKPT--------- 104
Query: 171 GSRSLVTERCNTSHPFIC 188
+ C F+C
Sbjct: 105 -NNKWWIIPCTRFKNFVC 121
|
| >d1sb2b1 d.169.1.1 (B:2-128) Snake coagglutinin beta chain {Malayan pit viper (Calloselasma rhodostoma), rhodocetin [TaxId: 8717]} Length = 127 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Snake coagglutinin beta chain species: Malayan pit viper (Calloselasma rhodostoma), rhodocetin [TaxId: 8717]
Score = 36.2 bits (82), Expect = 0.002
Identities = 22/138 (15%), Positives = 39/138 (28%), Gaps = 20/138 (14%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI--GGHLAALTSYEEEHSAQKLCGKNV 110
CP W K C+ ++W E+E +C + GHL ++ S E + N
Sbjct: 3 CPTTWS--ASKLYCYKPFKEKKTWIEAERFCAKQAENGHLVSIGSAAEADFLDLVIVVNF 60
Query: 111 NGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSN 170
+ +W + + +V N +
Sbjct: 61 DKQR----------YRAWTGLTERNLKWTNGASVSYENLY------EPYIRKCFVVQPWE 104
Query: 171 GSRSLVTERCNTSHPFIC 188
G C + F+C
Sbjct: 105 GKSKWYKADCEEKNAFLC 122
|
| >d1j34a_ d.169.1.1 (A:) Snake coagglutinin alpha chain {Habu snake (Trimeresurus flavoviridis) [TaxId: 88087]} Length = 129 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Snake coagglutinin alpha chain species: Habu snake (Trimeresurus flavoviridis) [TaxId: 88087]
Score = 36.3 bits (82), Expect = 0.003
Identities = 29/140 (20%), Positives = 51/140 (36%), Gaps = 18/140 (12%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYC--KEIGGHLAALTSYEEEHSAQKLCGKNV 110
CP W + C+ +++WD++E +C + GGHL ++ S E +L +N+
Sbjct: 2 CPSGWS--SYEGHCYKPFKLYKTWDDAERFCTEQAKGGHLVSIESAGEADFVAQLVTENI 59
Query: 111 NGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSN 170
+ W + E + + S S + A C +
Sbjct: 60 QNTKS------------YVWIGLRVQGKEKQCSSEWSDGSSVSYENWIEAESKTCLGLEK 107
Query: 171 --GSRSLVTERCNTSHPFIC 188
G R V C +PF+C
Sbjct: 108 ETGFRKWVNIYCGQQNPFVC 127
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 553 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1ypqa1 | 131 | Oxidised low density lipoprotein {Human (Homo sapi | 99.93 | |
| d1hq8a_ | 123 | NK cell-activating receptor nkg2d {Mouse (Mus musc | 99.93 | |
| d1xpha1 | 130 | DC-SIGNR (DC-SIGN related receptor) {Human (Homo s | 99.92 | |
| d1fvub_ | 125 | Snake coagglutinin beta chain {Jararaca (Bothrops | 99.92 | |
| d1t8da1 | 143 | Low affinity immunoglobulin epsilon Fc receptor {H | 99.92 | |
| d1j34b_ | 123 | Snake coagglutinin beta chain {Habu snake (Trimere | 99.92 | |
| d1oz7b_ | 123 | Snake coagglutinin beta chain {Saw-scaled viper (E | 99.92 | |
| d1tdqb_ | 126 | Aggrecan core protein {Rat (Rattus norvegicus) [Ta | 99.92 | |
| d1c3ab_ | 125 | Snake coagglutinin beta chain {Habu snake (Trimere | 99.92 | |
| d1jwib_ | 123 | Snake coagglutinin beta chain {Puff adder (Bitis a | 99.92 | |
| d1umrc_ | 125 | Snake coagglutinin beta chain {South american ratt | 99.91 | |
| d1qdda_ | 144 | Lithostathine, inhibitor of stone formation {Human | 99.91 | |
| d2afpa_ | 129 | Type II antifreeze protein {Sea raven (Hemitripter | 99.91 | |
| d1e87a_ | 117 | CD69 {Human (Homo sapiens) [TaxId: 9606]} | 99.91 | |
| d1dv8a_ | 128 | H1 subunit of the asialoglycoprotein receptor {Hum | 99.91 | |
| d1gz2a_ | 139 | Ovocleidin-17 {Chicken (Gallus gallus) [TaxId: 903 | 99.91 | |
| d1v7pb_ | 127 | Snake coagglutinin beta chain {Snake (Echis multis | 99.91 | |
| d1sb2a1 | 132 | Snake coagglutinin alpha chain {Malayan pit viper | 99.91 | |
| d1qo3c_ | 133 | NK cell receptor {Mouse (Mus musculus), ly49-a [Ta | 99.91 | |
| d1c3aa_ | 135 | Snake coagglutinin alpha chain {Habu snake (Trimer | 99.91 | |
| d1wmza_ | 140 | Lectin CEL-I {Cucumaria echinata [TaxId: 40245]} | 99.91 | |
| d1tn3a_ | 137 | Tetranectin {Human (Homo sapiens) [TaxId: 9606]} | 99.9 | |
| d1jwia_ | 124 | Snake coagglutinin alpha chain {Puff adder (Bitis | 99.9 | |
| d1umra_ | 135 | Snake coagglutinin alpha chain {South american rat | 99.9 | |
| d3c8ja1 | 122 | NK cell receptor {Mouse (Mus musculus), ly49-c [Ta | 99.9 | |
| d1jzna_ | 135 | Galactose-specific C-type lectin {Western diamondb | 99.9 | |
| d3bdwa1 | 121 | CD94 {Human (Homo sapiens) [TaxId: 9606]} | 99.9 | |
| d1uv0a_ | 140 | Pancreatitis-associated protein 1 {Human (Homo sap | 99.9 | |
| d1fvua_ | 133 | Snake coagglutinin alpha chain {Jararaca (Bothrops | 99.9 | |
| d1sb2b1 | 127 | Snake coagglutinin beta chain {Malayan pit viper ( | 99.89 | |
| d1j34a_ | 129 | Snake coagglutinin alpha chain {Habu snake (Trimer | 99.89 | |
| d1oz7a_ | 131 | Snake coagglutinin alpha chain {Saw-scaled viper ( | 99.89 | |
| d1egga_ | 136 | Macrophage mannose receptor, CRD4 {Human (Homo sap | 99.89 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.89 | |
| d1pwba1 | 121 | Surfactant protein, lectin domain {Human (Homo sap | 99.89 | |
| d1v7pa_ | 134 | Snake coagglutinin alpha chain {Snake (Echis multi | 99.89 | |
| d2msba_ | 112 | Mannose-binding protein A, C-lectin domain {Rat (R | 99.88 | |
| d1r13a1 | 119 | Surfactant protein, lectin domain {Rat (Rattus nor | 99.87 | |
| d1hupa1 | 117 | Mannose-binding protein A, C-lectin domain {Human | 99.87 | |
| d1rdl1_ | 111 | Mannose-binding protein A, C-lectin domain {Rat (R | 99.86 | |
| d1kg0c_ | 136 | EBV gp42 {Epstein-Barr virus [TaxId: 10376]} | 99.86 | |
| d1h8ua_ | 115 | Eosinophil major basic protein {Human (Homo sapien | 99.85 | |
| d1g1ta1 | 118 | E-selectin, C-lectin domain {Human (Homo sapiens) | 99.79 | |
| d1g1sa1 | 118 | P-selectin, C-lectin domain {Human (Homo sapiens) | 99.77 | |
| d1wk1a_ | 150 | Hypothetical protein F28B4.3 {Caenorhabditis elega | 99.77 | |
| d1byfa_ | 123 | Lectin TC14 {Tunicate (Polyandrocarpa misakiensis) | 99.68 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.55 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.99 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.46 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.97 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.14 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.02 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-52 Score=406.70 Aligned_cols=240 Identities=21% Similarity=0.314 Sum_probs=194.7
Q ss_pred eeecccCceeEEEEEeCCCCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCCHHH
Q 008785 275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR 354 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~ 354 (553)
+.||+|+||.||+|.+.+++.||||+++... ...++|.+|++++++++|||||+++|++.+.+..++||||+++|+|.+
T Consensus 11 ~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L~~ 89 (263)
T d1sm2a_ 11 QEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSD 89 (263)
T ss_dssp EEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHH
T ss_pred EEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCCcHHH
Confidence 3469999999999999889999999998653 445789999999999999999999999999999999999999999999
Q ss_pred HhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccceeeec
Q 008785 355 WLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA 434 (553)
Q Consensus 355 ~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 434 (553)
++.. ....+++..+..++.|||.||+|||++ +|+||||||+|||+++++.+||+|||+++............ .
T Consensus 90 ~l~~---~~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~-~ 162 (263)
T d1sm2a_ 90 YLRT---QRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG-T 162 (263)
T ss_dssp HHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC-----------------
T ss_pred Hhhc---cccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCceeecc-e
Confidence 9874 345689999999999999999999999 99999999999999999999999999998765443322222 2
Q ss_pred CccccccccccccCCCCCcccchHhHHHHHHHHhc-Cccc-cc---chHHHHHhcCCH-----HHHHHHHHHHhhccCCC
Q 008785 435 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-VLCR-RW---WTLYTLVHSMSL-----LCAQECLMLFISCNNWP 504 (553)
Q Consensus 435 ~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-~~~~-~~---~~l~~~~~~~~~-----~~~~~l~~l~~~Cl~~d 504 (553)
.||+.|+|||++.+..++.++|||||||++|||++ ..+. .. ..+.+.+..+.. ..+.++.+++.+||+.|
T Consensus 163 ~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~ 242 (263)
T d1sm2a_ 163 KFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKER 242 (263)
T ss_dssp --CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSS
T ss_pred ecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHHHccCC
Confidence 38999999999999999999999999999999997 2332 22 233334433322 55778999999999999
Q ss_pred CCCCCCHHHHHHHHHHHH
Q 008785 505 SHLSQSKFCNLKLWVFAI 522 (553)
Q Consensus 505 P~~RPs~~evl~~l~~~~ 522 (553)
|++|||++||+++|....
T Consensus 243 p~~Rps~~~il~~L~~i~ 260 (263)
T d1sm2a_ 243 PEDRPAFSRLLRQLAEIA 260 (263)
T ss_dssp GGGSCCHHHHHHHHHHHH
T ss_pred HhHCcCHHHHHHHHHHHH
Confidence 999999999999976543
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.2e-51 Score=410.46 Aligned_cols=261 Identities=23% Similarity=0.348 Sum_probs=202.7
Q ss_pred cCHHHHHHhhcccCCC--------CeeecccCceeEEEEEeCC-C---CEEEEEEeccC-ChhhHHHHHHHHHHhhccCC
Q 008785 258 FTTEELRSITKNFSEG--------NRLLGDSKTGGTYSGILPD-G---SRVAVKRLKRS-SFQRKKEFYSEIGRFARLHH 324 (553)
Q Consensus 258 ~~~~el~~~~~~~~~~--------~~~iG~G~~g~Vy~~~~~~-g---~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H 324 (553)
++++++.+++.+|... .++||+|+||+||+|.+.. | ..||||.+... .....++|.+|+.+|++++|
T Consensus 7 ~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H 86 (299)
T d1jpaa_ 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH 86 (299)
T ss_dssp GGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCC
T ss_pred CCHHHHHHHHhhhchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCC
Confidence 4556666666666432 3567999999999999753 3 26899998764 44456789999999999999
Q ss_pred CceeeEeeEEeeCCceEEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEE
Q 008785 325 PNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 404 (553)
Q Consensus 325 pnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NIL 404 (553)
||||+++|++.+.+..++||||+++|+|.+++.. ....+++.++..++.||+.||+|||++ +|+||||||+|||
T Consensus 87 pnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~---~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NIL 160 (299)
T d1jpaa_ 87 PNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNIL 160 (299)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEE
T ss_pred CCCccEEEEEeeCCEEEEEEEecCCCcceeeecc---ccCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEE
Confidence 9999999999999999999999999999998874 345699999999999999999999999 9999999999999
Q ss_pred ecCCCCeEEeeccccccCCcccccce---eeecCccccccccccccCCCCCcccchHhHHHHHHHHhc--Ccccccc---
Q 008785 405 LDEEFGAHLMGVGLSKFVPWEVMQER---TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL--VLCRRWW--- 476 (553)
Q Consensus 405 l~~~~~~kl~Dfgla~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~--~~~~~~~--- 476 (553)
++.++.+||+|||+|+.......... .....||+.|||||++.++.++.++|||||||++|||++ ..|....
T Consensus 161 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~ 240 (299)
T d1jpaa_ 161 VNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ 240 (299)
T ss_dssp ECTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH
T ss_pred ECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999987654432211 111237899999999999999999999999999999997 2333332
Q ss_pred hHHHHHhcCCH-----HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHhh
Q 008785 477 TLYTLVHSMSL-----LCAQECLMLFISCNNWPSHLSQSKFCNLKLWVFAILT 524 (553)
Q Consensus 477 ~l~~~~~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~~~~~ 524 (553)
++...+..+.. ..+..+.+|+.+||+.||++|||+.||++.|...+..
T Consensus 241 ~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 241 DVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HHHHHHHcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence 33444444322 5678899999999999999999999999998765543
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-50 Score=400.67 Aligned_cols=244 Identities=23% Similarity=0.324 Sum_probs=193.5
Q ss_pred ccCCCCeeecccCceeEEEEEeCCCCEEEEEEeccC--ChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEc
Q 008785 269 NFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF 346 (553)
Q Consensus 269 ~~~~~~~~iG~G~~g~Vy~~~~~~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 346 (553)
+|...+ .||+|+||+||+|+++ ..||||+++.. +....+.|.+|+.+|++++|||||+++|++.+ +..++||||
T Consensus 9 ~~~~~~-~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey 84 (276)
T d1uwha_ 9 QITVGQ-RIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQW 84 (276)
T ss_dssp CCCCCS-EEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred cEEEEE-EEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEec
Confidence 344444 5599999999999874 36999999754 34556889999999999999999999998754 568999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCccc
Q 008785 347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV 426 (553)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 426 (553)
+++|+|.+++.. ....+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+|+......
T Consensus 85 ~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~ 158 (276)
T d1uwha_ 85 CEGSSLYHHLHI---IETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS 158 (276)
T ss_dssp CCEEEHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred CCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence 999999999964 334699999999999999999999999 99999999999999999999999999998765443
Q ss_pred ccceeeecCccccccccccccC---CCCCcccchHhHHHHHHHHhcC-cccccc----hHHHHHhcCCH---------HH
Q 008785 427 MQERTVMAGGTYGYLAPEFVYR---NELTTKSDVYSFGVLLLEIRLV-LCRRWW----TLYTLVHSMSL---------LC 489 (553)
Q Consensus 427 ~~~~~~~~~gt~~y~aPE~~~~---~~~t~ksDVwSlGvil~ell~~-~~~~~~----~l~~~~~~~~~---------~~ 489 (553)
.........||+.|||||++.+ ..|+.++|||||||++|||++. .|.... .+...+..+.. ..
T Consensus 159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 238 (276)
T d1uwha_ 159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNC 238 (276)
T ss_dssp -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTC
T ss_pred CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccc
Confidence 3333333449999999999864 3589999999999999999983 333221 22223333321 45
Q ss_pred HHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 008785 490 AQECLMLFISCNNWPSHLSQSKFCNLKLWVFAI 522 (553)
Q Consensus 490 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~~~ 522 (553)
+..+.+++.+||+.||++|||+.||++++....
T Consensus 239 ~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~ 271 (276)
T d1uwha_ 239 PKAMKRLMAECLKKKRDERPLFPQILASIELLA 271 (276)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 778999999999999999999999999876544
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-51 Score=403.26 Aligned_cols=240 Identities=25% Similarity=0.350 Sum_probs=199.9
Q ss_pred eeecccCceeEEEEEeCCCCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCCHHH
Q 008785 275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR 354 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~ 354 (553)
+.||+|+||.||+|.+++++.||||+++... ...+.|.+|+.+|++++|||||+++|++.+ +..++||||+++|+|.+
T Consensus 19 ~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~~g~L~~ 96 (272)
T d1qpca_ 19 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVD 96 (272)
T ss_dssp EEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHH
T ss_pred EEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCCCCcHHH
Confidence 3459999999999999888999999997653 345789999999999999999999998754 56799999999999999
Q ss_pred HhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccceeeec
Q 008785 355 WLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA 434 (553)
Q Consensus 355 ~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 434 (553)
++.. .....+++..++.|+.||+.||.|||++ +|+||||||+|||+++++.+||+|||+|+........... ..
T Consensus 97 ~~~~--~~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~~~-~~ 170 (272)
T d1qpca_ 97 FLKT--PSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE-GA 170 (272)
T ss_dssp HTTS--HHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCT-TC
T ss_pred HHhh--cCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccCCcccccc-cc
Confidence 8864 2334589999999999999999999999 9999999999999999999999999999877644332222 22
Q ss_pred CccccccccccccCCCCCcccchHhHHHHHHHHhc-Cccc-cc---chHHHHHhcCCH-----HHHHHHHHHHhhccCCC
Q 008785 435 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-VLCR-RW---WTLYTLVHSMSL-----LCAQECLMLFISCNNWP 504 (553)
Q Consensus 435 ~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-~~~~-~~---~~l~~~~~~~~~-----~~~~~l~~l~~~Cl~~d 504 (553)
.||+.|+|||++.++.++.++|||||||++|||++ ..+. .. ..+...+..+.. ..+..+.+|+.+||+.|
T Consensus 171 ~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~ 250 (272)
T d1qpca_ 171 KFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKER 250 (272)
T ss_dssp CCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSS
T ss_pred CCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCcccChHHHHHHHHHHcCCC
Confidence 38999999999998999999999999999999998 3332 22 223334444322 56778999999999999
Q ss_pred CCCCCCHHHHHHHHHHHH
Q 008785 505 SHLSQSKFCNLKLWVFAI 522 (553)
Q Consensus 505 P~~RPs~~evl~~l~~~~ 522 (553)
|++|||+.||++.|..-+
T Consensus 251 P~~Rpt~~ei~~~L~~~f 268 (272)
T d1qpca_ 251 PEDRPTFDYLRSVLEDFF 268 (272)
T ss_dssp GGGSCCHHHHHHHHHHHH
T ss_pred HhHCcCHHHHHHHhhhhh
Confidence 999999999998776543
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.2e-51 Score=405.93 Aligned_cols=239 Identities=27% Similarity=0.412 Sum_probs=202.1
Q ss_pred eeecccCceeEEEEEeC-CCCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCCHH
Q 008785 275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 353 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~ 353 (553)
+.||+|+||+||+|.+. +|+.||||+++... ...++|.+|+++|++++|||||+++|++.+.+..++||||+++|+|.
T Consensus 23 ~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~ 101 (287)
T d1opja_ 23 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 101 (287)
T ss_dssp EETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHH
T ss_pred eEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecccCcchH
Confidence 34699999999999976 48899999997653 34678999999999999999999999999999999999999999999
Q ss_pred HHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccceeee
Q 008785 354 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVM 433 (553)
Q Consensus 354 ~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 433 (553)
+++.. .....+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+|+.............
T Consensus 102 ~~l~~--~~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~~~~~ 176 (287)
T d1opja_ 102 DYLRE--CNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGA 176 (287)
T ss_dssp HHHHH--SCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEEETTE
T ss_pred HHhhh--ccccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeecCCCCceeeccc
Confidence 99976 3446789999999999999999999999 999999999999999999999999999987765433322222
Q ss_pred cCccccccccccccCCCCCcccchHhHHHHHHHHhc-Cccc-c---cchHHHHHhcCCH-----HHHHHHHHHHhhccCC
Q 008785 434 AGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-VLCR-R---WWTLYTLVHSMSL-----LCAQECLMLFISCNNW 503 (553)
Q Consensus 434 ~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-~~~~-~---~~~l~~~~~~~~~-----~~~~~l~~l~~~Cl~~ 503 (553)
.||+.|+|||++.+..++.++|||||||++|||++ ..+. . ...+.+.+..+.. ..+..+.+|+.+||+.
T Consensus 177 -~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~ 255 (287)
T d1opja_ 177 -KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQW 255 (287)
T ss_dssp -EECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred -cccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCCccchHHHHHHHHHHcCC
Confidence 27899999999999999999999999999999997 3332 2 2223334444322 5677899999999999
Q ss_pred CCCCCCCHHHHHHHHHH
Q 008785 504 PSHLSQSKFCNLKLWVF 520 (553)
Q Consensus 504 dP~~RPs~~evl~~l~~ 520 (553)
||++|||+.||++.+..
T Consensus 256 dP~~Rps~~ei~~~L~~ 272 (287)
T d1opja_ 256 NPSDRPSFAEIHQAFET 272 (287)
T ss_dssp SGGGSCCHHHHHHHHHH
T ss_pred CHhHCcCHHHHHHHHHH
Confidence 99999999999987644
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-50 Score=399.29 Aligned_cols=239 Identities=20% Similarity=0.271 Sum_probs=201.6
Q ss_pred ccCCCCeeecccCceeEEEEEe-CCCCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEcc
Q 008785 269 NFSEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV 347 (553)
Q Consensus 269 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 347 (553)
.|.... .||+|+||+||+|.. .+|+.||||+++.......+.+.+|+.+|++++|||||++++++.+.+..|+||||+
T Consensus 21 ~Y~~~~-~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 21 KYTRFE-KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TBCSCE-ECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred ccEEEE-EEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 354444 459999999999996 469999999998765566788999999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccc
Q 008785 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM 427 (553)
Q Consensus 348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 427 (553)
++|+|.+++.. ..+++.++..++.||+.||+|||++ ||+||||||+|||++.++.+||+|||+|+.......
T Consensus 100 ~gg~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 171 (293)
T d1yhwa1 100 AGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (293)
T ss_dssp TTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred CCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeeccccc
Confidence 99999998864 3589999999999999999999999 999999999999999999999999999987654432
Q ss_pred cceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcCc-ccccchHHH----HHhcCCH------HHHHHHHHH
Q 008785 428 QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVL-CRRWWTLYT----LVHSMSL------LCAQECLML 496 (553)
Q Consensus 428 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~-~~~~~~l~~----~~~~~~~------~~~~~l~~l 496 (553)
.. ....||+.|+|||++.+..++.++|||||||++|||+++. |....+..+ ....+.. ..+..+.++
T Consensus 172 ~~--~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l 249 (293)
T d1yhwa1 172 KR--STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDF 249 (293)
T ss_dssp CB--CCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHH
T ss_pred cc--cccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHH
Confidence 22 2234999999999999999999999999999999999833 332222222 2222221 456789999
Q ss_pred HhhccCCCCCCCCCHHHHHHHH
Q 008785 497 FISCNNWPSHLSQSKFCNLKLW 518 (553)
Q Consensus 497 ~~~Cl~~dP~~RPs~~evl~~l 518 (553)
+.+||+.||++|||+.|++++-
T Consensus 250 i~~~L~~dP~~R~s~~eil~Hp 271 (293)
T d1yhwa1 250 LNRCLDMDVEKRGSAKELLQHQ 271 (293)
T ss_dssp HHHHTCSSTTTSCCHHHHTTCG
T ss_pred HHHHccCChhHCcCHHHHhcCH
Confidence 9999999999999999998763
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-50 Score=392.32 Aligned_cols=243 Identities=21% Similarity=0.305 Sum_probs=205.5
Q ss_pred cccCCCCeeecccCceeEEEEEeCCCCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEcc
Q 008785 268 KNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV 347 (553)
Q Consensus 268 ~~~~~~~~~iG~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 347 (553)
++|...++ ||+|+||+||+|++++++.||||+++... ...++|.+|+.++++++||||++++|++.+++..++||||+
T Consensus 4 ~~~~~~~~-iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~ 81 (258)
T d1k2pa_ 4 KDLTFLKE-LGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 81 (258)
T ss_dssp CCCCCCCC-CCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred HHCEEeEE-EecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence 35555554 59999999999999888899999998754 34578999999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccc
Q 008785 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM 427 (553)
Q Consensus 348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 427 (553)
++|+|.+++.. ....+++..+.+++.||++||+|||++ +|+||||||+|||+++++.+||+|||+++.......
T Consensus 82 ~~g~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 155 (258)
T d1k2pa_ 82 ANGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 155 (258)
T ss_dssp TTEEHHHHHHS---GGGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC
T ss_pred CCCcHHHhhhc---cccCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCCc
Confidence 99999999764 345689999999999999999999999 999999999999999999999999999987655433
Q ss_pred cceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhc--Cccccc---chHHHHHhcCCH-----HHHHHHHHHH
Q 008785 428 QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL--VLCRRW---WTLYTLVHSMSL-----LCAQECLMLF 497 (553)
Q Consensus 428 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~--~~~~~~---~~l~~~~~~~~~-----~~~~~l~~l~ 497 (553)
.... ...||+.|+|||.+.+..++.++||||||+++|||++ ..|... .++...+..+.. ..+..+.+++
T Consensus 156 ~~~~-~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li 234 (258)
T d1k2pa_ 156 TSSV-GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIM 234 (258)
T ss_dssp CCCC-CSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred eeec-ccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccccHHHHHHH
Confidence 3222 2338999999999999999999999999999999997 223332 233334444422 5567899999
Q ss_pred hhccCCCCCCCCCHHHHHHHHH
Q 008785 498 ISCNNWPSHLSQSKFCNLKLWV 519 (553)
Q Consensus 498 ~~Cl~~dP~~RPs~~evl~~l~ 519 (553)
.+||+.||++|||+.|++++|+
T Consensus 235 ~~cl~~dP~~RPt~~eil~~L~ 256 (258)
T d1k2pa_ 235 YSCWHEKADERPTFKILLSNIL 256 (258)
T ss_dssp HHTTCSSGGGSCCHHHHHHHHH
T ss_pred HHHccCCHhHCcCHHHHHHHhh
Confidence 9999999999999999999874
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-50 Score=397.77 Aligned_cols=241 Identities=21% Similarity=0.213 Sum_probs=195.6
Q ss_pred ccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCCh-hhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEc
Q 008785 269 NFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF-QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF 346 (553)
Q Consensus 269 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 346 (553)
+|... +.||+|+||+||+|+.. +|+.||||+++.... ...+.+.+|+.+|++++|||||++++++.+++..|+||||
T Consensus 6 dy~~~-~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 6 DWDLV-QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp EEEEE-EEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ceEEE-EEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 45443 45699999999999974 589999999976532 3346789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCccc
Q 008785 347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV 426 (553)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 426 (553)
+++|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+|+......
T Consensus 85 ~~gg~L~~~l~~----~~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 85 CSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp CTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred cCCCcHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence 999999999863 34699999999999999999999999 99999999999999999999999999998765443
Q ss_pred ccceeeecCccccccccccccCCCC-CcccchHhHHHHHHHHhcCc-cccc----chHHHHHhcCC-H-----HHHHHHH
Q 008785 427 MQERTVMAGGTYGYLAPEFVYRNEL-TTKSDVYSFGVLLLEIRLVL-CRRW----WTLYTLVHSMS-L-----LCAQECL 494 (553)
Q Consensus 427 ~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDVwSlGvil~ell~~~-~~~~----~~l~~~~~~~~-~-----~~~~~l~ 494 (553)
.........||+.|||||++.+..+ +.++|||||||++|||++.. |... ........... . ..+.++.
T Consensus 158 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 237 (271)
T d1nvra_ 158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 237 (271)
T ss_dssp EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHH
T ss_pred ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHH
Confidence 3332333459999999999988876 67899999999999999732 2211 11222222221 1 4567889
Q ss_pred HHHhhccCCCCCCCCCHHHHHHH
Q 008785 495 MLFISCNNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 495 ~l~~~Cl~~dP~~RPs~~evl~~ 517 (553)
+|+.+||+.||++|||+.|++++
T Consensus 238 ~li~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 238 ALLHKILVENPSARITIPDIKKD 260 (271)
T ss_dssp HHHHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHHHHcCCChhHCcCHHHHhcC
Confidence 99999999999999999998864
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-51 Score=400.13 Aligned_cols=246 Identities=24% Similarity=0.262 Sum_probs=190.6
Q ss_pred ccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCC--hhhHHHHHHHHHHhhccCCCceeeEeeEEee--CCceEEE
Q 008785 269 NFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYD--HGDRYIV 343 (553)
Q Consensus 269 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--~~~~~lV 343 (553)
+|...+ .||+|+||+||+|+.. +|+.||||.++... ....+.+.+|+++|++++|||||++++++.+ .+..|+|
T Consensus 5 dy~~~~-~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 5 DYEVLY-TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GEEEEE-EEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hCEEeE-EEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 444444 4599999999999964 58999999997653 3445778999999999999999999999865 4568999
Q ss_pred EEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCceecCCCCCcEEecCCCCeEEeecccccc
Q 008785 344 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV--KPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF 421 (553)
Q Consensus 344 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~--~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~ 421 (553)
|||+++|+|.+++....+....+++..+..++.||+.||+|||++. ..+|+||||||+|||++.++.+||+|||+|+.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999998653334467999999999999999999999861 11399999999999999999999999999987
Q ss_pred CCcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcC-ccccc---chHHHHHhcCCH-----HHHHH
Q 008785 422 VPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLV-LCRRW---WTLYTLVHSMSL-----LCAQE 492 (553)
Q Consensus 422 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~-~~~~~---~~l~~~~~~~~~-----~~~~~ 492 (553)
......... ...||+.|||||++.+..++.++|||||||++|||++. .|... ..+...+..+.. ..+.+
T Consensus 164 ~~~~~~~~~--~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~ 241 (269)
T d2java1 164 LNHDTSFAK--AFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDE 241 (269)
T ss_dssp C-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHH
T ss_pred cccCCCccc--cCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHH
Confidence 654432222 23499999999999999999999999999999999983 33332 233334444443 56778
Q ss_pred HHHHHhhccCCCCCCCCCHHHHHHH
Q 008785 493 CLMLFISCNNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 493 l~~l~~~Cl~~dP~~RPs~~evl~~ 517 (553)
+.+|+.+||+.||++|||+.|++++
T Consensus 242 l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 242 LNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHcCCChhHCcCHHHHHhC
Confidence 9999999999999999999999874
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-50 Score=394.82 Aligned_cols=238 Identities=24% Similarity=0.287 Sum_probs=201.3
Q ss_pred ccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCC---hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEE
Q 008785 269 NFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVY 344 (553)
Q Consensus 269 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 344 (553)
+|... +.||+|+||+||+|+.+ +|+.||||++.+.. ....+.+.+|+.++++++|||||++++++.+++..|+||
T Consensus 7 dy~i~-~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 7 DFEIG-RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GEEEE-EEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HeEEE-EEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 44443 45699999999999975 58999999997542 233577899999999999999999999999999999999
Q ss_pred EccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCc
Q 008785 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW 424 (553)
Q Consensus 345 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~ 424 (553)
||+++|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+....
T Consensus 86 Ey~~~g~L~~~l~~----~~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~ 158 (263)
T d2j4za1 86 EYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 158 (263)
T ss_dssp ECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred eecCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCC
Confidence 99999999999964 24589999999999999999999999 999999999999999999999999999987654
Q ss_pred ccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcC-cccccch---HHHHHhcCCH----HHHHHHHHH
Q 008785 425 EVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLV-LCRRWWT---LYTLVHSMSL----LCAQECLML 496 (553)
Q Consensus 425 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~-~~~~~~~---l~~~~~~~~~----~~~~~l~~l 496 (553)
... ....||+.|||||++.+..++.++|||||||++|||++. .|....+ +...+..+.. ..++++.++
T Consensus 159 ~~~----~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l 234 (263)
T d2j4za1 159 SRR----TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDL 234 (263)
T ss_dssp CCC----EETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHH
T ss_pred Ccc----cccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHH
Confidence 322 223499999999999999999999999999999999983 3333332 3334444443 467789999
Q ss_pred HhhccCCCCCCCCCHHHHHHHH
Q 008785 497 FISCNNWPSHLSQSKFCNLKLW 518 (553)
Q Consensus 497 ~~~Cl~~dP~~RPs~~evl~~l 518 (553)
+.+||+.||++|||+.|++++-
T Consensus 235 i~~~L~~dp~~R~t~~eil~hp 256 (263)
T d2j4za1 235 ISRLLKHNPSQRPMLREVLEHP 256 (263)
T ss_dssp HHHHTCSSGGGSCCHHHHHTCH
T ss_pred HHHHccCCHhHCcCHHHHHcCc
Confidence 9999999999999999999864
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-49 Score=393.40 Aligned_cols=244 Identities=21% Similarity=0.337 Sum_probs=195.8
Q ss_pred CeeecccCceeEEEEEeCCC-----CEEEEEEeccC-ChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEcc
Q 008785 274 NRLLGDSKTGGTYSGILPDG-----SRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV 347 (553)
Q Consensus 274 ~~~iG~G~~g~Vy~~~~~~g-----~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 347 (553)
.++||+|+||.||+|.++++ ..||||+++.. ......+|.+|+.+|++++|||||+++|++.+.+..++||||+
T Consensus 12 ~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e~~ 91 (283)
T d1mqba_ 12 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYM 91 (283)
T ss_dssp EEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred eeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEEec
Confidence 45679999999999997542 37999999764 3344567999999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccc
Q 008785 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM 427 (553)
Q Consensus 348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 427 (553)
.+|++.+++.. ....+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 92 ~~~~l~~~~~~---~~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~ 165 (283)
T d1mqba_ 92 ENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE 165 (283)
T ss_dssp TTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC---------
T ss_pred ccCcchhhhhc---ccccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhcccCCCc
Confidence 99999998865 335699999999999999999999999 999999999999999999999999999987654322
Q ss_pred cc-eeeecCccccccccccccCCCCCcccchHhHHHHHHHHhc-Cccc----ccchHHHHHhcCCH-----HHHHHHHHH
Q 008785 428 QE-RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-VLCR----RWWTLYTLVHSMSL-----LCAQECLML 496 (553)
Q Consensus 428 ~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-~~~~----~~~~l~~~~~~~~~-----~~~~~l~~l 496 (553)
.. ......||+.|+|||++.++.++.++|||||||++|||++ ..+. ....+.+.+..+.. ..+..+.+|
T Consensus 166 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~l 245 (283)
T d1mqba_ 166 ATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQL 245 (283)
T ss_dssp --------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBHHHHHH
T ss_pred cceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCCchhhHHHHHHH
Confidence 21 1222338999999999999999999999999999999997 2222 22234444444322 567789999
Q ss_pred HhhccCCCCCCCCCHHHHHHHHHHHHh
Q 008785 497 FISCNNWPSHLSQSKFCNLKLWVFAIL 523 (553)
Q Consensus 497 ~~~Cl~~dP~~RPs~~evl~~l~~~~~ 523 (553)
+.+||+.||++|||+.||++.|...+.
T Consensus 246 i~~cl~~~p~~RPt~~eil~~L~~l~~ 272 (283)
T d1mqba_ 246 MMQCWQQERARRPKFADIVSILDKLIR 272 (283)
T ss_dssp HHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence 999999999999999999998765443
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-49 Score=393.44 Aligned_cols=240 Identities=22% Similarity=0.290 Sum_probs=200.0
Q ss_pred ecccCceeEEEEEeC---CCCEEEEEEeccC-ChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCCH
Q 008785 277 LGDSKTGGTYSGILP---DGSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352 (553)
Q Consensus 277 iG~G~~g~Vy~~~~~---~g~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL 352 (553)
||+|+||.||+|.++ ++..||||+++.. .....++|.+|+++|++++|||||+++|++.+ +..|+||||+++|+|
T Consensus 17 iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~~~g~L 95 (285)
T d1u59a_ 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPL 95 (285)
T ss_dssp EECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEEH
T ss_pred EecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeCCCCcH
Confidence 699999999999864 3557999999765 34456789999999999999999999999865 568999999999999
Q ss_pred HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccc-ee
Q 008785 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE-RT 431 (553)
Q Consensus 353 ~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~-~~ 431 (553)
.+++.. ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+......... ..
T Consensus 96 ~~~l~~---~~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~ 169 (285)
T d1u59a_ 96 HKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR 169 (285)
T ss_dssp HHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCC
T ss_pred HHHhhc---cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhcccccccccccc
Confidence 999864 335699999999999999999999999 99999999999999999999999999998775443222 22
Q ss_pred eecCccccccccccccCCCCCcccchHhHHHHHHHHhc--Ccccc---cchHHHHHhcCCH-----HHHHHHHHHHhhcc
Q 008785 432 VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL--VLCRR---WWTLYTLVHSMSL-----LCAQECLMLFISCN 501 (553)
Q Consensus 432 ~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~--~~~~~---~~~l~~~~~~~~~-----~~~~~l~~l~~~Cl 501 (553)
....||+.|+|||++.++.++.++|||||||++|||++ ..|.. ..++...+..+.. ..+.++.+|+.+||
T Consensus 170 ~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl 249 (285)
T d1u59a_ 170 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCW 249 (285)
T ss_dssp CSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTT
T ss_pred cccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHc
Confidence 23348999999999999999999999999999999997 33332 2334445555443 56788999999999
Q ss_pred CCCCCCCCCHHHHHHHHHHHHh
Q 008785 502 NWPSHLSQSKFCNLKLWVFAIL 523 (553)
Q Consensus 502 ~~dP~~RPs~~evl~~l~~~~~ 523 (553)
+.||++|||+.+|+++|.....
T Consensus 250 ~~~p~~RPs~~~i~~~L~~~~~ 271 (285)
T d1u59a_ 250 IYKWEDRPDFLTVEQRMRACYY 271 (285)
T ss_dssp CSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCHhHCcCHHHHHHHHHHHHH
Confidence 9999999999999888755443
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-50 Score=398.55 Aligned_cols=235 Identities=22% Similarity=0.284 Sum_probs=197.2
Q ss_pred eeecccCceeEEEEEeC-CCCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCCCCHH
Q 008785 275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 353 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~ 353 (553)
+.||+|+||.||+|... +|+.||||+++.......+.+.+|+++|++++|||||++++++.+.+..++||||+++|+|.
T Consensus 18 ~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~g~L~ 97 (288)
T d2jfla1 18 GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVD 97 (288)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHH
T ss_pred EEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCCCcHH
Confidence 44699999999999975 58999999998776666788999999999999999999999999999999999999999999
Q ss_pred HHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccceeee
Q 008785 354 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVM 433 (553)
Q Consensus 354 ~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 433 (553)
+++.+ ....+++.++..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+|+......... ..
T Consensus 98 ~~~~~---~~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~--~~ 169 (288)
T d2jfla1 98 AVMLE---LERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR--DS 169 (288)
T ss_dssp HHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHH--TC
T ss_pred HHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCCcccc--cc
Confidence 99864 234699999999999999999999999 99999999999999999999999999997654332211 12
Q ss_pred cCcccccccccccc-----CCCCCcccchHhHHHHHHHHhcCc-cccc---chHHHHHhcCCH-------HHHHHHHHHH
Q 008785 434 AGGTYGYLAPEFVY-----RNELTTKSDVYSFGVLLLEIRLVL-CRRW---WTLYTLVHSMSL-------LCAQECLMLF 497 (553)
Q Consensus 434 ~~gt~~y~aPE~~~-----~~~~t~ksDVwSlGvil~ell~~~-~~~~---~~l~~~~~~~~~-------~~~~~l~~l~ 497 (553)
..||+.|+|||++. +..|+.++|||||||++|||++.. |... ......+..+.. ..+.++.+|+
T Consensus 170 ~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~li 249 (288)
T d2jfla1 170 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFL 249 (288)
T ss_dssp CCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHHHHHHH
T ss_pred cccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCHHHHHHH
Confidence 33999999999984 456899999999999999999833 3222 233332222221 5677899999
Q ss_pred hhccCCCCCCCCCHHHHHHH
Q 008785 498 ISCNNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 498 ~~Cl~~dP~~RPs~~evl~~ 517 (553)
.+||+.||++|||+.|++++
T Consensus 250 ~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 250 KKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp HHHSCSSTTTSCCHHHHTTS
T ss_pred HHHccCChhHCcCHHHHhcC
Confidence 99999999999999999875
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-49 Score=393.26 Aligned_cols=238 Identities=25% Similarity=0.305 Sum_probs=195.2
Q ss_pred eeecccCceeEEEEEeCC---CCEEEEEEeccC--ChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccCC
Q 008785 275 RLLGDSKTGGTYSGILPD---GSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 349 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~~---g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 349 (553)
+.||+|+||+||+|.+.+ ++.||||+++.. +....++|.+|+++|++++|||||+++|++.+ +..+|||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 456999999999998643 468999999754 23345789999999999999999999999864 567999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccc
Q 008785 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE 429 (553)
Q Consensus 350 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 429 (553)
|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.........
T Consensus 92 g~L~~~l~~----~~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 164 (277)
T d1xbba_ 92 GPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 164 (277)
T ss_dssp EEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred CcHHHHHhh----ccCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhcccccccc
Confidence 999999975 34599999999999999999999999 99999999999999999999999999998765443222
Q ss_pred -eeeecCccccccccccccCCCCCcccchHhHHHHHHHHhc--Cccccc---chHHHHHhcCCH-----HHHHHHHHHHh
Q 008785 430 -RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL--VLCRRW---WTLYTLVHSMSL-----LCAQECLMLFI 498 (553)
Q Consensus 430 -~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~--~~~~~~---~~l~~~~~~~~~-----~~~~~l~~l~~ 498 (553)
......||+.|+|||++.+..++.++|||||||++|||++ ..|... ..+...+..+.. ..+..+.+|+.
T Consensus 165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~ 244 (277)
T d1xbba_ 165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMN 244 (277)
T ss_dssp EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHH
Confidence 2223348999999999999999999999999999999997 333332 233445555432 56788999999
Q ss_pred hccCCCCCCCCCHHHHHHHHHH
Q 008785 499 SCNNWPSHLSQSKFCNLKLWVF 520 (553)
Q Consensus 499 ~Cl~~dP~~RPs~~evl~~l~~ 520 (553)
+||+.||++|||+.+|++.|..
T Consensus 245 ~cl~~dp~~RPs~~~i~~~L~~ 266 (277)
T d1xbba_ 245 LCWTYDVENRPGFAAVELRLRN 266 (277)
T ss_dssp HHTCSSTTTSCCHHHHHHHHHH
T ss_pred HHcCCCHhHCcCHHHHHHHhhC
Confidence 9999999999999999776543
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-49 Score=397.29 Aligned_cols=244 Identities=25% Similarity=0.323 Sum_probs=197.3
Q ss_pred CeeecccCceeEEEEEeCC-C-----CEEEEEEeccC-ChhhHHHHHHHHHHhhcc-CCCceeeEeeEEeeCCceEEEEE
Q 008785 274 NRLLGDSKTGGTYSGILPD-G-----SRVAVKRLKRS-SFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYE 345 (553)
Q Consensus 274 ~~~iG~G~~g~Vy~~~~~~-g-----~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E 345 (553)
.+.||+|+||+||+|+... + ..||||.+... .......+.+|+.+|.++ +|||||++++++.+.+..++|||
T Consensus 42 ~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E 121 (325)
T d1rjba_ 42 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFE 121 (325)
T ss_dssp EEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred eeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEEEEEE
Confidence 3566999999999998643 2 36999998654 333456789999999998 89999999999999999999999
Q ss_pred ccCCCCHHHHhccCCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEec
Q 008785 346 FVVNGPLDRWLHHIPR-------------------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD 406 (553)
Q Consensus 346 ~~~~gsL~~~l~~~~~-------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~ 406 (553)
|+++|+|.++|+.... ....+++..++.++.||+.||+|||++ +|+||||||+|||++
T Consensus 122 y~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlKp~Nill~ 198 (325)
T d1rjba_ 122 YCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVT 198 (325)
T ss_dssp CCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGGGEEEE
T ss_pred cCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCchhccccc
Confidence 9999999999975321 123589999999999999999999999 999999999999999
Q ss_pred CCCCeEEeeccccccCCcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhc-C-ccccc----chHHH
Q 008785 407 EEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-V-LCRRW----WTLYT 480 (553)
Q Consensus 407 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-~-~~~~~----~~l~~ 480 (553)
.++.+||+|||+|+...............||+.|||||++.++.++.++|||||||++|||++ . .|... ..+.+
T Consensus 199 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~~~~ 278 (325)
T d1rjba_ 199 HGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYK 278 (325)
T ss_dssp TTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHH
T ss_pred cCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 999999999999987654433322223337999999999999999999999999999999997 2 33322 22333
Q ss_pred HHhcCCH-----HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 008785 481 LVHSMSL-----LCAQECLMLFISCNNWPSHLSQSKFCNLKLWVF 520 (553)
Q Consensus 481 ~~~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~ 520 (553)
.+..+.. ..+..+.+|+.+||+.||++|||++||+++|..
T Consensus 279 ~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 279 LIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence 4444321 567789999999999999999999999998753
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-49 Score=385.71 Aligned_cols=232 Identities=20% Similarity=0.283 Sum_probs=190.4
Q ss_pred CeeecccCceeEEEEEeC-CCCEEEEEEeccC--ChhhHHHHHHHHHHhhccCCCceeeEeeEEee----CCceEEEEEc
Q 008785 274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD----HGDRYIVYEF 346 (553)
Q Consensus 274 ~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~----~~~~~lV~E~ 346 (553)
.+.||+|+||+||+|... +++.||+|++... .....+.+.+|+++|++++|||||++++++.+ ....|+||||
T Consensus 14 ~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~ 93 (270)
T d1t4ha_ 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTEL 93 (270)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEEC
T ss_pred eeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEEeC
Confidence 345699999999999975 5889999998754 33445779999999999999999999999875 3457999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--ceecCCCCCcEEec-CCCCeEEeeccccccCC
Q 008785 347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPH--VVHRDIRASNVLLD-EEFGAHLMGVGLSKFVP 423 (553)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~--ivHrDlkp~NILl~-~~~~~kl~Dfgla~~~~ 423 (553)
+++|+|.+++.. ...+++..+..++.||+.||+|||++ + |+||||||+|||++ +++.+||+|||+|+...
T Consensus 94 ~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~gl~yLH~~---~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 94 MTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp CCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred CCCCcHHHHHhc----cccccHHHHHHHHHHHHHHHHHHHHC---CCCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence 999999999964 24689999999999999999999998 7 99999999999996 47899999999998654
Q ss_pred cccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcC-ccccc----chHHHHHhcCCH------HHHHH
Q 008785 424 WEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLV-LCRRW----WTLYTLVHSMSL------LCAQE 492 (553)
Q Consensus 424 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~-~~~~~----~~l~~~~~~~~~------~~~~~ 492 (553)
.... ....||+.|||||++.+ +++.++|||||||++|||++. .|... ..+...+..+.. ..+++
T Consensus 167 ~~~~----~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 241 (270)
T d1t4ha_ 167 ASFA----KAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPE 241 (270)
T ss_dssp TTSB----EESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHH
T ss_pred CCcc----CCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCHH
Confidence 3322 22349999999998864 699999999999999999983 33322 223333433322 34567
Q ss_pred HHHHHhhccCCCCCCCCCHHHHHHH
Q 008785 493 CLMLFISCNNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 493 l~~l~~~Cl~~dP~~RPs~~evl~~ 517 (553)
+.+++.+||+.||++|||+.|++++
T Consensus 242 ~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 242 VKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHccCCHhHCcCHHHHhCC
Confidence 8999999999999999999999875
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-49 Score=392.09 Aligned_cols=243 Identities=25% Similarity=0.331 Sum_probs=195.7
Q ss_pred ccCCCCeeecccCceeEEEEEeCCCCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccC
Q 008785 269 NFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV 348 (553)
Q Consensus 269 ~~~~~~~~iG~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 348 (553)
+|....+ ||+|+||.||+|.+++++.||||+++... ...+.|.+|+.+|++++|||||+++|++. .+..++||||++
T Consensus 18 ~~~i~~~-iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~~ 94 (285)
T d1fmka3 18 SLRLEVK-LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS 94 (285)
T ss_dssp GEEEEEE-EEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCCT
T ss_pred HEEEeeE-EeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEecC
Confidence 3444444 59999999999999888899999997653 44578999999999999999999999985 456899999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCccccc
Q 008785 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ 428 (553)
Q Consensus 349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 428 (553)
+|+|..++.. .....+++.+++.++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++........
T Consensus 95 ~g~l~~~~~~--~~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~ 169 (285)
T d1fmka3 95 KGSLLDFLKG--ETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 169 (285)
T ss_dssp TCBHHHHHSH--HHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred CCchhhhhhh--cccccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCCCce
Confidence 9999998865 2234599999999999999999999999 9999999999999999999999999999876544332
Q ss_pred ceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhc-Cccc----ccchHHHHHhcCCH-----HHHHHHHHHHh
Q 008785 429 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-VLCR----RWWTLYTLVHSMSL-----LCAQECLMLFI 498 (553)
Q Consensus 429 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-~~~~----~~~~l~~~~~~~~~-----~~~~~l~~l~~ 498 (553)
.... ..||+.|+|||++.++.++.++||||||+++|||++ ..+. ....+...+..+.. ..+.++.+++.
T Consensus 170 ~~~~-~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~ 248 (285)
T d1fmka3 170 ARQG-AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMC 248 (285)
T ss_dssp -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHH
T ss_pred eecc-ccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccCHHHHHHHH
Confidence 2222 238999999999999999999999999999999997 2322 22233444443322 66778999999
Q ss_pred hccCCCCCCCCCHHHHHHHHHH
Q 008785 499 SCNNWPSHLSQSKFCNLKLWVF 520 (553)
Q Consensus 499 ~Cl~~dP~~RPs~~evl~~l~~ 520 (553)
+||+.||++|||+.+|++.+..
T Consensus 249 ~cl~~dP~~Rps~~~i~~~L~~ 270 (285)
T d1fmka3 249 QCWRKEPEERPTFEYLQAFLED 270 (285)
T ss_dssp HHTCSSGGGSCCHHHHHHHHHT
T ss_pred HHcccCHhHCcCHHHHHHHHhh
Confidence 9999999999999999876544
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-49 Score=391.94 Aligned_cols=241 Identities=18% Similarity=0.230 Sum_probs=198.5
Q ss_pred ccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCC---hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEE
Q 008785 269 NFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVY 344 (553)
Q Consensus 269 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 344 (553)
+|.. .+.||+|+||+||+|... +|+.||||++++.. ....+.+.+|+++|++++||||+++++++.+++..|+||
T Consensus 9 dy~i-~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 9 DFKF-GKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GEEE-EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCEE-EEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 3433 346699999999999974 68999999997542 234567999999999999999999999999999999999
Q ss_pred EccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCc
Q 008785 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW 424 (553)
Q Consensus 345 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~ 424 (553)
||+++|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+|+....
T Consensus 88 Ey~~gg~L~~~~~~----~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~ 160 (288)
T d1uu3a_ 88 SYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 160 (288)
T ss_dssp CCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EccCCCCHHHhhhc----cCCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceeccc
Confidence 99999999999864 24699999999999999999999999 999999999999999999999999999987765
Q ss_pred ccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcC-cccccc---hHHHHHhcCCH----HHHHHHHHH
Q 008785 425 EVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLV-LCRRWW---TLYTLVHSMSL----LCAQECLML 496 (553)
Q Consensus 425 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~-~~~~~~---~l~~~~~~~~~----~~~~~l~~l 496 (553)
...........||+.|+|||++.+..++.++|||||||++|||++. .|.... .+...+..+.. ..++.+.+|
T Consensus 161 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l 240 (288)
T d1uu3a_ 161 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDL 240 (288)
T ss_dssp ---------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCTTCCHHHHHH
T ss_pred CCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCCccCCHHHHHH
Confidence 4333333334499999999999999999999999999999999973 333322 33334444443 567789999
Q ss_pred HhhccCCCCCCCCCHHHHHHH
Q 008785 497 FISCNNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 497 ~~~Cl~~dP~~RPs~~evl~~ 517 (553)
+.+||+.||++|||+.|+++.
T Consensus 241 i~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 241 VEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp HHTTSCSSGGGSTTSGGGTCH
T ss_pred HHHHccCCHhHCcCHHHHcCC
Confidence 999999999999999997654
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.6e-48 Score=395.85 Aligned_cols=241 Identities=17% Similarity=0.187 Sum_probs=203.1
Q ss_pred hcccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEE
Q 008785 267 TKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYE 345 (553)
Q Consensus 267 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 345 (553)
.++|.... .||+|+||.||+|... +|+.||||++........+.+.+|+.+|++++|||||++++++.+.+..|+|||
T Consensus 25 l~~Y~i~~-~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 103 (350)
T d1koaa2 25 LDHYDIHE-ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 103 (350)
T ss_dssp GGTEEEEE-EEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEEC
T ss_pred ccCeEEEE-EEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 34565544 5699999999999964 589999999988777777889999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecC--CCCeEEeeccccccCC
Q 008785 346 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE--EFGAHLMGVGLSKFVP 423 (553)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~--~~~~kl~Dfgla~~~~ 423 (553)
|+++|+|.+++.. ....+++..+..++.||+.||+|||++ +|+||||||+|||++. ++.+||+|||+|+...
T Consensus 104 ~~~gg~L~~~l~~---~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~ 177 (350)
T d1koaa2 104 FMSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 177 (350)
T ss_dssp CCCSCBHHHHHTC---TTSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECC
T ss_pred cCCCCCHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheecc
Confidence 9999999999864 234699999999999999999999999 9999999999999964 5789999999998765
Q ss_pred cccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcC-cccccc---hHHHHHhcCCH--------HHHH
Q 008785 424 WEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLV-LCRRWW---TLYTLVHSMSL--------LCAQ 491 (553)
Q Consensus 424 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~-~~~~~~---~l~~~~~~~~~--------~~~~ 491 (553)
..... ....||+.|||||++.+..++.++|||||||++|||+++ .|.... .+...+..+.. ..+.
T Consensus 178 ~~~~~---~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 254 (350)
T d1koaa2 178 PKQSV---KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISE 254 (350)
T ss_dssp TTSCE---EEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCH
T ss_pred ccccc---ceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCH
Confidence 44322 223399999999999999999999999999999999973 333322 33333333222 4567
Q ss_pred HHHHHHhhccCCCCCCCCCHHHHHHH
Q 008785 492 ECLMLFISCNNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 492 ~l~~l~~~Cl~~dP~~RPs~~evl~~ 517 (553)
.+.+|+.+||+.||++|||+.|++++
T Consensus 255 ~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 255 DGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp HHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHHHccCChhHCcCHHHHhcC
Confidence 89999999999999999999999986
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.6e-48 Score=390.72 Aligned_cols=238 Identities=19% Similarity=0.219 Sum_probs=184.1
Q ss_pred ccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCCh-hhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEc
Q 008785 269 NFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF-QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF 346 (553)
Q Consensus 269 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 346 (553)
.|.. .+.||+|+||+||+|... +|+.||||++..... .....+.+|+.+|++++|||||++++++.+++..|+||||
T Consensus 10 ~Y~~-~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~ 88 (307)
T d1a06a_ 10 IYDF-RDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQL 88 (307)
T ss_dssp TEEE-EEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred ceEE-EEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 3443 455699999999999975 589999999976532 2345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEec---CCCCeEEeeccccccCC
Q 008785 347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD---EEFGAHLMGVGLSKFVP 423 (553)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~---~~~~~kl~Dfgla~~~~ 423 (553)
+++|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||+. +++.+||+|||+|+...
T Consensus 89 ~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~ 161 (307)
T d1a06a_ 89 VSGGELFDRIVE----KGFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED 161 (307)
T ss_dssp CCSCBHHHHHHT----CSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred cCCCcHHHhhhc----ccCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence 999999999964 34699999999999999999999999 999999999999994 57899999999998665
Q ss_pred cccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcC-cccccc---hHHHHHhcCCH--------HHHH
Q 008785 424 WEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLV-LCRRWW---TLYTLVHSMSL--------LCAQ 491 (553)
Q Consensus 424 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~-~~~~~~---~l~~~~~~~~~--------~~~~ 491 (553)
...... ...||+.|||||++.+..++.++|||||||++|||+++ .|.... .+...+..+.. ..++
T Consensus 162 ~~~~~~---~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 238 (307)
T d1a06a_ 162 PGSVLS---TACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISD 238 (307)
T ss_dssp --------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCH
T ss_pred CCCeee---eeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCH
Confidence 433221 23399999999999999999999999999999999983 333332 23333333322 4567
Q ss_pred HHHHHHhhccCCCCCCCCCHHHHHHH
Q 008785 492 ECLMLFISCNNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 492 ~l~~l~~~Cl~~dP~~RPs~~evl~~ 517 (553)
.+.+++.+||+.||++|||+.|++++
T Consensus 239 ~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 239 SAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 89999999999999999999999986
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.4e-48 Score=390.78 Aligned_cols=250 Identities=24% Similarity=0.337 Sum_probs=204.8
Q ss_pred hcccCCCCeeecccCceeEEEEEeC------CCCEEEEEEeccCC-hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCc
Q 008785 267 TKNFSEGNRLLGDSKTGGTYSGILP------DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGD 339 (553)
Q Consensus 267 ~~~~~~~~~~iG~G~~g~Vy~~~~~------~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 339 (553)
.++|...++ ||+|+||+||+|+.+ +++.||||+++... ....++|.+|+.+|++++||||+++++++.+.+.
T Consensus 12 ~~~~~~~~~-lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 90 (301)
T d1lufa_ 12 RNNIEYVRD-IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 90 (301)
T ss_dssp GGGCEEEEE-EEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred HHHcEEeEE-EeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCc
Confidence 345555444 599999999999863 35789999997653 3346789999999999999999999999999999
Q ss_pred eEEEEEccCCCCHHHHhccCC--------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCC
Q 008785 340 RYIVYEFVVNGPLDRWLHHIP--------------------RGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIR 399 (553)
Q Consensus 340 ~~lV~E~~~~gsL~~~l~~~~--------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlk 399 (553)
.+++|||+++|+|.+++.... .....+++..++.|+.|++.||+|||++ +|+|||||
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivHrDlK 167 (301)
T d1lufa_ 91 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLA 167 (301)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCS
T ss_pred eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeEeeEEc
Confidence 999999999999999996421 1123589999999999999999999999 99999999
Q ss_pred CCcEEecCCCCeEEeeccccccCCcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcC--ccccc--
Q 008785 400 ASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLV--LCRRW-- 475 (553)
Q Consensus 400 p~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~--~~~~~-- 475 (553)
|+|||++.++.+||+|||+|+...............||+.|+|||.+.+..+|.++|||||||++|||++. .|...
T Consensus 168 p~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~ 247 (301)
T d1lufa_ 168 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 247 (301)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred ccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCC
Confidence 99999999999999999999876554433333344588999999999999999999999999999999973 23332
Q ss_pred -chHHHHHhcCCH-----HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 008785 476 -WTLYTLVHSMSL-----LCAQECLMLFISCNNWPSHLSQSKFCNLKLWVF 520 (553)
Q Consensus 476 -~~l~~~~~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~ 520 (553)
.++...+..+.. ..+.++.+|+.+||+.||++||||.||++.|..
T Consensus 248 ~~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~ 298 (301)
T d1lufa_ 248 HEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQR 298 (301)
T ss_dssp HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 233445555543 567789999999999999999999999987754
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-48 Score=391.51 Aligned_cols=234 Identities=23% Similarity=0.303 Sum_probs=194.3
Q ss_pred cCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCC---hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEE
Q 008785 270 FSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYE 345 (553)
Q Consensus 270 ~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 345 (553)
|...++ ||+|+||+||+|+.. +|+.||||+++... ....+.+.+|+.+|++++|||||++++++.+++..|+|||
T Consensus 17 y~~l~~-lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 17 FSDLRE-IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp EEEEEE-EEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cEeeEE-EecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 444444 599999999999964 68899999997653 2334678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcc
Q 008785 346 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE 425 (553)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~ 425 (553)
|+++|+|..++.. ...+++..+..++.||+.||.|||++ ||+||||||+|||+++++.+||+|||+|+.....
T Consensus 96 ~~~~g~l~~~~~~----~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~ 168 (309)
T d1u5ra_ 96 YCLGSASDLLEVH----KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (309)
T ss_dssp CCSEEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred ecCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCCC
Confidence 9999999877654 34699999999999999999999999 9999999999999999999999999999865433
Q ss_pred cccceeeecCccccccccccccC---CCCCcccchHhHHHHHHHHhcC-cccccchHHH----HHhcCCH-----HHHHH
Q 008785 426 VMQERTVMAGGTYGYLAPEFVYR---NELTTKSDVYSFGVLLLEIRLV-LCRRWWTLYT----LVHSMSL-----LCAQE 492 (553)
Q Consensus 426 ~~~~~~~~~~gt~~y~aPE~~~~---~~~t~ksDVwSlGvil~ell~~-~~~~~~~l~~----~~~~~~~-----~~~~~ 492 (553)
. ...||+.|||||++.+ +.|+.++|||||||++|||++. .|.......+ ....... ..+..
T Consensus 169 ~------~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~ 242 (309)
T d1u5ra_ 169 N------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEY 242 (309)
T ss_dssp C------CCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHH
T ss_pred C------ccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHH
Confidence 2 2239999999999864 4689999999999999999983 3333322222 2222211 46778
Q ss_pred HHHHHhhccCCCCCCCCCHHHHHHH
Q 008785 493 CLMLFISCNNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 493 l~~l~~~Cl~~dP~~RPs~~evl~~ 517 (553)
+.+|+.+||+.||++|||+.|++++
T Consensus 243 ~~~li~~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 243 FRNFVDSCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred HHHHHHHHCcCChhHCcCHHHHHhC
Confidence 9999999999999999999999986
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-48 Score=383.10 Aligned_cols=243 Identities=24% Similarity=0.304 Sum_probs=191.3
Q ss_pred CeeecccCceeEEEEEeCC----CCEEEEEEeccC-ChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccC
Q 008785 274 NRLLGDSKTGGTYSGILPD----GSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV 348 (553)
Q Consensus 274 ~~~iG~G~~g~Vy~~~~~~----g~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 348 (553)
.+.||+|+||.||+|++.. +..||||.++.. .....+.+.+|+.+|++++|||||+++|++. ++..++||||++
T Consensus 12 ~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv~E~~~ 90 (273)
T d1mp8a_ 12 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCT 90 (273)
T ss_dssp EEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECCT
T ss_pred EEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEEEEecc
Confidence 3467999999999998643 347999998754 3344678999999999999999999999985 467899999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCccccc
Q 008785 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ 428 (553)
Q Consensus 349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 428 (553)
+|+|.+++.. ....+++..++.++.||+.||.|||++ +|+||||||+||++++++.+||+|||+|+........
T Consensus 91 ~g~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~~ 164 (273)
T d1mp8a_ 91 LGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY 164 (273)
T ss_dssp TEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-------------
T ss_pred CCcHHhhhhc---cCCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhheeccCCcce
Confidence 9999998765 335689999999999999999999999 9999999999999999999999999999876544332
Q ss_pred ceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhc-Cc-cc---ccchHHHHHhcCCH-----HHHHHHHHHHh
Q 008785 429 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-VL-CR---RWWTLYTLVHSMSL-----LCAQECLMLFI 498 (553)
Q Consensus 429 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-~~-~~---~~~~l~~~~~~~~~-----~~~~~l~~l~~ 498 (553)
... ...||+.|+|||++.+..++.++|||||||++|||++ .. |. ....+...+..+.. ..+..+.+|+.
T Consensus 165 ~~~-~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~ 243 (273)
T d1mp8a_ 165 KAS-KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMT 243 (273)
T ss_dssp -------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred ecc-ceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Confidence 222 2338999999999999999999999999999999986 22 22 23344444444432 56788999999
Q ss_pred hccCCCCCCCCCHHHHHHHHHHHHhh
Q 008785 499 SCNNWPSHLSQSKFCNLKLWVFAILT 524 (553)
Q Consensus 499 ~Cl~~dP~~RPs~~evl~~l~~~~~~ 524 (553)
+||+.||++|||+.||+++|...+.+
T Consensus 244 ~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 244 KCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp HHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 99999999999999999998765544
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-48 Score=395.16 Aligned_cols=242 Identities=19% Similarity=0.236 Sum_probs=196.3
Q ss_pred cccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccC-ChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEE
Q 008785 268 KNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYE 345 (553)
Q Consensus 268 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 345 (553)
++|...+ .||+|+||+||+|... +|+.||+|+++.. .....+.+.+|+.+|++++|||||++++++.+.+..++|||
T Consensus 6 d~y~~~~-~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 6 DDFEKIS-ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGEEEEE-EEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cCCEEEE-EEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 4555544 4599999999999964 5899999999765 33445789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCceecCCCCCcEEecCCCCeEEeeccccccCCc
Q 008785 346 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD-KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW 424 (553)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~ 424 (553)
|+++|+|.+++.. ...+++..+..++.||+.||.|||+ + +|+||||||+|||+++++.+||+|||+|+....
T Consensus 85 y~~gg~L~~~l~~----~~~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 157 (322)
T d1s9ja_ 85 HMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 157 (322)
T ss_dssp CCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred cCCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCCCccccCC
Confidence 9999999999964 2358999999999999999999996 6 899999999999999999999999999986543
Q ss_pred ccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcC-cccccch---HHH---HHhcCC-----------
Q 008785 425 EVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLV-LCRRWWT---LYT---LVHSMS----------- 486 (553)
Q Consensus 425 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~-~~~~~~~---l~~---~~~~~~----------- 486 (553)
... ....||+.|+|||++.+.+|+.++||||+||++|||++. .|....+ ... ....+.
T Consensus 158 ~~~----~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (322)
T d1s9ja_ 158 SMA----NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 233 (322)
T ss_dssp HTC-------CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------
T ss_pred Ccc----ccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccc
Confidence 221 123499999999999999999999999999999999973 2322111 100 000000
Q ss_pred ----------------H------------------HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 008785 487 ----------------L------------------LCAQECLMLFISCNNWPSHLSQSKFCNLKLWVFA 521 (553)
Q Consensus 487 ----------------~------------------~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~~ 521 (553)
. ..+.++.+++.+||..||++|||+.|+|++-...
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~ 302 (322)
T d1s9ja_ 234 GRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIK 302 (322)
T ss_dssp ------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred cccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhC
Confidence 0 1245789999999999999999999999984443
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=8.5e-48 Score=392.35 Aligned_cols=239 Identities=17% Similarity=0.192 Sum_probs=202.4
Q ss_pred ccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEcc
Q 008785 269 NFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV 347 (553)
Q Consensus 269 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 347 (553)
.|.. .+.||+|+||.||+|... +|+.||||+++.........+.+|+.+|++++|||||++++++.+++..|+||||+
T Consensus 30 ~Y~i-~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 30 YYDI-LEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp TEEE-EEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred ceEE-EEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 3444 345699999999999964 69999999998776666778999999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEec--CCCCeEEeeccccccCCcc
Q 008785 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD--EEFGAHLMGVGLSKFVPWE 425 (553)
Q Consensus 348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~--~~~~~kl~Dfgla~~~~~~ 425 (553)
++|+|.+++.. ....+++.++..++.||+.||+|||++ ||+||||||+|||++ .++.+||+|||+|+.....
T Consensus 109 ~gg~L~~~~~~---~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~ 182 (352)
T d1koba_ 109 SGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 182 (352)
T ss_dssp CCCBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCChHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCCC
Confidence 99999988754 345699999999999999999999999 999999999999998 5689999999999877654
Q ss_pred cccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcC-cccccc---hHHHHHhcCCH--------HHHHHH
Q 008785 426 VMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLV-LCRRWW---TLYTLVHSMSL--------LCAQEC 493 (553)
Q Consensus 426 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~-~~~~~~---~l~~~~~~~~~--------~~~~~l 493 (553)
... ....||+.|+|||++.+..++.++|||||||++|||+++ .|.... .+...+..+.. ..+.++
T Consensus 183 ~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 259 (352)
T d1koba_ 183 EIV---KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEA 259 (352)
T ss_dssp SCE---EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHH
T ss_pred Cce---eeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHH
Confidence 322 223399999999999999999999999999999999983 333332 23333333322 467789
Q ss_pred HHHHhhccCCCCCCCCCHHHHHHH
Q 008785 494 LMLFISCNNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 494 ~~l~~~Cl~~dP~~RPs~~evl~~ 517 (553)
.+|+.+||+.||++|||+.|++++
T Consensus 260 ~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 260 KDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHccCChhHCcCHHHHhcC
Confidence 999999999999999999999986
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-48 Score=383.53 Aligned_cols=238 Identities=17% Similarity=0.209 Sum_probs=198.1
Q ss_pred ccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCCh------hhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceE
Q 008785 269 NFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF------QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRY 341 (553)
Q Consensus 269 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~------~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 341 (553)
.|... +.||+|+||+||+|... +|+.||||++++... ...+.+.+|+.+|++++|||||++++++.+.+..|
T Consensus 11 ~Y~~~-~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 11 YYDTG-EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp TEEEE-EEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CEEEe-EEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 34443 45699999999999974 699999999975421 23578999999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCC----CeEEeecc
Q 008785 342 IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF----GAHLMGVG 417 (553)
Q Consensus 342 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~----~~kl~Dfg 417 (553)
|||||+++|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++ .+|++|||
T Consensus 90 iv~E~~~gg~L~~~i~~----~~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG 162 (293)
T d1jksa_ 90 LILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFG 162 (293)
T ss_dssp EEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEcCCCccccchhcc----ccccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecchh
Confidence 99999999999999965 24699999999999999999999999 999999999999998776 49999999
Q ss_pred ccccCCcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcC-cccccc---hHHHHHhcCCH------
Q 008785 418 LSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLV-LCRRWW---TLYTLVHSMSL------ 487 (553)
Q Consensus 418 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~-~~~~~~---~l~~~~~~~~~------ 487 (553)
+|.......... ...||+.|+|||++.+..++.++|||||||++|||++. .|.... .....+..+..
T Consensus 163 ~a~~~~~~~~~~---~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 239 (293)
T d1jksa_ 163 LAHKIDFGNEFK---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY 239 (293)
T ss_dssp TCEECTTSCBCS---CCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHH
T ss_pred hhhhcCCCcccc---ccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchh
Confidence 998765443222 22389999999999999999999999999999999973 333322 23333333332
Q ss_pred --HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008785 488 --LCAQECLMLFISCNNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 488 --~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 517 (553)
..+..+.+|+.+||+.||++|||+.|++++
T Consensus 240 ~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 240 FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred cCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 345678999999999999999999999986
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-47 Score=386.18 Aligned_cols=245 Identities=20% Similarity=0.314 Sum_probs=197.6
Q ss_pred cCCCCeeecccCceeEEEEEeC-CCC----EEEEEEeccC-ChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEE
Q 008785 270 FSEGNRLLGDSKTGGTYSGILP-DGS----RVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIV 343 (553)
Q Consensus 270 ~~~~~~~iG~G~~g~Vy~~~~~-~g~----~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 343 (553)
|... ++||+|+||+||+|.+. +|+ +||+|.++.. +....++|.+|+.++++++|||||+++|++.++ ..+++
T Consensus 11 y~~~-~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v 88 (317)
T d1xkka_ 11 FKKI-KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLI 88 (317)
T ss_dssp EEEE-EEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEE
T ss_pred CEEe-eEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEE
Confidence 4443 45699999999999864 344 6899998754 344567899999999999999999999998764 67888
Q ss_pred EEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCC
Q 008785 344 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVP 423 (553)
Q Consensus 344 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~ 423 (553)
+||+.+|+|.+++.. ....+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+...
T Consensus 89 ~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 89 TQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 162 (317)
T ss_dssp EECCTTCBHHHHHHH---TSSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred EEeccCCcccccccc---cccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceecc
Confidence 999999999998875 345699999999999999999999999 99999999999999999999999999998776
Q ss_pred cccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhc-Cc-cc---ccchHHHHHhcCCH-----HHHHHH
Q 008785 424 WEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-VL-CR---RWWTLYTLVHSMSL-----LCAQEC 493 (553)
Q Consensus 424 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-~~-~~---~~~~l~~~~~~~~~-----~~~~~l 493 (553)
............||+.|+|||++.++.++.++|||||||++|||++ .. |. ....+...+..+.. ..+..+
T Consensus 163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~~ 242 (317)
T d1xkka_ 163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDV 242 (317)
T ss_dssp TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCCCTTBCHHH
T ss_pred cccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHH
Confidence 5444333333348999999999999999999999999999999997 22 22 22345555554432 567789
Q ss_pred HHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 008785 494 LMLFISCNNWPSHLSQSKFCNLKLWVFAI 522 (553)
Q Consensus 494 ~~l~~~Cl~~dP~~RPs~~evl~~l~~~~ 522 (553)
.+|+.+||+.||++|||+.||++++....
T Consensus 243 ~~li~~cl~~dP~~RPs~~eil~~l~~~~ 271 (317)
T d1xkka_ 243 YMIMVKCWMIDADSRPKFRELIIEFSKMA 271 (317)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHhCCCChhhCcCHHHHHHHHHHHH
Confidence 99999999999999999999999976654
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-47 Score=383.53 Aligned_cols=252 Identities=23% Similarity=0.276 Sum_probs=194.0
Q ss_pred ccCCCCeeecccCceeEEEEEeC------CCCEEEEEEeccC-ChhhHHHHHHHHHHhhcc-CCCceeeEeeEEeeCC-c
Q 008785 269 NFSEGNRLLGDSKTGGTYSGILP------DGSRVAVKRLKRS-SFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHG-D 339 (553)
Q Consensus 269 ~~~~~~~~iG~G~~g~Vy~~~~~------~g~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~-~ 339 (553)
+|... +.||+|+||.||+|... +++.||||+++.. .....+.+.+|...+.++ +||||+.+++++.+.+ .
T Consensus 14 ~y~~~-~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~ 92 (299)
T d1ywna1 14 RLKLG-KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 92 (299)
T ss_dssp GEEEE-EEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred HEEEe-eEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCe
Confidence 34333 45699999999999853 2468999999764 334456788888888887 7899999999987654 5
Q ss_pred eEEEEEccCCCCHHHHhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecC
Q 008785 340 RYIVYEFVVNGPLDRWLHHIPR------------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE 407 (553)
Q Consensus 340 ~~lV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~ 407 (553)
.++||||+++|+|.++|+.... ....+++.++..++.||+.||+|||++ +|+||||||+|||+++
T Consensus 93 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NILl~~ 169 (299)
T d1ywna1 93 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSE 169 (299)
T ss_dssp CEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECG
T ss_pred EEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCccceeECC
Confidence 8999999999999999975321 124589999999999999999999999 9999999999999999
Q ss_pred CCCeEEeeccccccCCcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcC--ccccc----chHHHH
Q 008785 408 EFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLV--LCRRW----WTLYTL 481 (553)
Q Consensus 408 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~--~~~~~----~~l~~~ 481 (553)
++.+||+|||+|+...............||+.|+|||++.+..++.++|||||||++|||++. .|... ..+...
T Consensus 170 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~ 249 (299)
T d1ywna1 170 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 249 (299)
T ss_dssp GGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHH
T ss_pred CCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 999999999999876544333333333499999999999999999999999999999999972 22222 123334
Q ss_pred HhcCCH-----HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHhh
Q 008785 482 VHSMSL-----LCAQECLMLFISCNNWPSHLSQSKFCNLKLWVFAILT 524 (553)
Q Consensus 482 ~~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~~~~~ 524 (553)
+..+.. ..++++.+++.+||+.||++|||+.|++++|...+..
T Consensus 250 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~ 297 (299)
T d1ywna1 250 LKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297 (299)
T ss_dssp HHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 444332 5667899999999999999999999999998776644
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-48 Score=377.45 Aligned_cols=233 Identities=27% Similarity=0.374 Sum_probs=189.5
Q ss_pred eeecccCceeEEEEEeCCCCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeEEee-CCceEEEEEccCCCCHH
Q 008785 275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD-HGDRYIVYEFVVNGPLD 353 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~~lV~E~~~~gsL~ 353 (553)
+.||+|+||.||+|.+ .|+.||||+++.. ...+.+.+|++++++++||||++++|++.+ .+..++||||+++|+|.
T Consensus 13 ~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L~ 89 (262)
T d1byga_ 13 QTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLV 89 (262)
T ss_dssp EEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHH
T ss_pred EEEecCCCeEEEEEEE-CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCCHH
Confidence 3469999999999998 5789999999764 345779999999999999999999999865 45689999999999999
Q ss_pred HHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccceeee
Q 008785 354 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVM 433 (553)
Q Consensus 354 ~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 433 (553)
++|.. +....+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 90 ~~l~~--~~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~-----~~ 159 (262)
T d1byga_ 90 DYLRS--RGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----DT 159 (262)
T ss_dssp HHHHH--HHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC---------------
T ss_pred HHHHh--cCCCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCCCC-----cc
Confidence 99965 2223589999999999999999999999 99999999999999999999999999998654322 12
Q ss_pred cCccccccccccccCCCCCcccchHhHHHHHHHHhc-Cccc----ccchHHHHHhcCCH-----HHHHHHHHHHhhccCC
Q 008785 434 AGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-VLCR----RWWTLYTLVHSMSL-----LCAQECLMLFISCNNW 503 (553)
Q Consensus 434 ~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-~~~~----~~~~l~~~~~~~~~-----~~~~~l~~l~~~Cl~~ 503 (553)
..+|+.|+|||++.++.++.++||||||+++|||++ ..++ ...++...+.++.. ..++.+.+|+.+||+.
T Consensus 160 ~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~ 239 (262)
T d1byga_ 160 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHL 239 (262)
T ss_dssp --CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred ccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHccc
Confidence 237899999999999999999999999999999997 3332 22344445544332 5667899999999999
Q ss_pred CCCCCCCHHHHHHHHHH
Q 008785 504 PSHLSQSKFCNLKLWVF 520 (553)
Q Consensus 504 dP~~RPs~~evl~~l~~ 520 (553)
||++|||+.|++++|..
T Consensus 240 dP~~Rps~~~l~~~L~~ 256 (262)
T d1byga_ 240 DAAMRPSFLQLREQLEH 256 (262)
T ss_dssp SGGGSCCHHHHHHHHHH
T ss_pred CHhHCcCHHHHHHHHHH
Confidence 99999999999998754
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-47 Score=379.43 Aligned_cols=244 Identities=24% Similarity=0.345 Sum_probs=199.8
Q ss_pred eeecccCceeEEEEEeCCC----CEEEEEEeccC-ChhhHHHHHHHHHHhhccCCCceeeEeeEEeeC-CceEEEEEccC
Q 008785 275 RLLGDSKTGGTYSGILPDG----SRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH-GDRYIVYEFVV 348 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~~g----~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~-~~~~lV~E~~~ 348 (553)
++||+|+||+||+|.+.++ ..||||+++.. +....++|.+|+++|++++||||++++|++.+. +..++||||++
T Consensus 33 ~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~~ 112 (311)
T d1r0pa_ 33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMK 112 (311)
T ss_dssp EEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECCT
T ss_pred eEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEee
Confidence 4679999999999997542 26999999753 455568899999999999999999999998764 57899999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCccccc
Q 008785 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ 428 (553)
Q Consensus 349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 428 (553)
+|+|.+++.. ....+++..++.++.|++.||.|||+. +|+||||||+|||+++++.+||+|||+++........
T Consensus 113 ~g~l~~~~~~---~~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 113 HGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp TCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred cCchhhhhcc---ccccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence 9999999875 344678889999999999999999999 9999999999999999999999999999876544222
Q ss_pred c--eeeecCccccccccccccCCCCCcccchHhHHHHHHHHhc-Cccccc----chHHHHHhcCCH-----HHHHHHHHH
Q 008785 429 E--RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-VLCRRW----WTLYTLVHSMSL-----LCAQECLML 496 (553)
Q Consensus 429 ~--~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-~~~~~~----~~l~~~~~~~~~-----~~~~~l~~l 496 (553)
. ......||+.|+|||.+..+.++.++||||||+++|||++ ..|... .++...+..+.. ..+..+.+|
T Consensus 187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~~~~~l~~l 266 (311)
T d1r0pa_ 187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEV 266 (311)
T ss_dssp CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCcccCcHHHHHH
Confidence 1 1112238999999999999999999999999999999997 333222 122233333332 556789999
Q ss_pred HhhccCCCCCCCCCHHHHHHHHHHHHhh
Q 008785 497 FISCNNWPSHLSQSKFCNLKLWVFAILT 524 (553)
Q Consensus 497 ~~~Cl~~dP~~RPs~~evl~~l~~~~~~ 524 (553)
+.+||+.||++|||+.||+++|......
T Consensus 267 i~~cl~~dP~~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 267 MLKCWHPKAEMRPSFSELVSRISAIFST 294 (311)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 9999999999999999999998665543
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-47 Score=382.60 Aligned_cols=244 Identities=26% Similarity=0.362 Sum_probs=199.2
Q ss_pred eeecccCceeEEEEEeCC-CC--EEEEEEeccC-ChhhHHHHHHHHHHhhcc-CCCceeeEeeEEeeCCceEEEEEccCC
Q 008785 275 RLLGDSKTGGTYSGILPD-GS--RVAVKRLKRS-SFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVN 349 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~~-g~--~vAvK~~~~~-~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~~ 349 (553)
+.||+|+||.||+|++++ |. .||||+++.. .....++|.+|+++|+++ +|||||+++|++.+.+..++||||+++
T Consensus 16 ~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~~~ 95 (309)
T d1fvra_ 16 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 95 (309)
T ss_dssp EEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTT
T ss_pred EEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEecCC
Confidence 456999999999999754 43 5788888654 334556899999999999 799999999999999999999999999
Q ss_pred CCHHHHhccCC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeecc
Q 008785 350 GPLDRWLHHIP------------RGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVG 417 (553)
Q Consensus 350 gsL~~~l~~~~------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfg 417 (553)
|+|.++|+... .....+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||
T Consensus 96 g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~kl~DfG 172 (309)
T d1fvra_ 96 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG 172 (309)
T ss_dssp CBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTT
T ss_pred CcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCceEEcccc
Confidence 99999997531 2345699999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcC-c-ccccc---hHHHHHhcCCH-----
Q 008785 418 LSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLV-L-CRRWW---TLYTLVHSMSL----- 487 (553)
Q Consensus 418 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~-~-~~~~~---~l~~~~~~~~~----- 487 (553)
+++......... ...||..|+|||.+.+..++.++|||||||++|||++. . +.... .+.+.+..+..
T Consensus 173 ~a~~~~~~~~~~---~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~~~~~~~ 249 (309)
T d1fvra_ 173 LSRGQEVYVKKT---MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPL 249 (309)
T ss_dssp CEESSCEECCC-------CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCCCCCCT
T ss_pred cccccccccccc---ceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCCc
Confidence 998655433222 22389999999999999999999999999999999972 2 33332 33334444322
Q ss_pred HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHhh
Q 008785 488 LCAQECLMLFISCNNWPSHLSQSKFCNLKLWVFAILT 524 (553)
Q Consensus 488 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~~~~~ 524 (553)
..+..+.+|+.+||+.||++||||.||+++|...+.+
T Consensus 250 ~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 286 (309)
T d1fvra_ 250 NCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 286 (309)
T ss_dssp TBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 5678899999999999999999999999997665543
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-47 Score=384.02 Aligned_cols=240 Identities=22% Similarity=0.216 Sum_probs=201.6
Q ss_pred cccCCCCeeecccCceeEEEEEe-CCCCEEEEEEeccCC---hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEE
Q 008785 268 KNFSEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIV 343 (553)
Q Consensus 268 ~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 343 (553)
++|... ++||+|+||.||+++. .+|+.||||++++.. ....+.+.+|+.+|++++||||+++++++.+.+..|+|
T Consensus 5 ~dy~~~-~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 5 NDFDYL-KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGEEEE-EEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred HhcEEE-EEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 345444 4569999999999996 469999999997642 23457789999999999999999999999999999999
Q ss_pred EEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCC
Q 008785 344 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVP 423 (553)
Q Consensus 344 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~ 423 (553)
|||+++|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+...
T Consensus 84 ~ey~~gg~L~~~~~~----~~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~ 156 (337)
T d1o6la_ 84 MEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp EECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred eeccCCCchhhhhhc----ccCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeecccccccc
Confidence 999999999999875 34689999999999999999999999 99999999999999999999999999998765
Q ss_pred cccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcC-cccccc---hHHHHHhcCCH----HHHHHHHH
Q 008785 424 WEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLV-LCRRWW---TLYTLVHSMSL----LCAQECLM 495 (553)
Q Consensus 424 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~-~~~~~~---~l~~~~~~~~~----~~~~~l~~ 495 (553)
...... ....||+.|+|||++.+..|+.++|||||||++|||+++ .|.... .+.+.+..+.. ..+.++.+
T Consensus 157 ~~~~~~--~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~d 234 (337)
T d1o6la_ 157 SDGATM--KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKS 234 (337)
T ss_dssp CTTCCB--CCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHH
T ss_pred cCCccc--ccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHH
Confidence 433222 223399999999999999999999999999999999973 333333 34444444444 56778899
Q ss_pred HHhhccCCCCCCCCC-----HHHHHHH
Q 008785 496 LFISCNNWPSHLSQS-----KFCNLKL 517 (553)
Q Consensus 496 l~~~Cl~~dP~~RPs-----~~evl~~ 517 (553)
|+.+||+.||++||+ +.|++++
T Consensus 235 li~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 235 LLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp HHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred HHHhhccCCchhhcccccccHHHHHcC
Confidence 999999999999995 8999886
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-47 Score=382.26 Aligned_cols=249 Identities=23% Similarity=0.288 Sum_probs=206.1
Q ss_pred CeeecccCceeEEEEEe------CCCCEEEEEEeccCC-hhhHHHHHHHHHHhhcc-CCCceeeEeeEEeeCCceEEEEE
Q 008785 274 NRLLGDSKTGGTYSGIL------PDGSRVAVKRLKRSS-FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYE 345 (553)
Q Consensus 274 ~~~iG~G~~g~Vy~~~~------~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E 345 (553)
.+.||+|+||.||+|++ .+++.||||+++... .....++.+|+.+++++ +|||||+++|++.+.+..++|||
T Consensus 28 ~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~lvmE 107 (311)
T d1t46a_ 28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITE 107 (311)
T ss_dssp EEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred eeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEEEEEEE
Confidence 34669999999999985 236689999997653 34556799999999999 79999999999999999999999
Q ss_pred ccCCCCHHHHhccCCC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCe
Q 008785 346 FVVNGPLDRWLHHIPR--------------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGA 411 (553)
Q Consensus 346 ~~~~gsL~~~l~~~~~--------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~ 411 (553)
|+++|+|.++++.... ....+++..+..++.||+.||+|||++ +++||||||+||+++.++.+
T Consensus 108 ~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NIl~~~~~~~ 184 (311)
T d1t46a_ 108 YCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRIT 184 (311)
T ss_dssp CCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEETTTEE
T ss_pred cCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccccccccccccCcc
Confidence 9999999999975321 233589999999999999999999999 99999999999999999999
Q ss_pred EEeeccccccCCcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhc-Ccccc-c----chHHHHHhcC
Q 008785 412 HLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-VLCRR-W----WTLYTLVHSM 485 (553)
Q Consensus 412 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-~~~~~-~----~~l~~~~~~~ 485 (553)
|++|||+++...............||+.|+|||++.++.++.++||||||+++|||++ ..+.. . ..+.+.+..+
T Consensus 185 ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~i~~~ 264 (311)
T d1t46a_ 185 KICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEG 264 (311)
T ss_dssp EECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHT
T ss_pred cccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcC
Confidence 9999999997765443333333448999999999999999999999999999999997 32221 1 1233344443
Q ss_pred CH-----HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHhhc
Q 008785 486 SL-----LCAQECLMLFISCNNWPSHLSQSKFCNLKLWVFAILTI 525 (553)
Q Consensus 486 ~~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~~~~~~ 525 (553)
.. ..+..+.+|+.+||+.||++|||+.||++.|...+.+.
T Consensus 265 ~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~~ 309 (311)
T d1t46a_ 265 FRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309 (311)
T ss_dssp CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred CCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhccC
Confidence 32 56788999999999999999999999999888776553
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-46 Score=375.64 Aligned_cols=245 Identities=24% Similarity=0.321 Sum_probs=198.9
Q ss_pred eeecccCceeEEEEEeCC--------CCEEEEEEeccCC-hhhHHHHHHHHHHhhcc-CCCceeeEeeEEeeCCceEEEE
Q 008785 275 RLLGDSKTGGTYSGILPD--------GSRVAVKRLKRSS-FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVY 344 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~~--------g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~ 344 (553)
+.||+|+||.||+|+... +..||||+++... .....++.+|...+.++ +|||||++++++.+++..++||
T Consensus 19 ~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~~~~v~ 98 (299)
T d1fgka_ 19 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIV 98 (299)
T ss_dssp EECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred eEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCeEEEEE
Confidence 456999999999998532 3479999997653 34457889999999998 8999999999999999999999
Q ss_pred EccCCCCHHHHhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeE
Q 008785 345 EFVVNGPLDRWLHHIPR------------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAH 412 (553)
Q Consensus 345 E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~k 412 (553)
||+++|+|.++|..... ....+++.+++.++.||+.||+|||++ +|+||||||+|||++.++.+|
T Consensus 99 e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiLl~~~~~~k 175 (299)
T d1fgka_ 99 EYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMK 175 (299)
T ss_dssp CCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEE
T ss_pred EccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccceeecCCCCeE
Confidence 99999999999975321 134589999999999999999999999 999999999999999999999
Q ss_pred EeeccccccCCcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhc-Cc-ccccc---hHHHHHhcCCH
Q 008785 413 LMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-VL-CRRWW---TLYTLVHSMSL 487 (553)
Q Consensus 413 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-~~-~~~~~---~l~~~~~~~~~ 487 (553)
|+|||+++...............||+.|+|||.+.++.|+.++||||||+++|||++ .. |.... .+.+.+..+..
T Consensus 176 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~~i~~~~~ 255 (299)
T d1fgka_ 176 IADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHR 255 (299)
T ss_dssp ECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC
T ss_pred eccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHHHHHcCCC
Confidence 999999987765544443344458999999999999999999999999999999997 23 22222 23334444432
Q ss_pred -----HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 008785 488 -----LCAQECLMLFISCNNWPSHLSQSKFCNLKLWVFAI 522 (553)
Q Consensus 488 -----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~~~ 522 (553)
..+..+.+|+.+||+.||++|||+.||++.|...+
T Consensus 256 ~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~ 295 (299)
T d1fgka_ 256 MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295 (299)
T ss_dssp CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence 56678999999999999999999999999886554
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-47 Score=378.75 Aligned_cols=244 Identities=22% Similarity=0.332 Sum_probs=201.7
Q ss_pred eeecccCceeEEEEEeC------CCCEEEEEEeccC-ChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEcc
Q 008785 275 RLLGDSKTGGTYSGILP------DGSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV 347 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~------~g~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 347 (553)
+.||+|+||.||+|.+. +++.||||+++.. .......|.+|+.++++++|||||+++|++...+..++||||+
T Consensus 26 ~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~ 105 (308)
T d1p4oa_ 26 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELM 105 (308)
T ss_dssp EEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred eEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCceeEEEeec
Confidence 45699999999999863 3578999999764 3344567899999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCC------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeecccccc
Q 008785 348 VNGPLDRWLHHIP------RGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF 421 (553)
Q Consensus 348 ~~gsL~~~l~~~~------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~ 421 (553)
++|+|.+++.... .....+++..+..++.|+|.||.|||++ +|+||||||+|||+++++.+||+|||+|+.
T Consensus 106 ~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~Kl~DFGla~~ 182 (308)
T d1p4oa_ 106 TRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRD 182 (308)
T ss_dssp TTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEECCTTCCCG
T ss_pred CCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceEEEeeccccee
Confidence 9999999986421 1224578999999999999999999999 999999999999999999999999999987
Q ss_pred CCcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcC--cccccc---hHHHHHhcCCH-----HHHH
Q 008785 422 VPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLV--LCRRWW---TLYTLVHSMSL-----LCAQ 491 (553)
Q Consensus 422 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~--~~~~~~---~l~~~~~~~~~-----~~~~ 491 (553)
..............||+.|+|||.+.+..++.++||||||+++|||++. .|.... ...+.+..+.. ..+.
T Consensus 183 ~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~ 262 (308)
T d1p4oa_ 183 IYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPD 262 (308)
T ss_dssp GGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCH
T ss_pred ccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCCCCCCcccchH
Confidence 6544333322223389999999999999999999999999999999973 333333 23334444333 5667
Q ss_pred HHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 008785 492 ECLMLFISCNNWPSHLSQSKFCNLKLWVFA 521 (553)
Q Consensus 492 ~l~~l~~~Cl~~dP~~RPs~~evl~~l~~~ 521 (553)
.+.+++.+||+.||++|||+.||+++|...
T Consensus 263 ~l~~li~~cl~~~P~~RPs~~~il~~L~~~ 292 (308)
T d1p4oa_ 263 MLFELMRMCWQYNPKMRPSFLEIISSIKEE 292 (308)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred HHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 899999999999999999999999987443
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-46 Score=377.42 Aligned_cols=240 Identities=13% Similarity=0.112 Sum_probs=199.1
Q ss_pred cccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEc
Q 008785 268 KNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF 346 (553)
Q Consensus 268 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 346 (553)
++|...+ .||+|+||+||+|... +|+.||||+++... .....+.+|+++|++++|||||++++++.+++..|+||||
T Consensus 5 ~rY~i~~-~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 5 EKYMIAE-DLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTEEEEE-EEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred cceEEEE-EEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 3444434 4599999999999975 58899999998764 3446688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCC--CCeEEeeccccccCCc
Q 008785 347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE--FGAHLMGVGLSKFVPW 424 (553)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~--~~~kl~Dfgla~~~~~ 424 (553)
+++|+|.+++.. ....+++.++..++.||+.||+|||++ +|+||||||+|||++.+ ..+||+|||+++....
T Consensus 83 ~~gg~L~~~i~~---~~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~ 156 (321)
T d1tkia_ 83 ISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp CCCCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred CCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhcccc
Confidence 999999999964 334689999999999999999999999 99999999999999854 5799999999987654
Q ss_pred ccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcC-ccccc---chHHHHHhcCCH--------HHHHH
Q 008785 425 EVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLV-LCRRW---WTLYTLVHSMSL--------LCAQE 492 (553)
Q Consensus 425 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~-~~~~~---~~l~~~~~~~~~--------~~~~~ 492 (553)
..... ...+|+.|+|||.+.+..++.++|||||||++|||+++ .|... ..+...+..+.. ..+.+
T Consensus 157 ~~~~~---~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 233 (321)
T d1tkia_ 157 GDNFR---LLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIE 233 (321)
T ss_dssp TCEEE---EEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHH
T ss_pred CCccc---ccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHH
Confidence 33222 22389999999999999999999999999999999973 33322 233334433332 34667
Q ss_pred HHHHHhhccCCCCCCCCCHHHHHHHH
Q 008785 493 CLMLFISCNNWPSHLSQSKFCNLKLW 518 (553)
Q Consensus 493 l~~l~~~Cl~~dP~~RPs~~evl~~l 518 (553)
+.+|+.+||..||++|||+.|++++-
T Consensus 234 ~~~li~~~L~~dp~~R~s~~eil~hp 259 (321)
T d1tkia_ 234 AMDFVDRLLVKERKSRMTASEALQHP 259 (321)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred HHHHHHHHccCChhHCcCHHHHhcCH
Confidence 89999999999999999999999874
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.6e-46 Score=377.65 Aligned_cols=236 Identities=20% Similarity=0.258 Sum_probs=199.1
Q ss_pred ccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCC---hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEE
Q 008785 269 NFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVY 344 (553)
Q Consensus 269 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 344 (553)
+|.... .||+|+||+||+|+.. +|+.||||++++.. ....+.+.+|+.+|++++|||||++++++.+.+..|+||
T Consensus 5 dy~i~~-~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 5 DFQILR-TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GEEEEE-EEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HeEEEE-EEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 454444 4599999999999974 59999999997542 234578899999999999999999999999999999999
Q ss_pred EccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCc
Q 008785 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW 424 (553)
Q Consensus 345 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~ 424 (553)
||++||+|..++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+....
T Consensus 84 E~~~gg~l~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~ 156 (316)
T d1fota_ 84 DYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 156 (316)
T ss_dssp CCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred eecCCccccccccc----cccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEecc
Confidence 99999999998865 34578899999999999999999999 999999999999999999999999999987653
Q ss_pred ccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhc-Ccccccch---HHHHHhcCCH----HHHHHHHHH
Q 008785 425 EVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-VLCRRWWT---LYTLVHSMSL----LCAQECLML 496 (553)
Q Consensus 425 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-~~~~~~~~---l~~~~~~~~~----~~~~~l~~l 496 (553)
... ...||+.|||||++.+..++.++|||||||++|||++ ..|....+ +...+..+.. ..+.++.++
T Consensus 157 ~~~-----~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l 231 (316)
T d1fota_ 157 VTY-----TLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDL 231 (316)
T ss_dssp CBC-----CCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHH
T ss_pred ccc-----cccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 321 2349999999999999999999999999999999998 33433333 3334434433 456789999
Q ss_pred HhhccCCCCCCCC-----CHHHHHHH
Q 008785 497 FISCNNWPSHLSQ-----SKFCNLKL 517 (553)
Q Consensus 497 ~~~Cl~~dP~~RP-----s~~evl~~ 517 (553)
+.+||..||.+|| |+.|++++
T Consensus 232 i~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 232 LSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp HHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred HHHHhhhCHHhccccchhhHHHHHcC
Confidence 9999999999996 99999986
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-46 Score=380.56 Aligned_cols=240 Identities=17% Similarity=0.181 Sum_probs=195.3
Q ss_pred hhcccCCCCeeecccCceeEEEEEe-CCCCEEEEEEeccCChhhHHHHHHHHHHhhcc-CCCceeeEeeEEee----CCc
Q 008785 266 ITKNFSEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYD----HGD 339 (553)
Q Consensus 266 ~~~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~----~~~ 339 (553)
+.++|....++||+|+||.||+|.. .+|+.||||+++.. ..+.+|+.++.++ +|||||++++++.+ +..
T Consensus 9 i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~ 83 (335)
T d2ozaa1 9 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 83 (335)
T ss_dssp GGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred cccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCE
Confidence 3456766667779999999999996 46899999999753 4567899987665 89999999999876 356
Q ss_pred eEEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecC---CCCeEEeec
Q 008785 340 RYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE---EFGAHLMGV 416 (553)
Q Consensus 340 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~---~~~~kl~Df 416 (553)
.|+|||||+||+|.++|.. ++...+++.++..++.||+.||+|||++ +|+||||||+|||+++ ++.+||+||
T Consensus 84 ~~ivmEy~~gg~L~~~i~~--~~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DF 158 (335)
T d2ozaa1 84 LLIVMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDF 158 (335)
T ss_dssp EEEEEECCCSEEHHHHHHS--CSCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCC
T ss_pred EEEEEECCCCCcHHHHHHh--cCCCCcCHHHHHHHHHHHHHHHHHHHHc---CCcccccccccccccccccccccccccc
Confidence 8999999999999999975 3445699999999999999999999999 9999999999999985 457999999
Q ss_pred cccccCCcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcCc-ccccch---HHH----HHhcCCH-
Q 008785 417 GLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVL-CRRWWT---LYT----LVHSMSL- 487 (553)
Q Consensus 417 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~-~~~~~~---l~~----~~~~~~~- 487 (553)
|+|+........ ....||+.|+|||++.+..|+.++|||||||++|||++.. |....+ ... .+..+..
T Consensus 159 G~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~ 235 (335)
T d2ozaa1 159 GFAKETTSHNSL---TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE 235 (335)
T ss_dssp TTCEECCCCCCC---CCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSS
T ss_pred ceeeeccCCCcc---ccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCC
Confidence 999876544322 2234999999999999999999999999999999999843 332221 111 1222221
Q ss_pred -------HHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008785 488 -------LCAQECLMLFISCNNWPSHLSQSKFCNLKLW 518 (553)
Q Consensus 488 -------~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l 518 (553)
..++++.+|+.+||+.||++|||+.|++++-
T Consensus 236 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp 273 (335)
T d2ozaa1 236 FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP 273 (335)
T ss_dssp CCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSH
T ss_pred CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCH
Confidence 4567899999999999999999999999873
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-47 Score=372.14 Aligned_cols=238 Identities=22% Similarity=0.259 Sum_probs=185.8
Q ss_pred eecccCceeEEEEEeCC--C--CEEEEEEeccC---ChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccC
Q 008785 276 LLGDSKTGGTYSGILPD--G--SRVAVKRLKRS---SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV 348 (553)
Q Consensus 276 ~iG~G~~g~Vy~~~~~~--g--~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 348 (553)
.||+|+||.||+|++.. + ..||||++++. .....++|.+|+.+|++++|||||+++|++.+ +..++||||++
T Consensus 15 ~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~lv~e~~~ 93 (273)
T d1u46a_ 15 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMVTELAP 93 (273)
T ss_dssp ECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCT
T ss_pred EEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchheeeeeec
Confidence 35999999999998632 3 37999998754 23445789999999999999999999999975 46789999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCccccc
Q 008785 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ 428 (553)
Q Consensus 349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 428 (553)
+|+|.+++.. ....+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++........
T Consensus 94 ~~~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~~~ 167 (273)
T d1u46a_ 94 LGSLLDRLRK---HQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH 167 (273)
T ss_dssp TCBHHHHHHH---HGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCE
T ss_pred Ccchhhhhhc---ccCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhhcccCCCc
Confidence 9999998864 234599999999999999999999999 9999999999999999999999999999977554332
Q ss_pred ce-eeecCccccccccccccCCCCCcccchHhHHHHHHHHhc--Ccccccch---HHHHH-hcCCH-----HHHHHHHHH
Q 008785 429 ER-TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL--VLCRRWWT---LYTLV-HSMSL-----LCAQECLML 496 (553)
Q Consensus 429 ~~-~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~--~~~~~~~~---l~~~~-~~~~~-----~~~~~l~~l 496 (553)
.. .....||..|+|||++.+..++.++||||||+++|||++ ..|....+ +...+ +.+.. ..+..+.+|
T Consensus 168 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~l 247 (273)
T d1u46a_ 168 YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNV 247 (273)
T ss_dssp EEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHHHHHH
T ss_pred ceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCcccccHHHHHH
Confidence 21 222337889999999999999999999999999999997 23333322 22233 33221 567789999
Q ss_pred HhhccCCCCCCCCCHHHHHHHHHH
Q 008785 497 FISCNNWPSHLSQSKFCNLKLWVF 520 (553)
Q Consensus 497 ~~~Cl~~dP~~RPs~~evl~~l~~ 520 (553)
+.+||+.||++|||+.||++.|..
T Consensus 248 i~~cl~~dp~~RPt~~ei~~~L~~ 271 (273)
T d1u46a_ 248 MVQCWAHKPEDRPTFVALRDFLLE 271 (273)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHcCCChhHCcCHHHHHHHHHh
Confidence 999999999999999999887654
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-45 Score=369.47 Aligned_cols=241 Identities=21% Similarity=0.255 Sum_probs=186.9
Q ss_pred eeecccCceeEEEEEeCCCCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCC----ceEEEEEccCCC
Q 008785 275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHG----DRYIVYEFVVNG 350 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~----~~~lV~E~~~~g 350 (553)
+.||+|+||.||+|++ +|+.||||+++.... .......|+..+.+++|||||++++++.+.+ ..++||||+++|
T Consensus 9 ~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~-~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~g 86 (303)
T d1vjya_ 9 ESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHG 86 (303)
T ss_dssp EEEECCSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTC
T ss_pred EEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEecccCC
Confidence 4569999999999997 789999999975432 2233445666777889999999999998764 479999999999
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCceecCCCCCcEEecCCCCeEEeeccccccCCcc
Q 008785 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV-----KPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE 425 (553)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~-----~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~ 425 (553)
+|.++|+. ..+++..+..++.|+|.||+|||+.. +.+|+||||||+|||+++++.+||+|||+++.....
T Consensus 87 ~L~~~l~~-----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~ 161 (303)
T d1vjya_ 87 SLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSA 161 (303)
T ss_dssp BHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETT
T ss_pred CHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccCC
Confidence 99999975 35899999999999999999999631 249999999999999999999999999999876543
Q ss_pred cccc--eeeecCccccccccccccCC------CCCcccchHhHHHHHHHHhcCcccc-------------------cchH
Q 008785 426 VMQE--RTVMAGGTYGYLAPEFVYRN------ELTTKSDVYSFGVLLLEIRLVLCRR-------------------WWTL 478 (553)
Q Consensus 426 ~~~~--~~~~~~gt~~y~aPE~~~~~------~~t~ksDVwSlGvil~ell~~~~~~-------------------~~~l 478 (553)
.... ......||+.|+|||++.+. .++.++|||||||++|||++..+.. ...+
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (303)
T d1vjya_ 162 TDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 241 (303)
T ss_dssp TTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHH
T ss_pred CcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHHHH
Confidence 2221 12233499999999998754 2678999999999999999632211 0111
Q ss_pred HHHHhcCCH-----------HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 008785 479 YTLVHSMSL-----------LCAQECLMLFISCNNWPSHLSQSKFCNLKLWVFAI 522 (553)
Q Consensus 479 ~~~~~~~~~-----------~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~~~ 522 (553)
.+....+.. .....+.+|+.+||+.||++|||+.||++.|....
T Consensus 242 ~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 296 (303)
T d1vjya_ 242 RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296 (303)
T ss_dssp HHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 112211111 45667999999999999999999999999875443
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-46 Score=373.33 Aligned_cols=234 Identities=21% Similarity=0.225 Sum_probs=186.7
Q ss_pred eeecccCceeEEEEEeC-CCCEEEEEEeccCChhh-----HHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEccC
Q 008785 275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQR-----KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV 348 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~~~-----~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 348 (553)
++||+|+||+||+|... +|+.||||+++...... .+.+.+|+.+|++++|||||++++++.+++..|+||||+.
T Consensus 4 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~ 83 (299)
T d1ua2a_ 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME 83 (299)
T ss_dssp EEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCS
T ss_pred eEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhc
Confidence 46799999999999964 58999999997543221 2468899999999999999999999999999999999998
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCccccc
Q 008785 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ 428 (553)
Q Consensus 349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 428 (553)
++++..+.. ....+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+|+........
T Consensus 84 ~~~~~~~~~----~~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~ 156 (299)
T d1ua2a_ 84 TDLEVIIKD----NSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA 156 (299)
T ss_dssp EEHHHHHTT----CCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC
T ss_pred chHHhhhhh----cccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCccc
Confidence 887766553 345688899999999999999999999 9999999999999999999999999999876544322
Q ss_pred ceeeecCccccccccccccCC-CCCcccchHhHHHHHHHHhcCccc-ccc---hHHHHHhc--C----------------
Q 008785 429 ERTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIRLVLCR-RWW---TLYTLVHS--M---------------- 485 (553)
Q Consensus 429 ~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwSlGvil~ell~~~~~-~~~---~l~~~~~~--~---------------- 485 (553)
.. ...||+.|+|||++... .++.++|||||||++|||+++.+. ... +....+.+ +
T Consensus 157 ~~--~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~ 234 (299)
T d1ua2a_ 157 YT--HQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY 234 (299)
T ss_dssp CC--CSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTC
T ss_pred cc--ceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchh
Confidence 22 22389999999998754 579999999999999999984322 221 11111100 0
Q ss_pred ---------CH-----HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008785 486 ---------SL-----LCAQECLMLFISCNNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 486 ---------~~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 517 (553)
.. ..+..+.+|+.+||..||++|||+.|+|++
T Consensus 235 ~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 235 VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp CCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 00 235678999999999999999999999986
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=3.6e-46 Score=367.98 Aligned_cols=234 Identities=20% Similarity=0.242 Sum_probs=194.7
Q ss_pred CeeecccCceeEEEEEe-CCCCEEEEEEeccCCh---------hhHHHHHHHHHHhhccC-CCceeeEeeEEeeCCceEE
Q 008785 274 NRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSF---------QRKKEFYSEIGRFARLH-HPNLVAVKGCCYDHGDRYI 342 (553)
Q Consensus 274 ~~~iG~G~~g~Vy~~~~-~~g~~vAvK~~~~~~~---------~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~l 342 (553)
.+.||+|+||+||+|+. .+|+.||||+++.... ...+.+.+|+.++++++ ||||+++++++.+++..||
T Consensus 8 ~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~i 87 (277)
T d1phka_ 8 KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFL 87 (277)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred ceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCcceEE
Confidence 44569999999999996 4689999999975421 12356889999999997 9999999999999999999
Q ss_pred EEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccC
Q 008785 343 VYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV 422 (553)
Q Consensus 343 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~ 422 (553)
||||+++|+|.++|+. ...+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 88 vmE~~~~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~ 160 (277)
T d1phka_ 88 VFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQL 160 (277)
T ss_dssp EEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEcCCCchHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccchheeEc
Confidence 9999999999999965 24699999999999999999999999 9999999999999999999999999999877
Q ss_pred CcccccceeeecCccccccccccccC------CCCCcccchHhHHHHHHHHhcC-cccccc---hHHHHHhcCCH-----
Q 008785 423 PWEVMQERTVMAGGTYGYLAPEFVYR------NELTTKSDVYSFGVLLLEIRLV-LCRRWW---TLYTLVHSMSL----- 487 (553)
Q Consensus 423 ~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~t~ksDVwSlGvil~ell~~-~~~~~~---~l~~~~~~~~~----- 487 (553)
....... ...||+.|+|||.+.+ ..++.++||||+||++|||++. .|.... .....+..+..
T Consensus 161 ~~~~~~~---~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~ 237 (277)
T d1phka_ 161 DPGEKLR---EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSP 237 (277)
T ss_dssp CTTCCBC---CCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT
T ss_pred cCCCcee---eeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCc
Confidence 6543221 2239999999999853 3578899999999999999973 333222 23333333322
Q ss_pred ---HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008785 488 ---LCAQECLMLFISCNNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 488 ---~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 517 (553)
..++++.+++.+||+.||++|||+.|++++
T Consensus 238 ~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 238 EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred ccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 567889999999999999999999999875
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=5.9e-46 Score=367.30 Aligned_cols=245 Identities=20% Similarity=0.198 Sum_probs=192.9
Q ss_pred ccCCCCeeecccCceeEEEEEe-CCCCEEEEEEeccCC---hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCc----e
Q 008785 269 NFSEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGD----R 340 (553)
Q Consensus 269 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~----~ 340 (553)
+|.. .+.||+|+||.||+|.. .+|+.||||+++... ......+.+|+.++++++|||||++++++...+. .
T Consensus 8 rY~i-~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~ 86 (277)
T d1o6ya_ 8 RYEL-GEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 86 (277)
T ss_dssp TEEE-EEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred eeEE-eEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence 3433 34669999999999996 468999999997643 3345679999999999999999999999987543 7
Q ss_pred EEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccc
Q 008785 341 YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSK 420 (553)
Q Consensus 341 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~ 420 (553)
|+||||+++|+|.+++.. ...+++.++..++.||+.||+|||++ +|+||||||+|||++.++..+++|||.+.
T Consensus 87 ~lvmE~~~g~~L~~~~~~----~~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 87 YIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIAR 159 (277)
T ss_dssp EEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred EEEEECCCCCEehhhhcc----cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhhh
Confidence 999999999999998864 24589999999999999999999999 99999999999999999999999999987
Q ss_pred cCCccccc-ceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcC-cccccchHHH----HHhcCCH-------
Q 008785 421 FVPWEVMQ-ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLV-LCRRWWTLYT----LVHSMSL------- 487 (553)
Q Consensus 421 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~-~~~~~~~l~~----~~~~~~~------- 487 (553)
........ .......||+.|+|||++.+..++.++|||||||++|||++. .|....+..+ .+..+..
T Consensus 160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (277)
T d1o6ya_ 160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHE 239 (277)
T ss_dssp ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSS
T ss_pred hhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhcc
Confidence 65443221 122233499999999999999999999999999999999983 3333322222 2332221
Q ss_pred HHHHHHHHHHhhccCCCCCCCC-CHHHHHHHHHHH
Q 008785 488 LCAQECLMLFISCNNWPSHLSQ-SKFCNLKLWVFA 521 (553)
Q Consensus 488 ~~~~~l~~l~~~Cl~~dP~~RP-s~~evl~~l~~~ 521 (553)
..+..+.+++.+||+.||++|| |++++++.|...
T Consensus 240 ~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~ 274 (277)
T d1o6ya_ 240 GLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274 (277)
T ss_dssp SCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence 4567899999999999999999 889988877643
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1e-45 Score=376.86 Aligned_cols=237 Identities=19% Similarity=0.188 Sum_probs=199.5
Q ss_pred ccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCC---hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEE
Q 008785 269 NFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVY 344 (553)
Q Consensus 269 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 344 (553)
+|.... .||+|+||.||+|+.. +|+.||||++++.. ....+.+.+|+.+|++++|||||++++++.+....++||
T Consensus 42 ~y~i~~-~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 42 QFDRIK-TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GEEEEE-EEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CeEEEE-EeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 454444 4599999999999974 69999999997532 233567899999999999999999999999999999999
Q ss_pred EccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCc
Q 008785 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW 424 (553)
Q Consensus 345 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~ 424 (553)
||+.+|+|.+++.. ...+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+|+....
T Consensus 121 e~~~~g~l~~~l~~----~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~ 193 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp ECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred ccccccchhhhHhh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence 99999999999865 23589999999999999999999999 999999999999999999999999999987653
Q ss_pred ccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhc-Ccccccch---HHHHHhcCCH----HHHHHHHHH
Q 008785 425 EVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-VLCRRWWT---LYTLVHSMSL----LCAQECLML 496 (553)
Q Consensus 425 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-~~~~~~~~---l~~~~~~~~~----~~~~~l~~l 496 (553)
... ...||+.|||||++.+..++.++|||||||++|||++ ..|....+ +...+..+.. ..+..+.++
T Consensus 194 ~~~-----~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l 268 (350)
T d1rdqe_ 194 RTW-----TLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL 268 (350)
T ss_dssp CBC-----CCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHH
T ss_pred ccc-----cccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHH
Confidence 321 2239999999999999999999999999999999998 33333332 3334444443 567789999
Q ss_pred HhhccCCCCCCC-----CCHHHHHHHH
Q 008785 497 FISCNNWPSHLS-----QSKFCNLKLW 518 (553)
Q Consensus 497 ~~~Cl~~dP~~R-----Ps~~evl~~l 518 (553)
+.+||+.||++| ||+.|++++-
T Consensus 269 i~~~L~~dP~kR~~~~r~t~~ell~Hp 295 (350)
T d1rdqe_ 269 LRNLLQVDLTKRFGNLKNGVNDIKNHK 295 (350)
T ss_dssp HHHHSCSCTTTCTTSSTTTTHHHHTSG
T ss_pred HHHHhhhCHHhccccccccHHHHHcCc
Confidence 999999999999 4999999863
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-46 Score=374.45 Aligned_cols=234 Identities=21% Similarity=0.239 Sum_probs=195.0
Q ss_pred eeecccCceeEEEEEeC-CCCEEEEEEeccCC---hhhHHHHHHHHHHhh-ccCCCceeeEeeEEeeCCceEEEEEccCC
Q 008785 275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFA-RLHHPNLVAVKGCCYDHGDRYIVYEFVVN 349 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~-~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 349 (553)
+.||+|+||+||+|+.. +|+.||||++++.. ....+.+.+|..++. .++|||||++++++.+++..|+||||+++
T Consensus 8 ~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmEy~~~ 87 (320)
T d1xjda_ 8 KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNG 87 (320)
T ss_dssp EEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred eEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEeecCC
Confidence 45699999999999975 58999999997542 233456777777765 68999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcccccc
Q 008785 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE 429 (553)
Q Consensus 350 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 429 (553)
|+|.+++.. ...+++.++..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++.........
T Consensus 88 g~L~~~i~~----~~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~~~ 160 (320)
T d1xjda_ 88 GDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT 160 (320)
T ss_dssp CBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCB
T ss_pred CcHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhcccccccc
Confidence 999999965 24589999999999999999999999 99999999999999999999999999998665433222
Q ss_pred eeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcC-cccccc---hHHHHHhcCCH----HHHHHHHHHHhhcc
Q 008785 430 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLV-LCRRWW---TLYTLVHSMSL----LCAQECLMLFISCN 501 (553)
Q Consensus 430 ~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~-~~~~~~---~l~~~~~~~~~----~~~~~l~~l~~~Cl 501 (553)
. ...||+.|+|||++.+..++.++|||||||++|||+++ .|.... .+...+..+.. ..+..+.+|+.+||
T Consensus 161 ~--~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~~L 238 (320)
T d1xjda_ 161 N--TFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLF 238 (320)
T ss_dssp C--CCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHS
T ss_pred c--ccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHHhc
Confidence 2 23499999999999999999999999999999999983 333332 33334444443 45778999999999
Q ss_pred CCCCCCCCCHH-HHHHH
Q 008785 502 NWPSHLSQSKF-CNLKL 517 (553)
Q Consensus 502 ~~dP~~RPs~~-evl~~ 517 (553)
+.||++|||+. |++++
T Consensus 239 ~~dP~~R~s~~~~l~~h 255 (320)
T d1xjda_ 239 VREPEKRLGVRGDIRQH 255 (320)
T ss_dssp CSSGGGSBTTBSCGGGS
T ss_pred ccCCCCCcCHHHHHHhC
Confidence 99999999995 78765
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.6e-45 Score=375.76 Aligned_cols=238 Identities=19% Similarity=0.202 Sum_probs=191.6
Q ss_pred ccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCCh---hhHHHHH---HHHHHhhccCCCceeeEeeEEeeCCceE
Q 008785 269 NFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF---QRKKEFY---SEIGRFARLHHPNLVAVKGCCYDHGDRY 341 (553)
Q Consensus 269 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~---~~~~~~~---~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 341 (553)
+|... ++||+|+||.||+|+.. +|+.||||++.+... .....+. +|+.+++.++|||||++++++.+.+..|
T Consensus 5 dy~i~-~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 5 DFSVH-RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TEEEE-EEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred hCeee-eEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 45443 45699999999999975 599999999965321 1223333 4477788889999999999999999999
Q ss_pred EEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeecccccc
Q 008785 342 IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF 421 (553)
Q Consensus 342 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~ 421 (553)
+||||+++|+|.++|.. ...+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+|+.
T Consensus 84 ivmE~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~ 156 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACD 156 (364)
T ss_dssp EEECCCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred EEEEecCCCcHHHHHHh----cccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeee
Confidence 99999999999999965 24588999999999999999999999 999999999999999999999999999987
Q ss_pred CCcccccceeeecCccccccccccccC-CCCCcccchHhHHHHHHHHhcCc-cccc---chHHH---HHhcCCH----HH
Q 008785 422 VPWEVMQERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIRLVL-CRRW---WTLYT---LVHSMSL----LC 489 (553)
Q Consensus 422 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwSlGvil~ell~~~-~~~~---~~l~~---~~~~~~~----~~ 489 (553)
...... ....||+.|+|||++.. ..++.++|||||||++|||+++. |... ..... ....... ..
T Consensus 157 ~~~~~~----~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (364)
T d1omwa3 157 FSKKKP----HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSF 232 (364)
T ss_dssp CSSSCC----CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSS
T ss_pred cCCCcc----cccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCC
Confidence 654332 22349999999999975 46899999999999999999733 3221 22222 2222222 56
Q ss_pred HHHHHHHHhhccCCCCCCCCC-----HHHHHHHH
Q 008785 490 AQECLMLFISCNNWPSHLSQS-----KFCNLKLW 518 (553)
Q Consensus 490 ~~~l~~l~~~Cl~~dP~~RPs-----~~evl~~l 518 (553)
++.+.+|+.+||+.||++||| +.|++++-
T Consensus 233 s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp 266 (364)
T d1omwa3 233 SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESP 266 (364)
T ss_dssp CHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSG
T ss_pred CHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCc
Confidence 778999999999999999999 68998763
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-44 Score=360.84 Aligned_cols=240 Identities=21% Similarity=0.283 Sum_probs=188.9
Q ss_pred ccCCCCeeecccCceeEEEEEe-CCCCEEEEEEeccCCh--hhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEE
Q 008785 269 NFSEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSF--QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYE 345 (553)
Q Consensus 269 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 345 (553)
+|...+ .||+|+||+||+|.. .+|+.||||+++.... ...+.+.+|+++|++++|||||++++++.+.+..|+|||
T Consensus 3 ~Y~~~~-~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 3 NFQKVE-KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TEEEEE-EEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCEecc-EEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 444444 459999999999996 4699999999975432 235678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCcc
Q 008785 346 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE 425 (553)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~ 425 (553)
|+.+ ++.+++.. .....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.....
T Consensus 82 ~~~~-~~~~~~~~--~~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~ 155 (298)
T d1gz8a_ 82 FLHQ-DLKKFMDA--SALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 155 (298)
T ss_dssp CCSE-EHHHHHHH--TTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred ecCC-chhhhhhh--hcccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCC
Confidence 9965 45555543 2345699999999999999999999999 9999999999999999999999999999866543
Q ss_pred cccceeeecCccccccccccccCCC-CCcccchHhHHHHHHHHhcC-cccccchHHH----HHh-cC-------------
Q 008785 426 VMQERTVMAGGTYGYLAPEFVYRNE-LTTKSDVYSFGVLLLEIRLV-LCRRWWTLYT----LVH-SM------------- 485 (553)
Q Consensus 426 ~~~~~~~~~~gt~~y~aPE~~~~~~-~t~ksDVwSlGvil~ell~~-~~~~~~~l~~----~~~-~~------------- 485 (553)
..... ...||+.|+|||.+.... ++.++|||||||++|||+++ .|....+-.+ ... .+
T Consensus 156 ~~~~~--~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 233 (298)
T d1gz8a_ 156 VRTYT--HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 233 (298)
T ss_dssp SBCTT--CCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred cccce--eecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccc
Confidence 32222 123899999999887665 48899999999999999973 3332221111 110 00
Q ss_pred -------------CH-----HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008785 486 -------------SL-----LCAQECLMLFISCNNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 486 -------------~~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 517 (553)
.. ..+.++.+|+.+||+.||++|||+.|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 234 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp TTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 00 334678999999999999999999999987
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.7e-44 Score=357.03 Aligned_cols=239 Identities=18% Similarity=0.188 Sum_probs=190.5
Q ss_pred ccCCCCeeecccCceeEEEEEeCCCCEEEEEEeccCCh--hhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEc
Q 008785 269 NFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSF--QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF 346 (553)
Q Consensus 269 ~~~~~~~~iG~G~~g~Vy~~~~~~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 346 (553)
+|...++ ||+|+||+||+|+.++|+.||||+++.... ...+.+.+|+.+|++++|||||++++++.+.+..+++|||
T Consensus 3 ~Y~~~~~-iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 3 KYHGLEK-IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp SEEEEEE-EEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceeccE-EecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 3433344 599999999999998999999999976532 2357899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCccc
Q 008785 347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV 426 (553)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 426 (553)
+.++.+..+.. ....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+|++|||.+.......
T Consensus 82 ~~~~~~~~~~~----~~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~ 154 (286)
T d1ob3a_ 82 LDQDLKKLLDV----CEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (286)
T ss_dssp CSEEHHHHHHT----STTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred ehhhhHHHHHh----hcCCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCc
Confidence 98877766654 345699999999999999999999999 99999999999999999999999999998765433
Q ss_pred ccceeeecCccccccccccccCC-CCCcccchHhHHHHHHHHhcCc-ccccchHHH----HHh-cCC-------------
Q 008785 427 MQERTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIRLVL-CRRWWTLYT----LVH-SMS------------- 486 (553)
Q Consensus 427 ~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwSlGvil~ell~~~-~~~~~~l~~----~~~-~~~------------- 486 (553)
.... ...|++.|+|||.+.+. .++.++|||||||++|||+++. |....+..+ ... .+.
T Consensus 155 ~~~~--~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 232 (286)
T d1ob3a_ 155 RKYT--HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP 232 (286)
T ss_dssp ---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred cccc--eecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhh
Confidence 2221 22388999999998754 5699999999999999999733 332221111 000 000
Q ss_pred ------------------HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008785 487 ------------------LLCAQECLMLFISCNNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 487 ------------------~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 517 (553)
...+..+.+++.+||+.||++|||++|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0345678999999999999999999999875
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-45 Score=360.48 Aligned_cols=230 Identities=18% Similarity=0.207 Sum_probs=187.6
Q ss_pred CeeecccCceeEEEEEeC-CCCEEEEEEeccCCh------hhHHHHHHHHHHhhccC--CCceeeEeeEEeeCCceEEEE
Q 008785 274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF------QRKKEFYSEIGRFARLH--HPNLVAVKGCCYDHGDRYIVY 344 (553)
Q Consensus 274 ~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~------~~~~~~~~E~~~l~~l~--HpnIv~l~~~~~~~~~~~lV~ 344 (553)
.++||+|+||.||+|+.. +|+.||||+++.... ....++.+|+.+|++++ |||||++++++.+.+..++||
T Consensus 9 ~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~lv~ 88 (273)
T d1xwsa_ 9 GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLIL 88 (273)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEE
T ss_pred eEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeEEEEE
Confidence 456799999999999964 689999999975421 11234678999999996 899999999999999999999
Q ss_pred EccCC-CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCC-CCeEEeeccccccC
Q 008785 345 EFVVN-GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE-FGAHLMGVGLSKFV 422 (553)
Q Consensus 345 E~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~-~~~kl~Dfgla~~~ 422 (553)
||+.+ +++.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.+ +.+||+|||+|+..
T Consensus 89 e~~~~~~~l~~~~~~----~~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~ 161 (273)
T d1xwsa_ 89 ERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL 161 (273)
T ss_dssp ECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EeccCcchHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECccccceec
Confidence 99976 678888764 24689999999999999999999999 99999999999999854 78999999999865
Q ss_pred CcccccceeeecCccccccccccccCCCC-CcccchHhHHHHHHHHhcCc-ccccchHHHHHhcCCH----HHHHHHHHH
Q 008785 423 PWEVMQERTVMAGGTYGYLAPEFVYRNEL-TTKSDVYSFGVLLLEIRLVL-CRRWWTLYTLVHSMSL----LCAQECLML 496 (553)
Q Consensus 423 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDVwSlGvil~ell~~~-~~~~~~l~~~~~~~~~----~~~~~l~~l 496 (553)
...... ...||+.|+|||++.+..+ +.++|||||||++|||++.. |....+ + +..+.. ..+.++.++
T Consensus 162 ~~~~~~----~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--~-i~~~~~~~~~~~s~~~~~l 234 (273)
T d1xwsa_ 162 KDTVYT----DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--E-IIRGQVFFRQRVSSECQHL 234 (273)
T ss_dssp CSSCBC----CCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--H-HHHCCCCCSSCCCHHHHHH
T ss_pred cccccc----ccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch--H-HhhcccCCCCCCCHHHHHH
Confidence 443221 2339999999999987765 67799999999999999843 333221 1 111221 567789999
Q ss_pred HhhccCCCCCCCCCHHHHHHH
Q 008785 497 FISCNNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 497 ~~~Cl~~dP~~RPs~~evl~~ 517 (553)
+.+||+.||++|||+.|++++
T Consensus 235 i~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 235 IRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp HHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHccCCHhHCcCHHHHhcC
Confidence 999999999999999999875
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-43 Score=355.25 Aligned_cols=240 Identities=20% Similarity=0.248 Sum_probs=185.7
Q ss_pred cccCCCCeeecccCceeEEEEEeC-C-CCEEEEEEeccCCh--hhHHHHHHHHHHhhcc---CCCceeeEeeEEee----
Q 008785 268 KNFSEGNRLLGDSKTGGTYSGILP-D-GSRVAVKRLKRSSF--QRKKEFYSEIGRFARL---HHPNLVAVKGCCYD---- 336 (553)
Q Consensus 268 ~~~~~~~~~iG~G~~g~Vy~~~~~-~-g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l---~HpnIv~l~~~~~~---- 336 (553)
++|....+ ||+|+||+||+|+.. + ++.||||+++.... .....+.+|+.+|+.| +||||+++++++..
T Consensus 7 ~~Y~i~~~-LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 7 QQYECVAE-IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GTEEEEEE-EEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred CCEEEEEE-EecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 34544444 599999999999963 4 56799999875322 2233466777776665 89999999999864
Q ss_pred -CCceEEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEee
Q 008785 337 -HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMG 415 (553)
Q Consensus 337 -~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~D 415 (553)
....+++|||+.++++...... ....+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~---~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~d 159 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKV---PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLAD 159 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHS---CTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECS
T ss_pred cCceEEEEEEeccCCchhhhhhc---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecc
Confidence 2457999999988776554432 445689999999999999999999999 999999999999999999999999
Q ss_pred ccccccCCcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcCc-ccccchHHH----HHhc-CC---
Q 008785 416 VGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVL-CRRWWTLYT----LVHS-MS--- 486 (553)
Q Consensus 416 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~-~~~~~~l~~----~~~~-~~--- 486 (553)
||+++........ ....||+.|+|||++.+.+|+.++||||+||++|||++.. |....+-.+ .+.. +.
T Consensus 160 fg~~~~~~~~~~~---~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~ 236 (305)
T d1blxa_ 160 FGLARIYSFQMAL---TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 236 (305)
T ss_dssp CCSCCCCCGGGGG---CCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCG
T ss_pred hhhhhhhcccccC---CCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCch
Confidence 9999865544322 2234999999999999999999999999999999999833 332222111 1100 00
Q ss_pred --------------------------HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008785 487 --------------------------LLCAQECLMLFISCNNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 487 --------------------------~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 517 (553)
...+..+.+|+.+||+.||++|||+.|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 237 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp GGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0345678899999999999999999999986
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-42 Score=350.76 Aligned_cols=241 Identities=18% Similarity=0.213 Sum_probs=186.0
Q ss_pred cccCCCCeeecccCceeEEEEEe-CCCCEEEEEEeccCC-hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCC----ceE
Q 008785 268 KNFSEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHG----DRY 341 (553)
Q Consensus 268 ~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~----~~~ 341 (553)
..|.... .||+|+||+||+|.. .+|+.||||+++... ....+.+.+|+.+|++++||||+++++++.... ..+
T Consensus 8 ~rY~~~~-~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 8 PRYTNLS-YIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp TTEEEEE-ECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCeEEEE-EEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 3444433 459999999999986 469999999997543 344578899999999999999999999987653 234
Q ss_pred EEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeecccccc
Q 008785 342 IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF 421 (553)
Q Consensus 342 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~ 421 (553)
++++|+.+|+|.+++.. ..+++..+..++.||+.||+|||++ ||+||||||+|||+++++.+||+|||+++.
T Consensus 87 ~l~~~~~~g~L~~~l~~-----~~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~ 158 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARV 158 (345)
T ss_dssp EEEEECCCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEeecCCchhhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceee
Confidence 55566779999999965 3589999999999999999999999 999999999999999999999999999987
Q ss_pred CCcccccc-eeeecCccccccccccccC-CCCCcccchHhHHHHHHHHhcCc-ccccchHHH-------HHhcCC-----
Q 008785 422 VPWEVMQE-RTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIRLVL-CRRWWTLYT-------LVHSMS----- 486 (553)
Q Consensus 422 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwSlGvil~ell~~~-~~~~~~l~~-------~~~~~~----- 486 (553)
........ ......||+.|+|||++.. ..++.++||||+||++|||++.. |....+-.+ ......
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (345)
T d1pmea_ 159 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 238 (345)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred ccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhh
Confidence 65543322 1223348999999999854 46789999999999999999733 322221111 000000
Q ss_pred ---------------------H-----HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008785 487 ---------------------L-----LCAQECLMLFISCNNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 487 ---------------------~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 517 (553)
. ..+.++.+|+.+||+.||++|||+.|+|++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 239 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 223568899999999999999999999986
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-42 Score=351.20 Aligned_cols=234 Identities=21% Similarity=0.222 Sum_probs=182.2
Q ss_pred eeecccCceeEEEEEeC-CCCEEEEEEeccCChhhHHHHHHHHHHhhccCCCceeeEeeEEeeC------CceEEEEEcc
Q 008785 275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH------GDRYIVYEFV 347 (553)
Q Consensus 275 ~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~------~~~~lV~E~~ 347 (553)
++||+|+||+||+|+.. +|+.||||+++.... ...+|+++|++++||||+++++++... ...++||||+
T Consensus 26 k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~ 101 (350)
T d1q5ka_ 26 KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV 101 (350)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEECC
T ss_pred eEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEecc
Confidence 46799999999999975 599999999976532 234799999999999999999998643 2468999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCC-CeEEeeccccccCCccc
Q 008785 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF-GAHLMGVGLSKFVPWEV 426 (553)
Q Consensus 348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~-~~kl~Dfgla~~~~~~~ 426 (553)
+++.+ +.+.........+++..+..++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+++......
T Consensus 102 ~~~~~-~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~ 177 (350)
T d1q5ka_ 102 PETVY-RVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 177 (350)
T ss_dssp SEEHH-HHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEECCTTS
T ss_pred CCccH-HHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchhhccCCc
Confidence 76643 33332223445699999999999999999999999 999999999999999775 89999999998765443
Q ss_pred ccceeeecCccccccccccccC-CCCCcccchHhHHHHHHHHhcCcc-cccchHHH----HHh-cCC-------------
Q 008785 427 MQERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIRLVLC-RRWWTLYT----LVH-SMS------------- 486 (553)
Q Consensus 427 ~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwSlGvil~ell~~~~-~~~~~l~~----~~~-~~~------------- 486 (553)
... ...||+.|+|||.+.+ ..++.++||||+||++|||++..+ ....+-.+ .++ .|.
T Consensus 178 ~~~---~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~ 254 (350)
T d1q5ka_ 178 PNV---SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY 254 (350)
T ss_dssp CCC---SCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC--
T ss_pred ccc---cccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccch
Confidence 222 2238999999998875 568999999999999999997332 22211111 110 000
Q ss_pred ------------------HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 008785 487 ------------------LLCAQECLMLFISCNNWPSHLSQSKFCNLKLWV 519 (553)
Q Consensus 487 ------------------~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~ 519 (553)
...++.+.+|+.+||..||++|||+.|+|++-.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~ 305 (350)
T d1q5ka_ 255 TEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 305 (350)
T ss_dssp -CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred hhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHh
Confidence 034567899999999999999999999998743
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-42 Score=351.22 Aligned_cols=236 Identities=19% Similarity=0.256 Sum_probs=183.2
Q ss_pred cccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccC--ChhhHHHHHHHHHHhhccCCCceeeEeeEEeeCC------
Q 008785 268 KNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHG------ 338 (553)
Q Consensus 268 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~------ 338 (553)
+.|.... .||+|+||+||+|... +|+.||||+++.. +....+.+.+|+++|++++|||||++++++...+
T Consensus 18 ~~Y~~i~-~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 18 AVYRDLQ-PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp SSEEEEE-EC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CcEEEEE-EEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 3454444 4599999999999964 5999999999754 3344567899999999999999999999998654
Q ss_pred ceEEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccc
Q 008785 339 DRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGL 418 (553)
Q Consensus 339 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgl 418 (553)
..|+||||+ +++|..+++. ..+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+|++|||+
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~ 167 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL 167 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecc-cccHHHHHHh-----ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccc
Confidence 469999999 6788887754 3599999999999999999999999 999999999999999999999999999
Q ss_pred cccCCcccccceeeecCccccccccccccCC-CCCcccchHhHHHHHHHHhcCc-ccccchHHH----HHh-cCC-----
Q 008785 419 SKFVPWEVMQERTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIRLVL-CRRWWTLYT----LVH-SMS----- 486 (553)
Q Consensus 419 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwSlGvil~ell~~~-~~~~~~l~~----~~~-~~~----- 486 (553)
|+....... ...||+.|+|||++.+. .++.++||||+||++|||++.. |....+-.+ ... .+.
T Consensus 168 a~~~~~~~~-----~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 242 (346)
T d1cm8a_ 168 ARQADSEMT-----GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEF 242 (346)
T ss_dssp CEECCSSCC-----SSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred eeccCCccc-----cccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHH
Confidence 987654321 22389999999998764 5689999999999999999733 222211111 000 000
Q ss_pred -----------------------H-----HHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008785 487 -----------------------L-----LCAQECLMLFISCNNWPSHLSQSKFCNLKLW 518 (553)
Q Consensus 487 -----------------------~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l 518 (553)
+ ..++.+.+|+.+||..||++|||+.|+|++-
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp 302 (346)
T d1cm8a_ 243 VQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHP 302 (346)
T ss_dssp HHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred HhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcCh
Confidence 0 2356788999999999999999999999873
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-42 Score=345.63 Aligned_cols=243 Identities=18% Similarity=0.216 Sum_probs=185.4
Q ss_pred cccCCCCeeecccCceeEEEEEe-CCCCEEEEEEeccC--ChhhHHHHHHHHHHhhccCCCceeeEeeEEee--------
Q 008785 268 KNFSEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD-------- 336 (553)
Q Consensus 268 ~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-------- 336 (553)
++|...+++ |+|+||+||+|+. .+|+.||||++... ......++.+|+.+|++++||||+++++++..
T Consensus 10 ~rY~i~~~L-G~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 10 SKYEKLAKI-GQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGEEEEEEE-EECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred CCEEEEEEE-ecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 455554544 9999999999996 46999999998654 22335678999999999999999999999865
Q ss_pred CCceEEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeec
Q 008785 337 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGV 416 (553)
Q Consensus 337 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Df 416 (553)
.+..++||||+.++.+..+.. ....+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+||
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~----~~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~df 161 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSN----VLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADF 161 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTC----TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCC
T ss_pred CceEEEEEeccCCCccchhhh----cccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeec
Confidence 345799999998877665543 345689999999999999999999999 9999999999999999999999999
Q ss_pred cccccCCcccccc--eeeecCccccccccccccCC-CCCcccchHhHHHHHHHHhcCccc-cc---chHHHHHhc--CC-
Q 008785 417 GLSKFVPWEVMQE--RTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIRLVLCR-RW---WTLYTLVHS--MS- 486 (553)
Q Consensus 417 gla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwSlGvil~ell~~~~~-~~---~~l~~~~~~--~~- 486 (553)
|+++......... ......||+.|+|||++.+. .++.++|||||||++|||+++.+. .. ......+.. +.
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~ 241 (318)
T d3blha1 162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 241 (318)
T ss_dssp TTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred ceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 9998665432221 11223489999999998765 689999999999999999973322 11 111111100 00
Q ss_pred --------------------------H-------HHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008785 487 --------------------------L-------LCAQECLMLFISCNNWPSHLSQSKFCNLKLW 518 (553)
Q Consensus 487 --------------------------~-------~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l 518 (553)
. .....+.+|+.+||+.||++|||+.|++++-
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hp 306 (318)
T d3blha1 242 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD 306 (318)
T ss_dssp CTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred ChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcCh
Confidence 0 1244678899999999999999999999873
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-41 Score=338.91 Aligned_cols=238 Identities=18% Similarity=0.168 Sum_probs=192.3
Q ss_pred cCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCC--hhhHHHHHHHHHHhhccCCCceeeEeeEEeeCCceEEEEEc
Q 008785 270 FSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF 346 (553)
Q Consensus 270 ~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 346 (553)
|...+ .||+|+||+||+|+.. +|+.||||+++... ......+.+|+.+|++++||||+++++++.+....++|+|+
T Consensus 4 y~~i~-~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~ 82 (292)
T d1unla_ 4 YEKLE-KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_dssp EEEEE-EEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CEeee-EEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeee
Confidence 43434 4599999999999964 68899999997543 33467899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccccccCCccc
Q 008785 347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV 426 (553)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 426 (553)
+.+++|..++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||.++......
T Consensus 83 ~~~~~l~~~~~~----~~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~ 155 (292)
T d1unla_ 83 CDQDLKKYFDSC----NGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CSEEHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred cccccccccccc----ccccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCCC
Confidence 999998887753 35688999999999999999999999 99999999999999999999999999998765443
Q ss_pred ccceeeecCccccccccccccCCC-CCcccchHhHHHHHHHHhc-Ccccc-c---chHHHHHh--cCC------------
Q 008785 427 MQERTVMAGGTYGYLAPEFVYRNE-LTTKSDVYSFGVLLLEIRL-VLCRR-W---WTLYTLVH--SMS------------ 486 (553)
Q Consensus 427 ~~~~~~~~~gt~~y~aPE~~~~~~-~t~ksDVwSlGvil~ell~-~~~~~-~---~~l~~~~~--~~~------------ 486 (553)
.... ...+++.|+|||.+.... ++.++|||||||++|||++ ..|.. . .+....+. .+.
T Consensus 156 ~~~~--~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (292)
T d1unla_ 156 RCYS--AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233 (292)
T ss_dssp SCCC--SCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGS
T ss_pred ccce--eeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhc
Confidence 2222 223788899999987665 6999999999999999997 33321 1 11111110 000
Q ss_pred -------------------HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008785 487 -------------------LLCAQECLMLFISCNNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 487 -------------------~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 517 (553)
...+..+.+|+.+||+.||.+|||++|+|++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0345678899999999999999999999876
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.7e-41 Score=341.98 Aligned_cols=232 Identities=19% Similarity=0.235 Sum_probs=184.3
Q ss_pred ccCCCCeeecccCceeEEEEEe-CCCCEEEEEEeccCChhhHHHHHHHHHHhhccC-CCceeeEeeEEeeC--CceEEEE
Q 008785 269 NFSEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLH-HPNLVAVKGCCYDH--GDRYIVY 344 (553)
Q Consensus 269 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~--~~~~lV~ 344 (553)
+|.... .||+|+||+||+|+. .+|+.||||+++... .+++.+|+.+|++++ ||||+++++++... ...++||
T Consensus 36 ~y~i~~-~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 36 DYQLVR-KLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GEEEEE-EEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred CeEEEE-EEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 444443 459999999999997 458999999997653 467889999999995 99999999998754 5689999
Q ss_pred EccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCC-CeEEeeccccccCC
Q 008785 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF-GAHLMGVGLSKFVP 423 (553)
Q Consensus 345 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~-~~kl~Dfgla~~~~ 423 (553)
||+.+++|.++. +.+++..+..++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+|+...
T Consensus 112 e~~~~~~L~~~~-------~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~ 181 (328)
T d3bqca1 112 EHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 181 (328)
T ss_dssp ECCCSCBGGGTT-------TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECC
T ss_pred eecCCCcHHHHh-------cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceecc
Confidence 999999997654 3489999999999999999999999 999999999999998655 58999999998765
Q ss_pred cccccceeeecCccccccccccccCC-CCCcccchHhHHHHHHHHhcCc-ccccc--hH---HH---HH---------hc
Q 008785 424 WEVMQERTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIRLVL-CRRWW--TL---YT---LV---------HS 484 (553)
Q Consensus 424 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwSlGvil~ell~~~-~~~~~--~l---~~---~~---------~~ 484 (553)
..... ....+|+.|+|||.+.+. .++.++||||+|+++|||++.. |.... .. .. .+ ..
T Consensus 182 ~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~ 258 (328)
T d3bqca1 182 PGQEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK 258 (328)
T ss_dssp TTCCC---CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH
T ss_pred CCCcc---cccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhh
Confidence 44322 222389999999998765 4799999999999999999632 22110 00 00 00 00
Q ss_pred CC----------------------------HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 008785 485 MS----------------------------LLCAQECLMLFISCNNWPSHLSQSKFCNLKL 517 (553)
Q Consensus 485 ~~----------------------------~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 517 (553)
.. ...+.++.+|+.+||..||++|||+.|+|++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H 319 (328)
T d3bqca1 259 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319 (328)
T ss_dssp TTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 0245678999999999999999999999985
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4e-41 Score=336.17 Aligned_cols=243 Identities=17% Similarity=0.200 Sum_probs=184.7
Q ss_pred cCCCCeeecccCceeEEEEEe-CCCCEEEEEEeccCChhhHHHHHHHHHHhhccCCCce-eeEeeEEeeCCceEEEEEcc
Q 008785 270 FSEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNL-VAVKGCCYDHGDRYIVYEFV 347 (553)
Q Consensus 270 ~~~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnI-v~l~~~~~~~~~~~lV~E~~ 347 (553)
|... +.||+|+||.||+|.. .+|+.||||++.... ...++.+|++++++++|+|+ +.+.++..+.+..++||||+
T Consensus 9 Y~l~-~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~ 85 (299)
T d1ckia_ 9 YRLG-RKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL 85 (299)
T ss_dssp EEEE-EEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred EEEe-EEEeeCCCcEEEEEEECCCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc
Confidence 4433 4569999999999996 458999999987653 23457889999999987665 45555666777889999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEec---CCCCeEEeeccccccCCc
Q 008785 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD---EEFGAHLMGVGLSKFVPW 424 (553)
Q Consensus 348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~---~~~~~kl~Dfgla~~~~~ 424 (553)
+|+|.+.+.. ....+++..+..++.|++.||+|||++ +|+||||||+|||++ .+..+||+|||+|+....
T Consensus 86 -~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 86 -GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp -CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred -CCchhhhhhh---ccCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 5677776654 335699999999999999999999999 999999999999975 356799999999987654
Q ss_pred ccccc-----eeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcCc-cccc---chHHH---HHhc----CCH-
Q 008785 425 EVMQE-----RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVL-CRRW---WTLYT---LVHS----MSL- 487 (553)
Q Consensus 425 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~-~~~~---~~l~~---~~~~----~~~- 487 (553)
..... ......||+.|+|||++.+..++.++|||||||++|||++.. |... ..... .... ...
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (299)
T d1ckia_ 159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE 238 (299)
T ss_dssp TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHH
T ss_pred cccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChh
Confidence 32211 112234999999999999999999999999999999999732 2221 11111 1111 111
Q ss_pred ----HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 008785 488 ----LCAQECLMLFISCNNWPSHLSQSKFCNLKLWVFAI 522 (553)
Q Consensus 488 ----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~~~ 522 (553)
..+.++.+++..||+.||++||+++++.+.+...+
T Consensus 239 ~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~ 277 (299)
T d1ckia_ 239 VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 277 (299)
T ss_dssp HHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHH
T ss_pred HhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence 34577999999999999999999998877655443
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-41 Score=343.37 Aligned_cols=237 Identities=19% Similarity=0.216 Sum_probs=180.0
Q ss_pred cccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccC--ChhhHHHHHHHHHHhhccCCCceeeEeeEEeeC------C
Q 008785 268 KNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH------G 338 (553)
Q Consensus 268 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~------~ 338 (553)
+.|.... .||+|+||+||+|... +|+.||||+++.. +......+.+|+.++++++|||||++++++... .
T Consensus 17 ~~Y~i~~-~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 17 KRYQNLK-PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp TTEEEEE-ECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred CCeEEEE-EeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 3454444 4599999999999965 5999999999754 334456789999999999999999999999643 5
Q ss_pred ceEEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccc
Q 008785 339 DRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGL 418 (553)
Q Consensus 339 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgl 418 (553)
..|+||||+.++.+ +.+. ..+++..+..++.||+.||.|||+. ||+||||||+|||++.++.+|++|||+
T Consensus 96 ~~~iv~Ey~~~~l~-~~~~------~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~ 165 (355)
T d2b1pa1 96 DVYLVMELMDANLC-QVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_dssp EEEEEEECCSEEHH-HHHT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred eeEEEEeccchHHH-Hhhh------cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhh
Confidence 67999999976544 4443 3489999999999999999999999 999999999999999999999999999
Q ss_pred cccCCcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcCccc-ccch---HHH-H------------
Q 008785 419 SKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVLCR-RWWT---LYT-L------------ 481 (553)
Q Consensus 419 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~~~-~~~~---l~~-~------------ 481 (553)
++......... ...+|+.|+|||++.+..++.++||||+||+++||++..+. ...+ ... .
T Consensus 166 ~~~~~~~~~~~---~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~ 242 (355)
T d2b1pa1 166 ARTAGTSFMMT---PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 242 (355)
T ss_dssp ------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred hhccccccccc---cccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHH
Confidence 88655433222 22389999999999999999999999999999999973322 1111 110 0
Q ss_pred ----------HhcCC-----------------------HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008785 482 ----------VHSMS-----------------------LLCAQECLMLFISCNNWPSHLSQSKFCNLKLW 518 (553)
Q Consensus 482 ----------~~~~~-----------------------~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l 518 (553)
..... ...+..+.+|+.+||..||++|||+.|+|++-
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hp 312 (355)
T d2b1pa1 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP 312 (355)
T ss_dssp TTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTST
T ss_pred HHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCc
Confidence 00000 03567789999999999999999999999883
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-42 Score=345.65 Aligned_cols=241 Identities=18% Similarity=0.141 Sum_probs=192.0
Q ss_pred cccCCCCeeecccCceeEEEEEeC----CCCEEEEEEeccCC----hhhHHHHHHHHHHhhccCC-CceeeEeeEEeeCC
Q 008785 268 KNFSEGNRLLGDSKTGGTYSGILP----DGSRVAVKRLKRSS----FQRKKEFYSEIGRFARLHH-PNLVAVKGCCYDHG 338 (553)
Q Consensus 268 ~~~~~~~~~iG~G~~g~Vy~~~~~----~g~~vAvK~~~~~~----~~~~~~~~~E~~~l~~l~H-pnIv~l~~~~~~~~ 338 (553)
++|.... .||+|+||+||+|... +|+.||||++++.. ....+.+.+|+++|++++| |||+++++++.+..
T Consensus 24 ~~y~~~~-~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~ 102 (322)
T d1vzoa_ 24 ENFELLK-VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 102 (322)
T ss_dssp GGEEEEE-EEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred hceEEEE-EEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence 3455544 4599999999999852 47899999987532 2234668899999999966 89999999999999
Q ss_pred ceEEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccc
Q 008785 339 DRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGL 418 (553)
Q Consensus 339 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgl 418 (553)
..+++|||+.+|+|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 103 ~~~~v~e~~~~~~L~~~i~~----~~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~ 175 (322)
T d1vzoa_ 103 KLHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGL 175 (322)
T ss_dssp EEEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred ceeeeeecccccHHHHHHHh----cccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccc
Confidence 99999999999999999865 23578899999999999999999999 999999999999999999999999999
Q ss_pred cccCCcccccceeeecCccccccccccccCC--CCCcccchHhHHHHHHHHhcC-ccccc---chHHH----HHhcCCH-
Q 008785 419 SKFVPWEVMQERTVMAGGTYGYLAPEFVYRN--ELTTKSDVYSFGVLLLEIRLV-LCRRW---WTLYT----LVHSMSL- 487 (553)
Q Consensus 419 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~t~ksDVwSlGvil~ell~~-~~~~~---~~l~~----~~~~~~~- 487 (553)
++........... ...|++.|+|||.+.+. .++.++|||||||+||||+++ .|... ..... .......
T Consensus 176 a~~~~~~~~~~~~-~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~ 254 (322)
T d1vzoa_ 176 SKEFVADETERAY-DFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP 254 (322)
T ss_dssp EEECCGGGGGGGC-GGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCC
T ss_pred hhhhccccccccc-ccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCC
Confidence 9876544333222 23389999999999764 468899999999999999972 22221 11111 1111111
Q ss_pred ---HHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 008785 488 ---LCAQECLMLFISCNNWPSHLSQ-----SKFCNLKL 517 (553)
Q Consensus 488 ---~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~ 517 (553)
..+..+.+++.+||++||++|| |++|++++
T Consensus 255 ~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 255 YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred CcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence 5678899999999999999999 48999886
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=7.9e-41 Score=332.86 Aligned_cols=246 Identities=18% Similarity=0.201 Sum_probs=193.2
Q ss_pred ccCCCCeeecccCceeEEEEEeC-CCCEEEEEEeccCChhhHHHHHHHHHHhhccCC-CceeeEeeEEeeCCceEEEEEc
Q 008785 269 NFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHH-PNLVAVKGCCYDHGDRYIVYEF 346 (553)
Q Consensus 269 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H-pnIv~l~~~~~~~~~~~lV~E~ 346 (553)
+|... +.||+|+||.||+|+.. +|+.||||+++... ....+.+|++.++.++| +||+.+++++.+....++||||
T Consensus 6 ~Y~i~-~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~ 82 (293)
T d1csna_ 6 HYKVG-RRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 82 (293)
T ss_dssp TEEEE-EEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred ceEEE-EEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEe
Confidence 44443 45699999999999965 58899999986542 23456788899999965 8999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecC-----CCCeEEeecccccc
Q 008785 347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE-----EFGAHLMGVGLSKF 421 (553)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~-----~~~~kl~Dfgla~~ 421 (553)
+ +++|.+++.. ....++...+..++.|++.||+|||++ ||+||||||+|||++. ++.+||+|||+|+.
T Consensus 83 ~-~~~l~~~~~~---~~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 83 L-GPSLEDLLDL---CGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp C-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred c-CCCHHHHHHh---hccchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccceeEE
Confidence 9 7899999875 334689999999999999999999999 9999999999999974 56799999999987
Q ss_pred CCcccccc-----eeeecCccccccccccccCCCCCcccchHhHHHHHHHHhc-Ccccc---cchH---HHHHhc----C
Q 008785 422 VPWEVMQE-----RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRL-VLCRR---WWTL---YTLVHS----M 485 (553)
Q Consensus 422 ~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~-~~~~~---~~~l---~~~~~~----~ 485 (553)
........ ......||+.|||||++.+..++.++||||||+++|||++ ..|.. .... ...+.. .
T Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (293)
T d1csna_ 156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 235 (293)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred cccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCC
Confidence 65332111 1223349999999999999999999999999999999997 22322 1111 111111 1
Q ss_pred CH-----HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHhh
Q 008785 486 SL-----LCAQECLMLFISCNNWPSHLSQSKFCNLKLWVFAILT 524 (553)
Q Consensus 486 ~~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l~~~~~~ 524 (553)
.. ..++++.+++..|++.+|++||+.+.+.+.+...+..
T Consensus 236 ~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~ 279 (293)
T d1csna_ 236 PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER 279 (293)
T ss_dssp CHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred ChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHH
Confidence 11 3457899999999999999999998887766555543
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-40 Score=339.98 Aligned_cols=238 Identities=18% Similarity=0.225 Sum_probs=184.7
Q ss_pred hcccCCCCeeecccCceeEEEEEe-CCCCEEEEEEeccC--ChhhHHHHHHHHHHhhccCCCceeeEeeEEeeC-----C
Q 008785 267 TKNFSEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH-----G 338 (553)
Q Consensus 267 ~~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~-----~ 338 (553)
.+.|.... .||+|+||+||+|+. .+|+.||||+++.. +....+.+.+|+.+|++++|||||++++++... .
T Consensus 17 ~~rY~i~~-~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 17 PERYQNLS-PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95 (348)
T ss_dssp ETTEEEEE-ECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred CCCeEEEE-EEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence 33454444 459999999999996 46999999999754 334456789999999999999999999998643 3
Q ss_pred ceEEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEeeccc
Q 008785 339 DRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGL 418 (553)
Q Consensus 339 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgl 418 (553)
..+++|+|+.+|+|.+++.. ..+++..+..++.||+.||+|||++ ||+||||||+|||++.++.+|++|||+
T Consensus 96 ~~~~i~~~~~gg~L~~~~~~-----~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~ 167 (348)
T d2gfsa1 96 NDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGL 167 (348)
T ss_dssp CCCEEEEECCSEEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC--
T ss_pred ceEEEEEeecCCchhhhccc-----ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccch
Confidence 34667778889999999853 3599999999999999999999999 999999999999999999999999999
Q ss_pred cccCCcccccceeeecCccccccccccccCCC-CCcccchHhHHHHHHHHhcCcc-cccch---HHHHHh--cCC-----
Q 008785 419 SKFVPWEVMQERTVMAGGTYGYLAPEFVYRNE-LTTKSDVYSFGVLLLEIRLVLC-RRWWT---LYTLVH--SMS----- 486 (553)
Q Consensus 419 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~t~ksDVwSlGvil~ell~~~~-~~~~~---l~~~~~--~~~----- 486 (553)
+....... ....||+.|+|||.+.+.. ++.++|||||||++|||+++.+ ....+ ....+. .+.
T Consensus 168 a~~~~~~~-----~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~ 242 (348)
T d2gfsa1 168 ARHTDDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAEL 242 (348)
T ss_dssp --CCTGGG-----SSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred hcccCccc-----ccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHH
Confidence 97654322 1223899999999877654 6899999999999999997332 22111 111110 000
Q ss_pred -----------------------H-----HHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 008785 487 -----------------------L-----LCAQECLMLFISCNNWPSHLSQSKFCNLKLW 518 (553)
Q Consensus 487 -----------------------~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~l 518 (553)
+ ..+..+.+|+.+||..||++|||+.|+|++-
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp 302 (348)
T d2gfsa1 243 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 302 (348)
T ss_dssp HTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred hhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCH
Confidence 0 2356788999999999999999999999873
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5e-35 Score=299.57 Aligned_cols=234 Identities=15% Similarity=0.119 Sum_probs=177.8
Q ss_pred CeeecccCceeEEEEEe-CCCCEEEEEEeccCChhhHHHHHHHHHHhhccC-----------CCceeeEeeEEeeC--Cc
Q 008785 274 NRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLH-----------HPNLVAVKGCCYDH--GD 339 (553)
Q Consensus 274 ~~~iG~G~~g~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-----------HpnIv~l~~~~~~~--~~ 339 (553)
.+.||+|+||+||+|+. .+|+.||||+++... ...+.+.+|+.+++.++ ||||+++++++... ..
T Consensus 18 ~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~~~ 96 (362)
T d1q8ya_ 18 VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNG 96 (362)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTE
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeeccccc
Confidence 34569999999999996 469999999998653 33467788999888875 57899999988654 45
Q ss_pred eEEEEEccCCCCH-HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCceecCCCCCcEEecCCCC------e
Q 008785 340 RYIVYEFVVNGPL-DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD-KVKPHVVHRDIRASNVLLDEEFG------A 411 (553)
Q Consensus 340 ~~lV~E~~~~gsL-~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~ivHrDlkp~NILl~~~~~------~ 411 (553)
.+++|+++..+.. ...... .....+++..+..++.||+.||+|||+ . ||+||||||+|||++.++. +
T Consensus 97 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~~~~~~~~ 171 (362)
T d1q8ya_ 97 VHVVMVFEVLGENLLALIKK--YEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSPENLIQI 171 (362)
T ss_dssp EEEEEEECCCCEEHHHHHHH--TTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETTTTEEEE
T ss_pred eeeeeeeccccccccccccc--ccccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeeccCccccccee
Confidence 5677776655443 232322 344668999999999999999999998 6 9999999999999986543 8
Q ss_pred EEeeccccccCCcccccceeeecCccccccccccccCCCCCcccchHhHHHHHHHHhcCc-ccccch----------HHH
Q 008785 412 HLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIRLVL-CRRWWT----------LYT 480 (553)
Q Consensus 412 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ell~~~-~~~~~~----------l~~ 480 (553)
+++|||.+....... ....||+.|+|||++....++.++||||+||+++||++.. |....+ +..
T Consensus 172 kl~dfg~s~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~ 246 (362)
T d1q8ya_ 172 KIADLGNACWYDEHY-----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 246 (362)
T ss_dssp EECCCTTCEETTBCC-----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHH
T ss_pred eEeeccccccccccc-----ccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHH
Confidence 999999997554322 1233899999999999999999999999999999999732 211100 000
Q ss_pred ---H--------HhcC----------------------------------CHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 008785 481 ---L--------VHSM----------------------------------SLLCAQECLMLFISCNNWPSHLSQSKFCNL 515 (553)
Q Consensus 481 ---~--------~~~~----------------------------------~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl 515 (553)
. ...+ .-..+..+.+|+.+||..||.+|||+.|+|
T Consensus 247 ~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L 326 (362)
T d1q8ya_ 247 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLV 326 (362)
T ss_dssp HHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHH
T ss_pred HHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 0 0000 004577899999999999999999999999
Q ss_pred HHH
Q 008785 516 KLW 518 (553)
Q Consensus 516 ~~l 518 (553)
++-
T Consensus 327 ~Hp 329 (362)
T d1q8ya_ 327 NHP 329 (362)
T ss_dssp TCG
T ss_pred cCc
Confidence 873
|
| >d1ypqa1 d.169.1.1 (A:140-270) Oxidised low density lipoprotein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Oxidised low density lipoprotein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=5e-26 Score=197.22 Aligned_cols=127 Identities=20% Similarity=0.451 Sum_probs=107.2
Q ss_pred CCCCcCCcccCCCCeEEEEecCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHhhCCCCCCeEeeeeecCCCCCCceEE
Q 008785 51 APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKW 130 (553)
Q Consensus 51 ~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W 130 (553)
++||+||. .|+++||+|+.+++||.+|+.+|+++||+||+|+|++|++||.+++......+||||+ +...++.|+|
T Consensus 3 ~~Cp~gw~--~~~~~CY~~~~~~~tw~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~~~~~~~WiGl~--~~~~~~~w~w 78 (131)
T d1ypqa1 3 APCPQDWI--WHGENCYLFSSGSFNWEKSQEKCLSLDAKLLKINSTADLDFIQQAISYSSFPFWMGLS--RRNPSYPWLW 78 (131)
T ss_dssp CSSCTTSE--EETTEEEEECSSCBCHHHHHHHHHHTTCEECCCCSHHHHHHHHHHHTTCCCCEEEEEE--ESSTTSCCEE
T ss_pred CCCCCCCE--EECCEEEEEECCccCHHHHHHHHHHcCCeeccchhhhhhhhhhhhhhccCCceEEEEE--ecCCCCceEe
Confidence 57999999 8999999999999999999999999999999999999999999998755667999999 5566799999
Q ss_pred cCCCCCCcCcccccCccCCCCCCCCCCCCCCCCeeEEEeCCCCceecccCCCCCCccceecc
Q 008785 131 SDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVEH 192 (553)
Q Consensus 131 ~dg~~~~~~~~~~~~~~~~~~~~~~C~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~~~ 192 (553)
+||+++.+..++..++.+. ....++|+.+.. ..|.+..|....+|||+.+.
T Consensus 79 ~dg~~~~~~~~~~~~~~~~---------~~~~~~C~~~~~--~~w~~~~C~~~~~~ICek~a 129 (131)
T d1ypqa1 79 EDGSPLMPHLFRVRGAVSQ---------TYPSGTCAYIQR--GAVYAENCILAAFSICQKKA 129 (131)
T ss_dssp TTSCBCCTTSCCEEESCSC---------CCTTCEEEEEET--TEEEEEETTSCBEEEEEEEC
T ss_pred CCCCCccccccccCCCCCC---------CCCCCCEEEEEC--CeEEEeCCCCCEeEEEeEEC
Confidence 9999987766554433221 223458988864 47999999999999998753
|
| >d1hq8a_ d.169.1.1 (A:) NK cell-activating receptor nkg2d {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: NK cell-activating receptor nkg2d species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.93 E-value=8.5e-27 Score=199.98 Aligned_cols=120 Identities=24% Similarity=0.550 Sum_probs=103.2
Q ss_pred CCCCCCcCCcccCCCCeEEEEecCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHhhCCCCCCeEeeeeecCCCCCCce
Q 008785 49 WKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSW 128 (553)
Q Consensus 49 ~~~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w 128 (553)
.|++||.||+ .|+++||+|+.++++|.+|+.+|+.+||+||+|+|++|++||+... ..+||||+ +...++.|
T Consensus 2 ~c~~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~gg~La~i~s~~e~~fl~~~~----~~~WiGl~--~~~~~~~w 73 (123)
T d1hq8a_ 2 YCGPCPNNWI--CHRNNCYQFFNEEKTWNQSQASCLSQNSSLLKIYSKEEQDFLKLVK----SYHWMGLV--QIPANGSW 73 (123)
T ss_dssp CCCCCSTTCE--EETTEEEEEEEEEECHHHHHHHHHTTTCEECCCSCTTTTGGGGGCC----SCEEEEEE--ECTTTCCE
T ss_pred cCCCCCccCE--EECCEEEEEECcccCHHHHHHHHhhccCccceEehHHHHHHHhhhh----hceeeeee--ecCCCCce
Confidence 3789999999 8999999999999999999999999999999999999999997643 47999999 66677999
Q ss_pred EEcCCCCCCcCcccccCccCCCCCCCCCCCCCCCCeeEEEeCCCCceecccCCCCCCccceec
Q 008785 129 KWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVE 191 (553)
Q Consensus 129 ~W~dg~~~~~~~~~~~~~~~~~~~~~~C~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~~ 191 (553)
+|+||+++.+..|....|.+ .+|+.+.. ...|.+..|....+|||+.+
T Consensus 74 ~W~dgs~~~~~~w~~~~~~~--------------~~c~~~~~-~~~w~~~~C~~~~~~ICek~ 121 (123)
T d1hq8a_ 74 QWEDGSSLSYNQLTLVEIPK--------------GSCAVYGS-SFKAYTEDCANLNTYICMKR 121 (123)
T ss_dssp EETTSCBCCTTTCEEECCTT--------------CCEEEECS-TTEEEEECTTSCEEEEEEEC
T ss_pred EECCCCcccccccCCCCCCC--------------CCEEEEEC-CCeEEEeCCCCCEeEEEEEc
Confidence 99999999888877666521 25666643 46799999999999999864
|
| >d1xpha1 d.169.1.1 (A:265-394) DC-SIGNR (DC-SIGN related receptor) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: DC-SIGNR (DC-SIGN related receptor) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=6.6e-26 Score=196.22 Aligned_cols=126 Identities=21% Similarity=0.426 Sum_probs=106.0
Q ss_pred CCCCCcCCcccCCCCeEEEEecCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHhhCCCCCCeEeeeeecCCCCCCceE
Q 008785 50 KAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWK 129 (553)
Q Consensus 50 ~~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~ 129 (553)
|.+||+||. .|+++||+|+.+++||.+|+..|+++||+||+|+|++|++|+..+.......+|||++ +...++.|+
T Consensus 1 c~~Cp~gw~--~~~~~CY~~~~~~~tw~~A~~~C~~~gg~La~i~s~~~~~~~~~~~~~~~~~~wig~~--~~~~~~~~~ 76 (130)
T d1xpha1 1 CRHCPKDWT--FFQGNCYFMSNSQRNWHDSVTACQEVRAQLVVIKTAEEQNFLQLQTSRSNRFSWMGLS--DLNQEGTWQ 76 (130)
T ss_dssp SCBCCTTCE--EETTEEEEECSSCBCHHHHHHHHHHTTCEECCCCSHHHHHHHHHHHHHHTCCEEEEEE--CCSTTCCCE
T ss_pred CCCCCCCCE--EECCEEEEEECcccCHHHHHHHHhhcCCeEeeeCCHHHhhhhhhhhccccceeeeeee--ccCcccceE
Confidence 678999999 8999999999999999999999999999999999999999999887654667999999 777779999
Q ss_pred EcCCCCCCc---CcccccCccCCCCCCCCCCCCCCCCeeEEEeCCCCceecccCCCCCCccceecc
Q 008785 130 WSDNMSKWN---ESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVEH 192 (553)
Q Consensus 130 W~dg~~~~~---~~~~~~~~~~~~~~~~~C~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~~~ 192 (553)
|+||+++.+ ..|..+.| ++.+.++|+.+.. ..|++..|....+|||+.+.
T Consensus 77 W~dg~~~~~~~~~~W~~~~P-----------~~~~~~~Cv~~~~--~~w~~~~C~~~~~fICe~pA 129 (130)
T d1xpha1 77 WVDGSPLSPSFQRYWNSGEP-----------NNSGNEDCAEFSG--SGWNDNRCDVDNYWICKKPA 129 (130)
T ss_dssp ETTSCBCCGGGGGGBCTTCC-----------CCCTTCCEEEEET--TEEEEECTTSCBEEEEEEEC
T ss_pred eccccccccccccccCCcCC-----------CCCCCCcEEEEEC--CEEEECCCCCCEEEEEEEeC
Confidence 999988653 33433333 2234468998864 47999999999999998753
|
| >d1fvub_ d.169.1.1 (B:) Snake coagglutinin beta chain {Jararaca (Bothrops jararaca), botrocetin [TaxId: 8724]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Snake coagglutinin beta chain species: Jararaca (Bothrops jararaca), botrocetin [TaxId: 8724]
Probab=99.92 E-value=6.3e-26 Score=195.04 Aligned_cols=120 Identities=23% Similarity=0.554 Sum_probs=101.8
Q ss_pred CCCcCCcccCCCCeEEEEecCCCChHHHHHHHhh--cCCEEeeeCCHHHHHHHHHhhCCC--CCCeEeeeeecCCCCCCc
Q 008785 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKN--VNGCWVGGRSINTTVGLS 127 (553)
Q Consensus 52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~--~~~~L~~i~~~~e~~f~~~~~~~~--~~~~WiGl~~~~~~~~~~ 127 (553)
.||+||. .|+++||+|+...++|.+|+.+|.. .||+||+|+|++|++||.+++... ...+||||+ +...+|.
T Consensus 1 ~Cp~gw~--~~~~~CY~~~~~~~t~~~A~~~C~~~~~gg~L~~i~s~~e~~~l~~~~~~~~~~~~~WiGl~--~~~~~~~ 76 (125)
T d1fvub_ 1 DCPPDWS--SYEGHCYRFFKEWMHWDDAEEFCTEQQTGAHLVSFQSKEEADFVRSLTSEMLKGDVVWIGLS--DVWNKCR 76 (125)
T ss_dssp CCSTTCE--EETTEEEEEEEEEECHHHHHHHHHHHSTTCEECCCSSHHHHHHHHTTCTTSCTTCCEECSCC--CCSTTSC
T ss_pred CCCCCCE--eeCCEEEEEeCccCCHHHHHHhhhhccCCceecccCCHHHcccccccccccccceeEEeeee--ccCcccc
Confidence 3999999 8999999999999999999999964 589999999999999999987643 346899999 7777899
Q ss_pred eEEcCCCCCCcCcccccCccCCCCCCCCCCCCCCCCeeEEEeCCCCceecccCCCCCCccceec
Q 008785 128 WKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVE 191 (553)
Q Consensus 128 w~W~dg~~~~~~~~~~~~~~~~~~~~~~C~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~~ 191 (553)
|+|+||+++.+.+|...++ ++|+.+...+..|++..|....+|||+++
T Consensus 77 ~~W~dg~~~~~~~w~~~~~----------------~~Cv~~~~~~~~W~~~~C~~~~~fICe~~ 124 (125)
T d1fvub_ 77 FEWTDGMEFDYDDYYLIAE----------------YECVASKPTNNKWWIIPCTRFKNFVCEFQ 124 (125)
T ss_dssp EEETTSCCCCC----CCSC----------------CEEEEEETTTTEEEEEETTSCEEEEEEEC
T ss_pred cEecCCCccccCCCCCCCC----------------cceEEEEcCCCEEEeeCCCCCEEEEEEEc
Confidence 9999999998877755432 37888887778899999999999999875
|
| >d1t8da1 d.169.1.1 (A:1-143) Low affinity immunoglobulin epsilon Fc receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Low affinity immunoglobulin epsilon Fc receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=3e-25 Score=195.50 Aligned_cols=131 Identities=19% Similarity=0.380 Sum_probs=110.7
Q ss_pred CCCCCCCCcCCcccCCCCeEEEEecCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHhhCCCCCCeEeeeeecCCCCCC
Q 008785 47 KDWKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGL 126 (553)
Q Consensus 47 ~~~~~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~ 126 (553)
+-.|.+||+||. .|+++||+|+...++|.+|+.+|+.+|||||+|+|.+|++||.++.. ...+||||+ +...++
T Consensus 2 g~~c~~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~gg~La~i~s~~e~~~l~~~~~--~~~~wiGl~--~~~~~~ 75 (143)
T d1t8da1 2 GFVCNTCPEKWI--NFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHAS--HTGSWIGLR--NLDLKG 75 (143)
T ss_dssp CCSSCCCCSSSE--ECSSEEEEEEECCSSHHHHHHHHHHHTSBCCCCCSHHHHHHHHHHCS--SSCEEEEEE--ESSSSS
T ss_pred CCcCCCCCcccE--EECCEEEEEECcccCHHHHHHHhhhcCCEEeeecCHHHhhhcccccc--cccccccce--ecCCCC
Confidence 346789999999 89999999999999999999999999999999999999999999876 567999999 666779
Q ss_pred ceEEcCCCCCCcCcccccCccCCCCCCCCCCCCCCCCeeEEEeCCCCceecccCCCC-CCccceecccC
Q 008785 127 SWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTS-HPFICMVEHEN 194 (553)
Q Consensus 127 ~w~W~dg~~~~~~~~~~~~~~~~~~~~~~C~~~~~~~~C~~~~~~~~~w~~~~C~~~-~~~iC~~~~~~ 194 (553)
.|.|+||++..+.+|..++|.. ....++|+.+.. ...|++..|... .+|||+.....
T Consensus 76 ~~~w~dg~~~~~~~w~~~~P~~----------~~~~~~Cv~~~~-~g~W~~~~C~~~~~~fICek~~~~ 133 (143)
T d1t8da1 76 EFIWVDGSHVDYSNWAPGEPTS----------RSQGEDCVMMRG-SGRWNDAFCDRKLGAWVCDRLATC 133 (143)
T ss_dssp CEEETTSCBCSSCCBSSSCCCS----------CCSCCSEEEEET-TTEEEEECSCSCCCEEEEEEECSC
T ss_pred ccEeCCCCccccccccccCCCC----------CCCCCCEEEEcC-CCEEEeeCCCCCccCeEEEECCCC
Confidence 9999999998888777766521 223457888865 357999999876 57999976543
|
| >d1j34b_ d.169.1.1 (B:) Snake coagglutinin beta chain {Habu snake (Trimeresurus flavoviridis) [TaxId: 88087]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Snake coagglutinin beta chain species: Habu snake (Trimeresurus flavoviridis) [TaxId: 88087]
Probab=99.92 E-value=5.4e-26 Score=194.92 Aligned_cols=118 Identities=23% Similarity=0.559 Sum_probs=102.2
Q ss_pred CCCcCCcccCCCCeEEEEecCCCChHHHHHHHhhc--CCEEeeeCCHHHHHHHHHhhCCC--CCCeEeeeeecCCCCCCc
Q 008785 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI--GGHLAALTSYEEEHSAQKLCGKN--VNGCWVGGRSINTTVGLS 127 (553)
Q Consensus 52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~--~~~L~~i~~~~e~~f~~~~~~~~--~~~~WiGl~~~~~~~~~~ 127 (553)
.||+||. .|+++||+|+..+++|.+|+.+|..+ |||||+|+|++|++||.+++... ...|||||+ |...+|.
T Consensus 1 ~Cp~gw~--~~~~~CY~~~~~~~~~~~A~~~C~~~~~gg~L~~i~s~~e~~~l~~~~~~~~~~~~~WiGl~--~~~~~~~ 76 (123)
T d1j34b_ 1 DCPSDWS--SYEGHCYKPFSEPKNWADAENFCTQQHAGGHLVSFQSSEEADFVVKLAFQTFGHSIFWMGLS--NVWNQCN 76 (123)
T ss_dssp CCCTTSE--EETTEEEEEEEEEECHHHHHHHHHHHSTTCEECCCSSHHHHHHHHHHHHHHHCSCEEECSCC--SCSTTSC
T ss_pred CCCCCCE--eECCEEEEEEccccCHHHHHHHHHhccCCCcccccCCHhHhhhhhhhhccccceeEEeecee--cccccce
Confidence 3999999 89999999999999999999999754 99999999999999999876432 456999999 7778899
Q ss_pred eEEcCCCCCCcCcccccCccCCCCCCCCCCCCCCCCeeEEEeCCCCceecccCCCCCCccceec
Q 008785 128 WKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVE 191 (553)
Q Consensus 128 w~W~dg~~~~~~~~~~~~~~~~~~~~~~C~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~~ 191 (553)
|+|+||+++.+.+|.. .++|+.+...++.|++..|....+|+|+++
T Consensus 77 w~W~dg~~~~y~~W~~------------------~~~Cv~~~~~~~~W~~~~C~~~~~fiCe~~ 122 (123)
T d1j34b_ 77 WQWSNAAMLRYKAWAE------------------ESYCVYFKSTNNKWRSRACRMMAQFVCEFQ 122 (123)
T ss_dssp EEETTCCCCCCCCBSC------------------SCEEEEEETTSCCBEEEETTSCEEEEEEEE
T ss_pred eecCCCCcccccCCCC------------------CCCeEEEECCCCEEEeeCCCCCEeEEEEEc
Confidence 9999999987666532 137888887778899999999999999875
|
| >d1oz7b_ d.169.1.1 (B:) Snake coagglutinin beta chain {Saw-scaled viper (Echis carinatus), echicetin [TaxId: 40353]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Snake coagglutinin beta chain species: Saw-scaled viper (Echis carinatus), echicetin [TaxId: 40353]
Probab=99.92 E-value=5.9e-26 Score=194.65 Aligned_cols=118 Identities=20% Similarity=0.475 Sum_probs=101.9
Q ss_pred CCCcCCcccCCCCeEEEEecCCCChHHHHHHHhhc--CCEEeeeCCHHHHHHHHHhhCCC--CCCeEeeeeecCCCCCCc
Q 008785 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI--GGHLAALTSYEEEHSAQKLCGKN--VNGCWVGGRSINTTVGLS 127 (553)
Q Consensus 52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~--~~~L~~i~~~~e~~f~~~~~~~~--~~~~WiGl~~~~~~~~~~ 127 (553)
.||+||. .|+++||+|+.++++|.+|+.+|..+ ||+||+|+|++|++||.+++... ...+||||+ +...+|.
T Consensus 1 ~Cp~gw~--~~~~~CY~~~~~~~~~~~A~~~C~~~~~gg~L~~i~s~~e~~~l~~~~~~~~~~~~~WIGl~--~~~~~~~ 76 (123)
T d1oz7b_ 1 NCLPDWS--VYEGYCYKVFKERMNWADAEKFCTKQHKDGHLVSFRNSKEVDFVISLAFPMLKNDLVWIGLT--DYWRDCN 76 (123)
T ss_dssp CCCTTCE--EETTEEEEEEEEEECHHHHHHHHHHHSTTCEECCCCCSSHHHHHHHTSSTTTTCSEEEEEEE--CCCCGGG
T ss_pred CCCccCE--eECCEEEEEeCcccCHHHHHHHHhhccCCCcccccCCHHHhhhceeeeeecccceeEEEEee--ccCcccc
Confidence 3999999 89999999999999999999999754 99999999999999999987543 356899999 7777899
Q ss_pred eEEcCCCCCCcCcccccCccCCCCCCCCCCCCCCCCeeEEEeCCCCceecccCCCCCCccceec
Q 008785 128 WKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVE 191 (553)
Q Consensus 128 w~W~dg~~~~~~~~~~~~~~~~~~~~~~C~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~~ 191 (553)
|+|+||+++.+.+|.. .++|+.+...+..|.+..|....+|||+.+
T Consensus 77 ~~W~dg~~~~y~nW~~------------------~~~C~~~~~~~~~W~~~~C~~~~~fICe~P 122 (123)
T d1oz7b_ 77 WEWSDGAQLDYKAWDN------------------ERHCFIYKNTDNQWTRRDCTWTFSFVCKCP 122 (123)
T ss_dssp EEETTCCCCCSCCBCS------------------STTEEEEEGGGTEEEEECTTSCEEEEEEEE
T ss_pred eeccCCCEeeccccCC------------------CCCEEEEECCCCEEEeeCCCCcEEEEEEEc
Confidence 9999999987766521 136788877667899999999999999875
|
| >d1tdqb_ d.169.1.1 (B:) Aggrecan core protein {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Aggrecan core protein species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.92 E-value=1.3e-25 Score=193.31 Aligned_cols=123 Identities=24% Similarity=0.438 Sum_probs=106.3
Q ss_pred CCCcCCcccCCCCeEEEEecCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHhhCCCCCCeEeeeeecCCCCCCceEEc
Q 008785 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWS 131 (553)
Q Consensus 52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~ 131 (553)
.||+||+ .|+++||+|+.++++|.+|+.+|+.+||+||+|+|++|++||.++.. ..+||||+ +...+|.|+|+
T Consensus 2 ~Cp~gw~--~~~~~CY~~~~~~~sw~~A~~~C~~~g~~La~i~~~~e~~~l~~~~~---~~~wigl~--~~~~~~~~~W~ 74 (126)
T d1tdqb_ 2 QCEEGWT--KFQGHCYRHFPDRETWVDAERRCREQQSHLSSIVTPEEQEFVNKNAQ---DYQWIGLN--DRTIEGDFRWS 74 (126)
T ss_dssp CCCTTCE--EETTEEEEEEEEEECHHHHHHHHHHTTCEECCCCSHHHHHHHHHHHC---SCEEEEEE--CSSSTTCCEET
T ss_pred CCCCCCe--eeCCEEEEEECcccCHHHHHHHHHhhCcEEeEECChhHhhhhhcccc---ceeeeecc--cccCCCccCcC
Confidence 5999999 89999999999999999999999999999999999999999999875 57999999 66677999999
Q ss_pred CCCCCCcCcccccCccCCCCCCCCCCCCCCCCeeEEEeCC-CCceecccCCCCCCcccee
Q 008785 132 DNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNG-SRSLVTERCNTSHPFICMV 190 (553)
Q Consensus 132 dg~~~~~~~~~~~~~~~~~~~~~~C~~~~~~~~C~~~~~~-~~~w~~~~C~~~~~~iC~~ 190 (553)
||+++.+.+|.+.+|.+. ....++|+.+... ...|.+..|....+|||+.
T Consensus 75 dg~~~~~~~w~~~~p~~~---------~~~~~~C~~~~~~~~~~W~~~~C~~~~~fICek 125 (126)
T d1tdqb_ 75 DGHSLQFEKWRPNQPDNF---------FATGEDCVVMIWHERGEWNDVPCNYQLPFTCKK 125 (126)
T ss_dssp TCCCCCCCCBCTTCCCCC---------STTTEEEEEEETTTTTEEEEEETTSCEEEEEEE
T ss_pred CCCCcccccccccCCCcc---------ccCCcceEEEEeCCCCeEEecCCCCCEEEEeee
Confidence 999988888877665321 1234588888654 4579999999999999975
|
| >d1c3ab_ d.169.1.1 (B:) Snake coagglutinin beta chain {Habu snake (Trimeresurus flavoviridis), flavocetin-A [TaxId: 88087]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Snake coagglutinin beta chain species: Habu snake (Trimeresurus flavoviridis), flavocetin-A [TaxId: 88087]
Probab=99.92 E-value=1e-25 Score=193.73 Aligned_cols=118 Identities=19% Similarity=0.402 Sum_probs=101.8
Q ss_pred CCCcCCcccCCCCeEEEEecCCCChHHHHHHHhh--cCCEEeeeCCHHHHHHHHHhhCCC--CCCeEeeeeecCCCCCCc
Q 008785 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKN--VNGCWVGGRSINTTVGLS 127 (553)
Q Consensus 52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~--~~~~L~~i~~~~e~~f~~~~~~~~--~~~~WiGl~~~~~~~~~~ 127 (553)
.||+||. .|+++||+|+.+.++|.+|+.+|.+ .||+||+|+|++|++||.+++... ...+||||+ |...+|.
T Consensus 3 ~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~~~g~~L~~i~s~~e~~~l~~~~~~~~~~~~~WiGl~--~~~~~~~ 78 (125)
T d1c3ab_ 3 CCPLGWS--SYDEHCYQVFQQKMNWEDAEKFCTQQHKGSHLVSFHSSEEVDFVTSKTFPILKYDFVWIGLS--NVWNECT 78 (125)
T ss_dssp CCCTTCE--EETTEEEEEEEEEECHHHHHHHHHHHSTTCEECCCSSHHHHHHHHHHHHHHHCSCEEECSCC--CTTTSSC
T ss_pred CCCCCCE--EECCEEEEEECcccCHHHHHHhhccccCCCeecccCCHHHhhhhhhhhhccCCceeEEEEec--ccCccee
Confidence 5999999 8999999999999999999999965 489999999999999999876422 456899999 7778899
Q ss_pred eEEcCCCCCCcCcccccCccCCCCCCCCCCCCCCCCeeEEEeCCCCceecccCCCCCCccceec
Q 008785 128 WKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVE 191 (553)
Q Consensus 128 w~W~dg~~~~~~~~~~~~~~~~~~~~~~C~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~~ 191 (553)
|+|+|||++.+.+|..+ ++|+.+...+..|++..|....+|||+++
T Consensus 79 ~~W~dGs~~~y~~W~~~------------------e~Cv~~~~~~~~W~~~~C~~~~~fICe~~ 124 (125)
T d1c3ab_ 79 KEWSDGTKLDYKAWSGG------------------SDCIVSKTTDNQWLSMDCSSKYYVVCKFQ 124 (125)
T ss_dssp EEETTCCCCCSCCBCCC------------------CEEEEEESSSSCEEEEETTSCEEEEEEEE
T ss_pred eEeCCCCeeeccccCCC------------------CceEEEECCCCeEEeeCCCCCEEEEEEEe
Confidence 99999999877665321 36888877777899999999999999874
|
| >d1jwib_ d.169.1.1 (B:) Snake coagglutinin beta chain {Puff adder (Bitis arietans), bitiscetin [TaxId: 8692]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Snake coagglutinin beta chain species: Puff adder (Bitis arietans), bitiscetin [TaxId: 8692]
Probab=99.92 E-value=1.2e-25 Score=192.62 Aligned_cols=117 Identities=25% Similarity=0.548 Sum_probs=100.6
Q ss_pred CCcCCcccCCCCeEEEEecCCCChHHHHHHHhhc--CCEEeeeCCHHHHHHHHHhhCCC--CCCeEeeeeecCCCCCCce
Q 008785 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI--GGHLAALTSYEEEHSAQKLCGKN--VNGCWVGGRSINTTVGLSW 128 (553)
Q Consensus 53 Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~--~~~L~~i~~~~e~~f~~~~~~~~--~~~~WiGl~~~~~~~~~~w 128 (553)
||+||. .|+++||+|+.++++|.+|+.+|+++ ||+||+|+|++|++||.++.... ...+||||+ +...++.|
T Consensus 2 Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~~~gg~L~~i~s~~e~~~l~~~~~~~~~~~~~WiGl~--~~~~~~~~ 77 (123)
T d1jwib_ 2 CLPDWS--SYKGHCYKVFKVEKTWADAEKFCKELVNGGHLMSVNSREEGEFISKLALEKMRIVLVWIGLS--HFWRICPL 77 (123)
T ss_dssp CCTTCE--EETTEEEEEEEEEECHHHHHHHHHHHSTTCEECCCCSHHHHHHHHHHHHHTTCCCEEEEEEE--ECGGGSCE
T ss_pred CCCCcE--eeCCEEEEEeCcccCHHHHHHHhhhccCCccccccCCHHHhhhhhhheeccccccceEeeee--ccCcccee
Confidence 999999 89999999999999999999999875 99999999999999999876432 346899999 66677999
Q ss_pred EEcCCCCCCcCcccccCccCCCCCCCCCCCCCCCCeeEEEeCCCCceecccCCCCCCccceec
Q 008785 129 KWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVE 191 (553)
Q Consensus 129 ~W~dg~~~~~~~~~~~~~~~~~~~~~~C~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~~ 191 (553)
+|+||+++.+.+| .++ .+|+.+......|++..|....+|+|+++
T Consensus 78 ~W~dgs~~~y~~w-~~~-----------------~~c~~~~~~~~~W~~~~C~~~~~fiCe~k 122 (123)
T d1jwib_ 78 RWTDGARLDYRAL-SDE-----------------PICFVAESFHNKWIQWTCNRKKSFVCKYR 122 (123)
T ss_dssp EETTCCCCCSCCS-CCS-----------------CEEEEEETTTCCEEEEETTSCEEEEEEEE
T ss_pred EccCCCCcccccC-CCC-----------------CCEEEEECCCCeEEecCCCCCEeEEEeEE
Confidence 9999999877654 222 15777777777899999999999999875
|
| >d1umrc_ d.169.1.1 (C:) Snake coagglutinin beta chain {South american rattlesnake (Crotalus durissus terrificus), convulxin [TaxId: 8732]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Snake coagglutinin beta chain species: South american rattlesnake (Crotalus durissus terrificus), convulxin [TaxId: 8732]
Probab=99.91 E-value=2.3e-25 Score=191.54 Aligned_cols=118 Identities=23% Similarity=0.533 Sum_probs=102.4
Q ss_pred CCCcCCcccCCCCeEEEEecCCCChHHHHHHHhhc--CCEEeeeCCHHHHHHHHHhhCCC--CCCeEeeeeecCCCCCCc
Q 008785 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI--GGHLAALTSYEEEHSAQKLCGKN--VNGCWVGGRSINTTVGLS 127 (553)
Q Consensus 52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~--~~~L~~i~~~~e~~f~~~~~~~~--~~~~WiGl~~~~~~~~~~ 127 (553)
.||+||. .|+++||+|+.+.++|.+|+.+|.++ ||+||+|+|++|++||.+++... ...+||||+ +...+|.
T Consensus 3 ~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~~~gg~La~i~~~~e~~~l~~~~~~~~~~~~~WIGl~--~~~~~~~ 78 (125)
T d1umrc_ 3 CCPSHWS--SYDRYCYKVFKQEMTWADAEKFCTQQHTGSHLVSFHSTEEVDFVVKMTHQSLKSTFFWIGAN--NIWNKCN 78 (125)
T ss_dssp CCCTTCE--EETTEEEEEEEEEECHHHHHHHHHHHSTTCEECCCSSHHHHHHHHHHHHTTCSSSEEECSCC--CTTTSSC
T ss_pred CCCccCE--EECCEEEEEECCccCHHHHHHhhcccCCCCcccccCCHHHhhhhhhhhcccccceeEEEeee--ccccccc
Confidence 4999999 89999999999999999999999765 89999999999999999987543 456999999 7777899
Q ss_pred eEEcCCCCCCcCcccccCccCCCCCCCCCCCCCCCCeeEEEeCCCCceecccCCCCCCccceec
Q 008785 128 WKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVE 191 (553)
Q Consensus 128 w~W~dg~~~~~~~~~~~~~~~~~~~~~~C~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~~ 191 (553)
|+|+||+++.+.+|..+ ++|+.....+..|++..|....+|||+++
T Consensus 79 w~W~dgs~~~y~~w~~~------------------~~c~~~~~~~~~W~~~~C~~~~~fICe~~ 124 (125)
T d1umrc_ 79 WQWSDGTKPEYKEWHEE------------------FECLISRTFDNQWLSAPCSDTYSFVCKFE 124 (125)
T ss_dssp EEETTSCCCSSCCBCCC------------------CEEEEEESSCSCEEEEETTSCEEEEEEEE
T ss_pred eEecCCCcccccCcCCc------------------CCeeEEECCCCeEEeeCCCCCEEEEEEEe
Confidence 99999999877665321 36778877778899999999999999874
|
| >d1qdda_ d.169.1.1 (A:) Lithostathine, inhibitor of stone formation {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Lithostathine, inhibitor of stone formation species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.91 E-value=3.1e-25 Score=195.64 Aligned_cols=126 Identities=17% Similarity=0.414 Sum_probs=105.0
Q ss_pred CCCCcCCcccCCCCeEEEEecCCCChHHHHHHHhhc-CCEEeeeCCHHHHHHHHHhhCCC---CCCeEeeeeecCCCCCC
Q 008785 51 APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI-GGHLAALTSYEEEHSAQKLCGKN---VNGCWVGGRSINTTVGL 126 (553)
Q Consensus 51 ~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~-~~~L~~i~~~~e~~f~~~~~~~~---~~~~WiGl~~~~~~~~~ 126 (553)
..||+||. .|+++||+|+.++++|.+|+.+|.++ ||+||+|+|++|++||..++... ...+||||+ +...++
T Consensus 12 ~~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~~gg~L~~i~s~~e~~~l~~~l~~~~~~~~~~WiGl~--~~~~~~ 87 (144)
T d1qdda_ 12 ISCPEGTN--AYRSYCYYFNEDRETWVDADLYCQNMNSGNLVSVLTQAEGAFVASLIKESGTDDFNVWIGLH--DPKKNR 87 (144)
T ss_dssp TSCCTTCE--EETTEEEEEEEEEECHHHHHHHHHHTTSCEECCCCSHHHHHHHHHHHHHTTCCCSEEEEEEE--CTTSSS
T ss_pred CcCCCCCE--EECCEEEEEECCccCHHHHHHHHHhccccccceEEeeecchhhhhccccccccccceeeeee--cccccc
Confidence 46999999 89999999999999999999999986 78999999999999999876432 346899999 777789
Q ss_pred ceEEcCCCCCCcCcccccCccCCCCCCCCCCCCCCCCeeEEEeCC--CCceecccCCCCCCccceec
Q 008785 127 SWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNG--SRSLVTERCNTSHPFICMVE 191 (553)
Q Consensus 127 ~w~W~dg~~~~~~~~~~~~~~~~~~~~~~C~~~~~~~~C~~~~~~--~~~w~~~~C~~~~~~iC~~~ 191 (553)
.|+|+||++..+.+|..+.|. +....+|+.+... ...|.+..|....+|||+++
T Consensus 88 ~w~W~dGs~~~y~~W~~~~P~-----------~~~~~~C~~~~~~~~~~~W~~~~C~~~~~fICe~k 143 (144)
T d1qdda_ 88 AWHWSSGSLVSYKSWGIGAPS-----------SVNPGYCVSLTSSTGFQKWKDVPCEDKFSFVCKFK 143 (144)
T ss_dssp CCEETTCCCCCCCCBCTTCSC-----------SSSCCSEEEEEGGGTTCSEEEECTTSCEEEEEEEE
T ss_pred eeEecCCCeeecccccCCCCC-----------CCCCccEEEEEccCCCCcEEecCCCCCeEEEEEEC
Confidence 999999999888877766542 2223468777543 34699999999999999875
|
| >d2afpa_ d.169.1.1 (A:) Type II antifreeze protein {Sea raven (Hemitripterus americanus) [TaxId: 8094]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Type II antifreeze protein species: Sea raven (Hemitripterus americanus) [TaxId: 8094]
Probab=99.91 E-value=2.8e-25 Score=192.11 Aligned_cols=122 Identities=26% Similarity=0.525 Sum_probs=103.3
Q ss_pred CCCCcCCcccCCCCeEEEEecCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHhhCCCCCCeEeeeeecCCCCCCceEE
Q 008785 51 APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKW 130 (553)
Q Consensus 51 ~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W 130 (553)
..||+||. .|+++||+|+...++|.+|+.+|..+||+||+|+|++|++||+++.. ..+||||+ +...+|.|+|
T Consensus 5 ~~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~gg~La~i~s~~e~~fl~~~~~---~~~Wig~~--~~~~~~~w~W 77 (129)
T d2afpa_ 5 PNCPAGWQ--PLGDRCIYYETTAMTWALAETNCMKLGGHLASIHSQEEHSFIQTLNA---GVVWIGGS--ACLQAGAWTW 77 (129)
T ss_dssp CSSCSSSC--CCSSSEECCCCSCCCHHHHHHHHHHHSCEECCCSSSHHHHHHHHHCS---SCBCCSCB--CSSSSSCCBS
T ss_pred CCCCCCCE--EECCEEEEEECcccCHHHHHHHHHhcCCeEeeeeehhcchhhccccc---Cceeeeee--cccccceeec
Confidence 35999999 99999999999999999999999999999999999999999999864 57999999 6667799999
Q ss_pred cCCCCCCcCcccccCccCCCCCCCCCCCCCCCCeeEEEeC-CCCceecccCCCCCCcccee
Q 008785 131 SDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSN-GSRSLVTERCNTSHPFICMV 190 (553)
Q Consensus 131 ~dg~~~~~~~~~~~~~~~~~~~~~~C~~~~~~~~C~~~~~-~~~~w~~~~C~~~~~~iC~~ 190 (553)
+||+++.+..|.++.|. +..+ ++|+.+.. +...|++..|....+|||++
T Consensus 78 ~dgs~~~y~~W~~~~P~--~~~~---------~~c~~~~~~~~~~W~~~~C~~~~~~ICe~ 127 (129)
T d2afpa_ 78 SDGTPMNFRSWCSTKPD--DVLA---------ACCMQMTAAADQCWDDLPCPASHKSVCAM 127 (129)
T ss_dssp SSSCCCCCCCSSSCCSC--CSTT---------CCBCCBCCSSSSCBCCBCSCCCCCCCEEE
T ss_pred cCCCeeecccccCCCCC--CCCC---------CcEEEEECCCCCcEEeeCCCCCEeEEEEE
Confidence 99999888887766652 2222 34555543 34579999999999999986
|
| >d1e87a_ d.169.1.1 (A:) CD69 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: CD69 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.91 E-value=1.5e-24 Score=184.05 Aligned_cols=114 Identities=27% Similarity=0.578 Sum_probs=96.8
Q ss_pred CCCcCCcccCCCCeEEEEecCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHhhCCCCCCeEeeeeecCCCCCCceEEc
Q 008785 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWS 131 (553)
Q Consensus 52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~ 131 (553)
+||+||+ .|+++||+|+.++++|.+|+.+|+++||+||+|+|++|++||..++. ...+||||+ +. .++.|+|+
T Consensus 2 sCp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~g~~L~~i~s~~e~~~l~~~~~--~~~~WiGl~--~~-~~~~w~w~ 74 (117)
T d1e87a_ 2 SCSEDWV--GYQRKCYFISTVKRSWTSAQNACSEHGATLAVIDSEKDMNFLKRYAG--REEHWVGLK--KE-PGHPWKWS 74 (117)
T ss_dssp CSCTTSE--EETTEEEEECSSCBCHHHHHHHHHHTTCEECCCCSHHHHHHHHHHHC--SSCEEEEEE--CC-TTSCCEET
T ss_pred CCCCCCE--EECCEEEEEECcccCHHHHHHHHhhcCCEEeeecCHHHHHHHhhhhc--cceeecccc--cc-ccCccEeC
Confidence 6999999 89999999999999999999999999999999999999999999987 567999998 42 45789999
Q ss_pred CCCCCCcCcccccCccCCCCCCCCCCCCCCCCeeEEEeCCCCceecccCCCCCCccceec
Q 008785 132 DNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVE 191 (553)
Q Consensus 132 dg~~~~~~~~~~~~~~~~~~~~~~C~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~~ 191 (553)
||+++.+ |.... +.++|+.+.. ..|++..|....+|||+.+
T Consensus 75 dg~~~~~--w~~~~---------------~~~~C~~l~~--~~w~~~~C~~~~~~ICekp 115 (117)
T d1e87a_ 75 NGKEFNN--WFNVT---------------GSDKCVFLKN--TEVSSMECEKNLYWICNKP 115 (117)
T ss_dssp TSCBCCC--SSCCB---------------SSCSEEEEET--TEEEEECTTSCBEEEEEEE
T ss_pred CCCcccC--ccCCC---------------CCCcEEEEEC--CEEEEecCCCCEEEEEEEe
Confidence 9987532 22111 2247888864 4799999999999999865
|
| >d1dv8a_ d.169.1.1 (A:) H1 subunit of the asialoglycoprotein receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: H1 subunit of the asialoglycoprotein receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.91 E-value=3e-24 Score=185.21 Aligned_cols=125 Identities=21% Similarity=0.507 Sum_probs=103.7
Q ss_pred CCcCCcccCCCCeEEEEecCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHhhCCCCCCeEeeeeecCCCCCCceEEcC
Q 008785 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSD 132 (553)
Q Consensus 53 Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~d 132 (553)
||+||. .|+++||+|+.++++|.+|+.+|+++||+||+|+|++|++||.+++. ...+||||+ +.. +.|+|+|
T Consensus 1 Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~g~~La~i~~~~e~~~i~~~~~--~~~~WiG~~--~~~--~~~~W~d 72 (128)
T d1dv8a_ 1 CPVNWV--EHERSCYWFSRSGKAWADADNYCRLEDAHLVVVTSWEEQKFVQHHIG--PVNTWMGLH--DQN--GPWKWVD 72 (128)
T ss_dssp CCTTCE--EETTEEEEECSSCBCHHHHHHHHHHTTCEECCCCSHHHHHHHHHHHC--SSCEEEEEE--CTT--SSCEETT
T ss_pred CCCCCE--EECCEEEEEECCccCHHHHHHHHhhcCCEEeeecccchhhhhhcccc--ceeeeeecc--ccC--CceEEee
Confidence 999999 89999999999999999999999999999999999999999999987 568999999 644 8999999
Q ss_pred CCCCC--cCcccccCccCCCCCCCCCCCCCCCCeeEEEeCCCCceecccCCCCCCccceec
Q 008785 133 NMSKW--NESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVE 191 (553)
Q Consensus 133 g~~~~--~~~~~~~~~~~~~~~~~~C~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~~ 191 (553)
|++.. +..|.+++|.. .... ...+.++|+.+.. +..|.+..|....+|||+.+
T Consensus 73 gs~~~~~~~~W~~~~P~~--~~~~---~~~~~~~C~~~~~-~~~w~~~~C~~~~~fICe~~ 127 (128)
T d1dv8a_ 73 GTDYETGFKNWRPEQPDD--WYGH---GLGGGEDCAHFTD-DGRWNDDVCQRPYRWVCETE 127 (128)
T ss_dssp CCCSTTSCCCBCTTCCCC--CCTT---SSSSCCCEEEECT-TSCEEEECTTSCBEEEEEEE
T ss_pred ccccCCcceeeccCCCCc--cccc---cCCCCcceEEECC-CCEEEeEcCCCCEEEEEEEE
Confidence 98754 45666655521 1111 1234568998754 46799999999999999864
|
| >d1gz2a_ d.169.1.1 (A:) Ovocleidin-17 {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Ovocleidin-17 species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=99.91 E-value=1.4e-24 Score=189.97 Aligned_cols=123 Identities=25% Similarity=0.581 Sum_probs=103.3
Q ss_pred CCcCCcccCCCCeEEEEecCCCChHHHHHHHhhc--CCEEeeeCCHHHHHHHHHhhCCC----------CCCeEeeeeec
Q 008785 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI--GGHLAALTSYEEEHSAQKLCGKN----------VNGCWVGGRSI 120 (553)
Q Consensus 53 Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~--~~~L~~i~~~~e~~f~~~~~~~~----------~~~~WiGl~~~ 120 (553)
||+||. .|+++||+|+..+++|.+|+.+|+.+ ||+||+|+|.+|++||.+++... ...+||||+
T Consensus 2 Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~~~g~~L~~i~s~~e~~~i~~~l~~~~~~~~~~~~~~~~~WiGl~-- 77 (139)
T d1gz2a_ 2 CGPGWV--PTPGGCLGFFSRELSWSRAESFCRRWGPGSHLAAVRSAAELRLLAELLNASRGGDGSGEGADGRVWIGLH-- 77 (139)
T ss_dssp CCTTCE--EETTEEEEEEEEEECHHHHHHHHHTTCTTEEECCCCSHHHHHHHHHHHHCSSCCSSSCCCCSSCEEEEEE--
T ss_pred CCCCCE--eECCEEEEEeCeecCHHHHHhhhhcccCCceecchhhHHHHHHHHHHHHhhccccccccccccceeeeee--
Confidence 999999 89999999999999999999999865 99999999999999999987322 246999999
Q ss_pred CCCCCCceEEcCCCCCCcCcccccCccCCCCCCCCCCCCCCCCeeEEEeCC--CCceecccCCCCCCccceec
Q 008785 121 NTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNG--SRSLVTERCNTSHPFICMVE 191 (553)
Q Consensus 121 ~~~~~~~w~W~dg~~~~~~~~~~~~~~~~~~~~~~C~~~~~~~~C~~~~~~--~~~w~~~~C~~~~~~iC~~~ 191 (553)
+...++.|+|+||+++.+.+|....|+. ..++|+.+... ...|.+..|....+|+|+.+
T Consensus 78 ~~~~~~~w~W~dgs~~~y~~W~~~~p~~------------~~~~C~~l~~~~~~~~W~~~~C~~~~~fiCe~~ 138 (139)
T d1gz2a_ 78 RPAGSRSWRWSDGTAPRFASWHRTAKAR------------RGGRCAALRDEEAFTSWAARPCTERNAFVCKAA 138 (139)
T ss_dssp CCTTCSSCEETTSCCCCCCCBCSSSGGG------------CSCSEEEECTTTTSSCEEEECTTCCEEEEEEEE
T ss_pred ecccCCceEeccCCcceeecccCCCCCC------------CCCcEEEEEecCCCCcEEecCCCCCEeEEEEEc
Confidence 7777799999999999888877666521 12467777553 24599999999999999874
|
| >d1v7pb_ d.169.1.1 (B:) Snake coagglutinin beta chain {Snake (Echis multisquamatus), Ems16 [TaxId: 93050]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Snake coagglutinin beta chain species: Snake (Echis multisquamatus), Ems16 [TaxId: 93050]
Probab=99.91 E-value=7.5e-25 Score=188.78 Aligned_cols=119 Identities=28% Similarity=0.560 Sum_probs=98.8
Q ss_pred CCcCCcccCCCCeEEEEecCCCChHHHHHHHhh--cCCEEeeeCCHHHHHHHHHhhCC--CCCCeEeeeeecCCCCCCce
Q 008785 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGK--NVNGCWVGGRSINTTVGLSW 128 (553)
Q Consensus 53 Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~--~~~~L~~i~~~~e~~f~~~~~~~--~~~~~WiGl~~~~~~~~~~w 128 (553)
||+||. .|+++||+|+.++++|.+|+..|.. .||+||+|+|++|++||.+++.. ....|||||+ +...+|.|
T Consensus 1 Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~WiGl~--~~~~~~~w 76 (127)
T d1v7pb_ 1 CPLGWS--SFDQHCYKVFEPVKNWTEAEEICMQQHKGSRLASIHSSEEEAFVSKLASKALKFTSMWIGLN--NPWKDCKW 76 (127)
T ss_dssp CCTTCE--EETTEEEEEEEEEECHHHHHHHHHHHSTTCEECCCCSHHHHHHHHHHHHHHCSSCEEEEEEE--CTTTTCCC
T ss_pred CCCCCE--eeCCEEEEEECcccCHHHHHHhhcccCCCCcccchhhhhhhhhhceeecccccceeEEeeee--ccCcccee
Confidence 999999 8999999999999999999999965 48999999999999999987642 2457999999 77778999
Q ss_pred EEcCCCCCCcCcccccCccCCCCCCCCCCCCCCCCeeEEEeCC--CCceecccCCCCCCccceeccc
Q 008785 129 KWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNG--SRSLVTERCNTSHPFICMVEHE 193 (553)
Q Consensus 129 ~W~dg~~~~~~~~~~~~~~~~~~~~~~C~~~~~~~~C~~~~~~--~~~w~~~~C~~~~~~iC~~~~~ 193 (553)
+|+||+++.+.+|..+ ++|+.+... ...|.+..|....+|+|++...
T Consensus 77 ~W~dg~~~~y~~W~~~------------------~~c~~~~~~~~~~~W~~~~C~~~~~fiCe~~~~ 125 (127)
T d1v7pb_ 77 EWSDNARFDYKAWKRR------------------PYCTVMVVKPDRIFWFTRGCEKSVSFVCKFLTD 125 (127)
T ss_dssp EETTCCCCCCCCBCCC------------------CEEEEEEECSSCEEEEEEETTSCEEEEEEEECC
T ss_pred EecCCCcccccccCCC------------------CCcEEEEEECCCCeEEecCCCCCEEEEEEEcCC
Confidence 9999999877765322 245554333 3459999999999999998643
|
| >d1sb2a1 d.169.1.1 (A:1-132) Snake coagglutinin alpha chain {Malayan pit viper (Calloselasma rhodostoma), rhodocetin [TaxId: 8717]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Snake coagglutinin alpha chain species: Malayan pit viper (Calloselasma rhodostoma), rhodocetin [TaxId: 8717]
Probab=99.91 E-value=7e-25 Score=190.33 Aligned_cols=123 Identities=23% Similarity=0.488 Sum_probs=102.9
Q ss_pred CCCcCCcccCCCCeEEEEecCCCChHHHHHHHhh--cCCEEeeeCCHHHHHHHHHhhCC----CCCCeEeeeeecCCCCC
Q 008785 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGK----NVNGCWVGGRSINTTVG 125 (553)
Q Consensus 52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~--~~~~L~~i~~~~e~~f~~~~~~~----~~~~~WiGl~~~~~~~~ 125 (553)
.||+||. .|+++||+|+.++++|.+|+.+|+. .||+||+|+|++|++||.+++.. ....+||||++.+...+
T Consensus 1 ~Cp~gw~--~~~~~CY~~~~~~~~~~~A~~~C~~~~~g~~L~~i~s~~e~~~i~~~~~~~~~~~~~~~WiGl~~~~~~~~ 78 (132)
T d1sb2a1 1 DCPDGWS--STKSYCYRPFKEKKTWEEAERFCTEQEKEAHLVSMENRLEAVFVDMVMENNFENKIYRSWIGLKIENKGQR 78 (132)
T ss_dssp CCCTTCE--ECSSEEEEEEEEEECHHHHHHHHHTSSSCCEECCCSSHHHHHHHHHHHHHHTTTCCEEEEEEEEEECSSTT
T ss_pred CCCCcCE--EECCEEEEEECcccCHHHHHHHHhhccCCccccccCCHHHHHHHHHHHhcccccccchhhhhhhccccccc
Confidence 3999999 8999999999999999999999964 59999999999999999987642 23468999998777788
Q ss_pred CceEEcCCCCCCcCcccccCccCCCCCCCCCCCCCCCCeeEEEeCC--CCceecccCCCCCCccceecc
Q 008785 126 LSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNG--SRSLVTERCNTSHPFICMVEH 192 (553)
Q Consensus 126 ~~w~W~dg~~~~~~~~~~~~~~~~~~~~~~C~~~~~~~~C~~~~~~--~~~w~~~~C~~~~~~iC~~~~ 192 (553)
+.|+|+||+++.+.+|+..+ .++|+.+... ...|++..|....+|||+++.
T Consensus 79 ~~~~W~dG~~~~y~n~~~~~----------------~~~C~~~~~~~~~~~W~~~~C~~~~~fICe~~~ 131 (132)
T d1sb2a1 79 SNLEWSDGSSISYENLYEPY----------------MEKCFLMDHQSGLPKWHTADCEEKNVFMCKFQL 131 (132)
T ss_dssp SSEEETTCCCCCCCCBSSCC----------------CEEEEEEEESSSSCEEEEECTTSCEEEEEEEEC
T ss_pred cceecccCCcccceecCCCC----------------CccEEEEEcCCCCCcEEecCCCCCEeEEEEEeC
Confidence 99999999998877764322 1378877543 246999999999999999864
|
| >d1qo3c_ d.169.1.1 (C:) NK cell receptor {Mouse (Mus musculus), ly49-a [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: NK cell receptor species: Mouse (Mus musculus), ly49-a [TaxId: 10090]
Probab=99.91 E-value=7e-25 Score=190.54 Aligned_cols=123 Identities=19% Similarity=0.316 Sum_probs=98.5
Q ss_pred CCCCCCCcCCcccCCCCeEEEEecCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHhhCCCCCCeEeeeeecCCCCCCc
Q 008785 48 DWKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLS 127 (553)
Q Consensus 48 ~~~~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~ 127 (553)
..+..||.+|. .|+++||+|+.++++|.+|+.+|+++||+||+|+|++|++||+.++. ...|||||++ ...++.
T Consensus 9 ~~~~~c~~~W~--~~~~~CY~~~~~~~tw~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~--~~~~WIGl~~--~~~~~~ 82 (133)
T d1qo3c_ 9 HTGRGDKVYWF--CYGMKCYYFVMDRKTWSGCKQTCQSSSLSLLKIDDEDELKFLQLVVP--SDSCWVGLSY--DNKKKD 82 (133)
T ss_dssp C-----CEEEE--EETTEEEEEEEEEECHHHHHHHHHHTTCEECCCCSHHHHHHHHHHSC--SSCEEEEEEE--EGGGTE
T ss_pred cCCCCCCCceE--EECCEEEEEECccCCHHHHHHHHHhcCCEEeEEeecceeeehhcccc--cceeEEEEEE--cCCCCC
Confidence 44568999999 99999999999999999999999999999999999999999999987 5679999994 445699
Q ss_pred eEEcCCCCCCcCcccccCccCCCCCCCCCCCCCCCCeeEEEeCCCCceecccCCCCCCccceec
Q 008785 128 WKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVE 191 (553)
Q Consensus 128 w~W~dg~~~~~~~~~~~~~~~~~~~~~~C~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~~ 191 (553)
|+|+||+++.+..+.... +...++|+.+.. ..|++..|....+|||+.+
T Consensus 83 w~W~dg~~~~~~~~~~~~-------------~~~~~~C~~l~~--~~w~~~~C~~~~~~ICek~ 131 (133)
T d1qo3c_ 83 WAWIDNRPSKLALNTRKY-------------NIRDGGCMLLSK--TRLDNGNCDQVFICICGKR 131 (133)
T ss_dssp EEETTSCCCSSCCCTTSS-------------CGGGCSEEEECS--SCEEEECTTSCEEEEEEEE
T ss_pred EEECCCCccccccccCCC-------------CCCCCCEEEEEC--CEEEEcCCCCCEEEEEeEE
Confidence 999999886554332211 112347888754 4699999999999999864
|
| >d1c3aa_ d.169.1.1 (A:) Snake coagglutinin alpha chain {Habu snake (Trimeresurus flavoviridis), flavocetin-A [TaxId: 88087]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Snake coagglutinin alpha chain species: Habu snake (Trimeresurus flavoviridis), flavocetin-A [TaxId: 88087]
Probab=99.91 E-value=6.5e-25 Score=191.32 Aligned_cols=123 Identities=24% Similarity=0.488 Sum_probs=102.0
Q ss_pred CCCcCCcccCCCCeEEEEecCCCChHHHHHHHhhc--CCEEeeeCCHHHHHHHHHhhCC----CCCCeEeeeeecCCCCC
Q 008785 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI--GGHLAALTSYEEEHSAQKLCGK----NVNGCWVGGRSINTTVG 125 (553)
Q Consensus 52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~--~~~L~~i~~~~e~~f~~~~~~~----~~~~~WiGl~~~~~~~~ 125 (553)
.||+||. .|+++||+|+..++||.+|+.+|++. ||+||+|+|++|++||.+++.. ....+||||++.+....
T Consensus 3 ~Cp~gw~--~~~~~CY~~~~~~~tw~~A~~~C~~~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~~~WiGl~~~~~~~~ 80 (135)
T d1c3aa_ 3 DCIPGWS--AYDRYCYQAFSKPKNWEDAESFCEEGVKTSHLVSIESSGEGDFVAQLVAEKIKTSFQYVWIGLRIQNKEQQ 80 (135)
T ss_dssp CCCTTCE--EETTEEEEEEEEEECHHHHHHHHHHHSTTCEECCCCSHHHHHHHHHHHHHHCCSCCSEEEEEEEECCCSSS
T ss_pred CCCCCCE--eECCEEEEEECcccCHHHHHHHHhhccccccccccCCHHHHHHHHHhhhccccccccccceeeeecCCccc
Confidence 5999999 89999999999999999999999864 9999999999999999887632 24468999996665556
Q ss_pred CceEEcCCCCCCcCcccccCccCCCCCCCCCCCCCCCCeeEEEeCC--CCceecccCCCCCCccceecc
Q 008785 126 LSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNG--SRSLVTERCNTSHPFICMVEH 192 (553)
Q Consensus 126 ~~w~W~dg~~~~~~~~~~~~~~~~~~~~~~C~~~~~~~~C~~~~~~--~~~w~~~~C~~~~~~iC~~~~ 192 (553)
+.|.|+||+++.+.+|....| ++|+.+..+ ...|.+..|....+|||++++
T Consensus 81 ~~~~W~dgs~~~y~nw~~~~p----------------~~C~~~~~~~~~~~W~~~~C~~~~~fICe~~P 133 (135)
T d1c3aa_ 81 CRSEWSDASSVNYENLVKQFS----------------KKCYALKKGTELRTWFNVYCGTENPEVCKYTP 133 (135)
T ss_dssp CCCBCTTSCBCCCCCBCGGGC----------------CCEEEEETTSCSCSBEEECTTSCEEEEEEECC
T ss_pred ccccccccCcccccccCCCCC----------------CCeEEEEecCCCCCEEccCCCCCEeEEEEECC
Confidence 789999999988877655443 257777553 346999999999999999764
|
| >d1wmza_ d.169.1.1 (A:) Lectin CEL-I {Cucumaria echinata [TaxId: 40245]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Lectin CEL-I species: Cucumaria echinata [TaxId: 40245]
Probab=99.91 E-value=7.9e-25 Score=191.98 Aligned_cols=127 Identities=13% Similarity=0.315 Sum_probs=106.5
Q ss_pred CCCcCCcccCCCCeEEEEecCCCChHHHHHHHhhcC-------CEEeeeCCHHHHHHHHHhhCC---CCCCeEeeeeecC
Q 008785 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIG-------GHLAALTSYEEEHSAQKLCGK---NVNGCWVGGRSIN 121 (553)
Q Consensus 52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~-------~~L~~i~~~~e~~f~~~~~~~---~~~~~WiGl~~~~ 121 (553)
.||+||. .|+++||+|+.++++|.+|+.+|+++| ||||+|++++|++|+.+++.. ....+||||+ +
T Consensus 2 ~Cp~gw~--~~~~~CY~~~~~~~~~~~A~~~C~~~g~~l~~~~~~L~~i~~~~e~~~~~~~~~~~~~~~~~~WiGl~--~ 77 (140)
T d1wmza_ 2 QCPTDWE--AEGDHCYRFFNTLTTWENAHHECVSYSCSTLNVRSDLVSVHSAAEQAYVFNYWRGIDSQAGQLWIGLY--D 77 (140)
T ss_dssp CCCTTCE--EETTEEEEEEEEEECHHHHHHHHHTTCBGGGTEEEEECCCCSHHHHHHHHHHHHHHCCSSCCEEEEEE--C
T ss_pred CCCCCCE--eeCCEEEEEECccCCHHHHHHHHHHhhcccccccceeeeeCCHHHHHhhhhhhccccccccceeeeee--e
Confidence 5999999 899999999999999999999999987 679999999999999987632 2457999999 7
Q ss_pred CCCCCceEEcCCCCCCcCcccccCccCCCCCCCCCCCCCCCCeeEEEeCC-CCceecccCCCCCCccceecc
Q 008785 122 TTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNG-SRSLVTERCNTSHPFICMVEH 192 (553)
Q Consensus 122 ~~~~~~w~W~dg~~~~~~~~~~~~~~~~~~~~~~C~~~~~~~~C~~~~~~-~~~w~~~~C~~~~~~iC~~~~ 192 (553)
...+|.|.|+||+++.+.+|.+++|. +..+.++|+.+... ...|++..|....+|||+++.
T Consensus 78 ~~~~~~w~W~dG~~~~y~~W~~g~P~----------~~~~~~~c~~~~~~~~~~W~~~~C~~~~~fICe~~~ 139 (140)
T d1wmza_ 78 KYNEGDFIWTDGSKVGYTKWAGGQPD----------NWNNAEDYGQFRHTEGGAWNDNSAAAQAKYMCKLTF 139 (140)
T ss_dssp SSSTTCCEETTCCCCCCCCBCTTCCC----------CGGGCEEEEEECSSTTTCEEEEETTCCEEEEEEEEE
T ss_pred ccccceeeecCCcccccccccccccc----------cCCCCccEEEEEeCCCCEEEeeCCCCCEeEEEEEee
Confidence 77789999999999988887776652 12245688887653 457999999999999998753
|
| >d1tn3a_ d.169.1.1 (A:) Tetranectin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Tetranectin species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.90 E-value=4.4e-25 Score=192.92 Aligned_cols=127 Identities=17% Similarity=0.299 Sum_probs=104.8
Q ss_pred CCCcCCcccCCCCeEEEEecCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHhhCC---CCCCeEeeeeecCCCCCCce
Q 008785 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGK---NVNGCWVGGRSINTTVGLSW 128 (553)
Q Consensus 52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~---~~~~~WiGl~~~~~~~~~~w 128 (553)
.||+||. ++++||+|+.+.++|.+|+.+|+.+||+||+|+|.+|++||.+++.. ....+||||+ +...+|.|
T Consensus 5 ~C~~G~~---~~~~CY~~~~~~~tw~~A~~~C~~~gg~La~i~s~~e~~~l~~~l~~~~~~~~~~WiGl~--~~~~~~~w 79 (137)
T d1tn3a_ 5 VCLKGTK---VHMKCFLAFTQTKTFHEASEDCISRGGTLSTPQTGSENDALYEYLRQSVGNEAEIWLGLN--DMAAEGTW 79 (137)
T ss_dssp EEEECSS---SSEEEEEEEEEEECHHHHHHHHHHTTCEECCCCSHHHHHHHHHHHHHHTCTTCEEEEEEE--EEEETTEE
T ss_pred cCCCCeE---ECCEEEEEeCccCCHHHHHHHHHHcCCccccccchHhcccccccccccccccccEeeeec--cCCccccc
Confidence 4999997 88999999999999999999999999999999999999999987632 2457999999 55567999
Q ss_pred EEcCCCCCCcCcccccCccCCCCCCCCCCCCCCCCeeEEEeCC-CCceecccCCCCCCccceec
Q 008785 129 KWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNG-SRSLVTERCNTSHPFICMVE 191 (553)
Q Consensus 129 ~W~dg~~~~~~~~~~~~~~~~~~~~~~C~~~~~~~~C~~~~~~-~~~w~~~~C~~~~~~iC~~~ 191 (553)
.|.||+++.+..|....| + + +++...++|+.+... ...|.+..|....+|||++.
T Consensus 80 ~w~dg~~~~y~~w~~~~p--~----~--p~~~~~~~C~~~~~~~~~~W~~~~C~~~~~fICe~~ 135 (137)
T d1tn3a_ 80 VDMTGARIAYKNWETEIT--A----Q--PDGGKTENCAVLSGAANGKWFDKRCRDQLPYICQFG 135 (137)
T ss_dssp EETTSCBCSCCCBCCTTT--C----S--SCCGGGCCEEEEETTTTTEEEEECTTSCEEEEEEEE
T ss_pred EeCCCCeeeeeeeccccc--c----C--CCCCCcceeEEEEeCCCCEEEeeCCCCCEEEEEEEe
Confidence 999999987776654332 1 1 234456789988653 45799999999999999874
|
| >d1jwia_ d.169.1.1 (A:) Snake coagglutinin alpha chain {Puff adder (Bitis arietans), bitiscetin [TaxId: 8692]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Snake coagglutinin alpha chain species: Puff adder (Bitis arietans), bitiscetin [TaxId: 8692]
Probab=99.90 E-value=7.6e-25 Score=187.86 Aligned_cols=117 Identities=31% Similarity=0.619 Sum_probs=96.4
Q ss_pred CCcCCcccCCCCeEEEEecCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHhhCC----CCCCeEeeeeecCCCCCCce
Q 008785 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGK----NVNGCWVGGRSINTTVGLSW 128 (553)
Q Consensus 53 Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~----~~~~~WiGl~~~~~~~~~~w 128 (553)
||+||+ .|+++||+|+.++++|.+|+.+|+++||+||+|+|++|++||.+++.. ....+||||++.....++.|
T Consensus 1 Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~~i~~~~~~~~~~~~~~~WiGl~~~~~~~~~~~ 78 (124)
T d1jwia_ 1 CLPDWS--SYKGHCYKVFKKVGTWEDAEKFCVENSGHLASIDSKEEADFVTKLASQTLTKFVYDAWIGLRDESKTQQCSP 78 (124)
T ss_dssp CCTTSE--EETTEEEEEEEEEECHHHHHHHHHHTTCEECCCCSHHHHHHHHHHHHHHC--CCSCEEEEEEECCSSSSSCS
T ss_pred CCCCCE--eeCCEEEEEECcccCHHHHHHHHHhcCCeeeeeehHHHHHHHHHHHhccccccccceeeEeeeccCCCccce
Confidence 999999 899999999999999999999999999999999999999999887532 14569999996666667889
Q ss_pred EEcCCCCCCcCcccccCccCCCCCCCCCCCCCCCCeeEEEe--CCCCceecccCCCCCCccce
Q 008785 129 KWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVS--NGSRSLVTERCNTSHPFICM 189 (553)
Q Consensus 129 ~W~dg~~~~~~~~~~~~~~~~~~~~~~C~~~~~~~~C~~~~--~~~~~w~~~~C~~~~~~iC~ 189 (553)
+|+||+++.+.+| ++| + +|+.+. .....|++..|....+|||+
T Consensus 79 ~W~dgs~~~y~n~--~~p--~--------------~c~~~~~~~~~~~W~~~~C~~~~~fICe 123 (124)
T d1jwia_ 79 QWTDGSSVVYENV--DEP--T--------------KCFGLDVHTEYRTWTDLPCGEKNPFICK 123 (124)
T ss_dssp BCTTSCBCCSCCB--SSC--C--------------CEEEECGGGTTSSEEEECTTSCEEEEEE
T ss_pred ecCCCCcccccCC--CCC--C--------------ccEEEEEecCCCCEEccCCCCCEeeEeC
Confidence 9999999876554 222 2 344432 23457999999999999996
|
| >d1umra_ d.169.1.1 (A:) Snake coagglutinin alpha chain {South american rattlesnake (Crotalus durissus terrificus), convulxin [TaxId: 8732]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Snake coagglutinin alpha chain species: South american rattlesnake (Crotalus durissus terrificus), convulxin [TaxId: 8732]
Probab=99.90 E-value=6.7e-25 Score=191.20 Aligned_cols=123 Identities=24% Similarity=0.500 Sum_probs=102.9
Q ss_pred CCCcCCcccCCCCeEEEEecCCCChHHHHHHHhhc--CCEEeeeCCHHHHHHHHHhhCC----CCCCeEeeeeecCCCCC
Q 008785 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI--GGHLAALTSYEEEHSAQKLCGK----NVNGCWVGGRSINTTVG 125 (553)
Q Consensus 52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~--~~~L~~i~~~~e~~f~~~~~~~----~~~~~WiGl~~~~~~~~ 125 (553)
.||+||. .|+++||+|+.+++||.+|+.+|+.+ |||||+|+|++|++||.+++.. ....+||||++.+...+
T Consensus 3 ~Cp~gw~--~~~~~CY~~~~~~~tw~~A~~~C~~~~~g~~La~i~s~~e~~fl~~~~~~~~~~~~~~~WiGl~~~~~~~~ 80 (135)
T d1umra_ 3 HCPSDWY--YYDQHCYRIFNEEMNWEDAEWFCTKQAKGAHLVSIKSAKEADFVAWMVTQNIEESFSHVSIGLRVQNKEKQ 80 (135)
T ss_dssp SSCTTCE--EETTEEEEEEEEEECHHHHHHHHHHHSTTCEECCCCSHHHHHHHHHHHHHHSCTTCCEEECSEEECCSSSS
T ss_pred CCCCCCE--EECCEEEEEECcccCHHHHHHHhhccCCCcceeeehhhhhhHHHHHHhhcccCCCCcceeeeeeeeccccc
Confidence 5999999 89999999999999999999999764 8999999999999999886532 24568999998787788
Q ss_pred CceEEcCCCCCCcCcccccCccCCCCCCCCCCCCCCCCeeEEEeC--CCCceecccCCCCCCccceecc
Q 008785 126 LSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSN--GSRSLVTERCNTSHPFICMVEH 192 (553)
Q Consensus 126 ~~w~W~dg~~~~~~~~~~~~~~~~~~~~~~C~~~~~~~~C~~~~~--~~~~w~~~~C~~~~~~iC~~~~ 192 (553)
+.|+|+|||++.+.+|....+ ++|+.+.. +...|.+..|....+|||++++
T Consensus 81 ~~~~W~dGs~~~y~nw~~~~~----------------~~C~~~~~~~~~~~W~~~~C~~~~~fICe~pP 133 (135)
T d1umra_ 81 CSTKWSDGSSVSYDNLLDLYI----------------TKCSLLKKETGFRKWFVASCIGKIPFVCKFPP 133 (135)
T ss_dssp SCCBCTTSCBCCCCCBCGGGC----------------CCEEEEEGGGTTCSBEEECTTCCEEEEEEECC
T ss_pred CccccccCCcccccccCCCCC----------------CCEEEEEeeCCCCcEEecCCCCCEeEEEeECC
Confidence 999999999988777655443 14666654 3356999999999999999864
|
| >d3c8ja1 d.169.1.1 (A:138-259) NK cell receptor {Mouse (Mus musculus), ly49-c [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: NK cell receptor species: Mouse (Mus musculus), ly49-c [TaxId: 10090]
Probab=99.90 E-value=6.7e-25 Score=187.69 Aligned_cols=119 Identities=18% Similarity=0.317 Sum_probs=100.8
Q ss_pred CCcCCcccCCCCeEEEEecCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHhhCCCCCCeEeeeeecCCCCCCceEEcC
Q 008785 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSD 132 (553)
Q Consensus 53 Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~d 132 (553)
|+.+|. .|+++||+|+.+..||.+|+.+|+++||+||+|+|++|++||.+++. ...|||||+ +...++.|+|+|
T Consensus 2 ~~k~W~--~~~~~CY~~~~~~~tw~~A~~~C~~~g~~La~i~s~~e~~fi~~~~~--~~~~WIGl~--~~~~~~~w~W~d 75 (122)
T d3c8ja1 2 GVKYWF--CYSTKCYYFIMNKTTWSGCKANCQHYGVPILKIEDEDELKFLQRHVI--PGNYWIGLS--YDKKKKEWAWID 75 (122)
T ss_dssp CCEEEE--EEETEEEEEEEEEECHHHHHHHHHHTTCCBCCCCSHHHHHHHHHHSC--SSCEEEEEE--EETTTTEEEETT
T ss_pred CCcccE--EECCEEEEEeCCcCCHHHHHHHHHhCCCcccceehHHHhhhhhhhhe--eeeeEEEEE--EcCCCCcEEECC
Confidence 899999 89999999999999999999999999999999999999999999886 567999999 455669999999
Q ss_pred CCCCCcCcccccCccCCCCCCCCCCCCCCCCeeEEEeCCCCceecccCCCCCCccceecc
Q 008785 133 NMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVEH 192 (553)
Q Consensus 133 g~~~~~~~~~~~~~~~~~~~~~~C~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~~~ 192 (553)
|+++.+..+...++ ...++|+.+.. ..|++..|....+|||+.+.
T Consensus 76 g~~~~~~~~~~~~~-------------~~~~~Cv~~~~--~~w~~~~C~~~~~~ICek~l 120 (122)
T d3c8ja1 76 NGPSKLDMKIKKMN-------------FKSRGCVFLSK--ARIEDIDCNIPYYCICGKKL 120 (122)
T ss_dssp SCCCTTHHHHHTTC-------------CCSSSEEEECS--SCEEEECTTSCEEEEEEEEC
T ss_pred CCcccccccCCCCC-------------CCCCCEEEEEC--CEEEEcCCCCCEeEEEeEEC
Confidence 99876655443322 12347887754 46999999999999998753
|
| >d1jzna_ d.169.1.1 (A:) Galactose-specific C-type lectin {Western diamondback rattlesnake (Crotalus atrox) [TaxId: 8730]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Galactose-specific C-type lectin species: Western diamondback rattlesnake (Crotalus atrox) [TaxId: 8730]
Probab=99.90 E-value=1.5e-24 Score=188.96 Aligned_cols=126 Identities=21% Similarity=0.600 Sum_probs=105.1
Q ss_pred CCCcCCcccCCCCeEEEEecCCCChHHHHHHHhhc--CCEEeeeCCHHHHHHHHHhhCC---CCCCeEeeeeecCCCCCC
Q 008785 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI--GGHLAALTSYEEEHSAQKLCGK---NVNGCWVGGRSINTTVGL 126 (553)
Q Consensus 52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~--~~~L~~i~~~~e~~f~~~~~~~---~~~~~WiGl~~~~~~~~~ 126 (553)
.||+||. .|+++||+|+..+++|.+|+.+|+++ |++||+|+|.+|++||.+.+.. ....|||||+ +...++
T Consensus 2 ~Cp~gw~--~~~~~CY~~~~~~~tw~~A~~~C~~~~~g~~L~~i~s~~e~~~i~~~l~~~~~~~~~~WiGl~--~~~~~~ 77 (135)
T d1jzna_ 2 NCPLDWL--PMNGLCYKIFNQLKTWEDAEMFCRKYKPGCHLASFHRYGESLEIAEYISDYHKGQENVWIGLR--DKKKDF 77 (135)
T ss_dssp CSCTTSE--EETTEEEEEEEEEECHHHHHHHHHHHSSSEEECCCCSHHHHHHHHHHHHHHCCSSCCEEEEEE--CTTSSS
T ss_pred CCCCCCE--eECCEEEEEECcccCHHHHHHHhhhccccccccccCCHHHHHHHHHhhhhccCCCccEEEEEe--ecCccc
Confidence 5999999 89999999999999999999999876 7999999999999999987632 2457999999 667779
Q ss_pred ceEEcCCCCCCcCcccccCccCCCCCCCCCCCCCCCCeeEEEeC--CCCceecccCCCCCCccceec
Q 008785 127 SWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSN--GSRSLVTERCNTSHPFICMVE 191 (553)
Q Consensus 127 ~w~W~dg~~~~~~~~~~~~~~~~~~~~~~C~~~~~~~~C~~~~~--~~~~w~~~~C~~~~~~iC~~~ 191 (553)
.|+|+||+++.+.+|..+.|. +..+.++|+.+.. +...|++..|....+|||+.+
T Consensus 78 ~~~W~dg~~~~~~~W~~~~P~----------~~~~~~~Cv~~~~~~~~~~W~~~~C~~~~~fiCe~k 134 (135)
T d1jzna_ 78 SWEWTDRSCTDYLTWDKNQPD----------HYQNKEFCVELVSLTGYRLWNDQVCESKDAFLCQCK 134 (135)
T ss_dssp CCEETTCCCCCCCCBCTTCCC----------CGGGCCCEEEECGGGTTCSEEEECTTSCEEEEEEEC
T ss_pred ceeecCCceeeccccCCCCCC----------CCCCCCCEEEEEecCCCCcEEeeCCCCCEEEEeeec
Confidence 999999999988887776652 1234457888754 334799999999999999863
|
| >d3bdwa1 d.169.1.1 (A:59-179) CD94 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: CD94 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.90 E-value=9.9e-25 Score=186.35 Aligned_cols=118 Identities=17% Similarity=0.443 Sum_probs=99.9
Q ss_pred CCCcCCcccCCCCeEEEEecCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHhhCCCCCCeEeeeeecCCCCCCceEEc
Q 008785 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWS 131 (553)
Q Consensus 52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~ 131 (553)
+||.||. .|+++||+|+.++++|.+|+.+|+++||+||+|+|++|++||... ...+||||+ +...++.|+|+
T Consensus 2 ~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~g~~La~i~s~~~~~fl~~~----~~~~WiGl~--~~~~~~~w~w~ 73 (121)
T d3bdwa1 2 SCQEKWV--GYRCNCYFISSEQKTWNESRHLCASQKSSLLQLQNTDELDFMSSS----QQFYWIGLS--YSEEHTAWLWE 73 (121)
T ss_dssp CCTTTCE--EETTEEEEECSSCBCHHHHHHHHHHTTCEECCCSCGGGGGGGTTC----CCCEECSEE--EETTTTEEEET
T ss_pred cCCCCcE--EECCEEEEEEccccCHHHHHHHHhhcCCcccceeeeeeeeEeeec----ccceEEEEe--ecCccceeEeC
Confidence 5999999 999999999999999999999999999999999999999998653 457999999 44566999999
Q ss_pred CCCCCCcCcccccCccCCCCCCCCCCCCCCCCeeEEEeCCCCceecccCCCCCCccceec
Q 008785 132 DNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVE 191 (553)
Q Consensus 132 dg~~~~~~~~~~~~~~~~~~~~~~C~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~~ 191 (553)
||+++.+..|...+|. ..++|+.+... ..|.+..|....+|+|+.+
T Consensus 74 dg~~~~~~~w~~~~~~-------------~~~~C~~~~~~-g~w~~~~C~~~~~fICek~ 119 (121)
T d3bdwa1 74 NGSALSQYLFPSFETF-------------NTKNCIAYNPN-GNALDESCEDKNRYICKQQ 119 (121)
T ss_dssp TSCBCCTTTSGGGGGC-------------CTTSEEEEETT-TEEEEECTTSCBEEEEEEC
T ss_pred CCCcccccccCCCCCC-------------CCCCEEEEECC-CEEEeeCCCCCEEEEEeEE
Confidence 9999877766554431 12368877643 5799999999999999864
|
| >d1uv0a_ d.169.1.1 (A:) Pancreatitis-associated protein 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Pancreatitis-associated protein 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.90 E-value=6.1e-24 Score=186.11 Aligned_cols=128 Identities=20% Similarity=0.360 Sum_probs=102.6
Q ss_pred CCCCcCCcccCCCCeEEEEecCCCChHHHHHHHhhc-CCEEeeeCCHHHHHHHHHhhCCC---CCCeEeeeeecCCC---
Q 008785 51 APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI-GGHLAALTSYEEEHSAQKLCGKN---VNGCWVGGRSINTT--- 123 (553)
Q Consensus 51 ~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~-~~~L~~i~~~~e~~f~~~~~~~~---~~~~WiGl~~~~~~--- 123 (553)
..||+||. .|+++||+|+...++|.+|+.+|+++ ||+||+|+|.+|++||.+++... ...+||||++.+..
T Consensus 3 ~~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~~gg~La~i~s~~e~~~l~~~l~~~~~~~~~~WiGl~~~~~~~~~ 80 (140)
T d1uv0a_ 3 IRCPKGSK--AYGSHCYALFLSPKSWTDADLACQKRPSGNLVSVLSGAEGSFVSSLVKSIGNSYSYVWIGLHDPTQGTEP 80 (140)
T ss_dssp CCCCTTCE--EETTEEEEEEEEEECHHHHHHHHTTSTTCEECCCCSHHHHHHHHHHHTTSCTTCCEEEEEEECTTTTCC-
T ss_pred CccCcCcE--eeCCEEEEEECCccCHHHHHHhhhccccceecccCCHHHHHHHHHhhhccccccceeEEeeecccccccC
Confidence 46999999 99999999999999999999999875 99999999999999999987643 34699999843322
Q ss_pred CCCceEEcCCCCCCcCcccccCccCCCCCCCCCCCCCCCCeeEEEeCC--CCceecccCCCCCCccceec
Q 008785 124 VGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNG--SRSLVTERCNTSHPFICMVE 191 (553)
Q Consensus 124 ~~~~w~W~dg~~~~~~~~~~~~~~~~~~~~~~C~~~~~~~~C~~~~~~--~~~w~~~~C~~~~~~iC~~~ 191 (553)
..+.|.|+||+++.+.+|...+|. ....++|+.+... ...|++..|....+|||++.
T Consensus 81 ~~~~w~w~dg~~~~~~~w~~~~~~-----------~~~~~~C~~~~~~~~~~~W~~~~C~~~~~fICe~t 139 (140)
T d1uv0a_ 81 NGEGWEWSSSDVMNYFAWERNPST-----------ISSPGHCASLSRSTAFLRWKDYNCNVRLPYVCKFT 139 (140)
T ss_dssp -CCCCEETTCCCCCCCCBSSCGGG-----------SSSCCSEEEEEGGGTTCSEEEECTTSCEEEEEEEC
T ss_pred CCCceEccCCCcccccccCCCCCC-----------CCCCCCEEEEEccCCCCeEEecCCCCCEeEEEEEC
Confidence 124699999999888777554431 2234578887553 34699999999999999875
|
| >d1fvua_ d.169.1.1 (A:) Snake coagglutinin alpha chain {Jararaca (Bothrops jararaca), botrocetin [TaxId: 8724]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Snake coagglutinin alpha chain species: Jararaca (Bothrops jararaca), botrocetin [TaxId: 8724]
Probab=99.90 E-value=1.8e-24 Score=187.95 Aligned_cols=123 Identities=24% Similarity=0.512 Sum_probs=100.6
Q ss_pred CCCcCCcccCCCCeEEEEecCCCChHHHHHHHhh--cCCEEeeeCC-HHHHHHHHHhhCC----CCCCeEeeeeecCCCC
Q 008785 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTS-YEEEHSAQKLCGK----NVNGCWVGGRSINTTV 124 (553)
Q Consensus 52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~--~~~~L~~i~~-~~e~~f~~~~~~~----~~~~~WiGl~~~~~~~ 124 (553)
.||+||. .|+++||+|+.++++|.+|+.+|+. .||+||+|++ +||++||..++.. ....+||||++.+...
T Consensus 1 ~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~~~g~~La~i~~~~e~~~~~~~~~~~~~~~~~~~~WIGl~~~~~~~ 78 (133)
T d1fvua_ 1 DCPSGWS--SYEGNCYKFFQQKMNWADAERFCSEQAKGGHLVSIKIYSKEKDFVGDLVTKNIQSSDLYAWIGLRVENKEK 78 (133)
T ss_dssp CCCTTCE--EETTEEEEEEEEEECHHHHHHHHHHHSTTCEECCCCTTSTHHHHHHHHHHHHCCSSCCEEEEEEEECCSSS
T ss_pred CCCCCCE--EECCEEEEEECcccCHHHHHHHHhhccccccccccCCHHHHHHHHHhhhhccccCccccceEEEeeccccc
Confidence 3999999 8999999999999999999999975 5999999975 6788888876532 2456899999777667
Q ss_pred CCceEEcCCCCCCcCcccccCccCCCCCCCCCCCCCCCCeeEEEeCCC--CceecccCCCCCCccceecc
Q 008785 125 GLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS--RSLVTERCNTSHPFICMVEH 192 (553)
Q Consensus 125 ~~~w~W~dg~~~~~~~~~~~~~~~~~~~~~~C~~~~~~~~C~~~~~~~--~~w~~~~C~~~~~~iC~~~~ 192 (553)
.+.|+|+||+++.+.+|..+.| + +|+.+.... ..|++..|....+|||+.++
T Consensus 79 ~~~w~W~dGs~~~y~~w~~~~p--~--------------~C~~~~~~~~~~~W~~~~C~~~~~fICe~~P 132 (133)
T d1fvua_ 79 QCSSEWSDGSSVSYENVVERTV--K--------------KCFALEKDLGFVLWINLYCAQKNPFVCKSPP 132 (133)
T ss_dssp SSCCBCTTSCBCCCCCBCGGGC--C--------------CEEEEETTTTSCSEEEECTTCCEEEEEEECC
T ss_pred ccccccccCCcccccccCCCCC--C--------------CeEEEEecCCCCeEEccCCCCCEEEEEEECc
Confidence 7899999999998887766554 1 466665543 36999999999999999854
|
| >d1sb2b1 d.169.1.1 (B:2-128) Snake coagglutinin beta chain {Malayan pit viper (Calloselasma rhodostoma), rhodocetin [TaxId: 8717]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Snake coagglutinin beta chain species: Malayan pit viper (Calloselasma rhodostoma), rhodocetin [TaxId: 8717]
Probab=99.89 E-value=2.1e-24 Score=185.90 Aligned_cols=117 Identities=22% Similarity=0.478 Sum_probs=95.6
Q ss_pred CCCcCCcccCCCCeEEEEecCCCChHHHHHHHhh--cCCEEeeeCCHHHHHHHHHhhCC----CCCCeEeeeeecCCCCC
Q 008785 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGK----NVNGCWVGGRSINTTVG 125 (553)
Q Consensus 52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~--~~~~L~~i~~~~e~~f~~~~~~~----~~~~~WiGl~~~~~~~~ 125 (553)
.||+||+ .|+++||+|+.+.+||.+|+..|+. .|||||+|+|++|++||.+++.. ....+||||+ +
T Consensus 2 ~Cp~gw~--~~~~~CY~~~~~~~tw~~A~~~C~~~~~gg~La~i~s~~e~~fl~~~~~~~~~~~~~~~WiGl~--~---- 73 (127)
T d1sb2b1 2 RCPTTWS--ASKLYCYKPFKEKKTWIEAERFCAKQAENGHLVSIGSAAEADFLDLVIVVNFDKQRYRAWTGLT--E---- 73 (127)
T ss_dssp CCCTTCE--ECSSEEEEEEEEEECHHHHHHHHHHHSTTCEECCCCSHHHHHHHHHHHHHHC---CCCEEEEEE--E----
T ss_pred cCCCCCe--ecCCEEEEEECeecCHHHHHHHHHhhcCCcccccccCHHHHHHHHHHHhhhccccccceeeeec--c----
Confidence 4999999 8999999999999999999999976 49999999999999999987632 1456999998 4
Q ss_pred CceEEcCCCCCCcCcccccCccCCCCCCCCCCCCCCCCeeEEEeC--CCCceecccCCCCCCccceecc
Q 008785 126 LSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSN--GSRSLVTERCNTSHPFICMVEH 192 (553)
Q Consensus 126 ~~w~W~dg~~~~~~~~~~~~~~~~~~~~~~C~~~~~~~~C~~~~~--~~~~w~~~~C~~~~~~iC~~~~ 192 (553)
+.|+|+||+++.+.+|....+ ++|+.+.. +...|++..|....+|||+++.
T Consensus 74 ~~~~W~dGs~~~y~nw~~~~~----------------~~c~~~~~~~~~~~W~~~~C~~~~~fICe~Pk 126 (127)
T d1sb2b1 74 RNLKWTNGASVSYENLYEPYI----------------RKCFVVQPWEGKSKWYKADCEEKNAFLCKFPK 126 (127)
T ss_dssp CCCBCTTSCBCCSCCBSSCCC----------------CCEEEEEEETTEEEEEEECTTSCEEEEEEEEC
T ss_pred cceeecccCCccccccCCCCC----------------cceeEEEEeCCCCCEEecCCCCCEEEEEEEcC
Confidence 579999999988877653221 14555433 3446999999999999999853
|
| >d1j34a_ d.169.1.1 (A:) Snake coagglutinin alpha chain {Habu snake (Trimeresurus flavoviridis) [TaxId: 88087]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Snake coagglutinin alpha chain species: Habu snake (Trimeresurus flavoviridis) [TaxId: 88087]
Probab=99.89 E-value=6.4e-24 Score=183.36 Aligned_cols=120 Identities=28% Similarity=0.593 Sum_probs=99.2
Q ss_pred CCCcCCcccCCCCeEEEEecCCCChHHHHHHHhh--cCCEEeeeCCHHHHHHHHHhhCC----CCCCeEeeeeecCCCCC
Q 008785 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGK----NVNGCWVGGRSINTTVG 125 (553)
Q Consensus 52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~--~~~~L~~i~~~~e~~f~~~~~~~----~~~~~WiGl~~~~~~~~ 125 (553)
.||+||. .|+++||+|+..+++|.+|+.+|.. .||+||+|+|++|++||.+++.. ....+||||++.+....
T Consensus 1 ~Cp~gw~--~~~~~CY~~~~~~~~~~~A~~~C~~~~~g~~L~~i~s~~e~~~l~~~~~~~~~~~~~~~WIGl~~~~~~~~ 78 (129)
T d1j34a_ 1 DCPSGWS--SYEGHCYKPFKLYKTWDDAERFCTEQAKGGHLVSIESAGEADFVAQLVTENIQNTKSYVWIGLRVQGKEKQ 78 (129)
T ss_dssp CCCTTCE--EETTEEEEEEEEEECHHHHHHHHHHHSTTCEECCCCSHHHHHHHHHHHHHHCCCTTCCEEEEEEECSSCSC
T ss_pred CCCCcCE--eeCCEEEEEECcccCHHHHHHhhhhccCCccccccCCHHHHHHHHhhhccccccccceEEeeeeccccccc
Confidence 3999999 8999999999999999999999965 59999999999999999886532 24569999996665555
Q ss_pred CceEEcCCCCCCcCcccccCccCCCCCCCCCCCCCCCCeeEEEeC--CCCceecccCCCCCCccce
Q 008785 126 LSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSN--GSRSLVTERCNTSHPFICM 189 (553)
Q Consensus 126 ~~w~W~dg~~~~~~~~~~~~~~~~~~~~~~C~~~~~~~~C~~~~~--~~~~w~~~~C~~~~~~iC~ 189 (553)
+.|+|+||+++.+.+|.+++| + +|+.+.. +...|.+..|....+|||+
T Consensus 79 ~~~~W~dgs~~~y~~W~~~ep--~--------------~c~~~~~~~~~~~W~~~~C~~~~~fICe 128 (129)
T d1j34a_ 79 CSSEWSDGSSVSYENWIEAES--K--------------TCLGLEKETGFRKWVNIYCGQQNPFVCE 128 (129)
T ss_dssp SCCBCTTSCBCCCCCBCGGGS--C--------------CEEEECGGGTTCSBEEECTTSCEEEEEE
T ss_pred cceecCCCCcccccccCCCCC--C--------------cEEEEEccCCCCCEEecCCCCCcceEec
Confidence 789999999998888776654 2 3555533 3346999999999999996
|
| >d1oz7a_ d.169.1.1 (A:) Snake coagglutinin alpha chain {Saw-scaled viper (Echis carinatus), echicetin [TaxId: 40353]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Snake coagglutinin alpha chain species: Saw-scaled viper (Echis carinatus), echicetin [TaxId: 40353]
Probab=99.89 E-value=2.5e-24 Score=186.54 Aligned_cols=121 Identities=26% Similarity=0.562 Sum_probs=96.5
Q ss_pred CCcCCcccCCCCeEEEEecCCCChHHHHHHHhhcC--CEEeeeCCHHHHHHHHHhhCC---CCCCeEeeeeecCCCCCCc
Q 008785 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIG--GHLAALTSYEEEHSAQKLCGK---NVNGCWVGGRSINTTVGLS 127 (553)
Q Consensus 53 Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~--~~L~~i~~~~e~~f~~~~~~~---~~~~~WiGl~~~~~~~~~~ 127 (553)
||+||. .|+++||+|+.+.++|.+|+.+|+++| ||||+|+|.+|++||.+++.. ....+||||++...+..+.
T Consensus 2 Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~g~~g~L~~i~s~~e~~fi~~~~~~~~~~~~~~WIGl~~~~~~~~~~ 79 (131)
T d1oz7a_ 2 CPPGWS--SNGVYCYMLFKEPKTWDEAEKFCNKQGKDGHLLSIESKKEEILVDIVVSENIGKMYKIWTGLSERSKEQHCS 79 (131)
T ss_dssp CCTTCE--EETTEEEEEEEEEECHHHHHHHHHHHSTTCEECCCCSHHHHHHHHHHHHHHSCCCSEEEEEEEECCCGGGSC
T ss_pred CCCCCE--EECCEEEEEECcccCHHHHHhhhhccCCCccccccCCHHHhhhhhhheecccCCCccEEEEEEecCcccccc
Confidence 999999 899999999999999999999999886 999999999999999887632 2457999999443333356
Q ss_pred eEEcCCCCCCcCcccccCccCCCCCCCCCCCCCCCCeeEEEeCC--CCceecccCCCCCCccceecc
Q 008785 128 WKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNG--SRSLVTERCNTSHPFICMVEH 192 (553)
Q Consensus 128 w~W~dg~~~~~~~~~~~~~~~~~~~~~~C~~~~~~~~C~~~~~~--~~~w~~~~C~~~~~~iC~~~~ 192 (553)
|+|+|||++.+..++. ..++|+.+... ...|++..|....+|||+++.
T Consensus 80 ~~W~dgs~~~~~~~~~-----------------~~~~C~~~~~~~~~~~W~~~~C~~~~~fICe~~~ 129 (131)
T d1oz7a_ 80 SRWSDGSFFRSYEIAI-----------------RYSECFVLEKQSVFRTWVATPCENTFPFMCKYPV 129 (131)
T ss_dssp CBCSSSBCCSCCCCCC-----------------SCCCEEEEEGGGTTCSEEEECTTSCEEEEEEECT
T ss_pred cccCCCCcccCCccCC-----------------CCCCEEEEEecCCCCcEEecCCCCCEeEEEeEeC
Confidence 9999998765433221 12367777543 346999999999999999864
|
| >d1egga_ d.169.1.1 (A:) Macrophage mannose receptor, CRD4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Macrophage mannose receptor, CRD4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.89 E-value=7.1e-24 Score=184.80 Aligned_cols=127 Identities=24% Similarity=0.486 Sum_probs=100.6
Q ss_pred CCcCCcccCCCCeEEEEe----cCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHhhCCC---CCCeEeeeeecCCCCC
Q 008785 53 CPPDWIINEEKSKCFGYI----GNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKN---VNGCWVGGRSINTTVG 125 (553)
Q Consensus 53 Cp~~w~~~~~~~~Cy~~~----~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~---~~~~WiGl~~~~~~~~ 125 (553)
||+||....++++||+|+ .++++|.+|+.+|+++||+||+|+|++|++||.+++... ...+||||+ +...+
T Consensus 1 Cp~gW~~~~~~~~CY~~~~~~~~~~~~w~~A~~~C~~~gg~L~~i~s~~e~~~i~~~l~~~~~~~~~~wiG~~--~~~~~ 78 (136)
T d1egga_ 1 CPEDWGASSRTSLCFKLYAKGKHEKKTWFESRDFCRALGGDLASINNKEEQQTIWRLITASGSYHKLFWLGLT--YGSPS 78 (136)
T ss_dssp CCTTCEECSSSSCEEEEECSCGGGCBCHHHHHHHHHTTTCEECCCCSHHHHHHHHHHHHHHTCTTCEEEEEEE--CC---
T ss_pred CCCCCeeCCCCCEEEEEEecCCCcccCHHHHHHHHHHCCCEEeEEecchhhhhhhhhcccccccccccccccc--ccccc
Confidence 999997335679999984 567799999999999999999999999999999986432 456899999 77777
Q ss_pred CceEEcCCCCCCcCcccccCccCCCCCCCCCCCCCCCCeeEEEeCC-CCceecccCCCCCCccceec
Q 008785 126 LSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNG-SRSLVTERCNTSHPFICMVE 191 (553)
Q Consensus 126 ~~w~W~dg~~~~~~~~~~~~~~~~~~~~~~C~~~~~~~~C~~~~~~-~~~w~~~~C~~~~~~iC~~~ 191 (553)
+.|.|+||+++.+.+|.+++|. +..+.++|+.+... ...|++..|....+|||+.+
T Consensus 79 ~~~~W~dg~~~~y~~W~~g~P~----------~~~~~~~C~~~~~~~~~~W~~~~C~~~~~fICe~~ 135 (136)
T d1egga_ 79 EGFTWSDGSPVSYENWAYGEPN----------NYQNVEYCGELKGDPTMSWNDINCEHLNNWICQIQ 135 (136)
T ss_dssp -CCCCTTSCCCCCCCCCTTCSC----------GGGSCCEEEEEECSTTCCEEEEETTSCBEEEEECC
T ss_pred eeeeeecCCcceeecccCCCCC----------CCCCCcceEEEEcCCCCeEEecCCCCcEeEEEEEe
Confidence 9999999999888887766652 12345689887654 45699999999999999864
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.89 E-value=1e-23 Score=194.95 Aligned_cols=168 Identities=18% Similarity=0.169 Sum_probs=119.8
Q ss_pred CeeecccCceeEEEEEeCCCCEEEEEEeccCCh------------------hhHHHHHHHHHHhhccCCCceeeEeeEEe
Q 008785 274 NRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSF------------------QRKKEFYSEIGRFARLHHPNLVAVKGCCY 335 (553)
Q Consensus 274 ~~~iG~G~~g~Vy~~~~~~g~~vAvK~~~~~~~------------------~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 335 (553)
.+.||+|+||.||+|...+|+.||||+++.... .......+|...+.++.|++++..+++.
T Consensus 5 g~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~- 83 (191)
T d1zara2 5 GKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE- 83 (191)
T ss_dssp EEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE-
T ss_pred CCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec-
Confidence 345699999999999998999999998763211 1123345788899999999999887653
Q ss_pred eCCceEEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCcEEecCCCCeEEee
Q 008785 336 DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMG 415 (553)
Q Consensus 336 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~D 415 (553)
..+++|||++++.+.+ ++......++.|++.+|.|||++ +|+||||||+|||++++ .++|+|
T Consensus 84 ---~~~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~liD 145 (191)
T d1zara2 84 ---GNAVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWIID 145 (191)
T ss_dssp ---TTEEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEECC
T ss_pred ---CCEEEEEeeccccccc-----------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEEEE
Confidence 2479999998766533 23334567899999999999999 99999999999999965 589999
Q ss_pred ccccccCCcccccceeeecCccccccccccccCCCCCcccchHhHHHHHH
Q 008785 416 VGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLL 465 (553)
Q Consensus 416 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwSlGvil~ 465 (553)
||.|............. ..... -.+. ....|+.++|+||..--+.
T Consensus 146 FG~a~~~~~~~~~~~l~---rd~~~-~~~~-f~r~y~~~~d~~s~~~~~~ 190 (191)
T d1zara2 146 FPQSVEVGEEGWREILE---RDVRN-IITY-FSRTYRTEKDINSAIDRIL 190 (191)
T ss_dssp CTTCEETTSTTHHHHHH---HHHHH-HHHH-HHHHHCCCCCHHHHHHHHH
T ss_pred CCCcccCCCCCcHHHHH---HHHHH-HHHH-HcCCCCCcccHHHHHHHHh
Confidence 99997654332111000 00000 0111 1356788999999865443
|
| >d1pwba1 d.169.1.1 (A:235-355) Surfactant protein, lectin domain {Human (Homo sapiens), SP-D [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Surfactant protein, lectin domain species: Human (Homo sapiens), SP-D [TaxId: 9606]
Probab=99.89 E-value=4.4e-24 Score=182.24 Aligned_cols=121 Identities=15% Similarity=0.228 Sum_probs=101.9
Q ss_pred CcCCcccCCCCeEEEEecCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHhhCCCCCCeEeeeeecCCCCCCceEEcCC
Q 008785 54 PPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSDN 133 (553)
Q Consensus 54 p~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~dg 133 (553)
|.+| .++++||+|+.+.+||.+|+..|+++|||||+|+|++|++||.++.......+||||+ +...+|.|.|.||
T Consensus 1 P~g~---~~g~~cy~~~~~~~tw~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~~~~~~~WiGl~--~~~~~~~~~w~dg 75 (121)
T d1pwba1 1 PNGQ---SVGEKIFKTAGFVKPFTEAQLLCTQAGGQLASPRSAAENAALQQLVVAKNEAAFLSMT--DSKTEGKFTYPTG 75 (121)
T ss_dssp TTEE---EETTEEEEEEEEEEEHHHHHHHHHHTTSEECCCCSHHHHHHHHHHHHHHTCCEECSCB--CSSSTTCCBCTTS
T ss_pred CCcE---EECCEEEEEeCeeECHHHHHHHHHHcCCEecceeechhhhhhhhccccceeeeeeeee--ccCccceeeeccc
Confidence 5555 4899999999999999999999999999999999999999999987544567999999 7777799999999
Q ss_pred CCCCcCcccccCccCCCCCCCCCCCCCCCCeeEEEeCCCCceecccCCCCCCcccee
Q 008785 134 MSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMV 190 (553)
Q Consensus 134 ~~~~~~~~~~~~~~~~~~~~~~C~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~ 190 (553)
+++.+.+|.+++|. +..+.++|+.+.. ...|++..|....+|||++
T Consensus 76 ~~~~~~~W~~~eP~----------~~~~~~~C~~~~~-~~~W~~~~C~~~~~fICey 121 (121)
T d1pwba1 76 ESLVYSNWAPGEPN----------DDGGSEDCVEIFT-NGKWNDRACGEKRLVVCEF 121 (121)
T ss_dssp CBCSCCCBCTTCCC----------CGGGCCCEEEECT-TSCEEEECTTSEEEEEEEC
T ss_pred cccccceecCCCCC----------CCCCceeEEEECC-CCEEEeeCCCCCEEEEEeC
Confidence 99988887766652 1223467888754 4579999999999999974
|
| >d1v7pa_ d.169.1.1 (A:) Snake coagglutinin alpha chain {Snake (Echis multisquamatus), Ems16 [TaxId: 93050]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Snake coagglutinin alpha chain species: Snake (Echis multisquamatus), Ems16 [TaxId: 93050]
Probab=99.89 E-value=9.6e-24 Score=183.50 Aligned_cols=120 Identities=25% Similarity=0.501 Sum_probs=97.5
Q ss_pred CCCcCCcccCCCCeEEEEecCCCChHHHHHHHhhc--CCEEeeeCCHHHHHHHHHhhCCC----CCCeEeeeeecCCCCC
Q 008785 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI--GGHLAALTSYEEEHSAQKLCGKN----VNGCWVGGRSINTTVG 125 (553)
Q Consensus 52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~--~~~L~~i~~~~e~~f~~~~~~~~----~~~~WiGl~~~~~~~~ 125 (553)
.||+||. .|+++||+|+.++++|.+|+.+|+.+ ||+||+|+|++|++||.+++... ...+||||+ +...+
T Consensus 3 ~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~~~~g~La~i~s~~e~~fi~~~~~~~~~~~~~~~WIGl~--~~~~~ 78 (134)
T d1v7pa_ 3 DCPSDWT--AYDQHCYLAIGEPQNWYEAERFCTEQAKDGHLVSIQSREEGNFVAQLVSGFMHRSEIYVWIGLR--DRREE 78 (134)
T ss_dssp TSCTTCE--EETTEEEEEEEEEECHHHHHHHHHHHSTTCEECCCCSHHHHHHHHHHTGGGGGSSCSEEEEEEE--CCCSS
T ss_pred CCCCCCE--EECCEEEEEECcccCHHHHHHhhcccCCCccccccCCHHHhHHHHhhcccccccccchhhhhcc--ccCCc
Confidence 5999999 89999999999999999999999765 89999999999999999987532 345899999 44444
Q ss_pred C--ceEEcCCCCCCcCcccccCccCCCCCCCCCCCCCCCCeeEEE--eCCCCceecccCCCCCCccceec
Q 008785 126 L--SWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLV--SNGSRSLVTERCNTSHPFICMVE 191 (553)
Q Consensus 126 ~--~w~W~dg~~~~~~~~~~~~~~~~~~~~~~C~~~~~~~~C~~~--~~~~~~w~~~~C~~~~~~iC~~~ 191 (553)
+ .|+|+||+++.+.+|.+++| . +|+.. ......|++..|....+|||+.+
T Consensus 79 ~~~~~~W~dgs~~~y~~W~~~~p--~--------------~~~~~~~~~~~~~W~~~~C~~~~~fICe~~ 132 (134)
T d1v7pa_ 79 QQCNPEWNDGSKIIYVNWKEGES--K--------------MCQGLTKWTNFHDWNNINCEDLYPFVCKFS 132 (134)
T ss_dssp SCSCCBCTTSCBCCCCCBCTTCC--C--------------CEEEEEGGGTTCSEEEECTTSCEEEEEEEE
T ss_pred ceeeeeecCCCcccccccCCCCC--C--------------ceeEEEEecCCCcEEeeCCCCCEEEEEEEe
Confidence 4 67899999988887766554 2 23222 23445699999999999999875
|
| >d2msba_ d.169.1.1 (A:) Mannose-binding protein A, C-lectin domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Mannose-binding protein A, C-lectin domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.88 E-value=6.7e-23 Score=172.17 Aligned_cols=111 Identities=14% Similarity=0.232 Sum_probs=95.8
Q ss_pred eEEEEecCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHhhCCCCCCeEeeeeecCCCCCCceEEcCCCCCCcCccccc
Q 008785 65 KCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAV 144 (553)
Q Consensus 65 ~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~dg~~~~~~~~~~~ 144 (553)
+||+++.+++||.+|+.+|+++||+||+|+|++|++||.++.. ..+||||+ +...+|.|+|+||+++.+.+|..+
T Consensus 2 k~y~~~~~~~tw~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~---~~~WiGl~--~~~~~g~~~w~dg~~~~y~~W~~~ 76 (112)
T d2msba_ 2 KFFVTNHERMPFSKVKALCSELRGTVAIPRNAEENKAIQEVAK---TSAFLGIT--DEVTEGQFMYVTGGRLTYSNWKKD 76 (112)
T ss_dssp CEEEEEEEEECHHHHHHHHHHTTCEECCCSSHHHHHHHHHHHS---SCEEEEEE--CSSSTTCCEETTSSBCCSCCBCTT
T ss_pred cEEEECCcEeCHHHHHHHHHhCCCEEeeEcCHHHhhhhhhccc---ceEEEEEe--ecCccccccccccccccccccccC
Confidence 7999999999999999999999999999999999999999885 57999999 777779999999999988888776
Q ss_pred CccCCCCCCCCCCCCCCCCeeEEEeCCCCceecccCCCCCCccceec
Q 008785 145 GSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVE 191 (553)
Q Consensus 145 ~~~~~~~~~~~C~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~~ 191 (553)
.|.+ ..+.++|+.+.. ...|++..|....+|||+.|
T Consensus 77 eP~~----------~~~~~~Cv~~~~-~~~W~~~~C~~~~~fICe~P 112 (112)
T d2msba_ 77 EPND----------HGSGEDCVTIVD-NGLWNDISCQASHTAVCEFP 112 (112)
T ss_dssp CCCC----------CTTCCCEEEECT-TSCEEEECTTSCEEEEEEEC
T ss_pred CCCC----------CCCCCCEEEEeC-CCEEEEeCCCCcEEEEEecC
Confidence 6521 223468888753 46799999999999999864
|
| >d1r13a1 d.169.1.1 (A:110-228) Surfactant protein, lectin domain {Rat (Rattus norvegicus), SP-A [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Surfactant protein, lectin domain species: Rat (Rattus norvegicus), SP-A [TaxId: 10116]
Probab=99.87 E-value=1.2e-22 Score=172.62 Aligned_cols=116 Identities=16% Similarity=0.197 Sum_probs=99.6
Q ss_pred CCCCeEEEEecCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHhhCCCCCCeEeeeeecCCCCCCceEEcCCCCCCcCc
Q 008785 61 EEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSDNMSKWNES 140 (553)
Q Consensus 61 ~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~dg~~~~~~~ 140 (553)
..+++||+++..++||.+|+.+|+.+||+||+|+|.+|++||.+++......+||||+ +...+|.|+|.||+++.+.+
T Consensus 4 ~vG~~cy~~~~~~~~w~~A~~~C~~~gg~La~i~s~~e~~~l~~~~~~~~~~~WiGl~--~~~~~~~w~w~dg~~~~y~~ 81 (119)
T d1r13a1 4 SVGDKVFSTNGQSVNFDTIKEMCTRAGGNIAVPRTPEENEAIASIAKKYNNYVYLGMI--EDQTPGDFHYLDGASVSYTN 81 (119)
T ss_dssp EETTEEEEEEEEEECHHHHHHHHHHTTSEECCCCSHHHHHHHHHHHHHTTSCEEEEEE--ECSSTTCEEETTSCBCCSCC
T ss_pred cCccEEEEECCEEECHHHHHHHhhhCCCEEeEEeehHHhhhhhhcccccceEEEEEee--cCCcceeeeeecccccccce
Confidence 5789999999999999999999999999999999999999999988655678999999 66677999999999988887
Q ss_pred ccccCccCCCCCCCCCCCCCCCCeeEEEeCCCCceecccCCCCCCcccee
Q 008785 141 IHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMV 190 (553)
Q Consensus 141 ~~~~~~~~~~~~~~~C~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~ 190 (553)
|..++|. +...++|+.+.. +..|.+..|....+|+|++
T Consensus 82 W~~~~P~-----------~~~~~~Cv~~~~-~~~W~~~~C~~~~~~ICey 119 (119)
T d1r13a1 82 WYPGEPR-----------GQGKEKCVEMYT-DGTWNDRGCLQYRLAVCEF 119 (119)
T ss_dssp BCTTCCC-----------CSSCCCEEEECT-TSCEEEECSCSCEEEEEEC
T ss_pred EEeeccC-----------CCCCCCEEEEcC-CCEEEecCCCCCEeEEEeC
Confidence 7766552 223457888764 4679999999999999975
|
| >d1hupa1 d.169.1.1 (A:112-228) Mannose-binding protein A, C-lectin domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Mannose-binding protein A, C-lectin domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.87 E-value=1.3e-22 Score=171.88 Aligned_cols=115 Identities=14% Similarity=0.169 Sum_probs=98.9
Q ss_pred CCCCeEEEEecCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHhhCCCCCCeEeeeeecCCCCCCceEEcCCCCCCcCc
Q 008785 61 EEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSDNMSKWNES 140 (553)
Q Consensus 61 ~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~dg~~~~~~~ 140 (553)
.+|++||+++.+.+||.+|+.+|+++||+||+|+|++|++||.+++. ..+||||+ +...+|.|.|+||+++.+..
T Consensus 2 ~vG~~~y~~~~~~~tw~~A~~~C~~~gg~La~i~s~~e~~~l~~~~~---~~~WiGl~--~~~~~~~w~w~dg~~~~~~~ 76 (117)
T d1hupa1 2 QVGNKFFLTNGEIMTFEKVKALCVKFQASVATPRNAAENGAIQNLIK---EEAFLGIT--DEKTEGQFVDLTGNRLTYTN 76 (117)
T ss_dssp EETTEEEEEEEEEEEHHHHHHHHHHTTCEECCCCSHHHHHHHHHHCS---SCEEEEEE--CSSSTTCCEETTSCBCSCCC
T ss_pred cccCEEEEEcCEEECHHHHHHHHHHCCCEEcccCCHHHHHHHhhccc---ceEEEEee--ccCcccceeecccccccccc
Confidence 47899999999999999999999999999999999999999999975 57999999 66677999999999998888
Q ss_pred ccccCccCCCCCCCCCCCCCCCCeeEEEeCCCCceecccCCCCCCccceec
Q 008785 141 IHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVE 191 (553)
Q Consensus 141 ~~~~~~~~~~~~~~~C~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~~ 191 (553)
|..+.|. +..+.++|+.+.. +..|++..|....+|+|+++
T Consensus 77 w~~~~p~----------~~~~~~~Cv~~~~-~~~W~~~~C~~~~~fICe~P 116 (117)
T d1hupa1 77 WNEGEPN----------NAGSDEDCVLLLK-NGQWNDVPCSTSHLAVCEFP 116 (117)
T ss_dssp BCTTCCC----------CGGGCCCEEEECT-TSCEEEECTTSEEEEEEEEE
T ss_pred cCCCCCC----------CCCCcCCeEEECC-CCeEEeeCCCCCEEEEEEEe
Confidence 8766652 1224568888754 45899999999999999875
|
| >d1rdl1_ d.169.1.1 (1:) Mannose-binding protein A, C-lectin domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Mannose-binding protein A, C-lectin domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.86 E-value=6.3e-22 Score=165.84 Aligned_cols=110 Identities=13% Similarity=0.162 Sum_probs=94.3
Q ss_pred eEEEEecCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHhhCCCCCCeEeeeeecCCCCCCceEEcCCCCCCcCccccc
Q 008785 65 KCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAV 144 (553)
Q Consensus 65 ~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~dg~~~~~~~~~~~ 144 (553)
+||+++..+++|.+|+.+|+++||+||+|+|++|++||.++.. ..+||||+ |...+|.|.|+||+++.+.+|.++
T Consensus 1 kyy~~~~~~~~~~~A~~~C~~~gg~La~i~s~~e~~~l~~~~~---~~~WiGl~--~~~~~~~~~w~dG~~~~y~~W~~g 75 (111)
T d1rdl1_ 1 KYFMSSVRRMPLNRAKALCSELQGTVATPRNAEENRAIQNVAK---DVAFLGIT--DQRTENVFEDLTGNRVRYTNWNEG 75 (111)
T ss_dssp CEEEECSSCBCHHHHHHHHHHTTCEECCCCSHHHHHHHHHHCS---SCEEEEEE--CSSSTTCCEETTSCBCCCCCBCTT
T ss_pred CEEEECCcEeCHHHHHHHHHHcCCEEEEECCHHHhHHHhhccc---ceeeEEee--ecCccceeeecccccceeeecccc
Confidence 5899999999999999999999999999999999999999874 57999999 777779999999999988887766
Q ss_pred CccCCCCCCCCCCCCCCCCeeEEEeCCCCceecccCCCCCCcccee
Q 008785 145 GSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMV 190 (553)
Q Consensus 145 ~~~~~~~~~~~C~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~ 190 (553)
.|. +..+.++|+.+.. +..|.+..|....+|||++
T Consensus 76 eP~----------~~~~~~~Cv~~~~-~g~W~d~~C~~~~~fICe~ 110 (111)
T d1rdl1_ 76 EPN----------NVGSGENCVVLLT-NGKWNDVPCSDSFLVVCEF 110 (111)
T ss_dssp CCC----------CCTTCCCEEEECT-TSCEEEECTTSCBEEEEEE
T ss_pred CCC----------CCCCcceEEEECC-CCEEEeeCCCCCEEEEEEE
Confidence 652 1224568888754 4579999999999999986
|
| >d1kg0c_ d.169.1.1 (C:) EBV gp42 {Epstein-Barr virus [TaxId: 10376]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: EBV gp42 species: Epstein-Barr virus [TaxId: 10376]
Probab=99.86 E-value=4.3e-22 Score=172.60 Aligned_cols=115 Identities=17% Similarity=0.223 Sum_probs=93.6
Q ss_pred CCCcCCcccCCCCeEEEEecCCCChHHHHHHHhhc-CCEEeeeCCHHHHHHHHHhhCCCCCCeEeeeeecCCCCCCceEE
Q 008785 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI-GGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKW 130 (553)
Q Consensus 52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~-~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W 130 (553)
.||.+|. .|+++||+|+.+++||.+|+.+|+++ +++|++|++++|++||++++.. ...|||||++ + .+|.|+|
T Consensus 18 ~~~~~~~--~~~~~CY~~~~~~~tw~~A~~~C~~~~~~~L~~i~~~~e~~fl~~~~~~-~~~~WIGL~~-~--~~~~W~W 91 (136)
T d1kg0c_ 18 NTREYTF--SYKGCCFYFTKKKHTWNGCFQACAEKYPCTYFYGPTPDILPVVTRNLNA-IESLWVGVYR-V--GEGNWTS 91 (136)
T ss_dssp CTTTCSE--EETTEEEEECSSCBCTTHHHHHHHHHSTTCEECCCCTTTHHHHHHTSCS-SCCEECSEEE-S--SSSSEEE
T ss_pred CCCCCeE--eECCEEEEEEcccCcHHHHHHHHhcCCCCcEeccCCHHHHHHHHHhcCC-CCcEEEEEEe-c--CCCceEE
Confidence 5799999 89999999999999999999999987 5699999999999999998753 4579999984 2 4589999
Q ss_pred cCCCCCCcCcccccCccCCCCCCCCCCCCCCCCeeEEEeC-CCCceecccCCCCCCccceec
Q 008785 131 SDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSN-GSRSLVTERCNTSHPFICMVE 191 (553)
Q Consensus 131 ~dg~~~~~~~~~~~~~~~~~~~~~~C~~~~~~~~C~~~~~-~~~~w~~~~C~~~~~~iC~~~ 191 (553)
+||+++....+ .+ ++|+.+.. ....|++..|....++||...
T Consensus 92 ~Dgs~~~~~~~----------~~---------~~C~~l~~~~~~~w~~~~C~~~~~~IC~~~ 134 (136)
T d1kg0c_ 92 LDGGTFKVYQI----------FG---------SHCTYVSKFSTVPVSHHECSFLKPCLCVSQ 134 (136)
T ss_dssp TTCSCCCCBCS----------SC---------TTCEEECTTCSSCEECSCTTSCBCBEEEEE
T ss_pred CCCCccccccc----------cc---------cceEEEEecCCCcEeecCCCCCcceEEEEe
Confidence 99987543221 11 25666543 335799999999999999864
|
| >d1h8ua_ d.169.1.1 (A:) Eosinophil major basic protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Eosinophil major basic protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.85 E-value=1.2e-21 Score=165.31 Aligned_cols=112 Identities=15% Similarity=0.312 Sum_probs=95.4
Q ss_pred EEEecCCCChHHHHHHHhh-cCCEEeeeCCHHHHHHHHHhhCCC-CCCeEeeeeecCCCCCCceEEcCCCCCCcCccccc
Q 008785 67 FGYIGNFRSWDESETYCKE-IGGHLAALTSYEEEHSAQKLCGKN-VNGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAV 144 (553)
Q Consensus 67 y~~~~~~~~w~~a~~~C~~-~~~~L~~i~~~~e~~f~~~~~~~~-~~~~WiGl~~~~~~~~~~w~W~dg~~~~~~~~~~~ 144 (553)
|+++.+.+||.+|+.+|++ +|||||+|+|.+|++||.+++... ...+||||+..+...++.|.|+||+++.+.+|..+
T Consensus 2 Y~~~~~~~tw~~A~~~C~~~~gg~L~sI~s~~e~~~i~~~~~~~~~~~~WIGl~~~~~~~~~~~~W~dGs~~~y~~W~~~ 81 (115)
T d1h8ua_ 2 YLLVRSLQTFSQAWFTCRRCYRGNLVSIHNFNINYRIQCSVSALNQGQVWIGGRITGSGRCRRFQWVDGSRWNFAYWAAH 81 (115)
T ss_dssp EEEEEEEECHHHHHHHHHHHHSSEECCCCSHHHHHHHHHHHTTCSSSEEEEEEEEECSSSCCEEEETTCCCCCCCCBCSS
T ss_pred eEEECCccCHHHHHHHhhcccCCcCcccCHHHHHHHHHHHHhhcCCCcEEEEEEecCCCCcceEEEecCceeecccccCC
Confidence 8999999999999999987 699999999999999999988654 45699999877777789999999999988888766
Q ss_pred CccCCCCCCCCCCCCCCCCeeEEEeCCCCceecccCCCCCCcccee
Q 008785 145 GSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMV 190 (553)
Q Consensus 145 ~~~~~~~~~~~C~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~ 190 (553)
+|.. ..++|+.+...+..|++..|....+|||++
T Consensus 82 ~P~~------------~~~~Cv~~~~~~g~W~~~~C~~~~~fICe~ 115 (115)
T d1h8ua_ 82 QPWS------------RGGHCVALCTRGGYWRRAHCLRRLPFICSY 115 (115)
T ss_dssp SCCT------------TSCSEEEEETTTTCEEEECTTSCEEEEEEC
T ss_pred CCCC------------CCCCEEEEECCCCEEEeeCCCCCEeeEEeC
Confidence 6521 124788887666789999999999999975
|
| >d1g1ta1 d.169.1.1 (A:1-118) E-selectin, C-lectin domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: E-selectin, C-lectin domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.79 E-value=1.8e-19 Score=152.40 Aligned_cols=109 Identities=17% Similarity=0.311 Sum_probs=88.3
Q ss_pred EEEEecCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHhhCCCCCCeEeeeeecCCCCCCceEEcCCCCC---CcCccc
Q 008785 66 CFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSDNMSK---WNESIH 142 (553)
Q Consensus 66 Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~dg~~~---~~~~~~ 142 (553)
||+|+.+++||.+|+.+|+.+||+||+|+|++|++||.+++......+||||+ +.. +.|.|+||+.. .+.+|.
T Consensus 2 ~Y~~~~~~~tw~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~~~~~~~WiGl~--~~~--~~~~w~~~~~~~~~~~~~W~ 77 (118)
T d1g1ta1 2 SYNTSTEAMTYDEASAYCQQRYTHLVAIQNKEEIEYLNSILSYSPSYYWIGIR--KVN--NVWVWVGTQKPLTEEAKNWA 77 (118)
T ss_dssp EEEECSSCBCHHHHHHHHHHHSSEECCCCSHHHHHHHHHHSCCCTTCEEESEE--EET--TEEEETTTCCBCCTTTCCBC
T ss_pred EEEEeCCccCHHHHHHHHHHCCCEEeEEccHHHhHHHHhccccccceeeeccc--ccc--eeeeeecCCCCccccccccC
Confidence 69999999999999999999999999999999999999998766778999999 543 89999998753 355665
Q ss_pred ccCccCCCCCCCCCCCCCCCCeeEEEeC----CCCceecccCCCCCCccc
Q 008785 143 AVGSFNSSCTSLPCHVHATVDLCTLVSN----GSRSLVTERCNTSHPFIC 188 (553)
Q Consensus 143 ~~~~~~~~~~~~~C~~~~~~~~C~~~~~----~~~~w~~~~C~~~~~~iC 188 (553)
.++|. +..+.++|+.+.. ....|++..|....+|||
T Consensus 78 ~~eP~----------~~~~~~~Cv~l~~~~~~~~~~W~d~~C~~~~~fIC 117 (118)
T d1g1ta1 78 PGEPN----------NRQKDEDCVEIYIKREKDVGMWNDERCSKKKLALC 117 (118)
T ss_dssp TTCCC----------CCSTTCCEEEECTTCSSSTTCEEEECTTSCBEEEE
T ss_pred CCCcc----------CCCCCCCeEEEEecCCCCCCeEeccCCCCCeeEEc
Confidence 55542 1223457887743 334699999999999998
|
| >d1g1sa1 d.169.1.1 (A:1-118) P-selectin, C-lectin domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: P-selectin, C-lectin domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.77 E-value=3.4e-19 Score=150.74 Aligned_cols=108 Identities=19% Similarity=0.330 Sum_probs=86.4
Q ss_pred EEEecCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHhhCCCCCCeEeeeeecCCCCCCceEEcCCCCC---CcCcccc
Q 008785 67 FGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSDNMSK---WNESIHA 143 (553)
Q Consensus 67 y~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~dg~~~---~~~~~~~ 143 (553)
|+|+.++++|.+|+.+|+++||+||+|+|++|++||.+++......+||||+ +.. +.|+|+||+.. .+.+|..
T Consensus 3 Y~~~~~~~~w~~A~~~C~~~gg~La~i~s~~e~~fl~~~~~~~~~~~WiGl~--~~~--~~~~W~~~~~~~~~~~~~W~~ 78 (118)
T d1g1sa1 3 YHYSTKAYSWNISRKYCQNRYTDLVAIQNKNEIDYLNKVLPYYSSYYWIGIR--KNN--KTWTWVGTKKALTNEAENWAD 78 (118)
T ss_dssp EEEEEEEECHHHHHHHHHHHSSEECCCCCHHHHHHHHHHSCCCTTCEEEEEE--EET--TEEEETTTCCBCCTTTCCBCT
T ss_pred EEEECCccCHHHHHHHHHHcCCEEeEEeCHHHHHHHHhhhccccccchhhcc--ccc--cccceecCCCCccceecccCC
Confidence 9999999999999999999999999999999999999998765678999999 543 78999988653 2445555
Q ss_pred cCccCCCCCCCCCCCCCCCCeeEEEeC----CCCceecccCCCCCCccc
Q 008785 144 VGSFNSSCTSLPCHVHATVDLCTLVSN----GSRSLVTERCNTSHPFIC 188 (553)
Q Consensus 144 ~~~~~~~~~~~~C~~~~~~~~C~~~~~----~~~~w~~~~C~~~~~~iC 188 (553)
++|+ +..+.++|+.+.. ....|++..|....+|||
T Consensus 79 ~eP~----------~~~~~~~Cv~~~~~~~~~~~~W~d~~C~~~~~fIC 117 (118)
T d1g1sa1 79 NEPN----------NKRNNEDCVEIYIKSPSAPGKWNDEHCLKKKHALC 117 (118)
T ss_dssp TCCC----------CTTSCCCEEEECTTCSSSTTCEEEECTTSCEEEEE
T ss_pred CCCC----------CCCCCCCeEEEEccCCCCCCeEEeeCCCCCEeEEc
Confidence 4441 2234567888743 234699999999999998
|
| >d1wk1a_ d.169.1.1 (A:) Hypothetical protein F28B4.3 {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Hypothetical protein F28B4.3 species: Caenorhabditis elegans [TaxId: 6239]
Probab=99.77 E-value=6.2e-19 Score=155.73 Aligned_cols=116 Identities=16% Similarity=0.297 Sum_probs=91.5
Q ss_pred CCCCeEEEEecCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHhhCCCCCCeEeeeeecCCCCCCceEEcCCCCCCc--
Q 008785 61 EEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSDNMSKWN-- 138 (553)
Q Consensus 61 ~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~dg~~~~~-- 138 (553)
..+.+||.++.+.++|.+|+.+|+.+||+||+|++++|++||.++.. ...|||||++ . .+|.|+|+||+++..
T Consensus 5 ~~g~~~~~~~~~~~s~~~A~~~C~~~gg~La~i~~~~e~~fi~~~~~--~~~~WiGl~~--~-~~g~w~W~dg~~~~~~~ 79 (150)
T d1wk1a_ 5 SSGVKFLTVNDDILSMPQARNFCASAGGYLADDLGDDKNNFYSSIAA--NTQFWIGLFK--N-SDGQFYWDRGQGINPDL 79 (150)
T ss_dssp SCCCCSSSCCSSCBCHHHHHHHHHHHTCEECCCCSHHHHHHHHHHTT--TCEEEEEEEE--C-SSSCEEECCSSSSCCEE
T ss_pred CCCcEEEEEeCCccCHHHHHHHHHhCCCEEeeeCCHHHHHHhhhccc--ccceeEeeee--c-ccccccccccccccccc
Confidence 35666777888999999999999999999999999999999999986 5789999984 2 468999999998642
Q ss_pred -----CcccccCccCCCCCCCCCCCCCCCCeeEEEeCCC----CceecccCCCCCCccceecc
Q 008785 139 -----ESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS----RSLVTERCNTSHPFICMVEH 192 (553)
Q Consensus 139 -----~~~~~~~~~~~~~~~~~C~~~~~~~~C~~~~~~~----~~w~~~~C~~~~~~iC~~~~ 192 (553)
.+|..+.| ++...++|+.+.... ..|++..|....+|||+...
T Consensus 80 ~~~~~~~W~~~eP-----------~~~~~~~C~~~~~~~~~~~~~W~~~~C~~~~~fICe~~~ 131 (150)
T d1wk1a_ 80 LNQPITYWANGEP-----------SNDPTRQCVYFDGRSGDKSKVWTTDTCATPRPFICQKHR 131 (150)
T ss_dssp CCCSCCCBCTTCS-----------CCCSSCCEEEEESSCSCGGGCEEEECTTSCBCCCEECCC
T ss_pred cccccccccCCCC-----------CCCCCcceEEEeccCCCCCCceEccCCCCCEeEEEEECC
Confidence 23333332 233456788875432 35999999999999998754
|
| >d1byfa_ d.169.1.1 (A:) Lectin TC14 {Tunicate (Polyandrocarpa misakiensis) [TaxId: 7723]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Lectin TC14 species: Tunicate (Polyandrocarpa misakiensis) [TaxId: 7723]
Probab=99.68 E-value=2.7e-17 Score=139.66 Aligned_cols=116 Identities=18% Similarity=0.281 Sum_probs=90.3
Q ss_pred CeEEEEecCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHhhCCC--CCCeEeeeeecCCCCCC-ceEEcCCCCCCc--
Q 008785 64 SKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKN--VNGCWVGGRSINTTVGL-SWKWSDNMSKWN-- 138 (553)
Q Consensus 64 ~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~--~~~~WiGl~~~~~~~~~-~w~W~dg~~~~~-- 138 (553)
++.|+|+.+++||.+|+.+|+.+||+||+|.+++|+.|+..+.... ...+|||++ +...++ .|.|.||+++..
T Consensus 1 ~y~~~f~~~~~tw~~A~~~C~~~g~~La~i~~~~~~~~~~~~~~~~~~~~~~WiG~~--~~~~~~~~w~~~~~~~~~~~~ 78 (123)
T d1byfa_ 1 DYEILFSDETMNYADAGTYCQSRGMALVSSAMRDSTMVKAILAFTEVKGHDYWVGAD--NLQDGAYNFLWNDGVSLPTDS 78 (123)
T ss_dssp CEEEEEEEEEECHHHHHHHHHTTTCEESCGGGGSHHHHHHHHHHHHHHTCCEEEEEE--STTTCTTCCEETTSCBCCTTC
T ss_pred CeEEEEECcEeCHHHHHHHHHHCCCCCCccCCHHHHHHHHHHHhccCCCccEEEeec--cccccccccccccCCcccccc
Confidence 3579999999999999999999999999999999999987654322 567999998 544444 699999998653
Q ss_pred CcccccCccCCCCCCCCCCCCCCCCeeEEEeCCCCceecccCCCCCCccceec
Q 008785 139 ESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVE 191 (553)
Q Consensus 139 ~~~~~~~~~~~~~~~~~C~~~~~~~~C~~~~~~~~~w~~~~C~~~~~~iC~~~ 191 (553)
..|....| + +..+.++|+.+..+...|.+..|....+|||+..
T Consensus 79 ~~~~~~~p-~---------~~~~~~~Cv~l~~~~~~W~~~~C~~~~~fICe~~ 121 (123)
T d1byfa_ 79 DLWSPNEP-S---------NPQSWQLCVQIWSKYNLLDDVGCGGARRVICEKE 121 (123)
T ss_dssp TTBCTTCS-C---------SCTTSCCEEEEETTTTEEEEECSCSCEEEEEEEE
T ss_pred cccccccc-c---------cccCcceeEEEecCCCeEeeeCCCCCEeEEEEEc
Confidence 23322222 1 1123468999877777899999999999999875
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.55 E-value=1.1e-07 Score=89.94 Aligned_cols=150 Identities=12% Similarity=0.044 Sum_probs=99.3
Q ss_pred HHHHHhhcccCCCCeeecccCceeEEEEEeCCCCEEEEEEeccCChhhHHHHHHHHHHhhccC-CCceeeEeeEEeeCCc
Q 008785 261 EELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLH-HPNLVAVKGCCYDHGD 339 (553)
Q Consensus 261 ~el~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~ 339 (553)
.++......+.... ..+.++.+.||+... +++.+.||+...........+.+|...+..+. +--+.+++.+..+++.
T Consensus 7 ~~l~~~~~~~~~~~-~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~ 84 (263)
T d1j7la_ 7 PELKKLIEKYRCVK-DTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGW 84 (263)
T ss_dssp HHHHHHHTTSEEEE-CSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTE
T ss_pred HHHHHhhhceEEEE-cCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCc
Confidence 35555554443221 212334468998875 66778889887654444445677888877663 4336677888888888
Q ss_pred eEEEEEccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------
Q 008785 340 RYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV------------------------------ 389 (553)
Q Consensus 340 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~------------------------------ 389 (553)
.++||++++|.++.+.... ......++.+++..++.||+..
T Consensus 85 ~~lv~~~l~G~~~~~~~~~---------~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (263)
T d1j7la_ 85 SNLLMSEADGVLCSEEYED---------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDC 155 (263)
T ss_dssp EEEEEECCSSEEHHHHTTT---------CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCG
T ss_pred eEEEEEecccccccccccc---------cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhh
Confidence 9999999999888665421 0112334566666666676431
Q ss_pred --------------------------CCCceecCCCCCcEEecCCCCeEEeecccccc
Q 008785 390 --------------------------KPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF 421 (553)
Q Consensus 390 --------------------------~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~ 421 (553)
.+.++|+|+.|.|||+++++..-|+||+.+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 156 ENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp GGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred hcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 11378999999999999876667999987753
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.99 E-value=1.7e-05 Score=73.90 Aligned_cols=128 Identities=16% Similarity=0.129 Sum_probs=84.1
Q ss_pred cccCc-eeEEEEEeCCCCEEEEEEeccCChhhHHHHHHHHHHhhccC--CCceeeEeeEEeeCCceEEEEEccCCCCHHH
Q 008785 278 GDSKT-GGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLH--HPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR 354 (553)
Q Consensus 278 G~G~~-g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~--HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~ 354 (553)
..|.. +.||+....++..+++|....... ..+..|...++.+. .-.+.+++++..+.+..++||++++|.++.+
T Consensus 19 ~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~~ 95 (255)
T d1nd4a_ 19 TIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLLS 95 (255)
T ss_dssp SCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETTT
T ss_pred CCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccccc
Confidence 44443 678999987788899998765532 23566777776663 3336778888888888999999998766532
Q ss_pred HhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-----------------------------------------------
Q 008785 355 WLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD----------------------------------------------- 387 (553)
Q Consensus 355 ~l~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~----------------------------------------------- 387 (553)
.. .... ..+.+++..|+-||+
T Consensus 96 ~~---------~~~~---~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (255)
T d1nd4a_ 96 SH---------LAPA---EKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFA 163 (255)
T ss_dssp SC---------CCHH---HHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHH
T ss_pred cc---------ccHH---HHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHH
Confidence 10 1111 112233333333332
Q ss_pred ----C----CCCCceecCCCCCcEEecCCCCeEEeeccccc
Q 008785 388 ----K----VKPHVVHRDIRASNVLLDEEFGAHLMGVGLSK 420 (553)
Q Consensus 388 ----~----~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~ 420 (553)
. ..+.++|+|+.|.|||++++..+-|+||+.+.
T Consensus 164 ~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 164 RLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 1 11248999999999999987667899998764
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.46 E-value=0.00021 Score=71.02 Aligned_cols=73 Identities=15% Similarity=0.011 Sum_probs=46.8
Q ss_pred ecccCceeEEEEEeCC-CCEEEEEEeccC------C-hhhHHHHHHHHHHhhcc-CC--CceeeEeeEEeeCCceEEEEE
Q 008785 277 LGDSKTGGTYSGILPD-GSRVAVKRLKRS------S-FQRKKEFYSEIGRFARL-HH--PNLVAVKGCCYDHGDRYIVYE 345 (553)
Q Consensus 277 iG~G~~g~Vy~~~~~~-g~~vAvK~~~~~------~-~~~~~~~~~E~~~l~~l-~H--pnIv~l~~~~~~~~~~~lV~E 345 (553)
||.|....||+....+ ++.|+||.-... . ....++...|.+.|+.+ .+ ..+++++.+ +.+..++|||
T Consensus 34 ig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lvmE 111 (392)
T d2pula1 34 IGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTVME 111 (392)
T ss_dssp CCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEEEC
T ss_pred eCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEEEe
Confidence 5999999999998755 678999975431 0 11223445677777665 22 346666654 4556789999
Q ss_pred ccCCCC
Q 008785 346 FVVNGP 351 (553)
Q Consensus 346 ~~~~gs 351 (553)
++++..
T Consensus 112 ~L~~~~ 117 (392)
T d2pula1 112 DLSHLK 117 (392)
T ss_dssp CCTTSE
T ss_pred ccCCcc
Confidence 997644
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.97 E-value=0.0042 Score=59.53 Aligned_cols=164 Identities=12% Similarity=0.092 Sum_probs=87.9
Q ss_pred CcccCHHHHHHhhcccC--CCCeeec-ccCceeEEEEEeCCCCEEEEEEeccCChhhHHHHHHHHHHhhccCCCce--ee
Q 008785 255 WKVFTTEELRSITKNFS--EGNRLLG-DSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNL--VA 329 (553)
Q Consensus 255 ~~~~~~~el~~~~~~~~--~~~~~iG-~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnI--v~ 329 (553)
+..++.+.+..+...+. ...+++- .+---.||+...++|+.|++|+.+.. ....+++..|...+..|...+| +.
T Consensus 5 f~~L~pd~i~~al~~~g~~~~~~~~~L~s~EN~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~ 83 (325)
T d1zyla1 5 FQTLHPDTIMDALFEHGIRVDSGLTPLNSYENRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAA 83 (325)
T ss_dssp CCCCCHHHHHHHHHHTTCCCCSCCEEECCSSSEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCC
T ss_pred ccccCHHHHHHHHHHcCCCCCcCccccccccceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCC
Confidence 34455555555544332 2122211 22235899999999999999998765 2345667788888777632221 11
Q ss_pred Ee-----eEEeeCCceEEEEEccCCCCHH------------------HHhccCC-CCCCCCCH-----------------
Q 008785 330 VK-----GCCYDHGDRYIVYEFVVNGPLD------------------RWLHHIP-RGGRSLDW----------------- 368 (553)
Q Consensus 330 l~-----~~~~~~~~~~lV~E~~~~gsL~------------------~~l~~~~-~~~~~l~~----------------- 368 (553)
.+ ......+..+.++++++|..+. ....... ......+.
T Consensus 84 p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~ 163 (325)
T d1zyla1 84 PVAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLI 163 (325)
T ss_dssp CCCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSS
T ss_pred ceecCCCeeeeeeeEEEEEEeecCCcCCCCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcC
Confidence 11 1223455678899998763321 1111100 00111111
Q ss_pred --H---HHHHHHHHHHHHHHHH-HhCCCCCceecCCCCCcEEecCCCCeEEeecccccc
Q 008785 369 --A---MRMKVATTLAQGIAFL-HDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF 421 (553)
Q Consensus 369 --~---~~~~i~~qia~gL~yL-H~~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~~ 421 (553)
. .....+.++...+.-. .+....+++|+|+.+.|||++++ ..++||+.+..
T Consensus 164 ~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 164 PSGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CTTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred CHHHHHHHHHHHHHHHHHHHHhccccCCceeecCCCCcccEEEeCC--ceEEechhccc
Confidence 1 1122223333332222 12224479999999999999754 56899998764
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.14 E-value=0.0075 Score=59.36 Aligned_cols=70 Identities=13% Similarity=0.121 Sum_probs=47.4
Q ss_pred ecccCceeEEEEEeCC--------CCEEEEEEeccCChhhHHHHHHHHHHhhccC-CCceeeEeeEEeeCCceEEEEEcc
Q 008785 277 LGDSKTGGTYSGILPD--------GSRVAVKRLKRSSFQRKKEFYSEIGRFARLH-HPNLVAVKGCCYDHGDRYIVYEFV 347 (553)
Q Consensus 277 iG~G~~g~Vy~~~~~~--------g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lV~E~~ 347 (553)
|+.|-.-.+|+...++ ++.|.+++.-.. .......+|..+++.+. +.-..++++++.+ .+|+||+
T Consensus 50 l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~--~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~efi 123 (395)
T d1nw1a_ 50 IKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYI 123 (395)
T ss_dssp ECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCC
T ss_pred cCCccccceEEEEeCCCCccccCCCCcEEEEecCCc--chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEEe
Confidence 5888899999988654 356777776532 22334567888888874 4334577777643 6899999
Q ss_pred CCCCH
Q 008785 348 VNGPL 352 (553)
Q Consensus 348 ~~gsL 352 (553)
+|.+|
T Consensus 124 ~g~~l 128 (395)
T d1nw1a_ 124 PSRPL 128 (395)
T ss_dssp CEEEC
T ss_pred ccccC
Confidence 87543
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.02 E-value=0.02 Score=54.12 Aligned_cols=160 Identities=14% Similarity=0.106 Sum_probs=82.3
Q ss_pred cCHHHHHHhhcccCCCCe----eecccCceeEEEEEeCCCCEEEEEEeccCChhhHHHHHHHHHHhhccCC-----Ccee
Q 008785 258 FTTEELRSITKNFSEGNR----LLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHH-----PNLV 328 (553)
Q Consensus 258 ~~~~el~~~~~~~~~~~~----~iG~G~~g~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H-----pnIv 328 (553)
.+.+|+..+...|..+.- .|..|---+.|+....+| .+++|+..... ..+++..|++++..|.. |..+
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi 79 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL 79 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccc
Confidence 467888898888876432 134666678899887655 48999986532 22344456666666532 2222
Q ss_pred eEe-e--EEeeCCceEEEEEccCCCCHHH--------------Hhc----cC--CCCCCCC-----------------CH
Q 008785 329 AVK-G--CCYDHGDRYIVYEFVVNGPLDR--------------WLH----HI--PRGGRSL-----------------DW 368 (553)
Q Consensus 329 ~l~-~--~~~~~~~~~lV~E~~~~gsL~~--------------~l~----~~--~~~~~~l-----------------~~ 368 (553)
... | +..-.+....++.+..+..... .++ .. ....... ..
T Consensus 80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (316)
T d2ppqa1 80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 159 (316)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence 110 0 1122344566777765532210 000 00 0000000 00
Q ss_pred HHHHHHHHHHHHHHHHHHh-CCCCCceecCCCCCcEEecCCCCeEEeeccccc
Q 008785 369 AMRMKVATTLAQGIAFLHD-KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSK 420 (553)
Q Consensus 369 ~~~~~i~~qia~gL~yLH~-~~~~~ivHrDlkp~NILl~~~~~~kl~Dfgla~ 420 (553)
......+..+...+.-.+. ....+++|+|+.+.||+++++...-|+||+.+.
T Consensus 160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 0111222222222332221 123489999999999999988777899999874
|